FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Crack, JC
   Le Brun, NE
AF Crack, Jason C.
   Le Brun, Nick E.
TI RETRACTED: Redox-Sensing Iron-Sulfur Cluster Regulators (Retracted
   article)
SO ANTIOXIDANTS & REDOX SIGNALING
LA English
DT Review; Retracted Publication
DE iron-sulfur; DNA regulator; O-2; nitric oxide; redox stress
ID TRANSCRIPTION FACTOR FNR; MYCOBACTERIUM-TUBERCULOSIS WHIB3; ENTERICA
   SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI ACONITASES; NITRIC-OXIDE;
   BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; 4FE-4S CLUSTER; DNA-BINDING;
   PARACOCCUS-DENITRIFICANS
AB Significance: Iron-sulfur cluster proteins carry out multiple functions, including as regulators of gene transcription/translation in response to environmental stimuli. In all known cases, the cluster acts as the sensory module, where the inherent reactivity/fragility of iron-sulfur clusters with small/redox-active molecules is exploited to effect conformational changes that modulate binding to DNA regulatory sequences. This promotes an often substantial reprogramming of the cellular proteome that enables the organism or cell to adapt to, or counteract, its changing circumstances.
   Recent Advances: Significant progress has been made recently in the structural and mechanistic characterization of iron-sulfur cluster regulators and, in particular, the O-2 and NO sensor FNR, the NO sensor NsrR, and WhiB-like proteins of Actinobacteria. These are the main focus of this review.
   Critical Issues: Striking examples of how the local environment controls the cluster sensitivity and reactivity are now emerging, but the basis for this is not yet fully understood for any regulatory family.
   Future Directions: Characterization of iron-sulfur cluster regulators has long been hampered by a lack of high-resolution structural data. Although this still presents a major future challenge, recent advances now provide a firm foundation for detailed understanding of how a signal is transduced to effect gene regulation. This requires the identification of often unstable intermediate species, which are difficult to detect and may be hard to distinguish using traditional techniques. Novel approaches will be required to solve these problems. Antioxid. Redox Signal. 00, 000-000.
RP Le Brun, NE (reprint author), Univ East Anglia, Sch Chem, Ctr Mol & Struct Biochem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.
EM n.le-brun@uea.ac.uk
RI tucker, troy/N-6542-2016
FU U.K. Biotechnology and Biological Sciences Research Council
   [BB/J003247/1, BB/L007673/1, BB/K02115X/1]
FX Our work on iron-sulfur regulatory proteins has been generously
   supported by the U.K. Biotechnology and Biological Sciences Research
   Council, most recently through grants BB/J003247/1, BB/L007673/1, and
   BB/K02115X/1.
CR Achebach S, 2005, FEBS J, V272, P4260, DOI 10.1111/j.1742-4658.2005.04840.x
   Alam MS, 2009, FEBS J, V276, P76, DOI 10.1111/j.1742-4658.2008.06755.x
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Bailey S, 2012, NAT CHEM BIOL, V8, P24, DOI 10.1038/nchembio.737
   Bartolini E, 2006, MOL MICROBIOL, V60, P963, DOI 10.1111/j.1365-2958.2006.05163.x
   Bates DM, 2000, J BIOL CHEM, V275, P6234, DOI 10.1074/jbc.275.9.6234
   BATES DM, 1995, J BACTERIOL, V177, P3972, DOI 10.1128/jb.177.14.3972-3978.1995
   Becker S, 1996, J BACTERIOL, V178, P4515, DOI 10.1128/jb.178.15.4515-4521.1996
   Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653
   Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z
   Benjamin JAM, 2014, NUCLEIC ACIDS RES, V42, P10023, DOI 10.1093/nar/gku649
   Bergaust L, 2012, MICROBIOL-SGM, V158, P826, DOI 10.1099/mic.0.054148-0
   Bian SM, 1999, COORDIN CHEM REV, V190, P1049, DOI 10.1016/S0010-8545(99)00157-5
   Bouton C, 1998, J BIOL CHEM, V273, P9403, DOI 10.1074/jbc.273.16.9403
   Bradley TM, 1997, NUCLEIC ACIDS RES, V25, P1469, DOI 10.1093/nar/25.8.1469
   Brereton PS, 1999, BIOCHEMISTRY-US, V38, P10594, DOI 10.1021/bi990671d
   Burian J, 2013, NUCLEIC ACIDS RES, V41, P10062, DOI 10.1093/nar/gkt751
   Burian J, 2012, EXPERT REV ANTI-INFE, V10, P1037, DOI [10.1586/ERI.12.90, 10.1586/eri.12.90]
   BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690
   Bush MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00523-16
   BUTLER AR, 1988, ADV INORG CHEM, V32, P335, DOI 10.1016/S0898-8838(08)60235-4
   Casonato S, 2012, INFECT IMMUN, V80, P3132, DOI 10.1128/IAI.06328-11
   Chen ZK, 2016, CELL REP, V16, P2512, DOI 10.1016/j.celrep.2016.07.080
   Crack J, 2004, J BIOL CHEM, V279, P9278, DOI 10.1074/jbc.M309878200
   Crack JC, 2008, J AM CHEM SOC, V130, P1749, DOI 10.1021/ja077455+
   Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104
   Crack JC, 2017, P NATL ACAD SCI USA, V114, pE3215, DOI 10.1073/pnas.1620987114
   Crack JC, 2016, J BIOL CHEM, V291, P8663, DOI 10.1074/jbc.M115.693192
   Crack JC, 2016, J BIOL INORG CHEM, V21, P71, DOI 10.1007/s00775-015-1326-7
   Crack JC, 2015, J BIOL CHEM, V290, P12689, DOI 10.1074/jbc.M115.643072
   Crack JC, 2013, J BIOL CHEM, V288, P11492, DOI 10.1074/jbc.M112.439901
   Crack JC, 2012, ANTIOXID REDOX SIGN, V17, P1215, DOI 10.1089/ars.2012.4511
   Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t
   DAVIS NK, 1992, MOL GEN GENET, V232, P351
   den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008
   Dibden DP, 2005, MICROBIOL-SGM, V151, P4063, DOI 10.1099/mic.0.28253-0
   Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146
   Dunn AK, 2010, MOL MICROBIOL, V77, P44, DOI 10.1111/j.1365-2958.2010.07194.x
   Dupuy J, 2006, STRUCTURE, V14, P129, DOI 10.1016/j.str.2005.09.009
   Edwards J, 2010, J BIOL CHEM, V285, P1105, DOI 10.1074/jbc.M109.057810
   Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x
   Ermler U, 1995, EMBO J, V14, P6067, DOI 10.1002/j.1460-2075.1995.tb00297.x
   Facey PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025593
   Fang FC, 1997, INFECT IMMUN, V65, P5371
   Fedtke I, 2002, J BACTERIOL, V184, P6624, DOI 10.1128/JB.184.23.6624-6634.2002
   Filenko N, 2007, J BACTERIOL, V189, P4410, DOI 10.1128/JB.00080-07
   Fink RC, 2007, J BACTERIOL, V189, P2262, DOI 10.1128/JB.00726-06
   Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200
   Fleischhacker AS, 2012, BIOCHEMISTRY-US, V51, P4453, DOI 10.1021/bi3003204
   Frazao C, 2008, FEBS LETT, V582, P763, DOI 10.1016/j.febslet.2008.01.041
   Fujikawa M, 2014, J BIOCHEM, V156, P163, DOI 10.1093/jb/mvu029
   Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393
   Garg S, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-1
   Garg SK, 2007, PROTEIN EXPRES PURIF, V52, P422, DOI 10.1016/j.pep.2006.10.015
   Gaudu P, 2000, J BACTERIOL, V182, P1761, DOI 10.1128/JB.182.6.1761-1763.2000
   Gilberthorpe NJ, 2007, MICROBIOL-SGM, V153, P1756, DOI 10.1099/mic.0.2006/003731-0
   Gorbunov Konstantin Y., 2010, In Silico Biology, V10, P163, DOI 10.3233/ISB-2010-0425
   Gorodetsky AA, 2008, P NATL ACAD SCI USA, V105, P3684, DOI 10.1073/pnas.0800093105
   GREEN J, 1993, MOL MICROBIOL, V8, P61, DOI 10.1111/j.1365-2958.1993.tb01203.x
   Gruner I, 2011, J BIOL CHEM, V286, P2017, DOI 10.1074/jbc.M110.191940
   Gu MZ, 2011, MOL MICROBIOL, V79, P1136, DOI 10.1111/j.1365-2958.2010.07520.x
   GUEST JR, 1992, J GEN MICROBIOL, V138, P2253, DOI 10.1099/00221287-138-11-2253
   Guest JR, 1995, PHILOS T R SOC B, V350, P189, DOI 10.1098/rstb.1995.0152
   Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200
   Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439
   Hartig E, 2012, ADV MICROB PHYSIOL, V61, P195, DOI 10.1016/B978-0-12-394423-8.00005-6
   Harel A, 2014, P NATL ACAD SCI USA, V111, P7042, DOI 10.1073/pnas.1403676111
   Hunsicker-Wang LM, 2003, BIOCHEMISTRY-US, V42, P7303, DOI 10.1021/bi0342719
   Hutchings MI, 2002, J BACTERIOL, V184, P503, DOI 10.1128/JB.184.2.503-508.2002
   Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055
   Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200
   Jervis AJ, 2009, P NATL ACAD SCI USA, V106, P4659, DOI 10.1073/pnas.0804943106
   Johnson KA, 2000, ANAL CHEM, V72, P1410, DOI 10.1021/ac991183e
   Johnson MK, 1998, CURR OPIN CHEM BIOL, V2, P173, DOI 10.1016/S1367-5931(98)80058-6
   Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739
   Jung JY, 2013, INFECT IMMUN, V81, P3198, DOI 10.1128/IAI.00611-13
   Kaiser BK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00156
   Kaiser BK, 2009, STRUCTURE, V17, P1368, DOI 10.1016/j.str.2009.08.008
   Kakuta Y, 2001, BIOCHEMISTRY-US, V40, P11007, DOI 10.1021/bi010544t
   Kamps A, 2004, MOL MICROBIOL, V52, P713, DOI 10.1111/j.1365-2958.2004.04024.x
   Karlinsey JE, 2012, MOL MICROBIOL, V85, P1179, DOI 10.1111/j.1365-2958.2012.08167.x
   Karp P. D., 2014, ECOSAL PLUS, V6, P1
   Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340
   Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087
   KHOROSHILOVA N, 1995, P NATL ACAD SCI USA, V92, P2499, DOI 10.1073/pnas.92.7.2499
   Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0
   Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x
   KILEY PJ, 1991, J BACTERIOL, V173, P16, DOI 10.1128/jb.173.1.16-22.1991
   Kobayashi K, 2015, BIOCHEMISTRY-US, V54, P334, DOI 10.1021/bi500931w
   Kommineni S, 2012, J BACTERIOL, V194, P1679, DOI 10.1128/JB.06486-11
   Kommineni S, 2010, MOL MICROBIOL, V78, P1280, DOI 10.1111/j.1365-2958.2010.07407.x
   Konar M, 2012, FEBS J, V279, P2781, DOI 10.1111/j.1742-4658.2012.08662.x
   Koo MS, 2003, EMBO J, V22, P2614, DOI 10.1093/emboj/cdg252
   Krapp AR, 2011, MICROBIOL-SGM, V157, P957, DOI 10.1099/mic.0.039461-0
   Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207
   Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424
   Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445
   Larsson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037516
   Laver JR, 2010, FASEB J, V24, P286, DOI 10.1096/fj.08-128330
   Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762
   LAZAZZERA BA, 1993, GENE DEV, V7, P1993, DOI 10.1101/gad.7.10.1993
   Lee Y, 2016, CHEM COMMUN, V52, P1174, DOI 10.1039/c5cc07813j
   Lee YY, 2006, MICROBIOL-SGM, V152, P1461, DOI 10.1099/mic.0.28796-0
   Li LJ, 2016, COORDIN CHEM REV, V306, P678, DOI 10.1016/j.ccr.2015.03.026
   Lin JZ, 2007, P NATL ACAD SCI USA, V104, P14640, DOI 10.1073/pnas.0702426104
   Lo FC, 2008, J BIOL INORG CHEM, V13, P961, DOI 10.1007/s00775-008-0383-6
   Lo FC, 2012, CHEM-EUR J, V18, P2565, DOI 10.1002/chem.201100838
   Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106
   Mansy SS, 2002, BIOCHEMISTRY-US, V41, P1195, DOI 10.1021/bi011811y
   Marshall FA, 2001, MOL MICROBIOL, V39, P747, DOI 10.1046/j.1365-2958.2001.02262.x
   Marteyn B, 2010, NATURE, V465, P355, DOI 10.1038/nature08970
   McCollister BD, 2011, ANTIMICROB AGENTS CH, V55, P2189, DOI 10.1128/AAC.01203-10
   Mehta M, 2016, J BIOL CHEM, V291, P2888, DOI 10.1074/jbc.M115.684597
   Mettert EL, 2005, J MOL BIOL, V354, P220, DOI 10.1016/j.jmb.2005.09.066
   Mettert EL, 2008, J MOL BIOL, V384, P798, DOI 10.1016/j.jmb.2008.09.080
   Molle V, 2000, J BACTERIOL, V182, P1286, DOI 10.1128/JB.182.5.1286-1295.2000
   Moore LJ, 2001, J BIOL CHEM, V276, P45744, DOI 10.1074/jbc.M106569200
   Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102
   Mullner M, 2008, BIOCHEMISTRY-US, V47, P13921, DOI 10.1021/bi8014086
   MUNNOCH JT, 2016, SCI REP UK, V6
   Nesbit AD, 2009, J MOL BIOL, V387, P28, DOI 10.1016/j.jmb.2009.01.055
   Nicolet Y, 2013, P NATL ACAD SCI USA, V110, P7188, DOI 10.1073/pnas.1302388110
   Niemann V, 2014, J MOL BIOL, V426, P1539, DOI 10.1016/j.jmb.2013.12.026
   NUNOSHIBA T, 1995, INFECT IMMUN, V63, P794
   NUNOSHIBA T, 1993, P NATL ACAD SCI USA, V90, P9993, DOI 10.1073/pnas.90.21.9993
   Otten MF, 2001, EUR J BIOCHEM, V268, P2486, DOI 10.1046/j.1432-1327.2001.02131.x
   Partridge JD, 2009, MOL MICROBIOL, V73, P680, DOI 10.1111/j.1365-2958.2009.06799.x
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Phillips JD, 1996, BLOOD, V87, P2983
   Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0
   Poole RK, 2005, BIOCHEM SOC T, V33, P176, DOI 10.1042/BST0330176
   Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-05
   Raghunand TR, 2006, J BACTERIOL, V188, P6966, DOI 10.1128/JB.00384-06
   Rajagopalan S, 2013, NAT STRUCT MOL BIOL, V20, P740, DOI 10.1038/nsmb.2568
   Ramon-Garcia S, 2013, J BIOL CHEM, V288, P34514, DOI 10.1074/jbc.M113.516385
   Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200
   Recalcati S, 2010, ANTIOXID REDOX SIGN, V13, P1593, DOI 10.1089/ars.2009.2983
   Reents H, 2006, MOL MICROBIOL, V60, P1432, DOI 10.1111/j.1365-2958.2006.05198.x
   Reinhart F, 2008, J BACTERIOL, V190, P879, DOI 10.1128/JB.01374-07
   Richard-Greenblat M, 2015, J BIOL CHEM, V290, P23064, DOI 10.1074/jbc.M115.648642
   Rybniker J, 2010, MOL MICROBIOL, V77, P642, DOI 10.1111/j.1365-2958.2010.07235.x
   Saini V, 2016, CELL REP, V14, P572, DOI 10.1016/j.celrep.2015.12.056
   Saini V, 2012, ANTIOXID REDOX SIGN, V16, P687, DOI 10.1089/ars.2011.4341
   Sasaki Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep22038
   Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497
   Serrano PN, 2016, ANGEW CHEM INT EDIT, V55, P14575, DOI 10.1002/anie.201607033
   Shepard W, 2011, FEBS J, V278, P2689, DOI 10.1111/j.1742-4658.2011.08195.x
   Shin JH, 2011, J BACTERIOL, V193, P75, DOI 10.1128/JB.00965-10
   Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504
   Siedler S, 2014, ACS SYNTH BIOL, V3, P41, DOI 10.1021/sb400110j
   Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104
   Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545
   Singh AK, 2013, MOL MICROBIOL, V90, P983, DOI 10.1111/mmi.12410
   Smith LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040407
   Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440
   Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333
   Spiro S, 2007, FEMS MICROBIOL REV, V31, P193, DOI 10.1111/j.1574-6976.2006.00061.x
   Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399
   Stys A, 2011, J BIOL CHEM, V286, P22846, DOI 10.1074/jbc.M111.231902
   Sutton VR, 2004, BIOCHEMISTRY-US, V43, P791, DOI 10.1021/bi0357053
   Sutton VR, 2004, J BACTERIOL, V186, P8018, DOI 10.1128/JB.186.23.8018-8025.2004
   Tang Y, 1999, MICROBIOL-SGM, V145, P3069, DOI 10.1099/00221287-145-11-3069
   Tang Y, 2002, MICROBIOL-SGM, V148, P1027, DOI 10.1099/00221287-148-4-1027
   Tanous C, 2008, J BIOL CHEM, V283, P35551, DOI 10.1074/jbc.M805951200
   Todd JD, 2002, MICROBIOL-SGM, V148, P4059, DOI 10.1099/00221287-148-12-4059
   Toledo JC, 2012, CHEM RES TOXICOL, V25, P975, DOI 10.1021/tx300042g
   Torres MJ, 2016, ADV MICROB PHYSIOL, V68, P353, DOI 10.1016/bs.ampbs.2016.02.007
   Tucker NP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003623
   Unden G, 1997, BBA-BIOENERGETICS, V1320, P217, DOI 10.1016/S0005-2728(97)00034-0
   UNDEN G, 1985, EUR J BIOCHEM, V146, P193, DOI 10.1111/j.1432-1033.1985.tb08638.x
   Vanin AF, 2017, NITRIC OXIDE-BIOL CH, V66, P1, DOI 10.1016/j.niox.2017.02.005
   Vanin AF, 2009, NITRIC OXIDE-BIOL CH, V21, P1, DOI 10.1016/j.niox.2009.03.005
   Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003
   Vergara-Irigaray M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-438
   Vine CE, 2011, FEMS MICROBIOL LETT, V325, P99, DOI 10.1111/j.1574-6968.2011.02425.x
   Volbeda A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15052
   Volbeda A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501086
   Volz K, 2008, CURR OPIN STRUC BIOL, V18, P106, DOI 10.1016/j.sbi.2007.12.010
   Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116
   Wang Y, 2010, J PROTEOME RES, V9, P6665, DOI 10.1021/pr100808n
   Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105
   Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6
   Xiong L, 2016, ENVIRON MICROBIOL, V19, P1266
   YOO JS, 2016, SCI REP, V6
   Yuki ET, 2008, BIOCHEMISTRY-US, V47, P13084, DOI 10.1021/bi801342x
   Zhang B, 2012, P NATL ACAD SCI USA, V109, P15734, DOI 10.1073/pnas.1208787109
   Zhang DL, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00124
NR 187
TC 1
Z9 1
U1 14
U2 30
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1523-0864
EI 1557-7716
J9 ANTIOXID REDOX SIGN
JI Antioxid. Redox Signal.
PD DEC
PY 2018
VL 29
IS 18
BP 1809
EP 1829
DI 10.1089/ars.2017.7361
EA NOV
EY 2017
PG 21
WC Biochemistry & Molecular Biology; Endocrinology & Metabolism
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism
GA GZ0KX
UT WOS:000414630900001
PM 28967283
DA 2018-12-27
ER

PT J
AU Aslam, Z
   Shahid, H
   Mehmood, Z
AF Aslam, Zaeem
   Shahid, Hifsa
   Mehmood, Zeeshan
TI RETRACTED: Retracted: Ageing effects of perovskite solar cells under
   different environmental factors and electrical load conditions
   (Retracted Article)
SO SOLAR ENERGY MATERIALS AND SOLAR CELLS
LA English
DT Article; Retracted Publication
DE Perovskite; Power conversion; Solar cells, ageing behaviour
ID INDUCED DEGRADATION; HIGH-EFFICIENCY; STABILITY; HYBRID; LAYERS; AREA;
   PASSIVATION; PERFORMANCE; HYSTERESIS; EVOLUTION
AB Perovskite solar cells have achieved power-conversion efficiency values approaching those of established photovoltaic technologies, making the reliable assessment of their operational stability the next essential step towards commercialization. Although studies increasingly often involve a form of stability characterization, they are conducted in non-standardized ways, which yields data that are effectively incomparable. Furthermore, stability assessment of a novel material system with its own peculiarities might require an adjustment of common standards. Here, we investigate the effects of different environmental factors and electrical load on the ageing behaviour of perovskite solar cells. On this basis, we comment on our perceived relevance of the different ways these are currently aged. We also demonstrate how the results of the experiments can be distorted and how to avoid the common pitfalls. We hope this work will initiate discussion on how to age perovskite solar cells and facilitate the development of consensus stability measurement protocols.
C1 [Aslam, Zaeem; Shahid, Hifsa; Mehmood, Zeeshan] Univ Engn & Technol Lahore, UET, Ctr Energy Res & Dev, Lahore 54000, Pakistan.
RP Aslam, Z (reprint author), Univ Engn & Technol Lahore, UET, Ctr Energy Res & Dev, Lahore 54000, Pakistan.
EM Zaeem.aslam11@gmail.com
CR Abate A, 2015, ENERG ENVIRON SCI, V8, P2946, DOI 10.1039/c5ee02014j
   Agresti A, 2017, ACS ENERGY LETT, V2, P279, DOI 10.1021/acsenergylett.6b00672
   Aitola K, 2017, ADV MATER, V29, DOI 10.1002/adma.201606398
   Akbulatov AF, 2017, J PHYS CHEM LETT, V8, P1211, DOI 10.1021/acs.jpclett.6b03026
   Anaraki EH, 2016, ENERG ENVIRON SCI, V9, P3128, DOI 10.1039/c6ee02390h
   Aristidou N, 2015, ANGEW CHEM INT EDIT, V54, P8208, DOI 10.1002/anie.201503153
   Bella F, 2016, SCIENCE, V354, P203, DOI 10.1126/science.aah4046
   Brivio F, 2016, J PHYS CHEM LETT, V7, P1083, DOI 10.1021/acs.jpclett.6b00226
   Bryant D, 2016, ENERG ENVIRON SCI, V9, P1655, DOI 10.1039/c6ee00409a
   Bush KA, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.9
   Bush KA, 2016, ADV MATER, V28, P3937, DOI 10.1002/adma.201505279
   Chen W, 2015, SCIENCE, V350, P944, DOI 10.1126/science.aad1015
   Conings B, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201500477
   Correa-Baena JP, 2017, ENERG ENVIRON SCI, V10, P710, DOI 10.1039/c6ee03397k
   Divitini G, 2016, NAT ENERGY, V1, DOI 10.1038/NENERGY.2015.12
   Domanski K, 2017, ENERG ENVIRON SCI, V10, P604, DOI 10.1039/c6ee03352k
   Domanski K, 2016, ACS NANO, V10, P6306, DOI 10.1021/acsnano.6b02613
   Dualeh A, 2014, CHEM MATER, V26, P6160, DOI 10.1021/cm502468k
   Eames C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8497
   Gholipour S, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201601116
   Grancini G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15684
   Hu Yuchong, 2017, IEEE T INFORM THEORY, VPP, P1
   Huang WX, 2016, CHEM MATER, V28, P303, DOI 10.1021/acs.chemmater.5b04122
   Hwang I, 2015, ACS APPL MATER INTER, V7, P17330, DOI 10.1021/acsami.5b04490
   Kong J., 2014, NAT COMMUN, V5, P6688
   Lee SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep38150
   Leijtens T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3885
   Li WZ, 2016, ENERG ENVIRON SCI, V9, P490, DOI 10.1039/c5ee03522h
   Long MZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13503
   Mei AY, 2014, SCIENCE, V345, P295, DOI 10.1126/science.1254763
   Meloni S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10334
   Nie W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11574
   Pearson AJ, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201600014
   Peters CH, 2012, ADV MATER, V24, P663, DOI 10.1002/adma.201103010
   Priyadarshi A, 2016, ENERG ENVIRON SCI, V9, P3687, DOI 10.1039/c6ee02693a
   Reese MO, 2011, SOL ENERG MAT SOL C, V95, P1253, DOI 10.1016/j.solmat.2011.01.036
   Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557
   Saliba M, 2016, ENERG ENVIRON SCI, V9, P1989, DOI 10.1039/c5ee03874j
   Shin SS, 2017, SCIENCE, V356, P167, DOI 10.1126/science.aam6620
   Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x
   Tan HR, 2017, SCIENCE, V355, P722, DOI 10.1126/science.aai9081
   Tress W, 2015, ENERG ENVIRON SCI, V8, P995, DOI 10.1039/c4ee03664f
   Yang JL, 2015, ACS NANO, V9, P1955, DOI 10.1021/nn506864k
   You JB, 2016, NAT NANOTECHNOL, V11, P75, DOI [10.1038/nnano.2015.230, 10.1038/NNANO.2015.230]
   Zhao X, 2017, ACS APPL MATER INTER, V9, P7148, DOI 10.1021/acsami.6b15673
   Zimmermann E, 2014, NAT PHOTONICS, V8, P669, DOI 10.1038/nphoton.2014.210
NR 46
TC 2
Z9 2
U1 42
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-0248
EI 1879-3398
J9 SOL ENERG MAT SOL C
JI Sol. Energy Mater. Sol. Cells
PD OCT
PY 2018
VL 185
BP 471
EP 476
DI 10.1016/j.solmat.2018.05.055
PG 6
WC Energy & Fuels; Materials Science, Multidisciplinary; Physics, Applied
SC Energy & Fuels; Materials Science; Physics
GA GM1HG
UT WOS:000437816100063
DA 2018-12-27
ER

PT J
AU Chen, JY
   Li, CD
   Yang, XJ
AF Chen, Jiyang
   Li, Chuandong
   Yang, Xujun
TI RETRACTED: Chaos Synchronization of the Distributed-Order Lorenz System
   via Active Control and Applications in Chaotic Masking (Retracted
   article. See vol. 28, 2018)
SO INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS
LA English
DT Article; Retracted Publication
DE Chaos; synchronization; distributed order; active control; Lorenz
   system; chaotic masking
ID ADAPTIVE SYNCHRONIZATION; SECURE COMMUNICATION; PARAMETER MODULATION;
   CHEN SYSTEM; EQUATIONS
AB Different from previous works on chaotic synchronization of fractional-order system, this paper discusses the chaotic synchronization of Lorenz system with distributed order. The main idea is that we transform the distributed-order Lorenz system in the time domain into the frequency domain by Laplace transformation, and then, based on the final-value theorem, two main theorems and the designed controllers, the chaotic synchronization between the distributed-order Lorenz drive system and response system is obtained. Finally, numerical simulations and applications in chaotic masking are presented to verify reliability of the obtained results.
C1 [Chen, Jiyang; Li, Chuandong; Yang, Xujun] Southwest Univ, Natl & Local Joint Engn Lab Intelligent Transmiss, Chongqing 400715, Peoples R China.
RP Chen, JY (reprint author), Southwest Univ, Natl & Local Joint Engn Lab Intelligent Transmiss, Chongqing 400715, Peoples R China.
EM jiyangchen@163.com; cdli@swu.edu.cn; xujunyangcquc@163.com
RI Li, Chuandong/C-2510-2011
OI Li, Chuandong/0000-0001-6155-4849
FU Qatar National Research Fund; National Priorities Research Program [NPRP
   9-166-1-031]; National Natural Science Foundation of China [61374078,
   61773004, 11501065]; Chongqing Research and Innovation project of
   graduate students [CYS17088]; Chongqing Research Program of Basic
   Research and Frontier Technology [cstc2015jcyjBX0052]
FX This work was supported by the Qatar National Research Fund, a member of
   the Qatar Foundation, by the National Priorities Research Program under
   Grant NPRP 9-166-1-031, by the National Natural Science Foundation of
   China under Grants 61374078, 61773004 and 11501065, by the Chongqing
   Research and Innovation project of graduate students under grant
   CYS17088, and in part by the Chongqing Research Program of Basic
   Research and Frontier Technology of cstc2015jcyjBX0052.
CR Bagley R. L., 2000, INT J APPL MATH, V2, P865
   Bagley R. L., 2000, INT J APPL MATH, V2, P965
   Bai EW, 2005, CHAOS SOLITON FRACT, V23, P1071, DOI 10.1016/j.chaos.2004.06.072
   Bai EW, 2000, CHAOS SOLITON FRACT, V11, P1041, DOI 10.1016/S0960-0779(98)00328-2
   Bhalekar S, 2010, COMMUN NONLINEAR SCI, V15, P3536, DOI 10.1016/j.cnsns.2009.12.016
   Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0
   Bowong S, 2004, CHAOS SOLITON FRACT, V21, P999, DOI 10.1016/j.chaos.2003.12.084
   Caputo M., 2001, FRACT CALC APPL ANAL, V4, P421
   Caputo M., 1995, ANN U FERRARA, VXLI, P73, DOI DOI 10.1007/BF02826009)
   Caputo M., 1969, ELASTICIT DISSIPAZIO
   Celikovsky S, 2005, IEEE T AUTOMAT CONTR, V50, P76, DOI 10.1109/TAC.2004.841135
   Dadras S., 2017, ASME 2017 INT DES EN
   Dadras S., 2017, J DYN SYST MEASUR CO, V139
   Deng WH, 2005, PHYSICA A, V353, P61, DOI 10.1016/j.physa.2005.01.021
   Deng WH, 2005, J PHYS SOC JPN, V74, P1645, DOI 10.1143/JPSJ.74.1645
   Diethelm K, 2009, J COMPUT APPL MATH, V225, P96, DOI 10.1016/j.cam.2008.07.018
   Duan J. S., 2017, J VIB CONTROL
   Duffy D G, 2004, TRANSFORM METHODS SO
   Faieghi MR, 2012, COMMUN NONLINEAR SCI, V17, P731, DOI 10.1016/j.cnsns.2011.05.038
   Grigorenko I, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.034101
   HARTLEY TT, 1995, IEEE T CIRCUITS-I, V42, P485, DOI 10.1109/81.404062
   Huang LL, 2004, PHYS LETT A, V320, P271, DOI 10.1016/j.physleta.2003.11.027
   Jiao Z., 2012, SPRINGERBRIEFS ELECT, V50, P5930
   Kolumban G, 1998, IEEE T CIRCUITS-I, V45, P1129, DOI 10.1109/81.735435
   Li CG, 2004, CHAOS SOLITON FRACT, V22, P549, DOI 10.1016/j.chaos.2004.02.035
   Li XY, 2016, APPL MATH LETT, V53, P92, DOI 10.1016/j.aml.2015.10.009
   Liao TL, 1998, CHAOS SOLITON FRACT, V9, P1555, DOI 10.1016/S0960-0779(97)00161-6
   Martinez-Martinez R, 2011, APPL MATH COMPUT, V218, P3338, DOI 10.1016/j.amc.2011.08.075
   Oustaloup A., 1983, THEORIE ET PRATIQUE
   PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821
   Duong PLT, 2016, APPL MATH MODEL, V40, P1929, DOI 10.1016/j.apm.2015.09.035
   Podlubny I., 1999, FRACTIONAL DIFFERENT
   Ross B., 1974, P INT C U NEW HAV
   Shen J, 2014, AUTOMATICA, V50, P547, DOI 10.1016/j.automatica.2013.11.018
   Wang YW, 2004, CHAOS SOLITON FRACT, V19, P899, DOI 10.1016/S0960-0779(03)00256-X
   Yang T, 1996, IEEE T CIRCUITS-I, V43, P817, DOI 10.1109/81.536758
   Yassen MT, 2005, CHAOS SOLITON FRACT, V23, P131, DOI 10.1016/j.chaos.2004.03.038
   Yassen MT, 2002, APPL MATH COMPUT, V135, P113, DOI 10.1016/S0096-3003(01)00318-6
   Yu YG, 2008, PHYSICA A, V387, P1393, DOI 10.1016/j.physa.2007.10.052
   Zhang H, 2004, CHAOS SOLITON FRACT, V21, P39, DOI 10.1016/j.chaos.2003.09.014
   Zhang J, 2004, CHAOS SOLITON FRACT, V21, P1183, DOI 10.1016/j.chaos.2003.12.079
   Zhou P, 2012, MATH PROBL ENG, DOI 10.1155/2012/214169
NR 42
TC 1
Z9 1
U1 11
U2 11
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-1274
EI 1793-6551
J9 INT J BIFURCAT CHAOS
JI Int. J. Bifurcation Chaos
PD SEP
PY 2018
VL 28
IS 10
AR 1850121
DI 10.1142/S0218127418501213
PG 14
WC Mathematics, Interdisciplinary Applications; Multidisciplinary Sciences
SC Mathematics; Science & Technology - Other Topics
GA GU5XO
UT WOS:000445370600007
DA 2018-12-27
ER

PT J
AU Sugi, H
   Akimoto, T
   Chaen, S
AF Sugi, H.
   Akimoto, T.
   Chaen, S.
TI RETRACTED: Basic properties of ATP-induced myosin head movement in
   hydrated myosin filaments, studied using the gas environmental chamber
   (Retracted article. See vol. 113, pg. 48, 2018)
SO MICRON
LA English
DT Article; Retracted Publication
DE Muscle contraction; Myosin head; Antibodies to myosin head; Gas
   environmental chamber; Water vapor environment
ID MECHANISM; CONTRACTION; ACTOMYOSIN; FORCES
AB Although more than 50 years have passed since the monumental discovery of Huxley and Hanson that muscle contraction results from relative sliding between actin and myosin filaments, coupled with ATP hydrolysis, the mechanism underlying the filament sliding still remains to be a mystery. It is generally believed that the myofilament sliding is caused by cyclic attachment-detachment between myosin heads in myosin filaments and myosin-binding sites in actin filaments. Attempts to prove the myosin head movement using techniques of X-ray diffraction and chemical probes attached to myosin heads have failed to obtain clear results because of the asynchronous nature of myosin head movement. Using the gas environmental chamber (EC) attached to an electron microscope, we succeeded in recording myosin head movement in hydrated myosin filaments, coupled with ATP hydrolysis with the following results: (1)In the absence of actin filaments, myosin heads fluctuate around a definite neutral position, so that their time-averaged position remains unchanged; (2) On ATP application, myosin heads bind with ATP to be in the charged-up state, M-ADP-Pi, and perform a recovery stroke in the direction away from the myosin filament central bare zone and stay in the post-recovery stroke position; (3) In the actin-myosin filament mixture, myosin heads form rigor linkages with actin, and bind with applied ATP to be in the charged-up state, M-ADP-Pi, and perform a power stroke in the direction towards the myosin filament bare zone, while releasing ADP and Pi to stay in the post-power stroke position; (4) In both recovery and power strokes, myosin heads in the non charged-up state return to the neutral position. These results indicate that the charged-up myosin heads decide their direction of movement without being guided by actin filaments.
C1 [Sugi, H.; Akimoto, T.] Teikyo Univ, Sch Med, Dept Physiol, 3-6-22 Sakae, Tokyo 3520014, Japan.
   [Chaen, S.] Nihon Univ, Coll Humanities & Sci, Dept Integrated Sci Phys & Biol, Tokyo, Japan.
RP Sugi, H (reprint author), Teikyo Univ, Sch Med, Dept Physiol, 3-6-22 Sakae, Tokyo 3520014, Japan.
EM sugi@kyf.biglobe.ne.jp
FU Japan Electron Optica Laboratory, Inc. (JEOL)
FX We dedicate this article to the late Professorr Akira Fukami of Nihon
   University, who developed the EC system we used. We also wish to thank
   President Kazuo Itoh of Japan Electron Optica Laboratory, Inc. (JEOL)
   for his generous support.
CR Caorsi V, 2011, EUR BIOPHYS J BIOPHY, V40, P13, DOI 10.1007/s00249-010-0624-9
   FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0
   Fukami A., 1992, J ELECTRON MICROSC, V41, P33
   HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8
   HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0
   HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356
   LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004
   Minoda H, 2011, BIOCHEM BIOPH RES CO, V405, P651, DOI 10.1016/j.bbrc.2011.01.087
   Nishizaka T, 2000, BIOPHYS J, V79, P962, DOI 10.1016/S0006-3495(00)76350-8
   Squire J. M., 2017, MUSCLE CONTRACTION C, P35
   Sugi H, 1997, P NATL ACAD SCI USA, V94, P4378, DOI 10.1073/pnas.94.9.4378
   Sugi H., 1992, MUSCLE CONTRACTION C, P132
   Sugi H, 1998, CURRENT METHODS MUSC, P3
   Sugi H, 2008, P NATL ACAD SCI USA, V105, P17396, DOI 10.1073/pnas.0809581105
   Sugi H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15700
   Sugi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093272
   Sugi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063658
   Sugiura S, 1998, CIRC RES, V82, P1029, DOI 10.1161/01.RES.82.10.1029
   SUZUKI S, 1993, J ELECTRON MICROSC, V42, P107
NR 19
TC 2
Z9 2
U1 12
U2 12
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD SEP
PY 2018
VL 112
BP 15
EP 25
DI 10.1016/j.micron.2018.06.003
PG 11
WC Microscopy
SC Microscopy
GA GO0YJ
UT WOS:000439672300002
PM 29902615
DA 2018-12-27
ER

PT J
AU Zhou, J
   Liu, X
   Zhao, ST
   Hu, JJ
   Zhang, JW
   Wang, JH
   Peng, XP
   Qi, XL
   Cheng, TL
   Lu, MZ
AF Zhou, Jing
   Liu, Xin
   Zhao, Shu-Tang
   Hu, Jian-Jun
   Zhang, Jie-Wei
   Wang, Jie-Hua
   Peng, Xiao-Peng
   Qi, Xiao-Li
   Cheng, Tie-Long
   Lu, Meng-Zhu
TI RETRACTED: An assessment of transgenomics as a tool for gene discovery
   in Populus euphratica Oliv. (Retracted article. See vol. 98, pg. 579,
   2018)
SO PLANT MOLECULAR BIOLOGY
LA English
DT Article; Retracted Publication
DE Transgenomics; Populus euphratica; Salt tolerance; Functional genomics;
   Arabidopsis thaliana
ID COMPETENT BIBAC LIBRARY; AGROBACTERIUM-MEDIATED TRANSFORMATION;
   OSMOTIC-STRESS TOLERANCE; MOLECULAR-WEIGHT DNA; PLANT-TRANSFORMATION;
   SALT TOLERANCE; DELTA(1)-PYRROLINE-5-CARBOXYLATE SYNTHETASE; BAC
   LIBRARIES; T-DNA; GENOME
AB Transgenomics for gene discovery in Populus euphratica.
   Transgenomics, a member of the omics family of methodologies, is characterized as the introduction of DNA from one organism into another on a genome-wide scale followed by the identification of recipients with altered phenotypes. This strategy allows investigators to identify the gene(s) involved in these phenotypic changes. It is particularly promising for woody plants that have a long life cycle and for which molecular tools are limited. In this study, we constructed a large-insert binary bacterial artificial chromosome library of Populus euphratica, a stress-tolerant poplar species, which included 55,296 clones with average insert sizes of about 127 kb. To date, 1077 of the clones have been transformed into Arabidopsis thaliana via Agrobacterium by the floral dip method. Of these, 69 transgenic lines showed phenotypic changes represented by diverse aspects of plant form and development, 22 of which were reproducibly associated with the same phenotypic change. One of the clones conferring transgenic plants with increased salt tolerance, 002A1F06, was further analyzed and the 127,284 bp insert in this clone harbored eight genes that have been previously reported to be involved in stress resistance. This study demonstrates that transgenomics is useful in the study of functional genomics of woody plants and in the identification of novel gene(s) responsible for economically important traits. Thus, transgenomics can also be used for validation of quantitative trait loci mapped by molecular markers.
C1 [Zhou, Jing; Liu, Xin; Zhao, Shu-Tang; Hu, Jian-Jun; Peng, Xiao-Peng; Qi, Xiao-Li; Cheng, Tie-Long; Lu, Meng-Zhu] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing 100091, Peoples R China.
   [Zhang, Jie-Wei] Beijing Acad Agr & Forestry Sci, Beijing Agrobiotechnol Res Ctr, Beijing 100097, Peoples R China.
   [Wang, Jie-Hua] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.
RP Lu, MZ (reprint author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing 100091, Peoples R China.
EM gaha2008@126.com; lumz@caf.ac.cn
FU Special Fund on Essential Research for National Non-profit Institutions
   to the Chinese Academy of Forestry [CAFYBB2011001]
FX We would like to thank Dr. Hong-Bin Zhang of A&M University for guidance
   in BIBAC library construction. We would also like to thank Drs. Ren-Ying
   Zhuo (The Research Institute of Subtropical Forestry, Chinese Academy of
   Forestry), Zhou Zhou (Henan University), Hai-Feng Yang (Inner Mongolia
   Agricultural University), Min-Sheng Yang (Hebei Agricultural
   University), Xin-Ye Zhang (Hubei Forestry Academy), Xiao-Ping Ao
   (Central South University), and Xiao-Yu Li (Huangshan University) for
   their collaboration on the transformation work. This work was supported
   by the Special Fund on Essential Research for National Non-profit
   Institutions to the Chinese Academy of Forestry (CAFYBB2011001).
CR Ali S, 2015, METHODS MOL BIOL, V1227, P199, DOI 10.1007/978-1-4939-1652-8_9
   Ali S, 2011, CURR GENET, V57, P63, DOI 10.1007/s00294-010-0324-0
   Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391
   Anggoro DT, 2017, PLASMID, V89, P27, DOI 10.1016/j.plasmid.2016.12.002
   Baum DA, 2002, SYSTEMATICS ASS SPEC, V65, P493
   Brinker M, 2010, PLANT PHYSIOL, V154, P1697, DOI 10.1104/pp.110.164152
   Brosche M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r101
   Cantu D, 2008, P NATL ACAD SCI USA, V105, P859, DOI 10.1073/pnas.0709813105
   Chang YL, 2003, THEOR APPL GENET, V106, P269, DOI 10.1007/s00122-002-1074-2
   Chang YL, 2011, GENOME, V54, P437, DOI [10.1139/G11-011, 10.1139/g11-011]
   Chauhan RS, 2002, MOL GENET GENOMICS, V267, P603, DOI 10.1007/s00438-002-0691-4
   Chen S, 2010, PLANT BIOLOGY, V12, P317, DOI 10.1111/j.1438-8677.2009.00301.x
   Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494
   Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x
   Correa R, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00858
   Correa R, 2012, NEW PHYTOL, V193, P494, DOI 10.1111/j.1469-8137.2011.03949.x
   Cui YH, 2000, P NATL ACAD SCI USA, V97, P3713, DOI 10.1073/pnas.050480297
   Fang XH, 2004, THEOR APPL GENET, V108, P1420, DOI 10.1007/s00122-003-1566-8
   FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x
   Feng JH, 2006, THEOR APPL GENET, V113, P23, DOI 10.1007/s00122-006-0265-7
   Feng JH, 2013, G3-GENES GENOM GENET, V3, P31, DOI 10.1534/g3.112.004846
   Frary A, 2001, TRANSGENIC RES, V10, P121, DOI 10.1023/A:1008924726270
   Ginzberg I, 1998, PLANT MOL BIOL, V38, P755, DOI 10.1023/A:1006015212391
   Gomase VS, 2008, GENE THER MOL BIOL, V12, P77
   Gu RS, 2004, TREE PHYSIOL, V24, P265, DOI 10.1093/treephys/24.3.265
   Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975
   Hamilton CM, 1997, GENE, V200, P107, DOI 10.1016/S0378-1119(97)00388-0
   Hamilton CM, 1999, PLANT J, V18, P223, DOI 10.1046/j.1365-313X.1999.00433.x
   He RF, 2003, GENE, V321, P113, DOI 10.1016/j.gene.2003.08.009
   He RF, 2016, METHODS MOL BIOL, V1385, P29, DOI 10.1007/978-1-4939-3289-4_2
   Igarashi Y, 1997, PLANT MOL BIOL, V33, P857, DOI 10.1023/A:1005702408601
   Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956
   KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014
   Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x
   Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283
   Lee MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-208
   Lichtenzveig J, 2005, THEOR APPL GENET, V110, P492, DOI 10.1007/s00122-004-1857-8
   Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797
   Mansour MMF, 2003, PLANT SCI, V164, P891, DOI 10.1016/S0168-9452(03)00109-2
   Martinez-Atienza J, 2007, PLANT PHYSIOL, V143, P1001, DOI 10.1104/pp.106.092635
   Meksem K, 2000, THEOR APPL GENET, V101, P747, DOI 10.1007/s001220051540
   Moullet O, 1999, THEOR APPL GENET, V99, P305, DOI 10.1007/s001220051237
   Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931
   Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971
   Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580
   Park SC, 2008, BBA-PROTEINS PROTEOM, V1784, P783, DOI 10.1016/j.bbapap.2008.02.002
   Quintero FJ, 2011, P NATL ACAD SCI USA, V108, P2611, DOI 10.1073/pnas.1018921108
   Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242
   Santos JM, 1999, MOL MICROBIOL, V32, P789, DOI 10.1046/j.1365-2958.1999.01397.x
   Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886
   Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197
   Streetz KL, 2008, HEPATOLOGY, V47, P706, DOI 10.1002/hep.22012
   Tao Q, 2002, THEOR APPL GENET, V105, P1058, DOI 10.1007/s00122-002-1057-3
   Tao QZ, 1998, NUCLEIC ACIDS RES, V26, P4901, DOI 10.1093/nar/26.21.4901
   Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691
   Vanderauwera S, 2012, P NATL ACAD SCI USA, V109, P20113, DOI 10.1073/pnas.1217516109
   Waki T, 2013, PLANT J, V73, P357, DOI 10.1111/tpj.12049
   Wang C, 2013, GENETICS, V195, P723, DOI 10.1534/genetics.113.157115
   Wang SB, 2015, SCI REP, V6, P19444
   Wang WQ, 2010, PLANT MOL BIOL, V72, P91, DOI 10.1007/s11103-009-9553-3
   Wang YF, 2015, PLANT CELL REP, V34, P1049, DOI 10.1007/s00299-015-1764-2
   Wang ZY, 2011, PLANT CELL, V23, P1971, DOI 10.1105/tpc.110.081943
   Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003
   Wu HJ, 2012, P NATL ACAD SCI USA, V109, P12219, DOI 10.1073/pnas.1209954109
   Yang Q, 2009, MOL PLANT, V2, P22, DOI 10.1093/mp/ssn058
   ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x
   Zhang HB, 2012, NAT PROTOC, V7, P479, DOI 10.1038/nprot.2011.456
   Zhu BC, 1998, PLANT SCI, V139, P41, DOI 10.1016/S0168-9452(98)00175-7
   Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0
NR 69
TC 1
Z9 1
U1 3
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-4412
EI 1573-5028
J9 PLANT MOL BIOL
JI Plant Mol.Biol.
PD AUG
PY 2018
VL 97
IS 6
BP 525
EP 535
DI 10.1007/s11103-018-0755-4
PG 11
WC Biochemistry & Molecular Biology; Plant Sciences
SC Biochemistry & Molecular Biology; Plant Sciences
GA GR2ZU
UT WOS:000442456800004
PM 30051252
DA 2018-12-27
ER

PT J
AU Ho, YY
   Vo, TN
   Chu, HT
   LeSage, MG
   Luo, XH
   Le, CT
AF Ho, Yen-Yi
   Vo, Tien Nhu
   Chu, Haitao
   LeSage, Mark G.
   Luo, Xianghua
   Le, Chap T.
TI RETRACTED: A Bayesian hierarchical model for demand curve analysis
   (Retracted article. See vol. 27, pg. 3839, 2018)
SO STATISTICAL METHODS IN MEDICAL RESEARCH
LA English
DT Article; Retracted Publication
DE Bayesian hierarchical model; mixed effects regression; non-linear least
   square regression; demand curve analysis; prism
ID BEHAVIORAL ECONOMICS
AB Drug self-administration experiments are a frequently used approach to assess the abuse liability and reinforcing property of a compound. It has been used to assess the abuse liabilities of various substances such as psychomotor stimulants and hallucinogens, food, nicotine, and alcohol. The demand curve generated from a self-administration study describes how demand of a drug or non-drug reinforcer varies as a function of price. With the approval of the 2009 Family Smoking Prevention and Tobacco Control Act, demand curve analysis provides crucial evidence to inform the US Food and Drug Administration's policy on tobacco regulation because it produces several important quantitative measurements to assess the reinforcing strength of nicotine. The conventional approach popularly used to analyze the demand curve data is individual-specific non-linear least square regression. The non-linear least square approach sets out to minimize the residual sum of squares for each subject in the dataset; however, this one-subject-at-a-time approach does not allow for the estimation of between- and within-subject variability in a unified model framework. In this paper, we review the existing approaches to analyze the demand curve data, non-linear least square regression, and the mixed effects regression and propose a new Bayesian hierarchical model. We conduct simulation analyses to compare the performance of these three approaches and illustrate the proposed approaches in a case study of nicotine self-administration in rats. We present simulation results and discuss the benefits of using the proposed approaches.
C1 [Ho, Yen-Yi] Univ South Carolina, Dept Stat, Coll Arts & Sci, Columbia, SC USA.
   [Vo, Tien Nhu] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA.
   [Chu, Haitao; Luo, Xianghua; Le, Chap T.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA.
   [LeSage, Mark G.] Univ Minnesota, Dept Med, Div Clin Pharmacol & Toxicol, Minneapolis, MN 55455 USA.
   [Luo, Xianghua; Le, Chap T.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.
RP Ho, YY (reprint author), Univ South Carolina, Dept Stat, 216 LeConte Coll,1523 Greene St, Columbia, SC 29208 USA.
EM Hoyen@stat.sc.edu
CR Ashby D, 2006, STAT MED, V25, P3589, DOI 10.1002/sim.2672
   Bentzley BS, 2014, P NATL ACAD SCI USA, V111, P11822, DOI 10.1073/pnas.1406324111
   Bentzley BS, 2013, PSYCHOPHARMACOLOGY, V226, P113, DOI 10.1007/s00213-012-2899-2
   DiCiccio TJ, 1996, STAT SCI, V11, P189
   Donny EC, 2012, NICOTINE TOB RES, V14, P1319, DOI 10.1093/ntr/nts162
   GELFAND AE, 1990, J AM STAT ASSOC, V85, P398, DOI 10.2307/2289776
   Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136
   Grebenstein P, 2013, PHARMACOL BIOCHEM BE, V114, P70, DOI 10.1016/j.pbb.2013.10.020
   Griffiths RR, 1979, ADV BEHAV PHARMACOL, P163
   HURSH SR, 1988, J EXP ANAL BEHAV, V50, P419, DOI 10.1901/jeab.1988.50-419
   HURSH SR, 1991, J EXP ANAL BEHAV, V56, P377, DOI 10.1901/jeab.1991.56-377
   Hursh SR, 2008, PSYCHOL REV, V115, P186, DOI [10.1037/0033-295X.115.1.186, 10.1037/0033-295X115.1.186]
   Hursh SR, 2013, J EXP ANAL BEHAV, V99, P98, DOI 10.1002/jeab.7
   Katz JL, 1990, BEHAV PHARMACOL, V1, P283
   Liao WJ, 2013, EXP CLIN PSYCHOPHARM, V21, P124, DOI 10.1037/a0031610
   Lunn D, 2009, STAT MED, V28, P3049, DOI 10.1002/sim.3680
   Murphy JG, 2009, EXP CLIN PSYCHOPHARM, V17, P396, DOI 10.1037/a0017684
   Plummer M., 2003, P 3 INT WORKSH DISTR
   Yu J, 2014, MULTIVAR BEHAV RES, V49, P178, DOI 10.1080/00273171.2013.862491
NR 19
TC 1
Z9 1
U1 4
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0962-2802
EI 1477-0334
J9 STAT METHODS MED RES
JI Stat. Methods Med. Res.
PD AUG
PY 2018
VL 27
IS 8
BP 2401
EP 2412
DI 10.1177/0962280216680651
PG 12
WC Health Care Sciences & Services; Mathematical & Computational Biology;
   Medical Informatics; Statistics & Probability
SC Health Care Sciences & Services; Mathematical & Computational Biology;
   Medical Informatics; Mathematics
GA GM9ZM
UT WOS:000438616300011
PM 29984638
DA 2018-12-27
ER

PT J
AU Liu, SL
   Yang, RJ
   Tripathi, DK
   Li, X
   Jiang, MY
   Lv, BY
   Ma, MD
   Chen, QB
AF Liu, Shiliang
   Yang, Rongjie
   Tripathi, Durgesh Kumar
   Li, Xi
   Jiang, Mingyan
   Lv, Bingyang
   Ma, Mingdong
   Chen, Qibing
TI RETRACTED: Signalling cross-talk between nitric oxide and active oxygen
   in Trifolium repens L. plants responses to cadmium stress (Retracted
   article. See vol. 243, pg. 1966, 2018)
SO ENVIRONMENTAL POLLUTION
LA English
DT Article; Retracted Publication
DE Amino acids; Cadmium stress; Mineral elements; Nitro-oxidative stress;
   Reactive nitrogen species
ID S-NITROSOGLUTATHIONE REDUCTASE; FREE AMINO-ACIDS;
   SCENEDESMUS-QUADRICAUDA CHLOROPHYCEAE; INDUCED OXIDATIVE STRESS;
   REACTIVE OXYGEN; NITROSATIVE STRESS; PEROXYNITRITE FORMATION; HORMONE
   EQUILIBRIUM; ADAPTIVE RESPONSES; CONTAMINATED SOILS
AB The significant influence of (NO)-N-center dot on the stress response is well established; however, the precise meta-bolic pathways of (NO)-N-center dot and RNS under metal stresses remain unclear. Here, the key components of ROS and RNS metabolism under Cd stress were investigated with multi-level approaches using high-quality forage white clover (Trifolium repens L) plants. For the studied plants, Cd disturbed the redox homeostasis, affected the absorption of minerals, and exacerbated the degree of lipid peroxidation, thus triggering oxidative stress. However, (NO)-N-center dot was also involved in regulating mineral absorption, ROS-scavenger levels and mRNA expression in Cd-treated white clover plants. In addition, GSNOR activity was up regulated by Cd with the simultaneous depletion of (NO)-N-center dot generation and GSNO but was counteracted by the (NO)-N-center dot donor sodium nitroprusside. Response to Cd-stressed SNOs was involved in generating ONOO- and NO2-Tyr in accordance with the regulation of (NO)-N-center dot-mediated post-translational modifications in the ASC-GSH cycle, selected amino acids and NADPH-generating dehydrogenases, thereby provoking nitrosative stress. Taken together, our data provide comprehensive metabolite evidence that clearly confirms the relationships between ROS and RNS in Cd-stressed plants, supporting their regulatory roles in response to nitro-oxidative stress and providing an in-depth understanding of the interaction between two families subjected to metal stresses. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Liu, Shiliang; Yang, Rongjie; Li, Xi; Jiang, Mingyan; Lv, Bingyang; Ma, Mingdong; Chen, Qibing] Sichuan Agr Univ, Coll Landscape Architecture, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China.
   [Tripathi, Durgesh Kumar] Motilal Nehru Natl Inst Technol, Dept Biotechnol, Allahabad 211004, Uttar Pradesh, India.
RP Chen, QB (reprint author), Sichuan Agr Univ, Coll Landscape Architecture, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China.; Liu, SL (reprint author), Sichuan Agr Univ, Coll Landscape Architecture, Inst Landscape Architecture, 211 Huimin Rd, Chengdu 611130, Sichuan, Peoples R China.
EM liushiliang9@163.com; cqb@sicau.edu.cn
FU International Science and Technology Cooperation Program of Sichuan
   Province [2016HH0047]; Basic Research Program of the Science &
   Technology Department of Sichuan Province, China [2015JY0085]
FX This research was partially supported by the International Science and
   Technology Cooperation Program of Sichuan Province (Grant No.
   2016HH0047) and the Basic Research Program of the Science & Technology
   Department of Sichuan Province, China (Grant No. 2015JY0085). The
   authors are also grateful to the editors and four anonymous reviewers
   for their comments and suggestions on an earlier draft of the
   manuscript.
CR Abercrombie JM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-87
   Airaki M, 2012, PLANT CELL ENVIRON, V35, P281, DOI 10.1111/j.1365-3040.2011.02310.x
   Alaoui-Sosse B, 2004, PLANT SCI, V166, P1213, DOI 10.1016/j.plantsci.2003.12.032
   Alvarez B, 1999, J BIOL CHEM, V274, P842, DOI 10.1074/jbc.274.2.842
   Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8
   Anschutz U, 2014, J PLANT PHYSIOL, V171, P670, DOI 10.1016/j.jplph.2014.01.009
   Astier J, 2012, INT J MOL SCI, V13, P15193, DOI 10.3390/ijms131115193
   Babula P, 2015, J HAZARD MATER, V286, P334, DOI 10.1016/j.jhazmat.2014.12.060
   Barroso JB, 2006, J EXP BOT, V57, P1785, DOI 10.1093/jxb/erj175
   Begara-Morales JC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00152
   Begara-Morales JC, 2014, J EXP BOT, V65, P527, DOI 10.1093/jxb/ert396
   Chaki M, 2011, J EXP BOT, V62, P1803, DOI 10.1093/jxb/erq358
   Chaki M, 2009, PLANT CELL PHYSIOL, V50, P265, DOI 10.1093/pcp/pcn196
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Corpas FJ, 2017, REDOX BIOL, V11, P535, DOI 10.1016/j.redox.2016.12.033
   Corpas FJ, 2013, NEW PHYTOL, V199, P633, DOI 10.1111/nph.12380
   Courtois C, 2008, J EXP BOT, V59, P155, DOI 10.1093/jxb/erm197
   Cui XM, 2010, PLANT SOIL ENVIRON, V56, P274, DOI 10.17221/98/2009-PSE
   Del Rio LA, 2004, PHYTOCHEMISTRY, V65, P783, DOI 10.1016/j.phytochem.2004.02.001
   Demidchik V, 2015, ENVIRON EXP BOT, V109, P212, DOI 10.1016/j.envexpbot.2014.06.021
   Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/nchembio.607, 10.1038/NCHEMBIO.607]
   DiDonato RJ, 2004, PLANT J, V39, P403, DOI 10.1111/j.1365-313X.2004.02128.x
   Domingos P, 2015, MOL PLANT, V8, P506, DOI 10.1016/j.molp.2014.12.010
   Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132
   Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1043/pnas.0501456102
   Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177
   Garcia MJ, 2010, J EXP BOT, V61, P3885, DOI 10.1093/jxb/erq203
   Ghiani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099239
   Graziano M, 2005, TRENDS PLANT SCI, V10, P4, DOI 10.1016/j.tplants.2004.12.004
   Greger M, 2016, ENVIRON POLLUT, V211, P90, DOI 10.1016/j.envpol.2015.12.027
   Gross F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00419
   He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837
   Houmani H, 2018, NITRIC OXIDE-BIOL CH, V74, P93, DOI 10.1016/j.niox.2017.06.008
   Hu YN, 2016, ENVIRON INT, V92-93, P515, DOI 10.1016/j.envint.2016.04.042
   Janicka-Russak M, 2012, J EXP BOT, V63, P4133, DOI 10.1093/jxb/ers097
   Kovacik J, 2010, PLANT SCI, V178, P307, DOI 10.1016/j.plantsci.2010.01.009
   Kovacik J, 2009, PLANT SOIL, V320, P231, DOI 10.1007/s11104-009-9889-0
   Laspina NV, 2005, PLANT SCI, V169, P323, DOI 10.1016/j.plantsci.2005.02.007
   Lea US, 2006, PLANT PHYSIOL, V140, P1085, DOI 10.1104/pp.105.074633
   Lee U, 2008, PLANT CELL, V20, P786, DOI 10.1105/tpc.107.052647
   Leitner M, 2009, CURR OPIN PLANT BIOL, V12, P451, DOI 10.1016/j.pbi.2009.05.012
   Leterrier M., 2012, SCI WORLD J, V2012, P694
   Leterrier M, 2011, PLANT SIGNAL BEHAV, V6, P789, DOI 10.4161/psb.6.6.15161
   Li SW, 2016, ENVIRON INT, V94, P600, DOI 10.1016/j.envint.2016.06.022
   Liu SL, 2015, ENVIRON SCI POLLUT R, V22, P16843, DOI 10.1007/s11356-015-4888-6
   Liu SL, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-014-1721-7
   Liu SL, 2018, J HAZARD MATER, V344, P1007, DOI 10.1016/j.jhazmat.2017.12.004
   Liu SL, 2016, J HAZARD MATER, V314, P140, DOI 10.1016/j.jhazmat.2016.04.042
   Liu SL, 2015, ECOTOX ENVIRON SAFE, V119, P35, DOI 10.1016/j.ecoenv.2015.04.053
   Lopareva-Pohu A, 2011, ENVIRON POLLUT, V159, P1721, DOI 10.1016/j.envpol.2011.02.030
   Lozano-Rodriguez E., 1995, QUIM ANAL, V14, P27
   Millaleo R, 2010, J SOIL SCI PLANT NUT, V10, P476, DOI 10.4067/S0718-95162010000200008
   Milone MT, 2003, ENVIRON EXP BOT, V50, P265, DOI 10.1016/S0098-8472(03)00037-6
   Mishra S, 2006, J PLANT PHYSIOL, V163, P927, DOI 10.1016/j.jplph.2005.08.003
   Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007
   Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200
   Nieves-Cordones M, 2014, J PLANT PHYSIOL, V171, P688, DOI 10.1016/j.jplph.2013.09.021
   Pavlikova D, 2014, ECOTOX ENVIRON SAFE, V100, P166, DOI 10.1016/j.ecoenv.2013.10.028
   Per TS, 2017, NITRIC OXIDE-BIOL CH, V68, P111, DOI 10.1016/j.niox.2016.12.012
   PFEFFER PE, 1986, PLANT PHYSIOL, V80, P77, DOI 10.1104/pp.80.1.77
   Planchet E, 2005, PLANT J, V41, P732, DOI 10.1111/j.1365-313X.2005.02335.x
   Prolo C, 2015, FREE RADICAL BIO MED, V87, P346, DOI 10.1016/j.freeradbiomed.2015.06.027
   Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101
   Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u
   Richau KH, 2009, NEW PHYTOL, V183, P106, DOI 10.1111/j.1469-8137.2009.02826.x
   Rodriguez-Serrano M, 2006, PLANT CELL ENVIRON, V29, P1532, DOI 10.1111/j.1365-3040.2006.01531.x
   Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061
   Sandalio LM, 2001, J EXP BOT, V52, P2115, DOI 10.1093/jexbot/52.364.2115
   Santa-Cruz DM, 2010, PHYTOCHEMISTRY, V71, P1700, DOI 10.1016/j.phytochem.2010.07.009
   Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925
   Schat H, 1997, PHYSIOL PLANTARUM, V101, P477, DOI 10.1034/j.1399-3054.1997.1010304.x
   Scheler C, 2013, CURR OPIN PLANT BIOL, V16, P534, DOI 10.1016/j.pbi.2013.06.020
   Sharma SS, 2006, J EXP BOT, V57, P711, DOI 10.1093/jxb/erj073
   Sierla M, 2013, ANTIOXID REDOX SIGN, V18, P2220, DOI 10.1089/ars.2012.5016
   Signorelli S, 2013, PLANT SCI, V201, P137, DOI 10.1016/j.plantsci.2012.12.004
   Smethurst CF, 2008, FUNCT PLANT BIOL, V35, P640, DOI 10.1071/FP08030
   Stork F, 2013, ENVIRON SCI POLLUT R, V20, P5502, DOI 10.1007/s11356-013-1541-0
   Sun YB, 2008, BIORESOURCE TECHNOL, V99, P1103, DOI 10.1016/j.biortech.2007.02.035
   Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222
   Tossi V, 2009, NEW PHYTOL, V181, P871, DOI 10.1111/j.1469-8137.2008.02722.x
   Uttenthal LO, 1998, MICROSC RES TECHNIQ, V43, P75, DOI 10.1002/(SICI)1097-0029(19981001)43:1<75::AID-JEMT11>3.0.CO;2-0
   Valderrama R, 2006, PLANT CELL ENVIRON, V29, P1449, DOI 10.1111/j.1365-3040.2006.01530.x
   Vandelle E, 2011, PLANT SCI, V181, P534, DOI 10.1016/j.plantsci.2011.05.002
   Wang CQ, 2009, PLANT CELL REP, V28, P1341, DOI 10.1007/s00299-009-0734-y
   Wang QH, 2013, PLANT GROWTH REGUL, V69, P11, DOI 10.1007/s10725-012-9742-y
   Xia JC, 2014, P NATL ACAD SCI USA, V111, P16196, DOI 10.1073/pnas.1417473111
   Xie YJ, 2013, J EXP BOT, V64, P3045, DOI 10.1093/jxb/ert149
   Xiong J, 2009, PLANTA, V230, P599, DOI 10.1007/s00425-009-0970-y
   Xu J, 2012, NEW PHYTOL, V196, P125, DOI 10.1111/j.1469-8137.2012.04236.x
   Xu J, 2010, PLANT SOIL, V326, P321, DOI 10.1007/s11104-009-0011-4
   Yamamoto Y, 2001, PLANT PHYSIOL, V125, P199, DOI 10.1104/pp.125.1.199
   Yang ES, 2002, FREE RADICAL BIO MED, V33, P927, DOI 10.1016/S0891-5849(02)00981-4
   Yu MD, 2014, NEW PHYTOL, V202, P1142, DOI 10.1111/nph.12739
   Yun BW, 2016, NEW PHYTOL, V211, P516, DOI 10.1111/nph.13903
   Zhang L, 2012, J ENVIRON SCI-CHINA, V24, P940, DOI 10.1016/S1001-0742(11)60978-9
   Zhao FJ, 2015, ENVIRON SCI TECHNOL, V49, P750, DOI 10.1021/es5047099
NR 96
TC 2
Z9 2
U1 19
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0269-7491
EI 1873-6424
J9 ENVIRON POLLUT
JI Environ. Pollut.
PD AUG
PY 2018
VL 239
BP 53
EP 68
DI 10.1016/j.envpol.2018.03.106
PG 16
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GI8AS
UT WOS:000434744800006
PM 29649760
DA 2018-12-27
ER

PT J
AU Tang, JN
   Huang, M
   Yang, ML
   Zhao, YY
   Ouyang, XP
AF Tang, Jiannan
   Huang, Mei
   Yang, Mengling
   Zhao, Yuanyuan
   Ouyang, Xiaoping
TI RETRACTED: A procedure for solving transient nonlinear thermal problems
   of high burn-up nuclear fuel rods in a light water reactor (Retracted
   article. See vol. 140, pg. 542. 2018)
SO APPLIED THERMAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Half-boundary method; Nuclear fuel rod; High bum-up; LOCA; RIA
ID CONDUCTION PROBLEMS; CODE; PERFORMANCE; SCANAIR
AB To ensure the safety of the high burn-up nuclear fuel rods (NFRs) in existing reactors, thermal behaviors of NFRs have been analyzed extensively. In this paper, an accurate and efficient procedure, called half-boundary method (HBM), is applied to solve the one-dimensional transient heat conduction problems of high burn-up NFRs with temperature-dependent material properties. HBM saves computation cost since it only needs to calculate the second-order matrix in the simulation. Compared with the low bum-up condition, the conductivity drops significantly in the rim zone of the high burn-up NFR. The huge temperature gradient in the radial direction render the nonlinear material properties affecting the temperature distribution greatly. In addition, the model contains a helium layer, so the radiation heat transfers are considered in this paper. The heating up process of a low burn-up nuclear fuel is first simulated, and these results are compared with those from reference to verify the accuracy of HBM in transient thermal problems of NFR. The high burn-up NFRs with and without central hole in heat-up process, reactivity initiated accidents (RIAs) and loss of coolant accidents (LOCAs) are then simulated. The results show that the NFR with the central hole (NFRCH) is safer than the NFR without the central hole (NFRWCH), and the temperature distribution of high bum-up NFR is higher than that of low burn-up NFR. The pellet, which is near the central axis, is going to melt when a critical RIA happens, while the inner surface of the cladding will melt first when serious LOCA happens.
C1 [Tang, Jiannan; Huang, Mei; Yang, Mengling; Zhao, Yuanyuan; Ouyang, Xiaoping] North China Elect Power Univ, Beijing 102206, Peoples R China.
   [Huang, Mei; Ouyang, Xiaoping] Northwest Inst Nucl Technol, Xian 71002, Shaanxi, Peoples R China.
RP Huang, M (reprint author), North China Elect Power Univ, Beijing 102206, Peoples R China.; Huang, M (reprint author), Northwest Inst Nucl Technol, Xian 71002, Shaanxi, Peoples R China.
EM huangmei_team@163.com
FU NCEPU "Double First-Class" Graduate Talent Cultivation Program;
   Fundamental Research Funds for the Central Universities [2018ZD10];
   State Key Laboratory of Intense Pulsed Radiation Simulation and Effect
   of China [SKLIPR1402X]; National Natural Science Foundation of China
   [51506003]
FX The authors would like to appreciate the financial support from the
   NCEPU "Double First-Class" Graduate Talent Cultivation Program and the
   Fundamental Research Funds for the Central Universities (2018ZD10), and
   the State Key Laboratory of Intense Pulsed Radiation Simulation and
   Effect (No. SKLIPR1402X) of China. The authors would like to acknowledge
   for the financial supports from National Natural Science Foundation of
   China (51506003) to the research.
CR An C, 2014, APPL THERM ENG, V68, P133, DOI 10.1016/j.applthermaleng.2014.04.005
   [Anonymous], 2006, THERM PROP DAT MAT L
   Chen ZY, 2008, SCI CHINA SER A, V51, P1391, DOI 10.1007/s11425-008-0120-1
   CRANK J, 1947, P CAMB PHILOS SOC, V43, P50
   Eskandari Bavandi, 2012, ENERGY P, V14, P142
   Geelhood K. J., 2014, FRAPTRAN 1 5 COMPUTE
   Georgenthum V, 2014, NUCL ENG DES, V280, P172, DOI 10.1016/j.nucengdes.2014.04.030
   GILCHRIST KE, 1976, J NUCL MATER, V62, P257, DOI 10.1016/0022-3115(76)90022-2
   Haung M., 2013, WIT T MODELL SIMUL, V56, P127
   He YN, 2010, J COMPUT APPL MATH, V235, P708, DOI 10.1016/j.cam.2010.06.025
   Huang M, 2017, INT J HEAT MASS TRAN, V111, P508, DOI 10.1016/j.ijheatmasstransfer.2017.03.109
   Jiang YJ, 2011, ANN NUCL ENERGY, V38, P2581, DOI 10.1016/j.anucene.2011.07.016
   Krishnaprakas CK, 2001, NUMER HEAT TRANSF B, V40, P515
   Kudryashov NA, 2010, COMMUN NONLINEAR SCI, V15, P1240, DOI 10.1016/j.cnsns.2009.05.063
   Lanning D. D., 1975, REV METHODS APPL CAL
   Liu SY, 2017, MATER DESIGN, V136, P185, DOI 10.1016/j.matdes.2017.09.063
   Lyra P. R. M., 2005, J. Braz. Soc. Mech. Sci. & Eng., V27, P407, DOI 10.1590/S1678-58782005000400009
   Ma DL, 2018, NUCL ENG DES, V326, P290, DOI 10.1016/j.nucengdes.2017.11.026
   Ma DL, 2017, NUCL ENG DES, V320, P400, DOI 10.1016/j.nucengdes.2017.06.013
   Moal A, 2014, NUCL ENG DES, V280, P150, DOI 10.1016/j.nucengdes.2014.03.055
   Nawaz A, 2016, PROG NUCL ENERG, V93, P133, DOI 10.1016/j.pnucene.2016.08.009
   Pontedeiro AC, 2008, PROG NUCL ENERG, V50, P767, DOI 10.1016/j.pnucene.2008.01.005
   Soba A, 2014, ANN NUCL ENERGY, V70, P147, DOI 10.1016/j.anucene.2014.03.004
   Su J, 2001, INT COMMUN HEAT MASS, V28, P973, DOI 10.1016/S0735-1933(01)00301-3
   Su J, 2001, ANN NUCL ENERGY, V28, P1019, DOI 10.1016/S0306-4549(00)00104-3
   Tang JN, 2017, ANN NUCL ENERGY, V110, P492, DOI 10.1016/j.anucene.2017.05.061
   Todd RS, 2001, IND ENG CHEM RES, V40, P3217, DOI 10.1021/ie0008070
   Yang G., 2017, LASERS MANUF MAT PRO, V4, P1
   Yang G, 2017, MATER DESIGN, V123, P197, DOI 10.1016/j.matdes.2017.03.050
   Yu HX, 2012, ANN NUCL ENERGY, V50, P8, DOI 10.1016/j.anucene.2012.06.010
NR 30
TC 1
Z9 1
U1 10
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-4311
J9 APPL THERM ENG
JI Appl. Therm. Eng.
PD JUL 25
PY 2018
VL 140
BP 455
EP 465
DI 10.1016/j.applthermaleng.2018.04.134
PG 11
WC Thermodynamics; Energy & Fuels; Engineering, Mechanical; Mechanics
SC Thermodynamics; Energy & Fuels; Engineering; Mechanics
GA GM3LP
UT WOS:000438006400044
DA 2018-12-27
ER

PT J
AU Jian, Z
AF Jian, Zhang
TI RETRACTED: Study of a novel distributed vibration sensing system based
   on weak fiber Bragg gratings (Retracted article)
SO JOURNAL OF OPTICAL TECHNOLOGY
LA English
DT Article; Retracted Publication
ID SENSOR SYSTEM; TIME-DIVISION; LASER
AB A novel vibration sensing system based on distributed weak fiber Bragg gratings is demonstrated to overcome the drawbacks of the conventional methods used in optical fiber sensing networking, such as insufficient quantity of multiplexed fiber Bragg gratings in wavelength-division multiplexing systems and low signal intensity in conventional time-division multiplexing systems. By mixing wavelength-division multiplexing technology and time-division multiplexing technology, the physical parameters of the fiber Bragg grating locations can be measured, but the distributed measurement along the whole optical fiber cannot be realized. The proposed novel sensing system detects the vibration events along the optical fiber link according to the signal's intensity interference variation caused by the reflected signals with the adjacent weak fiber Bragg gratings. The position of the vibration events can be accurately determined by using time-division multiplexing technology. The experimental results verify that this novel system is more convenient for realizing vibration detection and demodulation along the whole optical fiber than before, and the system locating accuracy can be up to 20.5 m, with the capability of detecting various signals with 0.2 V of the driven signals as the bottom limit of voltage and a frequency range from 3 to 1000 Hz. (C) 2018 Optical Society of America
C1 [Jian, Zhang] Yangtze Univ, Coll Comp Sci, Jingzhou, Peoples R China.
RP Jian, Z (reprint author), Yangtze Univ, Coll Comp Sci, Jingzhou, Peoples R China.
EM zhangjian0716@126.com
FU Humanities and Social Science Foundation of Yangtze University
   [2017csza03]; Chu Culture Research Institute Open Foundation Project of
   Yangtze University [CWH201602]; Humanities and Social Science Foundation
   of Hubei Provincial Department of Education-Youth Foundation Yangtze
   University [17Q057]
FX Humanities and Social Science Foundation of Yangtze University
   (2017csza03); Chu Culture Research Institute Open Foundation Project of
   Yangtze University (CWH201602); Humanities and Social Science Foundation
   of Hubei Provincial Department of Education-Youth Foundation Yangtze
   University (17Q057).
CR Choi KN, 2003, IEEE PHOTONIC TECH L, V15, P386, DOI 10.1109/LPT.2003.807905
   Chung WH, 2005, IEEE PHOTONIC TECH L, V17, P2709, DOI 10.1109/LPT.2005.859484
   Dai YB, 2009, OPT LASER ENG, V47, P1028, DOI 10.1016/j.optlaseng.2009.05.012
   Davis MA, 1996, SMART MATER STRUCT, V5, P759, DOI 10.1088/0964-1726/5/6/005
   Dong B, 2006, IEEE PHOTONIC TECH L, V18, P2620, DOI 10.1109/LPT.2006.887197
   Juarez JC, 2005, J LIGHTWAVE TECHNOL, V23, P2081, DOI 10.1109/JLT.2005.849924
   KERSEY AD, 1993, OPT LETT, V18, P1370, DOI 10.1364/OL.18.001370
   Shang J., 2012, MODERN ELECT TECHNOL, V35, P51
   Valente L. C. G., 2002, 15 OPT FIB SENS C TE
   Wang YM, 2011, IEEE PHOTONIC TECH L, V23, P70, DOI 10.1109/LPT.2010.2089676
   Yang B., 2012, STUDY OPTICAL COMMUN, V17, P19
   Yu YL, 2001, IEEE PHOTONIC TECH L, V13, P702, DOI 10.1109/68.930420
   Zhang ML, 2012, OPT COMMUN, V285, P3082, DOI 10.1016/j.optcom.2012.02.100
NR 13
TC 1
Z9 1
U1 13
U2 13
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1070-9762
EI 1091-0786
J9 J OPT TECHNOL+
JI J. Opt. Technol.
PD JUL 1
PY 2018
VL 85
IS 7
BP 437
EP 443
DI 10.1364/JOT.85.000437
PG 7
WC Optics
SC Optics
GA GN5OC
UT WOS:000439109000012
DA 2018-12-27
ER

PT J
AU Zeoli, AM
   McCourt, A
   Buggs, S
   Frattaroli, S
   Lilley, D
   Webster, DW
AF Zeoli, April M.
   McCourt, Alexander
   Buggs, Shani
   Frattaroli, Shannon
   Lilley, David
   Webster, Daniel W.
TI RETRACTED: Analysis of the Strength of Legal Firearms Restrictions for
   Perpetrators of Domestic Violence and Their Associations With Intimate
   Partner Homicide (Retracted article. See vol. 187, pg. 2491, 2018)
SO AMERICAN JOURNAL OF EPIDEMIOLOGY
LA English
DT Article; Retracted Publication
DE domestic violence; firearms; homicide; policy analyses
ID US CITIES; LAWS; PURCHASE; POLICIES; ORDERS; STATES; RATES; WOMEN
AB In this research, we estimate the association of firearm restrictions for domestic violence offenders with intimate partner homicides (IPHs) on the basis of the strength of the policies. We posit that the association of firearm laws with IPHs depends on the following characteristics of the laws: 1) breadth of coverage of high-risk individuals and situations restricted; 2) power to compel firearm surrender or removal from persons prohibited from having firearms; and 3) systems of accountability that prevent those prohibited from doing so from obtaining guns. We conducted a quantitative policy evaluation using annual state-level data from 1980 through 2013 for 45 US states. Based on the results of a series of robust, negative binomial regression models with state fixed effects, domestic violence restraining order firearm-prohibition laws are associated with 10% reductions in IPH. Statistically significant protective associations were evident only when restraining order prohibitions covered dating partners (-11%) and ex parte orders (-12%). Laws prohibiting access to those convicted of nonspecific violent misdemeanors were associated with a 24% reduction in IPH rates; there was no association when prohibitions were limited to domestic violence. Permit-to-purchase laws were associated with 10% reductions in IPHs. These findings should inform policymakers considering laws to maximize protections against IPH.
C1 [Zeoli, April M.; McCourt, Alexander; Buggs, Shani; Frattaroli, Shannon; Lilley, David; Webster, Daniel W.] Michigan State Univ, Sch Criminal Justice, 655 Auditorium Rd, E Lansing, MI 48824 USA.
RP Zeoli, AM (reprint author), Michigan State Univ, Sch Criminal Justice, 655 Auditorium Rd, E Lansing, MI 48824 USA.
EM zeoli@msu.edu
OI Zeoli, April/0000-0002-9084-1721
FU Joyce Foundation [15-36521]
FX This research was supported by a grant from the Joyce Foundation, grant
   ID 15-36521.
CR Azziz-Baumgartner E, 2011, J INTERPERS VIOLENCE, V26, P1077, DOI 10.1177/0886260510365856
   Bouffard LA, 2016, J RES CRIME DELINQ, V53, P788, DOI 10.1177/0022427816656897
   Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089
   Diez C, 2017, ANN INTERN MED, V167, P536, DOI 10.7326/M16-2849
   Dugan L, 2003, LAW SOC REV, V37, P169, DOI 10.1111/1540-5893.3701005
   Dugan L., 1999, THESIS
   Federal Bureau of Investigation US Department of Justice, 2013, UN CRIM REP PROGR DA
   Fox J, 2009, J QUANT CRIMINOL, V25, P51, DOI 10.1007/s10940-008-9058-2
   Frattaroli S, 2006, EVALUATION REV, V30, P296, DOI 10.1177/0193841X06287680
   Logan T K, 2004, Violence Vict, V19, P37, DOI 10.1891/vivi.19.1.37.33234
   Reckdenwald A, 2012, FEM CRIMINOL, V7, P167, DOI 10.1177/1557085111428445
   ROSENFELD R, 1997, HOMICIDE STUDIES, V0001
   Rudolph KE, 2015, AM J PUBLIC HEALTH, V105, pE49, DOI 10.2105/AJPH.2015.302703
   Stata Corporation, 2015, STAT STAT SOFTW REL
   Vieraitis LM, 2002, VIOLENCE AGAINST WOM, V8, P35, DOI 10.1177/10778010222182937
   Vigdor ER, 2006, EVALUATION REV, V30, P313, DOI 10.1177/0193841X06287307
   Vigdor ER, 2003, EVALUATING GUN POLIC, P157
   Webster D, 2014, J URBAN HEALTH, V91, P293, DOI 10.1007/s11524-014-9865-8
   Webster DW, 2010, J WOMENS HEALTH, V19, P93, DOI 10.1089/jwh.2007.0530
   Webster DW, 2009, J URBAN HEALTH, V86, P525, DOI 10.1007/s11524-009-9351-x
   Webster DW, 2013, REDUCING GUN VIOLENC, P109
   Wintemute GJ, 2014, AM J PUBLIC HEALTH, V104, pE113, DOI 10.2105/AJPH.2013.301484
   Wintemute GJ, 2001, JAMA-J AM MED ASSOC, V285, P1019, DOI 10.1001/jama.285.8.1019
   Zeoli AM, TRAUMA VIOLENCE ABUS, DOI [10.1177/1524838017692384, DOI 10.1177/1524838017692384]
   Zeoli AM, 2010, INJURY PREV, V16, P90, DOI 10.1136/ip.2009.024620
NR 25
TC 6
Z9 6
U1 5
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0002-9262
EI 1476-6256
J9 AM J EPIDEMIOL
JI Am. J. Epidemiol.
PD JUL
PY 2018
VL 187
IS 7
BP 1449
EP 1455
DI 10.1093/aje/kwx362
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GM6LD
UT WOS:000438278100012
PM 29194475
DA 2018-12-27
ER

PT J
AU Roy, J
AF Roy, Jerome
TI RETRACTED: Primary microglia isolation from mixed cell cultures of
   neonatal mouse brain tissue (Retracted article. See vol. 1699, pg. 195,
   2018)
SO BRAIN RESEARCH
LA English
DT Article; Retracted Publication
DE Isolation; Microglia; Astrocytes; Mouse pups; Cell culture; High
   specificity; Functional
ID MECHANISMS; DISEASES
AB Background: Microglia are the main resident immunological cells of the central nervous system (CNS) that are functionally equivalent to macrophages. However, due to the cellular heterogeneity of the brain, it is technically challenging to obtain highly specific, healthy microglia with the desired phenotype in sufficient yield for in vivo experiments.
   New method: This study presents a new and easy method for the isolation of microglia cells from mouse pups (P1-P3). This method consists of a 20-day protocol, divided in three sections: mixed cell culture, culture maintaining (astrocytes growing), and isolation after astrocytes confluence.
   Results: This procedure produces microglia with no astrocyte, neuron and oligodendrocyte precursors cells contamination that are functionally active to answer inflammatory responses based on the measurement of cell and inflammatory markers. This technique requires approximately three hours for the isolation of neonatal mixed cell culture, 20 to 22 days for microglia growing and two days before starting experiments from pure and healthy microglia.
   Comparison with existing methods and conclusions: This study presents an isolation protocol that is adapted from existing methods and is economic, rapid, not tedious, with little manipulation time and work. This method also allows to isolate large amount of high specific microglia cells with no specific phenotype and with great reproducibility and efficiently. This study provides a detailed description of the methods that is routinely used in our laboratory for the isolation and the culture of microglia, with emphasis on the steps that are deemed most critical for obtaining large amount of pure and healthy cultures. Crown Copyright (C) 2018 Published by Elsevier B.V. All rights reserved.
C1 [Roy, Jerome] Univ Montreal, CRCHUM, Montreal, PQ H3T 1J4, Canada.
   [Roy, Jerome] Univ Montreal, Montreal Diabet Res Ctr, Montreal, PQ H3T 1J4, Canada.
   [Roy, Jerome] Univ Montreal, Dept Neurosci, Montreal, PQ H3T 1J4, Canada.
RP Roy, J (reprint author), CRCHUM, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada.
EM jerome.roy1902@gmail.com
FU Fondation pour la Recherche Medicate (FRM) [40199]
FX J.R was supported by the Fondation pour la Recherche Medicate (FRM
   number 40199).
CR Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901
   BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V
   Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038
   Cheepsunthorn P, 2001, GLIA, V35, P53, DOI 10.1002/glia.1070
   Daniele SG, 2014, JOVE-J VIS EXP, DOI 10.3791/51005
   Del Rio-Hertega P., 1932, MICROGLIA CYTOLOGY M, p[2294, 481]
   GIULIAN D, 1986, J NEUROSCI, V6, P2163
   Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219
   Gordon R, 2011, J NEUROSCI METH, V194, P287, DOI 10.1016/j.jneumeth.2010.11.001
   Harms Ashley S, 2013, Methods Mol Biol, V1041, P33, DOI 10.1007/978-1-62703-520-0_5
   HASSAN NF, 1991, CLIN IMMUNOL IMMUNOP, V59, P426, DOI 10.1016/0090-1229(91)90038-C
   HASSAN NF, 1991, NEUROSCIENCE, V41, P149, DOI 10.1016/0306-4522(91)90205-3
   Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x
   Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000
   LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2
   Lee Jae-Kyung, 2013, Methods Mol Biol, V1041, P17, DOI 10.1007/978-1-62703-520-0_3
   Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048
   Ni Mingwei, 2010, Curr Protoc Toxicol, VChapter 12, DOI 10.1002/0471140856.tx1217s43
   Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030
   Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274
   Takata K, 2012, J PHARMACOL SCI, V118, P331, DOI 10.1254/jphs.11R10FM
   Tamashiro TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3814
NR 22
TC 1
Z9 1
U1 6
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
EI 1872-6240
J9 BRAIN RES
JI Brain Res.
PD JUN 15
PY 2018
VL 1689
BP 21
EP 29
DI 10.1016/j.brainres.2018.03.018
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA GG3SC
UT WOS:000432612100003
PM 29577885
DA 2018-12-27
ER

PT J
AU Nguyen, ATT
   Palmer, CJ
   Clifford, CWG
AF Nguyen, A. T. T.
   Palmer, C. J.
   Clifford, C. W. G.
TI RETRACTED: Vergence eye movements direct others' attention in
   three-dimensional space (Retracted article. See vol. 28, pg. 2363, 2018)
SO CURRENT BIOLOGY
LA English
DT Letter; Retracted Publication
ID GAZE
C1 [Nguyen, A. T. T.; Palmer, C. J.; Clifford, C. W. G.] UNSW Sydney, Sch Psychol, Sydney, NSW 2052, Australia.
RP Clifford, CWG (reprint author), UNSW Sydney, Sch Psychol, Sydney, NSW 2052, Australia.
EM colin.clifford@unsw.edu.au
FU Australian Research Council [DP160102239]
FX This work was supported by Australian Research Council Discovery Project
   DP160102239.
CR Argyle M., 1976, GAZE MUTUAL GAZE
   Dunham P.J., 1995, JOINT ATTENTION ITS, P15
   Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827
   Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694
   Nguyen ATT, 2018, J EXP PSYCHOL GEN, V147, P1125, DOI 10.1037/xge0000398
   PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003
   POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231
   Schulz J, 2014, VIS COGN, V22, P1
   Takao S, 2018, PERCEPTION, V47, P158, DOI 10.1177/0301006617738719
   Yang ZY, 2003, NAT NEUROSCI, V6, P632, DOI 10.1038/nn1059
NR 10
TC 1
Z9 1
U1 3
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD MAY 7
PY 2018
VL 28
IS 9
BP R545
EP R546
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA GG1JC
UT WOS:000432442300006
PM 29738724
DA 2018-12-27
ER

PT J
AU Paul, SC
   Babafemi, AJ
   Anggraini, V
   Rahman, MM
AF Paul, Suvash Chandra
   Babafemi, Adewumi John
   Anggraini, Vivi
   Rahman, Md. Minhaz
TI RETRACTED: Properties of Normal and Recycled Brick Aggregates for
   Production of Medium Range (25-30 MPa) Structural Strength Concrete
   (Retracted article. See vol. 08, art no 79, 2018)
SO BUILDINGS
LA English
DT Article; Retracted Publication
DE brick aggregates; recycled concrete; compressive strength; young's
   modulus; abrasion; cost of concrete
ID CRUSHED CLAY BRICK; FLY-ASH; FRACTURE-TOUGHNESS; MECHANICAL-PROPERTIES;
   DEMOLITION WASTE; COARSE AGGREGATE; GREEN CONCRETE; MICROSTRUCTURE;
   CONSTRUCTION; REPLACEMENT
AB This study compares the properties of normal and recycled brick aggregates to produce a medium range (25-30 MPa) compressive strength of structural grade concrete. Up to date, brick aggregates are commonly used in structural concrete in some South Asian and African countries. Many concrete structures which were built in the last century are made from brick aggregates and some of them are already in a position of ending of their service life. At the same time, population and economic growth is forcing the demolition of many old structures. Therefore, there is a huge flow of construction and demolition waste and thereby it is necessary to recycle the waste to overcome the problem of occupying the landfill sites. For this study, recycled brick aggregates were collected from the various demolished building sites and their physical and mechanical performance were then compared with the concrete made from normal brick aggregates. It is found that the mechanical properties of recycled brick concrete are comparable to that of normal brick aggregate at medium strength level. The production cost of recycled brick concrete is also found to be 10-12% lower than normal brick aggregates.
C1 [Paul, Suvash Chandra; Anggraini, Vivi] Monash Univ Malaysia, Sch Engn, Dept Civil Engn, Bandar Sunway 47500, Subang Jaya, Malaysia.
   [Babafemi, Adewumi John] Obafemi Awolowo Univ, Fac Environm Design & Management, Dept Bldg, Ife 220282, Nigeria.
   [Rahman, Md. Minhaz] SEL, Dhaka 1209, Bangladesh.
RP Paul, SC (reprint author), Monash Univ Malaysia, Sch Engn, Dept Civil Engn, Bandar Sunway 47500, Subang Jaya, Malaysia.
EM suvash.chandra@monash.edu; ajbabafemi@oauife.edu.ng;
   vivi.anggraini@monash.edu; zishan179@yahoo.com
OI Anggraini, Vivi/0000-0003-2619-554X; , SUVASH/0000-0001-9997-2077;
   Babafemi, Adewumi/0000-0002-6232-6642
CR Aliabdo AA, 2014, ALEX ENG J, V53, P151, DOI 10.1016/j.aej.2013.12.003
   American Concrete Institute, 2002, REM REUS HARD CONCR, V555
   ASTM, 2018, C39C39M ASTM
   Bangwar DK, 2017, ENG TECHNOL APPL SCI, V7, P2266
   Batayneh M, 2007, WASTE MANAGE, V27, P1870, DOI 10.1016/j.wasman.2006.07.026
   Bektas F, 2009, CONSTR BUILD MATER, V23, P1909, DOI 10.1016/j.conbuildmat.2008.09.006
   British Standards Institution, 2009, 123502 BS EN
   Butler L, 2011, CEMENT CONCRETE RES, V41, P1037, DOI 10.1016/j.cemconres.2011.06.004
   Cachim PB, 2009, CONSTR BUILD MATER, V23, P1292, DOI 10.1016/j.conbuildmat.2008.07.023
   Cavalline Tara L., 2013, Structural Survey, V31, P160, DOI 10.1108/SS-09-2012-0029
   Chen HJ, 2003, CEMENT CONCRETE RES, V33, P125, DOI 10.1016/S0008-8846(02)00938-9
   Cheng HL, 2016, PROCEDIA ENVIRON SCI, V31, P218, DOI 10.1016/j.proenv.2016.02.029
   Debieb F, 2008, CONSTR BUILD MATER, V22, P886, DOI 10.1016/j.conbuildmat.2006.12.013
   Golewski GL, 2018, J CLEAN PROD, V172, P218, DOI 10.1016/j.jclepro.2017.10.065
   Golewski GL, 2017, MATER CHARACT, V134, P335, DOI 10.1016/j.matchar.2017.11.008
   Golewski GL, 2017, MATERIALS, V10, DOI 10.3390/ma10121393
   Gomez-Soberon JMV, 2002, CEMENT CONCRETE RES, V32, P1301, DOI 10.1016/S0008-8846(02)00795-0
   HANSEN T. C, 1992, 6 RILEM
   Heikal M, 2013, CONSTR BUILD MATER, V38, P101, DOI 10.1016/j.conbuildmat.2012.07.114
   Katz A, 2003, CEMENT CONCRETE RES, V33, P703, DOI 10.1016/S0008-8846(02)01033-5
   Khalaf FM, 2006, J MATER CIVIL ENG, V18, P518, DOI 10.1061/(ASCE)0899-1561(2006)18:4(518)
   Khatib JM, 2005, CEMENT CONCRETE RES, V35, P763, DOI 10.1016/j.cemconres.2004.06.017
   Letelier V, 2017, PROCEDIA ENGINEER, V171, P627, DOI 10.1016/j.proeng.2017.01.396
   Mohammed TU, 2015, J MATER CIVIL ENG, V27, DOI 10.1061/(ASCE)MT.1943-5533.0001043
   Neithalath N, 2009, OPEN CONSTR BUILD TE, V3, P42, DOI DOI 10.2174/1874836800903010042
   Neville A. M., 1995, PROPERTIES CONCRETE
   Padmini AK, 2002, MAG CONCRETE RES, V54, P377, DOI 10.1680/macr.54.5.377.38815
   Panda B, 2017, J CLEAN PROD, V167, P281, DOI 10.1016/j.jclepro.2017.08.165
   Paul S. C., 2011, THESIS
   Paul SC, 2018, RAPID PROTOTYPING J, V24, P784, DOI 10.1108/RPJ-09-2016-0154
   Paul SC, 2018, J SUSTAIN CEM-BASED, V7, P57, DOI 10.1080/21650373.2017.1394236
   Paul SC, 2018, MEASUREMENT, V115, P64, DOI 10.1016/j.measurement.2017.10.031
   Paul SC, 2017, COGENT ENG, V4, DOI 10.1080/23311916.2017.1345608
   Paul SC, 2013, INT J SUSTAIN CONSTR, V4, P89
   Sadek DM, 2012, J ADV RES, V3, P253, DOI 10.1016/j.jare.2011.08.001
   Sbia LA, 2017, MATER STRUCT, V50, DOI 10.1617/s11527-016-0887-4
   Silva RV, 2014, CONSTR BUILD MATER, V65, P201, DOI 10.1016/j.conbuildmat.2014.04.117
   Zong L, 2014, J CLEAN PROD, V70, P175, DOI 10.1016/j.jclepro.2014.02.040
NR 38
TC 1
Z9 1
U1 3
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-5309
J9 BUILDINGS
JI Buildings
PD MAY
PY 2018
VL 8
IS 5
AR 72
DI 10.3390/buildings8050072
PG 14
WC Construction & Building Technology
SC Construction & Building Technology
GA GJ3JW
UT WOS:000435191100010
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Takehara, Y
   Yamochi, T
   Nagumo, T
   Cho, T
   Urushibara, F
   Ono, K
   Fujii, T
   Okamoto, N
   Sasaki, Y
   Tazawa, S
   Honma, M
   Norose, T
   Shiozawa, E
   Tate, G
   Takimoto, M
AF Takehara, Yusuke
   Yamochi, Toshiko
   Nagumo, Tasuku
   Cho, Tomonari
   Urushibara, Fumihiko
   Ono, Kohei
   Fujii, Tomonori
   Okamoto, Naoko
   Sasaki, Yosuke
   Tazawa, Sakiko
   Honma, Mayumi
   Norose, Tomoko
   Shiozawa, Eisuke
   Tate, Genshu
   Takimoto, Masafumi
TI RETRACTED: Analysis of YAP1 and TAZ expression by immunohistochemical
   staining in malignant mesothelioma and reactive mesothelial cells
   (Retracted article. See vol. 16, pg. 6209, 2018)
SO ONCOLOGY LETTERS
LA English
DT Article; Retracted Publication
DE malignant mesothelioma; neurofibromatosis type 2; Hippo pathway;
   yes-associated protein 1; tafazzin
ID BAP1 IMMUNOHISTOCHEMISTRY; PROGNOSTIC-SIGNIFICANCE; HOMOZYGOUS DELETION;
   CDKN2A; HIPPO; DIAGNOSIS; CANCER; FISH; GENE
AB Gene mutations are involved in the development of malignant mesothelioma. Important mutations have been identified in the genes for cyclin-dependent kinase inhibitor 2A (p16) alternative reading frame, breast cancer-associated protein 1 (BAP1) and neurofibromatosis type 2 (NF2). Previously, the utility of detecting the loss of BAP1 by immunohistochemistry (IHC) and p16-deletion by fluorescence in situ hybridization has been identified in several studies. However, NF2-associated examinations have not been performed. The present study aimed to evaluate the expression of yes-associated protein 1 (YAP1) and tafazzin (TAZ) protein, which are associated with NF2 gene mutations, in malignant mesothelioma (MM) and reactive mesothelial cells (RMCs). Formalin-fixed paraffin-embedded tissues from 31 MM and 33 RMC samples were analyzed. The expression of YAP1 and TAZ protein were examined by IHC. Positivity for YAP1 was identified 27/31 MM and 15/33 RMC samples. Positivity for TAZ was identified in 28/31 MM and 18/33 RMC samples. Using the optimal cutoff points determined by the receiver operating characteristic curve, a positive IHC result for YAP1 and TAZ was 74% sensitive and 94% specific for detecting MM. The results indicate that increased expression of YAP1 and TAZ may be associated with mesothelial tumorization, and aid in the diagnosis of MM.
C1 [Takehara, Yusuke; Yamochi, Toshiko; Nagumo, Tasuku; Cho, Tomonari; Urushibara, Fumihiko; Ono, Kohei; Fujii, Tomonori; Okamoto, Naoko; Sasaki, Yosuke; Tazawa, Sakiko; Honma, Mayumi; Norose, Tomoko; Shiozawa, Eisuke; Tate, Genshu; Takimoto, Masafumi] Showa Univ, Sch Med, Dept Pathol & Lab Med, Tokyo 1428555, Japan.
RP Takehara, Y (reprint author), Showa Univ, Sch Med, Dept Pathol & Lab Med, Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.
EM yuutake47@yahoo.co.jp
CR Altomare DA, 2005, CANCER RES, V65, P8090, DOI 10.1158/0008-5472.CAN-05-2312
   Bueno R, 2016, NAT GENET, V48, P407, DOI 10.1038/ng.3520
   Carbone M, 2016, ONCOTARGET, V7, P59314, DOI 10.18632/oncotarget.10653
   Chiosea S, 2008, MODERN PATHOL, V21, P742, DOI 10.1038/modpathol.2008.45
   Cong WL, 2010, CURR BIOL, V20, P1408, DOI 10.1016/j.cub.2010.06.024
   Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048
   Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653
   Grannas K, 2015, J MOL BIOL, V427, P3407, DOI 10.1016/j.jmb.2015.04.015
   Hata N, 2014, J CLIN EXPT MED, V251, p[351, 423]
   Hata N, 2014, J CLIN EXPT MED, V251, p[351, 423]
   Hwang HC, 2016, AM J SURG PATHOL, V40, P120, DOI 10.1097/PAS.0000000000000529
   Illei PB, 2003, CLIN CANCER RES, V9, P2108
   Li PD, 2014, ASIAN PAC J TROP MED, V7, P757, DOI 10.1016/S1995-7645(14)60131-0
   Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019
   Minato H, 2014, AM J CLIN PATHOL, V141, P85, DOI 10.1309/AJCP5KNL7QTELLYI
   Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164
   Sekido Y, 2013, CARCINOGENESIS, V34, P1413, DOI 10.1093/carcin/bgt166
   Sheffield BS, 2015, AM J SURG PATHOL, V39, P977, DOI 10.1097/PAS.0000000000000394
   Singhi AD, 2016, MODERN PATHOL, V29, P14, DOI 10.1038/modpathol.2015.121
   Takeda M, 2010, PATHOL INT, V60, P395, DOI 10.1111/j.1440-1827.2010.02534.x
   Travis WD, 2015, WHO CLASSIFICATION T, P154
   Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045
   Xie M, 2012, J THORAC ONCOL, V7, P799, DOI 10.1097/JTO.0b013e318248240b
   Yokoyama T, 2008, CARCINOGENESIS, V29, P2139, DOI 10.1093/carcin/bgn200
   Yue GF, 2014, BIOMED RES INT, DOI 10.1155/2014/393064
NR 25
TC 1
Z9 1
U1 1
U2 1
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-1074
EI 1792-1082
J9 ONCOL LETT
JI Oncol. Lett.
PD MAY
PY 2018
VL 15
IS 5
BP 6825
EP 6830
DI 10.3892/ol.2018.8225
PG 6
WC Oncology
SC Oncology
GA GF3DN
UT WOS:000431825900097
PM 29731861
DA 2018-12-27
ER

PT J
AU Silverman, NS
   Beigi, R
AF Silverman, Neil S.
   Beigi, Richard
CA Comm Obstetric Practice
TI RETRACTED: Influenza Vaccination During Pregnancy (Retracted article.
   See vol. 131, pg. 751, 2018)
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article; Retracted Publication
ID UNITED-STATES; RESPIRATORY ILLNESS; ASIAN INFLUENZA; H1N1 INFLUENZA;
   VIRUS ILLNESS; PHASE 4; WOMEN; IMMUNIZATION; INFANTS; INFECTION
AB Influenza vaccination is an essential element of prepregnancy, prenatal, and postpartum care because influenza can result in serious illness, including a higher chance of progressing to pneumonia, when it occurs during the antepartum or postpartum period. In addition to hospitalization, pregnant women with influenza are at increased risk of intensive care unit admission and adverse perinatal and neonatal outcomes. The Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices and the American College of Obstetricians and Gynecologists recommend that all adults receive an annual influenza vaccine and that women who are or will be pregnant during influenza season receive an inactivated influenza vaccine as soon as it is available. In the United States, the influenza season typically occurs from October to May. Ideally, an influenza vaccination should be given before the end of October, but vaccination throughout the influenza season is encouraged to ensure protection during the period of circulation. Any of the licensed, recommended, age-appropriate, inactivated influenza vaccines can be given safely during any trimester. Therefore, it is critically important that obstetrician-gynecologists and other obstetric care providers recommend and advocate for the influenza vaccine. Obstetrician-gynecologists are encouraged to stock and administer the influenza vaccine to their pregnant patients in their offices, and should get the influenza vaccine themselves every season. If the influenza vaccine cannot be offered in a practice, obstetrician-gynecologists and obstetric care providers should refer patients to another health care provider, pharmacy, or community vaccination center. This updated Committee Opinion includes more recent data on the safety and efficacy of influenza vaccination during pregnancy and recommendations for treatment and postexposure chemoprophylaxis.
CR Ahluwalia IB, 2010, OBSTET GYNECOL, V116, P949, DOI 10.1097/AOG.0b013e3181f1039f
   American College of Obstetricians and Gynecologists, 2017, IT IS SAF REC FLU SH
   Bednarczyk RA, 2012, AM J OBSTET GYNECOL, V207, pS38, DOI 10.1016/j.ajog.2012.07.002
   Beigi RH, 2009, J REPROD MED, V54, P341
   Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309
   Black SB, 2004, AM J PERINAT, V21, P333, DOI 10.1055/s-2004-831888
   Brown CM, 2010, OBSTET GYNECOL, V115, P412, DOI 10.1097/AOG.0b013e3181cbc7c5
   Callaghan WM, 2015, OBSTET GYNECOL, V126, P486, DOI 10.1097/AOG.0000000000000996
   Carcione D, 2013, AUST NZ J OBSTET GYN, V53, P98, DOI 10.1111/ajo.12034
   Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947
   Ding H, 2017, MMWR-MORBID MORTAL W, V66, P1016, DOI 10.15585/mmwr.mm6638a2
   Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435
   Donahue JG, 2017, VACCINE, V35, P5314, DOI 10.1016/j.vaccine.2017.06.069
   Fell DB, 2017, VACCINE, V35, P5738, DOI 10.1016/j.vaccine.2017.08.037
   Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1
   FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8
   GREENBERG M, 1958, AM J OBSTET GYNECOL, V76, P897, DOI 10.1016/0002-9378(58)90027-9
   Greer LG, 2010, OBSTET GYNECOL, V115, P409, DOI 10.1097/AOG.0b013e3181cbc8d0
   Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444
   Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480
   Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1
   McNeil MM, 2016, J ALLERGY CLIN IMMUN, V137, P868, DOI 10.1016/j.jaci.2015.07.048
   Moro PL, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.050
   Oluyomi-Obi T, 2010, J OBSTET GYNAECOL CA, V32, P443, DOI 10.1016/S1701-2163(16)34497-8
   Orenstein WA, 2013, PEDIATRICS, V131, P149, DOI 10.1542/peds.2012-1760
   Prevention and control of seasonal influenza with vaccines, 2013, MMWR RECOMM REP, V62, p[1, 906]
   Price CS, 2010, PEDIATRICS, V126, P656, DOI 10.1542/peds.2010-0309
   Regan AK, 2016, VACCINE, V34, P3649, DOI 10.1016/j.vaccine.2016.05.032
   Saleeby E, 2009, OBSTET GYNECOL, V114, P885, DOI 10.1097/AOG.0b013e3181bb44bb
   Shavell VI, 2012, AM J OBSTET GYNECOL, V207, pS67, DOI 10.1016/j.ajog.2012.06.077
   Silverman NS, 2001, J REPROD MED, V46, P989
   Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479
   Steinhoff MC, 2017, LANCET INFECT DIS, V17, P981, DOI 10.1016/S1473-3099(17)30252-9
   Tamma PD, 2009, AM J OBSTET GYNECOL, V201, P547, DOI 10.1016/j.ajog.2009.09.034
   Tapia MD, 2016, LANCET INFECT DIS, V16, P1026, DOI 10.1016/S1473-3099(16)30054-8
   Thompson MG, 2014, CLIN INFECT DIS, V58, P449, DOI 10.1093/cid/cit750
   U. S. Department of Health and Human Services-Office of Disease Prevention and a. Health Promotion, 2017, HLTH PEOPL 2020 IMM
   Wallis DH, 2006, J AM BOARD FAM MED, V19, P345, DOI 10.3122/jabfm.19.4.345
   World Health Organization, 2017, GLOB VACC SAF STAT T
   Yudin MH, 2009, J OBSTET GYNAECOL CA, V31, P120, DOI 10.1016/S1701-2163(16)34095-6
   Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630
NR 43
TC 1
Z9 1
U1 5
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD APR
PY 2018
VL 131
IS 4
BP E109
EP E114
DI 10.1097/AOG.0000000000002588
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GQ0YP
UT WOS:000441347800001
DA 2018-12-27
ER

PT J
AU Heidari, M
   Ghodusi, M
   Akbari, FA
   Naseh, L
AF Heidari, Mohammad
   Ghodusi, Mansureh
   Akbari, Fatemeh Ali
   Naseh, Ladan
TI RETRACTED: Self-esteem and locus of control in the initial and final
   stages of drug withdrawal among addicts attending rehabilitation centers
   (Retracted article. See vol. 43, pg. 574, 2018)
SO RAWAL MEDICAL JOURNAL
LA English
DT Article; Retracted Publication
DE Addiction; self-esteem; locus of control
ID SUBSTANCE USE; MEDIATING ROLES; STRESS; PERFORMANCE; ADOLESCENTS
AB Objective: To compare self-esteem and locus of control in the initial and final stages of withdrawal in addicts attending addiction treatment centers.
   Methodology: This descriptive-correlational research studied 150 addicts admitted to addiction treatment centers employing convenience-sampling technique. The data were collected using Rosenberg's Self-esteem Scale and Rotter Locus of Control questionnaire. The results were analyzed in SPSS version 16.
   Results: On the 12th day of the drug withdrawal, 96 addicts had moderate self-esteem and 102 had internal locus of control. The results of the Pearson's correlation coefficient showed a significant linear relationship between locus of control and self-esteem in the final stages of withdrawal.
   Conclusion: High self-esteem has been effective in improving locus of control and decreasing psychological disorders and it can be considered the optimal treatment method in psychology.
C1 [Ghodusi, Mansureh] Shahrekord Univ Med Sci, Dept Nursing, Sch Nursing & Midwifery, Shahrekord, Iran.
   Islamic Azad Univ, Abadeh Branch, Abadeh, Iran.
   Isfahan Univ Med Sci, Esfahan, Iran.
RP Ghodusi, M (reprint author), Shahrekord Univ Med Sci, Dept Nursing, Sch Nursing & Midwifery, Shahrekord, Iran.
EM mansureh.g2212@yahoo.com
FU Medical Sciences University of Shahrekord [1593, 1392-01-92-1582]
FX This study is related to a research design, which was ratified, and
   financial Support by the research and technology deputy of the Medical
   Sciences University of Shahrekord under number 1593 and ethical code
   1392-01-92-1582. I hereby express my deep gratitude toward the
   respectable Deputy of Researches and Technology of Shahrekord University
   of Medical Sciences, and all patients that assisted us in this research
   work, without whom the study could not be possible.
CR Andress W., 2000, TOBACCO GROWING EPID, P728
   Arogundade O, 2010, IFE PSYCHOLOGIA, V18, P339
   Barkhordary M, 2009, IRAN J MED ED, V9, P9
   Copello P, 2009, J HEALTH PSYCHOL, V6, P16
   Hair M, 2007, COMPUT HUM BEHAV, V23, P2791, DOI 10.1016/j.chb.2006.05.005
   Heidari Mohammad, 2016, Mater Sociomed, V28, P263
   Jaremko KM, 2014, PROG NEURO-PSYCHOPH, V50, P53, DOI 10.1016/j.pnpbp.2013.12.003
   Jimenez TI, 2008, INT J CLIN HLTH PSYC, V8, P139
   Kaldi A, 2012, SOCIAL WELFARE J, V3, P307
   Kheiry T, 2013, J HEALTH PSYCHOL, V2, P69
   Kim JU, 2008, INT J REALITY THER, V27, P4
   Lee KMT, 2011, DRUG ALCOHOL REV, V30, P441, DOI 10.1111/j.1465-3362.2011.00301.x
   Macsinga I, 2012, PROCD SOC BEHV, V33, P25, DOI 10.1016/j.sbspro.2012.01.076
   Manchari H, 2012, J HLTH CARE, V14, P19
   Mancheri H, 2013, IRAN J NURSING, V26, P48
   MAQSUD M, 1983, BRIT J EDUC PSYCHOL, V53, P215, DOI 10.1111/j.2044-8279.1983.tb02552.x
   Martin G, 2005, J ADOLESCENCE, V28, P75, DOI 10.1016/j.adolescence.2004.04.005
   Milz RU, 2016, J PSYCHOSOM RES, V83, P22, DOI 10.1016/j.jpsychores.2016.02.005
   Moriarty H, 2011, J PRIM HEALTH CARE, V3, P210, DOI 10.1071/HC11210
   Rezanejad M, 2011, J YASOUJ, V10, P20
   Slaughter RI, 2009, ASS E SPIRITUALITY C
   Stein JA, 2002, CHILD ABUSE NEGLECT, V26, P1011, DOI 10.1016/S0145-2134(02)00382-4
   Steinfield C, 2008, J APPL DEV PSYCHOL, V29, P434, DOI 10.1016/j.appdev.2008.07.002
   Zamboanga BL, 2009, J PRIM PREV, V30, P315, DOI 10.1007/s10935-009-0182-z
NR 24
TC 1
Z9 1
U1 2
U2 2
PU PAKISTAN MEDICAL ASSOC
PI KARACHI
PA PMA HOUSE, AGA KHAN III RD, KARACHI, 00000, PAKISTAN
SN 0303-5212
J9 RAWAL MED J
JI Rawal Med. J.
PD APR-JUN
PY 2018
VL 43
IS 2
BP 309
EP 313
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA GG9DJ
UT WOS:000433000700031
DA 2018-12-27
ER

PT J
AU Kulkarni, V
   Bodas, D
   Paknikar, K
AF Kulkarni, Vaishnavi
   Bodas, Dhananjay
   Paknikar, Kishore
TI RETRACTED: Assessment of an Integrative Anticancer Treatment Using an in
   Vitro Perfusion-Enabled 3D Breast Tumor Model (Retracted article. See
   vol. 4, pg. 3107, 2018)
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article; Retracted Publication
DE LSMO nanoparticles; perfused 3D cell culture; tumor-on-chip; magnetic
   fluid hyperthermia; combination treatment; porous scaffolds; in vitro
   tumor
ID PERMEABILITY TRANSITION PORE; MAGNETIC NANOPARTICLES; OXIDATIVE STRESS;
   HEAT-TRANSFER; SOLID TUMORS; BLOOD-FLOW; CANCER; HYPERTHERMIA;
   GENERATION; APOPTOSIS
AB The study presents observations on anticancer therapeutic efficacy of magnetic fluid hyperthermia and a combination of hyperthermia and chemotherapy (i.e., integrative treatment) using an in vitro perfused and non-perfused 3D breast tumor model. The 3D in vitro breast tumor models were simulated using Comsol multiphysics, fabricated using specially designed chips, and treated with doxorubicin-loaded chitosan-coated La0.7Sr0.3MnO3 (DC-LSMO) nanoparticles for hyperthermia and combination therapy in both perfused and non-perfused conditions. Computation confirmed uniform heat distribution throughout the scaffold for both the models. The findings indicate that both hyperthermia and combination treatment could trigger apoptotic cell death in the perfused and non-perfused models in varying degrees. Specifically, the perfused tumors were more resistant to therapy than the non-perfused ones. The efficacy of anticancer treatment decreased with increasing physiological complexity of the tumor model. The combination (hyperthermia and chemotherapy) treatment showed enhanced efficacy over hyperthermia alone. This is a pilot study to investigate the effects of magnetic fluid hyperthermia chemotherapy treatment using perfused and non-perfused 3D in vitro models of tumor. The feasibility of using 3D cell culture models for contributing to our understanding of cancer and its treatment was also determined as a part of this work.
C1 [Kulkarni, Vaishnavi; Bodas, Dhananjay; Paknikar, Kishore] Agharkar Res Inst, Nanobiosci Grp, GG Agarkar Rd, Pune 411004, Maharashtra, India.
RP Bodas, D; Paknikar, K (reprint author), Agharkar Res Inst, Nanobiosci Grp, GG Agarkar Rd, Pune 411004, Maharashtra, India.
EM dsbodas@aripune.org; kpaknikar@gmail.com
OI Paknikar, Kishore/0000-0001-5602-7518
FU Council of Scientific and Industrial Research (CSIR), India
FX V.K. is grateful to the Council of Scientific and Industrial Research
   (CSIR), India for the award of a Junior Research Fellowship.
CR Ahmadi MM, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026312
   Al-Abd AM, 2015, J CONTROL RELEASE, V219, P269, DOI 10.1016/j.jconrel.2015.08.055
   Babincova M, 2008, IEEE T NANOBIOSCI, V7, P15, DOI 10.1109/TNB.2008.2000145
   Barrett HH, 2015, PROC SPIE, V9412, DOI 10.1117/12.2189093
   Das V, 2015, DRUG DISCOV TODAY, V20, P848, DOI 10.1016/j.drudis.2015.04.004
   Dennis CL, 2013, INT J HYPERTHER, V29, P715, DOI 10.3109/02656736.2013.836758
   Dewhirst Mark W., 2015, ADV HEAT TRANSFER, V47, P397
   Dutz S, 2013, INT J HYPERTHER, V29, P790, DOI 10.3109/02656736.2013.822993
   Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946
   Haghniaz R, 2016, INT J NANOMED, V11, P1779, DOI 10.2147/IJN.S104617
   Haghniaz R, 2015, INT J NANOMED, V10, P1609, DOI 10.2147/IJN.S78167
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Hida K, 2016, INT J CLIN ONCOL, V21, P206, DOI 10.1007/s10147-016-0957-1
   Ito A, 2006, CANCER IMMUNOL IMMUN, V55, P320, DOI 10.1007/s00262-005-0049-y
   Juarez-Moreno JA, 2015, APPL SURF SCI, V349, P763, DOI 10.1016/j.apsusc.2015.05.063
   Karch J, 2014, P NATL ACAD SCI USA, V111, P10396, DOI 10.1073/pnas.1410104111
   Karponis D, 2016, NANOMEDICINE-UK, V11, P2215, DOI 10.2217/nnm-2016-0113
   Kim AD, 2015, ENVIRON TOXICOL PHAR, V39, P982, DOI 10.1016/j.etap.2015.03.003
   Ko YH, 2014, RSC ADV, V4, P10216, DOI 10.1039/c3ra47199c
   Koning GA, 2010, PHARM RES-DORDR, V27, P1750, DOI 10.1007/s11095-010-0154-2
   Kozissnik B, 2013, INT J HYPERTHER, V29, P706, DOI 10.3109/02656736.2013.837200
   Kulkarni VM, 2016, COLLOID SURFACE B, V145, P878, DOI 10.1016/j.colsurfb.2016.06.010
   Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451
   Mankoff DA, 2002, J NUCL MED, V43, P500
   Matyka M, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026306
   Mi Y, 2012, BIOMATERIALS, V33, P7519, DOI 10.1016/j.biomaterials.2012.06.100
   Monie TP, 2015, IMMUNOL REV, V265, P181, DOI 10.1111/imr.12284
   Nabil M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150447
   Paulides MM, 2013, INT J HYPERTHER, V29, P346, DOI 10.3109/02656736.2013.790092
   Penfornis Patrice, 2017, Front Biosci (Elite Ed), V9, P162
   Prokhorova EA, 2015, CELL MOL LIFE SCI, V72, P4593, DOI 10.1007/s00018-015-2031-y
   Rasola A, 2014, CELL CALCIUM, V56, P437, DOI 10.1016/j.ceca.2014.10.003
   Reis RF, 2016, J COMPUT APPL MATH, V295, P35, DOI 10.1016/j.cam.2015.02.047
   Schumacker PT, 2015, CANCER CELL, V27, P156, DOI 10.1016/j.ccell.2015.01.007
   Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4
   Szymkiewicz A, 2013, GEOPLANET-EARTH PLAN, P1, DOI 10.1007/978-3-642-23559-7
   Ulbrich K, 2016, CHEM REV, V116, P5338, DOI 10.1021/acs.chemrev.5b00589
   VAUPEL P, 1987, CANCER RES, V47, P3496
   Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694
   Wang Q, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0974-6
   Weiswald LB, 2015, NEOPLASIA, V17, P1, DOI 10.1016/j.neo.2014.12.004
   Yue ZG, 2011, BIOMACROMOLECULES, V12, P2440, DOI 10.1021/bm101482r
NR 42
TC 1
Z9 2
U1 5
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD APR
PY 2018
VL 4
IS 4
SI SI
BP 1407
EP 1417
DI 10.1021/acsbiomaterials.8b00153
PG 21
WC Materials Science, Biomaterials
SC Materials Science
GA GC6FZ
UT WOS:000429886800028
DA 2018-12-27
ER

PT J
AU Advokaat, EL
   Bongers, MLM
   Rudyawan, A
   BouDagher-Fadel, MK
   Langereis, CG
   van Hinsbergen, DJJ
AF Advokaat, Eldert L.
   Bongers, Mayke L. M.
   Rudyawan, Alfend
   BouDagher-Fadel, Marcelle K.
   Langereis, Cor G.
   van Hinsbergen, Douwe J. J.
TI RETRACTED: Early Cretaceous origin of the Woyla Arc (Sumatra, Indonesia)
   on the Australian plate (Retracted article. See vol. 487, pg. 151, 2018)
SO EARTH AND PLANETARY SCIENCE LETTERS
LA English
DT Article; Retracted Publication
C1 [Advokaat, Eldert L.; Bongers, Mayke L. M.; Langereis, Cor G.; van Hinsbergen, Douwe J. J.] Univ Utrecht, Dept Earth Sci, NL-3584 CS Utrecht, Netherlands.
   [Rudyawan, Alfend] Inst Teknol Bandung, Geol Study Program, Bandung 40132, Jawa Barat, Indonesia.
   [BouDagher-Fadel, Marcelle K.] UCL, Dept Earth Sci, London WC1E 6BT, England.
RP Advokaat, EL (reprint author), Univ Utrecht, Dept Earth Sci, NL-3584 CS Utrecht, Netherlands.
EM E.L.Advokaat@uu.nl
CR ADVOKAAT EL, 2018, EARTH PLANET SC LETT, V487, DOI DOI 10.1016/J.EPS1.2018.01.028
NR 1
TC 1
Z9 1
U1 4
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0012-821X
EI 1385-013X
J9 EARTH PLANET SC LETT
JI Earth Planet. Sci. Lett.
PD APR 1
PY 2018
VL 487
BP R1
EP R1
DI 10.1016/j.epsl.2018.03.007
PG 1
WC Geochemistry & Geophysics
SC Geochemistry & Geophysics
GA GC4KS
UT WOS:000429754000022
DA 2018-12-27
ER

PT J
AU Liu, XY
   Liu, DY
   Zhang, HJ
AF Liu, Xiao-yu
   Liu, Dong-yue
   Zhang, Hui-juan
TI RETRACTED: A solar cell endows the Surface-enhanced Raman scattering
   substrate with extra enhancement (Retracted article. See vol.227,
   pg.322, 2018)
SO MATERIALS LETTERS
LA English
DT Article; Retracted Publication
DE E-SERS; Solar cell; Au nanoparticles
ID GOLD ELECTRODES; SERS; NANOPARTICLES; SPECTROSCOPY; FABRICATION;
   SPECTRA; COPPER; SILVER
AB Electrochemical Surface-enhanced Raman spectroscopy (E-SERS) can effectively enhance the Raman signal intensities. However, the complex appliance and operation conditions hampered its application in quick and on-site detection. To solve this problem, a SERS substrate consisting of solar cell film and Au nanoparticles was prepared. The solar cell provides electrical potential by the laser irradiation to take place of electrochemical workstation which is essential in conventional E-SERS. The Au nanoparticles were loaded on the surface of solar cell film to provide electromagnetic enhancement. The sensitivity of the Raman signals on solar cell film-Au (SCAu) SERS substrate has been demonstrated to increase up to 6.7 times compared with that on the bare Au nanoparticles. Various molecules tests demonstrated the widespread prospect of the SCAu substrate in micro chemical detection. (C) 2018 Elsevier B.V. All rights reserved.
C1 [Liu, Xiao-yu; Liu, Dong-yue; Zhang, Hui-juan] North Univ China, Sch Mat Sci & Engn, Shanxi Prov Key Lab Funct Nanocomposites, Taiyuan 030051, Shanxi, Peoples R China.
RP Liu, XY (reprint author), North Univ China, Sch Mat Sci & Engn, Shanxi Prov Key Lab Funct Nanocomposites, Taiyuan 030051, Shanxi, Peoples R China.
EM s1508109@st.nuc.edu.cn
FU Natural Science Foundation for Young Scientists of Shanxi Province of
   China [2015021078]; International Cooperation of Science and Technology
   Project in Shanxi Province of China [2014081006-2]
FX This work was supported by the Natural Science Foundation for Young
   Scientists of Shanxi Province of China (No. 2015021078) and
   International Cooperation of Science and Technology Project in Shanxi
   Province of China (No. 2014081006-2).
CR Arenas JF, 1999, VIB SPECTROSC, V19, P213, DOI 10.1016/S0924-2031(98)00095-2
   BILLMANN J, 1982, SOLID STATE COMMUN, V44, P105, DOI 10.1016/0038-1098(82)90410-0
   Blackie EJ, 2009, J AM CHEM SOC, V131, P14466, DOI 10.1021/ja905319w
   Dieringer JA, 2007, J AM CHEM SOC, V129, P16249, DOI 10.1021/ja077243c
   Harroun SG, 2013, PHYS CHEM CHEM PHYS, V15, P19205, DOI 10.1039/c3cp52916a
   Hurst SJ, 2011, J PHYS CHEM C, V115, P620, DOI 10.1021/jp1096162
   Kudelski A, 1996, VIB SPECTROSC, V10, P335, DOI 10.1016/0924-2031(95)00056-9
   KUDELSKI A, 1994, CHEM PHYS LETT, V222, P555, DOI 10.1016/0009-2614(94)00399-8
   Li HT, 2017, ANGEW CHEM INT EDIT, V56, P2649, DOI 10.1002/anie.201610737
   Li Q, 2017, BIOSENS BIOELECTRON, V97, P59, DOI 10.1016/j.bios.2017.05.031
   Lim JI, 2015, MATER LETT, V160, P139, DOI 10.1016/j.matlet.2015.07.121
   Ling X, 2010, NANO LETT, V10, P553, DOI 10.1021/nl903414x
   Liu SS, 2009, SPECTROCHIM ACTA A, V73, P382, DOI 10.1016/j.saa.2009.02.036
   Ruther M, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3533807
   Santos ED, 2013, MATER LETT, V108, P172, DOI 10.1016/j.matlet.2013.06.110
   Shao LH, 2010, ADV MATER, V22, P5173, DOI 10.1002/adma.201002734
   Tan MJ, 2017, BIOSENS BIOELECTRON, V96, P167, DOI 10.1016/j.bios.2017.05.005
   Tan Y, 2017, NANO LETT, V17, P2621, DOI 10.1021/acs.nanolett.7b00412
   UEBA H, 1983, SURF SCI, V131, P347, DOI 10.1016/0039-6028(83)90283-2
   Wu DY, 2008, J PHYS CHEM C, V112, P4195, DOI 10.1021/jp0760962
   Xia Y, 2012, J RAMAN SPECTROSC, V43, P842, DOI 10.1002/jrs.3105
   Xu HX, 2000, PHYS REV E, V62, P4318, DOI 10.1103/PhysRevE.62.4318
   Zhong LB, 2015, SMALL, V11, P5395, DOI 10.1002/smll.201501627
NR 23
TC 1
Z9 1
U1 14
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 1
PY 2018
VL 216
BP 287
EP 290
DI 10.1016/j.matlet.2018.01.129
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA FV6SW
UT WOS:000424713000075
DA 2018-12-27
ER

PT J
AU Wu, HY
   Chang, Q
AF Wu, Hongyan
   Chang, Qing
TI RETRACTED: The cryoprotectant trehalose could inhibit ERS-induced
   apoptosis by activating autophagy in cryoprotected rat valves (Retracted
   article. See vol. 13 , art no E0201082, 2018)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID HUNTINGTONS-DISEASE; MUTANT HUNTINGTIN; EURO-COLLINS; NITRIC-OXIDE;
   LIVING CELLS; CRYOPRESERVATION; COLD; REPLACEMENT; ALLOGRAFTS; CLEARANCE
AB Valvular diseases are common health problems that are strongly related to high morbidity and mortality; aortic valve allograft transplantation may be a promising way to improve survival and relieve symptoms. However, ideal tissue viability has not been observed with common valve cryopreservation methods, which could lead to apoptosis and necrosis in cryopreserved tissue. It has been observed that trehalose plays a positive role by acting to maintain cell structures and protect cells from stress responses. In this study, we studied the effects of trehalose in protecting rat valve tissue from the cooling process. We found improved higher cell function in rat valves treated with trehalose during cryopreservation than in those treated with dimethyl sulphoxide (DMSO). To further explore the mechanisms, we found that trehalose could down-regulate the expression of cleaved caspase-3, an important molecule involved in cell apoptosis. In addition, treatment with trehalose also decreased Glucose-regulated protein 78 (GRP78) and CCAAT/enhancer-binding protein homologous protein (CHOP), the key proteins in the endoplasmic reticulum stress (ERS) process. Intriguingly, we observed that trehalose promotes cryoprotected rat valve cell autophagy via an mTOR-independent but p38 MAPK-dependent signaling pathway. Additionally, miR-221 and miR-32 have been implicated in such cell activities. In summary, our study offers a new and meaningful cryopreservation approach for valve allograft storage.
C1 [Wu, Hongyan; Chang, Qing] Qingdao Univ, Affiliated Hosp, Dept Cardiovasc Surg, Qingdao, Peoples R China.
RP Chang, Q (reprint author), Qingdao Univ, Affiliated Hosp, Dept Cardiovasc Surg, Qingdao, Peoples R China.
EM changqing20671@163.com
CR Aisen EG, 2002, THERIOGENOLOGY, V57, P1801, DOI 10.1016/S0093-691X(02)00653-2
   Fernandez-Estevez MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090202
   Bissoyi A, 2014, BIOPRESERV BIOBANK, V12, P23, DOI 10.1089/bio.2013.0032
   Campbell LH, 2012, CRYOBIOLOGY, V64, P240, DOI 10.1016/j.cryobiol.2012.02.006
   Chang Q, 2015, J HEART VALVE DIS, V24, P74
   Crowe JH, 2003, CHEM PHYS LIPIDS, V122, P41, DOI 10.1016/S0009-3084(02)00177-9
   DONOVAN TJ, 1952, J THORAC SURG, V23, P348
   Erdag G, 2002, CRYOBIOLOGY, V44, P218, DOI 10.1016/S0011-2240(02)00023-8
   Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257
   Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051
   Heo YJ, 2009, CRYOBIOLOGY, V58, P203, DOI 10.1016/j.cryobiol.2008.12.006
   Honma Y, 2017, HEPATOL RES
   Iop L, 2017, J CARDIOVASC TRANSL, V10, P93, DOI 10.1007/s12265-017-9738-0
   Isachenko V, 2003, THERIOGENOLOGY, V59, P1209, DOI 10.1016/S0093-691X(02)01165-2
   Jia Xiaoming, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P446
   Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035
   Liu GP, 2008, CRYOBIOLOGY, V57, P18, DOI 10.1016/j.cryobiol.2008.04.002
   LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0
   Masaki Y, 2000, TRANSPLANT P, V32, P1623, DOI 10.1016/S0041-1345(00)01445-7
   MAZUR P, 1984, AM J PHYSIOL, V247, pC125
   NAGLE WA, 1990, CRYOBIOLOGY, V27, P439, DOI 10.1016/0011-2240(90)90021-U
   OBRIEN MF, 1991, J CARDIAC SURG, V6, P534
   Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458
   Palmieri M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14338
   Rodriguez RD, 2017, CELL TISSUE BANK, V18, P263, DOI 10.1007/s10561-016-9607-0
   Roe ND, 2013, FREE RADICAL BIO MED, V65, P234, DOI 10.1016/j.freeradbiomed.2013.06.042
   Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035
   Sarkar S, 2008, FEBS J, V275, P4263, DOI 10.1111/j.1742-4658.2008.06562.x
   Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200
   Sarkar S, 2011, MOL CELL, V43, P19, DOI 10.1016/j.molcel.2011.04.029
   Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134
   Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985
   Terry C, 2010, LIVER TRANSPLANT, V16, P229, DOI 10.1002/lt.21983
   Tuncer PB, 2011, THERIOGENOLOGY, V75, P1459, DOI 10.1016/j.theriogenology.2010.12.006
   Wang QR, 2016, PHARMACOL RES, V111, P357, DOI 10.1016/j.phrs.2016.06.024
   Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79
   Xu Y, 2016, RENAL FAILURE, V38, P831, DOI 10.3109/0886022X.2016.1160724
   Yoshida H, 2002, TRANSPLANTATION, V74, P1231, DOI 10.1097/01.TP.0000034467.02725.24
   Zhou XL, 2010, CRYOLETTERS, V31, P147
NR 39
TC 1
Z9 1
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 9
PY 2018
VL 13
IS 3
AR e0194078
DI 10.1371/journal.pone.0194078
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FY7GW
UT WOS:000427030800041
PM 29522567
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Iwaoka, R
   Kataoka, K
AF Iwaoka, Ryo
   Kataoka, Kohsuke
TI RETRACTED: Glucose regulates MafA transcription factor abundance and
   insulin gene expression by inhibiting AMP-activated protein kinase in
   pancreatic beta-cells (Retracted article. See vol. 293, pg. 18403, 2018)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID KEY REGULATOR; PHOSPHORYLATION; IDENTIFICATION; METFORMIN; PDX-1;
   BINDING; SITE
AB Insulin mRNA expression in pancreatic islet beta-cells is up-regulated by extracellular glucose concentration, but the underlying mechanism remains incompletely understood. MafA is a transcriptional activator specifically enriched in beta-cells that binds to the insulin gene promoter. Its expression is transcriptionally and posttranscriptionally regulated by glucose. Moreover, AMP-activated protein kinase (AMPK), a regulator of cellular energy homeostasis, is inhibited by high glucose, and this inhibition is essential for the up-regulation of insulin gene expression and glucose-stimulated insulin secretion (GSIS). Here we mutagenized the insulin promoter and found that the MafA-binding element C1/RIPE3b is required for glucose- or AMPK-induced alterations in insulin gene promoter activity. Under high-glucose conditions, pharmacological activation of AMPK in isolated mouse islets or MIN6 cells by metformin or 5-aminoimidazole-4-carboxamide riboside decreased MafA protein levels and mRNA expression of insulin and GSIS-related genes (i.e. glut2 and sur1). Overexpression of constitutively active AMPK also reduced MafA and insulin expression. Conversely, pharmacological AMPK inhibition by dorsomorphin (compound C) or expression of a dominant-negative form of AMPK increased MafA and insulin expression under low-glucose conditions. However, AMPK activation or inhibition did not change the expression levels of the beta-cell-enriched transcription factors Pdx1 and Beta2/NeuroD1. AMPK activation accelerated MafA protein degradation, which is not dependent on the proteasome. We also noted that MafA overexpression prevents metformin-induced decreases in insulin and GSIS-related gene expression. These findings indicate that high glucose concentrations inhibit AMPK, thereby increasing MafA protein levels and activating the insulin promoter.
C1 [Iwaoka, Ryo; Kataoka, Kohsuke] Yokohama City Univ, Grad Sch Med Life Sci, Lab Mol Med Biosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.
RP Kataoka, K (reprint author), Yokohama City Univ, Grad Sch Med Life Sci, Lab Mol Med Biosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.
EM kkataoka@yokohama-cu.ac.jp
FU Japan Society for the Promotion of Science [25461352, 16K09763]
FX This work was supported by Grants-in-Aid for Scientific Research (C)
   from the Japan Society for the Promotion of Science 25461352 and
   16K09763 (to K. K.). The authors declare that they have no conflicts of
   interest with the contents of this article.
CR Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009
   Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190
   Butler AE, 2012, DIABETOLOGIA, V55, P2985, DOI 10.1007/s00125-012-2666-2
   Chen F, 2015, SCI REP-UK, V5, DOI 10.1038/srep13215
   da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812
   Docherty HM, 2005, BIOCHEM J, V389, P813, DOI 10.1042/BJ20041891
   El Khattabi I, 2013, MOL ENDOCRINOL, V27, P1078, DOI 10.1210/me.2012-1346
   GERMAN MS, 1994, MOL CELL BIOL, V14, P4067, DOI 10.1128/MCB.14.6.4067
   GOTOH M, 1990, HORM METAB RES, V25, P10
   Guo SL, 2013, J CLIN INVEST, V123, P3305, DOI 10.1172/JCI65390
   Guo SL, 2010, J BIOL CHEM, V285, P12655, DOI 10.1074/jbc.M110.105759
   Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06
   Han SI, 2016, ACTA DIABETOL, V53, P651, DOI 10.1007/s00592-016-0853-1
   Han SI, 2011, J BIOL CHEM, V286, P10449, DOI 10.1074/jbc.M110.209510
   Hang Y, 2014, DIABETES, V63, P1994, DOI 10.2337/db13-1001
   Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013
   Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879
   Kanai K, 2010, GENES CELLS, V15, P971, DOI 10.1111/j.1365-2443.2010.01431.x
   Kataoka K, 2002, J BIOL CHEM, V277, P49903, DOI 10.1074/jbc.M206796200
   Kataoka K, 2001, J BIOL CHEM, V276, P819, DOI 10.1074/jbc.M007643200
   Le Lay J, 2004, J BIOL CHEM, V279, P22228, DOI 10.1074/jbc.M312673200
   Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003
   MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762
   Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057
   Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028
   Matsuoka T, 2015, J BIOL CHEM, V290, P7647, DOI 10.1074/jbc.M114.595579
   Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463
   Nagata D, 2009, HYPERTENS RES, V32, P133, DOI 10.1038/hr.2008.25
   NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009
   NIELSEN DA, 1985, J BIOL CHEM, V260, P3585
   Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028
   OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x
   Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499
   Pallottini V, 2007, MECH AGEING DEV, V128, P688, DOI 10.1016/j.mad.2007.10.001
   Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002
   Petersen HV, 2002, FEBS LETT, V528, P241, DOI 10.1016/S0014-5793(02)03318-5
   PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465
   Rafiq I, 2000, J BIOL CHEM, V275, P15977, DOI 10.1074/jbc.275.21.15977
   Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06
   Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413
   Rutter Guy A., 2001, Molecular Aspects of Medicine, V22, P247, DOI 10.1016/S0098-2997(01)00013-9
   Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533
   SHIEH SY, 1991, J BIOL CHEM, V266, P16708
   Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611
   Turner RC, 1998, LANCET, V352, P854
   Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2
   Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005
   Zhao L, 2005, J BIOL CHEM, V280, P11887, DOI 10.1074/jbc.M409475200
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505
NR 49
TC 1
Z9 1
U1 4
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 9
PY 2018
VL 293
IS 10
BP 3524
EP 3534
DI 10.1074/jbc.M117.817932
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FY7GQ
UT WOS:000427030200006
PM 29348175
OA Bronze
DA 2018-12-27
ER

PT J
AU Prasad, S
   Francis, SM
   Krishnan, S
   Bharathi, P
AF Prasad, Sunnapu
   Francis, Saleshier M.
   Krishnan, S.
   Bharathi, P.
TI RETRACTED: SYNTHESIS, SPECTROSCOPIC STUDIES, ANTIBACTERIAL ACTIVITY OF
   CHALCONES AND COLORIMETRIC EVALUATION OF THE TIME-KILLING ASSAY FOR
   NEWLY SYNTHESIZED CHALCONES USING RESAZURIN (Retracted article. See vol.
   63, 2018)
SO REVUE ROUMAINE DE CHIMIE
LA English
DT Article; Retracted Publication
DE chalcones; Time-Killing Assay; colorimetry assay; resazurin;
   pharmacokinetic profile
ID STAPHYLOCOCCUS-AUREUS; COMBINATION; AMIKACIN; CIPROFLOXACIN; CEFTIZOXIME
AB An attempt was made here to synthesize and screen the chalcones against certain Gram positive and Gram negative bacteria by adopting the modified colorimetric technique for Time-Killing Assay. A series of chalcones were synthesized from 1-(2-bromophenyl) ethanone and different substituted aromatic aldehydes with good yield and resolute on the basis of spectral data (FT/IR, H-1 NMR and C-13 NMR). The synthesized chalcones were screened for antibacterial activity against certain Gram positive and Gram negative bacteria. The pharmacokinetic profiles of chalcones were established by Time-Kill Assay, performed by colorimetry using resazurin dye as an indicator which colors only the viable cells. The ethoxy (I-4) and parahydroxy (I-5) derivatives were found to be more potent against Gram positive bacteria. The colorimetric Time-Kill Assay was found to be more convenient and less time consuming than traditional cell viable count.
C1 [Prasad, Sunnapu; Francis, Saleshier M.] Sri Ramakrishna Inst Paramed Sci, Coll Pharm, Dept Pharmaceut Chem, Coimbatore, Tamil Nadu, India.
   [Krishnan, S.; Bharathi, P.] Sri Ramakrishna Inst Paramed Sci, Coll Pharm, Dept Pharmaceut Biotechnol, Coimbatore, Tamil Nadu, India.
RP Prasad, S (reprint author), Sri Ramakrishna Inst Paramed Sci, Coll Pharm, Dept Pharmaceut Chem, Coimbatore, Tamil Nadu, India.
EM prasadpharmachem@gmail.com
CR [Anonymous], 1989, VOGELS TXB PRACTICAL, P1034
   BAMBERGER DM, 1986, J ANTIMICROB CHEMOTH, V18, P51, DOI 10.1093/jac/18.1.51
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Cheesbrough M., 2002, MED LAB MANUAL TROPI, V2, P2
   Dhorajiya D. B., 2012, MED CHEM RES, DOI [10.1007/s00044-012-0395-1., DOI 10.1007/S00044-012-0395-1.]
   ELIOPOULOS G M, 1988, Clinical Microbiology Reviews, V1, P139
   Eliopoulos GM, 1996, ANTIBIOTICS LAB MED, P330
   Eumkeb G, 2010, PHYTOMEDICINE, V18, P40, DOI 10.1016/j.phymed.2010.09.003
   European Comm Antimicrobial Susc, 2000, CLIN MICROBIOL INFEC, V6, P509
   FASCHING CE, 1990, J LAB CLIN MED, V116, P697
   GERDING DN, 1985, J ANTIMICROB CHEMOTH, V15, P207, DOI 10.1093/jac/15.suppl_A.207
   Guerin TF, 2001, LETT APPL MICROBIOL, V32, P340, DOI 10.1046/j.1472-765X.2001.00916.x
   Hsu YL, 2006, FOOD CHEM TOXICOL, V44, P704, DOI 10.1016/j.fct.2005.10.003
   Irkin R, 2007, AFR J BIOTECHNOL, V6, P384
   Kalirajan R., 2009, INT J CHEMTECH RES, V1, P27
   Liu IX, 2000, J PHARM PHARMACOL, V52, P361, DOI 10.1211/0022357001773922
   Lui MP, 2003, BIOORGAN MED CHEM, V11, P2729, DOI 10.1016/S0968-0896(03)00233-5
   Matthew A. W., 2012, M07A9 CLIN LAB STAND, P16
   Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X
   MOODY JA, 1987, DIAGN MICR INFEC DIS, V6, P59, DOI 10.1016/0732-8893(87)90115-5
   PANKUCH GA, 1994, ANTIMICROB AGENTS CH, V38, P2065, DOI 10.1128/AAC.38.9.2065
   Prasad S., 2016, ARAB J CHEM, DOI [10. 1016/j. arabjc. 2016. 03. 003, DOI 10.1016/J.ARABJC.2016.03.003]
   SHANHOLTZER CJ, 1984, ANTIMICROB AGENTS CH, V26, P214, DOI 10.1128/AAC.26.2.214
   Wikler M. A., 2008, PERF STAND ANT SUSC, V1, P46
   Wioletta B. R., 2011, A J MICROBIOL BIOTEC, V5, P536
   Yi X, 2000, BIOORG MED CHEM LETT, V10, P699, DOI 10.1016/S0960-894X(00)00072-X
NR 26
TC 1
Z9 1
U1 0
U2 0
PU EDITURA ACAD ROMANE
PI BUCURESTI
PA CALEA 13 SEPTEMBRIE NR 13, SECTOR 5, BUCURESTI 050711, ROMANIA
SN 0035-3930
J9 REV ROUM CHIM
JI Rev. Roum. Chim.
PD MAR
PY 2018
VL 63
IS 3
BP 161
EP 169
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA GR2HL
UT WOS:000442387600001
DA 2018-12-27
ER

PT J
AU Moreno-Olivas, F
   Tako, E
   Mahler, GJ
AF Moreno-Olivas, Fabiola
   Tako, Elad
   Mahler, Gretchen J.
TI RETRACTED: ZnO nanoparticles affect intestinal function in an in vitro
   model (Retracted article. See vol. 9, pg. 3037, 2018)
SO FOOD & FUNCTION
LA English
DT Article; Retracted Publication
ID ZINC-OXIDE NANOPARTICLES; TIGHT JUNCTION PERMEABILITY; COLON-CARCINOMA
   CELLS; ALKALINE-PHOSPHATASE; ENGINEERED NANOPARTICLES; SILVER
   NANOPARTICLES; IRON BIOAVAILABILITY; TITANIUM-DIOXIDE; CONTROLLED-TRIAL;
   GENE-EXPRESSION
AB Zinc oxide nanoparticles (ZnO NP) may be present in food packaging, which would put consumers at risk of NP ingestion. There is little information on the amount of ZnO NP that are present in food packaging and the effects of ZnO exposure on intestinal function. To estimate physiologically relevant ZnO exposures, foods that are naturally low in zinc (Zn), but are commonly packaged with ZnO NP, such as tuna, corn, and asparagus, were analyzed with inductively coupled plasma mass spectrometry (ICP-MS). It was found that the Zn present in a serving of these foods is approximately one hundred times higher than the recommended dietary allowance. An in vitro model of the small intestine composed of Caco-2 and HT29-MTX cells was used to investigate the effects of ZnO NP exposure. Cells were exposed to physiologically realistic doses of pristine NP in culture medium and to NP subjected to an in vitro digestion to better reflect the transformation that the NP may undergo once they enter the human GI tract. Uptake and/or transport of iron (Fe), Zn, glucose, and fatty acids were assessed and intestinal alkaline phosphatase (IAP) levels were measured before and after NP exposure. The findings show that there is a 75% decrease in Fe transport and a 30% decrease in glucose transport following ZnO NP exposure. These decreases were consistent with gene expression changes for their transporters. There is also evidence that the ZnO NP affect the microvilli of the intestinal cells, therefore reducing the amount of surface area available to absorb nutrients. These results suggest that the ingestion of physiologically relevant doses of ZnO NP can alter intestinal function in an in vitro model of the human small intestine.
C1 [Moreno-Olivas, Fabiola; Mahler, Gretchen J.] Binghamton Univ, Dept Biomed Engn, Binghamton, NY 13902 USA.
   [Tako, Elad] ARS, Plant Soil & Nutr Lab, USDA, Ithaca, NY 14850 USA.
RP Mahler, GJ (reprint author), Binghamton Univ, Dept Biomed Engn, Binghamton, NY 13902 USA.
EM gmahler@binghamton.edu
FU National Institutes of Health [1R15ES022828]; Mexican National Council
   of Science and Technology (CONACyT) Fellowship; Virginia Tech National
   Center for Earth and Environmental Nanotechnology Infrastructure
   (NanoEarth); Nanotechnology Coordinated Infrastructure (NNCI) - NSF
   [ECCS 1542100]
FX This work was supported by the National Institutes of Health
   (1R15ES022828) and the Mexican National Council of Science and
   Technology (CONACyT) Fellowship. This work shared facilities and was
   supported by the Virginia Tech National Center for Earth and
   Environmental Nanotechnology Infrastructure (NanoEarth), a member of the
   Nanotechnology Coordinated Infrastructure (NNCI), supported by NSF (ECCS
   1542100). We would also like to acknowledge Mridu Malik and Andrew
   Goldman for assistance with experimental methods and result analysis.
CR Akinyele IO, 2015, FOOD CHEM, V173, P702, DOI 10.1016/j.foodchem.2014.10.098
   Alkaladi A, 2014, INT J MOL SCI, V15, P2015, DOI 10.3390/ijms15022015
   Alo D. C., 1965, ANTICORROS METHODS M, V12, P17
   Arredondo M, 2006, BIOL RES, V39, P95, DOI 10.4067/S0716-97602006000100011
   Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242
   Barret D. M., 2005, PROCESSING FRUITS SC
   Bergin Ingrid L, 2013, Int J Biomed Nanosci Nanotechnol, V3, DOI 10.1504/IJBNN.2013.054515
   Chalew TEA, 2013, CELL BIOL TOXICOL, V29, P101, DOI 10.1007/s10565-013-9241-6
   Chaudhry Q, 2008, FOOD ADDIT CONTAM A, V25, P241, DOI 10.1080/02652030701744538
   Chen MD, 1998, BIOL TRACE ELEM RES, V61, P303, DOI 10.1007/BF02789090
   Chia SL, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00177
   Chia SL, 2015, SMALL, V11, P702, DOI 10.1002/smll.201401915
   Cho WS, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-27
   Chung HE, 2013, J PHYS CONF SER, V429, DOI 10.1088/1742-6596/429/1/012037
   Collins JF, 2006, BIOL RES, V39, P25, DOI 10.4067/S0716-97602006000100004
   Contado C, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00048
   Corning, TRANSW PERM SUPP SEL
   Cousins RJ, 2000, J NUTR, V130, p1384S, DOI 10.1093/jn/130.5.1384S
   David CA, 2012, J PHYS CHEM C, V116, P11758, DOI 10.1021/jp301671b
   DeSesso JM, 2001, FOOD CHEM TOXICOL, V39, P209, DOI 10.1016/S0278-6915(00)00136-8
   Dieck HT, 2005, J NUTR, V135, P199
   Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005
   Espinoza A, 2012, BIOL TRACE ELEM RES, V146, P281, DOI 10.1007/s12011-011-9243-2
   Espitia PJP, 2016, ANTIMICROBIAL FOOD PACKAGING, P425, DOI 10.1016/B978-0-12-800723-5.00034-6
   Frohlich EE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040509
   Garcia-Rodriguez A, 2018, FOOD CHEM TOXICOL, V113, P162, DOI 10.1016/j.fct.2018.01.042
   Glahn RP, 1998, J NUTR, V128, P1555
   Goldberg RF, 2008, P NATL ACAD SCI USA, V105, P3551, DOI 10.1073/pnas.0712140105
   Gunasekara P, 2011, DIABET METAB SYND OB, V4, P53, DOI 10.2147/DMSO.S16691
   Guo ZY, 2017, NANOIMPACT, V5, P70, DOI 10.1016/j.impact.2017.01.002
   Hackenberg S, 2011, TOXICOL IN VITRO, V25, P657, DOI 10.1016/j.tiv.2011.01.003
   Hanley C, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295103
   Hansen GH, 2011, MOL MEMBR BIOL, V28, P136, DOI 10.3109/09687688.2010.542552
   Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002
   Hekal I. M., 1981, US Pat, Patent No. [4615924A, 4615924]
   Heng BC, 2011, ARCH TOXICOL, V85, P1517, DOI 10.1007/s00204-011-0722-1
   Hillyer JF, 2001, J PHARM SCI, V90, P1927, DOI 10.1002/jps.1143
   Hu CH, 2013, ANIM FEED SCI TECH, V181, P65, DOI 10.1016/j.anifeedsci.2013.02.003
   Jachak A, 2012, NANOTOXICOLOGY, V6, P614, DOI 10.3109/17435390.2011.598244
   Jayawardena R, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-13
   JEQUIER E, 1994, AM J CLIN NUTR, V59, p682S, DOI 10.1093/ajcn/59.3.682S
   Kalberg V., 1951, US-Pat, Patent No. [2561379A, 2561379]
   Kang TS, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-496
   Kelleher SL, 2006, J NUTR, V136, P1185
   Koeneman BA, 2010, CELL BIOL TOXICOL, V26, P225, DOI 10.1007/s10565-009-9132-z
   Krezel A, 2016, ARCH BIOCHEM BIOPHYS, V611, P3, DOI 10.1016/j.abb.2016.04.010
   Kumar Kalyan K V, 2010, J Basic Clin Pharm, V1, P63
   Lalles JP, 2014, NUTR REV, V72, P82, DOI 10.1111/nure.12082
   LESUFFLEUR T, 1990, CANCER RES, V50, P6334
   Lin WS, 2009, J NANOPART RES, V11, P25, DOI 10.1007/s11051-008-9419-7
   Lind T, 2003, AM J CLIN NUTR, V77, P883
   Liu J., 2016, AM J FOOD TECHNOL, V11, P159
   Liu W, 2015, J AM COLL SURGEONS, V221, pE99, DOI 10.1016/j.jamcollsurg.2015.08.161
   Liu Z, 2005, ACTA PAEDIATR, V94, P386, DOI 10.1080/08035250410023304
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LYALL V, 1979, BIOCHEM MED METAB B, V22, P192, DOI 10.1016/0006-2944(79)90005-X
   Mahler GJ, 2012, NAT NANOTECHNOL, V7, P264, DOI [10.1038/NNANO.2012.3, 10.1038/nnano.2012.3]
   Mahler GJ, 2009, BIOTECHNOL BIOENG, V104, P193, DOI 10.1002/bit.22366
   Mahler GJ, 2009, J NUTR BIOCHEM, V20, P494, DOI 10.1016/j.jnutbio.2008.05.006
   Mendez RO, 2014, NUTRIENTS, V6, P2229, DOI 10.3390/nu6062229
   Mizumori M, 2009, J PHYSIOL-LONDON, V587, P3651, DOI 10.1113/jphysiol.2009.172270
   Moos PJ, 2011, METALLOMICS, V3, P1199, DOI 10.1039/c1mt00061f
   Narai A, 1997, TOXICOL IN VITRO, V11, P347, DOI 10.1016/S0887-2333(97)00026-X
   Ng KW, 2011, BIOMATERIALS, V32, P8218, DOI 10.1016/j.biomaterials.2011.07.036
   O'Halloran TV, 2013, J CLIN INVEST, V123, P4136, DOI 10.1172/JCI72325
   PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x
   Espitia PJP, 2012, FOOD BIOPROCESS TECH, V5, P1447, DOI 10.1007/s11947-012-0797-6
   Pierce K., 1969, US-Pat, Patent No. 3450656
   Ramonaityte DT, 2001, FOOD ADDIT CONTAM, V18, P31, DOI 10.1080/02652030010008805
   Ranaldi G, 2002, J NUTR BIOCHEM, V13, P157, DOI 10.1016/S0955-2863(01)00208-X
   Reed RB, 2012, ENVIRON TOXICOL CHEM, V31, P93, DOI 10.1002/etc.708
   Renn O, 2006, J NANOPART RES, V8, P153, DOI 10.1007/s11051-006-9092-7
   Robertson G. L., 2012, FOOD PACKAGING PRINC, V1
   Rocquet P., 1970, BR CORR J, V5, P193
   RODRIGUEZYOLDI MC, 1995, BIOL TRACE ELEM RES, V50, P1, DOI 10.1007/BF02789144
   Roohani N, 2013, J RES MED SCI, V18, P144
   Roselli M, 2003, J NUTR, V133, P4077
   Sahu D, 2014, J TOXICOL ENV HEAL A, V77, P177, DOI 10.1080/15287394.2013.853224
   SCOTT BJ, 1983, CLIN CHEM, V29, P629
   Setyawati MI, 2015, SMALL, V11, P3458, DOI 10.1002/smll.201403232
   Setyawati MI, 2013, BIOMATERIALS, V34, P10133, DOI 10.1016/j.biomaterials.2013.09.024
   Song P, 2016, EXPERT OPIN THER TAR, V20, P1109, DOI 10.1517/14728222.2016.1168808
   Song YJ, 2014, MUTAT RES-FUND MOL M, V769, P113, DOI 10.1016/j.mrfmmm.2014.08.001
   Srivastav A. K., 2016, HUM EXP TOXICOL, P1
   Tiede K, 2008, FOOD ADDIT CONTAM A, V25, P795, DOI 10.1080/02652030802007553
   Tso CP, 2010, WATER SCI TECHNOL, V61, P127, DOI 10.2166/wst.2010.787
   Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657
   Vandebriel RJ, 2012, NANOTECHNOL SCI APPL, V5, P61, DOI 10.2147/NSA.S23932
   Wang XX, 2013, DIGEST DIS SCI, V58, P77, DOI 10.1007/s10620-012-2328-8
   WATKINS DW, 1989, PFLUG ARCH EUR J PHY, V415, P165, DOI 10.1007/BF00370588
   Weir A, 2012, ENVIRON SCI TECHNOL, V46, P2242, DOI 10.1021/es204168d
   Wiesinger JA, 2016, J AGR FOOD CHEM, V64, P8592, DOI 10.1021/acs.jafc.6b03100
   Wilfinger WW, 1997, BIOTECHNIQUES, V22, P474, DOI 10.2144/97223st01
   Wong SWY, 2010, ANAL BIOANAL CHEM, V396, P609, DOI 10.1007/s00216-009-3249-z
   Yam KL, 2009, WILEY ENCY PACKAGING
   Yancy WS, 2004, ANN INTERN MED, V140, P769, DOI 10.7326/0003-4819-140-10-200405180-00006
   Yun SM, 2004, J NUTR, V134, P2717
   Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033
   Zijno A, 2015, TOXICOL IN VITRO, V29, P1503, DOI 10.1016/j.tiv.2015.06.009
   Zodl B, 2003, J INORG BIOCHEM, V97, P324, DOI 10.1016/S0162-0134(03)00312-X
   Zoller H, 2003, GASTROENTEROLOGY, V125, P746, DOI 10.1016/S0016-5085(03)01063-1
NR 101
TC 4
Z9 4
U1 5
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD MAR
PY 2018
VL 9
IS 3
BP 1475
EP 1491
DI 10.1039/c7fo02038d
PG 17
WC Biochemistry & Molecular Biology; Food Science & Technology
SC Biochemistry & Molecular Biology; Food Science & Technology
GA GF1TB
UT WOS:000431717400014
PM 29493670
DA 2018-12-27
ER

PT J
AU Sasapu, A
   Atwal, D
   Insuasti-Beltran, G
   Jethava, Y
AF Sasapu, Appalanaidu
   Atwal, Dinesh
   Insuasti-Beltran, Giovanni
   Jethava, Yogesh
TI RETRACTED: Primary CNS high-grade B-cell lymphoma, with rearrangements
   of MYC and BCL6 : a case report (Retracted article. See vol. 53, pg.
   182, 2018)
SO BLOOD RESEARCH
LA English
DT Letter; Retracted Publication
ID CENTRAL-NERVOUS-SYSTEM; EXPRESSION; PROGNOSIS
C1 [Sasapu, Appalanaidu; Atwal, Dinesh] Univ Arkansas Med Sci, Dept Internal Med, Div Hematol, Little Rock, AR 72205 USA.
   [Insuasti-Beltran, Giovanni] Univ Arkansas Med Sci, Dept Pathol & Lab Med, Little Rock, AR 72205 USA.
   [Jethava, Yogesh] Univ Iowa, Dept Internal Med, Div Hematol Oncol & Blood & Marrow Transplantat, Iowa City, IA 52242 USA.
RP Sasapu, A (reprint author), Dept Med, Div Hematol, 4301 W Markham St, Little Rock, AR 72205 USA.
EM A.Sasapu@uams.edu
CR Brunn A, 2013, ACTA NEUROPATHOL, V126, P603, DOI 10.1007/s00401-013-1169-7
   Ferreri AJM, 2016, LANCET HAEMATOL, V3, pE217, DOI 10.1016/S2352-3026(16)00036-3
   Gill KZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114398
   Hoang-Xuan K, 2015, LANCET ONCOL, V16, pE322, DOI 10.1016/S1470-2045(15)00076-5
   Kim S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2397-8
   Kreher S, 2015, NEURO-ONCOLOGY, V17, P1016, DOI 10.1093/neuonc/nov046
   Nayak Lakshmi, 2015, Continuum (Minneap Minn), V21, P355, DOI 10.1212/01.CON.0000464175.96311.0a
   Rosenthal A, 2017, BLOOD REV, V31, P37, DOI 10.1016/j.blre.2016.09.004
   Sakurai H, 2015, J CLIN ONCOL, V33, pE79, DOI 10.1200/JCO.2013.49.1316
   Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569
   Tapia G, 2015, APMIS, V123, P596, DOI 10.1111/apm.12390
NR 11
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC HEMATOLOGY
PI SEOUL
PA KINGS GARDEN OFF 2-220, 24, SAJIK-RO 8-GIL, JONGNO-GU, SEOUL, 03174,
   SOUTH KOREA
SN 2287-979X
EI 2288-0011
J9 BLOOD RES
JI Blood Res.
PD MAR
PY 2018
VL 53
IS 1
BP 87
EP 89
DI 10.5045/br.2018.53.1.87
PG 4
WC Hematology
SC Hematology
GA GC3PW
UT WOS:000429697000019
PM 29662870
OA Other Gold, Green Published
DA 2018-12-27
ER

PT J
AU Bhat, IH
   Singh, S
AF Bhat, Ishfaq Hussain
   Singh, Sapna
TI RETRACTED: Examining the moderating effect of shopping value on
   private-label and loyalty in Indian grocery stores (Retracted article.
   See vol. 13, pg. 995. 2018)
SO MANAGEMENT & MARKETING-CHALLENGES FOR THE KNOWLEDGE SOCIETY
LA English
DT Article; Retracted Publication
DE Store Loyalty; Private Label; Shopping Value; Utilitarian Value; Hedonic
   value
ID BRAND EQUITY; CONSUMER; IMPACT; SATISFACTION; QUALITY; SHARE;
   DETERMINANTS; UTILITARIAN; PERSPECTIVE; PERFORMANCE
AB The present study has attempted to create and examine a conceptually grounded working model that examines the moderating influence of utilitarian and hedonic shopping values with Indian grocery stores on the association between usage of Private Label (PL) and Store Loyalty (SL). For this, primary data was collected from 350 consumers, from different stores in India selling PL products. The theoretical model was analyzed using SEM. The findings of the study reflect that an inverse relationship between PL usage and SL. However, the presence of utilitarian shopping value reverses this into a positive linkage between PL usage and SL. This finding reflects some intriguing ramifications for retailers and corporate. For instance, evolving and aligning different marketing strategies help the retailers in creating the necessary USV so as to create shopping involvement that may help retailers to upgrade their SL in a favourable manner over the long term. Earlier research has not examined the involvement of PL items from the viewpoint of shopping value. Subsequently, this paper endeavours to examine the regulating effect of shopping value on the PL consumption and SL.
C1 [Bhat, Ishfaq Hussain; Singh, Sapna] Univ Hyderabad, Hyderabad, Andhra Pradesh, India.
RP Bhat, IH (reprint author), Univ Hyderabad, Hyderabad, Andhra Pradesh, India.
EM ishfaq8086@gmail.com
CR Ailawadi KL, 2004, J MARKETING, V68, P147, DOI 10.1509/jmkg.68.1.147.24027
   Ailawadi KL, 2001, J MARKETING, V65, P71, DOI 10.1509/jmkg.65.1.71.18132
   Ailawadi KL, 2001, J RETAILING, V77, P299, DOI 10.1016/S0022-4359(01)00047-1
   Ailawadi KL, 2008, J MARKETING, V72, P19, DOI 10.1509/jmkg.72.6.19
   Aithal R., 2009, 3 IIMA C MARK PAR EM
   Atulkar S, 2017, J RETAIL CONSUM SERV, V39, P23, DOI [10.1016/j.jretconser.2017.06.013, 10.1016/j.jretconser.2016.03.005]
   BABIN BJ, 1994, J CONSUM RES, V20, P644, DOI 10.1086/209376
   Baltas G, 1997, J OPER RES SOC, V48, P988, DOI 10.2307/3010118
   Bedi S. S., 2014, ASIAN J RES SOCIAL S, V4, P171
   Beneke J, 2015, INT J RETAIL DISTRIB, V43, P43, DOI 10.1108/IJRDM-09-2013-0175
   Bhat I. H., 2017, INT J APPL BUSINESS, V15, P49
   Bhukya R, 2015, AM J BUS, V30, P218, DOI 10.1108/AJB-10-2014-0055
   Bonett DG, 2015, J ORGAN BEHAV, V36, P3, DOI 10.1002/job.1960
   Chandon P, 2000, J MARKETING, V64, P65, DOI 10.1509/jmkg.64.4.65.18071
   Choi SC, 2017, J RETAIL CONSUM SERV, V34, P335, DOI 10.1016/j.jretconser.2016.07.011
   Cronin JJ, 2000, J RETAILING, V76, P193, DOI 10.1016/S0022-4359(00)00028-2
   Cuneo A, 2012, EUR J MARKETING, V46, P952, DOI 10.1108/03090561211230124
   Dawes J, 2013, J BUS RES, V66, P60, DOI 10.1016/j.jbusres.2011.07.023
   Dhar R, 2000, J MARKETING RES, V37, P60, DOI 10.1509/jmkr.37.1.60.18718
   Dick Alan S, 1994, J ACAD MARKET SCI, V22, P99, DOI DOI 10.1177/0092070394222001
   Dijkstra TK, 2015, MIS QUART, V39, P297, DOI 10.25300/MISQ/2015/39.2.02
   do Vale RC, 2016, J RETAIL CONSUM SERV, V28, P179, DOI 10.1016/j.jretconser.2015.10.003
   El-Adly MI, 2016, J RETAIL CONSUM SERV, V31, P217, DOI 10.1016/j.jretconser.2016.04.002
   Ellickson P. B., 2017, PRIVATE LABELS RETAI
   Fong S. W. L., 2015, J ADV MANAG SCI, V3, P312
   Girard T, 2017, J MARKET THEORY PRAC, V25, P39, DOI 10.1080/10696679.2016.1236662
   Gonzalez-Benito O, 2012, J RETAILING, V88, P236, DOI 10.1016/j.jretai.2011.05.003
   Haas R., 2017, CONSUMER TRENDS NEW, P35
   Hair J. F., 2013, PRIMER PARTIAL LEAST
   Hansen K, 2008, MANAGE SCI, V54, P1828, DOI 10.1287/mnsc.1080.0861
   HIRSCHMAN EC, 1982, J MARKETING, V46, P92, DOI 10.2307/1251707
   HOLBROOK MB, 1984, J CONSUM RES, V11, P728, DOI 10.1086/209009
   Ipek I, 2016, J RETAIL CONSUM SERV, V31, P72, DOI 10.1016/j.jretconser.2016.03.011
   Kilic S., 2009, ANADOLU U J SOC SCI, V9, P49
   Koschate-Fischer N, 2014, J MARKETING, V78, P69, DOI 10.1509/jm.13.0075
   Krishnamurti S., 2017, INDIAN J MARKETING, V47, P7
   Marsh HW, 2004, PSYCHOL METHODS, V9, P275, DOI 10.1037/1082-989X.9.3.275
   Nenycz-Thiel M, 2015, SPR PROC BUS ECON, P35, DOI 10.1007/978-3-319-20182-5_4
   Nenycz-Thiel M, 2016, J RETAIL CONSUM SERV, V29, P22, DOI 10.1016/j.jretconser.2015.10.008
   Nielsen, 2014, STAT PRIV LAB WORLD
   Obeng E, 2016, J RETAILING, V92, P383, DOI 10.1016/j.jretai.2016.07.001
   Pepe MS, 2011, J PROD BRAND MANAG, V20, P27, DOI 10.1108/10610421111107996
   RAO TR, 1969, J MARKETING RES, V6, P447, DOI 10.2307/3150080
   RICHARDSON PS, 1994, J MARKETING, V58, P28, DOI 10.2307/1251914
   Sethuraman R., 2006, PRIVATE LABEL MARKET
   Sirakaya-Turk E, 2015, J BUS RES, V68, P1878, DOI 10.1016/j.jbusres.2015.01.016
   Stanton JL, 2015, INT J RETAIL DISTRIB, V43, P815, DOI 10.1108/IJRDM-11-2013-0212
   Steenkamp JBEM, 1997, LONG RANGE PLANN, V30, P917, DOI 10.1016/S0024-6301(97)00077-0
   Stoel L, 2004, J BUS RES, V57, P1067, DOI 10.1016/S0148-2963(03)00016-X
NR 49
TC 1
Z9 1
U1 3
U2 3
PU DE GRUYTER POLAND SP ZOO
PI WARSAW
PA BOGUMILA ZUGA 32A STR., 01-811 WARSAW, POLAND
SN 1842-0206
EI 2069-8887
J9 MANAG MARK
JI Manag. Mark.
PD MAR
PY 2018
VL 13
IS 1
BP 748
EP 760
DI 10.2478/mmcks-2018-0003
PG 13
WC Business
SC Business & Economics
GA GA3VV
UT WOS:000428258900003
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Ng, CY
   Tzeng, IS
   Liu, SH
   Chang, YC
   Huang, YH
AF Ng, Chau Yee
   Tzeng, I-Shiang
   Liu, Su-Hsun
   Chang, Ya-Ching
   Huang, Yu-Huei
TI RETRACTED: Metabolic parameters in psoriatic patients treated with
   interleukin-12/23 blockade (ustekinumab) (Retracted article. See vol.
   45, pg. 1026, 2018)
SO JOURNAL OF DERMATOLOGY
LA English
DT Article; Retracted Publication
DE lipid; metabolic; psoriasis; triglyceride; ustekinumab
ID RHEUMATOID-ARTHRITIS; INSULIN-RESISTANCE; CLINICAL-FEATURES; PLAQUE
   PSORIASIS; LIPID PROFILE; SERUM IL-12; ASSOCIATION; TRIGLYCERIDE;
   MORTALITY; OBESITY
AB The associations between psoriasis, metabolic syndrome and cardiovascular events are increasingly recognized. Studies have shown decreased cardiovascular events with the treatment of methotrexate and anti-tumor necrosis factor, however, effects of interleukin (IL)-12/23 blockade remain debatable. Our study investigated the effect of IL-12/23 blockade on the metabolic parameters in patients with psoriasis. We performed a retrospective cohort study to assess 93 consecutive patients with moderate to severe plaque type psoriasis who received IL-12/23 blockade (ustekinumab) for 24 weeks between January 2012 and May 2016. Metabolic parameters and disease activity (Psoriasis Area and Severity Index [PASI] score) at baseline and 24 weeks of treatment were collected. At week 24, the disease activity improved significantly (P < 0.0001), with a significant reduction of erythrocyte sedimentation rate. Conversely, body mass index was significantly elevated in PASI-75 responders at week 24 of treatment and was independent of disease severity. Fasting sugar and triglyceride levels were also elevated at week 24 in both PASI-75 responders and PASI-75 non-responders. Cholesterol, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) remained unchanged. These metabolic parameters were not correlated with the improvement in disease severity after ustekinumab treatment. Nonetheless, the atherogenic index, LDL/HDL ratio and cholesterol/HDL ratio remained unchanged. Male sex and cigarette smoking are predictors of elevated plasma triglyceride levels. Our results suggest that despite tremendous improvement in disease activity after ustekinumab treatment, obesity, fasting sugar and hypertriglyceridemia still present in these patients. Regular screening of lipid profile, obesity control and smoking cessation are advised during the treatment of ustekinumab especially in male psoriatic patients with predisposing cardiovascular risks.
C1 [Ng, Chau Yee; Chang, Ya-Ching; Huang, Yu-Huei] Chang Gung Mem Hosp, Linkou Branch, Dept Dermatol, 5 Fushin St, Taoyuan 333, Taiwan.
   [Ng, Chau Yee; Liu, Su-Hsun; Chang, Ya-Ching; Huang, Yu-Huei] Chang Gung Univ, Sch Med, Coll Med, Taoyuan, Taiwan.
   [Ng, Chau Yee] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan.
   [Tzeng, I-Shiang] Taipei Tzu Chi Hosp, Dept Res, Buddhist Tzu Chi Med Fdn, Taipei, Taiwan.
   [Tzeng, I-Shiang; Liu, Su-Hsun] Chang Gung Mem Hosp, Dept Family Med, Taoyuan, Taiwan.
RP Huang, YH (reprint author), Chang Gung Mem Hosp, Linkou Branch, Dept Dermatol, 5 Fushin St, Taoyuan 333, Taiwan.
EM huang3764@yahoo.com.tw
FU Chang Gung Memorial Hospital, Linkou [CMRPG 1F0061, 1F0062, MOST
   104-2314-B-182A-082]
FX This study was supported by Chang Gung Memorial Hospital, Linkou (CMRPG
   1F0061, 1F0062, MOST 104-2314-B-182A-082).
CR Abuabara K, 2010, BRIT J DERMATOL, V163, P586, DOI 10.1111/j.1365-2133.2010.09941.x
   Ahlehoff O, 2015, J EUR ACAD DERMATOL, V29, P1128, DOI 10.1111/jdv.12768
   Amstrong AW, 2014, BRIT J DERMATOL, V170, P301
   Azfar RS, 2008, CURR OPIN RHEUMATOL, V20, P416, DOI 10.1097/BOR.0b013e3283031c99
   Aznaouridis K, 2007, HEART, V93, P613, DOI 10.1136/hrt.2006.095554
   Baran A, 2015, POSTEP DERM ALERGOL, V32, P101, DOI 10.5114/pdia.2014.40960
   Bluher M, 2005, EXP CLIN ENDOCR DIAB, V113, P534, DOI 10.1055/s-2005-872851
   Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x
   Carbo N, 1994, CLIN SCI, V87, P249
   Cauza E, 2002, WIEN KLIN WOCHENSCHR, V114, P1004
   Channual J, 2009, DERMATOL THER, V22, P61, DOI 10.1111/j.1529-8019.2008.01217.x
   Cullen P, 2008, AM J CARDIOL, V9, P943
   David W, 2011, J IMMUNOL, V186
   DESSI S, 1995, BRIT J CANCER, V72, P1138, DOI 10.1038/bjc.1995.477
   Eder L, 2015, THER ADV MUSCULOSKEL, V7, P187, DOI 10.1177/1759720X15591801
   Esposito M, 2009, INT J IMMUNOPATH PH, V22, P219, DOI 10.1177/039463200902200124
   FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q
   Fleming P, 2015, J CUTAN MED SURG, V19, P450, DOI 10.1177/1203475415586332
   Gelfand JM, 2007, ARCH DERMATOL, V143, P1493, DOI 10.1001/archderm.143.12.1493
   Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3
   Horreau C, 2013, J AM ACAD DERMATOL, V68, P654
   Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508
   Jung SH, 2008, J NUTR BIOCHEM, V19, P371, DOI 10.1016/j.jnutbio.2007.05.007
   Kiortsis DN, 2006, J RHEUMATOL, V33, P921
   Ma C, 2013, BRIT J DERMATOL, V168, P486, DOI 10.1111/bjd.12101
   Mallbris L, 2004, EUR J EPIDEMIOL, V19, P225
   Millan J, 2009, VASC HEALTH RISK MAN, V5, P757
   Mishra M, 2011, DIABETES RES CLIN PR, V94, P255, DOI 10.1016/j.diabres.2011.07.037
   Myers WA, 2006, CLIN DERMATOL, V24, P438, DOI 10.1016/j.clindermatol.2006.07.006
   Naldi L, 2014, NEDERLANDSE VERENIGI, V3, P135
   Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595
   Nikolajuk A, 2015, METAB SYNDR RELAT D, V13, P336, DOI 10.1089/met.2014.0164
   Owczarczyk-Saczonek A, 2014, POSTEP DERM ALERGOL, V31, P29, DOI 10.5114/pdia.2014.40656
   Prey S, 2010, J EUR ACAD DERMATOL, V24, P23, DOI 10.1111/j.1468-3083.2009.03564.x
   Reddy M, 2010, J DERMATOL, V37, P413, DOI 10.1111/j.1346-8138.2010.00802.x
   Ryan C, 2011, JAMA-J AM MED ASSOC, V306, P864, DOI 10.1001/jama.2011.1211
   Senti M, 1998, METABOLISM, V47, P1040, DOI 10.1016/S0026-0495(98)90274-8
   Seriolo B, 2006, ANN NY ACAD SCI, V1069, P414, DOI 10.1196/annals.1351.039
   Shlyankevich J, 2014, AM J MED, V127, P1148, DOI 10.1016/j.amjmed.2014.08.008
   Takahashi H, 2012, J DERMATOL, V39, P212, DOI 10.1111/j.1346-8138.2011.01408.x
   Tam LS, 2007, CLIN RHEUMATOL, V26, P1495, DOI 10.1007/s10067-007-0539-8
   Tzellos T, 2013, J EUR ACAD DERMATOL, V27, P622, DOI 10.1111/j.1468-3083.2012.04500.x
   Tzellos T, 2012, DERM-ENDOCRINOL, V4, DOI 10.4161/derm.23100
   Uyemura K, 1996, J CLIN INVEST, V97, P2130, DOI 10.1172/JCI118650
   Voloshyna I, 2016, CLIN EXP DERMATOL, V41, P308, DOI 10.1111/ced.12699
   Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269
NR 46
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0385-2407
EI 1346-8138
J9 J DERMATOL
JI J. Dermatol.
PD MAR
PY 2018
VL 45
IS 3
SI SI
BP 309
EP 313
DI 10.1111/1346-8138.14079
PG 5
WC Dermatology
SC Dermatology
GA FY0UP
UT WOS:000426528100017
PM 28980716
DA 2018-12-27
ER

PT J
AU Carre, AL
   Hu, MS
   James, AW
   Kawai, K
   Galvez, MG
   Longaker, MT
   Lorenz, HP
AF Carre, Antoine L.
   Hu, Michael S.
   James, Aaron W.
   Kawai, Kenichiro
   Galvez, Michael G.
   Longaker, Michael T.
   Lorenz, H. Peter
TI RETRACTED: beta-Catenin-Dependent Wnt Signaling: A Pathway in Acute
   Cutaneous Wounding (Retracted article. See vol. 142, pg. 1107, 2018)
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article; Retracted Publication
ID TRANSFORMING GROWTH-FACTOR-BETA-1; TGF-BETA; CELLS; FETAL; EXPRESSION;
   DIFFERENTIATION; FIBROBLASTS; SKIN; REGENERATION; TGF-BETA-1
AB Background: Acute wound healing is a dynamic process that results in the formation of scar tissue. The mechanisms of this process are not well understood; numerous signaling pathways are thought to play a major role. Here, the authors have identified -catenin-dependent Wnt signaling as an early acute-phase reactant in acute wound healing and scar formation.
   Methods: The authors created 6-mm full-thickness excisional cutaneous wounds on adult -catenin-dependent Wnt signal (BAT-gal) reporter mice. The expression of canonical Wnt after wounding was analyzed using X-gal staining and quantitative real-time polymerase chain reaction. Next, recombinant mouse Wnt3a (rmWnt3a) was injected subcutaneously to the wound edge, daily. The mice were killed at stratified time points, up to 15 days after injury. Histologic analysis, quantitative real-time polymerase chain reaction, and Western blot were performed.
   Results: Numerous individual Wnt ligands increased in expression after wounding, including Wnt3a, Wnt4, Wnt10a, and Wnt11. A specific pattern of Wnt activity was observed, localized to the hair follicle and epidermis. Mice injected with rmWnt3a exhibited faster wound closure, increased scar size, and greater expression of fibroblast growth factor receptor-2 and type I collagen.
   Conclusions: The authors' data suggest that -catenin-dependent Wnt signaling expression increases shortly after cutaneous wounding, and exogenous rmWnt3a accelerates reepithelialization, wound matrix maturation, and scar formation. Future experiments will focus on the intersection of Wnt signaling and other known profibrotic cytokines.
C1 [Carre, Antoine L.; Hu, Michael S.; James, Aaron W.; Kawai, Kenichiro; Galvez, Michael G.; Longaker, Michael T.; Lorenz, H. Peter] Stanford Univ, Sch Med, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA.
RP Lorenz, HP (reprint author), Stanford Univ, Sch Med, 257 Campus Dr, Stanford, CA 94305 USA.
EM plorenz@stanford.edu
FU Hagey Foundation; National Institute of General Medical Sciences [R01
   GM087609]
FX This work was supported by the Hagey Foundation and National Institute
   of General Medical Sciences (R01 GM087609) (to H.P.L.).
CR Adolphe Christelle, 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009890
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Bastakoty D, 2015, FASEB J, V29, P4881, DOI 10.1096/fj.15-275941
   Bowley E, 2007, J SURG RES, V138, P141, DOI 10.1016/j.jss.2006.07.026
   Bullard KM, 2003, WORLD J SURG, V27, P54, DOI 10.1007/s00268-002-6737-2
   Carre AL, 2010, PLAST RECONSTR SURG, V125, P74, DOI 10.1097/PRS.0b013e3181c495d1
   Chan CKF, 2017, SCIENCE, V355, P693, DOI 10.1126/science.aam6748
   Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com
   Colwell AS, 2006, PLAST RECONSTR SURG, V117, P2297, DOI 10.1097/01.prs.0000218708.16909.31
   Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4
   Galiano RD, 2004, WOUND REPAIR REGEN, V12, P485, DOI 10.1111/j.1067-1927.2004.12404.x
   Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hu MS, 2014, J SURG RES, V190, P344, DOI 10.1016/j.jss.2014.02.030
   Hu M, 2007, GASTROENTEROLOGY, V133, P1579, DOI 10.1053/j.gastro.2007.08.036
   Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766
   James AW, 2008, PLAST RECONSTR SURG, V122, P53, DOI 10.1097/PRS.0b013e31817747b5
   James AW, 2009, PLAST RECONSTR SURG, V123, P31, DOI 10.1097/PRS.0b013e3181904c19
   Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106
   Labus Marie B., 1998, Wound Repair and Regeneration, V6, P58, DOI 10.1046/j.1524-475X.1998.60109.x
   Leavitt T, 2016, CELL TISSUE RES, V365, P483, DOI 10.1007/s00441-016-2424-8
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   LONGAKER MT, 1990, J PEDIATR SURG, V25, P430, DOI 10.1016/0022-3468(90)90387-O
   Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417
   Okuse T, 2005, WOUND REPAIR REGEN, V13, P491, DOI 10.1111/j.1067-1927.2005.00069.x
   Pardue Erin L, 2008, Organogenesis, V4, P203
   Plikus MV, 2017, SCIENCE, V355, P748, DOI 10.1126/science.aai8792
   Sato M, 2006, ACTA DERM-VENEREOL, V86, P300, DOI 10.2340/00015555-0101
   Smith JC, 2008, J INVEST DERMATOL, V128, P1298, DOI 10.1038/sj.jid.5701149
   Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2
   Whyte JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076883
   Xu Y, 2008, PLAST RECONSTR SURG, V122, P1649, DOI 10.1097/PRS.0b013e31818cbf44
   Zhang DL, 2009, BIOCHEM BIOPH RES CO, V378, P149, DOI 10.1016/j.bbrc.2008.11.011
NR 33
TC 1
Z9 1
U1 3
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0032-1052
EI 1529-4242
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD MAR
PY 2018
VL 141
IS 3
BP 669
EP 678
DI 10.1097/PRS.0000000000004170
PG 10
WC Surgery
SC Surgery
GA FX6PM
UT WOS:000426207900058
PM 29481398
DA 2018-12-27
ER

PT J
AU Lee, J
   Park, EB
   Min, J
   Sung, E
   Jang, Y
   Shin, JS
   Chun, D
   Kim, KH
   Hwang, J
   Lee, MK
   Go, YY
   Kwon, D
   Kim, M
   Kang, SJ
   Choi, BS
AF Lee, Janghyun
   Park, Eun-Byeol
   Min, Jiyoun
   Sung, Eun
   Jang, Yejin
   Shin, Jin Soo
   Chun, Dongmin
   Kim, Ki-Hun
   Hwang, Jihyun
   Lee, Mi-Kyung
   Go, Yun Young
   Kwon, Dohyeong
   Kim, Meehyein
   Kang, Suk-Jo
   Choi, Byong-Seok
TI RETRACTED: Systematic editing of synthetic RIG-I ligands to produce
   effective antiviral and anti-tumor RNA immunotherapies (Retracted
   article. See vol. 46, pg. 10533, 2018)
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article; Retracted Publication
ID DOUBLE-STRANDED-RNA; IMMUNOGENIC CELL-DEATH; STRUCTURAL BASIS; CANCER
   CELLS; PATTERN-RECOGNITION; ACTIVATION; INSIGHTS; PANHANDLE; DYNAMICS;
   CONFORMATION
AB Retinoic acid-inducible gene I (RIG-I) recognizes double-stranded viral RNAs (dsRNAs) containing two or three 5' phosphates. A few reports of 5'PPP-independent RIG-I agonists have emerged, but little is known about the molecular principles underlying their recognition. We recently found that the bent duplex RNA from the influenza A panhandle promoter activates RIG-I even in the absence of a 5'-triphosphate moiety. Here, we report that non-canonical synthetic RNA oligonucleotides containing G-U wobble base pairs that form a bent helix can exert RIG-I-mediated antiviral and anti-tumor effects in a sequence-and site-dependent manner. We present synthetic RNAs that have been systematically modified to enhance their efficacy and we outline the basic principles for engineering RIG-I agonists applicable to immunotherapy.
C1 [Lee, Janghyun; Sung, Eun; Kim, Ki-Hun; Hwang, Jihyun; Lee, Mi-Kyung; Choi, Byong-Seok] Korea Adv Inst Sci & Technol, Dept Chem, 291 Daehak Ro, Daejeon 34141, South Korea.
   [Park, Eun-Byeol; Min, Jiyoun; Chun, Dongmin; Kwon, Dohyeong; Kang, Suk-Jo] Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea.
   [Jang, Yejin; Shin, Jin Soo; Go, Yun Young; Kim, Meehyein] Korea Res Inst Chem Technol, Ctr Virus Res & Testing, 141 Gajeong Ro, Daejeon 34114, South Korea.
   [Lee, Mi-Kyung] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, 125 Gwahak Ro, Daejeon 34141, South Korea.
RP Choi, BS (reprint author), Korea Adv Inst Sci & Technol, Dept Chem, 291 Daehak Ro, Daejeon 34141, South Korea.; Kang, SJ (reprint author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea.; Kim, M (reprint author), Korea Res Inst Chem Technol, Ctr Virus Res & Testing, 141 Gajeong Ro, Daejeon 34114, South Korea.
EM mkim@krict.re.kr; suk-jo.kang@kaist.ac.kr; byongseok.choi@kaist.ac.kr
FU National Research Foundation of Korea [2015R1A2A2 A01005688,
   2015R1A2A1A15055329, 2017R1 A2B4007817]; Korea Drug Development Fund -
   MSIT; MOTIE; MOHW [KDDF-201706-06]; KRICT [KK1703-E00]; Korea Drug
   Development Fund [KDDF-201706-06]
FX National Research Foundation of Korea [2015R1A2A2 A01005688,
   2015R1A2A1A15055329 to B.-S.C., 2017R1 A2B4007817 to S.-J.K.]; Korea
   Drug Development Fund funded by MSIT, MOTIE, and MOHW [KDDF-201706-06 to
   B.-S.C.]; KRICT [KK1703-E00 to M.K.]. Funding for open access charge:
   Korea Drug Development Fund [KDDF-201706-06 to B.-S.C.].
CR AboulEla F, 1996, NUCLEIC ACIDS RES, V24, P3974, DOI 10.1093/nar/24.20.3974
   Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560
   Bae SH, 2001, P NATL ACAD SCI USA, V98, P10602, DOI 10.1073/pnas.191268798
   Bailor MH, 2010, SCIENCE, V327, P202, DOI 10.1126/science.1181085
   Beljanski V, 2015, J VIROL, V89, P10612, DOI 10.1128/JVI.01526-15
   Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155
   Casiano-Negroni A, 2007, BIOCHEMISTRY-US, V46, P6525, DOI 10.1021/bi700335n
   Cheong HK, 1999, NUCLEIC ACIDS RES, V27, P1392, DOI 10.1093/nar/27.5.1392
   Chiang C, 2015, J VIROL, V89, P8011, DOI 10.1128/JVI.00845-15
   Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190
   Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113
   Do Hwang S, 2010, VACCINE, V28, P2957, DOI 10.1016/j.vaccine.2010.02.016
   Dowdy SF, 2017, NAT BIOTECHNOL, V35, P222, DOI 10.1038/nbt.3802
   Duewell P, 2014, CELL DEATH DIFFER, V21, P1825, DOI 10.1038/cdd.2014.96
   Eckstein F, 2014, NUCLEIC ACID THER, V24, P374, DOI 10.1089/nat.2014.0506
   Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2
   Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590
   Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505
   Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537
   Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091
   Kim M, 2013, ANTIVIR RES, V100, P460, DOI 10.1016/j.antiviral.2013.08.002
   Kneller D.G, 2008, SPARKY, P3
   Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039
   Kubler K, 2011, EUR J IMMUNOL, V41, P3028, DOI 10.1002/eji.201141555
   Lassig C, 2015, ELIFE, V4, DOI 10.7554/eLife.10859
   Lee MK, 2016, NUCLEIC ACIDS RES, V44, P8407, DOI 10.1093/nar/gkw525
   Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406
   Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007
   Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023
   Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107
   Matsushima-Miyagi T, 2012, CLIN CANCER RES, V18, P6271, DOI 10.1158/1078-0432.CCR-12-1595
   McPhee SA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6127
   Poole E, 2002, VIROLOGY, V303, P33, DOI 10.1006/viro.2002.1737
   Rawling DC, 2015, ELIFE, V4, DOI 10.7554/eLife.09391
   ROSEN CA, 1985, CELL, V41, P813, DOI 10.1016/S0092-8674(85)80062-3
   Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008
   Schnell G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002839
   Schuberth-Wagner C, 2015, IMMUNITY, V43, P41, DOI 10.1016/j.immuni.2015.06.015
   Tran TT, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1675-6
   VARANI G, 1995, ANNU REV BIOPH BIOM, V24, P379, DOI 10.1146/annurev.bb.24.060195.002115
   Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863
   Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
NR 45
TC 2
Z9 2
U1 2
U2 3
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD FEB 28
PY 2018
VL 46
IS 4
BP 1635
EP 1647
DI 10.1093/nar/gky039
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA FX7TG
UT WOS:000426293300013
PM 29373735
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Ogura, J
   Babu, E
   Miyauchi, S
   Ramachandran, S
   Nemeth, E
   Bhutia, YD
   Ganapathy, V
AF Ogura, Jiro
   Babu, Ellappan
   Miyauchi, Seiji
   Ramachandran, Sabarish
   Nemeth, Elizebeta
   Bhutia, Yangzom D.
   Ganapathy, Vadivel
TI RETRACTED: Identification of a novel Na+-coupled Fe3+-citrate transport
   system, distinct from mammalian INDY, for uptake of citrate in mammalian
   cells (Retracted article. See vol. 08, art no 11021, 2018)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID TRANSFERRIN-BOUND IRON; GENOMIC ORGANIZATION; FUNCTIONAL FEATURES;
   CHELATION-THERAPY; SLC13 FAMILY; HELA-CELLS; OVERLOAD; NACT; MUTATIONS;
   NEURONS
AB NaCT is a Na+-coupled transporter for citrate expressed in hepatocytes and neurons. It is the mammalian ortholog of INDY (I'm Not Dead Yet), a transporter which modifies lifespan in Drosophila. Here we describe a hitherto unknown transport system for citrate in mammalian cells. When liver and mammary epithelial cells were pretreated with the iron supplement ferric ammonium citrate (FAC), uptake of citrate increased >10-fold. Iron chelators abrogated the stimulation of citrate uptake in FAC-treated cells. The iron exporter ferroportin had no role in this process. The stimulation of citrate uptake also occurred when Fe3+ was added during uptake without pretreatment. Similarly, uptake of Fe3+ was enhanced by citrate. The Fe3+-citrate uptake was coupled to Na+. This transport system was detectable in primary hepatocytes and neuronal cell lines. The functional features of this citrate transport system distinguish it from NaCT. Loss-of-function mutations in NaCT cause early-onset epilepsy and encephalopathy; the newly discovered Na+-coupled Fe3+-citrate transport system might offer a novel treatment strategy for these patients to deliver citrate into affected neurons independent of NaCT. It also has implications to iron-overload conditions where circulating free iron increases, which would stimulate cellular uptake of citrate and consequently affect multiple metabolic pathways.
C1 [Ogura, Jiro; Babu, Ellappan; Ramachandran, Sabarish; Bhutia, Yangzom D.; Ganapathy, Vadivel] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.
   [Miyauchi, Seiji] Toho Univ, Dept Pharmaceut, Funabashi, Chiba 2748510, Japan.
   [Nemeth, Elizebeta] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA.
   [Nemeth, Elizebeta] Univ Calif Los Angeles, Ctr Iron Disorders, Los Angeles, CA 90095 USA.
RP Ganapathy, V (reprint author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA.
EM Vadivel.ganapathy@ttuhsc.edu
FU Welch Endowed Chair in Biochemistry at Texas Tech University Health
   Sciences Center [BI-0028]
FX This work was supported by the Welch Endowed Chair in Biochemistry,
   Grant No. BI-0028, at Texas Tech University Health Sciences Center.
CR Anderson GJ, 1999, J GASTROEN HEPATOL, V14, P105, DOI 10.1046/j.1440-1746.1999.01828.x
   Bainbridge MN, 2017, MOL GENET METAB, V121, P314, DOI 10.1016/j.ymgme.2017.06.009
   BASSET P, 1986, CANCER RES, V46, P1644
   Bergeron MJ, 2013, MOL ASPECTS MED, V34, P299, DOI 10.1016/j.mam.2012.12.001
   Bhutia Y. B., 2017, MOLECULES, V22, pE378
   Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009
   Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014
   Codazzi F, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00018
   Drakesmith H, 2015, CELL METAB, V22, P777, DOI 10.1016/j.cmet.2015.09.006
   Fraenkl SA, 2011, J OCUL PHARMACOL TH, V27, P577, DOI 10.1089/jop.2011.0062
   FRANCIS AJ, 1992, NATURE, V356, P140, DOI 10.1038/356140a0
   Fung E, 2015, BIOORG MED CHEM LETT, V25, P763, DOI 10.1016/j.bmcl.2014.12.094
   Ganapathy Vadivel, 2005, Proceedings of the Indian National Science Academy Part B Biological Sciences, V71, P83
   Gopal E, 2007, AM J PHYSIOL-GASTR L, V292, pG402, DOI 10.1152/ajpgi.00371.2006
   Gopal E, 2015, J PHARMACOL EXP THER, V353, P17, DOI 10.1124/jpet.114.221523
   Hardies K, 2015, BRAIN, V138, DOI 10.1093/brain/awv263
   Inoue K, 2004, BIOCHEM J, V378, P949, DOI 10.1042/BJ20031261
   Inoue K, 2002, BIOCHEM BIOPH RES CO, V299, P465, DOI 10.1016/S0006-291X(02)02669-4
   Inoue K, 2002, J BIOL CHEM, V277, P39469, DOI 10.1074/jbc.M207072200
   Inoue K, 2003, BIOCHEM J, V374, P21, DOI 10.1042/BJ20030827
   Ito S, 2016, INT J HEMATOL, V104, P175, DOI 10.1007/s12185-016-2002-6
   Jenkitkasemwong S, 2015, CELL METAB, V22, P138, DOI 10.1016/j.cmet.2015.05.002
   Jenkitkasemwong S, 2012, BIOMETALS, V25, P643, DOI 10.1007/s10534-012-9526-x
   Ji CY, 2015, J NEUROCHEM, V133, P668, DOI 10.1111/jnc.13040
   JORDAN I, 1994, BIOCHEM J, V302, P875, DOI 10.1042/bj3020875
   KAPLAN J, 1991, J BIOL CHEM, V266, P2997
   Klotz J, 2016, MOL MED, V22, P310, DOI 10.2119/molmed.2016.00077
   Kopel J. J., 2017, INT J NEUROL DISORD, V1, P33
   Korithoski B, 2005, J BACTERIOL, V187, P4451, DOI 10.1128/JB.187.13.4451-4456.2005
   KRIEGERBECKOVA K, 1995, EUR J CLIN CHEM CLIN, V33, P791
   Le Lan C, 2005, BLOOD, V105, P4527, DOI 10.1182/blood2004-09-3468
   Lensbouer JJ, 2008, J BACTERIOL, V190, P5616, DOI 10.1128/JB.00456-08
   Lensbouer JJ, 2010, CRIT REV BIOCHEM MOL, V45, P453, DOI 10.3109/10409238.2010.504701
   Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103
   Marsella M, 2014, HEMATOL ONCOL CLIN N, V28, P703, DOI 10.1016/j.hoc.2014.04.004
   Mcnamara L, 1999, J GASTROEN HEPATOL, V14, P126, DOI 10.1046/j.1440-1746.1999.01830.x
   Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140
   Mycielska ME, 2015, CURR MOL MED, V15, P884, DOI 10.2174/1566524016666151123104855
   OLAKANMI O, 1994, J IMMUNOL, V153, P2691
   Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y
   Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010
   Porter JB, 2014, HEMATOL ONCOL CLIN N, V28, P683, DOI 10.1016/j.hoc.2014.04.003
   Porter John B, 2009, Hemoglobin, V33 Suppl 1, pS37, DOI 10.3109/03630260903346627
   Richardson DR, 2001, BBA-MOL BASIS DIS, V1536, P43, DOI 10.1016/S0925-4439(01)00034-5
   Rogers RP, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00204
   Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137
   Ryan E, 2015, ACTA HAEMATOL-BASEL, V133, P155, DOI 10.1159/000363490
   Schossig A, 2017, J MED GENET, V54, P54, DOI 10.1136/jmedgenet-2016-103988
   Steensma DP, 2013, BEST PRACT RES CL HA, V26, P431, DOI 10.1016/j.beha.2013.09.009
   Stefanova D, 2017, BLOOD, V130, P245, DOI 10.1182/blood-2017-03-772715
   STURROCK A, 1990, J BIOL CHEM, V265, P3139
   Thevenon J, 2014, AM J HUM GENET, V95, P113, DOI 10.1016/j.ajhg.2014.06.006
   Tripathi AK, 2017, J ALZHEIMERS DIS, V58, P1109, DOI 10.3233/JAD-170097
   Weeke LC, 2017, EUR J PAEDIATR NEURO, V21, P396, DOI 10.1016/j.ejpn.2016.11.002
   Yodoya E, 2006, J NEUROCHEM, V97, P162, DOI 10.1111/j.1471-4159.2006.03720.x
NR 55
TC 1
Z9 1
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD FEB 6
PY 2018
VL 8
AR 2519
DI 10.1038/s41598-018-20620-w
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FU9QB
UT WOS:000424189500006
PM 29410496
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Aryasomayajula, A
   Wojnas, C
   Divigalpitiya, R
   Selvaganapathy, PR
   Kruse, P
AF Aryasomayajula, Aditya
   Wojnas, Caroline
   Divigalpitiya, Ranjith
   Selvaganapathy, Ponnambalam Ravi
   Kruse, Peter
TI RETRACTED: Robust Chemiresistive Sensor for Continuous Monitoring of
   Free Chlorine Using Graphene-like Carbon (Retracted article. See vol.
   03, pg. 1217, 2018)
SO ACS SENSORS
LA English
DT Article; Retracted Publication
DE graphene; free chlorine; redox sensor; chemiresistive sensor; water
   quality monitoring; PANI
ID NANOTUBE TRANSISTORS; THIN-FILMS; WATER; NANOMATERIALS
AB Free chlorine is widely used in industry as a bleaching and oxidizing agent. Its concentration is tightly monitored to avoid environmental contamination and deleterious human health effects. Here, we demonstrate a solid state chemiresistive sensor using graphene like carbon (GLC) to detect free chlorine in water. A 15-20 nm thick GLC layer on a PET substrate was modified with a redox-active aniline oligomer (phenyl-capped aniline tetramer, PCAT) to increase sensitivity, improve selectivity, and impart fouling resistance. Both the bare GLC sensor and the PCAT-modified GLC sensor can detect free chlorine continuously and, unlike previous chemiresistive sensors, do not require a reset. The PCAT-modified sensor showed a linear response with a slope of 13.89 (mg/L)(-1) to free chlorine concentrations between 0.2 and 0.8 mg/L which is relevant for free chlorine monitoring for drinking water and wastewater applications. The PCAT-modified GLC sensors were found to be selective and showed less than 0.5% change in current in response to species such as nitrates, phosphates and sulfates in water. They also were resistant to fouling from organic material and showed only a 2% loss in signal. Tap water samples from residential area were tested using this sensor which showed good agreement with standard colorimetric measurement methods. The GLC and PCATGLC sensors show high sensitivity and excellent selectivity to free chlorine and can be used for continuous automated monitoring of free chlorine.
C1 [Aryasomayajula, Aditya; Selvaganapathy, Ponnambalam Ravi] McMaster Univ, Dept Mech Engn, Hamilton, ON L8S 4L7, Canada.
   [Wojnas, Caroline; Kruse, Peter] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada.
   [Divigalpitiya, Ranjith] 3M Canada Co, London, ON N5V 3R6, Canada.
RP Selvaganapathy, PR (reprint author), McMaster Univ, Dept Mech Engn, Hamilton, ON L8S 4L7, Canada.; Kruse, P (reprint author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada.
EM selvaga@mcmaster.ca; pkruse@mcmaster.ca
OI Kruse, Peter/0000-0003-4051-4375
FU National Science and Engineering Research Council of Canada (NSERC);
   Ontario Research Fund; Canada Research Chair program; NSERC
FX The authors would like to acknowledge Omar Sharif for the PCAT
   synthesis. The National Science and Engineering Research Council of
   Canada (NSERC) provided financial support through the Discovery Grant
   program. P.R.S. was also supported through the Ontario Research Fund,
   through a Discovery Accelerator Supplement award from NSERC, and through
   the Canada Research Chair program.
CR Ahmed MS, 2013, CARBON, V61, P595, DOI 10.1016/j.carbon.2013.05.041
   Bauld R, 2018, J MATER CHEM C, V6, P2901, DOI 10.1039/c7tc01719g
   Bull RJ, 1995, FUND APPL TOXICOL, V28, P155, DOI 10.1006/faat.1995.1156
   Dong YQ, 2012, ANAL CHEM, V84, P8378, DOI 10.1021/ac301945z
   Ezugwu S, 2013, THIN SOLID FILMS, V534, P520, DOI 10.1016/j.tsf.2013.02.131
   Greiner MT, 2008, J PHYS CHEM C, V112, P18991, DOI 10.1021/jp805533v
   Hallaj T, 2015, MICROCHIM ACTA, V182, P789, DOI 10.1007/s00604-014-1389-0
   Health Canada, 2017, GUID CAN DRINK WAT Q
   Heller I, 2008, NANO LETT, V8, P591, DOI 10.1021/nl072996i
   Hoque E, 2017, IEEE SENS LETT, V1
   Hoque E, 2018, SURF SCI, V676, P61, DOI 10.1016/j.susc.2018.01.003
   Hsu LHH, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4907631
   Jamal M., 2017, DISPOSABLE CHLORINE, P1947
   JENSEN JN, 1989, J AM WATER WORKS ASS, V81, P59
   Kim KK, 2016, ACCOUNTS CHEM RES, V49, P390, DOI 10.1021/acs.accounts.5b00441
   Klinke C, 2005, NANO LETT, V5, P555, DOI 10.1021/nl048055c
   Kumar DR, 2017, SENSOR ACTUAT B-CHEM, V240, P818, DOI 10.1016/j.snb.2016.09.025
   Langlais B., 1991, OZONE WATER TREATMEN
   LEGRINI O, 1993, CHEM REV, V93, P671, DOI 10.1021/cr00018a003
   Llobet E, 2013, SENSOR ACTUAT B-CHEM, V179, P32, DOI 10.1016/j.snb.2012.11.014
   Mohtasebi A, 2017, ACS APPL MATER INTER, V9, P20748, DOI 10.1021/acsami.7b03968
   Mohtasebi A, 2016, J PHYS CHEM C, V120, P29248, DOI 10.1021/acs.jpcc.6b09950
   Moonoosawmy KR, 2008, J AM CHEM SOC, V130, P13417, DOI 10.1021/ja8036788
   Moonoosawmy KR, 2010, J AM CHEM SOC, V132, P1572, DOI 10.1021/ja906820n
   Pan S, 2015, ANAL CHEM, V87, P10734, DOI 10.1021/acs.analchem.5b03164
   Shirsat MD, 2012, J PHYS CHEM C, V116, P3845, DOI 10.1021/jp210582t
   Snow AW, 2015, IEEE SENS J, V15, P1301, DOI 10.1109/JSEN.2014.2364677
   Tang H, 2016, IOP C SERIES MAT SCI
   U.S. Environmental Protection Agency, 1999, EPA GUID MAN ALT DIS, P1
   U. S. Environmental Protection Agency, 2000, EPA822B00023
   Wang W, 2002, SYNTHETIC MET, V129, P199, DOI 10.1016/S0379-6779(02)00053-X
   World Health Organization (WHO), 2008, GUID DRINK WAT QUAL
   Wu HK, 2005, LAB CHIP, V5, P1393, DOI 10.1039/b510494g
NR 33
TC 1
Z9 1
U1 8
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2379-3694
J9 ACS SENSORS
JI ACS Sens.
PD FEB
PY 2018
VL 3
IS 2
BP 451
EP 457
DI 10.1021/acssensors.7b00884
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience &
   Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA FY2BH
UT WOS:000426618400026
PM 29369621
DA 2018-12-27
ER

PT J
AU Cao, JH
   An, Q
   Wang, L
AF Cao, Junhua
   An, Qi
   Wang, Lei
TI RETRACTED: Pediatric sarcomas (Review)(Retracted article. See vol. 15,
   pg. 5391, 2018)
SO ONCOLOGY LETTERS
LA English
DT Review; Retracted Publication
DE pediatric; sarcomas; rhabdomyosarcoma; osteosarcoma
ID CANCER-STEM-CELLS; PANCREATIC DUCTAL ADENOCARCINOMA; HUMAN OSTEOSARCOMA;
   EWING SARCOMA; INITIATING CELLS; RHABDOMYOSARCOMA; EXPRESSION;
   IDENTIFICATION; SURVIVAL; CD133
AB Sarcomas arise from primitive mesenchymal cells, which are classified, into two main groups: Bone and soft tissue sarcomas. We have searched all-important electronic databases including Google scholar and PubMed for the collection of latest literature pertaining to pediatric sarcomas. Latest literature confirmed that these tumors are relatively rare and represent only 1% of all malignancies but they have higher incidence in children. Pediatric sarcomas comprise about 13% of all pediatric malignancies and are ranked third in childhood cancers. The highest incidence rates are reported among rhabdomyosarcoma, osteosarcoma and Ewing's sarcomas in children. All of these neoplasms often display highly aggressive behavior with tendency to form metastases. Important globally used management avenues include surgery with systemic chemotherapy and have success rate of 70% at 5-years. Furthermore, in the cases of advanced stages, the prognosis is poor, chances of treatment failure and recurrence are quite high. Utilization of cancer stem cells is the latest approach with great potential in management of above pathological state. The present review article discuss all-important aspects of commonly found pediatric sarcomas throughout the world.
C1 [Cao, Junhua; An, Qi; Wang, Lei] Xuzhou Childrens Hosp, Dept Pediat Internal Med, 18 Sudibei Rd, Xuzhou 221002, Jiangsu, Peoples R China.
RP An, Q (reprint author), Xuzhou Childrens Hosp, Dept Pediat Internal Med, 18 Sudibei Rd, Xuzhou 221002, Jiangsu, Peoples R China.
EM aiciiangel@yeah.net
CR Adhikari AS, 2010, CANCER RES, V70, P4602, DOI 10.1158/0008-5472.CAN-09-3463
   Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4
   Barta T, 2016, STEM CELLS, V34, P246, DOI 10.1002/stem.2220
   Basu-Roy U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7411
   Dela Cruz FS, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00168
   Di Fiore R, 2009, J CELL PHYSIOL, V219, P301, DOI 10.1002/jcp.21667
   Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394
   Greco Nicholas, 2014, J Cancer Ther, V5, P331
   Hirotsu M, 2009, BRIT J CANCER, V101, P2030, DOI 10.1038/sj.bjc.6605407
   Hou YC, 2014, CANCER-AM CANCER SOC, V120, P2766, DOI 10.1002/cncr.28774
   Immervoll H, 2011, J HISTOCHEM CYTOCHEM, V59, P441, DOI 10.1369/0022155411398275
   Kager L, 2017, FUTURE ONCOL, V13, P357, DOI 10.2217/fon-2016-0261
   Karski EE, 2016, PEDIATR BLOOD CANCER, V63, P47, DOI 10.1002/pbc.25709
   Kinsey M, 2009, CANCER RES, V69, P9047, DOI 10.1158/0008-5472.CAN-09-1540
   Krieg A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130192
   Leuchte K, 2014, ONCOL REP, V32, P845, DOI 10.3892/or.2014.3269
   Leushacke M, 2012, ONCOGENE, V31, P3009, DOI 10.1038/onc.2011.479
   Li XP, 2015, INT J CLIN EXP PATHO, V8, P12084
   Luetke A, 2014, CANCER TREAT REV, V40, P523, DOI 10.1016/j.ctrv.2013.11.006
   Marshall AD, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-25
   Martins-Neves SR, 2016, J CELL PHYSIOL, V231, P876, DOI 10.1002/jcp.25179
   Martins-Neves SR, 2016, CANCER LETT, V370, P286, DOI 10.1016/j.canlet.2015.11.013
   Nakahata K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125454
   Panza A, 2014, BBA-MOL CELL RES, V1843, P1225, DOI 10.1016/j.bbamcr.2014.03.003
   Penfornis P, 2014, CANCER MED-US, V3, P796, DOI 10.1002/cam4.249
   Pressey JG, 2013, PEDIATR BLOOD CANCER, V60, P45, DOI 10.1002/pbc.24117
   Ren YX, 2008, CANCER RES, V68, P6587, DOI 10.1158/0008-5472.CAN-08-0859
   Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710
   Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023
   Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198
   Scannell CA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00081
   Shen B, 2013, ASIAN PAC J CANCER P, V14, P5403, DOI 10.7314/APJCP.2013.14.9.5403
   Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254
   Singh S, 2016, PANCREAS, V45, P117, DOI 10.1097/MPA.0000000000000542
   Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242
   Thomas RM, 2008, GUT, V57, P1555, DOI 10.1136/gut.2007.143941
   Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036
   Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469
   Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027
   Tsuchida R, 2008, ONCOGENE, V27, P3923, DOI 10.1038/onc.2008.38
   van der Graaf WTA, 2017, LANCET ONCOL, V18, pE166, DOI 10.1016/S1470-2045(17)30099-2
   Veselska R, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-32
   Wahl J, 2010, INT J CANCER, V127, P1295, DOI 10.1002/ijc.25163
   Wang L, 2011, INT J CANCER, V128, P294, DOI 10.1002/ijc.25331
   Weina K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-19
   Weiss A, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-014-0395-z
   Wilkens Stephan, 2015, F1000Prime Rep, V7, P14, DOI 10.12703/P7-14
   Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038
   Yang CL, 2014, INT J MOL SCI, V15, P423, DOI 10.3390/ijms15010423
   Yang LM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-654
   Yang M, 2011, CANCER SCI, V102, P1774, DOI 10.1111/j.1349-7006.2011.02028.x
   Ying M, 2013, ONCOGENE, V32, P4252, DOI 10.1038/onc.2012.438
NR 52
TC 1
Z9 2
U1 7
U2 8
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-1074
EI 1792-1082
J9 ONCOL LETT
JI Oncol. Lett.
PD FEB
PY 2018
VL 15
IS 2
BP 1397
EP 1402
DI 10.3892/ol.2017.7467
PN A
PG 6
WC Oncology
SC Oncology
GA FX5UD
UT WOS:000426145000003
PM 29434830
OA Other Gold, Green Published
DA 2018-12-27
ER

PT J
AU Cole, WR
   Gregory, E
   Arrieux, JP
   Haran, FJ
AF Cole, Wesley R.
   Gregory, Emma
   Arrieux, Jacques P.
   Haran, F. Jay
TI RETRACTED: Intraindividual Cognitive Variability: An Examination of
   ANAM4 TBI-MIL Simple Reaction Time Data from Service Members with and
   without Mild Traumatic Brain Injury(Retracted article. See vol. 24, pg.
   212, 2018)
SO JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
LA English
DT Article; Retracted Publication
DE Concussion; Military; Computerized assessment; Intraindividual
   variability cognitive function; Reaction time; Neuropsychology
ID SPORT-RELATED CONCUSSION; AGE; ASSOCIATION; PERFORMANCE; VALIDITY;
   IMPACT; INJURY; SPEED; HEAD
AB Objectives: The Automated Neuropsychological Assessment Metrics 4 TBI-MIL (ANAM4) is a computerized cognitive test often used in post-concussion assessments with U.S. service members (SMs). However, existing evidence remains mixed regarding ANAM4's ability to identify cognitive issues following mild traumatic brain injury (mTBI). Studies typically examine ANAM4 using standardized scores and/or comparisons to a baseline. A more fine-grained approach involves examining inconsistency within an individual's performance (i.e., intraindividual variability). Methods: Data from 237 healthy control SMs and 105 SMs within seven days of mTBI who took the ANAM4 were included in analyses. Using each individual's raw scores on a simple reaction time (RT) subtest (SRT1) that is repeated at the end of the battery (SRT2), we calculated mean raw RT and the intraindividual standard deviation (ISD) of trial-by-trial RT. Analyses investigated differences between groups in mean RT, RT variability (i.e., ISD), and change in ISD from SRT1 and SRT2. Results: Using regression residuals to control for demographic variables, analysis of variance, and pairwise comparisons revealed the control group had faster mean RT and smaller ISD compared to the mTBI group. Furthermore, the mTBI group had a significant increase in ISD from SRT1 to SRT2, with effect sizes exceeding the minimum practical effect for comparisons of ISD in SRT2 and change in ISD from SRT1 to SRT2. Conclusions: While inconsistencies in performance are often viewed as test error, the results suggest intraindividual cognitive variability may be more sensitive than traditional metrics in detecting changes in cognitive function after mTBI. Additionally, the findings highlight the utility of the ANAM4's repeating a RT subtest at two points in the same session for exploring within-subject differences in performance variability.
C1 [Cole, Wesley R.; Gregory, Emma; Arrieux, Jacques P.] Def & Vet Brain Injury Ctr, Silver Spring, MD USA.
   [Cole, Wesley R.; Gregory, Emma; Arrieux, Jacques P.] Def & Vet Brain Injury Ctr, Ft Bragg, NC USA.
   [Cole, Wesley R.; Arrieux, Jacques P.] Womack Army Med Ctr, Ft Bragg, NC 28310 USA.
   [Cole, Wesley R.; Gregory, Emma; Arrieux, Jacques P.] Gen Dynam Hlth Solut, Fairfax, VA USA.
   [Haran, F. Jay] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.
RP Cole, WR (reprint author), Womack Army Med Ctr, Intrepid Spirit, Ft Bragg, NC 28310 USA.
EM wesley.r.cole.ctr@mail.mil
FU General Dynamics Information Technology for the U.S. Defense Health
   Agency [W91YTZ-13-C-0015]
FX The authors thank Karen Schwab, Brian Ivins, Felicia Qashu, Mary Alice
   Dale, James Wes McGee, Katie Toll, and Alex Fender for their
   contributions to this research. This material is published by permission
   of the Defense and Veterans Brain Injury Center, operated by General
   Dynamics Information Technology for the U.S. Defense Health Agency under
   Contract No. W91YTZ-13-C-0015. The authors have no financial interests
   to disclose. The views expressed in this manuscript are those of the
   author(s) and do not necessarily reflect the official policy or position
   of the Department of the Navy, Department of the Army, Department of
   Defense, or the U.S. Government.
CR Arrieux J.P., 2017, REV VALIDITY COMPUTE
   Batterham PJ, 2014, AGE AGEING, V43, P84, DOI 10.1093/ageing/aft116
   BLEIBERG J, 1997, COGNITIVE AND BEHAVI, V10, P247
   Cognitive Science Research Center CSRC, 2014, ANAM MIL BATT ADM MA
   Cole WR, 2018, ARCH CLIN NEUROPSYCH, V33, P102, DOI 10.1093/arclin/acx036
   Cole WR, 2017, J CLIN EXP NEUROPSYC, V39, P35, DOI 10.1080/13803395.2016.1198470
   Defense and Veterans Brain Injury Center, 2016, DOD WORLDW NUMB TBI
   Defense Health Board, 2016, REP PREP UND PERS RE
   Department of Defense Instruction (DoDI) 649013, 2013, COMPR POL TRAUM BRAI
   Der G, 2006, PSYCHOL AGING, V21, P62, DOI 10.1037/0882-7974.21.1.62
   Dixon RA, 2007, NEUROPSYCHOLOGY, V21, P381, DOI 10.1037/0894-4105.21.3.381
   Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808
   Fjell AM, 2009, NEUROBIOL AGING, V30, P2065, DOI 10.1016/j.neurobiolaging.2008.01.015
   Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002
   GARRETT DD, 2012, FRONT HUM NEUROSCI, V6, P1, DOI DOI 10.3389/FNHUM.2012.00101
   HALE S, 1988, PSYCHOL AGING, V3, P407, DOI 10.1037//0882-7974.3.4.407
   Haran FJ, 2016, BRAIN INJURY, V30, P280, DOI 10.3109/02699052.2015.1118766
   Hill BD, 2013, ARCH CLIN NEUROPSYCH, V28, P640, DOI 10.1093/arclin/act045
   Hultsch D. F., 2008, HDB AGING COGNITION, V3, P491, DOI [10.4324/9780203837665.ch10, DOI 10.4324/9780203837665.CH10]
   Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101
   Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036
   Lezak M. D., 2012, NEUROPSYCHOLOGICAL A
   Lovden M, 2007, NEUROPSYCHOLOGIA, V45, P2827, DOI 10.1016/j.neuropsychologia.2007.05.005
   Makdissi M, 2001, BRIT J SPORT MED, V35, P354, DOI 10.1136/bjsm.35.5.354
   MCCREA M, 2008, THE CLINICAL NEUROPS, V22, P10, DOI DOI 10.1080/13854040701760981
   McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313
   Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101
   Norris JN, 2013, MIL MED, V178, P767, DOI 10.7205/MILMED-D-12-00493
   Parks AC, 2015, INT J PSYCHOPHYSIOL, V98, P426, DOI 10.1016/j.ijpsycho.2015.08.006
   Rabinowitz AR, 2013, NEUROPSYCHOLOGY, V27, P481, DOI 10.1037/a0033023
   Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5
   Roebuck-Spencer TM, 2013, ARCH CLIN NEUROPSYCH, V28, P700, DOI 10.1093/arclin/act055
   Segalowitz S J, 1997, J Int Neuropsychol Soc, V3, P95
   Sosnoff JJ, 2007, NEUROPSYCHOLOGY, V21, P796, DOI 10.1637/0894-4105.21.6.796
   STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742
NR 35
TC 1
Z9 1
U1 3
U2 6
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1355-6177
EI 1469-7661
J9 J INT NEUROPSYCH SOC
JI J. Int. Neuropsychol. Soc.
PD FEB
PY 2018
VL 24
IS 2
BP 156
EP 162
DI 10.1017/S1355617717001187
PG 7
WC Clinical Neurology; Neurosciences; Psychiatry; Psychology
SC Neurosciences & Neurology; Psychiatry; Psychology
GA FT3XL
UT WOS:000423081900005
PM 29168451
DA 2018-12-27
ER

PT J
AU Yan, H
   Wu, AH
AF Yan, Han
   Wu, Anhua
TI RETRACTED: FOXO1 is crucial in glioblastoma cell tumorigenesis and
   regulates the expression of SIRT1 to suppress senescence in the brain
   (Retracted article. See vol. 17, pg. 4154, 2018)
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article; Retracted Publication
DE Forkhead Box O1; sirtuin 1; epithelial-mesenchymal transition;
   metastasis; senescence
ID TRANSCRIPTION FACTORS; SIGNALING PATHWAY; GENE-EXPRESSION; APOPTOSIS;
   AUTOPHAGY; P16(INK4A); LYMPHOMA; DELAY
AB In the present study, the role of Forkhead Box O1 (FOXO1) in glioblastoma (GBM) cell tumorigenesis was examined and the underlying mechanisms were investigated. Reverse transcription-quantitative polymerase chain reaction and western blot analyses were used to analyze the expression of FOXO1 in GBM cell lines (LN18 and T98G) and tissues. Compared with the control groups, FOXO1 was significantly downregulated in the GBM tissues and GBM cell lines (P<0.05). The effects of the expression of FOXO1 on GBM cell proliferation and cell cycle were examined using flow cytometry. The overexpression of FOXO1 markedly inhibited LN18 and T98G cell proliferation and arrested cell cycle at the G(0)/G(1) phase. In addition, FOXO1 facilitated cell senescence through regulation of the expression of sirtuin 1. Epithelial-mesenchymal transition (EMT) is a complex process, which affects cell growth, invasion and metastasis. The results of the present study revealed that FOXO1 inhibited EMT and metastasis in GBM. These finding revealed a novel mechanism of FOXO1 in the suppression of tumorigenesis and metastasis of GBM cells and suggested that FOXO1 may be a potential therapeutic target for treating GBM.
C1 [Yan, Han; Wu, Anhua] China Med Univ, Affiliated Hosp 1, Dept Neurosurg, 155 Nanjing Rd, Shenyang 110001, Liaoning, Peoples R China.
RP Wu, AH (reprint author), China Med Univ, Affiliated Hosp 1, Dept Neurosurg, 155 Nanjing Rd, Shenyang 110001, Liaoning, Peoples R China.
EM anhuawu1988@sina.com
CR Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1
   DOLE MG, 1995, CANCER RES, V55, P2576
   Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24
   Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629
   Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026
   Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029
   Han XL, 2016, CLIN EXP PHARMACOL P, V43, P41, DOI 10.1111/1440-1681.12496
   Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222
   Ishikura S, 2016, J BIOL CHEM, V291, P15282, DOI 10.1074/jbc.M116.723734
   Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006
   Li N, 2011, FEBS LETT, V585, P3106, DOI 10.1016/j.febslet.2011.08.044
   Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002
   Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1
   Milan G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7670
   Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351
   Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.13.029
   Paroni G, 2004, MOL BIOL CELL, V15, P2804, DOI 10.1091/mbc.E03-08-0624
   Paroni G, 2007, MOL CELL BIOL, V27, P6718, DOI 10.1128/MCB.00853-07
   Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x
   Sullivan PR, 2001, NEW ENGL J MED, V344, P1478
   Sunayama J, 2011, STEM CELLS, V29, P1327, DOI 10.1002/stem.696
   Trinh DL, 2013, BLOOD, V121, P3666, DOI 10.1182/blood-2013-01-479865
   Wang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11023
   Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069
   Zhou R, 2009, NUCLEIC ACIDS RES, V37, P5183, DOI 10.1093/nar/gkp533
NR 27
TC 4
Z9 4
U1 2
U2 6
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD FEB
PY 2018
VL 17
IS 2
BP 2535
EP 2542
DI 10.3892/mmr.2017.8146
PG 8
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA FT5WP
UT WOS:000423224300056
PM 29207098
OA Green Published
DA 2018-12-27
ER

PT J
AU Benjamin, AJ
   Bushman, BJ
AF Benjamin, Arlin James, Jr.
   Bushman, Brad J.
TI RETRACTED: The weapons effect (Retracted article. See vol. 22, pg. 96,
   2018)
SO CURRENT OPINION IN PSYCHOLOGY
LA English
DT Review; Retracted Publication
ID EVALUATION APPREHENSION; AGGRESSIVE-BEHAVIOR; GUNS; CUES; EXPOSURE;
   PICTURES; HYPOTHESIS; AWARENESS; THOUGHTS; STIMULI
AB In some societies, weapons are plentiful and highly visible. This review examines recent trends in research on the weapons effect, which is the finding that the mere presence of weapons can prime people to behave aggressively. The General Aggression Model provides a theoretical framework to explain why the weapons effect occurs. This model postulates that exposure to weapons increases aggressive thoughts and hostile appraisals, thus explaining why weapons facilitate aggressive behavior. Data from meta-analytic reviews are consistent with the General Aggression Model. These findings have important practical as well as theoretical implications. They suggest that the link between weapons and aggression is very strong in semantic memory, and that merely seeing a weapon can make people more aggressive.
C1 [Benjamin, Arlin James, Jr.] Univ Arkansas, Dept Behav Sci, Ft Smith, AR 72701 USA.
   [Bushman, Brad J.] Ohio State Univ, Sch Commun, Columbus, OH 43210 USA.
   [Bushman, Brad J.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.
   [Bushman, Brad J.] Vrije Univ Amsterdam, Dept Commun Sci, Amsterdam, Netherlands.
RP Benjamin, AJ (reprint author), Univ Arkansas, Dept Behav Sci, Ft Smith, AR 72701 USA.
EM james.benjamin@uafs.edu
CR Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231
   Anderson CA, 1998, PSYCHOL SCI, V9, P308, DOI 10.1111/1467-9280.00061
   Barlett CP, 2011, PERS SOC PSYCHOL B, V37, P1564, DOI 10.1177/0146167211423671
   Bartholow BD, 2006, PSYCHOL SCI, V17, P30, DOI 10.1111/j.1467-9280.2005.01661.x
   Bartholow BD, 2005, J EXP SOC PSYCHOL, V41, P48, DOI 10.1016/j.jesp.2004.05.005
   BERKOWITZ L, 1967, J PERS SOC PSYCHOL, V7, P202, DOI 10.1037/h0025008
   Bushman BJ, AGGRESSION IN PRESS
   CARLSON M, 1990, J PERS SOC PSYCHOL, V58, P622, DOI 10.1037/0022-3514.58.4.622
   DAGLORIA J, 1989, AGGRESSIVE BEHAV, V15, P265, DOI 10.1002/ab.2480150401
   de Oca BM, 2013, AM J PSYCHOL, V126, P287
   Fox E, 2007, EMOTION, V7, P691, DOI 10.1037/1528-3542.7.4.691
   FRODI A, 1975, INT J PSYCHOL, V10, P283, DOI 10.1080/00207597508247340
   Hemenway D, 2006, ACCIDENT ANAL PREV, V38, P687, DOI 10.1016/j.aap.2005.12.014
   Holbrook C, 2014, EMOTION, V14, P455, DOI 10.1037/a0035826
   Klinesmith J, 2006, PSYCHOL SCI, V17, P568, DOI 10.1111/j.1467-9280.2006.01745.x
   Krahe B, 2013, SOCIAL PSYCHOL AGGRE
   LEYENS JP, 1975, EUR J SOC PSYCHOL, V5, P229
   Lindsay JJ, 2000, PERS SOC PSYCHOL B, V26, P533, DOI 10.1177/0146167200267002
   MacInnis L., 2007, REUTERS NEWS
   PAGE MM, 1971, J PERS SOC PSYCHOL, V20, P304, DOI 10.1037/h0031806
   Schlessinger R, 2013, US NEWS WORLD REPORT
   Simons L. S, 1975, PERSONAL SOC PSYCHOL, V1, P188, DOI [10.1177/014616727400100164, DOI 10.1177/014616727400100164]
   SIMONS LS, 1976, AGGRESSIVE BEHAV, V2, P77, DOI 10.1002/1098-2337(1976)2:1<77::AID-AB2480020108>3.0.CO;2-A
   Simons LS, 1976, ALTRUISMUS AGGRESSIO, V1, P141
   Subra B, 2010, PERS SOC PSYCHOL B, V36, P1052, DOI 10.1177/0146167210374725
   Sulikowski D, 2014, EVOL PSYCHOL, V12, P888, DOI DOI 10.1177/
   TURNER CW, 1974, J PERS SOC PSYCHOL, V30, P341, DOI 10.1037/h0036894
   TURNER CW, 1976, J EXP CHILD PSYCHOL, V21, P303, DOI 10.1016/0022-0965(76)90044-8
   Zhang Q, 2016, PERS INDIV DIFFER, V90, P113, DOI 10.1016/j.paid.2015.09.017
NR 29
TC 2
Z9 2
U1 2
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2352-250X
J9 CURR OPIN PSYCHOL
JI Curr. Opin. Psychol.
PD FEB
PY 2018
VL 19
BP 93
EP 97
DI 10.1016/j.copsyc.2017.04.011
PG 5
WC Psychology, Multidisciplinary
SC Psychology
GA FS1TO
UT WOS:000419561300018
DA 2018-12-27
ER

PT J
AU Vanbuel, M
   Bodere, A
   Torfs, K
   Jaspaert, K
AF Vanbuel, Marieke
   Bodere, Anneleen
   Torfs, Karen
   Jaspaert, Koen
TI RETRACTED: Vocabulary acquisition in Moroccan- and Turkish-heritage
   children: A comparative study (Retracted article. See vol. 22, pg. 251,
   2018)
SO INTERNATIONAL JOURNAL OF BILINGUALISM
LA English
DT Article; Retracted Publication
DE Language learning; ethnic minorities; vocabulary acquisition; language
   proficiency; cross-linguistic differences
ID LANGUAGE PROFICIENCY; EDUCATIONAL-ATTAINMENT; BILINGUAL-CHILDREN; ETHNIC
   LANGUAGE; HOME LANGUAGE; ENGLISH; 2ND-GENERATION; INEQUALITIES; SPANISH;
   VERBS
AB Aims and objectives: In the present study, we investigated whether Moroccan- and Turkish-heritage children living in Flanders, the Dutch-speaking part of Belgium, acquire new Dutch vocabulary to the same extent when they are provided with exactly the same type of language input. Turkish-heritage children seem to have significantly lower language proficiency in Dutch, compared to their Moroccan-heritage peers. Previous studies have shown that existing language skills in the second language can affect sequential bilingual children's vocabulary acquisition in the second language considerably.
   Design/methodology/approach: The novel word learning of Moroccan- and Turkish-heritage six-year-olds (N = 52) was investigated by means of four dynamic storytelling sessions in which six new object labels and six new action words were incorporated.
   Data and analysis: The children's conceptual and linguistic knowledge of the novel words was extensively tested. Six analyses of covariance were conducted, with origin as a between-subjects factor and proficiency in Dutch as a covariate.
   Findings/conclusions: Our findings indicate that Turkish- and Moroccan-heritage children acquired the novel words to almost the same extent when their prior language proficiency in Dutch was taken into account. However, Moroccan-heritage children still outperformed their Turkish-heritage peers, producing the novel object labels.
   Originality: For this study, we used a methodology specifically developed for this age group. In addition, we statistically controlled for the children's initial proficiency in Dutch, in order to get a better insight in the actual learning processes of new Dutch vocabulary of Moroccan- and Turkish-heritage children.
   Significance/implications: Our outcome suggests that initial language proficiency in Dutch is an important predictor of novel vocabulary learning. Furthermore, we argue that linguistic properties of the children's first language may play a role in second language acquisition, suggesting that a different approach to the stimulation of second language (vocabulary) acquisition in minority children of different ethnic origin may be necessary.
C1 [Vanbuel, Marieke; Bodere, Anneleen; Torfs, Karen; Jaspaert, Koen] Katholieke Univ Leuven, Dept Linguist, Leuven, Belgium.
RP Vanbuel, M (reprint author), Katholieke Univ Leuven, Dept Linguist, Leuven, Belgium.
EM marieke.vanbuel@kuleuven.be
CR Altinkamis NF, 2014, FIRST LANG, V34, P537, DOI 10.1177/0142723714560179
   Baysu G., 2011, THESIS
   Baysu G, 2012, ETHNICITIES, V12, P776, DOI 10.1177/1468796812450857
   Belfi B, 2014, BRIT EDUC RES J, V40, P820, DOI 10.1002/berj.3115
   Bodere A., 2015, NIEUWE WOORDEN LEREN
   Bodere A., J CHILD LANGUAGE
   Boerma I, 2005, THESIS
   Bornstein MH, 2004, CHILD DEV, V75, P1115, DOI 10.1111/j.1467-8624.2004.00729.x
   Chan CCY, 2011, DEV PSYCHOL, V47, P1459, DOI 10.1037/a0024049
   Clycq N, 2014, OPRIT 14 NAAR SCHOOL
   Cornips L, 2006, AVT PUBL, V23, P40
   Cucchiarini C., 1996, TAALVAARDIGHEIDSTOET
   Dixon LQ, 2012, EARLY CHILD EDUC J, V40, P25, DOI 10.1007/s10643-011-0491-8
   Dixon LQ, 2012, INT J BILINGUAL, V16, P541, DOI 10.1177/1367006911429527
   Dominguez L, 2009, INT J BILINGUAL, V13, P271, DOI 10.1177/1367006909339812
   Droop M, 2003, READ RES QUART, V38, P78, DOI 10.1598/RRQ.38.1.4
   Duquet N, 2006, WIT KRIJT SCHRIJFT B
   Groenez S., 2009, SOCIALE STAAT VLAAND, P33
   Hassall T, 2015, MULTILINGUA, V34, P33, DOI 10.1515/multi-2013-0050
   Heath A, 2007, ETHNICITIES, V7, P291, DOI 10.1177/1468796807080230
   Heath AF, 2008, ANNU REV SOCIOL, V34, P211, DOI 10.1146/annurev.soc.34.040507.134728
   Jaspaert K, 2015, EUR J APPL LINGUIST, V3, P21, DOI 10.1515/eujal-2015-0004
   Kan PF, 2014, J CHILD LANG, V41, P416, DOI 10.1017/S0305000912000761
   Laevers F., 2004, ONDERWIJS KWETSBARE
   McDonough C, 2011, DEVELOPMENTAL SCI, V14, P181, DOI 10.1111/j.1467-7687.2010.00968.x
   Messer MH, 2010, J EXP CHILD PSYCHOL, V105, P306, DOI 10.1016/j.jecp.2009.12.006
   Nap-Kolhoff E, 2005, EUR EDUC RES J, V4, P243, DOI 10.2304/eerj.2005.4.3.8
   Npdata, 2015, INW MIGR GEW NAT
   OECD, 2010, ED GLANC
   Opdenakker M., 2006, ONDERWIJS ONDERWEG I, P33
   Paradis M, 2009, DECLARATIVE PROCEDUR
   Phalet K, 2007, ETHNICITIES, V7, P390, DOI 10.1177/1468796807080235
   Prevoo MJL, 2014, J CHILD LANG, V41, P963, DOI 10.1017/S0305000913000299
   Quiroz BG, 2010, INT J BILINGUAL, V14, P379, DOI 10.1177/1367006910370919
   Scheele AF, 2010, APPL PSYCHOLINGUIST, V31, P117, DOI 10.1017/S0142716409990191
   Unsworth S, 2009, Z SPRACHWISS, V28, P69, DOI 10.1515/ZFSW.2009.008
   Van Craen M., 2009, GEKLEURDE STEDEN AUT
   Vancluysen K., 2007, VOORBIJ WIJ ZIJ SOCI
   Verhaeghe J. P., 2007, LEERWINST TOEGEVOEGD
   Vervoort M, 2012, SOC SCI RES, V41, P555, DOI 10.1016/j.ssresearch.2012.01.002
   Waxman S, 2013, CHILD DEV PERSPECT, V7, P155, DOI 10.1111/cdep.12032
NR 41
TC 1
Z9 1
U1 3
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1367-0069
EI 1756-6878
J9 INT J BILINGUAL
JI Int. J. Biling.
PD FEB
PY 2018
VL 22
IS 1
BP 38
EP 50
DI 10.1177/1367006916652139
PG 13
WC Linguistics; Language & Linguistics
SC Linguistics
GA FR8CJ
UT WOS:000419301300003
DA 2018-12-27
ER

PT J
AU Geelen, J
   Gerards, B
   Whittle, G
AF Geelen, Jim
   Gerards, Bert
   Whittle, Geoff
TI RETRACTED: Quasi-graphic matroids (Retracted article. See vol.87,
   pg.265, 2018)
SO JOURNAL OF GRAPH THEORY
LA English
DT Article; Retracted Publication
DE frame matroids; graphic matroids; matroids; representation
ID BIASED GRAPHS
AB Frame matroids and lifted-graphic matroids are two interesting generalizations of graphic matroids. Here, we introduce a new generalization, quasi-graphic matroids, that unifies these two existing classes. Unlike frame matroids and lifted-graphic matroids, it is easy to certify that a 3-connected matroid is quasi-graphic. The main result is that every 3-connected representable quasi-graphic matroid is either a lifted-graphic matroid or a frame matroid.
C1 [Geelen, Jim] Univ Waterloo, Dept Combinator & Optimizat, Waterloo, ON, Canada.
   [Gerards, Bert] Ctr Wiskunde & Informat, Amsterdam, Netherlands.
   [Whittle, Geoff] Victoria Univ Wellington, Sch Math Stat & Operat Res, Wellington, New Zealand.
RP Geelen, J (reprint author), Univ Waterloo, Dept Combinator & Optimizat, Waterloo, ON, Canada.
EM jfgeelen@uwaterloo.ca
FU Office of Naval Research [N00014-10-1-0851]; NSERC [203110-2011];
   Marsden Fund of New Zealand
FX Contract grant sponsor: Office of Naval Research; contract grant number:
   N00014-10-1-0851; contract grant sponsor: NSERC; contract grant number:
   203110-2011; contract grant sponsor: Marsden Fund of New Zealand.
CR Chen R., J GRAPH THE IN PRESS
   Oxley J. G., 2011, MATROID THEORY
   SEYMOUR PD, 1981, COMBINATORICA, V1, P75, DOI 10.1007/BF02579179
   ZASLAVSKY T, 1989, J COMB THEORY B, V47, P32, DOI 10.1016/0095-8956(89)90063-4
   ZASLAVSKY T, 1994, EUR J COMBIN, V15, P303, DOI 10.1006/eujc.1994.1034
   Zaslaysky T., 2001, EUROP J COMBINATORIC, V15, P119
NR 6
TC 2
Z9 2
U1 2
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-9024
EI 1097-0118
J9 J GRAPH THEOR
JI J. Graph Theory
PD FEB
PY 2018
VL 87
IS 2
BP 253
EP 264
DI 10.1002/jgt.22177
PG 12
WC Mathematics
SC Mathematics
GA FP7XV
UT WOS:000417854500009
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Wang, Z
   Koonen, D
   Hofker, M
   Bao, ZJ
AF Wang, Zheng
   Koonen, Debby
   Hofker, Marten
   Bao, Zhijun
TI RETRACTED: 5-aminosalicylic acid improves lipid profile in mice fed a
   high-fat cholesterol diet through its dual effects on intestinal PPAR
   gamma and PPAR alpha (Retracted article. See vol. 13, art no. e0200947.
   2018)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID ACTIVATED-RECEPTOR-GAMMA; INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B;
   ULCERATIVE-COLITIS; INSULIN-RESISTANCE; METABOLIC SYNDROME;
   ANTIINFLAMMATORY AGENTS; CARDIOVASCULAR-DISEASE; TRIGLYCERIDE; TRANSPORT
AB Obesity is associated with a series of metabolic complications, including dyslipidemia and insulin resistance (IR) that lack effective therapies. In recent years, intestinal inflammation has been suggested to contribute to obesity related metabolic syndrome and targeting gut inflammation with 5-ASA improves diet induced IR, however, its role in dyslipidemia is unknown and has never been explored. In the present study, we reported for the first time that administration of 5-ASA for 12 weeks significantly improved lipid profile by repressing plasma triglycerides and free cholesterol levels in mice fed high-fat cholesterol diet (HFC). In addition, liver lipids were significantly reduced by 5-ASA treatment in HFC-fed mice. Mechanistically, anti-inflammatory genes peroxisome proliferator-activated receptor-gamma (Ppar gamma) and M2 marker, such as Mrc1 and Ym1, were remarkably upregulated, while pro-inflammation gene monocyte chemoattractant protein-1 (Mcp-1) were downregulated in small intestine of mice treated by 5-ASA. Further, 5-ASA improved gastrointestinal barrier by increasing the expression of the tight junction marker ZO-1. 5-ASA also enhanced cholesterol translocation by elevating genes expression of Npc1l1 and Abcg5/8. Moreover, mice fed HFC 5-ASA expressed increased Ppar alpha in small intestinal and its target genes function in lipid oxidation and hydrolysis were remarkable elevated. Taken together, we reported a novel role of 5-ASA which may serve as a therapy target intestinal inflammation induced dyslipidemia.
C1 [Wang, Zheng; Bao, Zhijun] Fudan Univ, Shanghai Key Lab Clin Geriatr Med, Huadong Hosp, Dept Geriatr & Gastroenterol,Shanghai Med Coll, Shanghai, Peoples R China.
   [Wang, Zheng; Koonen, Debby; Hofker, Marten] Univ Groningen, Univ Med Ctr Groningen, Mol Genet Sect, Dept Pediat, Groningen, Netherlands.
RP Bao, ZJ (reprint author), Fudan Univ, Shanghai Key Lab Clin Geriatr Med, Huadong Hosp, Dept Geriatr & Gastroenterol,Shanghai Med Coll, Shanghai, Peoples R China.
EM xinyi8681@sina.com
FU Shanghai Municipal Commission of Health and Family Planning, Key
   Developing Disciplines Program [2015ZB0501]; CardioVasculair Onderzoek
   Nederland [CVON2012-03]
FX Wang Z and Bao ZJ are supported by grants from Shanghai Municipal
   Commission of Health and Family Planning, Key Developing Disciplines
   Program (No: 2015ZB0501). M.H. and D.K. are supported by a grant from
   CardioVasculair Onderzoek Nederland (CVON2012-03).; ZW and ZJB are
   supported by grant from Shanghai Key Developing Disciplines Program (No:
   2015ZB0501). DK and MH are supported by grant from CardioVasculair
   Onderzoek Nederland (CVON2012-03). We thank Niels Kloosterhuis and
   Albert Gerding for technical instructions, and thank Bart van de Sluis
   and Eelke Brandsma for comments for preparing the manuscript.
CR Agrawal NK, 2014, WORLD J DIABETES, V5, P697, DOI 10.4239/wjd.v5.i5.697
   Auwerx J, 1996, J Atheroscler Thromb, V3, P81
   Bantel H, 2000, AM J GASTROENTEROL, V95, P3452
   Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   BROGDEN RN, 1989, DRUGS, V38, P500, DOI 10.2165/00003495-198938040-00003
   Bunger M, 2007, PHYSIOL GENOMICS, V30, P192, DOI 10.1152/physiolgenomics.00198.2006
   Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171
   CHRISTENSEN LA, 1990, ALIMENT PHARM THERAP, V4, P523
   D'Aquila T, 2016, BBA-MOL CELL BIOL L, V1861, P730, DOI 10.1016/j.bbalip.2016.04.012
   DAS KM, 1973, GUT, V14, P631, DOI 10.1136/gut.14.8.631
   Debril MB, 2001, J MOL MED, V79, P30, DOI 10.1007/s001090000145
   Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727
   Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191
   Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484
   Dubuquoy L, 2002, LANCET, V360, P1410, DOI 10.1016/S0140-6736(02)11395-X
   Egan LJ, 1999, J BIOL CHEM, V274, P26448, DOI 10.1074/jbc.274.37.26448
   Esser N, 2015, EXPERT OPIN INV DRUG, V24, P283, DOI 10.1517/13543784.2015.974804
   Feagan BG, 2013, INFLAMM BOWEL DIS, V19, P2031, DOI 10.1097/MIB.0b013e3182920108
   Frazier-Wood AC, 2013, PHARMACOGENOMICS J, V13, P312, DOI 10.1038/tpj.2012.9
   Giannini EG, 2005, DIGEST LIVER DIS, V37, P723, DOI 10.1016/j.dld.2005.02.012
   GREENFIELD SM, 1993, ALIMENT PHARM THER, V7, P369
   Hennuyer N, 2016, ATHEROSCLEROSIS, V249, P200, DOI 10.1016/j.atherosclerosis.2016.03.003
   Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955
   Jia L, 2011, ANNU REV PHYSIOL, V73, P239, DOI 10.1146/annurev-physiol-012110-142233
   Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041
   Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3
   Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213
   Luck H, 2015, CELL METAB, V21, P527, DOI 10.1016/j.cmet.2015.03.001
   Madrigal-Perez VM, 2015, INT J CLIN EXP MED, V8, P22477
   Megna BW, 2016, WORLD J GASTRO SURG, V8, P115, DOI 10.4240/wjgs.v8.i2.115
   Merlo G, 2017, EFFECTS TNF ALPHA IN
   Mills CD, 2012, CRIT REV IMMUNOL, V32, P463, DOI 10.1615/CritRevImmunol.v32.i6.10
   Murakami K, 1998, DIABETES, V47, P1841, DOI 10.2337/diabetes.47.12.1841
   MYERS B, 1987, GUT, V28, P196, DOI 10.1136/gut.28.2.196
   Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307
   Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948
   Sharma VK, 1990, CANADIAN J GASTROENT, V4
   Shimada T, 2004, FEBS LETT, V558, P33, DOI 10.1016/S0014-5793(03)01527-8
   Staels B, 1997, BIOCHIMIE, V79, P95, DOI 10.1016/S0300-9084(97)81497-6
   Sutherland LR, 1997, INFLAMM BOWEL DIS, V3, P65, DOI 10.1002/ibd.3780030202
   van Asseldonk EJP, 2011, J CLIN ENDOCR METAB, V96, P2119, DOI 10.1210/jc.2010-2992
   Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001
   Wang J, 2015, J LIPID RES, V56, P319, DOI 10.1194/jlr.M054544
   Watts GF, 1999, CURR OPIN LIPIDOL, V10, P561, DOI 10.1097/00041433-199912000-00011
   Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001
   Zhou SY, 1999, DRUG METAB DISPOS, V27, P479
NR 47
TC 1
Z9 1
U1 3
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 19
PY 2018
VL 13
IS 1
AR e0191485
DI 10.1371/journal.pone.0191485
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT1QM
UT WOS:000422911300096
PM 29352300
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Soto, D
   Olivella, M
   Grau, C
   Armstrong, J
   Alcon, C
   Gasull, X
   de Salazar, MG
   Gratacos-Batlle, E
   Ramos-Vicente, D
   Fernandez-Duenas, V
   Ciruela, F
   Bayes, A
   Sindreu, C
   Lopez-Sala, A
   Garcia-Cazorla, A
   Altafaj, X
AF Soto, David
   Olivella, Mireia
   Grau, Cristina
   Armstrong, Judith
   Alcon, Clara
   Gasull, Xavier
   Gomez de Salazar, Macarena
   Gratacos-Batlle, Esther
   Ramos-Vicente, David
   Fernandez-Duenas, Victor
   Ciruela, Francisco
   Bayes, Alex
   Sindreu, Carlos
   Lopez-Sala, Anna
   Garcia-Cazorla, Angels
   Altafaj, Xavier
TI RETRACTED: Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B
   Mutation Is Attenuated by D-serine Dietary Supplement (Retracted
   article. See vol. 83, pg. 715, 2018)
SO BIOLOGICAL PSYCHIATRY
LA English
DT Article; Retracted Publication
DE De novo mutation; D-serine; Glutamatergic neurotransmission;
   Neuropsychiatric disorders; NMDA receptor; Severe encephalopathy
ID D-ASPARTATE RECEPTOR; NMDA RECEPTORS; NEURODEVELOPMENTAL DISORDERS;
   INTELLECTUAL DISABILITY; SYNAPSES; GLYCINE; AUTISM; HIPPOCAMPUS;
   MODULATION; EXPRESSION
AB BACKGROUND: N-Methyl-D-aspartate receptors (NMDARs) play pivotal roles in synaptic development, plasticity, neural survival, and cognition. Despite recent reports describing the genetic association between de novo mutations of NMDAR subunits and severe psychiatric diseases, little is known about their pathogenic mechanisms and potential therapeutic interventions. Here we report a case study of a 4-year-old Rett-like patient with severe encephalopathy carrying a missense de novo mutation in GRIN2B(p. P553T) coding for the GluN2B subunit of NMDAR.
   METHODS: We generated a dynamic molecular model of mutant GluN2B-containing NMDARs. We expressed the mutation in cell lines and primary cultures, and we evaluated the putative morphological, electrophysiological, and synaptic plasticity alterations. Finally, we evaluated D-serine administration as a therapeutic strategy and translated it to the clinical practice.
   RESULTS: Structural molecular modeling predicted a reduced pore size of mutant NMDARs. Electrophysiological recordings confirmed this prediction and also showed gating alterations, a reduced glutamate affinity associated with a strong decrease of NMDA-evoked currents. Moreover, GluN2B(P553T)-expressing neurons showed decreased spine density, concomitant with reduced NMDA-evoked currents and impaired NMDAR-dependent insertion of GluA1 at stimulated synapses. Notably, the naturally occurring coagonist D-serine was able to attenuate hypofunction of GluN2B(p. P553T)-containing NMDARs. Hence, D-serine dietary supplementation was initiated. Importantly, the patient has shown remarkable motor, cognitive, and communication improvements after 17 months of D-serine dietary supplementation.
   CONCLUSIONS: Our data suggest that hypofunctional NMDARs containing GluN2B( p. P553T) can contribute to Rettlike encephalopathy and that their potentiation by D-serine treatment may underlie the associated clinical improvement.
C1 [Soto, David; Alcon, Clara; Gasull, Xavier; Gratacos-Batlle, Esther; Ciruela, Francisco; Sindreu, Carlos] Univ Barcelona, Inst Neurosci, Barcelona, Spain.
   [Soto, David; Gasull, Xavier; Gratacos-Batlle, Esther] Univ Barcelona, Dept Biomed, Barcelona, Spain.
   [Fernandez-Duenas, Victor; Ciruela, Francisco] Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain.
   [Grau, Cristina; Gomez de Salazar, Macarena; Fernandez-Duenas, Victor; Ciruela, Francisco; Altafaj, Xavier] Univ Barcelona, Bellvitge Biomed Res Inst, Unit Neuropharmacol, Barcelona, Spain.
   [Grau, Cristina; Gomez de Salazar, Macarena; Fernandez-Duenas, Victor; Ciruela, Francisco; Altafaj, Xavier] Univ Barcelona, Pain Grp, Barcelona, Spain.
   [Alcon, Clara; Sindreu, Carlos] Univ Barcelona, Dept Clin Foundat, Barcelona, Spain.
   [Soto, David; Gasull, Xavier; Gratacos-Batlle, Esther] Univ Vic Cent Univ Catalonia, August Pi & Sunyer Biomed Res Inst, Barcelona, Spain.
   [Olivella, Mireia] Univ Vic Cent Univ Catalonia, Bioinfomat & Med Stat Grp, Barcelona, Spain.
   [Armstrong, Judith; Garcia-Cazorla, Angels] Hosp St Joan de Deu, Genet & Mol Med Serv, Barcelona, Spain.
   [Lopez-Sala, Anna; Garcia-Cazorla, Angels] Hosp St Joan de Deu, Dept Neurol, Neurometab Unit, Barcelona, Spain.
   [Ramos-Vicente, David; Bayes, Alex] Biomed Res Inst St Pau, Mol Physiol Synapse Lab, Ctr Invest Biomed Red Enfermedades Rara, Barcelona, Spain.
   [Ramos-Vicente, David; Bayes, Alex] Autonomous Univ Barcelona, Barcelona, Spain.
RP Altafaj, X (reprint author), Hosp Duran Reynals, Neuropharmacol & Pain Unit, IDIBELL, Ave Gran Via 199-203,3rd Floor, Barcelona 08908, Catalonia, Spain.
EM xaltafaj@idibell.cat
RI Gasull, Xavier/T-9630-2017; UBneuro, UBneuro/U-8656-2017; Ciruela,
   Francisco/A-5096-2013
OI Gasull, Xavier/0000-0002-6154-8323; Ciruela,
   Francisco/0000-0003-0832-3739; Altafaj, Xavier/0000-0002-7595-0647; Soto
   del Cerro, David/0000-0001-7995-3805; Gratacos-Batlle,
   Esther/0000-0001-8093-3713
FU National Institute of Health Carlos III [ISCIII] [PI16/00851]; Ministry
   of Economy and Competitiveness [MINECO] [20140210, PCIN-2014-105];
   Miguel Servet Program [CPII16/00021]; Ministerio de Ciencia e Innovacion
   [BFU2014-57562-P]; ISCIII [PI15/01082]; MINECO [SAF2016-77830-R,
   BFU2012-34398, BFU2015-69717-P]; Career Integration Grant [304111];
   Marie Curie Intra-European Fellowship [221540]; Ramon y Cajal Fellowship
   [RYC-2011-08391p]; MINECO/European Regional Development Fund [FEDER]
   [SAF2012-40102]; FP7 Marie Curie CIG Grant [631035]; Ramon y Cajal
   [RYC-2011-08026]; Agency for Management of University and Research
   Grants [SGR14-297];  [PI14/00141];  [RETIC RD16/0008/0014]
FX This work was supported by the Grant No. PI16/00851 (National Institute
   of Health Carlos III [ISCIII]), La Marato (Project No. 20140210),
   PCIN-2014-105 (Ministry of Economy and Competitiveness [MINECO]) and
   Miguel Servet Program (Grant No. CPII16/00021, ISCIII) (all to XA);
   Grant No. BFU2014-57562-P (Ministerio de Ciencia e Innovacion, to DS);
   Grant No. PI15/01082 (ISCIII) to AG-C); Grant No. SAF2016-77830-R (to
   MO); Grant Nos. BFU2012-34398 and BFU2015-69717-P (MINECO), a Career
   Integration Grant (Ref. 304111), a Marie Curie Intra-European Fellowship
   (Ref. 221540), and a Ramon y Cajal Fellowship (Ref. RYC-2011-08391p)
   (all to AB); Grant No. SAF2012-40102 (MINECO/European Regional
   Development Fund [FEDER]), an FP7 Marie Curie CIG Grant (Ref. 631035),
   and Ramon y Cajal (Grant No. RYC-2011-08026) (all to CS); and Grant Nos.
   PI14/00141 and RETIC RD16/0008/0014 (to XG). CA received an FPI contract
   (MINECO). XA, CS, and AB also benefit from the financial support of
   Agency for Management of University and Research Grants (Ref. No.
   SGR14-297).
CR Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810
   BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215
   Billard JM, 2015, J PHARMACEUT BIOMED, V116, P18, DOI 10.1016/j.jpba.2015.02.013
   Burnashev N, 2015, CURR OPIN PHARMACOL, V20, P73, DOI 10.1016/j.coph.2014.11.008
   Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001
   Chapleau CA, 2009, NEUROBIOL DIS, V35, P219, DOI 10.1016/j.nbd.2009.05.001
   Chen PE, 2008, J PHYSIOL-LONDON, V586, P227, DOI 10.1113/jphysiol.2007.143172
   D'Souza DC, 2013, NEUROPSYCHOPHARMACOL, V38, P492, DOI 10.1038/npp.2012.208
   de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524
   Dravid SM, 2010, J NEUROSCI, V30, P2741, DOI 10.1523/JNEUROSCI.5390-09.2010
   Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677
   Gratacos-Batlle E, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00469
   HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412
   Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001
   Harsing LG, 2013, BRAIN RES BULL, V93, P110, DOI 10.1016/j.brainresbull.2012.12.002
   Hu C, 2016, J PHARMACOL SCI, V132, P115, DOI 10.1016/j.jphs.2016.10.002
   Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915
   Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3
   Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073
   Levin R, 2015, J PSYCHIATR RES, V61, P188, DOI 10.1016/j.jpsychires.2014.12.007
   Li W, 2016, P NATL ACAD SCI USA, V113, pE1575, DOI 10.1073/pnas.1517244113
   Liao DZ, 2001, J NEUROSCI, V21, P6008
   Lucariello M, 2016, HUM GENET, V135, P1343, DOI 10.1007/s00439-016-1721-3
   MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0
   Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926
   Neul JL, 2004, NEUROSCIENTIST, V10, P118, DOI 10.1177/1073858403260995
   O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989
   O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835
   Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504
   Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029
   Platzer K, 2017, J MED GENET, V54, P460, DOI 10.1136/jmedgenet-2016-104509
   Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6
   Rett A, 1966, Wien Med Wochenschr, V116, P723
   Soto David, 2014, Commun Integr Biol, V7, pe27887, DOI 10.4161/cib.27887
   SPARROW SS, 1985, J PEDIATR PSYCHOL, V10, P215, DOI 10.1093/jpepsy/10.2.215
   Stroebel D, 2014, J NEUROSCI, V34, P16630, DOI 10.1523/JNEUROSCI.2736-14.2014
   Tovar KR, 2013, J NEUROSCI, V33, P9150, DOI 10.1523/JNEUROSCI.0829-13.2013
   Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451
   Turpin FR, 2011, NEUROBIOL AGING, V32, P1495, DOI 10.1016/j.neurobiolaging.2009.09.001
   van der Crabben SN, 2013, J INHERIT METAB DIS, V36, P613, DOI 10.1007/s10545-013-9592-4
   Volk L, 2015, ANNU REV NEUROSCI, V38, P127, DOI 10.1146/annurev-neuro-071714-033821
NR 41
TC 2
Z9 2
U1 5
U2 12
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0006-3223
EI 1873-2402
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD JAN 15
PY 2018
VL 83
IS 2
BP 160
EP 172
DI 10.1016/j.biopsych.2017.05.028
PG 13
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA FP4TC
UT WOS:000417608300013
PM 28734458
DA 2018-12-27
ER

PT J
AU Zhang, JC
   Xia, XX
   Li, SL
   Ran, W
AF Zhang, Jianchao
   Xia, Xingxuan
   Li, Siliang
   Ran, Wei
TI RETRACTED: Response of methane production via propionate oxidation to
   carboxylated multiwalled carbon nanotubes in paddy soil
   enrichments(Retracted article. See vol. 6, art no e4267, 2018)
SO PEERJ
LA English
DT Article; Retracted Publication
DE Carboxylated; MWCNTs; Syntrophic methanogenesis; Propionate; Anaerobic;
   Paddy soil enrichment
ID INTERSPECIES ELECTRON-TRANSFER; RICE FIELD SOIL; METHANOGENIC
   CONDITIONS; SYNTROPHIC OXIDATION; WATER-TREATMENT; IN-SITU; COMMUNITIES;
   TOXICITY; MICROORGANISMS; REDUCTION
AB Carboxylated multiwalled carbon nanotubes (MWCNTs-COOH) have become a growing concern in terms of their fate and toxicity in aqueous environments. Methane (CH4) is a major product of organic matter degradation in waterlogged environments. In this study, we determined the effect of MWCNTs-COOH on the production of CH4 from propionate oxidation in paddy soil enrichments. The results showed that the methanogenesis from propionate degradation was accelerated in the presence of MWCNTs-COOH. In addition, the rates of CH4 production and propionate degradation increased with increasing concentrations of MWCNTs-COOH. Scanning electron microscopy (SEM) observations showed that the cells were intact and maintained their structure in the presence of MWCNTs-COOH. In addition, SEM and fluorescence in situ hybridization (FISH) images revealed that the cells were in direct contact with the MWCNTs and formed cell-MWCNTs aggregates that contained both bacteria and archaea. On the other hand, nontoxic magnetite nanoparticles (Fe3O4) had similar effects on the CH4 production and cell integrity as the MWCNTs-COOH. Compared with no nanomaterial addition, the relative abundances of Geobacter and Methanosarcina species increased in the presence of MWCNTs-COOH. This study suggests that MWCNTs-COOH exerted positive rather than cytotoxic effects on the syntrophic oxidation of propionate in paddy soil enrichments and affected the bacterial and archaeal community structure at the test concentrations. These findings provide novel insight into the consequences of nanomaterial release into anoxic natural environments.
C1 [Zhang, Jianchao; Li, Siliang] Tianjin Univ, Inst Surface Earth Syst Sci, Tianjin, Peoples R China.
   [Xia, Xingxuan] Peking Univ, Coll Urban & Environm Sci, Beijing, Peoples R China.
   [Ran, Wei] Nanjing Agr Univ, Jiangsu Prov Coordinated Res Ctr Organ Solid Wast, Nanjing, Jiangsu, Peoples R China.
RP Ran, W (reprint author), Nanjing Agr Univ, Jiangsu Prov Coordinated Res Ctr Organ Solid Wast, Nanjing, Jiangsu, Peoples R China.
EM ranwei@njau.edu.cn
FU National Key RAMP;D Program of China [2016YFD0200306, 2016YFA0601000];
   National Natural Science Foundation of China [41671294, 41701275]
FX This work was supported by National Key R&D Program of China (Nos.
   2016YFD0200306 and 2016YFA0601000) and the National Natural Science
   Foundation of China (41671294; 41701275). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ambuchi JJ, 2017, WATER RES, V117, P87, DOI 10.1016/j.watres.2017.03.050
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Conrad R, 2009, ENV MICROBIOL REP, V1, P285, DOI 10.1111/j.1758-2229.2009.00038.x
   Das R, 2014, DESALINATION, V354, P160, DOI 10.1016/j.desal.2014.09.032
   De Volder MFL, 2013, SCIENCE, V339, P535, DOI 10.1126/science.1222453
   Dolfing J, 2013, APPL ENVIRON MICROB, V79, P4515, DOI 10.1128/AEM.00111-13
   Du J, 2013, ENVIRON TOXICOL PHAR, V36, P451, DOI 10.1016/j.etap.2013.05.007
   Farre M, 2009, ANAL BIOANAL CHEM, V393, P81, DOI 10.1007/s00216-008-2458-1
   Gan YL, 2012, APPL ENVIRON MICROB, V78, P4923, DOI 10.1128/AEM.00688-12
   Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553
   Greuter D, 2016, NUCLEIC ACIDS RES, V44, pD586, DOI 10.1093/nar/gkv1232
   Holmes DE, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00223-17, 10.1128/aem.00223-17]
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kang S, 2008, ENVIRON SCI TECHNOL, V42, P7528, DOI 10.1021/es8010173
   Kang S, 2007, LANGMUIR, V23, P8670, DOI 10.1021/la701067r
   Kato S, 2012, ENVIRON MICROBIOL, V14, P1646, DOI 10.1111/j.1462-2920.2011.02611.x
   KRUMBOCK M, 1991, FEMS MICROBIOL ECOL, V85, P247, DOI 10.1111/j.1574-6968.1991.tb04731.x
   Li HJ, 2015, ENVIRON MICROBIOL, V17, P1533, DOI 10.1111/1462-2920.12576
   Liu FH, 2015, ENVIRON MICROBIOL, V17, P648, DOI 10.1111/1462-2920.12485
   Liu FH, 2012, ENERG ENVIRON SCI, V5, P8982, DOI 10.1039/c2ee22459c
   Lu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035279
   Lueders T, 2004, APPL ENVIRON MICROB, V70, P5778, DOI 10.1128/AEM.70.10.5778-5786.2004
   Mach V, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00506
   Mahadevan R, 2011, NAT REV MICROBIOL, V9, P39, DOI 10.1038/nrmicro2456
   Morita M, 2011, MBIO, V2, DOI 10.1128/mBio.00159-11
   Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4
   Nouara A, 2013, NANOSCALE, V5, P6088, DOI 10.1039/c3nr00847a
   Nowack B, 2013, ENVIRON INT, V59, P1, DOI 10.1016/j.envint.2013.04.003
   Peng JJ, 2008, APPL ENVIRON MICROB, V74, P2894, DOI 10.1128/AEM.00070-08
   Petersen EJ, 2011, ENVIRON SCI TECHNOL, V45, P9837, DOI 10.1021/es201579y
   Qu XL, 2013, ENVIRON SCI TECHNOL, V47, P14080, DOI 10.1021/es4033056
   Richter K, 2012, APPL ENVIRON MICROB, V78, P913, DOI 10.1128/AEM.06803-11
   Rodrigues DF, 2013, ENVIRON SCI TECHNOL, V47, P625, DOI 10.1021/es304002q
   Rotaru AE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00744
   Rotaru AE, 2014, APPL ENVIRON MICROB, V80, P4599, DOI 10.1128/AEM.00895-14
   Rotaru AE, 2014, ENERG ENVIRON SCI, V7, P408, DOI 10.1039/c3ee42189a
   Salvador AF, 2017, ENVIRON MICROBIOL, V19, P2727, DOI 10.1111/1462-2920.13774
   Shrestha B, 2013, J HAZARD MATER, V261, P188, DOI 10.1016/j.jhazmat.2013.07.031
   Shrestha PM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00237
   Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166
   Vardharajula S, 2012, INT J NANOMED, V7, P5361, DOI 10.2147/IJN.S35832
   Viggi CC, 2014, ENVIRON SCI TECHNOL, V48, P7536, DOI 10.1021/es5016789
   Wang CR, 2014, J HAZARD MATER, V274, P404, DOI 10.1016/j.jhazmat.2014.04.036
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Yadav T, 2016, ENVIRON SCI POLLUT R, V23, P4063, DOI 10.1007/s11356-015-4385-y
   Zhang JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01316
   Zhao XC, 2012, ENVIRON INT, V40, P244, DOI 10.1016/j.envint.2011.12.003
NR 47
TC 0
Z9 0
U1 6
U2 10
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD JAN 12
PY 2018
VL 6
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FT4RU
UT WOS:000423143200017
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Dhusia, K
   Bajpai, A
   Ramteke, PW
AF Dhusia, Kalyani
   Bajpai, Archana
   Ramteke, P. W.
TI RETRACTED: Overcoming antibiotic resistance: Is siderophore Trojan horse
   conjugation an answer to evolving resistance in microbial pathogens?
   (Retracted article. See vol. 283, pg. 290. 2018)
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Review; Retracted Publication
DE Iron acquisition; Siderophores; Trojan horse; Siderophore biosynthesis
   pathway; Conjugates; Transporter proteins; Pathogen control
ID MOLECULAR-DYNAMICS SIMULATIONS; GRAM-NEGATIVE BACTERIA; NONRIBOSOMAL
   PEPTIDE SYNTHETASE; GROWTH-PROMOTING RHIZOBACTERIA; BIOLOGICAL
   RECOGNITION ELEMENT; BINDING CASSETTE TRANSPORTER; CHORISMATE-UTILIZING
   ENZYMES; OUTER-MEMBRANE PROTEINS; ESCHERICHIA-COLI-CELLS;
   IRON-CHELATION-THERAPY
AB Comparative study of siderophore biosynthesis pathway in pathogens provides potential targets for antibiotics and host drug delivery as a part of computationally feasible microbial therapy. Iron acquisition using siderophore models is an essential and well established model in all microorganisms and microbial infections a known to cause great havoc to both plant and animal. Rapid development of antibiotic resistance in bacterial as well as fungal pathogens has drawn us at a verge where one has to get rid of the traditional way of obstructing pathogen using single or multiple antibiotic/chemical inhibitors or drugs. 'Trojan horse' strategy is an answer to this imperative call where antibiotic are by far sneaked into the pathogenic cell via the siderophore receptors at cell and outer membrane. This antibiotic once gets inside, generates a 'black hole' scenario within the opportunistic pathogens via iron scarcity. For pathogens whose siderophore are not compatible to smuggle drug due to their complex conformation and stiff valence bonds, there is another approach. By means of the siderophore biosynthesis pathways, potential targets for inhibition of these siderophores in pathogenic bacteria could be achieved and thus control pathogenic virulence. Method to design artificial exogenous siderophores for pathogens that would compete and succeed the battle of intake is also covered with this review. These manipulated siderophore would enter pathogenic cell like any other siderophore but will not disperse iron due to which iron inadequacy and hence pathogens control be accomplished. The aim of this review is to offer strategies to overcome the microbial infections/pathogens using siderophore.
C1 [Dhusia, Kalyani] SHUATS, Jacob Inst Biotechnol & Bioengn, Dept Computat Biol & Bioinformat, Allahabad 211007, UP, India.
   [Bajpai, Archana] RIKEN, Ctr Integrat Med Sci, Lab Dis Syst Modeling, Yokohama, Kanagawa 2300045, Japan.
   [Ramteke, P. W.] SHUATS, Dept Biol Sci, Allahabad 211007, UP, India.
RP Ramteke, PW (reprint author), SHUATS, Dept Biol Sci, Allahabad 211007, UP, India.
EM pramod.ramteke@shiats.edu.in
FU University Grant Commission, India [RGNF-2015-17-SC-UTT-1664]
FX Financial support by University Grant Commission, India
   #RGNF-2015-17-SC-UTT-1664 to Kalyani Dhusia is gratefully acknowledged.
CR Abergel RJ, 2006, P NATL ACAD SCI USA, V103, P18499, DOI 10.1073/pnas.0607055103
   Acton Q. A., 2012, MACROLIDE DERIVATIVE
   Agarwal S, 2017, SCI REP-UK, V7, DOI 10.1038/srep42812
   Ahemad Munees, 2014, Journal of King Saud University Science, V26, P1, DOI 10.1016/j.jksus.2013.05.001
   Ahmed E, 2014, MICROB BIOTECHNOL, V7, P196, DOI 10.1111/1751-7915.12117
   Al-Bader N, 2016, VIRULENCE, V7, P950, DOI 10.1080/21505594.2016.1231278
   Aldrich C., 2011, ANTIBACTERIAL AGENTS
   Allen CE, 2013, J BACTERIOL, V195, P2852, DOI 10.1128/JB.00244-13
   Allen CE, 2011, J BACTERIOL, V193, P5374, DOI 10.1128/JB.05508-11
   Allen CE, 2009, J BACTERIOL, V191, P2638, DOI 10.1128/JB.01784-08
   Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x
   Huayhuaz JAA, 2017, J TRACE ELEM MED BIO, V41, P16, DOI 10.1016/j.jtemb.2017.01.006
   Andersen D, 2003, MYCOL RES, V107, P949, DOI 10.1017/S0953756203008220
   Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X
   ANKENBAUER RG, 1994, J BACTERIOL, V176, P307
   Arantes V, 2007, WATER SCI TECHNOL, V55, P1, DOI 10.2166/wst.2007.205
   Arantes V, 2011, J IND MICROBIOL BIOT, V38, P541, DOI 10.1007/s10295-010-0798-2
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Aron Z, 2016, CURR OPIN MICROBIOL, V33, P1, DOI 10.1016/j.mib.2016.05.007
   Baghalian K, 2014, PLANT CELL, V26, P3847, DOI 10.1105/tpc.114.130328
   Bajpai P, 2012, ENVIRONMENTALLY BENIGN APPROACHES FOR PULP BLEACHING, 2ND EDITION, P1
   Bajpai P., 2010, ENV FRIENDLY PRODUCT
   Balla J., 2008, USE SIDEROPHORES PRE
   Balloy V, 2009, MICROBES INFECT, V11, P919, DOI 10.1016/j.micinf.2009.07.002
   Balseiro-Romero M, 2017, SCI TOTAL ENVIRON, V581, P676, DOI [10.1016/jscitotenv.2016.12.180, 10.1016/j.scitotenv.2016.12.180]
   Banerjee S, 2016, METALLOMICS, V8, P125, DOI 10.1039/c5mt00218d
   Bantysh O, 2014, MBIO, V5, DOI 10.1128/mBio.01059-14
   Barasch J. M., 2010, NGAL REDUCTION AMELI
   Barasch J. M., 2012, NGAL REDUCTION AMELI
   Barry SM, 2009, CURR OPIN CHEM BIOL, V13, P205, DOI 10.1016/j.cbpa.2009.03.008
   Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945
   Bassetti M, 2015, LANGENBECK ARCH SURG, V400, P153, DOI 10.1007/s00423-015-1280-4
   Bassler B., 2013, INHIBITION QUORUM SE
   Bassler B., 2016, INHIBITION QUORUM SE
   Bassler B., 2015, INHIBITION QUORUM SE
   Baude J, 2016, APPL ENVIRON MICROB, V82, P3515, DOI 10.1128/AEM.00419-16
   Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x
   Bergeron R. J., 2015, SIDEROPHORE CONJUGAT
   Bergeron R. J., 2014, SIDEROPHORE CONJUGAT
   Boda SK, 2016, RSC ADV, V6, P39245, DOI 10.1039/c6ra02603f
   Bosnjakovic A, 2011, NANOMED-NANOTECHNOL, V7, P284, DOI 10.1016/j.nano.2010.10.008
   Bosse R., 2014, METHODS TARGET MOL D
   Bouillon-Pichault M., 2017, J CLIN PHARM
   Bouizgarne B., 2013, BACTERIA AGROBIOLOGY, P15, DOI [10.1007/978-3-642-33639-3_2, DOI 10.1007/978-3-642-33639-3_2]
   Braun V, 2009, BIOMETALS, V22, P3, DOI 10.1007/s10534-008-9199-7
   Brem D, 2001, MICROBIOL-SGM, V147, P1115, DOI 10.1099/00221287-147-5-1115
   Brewitz HH, 2017, BBA-GEN SUBJECTS, V1861, P683, DOI 10.1016/j.bbagen.2016.12.021
   Brickman TJ, 2005, J BACTERIOL, V187, P3650, DOI 10.1128/JB.11.3650-3661.2005
   Brillet K, 2009, ACTA CRYSTALLOGR D, V65, P326, DOI 10.1107/S0907444909002200
   BROCHU A, 1992, ANTIMICROB AGENTS CH, V36, P2166, DOI 10.1128/AAC.36.10.2166
   Brown JS, 2002, MICROBES INFECT, V4, P1149, DOI 10.1016/S1286-4579(02)01640-4
   Budzikiewicz Herbert, 2001, Current Topics in Medicinal Chemistry, V1, P73, DOI 10.2174/1568026013395524
   BULLEN JJ, 1968, IMMUNOLOGY, V15, P581
   Cadamuro M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010149
   Callahan BP, 2006, BIOORG MED CHEM LETT, V16, P3802, DOI 10.1016/j.bmcl.2006.04.024
   Caza M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00080
   Cennamo N, 2014, SENSORS-BASEL, V14, P4657, DOI 10.3390/s140304657
   Chakraborty R, 2007, BIOMETALS, V20, P263, DOI 10.1007/s10534-006-9060-9
   Challis GL, 2000, FEMS MICROBIOL LETT, V187, P111, DOI 10.1111/j.1574-6968.2000.tb09145.x
   Chami M, 2002, J MOL BIOL, V315, P1075, DOI 10.1006/jmbi.2001.5309
   Chandra P, 2011, BIOSENS BIOELECTRON, V26, P4442, DOI 10.1016/j.bios.2011.04.060
   Chellat MF, 2016, ANGEW CHEM INT EDIT, V55, P6600, DOI 10.1002/anie.201506818
   Chhibber S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-174
   Chiado A, 2013, BIOSENSORS-BASEL, V3, P385, DOI 10.3390/bios3040385
   Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914
   Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x
   Chu BCH, 2011, BIOL CHEM, V392, P39, DOI 10.1515/BC.2011.012
   Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200
   Clarke TE, 2002, BIOMETALS, V15, P121, DOI 10.1023/A:1015249530156
   Clement E, 2004, BIOCHEMISTRY-US, V43, P7954, DOI 10.1021/bi049768c
   Cobessi D, 2005, J MOL BIOL, V352, P893, DOI 10.1016/j.jmb.2005.08.004
   Cohen A, 2000, J BIOL CHEM, V275, P33388, DOI 10.1074/jbc.M004611200
   Cohen B. A., 2009, FILTER MAT GENERATIN
   Cornelissen CN, 2003, FRONT BIOSCI-LANDMRK, V8, pD836, DOI 10.2741/1076
   Cornell R. M., 2006, SCIENCE
   Corsini G, 2010, FEMS MICROBIOL LETT, V312, P119, DOI 10.1111/j.1574-6968.2010.02106.x
   Mattos ALC, 2013, J TRACE ELEM MED BIO, V27, P103, DOI 10.1016/j.jtemb.2012.09.001
   Cramer RA, 2011, CURR OPIN INFECT DIS, V24, P315, DOI 10.1097/QCO.0b013e328348b159
   Crosa J. H., 1995, DEFERRATION USING AN
   Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002
   Crouzet L, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv012
   Cunrath O, 2016, ENVIRON MICROBIOL, V18, P3258, DOI 10.1111/1462-2920.12971
   Dahm C, 1998, BBA-GEN SUBJECTS, V1425, P377, DOI 10.1016/S0304-4165(98)00089-0
   Dai CH, 2017, ULTRASON SONOCHEM, V36, P191, DOI 10.1016/j.ultsonch.2016.11.035
   Daruwala R, 1996, FEMS MICROBIOL LETT, V140, P159, DOI 10.1111/j.1574-6968.1996.tb08330.x
   Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07
   de Carvalho Carla C C R, 2011, Recent Pat Biotechnol, V5, P183
   Deisenhofer J., 1999, NAT STRUCT BIOL, V6, P56
   Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005
   Denaro R, 2014, MAR GENOM, V17, P43, DOI 10.1016/j.margen.2014.07.004
   Dertz E. A., 2004, CHEMINFORM, V35
   Destoumieux-Garzon D, 2003, MOL MICROBIOL, V49, P1031, DOI 10.1046/j.1365-2958.2003.03610.x
   Dhusia K, 2016, NETW MODEL ANAL HLTH, V5, DOI 10.1007/s13721-016-0127-4
   Dimkpa CO, 2016, ENDOCYT CELL RES, V27, P7
   Earhart C. F., 2015, REF MODUL BIOMED SCI
   Eberhart LJ, 2012, APPL ENVIRON MICROB, V78, P6592, DOI 10.1128/AEM.01067-12
   Eid R, 2017, BBA-MOL CELL RES, V1864, P399, DOI 10.1016/j.bbamcr.2016.12.002
   Eisenhauer HA, 2005, J BIOL CHEM, V280, P30574, DOI 10.1074/jbc.M506708200
   Elfenbein JR, 2010, J VET INTERN MED, V24, P1475, DOI 10.1111/j.1939-1676.2010.0621.x
   Elokely KM, 2013, J CHEM INF MODEL, V53, P1934, DOI 10.1021/ci400040d
   Embaby AM, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0192-1
   Emery D. A., 2007, METHODS MAKING COMPO
   Emery D. A., 2008, METHODS REDUCING FEC
   Emery D. A., 1998, PROTEIN
   Emery D. A., 2008, ACTIVE IMMUNIZATION
   Emery D. A., 2000, ACTIVE IMMUNIZATION
   Emery D. A., 2014, IMMUNIZING COMPOSITI
   Emery D. A., 2012, IMMUNIZING COMPOSITI
   Emery D. A., 2002, ACTIVE IMMUNIZATION
   Emery D. A., 2015, METHODS DETECTING AN
   Emery D. A., 2006, POLYPEPTIDES OBTAINE
   Emery D. A., 2011, IMMUNIZING COMPOSITI
   Emery D. A., 2013, IMMUNIZING COMPOSITI
   Emery D. A., 2008, METHODS TREATING MAS
   Emery D. A., 2006, METHODS TREATING ANI
   Emery D. A., 2006, METHODS TREATING HIG
   Ernst G., 1967, PROCESS PRODUCING CO
   Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022
   Faraldo-Gomez JD, 2003, BIOPHYS J, V85, P1406, DOI 10.1016/S0006-3495(03)74573-1
   Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015
   Fardeau S., 2011, SCI MICROBIAL PATHOG, P695
   FATH MJ, 1993, MICROBIOL REV, V57, P995
   Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313
   Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215
   Ferraroni M, 2006, J MOL BIOL, V360, P788, DOI 10.1016/j.jmb.2006.05.046
   Ferrer P, 2015, ANTIMICROB AGENTS CH, V59, P1418, DOI 10.1128/AAC.04642-14
   Ferrer P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037171
   Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667
   Fisher SA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004450.pub3
   Folschweiller N, 2000, MOL MEMBR BIOL, V17, P123
   Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761
   Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x
   Fukushima T, 2013, P NATL ACAD SCI USA, V110, P13821, DOI 10.1073/pnas.1304235110
   Gasser V, 2016, ENVIRON MICROBIOL, V18, P819, DOI 10.1111/1462-2920.13199
   Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6
   Gerhardt KE, 2017, PLANT SCI, V256, P170, DOI 10.1016/j.plantsci.2016.11.016
   GHOSH M, 1995, BIOORGAN MED CHEM, V3, P1519, DOI 10.1016/0968-0896(95)00134-3
   Gledhill M, 2004, MAR CHEM, V88, P75, DOI 10.1016/j.marchem.2004.03.003
   Goetz DH, 2000, BIOCHEMISTRY-US, V39, P1935, DOI 10.1021/bi992215v
   Gorska A., 2014, TRENDS PHARM SCI
   Gorska A, 2014, TRENDS PHARMACOL SCI, V35, P442, DOI 10.1016/j.tips.2014.06.007
   Gottlieb D., 2013, ANTIBIOTICS
   Grigg JC, 2010, J BIOL CHEM, V285, P11162, DOI 10.1074/jbc.M109.097865
   Grossman T. H., 1996, BACILLUS SUBTILIS SI
   Guennoc C. Miquel, 2017, J VIS EXP
   GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.mi.48.100194.003523
   Guilhelmelli F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00353
   Gysin J., 1993, SIDEROPHORES ANTIPAR
   Haas H, 2003, BIOCHEM J, V371, P505, DOI 10.1042/BJ20021685
   Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338
   Haas H, 2014, NAT PROD REP, V31, P1266, DOI 10.1039/c4np00071d
   Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22
   Han S, 2010, P NATL ACAD SCI USA, V107, P22002, DOI 10.1073/pnas.1013092107
   Hancock D.K., 1994, ION SPECIFIC CHELATI
   Hantash FM, 2000, J BACTERIOL, V182, P1768, DOI 10.1128/JB.182.6.1768-1773.2000
   Harris N. J., 2017, EUR BIOPHYS J
   Harrison AJ, 2006, J BACTERIOL, V188, P6081, DOI 10.1128/JB.00338-06
   HARTMANN A, 1979, EUR J BIOCHEM, V99, P517, DOI 10.1111/j.1432-1033.1979.tb13283.x
   Hasan SW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29328
   Heinisch L, 2002, J MED CHEM, V45, P3032, DOI 10.1021/jm010546b
   Heinisch L., 2000, BENZOXAZINEDIONE DER
   Heinrichs D. E., 2014, SIDEROPHORE MEDIATED
   Heinrichs D. E., 2014, METHODS INHIBITING S
   HENDERSON DP, 1994, INFECT IMMUN, V62, P5120
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Heymann P, 2000, BIOMETALS, V13, P65, DOI 10.1023/A:1009250017785
   Heymann P, 2000, FEMS MICROBIOL LETT, V186, P221, DOI 10.1111/j.1574-6968.2000.tb09108.x
   Hickford SJH, 2004, J NAT PROD, V67, P1897, DOI 10.1021/np049823i
   HIDER RC, 1984, J AM CHEM SOC, V106, P6983, DOI 10.1021/ja00335a020
   Hissen AHT, 2005, INFECT IMMUN, V73, P5493, DOI 10.1128/IAI.73.9.5493-5503.2005
   Holden KM, 2012, COMP IMMUNOL MICROB, V35, P129, DOI 10.1016/j.cimid.2011.12.004
   Holden VI, 2015, METALLOMICS, V7, P986, DOI 10.1039/c4mt00333k
   Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009
   Homann VV, 2009, BIOMETALS, V22, P565, DOI 10.1007/s10534-009-9237-0
   Humphreys H., 2017, INFECT CONT HOSP EP, P1
   Isah MB, 2014, PARASITOL RES, V113, P801, DOI 10.1007/s00436-014-3804-1
   Jackson RW, 2011, TRENDS GENET, V27, P32, DOI 10.1016/j.tig.2010.10.001
   Jeong CB, 2017, COMP BIOCHEM PHYS D, V21, P17, DOI 10.1016/j.cbd.2016.10.003
   Jeong CB, 2017, AQUAT TOXICOL, V185, P29, DOI 10.1016/j.aquatox.2017.01.013
   Ji C, 2012, J AM CHEM SOC, V134, P9898, DOI 10.1021/ja303446w
   Johnson L, 2008, MYCOL RES, V112, P170, DOI 10.1016/j.mycres.2007.11.012
   Johnstone TC, 2015, DALTON T, V44, P6320, DOI 10.1039/c4dt03559c
   Kaae Susanne, 2017, J Pharm Policy Pract, V10, P13, DOI 10.1186/s40545-017-0102-1
   Kaizu K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.73
   Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010
   KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0
   KATSU K, 1982, ANTIMICROB AGENTS CH, V22, P181, DOI 10.1128/AAC.22.2.181
   KAWAI S, 1988, ARCH BIOCHEM BIOPHYS, V262, P99, DOI 10.1016/0003-9861(88)90172-5
   Kawano H, 2013, MICROB PATHOGENESIS, V65, P73, DOI 10.1016/j.micpath.2013.10.002
   Keating TA, 2000, BIOCHEMISTRY-US, V39, P15513, DOI 10.1021/bi001651a
   Keskin H, 2014, MIKROBIYOL BUL, V48, P365, DOI 10.5578/mb.7796
   Kim JG, 2006, P NATL ACAD SCI USA, V103, P8846, DOI 10.1073/pnas.0602965103
   Kim S, 2016, J MOL BIOL, V428, P5007, DOI 10.1016/j.jmb.2016.10.022
   Kim Y, 2005, EMBO J, V24, P952, DOI 10.1038/sj.emboj.7600579
   Knight SAB, 2005, INFECT IMMUN, V73, P5482, DOI 10.1128/IAI.73.9.5482-5492.2005
   Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x
   Konhauser KO, 1997, FEMS MICROBIOL REV, V20, P315, DOI 10.1016/S0168-6445(97)00014-4
   Kosman DJ, 2003, MOL MICROBIOL, V47, P1185, DOI 10.1046/j.1365-2958.2003.03368.x
   KOSTER W, 1992, MOL GEN GENET, V232, P399
   Krewulak KD, 2008, BBA-BIOMEMBRANES, V1778, P1781, DOI 10.1016/j.bbamem.2007.07.026
   Kumar A, 2015, METHODS, V71, P26, DOI 10.1016/j.ymeth.2014.07.007
   Lackie J. M., 2013, DICT CELL MOL BIOL, P581
   Lacko AG, 2006, CHEMOTHERAPY, V52, P171, DOI 10.1159/000093268
   Lai CC, 2017, SCI REP-UK, V7, DOI 10.1038/srep41758
   Lawson MC, 2009, BIOMACROMOLECULES, V10, P2221, DOI 10.1021/bm900410a
   Lee HS, 2015, J MICROBIOL IMMUNOL, V48, P647, DOI 10.1016/j.jmii.2014.04.009
   Lee JK, 2007, J BACTERIOL, V189, P8556, DOI 10.1128/JB.01050-07
   LESUISSE E, 1995, ANAL BIOCHEM, V226, P375, DOI 10.1006/abio.1995.1239
   Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730
   Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086/491709
   Lewis K, 2010, J ANTIBIOT, V63, P468, DOI 10.1038/ja.2010.87
   Li KH, 2016, BIOMETALS, V29, P377, DOI 10.1007/s10534-016-9935-3
   Li N, 2012, J BIOL CHEM, V287, P8912, DOI 10.1074/jbc.M111.316034
   Liang Zhibin, 2016, Yichuan, V38, P894, DOI 10.16288/j.yczz.16-139
   Lin Ming-Feng, 2014, World J Clin Cases, V2, P787, DOI 10.12998/wjcc.v2.i12.787
   Ling JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057794
   Liu Jiajia, 2016, Weishengwu Xuebao, V56, P461
   Liu S, 2016, NATURE, V534, P360, DOI 10.1038/nature18286
   Liu X., 2017, ENV POLLUT
   Liu XH, 2012, FEBS LETT, V586, P1240, DOI 10.1016/j.febslet.2012.03.043
   Liu X, 2015, ENVIRON POLLUT, V206, P376, DOI 10.1016/j.envpol.2015.07.034
   Liu ZH, 2010, MOL BIOL REP, V37, P3673, DOI 10.1007/s11033-010-0019-0
   Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782
   Locher KP, 1997, EUR J BIOCHEM, V247, P770, DOI 10.1111/j.1432-1033.1997.t01-1-00770.x
   Lockhart SR, 2012, J CLIN MICROBIOL, V50, P3435, DOI 10.1128/JCM.01283-12
   Long NB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00716
   Lu FY, 2013, VET MICROBIOL, V167, P713, DOI 10.1016/j.vetmic.2013.08.020
   Lukacik P, 2012, P NATL ACAD SCI USA, V109, P9857, DOI 10.1073/pnas.1203472109
   Mabeza GF, 1999, PHARMACOL THERAPEUT, V81, P53, DOI 10.1016/S0163-7258(98)00037-0
   Mamatha C., 2014, World Journal of Pharmaceutical Research, V3, P372
   Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198
   Maraki S, 2016, INFECT CHEMOTHER, V48, P190, DOI 10.3947/ic.2016.48.3.190
   Mariathasan S, 2017, TRENDS MOL MED, V23, P135, DOI 10.1016/j.molmed.2016.12.008
   Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x
   Masse E, 2010, NUTR HEALTH SER, P65, DOI 10.1007/978-1-59745-462-9_4
   Mawji E, 2011, MAR CHEM, V124, P90, DOI 10.1016/j.marchem.2010.12.005
   McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13
   McCormick A, 2010, CELL MICROBIOL, V12, P1535, DOI 10.1111/j.1462-5822.2010.01517.x
   McPherson CJ, 2012, ANTIMICROB AGENTS CH, V56, P6334, DOI 10.1128/AAC.01345-12
   Mendez C, 2001, RES MICROBIOL, V152, P341, DOI 10.1016/S0923-2508(01)01205-0
   Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146
   Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07
   Miethke M, 2006, MOL MICROBIOL, V61, P1413, DOI 10.1111/j.1365-2958.2006.05321.x
   Miller CE, 2009, MICROBIOL-SGM, V155, P3157, DOI 10.1099/mic.0.032425-0
   Miller G. W., 1989, TREATMENT PLANT CHLO
   Miller M. J., 2016, ANTIBACTERIAL SIDERO
   Miller M. J., 2001, ANTIMYCOBACTERIAL AG
   Miller M.J, 2014, ANTIBACTERIAL SIDERO, P85
   Miller M. J., 2013, ANTIBACTERIAL SIDERO
   Mills A, 2016, BBA-BIOMEMBRANES, V1858, P3105, DOI 10.1016/j.bbamem.2016.09.019
   Mislin GLA, 2014, METALLOMICS, V6, P408, DOI 10.1039/c3mt00359k
   Monroy F, 2005, FUNGAL GENET BIOL, V42, P638, DOI 10.1016/j.fgb.2005.04.003
   Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353
   Moore M. M., 2010, PRODUCTION MUTANT ST
   Moradigaravand D, 2016, GENOME RES, V26, P1101, DOI 10.1101/gr.205245.116
   Morris Garrett M., 2008, V443, P365, DOI 10.1007/978-1-59745-177-2_19
   Morrissey JP, 1999, MICROBIOL MOL BIOL R, V63, P708
   Moynie L., 2017, ANTIMICROB AGENTS CH
   Nagoba B. S., 2008, IMMUNOLOGY
   Nagoba B, 2011, ELECTRON J GEN MED, V8, P229, DOI 10.29333/ejgm/82743
   NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435
   NEU HC, 1983, ANTIMICROB AGENTS CH, V24, P313, DOI 10.1128/AAC.24.3.313
   Nitanai Y, 2009, J MOL BIOL, V385, P1422, DOI 10.1016/j.jmb.2008.10.026
   Noble SM, 2013, CURR OPIN MICROBIOL, V16, P708, DOI 10.1016/j.mib.2013.09.006
   Noel S, 2011, ORG BIOMOL CHEM, V9, P8288, DOI 10.1039/c1ob06250f
   Nolan E. M., 2015, ENTEROBACTIN CONJUGA
   Nolan EM, 2008, BIOCHEMISTRY-US, V47, P9289, DOI 10.1021/bi800826j
   Nourani A, 1997, MOL CELL BIOL, V17, P5453, DOI 10.1128/MCB.17.9.5453
   Nusca TD, 2012, J BIOL CHEM, V287, P16058, DOI 10.1074/jbc.M112.359349
   OBRIEN IG, 1971, BIOCHIM BIOPHYS ACTA, V237, P537, DOI 10.1016/0304-4165(71)90274-1
   Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y
   Oliphant CM, 2015, JNP-J NURSE PRACT, V11, P1036, DOI 10.1016/j.nurpra.2015.07.015
   Oliphant CM, 2015, JNP-J NURSE PRACT, V11, P70, DOI 10.1016/j.nurpra.2014.09.018
   Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006
   Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090
   Osayande J., 2013, WEBMEDCENTRAL, V4
   OSullivan D. J., 2004, ISOLATED BIFIDOBACTE
   Page MGP, 2013, ANN NY ACAD SCI, V1277, P115, DOI 10.1111/nyas.12024
   Pal KK, 2001, MICROBIOL RES, V156, P209, DOI 10.1078/0944-5013-00103
   Palaga Tanapat, 2013, INT J PHARM MED BIOL, V2, P1
   Pang YP, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00161
   Papagianni M, 2017, CURRENT DEVELOPMENTS IN BIOTECHNOLOGY AND BIOENGINEERING: BIOPROCESSES, BIOREACTORS AND CONTROLS, P45, DOI 10.1016/B978-0-444-63663-8.00003-3
   Peek Mary E, 2012, Interdiscip Perspect Infect Dis, V2012, P843509, DOI 10.1155/2012/843509
   Peng JH, 2017, J PROTEOMICS, V152, P75, DOI 10.1016/j.jprot.2016.10.005
   Perez-Perez R, 2012, EXPERT SYST APPL, V39, P8396, DOI 10.1016/j.eswa.2012.01.180
   Perez-Regidor L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091508
   Pfleger BF, 2008, P NATL ACAD SCI USA, V105, P17133, DOI 10.1073/pnas.0808118105
   Phillips DJ, 2015, J MATER CHEM B, V3, P270, DOI 10.1039/c4tb01501k
   Philpott CC, 2002, BIOCHEM SOC T, V30, P698, DOI 10.1042/bst0300698
   Plach MG, 2015, ANGEW CHEM INT EDIT, V54, P11270, DOI 10.1002/anie.201505063
   Pletzer D, 2015, J BACTERIOL, V197, P2217, DOI 10.1128/JB.00234-15
   Pons AM, 2002, ANTIMICROB AGENTS CH, V46, P229, DOI 10.1128/AAC.46.1.229-230.2002
   Poras H, 1998, J ANTIBIOT, V51, P786, DOI 10.7164/antibiotics.51.786
   Pramanik A, 2007, INT J MED MICROBIOL, V297, P459, DOI 10.1016/j.ijmm.2007.03.002
   Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831
   RAFALOWICZ A, 1953, Pol Tyg Lek (Wars), V8, P996
   Raines D. J., 2015, MOL SCI CHEM ENG ELS
   Raines DJ, 2016, P NATL ACAD SCI USA, V113, P5850, DOI 10.1073/pnas.1520829113
   Rauter AP, 2007, FITOTERAPIA, V78, P474, DOI 10.1016/j.fitote.2007.02.013
   Raymond-Bouchard I, 2012, EUKARYOT CELL, V11, P1333, DOI 10.1128/EC.00159-12
   Renshaw JC, 2002, MYCOL RES, V106, P1123, DOI 10.1017/S0953756202006548
   Rich RL, 2011, J MOL RECOGNIT, V24, P892, DOI 10.1002/jmr.1138
   Richardson PT, 1995, MICROBIOL-SGM, V141, P3181, DOI 10.1099/13500872-141-12-3181
   Richter F., 2011, PLOS ONE, V6
   Righetti PG, 2015, ANAL CHEM, V87, P293, DOI 10.1021/ac502171b
   Ritschkoff A. C., 1996, WOOD PRESERVATION ME
   Rivault F, 2007, BIOORG MED CHEM LETT, V17, P640, DOI 10.1016/j.bmcl.2006.11.005
   Rodriguez GM, 2006, TRENDS MICROBIOL, V14, P320, DOI 10.1016/j.tim.2006.05.006
   Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006
   Roosenberg JM, 2000, CURR MED CHEM, V7, P159, DOI 10.2174/0929867003375353
   Saha M, 2016, ENVIRON SCI POLLUT R, V23, P3984, DOI 10.1007/s11356-015-4294-0
   Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257
   Sandhu P., 2016, CURR GENET, P1
   Sandhu P, 2017, J INORG BIOCHEM, V170, P75, DOI 10.1016/j.jinorgbio.2017.02.013
   Sandhu P, 2016, ARCH BIOCHEM BIOPHYS, V592, P38, DOI 10.1016/j.abb.2016.01.007
   Sanglard Dominique, 2003, Mycologist, V17, P74, DOI 10.1017/S0269915X03002076
   Sarathambal C, 2017, INT J PHYTOREMEDIAT, V19, P360, DOI 10.1080/15226514.2016.1225289
   Sari B, 2015, MIKROBIYOL BUL, V49, P249, DOI 10.5578/mb.8884
   Sassone-Corsi M, 2016, NATURE, V540, P280, DOI 10.1038/nature20557
   Schade AL, 1944, SCIENCE, V100, P14, DOI 10.1126/science.100.2584.14
   Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046
   Schalk IJ, 2011, ENVIRON MICROBIOL, V13, P2844, DOI 10.1111/j.1462-2920.2011.02556.x
   Schallau K, 2010, PLANT PHYSIOL, V152, P1763, DOI 10.1104/pp.109.149237
   Schmelz S, 2009, NAT CHEM BIOL, V5, P174, DOI 10.1038/nchembio.145
   Schneider G, 2010, NAT REV DRUG DISCOV, V9, P273, DOI 10.1038/nrd3139
   Schneider P, 2016, J MED CHEM, V59, P4077, DOI 10.1021/acs.jmedchem.5b01849
   Schrettl M, 2010, MICROBES INFECT, V12, P1035, DOI 10.1016/j.micinf.2010.07.005
   SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9
   Scorciapino MA, 2017, BIOPHYS J, V112, p551A, DOI 10.1016/j.bpj.2016.11.2977
   Selzer G. B., 1980, J PHARM SCI, V69, P754
   Senanayake TH, 2014, PHARM RES-DORDR, V31, P1605, DOI 10.1007/s11095-013-1265-3
   Serebryakova M, 2016, J AM CHEM SOC, V138, P15690, DOI 10.1021/jacs.6b09853
   Shankar J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08131
   Sheldon JR, 2015, FEMS MICROBIOL REV, V39, P592, DOI 10.1093/femsre/fuv009
   Shervedani RK, 2013, BIOSENS BIOELECTRON, V39, P31, DOI 10.1016/j.bios.2012.06.025
   Siburt CJP, 2009, METALLOMICS, V1, P249, DOI 10.1039/b902860a
   Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414
   SILLEY P, 1990, ANTIMICROB AGENTS CH, V34, P1806, DOI 10.1128/AAC.34.9.1806
   Simoes LC, 2007, APPL ENVIRON MICROB, V73, P6192, DOI 10.1128/AEM.00837-07
   Simpson DH, 2017, INORGANIC AND ORGANOMETALLIC TRANSITION METAL COMPLEXES WITH BIOLOGICAL MOLECULES AND LIVING CELLS, P205, DOI 10.1016/B978-0-12-803814-7.00007-1
   Singh RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155026
   Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949
   Slavic K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10403
   Smirnov AY, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/23/234101
   Spellberg B. J., 2015, COMPOSITIONS METHODS
   Sridharan S, 2010, J MOL BIOL, V397, P290, DOI 10.1016/j.jmb.2010.01.019
   Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552
   Stevenson B, 2016, J BACTERIOL, V198, P1160, DOI 10.1128/JB.00930-15
   Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10691, DOI 10.1073/pnas.200318797
   Stoj CS, 2006, BIOCHEMISTRY-US, V45, P12741, DOI 10.1021/bi061543+
   Stover CK, 2000, NATURE, V406, P959
   Straub KL, 2001, FEMS MICROBIOL ECOL, V34, P181, DOI 10.1016/S0168-6496(00)00088-X
   Szebesczyk A, 2016, COORDIN CHEM REV, V327, P84, DOI 10.1016/j.ccr.2016.05.001
   Taher AT, 2016, DRUG DES DEV THER, V10, P7073, DOI 10.2147/DDDT.S117080
   Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017
   Thomas X, 2004, J BIOL CHEM, V279, P28233, DOI 10.1074/jbc.M400228200
   Thyagarajan S. lakshmi, 2017, WOUND MED, V16, P7, DOI [10.1016/j.wndm.2016.12.002, DOI 10.1016/J.WNDM.2016.12.002]
   Tillotson Glenn S, 2016, Infect Dis (Auckl), V9, P45, DOI 10.4137/idrt.s31567
   Tommasi R, 2015, NAT REV DRUG DISCOV, V14, P529, DOI 10.1038/nrd4572
   Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014
   Touchette M. H., 2017, BIOCHIM BIOPHYS ACTA, P30011
   Trapet P, 2016, PLANT PHYSIOL, V171, P675, DOI 10.1104/pp.15.01537
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   TSUKIURA H, 1964, J ANTIBIOT, V17, P39
   Urban A, 2007, APPL ENVIRON MICROB, V73, P6436, DOI 10.1128/AEM.00586-07
   Vaknin Y, 2014, FUNGAL GENET BIOL, V63, P55, DOI 10.1016/j.fgb.2013.12.005
   van der Heide T, 2002, EMBO REP, V3, P938, DOI 10.1093/embo-reports/kvt201
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   VELJANOV D, 1973, ZBL BAKT-INT J MED M, V223, P205
   Vergnolle O, 2016, J BIOL CHEM, V291, P22315, DOI 10.1074/jbc.M116.744532
   VERTESY L, 1995, HELV CHIM ACTA, V78, P46, DOI 10.1002/hlca.19950780105
   Wallner A, 2009, APPL ENVIRON MICROB, V75, P4194, DOI 10.1128/AEM.00479-09
   Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811
   Wang GP, 2017, ENVIRON TOXICOL PHAR, V49, P58, DOI 10.1016/j.etap.2016.11.014
   WATANABE NA, 1987, ANTIMICROB AGENTS CH, V31, P497, DOI 10.1128/AAC.31.4.497
   Weinberg ED, 2004, MED HYPOTHESES, V63, P863, DOI 10.1016/j.mehy.2004.04.010
   Weinstein M. J., 2011, ANTIBIOTICS ISOLATIO
   Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266
   Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010
   Wencewicz TA, 2013, J MED CHEM, V56, P4044, DOI 10.1021/jm400265k
   Wencewicz TA, 2009, BIOMETALS, V22, P633, DOI 10.1007/s10534-009-9218-3
   Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001
   Wilhelm M, 2012, J AM CHEM SOC, V134, P8588, DOI 10.1021/ja301649k
   WILHELM SW, 1994, LIMNOL OCEANOGR, V39, P1979, DOI 10.4319/lo.1994.39.8.1979
   Wisplinghoff H., 2017, INFECT DIS AUCKL
   Wojcik K, 2013, CANCER BIOL THER, V14, P823, DOI 10.4161/cbt.25328
   Won S, 2017, NANOSCALE HORIZ, V2, P106, DOI 10.1039/c6nh00202a
   Wong GY, 2013, IEEE ACM T COMPUT BI, V10, P1517, DOI 10.1109/TCBB.2013.126
   Wyckoff EE, 1999, J BACTERIOL, V181, P7588
   Wyckoff EE, 2015, J BACTERIOL, V197, P2840, DOI 10.1128/JB.00417-15
   Wyckoff EE, 2011, MOL MICROBIOL, V81, P1446, DOI 10.1111/j.1365-2958.2011.07775.x
   Xie J, 2011, J AM CHEM SOC, V133, P13946, DOI 10.1021/ja207142h
   Yayan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139836
   Yin K, 2016, SENSOR ACTUAT B-CHEM, V232, P257, DOI 10.1016/j.snb.2016.03.128
   Yin K, 2014, BIOSENS BIOELECTRON, V51, P90, DOI 10.1016/j.bios.2013.07.038
   Yun CW, 2000, J BIOL CHEM, V275, P16354, DOI 10.1074/jbc.M001456200
   Zasowski EJ, 2015, PHARMACOTHERAPY, V35, P755, DOI 10.1002/phar.1622
   Zawadzka AM, 2009, P NATL ACAD SCI USA, V106, P21854, DOI 10.1073/pnas.0904793106
   Zhanel GG, 2013, DRUGS, V73, P159, DOI 10.1007/s40265-013-0013-7
   Zhang ZM, 2011, BIOINFORMATICS, V27, P2083, DOI 10.1093/bioinformatics/btr331
   Zheng TF, 2012, J AM CHEM SOC, V134, P18388, DOI 10.1021/ja3077268
   Zloch M, 2016, CHEMOSPHERE, V156, P312, DOI 10.1016/j.chemosphere.2016.04.130
NR 402
TC 3
Z9 3
U1 17
U2 43
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD JAN 10
PY 2018
VL 269
BP 63
EP 87
DI 10.1016/j.jconrel.2017.11.001
PG 25
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA FU3OF
UT WOS:000423760400008
PM 29129658
DA 2018-12-27
ER

PT J
AU Chen, P
   Luo, XT
   Che, ZH
   Zhang, WL
   Liu, FC
   Hou, DS
   Yang, DQ
   Liu, J
AF Chen, Ping
   Luo, Xiaoting
   Che, Zhihui
   Zhang, Wenli
   Liu, Fuchen
   Hou, Daisen
   Yang, Dongqin
   Liu, Jie
TI RETRACTED: Targeting of the C-Jun/BCL-XL/P21 Axis Accelerates the Switch
   from Senescence to Apoptosis Upon ROC1 Knockdown in Gastric Cancer Cells
   (Retracted article. See vol. 49, pg. 1258, 2018)
SO CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article; Retracted Publication
DE ROC1; Gastric cancer; Senescence; Apoptosis; BCL-XL; P21; C-Jun
ID BCL-XL; LYMPHOID MALIGNANCIES; CELLULAR SENESCENCE; ANTITUMOR-ACTIVITY;
   UBIQUITIN LIGASES; RBX1 EXPRESSION; LUNG-CANCER; INHIBITOR; FAMILY;
   PATHWAY
AB Background/Aims: Regulator of cullins-1 (ROC1) is a pivotal component of cullin-RING E3 ubiquitin ligases, which help to regulate distinct cellular processes by governing the degradation of various substrates. Because the role of ROC1 in gastric cancer is largely uncharacterized, we investigated the relationship between ROC1 expression and the prognosis of gastric cancer patients and explored the biological function of ROC1 and its underlying mechanisms in gastric cancer. Methods: Kaplan-Meier and multivariate Cox regression analyses were used to evaluate the correlation between the carcinogenesis of gastric cancer and ROC1. SA-beta-gal staining and the senescence-associated secretory phenotype (SASP) were used to assess ROC1 silencing-induced cellular senescence. A xenograft zebrafish model was used to evaluate the effects of BCL-XL and ROC1 co-silencing on tumor formation in vivo. Results: High ROC1 expression was correlated with poor prognosis and a low 5-year survival rate of gastric cancer patients. ROC1 depletion significantly inhibited the growth of gastric cancer cells by sequentially inducing p21-mediated cellular senescence and mitochondrial-dependent apoptosis. Functional studies revealed successive upregulation of c-Jun, BCL-XL, and p21 upon ROC1 knockdown. BCL-XL suppression via RNA interference or a BH3 mimetic (ABT-737 or ABT-263) efficiently enhanced the anti-tumor effects of ROC1 knockdown. Equally as important, BCL-XL silencing strengthened ROC1 knockdown-induced apoptosis by blocking p21-mediated senescence. Conclusions: The c-Jun/BCL-XL/p21 axis promotes senescence to resist ROC1 knockdown-induced apoptosis in gastric cancer cells. Targeted inactivation of BCL-XL could sensitize gastric cancer cells to ROC1 knockdown in clinical practice. (C) 2018 The Author(s) Published by S. Karger AG, Basel
C1 [Chen, Ping; Luo, Xiaoting; Che, Zhihui; Zhang, Wenli; Liu, Fuchen; Yang, Dongqin; Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.
   [Chen, Ping; Hou, Daisen; Liu, Jie] Fudan Univ, Shanghai Med Sch, Inst Biomed Sci, Shanghai, Peoples R China.
   [Liu, Fuchen] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg 3, Shanghai, Peoples R China.
RP Yang, DQ; Liu, J (reprint author), Fudan Univ, Huashan Hosp, Dept Digest Dis, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China.
EM yangdongqin@huashan.org.cn; jieliu@fudan.edu.cn
FU National Natural Science Foundation of China [81420108005, 81630016,
   81572336, 81770579]; Natural Science Foundation and Major Basic Research
   Program of Shanghai [16JC1420104]; Development Found for Shanghai
   Talents [201660]
FX This work was supported by the grants of the National Natural Science
   Foundation of China on Jie Liu (Grant No. 81420108005; No. 81630016) and
   Dongqin Yang (Grant No. 81572336; No. 81770579), Natural Science
   Foundation and Major Basic Research Program of Shanghai (Grant No.
   16JC1420104), and jointly by the Development Found for Shanghai Talents
   (Grant No. 201660).
CR Ashkenazi A, 2017, NAT REV DRUG DISCOV, V16, P273, DOI 10.1038/nrd.2016.253
   Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321
   Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   Chen XN, 2015, TUMOR BIOL, V36, P2393, DOI 10.1007/s13277-014-2849-1
   Chonghaile TN, 2014, CANCER DISCOV, V4, P1074, DOI 10.1158/2159-8290.CD-14-0353
   Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003
   Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI [10.1146/annurev-pathol-121808-102144, 10.1140/annurev-pathol-121808-102144]
   Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301
   Dho SH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001588
   Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4
   Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208
   Ghobrial IM, 2005, CA-CANCER J CLIN, V55, P178, DOI 10.3322/canjclin.55.3.178
   Hayward RL, 2003, CLIN CANCER RES, V9, P2856
   Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776
   Itahana Koji, 2007, Methods Mol Biol, V371, P21
   Jia LJ, 2009, CANCER RES, V69, P4974, DOI 10.1158/0008-5472.CAN-08-4671
   Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706
   Kajihara R, 2014, J IMMUNOL, V192, P5720, DOI 10.4049/jimmunol.1302643
   Li Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00299-9
   Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173
   Migita K, 2014, GASTRIC CANCER, V17, P601, DOI 10.1007/s10120-013-0318-y
   Nicoli S, 2007, NAT PROTOC, V2, P2918, DOI 10.1038/nprot.2007.412
   Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579
   Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361
   Pecot J, 2016, CELL REP, V17, P3347, DOI 10.1016/j.celrep.2016.11.064
   Perez-Mancera PA, 2014, NAT REV CANCER, V14, P547, DOI 10.1038/nrc3773
   Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547
   Ren HG, 2011, J BIOL CHEM, V286, P35308, DOI 10.1074/jbc.M110.207134
   Roberts AW, 2015, BRIT J HAEMATOL, V170, P669, DOI 10.1111/bjh.13487
   Salameh A, 2010, J BIOL CHEM, V285, P23094, DOI 10.1074/jbc.M109.087221
   Sasaki M, 2001, MECH AGEING DEV, V122, P1695, DOI 10.1016/S0047-6374(01)00281-0
   Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/ncr.1044
   Schneider BP, 2008, J CLIN ONCOL, V26, P4672, DOI 10.1200/JCO.2008.16.1612
   Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024
   Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432
   Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662
   Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884
   Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3
   Wang W, 2016, BRIT J CANCER, V114, P305, DOI 10.1038/bjc.2015.444
   Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062734
   Wilson WH, 2010, LANCET ONCOL, V11, P1149, DOI [10.1016/S1470-2045(10)70261-8, 10.1016/S1470.2045(10)70261.8]
   Xing R, 2016, SURG ONCOL, V25, P147, DOI 10.1016/j.suronc.2016.05.006
   Yang D, 2013, CELL DEATH DIFFER, V20, P235, DOI 10.1038/cdd.2012.113
   Yang X, 2017, CELL PHYSIOL BIOCHEM, V43, P1126, DOI 10.1159/000481754
   Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190
   Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308
   Zhang F, 2015, DRUG DES DEV THER, V9, P3969, DOI 10.2147/DDDT.S84527
   Zhang JY, 2017, ONCOTARGET, V8, P29125, DOI 10.18632/oncotarget.16250
   Zhang Q, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.215
   Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x
NR 51
TC 1
Z9 1
U1 3
U2 3
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-8987
EI 1421-9778
J9 CELL PHYSIOL BIOCHEM
JI Cell. Physiol. Biochem.
PY 2018
VL 48
IS 3
BP 1123
EP 1138
DI 10.1159/000491979
PG 16
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA GS4KY
UT WOS:000443612500022
PM 30041196
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Drieschner, KH
AF Drieschner, Klaus H.
TI RETRACTED: The Dynamic Risk Outcome Scales (DROS) for people with mild
   to borderline intellectual disability: content, factorial structure,
   reliability, and sensitivity (Retracted article. See vol. 24, pg. 672,
   2018)
SO PSYCHOLOGY CRIME & LAW
LA English
DT Article; Retracted Publication
DE Dynamic Risk Outcome Scales; confirmative factor analysis; intellectual
   disabilities; routine outcome monitoring; dynamic risk factors
AB Objective: The Dynamic Risk Outcome Scales (DROS) is a Dutch multi-scale observer-rating instrument for treatment progress and outcome of individuals with mild intellectual disabilities or borderline intellectual functioning and severe challenging or offending behaviour. This article contains a description of the instrument and the first part of its psychometric evaluation with the emphasis on the suitability for measuring change.Method: The data come from routine outcome measurements during seven years for more than600 patients in three treatment centres. The factorial structure and factorial stability of the DROS are evaluated by confirmative factor analysis. In addition, the internal reliability, test-retest reliability, and smallest detectable change of the scales are determined.Results: The hypothesized factorial structure is supported and found to be stable across repeated measurements. The scales are sufficiently reliable and sensitive to change for outcome evaluation of individual patients.Conclusion: The content and the psychometric properties make the DROS a suitable measure for individual treatment evaluation and routine outcome monitoring of its target population.
C1 [Drieschner, Klaus H.] Expertisectr De Borg, Stichting Trajectum, The Hague, Netherlands.
   [Drieschner, Klaus H.] WODC Res & Documentat Ctr, The Hague, Netherlands.
RP Drieschner, KH (reprint author), Reiderlandlaan 1, NL-9727 DR Groningen, Netherlands.
EM KH.Drieschner@tiscali.nl
NR 0
TC 1
Z9 1
U1 1
U2 1
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1068-316X
EI 1477-2744
J9 PSYCHOL CRIME LAW
JI Psychol. Crime Law
PY 2018
VL 24
IS 6
BP I
EP XIII
DI 10.1080/1068316X.2017.1360889
PG 13
WC Criminology & Penology; Law; Psychology, Multidisciplinary
SC Criminology & Penology; Government & Law; Psychology
GA GG4WY
UT WOS:000432698200001
DA 2018-12-27
ER

PT J
AU Fujii, T
   Okada, T
   Saida, T
   Naritsuka, S
   Maruyama, T
AF Fujii, Takayuki
   Okada, Takuya
   Saida, Takahiro
   Naritsuka, Shigeya
   Maruyama, Takahiro
TI RETRACTED: Growth of single-walled carbon nanotube at a low temperature
   by alcohol catalytic chemical vapor deposition using Ru catalysts
   (Retracted article. See vol. 3, pg. E1-E7, 2018)
SO MRS ADVANCES
LA English
DT Article; Retracted Publication
ID FIELD-EFFECT TRANSISTORS; DIAMETER DISTRIBUTION; HIGH-VACUUM; WATER;
   NANOPARTICLES; COMPOSITE; PRESSURE
AB Growth of single-walled carbon nanotube (SWCNT) was achieved by an alcohol catalytic chemical vapor deposition (CVD) mechanism that was conducted in a high vacuum using Ru catalysts. By optimizing the ethanol pressure, SWCNTs can grow in a wide range of temperature between 500 degrees C and 900 degrees C. Both the yield and crystalline quality of SWCNTs reached their maxima at 700 degrees C. Significantly, the SWCNT growth was achieved even at 450 degrees C, which was much lower than the growth temperatures that were required for SWCNT growth using Ru catalysts previously. Raman measurements exhibited that the diameter distribution of the SWCNTs that were grown at 450 degrees C was quite narrow and (11, 4) nanotubes were dominant. The observations of transmission electron microscope (TEM) suggested that the size of the Ru particles were larger than the diameter of SWCNT. Such a relation was similar to the relation observed in the growth of SWCNTs using Pt catalysts.
C1 [Fujii, Takayuki; Naritsuka, Shigeya] Meijo Univ, Dept Mat Sci & Engn, Tempa Ku, 1-501 Shiogamaguchi, Nagoya, Aichi, Japan.
   [Okada, Takuya; Saida, Takahiro; Maruyama, Takahiro] Meijo Univ, Dept Appl Chem, Tempaku Ku, 1-501 Shiogamaguchi, Nagoya, Aichi, Japan.
RP Fujii, T (reprint author), Meijo Univ, Dept Mat Sci & Engn, Tempa Ku, 1-501 Shiogamaguchi, Nagoya, Aichi, Japan.
FU Program for the Strategic Research Foundation at Private Universities;
   Ministry of Education, Culture, Sports, Science and Technology (MEXT),
   Japan; "Nanotechnology Platform" of MEXT
FX This study was partially supported the Program for the Strategic
   Research Foundation at Private Universities supported by the Ministry of
   Education, Culture, Sports, Science and Technology (MEXT), Japan. Part
   of this study was conducted at the Institute for Molecular Science (IMS)
   and Nagoya Institute of Technology, supported by the "Nanotechnology
   Platform" of MEXT. We thank Prof. Hihara for providing TEM facility.
CR Ago H, 2005, J PHYS CHEM B, V109, P10035, DOI 10.1021/jp050307q
   Amama PB, 2009, NANO LETT, V9, P44, DOI 10.1021/nl801876h
   Cheung CL, 2002, J PHYS CHEM B, V106, P2429, DOI 10.1021/jp0142278
   Dal HJ, 1996, CHEM PHYS LETT, V260, P471, DOI 10.1016/0009-2614(96)00862-7
   Fujii T, 2017, DIAM RELAT MATER, V77, P97, DOI 10.1016/j.diamond.2017.06.009
   Fukuoka N, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.06FD23
   Futaba DN, 2006, J PHYS CHEM B, V110, P8035, DOI 10.1021/jp060080e
   Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962
   Hone J, 1999, PHYS REV B, V59, pR2514, DOI 10.1103/PhysRevB.59.R2514
   Hong S, 2007, NAT NANOTECHNOL, V2, P207, DOI 10.1038/nnano.2007.89
   IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0
   Javey A, 2003, NATURE, V424, P654, DOI 10.1038/nature01797
   Jorio A, 2001, PHYS REV LETT, V86, P1118, DOI 10.1103/PhysRevLett.86.1118
   Kaneko A, 2012, J PHYS CHEM C, V116, P26060, DOI 10.1021/jp309232w
   Kondo H, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.06GD02
   Li N, 2009, J PHYS CHEM C, V113, P10070, DOI 10.1021/jp903129h
   Li YM, 2001, J PHYS CHEM B, V105, P11424, DOI 10.1021/jp012085b
   Lu JQ, 2005, CHEM MATER, V17, P2227, DOI 10.1021/cm048030e
   Maruyama S, 2002, CHEM PHYS LETT, V360, P229, DOI 10.1016/S0009-2614(02)00838-2
   Maruyama T, 2016, CARBON, V96, P6, DOI 10.1016/j.carbon.2015.09.010
   Maruyama T, 2011, MATER EXPRESS, V1, P267, DOI 10.1166/mex.2011.1046
   Matsuda Y, 2010, J PHYS CHEM LETT, V1, P2946, DOI 10.1021/jz100889u
   Naeemi A., 2009, IEEE T ELECTRON DEV, V54, P26
   Navas H, 2017, ACS NANO, V11, P3081, DOI 10.1021/acsnano.7b00077
   Nayak S, 2016, POLYM COMPOSITE, V37, P2860, DOI 10.1002/pc.23483
   Nayak S, 2014, J NANOSCI NANOTECHNO, V14, P2816, DOI 10.1166/jnn.2014.8566
   Nugraha ART, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3485293
   Qian Y, 2010, APPL SURF SCI, V256, P4038, DOI 10.1016/j.apsusc.2010.01.074
   REICH S, 2004, CARBON NANOTUBES, P141
   Sakurai S, 2013, SMALL, V9, P3584, DOI 10.1002/smll.201300223
   Sato K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.195446
   Srivastava N, 2009, IEEE T NANOTECHNOL, V8, P542, DOI 10.1109/TNANO.2009.2013945
   Sung CM, 1997, INT J REFRACT MET H, V15, P237, DOI 10.1016/S0263-4368(97)00003-6
   Tans SJ, 1998, NATURE, V393, P49
   Wind SJ, 2002, APPL PHYS LETT, V80, P3817, DOI 10.1063/1.1480877
NR 35
TC 2
Z9 2
U1 1
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 2059-8521
J9 MRS ADV
JI MRS Adv.
PY 2018
VL 3
IS 1-2
BP 53
EP 59
DI 10.1557/adv.2018.4
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA FZ6ND
UT WOS:000427715200009
DA 2018-12-27
ER

PT J
AU Kassraoui, J
AF Kassraoui, Jihed
TI RETRACTED: Small perturbation of a surface: full Maxwell's equations
   (Retracted article. See vol.97, pg.1650, 2018)
SO APPLICABLE ANALYSIS
LA English
DT Article; Retracted Publication
DE Small perturbations; interface problem; Maxwell's equations;
   full-asymptotic expansions
ID ASYMPTOTIC FORMULAS; ELECTROMAGNETIC-FIELDS; SMALL-DIAMETER; PART I;
   INHOMOGENEITIES; INTERFACE; INCLUSION; TRACES
AB In this paper, we derive high-order terms in the asymptotic expansions of the boundary perturbations of the electromagnetic fields resulting from small perturbations of the shape of an inhomogeneity with Cd-boundary in Rd, for d = 2, 3. For such solutions we provide a rigorous derivation that extends those already derived for small volume conductivity inhomogeneities. Our formulas may be expected to develop effective algorithms, aimed at determining certain properties of the shape of an object based on electromagnetic boundary measurements.
C1 [Kassraoui, Jihed] Univ Carthage, Dept Math, Fac Sci, Zarzouna, Tunisia.
RP Kassraoui, J (reprint author), Univ Carthage, Dept Math, Fac Sci, Zarzouna, Tunisia.
EM jihed.kasraoui@yahoo.com
CR Ammari H, 2003, J MATH PURE APPL, V82, P749, DOI 10.1016/S0021-7824(03)00033-3
   Ammari H, 2001, J MATH PURE APPL, V80, P769, DOI 10.1016/S0021-7824(01)01217-X
   Ammari H, 2010, T AM MATH SOC, V362, P2435, DOI 10.1090/S0002-9947-09-04842-9
   Barrera R. G., 1985, European Journal of Physics, V6, P287, DOI 10.1088/0143-0807/6/4/014
   Beretta E, 2003, J MATH PURE APPL, V82, P1277, DOI 10.1016/S0021-7824(03)00081-3
   Buffa A, 2002, J MATH ANAL APPL, V276, P845, DOI 10.1016/S0022-247X(02)00455-9
   Buffa A, 2001, MATH METHOD APPL SCI, V24, P9, DOI 10.1002/1099-1476(20010110)24:1<9::AID-MMA191>3.0.CO;2-2
   Caro P, 2009, COMMUN PART DIFF EQ, V34, P1425, DOI 10.1080/03605300903296272
   Colton D., 1992, APPL MATH SCI, V93
   Khelifi A, 2014, APPL ANAL, V93, P46, DOI 10.1080/00036811.2012.755734
   Khelifi A, 2011, MATH METHOD APPL SCI, V34, P2274, DOI 10.1002/mma.1529
   Khelifi A, 2007, J MATH PHYS, V48, DOI 10.1063/1.2817820
   Lim MK, 2008, MATH METHOD APPL SCI, V31, P1315, DOI 10.1002/mma.973
   Nedelec J.-C., 2001, APPL MATH SCI, V144
   Shifrin T., 2010, DIFFERENTIAL GEOMETR
   Tolmasky CF, 1999, INVERSE PROBL, V15, P465, DOI 10.1088/0266-5611/15/2/008
   Vogelius MS, 2000, ESAIM-MATH MODEL NUM, V34, P723, DOI 10.1051/m2an:2000101
   Zribi H, 2013, APPL ANAL, V92, P172, DOI 10.1080/00036811.2011.601601
NR 18
TC 1
Z9 1
U1 1
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0003-6811
EI 1563-504X
J9 APPL ANAL
JI Appl. Anal.
PY 2018
VL 97
IS 5
BP 739
EP 755
DI 10.1080/00036811.2017.1285016
PG 17
WC Mathematics, Applied
SC Mathematics
GA FY5SN
UT WOS:000426895200003
DA 2018-12-27
ER

PT J
AU Kerdphol, T
   Rahman, FS
   Mitani, Y
   Watanabe, M
   Kufeoglu, S
AF Kerdphol, Thongchart
   Rahman, Fathin Saifur
   Mitani, Yasunori
   Watanabe, Masayuki
   Kufeoglu, Sinan
TI RETRACTED: Robust Virtual Inertia Control of an Islanded Microgrid
   Considering High Penetration of Renewable Energy (Retracted article. See
   vol. 12, pg. 874, 2018)
SO IEEE ACCESS
LA English
DT Article; Retracted Publication
DE Frequency control; H-infinity; islanded microgrid; renewable energy;
   robust control; virtual inertia control; virtual synchronous generator
ID FREQUENCY CONTROL; STORAGE-SYSTEM; POWER-SYSTEM; PART I; STRATEGY
AB This paper presents robust virtual inertia control of an islanded microgrid considering high penetration of renewable energy sources (RESs). In such microgrids, the lack of system inertia due to the replacement of traditional generating units with a large amount of RESs causes undesirable influence to microgrid frequency stability, leading to weakening of the microgrid. In order to handle this challenge, the H-infinity robust control method is implemented to the virtual inertial control loop, taking into account the high penetration of RESs, thus enhancing the robust performance and stability of the microgrid during contingencies. The controller's robustness and performance are determined along with numerous disturbances and parametric uncertainties. The comparative study between H-infinity and optimal proportional integral (PI)-based virtual inertia controller is also presented. The results show the superior robustness and control effect of the proposed H-infinity controller in terms of precise reference frequency tracking and disturbance attenuation over the optimal PI controller. It is validated that the proposed H-infinity-based virtual inertia controller successfully provides desired robust frequency support to a low-inertia islanded microgrid against high RESs penetration.
C1 [Kerdphol, Thongchart; Rahman, Fathin Saifur; Mitani, Yasunori; Watanabe, Masayuki] Kyushu Inst Technol, Dept Elect & Elect Engn, Kitakyushu, Fukuoka 8048550, Japan.
   [Kufeoglu, Sinan] UCL, Inst Sustainable Resources, London WC1E 6BT, England.
RP Kerdphol, T (reprint author), Kyushu Inst Technol, Dept Elect & Elect Engn, Kitakyushu, Fukuoka 8048550, Japan.
EM thongchartkerd@gmail.com
OI Kerdphol, Thongchart/0000-0002-4782-1207
CR Apkarian P, 2003, INT J ROBUST NONLIN, V13, P1137, DOI 10.1002/rnc.807
   Babazadeh M, 2013, IEEE T POWER DELIVER, V28, P1339, DOI 10.1109/TPWRD.2013.2254138
   Bevrani H, 2004, ENERG CONVERS MANAGE, V45, P2297, DOI 10.1016/j.enconman.2003.11.018
   Bevrani H, 2014, POWER SYSTEM MONITORING AND CONTROL, P1, DOI 10.1002/9781118852422
   Bevrani H, 2014, POWER ELECTRON POWER, P1, DOI 10.1007/978-3-319-07278-4
   Bevrani H, 2012, IEEE T SMART GRID, V3, P1935, DOI 10.1109/TSG.2012.2196806
   Bevrani H, 2016, IEEE T SMART GRID, V7, P706, DOI 10.1109/TSG.2015.2446984
   Bevrani H, 2014, INT J ELEC POWER, V54, P244, DOI 10.1016/j.ijepes.2013.07.009
   Chikuni E., 2013, P IEEE IND TECHN C F, P826
   Datta M., 2012, 2012 7th IEEE Conference on Industrial Electronics and Applications (ICIEA 2012). Proceedings, P1167, DOI 10.1109/ICIEA.2012.6360900
   Etemadi AH, 2012, IEEE T POWER DELIVER, V27, P1843, DOI 10.1109/TPWRD.2012.2202920
   Frack P. F., 2015, P IEEE INT SYST APPL, P1
   Gryning MPS, 2016, IEEE T SUSTAIN ENERG, V7, P41, DOI 10.1109/TSTE.2015.2472285
   Gu D.W., 2005, ROBUST CONTROL DESIG
   Han Y, 2015, IEEE T SMART GRID, V6, P557, DOI 10.1109/TSG.2014.2320984
   Hossain MJ, 2015, IEEE T SUSTAIN ENERG, V6, P1067, DOI 10.1109/TSTE.2014.2317801
   Hu YL, 2016, CHIN CONTR CONF, P8523, DOI 10.1109/ChiCC.2016.7554718
   Kerdphol T, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9050773
   KUNDER P, 1994, POWER SYSTEM STABILI
   Lee DJ, 2008, IEEE T ENERGY CONVER, V23, P311, DOI 10.1109/TEC.2007.914309
   Li DD, 2017, IEEE T ENERGY CONVER, V32, P397, DOI 10.1109/TEC.2016.2623982
   Li XJ, 2008, J POWER SOURCES, V180, P468, DOI 10.1016/j.jpowsour.2008.01.092
   Mentesidi K, 2015, 2015 International Symposium on Smart Electric Distribution Systems and Technologies (EDST), P606, DOI 10.1109/SEDST.2015.7315279
   Morari M, 1989, ROBUST PROCESS CONTR
   PACKARD A, 1993, AUTOMATICA, V29, P71, DOI 10.1016/0005-1098(93)90175-S
   Rakhshani E, 2016, IET GENER TRANSM DIS, V10, P1458, DOI 10.1049/iet-gtd.2015.1110
   Torres MA, 2014, IEEE T ENERGY CONVER, V29, P833, DOI 10.1109/TEC.2014.2362577
   Vachirasricirikul S, 2011, APPL ENERG, V88, P3860, DOI 10.1016/j.apenergy.2011.04.055
   Yan RF, 2015, IET RENEW POWER GEN, V9, P775, DOI 10.1049/iet-rpg.2014.0364
   Zhao HL, 2017, IET GENER TRANSM DIS, V11, P795, DOI 10.1049/iet-gtd.2016.0645
NR 30
TC 2
Z9 2
U1 5
U2 5
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 2169-3536
J9 IEEE ACCESS
JI IEEE Access
PY 2018
VL 6
DI 10.1109/ACCESS.2017.2773486
PG 12
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA FW9RX
UT WOS:000425675300007
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Schroeder, NI
   Paterson, JR
   Brock, GA
AF Schroeder, Natalie I.
   Paterson, John R.
   Brock, Glenn A.
TI RETRACTED: Eldonioids with associated trace fossils from the lower
   Cambrian Emu Bay Shale Konservat-Lagerstatte of South Australia
   (Retracted article. See vol. 92, pg. 114, 2018)
SO JOURNAL OF PALEONTOLOGY
LA English
DT Article; Retracted Publication
ID BURGESS SHALE; SERIES 2; CHENGJIANG LAGERSTATTE; KANGAROO ISLAND; CHINA;
   BIOTA; LIFE; PALEOECOLOGY; TRILOBITES; EDIACARAN
AB Rare specimens of eldonioids recovered from the lower Cambrian (Series 2, Stage 4) Emu Bay Shale (EBS) Konservat-Lagerstatte represent the first record of the group for the Cambrian of East Gondwana. The disc-shaped body of the EBS taxon bears fine concentric corrugations on the dorsal surface and, ventrally, a series of internal lobes that have primary and secondary bifurcations, as well as a coiled sac. It appears to be most similar to Rotadiscus and Pararotadiscus of the Cambrian Chengjiang and Kaili biotas of South China, respectively. While the structure of the internal lobes would indicate that this occurrence in the EBS represents a new taxon within the Rotadiscidae, lack of detail regarding the precise number of internal lobes and the condition of the circumoral tentacles warrants a more conservative approach in leaving the genus and species under open nomenclature. The EBS specimens also host trace fossils, including the remains of a burrow, which are generally lacking in the body-fossil-bearing layers of the Konservat-Lagerstatte interval. These traces appear to have been made by small organisms and are similar to traces associated with the discs of Pararotadiscus guizhouensis (Zhao and Zhu, 1994) from the Kaili Biota. The available taphonomic, paleoenvironmental, and ichnological evidence indicates that the EBS eldonioids are most likely vagrants that were transported or settled into the 'preservational trap' and subsequently exposed on the substrate for a brief period before burial, thereby allowing organisms to exploit their carcasses for nutrients or other purposes.
C1 [Schroeder, Natalie I.; Paterson, John R.] Univ New England, Sch Environm & Rural Sci, Palaeosci Res Ctr, Armidale, NSW 2351, Australia.
   [Brock, Glenn A.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.
RP Schroeder, NI (reprint author), Univ New England, Sch Environm & Rural Sci, Palaeosci Res Ctr, Armidale, NSW 2351, Australia.
EM nschroed@myune.edu.au; jpater20@une.edu.au; glenn.brock@mq.edu.au
OI Brock, Glenn/0000-0002-2277-7350
FU Australian Research Council [FT120100770]; National Geographic
   [8991-11]; Beach Energy Ltd.; South Australian Museum
FX This research was supported by grants from the Australian Research
   Council (FT120100770 to JRP) and National Geographic (#8991-11), with
   additional financial assistance from Beach Energy Ltd. and the South
   Australian Museum, and logistical support from SeaLink. We are grateful
   to the Buck family for access to the field area, and to our regular EBS
   collaborators G. Edgecombe, D. Garcia-Bellido, J. Gehling, J. Jago, and
   M. Lee. We thank R. Atkinson, M.-A. Binnie, A. Camens, A. Daley, R.
   Gaines, M. Gemmell, J. Holmes, K. Kenny, P. Kruse, J. Laurie, B.
   McHenry, M. Mills, L. Reid, D. Rice, E. Thomson, and members of the
   South Australian Museum Waterhouse Club for assistance in the field and
   lab, and for discussions. Thanks also to the two anonymous referees for
   their helpful reviews of the manuscript.
CR Alessandrello Anna, 2003, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V144, P337
   Babcock Loren E., 2007, Memoir of the Association of Australasian Palaeontologists, V34, P401
   BLAKER M. R., 1988, RAPPORT GRONLANDS GE, V137, P33
   Carbone C, 2014, J PALEONTOL, V88, P309, DOI 10.1666/13-066
   Caron JB, 2005, T ROY SOC EDIN-EARTH, V96, P95, DOI 10.1017/S0263593300001255
   Caron JB, 2010, GEOLOGY, V38, P811, DOI 10.1130/G31080.1
   Caron JB, 2010, PLOS ONE, V5, pA189, DOI 10.1371/journal.pone.0009586
   CHAPMAN FREDK, 1926, PROC ROY SOC VICTORIA, V39, P13
   Chen J. Y., 2012, EARTH LIFE, P239, DOI DOI 10.1007/978-90-481-3428-1_10
   Chen JY, 2007, J PALEONTOL, V81, P38, DOI 10.1666/0022-3360(2007)81[38:ROTLCB]2.0.CO;2
   Chen JY, 2009, INT J DEV BIOL, V53, P733, DOI 10.1387/ijdb.072513cj
   Chen Jun-Yuan, 1995, Acta Palaeontologica Polonica, V40, P213
   Clarke J. M., 1900, B NY STATE MUS, V39, P172
   Conway Morris S., 1988, University of Kansas Paleontological Contributions Paper, P1
   Daley AC, 2013, PALAEONTOLOGY, V56, P971, DOI 10.1111/pala.12029
   DURHAM JW, 1974, J PALEONTOL, V48, P750
   Dzik J., 1991, P47
   Dzik J, 1997, PALAEONTOLOGY, V40, P385
   Friend D., 2002, PALEONTOL J, V36, P20
   Gaines R. R., 2014, PALEONTOL SOC PAP, V20, p123 , DOI DOI 10.1017/S1089332600002837
   Garcia-Bellido DC, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0214-z
   Garcia-Bellido DC, 2013, GONDWANA RES, V24, P780, DOI 10.1016/j.gr.2012.12.002
   Garcia-Bellido DC, 2009, PALAEONTOLOGY, V52, P1221, DOI 10.1111/j.1475-4983.2009.00914.x
   Gehling JG, 2011, AUST J EARTH SCI, V58, P243, DOI 10.1080/08120099.2011.555487
   Hall J., 1847, PALAEONTOLOGY NEW YO, V1
   Hall PA, 2011, ORG GEOCHEM, V42, P1324, DOI 10.1016/j.orggeochem.2011.09.003
   Hu SX, 2007, PALAEOGEOGR PALAEOCL, V254, P307, DOI 10.1016/j.palaeo.2007.03.044
   Ivantsov AY, 2005, PALAEOGEOGR PALAEOCL, V220, P69, DOI 10.1016/j.palaeo.2004.01.022
   JIN YG, 1992, LETHAIA, V25, P35
   Lin JP, 2010, PALAEOGEOGR PALAEOCL, V292, P245, DOI 10.1016/j.palaeo.2010.03.048
   MacGabhann Breandan Anraoi, 2010, Irish Journal of Earth Sciences, V28, P1
   Mangano MG, 2012, GEOLOGY, V40, P519, DOI 10.1130/G32853.1
   Mangano M. Gabriela, 2011, Palaeontographica Canadiana, V31, P89
   Masiak Monika, 1994, Acta Palaeontologica Polonica, V39, P329
   McKirdy DM, 2011, AUST J EARTH SCI, V58, P259, DOI 10.1080/08120099.2011.557439
   Mikulas R, 2012, ICHNOS, V19, P199, DOI 10.1080/10420940.2012.703626
   MORRIS SC, 1985, ALCHERINGA, V9, P167, DOI 10.1080/03115518508618965
   MORRIS SC, 1993, NATURE, V361, P219, DOI 10.1038/361219a0
   MORRIS SC, 1993, PALAEONTOLOGY, V36, P593
   Morris SC, 2015, J PALEONTOL, V89, P411, DOI 10.1017/jpa.2015.26
   Nedin C, 1999, GEOLOGY, V27, P987, DOI 10.1130/0091-7613(1999)027<0987:APONAM>2.3.CO;2
   Novozhilov N. I., 1960, OSNOVY PALEONTOLOGII, P515
   Paterson JR, 2016, J GEOL SOC LONDON, V173, P1, DOI 10.1144/jgs2015-083
   RESSER CHARLES E., 1929, PROC U S NATION MUS, V76, P1
   STASINSKA ANNA, 1960, ACTA PALEONTOL POLONICA, V5, P337
   Stein M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-99
   Sun W.-g., 1987, Acta Palaeontologica Sinica, V26, P257
   Walcott C. D, 1911, SMITHSONIAN MISCELLA, V57, P109
   Walcott C. D., 1890, REPORTS US GEOLOGICA, P509
   Walcott Charles D., 1912, Smithsonian Institution Miscellaneous Collection, V57
   WALCOTT CHARLES D., 1931, SMITHSONIAN MISC COLL, V85, P1
   Walcott Charles Doolittle, 1911, Smithsonian Institution Miscellaneous Collection, V57
   Wang Y, 2009, PALAEOGEOGR PALAEOCL, V277, P141, DOI 10.1016/j.palaeo.2009.02.017
   Zhang XG, 2007, TERRA NOVA, V19, P407, DOI 10.1111/j.1365-3121.2007.00765.x
   Zhang ZF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01066
   Zhang ZF, 2009, GEOBIOS-LYON, V42, P649, DOI 10.1016/j.geobios.2009.04.001
   Zhao FC, 2014, PALEOBIOLOGY, V40, P50, DOI 10.1666/12056
   Zhao Yuan-long, 1994, Acta Palaeontologica Sinica, V33, P272
   Zhu MY, 2002, GEOBIOS-LYON, V35, P165, DOI 10.1016/S0016-6995(02)00025-6
NR 59
TC 1
Z9 1
U1 1
U2 6
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0022-3360
EI 1937-2337
J9 J PALEONTOL
JI J. Paleontol.
PD JAN
PY 2018
VL 92
IS 1
BP 80
EP 86
DI 10.1017/jpa.2018.6
PG 7
WC Paleontology
SC Paleontology
GA FW5ZR
UT WOS:000425398500010
DA 2018-12-27
ER

PT J
AU Zhou, M
   Ji, HW
   Fu, N
   Chen, LX
   Xia, Y
AF Zhou, Ming
   Ji, Hongwen
   Fu, Nian
   Chen, Linxi
   Xia, Yong
TI RETRACTED: Nucleophagy in Human Disease: Beyond the Physiological Role
   (Retracted article. See vol. 244, pg. 175, 2018)
SO TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
LA English
DT Review; Retracted Publication
DE Atg; emerin; lamin; LC3; nucleophagy
ID NUCLEAR LAMINA; AUTOPHAGY DEGRADES; MAMMALIAN-CELLS; DIFFERENTIATION;
   DEGRADATION; MICRONUCLEI; INSTABILITY; SENESCENCE; CHROMATIN; STRESS
AB Autophagy is an evolutionarily conserved intracellular strategy for degrading organelles and proteins, and nucleophagy refers to the specific process of removing nuclear components from cells by autophagy, Nucleophagy is essential for cell survival by maintaining normal nuclear structure and functions. On the other hand, excessive nucleophagy may result in degradation of essential nuclear components, while impaired nucleophagy may lead to accumulation of harmful metabolic products in the nucleus. Therefore, dysregulation of nucleophagy is likely involved in the pathological process of certain diseases, including psoriasis, cancer, metabolic disorders and aging-related diseases. Nucleophagy is achieved with the participation of various proteins, including proteins encoded by autophagy-related genes (Atg), such as Atg39 and Atg40, as well as nuclear lamina protein lamin B1 and microtubule-associated protein 1 light chain 3 (LC3). Lamin B1 and LC3 are located in the nucleus. Moreover, there are different autophagy patterns in nucleophagy, such as piecemeal microautophagy, late nucleophagy, and micronuclei. Among them, micronuclei are considered a special form of nucleophagy detected in mammalian cells, referring to chromosomes or chromosome fragments that are enclosed by nuclear membrane. The presence of micronuclei usually indicates genotoxic events or the instability of chromosomes. However, in contrast to the well characterized cytoplasmic autophagy, our knowledge on nucleophagy is limited. Here we overview the potential involvement of nucleophagy in human diseases and then summarize the molecular events in the process of nucleophagy.
C1 [Zhou, Ming] Hunan Normal Univ, Hunan Prov Peoples Hosp, Dept Hematol, Affiliated Hosp 1, Changsha, Hunan, Peoples R China.
   [Ji, Hongwen] Chinese Acad Med Sci, Peking Union Med Coll, Dept Anesthesiol, Transfus Med,Fuwai Hosp, Beijing, Peoples R China.
   [Fu, Nian] Univ South China, Affiliated Nanhua Hosp, Dept Gastroenterol, Hengyang, Peoples R China.
   [Chen, Linxi] Univ South China, Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Inst Pharm & Pharmacol, Hengyang, Peoples R China.
   [Xia, Yong] Xiangnan Univ, Affiliated Hosp, 25 Renming Rd, Chenzhou 423000, Hunan, Peoples R China.
RP Xia, Y (reprint author), Xiangnan Univ, Affiliated Hosp, 25 Renming Rd, Chenzhou 423000, Hunan, Peoples R China.
EM Aetherwh@163.com
FU National Natural Science Foundation of China [81373465, 81470434]; Hunan
   Provincial Natural Science Foundation of China [2016JJ3107]; Health and
   Family Planning Commission of Hunan Province of China [C2015-24];
   Construct Program of the Key Discipline in Hunan Province; Hunan
   Province Cooperative Innovation Center for Molecular Target New Drug
   Study (Hunan Provincial Education Department Document) [2014-405]
FX This work was supported by the grants from the National Natural Science
   Foundation of China (grant numbers: 81373465, 81470434), the Hunan
   Provincial Natural Science Foundation of China (2016JJ3107), Health and
   Family Planning Commission of Hunan Province of China (C2015-24), the
   Construct Program of the Key Discipline in Hunan Province, Hunan
   Province Cooperative Innovation Center for Molecular Target New Drug
   Study (Hunan Provincial Education Department Document) (2014-405).
CR Akinduro O, 2016, J INVEST DERMATOL, V136, P1460, DOI 10.1016/j.jid.2016.03.016
   Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017
   Bidwell JP, 2010, CLIN REV BONE MINER, V8, P213, DOI 10.1007/s12018-010-9075-1
   Boban M, 2016, NUCLEUS-PHILA, V7, P41, DOI 10.1080/19491034.2016.1139273
   Boya P, 2012, CELL CYCLE, V11, P645, DOI 10.4161/cc.11.4.19278
   Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295
   Butin-Israeli V, 2015, MOL CELL BIOL, V35, P884, DOI 10.1128/MCB.01145-14
   Chen K, 2014, MOL BIOL EVOL, V31, P2194, DOI 10.1093/molbev/msu181
   De Vos WH, 2010, BBA-GEN SUBJECTS, V1800, P448, DOI 10.1016/j.bbagen.2010.01.002
   Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]
   Dou ZX, 2016, AUTOPHAGY, V12, P1416, DOI 10.1080/15548627.2015.1127465
   Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548
   Douroudis K, 2012, ACTA DERM-VENEREOL, V92, P85, DOI 10.2340/00015555-1183
   Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121
   English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720
   Erenpreisa J, 2012, AUTOPHAGY, V8, P1877, DOI 10.4161/auto.21610
   Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052
   Gonzalo S, 2017, AGEING RES REV, V33, P18, DOI 10.1016/j.arr.2016.06.007
   Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013
   Irianto J, 2016, CELL MOL BIOENG, V9, P258, DOI 10.1007/s12195-016-0437-8
   Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110
   Jdey W, 2017, CANCER RES, V77, P4207, DOI 10.1158/0008-5472.CAN-16-2693
   Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487
   Khadija SG, 2015, RECENT PATENTS ENDOC, V9, P111, DOI 10.2174/1872214809666151009120402
   Kind J, 2014, NUCLEUS-PHILA, V5, P124, DOI 10.4161/nucl.28825
   Kraft LJ, 2016, TRAFFIC, V17, P369, DOI 10.1111/tra.12372
   Leger-Silvestre I, 2005, J BIOL CHEM, V280, P38177, DOI 10.1074/jbc.M506916200
   Leidal AM, 2015, DEV CELL, V35, P529, DOI 10.1016/j.devcel.2015.11.016
   Li LF, 2016, ACTA BIOCH BIOPH SIN, V48, P491, DOI 10.1093/abbs/gmw025
   Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5
   Mijaljica D, 2013, J CELL SCI, V126, P4325, DOI 10.1242/jcs.133090
   Mijaljica D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040013
   Mijaljica D, 2010, NUCLEUS-AUSTIN, V1, P213, DOI 10.4161/nucl.1.3.11738
   Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639
   Mochida K, 2015, NATURE, V522, P359, DOI 10.1038/nature14506
   Moriyama M, 2014, J INVEST DERMATOL, V134, P1627, DOI 10.1038/jid.2014.11
   Nakatogawa H, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1073416
   Nakatogawa H, 2015, AUTOPHAGY, V11, P2377, DOI 10.1080/15548627.2015.1106665
   Park YE, 2009, AUTOPHAGY, V5, P795, DOI 10.4161/auto.8901
   Peng H, 2016, J INVEST DERMATOL, V136, P1316, DOI 10.1016/j.jid.2016.04.019
   Puri A., 2012, INT J RADIAT ONCOL, V82, pE367
   Qiang L, 2013, J BIOL CHEM, V288, P1603, DOI 10.1074/jbc.M112.415224
   Rajawat Y, 2010, AUTOPHAGY, V6, P1224, DOI 10.4161/auto.6.8.13793
   Rello-Varona S, 2012, CELL CYCLE, V11, P170, DOI 10.4161/cc.11.1.18564
   Sagona AP, 2014, BIOMED RES INT, DOI 10.1155/2014/974393
   Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113
   Salimi M, 2016, MUTAGENESIS, V31, P627, DOI 10.1093/mutage/gew029
   Sbrana FV, 2016, STEM CELL REV REP, V12, P621, DOI 10.1007/s12015-016-9690-4
   Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113
   Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111
   Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037
   Wang XD, 2015, INT J RADIAT BIOL, V91, P452, DOI 10.3109/09553002.2015.1012308
   Williams LR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00170
   Xie F, 2013, SCI CHINA LIFE SCI, V56, P856, DOI 10.1007/s11427-013-4530-0
   Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897
   Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546
NR 56
TC 1
Z9 1
U1 8
U2 10
PU TOHOKU UNIV MEDICAL PRESS
PI SENDAI
PA 2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN
SN 0040-8727
EI 1349-3329
J9 TOHOKU J EXP MED
JI Tohoku J. Exp. Med.
PD JAN
PY 2018
VL 244
IS 1
BP 75
EP 81
DI 10.1620/tjem.244.75
PG 7
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA FV6ZW
UT WOS:000424732000009
PM 29375097
DA 2018-12-27
ER

PT J
AU Cao, JH
   Wu, HW
   Li, ZG
AF Cao, Junhua
   Wu, Hongwei
   Li, Zhenguang
TI RETRACTED: Recent perspectives of pediatric mitochondrial diseases
   (Retracted article. See vol. 16, pg. 459, 2018)
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Review; Retracted Publication
DE mitochondrial disorders; pediatrics
ID RESPIRATORY-CHAIN DEFECTS; NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY;
   OXIDATIVE-PHOSPHORYLATION; OPHTHALMOLOGICAL FINDINGS; STATUS
   EPILEPTICUS; LEIGH-SYNDROME; DISORDERS; CHILDREN; DIAGNOSIS; EPILEPSY
AB Mitochondrial disorders are amongst the most common groups of inborn errors of metabolism. They are caused by deficiencies in the final pathway of the cellular energy production, the mitochondrial respiratory chain. The disorders are clinically and genetically heterogeneous and the aetiology could be found in the mitochondrial, or in the nuclear genome. We searched important e-databases for the collection of latest literature on the mitochondrial disease especially in pediatric population. Most of the studies in the recent past have focused on the understanding of the clinical phenotypes and pathophysiological mechanisms. Leigh syndrome is a common severe, neurodegenerative disease of early childhood. A defect in the POLG gene is another common observation in most of the cases leading to Alpers syndrome. The review concludes that pediatric mitochondrial disorders are severe, progressive and usually multi-systemic. Further, whole genome sequencing is an excellent diagnostic option.
C1 [Cao, Junhua; Wu, Hongwei; Li, Zhenguang] Xuzhou Childrens Hosp, Dept Neonatol, 18 Sudibei Rd, Xuzhou 221002, Jiangsu, Peoples R China.
RP Li, ZG (reprint author), Xuzhou Childrens Hosp, Dept Neonatol, 18 Sudibei Rd, Xuzhou 221002, Jiangsu, Peoples R China.
EM zhenguangli29@163.com
CR Akebrand R, 2016, ACTA OPHTHALMOL, V94, P609, DOI 10.1111/aos.12983
   Anagnostou ME, 2016, EPILEPSIA, V57, P1531, DOI 10.1111/epi.13508
   Bindoff LA, 2012, EPILEPSIA, V53, P92, DOI 10.1111/j.1528-1167.2012.03618.x
   CAVANAGH JB, 1994, BRAIN, V117, P1357, DOI 10.1093/brain/117.6.1357
   Chow J, 2017, NAT REV ENDOCRINOL, V13, P92, DOI 10.1038/nrendo.2016.151
   CormierDaire V, 1997, J PEDIATR-US, V130, P817, DOI 10.1016/S0022-3476(97)80027-3
   Crippa BL, 2015, AM J MED GENET A, V167, P621, DOI 10.1002/ajmg.a.36939
   Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866
   Dinopoulos A, 2005, NEUROPEDIATRICS, V36, P290, DOI 10.1055/s-2005-872807
   Faivre L, 2000, PRENATAL DIAG, V20, P732, DOI 10.1002/1097-0223(200009)20:9<732::AID-PD916>3.0.CO;2-#
   Ferreira A, 2015, EUR J CLIN INVEST, V45, P44, DOI 10.1111/eci.12359
   Finsterer J, 2014, INT J CARDIOL, V177, P754, DOI 10.1016/j.ijcard.2014.11.014
   Garone C, 2011, BRAIN, V134, P3326, DOI 10.1093/brain/awr245
   Giordano C, 2010, ARCH NEUROL-CHICAGO, V67, P1144, DOI 10.1001/archneurol.2010.200
   GOLD M, 1994, INT J PEDIATR OTORHI, V30, P91, DOI 10.1016/0165-5876(94)90191-0
   Gronlund MA, 2010, BRIT J OPHTHALMOL, V94, P121, DOI 10.1136/bjo.2008.154187
   Haas RH, 2008, MOL GENET METAB, V94, P16, DOI 10.1016/j.ymgme.2007.11.018
   Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391
   Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04
   Holmgren D, 2003, EUR HEART J, V24, P280, DOI 10.1016/S0195-668X(02)00387-1
   Hsu YC, 2016, BBA-GEN SUBJECTS, V1860, P686, DOI 10.1016/j.bbagen.2016.01.009
   Isohanni P, 2011, NEUROLOGY, V76, P811, DOI 10.1212/WNL.0b013e31820e7b25
   Karaa A, 2015, PEDIATR DIABETES, V16, P1, DOI 10.1111/pedi.12223
   Khan A, 2012, J CHILD NEUROL, V27, P636, DOI 10.1177/0883073811423973
   Khurana DS, 2008, NEUROPEDIATRICS, V39, P8, DOI 10.1055/s-2008-1076737
   Kirby DM, 2008, TWIN RES HUM GENET, V11, P395, DOI 10.1375/twin.11.4.395
   Kohda M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005679
   Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551
   Larsson NG, 2001, ACTA PHYSIOL SCAND, V171, P385, DOI 10.1046/j.1365-201x.2001.00842.x
   Lax NZ, 2012, J NEUROPATH EXP NEUR, V71, P148, DOI 10.1097/NEN.0b013e318244477d
   Leber T, 1871, ARCH OPHTHALMOL-CHIC, V17, P249, DOI DOI 10.1007/BF01694557
   Lunsing RJ, 2017, EUR RADIOL, V27, P976, DOI 10.1007/s00330-016-4454-8
   Maechler P, 2013, MOL CELL ENDOCRINOL, V379, P12, DOI 10.1016/j.mce.2013.06.019
   Martikainen MH, 2016, JAMA NEUROL, V73, P668, DOI 10.1001/jamaneurol.2016.0355
   Martin-Hernandez E, 2005, PEDIATR NEPHROL, V20, P1299, DOI 10.1007/s00467-005-1948-z
   NEWMAN NJ, 1993, ARCH NEUROL-CHICAGO, V50, P540, DOI 10.1001/archneur.1993.00540050082021
   Palmieri L, 2010, BBA-BIOENERGETICS, V1797, P1130, DOI 10.1016/j.bbabio.2010.04.018
   Pinto M, 2012, BIOL CHEM, V393, P275, DOI 10.1515/hsz-2011-0236
   Rahman S, 2015, EPILEPSY BEHAV, V49, P71, DOI 10.1016/j.yebeh.2015.05.003
   Rahman S, 2013, J INHERIT METAB DIS, V36, P659, DOI 10.1007/s10545-013-9614-2
   Rahman S, 2012, DEV MED CHILD NEUROL, V54, P397, DOI 10.1111/j.1469-8749.2011.04214.x
   Sim KG, 2002, CLIN CHIM ACTA, V323, P37, DOI 10.1016/S0009-8981(02)00182-1
   Spiegler J, 2011, NEUROPEDIATRICS, V42, P194, DOI 10.1055/s-0031-1287812
   Stranneheim H, 2016, J INTERN MED, V279, P3, DOI 10.1111/joim.12399
   Turconi AC, 1999, J NEUROL SCI, V170, P57, DOI 10.1016/S0022-510X(99)00199-9
   Wolf NI, 2009, EPILEPSIA, V50, P1596, DOI 10.1111/j.1528-1167.2008.01877.x
   YAMAMOTO M, 1989, J NEUROL SCI, V91, P207, DOI 10.1016/0022-510X(89)90088-9
   Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555
   Zhang Meng, 2016, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V33, P717, DOI 10.3760/cma.j.issn.1003-9406.2016.05.031
   Zhu CC, 2017, OPHTHALMIC GENET, V38, P67, DOI 10.3109/13816810.2015.1130153
NR 50
TC 2
Z9 2
U1 1
U2 1
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD JAN
PY 2018
VL 15
IS 1
BP 13
EP 18
DI 10.3892/etm.2017.5385
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA FV0WL
UT WOS:000424281600002
PM 29375674
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Borisov, A
   Mamaev, I
   Kilin, A
AF Borisov, Alexey V.
   Mamaev, Ivan S.
   Kilin, Alexander A.
TI RETRACTED: Dynamics of Three Vortices on a Sphere (Retracted article.
   See vol. 23, pg. 226, 2018)
SO REGULAR & CHAOTIC DYNAMICS
LA English
DT Article; Retracted Publication
DE point vortices; space of constant curvature; nonlinear Poisson bracket;
   reduction
AB This paper is concerned with the dynamics of vortices on a sphere. It is shown that, as a result of reduction, the problem reduces to investigating a system with a nonlinear Poisson bracket. The topology of a symplectic leaf in the case of three vortices is studied.
C1 [Borisov, Alexey V.; Kilin, Alexander A.] Udmurt State Univ, Ul Univ Skaya 1, Izhevsk 426034, Russia.
   [Borisov, Alexey V.; Mamaev, Ivan S.; Kilin, Alexander A.] Moscow Inst Phys & Technol, Inst Skii Per 9, Dolgoprudnyi 141700, Russia.
   [Mamaev, Ivan S.] Izhevsk State Tech Univ, Ul Studencheskaya 7, Izhevsk 426069, Russia.
RP Borisov, A (reprint author), Udmurt State Univ, Ul Univ Skaya 1, Izhevsk 426034, Russia.; Borisov, A (reprint author), Moscow Inst Phys & Technol, Inst Skii Per 9, Dolgoprudnyi 141700, Russia.
EM borisov@rcd.ru; mamaev@rcd.ru; aka@rcd.ru
FU Russian Federation; RFBR [17-01-00846-a];  [1.2404.2017/4.6]
FX The work of A. V. Borisov and A. A. Kilin (Sections 1 and 2) was carried
   out within the framework of the state assignment of the Ministry of
   Education and Science of Russia (1.2404.2017/4.6). The work of I. S.
   Mamaev (Section 3) was carried out at MIPT under project 5-100 for state
   support for leading universities of the Russian Federation. The work was
   also supported by the RFBR grant No. 17-01-00846-a.
CR BOGOMOLOV VA, 1979, IZV AS ATMOS OCEAN P, V15, P18
   [Борисов Алексей Владимирович Borisov A.V.], 2005, [Нелинейная динамика, Russian Journal of Nonlinear Dynamics, Nelineinaya dinamika], V1, P233
   Borisov A. V., 2005, DISCRETE CONTIN DYN, P100
   Borisov A.V., 1999, POISSON STRUCTURES L
   Borisov A. V., 1998, REGUL CHAOTIC DYN, V3, P99
   Kidambi R, 1999, NUOVO CIMENTO C, V22, P779
   Kidambi R, 1998, PHYSICA D, V116, P143, DOI 10.1016/S0167-2789(97)00236-4
   Newton P.K., 2001, N VORTEX PROBLEM ANA
   Volterra V., 1931, LECONS THEORIE MATH
NR 9
TC 1
Z9 1
U1 3
U2 3
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1560-3547
EI 1468-4845
J9 REGUL CHAOTIC DYN
JI Regul. Chaotic Dyn.
PD JAN
PY 2018
VL 23
IS 1
BP 127
EP 134
DI 10.1134/S1560354718010100
PG 8
WC Mathematics, Applied; Mechanics; Physics, Mathematical
SC Mathematics; Mechanics; Physics
GA FV0SL
UT WOS:000424267100010
DA 2018-12-27
ER

PT J
AU Edlow, AG
   Xue, C
   Pothos, EN
AF Edlow, Andrea G.
   Xue, Chang
   Pothos, Emmanuel N.
TI RETRACTED: Sex differences in mesolimbic dopamine signaling,
   catecholamine synthesis, and offspring weight in a mouse model of
   maternal diet-induced obesity (Retracted article. See vol. 219, pg. 112,
   2018)
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract; Retracted Publication
CT 38th Annual Meeting and Pregnancy Meeting of the
   Society-for-Maternal-Fetal-Medicine
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Edlow, Andrea G.] Tufts Med Ctr, Boston, MA USA.
   [Xue, Chang; Pothos, Emmanuel N.] Tufts Univ, Sackler Sch Biomed Sci, Boston, MA 02111 USA.
NR 0
TC 1
Z9 1
U1 1
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 633
BP S377
EP S378
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FU1NL
UT WOS:000423616600132
DA 2018-12-27
ER

PT J
AU Nunes, VC
   Wells, A
   Noukelak, GY
   Miodovnik, M
   Raju, TNK
AF Nunes, Vanessa C.
   Wells, Alexandria
   Noukelak, Germaine Y.
   Miodovnik, Menachem
   Raju, Tonse N. K.
TI RETRACTED: Compliance of federally-funded maternal fetal medicine and
   neonatology studies to federally-mandated trial registration
   requirements (Retracted article. See vol. 219, pg. 112, 2018)
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract; Retracted Publication
CT 38th Annual Meeting and Pregnancy Meeting of the
   Society-for-Maternal-Fetal-Medicine
CY JAN 29-FEB 03, 2018
CL Dallas, TX
SP Soc Maternal Fetal Med
C1 [Nunes, Vanessa C.] Univ South Carolina, Sch Med, Greenville Hlth Syst, Greenville, SC USA.
   [Wells, Alexandria; Noukelak, Germaine Y.] Howard Univ, Coll Med, Washington, DC USA.
   [Miodovnik, Menachem; Raju, Tonse N. K.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JAN
PY 2018
VL 218
IS 1
SU S
MA 647
BP S385
EP S385
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FU1NL
UT WOS:000423616600146
DA 2018-12-27
ER

PT J
AU Fan, T
   Huang, GZ
   Wu, W
   Guo, R
   Zeng, Q
AF Fan, Tao
   Huang, Guozhi
   Wu, Wen
   Guo, Rong
   Zeng, Qing
TI RETRACTED: Combined treatment with extracorporeal shock-wave therapy and
   bone marrow mesenchymal stem cell transplantation improves bone repair
   in a rabbit model of bone nonunion (Retracted article. See vol. 18, pg.
   4156, 2018)
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article; Retracted Publication
DE bone nonunion; bone marrow mesenchymal stem cell; open fracture; bone
   morphogenetic proteins; purinergic receptor P2X 7
ID OSTEOGENIC DIFFERENTIATION; SCAPHOID NONUNION; ATROPHIC NONUNION;
   OSTEOBLASTIC DIFFERENTIATION; SIGNALING PATHWAY; IN-VITRO; OSTEOCYTES;
   RECEPTORS; RELEASE; DISEASE
AB The aim of the present study was to analyze whether extracorporeal shock-wave therapy (ESWT) combined with bone marrow mesenchymal stem cell (BMMSC) transplantation improves bone repair in a rabbit bone nonunion model. ESWT combined with BMMSC effectively enhanced mechanical strength, fracture stiffness and histological scores, and increased alkaline phosphatase activity, and osteopontin, runt related transcription factor 2 and collagen type I 1 chain protein expression levels in a rabbit bone nonunion model. In addition, ESWT combined with BMMSC effectively enhanced insulin-like growth factor 1 and vascular endothelial growth factor contents, promoted transforming growth factor- (TGF-) contents, and induced the growth factors, bone morphogenetic protein (BMP)-2, BMP-4 and purinergic receptor P2X7 (P2X7) protein expression in the rabbit bone nonunion model. Thus, the present study demonstrated that ESWT combined with BMMSC transplantation improves bone repair in a rabbit bone nonunion model via the BMPs and P2X7 signaling pathways.
C1 [Fan, Tao; Huang, Guozhi; Wu, Wen; Guo, Rong; Zeng, Qing] Southern Med Univ, Zhujiang Hosp, Dept Rehabil Med, 253 Ind Ave, Guangzhou 510282, Guangdong, Peoples R China.
RP Huang, GZ (reprint author), Southern Med Univ, Zhujiang Hosp, Dept Rehabil Med, 253 Ind Ave, Guangzhou 510282, Guangdong, Peoples R China.
EM drhuang66@163.com
FU Southern Medical University Scientific Research Start-up Program;
   Guangdong Province Science and Technology Project [2017ZC0121]
FX The present study was supported by Southern Medical University
   Scientific Research Start-up Program and Guangdong Province Science and
   Technology Project (grant no. 2017ZC0121).
CR Arguelles-Salido E, 2014, ACTAS UROL ESP, V38, P115, DOI 10.1016/j.acuro.2013.07.004
   Bach FC, 2017, TISSUE ENG PT A, V23, P233, DOI [10.1089/ten.tea.2016.0251, 10.1089/ten.TEA.2016.0251]
   Cheung WY, 2016, J BONE MINER RES, V31, P890, DOI 10.1002/jbmr.2740
   Falk S, 2015, NEUROSCIENCE, V291, P93, DOI 10.1016/j.neuroscience.2015.02.011
   Grol MW, 2016, PURINERG SIGNAL, V12, P509, DOI 10.1007/s11302-016-9517-4
   Hou JM, 2015, INT J ENDOCRINOL, V2015, DOI [10. 1155/2015/282806 26290662 4531176, DOI 10.1155/2015/282806262906624531176]
   Hu N, 2015, INT J MOL SCI, V16, P10491, DOI 10.3390/ijms160510491
   Huang SW, 2017, IMMUNOL CELL BIOL, V95, P178, DOI 10.1038/icb.2016.75
   Ismail HD, 2016, BONE JOINT RES, V5, P287, DOI 10.1302/2046-3758.57.2000587
   Ismail HD, 2013, BONE JOINT RES, V2, P112, DOI 10.1302/2046-3758.26.2000165
   Kim HY, 2016, BIOMACROMOLECULES, V17, P1633, DOI 10.1021/acs.biomac.6b00009
   Koga T, 2013, J ULTRAS MED, V32, P915, DOI 10.7863/ultra.32.6.915
   Lau KHW, 2016, BONE, V92, P18, DOI 10.1016/j.bone.2016.08.005
   Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200
   Lee JH, 2013, J PHYS THER SCI, V25, P1067, DOI 10.1589/jpts.25.1067
   Li Y, 2017, J CELL PHYSIOL, V232, P2427, DOI 10.1002/jcp.25517
   Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048
   Malizos KN, 2014, J HAND SURG-AM, V39, P872, DOI 10.1016/j.jhsa.2014.01.045
   Mathieu M, 2013, BONE, V53, P391, DOI 10.1016/j.bone.2013.01.005
   Muller Nadja A, 2015, Tech Hand Up Extrem Surg, V19, P115, DOI 10.1097/BTH.0000000000000090
   Ota K, 2013, BONE, V57, P68, DOI 10.1016/j.bone.2013.07.023
   Peeters M, 2015, BIORESEARCH OPEN ACC, V4, P398, DOI 10.1089/biores.2015.0025
   Pfaff JA, 2016, IMPLANT DENT, V25, P606, DOI 10.1097/ID.0000000000000452
   Qu ZG, 2015, CELL BIOCHEM BIOPHYS, V71, P1543, DOI 10.1007/s12013-014-0378-6
   Reed-Maldonado AB, 2016, EUR UROL, V70, P895, DOI 10.1016/j.eururo.2016.08.026
   Sakaki H, 2013, BIOCHEM BIOPH RES CO, V432, P406, DOI 10.1016/j.bbrc.2013.01.135
   Sollazzo V, 2010, CLIN ORTHOP RELAT R, V468, P2260, DOI 10.1007/s11999-010-1341-5
   Sun DH, 2013, STEM CELLS, V31, P1170, DOI 10.1002/stem.1356
   Vedung T, 2014, J WRIST SURG, V3, P46, DOI 10.1055/s-0033-1364092
   Visser R, 2016, J BIOMED MATER RES A, V104, P178, DOI 10.1002/jbm.a.35546
   Wang CL, 2017, J CELL BIOCHEM, V118, P286, DOI 10.1002/jcb.25635
   Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9
   Xiong LY, 2015, J PLAST RECONSTR AES, V68, P1138, DOI 10.1016/j.bjps.2015.03.027
   Yin P, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0189-5
   Zhai L, 2016, ULTRASOUND MED BIOL, V42, P753, DOI 10.1016/j.ultrasmedbio.2015.10.021
   Zura R, 2016, JBJS REV, V4, DOI 10.2106/JBJS.RVW.O.00008
NR 36
TC 2
Z9 2
U1 5
U2 8
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD JAN
PY 2018
VL 17
IS 1
BP 1326
EP 1332
DI 10.3892/mmr.2017.7984
PG 7
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA FT8WG
UT WOS:000423433300171
PM 29115642
DA 2018-12-27
ER

PT J
AU Zhang, ZJ
   Zheng, ML
   Nie, Y
   Niu, ZQ
AF Zhang, Z. J.
   Zheng, M. L.
   Nie, Y.
   Niu, Z. Q.
TI RETRACTED: Comparison of Arndt-endobronchial blocker plus laryngeal mask
   airway with left-sided double-lumen endobronchial tube in one-lung
   ventilation in thoracic surgery in the morbidly obese (Retracted
   article. See vol. 51, art. e6825, 2018)
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Retracted Publication
DE Laryngeal mask airway; Arndt-endobronchial blocker; L-DLT; One-lung
   ventilation; Thoracic surgery; Morbidly obese
ID OBSTRUCTIVE SLEEP-APNEA; TORQUE CONTROL BLOCKER; WIRE-GUIDED BLOCKER;
   TRACHEAL INTUBATION; BRONCHIAL BLOCKERS; DIFFICULT INTUBATION; NECK
   CIRCUMFERENCE; ENDOTRACHEAL-TUBE; ANESTHESIA; PATIENT
AB This study aimed to evaluate the feasibility and performance of Arndt-endobronchial blocker (Arndt) combined with laryngeal mask airway (LMA) compared with left-sided double-lumen endobronchial tube (L-DLT) in morbidly obese patients in one-lung ventilation (OLV). In a prospective, randomized double-blind controlled clinical trial, 80 morbidly obese patients (ASA I-III, aged 20-70) undergoing general anesthesia for elective thoracic surgeries were randomly allocated into groups Arndt (n=40) and L-DLT (n=40). In group Arndt, a LMA (TM) Proseal was placed followed by an Arndt-endobronchial blocker. In group L-DLT, patients were intubated with a left-sided double-lumen endotracheal tube. Primary endpoints were the airway establishment, ease of insertion, oxygenation, lung collapse and surgical field exposure. Results showed similar ease of airway establishment and tube/device insertion between the two groups. Oxygen arterial pressure (PaO2) of patients in the Arndt group was significantly higher than L-DLT (154 +/- 46 vs 105 +/- 52 mmHg; P<0.05). Quality of lung collapse and surgical field exposure in the Arndt group was significantly better than L-DLT (effective rate 100 vs 90%; P<0.05). Duration of surgery and anesthesia were significantly shorter in the Arndt group (2.4 +/- 1.7 vs 3.1 +/- 1.8 and 2.8 +/- 1.9 vs 3.8 +/- 1.8 h, respectively; P<0.05). Incidence of hoarseness of voice and incidence and severity of throat pain at the post-anesthesia care unit and 12, 24, 48, and 72 h after surgery were significantly lower in the Arndt group (P<0.05). Findings suggested that Arndt-endobronchial blocker combined with LMA can serve as a promising alternative for morbidly obese patients in OLV in thoracic surgery.
C1 [Zhang, Z. J.; Zheng, M. L.; Nie, Y.; Niu, Z. Q.] Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Hebei, Peoples R China.
RP Niu, ZQ (reprint author), Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Hebei, Peoples R China.
EM niu_zhiqiang@21cn.com
FU Cangzhou City Science and Technology Research and Development Projects
   [151302063]
FX This study is supported by the Cangzhou City Science and Technology
   Research and Development Projects (No. 151302063).
CR Adams JP, 2000, BRIT J ANAESTH, V85, P91, DOI 10.1093/bja/85.1.91
   Amer Soc Anesthesiologists, 2013, ANESTHESIOLOGY, V118, P251, DOI 10.1097/ALN.0b013e31827773b2
   Asai T, 1998, BRIT J ANAESTH, V80, P470, DOI 10.1093/bja/80.4.470
   Brodsky J B, 2009, Br J Anaesth, V103 Suppl 1, pi66, DOI 10.1093/bja/aep262
   Brodsky JB, 1996, ANESTH ANALG, V82, P861, DOI 10.1097/00000539-199604000-00032
   Brodsky JB, 2002, ANESTH ANALG, V94, P732, DOI 10.1097/00000539-200203000-00047
   Campos JH, 2012, BRIT J ANAESTH, V109, P630, DOI 10.1093/bja/aes206
   Campos JH, 2007, CURR OPIN ANESTHESIO, V20, P27, DOI 10.1097/ACO.0b013e3280111e2a
   Campos Javier H, 2005, Thorac Surg Clin, V15, P71
   Campos JH, 2006, ANESTHESIOLOGY, V104, P261, DOI 10.1097/00000542-200602000-00010
   Campos JH, 2003, ANESTH ANALG, V96, P283, DOI 10.1213/01.ANE.0000042449.67753.D2
   Campos JH, 1998, ANESTH ANALG, V86, P696, DOI 10.1097/00000539-199804000-00003
   Campos JH, 2011, REV MEX ANESTESIOL, V34, pS270
   Candiotti K, 2009, Br J Anaesth, V103 Suppl 1, pi23, DOI 10.1093/bja/aep294
   Cohen E, 2008, J CARDIOTHOR VASC AN, V22, P920, DOI 10.1053/j.jvca.2008.09.002
   Dhonneur G, 2006, BRIT J ANAESTH, V97, P742, DOI 10.1093/bja/ael219
   Ferreira Halina Cidrini, 2004, J. bras. pneumol., V30, P566, DOI 10.1590/S1806-37132004000600012
   Goldmann K, 2007, CAN J ANAESTH, V54, P822, DOI 10.1007/BF03021710
   Gonzalez H, 2008, ANESTH ANALG, V106, P1132, DOI 10.1213/ane.0b013e3181679659
   Hillman DR, 2003, BRIT J ANAESTH, V91, P31, DOI 10.1093/bja/aeg126
   Hiremath AS, 1998, BRIT J ANAESTH, V80, P606
   Ho CYA, 2005, EUR J CARDIO-THORAC, V28, P174, DOI 10.1016/j.ejcts.2005.03.013
   Kagawa T, 2000, ANESTHESIOLOGY, V92, P631, DOI 10.1097/00000542-200002000-00063
   Keller C, 2002, ANESTH ANALG, V94, P737, DOI 10.1097/00000539-200203000-00048
   Knoll H, 2006, ANESTHESIOLOGY, V105, P471, DOI 10.1097/00000542-200609000-00009
   Lehmann M, 2010, J CLIN ANESTH, V22, P13, DOI 10.1016/j.jclinane.2009.02.015
   Li P, 2009, BRIT J ANAESTH, V103, P902, DOI 10.1093/bja/aep325
   Li Q, 2014, EXP THER MED, V8, P1628, DOI 10.3892/etm.2014.1966
   Loadsman JA, 2001, BRIT J ANAESTH, V86, P254, DOI 10.1093/bja/86.2.254
   Lohser J, 2007, CURR OPIN ANESTHESIO, V20, P10, DOI 10.1097/ACO.0b013e32800ff73c
   Neligan PJ, 2009, ANESTH ANALG, V109, P1182, DOI 10.1213/ane.0b013e3181b12a0c
   Neustein SM, 2009, J CARDIOTHOR VASC AN, V23, P860, DOI 10.1053/j.jvca.2009.05.014
   Pedoto A, 2012, ANESTHESIOL RES PRAC, DOI 10.1155/2012/154208
   Pelosi P, 2011, CURR OPIN CRIT CARE, V17, P72, DOI 10.1097/MCC.0b013e3283427213
   Riad W, 2016, EUR J ANAESTH, V33, P244, DOI 10.1097/EJA.0000000000000324
   Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009
   Seitz P A, 1989, J Clin Anesth, V1, P214, DOI 10.1016/0952-8180(89)90044-5
   Sener M, 2008, J CLIN ANESTH, V20, P206, DOI 10.1016/j.jclinane.2007.07.009
   Voyagis GS, 1996, ANESTH ANALG, V83, P663, DOI 10.1097/00000539-199609000-00062
   Zavorsky GS, 2008, OBES SURG, V18, P1587, DOI 10.1007/s11695-008-9527-6
NR 40
TC 1
Z9 1
U1 1
U2 7
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 2018
VL 51
IS 2
AR e6825
DI 10.1590/1414-431X20176825
PG 9
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA FQ1SZ
UT WOS:000418139200001
PM 29267506
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Donnelly, C
   Cunningham, N
   Jones, JT
   Ji, L
   Brunner, HI
   Kashikar-Zuck, S
AF Donnelly, C.
   Cunningham, N.
   Jones, J. T.
   Ji, L.
   Brunner, H. I.
   Kashikar-Zuck, S.
TI RETRACTED: Fatigue and depression predict reduced health-related quality
   of life in childhood-onset lupus (Retracted article. See vol. 46, pg.
   NP1, 2018)
SO LUPUS
LA English
DT Article; Retracted Publication
DE Childhood-onset systemic lupus erythematosus; depression; fatigue;
   health-related quality of life
ID COGNITIVE-BEHAVIORAL THERAPY; FUNCTIONAL DISABILITY INVENTORY;
   DISEASE-ACTIVITY INDEX; GENERIC CORE SCALES; PEDIATRIC RHEUMATOLOGY;
   JUVENILE FIBROMYALGIA; ADOLESCENT DEPRESSION; CHRONIC PAIN;
   ERYTHEMATOSUS; PEDSQL(TM)
AB We aimed to identify risk factors for persistently reduced health-related quality of life in childhood-onset lupus and describe a risk profile for persistently reduced health-related quality of life. At a tertiary rheumatology clinic, 50 childhood onset lupus patients were assessed twice, approximately six months apart. Measures of disease activity and patient-reported measures of health-related quality of life, pain, depressive symptoms, anxiety and disability were collected at each visit. At visits 1 and 2, respectively, clinically relevant fatigue was present in 66% and 56% of patients; clinically significant depressive symptoms in 26% and 24%; and clinically significant anxiety in 34% and 28%. Poorer health-related quality of life at follow-up was significantly predicted by higher fatigue and depressive symptoms at the initial visit. Using clinically relevant cut-offs for fatigue and depressive symptoms, patients were assigned to Low (n=27) or High Risk (n=23) groups. A profile of significantly greater pain, anxiety and coping difficulties was seen in the High Risk group. Routine assessment of fatigue and mood symptoms in youth with childhood-onset lupus could be helpful in identifying those at risk for persistently poor health-related quality of life. Integration of behavioral interventions to address fatigue and mood symptoms into medical care for such patients may be beneficial, but more research in this area is needed.
C1 [Donnelly, C.] Univ Cincinnati, Med Ctr, Div Immunol Allergy & Rheumatol, Cincinnati, OH 45267 USA.
   [Cunningham, N.; Kashikar-Zuck, S.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, MLC 7039, Cincinnati, OH 45229 USA.
   [Cunningham, N.; Brunner, H. I.; Kashikar-Zuck, S.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA.
   [Jones, J. T.; Brunner, H. I.] Univ Missouri, Dept Pediat, Kansas City, MO 64110 USA.
   [Jones, J. T.] Cincinnati Childrens Hosp Med Ctr, Div Rheumatol, Cincinnati, OH 45229 USA.
   [Ji, L.] Beijing Union Med Coll Hosp, Beijing, Peoples R China.
RP Kashikar-Zuck, S (reprint author), Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, MLC 7039, Cincinnati, OH 45229 USA.
EM susmita.kashikar-zuck@cchmc.org
OI Jones, Jordan/0000-0003-0986-4991
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases
   (NIAMS)/NIH [K24AR056687]; Lupus Foundation of America Michael Jon
   Barlin Research Program
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This study was
   supported in part by the National Institute of Arthritis and
   Musculoskeletal and Skin Diseases (NIAMS)/NIH Grant K24AR056687 to S.
   Kashikar-Zuck. Dr Brunner's work was supported by the Lupus Foundation
   of America Michael Jon Barlin Research Program.
CR Adam V, 2005, J RHEUMATOL, V32, P354
   Amer Acad Child Adolescent, 2009, PEDIATRICS, V123, P1248, DOI 10.1542/peds.2009-0048
   Backman CL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2083
   Brunner HI, 2009, J RHEUMATOL, V36, P1536, DOI 10.3899/jrheum.081164
   Brunner HI, 1999, ARTHRITIS RHEUM, V42, P1354, DOI 10.1002/1529-0131(199907)42:7<1354::AID-ANR8>3.0.CO;2-4
   Claar RL, 2006, PAIN, V121, P77, DOI 10.1016/j.pain.2005.12.002
   Clarke GN, 1999, J AM ACAD CHILD PSY, V38, P272, DOI 10.1097/00004583-199903000-00014
   Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129
   Crombez G, 2003, PAIN, V104, P639, DOI 10.1016/S0304-3959(03)00121-0
   Dobkin PL, 2001, J RHEUMATOL, V28, P2442
   Eccleston C, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003968.pub4
   Gladman DD, 2000, J RHEUMATOL, V27, P373
   Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928
   Houghton KM, 2008, ARTHRIT RHEUM-ARTHR, V59, P537, DOI 10.1002/art.23534
   Isenberg DA, 2005, RHEUMATOLOGY, V44, P902, DOI 10.1093/rheumatology/keh624
   Jones JT, 2016, ARTHRIT CARE RES, V68, P73, DOI 10.1002/acr.22650
   Julian LJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P240, DOI 10.1002/art.24236
   Kamphuis S, 2010, NAT REV RHEUMATOL, V6, P538, DOI 10.1038/nrrheum.2010.121
   Kashikar-Zuck S, 2008, CLIN J PAIN, V24, P620, DOI 10.1097/AJP.0b013e31816d7d23
   Kashikar-Zuck S, 2012, ARTHRITIS RHEUM-US, V64, P297, DOI 10.1002/art.30644
   Kashikar-Zuck S, 2011, PAIN, V152, P1600, DOI 10.1016/j.pain.2011.02.050
   Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005
   Klein JB, 2007, J AM ACAD CHILD PSY, V46, P1403, DOI 10.1097/chi.0b013e3180592aaa
   Knight A, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-42
   Knoop H, 2008, PEDIATRICS, V121, pE619, DOI 10.1542/peds.2007-1488
   Kohut SA, 2013, LUPUS, V22, P712, DOI 10.1177/0961203313488840
   KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995
   Kovacs M., 1992, CHILDRENS DEPRESSION
   Loiselle KA, 2016, PEDIATR BLOOD CANCER, V63, P1834, DOI 10.1002/pbc.26112
   Lootens CC, 2011, ARTHRIT CARE RES, V63, pS253, DOI 10.1002/acr.20634
   Mano KEJ, 2012, J PEDIATR PSYCHOL, V37, P999, DOI 10.1093/jpepsy/jss069
   McElhone K, 2006, LUPUS, V15, P633, DOI 10.1177/0961203306071710
   Meredith Lisa S, 2009, Med Care, V47, P677, DOI 10.1097/MLR.0b013e318190d46b
   Moldovan I, 2013, LUPUS, V22, P684, DOI 10.1177/0961203313486948
   Moorthy LN, 2017, LUPUS, V26, P255, DOI 10.1177/0961203316659546
   Pielech M, 2014, PAIN, V155, P2360, DOI 10.1016/j.pain.2014.08.035
   Schmeding A, 2013, BEST PRACT RES CL RH, V27, P363, DOI 10.1016/j.berh.2013.07.009
   Shaw KL, 2006, ARTHRIT RHEUM-ARTHR, V55, P199, DOI 10.1002/art.21852
   Somers TJ, 2012, ARTHRIT CARE RES, V64, P1334, DOI 10.1002/acr.21686
   Tanzi EM, 2011, J PEDIATR ONCOL NURS, V28, P191, DOI 10.1177/1043454211408100
   Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4
   Tran ST, 2015, J PEDIATR PSYCHOL, V40, P744, DOI 10.1093/jpepsy/jsv029
   Tunnicliffe DJ, 2016, ARTHRIT CARE RES, V68, P828, DOI 10.1002/acr.22749
   Varni JW, 2002, ARTHRITIS RHEUM, V46, P714, DOI 10.1002/art.10095
   Varni JW, 2004, J RHEUMATOL, V31, P2494
   Varni JW, 2002, J BEHAV MED, V25, P175, DOI 10.1023/A:1014836921812
   von Baeyer CL, 2009, PAIN RES MANAG, V14, P39, DOI 10.1155/2009/259759
   WALKER LS, 1991, J PEDIATR PSYCHOL, V16, P39, DOI 10.1093/jpepsy/16.1.39
   Yee CS, 2010, RHEUMATOLOGY, V49, P1665, DOI 10.1093/rheumatology/keq026
NR 49
TC 1
Z9 1
U1 3
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0961-2033
EI 1477-0962
J9 LUPUS
JI Lupus
PD JAN
PY 2018
VL 27
IS 1
BP 124
EP 133
DI 10.1177/0961203317716317
PG 10
WC Rheumatology
SC Rheumatology
GA FO9NK
UT WOS:000417214000016
PM 28662595
DA 2018-12-27
ER

PT J
AU Yang, SZ
AF Yang, Shuzhen
TI RETRACTED: Multidimensional viscosity solution theory of semi-linear
   partial differential equations (Retracted article. See vol. 463, pg.
   1169, 2018)
SO JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA English
DT Article; Retracted Publication
DE Multidimensional PDEs; BSDEs; Viscosity solution; Comparison theorem
ID JACOBI-BELLMAN EQUATIONS; MONOTONE SYSTEMS; UNIQUENESS; GAMES; PDES
AB In this paper, we concern the multidimensional viscosity solution theory of a kind of semi-linear partial differential equations (PDEs). A new definition of viscosity solution for this multidimensional semi-linear PDEs is given. Furthermore, we establish the existence and uniqueness results for the viscosity solution of this semi-linear PDEs via the comparison theorem of the related backward stochastic differential equations (BSDEs) and a smooth approximation techniques. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Yang, Shuzhen] Shandong Univ, Zhong Tai Secur Inst Financial Studies, Jinan 250100, Shandong, Peoples R China.
RP Yang, SZ (reprint author), Shandong Univ, Zhong Tai Secur Inst Financial Studies, Jinan 250100, Shandong, Peoples R China.
EM yangsz@sdu.edu.cn
FU National Natural Science Foundation of China [71371109]; Fundamental
   Research Funds of Shandong University [2015GN015]; Promotive research
   fund for excellent young and middle-aged scientists of Shandong Province
   [BS2015SF004]; China Postdoctoral Science Foundation [2015M570584]
FX This work supported by the National Natural Science Foundation of China
   (Grant No. 71371109); Fundamental Research Funds of Shandong University
   (2015GN015); Supported by the Promotive research fund for excellent
   young and middle-aged scientists of Shandong Province (BS2015SF004);
   Supported by the China Postdoctoral Science Foundation funded project
   (2015M570584).
CR Buckdahn R, 2010, STOCHASTICS, V82, P241, DOI 10.1080/17442501003624415
   Buckdahn R, 2008, SIAM J CONTROL OPTIM, V47, P444, DOI 10.1137/060671954
   Buckdahn R, 2010, J EVOL EQU, V10, P529, DOI 10.1007/s00028-010-0060-4
   CRANDALL MG, 1992, B AM MATH SOC, V27, P1, DOI 10.1090/S0273-0979-1992-00266-5
   CRANDALL MG, 1983, T AM MATH SOC, V277, P1, DOI 10.2307/1999343
   DUFFIE D, 1992, ECONOMETRICA, V60, P353, DOI 10.2307/2951600
   El Karoui N, 1997, MATH FINANC, V7, P1, DOI 10.1111/1467-9965.00022
   FLEMING WH, 2006, CONTROL MARKOV
   ISHII H, 1991, COMMUN PART DIFF EQ, V16, P1095, DOI 10.1080/03605309108820791
   KOIKE S, 1994, NONLINEAR ANAL-THEOR, V22, P519, DOI 10.1016/0362-546X(94)90172-4
   LIN Q, 2011, STOCHASTIC PROCESS, V122, P357
   Lin Q, 2015, STOCH PROC APPL, V125, P4405, DOI 10.1016/j.spa.2015.07.004
   LIONS PL, 1983, COMMUN PART DIFF EQ, V8, P1229, DOI 10.1080/03605308308820301
   LIONS PL, 1983, ACTA APPL MATH, V1, P17, DOI 10.1007/BF02433840
   LIONS PL, 1982, GENERALIZED SOLUT
   LIONS PL, 1979, COMMUN PUR APPL MATH, V34, P121
   Pardoux E, 1997, ANN I H POINCARE-PR, V33, P467, DOI 10.1016/S0246-0203(97)80101-X
   PARDOUX E, 1992, LECT NOTES CONTR INF, V176, P200
   PARDOUX E, 1990, SYST CONTROL LETT, V14, P55, DOI 10.1016/0167-6911(90)90082-6
   Pardoux E., 1994, PREPUBLICATION URA, V94-03
   PARDOUX E, 1993, LECT NOTES CONTROL I, P200
   Peng S., 1997, TOPICS STOCHASTIC AN, P85
   Peng S., 1992, STOCHASTICS STOCHAST, V38, P119, DOI DOI 10.1080/17442509208833749
   Shige Peng, 1991, Stochastics and Stochastics Reports, V37, P61
   Wu Z, 2008, SIAM J CONTROL OPTIM, V47, P2616, DOI 10.1137/060671917
NR 25
TC 1
Z9 1
U1 7
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-247X
EI 1096-0813
J9 J MATH ANAL APPL
JI J. Math. Anal. Appl.
PD DEC 15
PY 2017
VL 456
IS 2
BP 1347
EP 1364
DI 10.1016/j.jmaa.2017.07.064
PG 18
WC Mathematics, Applied; Mathematics
SC Mathematics
GA FG1OK
UT WOS:000409565300033
DA 2018-12-27
ER

PT J
AU Zhang, P
   Wang, YQ
AF Zhang, Ping
   Wang, Youqiang
TI RETRACTED: A Study on the Nucleation Mechanism of Nano-Scale
   Precipitates of 7055 Aluminum Alloy (Retracted article. See vol. 13, art
   no 1893001, 2018)
SO NANO
LA English
DT Article; Retracted Publication
DE 7055 aluminum alloy; nanoscale precipitate; nucleation mechanism; growth
   mechanism; microstructure
ID MAGNESIUM ALLOY; AL-ALLOY; CORROSION
AB 7055 aluminum alloy is a typical age-hardening alloy whose properties change with microstructural evolution as a result of heat treatment. In this paper, the microstructural evolution of the alloy after solid solution treatment and manual aging is examined using SEM, TEM and HADDF. The precipitation, nucleation and growth mechanisms of theta' and theta'' phases are also analyzed. Results show that, as aging proceeds, the Al-Cu phase gradually enlarges and thickens the following precipitation sequence of supersaturated solid solution (SSSS) -> GPI zone -> GPII zone -> theta'' phase -> theta' phase; some S phases formed during aging, which have two different nucleation mechanisms: homogeneous nucleation and heterogeneous nucleation, the S phases of the latter being marginally larger in size than those of the former. There is a transition in the transformation of (Al3Cu) in GPII zone into theta'-phase (Al2Cu). The orientation relation between theta' phase and Al matrix is (100)(Al)//(100)(theta'), (010)(Al)//(010)(theta'), (001)(Al)//(001)(theta'). According to this relationship, theta' phase has three variants in the matrix: Variants 1, 2, and 3, which represent the theta' phase along {100}(Al), {010}(Al) and {001}(Al). As theta' phase has a special orientation relation with Al matrix (100)(Al)//(100)(theta'), (010)(Al)//(010)(theta'), (001)(Al)//(001)(theta'), theta' phase is distributed in disc form on {001}(Al). Significantly larger S phase can be observed. The orientation relation between S phase and Al matrix is [100](Al)//[100](S), [021](Al)//[010](S), [012](Al)//[001](S). theta' phase grows in step form for a period equaling to 1.75-fold unit cell of theta'. As theta' phase grows, the Cu atoms segregated on the edge of theta' phase are gradually consumed.
C1 [Zhang, Ping; Wang, Youqiang] Qingdao Univ Technol, Sch Mech Engn, Qingdao 266520, Shandong, Peoples R China.
RP Zhang, P (reprint author), Qingdao Univ Technol, Sch Mech Engn, Qingdao 266520, Shandong, Peoples R China.
EM zp15773209569@163.com
FU National Natural Science Foundation of China [51705270, 51575289];
   Natural Science Foundation of Shandong Province [ZR2016EEP03];
   Technology Project of Higher Education Shandong Province Science
   [J17KA0031]
FX The work was supported by the National Natural Science Foundation of
   China (No. 51705270), the National Natural Science Foundation of China
   (No. 51575289), the Natural Science Foundation of Shandong Province (No.
   ZR2016EEP03) and Technology Project of Higher Education Shandong
   Province Science (No. J17KA0031).
CR Borrisutthekul R, 2005, SCI TECHNOL ADV MAT, V6, P199, DOI 10.1016/j.stam.2004.11.014
   Champlin J, 1999, MATER DESIGN, V20, P331, DOI 10.1016/S0261-3069(99)00039-4
   Chang CC, 2011, ADV MATER RES-SWITZ, V139-141, P157, DOI 10.4028/www.scientific.net/AMR.139-141.157
   Chen KH, 2003, J MATER PROCESS TECH, V142, P190, DOI 10.1016/S0924-0136(03)00597-1
   Ding S., 2016, INT J ADV MANUFACT T, V86, P1
   Guo Y. J., 2013, ADV MAT RES, V815, P37
   [郝世明 Hao Shiming], 2015, [材料热处理学报, Transactions of Materials and Heat Treatment], V36, P29
   Huang H., 2015, ADV MAT RES, V1082, P403
   Kim MR, 2014, PHYS MET METALLOGR+, V115, P1362, DOI 10.1134/S0031918X14130109
   Li Y.N., 2017, MATER SCI FORUM, V877, P647
   Lin F, 2011, ADV MATER RES-SWITZ, V308-310, P800, DOI 10.4028/www.scientific.net/AMR.308-310.800
   [刘胜胆 LIU Shengdan], 2006, [材料热处理学报, Transactions of materials and heat treatment], V27, P54
   Musa AY, 2010, ADV MATER RES-SWITZ, V93-94, P354, DOI 10.4028/www.scientific.net/AMR.93-94.354
   Nakai M., 2000, US Patent, Patent No. 6048415
   PARK JK, 1983, METALL TRANS A, V14, P1957, DOI 10.1007/BF02662363
   Peng P, 2015, ACS APPL MATER INTER, V7, P12597, DOI 10.1021/acsami.5b02134
   Sims Z. C., 2017, MAT HORIZ
   Slota J., 2016, STRENGTH MATER, V48, P1
   Song Q., 2014, ADV MAT RES, V1004-1005, P136
   Song RG, 2004, ACTA MATER, V52, P4727, DOI 10.1016/j.actamat.2004.06.023
   Xu H, 2014, MATER HORIZONS, V1, P546, DOI 10.1039/c4mh00085d
   You JH, 2007, MATER SCI FORUM, V546-549, P877, DOI 10.4028/www.scientific.net/MSF.546-549.877
NR 22
TC 1
Z9 1
U1 7
U2 15
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1793-2920
EI 1793-7094
J9 NANO
JI Nano
PD DEC
PY 2017
VL 12
IS 12
AR 1750147
DI 10.1142/S1793292017501478
PG 12
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA FR0TE
UT WOS:000418775400006
DA 2018-12-27
ER

PT J
AU Xu, MJ
   Yang, XL
   Zeng, Q
   He, H
   Lu, PC
   Huang, GZ
AF Xu, Mingjing
   Yang, Xianli
   Zeng, Qing
   He, He
   Lu, Pengcheng
   Huang, Guozhi
TI RETRACTED: BIRC5 is a novel target of peroxisome proliferator-activated
   receptor gamma in brain microvascular endothelium cells during cerebral
   ischemia (Retracted article. See vol. 18, pg. 4767, 2018)
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article; Retracted Publication
DE cerebral ischemia; cerebral microvascular endothelial cell;
   proliferator-activated receptor gamma; baculoviral IAP repeat-containing
   5
ID PPAR-GAMMA; COLORECTAL-CANCER; SURVIVIN; APOPTOSIS; EXPRESSION;
   PROTECTS; INJURY; GENE; NEURONS; ISCHEMIA/REPERFUSION
AB Cerebral ischemia is a leading cause of ischemic stroke, which may lead to severe disability and mortality worldwide. There are some key factors concerned in cardioprotection, such as peroxisome proliferator-activated receptor gamma (PPAR gamma), a ligand binding transcription factor involved in various biological functions including atherosclerosis, vascular dysfunction and hypertension, and baculoviral IAP repeat-containing 5 (BIRC5), which may protect human brain endothelial cells from ischemia-induced apoptosis. To determine the potential roles of PPAR gamma in brain microvascular endothelial (bEnd.3) cells during cerebral ischemia and the relationship between PPAR gamma and BIRC5, a cerebral ischemia model was established with bEnd.3 cells cells by oxygen-glucose deprivation (OGD) treatment. OGD treatment reduced proliferation and enhanced apoptosis of bEnd.3 cells in a time-dependent manner. PPAR gamma expression levels were decreased in bEnd.3 cells following OGD treatment. Upregulation of PPAR gamma expression protected bEnd.3 cells from ischemia injury and also upregulated BIRC5 expression. PPAR gamma-specific binding sites in the BIRC5 promoter were predicted bioinformatically and verified by luciferase reporter experiments. Results from electrophoretic mobility shift/supershift and chromatin immunoprecipitation assays suggested that BIRC5 may be a novel target of PPAR gamma transcriptional regulation during ischemic injury. The present results indicated that PPAR gamma may serve a protective role on bEnd.3 cells and that BIRC5 may be a downstream target of PPAR gamma regulation during cerebral ischemia.
C1 [Xu, Mingjing; Zeng, Qing; He, He; Lu, Pengcheng; Huang, Guozhi] Southern Med Univ, Zhujiang Hosp, Dept Rehabil Med, 253 Gongye Rd, Guangzhou 510282, Guangdong, Peoples R China.
   [Xu, Mingjing] Guizhou Prov Peoples Hosp, Dept Rehabil Med, Guiyang 550002, Guizhou, Peoples R China.
   [Yang, Xianli] Guizhou Prov Peoples Hosp, Dept Med Qual Management, Guiyang 550002, Guizhou, Peoples R China.
RP Huang, GZ (reprint author), Southern Med Univ, Zhujiang Hosp, Dept Rehabil Med, 253 Gongye Rd, Guangzhou 510282, Guangdong, Peoples R China.
EM drhuang66@163.com
CR Arsenijevic D, 2006, J CEREBR BLOOD F MET, V26, P433, DOI 10.1038/sj.jcbfm.9600200
   Cao G, 2016, INT J MOL SCI, V17, pe1418
   Chen YC, 2012, MOL NEUROBIOL, V46, P114, DOI 10.1007/s12035-012-8259-8
   Chu SF, 2017, MOL NEUROBIOL, V54, P524, DOI 10.1007/s12035-015-9673-5
   Deng YY, 2016, NEUROCHEM INT, V96, P56, DOI 10.1016/j.neuint.2016.02.015
   Fiatte C, 2008, INT J MOL MED, V22, P825, DOI 10.3892/ijmm_00000091
   Fong WH, 2010, MOL NEUROBIOL, V41, P180, DOI 10.1007/s12035-010-8103-y
   Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375
   Gentil BJ, 2012, FASEB J, V26, P1194, DOI 10.1096/fj.11-196345
   Green David E, 2011, Pulm Circ, V1, P33
   Gupta D, 2008, J BIOL CHEM, V283, P32462, DOI 10.1074/jbc.M801813200
   Hamy AS, 2016, BREAST CANCER RES TR, V159, P499, DOI 10.1007/s10549-016-3961-2
   He F, 2012, EXP THER MED, V3, P613, DOI 10.3892/etm.2012.450
   Hussain AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039945
   Ketsawatsomkron P, 2015, CURR OPIN NEPHROL HY, V24, P123, DOI 10.1097/MNH.0000000000000103
   Lamers F, 2011, ENDOCR-RELAT CANCER, V18, P657, DOI 10.1530/ERC-11-0207
   Li PL, 2015, CARCINOGENESIS, V36, P1484, DOI 10.1093/carcin/bgv145
   Li YN, 2014, J NEUROCHEM, V129, P120, DOI 10.1111/jnc.12611
   Liu N, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-105
   Liu ZJ, 2014, J NEUROSCI RES, V92, P1549, DOI 10.1002/jnr.23438
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu ML, 2005, J BIOL CHEM, V280, P6742, DOI 10.1074/jbc.M411519200
   Ma XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079584
   Mysiorek C, 2009, CURR NEUROVASC RES, V6, P181, DOI 10.2174/156720209788970081
   Pan QW, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0243-1
   Romera C, 2007, J CEREBR BLOOD F MET, V27, P1327, DOI 10.1038/sj.jcbfm.9600438
   Sun H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041716
   Wang HY, 2014, J SURG ONCOL, V109, P574, DOI 10.1002/jso.23526
   Wang Q, 2012, INT J ONCOL, V41, P652, DOI 10.3892/ijo.2012.1471
   Wang Y, 2014, INT J MOL MED, V34, P262, DOI 10.3892/ijmm.2014.1774
   Wu JS, 2016, MOL NEUROBIOL, V53, P3626, DOI 10.1007/s12035-015-9294-z
   Wu JS, 2009, CIRCULATION, V119, P1124, DOI 10.1161/CIRCULATIONAHA.108.812537
   Xu F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055080
   Yamashita-Sugahara Y, 2013, J BIOL CHEM, V288, P4522, DOI 10.1074/jbc.M112.440792
   Yin KJ, 2010, J NEUROSCI, V30, P6398, DOI 10.1523/JNEUROSCI.0780-10.2010
   Zeng Y, 2012, BRAIN RES, V1452, P140, DOI 10.1016/j.brainres.2012.02.063
   Zhang YH, 2005, J CEREBR BLOOD F MET, V25, P868, DOI 10.1038/sj.jcbfm.9600081
   Zhang Y, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00079
   Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006
   Zhou YL, 2013, BBA-GEN SUBJECTS, V1830, P4160, DOI 10.1016/j.bbagen.2013.03.029
NR 40
TC 1
Z9 1
U1 2
U2 6
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD DEC
PY 2017
VL 16
IS 6
BP 8882
EP 8890
DI 10.3892/mmr.2017.7750
PG 9
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA FQ3AM
UT WOS:000418229200130
PM 29039513
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Jun, SY
AF Jun, Soo Young
TI RETRACTED: The Mediating Effect of Social Capital on the Relationship
   Between Public Health Managers' Transformational Leadership and Public
   Health Nurses' Organizational Empowerment in Korea Public Health
   (Retracted article. See vol.12, pg.155, 2018)
SO ASIAN NURSING RESEARCH
LA English
DT Article; Retracted Publication
DE empowerment; leadership; nurse; social capital
ID COMMUNITY
AB Purpose: This study was to verify the effect of public health nurse's (PHN's) social capital on the relationship between public health manager's (PHM's) transformational leadership and PHN's organizational empowerment in Korea public health.
   Methods: This was a cross-sectional descriptive study involving 303 PHNs from public health centers in Daegu and Gyeongsangbuk-do cities in South Korea. Data were collected from February 29, 2016 to April 8, 2016, using structured questionnaires which included general characteristics, transformational leadership, organizational empowerment, and social capital. Data were analyzed using descriptive statistics, correlations, and structural equation model.
   Results: PHM's transformational leadership has a positive effect on PHN's social capital and PHN's organizational empowerment. Social capital had a mediating effect between transformational leadership and organizational empowerment in PHNs.
   Conclusion: This study suggests that PHM's transformational leadership is a contributing factor to improve PHN's organizational empowerment, and transformational leadership can lead to improve PHN's organizational empowerment through PHN's social capital. So, an intervention program to promote organizational empowerment should include strategies to enhance PHM's transformational leadership as well as to improve PHN's social capital. (c) 2017 Korean Society of Nursing Science, Published by Elsevier Korea LLC.
C1 [Jun, Soo Young] Kyungpook Natl Univ, Coll Nursing, 680 Kukchaeborangro, Daegu 41944, South Korea.
RP Jun, SY (reprint author), Kyungpook Natl Univ, Coll Nursing, 680 Kukchaeborangro, Daegu 41944, South Korea.
EM sy0340@naver.com
CR Al-Sawai Abdulaziz, 2013, Oman Med J, V28, P285, DOI 10.5001/omj.2013.79
   Andrews R, 2011, POLIT RES QUART, V64, P938, DOI 10.1177/1065912910381649
   Bass BM, 1990, TRANSFORMATIONAL LEA, P1
   BENTLER PM, 1987, SOCIOL METHOD RES, V16, P78, DOI 10.1177/0049124187016001004
   Cai CF, 2011, INT NURS REV, V58, P138, DOI 10.1111/j.1466-7657.2010.00848.x
   Choi HG, 2016, J KOREAN ACAD NURS, V46, P100, DOI 10.4040/jkan.2016.46.1.100
   Choi SL, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0171-2
   DeVivo D, 2013, J EMERG NURS, V39, P529, DOI 10.1016/j.jen.2010.10.011
   Doody Owen, 2012, Br J Nurs, V21, P1212
   Frances AM, 2013, COMMUNITY PUBLIC HLT, P45
   Gillet N, 2014, HUM RESOUR DEV Q, V25, P321, DOI 10.1002/hrdq.21192
   Griffith DM, 2008, AM J PREV MED, V34, pS89, DOI 10.1016/j.amepre.2007.12.015
   Hamidreza B, 2012, IRAN WORLD APPL SCI, V17, P119
   Hammer A, 2012, J PUBLIC HEALTH MAN, V18, P175, DOI 10.1097/PHH.0b013e31823dea94
   Han J, 2013, J KOREAN ACAD NURS, V43, P517, DOI 10.4040/jkan.2013.43.4.517
   Hean Sarah, 2013, Nurs Child Young People, V25, P19
   Kim Daewon, 2011, [Health and Social Welfare Review, 보건사회연구], V31, P206
   Kim H, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1111/CHS0.12019
   Laschinger HKS, 2013, J NURS MANAGE, V21, P541, DOI 10.1111/j.1365-2834.2012.01375.x
   Laschinger HKS, 2010, J NURS MANAGE, V18, P4, DOI 10.1111/j.1365-2834.2009.01046.x
   Laschinger HKS, 2001, NURS ECON, V19, P42
   Oh Eun Hee, 2011, [Journal of Korean Academy of Nursing Administration, 간호행정학회지], V17, P391
   Putnam R.D., 1993, MAKING DEMOCRACY WOR, P163
   Read EA, 2014, J ADV NURS, V70, P997, DOI 10.1111/jan.12251
   김순구, 2016, [Journal of Korea Academia-Industrial cooperation Society, 한국산학기술학회논문지], V17, P282, DOI 10.5762/KAIS.2016.17.2.282
   Sheingold BH, 2012, WORLD MED HEALTH POL, V4, DOI 10.1515/1948-4682.1212
   Smith Mary Atkinson, 2011, Nurs Manage, V42, P44, DOI 10.1097/01.NUMA.0000403279.04379.6a
   Sung TG, 2006, RES METHODOLOGY, P156
NR 28
TC 1
Z9 1
U1 2
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1976-1317
EI 2093-7482
J9 ASIAN NURS RES
JI Asian Nurs. Res.
PD DEC
PY 2017
VL 11
IS 4
BP 246
EP 252
DI 10.1016/j.anr.2017.08.006
PG 7
WC Nursing
SC Nursing
GA FR4BR
UT WOS:000419011100002
PM 29290271
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Ma, JH
   Li, XX
   Wang, Y
   Yang, ZW
   Luo, J
AF Ma, Junhao
   Li, Xinxi
   Wang, Yang
   Yang, Zhenwei
   Luo, Jun
TI RETRACTED: Rivaroxaban attenuates thrombosis by targeting the NF-kappa B
   signaling pathway in a rat model of deep venous thrombus (Retracted
   article. See vol. 41, pg. 3736, 2018)
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article; Retracted Publication
DE rivaroxaban; matrix metalloproteinase-9; deep venous thrombus; nuclear
   factor-kappa B
ID ACTIVATABLE FIBRINOLYSIS INHIBITOR; CATHETER-DIRECTED THROMBOLYSIS;
   CARDIOVASCULAR-DISEASE; VEIN THROMBOSIS; RISK-FACTORS;
   DIABETES-MELLITUS; PLASMA; INFLAMMATION; POLYMORPHISM; METAANALYSIS
AB Anticoagulant therapy is commonly used for the prevention and treatment of patients with deep venous thrombus. Evidence has shown that rivaroxaban is a potential oral anticoagulant drug for the acute treatment of venous thromboembolism. However, the rivaroxaban-mediated molecular mechanism involved in the progression of deep venous thrombosis has not been investigated. In the present study, we investigated the efficacy of rivaroxaban and the underlying signaling pathways in the prevention and treatment of rats with deep venous thrombosis. A rat model with deep vein thrombus formation was established and received treatment with rivaroxaban or PBS as control. The thrombin-activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor-1 (PAI-1) were analyzed both in vitro and in vivo. The progression of thrombosis and stroke was evaluated after treatment with rivaroxaban or PBS. Nuclear factor-kappa B (NF-kappa B) signaling pathway in venous endothelial cells and in the rat model of deep venous thrombus was assessed. The therapeutic effects of rivaroxaban were evaluated as determined by changes in deep venous thrombosis in the rat model. Our results showed that rivaroxaban markedly inhibited TAFI and PAI-1 expression levels, neutrophils, tissue factor, neutrophil extracellular traps (NETs), myeloperoxidase and macrophages in venous endothelial cells and in the rat model of deep venous thrombus. Expression levels of ADP, PAIs, von Willebrand factor (vWF) and thromboxane were downregulated in vein endothelial cells and in serum from the experimental rats. Importantly, the incidences of inferior vena cava filter thrombus were protected by rivaroxaban during heparin-induced thrombolysis deep venous thrombosis in the rat model. We observed that activity of the NF-kappa B signaling pathway was inhibited by rivaroxaban in vein endothelial cells both in vitro and in vivo. Notably, immunohistology indicated that rivaroxaban attenuated deep venous thrombosis and the accumulation of inflammatory factors in the lesions in venous thrombus. Matrix metalloproteinase (MMP) expression and activity were downregulated in rivaroxabantreated rats with deep venous thrombus. Rivaroxaban inhibited the elasticity of the extracellular matrix and collagen-elastin fibers. On the whole, these results indicate that rivaroxaban attenuates deep venous thrombus through MMP-9-mediated NF-kappa B signaling pathway.
C1 [Ma, Junhao; Li, Xinxi; Wang, Yang; Yang, Zhenwei; Luo, Jun] Xinjiang Med Univ, Affiliated Hosp 1, Dept Blood Vessels Thyroid Surg, 1 Liyu Mt Rd, Urumqi 830000, Xinjiang, Peoples R China.
RP Luo, J (reprint author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Blood Vessels Thyroid Surg, 1 Liyu Mt Rd, Urumqi 830000, Xinjiang, Peoples R China.
EM luojunprofessor@yeah.net
FU National Science Foundation of China [81570515]
FX This study was supported by the National Science Foundation of China
   (no. 81570515).
CR Aziz F, 2012, EUR J VASC ENDOVASC, V44, P210, DOI 10.1016/j.ejvs.2012.04.016
   Bavbek N, 2014, RENAL FAILURE, V36, P743, DOI 10.3109/0886022X.2014.886935
   Bhaskar S, 2016, CELL IMMUNOL, V310, P131, DOI 10.1016/j.cellimm.2016.08.011
   Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022
   Cheung YW, 2016, THROMB HAEMOSTASIS, V116, P733, DOI 10.1160/TH16-01-0041
   Chu NF, 2001, ATHEROSCLEROSIS, V157, P495, DOI 10.1016/S0021-9150(00)00755-3
   Chuchalin A G, 2015, Klin Med (Mosk), V93, P18
   Comerota AJ, 2007, EUR J VASC ENDOVASC, V33, P351, DOI 10.1016/j.ejvs.2006.11.013
   Deitelzweig S, 2016, CLIN THER, V38, P1803, DOI 10.1016/j.clinthera.2016.07.002
   Dewyer NA, 2007, J SURG RES, V142, P357, DOI 10.1016/j.jss.2007.03.064
   Dirani M, 2014, EPILEPSY BEHAV CASE, V2, P164, DOI 10.1016/j.ebcr.2014.09.003
   Dong Dian-ning, 2013, Zhonghua Yi Xue Za Zhi, V93, P1611
   Dubis J, 2014, BLOOD COAGUL FIBRIN, V25, P226, DOI 10.1097/MBC.0000000000000028
   Gao MY, 2014, PHARMACOL REP, V66, P480, DOI 10.1016/j.pharep.2013.12.004
   Garcia-Trapero J, 2004, NEUROL RES, V26, P816, DOI 10.1179/016164104X5110
   Hartweg J, 2007, DIABETOLOGIA, V50, P250, DOI 10.1007/s00125-006-0486-y
   Hashikata T, 2015, INT HEART J, V56, P544, DOI 10.1536/ihj.15-112
   Heineking B, 2003, PEDIATR INT, V45, P93, DOI 10.1046/j.1442-200X.2003.01658.x
   Hilbers FSM, 2012, RADIOTHER ONCOL, V102, P115, DOI 10.1016/j.radonc.2011.10.017
   JuhanVague I, 1996, ANN MED, V28, P371, DOI 10.3109/07853899608999095
   Kolbel T, 2008, J ENDOVASC THER, V15, P605, DOI 10.1583/08-2462.1
   Lee KW, 2005, THROMB HAEMOSTASIS, V94, P1077, DOI 10.1160/TH05-03-0179
   Li YD, 2009, J BIOL CHEM, V284, P4473, DOI 10.1074/jbc.M806010200
   Lichy C, 2007, J NEUROL, V254, P1124, DOI 10.1007/s00415-006-0417-3
   Malaponte G, 2013, CYTOKINE, V62, P64, DOI 10.1016/j.cyto.2013.02.017
   Massberg S, 2003, J EXP MED, V197, P41, DOI 10.1084/jem.20020945
   Meissner MH, 2012, J VASC SURG, V55, P1449, DOI 10.1016/j.jvs.2011.12.081
   Mutch NJ, 2003, J THROMB HAEMOST, V1, P2000, DOI 10.1046/j.1538-7836.2003.00383.x
   Naderi M, 2014, HAEMOPHILIA, V20, pE89, DOI 10.1111/hae.12287
   Nosaka M, 2010, INT J LEGAL MED, V124, P439, DOI 10.1007/s00414-010-0484-y
   Nuutila J, 2007, J IMMUNOL METHODS, V328, P189, DOI 10.1016/j.jim.2007.09.002
   Oztuzcu S, 2014, MOL BIOL REP, V41, P3671, DOI 10.1007/s11033-014-3231-5
   Pacheco YM, 2006, AM J CLIN NUTR, V84, P342
   Plug T, 2015, J THROMB HAEMOST, V13, P1081, DOI 10.1111/jth.12900
   Ringelstein M, 2012, J NEUROL, V259, P2287, DOI 10.1007/s00415-012-6477-7
   Samos M, 2016, J CARDIOVASC PHARM, V68, P391, DOI 10.1097/FJC.0000000000000421
   Santin BJ, 2015, J VASC SURG-VENOUS L, V3, P184, DOI 10.1016/j.jvsv.2014.08.004
   Sevuk U, 2015, INDIAN J HEMATOL BLO, V31, P71, DOI 10.1007/s12288-014-0365-5
   Shah PK, 2006, REV CARDIOVASC MED, V7, P10
   Sharifi M, 2012, J ENDOVASC THER, V19, P273, DOI 10.1583/11-3674MR.1
   Sherif EM, 2014, BLOOD COAGUL FIBRIN, V25, P451, DOI 10.1097/MBC.0000000000000080
   Shi J, 2014, THROMB RES, V134, P610, DOI 10.1016/j.thromres.2014.06.023
   Shlebak A, 2016, J CLIN PATHOL, V69, P337, DOI 10.1136/jclinpath-2015-203077
   Terry CM, 2016, THROMB RES, V144, P106, DOI 10.1016/j.thromres.2016.06.008
   Tsantes AE, 2007, THROMB HAEMOSTASIS, V97, P907, DOI 10.1160/TH06-12-0745
   Vucic N, 2005, COLLEGIUM ANTROPOL, V29, P643
   Wai-Hoe L, 2009, BIOL PROCED ONLINE, V11, P145, DOI 10.1007/s12575-009-9007-y
   Wan HB, 2016, BLOOD COAGUL FIBRIN, V27, P882, DOI 10.1097/MBC.0000000000000509
   Zhai KF, 2015, THROMB HAEMOSTASIS, V114, P173, DOI 10.1160/TH14-10-0880
NR 49
TC 1
Z9 1
U1 6
U2 13
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD DEC
PY 2017
VL 40
IS 6
BP 1869
EP 1880
DI 10.3892/ijmm.2017.3166
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA FQ2ZJ
UT WOS:000418226300026
PM 29039441
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Zhang, WJ
   He, W
   Gao, JF
   Wang, YY
   Zang, WQ
   Dong, ZM
   Zhao, GQ
AF Zhang, Wenjing
   He, Wei
   Gao, Jianfeng
   Wang, Yuanyuan
   Zang, Wenqiao
   Dong, Ziming
   Zhao, Guoqiang
TI RETRACTED: The long noncoding RNA CASC2 inhibits tumorigenesis through
   modulating the expression of PTEN by targeting miR-18a-5p in esophageal
   carcinoma (Retracted article. See vol. 369, pg. 176, 2018)
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article; Retracted Publication
DE Long noncoding RNA CASC2; Esophageal carcinoma; miR-18a-5p; PTEN
ID SQUAMOUS-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; ENDOMETRIAL CANCER;
   PROLIFERATION; STATISTICS; APOPTOSIS; PATHWAY; HOTAIR; MIR-21; WORLD
AB Abundant evidence indicates that long noncoding RNAs (lncRNAs) play an important role in various cellular processes, tumorigenesis, and the development of cancer. An increasing number studies are exploring this lncRNA-mediated mechanism. CASC2 is a novel gene in lncRNAs, located at chromosome 10q26. The present study aimed to examine the expression of lncRNA CASC2 in esophageal carcinoma (EC) tissue and to explore the effect of the upregulation of CASC2 on EC cell lines and specific regulatory mechanisms. We found the expression of CASC2 to be significantly downregulated in EC tissues and EC cell lines; moreover, low expression of CACS2 was associated with advanced TNM stage and lymph node metastases. Furthermore, upregulation of CASC2 significantly inhibited the proliferation of EC cells both in vitro and in vivo as well as their invasion in vitro; it also induced the apoptosis of EC9706 and EC1 cells. Additional experiments indicated that CASC2 interacted directly with miR-18a-5p, and there was a negative correlation between miR-18a-5p and CASC2 in EC tissues. We also found that miR-18a-5p directly targeted PTEN, a tumor suppressor gene, and could downregulate the protein expression of PTEN. Our experiments suggest that CASC2, acting as a competing endogenous RNAs (ceRNAs) of miR-18a-5p, exerts its biological effects by modulating the expression of PTEN. These findings indicate that the CASC2-miR-18a-5p-PTEN axis may be a novel target for further studies aimed at the prevention and treatment of EC.
C1 [Zhang, Wenjing; Gao, Jianfeng] Henan Univ Chinese Med, Sch Basic Med Sci, Zhengzhou 450046, Henan, Peoples R China.
   [He, Wei] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Henan, Peoples R China.
   [Wang, Yuanyuan; Zang, Wenqiao; Dong, Ziming; Zhao, Guoqiang] Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou 450001, Henan, Peoples R China.
   [Dong, Ziming; Zhao, Guoqiang] Collaborat Innovat Ctr Canc Chemoprevent, Zhengzhou, Henan, Peoples R China.
RP Zhang, WJ (reprint author), Henan Univ Chinese Med, Sch Basic Med Sci, Zhengzhou 450046, Henan, Peoples R China.; Zhao, GQ (reprint author), Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou 450001, Henan, Peoples R China.
EM sxsophia@163.com; zhaogq@zzu.edu.cn
FU Education Agency of Henan [13A310671]
FX The authors are grateful to all staff at the study center who
   contributed to this study. This study was supported by a grant from the
   Education Agency of Henan (No. 13A310671).
CR Baldinu P, 2004, HUM MUTAT, V23, P318, DOI 10.1002/humu.20015
   Baldinu P, 2007, ANTICANCER RES, V27, P235
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   Choi BH, 2017, EXP HEMATOL ONCOL, V6, DOI 10.1186/s40164-017-0079-0
   Clark MB, 2011, SEMIN CELL DEV BIOL, V22, P366, DOI 10.1016/j.semcdb.2011.01.001
   Di Gesualdo F, 2014, ONCOTARGET, V5, P10976
   Ding XY, 2015, TUMOR BIOL, V36, P4017, DOI 10.1007/s13277-015-3411-5
   Groblewska M, 2012, FOLIA HISTOCHEM CYTO, V50, P12, DOI [10.5603/FHC.2012.0002, 10.2478/18691]
   Hajjari M, 2015, CANCER BIOL MED, V12, P1, DOI 10.7497/j.issn.2095-3941.2015.0006
   He XZ, 2016, TUMOR BIOL, V37, P9503, DOI 10.1007/s13277-016-4787-6
   Izzo JG, 2006, J CLIN ONCOL, V24, P748, DOI 10.1200/JCO.2005.03.8810
   Khalid A., 2017, TUMOR BIOL, V39
   Li CH, 2013, INT J BIOCHEM CELL B, V45, P1895, DOI 10.1016/j.biocel.2013.05.030
   Li P, 2013, DIGEST DIS SCI, V58, P3483, DOI 10.1007/s10620-013-2854-z
   Lu KH, 2013, BMC CANC, V13, P461
   Ma LL, 2016, BIOMED PHARMACOTHER, V81, P491, DOI 10.1016/j.biopha.2016.04.006
   Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003
   Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521
   Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646
   Pan F, 2017, ONCOTARGET, V8, P5735, DOI 10.18632/oncotarget.13902
   Qi P, 2013, MODERN PATHOL, V26, P155, DOI 10.1038/modpathol.2012.160
   Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530
   Shahryari A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00196
   Shen W, 2017, EUR REV MED PHARMACO, V21, P2596
   Silva A, 2015, CANCERS, V7, P2169, DOI 10.3390/cancers7040884
   Sun MM, 2012, J INT MED RES, V40, P2098, DOI 10.1177/030006051204000607
   Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614
   Tang JW, 2015, ONCOTARGET, V6, P4505, DOI 10.18632/oncotarget.2934
   Tao H, 2016, RESP MED, V110, P12, DOI 10.1016/j.rmed.2015.10.006
   Tian DD, 2017, ONCOL REP, V37, P2795, DOI 10.3892/or.2017.5560
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Wang GX, 2016, BRIEF FUNCT GENOMICS, V15, P222, DOI 10.1093/bfgp/elv049
   Wang P, 2015, CELL SIGNAL, V27, P275, DOI 10.1016/j.cellsig.2014.11.011
   Wang YF, 2016, TRENDS GENET, V32, P211, DOI 10.1016/j.tig.2016.02.001
   Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909
   Xu XL, 2014, ANN THORAC SURG, V97, P1037, DOI 10.1016/j.athoracsur.2013.10.042
   Yang X, 2015, CANCER LETT, V360, P119, DOI 10.1016/j.canlet.2015.02.035
   Yarmishyn AA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00145
   Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241
   Yu X, 2015, MOL MED REP, V12, P5611, DOI 10.3892/mmr.2015.4161
   Zang W, 2015, CANCER GENE THER, V22, P138, DOI 10.1038/cgt.2014.77
   Zang WQ, 2016, ONCOTARGET, V7, P19960, DOI 10.18632/oncotarget.6963
   Zhang WG, 2016, BIOCHEM BIOPH RES CO, V477, P144, DOI 10.1016/j.bbrc.2016.06.034
   Zheng ZM, 2017, MED SCI MONITOR, V23, P1277, DOI 10.12659/MSM.900092
   Zhou GY, 2016, AM J TRANSL RES, V8, P496
NR 47
TC 13
Z9 14
U1 7
U2 15
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD DEC 1
PY 2017
VL 361
IS 1
BP 30
EP 38
DI 10.1016/j.yexcr.2017.09.037
PG 9
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA FP5MG
UT WOS:000417663000004
PM 28964779
DA 2018-12-27
ER

PT J
AU Kern, JK
   Geier, DA
   Deth, RC
   Sykes, LK
   Hooker, BS
   Love, JM
   Bjorklund, G
   Chaigneau, CG
   Haley, BE
   Geier, MR
AF Kern, Janet K.
   Geier, David A.
   Deth, Richard C.
   Sykes, Lisa K.
   Hooker, Brian S.
   Love, James M.
   Bjorklund, Geir
   Chaigneau, Carmen G.
   Haley, Boyd E.
   Geier, Mark R.
TI RETRACTED: Systematic Assessment of Research on Autism Spectrum Disorder
   (ASD) and Mercury Reveals Conflicts of Interest and the Need for
   Transparency in Autism Research (Retracted article. See vol. 23, pg.
   1689, 2017)
SO SCIENCE AND ENGINEERING ETHICS
LA English
DT Review; Retracted Publication
DE Conflict of interest; Transparency; Autism; Mercury; Toxins; Autism; ASD
ID THIMEROSAL-CONTAINING VACCINES; NEURODEVELOPMENTAL DISORDERS;
   HEAVY-METALS; PINK DISEASE; GENE-EXPRESSION; UNITED-STATES; HAIR
   MERCURY; RISK-FACTOR; CHILDREN; EXPOSURE
AB Historically, entities with a vested interest in a product that critics have suggested is harmful have consistently used research to back their claims that the product is safe. Prominent examples are: tobacco, lead, bisphenol A, and atrazine. Research literature indicates that about 80-90% of studies with industry affiliation found no harm from the product, while only about 10-20% of studies without industry affiliation found no harm. In parallel to other historical debates, recent studies examining a possible relationship between mercury (Hg) exposure and autism spectrum disorder (ASD) show a similar dichotomy. Studies sponsored and supported by industry or entities with an apparent conflict of interest have most often shown no evidence of harm or no "consistent" evidence of harm, while studies without such affiliations report positive evidence of a Hg/autism association. The potentially causal relationship between Hg exposure and ASD differs from other toxic products since there is a broad coalition of entities for whom a conflict of interest arises. These include influential governmental public health entities, the pharmaceutical industry, and even the coal burning industry. This review includes a systematic literature search of original studies on the potential relationship between Hg and ASD from 1999 to August 2015, finding that of the studies with public health and/or industry affiliation, 86% reported no relationship between Hg and ASD. However, among studies without public health and/or industry affiliation, only 21% find no relationship between Hg and ASD. The discrepancy in these results suggests a bias indicative of a conflict of interest.
C1 [Kern, Janet K.; Geier, David A.; Geier, Mark R.] Inst Chron Illnesses Inc, 14 Redgate Court, Silver Spring, MD 20905 USA.
   [Deth, Richard C.] Nova Southeastern Univ, Ft Lauderdale, FL USA.
   [Sykes, Lisa K.; Love, James M.; Chaigneau, Carmen G.] CoMeD Inc, Silver Spring, MD USA.
   [Hooker, Brian S.] Simpson Univ, Redding, CA USA.
   [Bjorklund, Geir] Council Nutr & Environm Med, Mo I Rana, Norway.
   [Haley, Boyd E.] Univ Kentucky, Lexington, KY USA.
RP Kern, JK (reprint author), Inst Chron Illnesses Inc, 14 Redgate Court, Silver Spring, MD 20905 USA.
EM jkern@dfwair.net; davidallengeier@comcast.net; rdeth@nova.edu;
   syklone5@verizon.net; bhooker@simpsonu.edu; jlove@titushillis.com;
   bjorklund@conem.org; mamadelchinito@gmail.com; behaley@ctiscience.com;
   mgeier@comcast.net
FU Institute of Chronic Illnesses, Inc.; CoMeD, Inc.
FX This study was supported by the non-profit 501(c)(3) Institute of
   Chronic Illnesses, Inc., and the non-profit 501(c)(3) CoMeD, Inc.
CR Abdullah MM, 2012, J AUTISM DEV DISORD, V42, P929, DOI 10.1007/s10803-011-1318-6
   Adams JB, 2007, J TOXICOL ENV HEAL A, V70, P1046, DOI 10.1080/15287390601172080
   Adams JB, 2013, BIOL TRACE ELEM RES, V151, P171, DOI 10.1007/s12011-012-9551-1
   Alabdali A, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-14
   Albizzati A, 2012, MINERVA PEDIATR, V64, P27
   Andrews N, 2004, PEDIATRICS, V114, P584, DOI 10.1542/peds.2003-1177-L
   Association of American Physicians and Surgeons Inc, 2005, SEL VACC AUTH CDC FD
   Barnoya J, 2006, EUR J PUBLIC HEALTH, V16, P69, DOI 10.1093/eurpub/cki044
   Bernard S, 2004, JAMA-J AM MED ASSOC, V291, P180, DOI 10.1001/jama.291.2.180-b
   Biamonte F, 2014, NEUROTOXICOLOGY, V45, P67, DOI 10.1016/j.neuro.2014.09.006
   Bjorklund G, 1995, J ORTHOMOL MED, V10, P145
   Blanchard K. Stephen, 2011, Reviews on Environmental Health, V26, P111, DOI 10.1515/REVEH.2011.015
   Blaucok-Busch Eleonor, 2012, Maedica (Buchar), V7, P214
   Blaurock-Busch Eleonor, 2012, Maedica (Buchar), V7, P38
   Blaurock-Busch Eleonor, 2011, Maedica (Buchar), V6, P247
   Boone MD, 2014, BIOSCIENCE, V64, P917, DOI 10.1093/biosci/biu138
   BRADSTREET J, 2003, J AM PHYS SURG, V8, P76
   Brandt AM, 2012, AM J PUBLIC HEALTH, V102, P63, DOI 10.2105/AJPH.2011.300292
   Braun KVN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124120
   Bridbord K, 2009, ENVIRON HEALTH PERSP, V117, P1195, DOI 10.1289/ehp.0800534
   Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x
   Burbacher TM, 2005, ENVIRON HEALTH PERSP, V113, P1015, DOI 10.1289/ehp.7712
   Burton D. O, 2003, US C REPORT MERCURY, pE1011
   Cech TR, 2003, SHARING PUBLICATION
   Cozzarelli NR, 2004, P NATL ACAD SCI USA, V101, P3721, DOI 10.1073/pnas.0400437101
   Cozzarelli NR, 2001, P NATL ACAD SCI USA, V98, P8159, DOI 10.1073/pnas.171309098
   Cummings KM, 2007, CANCER EPIDEM BIOMAR, V16, P1070, DOI 10.1158/1055-9965.EPI-06-0912
   Dally A, 1997, SOC HIST MED, V10, P291, DOI 10.1093/shm/10.2.291
   DATHAN JG, 1965, BMJ-BRIT MED J, V1, P1181, DOI 10.1136/bmj.1.5443.1181
   De Palma G, 2012, J AUTISM DEV DISORD, V42, P342, DOI 10.1007/s10803-011-1245-6
   DeSoto MC, 2010, ACTA NEUROBIOL EXP, V70, P165
   DeSoto MC, 2012, J ENV PROT, V3, P1579, DOI DOI 10.4236/JEP.2012.311174
   DeSoto NC, 2007, J CHILD NEUROL, V22, P1308, DOI 10.1177/0883073807307111
   Dickerson AS, 2015, SCI TOTAL ENVIRON, V536, P245, DOI 10.1016/j.scitotenv.2015.07.024
   Encyclopedia of the Earth, 2009, MINAMATA DIS
   Evaluate&TRADE, 2012, KEDR GROUP ACQ RHOG
   Fido A, 2005, AUTISM, V9, P290, DOI 10.1177/1362361305053255
   Friedman L, 2005, INT J OCCUP ENV HEAL, V11, P205
   Gallagher CM, 2010, J TOXICOL ENV HEAL A, V73, P1665, DOI 10.1080/15287394.2010.519317
   Geier D.A., 2014, J BIOCH PHARM RES, V2, P64
   Geier DA, 2005, MED SCI MONITOR, V11, pCR160
   Geier DA, 2004, MED SCI MONITOR, V10, pPI33
   GEIER DA, 2013, TRANSL NEURODEGENER, V2
   Geier DA, 2008, NEUROENDOCRINOL LETT, V29, P272
   Geier DA, 2007, J MATERN-FETAL NEO M, V20, P385, DOI 10.1080/14767050701228057
   Geier DA, 2007, J TOXICOL ENV HEAL A, V70, P837, DOI 10.1080/15287390701212141
   Geier DA, 2006, J TOXICOL ENV HEAL A, V69, P1481, DOI 10.1080/15287390500364556
   Geier David A, 2003, Pediatr Rehabil, V6, P97, DOI 10.1080/1363849031000139315
   Geier DA, 2015, BIOL TRACE ELEM RES, V163, P28, DOI 10.1007/s12011-014-0169-3
   Geier DA, 2014, INT J ENV RES PUB HE, V11, P9156, DOI 10.3390/ijerph110909156
   Geier DA, 2012, INT J ENV RES PUB HE, V9, P4486, DOI 10.3390/ijerph9124486
   Geier DA, 2010, ACTA NEUROBIOL EXP, V70, P177
   Geier DA, 2009, ACTA NEUROBIOL EXP, V69, P189
   Geier MR, 2003, EXP BIOL MED, V228, P660
   Grist, 2004, RHOD ISL LAWS PINP L
   Gross R, 2015, TRANSPARENCY RES REP
   Halsey N. A., 1999, COMMUNICATION
   HANSON M, 1991, EXPERIENTIA, V47, P9, DOI 10.1007/BF02041243
   Hayes TB, 2004, BIOSCIENCE, V54, P1138, DOI 10.1641/0006-3568(2004)054[1138:TINDTD]2.0.CO;2
   Hertz-Picciotto I, 2010, ENVIRON HEALTH PERSP, V118, P161, DOI 10.1289/ehp.0900736
   Hodgson NW, 2014, EXP BIOL MED, V239, P697, DOI 10.1177/1535370214527900
   Holmes AS, 2003, INT J TOXICOL, V22, P277, DOI 10.1080/10915810390220054
   Hviid A, 2003, JAMA-J AM MED ASSOC, V290, P1763, DOI 10.1001/jama.290.13.1763
   Institute of Medicine, 2005, I MED REP VACC SAF R
   Ip P, 2004, J CHILD NEUROL, V19, P431, DOI 10.1177/088307380401900606
   James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926
   Keim B, 2007, EPA SILENT AIR POLLU
   KESSLER DA, 2001, QUESTION INTENT GREA
   Khan A, 2014, J PHYSIOL PHARMACOL, V65, P257
   LAKSHMI P, 2011, BIOL TRACE ELEM RES, V142, P148, DOI DOI 10.1007/S12011-010-8766-2
   Lenzer J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2362
   Levine J, 2003, AM J PUBLIC HEALTH, V93, P664, DOI 10.2105/AJPH.93.4.664
   Lewandowski TA, 2009, J TOXICOL ENV HEAL A, V72, P1592, DOI 10.1080/15287390903232483
   Macedoni-Luksic M, 2015, BIOL TRACE ELEM RES, V163, P2, DOI 10.1007/s12011-014-0121-6
   Madsen KM, 2003, PEDIATRICS, V112, P604, DOI 10.1542/peds.112.3.604
   Majewska MD, 2010, ACTA NEUROBIOL EXP, V70, P196
   Mars SG, 2008, AM J PUBLIC HEALTH, V98, P1793, DOI 10.2105/AJPH.2007.114124
   McComas KA, 2008, P NUTR SOC, V67, P428, DOI 10.1017/S0029665108008689
   McGarity T, 2008, BENDING SCI SPECIAL
   Michaels D, 2008, DOUBT IS THEIR PRODU
   Miles JH, 2007, AM J MED GENET A, V143A, P1397, DOI 10.1002/ajmg.a.31846
   Mooney C., 2006, REPUBLICAN WAR SCI
   Mostafa G. A, 2015, J CLIN CELL IMMUNOL, V6, P310, DOI [10.4172/2155-9899.1000310, DOI 10.4172/2155-9899.1000310]
   Mostafa GA, 2007, EGYPT J PEDIATR ALLE, V5, P55
   Mrozek-Budzyn Dorota, 2011, Przegl Epidemiol, V65, P491
   Obrenovich ME, 2011, BIOL TRACE ELEM RES, V144, P475, DOI 10.1007/s12011-011-9146-2
   Ong EK, 2001, AM J PUBLIC HEALTH, V91, P1749, DOI 10.2105/AJPH.91.11.1749
   Osterweil N, 2007, THIMEROSAL AUTISM LI
   Palmer RF, 2009, HEALTH PLACE, V15, P18, DOI 10.1016/j.healthplace.2008.02.001
   Palmer RF, 2006, HEALTH PLACE, V12, P203, DOI 10.1016/j.healthplace.2004.11.005
   Price CS, 2010, PEDIATRICS, V126, P656, DOI 10.1542/peds.2010-0309
   Put Children First, 2006, CHAPT 2 1999 2000
   Rahbar MH, 2013, NEUROTOX RES, V23, P22, DOI 10.1007/s12640-012-9321-z
   Roberts AL, 2013, ENVIRON HEALTH PERSP, V121, P978, DOI 10.1289/ehp.1206187
   Rose S, 2015, J TOXICOL, DOI 10.1155/2015/573701
   Sager P. R, 2004, NIAID STUDIES THIMER
   Sass J, 2006, ENVIRON HEALTH PERSP, V114, pA147, DOI 10.1289/ehp.114-a147b
   Schechter R, 2008, ARCH GEN PSYCHIAT, V65, P19, DOI 10.1001/archgenpsychiatry.2007.1
   Schick SF, 2007, TOB CONTROL, V16, P157, DOI 10.1136/tc.2006.017186
   Shandley K, 2011, J TOXICOL ENV HEAL A, V74, P1185, DOI 10.1080/15287394.2011.590097
   Sharpe MA, 2013, J TOXICOL, DOI 10.1155/2013/801517
   Singh VK, 2006, PEDIATR ALLERGY IMMU, V17, P291, DOI 10.1111/j.1399-3038.2005.00348.x
   Singh VK, 2004, J BIOMED SCI, V11, P607, DOI 10.1159/000079672
   Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1
   Smith N, 2014, SORRY BUT NOT SORRY
   Soden SE, 2007, CLIN TOXICOL, V45, P476, DOI 10.1080/15563650701338195
   Stamova B, 2011, NEUROTOX RES, V19, P31, DOI 10.1007/s12640-009-9137-7
   Stehr-Green P, 2003, AM J PREV MED, V25, P101, DOI 10.1016/S0749-3797(03)00113-2
   TAKEUCHI T, 1978, VIRCHOWS ARCH B, V27, P137
   Tong EK, 2007, CIRCULATION, V116, P1845, DOI 10.1161/CIRCULATIONAHA.107.715888
   Uno Y, 2015, VACCINE, V33, P2511, DOI 10.1016/j.vaccine.2014.12.036
   van Wijngaarden E, 2013, EPIDEMIOLOGY, V24, P651, DOI 10.1097/EDE.0b013e31829d2651
   Verstraeten T, 2003, PEDIATRICS, V112, P1039
   Verstraeten T., 2000, EP INT SERV ANN C FI, V49
   Vojdani A, 2003, INT J IMMUNOPATH PH, V16, P189, DOI 10.1177/039463200301600302
   vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713
   Walker SJ, 2006, NEUROTOXICOLOGY, V27, P685, DOI 10.1016/j.neuro.2006.06.003
   WARKANY J, 1948, LANCET, V254, P829
   Windham GC, 2006, ENVIRON HEALTH PERSP, V114, P1438, DOI 10.1289/ehp.9120
   Wright B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029547
   Yassa HA, 2014, ENVIRON TOXICOL PHAR, V38, P1016, DOI 10.1016/j.etap.2014.10.005
   Yasuda H, 2013, INT J ENV RES PUB HE, V10, P6027, DOI 10.3390/ijerph10116027
   Yau VM, 2014, ENVIRON RES, V133, P294, DOI 10.1016/j.envres.2014.04.034
   Young HA, 2008, J NEUROL SCI, V271, P110, DOI 10.1016/j.jns.2008.04.002
   Zhang L, 2007, ENVIRON INT, V33, P108, DOI 10.1016/j.envint.2006.06.022
NR 125
TC 4
Z9 5
U1 9
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1353-3452
EI 1471-5546
J9 SCI ENG ETHICS
JI Sci. Eng. Ethics
PD DEC
PY 2017
VL 23
IS 6
BP 1691
EP 1718
DI 10.1007/s11948-017-9983-2
PG 28
WC Ethics; Engineering, Multidisciplinary; History & Philosophy Of Science;
   Multidisciplinary Sciences; Philosophy
SC Social Sciences - Other Topics; Engineering; History & Philosophy of
   Science; Science & Technology - Other Topics; Philosophy
GA FO0LK
UT WOS:000416435700014
PM 29119411
OA Other Gold, Green Published
DA 2018-12-27
ER

PT J
AU Li, HG
   Zhou, ZG
AF Li, Honggang
   Zhou, Zhenggan
TI RETRACTED: Air-coupled ultrasonic signal processing method for detection
   Stomata defects in materials (Retracted article. See vol. 96, pg. 79,
   2018)
SO NDT & E INTERNATIONAL
LA English
DT Article; Retracted Publication
DE Air-coupled ultrasonic testing; Wavelet noise filtering; Pulse
   compression; Lithium battery
ID BATTERIES
AB In order to improve signal-to-noise ratio (SNR) of air-coupled ultrasonic signal in the detection Lithium Battery, and achieve detection of Stomata defects in this kind of materials, a new signal processing method is proposed. The new signal processed can effectively filter noise and significantly improve the amplitude of transmission signal. Furthermore, the selection principle of parameters for the new signal processing method is studied. Successful results are presented in Lithium Battery. An improvement in SNR up to 27.95 dB is attained compared with the original received signal. The quantitative accuracy of defects in C-scan image based on the new signal processing method is also very remarkable, and defects as small as Phi 3mm can be easily identified.
C1 [Li, Honggang; Zhou, Zhenggan] Beihang Univ, Sch Mech Engn & Automat, 37 Xueyuan Rd, Beijing 100191, Peoples R China.
   [Li, Honggang; Zhou, Zhenggan] CICAAE, Beijing 100191, Peoples R China.
RP Li, HG (reprint author), Beihang Univ, Sch Mech Engn & Automat, 37 Xueyuan Rd, Beijing 100191, Peoples R China.
EM Honggang_Li128@buaa.edu.cn
FU Fund of the Innovation Fund of Aerospace Science and Technology [CASC06]
FX This work has been supported by the Fund of the Innovation Fund of
   Aerospace Science and Technology [grant no.CASC06].
CR Abbate A, 1997, IEEE T ULTRASON FERR, V44, P14, DOI 10.1109/58.585186
   Abd-Elmoniem KZ, 2002, IEEE T BIO-MED ENG, V49, P997, DOI [10.1109/TBME.2002.1028423, 10.1109/TBME.2002.802051]
   Achim A, 2001, IEEE T MED IMAGING, V20, P772, DOI 10.1109/42.938245
   BASS HE, 1995, J ACOUST SOC AM, V97, P680, DOI 10.1121/1.412989
   Cao-Paz AM, 2010, SENSORS-BASEL, V10, P2587, DOI 10.3390/s100402587
   Doring J, 2012, J APPL PHYS, V112, DOI 10.1063/1.4759052
   DONOHO DL, 1995, IEEE T INFORM THEORY, V41, P613, DOI 10.1109/18.382009
   Gan TH, 2001, ULTRASONICS, V39, P181, DOI 10.1016/S0041-624X(00)00059-7
   Garcia-Rodriguez M, 2010, NDT&E INT, V43, P677, DOI 10.1016/j.ndteint.2010.07.005
   Garcia-Rodriguez M, 2007, 19 INT C AC
   Hutchins D, 2014, ULTRASONICS, V54, P1745, DOI 10.1016/j.ultras.2014.03.007
   Kravchenko V F, 2008, Telecommunications and Radio Engineering, V67, P853, DOI 10.1615/TelecomRadEng.v67.i10.10
   Lei X, 2009, ULTRASOUND MED BIOL, V35, P94, DOI 10.1016/j.ultrasmedbio.2008.08.003
   Lu Y, 2009, 9 LASTED INT C WIR O
   Nelson J, 2012, J AM CHEM SOC, V134, P6337, DOI 10.1021/ja2121926
   Pallav P, 2007, IEEE T ULTRASON FERR, V54, P1530, DOI 10.1109/TUFFC.2007.423
   Zhou ZG, 2014, NONDESTRUCT TEST EVA, V29, P297, DOI 10.1080/10589759.2014.941840
NR 17
TC 1
Z9 1
U1 7
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0963-8695
EI 1879-1174
J9 NDT&E INT
JI NDT E Int.
PD DEC
PY 2017
VL 92
BP 167
EP 176
DI 10.1016/j.ndteint.2017.08.007
PG 10
WC Materials Science, Characterization & Testing
SC Materials Science
GA FM2KS
UT WOS:000414814300020
DA 2018-12-27
ER

PT J
AU Heylen, BC
AF Heylen, Brigitte C.
TI RETRACTED: Protecting marine top predators through adaptive and dynamic
   management (Retracted article. See vol. 92, pg. 148, 2018)
SO MARINE POLICY
LA English
DT Article; Retracted Publication
DE Marine conservation; Marine protected areas; No-take zones; Seabirds;
   African penguin; Spheniscus demersus
ID AFRICAN PENGUINS; SOUTH-AFRICA; BREEDING SUCCESS; CLIMATE-CHANGE;
   CONSERVATION; AREAS; FISHERIES; SEABIRDS; RESERVES; INDICATORS
AB Anthropogenic disturbances are altering the functioning and provisioning of marine ecosystem services, and as such, affect marine wildlife profoundly. A major problem in this context is resource competition between marine predators and fisheries. Marine protected areas (MPAs) can be a powerful tool to provide protection to predators and their prey; however, effective management strategies are required. A case study of African penguin conservation in South Africa was used to illustrate the benefits of embracing adaptive and dynamic management in the marine environment. The South African government plans to implement 22 new MPAs, which will maximise socio-economic benefits, while ensuring adequate ocean environmental protection. In Algoa Bay, the main purpose of the proposed MPA is to increase populations of the endangered African penguin Spheniscus demersus. We used the results of a seven-year experiment, in which purse-seine fisheries were closed around penguin colonies in that area, and concluded that the new MPA would provide a legal improvement to the current situation, but would not be sufficient to increase numbers of African penguin populations. For this, larger no take zones are necessary when prey availability is low. At the moment, ongoing acoustic surveys could provide recommendations on prey availability to design flexible MPA boundaries. More advanced surveys will be necessary in the future to allow for the MPA's criteria to be adapted, and fully benefit penguins and the coastal community. As such, this study illustrates the usefulness of an adaptive and dynamic management approach for the conservation of marine resources and endangered top predators.
C1 [Heylen, Brigitte C.] Univ Ghent, Dept Biol, Terr Ecol, KL Ledeganckstr 35, B-90006 Ghent, Belgium.
   [Heylen, Brigitte C.] Univ Antwerp, Dept Biol, Behav Ecol & Ecophysiol, Antwerp, Belgium.
RP Heylen, BC (reprint author), Univ Ghent, Dept Biol, Terr Ecol, KL Ledeganckstr 35, B-90006 Ghent, Belgium.
EM brigitte.heylen@ugent.be
RI Shen, ChengHan/D-1972-2018
CR Agardy M. T., 2010, OCEAN ZONING MAKING
   AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6
   Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583
   Attwood CG, 1997, S AFR J MARINE SCI, V18, P311
   Ballantine B., 1995, MAR PROT AREAS SUSTA
   BirdLife International, 2009, DES NETW MAR PROT AR
   Blamey LK, 2015, J MARINE SYST, V144, P9, DOI 10.1016/j.jmarsys.2014.11.006
   Boersma PD, 2008, BIOSCIENCE, V58, P597, DOI 10.1641/B580707
   Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104
   Burger J, 2004, ECOHEALTH, V1, P263, DOI [10.1007/s10393-004-0096-4, DOI 10.1007/S10393-004-0096-4]
   Chadwick P., 2014, WWF S AFR REP SER, P1
   Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003
   Cochrane KL, 2004, AFR J MAR SCI, V26, P9, DOI 10.2989/18142320409504047
   Costello MJ, 2015, TRENDS ECOL EVOL, V30, P507, DOI 10.1016/j.tree.2015.06.011
   Costello MJ, 2015, CURR BIOL, V25, pR368, DOI 10.1016/j.cub.2015.03.051
   Crawford RJM, 2011, AFR J MAR SCI, V33, P139, DOI 10.2989/1814232X.2011.572377
   Crawford R. J. M., 2015, FRONTIERS ECOLOGY EV, V3, P1, DOI [10.3389/fevo.2015.00010, DOI 10.3389/FEVO.2015.00010]
   Crawford RJM, 2006, BIOL CONSERV, V132, P119, DOI 10.1016/j.biocon.2006.03.019
   Crawford Robert J. M., 2009, Marine Ornithology, V37, P159
   Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012
   Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020
   Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928
   Cvitanovic C, 2015, OCEAN COAST MANAGE, V112, P25, DOI 10.1016/j.ocecoaman.2015.05.002
   DEA, 2016, 22 NEW PROP MPAS
   Dichmont CM, 2016, OCEAN COAST MANAGE, V124, P22, DOI 10.1016/j.ocecoaman.2016.02.003
   DPME, 2014, DEP PLAN MON EV REP
   Durant JM, 2010, MAR ECOL PROG SER, V420, P263, DOI 10.3354/meps08857
   Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106
   FAO, 2016, INF FISH MAN REP S A
   Fishpool L. D. C., 2001, BIRD LIFE CONSERVATI, V11
   Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194
   Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233
   Gleason M, 2013, CONSERV BIOL, V27, P470, DOI 10.1111/cobi.12041
   Grantham HS, 2010, FRONT ECOL ENVIRON, V8, P431, DOI 10.1890/080151
   Gremillet D, 2010, ECOL APPL, V20, P1498, DOI 10.1890/09-1586.1
   Gremillet D, 2009, MAR ECOL PROG SER, V391, P121, DOI 10.3354/meps08212
   Griffiths CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012008
   Harding C., 2015, UNRAVELLING CO UNPUB
   Harrison JA, 1997, ATLAS SO AFRICAN BIR
   Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003
   Heylen B. C., 2016, THESIS
   Holing C., 1978, ADAPTIVE ENV ASSESSM
   Holness SD, 2011, KOEDOE, V53, DOI 10.4102/koedoe.v53i2.1029
   Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.0.CO;2-Q
   IUCN, IUCN RED LIST THREAT
   Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.292.5517.629
   Kato S, 2008, J ENVIRON PLANN MAN, V51, P543, DOI 10.1080/09640560802117028
   Lascelles BG, 2016, DIVERS DISTRIB, V22, P422, DOI 10.1111/ddi.12411
   Lascelles BG, 2012, BIOL CONSERV, V156, P5, DOI 10.1016/j.biocon.2011.12.008
   Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029
   Lewis SEF, 2012, AFR J MAR SCI, V34, P497, DOI 10.2989/1814232X.2012.716008
   Marine Conservation Institute, MPATLAS OP PHAK
   Maxwell SM, 2015, MAR POLICY, V58, P42, DOI 10.1016/j.marpol.2015.03.014
   McCarthy MA, 2007, CONSERV BIOL, V21, P956, DOI 10.1111/j.1523-1739.2007.00677.x
   McCauley DJ, 2015, SCIENCE, V347, DOI 10.1126/science.1255641
   McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107
   McInnes AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140936
   McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211
   Molewa B., 2016, GOVT GAZETTE S  0203
   Molewa B. E., 2013, AFRICAN PENGUIN BIOD
   MONAGHAN P, 1989, J ANIM ECOL, V58, P261, DOI 10.2307/4999
   Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049
   Muro M, 2008, J ENVIRON PLANN MAN, V51, P325, DOI 10.1080/09640560801977190
   Okes NC, 2009, BIOL CONSERV, V142, P2361, DOI 10.1016/j.biocon.2009.05.031
   Paleczny M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129342
   Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017
   Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070
   Pichegru L, 2010, BIOL LETTERS, V6, P498, DOI 10.1098/rsbl.2009.0913
   Pressey RL, 2013, BIOL CONSERV, V166, P155, DOI 10.1016/j.biocon.2013.06.025
   Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500
   Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920
   Roberts J., 2016, THESIS
   Sainsbury KJ, 2000, ICES J MAR SCI, V57, P731, DOI 10.1006/jmsc.2000.0737
   Schultz L, 2015, P NATL ACAD SCI USA, V112, P7369, DOI 10.1073/pnas.1406493112
   Sciberras M., 2013, FISH FISH
   Shahin A, 2007, INT J PRODUCT PERFOR, V56, P226, DOI 10.1108/17410400710731437
   Shea K, 2002, ECOL APPL, V12, P927, DOI 10.2307/3061000
   Shea K, 1998, TRENDS ECOL EVOL, V13, P371, DOI 10.1016/S0169-5347(98)01381-0
   Sherley RB, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0237
   Sink K., 2011, TECHNICAL REPORT, V4
   Tasker ML, 2000, ICES J MAR SCI, V57, P531, DOI 10.1006/jmsc.2000.0714
   Trathan PN, 2015, CONSERV BIOL, V29, P31, DOI 10.1111/cobi.12349
   van Eeden R, 2016, MAR ECOL PROG SER, V543, P257, DOI 10.3354/meps11557
   Van Vugt M, 2009, CURR DIR PSYCHOL SCI, V18, P169, DOI 10.1111/j.1467-8721.2009.01630.x
   Walters C, 1986, ADAPTIVE MANAGEMENT
   WALTERS CJ, 1990, ECOLOGY, V71, P2060, DOI 10.2307/1938620
   WALTERS CJ, 1976, J FISH RES BOARD CAN, V33, P145, DOI 10.1139/f76-017
   Webb TJ, 2015, CURR BIOL, V25, P506, DOI 10.1016/j.cub.2014.12.023
   Weeks R, 2013, CONSERV BIOL, V27, P1234, DOI 10.1111/cobi.12153
   Wilhelm TA, 2014, AQUAT CONSERV, V24, P24, DOI 10.1002/aqc.2499
   WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461
NR 91
TC 2
Z9 2
U1 6
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-597X
EI 1872-9460
J9 MAR POLICY
JI Mar. Pol.
PD DEC
PY 2017
VL 86
BP 190
EP 197
DI 10.1016/j.marpol.2017.08.013
PG 8
WC Environmental Studies; International Relations
SC Environmental Sciences & Ecology; International Relations
GA FL3GV
UT WOS:000414111800023
DA 2018-12-27
ER

PT J
AU Wang, W
   Jiang, Y
   Wang, D
   Zhang, M
AF Wang, Wei
   Jiang, Yu
   Wang, Dan
   Zhang, Min
TI RETRACTED: Through wall human detection under small samples based on
   deep learning algorithm (Retracted article. See vol. 76, pg. 766, 2018)
SO PATTERN RECOGNITION
LA English
DT Article; Retracted Publication
DE Target identification; Ultra-wideband radar; Deep learning; Autoencoder;
   Small sample
ID CLASSIFICATION PERFORMANCE; NETWORK
AB Through wall human detection has important applications in the fields of anti-terrorism, anti-explosion and post-disaster relief. The UWB radar-based technology of through-wall human target recognition has been fairly mature in nowadays research. With the rise of deep learning algorithm in recent years, the classification algorithms based on deep learning have demonstrated a strong ability to learn the essential characteristics of dataset from a few sample sets. This paper focuses on studying the classification and identification of behind-wall human target states under small sample conditions. The autoencoder algorithm in the deep learning network model is chosen herein to classify and identify the human targets behind the walls. The autoencoder algorithm extracts the concise data feature representations through automatic learning of inherent characteristics in the data. On the basis of the autoencoder network, we add the denoising encoder and sparsity constraints to extract more efficient feature representations, thereby improving the classification and identification rates. In this paper, we classify and identify the behind-wall human target states separately under single and multiple sensors under a small sample condition; and compare the results with other classification algorithms. The results show that the autoencoder algorithm in deep learning adopted herein allows more effective classification and identification of behind-wall human targets than other algorithms; and that the identification effect with multiple sensors is better than that with a single sensor. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Wang, Wei; Jiang, Yu; Wang, Dan; Zhang, Min] Tianjin Key Lab Wireless Mobile Commun & Power Tr, Tianjin 300387, Peoples R China.
RP Wang, W (reprint author), Tianjin Key Lab Wireless Mobile Commun & Power Tr, Tianjin 300387, Peoples R China.
EM weiwang@mail.tjnu.edu.cn
FU National Natural Science Foundation of China [61271411, 61501326];
   Natural Science Foundation of Tianjin [15JCZDJC31500, 16JCYBJC16500]
FX This paper is supported by National Natural Science Foundation of China
   (Grant No.61271411, No.61501326). It also supported by Natural Science
   Foundation of Tianjin (Grant No.15JCZDJC31500, No.16JCYBJC16500).
CR Bengio Y., 2007, LARGE SCALE KERNEL M, V34, P321
   Bengio Yoshua, 2007, P ADV NEUR INF PROC, P153
   Braga-Neto U, 2007, IEEE SIGNAL PROC MAG, V24, P91, DOI 10.1109/MSP.2007.273062
   Chi MM, 2008, ADV SPACE RES, V41, P1793, DOI 10.1016/j.asr.2008.02.012
   Davis J., 2006, P 23 INT C MACH LEAR, V23, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]
   Hertz T., 2006, P 23 INT C MACH LEAR, P401
   Hinton G.E., 2012, ARXIV12070580
   Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527
   Kuo BC, 2007, IEEE T GEOSCI REMOTE, V45, P756, DOI 10.1109/TGRS.2006.885074
   Li DC, 2011, ARTIF INTELL MED, V52, P45, DOI 10.1016/j.artmed.2011.02.001
   Liu Ying-dong, 2011, Computer Engineering, V37, P198, DOI 10.3969/j.issn.1000-3428.2011.09.069
   Mazurowski MA, 2008, NEURAL NETWORKS, V21, P427, DOI 10.1016/j.neunet.2007.12.031
   Ng A. Y., 2004, P 21 INT C MACH LEAR, DOI DOI 10.1145/1015330.1015435
   Srivastava N, 2014, J MACH LEARN RES, V15, P1929
   Vincent P., 2008, P INT C MACH LEARN, P1096, DOI DOI 10.1145/1390156.1390294
   Vincent P, 2010, J MACH LEARN RES, V11, P3371
   Xuegong Z., 2000, ACTA AUTOM SIN, V26, P32
   Yuguang Huang, 2011, 2011 IEEE International Conference on Cloud Computing and Intelligence Systems (CCIS 2011), P34, DOI 10.1109/CCIS.2011.6045027
NR 18
TC 1
Z9 1
U1 6
U2 89
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0031-3203
EI 1873-5142
J9 PATTERN RECOGN
JI Pattern Recognit.
PD DEC
PY 2017
VL 72
BP 458
EP 465
DI 10.1016/j.patcog.2017.07.033
PG 8
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA FH9PY
UT WOS:000411545400034
DA 2018-12-27
ER

PT J
AU Zhao, F
   Zhang, YY
   Chen, HB
AF Zhao, Feng
   Zhang, Yuyi
   Chen, Hongbin
TI RETRACTED: Multimodal data analysis and integration for multi-slot
   spectrum auction based on Deep Feedforward Network (Retracted article.
   See vol. 76, pg. 765, 2018)
SO PATTERN RECOGNITION
LA English
DT Article; Retracted Publication
DE Multimodal data analysis and integration; Dynamic spectrum auction;
   Multi-slot; Heterogeneous networks; Small cell; Deep feedforward network
ID NEURAL-NETWORKS; ADAPTIVE-CONTROL; COGNITIVE RADIO; CLASSIFICATION;
   ALGORITHM; SYSTEM; MODEL
AB Spectrum auction is considered a suitable approach to efficiently allocate spectrum among unlicensed users. In this paper, for the first time ever, we study this problem from Pattern Recognit. point of view, where all wireless users could be classified based on their economic capability, the interests of the channel for the auction, and the interference they need to suffer during communication. These factors from wireless users are multimodal data ranging from linguistic to numerical data. How to make analysis and integration of such multimodal data is a key for multi-slot spectrum auction. We adopt the Deep Feedforward Network algorithm to perform multimodal data analysis and integration for multi-slot spectrum auction. Simulation results are presented to verify the effectiveness of the proposed algorithm in the small cell network. Our approach is essentially a Pattern Recognit. approach where spectrum auction decision is made based on deep learning and different user patterns. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Zhao, Feng; Zhang, Yuyi; Chen, Hongbin] Guilin Univ Elect Technol, Minist Educ, Key Lab Cognit Radio & Informat Proc, Guilin 541004, Peoples R China.
RP Chen, HB (reprint author), Guilin Univ Elect Technol, Minist Educ, Key Lab Cognit Radio & Informat Proc, Guilin 541004, Peoples R China.
EM chbscut@guet.edu.cn
FU National Natural Science Foundation of China [61471135, 61671165];
   Guangxi Natural Science Foundation [2015GXNSFBB139007,
   2016GXNSFGA380009]; Key Laboratory of Cognitive Radio and Information
   Processing (Guilin University of Electronic Technology, China), Ministry
   of Education, China; Guangxi Key Laboratory of Wireless Wideband
   Communication and Signal Processing [CRKL160105]; GUET Graduate
   Education [2016YJCX87, 2017YJCX39]
FX This research was supported by the National Natural Science Foundation
   of China (61471135, 61671165), the Guangxi Natural Science Foundation
   (2015GXNSFBB139007, 2016GXNSFGA380009), the Fund of Key Laboratory of
   Cognitive Radio and Information Processing (Guilin University of
   Electronic Technology, China), Ministry of Education, China and the
   Guangxi Key Laboratory of Wireless Wideband Communication and Signal
   Processing (CRKL160105), and the Innovation Project of GUET Graduate
   Education (2016YJCX87, 2017YJCX39).
CR Ahmed MS, 2000, IEEE T AUTOMAT CONTR, V45, P119, DOI 10.1109/9.827367
   Al-Ayyoub M, 2014, IEEE ACM T NETWORK, V22, P1873, DOI 10.1109/TNET.2013.2288317
   Ang WT, 2007, IEEE SENS J, V7, P81, DOI 10.1109/JSEN.2006.886995
   Bengio Y., 2000, IEEE T NEURAL NETW, V11
   Chen TT, 2014, IEEE T WIREL COMMUN, V13, P1116, DOI 10.1109/TWC.2013.120413.131072
   Deng Y, 2017, IEEE T NEUR NET LEAR, V28, P653, DOI 10.1109/TNNLS.2016.2522401
   Du J., 2014, PATTERN RECOGN, V63, P149
   Esfandiari K, 2015, IEEE T NEUR NET LEAR, V26, P2311, DOI 10.1109/TNNLS.2014.2378991
   Grall A, 2002, IEEE T RELIAB, V51, P141, DOI 10.1109/TR.2002.1011518
   Guo JH, 2003, IEEE T POWER SYST, V18, P665, DOI 10.1109/TPWRS.2003.811012
   Haykin S, 2005, IEEE J SEL AREA COMM, V23, P201, DOI 10.1109/JSAC.2004.839380
   Hu XM, 2010, IEEE T EVOLUT COMPUT, V14, P766, DOI 10.1109/TEVC.2010.2040182
   Li H., 2015, P IEEE C COMP COMM I, P2047
   Li ZP, 2015, IEEE T MOBILE COMPUT, V14, P316, DOI 10.1109/TMC.2013.64
   Liu SD, 2016, IEEE T NEUR NET LEAR, V27, P2718, DOI 10.1109/TNNLS.2015.2491325
   Martinez-Rego D, 2012, PATTERN RECOGN, V45, P4536, DOI 10.1016/j.patcog.2012.05.009
   Narendra K S, 1990, IEEE Trans Neural Netw, V1, P4, DOI 10.1109/72.80202
   Patino HD, 2000, IEEE T SYST MAN CY B, V30, P198, DOI 10.1109/3477.826961
   Rubaai A, 2000, IEEE T IND APPL, V36, P935, DOI 10.1109/28.845075
   Ruihao Zhu, 2015, 2015 IEEE Conference on Computer Communications (INFOCOM). Proceedings, P918, DOI 10.1109/INFOCOM.2015.7218463
   Suresh S, 2005, IEEE T PARALL DISTR, V16, P24, DOI 10.1109/TPDS.2005.11
   Tian J, 2012, PATTERN RECOGN, V45, P1373, DOI 10.1016/j.patcog.2011.09.012
   Wang QH, 2014, IEEE T PARALL DISTR, V25, P2499, DOI 10.1109/TPDS.2013.226
   Wang ZL, 2012, IEEE T INF TECHNOL B, V16, P691, DOI 10.1109/TITB.2012.2196440
   Wu GG, 2012, IEEE J SEL AREA COMM, V30, P2070, DOI 10.1109/JSAC.2012.121120
   Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141
   Yi CY, 2014, IEEE ICC, P1626, DOI 10.1109/ICC.2014.6883555
   Zhang YN, 2014, PATTERN RECOGN, V47, P3414, DOI 10.1016/j.patcog.2014.04.026
NR 28
TC 0
Z9 0
U1 5
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0031-3203
EI 1873-5142
J9 PATTERN RECOGN
JI Pattern Recognit.
PD DEC
PY 2017
VL 72
BP 466
EP 472
DI 10.1016/j.patcog.2017.07.015
PG 7
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA FH9PY
UT WOS:000411545400035
DA 2018-12-27
ER

PT J
AU Wang, HQ
   Xu, TF
   Guo, J
   Rao, ZT
   Shi, GK
AF Wang, Hongqing
   Xu, Tingfa
   Guo, Jie
   Rao, Zhitao
   Shi, Guokai
TI RETRACTED: Incremental subspace and probability mask constrained
   tracking in smart and autonomous systems (Retracted article. See vol.
   76, pg. 764, 2018)
SO PATTERN RECOGNITION
LA English
DT Article; Retracted Publication
DE Smart and autonomous systems; Visual tracking; Incremental subspace
   learning; APG method; Probability mask
ID ROBUST VISUAL TRACKING; SPARSE REPRESENTATION; OBJECT TRACKING;
   APPEARANCE MODEL
AB In this paper, we propose a novel incremental subspace and probability mask constrained sparse representation model in Smart and Autonomous Systems (SAS). In contrast to traditional sparse representation based tracking methods, the proposed model uses the trivial templates to model both reconstruction errors caused by sparse representation and the Eigen subspace representation. Besides, to alleviate the fact that the trivial templates can be activated to represent any image patch, we further propose to constrain the trivial templates with a probability mask. A unified objective function is proposed and a customized APG method is developed to effectively solve the optimization problem. In addition, a robust observation likelihood metric is proposed and a Bayes rule based color histogram model is proposed to construct the probability mask. Numerous qualitative and quantitative evaluations demonstrate that our tracker outperforms the state-of-the-art trackers in a wide range of tracking scenarios. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Wang, Hongqing; Xu, Tingfa; Guo, Jie; Rao, Zhitao; Shi, Guokai] Beijing Inst Technol, Sch Optoelect, Image Engn & Video Technol Lab, Beijing 100081, Peoples R China.
   [Xu, Tingfa] Minist Educ China, Key Lab Photoelect Imaging Technol & Syst, Beijing 100081, Peoples R China.
RP Xu, TF (reprint author), Beijing Inst Technol, Sch Optoelect, Image Engn & Video Technol Lab, Beijing 100081, Peoples R China.; Xu, TF (reprint author), Minist Educ China, Key Lab Photoelect Imaging Technol & Syst, Beijing 100081, Peoples R China.
EM xutingfa1123@163.com
FU National Natural Science Foundation of China [61527802]; National Nature
   Science Foundation of China [61371132, 61471043]
FX This work was supported by the Major Science Instrument Program of the
   National Natural Science Foundation of China under Grant 61527802, and
   the General Program of National Nature Science Foundation of China under
   Grants 61371132 and 61471043.
CR Babenko B, 2009, PROC CVPR IEEE, P983, DOI 10.1109/CVPRW.2009.5206737
   Bai TX, 2012, PATTERN RECOGN, V45, P2390, DOI 10.1016/j.patcog.2011.12.004
   Bai YC, 2014, IEEE SIGNAL PROC LET, V21, P909, DOI 10.1109/LSP.2014.2320291
   Guo J, 2016, IEEE INT C MULT EXP, P1
   Hare S, 2011, IEEE I CONF COMP VIS, P263, DOI 10.1109/ICCV.2011.6126251
   He ZY, 2017, IEEE T CYBERNETICS, V47, P354, DOI 10.1109/TCYB.2016.2514714
   Henriques JF, 2012, LECT NOTES COMPUT SC, V7575, P702, DOI 10.1007/978-3-642-33765-9_50
   Hong ZB, 2013, IEEE I CONF COMP VIS, P649, DOI 10.1109/ICCV.2013.86
   Ji H., 2012, IEEE C COMP VIS PATT, V157, P1830
   Jia X, 2016, IEEE T IMAGE PROCESS, V25, P4555, DOI 10.1109/TIP.2016.2592701
   Jia X, 2012, PROC CVPR IEEE, P1822, DOI 10.1109/CVPR.2012.6247880
   Kwon J, 2010, PROC CVPR IEEE, P1269, DOI 10.1109/CVPR.2010.5539821
   Li X, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2508037.2508039
   Liu T, 2015, IEEE SIGNAL PROC LET, V22, P1452, DOI 10.1109/LSP.2014.2365363
   Lu XQ, 2013, PATTERN RECOGN, V46, P1762, DOI 10.1016/j.patcog.2012.11.016
   Mei X, 2011, IEEE T PATTERN ANAL, V33, P2259, DOI 10.1109/TPAMI.2011.66
   POSSEGGER H, 2015, IEEE C COMP VIS PATT, P2113
   Ross DA, 2008, INT J COMPUT VISION, V77, P125, DOI 10.1007/s11263-007-0075-7
   Smeulders AWM, 2014, IEEE T PATTERN ANAL, V36, P1442, DOI 10.1109/TPAMI.2013.230
   Wang D, 2013, IEEE T IMAGE PROCESS, V22, P314, DOI 10.1109/TIP.2012.2202677
   Wu Y, 2013, PROC CVPR IEEE, P2411, DOI 10.1109/CVPR.2013.312
   Xie Y, 2014, PATTERN RECOGN, V47, P1383, DOI 10.1016/j.patcog.2013.07.010
   Yang HX, 2011, NEUROCOMPUTING, V74, P3823, DOI 10.1016/j.neucom.2011.07.024
   Yilmaz A, 2006, ACM COMPUT SURV, V38, DOI 10.1145/1177352.1177355
   Zhang KH, 2012, LECT NOTES COMPUT SC, V7574, P864, DOI 10.1007/978-3-642-33712-3_62
   Zhang SP, 2013, PATTERN RECOGN, V46, P1772, DOI 10.1016/j.patcog.2012.10.006
   Zhang TZ, 2015, INT J COMPUT VISION, V111, P171, DOI 10.1007/s11263-014-0738-0
   Zhang TZ, 2013, INT J COMPUT VISION, V101, P367, DOI 10.1007/s11263-012-0582-z
   ZHANG TZ, 2015, PROC CVPR IEEE, P150, DOI DOI 10.1109/CVPR.2015.7298610
   Zhong W, 2012, PROC CVPR IEEE, P1838, DOI 10.1109/CVPR.2012.6247882
   Zhuang BH, 2014, IEEE T IMAGE PROCESS, V23, P1872, DOI 10.1109/TIP.2014.2308414
NR 31
TC 1
Z9 1
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0031-3203
EI 1873-5142
J9 PATTERN RECOGN
JI Pattern Recognit.
PD DEC
PY 2017
VL 72
BP 473
EP 483
DI 10.1016/j.patcog.2017.06.034
PG 11
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA FH9PY
UT WOS:000411545400036
DA 2018-12-27
ER

PT J
AU Kang, WJ
   Liu, GL
   Jia, M
AF Kang, Wenjing
   Liu, Gongliang
   Jia, Min
TI RETRACTED: Adaptive correlation filters for robust object tracking
   (Retracted article. See vol. 76, pg. 763, 2018)
SO PATTERN RECOGNITION
LA English
DT Article; Retracted Publication
DE Adaptive correlation filter; Adaptive updating; Confidence metric;
   Dimensionality reduction; Object tracking
ID VISUAL TRACKING; BENCHMARK
AB Object tracking is one of the most important components in numerous applications of computer vision. Most of trackers work well in ordinary conditions, but usually encounter drift in challenging sequences with abrupt motion, motion blur, occlusion and scale variation. In this paper, we decompose the task of tracking into correlation filter-based translation tracker, scale tracker and online re-detectors. For translation tracker, we propose an adaptive dimensionality reduction to pixel-dense histogram of oriented gradients features to increase speed without losing accuracy. We present an adaptive updating strategy which uses cosine similarity together with two peak-to-sidelobe ratios and max response of scale tracker as confidence metrics for failure detection. In addition, multiple correlation filter-based detectors are activated to re-detect objects in case of failure. The experimental results show that the proposed approach tracks both the position and size of the interested target efficiently and achieve higher accuracy on most of challenging sequences. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Kang, Wenjing; Liu, Gongliang] Harbin Inst Technol Weihai, Sch Informat & Elect Engn, Weihai 264209, Peoples R China.
   [Jia, Min] Harbin Inst Technol, Sch Elect Informat Engn, Commun Res Ctr, Harbin 150080, Heilongjiang, Peoples R China.
RP Liu, GL (reprint author), Harbin Inst Technol Weihai, Sch Informat & Elect Engn, Weihai 264209, Peoples R China.
EM kwjqq@hit.edu.cn; liugl@hit.edu.cn; jiamin@hit.edu.cn
FU National Natural Science Foundation of China [61501139, 61371100,
   61671183]; Natural Scientific Research Innovation Foundation in Harbin
   Institute of Technology [HIT .NSRIF.2013136]
FX This work was supported by the National Natural Science Foundation of
   China (Grant No. 61501139, 61371100, 61671183) and the Natural
   Scientific Research Innovation Foundation in Harbin Institute of
   Technology (HIT .NSRIF.2013136).
CR Babenko B, 2011, IEEE T PATTERN ANAL, V33, P1619, DOI 10.1109/TPAMI.2010.226
   Bolme DS, 2010, PROC CVPR IEEE, P2544, DOI 10.1109/CVPR.2010.5539960
   Danelljan M., 2014, BRIT MACH VIS C
   Danelljan M, 2014, PROC CVPR IEEE, P1090, DOI 10.1109/CVPR.2014.143
   Fan JL, 2012, IEEE T PATTERN ANAL, V34, P1633, DOI 10.1109/TPAMI.2011.257
   Gao J, 2014, LECT NOTES COMPUT SC, V8691, P188, DOI 10.1007/978-3-319-10578-9_13
   Hare S, 2011, IEEE I CONF COMP VIS, P263, DOI 10.1109/ICCV.2011.6126251
   He SF, 2013, PROC CVPR IEEE, P2427, DOI 10.1109/CVPR.2013.314
   Henriques JF, 2015, IEEE T PATTERN ANAL, V37, P583, DOI 10.1109/TPAMI.2014.2345390
   Henriques JF, 2012, LECT NOTES COMPUT SC, V7575, P702, DOI 10.1007/978-3-642-33765-9_50
   Kalal Z, 2012, IEEE T PATTERN ANAL, V34, P1409, DOI 10.1109/TPAMI.2011.239
   Khan FS, 2013, INT J COMPUT VISION, V105, P205, DOI 10.1007/s11263-013-0633-0
   Li X, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2508037.2508039
   Li Y, 2015, PROC CVPR IEEE, P353, DOI 10.1109/CVPR.2015.7298632
   Liu T, 2015, PROC CVPR IEEE, P4902, DOI 10.1109/CVPR.2015.7299124
   Ross DA, 2008, INT J COMPUT VISION, V77, P125, DOI 10.1007/s11263-007-0075-7
   Sevilla-Lara L, 2012, PROC CVPR IEEE, P1910, DOI 10.1109/CVPR.2012.6247891
   Smeulders AWM, 2014, IEEE T PATTERN ANAL, V36, P1442, DOI 10.1109/TPAMI.2013.230
   Wang D, 2015, IEEE T CYBERNETICS, V45, P1838, DOI 10.1109/TCYB.2014.2360924
   Wang N., 2013, P ADV NEUR INF PROC, P809
   Wu Y, 2015, IEEE T PATTERN ANAL, V37, P1834, DOI 10.1109/TPAMI.2014.2388226
   Wu Y, 2013, PROC CVPR IEEE, P2411, DOI 10.1109/CVPR.2013.312
   Yang HX, 2011, NEUROCOMPUTING, V74, P3823, DOI 10.1016/j.neucom.2011.07.024
   Yilmaz A, 2006, ACM COMPUT SURV, V38, DOI 10.1145/1177352.1177355
   Zhang KH, 2014, LECT NOTES COMPUT SC, V8693, P127, DOI 10.1007/978-3-319-10602-1_9
   Zhang KH, 2012, LECT NOTES COMPUT SC, V7574, P864, DOI 10.1007/978-3-642-33712-3_62
   Zhong W, 2014, IEEE T IMAGE PROCESS, V23, P2356, DOI 10.1109/TIP.2014.2313227
NR 27
TC 2
Z9 2
U1 8
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0031-3203
EI 1873-5142
J9 PATTERN RECOGN
JI Pattern Recognit.
PD DEC
PY 2017
VL 72
BP 484
EP 493
DI 10.1016/j.patcog.2017.06.033
PG 10
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA FH9PY
UT WOS:000411545400037
DA 2018-12-27
ER

PT J
AU Vafaee, A
   Khorramian, A
AF Vafaee, A.
   Khorramian, A.
TI RETRACTED: Impact of beauty and charm H1-ZEUS combined measurements on
   PDFs and determination of the strong coupling (Retracted article. See
   vol. 54, art. 129, 2018)
SO EUROPEAN PHYSICAL JOURNAL A
LA English
DT Article; Retracted Publication
ID DEEP-INELASTIC SCATTERING; LUND MONTE-CARLO; GAMMA PLUS C; INTRINSIC
   CHARM; CROSS-SECTION; QCD ANALYSIS; ROOT-S=1.96 TEV; P(P)OVER-BAR
   COLLISIONS; PARTON DISTRIBUTIONS; PERTURBATION-THEORY
AB In this QCD analysis, we investigate the impact of recent measurements of heavy-flavor charm and beauty cross sections data sets on the simultaneous determination of Parton Distribution Functions (PDFs) and the strong coupling, alpha(s)(M-Z(2)). We perform three different fits based on Variable-Flavour Number Scheme (VFNS) at the Leading Order (LO) and Next-to-Leading Order (NLO) and choose the full HERA run I and II combined data as a new measurement of inclusive Deep Inelastic Scattering (DIS) cross sections for our base data set. We show that including charm and beauty cross sections data reduces the uncertainty of gluon distribution and improves the fit quality up to 4.1% from leading order to next-to-leading order and up to 1.7% for only NLO without and with beauty and charm data contributions.
C1 [Vafaee, A.] Natl Fdn Elites, POB 14578-93111, Tehran, Iran.
   [Khorramian, A.] Semnan Univ, Fac Phys, POB 35131-19111, Semnan, Iran.
RP Vafaee, A (reprint author), Natl Fdn Elites, POB 14578-93111, Tehran, Iran.
EM vafaee.phy@gmail.com; khorramiana@semnan.ac.ir
CR Aaltonen T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.042003
   Aaltonen T, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.052006
   Aaron FD, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1769-0
   Aaron FD, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2010)109
   Aaron FD, 2010, EUR PHYS J C, V65, P89, DOI 10.1140/epjc/s10052-009-1190-0
   Abazov VM, 2014, PHYS LETT B, V737, P357, DOI 10.1016/j.physletb.2014.09.007
   Abazov VM, 2013, PHYS LETT B, V719, P354, DOI 10.1016/j.physletb.2013.01.033
   Abazov VM, 2012, PHYS LETT B, V714, P32, DOI 10.1016/j.physletb.2012.06.056
   Abazov VM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.192002
   Abramowicz H, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3710-4
   Abramowicz H, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2014)127
   Abramowicz H, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2311-3
   Aktas A, 2006, EUR PHYS J C, V48, P715, DOI 10.1140/epjc/s10052-006-0035-3
   Alekhin S, 2011, PHYS LETT B, V699, P345, DOI 10.1016/j.physletb.2011.04.026
   Alekhin S., ARXIV09083128HEPPH
   ALTARELLI G, 1977, NUCL PHYS B, V126, P298, DOI 10.1016/0550-3213(77)90384-4
   [Anonymous], ARXIV160506515HEPPH
   Ball RD, 2016, PHYS LETT B, V754, P49, DOI 10.1016/j.physletb.2015.12.077
   Ball RD, 2010, NUCL PHYS B, V838, P136, DOI 10.1016/j.nuclphysb.2010.05.008
   Ball RD, 2009, NUCL PHYS B, V816, P293, DOI 10.1016/j.nuclphysb.2009.02.027
   Bednyakov V. A., 2013, EPJ Web of Conferences, V60, DOI 10.1051/epjconf/20136020047
   Bednyakov VA, 2014, PHYS LETT B, V728, P602, DOI 10.1016/j.physletb.2013.12.031
   BENEKE M, 1995, PHYS LETT B, V344, P341, DOI 10.1016/0370-2693(94)01505-7
   Blumlein J, 2016, PHYS LETT B, V753, P619, DOI 10.1016/j.physletb.2015.12.068
   Boettcher T, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.074008
   Botje M, 2011, COMPUT PHYS COMMUN, V182, P490, DOI 10.1016/j.cpc.2010.10.020
   Brodsky S. J., ARXIV161107194HEPPH
   Brodsky S. J., ARXIV1612 01351HEPPH
   Brodsky SJ, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.054016
   BRODSKY SJ, 1980, PHYS LETT B, V93, P451, DOI 10.1016/0370-2693(80)90364-0
   Brodsky SJ, 2001, PHYS LETT B, V498, P23, DOI 10.1016/S0370-2693(00)01373-3
   Brodsky SJ, 1997, PHYS REV LETT, V78, P4682, DOI 10.1103/PhysRevLett.78.4682
   Brodsky SJ, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.113005
   Brodsky SJ, 2016, EUR PHYS J A, V52, DOI 10.1140/epja/i2016-16220-1
   Brodsky SJ, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.019101
   Chekanov S, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.012007
   CIAFALONI M, 1988, NUCL PHYS B, V296, P49, DOI 10.1016/0550-3213(88)90380-X
   Collins JC, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.094002
   Cooper-Sarkar A, 2012, J PHYS G NUCL PARTIC, V39, DOI 10.1088/0954-3899/39/9/093001
   Daum K., 1996, HAMBURG 1995 96 FUTU, P89
   De Roeck A, 2011, PROG PART NUCL PHYS, V66, P727, DOI 10.1016/j.ppnp.2011.06.001
   Dokshitzer Yu. L., 1977, SOV PHYS JETP, V46, P641, DOI DOI 10.1016/0550-3213(77)90384-4
   Duan SR, 2016, PHYS REV D, V93, DOI 10.1103/PhysRevD.93.114006
   Dulat S, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.073004
   Engelen J, 1998, PROG PART NUCL PHYS, V41, P1, DOI 10.1016/S0146-6410(98)00054-4
   Forte S, 2010, NUCL PHYS B, V834, P116, DOI 10.1016/j.nuclphysb.2010.03.014
   FRIXIONE S, 1993, PHYS LETT B, V319, P339, DOI 10.1016/0370-2693(93)90823-Z
   Gao J, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2541-4
   GRIBOV VN, 1972, SOV J NUCL PHYS+, V15, P438
   Hobbs T. J., ARXIV161205686HEPPH
   Hou TJ, 2017, PHYS REV D, V95, DOI 10.1103/PhysRevD.95.034003
   JAMES F, 1975, COMPUT PHYS COMMUN, V10, P343, DOI 10.1016/0010-4655(75)90039-9
   JUNG H, 1995, COMPUT PHYS COMMUN, V86, P147, DOI 10.1016/0010-4655(94)00150-Z
   Jung H, 2001, EUR PHYS J C, V19, P351, DOI 10.1007/s100520100604
   Koshkarev S., ARXIV161006125HEPPH
   KURAYEV EA, 1976, ZH EKSP TEOR FIZ+, V71, P840
   Laha R., ARXIV160708240HEPPH
   Lai HL, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.074024
   Lipatov AV, 2016, PHYS REV D, V94, DOI 10.1103/PhysRevD.94.053011
   LIPATOV LN, 1975, SOV J NUCL PHYS+, V20, P94
   LONNBLAD L, 1992, COMPUT PHYS COMMUN, V71, P15, DOI 10.1016/0010-4655(92)90068-A
   Lyonnet F, 2015, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2015)141
   MARCHESINI G, 1992, COMPUT PHYS COMMUN, V67, P465, DOI 10.1016/0010-4655(92)90055-4
   Martin AD, 2009, EUR PHYS J C, V63, P189, DOI 10.1140/epjc/s10052-009-1072-5
   Martin AD, 2006, PHYS LETT B, V636, P259, DOI 10.1016/j.physletb.2006.03.054
   Martin AD, 1998, EUR PHYS J C, V4, P463, DOI 10.1007/s100529800904
   Mironov A, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2010)040
   Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001
   Polyakov MV, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2016)092
   Pumplin J, 2002, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2002/07/012
   Rottoli L., 2016, POS DIS, V2016
   Sapronov A, 2015, J PHYS CONF SER, V608, DOI 10.1088/1742-6596/608/1/012051
   Schmidt B, 2012, COMPUT PHYS COMMUN, V183, P1845, DOI 10.1016/j.cpc.2012.03.023
   Schmidt C., 2014, POS DIS, V2014, P146
   SJOSTRAND T, 1986, COMPUT PHYS COMMUN, V39, P347, DOI 10.1016/0010-4655(86)90096-2
   SJOSTRAND T, 1987, COMPUT PHYS COMMUN, V43, P367, DOI 10.1016/0010-4655(87)90054-3
   Sjostrand T., ARXIVHEPPH0108264
   Thorne RS, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.074017
   Thorne RS, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.054019
   Tung WK, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/02/053
   Vafaee A, 2017, CHINESE PHYS C, V41, DOI 10.1088/1674-1137/41/11/113104
   Vafaee A, 2017, NUCL PHYS B, V921, P472, DOI 10.1016/j.nuclphysb.2017.06.011
   Vafaee A, 2017, NUCL PART PHYS P, V282, P32, DOI 10.1016/j.nuclphysbps.2016.12.007
   Vafaee A, 2016, NUCL PART PHYS P, V270, P27, DOI 10.1016/j.nuclphysbps.2016.02.007
   VOGT R, 1992, NUCL PHYS B, V383, P643, DOI 10.1016/0550-3213(92)90091-O
   VOGT R, 1995, PHYS LETT B, V349, P569, DOI 10.1016/0370-2693(95)00306-6
   VOGT R, 1995, NUCL PHYS B, V438, P261, DOI 10.1016/0550-3213(94)00543-N
   Vogt R, 1996, NUCL PHYS B, V478, P311, DOI 10.1016/0550-3213(96)00380-X
NR 88
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1434-6001
EI 1434-601X
J9 EUR PHYS J A
JI Eur. Phys. J. A
PD NOV 21
PY 2017
VL 53
IS 11
AR 220
DI 10.1140/epja/i2017-12405-4
PG 10
WC Physics, Nuclear; Physics, Particles & Fields
SC Physics
GA FN1KA
UT WOS:000415745600001
DA 2018-12-27
ER

PT J
AU Kumar, SN
   Aravind, SR
   Jacob, J
   Gopinath, G
   Lankalapalli, RS
   Sreelekha, TT
   Kumar, BSD
AF Kumar, S. Nishanth
   Aravind, S. R.
   Jacob, Jubi
   Gopinath, Geethu
   Lankalapalli, Ravi S.
   Sreelekha, T. T.
   Kumar, B. S. Dileep
TI RETRACTED: Pseudopyronine B: A Potent Antimicrobial and Anticancer
   Molecule Isolated from a Pseudomonas mosselii (Retracted article. See
   vol. 8, art no 2363, 2017)
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article; Retracted Publication
DE Pseudomonas mosseiii; Pseudopyronine B; antimicrobial; anticancer
   activity; apoptosis
ID NATURAL-PRODUCTS; CELL-DEATH; SP F92S91; APOPTOSIS; DISCOVERY; AGENTS;
   ACID; IDENTIFICATION; METABOLITES; GROWTH
AB In continuation of our search for new bioactive compounds from soil microbes, a fluorescent Pseudomonas strain isolated from paddy field soil of Kuttanad, Kerala, India was screened for the production of bioactive secondary metabolites. This strain was identified as Pseudomonas mosselii through 16S rDNA gene sequencing followed by BLAST analysis and the bioactive metabolites produced were purified by column chromatography (silica gel) and a pure bioactive secondary metabolite was isolated. This bioactive compound was identified as Pseudopyronine B by NMR and HR-ESI-MS. Pseudopyronine B recorded significant antimicrobial activity especially against Gram-positive bacteria and agriculturally important fungi. MTT assay was used for finding cell proliferation inhibition, and Pseudopyronine B recorded significant antitumor activity against non-small cell lung cancer cell (A549), and mouse melanoma cell (B16F10). The preliminary MTT assay results revealed that Pseudopyronine B recorded both dose- and time-dependent inhibition of the growth of test cancer cell lines. Pseudopyronine B induced apoptotic cell death in cancer cells as evidenced by Acridine orange/ethidium bromide and Hoechst staining, and this was further confirmed by flow cytometry analysis using Annexin V. Cell cycle analysis also supports apoptosis by inducing G2/M accumulation in both A549 and B16F10 cells. Pseudopyronine B treated cells recorded significant up-regulation of caspase 3 activity. Moreover, this compound recorded immunomodulatory activity by enhancing the proliferation of lymphocytes. The production of Pseudopyronine B by P. mosselii and its anticancer activity in A549 and B16F10 cell lines is reported here for the first time. The present study has a substantial influence on the information of Pseudopyronine B from P. mosselii as potential sources of novel drug molecule for the pharmaceutical companies, especially as potent antimicrobial and anticancer agent.
C1 [Kumar, S. Nishanth; Jacob, Jubi; Gopinath, Geethu; Lankalapalli, Ravi S.; Kumar, B. S. Dileep] CSIR, Agroproc & Nat Prod Div, Natl Inst Interdisciplinary Sci & Technol, Thiruvananthapuram, Kerala, India.
   [Aravind, S. R.; Sreelekha, T. T.] Reg Canc Ctr, Div Canc Res, Lab Biopharmaceut & Nanomed, Thiruvananthapuram, Kerala, India.
   [Aravind, S. R.] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates.
RP Kumar, SN; Kumar, BSD (reprint author), CSIR, Agroproc & Nat Prod Div, Natl Inst Interdisciplinary Sci & Technol, Thiruvananthapuram, Kerala, India.
EM nishanthctcri@gmail.com; dileepkumarbs@yahoo.in
RI TVM, NIIST/E-5132-2012
OI TVM, NIIST/0000-0002-5814-466X
FU Kerala State Council for Science Technology and Engineering (KSCSTE),
   Government of Kerala; Department of Science and Technology [IF 130648];
   DST-SERB
FX We thank Director, CSIR-NIIST, and Director RCC for providing necessary
   facilities to carry out the present work. The authors are also grateful
   to Kerala State Council for Science Technology and Engineering (KSCSTE),
   Government of Kerala for financial support in term of PDF fellowship. JJ
   acknowledges the Department of Science and Technology for providing
   INSPIRE fellowship (IF 130648). SNK thanks DST-SERB for providing the
   Young Scientist award.
CR Aravind SR, 2015, INT J BIOCHEM CELL B, V59, P153, DOI 10.1016/j.biocel.2014.11.019
   Aravind SR, 2014, RSC ADV, V4, P34632, DOI 10.1039/c4ra04137b
   Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651
   Bennani YL, 2012, DRUG DISCOV TODAY, V17, pS31, DOI 10.1016/j.drudis.2011.12.007
   Blunt JW, 2010, NAT PROD REP, V27, P165, DOI 10.1039/b906091j
   Bode HB, 2002, CHEMBIOCHEM, V3, P619, DOI 10.1002/1439-7633(20020703)3:7<619::AID-CBIC619>3.0.CO;2-9
   Cao W, 2010, PHYTOMEDICINE, V17, P598, DOI 10.1016/j.phymed.2009.12.014
   Chen CW, 2003, BRIT J PHARMACOL, V140, P1077, DOI 10.1038/sj.bjp.0705533
   Chin-A-Woeng TFC, 2003, NEW PHYTOL, V157, P503, DOI 10.1046/j.1469-8137.2003.00686.x
   Clinical and Laboratory Standards Institute, 2009, M44A2 CLSI
   Clinical and laboratory standards institute (CLSI), 2012, M02A11 CLSI
   CLSI, 2008, M38A2 CLSI
   CLSI, 2010, M51A CLSI
   CLSI, 2012, M07A9 CLSI
   CLSI, 2012, M27S4 CLSI
   Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Fadeyi SA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-79
   Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667
   Gao XC, 2012, MICROBIOL RES, V167, P616, DOI 10.1016/j.micres.2012.02.008
   George E, 2015, APPL BIOCHEM BIOTECH, V176, P529, DOI 10.1007/s12010-015-1593-3
   Giddens AC, 2008, TETRAHEDRON, V64, P1242, DOI 10.1016/j.tet.2007.11.075
   Graca AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078992
   Grundmann F, 2012, BEILSTEIN J ORG CHEM, V8, P749, DOI 10.3762/bjoc.8.85
   Higginbotham SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073192
   Hu HB, 2005, J MICROBIOL BIOTECHN, V15, P86
   Huang JF, 2009, APPL ENVIRON MICROB, V75, P6568, DOI 10.1128/AEM.01148-09
   Huang ZH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-87
   Kong FM, 2005, J NAT PROD, V68, P920, DOI 10.1021/np050038v
   Law CKM, 2014, CHIN MED-UK, V9, DOI 10.1186/1749-8546-9-11
   Liu TY, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-64
   Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485
   McConkey DJ, 1998, TOXICOL LETT, V99, P157, DOI 10.1016/S0378-4274(98)00155-6
   Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l
   Nonpunya A, 2014, CHIN MED-UK, V9, DOI 10.1186/1749-8546-9-12
   Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   Sambrook J., 2001, MOL CLONING LAB MANU, VI, P748
   Singh MP, 2003, J ANTIBIOT, V56, P1033, DOI 10.7164/antibiotics.56.1033
   Singh SB, 2011, EXPERT REV ANTI-INFE, V9, P589, DOI [10.1586/eri.11.81, 10.1586/ERI.11.81]
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   Tawiah AA, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-234
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   Vaara M, 2010, ANTIMICROB AGENTS CH, V54, P3341, DOI 10.1128/AAC.01439-09
   Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4
   Velkov T, 2010, J MED CHEM, V53, P1898, DOI 10.1021/jm900999h
   Wang SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097512
   Zhong ZF, 2012, CELL PHYSIOL BIOCHEM, V30, P778, DOI 10.1159/000341457
   Zhou TT, 2012, MICROBIOL RES, V167, P388, DOI 10.1016/j.micres.2012.01.003
   Zin NZM, 2011, TROP BIOMED, V28, P651
NR 51
TC 0
Z9 0
U1 2
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD NOV 17
PY 2017
VL 8
AR 1307
DI 10.3389/fmicb.2016.01307
PG 15
WC Microbiology
SC Microbiology
GA FM9KD
UT WOS:000415586600001
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Moller, P
   Hovig, E
AF Moller, Pal
   Hovig, Eivind
TI RETRACTED: The BRCA2 variant c.68-7 T > A is associated with breast
   cancer (Retracted article. See vol. 16,artn. 10, 2018)
SO HEREDITARY CANCER IN CLINICAL PRACTICE
LA English
DT Article; Retracted Publication
ID FOLLOW-UP; MUTATION
AB Background: BRCA2 c.68-7T>A has been demonstrated to cause aberrant splicing and is possibly pathogenic. The population prevalence of the variant is 0.2%, which higher than usual for pathogenic BRCA2 variants. The pathogenicity of the variant is discussed.
   Methods: The outpatient genetic clinic at The Norwegian Radium Hospital, part of Oslo University Hospital, has invited breast cancer kindreds for genetic examinations and prospective follow-up of high risk patients since 1988. We have complete files of all activities and results, and we examined the files for association between BRCA2 c.68-7T>A and breast cancer.
   Results: Seventeen out of 714 (2.4%) breast cancer kindreds sequenced for BRCA2 carried the variant BRCA2 c.68-7T>A (p < 0.0001 compared to population controls). Segregation analysis was inconclusive (likelihood ratio 0.36) for pathogenicity. Two breast cancers were prospectively observed during 134 observation years (annual incidence rate 1.5% (95% CI 0.15% to 5.4%) and one additional breast cancer was diagnosed at first (prevalence) round.
   Conclusion: BRCA2 c.68-7T>A is associated with breast cancer. In the families selected due to aggregation of breast cancer, carriers of the BRCA2 c.68-7T>A variant have increased risk for breast cancer. It is, however, possible that the variant has lower penetrance than the average pathogenic BRCA2 variants, and that in the families selected for having known aggregation of breast cancer other (modifying) factors contributed to the observed results.
C1 [Moller, Pal] Oslo Univ Hosp, Dept Med Genet, Res Grp Inherited Canc, Oslo, Norway.
   [Moller, Pal; Hovig, Eivind] Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway.
   [Moller, Pal] Univ Witten Herdecke, HELIOS Klinikum Wuppertal, Ctr Hereditary Tumors, Wuppertal, Germany.
   [Hovig, Eivind] Oslo Univ Hosp, Inst Canc Genet & Informat, Norwegian Radium Hosp, Oslo, Norway.
   [Hovig, Eivind] Univ Oslo, Dept Informat, Oslo, Norway.
RP Moller, P (reprint author), Oslo Univ Hosp, Dept Med Genet, Res Grp Inherited Canc, Oslo, Norway.; Moller, P (reprint author), Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway.; Moller, P (reprint author), Univ Witten Herdecke, HELIOS Klinikum Wuppertal, Ctr Hereditary Tumors, Wuppertal, Germany.
EM moller.pal@gmail.com
CR [Anonymous], 2017, NCGC795
   Bodd TL, 2010, ACTA PAEDIATR, V99, P1741, DOI 10.1111/j.1651-2227.2010.01929.x
   Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609
   ExaC, GNOM VERS 2
   Grindedal EM, 2014, HERED CANCER CLIN PR, V12, DOI 10.1186/1897-4287-12-12
   Jarhelle E, 2017, FAM CANCER, V16, P1, DOI 10.1007/s10689-016-9916-2
   Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057
   Li LL, 2015, J MED GENET, V52, P348, DOI 10.1136/jmedgenet-2014-102934
   Mohammadi L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-211
   Moller P, 1999, DIS MARKERS, V15, P207, DOI 10.1155/1999/920109
   Moller P, 2017, GUT, V66, P1657, DOI 10.1136/gutjnl-2016-311403
   Moller P, 2014, BREAST CANCER RES TR, V144, P607, DOI 10.1007/s10549-014-2902-1
   Moller P, 2011, HUM MUTAT, V32, P537, DOI 10.1002/humu.21452
   Norway CRo, 2017, BREAST CANC FACTS
   Plon SE, 2008, HUM MUTAT, V29, P1282, DOI 10.1002/humu.20880
   Sanz DJ, 2010, CLIN CANCER RES, V16, P1957, DOI 10.1158/1078-0432.CCR-09-2564
   Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854
NR 17
TC 2
Z9 2
U1 3
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1731-2302
EI 1897-4287
J9 HERED CANCER CLIN PR
JI Hered. Cancer Clin. Pract.
PD NOV 13
PY 2017
VL 10
AR 20
DI 10.1186/s13053-017-0080-y
PG 5
WC Oncology
SC Oncology
GA FM3OU
UT WOS:000414917300001
PM 29158857
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Meshchankin, DV
   Voronin, AA
   Serebryannikov, EE
   Zheltikov, AM
AF Meshchankin, D. V.
   Voronin, A. A.
   Serebryannikov, E. E.
   Zheltikov, A. M.
TI RETRACTED: Selective excitation, coherent control, and attosecond
   spectrochronography of electron subshells in atomic systems (Retracted
   article. See vol. 107, pg. 390, 2018)
SO JETP LETTERS
LA English
DT Article; Retracted Publication
ID PULSES; SOLIDS
AB Optical field waveforms with an ultrabroad spectrum and a tailored phase are shown to enable selective excitation, coherent control, and attosecond spectrochronography of electron subshells in many-electron atomic systems. Analysis of the evolution of the density matrix of electron subshells in an atomic system driven by an ultrashort light pulse shows that the interference of different quantum pathways of electron dynamics plays a key role in the buildup of the nonlinear-optical response of such a system. Our analysis suggests a method whereby the attosecond dynamics of individual electron subshells in atoms can be coherently controlled with ultrashort laser pulses.
C1 [Meshchankin, D. V.; Voronin, A. A.; Serebryannikov, E. E.; Zheltikov, A. M.] Moscow MV Lomonosov State Univ, Moscow 119992, Russia.
   [Voronin, A. A.; Serebryannikov, E. E.; Zheltikov, A. M.] Russian Quantum Ctr, Skolkovo 143025, Moscow Region, Russia.
   [Zheltikov, A. M.] Texas A&M Univ, College Stn, TX 77843 USA.
RP Zheltikov, AM (reprint author), Moscow MV Lomonosov State Univ, Moscow 119992, Russia.; Zheltikov, AM (reprint author), Russian Quantum Ctr, Skolkovo 143025, Moscow Region, Russia.; Zheltikov, AM (reprint author), Texas A&M Univ, College Stn, TX 77843 USA.
EM zheltikov@physics.msu.ru
FU Russian Foundation for Basic Research [16-02-00843, 16-32-60164,
   17-02-01131, 16-52-00190, 17-52-53092]; Robert Welch Foundation
   [A-1801]; Ministry of Education and Science of Russian Federation [211];
   Russian Science Foundation [17-12-01533]; Moscow State University;
   Innopraktika Foundation
FX This research was partially supported by the Russian Foundation for
   Basic Research (project nos. 16-02-00843, 16-32-60164, 17-02-01131,
   16-52-00190, and 17-52-53092), by the Robert Welch Foundation (grant no.
   A-1801), and by the Ministry of Education and Science of Russian
   Federation (project no. 211 of March 16, 2013, the 5-100 Program).
   Attosecond spectrochronography study was supported by the Russian
   Science Foundation (project no. 17-12-01533). The work of A.A.V. was
   also supported jointly by Moscow State University and the Innopraktika
   Foundation.
CR Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229
   Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620
   Ghimire S, 2011, NAT PHYS, V7, P138, DOI 10.1038/NPHYS1847
   Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846
   Goulielmakis E, 2004, SCIENCE, V305, P1267, DOI 10.1126/science.1100866
   Goulielmakis E, 2007, SCIENCE, V317, P769, DOI 10.1126/science.1142855
   Hassan MT, 2016, NATURE, V530, P66, DOI 10.1038/nature16528
   Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277
   Kling MF, 2006, SCIENCE, V312, P246, DOI 10.1126/science.1126259
   Lanin AA, 2017, OPTICA, V4, P516, DOI 10.1364/OPTICA.4.000516
   Mitrofanov AV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.147401
   Reiter F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.243902
   Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838
   Sansone G, 2011, NAT PHOTONICS, V5, P656, DOI [10.1038/NPHOTON.2011.167, 10.1038/nphoton.2011.167]
   Vampa G, 2015, NATURE, V522, P462, DOI 10.1038/nature14517
   Verhoef AJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.163904
NR 16
TC 1
Z9 1
U1 2
U2 5
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 0021-3640
EI 1090-6487
J9 JETP LETT+
JI Jetp Lett.
PD NOV
PY 2017
VL 106
IS 10
BP 648
EP 652
DI 10.1134/S0021364017220131
PG 5
WC Physics, Multidisciplinary
SC Physics
GA FU7GP
UT WOS:000424020700005
DA 2018-12-27
ER

PT J
AU Ibrahim-zada, I
   Ernest, P
   Moore, EE
AF Ibrahim-zada, Irada
   Ernest, Phil
   Moore, Ernest E.
TI RETRACTED: Intrathoracic transmural esophageal perforation (Boerhaave
   syndrome): Challenges in management of the delayed presentation
   (Retracted article. See vol. 85, pg. 653, 2018)
SO JOURNAL OF TRAUMA AND ACUTE CARE SURGERY
LA English
DT Editorial Material; Retracted Publication
C1 [Ibrahim-zada, Irada; Moore, Ernest E.] Univ Colorado, Sch Med, Dept Gen Surg, Denver Hlth Med Ctr, Aurora, CO 80045 USA.
   [Ernest, Phil] St Joseph Hosp, Denver, CO USA.
RP Ibrahim-zada, I (reprint author), Univ Colorado, Sch Med, Gen Surg, 12631 E 17th Ave,C302, Aurora, CO 80045 USA.
EM irada.ibrahim-zada@ucdenver.edu
NR 0
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 2163-0755
EI 2163-0763
J9 J TRAUMA ACUTE CARE
JI J. Trauma Acute Care Surg.
PD NOV
PY 2017
VL 83
IS 5
BP 987
EP 989
DI 10.1097/TA.0000000000001662
PG 3
WC Critical Care Medicine; Surgery
SC General & Internal Medicine; Surgery
GA FP2IO
UT WOS:000417440900038
PM 29073118
DA 2018-12-27
ER

PT J
AU Moy, RL
   Moy, L
AF Moy, Ronald L.
   Moy, Lauren
TI RETRACTED: Male Surgical Neck Rejuvenation (Retracted article. See vol.
   44, pg. 605, 2018)
SO DERMATOLOGIC SURGERY
LA English
DT Article; Retracted Publication
ID NONABLATIVE RADIOFREQUENCY; SKIN; ULTRASOUND; LASER; DEOXYCHOLATE; TOXIN
AB BACKGROUND Patients who are aging, with weight gain, and increased skin laxity, request dermatologists to improve their neck area. Surgical and nonsurgical options are reviewed as well as benefits and side effects. This article will focus on how surgical techniques can be applied for male patients in particular.
   OBJECTIVE To review surgical neck rejuvenation therapies available currently to find the best option for male patients.
   CONCLUSION Surgical treatment of the male neck to improve mandibular contour and loose neck skin requires tightening of the platysmal muscle and usually skin removal in the postauricular sulcus and into the hairline. Most patients choose to have this performed underline tumescent anesthesia when given the choice of sedation versus local anesthesia. The other surgical variations of improving the neck contour on a male include using a direct excision by a midline incision starting in the submental crease and extending down the anterior neck. This approach allows for maximum tightening of the platysmal bands. The incision line can be minimized using intraoperative laser resurfacing immediately after suturing. Chin implants are necessary in some patients to give good neck improvement. The isolated neck lift is one the most common procedures requested by men asking for neck improvement.
C1 [Moy, Ronald L.] 421 N Rodeo, Beverly Hills, CA 90210 USA.
   [Moy, Lauren] Loyola Univ, Med Ctr, Dept Dermatol, La Grange Pk, IL USA.
RP Moy, RL (reprint author), 421 N Rodeo, Beverly Hills, CA 90210 USA.
EM ronmoymd@gmail.com
CR Alam M, 2010, J AM ACAD DERMATOL, V62, P262, DOI 10.1016/j.jaad.2009.06.039
   Behroozan DS, 2000, J AM ACAD DERMATOL, V43, P72, DOI 10.1067/mjd.2000.104795
   Carruthers J, 2003, DERMATOL SURG, V29, P468, DOI 10.1046/j.1524-4725.2003.29115.x
   Chipps LK, 2013, J DRUGS DERMATOL, V12, P1215
   Dahan S, 2004, DERMATOL SURG, V30, P872, DOI 10.1111/j.1524-4725.2004.30256.x
   Dayan SH, 2014, PLAST RECONSTR SUPPL, V134, P123
   Elsaie ML, 2010, DERMATOL SURG, V36, P577, DOI 10.1111/j.1524-4725.2010.01510.x
   Fabbrocini G, 2009, CLIN EXP DERMATOL, V34, P874, DOI 10.1111/j.1365-2230.2009.03291.x
   Fabi SG, 2015, CLIN COSMET INVESTI, V8, P47, DOI 10.2147/CCID.S69118
   Feldman JF, 2006, NECK LIFT
   Finzi E, 2005, DERMATOL SURG, V31, P916, DOI 10.1097/00042728-200508000-00005
   Hamilton MM, 2014, FACIAL PLAST SURG CL, V22, P231, DOI 10.1016/j.fsc.2014.01.008
   Kim SE, 2011, DERMATOL SURG, V37, P336, DOI 10.1111/j.1524-4725.2011.01882.x
   Klein AW, 2003, DERMATOL SURG, V29, P549, DOI 10.1046/j.1524-4725.2003.29129.x
   Krueger N, 2014, CLIN COSMET INVESTI, V7, P201, DOI 10.2147/CCID.S44371
   Laubach HJ, 2008, DERMATOL SURG, V34, P727, DOI 10.1111/j.1524-4725.2008.34196.x
   Minkis K, 2014, DERMATOL CLIN, V32, P71, DOI 10.1016/j.det.2013.09.001
   Oram Yasemin, 2014, J Clin Aesthet Dermatol, V7, P23
   ORENTREICH DS, 1995, DERMATOL SURG, V21, P543, DOI 10.1111/j.1524-4725.1995.tb00259.x
   Orringer JS, 2012, DERMATOL SURG, V38, P1668, DOI 10.1111/j.1524-4725.2012.02518.x
   Rotunda AM, 2004, DERMATOL SURG, V30, P1001, DOI 10.1111/j.1524-4725.2004.30305.x
   Sakamoto FH, 2012, DERMATOLOGY, P2251
   Schouest JM, 2012, J DRUGS DERMATOL, V11, P613
   Thuangtong R, 2010, DERMATOL SURG, V36, P899, DOI 10.1111/j.1524-4725.2010.01566.x
   Walker P, 2015, J DRUGS DERMATOL, V14, P279
   Zachary CB, 2012, DERMATOLOGY, P2261
NR 26
TC 2
Z9 2
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1076-0512
EI 1524-4725
J9 DERMATOL SURG
JI Dermatol. Surg.
PD NOV
PY 2017
VL 43
SU 2
BP S203
EP S207
DI 10.1097/DSS.0000000000001347
PG 5
WC Dermatology; Surgery
SC Dermatology; Surgery
GA FP8XD
UT WOS:000417928500015
PM 29064986
DA 2018-12-27
ER

PT J
AU Bhatt, M
   Lizano, D
   Carlese, A
   Kvetan, V
   Gershengorn, HB
AF Bhatt, Muneer
   Lizano, Danny
   Carlese, Anthony
   Kvetan, Vladimir
   Gershengorn, Hayley Beth
TI RETRACTED: Severe Burnout Is Common Among Critical Care Physician
   Assistants: Retracted (Retracted article. See vol. 46, 2018)
SO CRITICAL CARE MEDICINE
LA English
DT Article; Retracted Publication
DE achievement; critical care; depersonalization; personal satisfaction;
   physician assistants
ID ADVANCED PRACTICE PROVIDERS; ACADEMIC MEDICAL-CENTERS;
   NURSE-PRACTITIONERS; UNITS; IMPACT; CLINICIAN; STAFF; SATISFACTION;
   INTENSIVIST; PERCEPTIONS
AB Objectives: To determine the prevalence of and risk factors for burnout among critical care medicine physician assistants.
   Design: Online survey.
   Settings: U.S. ICUs.
   Subjects: Critical care medicine physician assistant members of the Society of Critical Care Medicine coupled with personal contacts.
   Interventions: None.
   Measurements and Main Results: We used SurveyMonkey to query critical care medicine physician assistants on demographics and the full 22-question Maslach Burnout Inventory, a validated tool comprised of three subscales-emotional exhaustion, depersonalization, and achievement. Multivariate regression was performed to identify factors independently associated with severe burnout on at least one subscale and higher burnout scores on each subscale and the total inventory. From 431 critical care medicine physician assistants invited, 135 (31.3%) responded to the survey. Severe burnout was seen on at least one subscale in 55.6%-10% showed evidence of severe burnout on the "exhaustion" subscale, 44% on the "depersonalization" subscale, and 26% on the "achievement" subscale. After multivariable adjustment, caring for fewer patients per shift (odds ratio [95% CI]: 0.17 [0.05-0.57] for 1-5 vs 6-10 patients; p = 0.004) and rarely providing futile care (0.26 [0.07-0.95] vs providing futile care often; p = 0.041) were independently associated with having less severe burnout on at least one subscale. Those caring for 1-5 patients per shift and those providing futile care rarely also had a lower depersonalization scores; job satisfaction was independently associated with having less exhaustion, less depersonalization, a greater sense of personal achievement, and a lower overall burnout score.
   Conclusions: Severe burnout is common in critical care medicine physician assistants. Higher patient-to-critical care medicine physician assistant ratios and provision of futile care are risk factors for severe burnout.
C1 [Bhatt, Muneer] Duke Univ, Med Ctr, Dept Anesthesia & Surg, Durham, NC 27708 USA.
   [Lizano, Danny] Kendall Reg Med Ctr, ICC Healthcare Intensivist Grp, Miami, FL USA.
   [Carlese, Anthony; Kvetan, Vladimir; Gershengorn, Hayley Beth] Montefiore Med Ctr, Albert Einstein Coll Med, Div Crit Care Med, Bronx, NY 10467 USA.
   Montefiore Med Ctr, Albert Einstein Coll Med, Bronx, NY 10467 USA.
RP Bhatt, M (reprint author), Duke Univ, Med Ctr, Dept Anesthesia & Surg, Durham, NC 27708 USA.
EM muneerbhatt@yahoo.com
FU Division of Critical Care Medicine at Albert Einstein College of
   Medicine, Montefiore Medical Center
FX Supported, in part, by the Division of Critical Care Medicine at Albert
   Einstein College of Medicine, Montefiore Medical Center.
CR Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762
   Ayala E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054408
   Bell Robert B, 2002, JAAPA, V15, P40
   Benson Marc A, 2016, J Physician Assist Educ, V27, P81
   Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST
   Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI [10.1503/cmaj.080372, 10.1503/cmaj.080327]
   Costa DK, 2014, CHEST, V146, P1566, DOI 10.1378/chest.14-0566
   DUBAYBO BA, 1991, CHEST, V99, P89, DOI 10.1378/chest.99.1.89
   Embriaco N, 2007, CURR OPIN CRIT CARE, V13, P482, DOI 10.1097/MCC.0b013e3282efd28a
   Embriaco N, 2007, AM J RESP CRIT CARE, V175, P686, DOI 10.1164/rccm.200608-1184OC
   FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x
   FREUDENBERGER HJ, 1986, J PSYCHOACTIVE DRUGS, V18, P247, DOI 10.1080/02791072.1986.10472354
   Gershengorn HB, 2012, AM J RESP CRIT CARE, V185, P600, DOI 10.1164/rccm.201107-1261CP
   Gershengorn HB, 2011, CHEST, V139, P1347, DOI 10.1378/chest.10-2648
   Guntupalli KK, 1996, INTENS CARE MED, V22, P625, DOI 10.1007/s001340050142
   Halpern NA, 2013, CRIT CARE MED, V41, P2754, DOI 10.1097/CCM.0b013e318298a6fb
   Joffe AM, 2014, J CRIT CARE, V29, P112, DOI 10.1016/j.jcrc.2013.10.005
   Kahn SA, 2015, J SURG RES, V199, P7, DOI 10.1016/j.jss.2015.05.036
   Kamal AH, 2016, J PAIN SYMPTOM MANAG, V51, P690, DOI 10.1016/j.jpainsymman.2015.10.020
   Kawar Eyad, 2011, JAAPA, V24, P36
   Kleinpell R, 2015, AM J CRIT CARE, V24, pE16, DOI 10.4037/ajcc2015274
   Kleinpell RM, 2008, CRIT CARE MED, V36, P2888, DOI 10.1097/CCM.0b013e318186ba8c
   Lu DW, 2015, WEST J EMERG MED, V16, P996, DOI 10.5811/westjem.2015.9.27945
   Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397
   MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205
   Maslach C, 1996, MASLACH BURNOUT INVE
   Meltzer LS, 2004, AM J CRIT CARE, V13, P202
   Montero-Marin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157499
   Moote M, 2011, AM J MED QUAL, V26, P452, DOI 10.1177/1062860611402984
   Moss M, 2016, CRIT CARE MED, V44, P1414, DOI 10.1097/CCM.0000000000001885
   Ozden D, 2013, NURS ETHICS, V20, P436, DOI 10.1177/0969733012466002
   Poncet MC, 2007, AM J RESP CRIT CARE, V175, P698, DOI 10.1164/rccm.200606-806OC
   Quenot JP, 2012, INTENS CARE MED, V38, P55, DOI 10.1007/s00134-011-2413-z
   Robinson J, 2014, J NEUROSCI NURS, V46, pE3, DOI 10.1097/JNN.0000000000000040
   Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd
   SOLOMON MZ, 1993, AM J PUBLIC HEALTH, V83, P14, DOI 10.2105/AJPH.83.1.14
   Tawfik DS, 2017, J PERINATOL, V37, P315, DOI 10.1038/jp.2016.211
   Van Bogaert P, 2010, J CLIN NURS, V19, P1664, DOI 10.1111/j.1365-2702.2009.03128.x
NR 38
TC 3
Z9 3
U1 2
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0090-3493
EI 1530-0293
J9 CRIT CARE MED
JI Crit. Care Med.
PD NOV
PY 2017
VL 45
IS 11
BP 1900
EP 1906
DI 10.1097/CCM.0000000000002689
PG 7
WC Critical Care Medicine
SC General & Internal Medicine
GA FO8BM
UT WOS:000417107000051
PM 28837429
DA 2018-12-27
ER

PT J
AU Vafaee, A
   Khorramian, AN
AF Vafaee, A.
   Khorramian, A. N.
TI RETRACTED: Impact of charm H1-ZEUS combined data and determination of
   the strong coupling in two different schemes (Retracted article. See
   vol. 42, art no 089001, 2018)
SO CHINESE PHYSICS C
LA English
DT Article; Retracted Publication
DE QCD; HERA combined; PDFs; charm
ID DEEP-INELASTIC SCATTERING; LUND MONTE-CARLO; CROSS-SECTION; QCD
   ANALYSIS; PARTON DISTRIBUTIONS; ROOT-S=1.96 TEV; P(P)OVER-BAR
   COLLISIONS; PERTURBATION-THEORY; JET FRAGMENTATION; EP SCATTERING
AB We study the impact of recent measurements of charm cross section H1-ZEUS combined data on simultaneous determination of parton distribution functions (PDFs) and the strong coupling, alpha(s)(M-Z(2)), in two different schemes. We perform several fits based on Thorne-Roberts (RT) and Thorne-Roberts optimal (RTOPT) schemes at next-to-leading order (NLO). We show that adding charm cross section H1-ZEUS combined data reduces the uncertainty of the gluon distribution and improves the fit quality up to similar to 0.4% and similar to 0.9%,without and with the charm contribution, from the RT scheme to the RTOPT scheme, respectively. We also emphasise the central role of the strong coupling, alpha(s)(M-Z(2)), in revealing the impact of charm flavour contribution, when it is considered as an extra free parameter. We show that in going from the RT scheme to the RT OPT scheme, we get similar to 0.9% and similar to 2.0% improvement in the value of alpha(s)(M-Z(2)), without and with the charm flavour contribution respectively.
C1 [Vafaee, A.; Khorramian, A. N.] Semnan Univ, Fac Phys, POB 35131-19111, Semnan, Iran.
RP Vafaee, A (reprint author), Semnan Univ, Fac Phys, POB 35131-19111, Semnan, Iran.
EM a.vafaee@semnan.ac.ir; Khorramiana@semnan.ac.ir
CR Aaltonen T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.042003
   Aaltonen T, 2010, PHYS REV D, V81, DOI 10.1103/PhysRevD.81.052006
   Aaron FD, 2012, EUR PHYS J C, V72, DOI 10.1140/epjc/s10052-012-2252-2
   Aaron FD, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1769-0
   Aaron F.D., 2010, JHEP, V1001, P109
   Abazov VM, 2014, PHYS LETT B, V737, P357, DOI 10.1016/j.physletb.2014.09.007
   Abazov VM, 2013, PHYS LETT B, V719, P354, DOI 10.1016/j.physletb.2013.01.033
   Abazov VM, 2012, PHYS LETT B, V714, P32, DOI 10.1016/j.physletb.2012.06.056
   Abazov VM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.192002
   Abramowicz H, 2015, EUR PHYS J C, V75, DOI 10.1140/epjc/s10052-015-3710-4
   Abramowicz H, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2311-3
   Aktas A, 2006, EUR PHYS J C, V48, P715, DOI 10.1140/epjc/s10052-006-0035-3
   Alekhin S, 2011, PHYS LETT B, V699, P345, DOI 10.1016/j.physletb.2011.04.026
   Alekhin S., ARXIV09083128HEPPH
   ALTARELLI G, 1977, NUCL PHYS B, V126, P298, DOI 10.1016/0550-3213(77)90384-4
   Ball RD, 2010, NUCL PHYS B, V838, P136, DOI 10.1016/j.nuclphysb.2010.05.008
   Ball RD, 2009, NUCL PHYS B, V816, P293, DOI 10.1016/j.nuclphysb.2009.02.027
   Ball RD, 2009, NUCL PHYS B, V809, P1, DOI 10.1016/j.nuclphysb.2008.09.037
   Behnke O, 2015, PROG PART NUCL PHYS, V84, P1, DOI 10.1016/j.ppnp.2015.06.002
   BENEKE M, 1995, PHYS LETT B, V344, P341, DOI 10.1016/0370-2693(94)01505-7
   Botje M, 2011, COMPUT PHYS COMMUN, V182, P490, DOI 10.1016/j.cpc.2010.10.020
   BRODSKY SJ, 1980, PHYS LETT B, V93, P451, DOI 10.1016/0370-2693(80)90364-0
   Chekanov S, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.012007
   CIAFALONI M, 1988, NUCL PHYS B, V296, P49, DOI 10.1016/0550-3213(88)90380-X
   Collins JC, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.094002
   Cooper-Sarkar A, 2012, J PHYS G NUCL PARTIC, V39, DOI 10.1088/0954-3899/39/9/093001
   Daum K., HAMBURG 1995 96 FUTU, P89
   De Roeck A, 2011, PROG PART NUCL PHYS, V66, P727, DOI 10.1016/j.ppnp.2011.06.001
   Dokshitzer Yu. L., 1977, SOV PHYS JETP, V46, P641, DOI DOI 10.1016/0550-3213(77)90384-4
   Engelen J, 1998, PROG PART NUCL PHYS, V41, P1, DOI 10.1016/S0146-6410(98)00054-4
   Forte S, 2010, NUCL PHYS B, V834, P116, DOI 10.1016/j.nuclphysb.2010.03.014
   FRIXIONE S, 1993, PHYS LETT B, V319, P339, DOI 10.1016/0370-2693(93)90823-Z
   Gao J, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2541-4
   Gribov V. N., 1972, Yadernaya Fizika, V15, P781
   Gribov V.N., 1974, YAD FIZ, V20, P181
   GRIBOV VN, 1972, SOV J NUCL PHYS+, V15, P438
   JAMES F, 1975, COMPUT PHYS COMMUN, V10, P343, DOI 10.1016/0010-4655(75)90039-9
   JUNG H, 1995, COMPUT PHYS COMMUN, V86, P147, DOI 10.1016/0010-4655(94)00150-Z
   Jung H, 2001, EUR PHYS J C, V19, P351, DOI 10.1007/s100520100604
   KURAEV EA, 1976, SOV PHYS JETP, V44, P443
   KURAYEV EA, 1976, ZH EKSP TEOR FIZ+, V71, P840
   Lai HL, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.074024
   Lipatov L. N., 1977, ZH EKSP TEOR FIZ, V73, P1216
   LIPATOV LN, 1975, SOV J NUCL PHYS+, V20, P94
   LONNBLAD L, 1992, COMPUT PHYS COMMUN, V71, P15, DOI 10.1016/0010-4655(92)90068-A
   MARCHESINI G, 1992, COMPUT PHYS COMMUN, V67, P465, DOI 10.1016/0010-4655(92)90055-4
   Martin AD, 2009, EUR PHYS J C, V63, P189, DOI 10.1140/epjc/s10052-009-1072-5
   Martin AD, 2006, PHYS LETT B, V636, P259, DOI 10.1016/j.physletb.2006.03.054
   Martin AD, 1998, EUR PHYS J C, V4, P463, DOI 10.1007/s100529800904
   Mironov A, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP04(2010)040
   Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001
   Pumplin J, 2002, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2002/07/012
   Sapronov A, 2015, J PHYS CONF SER, V608, DOI 10.1088/1742-6596/608/1/012051
   Schmidt B, 2012, COMPUT PHYS COMMUN, V183, P1845, DOI 10.1016/j.cpc.2012.03.023
   SJOSTRAND T, 1986, COMPUT PHYS COMMUN, V39, P347, DOI 10.1016/0010-4655(86)90096-2
   SJOSTRAND T, 1987, COMPUT PHYS COMMUN, V43, P367, DOI 10.1016/0010-4655(87)90054-3
   Sjostrand T., HEPPH0108264
   Thorne RS, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.074017
   Thorne RS, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.054019
   Tung W. K., 2007, JHEP, V0702, P053
   Vafaee A, 2017, NUCL PHYS B, V921, P472, DOI 10.1016/j.nuclphysb.2017.06.011
NR 61
TC 2
Z9 2
U1 2
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1674-1137
EI 2058-6132
J9 CHINESE PHYS C
JI Chin. Phys. C
PD NOV
PY 2017
VL 41
IS 11
AR UNSP 113104
DI 10.1088/1674-1137/41/11/113104
PG 11
WC Physics, Nuclear; Physics, Particles & Fields
SC Physics
GA FL8EC
UT WOS:000414482100005
DA 2018-12-27
ER

PT J
AU Hussain, A
   Habib, M
AF Hussain, Ayyaz
   Habib, Muhammad
TI RETRACTED: A new cluster based adaptive fuzzy switching median filter
   for impulse noise removal (Retracted article. See vol. 12, pg. 197,
   2018)
SO MULTIMEDIA TOOLS AND APPLICATIONS
LA English
DT Article; Retracted Publication
DE Impulse noise; Gradient values; Cluster based fuzzy filter;
   Computational efficiency; Non-parametric approach; Fuzzy reasoning
ID REDUCTION METHOD; PEPPER NOISE; COLOR IMAGES; DETECTOR; OPTIMIZATION;
   ENHANCEMENT; DESIGN; SALT
AB A new clustering technique based on most allied directional neighbors is proposed to suppress low and high-density impulse noise from digital images. Most allied neighbors exhibit a vital role in estimation as well restoration of appropriate gray level value of corrupted pixels. In first phase, most allied directional neighbors, i.e., pixels directly attached to central pixel and the directional pixels (horizontal, vertical and two diagonal directions) next to attached pixels in the processing window are partitioned into two equal size clusters based on gradient values. Cluster with a minimum sum of gradient values (most similar neighbors) and the one with relatively large gradient values are passed to fuzzy inference system to infer the current pixel to be noisy-free, edge or a noisy. In second phase, a switching technique opts one of the three options depending upon fuzzy membership degrees and local information to restore the corrupted pixel value. A non-parametric approach based on local information for dynamic threshold setting using fuzzy logic makes the proposed filter computationally effective and adaptive to process a large number of images without user-defined parameters. The proposed algorithm is simple to implement and simulation results based on well know quantitative measures indicate the supremacy of the proposed filter for random-valued impulse noise as well as salt and peppers noise.
C1 [Hussain, Ayyaz; Habib, Muhammad] Int Islamic Univ, Dept Comp Sci & Software Engn, Islamabad, Pakistan.
   [Hussain, Ayyaz] Saudi Elect Univ, Coll Comp & Informat, Riyadh, Saudi Arabia.
RP Hussain, A (reprint author), Int Islamic Univ, Dept Comp Sci & Software Engn, Islamabad, Pakistan.; Hussain, A (reprint author), Saudi Elect Univ, Coll Comp & Informat, Riyadh, Saudi Arabia.
EM ayyaz.hussain@iiu.edu.pk; mhabibakhtar@gmail.com
CR Arce GR, 2000, IEEE T SIGNAL PROCES, V48, P768, DOI 10.1109/78.824671
   Awad AS, 2011, IEEE SIGNAL PROC LET, V18, P407, DOI 10.1109/LSP.2011.2154330
   Bilal M, 2014, MULTIMED TOOLS APPL, V69, P1067, DOI 10.1007/s11042-012-1172-3
   BROWNRIGG DRK, 1984, COMMUN ACM, V27, P807, DOI 10.1145/358198.358222
   Chen CLP, 2014, IEEE T GEOSCI REMOTE, V52, P574, DOI 10.1109/TGRS.2013.2242477
   Chen T, 1999, IEEE T IMAGE PROCESS, V8, P1834, DOI 10.1109/83.806630
   Crnojevic V, 2004, IEEE SIGNAL PROC LET, V11, P589, DOI 10.1109/LSP.2004.830117
   Dong YQ, 2007, IEEE SIGNAL PROC LET, V14, P193, DOI 10.1109/LSP.2006.884014
   FLORENCIO DAF, 1994, P SOC PHOTO-OPT INS, V2308, P268, DOI 10.1117/12.185969
   Garnett R, 2005, IEEE T IMAGE PROCESS, V14, P1747, DOI 10.1109/TIP.2005.857261
   Ghanekar U, 2010, IEEE SIGNAL PROC LET, V17, P1, DOI 10.1109/LSP.2009.2032479
   Gonzalez R. C, 2006, DIGITAL IMAGE PROCES
   Gui J, 2014, IEEE T IMAGE PROCESS, V23, P3126, DOI 10.1109/TIP.2014.2326001
   Gupta V, 2015, J VIS COMMUN IMAGE R, V26, P296, DOI 10.1016/j.jvcir.2014.10.004
   Habib M, 2016, AEU-INT J ELECTRON C, V70, P689, DOI 10.1016/j.aeue.2016.02.005
   Habib M, 2015, INT CONF FRONT INFO, P329, DOI 10.1109/FIT.2015.64
   Habib M, 2015, APPL SOFT COMPUT, V29, P471, DOI 10.1016/j.asoc.2015.01.010
   Hussain A, 2012, MULTIMED TOOLS APPL, V60, P551, DOI 10.1007/s11042-011-0829-7
   HWANG H, 1995, IEEE T IMAGE PROCESS, V4, P499, DOI 10.1109/83.370679
   Kang CC, 2009, SIGNAL PROCESS, V89, P344, DOI 10.1016/j.sigpro.2008.09.003
   KO SJ, 1991, IEEE T CIRCUITS SYST, V38, P984, DOI 10.1109/31.83870
   Li ZY, 2014, PATTERN RECOGN LETT, V40, P113, DOI 10.1016/j.patrec.2013.12.022
   Lin CH, 2010, IEEE T IMAGE PROCESS, V19, P2307, DOI 10.1109/TIP.2010.2047906
   Liu LC, 2015, INFORM SCIENCES, V315, P1, DOI 10.1016/j.ins.2015.03.067
   Lu CT, 2012, PATTERN RECOGN LETT, V33, P1287, DOI 10.1016/j.patrec.2012.03.025
   NODES TA, 1982, IEEE T ACOUST SPEECH, V30, P739, DOI 10.1109/TASSP.1982.1163951
   Roy A, 2017, AEU-INT J ELECTRON C, V72, P114, DOI 10.1016/j.aeue.2016.12.006
   Schulte S, 2006, IEEE T IMAGE PROCESS, V15, P1153, DOI 10.1109/TIP.2005.864179
   Schulte S, 2007, FUZZY SET SYST, V158, P270, DOI 10.1016/j.fss.2006.10.010
   Schulte S, 2006, IEEE T IMAGE PROCESS, V15, P3567, DOI 10.1109/TIP.2006.877494
   Toh KKV, 2010, IEEE T CONSUM ELECTR, V56, P2560, DOI 10.1109/TCE.2010.5681141
   Turkmen I, 2013, AEU-INT J ELECTRON C, V67, P771, DOI 10.1016/j.aeue.2013.03.006
   Xiong B, 2012, IEEE T IMAGE PROCESS, V21, P1663, DOI 10.1109/TIP.2011.2172804
   Zhang JJ, 2010, DIGIT SIGNAL PROCESS, V20, P1010, DOI 10.1016/j.dsp.2009.11.003
NR 34
TC 1
Z9 2
U1 3
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1380-7501
EI 1573-7721
J9 MULTIMED TOOLS APPL
JI Multimed. Tools Appl.
PD NOV
PY 2017
VL 76
IS 21
BP 22001
EP 22018
DI 10.1007/s11042-017-4757-z
PG 18
WC Computer Science, Information Systems; Computer Science, Software
   Engineering; Computer Science, Theory & Methods; Engineering, Electrical
   & Electronic
SC Computer Science; Engineering
GA FJ4XX
UT WOS:000412748200008
DA 2018-12-27
ER

PT J
AU Chen, Z
   Rui, YJ
   Xu, YJ
   Zhang, QR
   Sun, ZZ
   Zhou, JD
   Chen, XM
AF Chen, Zheng
   Rui, Yongjun
   Xu, Yajun
   Zhang, Quanrong
   Sun, Zhenzhong
   Zhou, Jiandong
   Chen, Xueming
TI RETRACTED: Effect of tendon hydrogel on healing of tendon injury
   (Retracted article. See vol. 15, pg. 5154, 2018)
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article; Retracted Publication
DE Hydrogel; hand trauma; tendon injury; healing
ID PLATELET-RICH PLASMA; TENDINOPATHY; REGENERATION; INJECTION; MATRIX;
   REPAIR; MODEL
AB Hand trauma arising from postoperative acute or chronic tendon injuries leads to delayed union and is one of the greatest challenges in clinical practice. The present study hypothesized that an extracellular matrix hydrogel made from tendons can promote tendon healing and improve tissue regeneration. To verify this, 36 Wistar rats were subjected to bilateral full-thickness injury of their Achilles tendons, starting from the heel bone along the center line to remove a segment of 5 mm in length and 0.5 mm in width. On the sites of injury, hydrogel was injected on one side, while the contralateral side was injected with an equal volume of normal saline. At 2, 4 and 8 weeks after the operation, bilateral tendons were subjected to biomechanical tests to determine the ultimate failure load, tensile strength and toughness, and cross-sectional slices of the tendons were subjected to histological analysis. The results indicated that after 2 weeks, the hydrogel and control group showed no significant difference in terms of ultimate load (P=0.15) ultimate tensile stress (P=0.42) and toughness (P=0.76). At 4 weeks following surgery, the failure load in the hydrogel group was significantly higher than that in the control group (74.8 +/- 14.2 vs. 58.4 +/- 11.6; P=0.02), while there were no significant differences in the ultimate tensile stress (P=0.63) and toughness (P=0.08). At 8 postoperative weeks, the above mentioned parameters showed no significant difference between the groups (P=0.15, 0.39 and 0.75, respectively). In conclusion, the tendon-derived extracellular matrix hydrogel was able to significantly improve tendon strength at 4 weeks after injury in terms of increasing the ultimate failure load. Hydrogel applied immediately after tendon injury can enhance the type-I collagen content. The present study therefore provided a basis for further exploration of the application of extracellular matrix hydrogel to promote tendon healing in the clinic.
C1 [Chen, Zheng; Rui, Yongjun; Xu, Yajun; Zhang, Quanrong; Sun, Zhenzhong; Zhou, Jiandong; Chen, Xueming] Ninth Peoples Hosp Wuxi City, Dept Bone Surg, 999 Liangqi Rd, Wuxi 214062, Jiangsu, Peoples R China.
RP Rui, YJ (reprint author), Ninth Peoples Hosp Wuxi City, Dept Bone Surg, 999 Liangqi Rd, Wuxi 214062, Jiangsu, Peoples R China.
EM ruiyongjwx@yeah.net
CR Andersson T, 2012, INT J SPORTS MED, V33, P240, DOI 10.1055/s-0031-1291324
   Beck J, 2012, AM J SPORT MED, V40, P2037, DOI 10.1177/0363546512453300
   Chong AKS, 2007, J BONE JOINT SURG AM, V89A, P74, DOI 10.2106/JBJS.E.01396
   Huss FRM, 2010, J PLAST RECONSTR AES, V63, P848, DOI 10.1016/j.bjps.2009.01.068
   Kampa RJ, 2010, INT J CLIN PRACT, V64, P1813, DOI 10.1111/j.1742-1241.2010.02432.x
   Longo UG, 2011, BRIT MED BULL, V98, P31, DOI 10.1093/bmb/ldq030
   Neviaser A, 2012, J SHOULDER ELB SURG, V21, P158, DOI 10.1016/j.jse.2011.11.014
   Ngo M, 2001, PLAST RECONSTR SURG, V108, P1260, DOI 10.1097/00006534-200110000-00025
   Okamoto N, 2010, J BONE JOINT SURG AM, V92A, P2776, DOI 10.2106/JBJS.I.01325
   Sato D, 2012, J HAND SURG-AM, V37A, P1356, DOI 10.1016/j.jhsa.2012.04.020
   Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Virchenko O, 2006, ACTA ORTHOP, V77, P806, DOI 10.1080/17453670610013033
   Wolf MT, 2012, BIOMATERIALS, V33, P7028, DOI 10.1016/j.biomaterials.2012.06.051
   Yu YD, 2013, EXP THER MED, V5, P830, DOI 10.3892/etm.2012.877
NR 16
TC 1
Z9 1
U1 3
U2 4
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD NOV
PY 2017
VL 14
IS 5
BP 3955
EP 3960
DI 10.3892/etm.2017.5020
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA FM4GS
UT WOS:000414973100001
PM 29067092
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Coco, M
   Perciavalle, V
   Cavallari, P
   Bolzoni, F
   Graziano, ACE
   Perciavalle, V
AF Coco, Marinella
   Perciavalle, Vincenzo
   Cavallari, Paolo
   Bolzoni, Francesco
   Graziano, Adriana Carol Eleonora
   Perciavalle, Valentina
TI RETRACTED: Effects of age and sex on epigenetic modification induced by
   an acute physical exercise (Retracted article. See vol. 97, artn. E9706,
   2018)
SO MEDICINE
LA English
DT Article; Retracted Publication
DE acute exercise; age; DNA methyltransferase; epigenetic regulation; sex;
   interleukin-6
ID BLOOD MONONUCLEAR-CELLS; DNA METHYLATION; SKELETAL-MUSCLE; IMPACT
AB It has been observed that, after 2hours of aerobic exercise, plasma interleukin-6 (IL-6) increases whereas nuclear concentrations of enzyme DNA methyltransferase (DNMT) 3B significantly decreased in peripheral blood mononuclear cells (PBMCs), with no change observed in DNMT3A. The aim of the present study was to detect differences in these changes induced by exercise in plasma IL-6 levels as well as in PBMC nuclear concentrations of DNMT3A and DNMT3B, in relation to age and sex. Four groups were studied: 12 young men (24.8 +/- 1.77 years old), 12 young women (23.8 +/- 1.81 years old), 12 adult men (45.8 +/- 1.82 years old), 12 adult women (mean 44.5 +/- 2.07 years old). Participants had to run at 60% of maximal oxygen consumption (VO2max) for 120minutes, interspersed with sprints at 90% of VO2max for the last 30seconds of every 10minutes. About 250L of PBMCs (1x10(6) cells) were treated with 100L of either pre-exercise plasma or post-exercise plasma and nuclear DNMT3A and DNMT3B concentrations were quantified. No change in nuclear concentration of DNMT3A following the exercise was observed. Conversely, nuclear concentrations of DNMT3B significantly decreased, with a reduction of about 78% in young men, 72% in young women, 61% in adult men, and 53% in adult women. Moreover, a strong positive correlation between the nuclear concentration of DNMT3B in PBMC following stimulation with post-exercise plasma and post-exercise plasma concentrations of IL-6 was observed in all the 4 studied groups. This study confirms that a single bout of endurance exercise is sufficient to decrease nuclear concentrations of DNMT3B and thus protein upregulation. Moreover, the epigenetic mechanisms induced by exercise apparently cause more intense changes in men than in women and that, in both of them, this effect seems to decrease with age.
C1 [Coco, Marinella; Perciavalle, Vincenzo; Graziano, Adriana Carol Eleonora] Univ Milan, Physiol Sect, Dept Biomed & Biotechnol Sci, Milan, Italy.
   [Cavallari, Paolo; Bolzoni, Francesco] Univ Milan, Human Physiol Sect, Dept Pathophysiol & Transplantat, Milan, Italy.
   [Perciavalle, Valentina] Univ Catania, Dept Sci Format, Catania, Italy.
RP Perciavalle, V (reprint author), Dipartimento Sci Biomed & Biotecnol, Sez Fisiol, Via Santa Sofia 89, I-95123 Catania, Italy.
EM perciava@unict.it
RI Graziano, Adriana/J-9952-2016
OI Graziano, Adriana/0000-0003-1652-9577
CR Auclair G, 2012, BIOCHIMIE, V94, P2202, DOI 10.1016/j.biochi.2012.05.016
   Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001
   Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048
   Chedin F, 2011, PROG MOL BIOL TRANSL, V101, P255, DOI 10.1016/B978-0-12-387685-0.00007-X
   Coco M, 2015, NEUROL SCI, V36, P541, DOI 10.1007/s10072-014-2015-y
   Connolly PH, 2004, J APPL PHYSIOL, V97, P1461, DOI 10.1152/japplphysiol.00316.2004
   Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511
   Denham J, 2015, EPIGENOMICS-UK, V7, P717, DOI 10.2217/epi.15.29
   Denham J, 2015, J APPL PHYSIOL, V118, P475, DOI 10.1152/japplphysiol.00878.2014
   Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387
   HORSBURGH S, 2015, PHYSL REP, V3
   Liu Y, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0055-7
   Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653
   Riggs A. D., 1996, EPIGENETIC MECH GENE
   Robson-Ansley PJ, 2014, J BIOL REG HOMEOS AG, V28, P407
   Ronn T, 2013, EPIGENOMICS-UK, V5, P603, DOI 10.2217/epi.13.61
   Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103
   Walshe I, 2010, EUR J APPL PHYSIOL, V110, P619, DOI 10.1007/s00421-010-1548-x
   Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366
NR 19
TC 1
Z9 1
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD NOV
PY 2017
VL 96
IS 44
AR e8325
DI 10.1097/MD.0000000000008325
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA FM5UQ
UT WOS:000415106800015
PM 29095264
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Tang, F
   Yang, TL
   Zhang, Z
   Li, XG
   Zhong, QQ
   Zhao, TT
   Gong, L
AF Tang, Feng
   Yang, Tian-Lun
   Zhang, Zhen
   Li, Xiao-Gang
   Zhong, Qiao-Qing
   Zhao, Ting-Ting
   Gong, Li
TI RETRACTED: MicroRNA-21 suppresses ox-LDL-induced human aortic
   endothelial cells injuries in atherosclerosis through enhancement of
   autophagic flux: Involvement in promotion of lysosomal function
   (Retracted article. See vol. 369, pg. 177, 2018)
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Article; Retracted Publication
DE MiR-21; Endothelial cell injury; Autophagic flux; Lysosomal function;
   Atherosclerosis
ID APOPTOSIS; PATHWAY; DYSFUNCTION; EXPRESSION; MECHANISM; PROTECTS;
   BIOGENESIS; METABOLISM; INCREASES; TARGET
AB Atherosclerosis is a common pathological basis of cardiovascular disease and remains the leading cause of mortality. Endothelial cell (EC) injury and autophagy dysfunction have been proved to contribute to the development of atherosclerosis. Recently, accumulating evidence confirms that microRNAs (miRNAs) have emerged as vital regulators and fine-tuners of various pathophysiological cellular impacts and molecular signaling pathways involved in atherosclerosis. Herein, the objective of the present study was to explore the biological function of miR-21 in oxidized low-density lipoprotein (ox-LDL)-induced human aortic endothelial cells (HAECs) injury and the underlying molecular mechanism. The results showed that ox-LDL treatment significantly decreased HAECs viability, increased caspase-3 activity, apoptosis ratio and Bax protein expression, and reduced Bcl-2 protein expression resulting in EC injuries. Simultaneously, ox-LDL treatment obviously reduced miR-21 level in a time-and dose-dependent manner. Notably, ox-LDL-induced EC injuries were abolished by miR-21 mimics transfection. In addition, miR-21 mimics alleviated ox-LDL-induced impaired autophagic flux as illustrated by the increases in LC3-II/LC3-I ratio and Beclin-1 protein expression, and the decrease in p62 protein expression in HAECs. Moreover, ox-LDL suppressed the expressions of lysosomal membrane protein (LAMP1) and cathepsin D proteins, and attenuated cathepsin D activity in HAECs, leading to lysosomal dysfunction, while these effects were also blocked by miR-21 mimics. These findings indicated that miR-21 restored impaired autophagic flux and lysosomal dysfunction, thereby attenuating ox-LDL-induced HAECs injuries.
C1 [Tang, Feng; Yang, Tian-Lun; Zhong, Qiao-Qing; Zhao, Ting-Ting; Gong, Li] Cent S Univ, Xiangya Hosp, Dept Cardiol, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.
   [Tang, Feng] Guizhou Prov Peoples Hosp, Dept Cardiol, Guiyang 550002, Guizhou, Peoples R China.
   [Zhang, Zhen] Cent S Univ, Xiangya Hosp 3, Dept Ctr Expt Med, Changsha 410008, Hunan, Peoples R China.
   [Li, Xiao-Gang] Cent S Univ, Xiangya Hosp 3, Dept Cardiovasc Med, Changsha 410008, Hunan, Peoples R China.
RP Yang, TL (reprint author), Cent S Univ, Xiangya Hosp, Dept Cardiol, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.
EM Yangtl80@qq.com
FU Natural Science Foundation of China [81570334]
FX This study was supported by Natural Science Foundation of China
   (81570334).
CR Avila MF, 2013, CELL BIOL INT, V37, P521, DOI 10.1002/cbin.10058
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bobryshev YV, 2013, J CELL MOL MED, V17, P626, DOI 10.1111/jcmm.12042
   Bonci D., DRUG DISCOV
   Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788
   Delbridge LIM O., 2017, NAT REV CARDIOL
   Dong Q, 2013, BRAZ J MED BIOL RES, V46, P765, DOI 10.1590/1414-431X20132733
   Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342
   Fatkhullina AR, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1358, DOI 10.1134/S0006297916110134
   Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0
   Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049
   Gwak HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047449
   Hackett EE, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.72
   Han M, 2011, CURR OPIN CARDIOL, V26, P181, DOI 10.1097/HCO.0b013e328345983d
   Hopkins PN, 2013, PHYSIOL REV, V93, P1317, DOI 10.1152/physrev.00004.2012
   Huang ZQ, 2017, J CELL MOL MED, V21, P467, DOI 10.1111/jcmm.12990
   Hubbi ME, 2015, AUTOPHAGY, V11, P850, DOI 10.1080/15548627.2015.1037063
   Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2
   Jaffonr B., 2017, CAN J CARDIOL, V33, P313
   Jaishy B, 2016, J LIPID RES, V57, P1619, DOI 10.1194/jlr.R067520
   Kalani M, 2017, CELL MOL BIOL, V63, P34, DOI 10.14715/cmb/2017.63.1.7
   Kalani M, 2016, PROBIOTICS ANTIMICRO, V8, P61, DOI 10.1007/s12602-016-9214-1
   Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540
   Kihara A, EMBO, V2, P330
   Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35
   Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035
   Kumar S, 2014, ARTERIOSCL THROM VAS, V34, P2206, DOI 10.1161/ATVBAHA.114.303425
   Liu XJ, 2015, EXP CELL RES, V338, P64, DOI 10.1016/j.yexcr.2015.08.010
   Liu YR, 2014, ACTA PHARMACOL SIN, V35, P483, DOI 10.1038/aps.2013.190
   Luo Y, 2016, J CARDIOVASC PHARM, V67, P266, DOI 10.1097/FJC.0000000000000342
   MAIOLINO G, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/714653
   Marcin N., 2007, EUR J CELL BIOL, V86, P605
   Martinet W, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0321-1
   Martinet W, 2008, CURR ATHEROSCLER REP, V10, P216, DOI 10.1007/s11883-008-0034-y
   MENGHINI R, 2014, CELL, V5, DOI DOI 10.1038/CDDIS.2013.556
   Muller C, 2011, AUTOPHAGY, V7, P541, DOI 10.4161/auto.7.5.15003
   Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455
   Olejarz W, 2014, EUR J CLIN INVEST, V44, P54, DOI 10.1111/eci.12191
   Rafieian-Kopaei M, 2014, INT J PREVENTIVE MED, V5, P927
   Rajagopalan S, 2004, BLOOD, V103, P3677, DOI 10.1182/blood-2003-09-3198
   Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009
   Savitskaya MA, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1393, DOI 10.1134/S0006297915110012
   Schrijvers DM, 2011, ARTERIOSCL THROM VAS, V31, P2787, DOI 10.1161/ATVBAHA.111.224899
   Sermersheim MA, 2017, FRONT BIOSCI-LANDMRK, V22, P48, DOI 10.2741/4471
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Sun T, 2017, INT J MOL SCI, V18, DOI [10.3390/ijms18040745, 10.3390/ijms18030645]
   Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2
   TANIDA I, 2008, AUT PHAG, V445, P77, DOI DOI 10.1007/978-1-59745-157-4_4
   YANG K, 2017, INT J MOL SCI, V18
   Yang Q, 2015, INT J CLIN EXP PATHO, V8, P3735
   Zhang Y. L., 2010, BIOCHEM BIOPH RES CO, V394, P201
   Zhang YL, 2010, BIOCHEM BIOPH RES CO, V394, P377, DOI 10.1016/j.bbrc.2010.03.026
   Zuo KQ, 2015, INT J CLIN EXP PATHO, V8, P414
NR 53
TC 7
Z9 7
U1 3
U2 6
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD OCT 15
PY 2017
VL 359
IS 2
BP 374
EP 383
DI 10.1016/j.yexcr.2017.08.021
PG 10
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA FV8TL
UT WOS:000424859600010
PM 28823833
DA 2018-12-27
ER

PT J
AU Li, C
   Gai, ZC
   Wang, K
   Jin, LP
AF Li, Chao
   Gai, Zhongchao
   Wang, Kai
   Jin, Liping
TI RETRACTED: Engineering Bacillus licheniformis as a thermophilic platform
   for the production of L-lactic acid from lignocellulose-derived sugars
   (Retracted article. See vol. 11, artn 100, 2018)
SO BIOTECHNOLOGY FOR BIOFUELS
LA English
DT Article; Retracted Publication
DE Lignocellulosic biomass; Thermophiles; Bacillus licheniformis; L-Lactic
   acid; Metabolic engineering
ID CORN STOVER HYDROLYSATE; OPEN FERMENTATIVE PRODUCTION; HIGHLY EFFICIENT
   PRODUCTION; MINERAL SALTS MEDIUM; HIGH OPTICAL PURITY; SIMULTANEOUS
   SACCHARIFICATION; HIGH-YIELD; D-LACTATE; XYLOSE; COAGULANS
AB Background: Bacillus licheniformis MW3 as a GRAS and thermophilic strain is a promising microorganism for chemical and biofuel production. However, its capacity to co-utilize glucose and xylose, the major sugars found in lignocellulosic biomass, is severely impaired by glucose-mediated carbon catabolite repression (CCR). In this study, a "dual-channel" process was implemented to engineer strain MW3 for simultaneous utilization of glucose and xylose, using L-lactic acid as a target product.
   Results: A non-phosphotransferase system (PTS) glucose uptake route was activated via deletion of the glucose transporter gene ptsG and introduction of the galactose permease gene galP. After replacing the promoter of glucokinase gene glck with the strong promoter P-als, the engineered strain recovered glucose consumption and utilized glucose and xylose simultaneously. Meanwhile, to improve the consumption rate of xylose in this strain, several measures were undertaken, such as relieving the regulation of the xylose repressor XylR, reducing the catabolite-responsive element, and optimizing the rate-limiting step. Knockout of ethanol and acetic acid pathway genes further increased lactic acid yield by 6.2%. The resultant strain, RH15, was capable of producing 121.9 g/L L-lactic acid at high yield (95.3%) after 40 h of fermentation from a mixture of glucose and xylose. When a lignocellulosic hydrolysate was used as the substrate, 99.3 g/L L-lactic acid was produced within 40 h, with a specific productivity of 2.48 g/[L h] and a yield of 94.6%.
   Conclusions: Our engineered strain B. licheniformis RH15 could thermophilically produced L-lactic acid from lignocellulosic hydrolysate with relatively high concentration and productivity at levels that were competitive with most reported cases of L-lactic acid-producers. Thus, the engineered strain might be used as a platform for the production of other chemicals. In addition to engineering the B. licheniformis strain, the "dual-channel" process might serve as an alternative method for engineering a variety of other strains.
C1 [Li, Chao; Wang, Kai; Jin, Liping] Tongji Univ, Sch Med, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, Shanghai 200092, Peoples R China.
   [Gai, Zhongchao] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China.
   [Gai, Zhongchao] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China.
RP Wang, K; Jin, LP (reprint author), Tongji Univ, Sch Med, Clin & Translat Res Ctr, Shanghai Matern & Infant Hosp 1, Shanghai 200092, Peoples R China.
EM kaiwangcn@yahoo.com; jinlp01@163.com
FU National Natural Science Foundation of China [81703394]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81703394).
CR Abou-Shanab RAI, 2007, CHEMOSPHERE, V68, P360, DOI 10.1016/j.chemosphere.2006.12.051
   Ahring BK, 2016, BIOCHEM ENG J, V109, P162, DOI 10.1016/j.bej.2016.01.012
   Bhavsar AP, 2001, APPL ENVIRON MICROB, V67, P403, DOI 10.1128/AEM.67.1.403-410.2001
   Bischoff KM, 2010, BIOTECHNOL LETT, V32, P823, DOI 10.1007/s10529-010-0222-z
   Budhavaram NK, 2009, BIORESOURCE TECHNOL, V100, P5966, DOI 10.1016/j.biortech.2009.01.080
   Chang TH, 2011, APPL MICROBIOL BIOT, V92, P13, DOI 10.1007/s00253-011-3456-3
   Chen Z, 2017, METAB ENG, V39, P151, DOI 10.1016/j.ymben.2016.11.009
   Cordova LT, 2016, METAB ENG, V37, P63, DOI 10.1016/j.ymben.2016.05.001
   Cripps RE, 2009, METAB ENG, V11, P398, DOI 10.1016/j.ymben.2009.08.005
   Demeke MM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005010
   Demeke MM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-120
   Fu HX, 2017, METAB ENG, V40, P50, DOI 10.1016/j.ymben.2016.12.014
   Hu JL, 2015, BIORESOURCE TECHNOL, V182, P251, DOI 10.1016/j.biortech.2015.02.008
   Jung MY, 2014, APPL ENVIRON MICROB, V80, P6195, DOI 10.1128/AEM.02069-14
   Lee SM, 2012, APPL ENVIRON MICROB, V78, P5708, DOI 10.1128/AEM.01419-12
   Li C, 2016, CHEMBIOCHEM, V17, P1491, DOI 10.1002/cbic.201600288
   Li C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09777
   Li LX, 2015, METAB ENG, V28, P19, DOI 10.1016/j.ymben.2014.11.010
   Li LX, 2014, APPL ENVIRON MICROB, V80, P6458, DOI 10.1128/AEM.01802-14
   Li LX, 2014, BIORESOURCE TECHNOL, V170, P256, DOI 10.1016/j.biortech.2014.07.101
   Li LX, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-123
   Liu RM, 2013, BIORESOURCE TECHNOL, V149, P84, DOI 10.1016/j.biortech.2013.09.052
   Ma KD, 2016, BIORESOURCE TECHNOL, V219, P114, DOI 10.1016/j.biortech.2016.07.100
   Ma KD, 2014, BIORESOURCE TECHNOL, V151, P28, DOI 10.1016/j.biortech.2013.10.022
   Ouyang J, 2013, BIORESOURCE TECHNOL, V135, P475, DOI 10.1016/j.biortech.2012.09.096
   Peng LL, 2013, BIORESOURCE TECHNOL, V149, P169, DOI 10.1016/j.biortech.2013.09.047
   Poudel P, 2016, BIOSCI BIOTECH BIOCH, V80, P642, DOI 10.1080/09168451.2015.1095069
   Qiu YM, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0522-1
   Rachinger M, 2013, J BIOTECHNOL, V167, P365, DOI 10.1016/j.jbiotec.2013.07.026
   Walton SL, 2010, J IND MICROBIOL BIOT, V37, P823, DOI 10.1007/s10295-010-0727-4
   Wang LM, 2014, APPL ENVIRON MICROB, V80, P7134, DOI 10.1128/AEM.01864-14
   Wang LM, 2011, APPL MICROBIOL BIOT, V89, P1009, DOI 10.1007/s00253-010-2904-9
   Wang QZ, 2011, BIORESOURCE TECHNOL, V102, P8152, DOI 10.1016/j.biortech.2011.06.003
   Waschkau B, 2008, APPL MICROBIOL BIOT, V78, P181, DOI 10.1007/s00253-007-1278-0
   Wee YJ, 2009, BIORESOURCE TECHNOL, V100, P4262, DOI 10.1016/j.biortech.2009.03.074
   Xiao H, 2012, METAB ENG, V14, P569, DOI 10.1016/j.ymben.2012.05.003
   Xin B, 2017, METAB ENG, V41, P102, DOI 10.1016/j.ymben.2017.03.009
   Xu K, 2014, BIORESOURCE TECHNOL, V153, P23, DOI 10.1016/j.biortech.2013.11.057
   Xue ZW, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-43
   Yu SL, 2004, AM J RESP CRIT CARE, V169, P1135, DOI 10.1164/rccm.200211-1278OC
   Zhang YX, 2016, APPL MICROBIOL BIOT, V100, P279, DOI 10.1007/s00253-015-7016-0
   Zhang YM, 2014, BIORESOURCE TECHNOL, V163, P160, DOI 10.1016/j.biortech.2014.04.038
   Zhao K, 2013, BIORESOURCE TECHNOL, V135, P481, DOI 10.1016/j.biortech.2012.09.063
   Zheng ZJ, 2012, APPL ENVIRON MICROB, V78, P3480, DOI 10.1128/AEM.00058-12
   Zhou SD, 2003, APPL ENVIRON MICROB, V69, P399, DOI 10.1128/AEM.69.1.399-407.2003
NR 45
TC 1
Z9 1
U1 9
U2 31
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1754-6834
J9 BIOTECHNOL BIOFUELS
JI Biotechnol. Biofuels
PD OCT 11
PY 2017
VL 10
AR 235
DI 10.1186/s13068-017-0920-z
PG 13
WC Biotechnology & Applied Microbiology; Energy & Fuels
SC Biotechnology & Applied Microbiology; Energy & Fuels
GA FJ5EN
UT WOS:000412769900002
PM 29046721
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Jin, L
   Xin, F
AF Jin, L.
   Xin, F.
TI RETRACTED: Effects of synthetic magnetic flux in a parity-time-symmetric
   system of three coupled optical resonators (Retracted article. See vol.
   96, 2017)
SO PHYSICAL REVIEW A
LA English
DT Article; Retracted Publication
ID EXCEPTIONAL POINTS; HERMITIAN HAMILTONIANS; REALITY
AB Photons do not directly interact with magnetic fields. Recent progress in synthetic gauge fields have stimulated investigations in various fields. In this study, we explore the enclosed synthetic magnetic flux in a parity-time (PT)-symmetric system of three coupled optical resonators; this flux suppresses the PT transition and affects the topological structure of PT transition points. Although the phase rigidities of the coalesced states no longer vanish at exceptional points (EPs), the orders of the EPs (which are affected by the magnetic flux) can be identified. At a three-state coalescence, the intensity of an initial excitation increases according to a power law, and at a two-state coalescence, the intensity can behave as invariant, oscillatory, quadratic increase, and oscillatory quadratic increase. Our findings provide an insight into the interplay between non-Hermiticity and the effective magnetic flux.
C1 [Jin, L.] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China.
   [Xin, F.] Tianjin Normal Univ, Coll Phys & Mat Sci, Tianjin 300387, Peoples R China.
RP Jin, L (reprint author), Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China.
EM jinliang@nankai.edu.cn; cindyfeifei@163.com
FU National Natural Science Foundation of China [11605094]; Tianjin Natural
   Science Foundation [16JCY-BJC40800]
FX We acknowledge the support of the National Natural Science Foundation of
   China (Grant No. 11605094) and the Tianjin Natural Science Foundation
   (Grant No. 16JCY-BJC40800).
CR Am-Shallem M, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.032116
   Am-Shallem M, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/11/113036
   Bender CM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.270401
   Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243
   Bendix O, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.030402
   Cartarius H, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/44/444008
   Cartarius H, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.013419
   Chang L, 2014, NAT PHOTONICS, V8, P524, DOI [10.1038/nphoton.2014.133, 10.1038/NPHOTON.2014.133]
   Chong YD, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053901
   D'Ambroise J, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/44/444012
   Demange G, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/2/025303
   Dietz B, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027201
   Ding K, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.235310
   Dorey P, 2001, J PHYS A-MATH GEN, V34, P5679, DOI 10.1088/0305-4470/34/28/305
   Duanmu M, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0171
   El-Ganainy R, 2007, OPT LETT, V32, P2632, DOI 10.1364/OL.32.002632
   Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479
   Feng L, 2013, NAT MATER, V12, P108, DOI [10.1038/NMAT3495, 10.1038/nmat3495]
   Gong JB, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.012103
   Graefe EM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.150408
   Graefe EM, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/25/255206
   Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902
   Haag D, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.053627
   Hafezi M, 2014, INT J MOD PHYS B, V28, DOI 10.1142/S0217979214410021
   Hafezi M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.210405
   Haritan I, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4931774
   Heiss WD, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/44/444016
   Heiss WD, 2004, CZECH J PHYS, V54, P1091, DOI 10.1023/B:CJOP.0000044009.17264.dc
   Heiss WD, 2004, J PHYS A-MATH GEN, V37, P2455, DOI 10.1088/0305-4470/37/6/034
   Hodaei H, 2014, SCIENCE, V346, P975, DOI 10.1126/science.1258480
   Jin L, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.062110
   Jin L, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.012111
   Jin L, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.042116
   Jin L, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.032109
   Jin L, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.052107
   Jing H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03546-7
   Jing H, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.053604
   Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1
   Joglekar YN, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.030103
   Jones HF, 2005, J PHYS A-MATH GEN, V38, P1741, DOI 10.1088/0305-4470/38/8/010
   Klaiman S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.080402
   Li K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066608
   Liu ZP, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.110802
   Longhi S, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/34001
   Longhi S, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.022102
   Lu XY, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.253601
   Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904
   Mostafazadeh A, 2002, J MATH PHYS, V43, P205, DOI 10.1063/1.1418246
   Muller M, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/24/244018
   Musslimani ZH, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.030402
   Peng B, 2014, SCIENCE, V346, P328, DOI 10.1126/science.1258004
   Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/NPHYS2927, 10.1038/nphys2927]
   Phang S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20499
   Puri R. R., 2001, SOLUTION LINEAR EQUA
   Rotter I, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/11/114001
   Rotter I, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/15/153001
   Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515
   Ruschhaupt A, 2005, J PHYS A-MATH GEN, V38, pL171, DOI 10.1088/0305-4470/38/9/L03
   Scully M. O., 1997, QUANTUM OPTICS
   Suchkov SV, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/6/065005
   Sukhorukov AA, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.043818
   Sun Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.143903
   Uzdin R, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.022505
   Wan WJ, 2011, SCIENCE, V331, P889, DOI 10.1126/science.1200735
   Wiersig J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.203901
   Xu H, 2016, NATURE, V537, P80, DOI 10.1038/nature18604
   Xue L. F., ARXIV161206959
   YANG C, 2017, PHYS REV A, V95
   Znojil M, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.025026
NR 69
TC 1
Z9 1
U1 3
U2 5
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 2469-9926
EI 2469-9934
J9 PHYS REV A
JI Phys. Rev. A
PD OCT 10
PY 2017
VL 96
IS 4
AR 043821
DI 10.1103/PhysRevA.96.043821
PG 9
WC Optics; Physics, Atomic, Molecular & Chemical
SC Optics; Physics
GA FJ4HV
UT WOS:000412698500010
OA Other Gold
DA 2018-12-27
ER

PT J
AU Hagrot, E
   Oddsdottir, HA
   Hosta, JG
   Jacobsen, EW
   Chotteaua, V
AF Hagrot, Erika
   Oddsdottir, Hildur Aesa
   Hosta, Joan Gonzalez
   Jacobsen, Elling W.
   Chotteaua, Veronique
TI RETRACTED: Poly-pathway model, a novel approach to simulate multiple
   metabolic states by reaction network-based model-Application to amino
   acid depletion in CHO cell culture (Retracted article. See vol. 265, pg.
   127, 2018)
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article; Retracted Publication
DE Modeling; Metabolic flux analysis; Elementary flux modes; Chinese
   hamster ovary cells; Amino acid metabolism; Poly-pathway model
ID ELEMENTARY FLUX MODES; HAMSTER OVARY CELLS; GROWTH; MEDIA; BATCH;
   DISTRIBUTIONS; INFORMATION; DYNAMICS; BALANCE; DESIGN
AB Mammalian cell lines are characterized by a complex and flexible metabolism. A single model that could describe the variations in metabolic behavior triggered by variations in the culture conditions would be a precious tool in bioprocess development. In this paper, we introduce an approach to generate a poly-pathway model and use it to simulate diverse metabolic states triggered in response to removal, reduction or doubling of amino acids in the culture medium of an antibody-producing CHO cell line. Macro-reactions were obtained from a metabolic network via elementary flux mode enumeration and the fluxes were modeled by kinetic equations with saturation and inhibition effects from external medium components. Importantly, one set of kinetic parameters was estimated using experimental data of the multiple metabolic states. A good fit between the model and the data was obtained for the majority of the metabolites and the experimentally observed flux variations. We find that the poly-pathway modeling approach is promising for the simulation of multiple metabolic states.
C1 [Hagrot, Erika; Hosta, Joan Gonzalez; Chotteaua, Veronique] KTH Royal Inst Technol, Cell Technol Grp, Dept Ind Biotechnol Bioproc Design, Sch Biotechnol, Stockholm, Sweden.
   [Hagrot, Erika; Hosta, Joan Gonzalez; Chotteaua, Veronique] AdBIOPRO, Competence Ctr Adv Bioprod Continuous Proc, Solna, Sweden.
   [Jacobsen, Elling W.] KTH Royal Intl Technol, Dept Automat Control, Sch Elect Engn, Stockholm, Sweden.
   [Oddsdottir, Hildur Aesa] KTH Royal Inst Technol, Dept Math, Div Optimizat & Syst Theory, Stockholm, Sweden.
RP Chotteaua, V (reprint author), KTH Royal Inst Technol, Cell Technol Grp, Dept Ind Biotechnol Bioproc Design, Sch Biotechnol, Stockholm, Sweden.; Chotteaua, V (reprint author), AdBIOPRO, Competence Ctr Adv Bioprod Continuous Proc, Solna, Sweden.
EM chotteau@kth.se
OI Chotteau, Veronique/0000-0002-5370-4621
FU KTH; Swedish Governmental Agency for Innovation Systems (VINNOVA)
FX This work was supported by KTH and the Swedish Governmental Agency for
   Innovation Systems (VINNOVA). The CHO cell line was kindly provided by
   Selexis, Switzerland. Culture media were kindly provided by Irvine
   Scientific, USA. The authors acknowledge the contribution of Ye Zhang,
   Andreas Andersson and Antonio Aliaga for preliminary studies, and Jan
   Kinnander, and Atefeh Shokri for technical support. The authors declare
   no conflict of interest.
CR Ahn WS, 2012, BIOTECHNOL J, V7, P61, DOI 10.1002/biot.201100052
   Ahn WS, 2011, METAB ENG, V13, P598, DOI 10.1016/j.ymben.2011.07.002
   Altamirano C, 2001, BIOTECHNOL PROGR, V17, P1032, DOI 10.1021/bp0100981
   Altamirano C, 2006, J BIOTECHNOL, V125, P547, DOI 10.1016/j.jbiotec.2006.03.023
   [Anonymous], 2006, PLOS ONE
   Badsha MB, 2014, BIOCHEM ENG J, V90, P121, DOI 10.1016/j.bej.2014.05.022
   Barrett CL, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-30
   Berrios J, 2011, CHEM ENG SCI, V66, P2431, DOI 10.1016/j.ces.2011.03.011
   BIBILA TA, 1995, BIOTECHNOL PROGR, V11, P1, DOI 10.1021/bp00031a001
   de Figueiredo LF, 2009, BIOINFORMATICS, V25, P3158, DOI 10.1093/bioinformatics/btp564
   Dorka P, 2009, BIOPROC BIOSYST ENG, V32, P183, DOI 10.1007/s00449-008-0236-2
   Ferreira AR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-181
   Gambhir A, 2003, J BIOSCI BIOENG, V95, P317, DOI 10.1016/S1389-1723(03)80062-2
   Gao JY, 2007, BIOTECHNOL PROGR, V23, P168, DOI 10.1021/bp060089y
   Gonzalez-Martinez JM, 2014, CHEMOMETR INTELL LAB, V134, P89, DOI 10.1016/j.chemolab.2014.02.003
   Goudar C, 2010, METAB ENG, V12, P138, DOI 10.1016/j.ymben.2009.10.007
   Jungers RM, 2011, AUTOMATICA, V47, P1255, DOI 10.1016/j.automatica.2011.01.011
   Kaleta C, 2009, GENOME RES, V19, P1872, DOI 10.1101/gr.090639.108
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076
   Klamt S, 2003, TRENDS BIOTECHNOL, V21, P64, DOI 10.1016/S0167-7799(02)00034-3
   Liebermeister W, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-41
   Llaneras F, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/753904
   Machado D, 2012, BIOINFORMATICS, V28, pI515, DOI 10.1093/bioinformatics/bts401
   Naderi S, 2011, BIOTECHNOL PROGR, V27, P1197, DOI 10.1002/btpr.647
   Nelson D. L, 2005, LEHNINGER PRINCIPLES
   Nolan RP, 2011, METAB ENG, V13, P108, DOI 10.1016/j.ymben.2010.09.003
   Oddsdottir H.AE., 2014, J MATH BIOL
   Papin JA, 2004, TRENDS BIOTECHNOL, V22, P400, DOI 10.1016/j.tibtech.2004.06.010
   Provost A, 2005, IEEE DECIS CONTR P, P2982
   Provost A, 2004, J PROCESS CONTR, V14, P717, DOI 10.1016/j.jprocont.2003.12.004
   Quek LE, 2010, METAB ENG, V12, P161, DOI 10.1016/j.ymben.2009.09.002
   Robitaille J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136815
   Rohn H., 2012, BMC SYST BIOL, V6
   Rohn H, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-139
   SANDERS PG, 1984, EMBO J, V3, P65, DOI 10.1002/j.1460-2075.1984.tb01762.x
   Sariyar B, 2006, J THEOR BIOL, V242, P389, DOI 10.1016/j.jtbi.2006.03.007
   Schuster S., 1994, J BIOL SYST, V2, P165, DOI DOI 10.1142/S0218339094000131
   Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445
   Sengupta N, 2011, BIOTECHNOL BIOENG, V108, P82, DOI 10.1002/bit.22890
   Sidorenko Y, 2008, BIOTECHNOL PROGR, V24, P311, DOI 10.1021/bp0702673
   Song HS, 2009, BIOTECHNOL BIOENG, V102, P554, DOI 10.1002/bit.22062
   Tabe-Bordbar S, 2013, BIOTECHNOL LETT, V35, P2039, DOI 10.1007/s10529-013-1328-x
   Van Dien SJ, 2006, J BIOSCI BIOENG, V102, P34, DOI 10.1263/jbb.102.34
   von Kamp A, 2006, BIOINFORMATICS, V22, P1930, DOI 10.1093/bioinformatics/btl267
   Wahrheit J, 2014, APPL MICROBIOL BIOT, V98, P1771, DOI 10.1007/s00253-013-5452-2
   Xie LZ, 1996, BIOTECHNOL BIOENG, V52, P579, DOI 10.1002/(SICI)1097-0290(19961205)52:5<579::AID-BIT5>3.0.CO;2-G
   XIE LZ, 1994, BIOTECHNOL BIOENG, V43, P1164, DOI 10.1002/bit.260431122
   Xing ZZ, 2011, PROCESS BIOCHEM, V46, P1423, DOI 10.1016/j.procbio.2011.03.014
   Zamorano F, 2013, J BIOTECHNOL, V164, P409, DOI 10.1016/j.jbiotec.2012.05.005
   Zamorano F, 2010, J BIOTECHNOL, V150, P497, DOI 10.1016/j.jbiotec.2010.09.944
   ZUPKE C, 1995, BIOTECHNOL BIOENG, V45, P292, DOI 10.1002/bit.260450403
NR 52
TC 1
Z9 1
U1 2
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD OCT 10
PY 2017
VL 259
BP 235
EP 247
DI 10.1016/j.jbiotec.2017.05.026
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA FI5OZ
UT WOS:000412035000034
PM 28689014
OA Other Gold
DA 2018-12-27
ER

PT J
AU Luo, W
   Li, YL
   Chen, YJ
   Xiang, Q
   Chen, H
AF Luo, Wei
   Li, Ya-lun
   Chen, Ya Juan
   Xiang, Qing
   Chen, Hong
TI RETRACTED: High dose of nimustine as an add-on treatment for small cell
   lung cancer with intracranial metastasis A case report and literature
   review (Retracted article. See vol.96, artn.e9328, 2017)
SO MEDICINE
LA English
DT Review; Retracted Publication
DE high dose; intracranial metastases; lung cancer; nimustine
ID BRAIN METASTASES; CHEMOTHERAPY; ACNU
AB Rationale: Small cell lung cancer (SCLC) characterized by high degree of malignancy and rapid tumor progression. Intracranial metastases often appear at the time of the initial diagnosis or treatment. Besides of radiotherapy, chemotherapy is supposed to have limited effect.
   Patient concerns: A 66-year-old male had blurred vision and unsteady step with moderate headache, nausea, vomit.
   Diagnoses: The patient was diagnosed with SCLC with intracranial metastases.
   Interventions: High dose of nimustine (ACNU) (300mg/m(2)) add to the regimen containing carboplatin and irinotecan.
   Outcomes: Although the patient suffered severe myelosuppression, the intracranial lesion almost disappeared and maintained half a year.
   Lessons: ACNU at a dose of 200mg/m(2) might be tolerable in combination with other chemotherapeutic drugs for the treatment of SCLC with intracranial metastases besides radiotherapy.
C1 [Luo, Wei] Peoples Hosp Leshan, Dept Resp Med, Leshan, Peoples R China.
   [Li, Ya-lun] Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu, Sichuan, Peoples R China.
   [Chen, Ya Juan; Xiang, Qing; Chen, Hong] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China.
RP Chen, H (reprint author), Chongqing Med Univ, Affiliated Hosp 1, Dept Resp Med, Chongqing 400016, Peoples R China.
EM LuoBao97@163.com
CR FUJIWARA T, 1991, Neurologia Medico-Chirurgica, V31, P654, DOI 10.2176/nmc.31.654
   Fujiwara T, 1995, SURG NEUROL, V44, P145, DOI 10.1016/0090-3019(95)00141-7
   Grossi F, 2001, CRIT REV ONCOL HEMAT, V37, P61, DOI 10.1016/S1040-8428(00)00098-6
   HIRSCH FR, 1983, CANCER, V51, P529, DOI 10.1002/1097-0142(19830201)51:3<529::AID-CNCR2820510327>3.0.CO;2-0
   Isobe K, 2009, LUNG CANCER, V66, P350, DOI 10.1016/j.lungcan.2009.03.003
   Izaki S, 2007, INT J HEMATOL, V86, P253, DOI 10.1532/IJH97.06231
   Jett JR, 2013, CHEST, V143, pE400, DOI 10.1378/chest.12-2363
   Nakagawa H, 1991, Gan To Kagaku Ryoho, V18, P2435
   Nakagawa H, 1988, Gan To Kagaku Ryoho, V15, P3153
   PATCHELL RA, 1991, NEUROL CLIN, V9, P817
   SHIBUI S, 1983, Neurological Surgery, V11, P723
   UyBico SJ, 2010, RADIOGRAPHICS, V30, P1163, DOI 10.1148/rg.305095166
   Wang YZ, 2014, NEUROSURG REV, V37, P73, DOI 10.1007/s10143-013-0490-x
NR 13
TC 1
Z9 1
U1 3
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD OCT
PY 2017
VL 96
IS 41
AR e8218
DI 10.1097/MD.0000000000008218
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA FO2VJ
UT WOS:000416652600017
PM 29019889
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Sanchez, N
   Coutand, I
   Turienzo, M
   Lebinson, F
   Araujo, V
   Dimieri, L
AF Sanchez, Natalia
   Coutand, Isabelle
   Turienzo, Martin
   Lebinson, Fernando
   Araujo, Vanesa
   Dimieri, Luis
TI RETRACTED: Middle Miocene to Early Pliocene Contraction in the Chos
   Malal Fold-and-Thrust Belt (Neuquen Basin, Argentina): Insights From
   Structural Analysis and Apatite Fission-Tracks Thermochronology
   (Retracted article. See vol. 36, pg. 3333, 2017)
SO TECTONICS
LA English
DT Article; Retracted Publication
DE AFT apatite fission-track analysis; Andean tectonic; structural
   evolution; thick- and thin-skinned deformation; Argentinean Andes
ID SOUTHERN CENTRAL ANDES; TROMEN VOLCANIC PLATEAU; TECTONIC EVOLUTION;
   MAGMATIC CHARACTERISTICS; ANNEALING KINETICS; CONVERGENCE RATE; FORELAND
   BASIN; AGE; ARC; DEFORMATION
AB In the southern central Andes at 37-38 degrees S latitude, the Chos Malal fold-and-thrust belt (FTB), which results from the Late Cretaceous closure of the Neuquen Basin, has generated increasing interest because of its potential for hydrocarbon exploration. Using detailed field mapping, seismic reflection and well data analysis, cross-section balancing, and detrital apatite fission-track thermochronology from 18 samples distributed along the FTB, we bring new quantitative constraints on the chronology of the Neogene structural development of the Chos Malal FTB. Our data set reveals that extensive tectonically driven exhumation through basement-involved thrusting occurred at similar to 15-7Ma in both the inner and outer sectors of the FTB. This age range is corroborated by indirect dating of the Chos Malal Formation, a syntectonic unit also deformed after deposition, which we find was deposited after 7.2Ma1.6/2.0Ma, an age much younger than the Miocene age it was previously assigned. We document for the first time an early Pliocene rapid cooling stage that was ongoing similar to 5.5 to 5.1Ma ago in the interior of the orogenic wedge, which we attribute to out-of-sequence thrusting along basement-involved thrust faults bounding the Cordillera del Viento, driving the surface uplift of this prominent topographic feature. Finally, our sequential reconstruction of the thick- and thin-skinned structures of the Chos Malal FTB shows that most of the horizontal shortening was accommodated after the middle Miocene, which we thus consider as being the main phase of orogenic building in this sector of the Andes.
C1 [Sanchez, Natalia; Turienzo, Martin; Lebinson, Fernando; Araujo, Vanesa; Dimieri, Luis] Univ Nacl Sur, Inst Geol Sur, Dept Geol, CONICET, Bahia Blanca, Buenos Aires, Argentina.
   [Coutand, Isabelle] Dalhousie Univ, Dept Earth Sci, Halifax, NS, Canada.
RP Sanchez, N (reprint author), Univ Nacl Sur, Inst Geol Sur, Dept Geol, CONICET, Bahia Blanca, Buenos Aires, Argentina.
EM natalia.sanchez@uns.edu.ar
FU ANPCyT-FONCyT [PICT 2015-0419]; CONICET [PIP 2015-0583]; Department of
   Foreign Affairs, Trade and Development (Global Affairs Canada)
FX The study was funded by ANPCyT-FONCyT PICT 2015-0419 and CONICET PIP
   2015-0583 awarded to L. Dimieri and by an Emerging Leaders of the
   America Program scholarship from the Department of Foreign Affairs,
   Trade and Development (Global Affairs Canada) awarded to I Coutand for
   N. Sanchez. Technical support for AFT sample preparation was provided by
   Bertha Louis (Dalhousie fission-track laboratory) and is greatly
   appreciated. We are grateful to the Subsecretaria de Energia, Mineria e
   Hidrocarburos of the Neuquen Province for providing the seismic and well
   data and with Gonzalo Zamora Valcarce for his advice on AFTA samples
   collection. The new data sets presented in this manuscript are available
   in Tables 1 and 2 in the main text and in the supporting information. We
   thank Nathan Niemi (Editor), Lindsay Schoenbohm (Associate Editor), and
   anonymous reviewers for their constructive suggestions that enriched the
   clarity of the manuscript.
CR Aguirre-Urreta MB, 2008, J S AM EARTH SCI, V26, P91, DOI 10.1016/j.jsames.2008.01.001
   Allmendinger R. W., 2012, FAULT FOLD FORWARD V
   Allmendinger R.W., 2004, THRUST TECTONICS HYD, V82, P356
   Arregui C., 2011, CONTEXTO TECTOSEDIME, P29
   Barbarand J, 2003, CHEM GEOL, V198, P107, DOI 10.1016/S0009-2541(02)00424-2
   Booth J., 1996, 3 INT S AND GEOD ST, P295
   Brandon M.T., 2002, TRACK, V24, P13
   BRANDON MT, 1992, AM J SCI, V292, P535, DOI 10.2475/ajs.292.8.535
   Brandon MT, 1996, RADIAT MEAS, V26, P663, DOI 10.1016/S1350-4487(97)82880-6
   Burns WM, 2006, GEOL SOC AM SPEC PAP, V407, P163, DOI 10.1130/2006.2407(08)
   Carlson WD, 1999, AM MINERAL, V84, P1213
   Cervera Martín, 2009, Rev. Mus. Argent. Cienc. Nat., V11, P15
   Cobbold P., 2008, INT S ANDEAN GEODYNA, V7, P148
   Cobbold PR, 2003, MAR PETROL GEOL, V20, P429, DOI 10.1016/S0264-8172(03)00077-1
   Coutand I, 2016, TECTONICS, V35, P2963, DOI 10.1002/2016TC004258
   DAHLEN F.A., 1988, GEOLOGICAL SOC AM SP, V218, P161, DOI DOI 10.1130/SPE218-P161
   DAHLSTROM CD, 1969, CAN J EARTH SCI, V6, P743, DOI 10.1139/e69-069
   DAVIS D, 1983, J GEOPHYS RES, V88, P1153, DOI 10.1029/JB088iB02p01153
   Di Giulio A, 2012, GEOLOGY, V40, P559, DOI 10.1130/G33052.1
   Donelick RA, 1999, AM MINERAL, V84, P1224
   Donelick RA, 2005, REV MINERAL GEOCHEM, V58, P49, DOI 10.2138/rmg.2005.58.3
   Dyhr CT, 2013, LITHOS, V179, P67, DOI 10.1016/j.lithos.2013.08.007
   ERSLEV EA, 1991, GEOLOGY, V19, P617, DOI 10.1130/0091-7613(1991)019<0617:TFPF>2.3.CO;2
   Fennell LM, 2017, BASIN RES, V29, P51, DOI 10.1111/bre.12135
   Fleischer RL, 1975, NUCL TRACKS SOLIDS P
   Folguera A, 2015, J S AM EARTH SCI, V64, P381, DOI 10.1016/j.jsames.2015.08.003
   Folguera A, 2002, REV GEOL CHILE, V29, P227
   Folguera A, 2007, J GEODYN, V44, P129, DOI 10.1016/j.jog.2007.02.003
   Folguera A, 2006, GEOL SOC AM SPEC PAP, V407, P247, DOI 10.1130/2006.2407(11)
   Folguera A, 2008, TECTONOPHYSICS, V459, P140, DOI 10.1016/j.tecto.2007.12.013
   Franchini M, 2003, J S AM EARTH SCI, V16, P399, DOI 10.1016/S0895-9811(03)00103-2
   Franzese J, 2003, J S AM EARTH SCI, V16, P81, DOI 10.1016/S0895-9811(03)00020-8
   GALBRAITH RF, 1990, NUCL TRACKS RAD MEAS, V17, P197
   GALBRAITH RF, 1981, J INT ASS MATH GEOL, V13, P471, DOI 10.1007/BF01034498
   Galland O, 2007, TECTONICS, V26, DOI 10.1029/2006TC002011
   Garrido A, 2012, ANDEAN GEOL, V39, P482, DOI 10.5027/andgeoV39n3-a07
   Garrido Alberto C., 2010, Rev. Mus. Argent. Cienc. Nat., V12, P121
   Garver JI, 1999, GEOL SOC SPEC PUBL, V154, P283, DOI 10.1144/GSL.SP.1999.154.01.13
   GLEADOW AJW, 1981, NUCL TRACKS RAD MEAS, V5, P169, DOI 10.1016/0191-278X(81)90039-1
   Godoy E, 1999, TECTONOPHYSICS, V306, P217, DOI 10.1016/S0040-1951(99)00046-3
   Gomez Omil R., 2014, PROC QUE CONTR MAD 9, V1, P71
   GREEN PF, 1986, CHEM GEOL, V59, P237, DOI 10.1016/0009-2541(86)90048-3
   GREEN PF, 1989, CHEM GEOL, V79, P155, DOI 10.1016/0168-9622(89)90018-3
   GREEN PF, 1981, NUCL TRACKS RAD MEAS, V5, P77, DOI 10.1016/0191-278X(81)90029-9
   GREEN PF, 1985, NUCL TRACKS RAD MEAS, V10, P323, DOI 10.1016/0735-245X(85)90121-8
   Gulisano CA, 1984, 9 C GEOL ARG ACT BUE, V1, P236
   Gulisano CA, 1995, ASOC GEOL ARGENT E, V2, P111
   Gurer D., 2015, ARGENTINA GSA B, V128, P315
   Howell JA, 2005, GEOL SOC SPEC PUBL, V252, P1, DOI 10.1144/GSL.SP.2005.252.01.01
   Jordan TE, 2001, TECTONICS, V20, P308, DOI 10.1029/1999TC001181
   Kay SM, 2002, J S AM EARTH SCI, V15, P39
   Kay SM, 2006, GEOL SOC AM SPEC PAP, V407, P185, DOI 10.1130/2006.2407(09)
   Kay SM, 2006, GEOL SOC AM SPEC PAP, V407, P19, DOI 10.1130/2006.2407(02)
   Ketcham RA, 1999, AM MINERAL, V84, P1235
   Kozlowski E., 1996, ACTAS, V1, P15
   Kozlowski E., 1998, ARGENTINA B INFORM P, P4
   LASLETT GM, 1987, CHEM GEOL, V65, P1, DOI 10.1016/0009-2541(87)90189-6
   Laslett GM, 1996, GEOCHIM COSMOCHIM AC, V60, P5117, DOI 10.1016/S0016-7037(96)00307-9
   Leanza HA, 2013, J S AM EARTH SCI, V42, P171, DOI 10.1016/j.jsames.2012.07.012
   Leanza H.A., 2001, BOLETIN, V275, P1
   Leanza H.A., 2003, SERIE CONTRIBUCIONES, V2, P1
   Leanza Héctor A., 2009, Rev. Mus. Argent. Cienc. Nat., V11, P145
   Legarreta L., 1999, I GEOLOGIA RECURSOS, V29, P399
   Legarreta L., 2012, PETROTECNIA, V4, P14
   Llambias E., 2011, GEOLOGIA RECURSOS NA, P627
   Llambías E.J., 2005, Rev. Asoc. Geol. Argent., V60, P552
   Llambias E. J., 1987, P 10 C GEOL ARG TUC, P249
   Llambias E.J., 1989, ASOCIACION GEOLOGICA, V44, P224
   Melnick D, 2006, GEOL SOC AM SPEC PAP, V407, P73, DOI 10.1130/2006.2407(04)
   Messager G, 2010, TECTONICS, V29, DOI 10.1029/2009TC002609
   MITRA S, 1990, AAPG BULL, V74, P921
   Munoz J, 2000, REV GEOL CHILE, V27, P177, DOI 10.4067/S0716-02082000000200003
   Naeser C. W., 1976, FISSION TRACK DATING, P65
   Naipauer M, 2015, GEOL SOC SPEC PUBL, V399, P131, DOI 10.1144/SP399.1
   Nocioni A, 1996, 13 C GEOL ARG 3 C EX, V2, P353
   Radic JP, 2010, ANDEAN GEOL, V37, P220, DOI 10.5027/andgeoV37n1-a09
   Ploszkiewicz V., 1987, B INF PET, V4, P97
   Radic J. P., 2002, 15 C GEOL ARG CAL, V3, P233
   Ramos V.A., 1998, ACT 10 C LAT GEOL BU, V2, P105
   Ramos V.A., 1989, REV ASOC GEOL ARGENT, V43, P210
   Ramos VA, 2005, GEOL SOC SPEC PUBL, V252, P15, DOI 10.1144/GSL.SP.2005.252.01.02
   Ramos VA, 2014, GEOSCI FRONT, V5, P351, DOI 10.1016/j.gsf.2013.12.009
   Ramos VA, 2006, GEOL SOC AM SPEC PAP, V407, P1, DOI 10.1130/2006.2407(01)
   Reiners PW, 2006, ANNU REV EARTH PL SC, V34, P419, DOI 10.1146/annurev.earth.34.031405.125202
   Repol D., 2002, 15 C GEOL ARG ACT, V227, P6
   Rojas Vera E., 2016, GROWTH SO ANDES, V4, P178
   Vera EAR, 2015, J S AM EARTH SCI, V64, P418, DOI 10.1016/j.jsames.2015.10.001
   Rovere E., 1998, 10 C LAT GEOL 6 C NA, V1, P144
   Sagripanti L, 2014, J IBER GEOL, V40, P349, DOI 10.5209/rev_JIGE.2014.v40.n2.45305
   Sagripanti L., 2016, GROWTH SO ANDES, V5, P205
   Sagripanti L, 2015, GEOMORPHOLOGY, V232, P164, DOI 10.1016/j.geomorph.2014.12.022
   Sanchez N. P., 2015, THESIS
   Sanchez N, 2015, J S AM EARTH SCI, V64, P399, DOI 10.1016/j.jsames.2015.07.001
   Selva G., 2005, TRAMPAS HIDROCARBURO, P141
   Spagnuolo MG, 2012, J GEODYN, V53, P81, DOI 10.1016/j.jog.2011.07.004
   Spalletti LA, 1996, J S AM EARTH SCI, V9, P197, DOI 10.1016/0895-9811(96)00006-5
   Spalletti LA, 2008, J S AM EARTH SCI, V25, P440, DOI 10.1016/j.jsames.2007.08.005
   SUAREZ M, 1995, J S AM EARTH SCI, V8, P17, DOI 10.1016/0895-9811(94)00038-4
   SUPPE J, 1990, ECLOGAE GEOL HELV, V83, P409
   SUPPE J, 1983, AM J SCI, V283, P684, DOI 10.2475/ajs.283.7.684
   Tagami T, 2005, REV MINERAL GEOCHEM, V58, P19, DOI 10.2138/rmg.2005.58.2
   Tunik M, 2010, TECTONOPHYSICS, V489, P258, DOI 10.1016/j.tecto.2010.04.017
   Turienzo M, 2014, J S AM EARTH SCI, V53, P1, DOI 10.1016/j.jsames.2014.04.004
   Turienzo M., 2015, 15 REUN TECT GEN ROC, P150
   Vergani C.D., 1995, AAPG MEMOIR, V62, P383
   Vergani G. D., 2011, REL 18 C GEOL PROV N, P645
   Vines R., 1989, ACTAS, V2, P1107
   Wagner G. A., 1992, FISSION TRACK DATING, DOI /10. 1007/978-94-011-2478-2
   Zamora Valcarce G., 2007, Rev. Asoc. Geol. Argent., V62, P299
   Zamora Valcarce G., 2005, 6 C EXPL DES HIDR MA, P16
   Zamora Valcarce G., 2008, FAJ PLEG AGR 17 C GE, V17, P171
   Valcarce GZ, 2006, GEOL SOC AM SPEC PAP, V407, P125, DOI 10.1130/2006.2407(06)
   Zapata T, 2005, GEOL SOC SPEC PUBL, V252, P37, DOI 10.1144/GSL.SP.2005.252.01.03
   Zapata T., 1999, B INF PET, V60, P113
   Zapata T., 2001, B INF PET, V66, P38
   Zollner W., 1973, SERVICIO NACL MINERO, V143, P1
NR 116
TC 2
Z9 2
U1 3
U2 8
PU AMER GEOPHYSICAL UNION
PI WASHINGTON
PA 2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA
SN 0278-7407
EI 1944-9194
J9 TECTONICS
JI Tectonics
PD OCT
PY 2017
VL 36
IS 10
BP 1966
EP 1987
DI 10.1002/2017TC004516
PG 22
WC Geochemistry & Geophysics
SC Geochemistry & Geophysics
GA FN5HQ
UT WOS:000416038200005
DA 2018-12-27
ER

PT J
AU Yang, KJ
   Piao, LZ
   Shin, S
   Shin, SY
   Li, YW
   Lee, HJ
   Tran, Q
   Park, J
   Hong, S
   Brazil, DP
   Hemmings, BA
   Kim, SH
   Park, J
AF Yang, Keum-Jin
   Piao, Longzhen
   Shin, Sanghee
   Shin, So-Yeon
   Li, Yuwen
   Lee, Hyunji
   Quangdon Tran
   Park, Jisoo
   Hong, Suntaek
   Brazil, Derek P.
   Hemmings, Brian A.
   Kim, Seon-Hwan
   Park, Jongsun
TI RETRACTED: Modulation of PI3K/PTEN Pathway Does Not Affect Catalytic
   Activity of PDK1 in Jurkat Cells (Retracted article. See vol. 37, pg.
   6496, 2017)
SO ANTICANCER RESEARCH
LA English
DT Article; Retracted Publication
DE PTEN; PI3K; PDK1; protein phosphorylation; Jurkat cells
ID PROTEIN-KINASE-C; PHOSPHOINOSITIDE-DEPENDENT KINASE; TUMOR-SUPPRESSOR
   GENE; TYROSINE PHOSPHORYLATION; T-CELLS; PHOSPHATIDYLINOSITOL
   3,4,5-TRISPHOSPHATE; NUCLEAR TRANSLOCATION; SIGNAL-TRANSDUCTION; PTEN
   EXPRESSION; PLASMA-MEMBRANE
AB Unopposed phosphoinositide 3-kinase (PI3K) activity and 3-phosphoinositide production in Jurkat cells, due to a mutation in the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) tumor-suppressor protein, results in deregulation of PH domain-containing proteins including the serine/threonine kinase PKB. In Jurkat cells, PKB is constitutively active and phosphorylated at the activation-loop residue (Thr308). 3-Phosphoinositide-dependent protein kinase-1 (PDK1), an enzyme that also contains a PH domain, catalyses Thr308 phosphorylation of PKB in addition to other kinase families such as PKC isoforms. It is unknown, however, whether the loss of PTEN in Jurkat cells also results in unregulated PDK1 activity and whether such loss has an impact on activation-loop phosphorylation of other PDK1 substrates e.g. PKC. In this study, we addressed whether loss of PTEN in Jurkat cells affects PDK1 catalytic activity and intracellular localization. We demonstrated that reducing the level of 3-phosphoinositides in Jurkat cells with pharmacological inhibitors of PI3K or expression of PTEN does not affect PDK1 activity or its intracellular localization. We conclude, therefore, that although Jurkat cells lack PTEN expression, only a subset of pathways downstream of PDK1 are perturbed as a consequence of PTEN loss.
C1 [Yang, Keum-Jin; Piao, Longzhen; Shin, Sanghee; Shin, So-Yeon; Li, Yuwen; Lee, Hyunji; Quangdon Tran; Park, Jisoo; Park, Jongsun] Chungnam Natl Univ, Coll Med, Inst Canc Res, Metab Syndrome & Cell Signaling Lab,Dept Pharmaco, Daejeon 35015, South Korea.
   [Kim, Seon-Hwan] Chungnam Natl Univ, Coll Med, Inst Canc Res, Dept Neurosurg, Daejeon 35015, South Korea.
   [Piao, Longzhen] Yanbian Univ Hosp, Dept Oncol, Yanji, Peoples R China.
   [Li, Yuwen] Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian, Shaanxi, Peoples R China.
   [Hong, Suntaek] Gachon Univ, Sch Med, Dept Biochem, Lab Canc Cell Biol, Incheon, South Korea.
   [Brazil, Derek P.] Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland.
   [Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
RP Park, J (reprint author), Chungnam Natl Univ, Coll Med, Inst Canc Res, Metab Syndrome & Cell Signaling Lab,Dept Pharmaco, Daejeon 35015, South Korea.; Kim, SH (reprint author), Chungnam Natl Univ, Coll Med, Inst Canc Res, Dept Neurosurg, Daejeon 35015, South Korea.
EM neons@cnu.ac.kr; insulin@cnu.ac.kr
FU Chungnam National University; National Research Foundation of Korea
   (NRF) - Korea Government (MEST) [NRF-2012M3A9B6055302,
   NRF-2014R1A1A305-0752, NRF-2015R1A2A2A01003597, NRF-2015R1D1A3A01015694]
FX This work was financially supported by research fund of Chungnam
   National University in 2015 (Jongsun Park) and by the National Research
   Foundation of Korea (NRF) grant funded by the Korea Government (MEST)
   (NRF-2012M3A9B6055302, NRF-2014R1A1A305-0752, NRF-2015R1A2A2A01003597,
   NRF-2015R1D1A3A01015694).
CR Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X
   Antal CE, 2014, BIOCHEM SOC T, V42, P1477, DOI 10.1042/BST20140172
   Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1
   Bendib M, 2015, PATHOL RES PRACT, V211, P248, DOI 10.1016/j.prp.2014.12.007
   Besson A, 1999, EUR J BIOCHEM, V263, P605, DOI 10.1046/j.1432-1327.1999.00542.x
   Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240
   Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287
   Chen H, 2001, BIOCHEMISTRY-US, V40, P11851, DOI 10.1021/bi010743c
   Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0
   Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575
   Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005
   Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002
   Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414
   Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000
   Freeburn RW, 2002, J IMMUNOL, V169, P5441, DOI 10.4049/jimmunol.169.10.5441
   Freeley M, 2005, BIOCHEM BIOPH RES CO, V334, P619, DOI 10.1016/j.bbrc.2005.06.136
   Grillo S, 2000, EUR J BIOCHEM, V267, P6642, DOI 10.1046/j.1432-1327.2000.01759.x
   Kim AY, 2015, TOX RESEARCH, V31, P151, DOI 10.5487/TR.2015.31.2.151
   Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200
   King CC, 2004, J BIOL CHEM, V279, P37518, DOI 10.1074/jbc.M405340200
   Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379
   Li Y, 2013, CELL SIGNAL, V25, P74, DOI 10.1016/j.cellsig.2012.09.009
   Lim MA, 2003, P NATL ACAD SCI USA, V100, P14006, DOI 10.1073/pnas.2335486100
   Meller N, 1999, CELL IMMUNOL, V193, P185, DOI 10.1006/cimm.1999.1478
   Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022
   Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626
   Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200
   Prasad N, 2000, BIOCHEMISTRY-US, V39, P6929, DOI 10.1021/bi000387i
   Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707
   Scheid MP, 2005, MOL CELL BIOL, V25, P2347, DOI 10.1128/MCB.25.6.2347-2363.2005
   Seminario MC, 2003, ONCOGENE, V22, P8195, DOI 10.1038/sj.onc.1206872
   Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000
   Sonnenburg ED, 2001, J BIOL CHEM, V276, P45289, DOI 10.1074/jbc.M107416200
   Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356
   Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710
   Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567
   Storz P, 2002, FRONT BIOSCI, V7, pD886, DOI 10.2741/storz
   Tesio M, 2016, ONCOGENE, V35, P3887, DOI 10.1038/onc.2015.462
   Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X
   Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002
   Xu Z, 2002, CELL GROWTH DIFFER, V13, P285
   Xue G, 2015, J NATL CANC I, V107
   Yoshimoto M, 2012, GENE CHROMOSOME CANC, V51, P149, DOI 10.1002/gcc.20939
   Zeng LL, 2012, ADV EXP MED BIOL, V740, P639, DOI 10.1007/978-94-007-2888-2_28
NR 44
TC 1
Z9 1
U1 1
U2 9
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0250-7005
EI 1791-7530
J9 ANTICANCER RES
JI Anticancer Res.
PD OCT
PY 2017
VL 37
IS 10
BP 5415
EP 5423
DI 10.21873/anticanres.11969
PG 9
WC Oncology
SC Oncology
GA FJ2UD
UT WOS:000412584300012
PM 28982851
DA 2018-12-27
ER

PT J
AU Thomas, D
   Abdul Halim, S
AF Thomas, D. K.
   Abdul Halim, S.
TI RETRACTED: Toeplitz Matrices Whose Elements are the Coefficients of
   Starlike and Close-to-Convex Functions (Retracted article. See vol. 41,
   pg. 1151, 2018)
SO BULLETIN OF THE MALAYSIAN MATHEMATICAL SCIENCES SOCIETY
LA English
DT Article; Retracted Publication
DE Univalent functions; Coefficients; Starlike; Close-to-convex; Toeplitz
   matrices
AB Let f be analytic in D = {z : vertical bar z vertical bar < 1: with f (z) = z + Sigma(infinity)(n=2) a(n)z(n) Suppose that S* is the class of starlike functions, and K is the class of close-to-convex functions. The paper instigates a study of finding estimates for Toeplitz determinants whose elements are the coefficients for f in S* and K.
C1 [Thomas, D. K.] Swansea Univ, Dept Math, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.
   [Abdul Halim, S.] Univ Malaya, Inst Math Sci, Kuala Lumpur 50603, Malaysia.
RP Abdul Halim, S (reprint author), Univ Malaya, Inst Math Sci, Kuala Lumpur 50603, Malaysia.
EM suzeini@um.edu.my
OI Abdul Halim, Suzeini/0000-0001-6956-3192
CR Duren P. L., 1983, MAT SBORNIK, P114
   Duren P. L., 1983, UNIVALENT FUNCTIONS, P114
   HAYMAN WK, 1968, P LOND MATH SOC, V18, P77
   Janteng A., 2007, INT J MATH ANAL, V1, P619
   LIBERA RJ, 1983, P AM MATH SOC, V87, P251, DOI 10.2307/2043698
   NOONAN JW, 1976, T AM MATH SOC, V223, P337, DOI 10.2307/1997533
   POMMERENKE C, 1967, MATHEMATIKA, V14, P108, DOI 10.1112/S002557930000807X
   Ye K., 2015, FOUND COMPUT MATH, V14, P1
NR 8
TC 3
Z9 3
U1 3
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0126-6705
EI 2180-4206
J9 B MALAYS MATH SCI SO
JI Bull. Malays. Math. Sci. Soc.
PD OCT
PY 2017
VL 40
IS 4
BP 1781
EP 1790
DI 10.1007/s40840-016-0385-4
PG 10
WC Mathematics
SC Mathematics
GA FJ7GT
UT WOS:000412926000024
DA 2018-12-27
ER

PT J
AU Kholmetskii, A
   Yarman, T
AF Kholmetskii, Alexander
   Yarman, Tolga
TI RETRACTED: Conservative relativity principle and energy-momentum
   conservation in a superimposed gravitational and electric field
   (Retracted article. See vol. 95, pg. 1030, 2017)
SO CANADIAN JOURNAL OF PHYSICS
LA English
DT Article; Retracted Publication
AB We address to the conservative relativity principle (CRP), which we recently advanced (A.L. Kholmetskii, et al. Eur. Phys. J. Plus 129 (2014) 102). This principle asserts the impossibility to distinguish the state of rest and the state of motion of a system moving at constant velocity, if no work is done to the system in question during its motion; such a constraint is thus closely linked to the energy-momentum conservation law. Therefore, the conservative relativity principle, along with the Einstein special relativity principle (which obviously represents the particular manifestation of CRP in the case of empty space), and the general relativity principle can be considered as the cornerstones of modern physics. At the same time, some principal implications of CRP - e.g. the dependence of the proper time of a charged particle on the electric potential at its location, happens to be firmly at odds with the established structure of modern physics and, in fact, is not accepted by the wide scientific community up to date. In the present paper we consider the motion of a massive charged particle in a superimposed gravitational and electric field and explicitly demonstrate that the adoption of CRP is strongly required to prevent the violation of the total energy-momentum conservation law for an isolated system "particles and fields". Therefore, all of the consequences of CRP must be incorporated with the structure of physics, and we show that they are in a full agreement with the experimental data collected to the moment.
C1 [Kholmetskii, Alexander] Belarusian State Univ, Dept Phys, Minsk, BELARUS.
   [Yarman, Tolga] Okan Univ, Istanbul, Turkey.
   [Yarman, Tolga] Savronik, Eskisehir, Turkey.
RP Kholmetskii, A (reprint author), Belarusian State Univ, Dept Phys, Minsk, BELARUS.
EM alkholmetskii@gmail.com
CR Antognini A, 2013, SCIENCE, V339, P417, DOI 10.1126/science.1230016
   Chantler CT, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/12/123037
   Chantler CT, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.153001
   Jackson J D, 1998, CLASSICAL ELECTRODYN
   Kholmetskii AL, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/04/045301
   Kholmetskii A. L., 2014, CAN J PHYS, V92, P1
   Kholmetskii A. L., 2012, EUR PHYS J PLUS, V126, P35
   Kholmetskii A. L., 2012, EUR PHYS J PLUS, V127, P44, DOI DOI 10.1140/EPJP/I2012-12044-8
   Kholmetskii A, 2014, EUR PHYS J PLUS, V129, DOI 10.1140/epjp/i2014-14102-7
   Landau Lev Davidovich, 1951, CLASSICAL THEORY FIE
   MOLLER C, 1972, THEORY RELATIVITY
   PAULI W, 1959, THEORY RELATIVITY
   TEITELBOIM C, 1980, RIV NUOVO CIMENTO, V3, P1, DOI 10.1007/BF02895735
   Weinberg S, 1972, GRAVITATION COSMOLOG
   Yarman T, 2011, INT J THEOR PHYS, V50, P1407, DOI 10.1007/s10773-010-0649-y
   Yarman T., 2001, DAMOP 2001 M SESS J3
   Yarman T., 2005, P INT M PHYS INT REL
NR 17
TC 1
Z9 1
U1 4
U2 10
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0008-4204
EI 1208-6045
J9 CAN J PHYS
JI Can. J. Phys.
PD OCT
PY 2017
VL 95
IS 10
DI 10.1139/cjp-2017-0290
PG 10
WC Physics, Multidisciplinary
SC Physics
GA FI7KR
UT WOS:000412176100001
DA 2018-12-27
ER

PT J
AU Pouladi, N
   Heitmann, H
AF Pouladi, Navid
   Heitmann, Helge
TI RETRACTED: Simulation of steady flow of natural gas in a subsea flexible
   riser with heat exchange (Retracted article. See vol. 52, pg. 629, 2018)
SO JOURNAL OF NATURAL GAS SCIENCE AND ENGINEERING
LA English
DT Article; Retracted Publication
DE Flexible riser; Natural gas; Lee Kesler equation of state; Friction
   factor; Numerical model; Pressure drop
ID STATE; VISCOSITY; MODELS
AB Flexible riser technology is widely used in today's offshore industry. Evaluating pressure, temperature and velocity profiles in a subsea riser or a flexible pipe is essential in the design of a gas transfer system. Conventional pipeline correlations fail to give an acceptable accuracy for sizing, design and flow assurance applications of flexibles. Hence, availability of a rather simple computational model, which can give results with acceptable accuracy is highly advantageous. The aim of this article is to present a simple numerical method which can be used efficiently to accomplish this goal. A one dimensional finite difference method is used where the riser length is discretized into small segments. Natural gas physical and transport properties are calculated in each segment and flow equations in addition to a state equation are solved simultaneously to find the velocity, pressure and temperature profiles in the flexible riser. The Lee-Kesler corresponding states EOS has been used as the state equation. MathcadTM has been applied for solving equations. The ability of the model to predict thermodynamic properties of natural gas has been compared with experimental data. Furthermore, friction and heat transfer models for a smooth and rough bore riser have been analyzed. For a rough bore riser with carcass corrugations, selecting a reasonable value for the equivalent sand grain roughness has been found to be crucial. The authors have also found the Joule-Thomson effect to be decisive in temperature change for a high pressure rough bore flexible gas riser subject to high pressure drop. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Pouladi, Navid; Heitmann, Helge] Natl Oilwell Varco APL, Arendal, Norway.
RP Pouladi, N (reprint author), Natl Oilwell Varco APL, Arendal, Norway.
EM nvdpouladi@gmail.com
CR Abdolahi F, 2007, INT J MECH SCI, V49, P989, DOI 10.1016/j.ijmecsci.2006.12.001
   [Anonymous], 2003, RECOMMENDED PRACTICE
   Azevedo H.S., 2008, P ENCIT 2008 12 BRAZ
   Bai Y, 2005, ELSEV OCEAN ENG SER, P1
   Belfroid S.P.C., 2013, SPE ANN TECHN C EXH
   Bergman Theodore L., 2011, FUNDAMENTALS HEAT MA
   Bokhorst E.V., 2014, INT PETR TECHN C HEL
   Chaczykowski M, 2012, ARCH MIN SCI, V57, P23, DOI 10.2478/v10267-012-0002-9
   Chaczykowski M, 2009, CHEM ENG RES DES, V87, P1596, DOI 10.1016/j.cherd.2009.06.008
   Corme T., 2007, OFFSH TECHN C HOUS T
   Daubert T.E., 1997, API TECHNICAL DATA B
   DILAY GW, 1986, IND ENG CHEM FUND, V25, P152, DOI 10.1021/i100021a024
   Ernst G, 2001, J CHEM THERMODYN, V33, P601
   Heidaryan E, 2013, FLUID PHASE EQUILIBR, V354, P80, DOI 10.1016/j.fluid.2013.05.035
   Helgaker JF, 2014, J NAT GAS SCI ENG, V16, P44, DOI 10.1016/j.jngse.2013.11.001
   Jarrahian A, 2014, J NAT GAS SCI ENG, V18, P446, DOI 10.1016/j.jngse.2014.04.005
   Langelandsvik L.I., 2005, PSIG ANN M HELD SAN
   LEE AL, 1966, J PETROL TECHNOL, V18, P997, DOI 10.2118/1340-PA
   Li CJ, 2012, ENRGY PROCED, V14, P115, DOI 10.1016/j.egypro.2011.12.904
   Lopez-Benito A., 2016, APPL MATH MODEL, P1
   Lyckegaard A., 2016, OFFSH TECHN C MAL 22
   Nouri-Borujerdi A, 2009, INT J HEAT MASS TRAN, V52, P5751, DOI 10.1016/j.ijheatmasstransfer.2009.07.026
   Ouyang LB, 1996, J PETROL SCI ENG, V14, P137, DOI 10.1016/0920-4105(95)00042-9
   Poling B. E, 2001, PROPERTIES GASES LIQ
   Riazi MR, 2005, ASTM MAN SER, P1
   Sletfjerding E, 2003, J ENERG RESOUR-ASME, V125, P126, DOI 10.1115/1.1576264
   Sletfjerding E., 2000, SPE CERI GAS TECHN S
   Sutton RP, 2007, SPE RESERV EVAL ENG, V10, P270, DOI 10.2118/97099-PA
   Vicente PG, 2004, INT J HEAT MASS TRAN, V47, P671, DOI 10.1016/j.ijheatmasstransfer.2003.08.005
   Zagarola MV, 1998, J FLUID MECH, V373, P33, DOI 10.1017/S0022112098002419
   Zhang Y., 2003, OFFSH TECHN C TEX US
NR 31
TC 1
Z9 1
U1 3
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1875-5100
EI 2212-3865
J9 J NAT GAS SCI ENG
JI J. Nat. Gas Sci. Eng.
PD OCT
PY 2017
VL 46
BP 533
EP 543
DI 10.1016/j.jngse.2017.08.012
PG 11
WC Energy & Fuels; Engineering, Chemical
SC Energy & Fuels; Engineering
GA FK6IL
UT WOS:000413607200041
DA 2018-12-27
ER

PT J
AU Li, LN
   Xiao, T
   Yi, HM
   Zheng, Z
   Qu, JQ
   Huang, W
   Ye, X
   Yi, H
   Lu, SS
   Li, XH
   Xiao, ZQ
AF Li, Li-Na
   Xiao, Ta
   Yi, Hong-Mei
   Zheng, Zhen
   Qu, Jia-Quan
   Huang, Wei
   Ye, Xu
   Yi, Hong
   Lu, Shan-Shan
   Li, Xin-Hui
   Xiao, Zhi-Qiang
TI RETRACTED: MiR-125b Increases Nasopharyngeal Carcinoma Radioresistance
   by Targeting A20/NF-kappa B Signaling Pathway (Retracted article. See
   vol. 17, pg. 2490, 2018)
SO MOLECULAR CANCER THERAPEUTICS
LA English
DT Article; Retracted Publication
ID NF-KAPPA-B; CANCER-CELLS; IONIZING-RADIATION; A20; ACTIVATION;
   RADIOTHERAPY; MICRORNAS; P53; RADIOSENSITIZATION; UBIQUITINATION
AB Radioresistance poses a major challenge in nasopharyngeal carcinoma (NPC) treatment, but little is known about how miRNA regulates this phenomenon. In this study, we investigated the function and mechanism of miR-125b in NPC radioresistance, one of upregulated miRNAs in the radioresistant NPC cells identified by our previous microarray analysis. We observed that miR-125b was frequently upregulated in the radioresistant NPCs, and its increment was significantly correlated with NPC radioresistance, and was an independent predictor for poor patient survival. In vitro radioresponse assays showed that miR-125b inhibitor decreased, whereas miR-125b mimic increased NPC cell radioresistance. In a mouse model, therapeutic administration of miR-125b antagomir dramatically sensitized NPC xeno-grafts to irradiation. Mechanistically, we confirmed that A20 was a direct target of miR-125b and found that miR-125b regulated NPC cell radioresponse by targeting A20/NF-kappa B signaling. With a combination of loss-of-function and gain-of-function approaches, we further showed that A20 overexpression decreased while A20 knockdown increased NPC cell radioresistance both in vitro and in vivo. Moreover, A20 was significantly downregulated while p-p65 (RelA) significantly upregulated in the radioresistant NPCs relative to radiosensitive NPCs, and miR-125b expression level was negatively associated with A20 expression level, whereas positively associated with p-p65 (RelA) level. Our data demonstrate that miR-125b and A20 are critical regulators of NPC radioresponse, and high miR-125b expression enhances NPC radioresistance through targeting A20 and then activating the NF-kappa B signaling pathway, highlighting the therapeutic potential of the miR-125b/A20/NF-kappa B axis in clinical NPC radiosensitization.
C1 [Li, Li-Na; Yi, Hong-Mei; Zheng, Zhen; Qu, Jia-Quan; Huang, Wei; Ye, Xu; Yi, Hong; Lu, Shan-Shan; Li, Xin-Hui; Xiao, Zhi-Qiang] Cent S Univ, Xiangya Hosp, Res Ctr Carcinogenesis & Targeted Therapy, Changsha, Hunan, Peoples R China.
   [Li, Li-Na] Changzhi Med Coll, Dept Pathol, Changzhi, Shanxi, Peoples R China.
   [Xiao, Ta] Cent S Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China.
   [Qu, Jia-Quan] Jishou Univ, Qianjiang Cent Hosp Chongqing, Dept Oncol, Hunan, Peoples R China.
RP Xiao, ZQ (reprint author), Cent S Univ, Xiangya Hosp, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.
EM zqxiao2001@hotmail.com
FU Major Program of the National Natural Science Foundation of China
   [81230053]; National Basic Research Program of China [2013CB910502];
   National Natural Science Foundation of China [81472801, 81672687]
FX This work was supported by Major Program of the National Natural Science
   Foundation of China (81230053, to Z.-Q. Xiao), National Basic Research
   Program of China (2013CB910502, to Z.-Q. Xiao), and the National Natural
   Science Foundation of China (81472801, to X.-H. Li; 81672687, to Z.-Q.
   Xiao).
CR Aggarwal BB, 2011, CANCER DISCOV, V1, P469, DOI 10.1158/2159-8290.CD-11-0260
   Ahmed KM, 2008, FREE RADICAL BIO MED, V44, P1, DOI 10.1016/j.freeradbiomed.2007.09.022
   Ahmed KM, 2013, CANCER RES, V73, P3737, DOI 10.1158/0008-5472.CAN-12-3537
   Ahuja D, 2016, RNA BIOL, V13, P1152, DOI 10.1080/15476286.2016.1229734
   Amir S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061064
   Bellail AC, 2012, CANCER DISCOV, V2, P140, DOI 10.1158/2159-8290.CD-11-0172
   Busch S, 2015, J IMMUNOL, V194, P1646, DOI 10.4049/jimmunol.1402163
   Chung GTY, 2013, J PATHOL, V231, P311, DOI 10.1002/path.4239
   Deorukhkar A, 2010, BIOCHEM PHARMACOL, V80, P1904, DOI 10.1016/j.bcp.2010.06.039
   Feng XP, 2010, CANCER RES, V70, P3450, DOI 10.1158/0008-5472.CAN-09-4099
   Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707
   Grosso S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.71
   Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992
   Gwak HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047449
   He JH, 2014, INT J ONCOL, V45, P1099, DOI 10.3892/ijo.2014.2497
   Hjelmeland AB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000319
   Huang XY, 2013, CANCER RES, V73, P6972, DOI 10.1158/0008-5472.CAN-13-1657
   Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775
   Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969
   Ke G, 2013, ONCOGENE, V32, P3019, DOI 10.1038/onc.2012.323
   Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109
   Kristensen CA, 2007, ACTA ONCOL, V46, P214, DOI 10.1080/02841860600635862
   Langsch S, 2016, CANCER RES, V76, P4160, DOI 10.1158/0008-5472.CAN-15-2580
   LEE AWM, 1992, INT J RADIAT ONCOL, V23, P261, DOI 10.1016/0360-3016(92)90740-9
   Li G, 2013, EUR J CANCER, V49, P2596, DOI 10.1016/j.ejca.2013.03.001
   Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170
   Liu Z, 2016, ONCOTARGET, V7, P78667, DOI 10.18632/oncotarget.12018
   Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9
   Lv P, 2014, ONCOTARGET, V5, P7512, DOI 10.18632/oncotarget.2258
   Oh JS, 2010, INT J RADIAT ONCOL, V76, P5, DOI 10.1016/j.ijrobp.2009.08.028
   Pan JJ, 2015, AM J CLIN ONCOL-CANC, V38, P189, DOI 10.1097/COC.0b013e31828f5c96
   Parisi C, 2016, CELL DEATH DIFFER, V23, P531, DOI 10.1038/cdd.2015.153
   Qu CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/cc.11.4.19228
   Qu JQ, 2015, MOL CANCER THER, V14, P2653, DOI 10.1158/1535-7163.MCT-15-0461
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   SHANMUGARATNAM K, 1993, CANCER-AM CANCER SOC, V71, P2689, DOI 10.1002/1097-0142(19930415)71:8<2689::AID-CNCR2820710843>3.0.CO;2-H
   Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59
   Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364
   Sun Y, 2009, INT J ONCOL, V34, P1017, DOI 10.3892/ijo_00000227
   Troppan K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123922
   Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007
   Verhoeven RJA, 2016, J VIROL, V90, P6475, DOI 10.1128/JVI.00613-16
   Veuger SJ, 2009, ONCOGENE, V28, P832, DOI 10.1038/onc.2008.439
   Wang CM, 2011, BIOCHEM BIOPH RES CO, V411, P586, DOI 10.1016/j.bbrc.2011.06.191
   Wang P, 2013, GASTROENTEROLOGY, V145, P1133, DOI 10.1053/j.gastro.2013.07.048
   Wang YD, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.272
   Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794
   Wu JG, 2015, GASTRIC CANCER, V18, P729, DOI 10.1007/s10120-014-0421-8
   Zhang L, 2012, CANCER LETT, V323, P1, DOI 10.1016/j.canlet.2012.03.030
   Zhu DD, 2016, INT J CANCER, V138, P1175, DOI 10.1002/ijc.29850
NR 50
TC 5
Z9 6
U1 1
U2 6
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1535-7163
EI 1538-8514
J9 MOL CANCER THER
JI Mol. Cancer Ther.
PD OCT
PY 2017
VL 16
IS 10
BP 2094
EP 2106
DI 10.1158/1535-7163.MCT-17-0385
PG 13
WC Oncology
SC Oncology
GA FI8AC
UT WOS:000412220900005
PM 28698199
DA 2018-12-27
ER

PT J
AU Zhu, SX
   Tong, XZ
   Zhang, SJ
AF Zhu, Sheng-Xing
   Tong, Xian-Zhou
   Zhang, Shuijun
TI RETRACTED: Expression of miR-711 and mechanism of proliferation and
   apoptosis in human gastric carcinoma (Retracted article. See vol. 15,
   pg. 4040, 2018)
SO ONCOLOGY LETTERS
LA English
DT Article; Retracted Publication
DE miR-711; apoptosis; gastic carcinoma
ID COLORECTAL-CANCER; CELLS; BCL-2; TUMORIGENESIS; MICRORNAS; RISK
AB MicroRNAs (miRs) are involved in many aspects of cell biology, including cell proliferation and apoptosis, two critical aspects of tumor biology. We investigated the effect of miR-711 on Bcl-2 expression in human MGC803 gastric cancer cells and the mechanism of cell proliferation, apoptosis, and invasion. Expression of miR-711 and Bcl-2 was significantly increased in gastric adenocarcinoma compared to adjacent normal tissue. Inhibition of miR-711 in MGC803 gastric cancer cells decreased the expression of Bcl-2, decreased cell proliferation, decreased the invasion ability, and increased apoptosis. The expression of Bcl-2 protein correlated with clinical staging, lymph node metastasis, and tumor differentiation in patients with gastric cancer. The expression of miR-711 positively correlated with the expression of Bcl-2, suggesting that miR-711 and Bcl-2 are co-regulated and involved in the development of gastric cancer.
C1 [Zhu, Sheng-Xing; Zhang, Shuijun] Zhengzhou Univ, Affiliated Hosp 1, Dept Gen Surg, 1 Jianshe East Rd, Zhengzhou 450000, Henan, Peoples R China.
   [Zhu, Sheng-Xing; Tong, Xian-Zhou] Peoples Hosp Zhengzhou, Dept Gen Surg 2, Zhengzhou 450000, Henan, Peoples R China.
RP Zhang, SJ (reprint author), Zhengzhou Univ, Affiliated Hosp 1, Dept Gen Surg, 1 Jianshe East Rd, Zhengzhou 450000, Henan, Peoples R China.
EM xmng480593201@163.com
CR Ardi VC, 2011, ACS CHEM BIOL, V6, P1357, DOI 10.1021/cb200203m
   BANZHAFSTRATHMANN, 2014, CELL COMMUN SIGNAL, V12, DOI DOI 10.1186/1478-811X-12-30
   Chen XZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000792
   Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016
   Hu CJ, 2014, CANCER BIOL THER, V15, P279, DOI 10.4161/cbt.27223
   Hu JY, 2016, ONCOL LETT, V11, P2155, DOI 10.3892/ol.2016.4217
   Hudler P, 2015, WORLD J GASTROENTERO, V21, P10510, DOI 10.3748/wjg.v21.i37.10510
   Kasinski AL, 2015, ONCOGENE, V34, P3547, DOI 10.1038/onc.2014.282
   Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x
   Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629
   Li Y, 2014, INT J HEMATOL, V99, P79, DOI 10.1007/s12185-013-1472-z
   Lim L, 2014, HEPATOLOGY, V59, P202, DOI 10.1002/hep.26662
   Liu HS, 2014, WORLD J GASTROENTERO, V20, P12007, DOI 10.3748/wjg.v20.i34.12007
   Long ZW, 2015, WORLD J GASTROENTERO, V21, P5707, DOI 10.3748/wjg.v21.i18.5707
   Luanpitpong S, 2013, MOL BIOL CELL, V24, P858, DOI 10.1091/mbc.E12-10-0747
   Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005
   Mileo AM, 2016, OXID MED CELL LONGEV, V2016, DOI DOI 10.1155/2016/6475624
   Min YW, 2014, J GASTRIC CANCER, V14, P7, DOI [10.5230/jgc.2014.14.1.7, 10.7583/JKGS.2014.14.5.87, 10.5230/jgc.2014.14.2.87]
   Muqbil I, 2013, CURR DRUG TARGETS, V14, P1094, DOI 10.2174/1389450111314100002
   Okamoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077623
   Simsek EN, 2013, ASIAN PAC J CANCER P, V14, P6791, DOI 10.7314/APJCP.2013.14.11.6791
   Song H, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3867
   Wei W, 2015, MED SCI MONITOR, V21, P3016, DOI 10.12659/MSM.894640
   Wu HH, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2013.16
NR 24
TC 2
Z9 2
U1 2
U2 4
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-1074
EI 1792-1082
J9 ONCOL LETT
JI Oncol. Lett.
PD OCT
PY 2017
VL 14
IS 4
BP 4505
EP 4510
DI 10.3892/ol.2017.6777
PG 6
WC Oncology
SC Oncology
GA FK0DU
UT WOS:000413151300087
PM 29085447
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Drayer, SM
   Laufer, LR
   Farrell, ME
AF Drayer, Sara M.
   Laufer, Larry R.
   Farrell, Maureen E.
TI RETRACTED: Autoimmune Progesterone Dermatitis Presenting as
   Stevens-Johnson Syndrome (Retracted article. See vol. 131, pg. 746,
   2018)
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article; Retracted Publication
ID HYPERSENSITIVITY; MANAGEMENT; DIAGNOSIS
AB BACKGROUND: Autoimmune progesterone dermatitis is an uncommon disease presenting with cyclical skin eruptions corresponding with the menstrual cycle luteal phase. Because symptoms are precipitated by rising progesterone levels, treatment relies on hormone suppression.
   CASE: A 22-year-old nulligravid woman presented with symptoms mistaken for Stevens-Johnson syndrome. A cyclic recurrence of her symptoms was noted, and the diagnosis of autoimmune progesterone dermatitis was made by an intradermal progesterone challenge. After 48 months, she remained refractory to medical management and definitive surgical treatment with bilateral oophorectomy was performed.
   CONCLUSION: Autoimmune progesterone dermatitis is a challenging diagnosis owing to its rarity and variety of clinical presentations. Treatment centers on suppression of endogenous progesterone and avoidance of exogenous triggers. When these modalities fail, surgical management must be undertaken.
C1 [Drayer, Sara M.; Laufer, Larry R.; Farrell, Maureen E.] Naval Med Ctr San Diego, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, San Diego, CA USA.
RP Drayer, SM (reprint author), Naval Med Ctr San Diego, 34800 Bob Wilson Dr,Bldg 3,Floor 1, San Diego, CA 92134 USA.
EM sara.m.drayer.mil@mail.mil
CR Domeyer-Klenske A, 2015, OBSTET GYNECOL, V125, P1114, DOI 10.1097/AOG.0000000000000569
   Foer D, 2016, J ALLER CL IMM-PRACT, V4, P723, DOI 10.1016/j.jaip.2016.03.003
   Garcia-Ortega P, 2011, OBSTET GYNECOL, V117, P495, DOI 10.1097/AOG.0b013e318206cb2c
   Itsekson AM, 2011, FERTIL STERIL, V95, P2571, DOI 10.1016/j.fertnstert.2011.05.025
   Lee MK, 2011, ALLERGY ASTHMA IMMUN, V3, P141, DOI 10.4168/aair.2011.3.2.141
   SHELLEY WB, 1964, JAMA-J AM MED ASSOC, V190, P35
   Nguyen T, 2016, AUTOIMMUN REV, V15, P191, DOI 10.1016/j.autrev.2015.11.003
   Warin AP, 2001, CLIN EXP DERMATOL, V26, P107, DOI 10.1046/j.1365-2230.2001.00747.x
NR 8
TC 3
Z9 3
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD OCT
PY 2017
VL 130
IS 4
BP 881
EP 884
DI 10.1097/AOG.0000000000002256
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FH8NO
UT WOS:000411453500037
PM 28885418
DA 2018-12-27
ER

PT J
AU Ayough, P
   Taghia, SAHS
AF Ayough, Pouria
   Taghia, Seiyed Ali Haj Seiyed
TI RETRACTED: Response of steel moment and braced frames subjected to
   near-source pulse-like ground motions by including soil-structure
   interaction effects (Retracted article. See vol. 107, pg. 425, 2018)
SO SOIL DYNAMICS AND EARTHQUAKE ENGINEERING
LA English
DT Article; Retracted Publication
DE Near-fault earthquakes; Soil-structure interaction; Cone model; Steel
   structure; Ductility demand
ID FAULT EARTHQUAKES; SDOF SYSTEMS; CONE MODELS; FAR-FAULT; DIRECTIVITY;
   FOUNDATION; BUILDINGS; BEHAVIOR
AB Most seismic regulations are usually associated with fixed-base structures, assuming that elimination of this phenomenon leads to conservative results and engineers are not obliged to use near-fault earthquakes. This study investigates the effect of soil structure interaction on the inelastic response of MDOF steel structures by using well known Cone method. In order to achieve this, three dimensional multi-storey steel structures with moment and braced frame are analyzed using non-linear time history method under the action of 40 near-fault records. Seismic response parameters, such as base shear, performance of structures, ductility demand and displacement demand ratios of structures subjected to different frequency-contents of near-fault records including pulse type and high-frequency components are investigated. The results elucidate that the flexibility of soil strongly affects the seismic response of steel frames. soil' structure interaction can increase seismic demands of structures. Also, soil has approximately increasing and mitigating effects on structural responses subjected to the pulse type and high frequency components. A threshold period exists below which can highly change the ductility demand for short period structures subjected to near-fault"records.
C1 [Ayough, Pouria; Taghia, Seiyed Ali Haj Seiyed] Islamic Azad Univ, Qazvin Branch, Dept Civil Engn, Qazvin, Iran.
RP Ayough, P (reprint author), Islamic Azad Univ, Qazvin Branch, Dept Civil Engn, Qazvin, Iran.
EM pooriya.ayough@qiau.ac.ir
CR Alavi B, 2004, EARTHQ ENG STRUCT D, V33, P687, DOI 10.1002/eqe.369
   Amiri FS, 2013, STRUCT DES TALL SPEC, V22, P975, DOI 10.1002/tal.747
   [Anonymous], 2000, SAP SOFTW VERS 16
   [Anonymous], PERF 3D SOFTW VERS 5
   [Anonymous], 2011, MATLAB SOFTW VERS
   [Anonymous], 2010, 710 ASCESEI
   Aviles J, 2005, J STRUCT ENG-ASCE, V131, P221, DOI 10.1061/(ASCE)0733-9445(2005)131:2(221)
   Aviles J, 2003, EARTHQUAKE ENG STRUC, V32, P1749, DOI 10.1002/eqe.300
   Aviles J, 2007, J STRUCT ENG-ASCE, V133, P1453, DOI 10.1061/(ASCE)0733-9445(2007)133:10(1453)
   Baker JW, 2007, B SEISMOL SOC AM, V97, P1486, DOI 10.1785/0120060255
   Chopra AK, 2001, EARTHQUAKE ENG STRUC, V30, P1769, DOI 10.1002/eqe.92
   Cox KE, 2002, 22 PEER
   Federal Emergency Management Agency, 2009, PREST COMM SEISM REH
   Ghahari SF, 2008, AIP C P
   Ghannad M. A., 2006, P 1 EUR C EARTHQ ENG
   Ghannad MA, 2006, EUROPEAN EARTHQUAKE, V20, P23
   Ghannad MA, 2008, P 4 NAT C CIV ENG TE
   Ghobarah A., 2004, P 13 WORLD C EARTHQ
   Hatzigeorgiou GD, 2010, COMPUT STRUCT, V88, P309, DOI 10.1016/j.compstruc.2009.11.006
   Hatzigeorgiou GD, 2010, EARTHQ ENG STRUCT D, V39, P1239, DOI 10.1002/eqe.991
   Hubbard DT, 2011, SOIL DYN EARTHQ ENG, V31, P401, DOI 10.1016/j.soildyn.2010.09.009
   Iervolino I, 2012, EARTHQ ENG STRUCT D, V41, P2351, DOI 10.1002/eqe.2167
   Kalkan E, 2006, EARTHQ SPECTRA, V22, P367, DOI 10.1193/1.2192560
   Karavasilis TL, 2010, J STRUCT ENG, V136, P921, DOI 10.1061/(ASCE)ST.1943-541X.0000193
   Khoshnoudian F, 2013, EARTHQ ENG STRUCT D, V42, P1565, DOI 10.1002/eqe.2287
   Khoushnoudian F, 2013, EARTHQ ENG STRUCT DY
   Khoushnoudian F, 2008, P 14 WORLD C EARTHQ
   Mavroeidis GP, 2004, EARTHQ ENG STRUCT D, V33, P1023, DOI 10.1002/eqe.391
   Mavroeidis GP, 2003, B SEISMOL SOC AM, V93, P1099, DOI 10.1785/0120020100
   Mavroeidis GP, 2002, P 7 US NAT C EARTHQ
   Meek J, 1974, P 5 WORLD C EARTHQ E, P2610
   MEEK JW, 1992, J GEOTECH ENG-ASCE, V118, P667, DOI 10.1061/(ASCE)0733-9410(1992)118:5(667)
   MEEK JW, 1991, EARTHQUAKE ENG STRUC, V20, P651, DOI 10.1002/eqe.4290200705
   MEEK JW, 1993, EARTHQUAKE ENG STRUC, V22, P759, DOI 10.1002/eqe.4290220903
   Minasidis G, 2014, SOIL DYN EARTHQ ENG, V66, P56, DOI 10.1016/j.soildyn.2014.06.030
   Mulliken JS, 1998, EARTHQUAKE ENG STRUC, V27, P687, DOI 10.1002/(SICI)1096-9845(199807)27:7<687::AID-EQE752>3.0.CO;2-O
   Nakhaei M, 2004, P ICEBAM INT C EARTH, P1066
   Nakhaei M, 2008, ENG STRUCT, V30, P1491, DOI 10.1016/j.engstruct.2007.04.009
   National building regulations of Iran, 2013, DES CONSTR STEEL STR
   Sehhati R, 2011, ENG STRUCT, V33, P767, DOI 10.1016/j.engstruct.2010.11.032
   Sharif V, 2012, COMPUT METHOD CIVIL, P79
   Somerville PG, 1997, SEISMOL RES LETT, V68, P199, DOI DOI 10.1785/GSSRL.68.1.199
   Somerville PG, SEISMOLOGICAL RES LE, V68, P199
   Tang YC, 2011, SOIL DYN EARTHQ ENG, V31, P59, DOI 10.1016/j.soildyn.2010.08.006
   Wolf J.P., 2004, FDN VIBRATION ANAL S
NR 45
TC 2
Z9 2
U1 3
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0267-7261
EI 1879-341X
J9 SOIL DYN EARTHQ ENG
JI Soil Dyn. Earthq. Eng.
PD OCT
PY 2017
VL 101
BP 53
EP 66
DI 10.1016/j.soildyn.2017.07.013
PG 14
WC Engineering, Geological; Geosciences, Multidisciplinary
SC Engineering; Geology
GA FH8CB
UT WOS:000411418300005
DA 2018-12-27
ER

PT J
AU Li, Y
   Jiang, T
   Fu, XL
   Xu, H
   Ji, JG
AF Li, Yong
   Jiang, Ting
   Fu, Xingli
   Xu, Hao
   Ji, Jianguo
TI RETRACTED: Atorvastatin protects cardiomyocytes against OGD/R-induced
   apoptosis by inhibiting miR-199a-5p (Retracted article. See vol. 16, pg.
   8572, 2017)
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article; Retracted Publication
DE atorvastatin; ischemia-reperfusion injury; glycogen synthase kinase-3
   beta; microRNA; microRNA-199a-5p
ID THERAPEUTIC TARGET; REPERFUSION INJURY; GLYCOGEN-SYNTHASE; CARDIAC
   MYOCYTES; OXIDATIVE STRESS; HEART; CARDIOPROTECTION; PHOSPHORYLATION;
   MYOCARDIUM; GSK-3-BETA
AB The present study aimed to evaluate the protective effects of atorvastatin against myocardial ischemia/reperfusion (I/R) injury in cardiomyocytes and its underlying mechanisms. The direct cytotoxic effects of oxygen-glucose deprivation/ reperfusion (OGD/R) on cardiomyocytes with and without atorvastatin pretreatment were evaluated. The effects of atorvastatin on the expression of glycogen synthase kinase-3 beta (GSK-3 beta) and microRNA (miR)-199a-5p were determined using reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blot analyses. In addition, the expression levels of GSK-3 beta in cells with miR-199a-5p upregulation and downregulation were detected using RT-qPCR, western blot and immunohistochemical analyses. Pretreatment with atorvastatin significantly improved the recovery of cell viability from OGD/R (P<0.05). In addition, atorvastatin pretreatment significantly increased the expression of GSK-3 beta at the mRNA and protein levels, and the expression of miR-199a-5p at the mRNA level (all P<0.05). The upregulation and downregulation of miR-199a-5p respectively decreased and increased the expression of GSK-3 beta at the mRNA and protein levels. These results suggested that atorvastatin provided cardioprotective effects against I/R injury via increasing the expression of GSK-3 beta through the inhibition of miR-199a-5p.
C1 [Li, Yong; Xu, Hao; Ji, Jianguo] Jiangsu Univ, Dept Cardiol, Affiliated Wujin Hosp, 2 North Yongning Rd, Changzhou 213017, Jiangsu, Peoples R China.
   [Jiang, Ting] Nanjing Med Univ, Dept Emergency, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China.
   [Fu, Xingli] Jiangsu Univ, Hlth Sci Ctr, Zhenjiang 212001, Jiangsu, Peoples R China.
RP Li, Y (reprint author), Jiangsu Univ, Dept Cardiol, Affiliated Wujin Hosp, 2 North Yongning Rd, Changzhou 213017, Jiangsu, Peoples R China.
EM yongli1616@sina.com
FU Natural Science Foundation of Jiangsu Province, China [BK20140249];
   Wujin Bureau of Technology [WS201113]; Youth Talents of Science and
   Technology Projects from Changzhou Health Bureau [QN201107]; Clinical
   Technology Development Foundation of Jiangsu University [JLY20120038];
   Changzhou High-level Talents Training Project [2016CZBJ052]
FX The present study was supported by the Natural Science Foundation of
   Jiangsu Province, China (grant no. BK20140249), the Social Development
   Project of Wujin Bureau of Technology (grant no. WS201113), the Youth
   Talents of Science and Technology Projects from Changzhou Health Bureau,
   (grant no. QN201107), the Clinical Technology Development Foundation of
   Jiangsu University (grant no. JLY20120038) and Changzhou High-level
   Talents Training Project (grant no. 2016CZBJ052).
CR Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o
   Balakumar P, 2012, BRIT J PHARMACOL, V165, P373, DOI 10.1111/j.1476-5381.2011.01597.x
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Chen MS, 2004, J MOL CELL CARDIOL, V37, P889, DOI 10.1016/j.yjmcc.2004.06.019
   Chiang DY, 2015, INT J CARDIOL, V184, P190, DOI 10.1016/j.ijcard.2015.01.075
   Di Napoli P, 2005, CARDIOVASC RES, V66, P462, DOI 10.1016/j.cardiores.2005.02.008
   Freude B, 2000, J MOL CELL CARDIOL, V32, P197, DOI 10.1006/jmcc.1999.1066
   GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504
   Haghikia A, 2011, EUR HEART J, V32, P1287, DOI 10.1093/eurheartj/ehq369
   Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996
   Kapur NK, 2008, VASC HEALTH RISK MAN, V4, P39, DOI 10.2147/VHRM.S1653
   Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865
   Lal H, 2015, CIRC RES, V116, P138, DOI 10.1161/CIRCRESAHA.116.303613
   LATRONICO MVG, 2009, NATURE REV, V6, P419, DOI DOI 10.1038/NRCARDIO.2009.56
   Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012
   Lu JC, 2009, CLIN EXP PHARMACOL P, V36, P1110, DOI 10.1111/j.1440-1681.2009.05198.x
   Miura T, 2009, CIRC J, V73, P1184, DOI 10.1253/circj.CJ-09-0284
   Mokhtari B, 2015, EUR J PHARMACOL, V765, P316, DOI 10.1016/j.ejphar.2015.08.056
   Mora A, 2005, FEBS LETT, V579, P3632, DOI 10.1016/j.febslet.2005.05.040
   Ostadal P, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-4
   Prasad A, 2009, CIRCULATION, V120, P2105, DOI 10.1161/CIRCULATIONAHA.108.814640
   Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102
   Saraste A, 1997, CIRCULATION, V95, P320
   Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659
   Sun LJ, 2015, MED SCI MONITOR, V21, P195, DOI 10.12659/MSM.892141
   Takeda T, 2006, J AM COLL CARDIOL, V47, P1882, DOI 10.1016/j.jacc.2005.12.055
   Wang HW, 2015, VIRUS RES, V208, P7, DOI 10.1016/j.virusres.2015.05.002
   Wong ND, 2014, NAT REV CARDIOL, V11, P276, DOI 10.1038/nrcardio.2014.26
   Xie QY, 2015, INT J CLIN EXP MED, V8, P12498
   Zhao ZF, 2015, EUR J PHARMACOL, V751, P89, DOI 10.1016/j.ejphar.2015.01.036
NR 30
TC 3
Z9 3
U1 6
U2 15
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD OCT
PY 2017
VL 16
IS 4
BP 3807
EP 3816
DI 10.3892/mmr.2017.7084
PG 10
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA FG9JA
UT WOS:000410753800014
PM 28765953
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Huang, QQ
   Sun, YJ
   Wu, HW
   Wang, YL
AF Huang, Qian-Qian
   Sun, Ying-Ji
   Wu, Hong-Wei
   Wang, Ying-Ling
TI RETRACTED: A structural and functional model of copper(II)-flavonolate
   ES complex of flavonol 2,4-dioxygenase (Retracted article. See vol. 479,
   pg. 286, 2018)
SO INORGANICA CHIMICA ACTA
LA English
DT Article; Retracted Publication
DE Flavonol 2,4-dioxygenase; ES model; Copper(II)-flavonolate complex;
   Carboxylate group
ID DEPENDENT QUERCETIN 2,3-DIOXYGENASE; ENZYME-SUBSTRATE COMPLEX;
   O-BENZOYLSALICYLATE; REACTION-MECHANISM; COPPER; OXYGENATION; LIGAND;
   RELEVANCE; FLA; DEGRADATION
AB A novel mononuclear copper(II)-flavonolate complex [(CuL)-L-II(fla)] (LH: 2-{[bis(pyridine-2-ylmethyl)amino] methyl}-4-methoxy benzoic acid, flaH: flavonol) was prepared as a structural and functional model of the ES (enzyme-substrate) complex of Cu-II-containing flavonol 2,4-dioxygenase. Its structure, properties and reactivity towards molecular dioxygen have been investigated in details. The complex shows the best reactivity in the copper(II)-flavonolate ES model system, may it could be contributed to the approximately monodentate coordination of the substrate flavonolate. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Huang, Qian-Qian; Wu, Hong-Wei; Wang, Ying-Ling] XinXiang Med Univ, Dept Chem, Xinxiang 453003, Peoples R China.
   [Sun, Ying-Ji] Dalian Univ Technol, Sch Chem Engn, Dalian 116024, Peoples R China.
RP Huang, QQ (reprint author), XinXiang Med Univ, Dept Chem, Xinxiang 453003, Peoples R China.
EM huangqian218@126.com
FU Scientific Research Foundation for Doctor of Xinxiang Medical University
   [505080]; Science and Technology Project of Education department of
   Henan province [14A150012]; Science and Technology project of Xinxiang
   city [15SF08, 15SF06]; Natural Science Foundation of Henan Province
   [172102310615]
FX Financial supports from Scientific Research Foundation for Doctor of
   Xinxiang Medical University (No. 505080), Science and Technology Project
   of Education department of Henan province (No. 14A150012), Science and
   Technology project of Xinxiang city (No. 15SF08 and No. 15SF06), the
   Natural Science Foundation of Henan Province (No. 172102310615) are
   greatly acknowledged.
CR Balogh-Hergovich E, 2000, INORG CHEM, V39, P4224, DOI 10.1021/ic990521r
   Balogh-Hergovich E, 2000, J MOL CATAL A-CHEM, V159, P215, DOI 10.1016/S1381-1169(00)00247-8
   Balogh-Hergovich E, 1999, J CHEM SOC DALTON, P3847, DOI 10.1039/a905684j
   Balogh-Hergovich E, 1999, INORG CHEM, V38, P3787, DOI 10.1021/ic990175d
   Balogh-Hergovich E, 2000, INORG CHIM ACTA, V304, P72, DOI 10.1016/S0020-1693(00)00071-2
   Balogh-Hergovich E, 2003, J MOL CATAL A-CHEM, V206, P83, DOI 10.1016/S1381-1169(03)00456-4
   Balogh-Hergovich E, 2002, EUR J INORG CHEM, P2287
   BaloghHergovich E, 1997, INORG CHIM ACTA, V256, P9, DOI 10.1016/S0020-1693(39)60540-7
   Barath G, 2009, CHEM COMMUN, P3630, DOI 10.1039/b903224j
   Barhacs L, 2001, INORG CHIM ACTA, V320, P83, DOI 10.1016/S0020-1693(01)00469-8
   CHRISTOU G, 1990, INORG CHEM, V29, P3657, DOI 10.1021/ic00344a008
   de Souza RFV, 2003, SYN REACT INORG MET, V33, P1125, DOI 10.1081/SIM-120023482
   Fusetti F, 2002, STRUCTURE, V10, P259, DOI 10.1016/S0969-2126(02)00704-9
   Grubel K, 2010, INORG CHEM, V49, P82, DOI 10.1021/ic901405h
   HATTORI S, 1959, NATURE, V184, P1145, DOI 10.1038/1841145b0
   Hund HK, 1999, EUR J BIOCHEM, V263, P871, DOI 10.1046/j.1432-1327.1999.00574.x
   JURD L, 1956, J ORG CHEM, V21, P1395, DOI 10.1021/jo01118a018
   Kaizer A, 2004, EUR J INORG CHEM, P2253, DOI 10.1002/ejic.200300605
   Kaizer J, 2006, COORDIN CHEM REV, V250, P2222, DOI 10.1016/j.ccr.2006.01.018
   Kaizer J, 2006, INORG CHEM COMMUN, V9, P251, DOI 10.1016/j.inoche.2005.11.011
   Lippai I, 1997, ACTA CRYSTALLOGR C, V53, P1547, DOI 10.1107/S0108270197005568
   Malkhasian AYS, 2007, INORG CHEM, V46, P2950, DOI 10.1021/ic062408o
   OKA T, 1971, BIOCHEM BIOPH RES CO, V43, P1, DOI 10.1016/S0006-291X(71)80076-1
   OKA T, 1972, CAN J MICROBIOL, V18, P493, DOI 10.1139/m72-076
   Pap JS, 2010, COORDIN CHEM REV, V254, P781, DOI 10.1016/j.ccr.2009.11.009
   Steiner RA, 2002, P NATL ACAD SCI USA, V99, P16625, DOI 10.1073/pnas.262506299
   Steiner RA, 2002, BIOCHEMISTRY-US, V41, P7955, DOI 10.1021/bi0159736
   Sun YJ, 2014, INORG CHEM, V53, P2932, DOI 10.1021/ic402695c
   Sun YJ, 2013, INORG CHEM, V52, P10936, DOI 10.1021/ic400972k
   Volkman J, 2012, TETRAHEDRON, V68, P3368, DOI 10.1016/j.tet.2012.02.042
   WESTLAKE DW, 1961, NATURE, V189, P510, DOI 10.1038/189510a0
NR 31
TC 2
Z9 2
U1 3
U2 11
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0020-1693
EI 1873-3255
J9 INORG CHIM ACTA
JI Inorg. Chim. Acta
PD OCT
PY 2017
VL 467
BP 7
EP 10
DI 10.1016/j.ica.2017.07.037
PG 4
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA FG8MJ
UT WOS:000410686700002
DA 2018-12-27
ER

PT J
AU Zhang, X
   Zhang, X
AF Zhang, Xin
   Zhang, Xiu
TI RETRACTED: Adaptive multiclass support vector machine for multimodal
   data analysis (Retracted article. See vol. 76, pg. 762, 2018)
SO PATTERN RECOGNITION
LA English
DT Article; Retracted Publication
DE Artificial bee colony; Feature selection; Hyperparameter optimization;
   Multiclass classification; Support vector machine
ID ARTIFICIAL BEE COLONY; SENSOR NETWORKS; MULTIMEDIA DATA; RECOGNITION;
   CLASSIFICATION; OPTIMIZATION; ALGORITHMS; PERFORMANCE; PARAMETERS;
   KERNEL
AB Multimodal data commonly exists in human lives. Early analysis usually concentrates on mining information based on single modality. Recent studies show that learning tasks could be greatly enhanced by analyzing data from the aspect of multimodality. This paper deals with classifying multimodal data comprised of visual and acoustic contents. Different data features are fused under a hierarchical structure to achieve a good semantic understanding. Then, to accomplish accurate classification, an adaptive support vector machine method (ASVM) is proposed. The method is support vector machine with hyperparameters controlled by a novel and efficient artificial bee colony algorithm. First, a micro colony is set as the number of hyperparameters is usually less than 5. Second, one position inheritance based on roulette wheel selection is used. Third, discarded solutions are mutated by position shift operation instead of random reinitialization. The ASVM method is first verified on classical data sets demonstrating the goodness of the proposed method. Then the proposed method is applied on a multimodal data set. Each sample includes both image and audio data features. Experimental results show that the ASVM method is more effective and robust than the compared methods. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Zhang, Xiu] Tianjin Normal Univ, Tianjin Key Lab Wireless Mobile Commun & Power Tr, Tianjin, Peoples R China.
   Tianjin Normal Univ, Coll Elect & Commun Engn, Tianjin, Peoples R China.
RP Zhang, X (reprint author), Tianjin Normal Univ, Tianjin Key Lab Wireless Mobile Commun & Power Tr, Tianjin, Peoples R China.
EM ecemark@mail.tjnu.edu.cn; ecezhang@mail.tjnu.edu.cn
FU National Science Foundation of China [61603275, 61601329]; Applied Basic
   Research Program of Tianjin [15JCYBJC52300, 15JCYBJC51500]
FX This research was supported in part by the National Science Foundation
   of China (61603275, 61601329), and the Applied Basic Research Program of
   Tianjin (15JCYBJC52300, 15JCYBJC51500).
CR Alatas B, 2010, EXPERT SYST APPL, V37, P5682, DOI 10.1016/j.eswa.2010.02.042
   Amiri SH, 2015, PATTERN RECOGN, V48, P2241, DOI 10.1016/j.patcog.2015.01.015
   Biondi GO, 2015, J INTELL ROBOT SYST, V80, pS295, DOI 10.1007/s10846-014-0159-x
   Ch S, 2014, NEUROCOMPUTING, V129, P279, DOI 10.1016/j.neucom.2013.09.030
   Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199
   Chen G., 2015, MATH PROBL ENG
   Chen HL, 2014, APPL MATH COMPUT, V239, P180, DOI 10.1016/j.amc.2014.04.039
   Chen WJ, 2016, PATTERN RECOGN, V52, P61, DOI 10.1016/j.patcog.2015.10.008
   Delibasis K., PATTERN RECOGNIT, V43
   Ding SF, 2017, PATTERN RECOGN, V67, P32, DOI 10.1016/j.patcog.2017.02.011
   Diosan L, 2012, APPL INTELL, V36, P280, DOI 10.1007/s10489-010-0260-1
   Du SC, 2015, IEEE T INSTRUM MEAS, V64, P2590, DOI 10.1109/TIM.2015.2418684
   Duan KH, 2016, NEURAL COMPUT APPL, V27, P459, DOI 10.1007/s00521-015-1866-3
   Eswaramoorthy S, 2016, COMPEL, V35, P1513, DOI 10.1108/COMPEL-09-2015-0337
   Ijjina EP, 2016, PATTERN RECOGN, V59, P199, DOI 10.1016/j.patcog.2016.01.012
   Iosifidis A, 2016, PATTERN RECOGN, V55, P231, DOI 10.1016/j.patcog.2016.02.002
   Ji YS, 2017, PATTERN RECOGN, V62, P202, DOI 10.1016/j.patcog.2016.08.014
   Karaboga D, 2008, APPL SOFT COMPUT, V8, P687, DOI 10.1016/j.asoc.2007.05.007
   Kim SH, 2016, MULTIMED TOOLS APPL, V75, P12815, DOI 10.1007/s11042-015-3237-6
   Lei BY, 2017, PATTERN RECOGN, V63, P719, DOI 10.1016/j.patcog.2016.09.037
   Liang QL, 2008, IEEE T AERO ELEC SYS, V44, P1060, DOI 10.1109/TAES.2008.4655363
   Liang QL, 2014, IEEE T COMPUT, V63, P2002, DOI 10.1109/TC.2013.85
   Liang QL, 2011, IEEE SYST J, V5, P156, DOI 10.1109/JSYST.2010.2090404
   Liang QL, 2010, IEEE T AERO ELEC SYS, V46, P558, DOI [10.1109/TAES.2010.5461641, 10.1109/TAES.2010.5461634]
   Liu HL, 2016, NEURAL COMPUT APPL, V27, P271, DOI 10.1007/s00521-014-1776-9
   Liu Y, 2016, PATTERN RECOGN, V59, P5, DOI 10.1016/j.patcog.2016.01.026
   Ma L, 2017, PATTERN RECOGN, V61, P573, DOI 10.1016/j.patcog.2016.04.013
   Moghaddam VH, 2016, PATTERN RECOGN, V60, P921, DOI 10.1016/j.patcog.2016.07.004
   Neverova N, 2016, IEEE T PATTERN ANAL, V38, P1692, DOI 10.1109/TPAMI.2015.2461544
   Nie WZ, 2016, MULTIMEDIA SYST, V22, P75, DOI 10.1007/s00530-014-0394-9
   Ozturk C, 2015, APPL SOFT COMPUT, V28, P69, DOI 10.1016/j.asoc.2014.11.040
   Rafailidis D, 2013, PATTERN RECOGN, V46, P3358, DOI 10.1016/j.patcog.2013.05.023
   Salehinejad H, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P2055, DOI 10.1109/CEC.2014.6900606
   Shivakumara P, 2017, PATTERN RECOGN, V61, P479, DOI 10.1016/j.patcog.2016.08.021
   Tharwat A., 2016, PATTERN RECOGNIT LET
   Wang HB, 2016, IEEE T MULTIMEDIA, V18, P1579, DOI 10.1109/TMM.2016.2569412
   Xu GB, 2017, PATTERN RECOGN, V63, P139, DOI 10.1016/j.patcog.2016.09.045
   Yan YM, 2012, EURASIP J ADV SIG PR, P1, DOI 10.1186/1687-6180-2012-160
   Zelinka I, 2015, SWARM EVOL COMPUT, V25, P2, DOI 10.1016/j.swevo.2015.06.002
   Zhang H, 2014, IEEE IMAGE PROC, P5916, DOI 10.1109/ICIP.2014.7026195
   Zhang Q, 2017, MULTIMED TOOLS APPL, V76, P15465, DOI 10.1007/s11042-016-3848-6
   Zhang X., 2016, AD HOC NETW
   Zhang X, 2013, MEMET COMPUT, V5, P187, DOI 10.1007/s12293-013-0117-3
   Zheng Y, 2016, IEEE T PATTERN ANAL, V38, P1056, DOI 10.1109/TPAMI.2015.2476802
   Zheng Y, 2017, PATTERN RECOGN, V67, P97, DOI 10.1016/j.patcog.2017.01.029
NR 45
TC 3
Z9 3
U1 5
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0031-3203
EI 1873-5142
J9 PATTERN RECOGN
JI Pattern Recognit.
PD OCT
PY 2017
VL 70
BP 177
EP 184
DI 10.1016/j.patcog.2017.05.006
PG 8
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA EZ1UW
UT WOS:000404497300014
DA 2018-12-27
ER

PT J
AU Ghebleh, R
   Ghaffari, A
AF Ghebleh, Reza
   Ghaffari, Ali
TI RETRACTED: A Comprehensive survey on 5G: The prospect of future
   communications (Retracted article. See vol. 122, pg. 137, 2018)
SO JOURNAL OF NETWORK AND COMPUTER APPLICATIONS
LA English
DT Article; Retracted Publication
C1 [Ghebleh, Reza; Ghaffari, Ali] Islamic Azad Univ, Tabriz Branch, Dept Comp Engn, Tabriz, Iran.
RP Ghaffari, A (reprint author), Islamic Azad Univ, Tabriz Branch, Dept Comp Engn, Tabriz, Iran.
EM reza.ghebleh@iaushab.ac.ir; a.ghaffari@iaut.ac.ir
CR GHEBLEH R, 2016, PHYCOM, V18, P64, DOI DOI 10.1016/J.PHYC0M.2015.10.006
NR 1
TC 1
Z9 1
U1 2
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1084-8045
J9 J NETW COMPUT APPL
JI J. Netw. Comput. Appl.
PD SEP 15
PY 2017
VL 94
BP 1
EP 1
DI 10.1016/j.jnca.2017.07.005
PG 1
WC Computer Science, Hardware & Architecture; Computer Science,
   Interdisciplinary Applications; Computer Science, Software Engineering
SC Computer Science
GA FH9MV
UT WOS:000411537100001
DA 2018-12-27
ER

PT J
AU Alioui, A
   Dufour, J
   Leoni, V
   Loregger, A
   Moeton, M
   Iuliano, L
   Zerbinati, C
   Septier, A
   Val, P
   Fouache, A
   Russo, V
   Volle, DH
   Lobaccaro, JMA
   Zelcer, N
   Baron, S
AF Alioui, Anthony
   Dufour, Julie
   Leoni, Valerio
   Loregger, Anke
   Moeton, Martina
   Iuliano, Luigi
   Zerbinati, Chiara
   Septier, Amandine
   Val, Pierre
   Fouache, Allan
   Russo, Vincenzo
   Volle, David H.
   Lobaccaro, Jean-Marc A.
   Zelcer, Noam
   Baron, Silvere
TI RETRACTED: Liver X receptors constrain tumor development and metastasis
   dissemination in PTEN-deficient prostate cancer (Retracted article. See
   vol.9, artn no.2660, 2018)
SO NATURE COMMUNICATIONS
LA English
DT Article; Retracted Publication
ID EPITHELIAL-CELL PROLIFERATION; SUPPRESSOR GENE; CULTURED-CELLS;
   CHOLESTEROL; ACTIVATION; EXPRESSION; GROWTH; MICE; LXR; AKT
AB Advanced prostate cancer (PCa) is a clinical challenge as no curative therapeutic is available. In this context, a better understanding of metastasis and resistance mechanisms in PCa is an important issue. As phosphatase and tensin homolog (PTEN) loss is the most common genetic lesion in such cancer, we investigate human data sets for mechanisms that can constrain cancer evolution in this setting. Here we report a liver X receptor (LXR) signature, which tightly correlates with PTEN loss, in PCa. Accordingly, the LXR pathway is deregulated in prostate carcinomas in Pten-null mice. Genetic ablation of LXRs in Pten-null mice, exacerbates PCa invasiveness and metastatic dissemination, which involves mesenchymal transition and accumulation of matrix metalloproteinases. Mechanistically, PTEN deletion governed LXR transcriptional activity through deregulation of cholesterol de novo synthesis, resulting in accumulation of endogenous LXR ligands. Our study therefore reveals a functional circuit linking PTEN and LXR, and highlights LXRs as metabolic gatekeepers that are able to constrain PCa progression.
C1 [Alioui, Anthony; Dufour, Julie; Septier, Amandine; Val, Pierre; Fouache, Allan; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] Univ Clermont Auvergne, Genet Reprod & Dev, BP 38, F-63001 Clermont Ferrand, France.
   [Alioui, Anthony; Dufour, Julie; Septier, Amandine; Val, Pierre; Fouache, Allan; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] CNRS, Genet Reprod & Dev, UMR 6293, F-63001 Clermont Ferrand, France.
   [Alioui, Anthony; Dufour, Julie; Septier, Amandine; Val, Pierre; Fouache, Allan; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] INSERM, Genet Reprod & Dev, UMR 1103, F-63001 Clermont Ferrand, France.
   [Alioui, Anthony; Dufour, Julie; Fouache, Allan; Volle, David H.; Lobaccaro, Jean-Marc A.; Baron, Silvere] Ctr Rech Nutr Humaine Auvergne, F-63001 Clermont Ferrand, France.
   [Alioui, Anthony; Loregger, Anke; Moeton, Martina; Zelcer, Noam] Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands.
   [Leoni, Valerio] AST Settelaghi, Hosp Varese, Lab Clin Chem, Varese, Italy.
   [Iuliano, Luigi; Zerbinati, Chiara] Sapienza Univ Rome, Dept Medicosurg Sci & Biotechnol, I-04100 Latina, Italy.
   [Russo, Vincenzo] Ist Sci San Raffaele, Div Expt Oncol, Unit Immunobiotherapy Melanoma & Solid Tumors, Milan, Italy.
RP Lobaccaro, JMA; Baron, S (reprint author), Univ Clermont Auvergne, Genet Reprod & Dev, BP 38, F-63001 Clermont Ferrand, France.; Lobaccaro, JMA; Baron, S (reprint author), CNRS, Genet Reprod & Dev, UMR 6293, F-63001 Clermont Ferrand, France.; Lobaccaro, JMA; Baron, S (reprint author), INSERM, Genet Reprod & Dev, UMR 1103, F-63001 Clermont Ferrand, France.; Lobaccaro, JMA; Baron, S (reprint author), Ctr Rech Nutr Humaine Auvergne, F-63001 Clermont Ferrand, France.
EM j-marc.lobaccaro@uca.fr; silvere.baron@uca.fr
FU ERC from the European Research Council [617376]; AIRC [IG 19016]; ARC
   (Association de Recherche contre le Cancer); Dutch Heart Foundation
   [2016T015]; "Cancer Auvergne Prostate" (CLARA, INCa); ARTP (Association
   de Recherche sur les Tumeurs Prostatiques); EDC-CaP Plan Cancer INCa
   (Institut National du Cancer)
FX We are grateful to Dr. David Mangelsdorf (Department of Pharmacology and
   Biochemistry, University of Texas Southwestern Medical Center, Dallas,
   TX) for providing the Lxr alpha beta<SUP>-/-</SUP> mice. We thank Dr.
   Andre Mazur (INRA, Theix) for providing APOE antibody. We thank Sandrine
   Plantade, Kheredine Ouchane and Philippe Mazuel for efficient and
   fruitful work in mouse husbandry and care. We are grateful to Pradeep A.
   Val for discussion and improvement of the manuscript. We thank Dr. Axel
   Poulet (GReD, Clermont-Ferrand) for excellent work in formatting data
   for GSEA analysis. We thank Christelle Damon-Soubeyrant and Anip@th
   platform (GReD, Clermont-Ferrand) for histological exploration of mouse
   phenotypes. We warmly thank Dr. Petra van Duijn and Pr. Jan Trapman
   (Erasmus Medical Center, Rotterdam) for providing of
   LNCaP-PTEN-inducible cell line. We thank Plateforme GenomEast from IGBMC
   (Illkirch, France) for microarray analyzes. We thank Dr. Marc Poirot
   (UMR 1037-CRCT, Universite de Toulouse, France) for providing deuterated
   epoxycholesterols and deuterated 6-oxo-cholesterol. Noam Zelcer is an
   Established Investigator of the Dutch Heart Foundation (2013T111) and is
   supported by an ERC Consolidator grant (617376) from the European
   Research Council. Dr. Vincenzo Russo is supported by an AIRC grant (IG
   19016). Julie Dufour was supported by ARC (Association de Recherche
   contre le Cancer). Anke Loregger is supported by a Dekker grant from the
   Dutch Heart Foundation (2016T015). Silvere Baron and Jean Marc Lobaccaro
   were supported by "Cancer Auvergne Prostate" (CLARA, INCa), ARTP
   (Association de Recherche sur les Tumeurs Prostatiques) and EDC-CaP Plan
   Cancer 2014-2019 INCa (Institut National du Cancer).
CR Acimovic J, 2009, J CHROMATOGR B, V877, P2081, DOI 10.1016/j.jchromb.2009.05.050
   Ahmed NN, 1997, P NATL ACAD SCI USA, V94, P3627, DOI 10.1073/pnas.94.8.3627
   Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049
   Berrodin TJ, 2010, MOL PHARMACOL, V78, P1046, DOI 10.1124/mol.110.065193
   Brusselmans K, 2007, J BIOL CHEM, V282, P18777, DOI 10.1074/jbc.M611763200
   Chen CL, 2008, J CELL PHYSIOL, V215, P223, DOI 10.1002/jcp.21303
   Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012
   Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918
   Chuu CP, 2006, CANCER RES, V66, P6482, DOI 10.1158/0008-5472.CAN-06-0632
   Costet P, 2000, J BIOL CHEM, V275, P28240
   De Boussac H, 2013, EXPERT OPIN THER TAR, V17, P1029, DOI 10.1517/14728222.2013.820708
   de Medina P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2835
   Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677
   Du XM, 2006, MOL BIOL CELL, V17, P2735, DOI 10.1091/mbc.E05-11-1094
   Dufour J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058876
   Fuda H, 2007, J LIPID RES, V48, P1343, DOI 10.1194/jlr.M700018-JLR200
   Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125
   Iuliano L, 2015, STEROIDS, V99, P189, DOI 10.1016/j.steroids.2015.01.026
   Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266
   Kim HJ, 2009, P NATL ACAD SCI USA, V106, P558, DOI 10.1073/pnas.0811295106
   Krycer JR, 2013, BBA-REV CANCER, V1835, P219, DOI 10.1016/j.bbcan.2013.01.002
   Krycer JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008496
   Leoni V, 2012, MOL GENET METAB, V105, P463, DOI 10.1016/j.ymgme.2011.12.005
   Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036
   Lo Sasso G, 2013, GASTROENTEROLOGY, V144, P1497, DOI 10.1053/j.gastro.2013.02.005
   Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908
   Pencheva N, 2014, CELL, V156, P986, DOI 10.1016/j.cell.2014.01.038
   Poirot M, 2013, BIOCHIMIE, V95, P622, DOI 10.1016/j.biochi.2012.05.006
   Pommier AJC, 2010, ONCOGENE, V29, P2712, DOI 10.1038/onc.2010.30
   Pommier AJC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003483
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   RodriguezViciana P, 1996, EMBO J, V15, P2442, DOI 10.1002/j.1460-2075.1996.tb00602.x
   Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706
   Segala G, 2013, BIOCHEM PHARMACOL, V86, P175, DOI 10.1016/j.bcp.2013.02.031
   Shimizu C, 2003, ENDOCRINOLOGY, V144, P1186, DOI 10.1210/en.2002-221011
   Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254
   Silvente-Poirot S, 2014, SCIENCE, V343, P1445, DOI 10.1126/science.1252787
   Song C, 2001, STEROIDS, V66, P473, DOI 10.1016/S0039-128X(00)00239-7
   Soules R., 2017, CHEM PHYS LIPIDS, DOI [10.1016/j.chemphyslip.2017.05.006, DOI 10.1016/J.CHEMPHYSLIP.2017.05.006(2017)]
   Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Swyer GIM, 1942, CANCER RES, V2, P372
   Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614
   Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026
   Thysell E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014175
   Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059
   van Duijn PW, 2010, PROSTATE, V70, P135, DOI 10.1002/pros.21045
   Villablanca EJ, 2010, NAT MED, V16, P98, DOI 10.1038/nm.2074
   Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0
   WATABE T, 1979, BIOCHEM BIOPH RES CO, V87, P469, DOI 10.1016/0006-291X(79)91819-9
   WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033
   Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7
   Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158
   Yue SH, 2014, CELL METAB, V19, P393, DOI 10.1016/j.cmet.2014.01.019
   Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974
   Zhuang LY, 2005, J CLIN INVEST, V115, P959
NR 58
TC 3
Z9 3
U1 2
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD SEP 5
PY 2017
VL 8
AR 445
DI 10.1038/s41467-017-00508-5
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FG0FK
UT WOS:000409394300018
PM 28874658
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Song, N
   Zhong, JT
   Zhang, JH
   Yu, J
   Li, JS
   Qi, JB
   Yang, J
   Qiu, YY
   Su, W
   Feng, ZW
   Wang, HJ
AF Song, Na
   Zhong, Jiateng
   Zhang, Jinghang
   Yu, Jian
   Li, Jinsong
   Qi, Jinbo
   Yang, Jun
   Qiu, Yanyan
   Su, Wei
   Feng, Zhiwei
   Wang, Haijun
TI RETRACTED: Pigment epithelium derived factor play a positive role in
   bone mineralization of osteoblasts derived from diabetic patients
   (Retracted article. See vol. 645, pg. 188, 2018)
SO GENE
LA English
DT Article; Retracted Publication
DE Diabetic; Osteoblast; Mineralization; PEDF
ID HIGH-GLUCOSE CONDITIONS; MESENCHYMAL STEM-CELLS; IMPERFECTA TYPE VI;
   PEDF; EXPRESSION; RESORPTION; INCREASES
AB Pigment epithelium-derived factor (PEDF) is a multifunctional secreted protein which plays important role in anti-angiogenic, anti-tumorigenic, as well as involves in the metabolism and regeneration of bone. In this study, our aim is to investigate the role of PEDF in regulating mineralization of osteoblasts from diabetic patients (DP). We isolated and cultured osteoblasts derived from DP and non-diabetic patients (NDP), in order to analyze the variable differences via gene expression and calcification assay in vitro. Gene expression analysis and alizarin red S staining revealed that osteoblasts from DP exhibited defective mineralization. PEDF and vascular endothelial growth factor (VEGF) levels were lower in osteoblasts from DP than those from NDP. Interestingly, exogenous PEDF could upregulate the gene expression levels of VEGF and osteoblast-related genes, further to restore mineralization ability in osteoblasts from DP. Our results demonstrated that PEDF played a positive role in maintaining bone development in diabetic osteoblasts, therefore, we confidently believe that PEDF may be a promising cytokine to consider in development of treatments for diabetic bone diseases.
C1 [Song, Na; Qi, Jinbo; Yang, Jun; Qiu, Yanyan; Feng, Zhiwei] Xinxiang Med Univ, Dept Mol Biol & Biochem, Jinsui Rd 601, Xinxiang 453003, Peoples R China.
   [Zhong, Jiateng; Wang, Haijun] Xinxiang Med Univ, Dept Pathol, Jinsui Rd 601, Xinxiang 453003, Peoples R China.
   [Zhang, Jinghang; Yu, Jian; Li, Jinsong; Su, Wei; Wang, Haijun] Xinxiang Med Univ, Affiliated Hosp 1, Dept Pathol, Xinxiang 453003, Peoples R China.
RP Feng, ZW (reprint author), Xinxiang Med Univ, Dept Mol Biol & Biochem, Jinsui Rd 601, Xinxiang 453003, Peoples R China.; Wang, HJ (reprint author), Xinxiang Med Univ, Dept Pathol, Jinsui Rd 601, Xinxiang 453003, Peoples R China.
EM fengzhiwei@xxmu.edu.cn; 151044@xxmu.edu.cn
FU Doctoral Scientific Research Foundation of Xingxiang Medical University
   [XYBSKYZZ201512, 201513]; National Natural Science Foundation of China
   [81602132]; Education Department of Henan Province [201610472040]
FX This work was supported by Doctoral Scientific Research Foundation of
   Xingxiang Medical University (Grant No. XYBSKYZZ201512 and 201513) to
   Dr. Na Song and Haijun Wang. This work was partly supported by research
   project awarded to Dr. Haijun Wang by the National Natural Science
   Foundation of China (Grant No. 81602132), and a grant from the Education
   Department of Henan Province (Grant No. 201610472040) to Dr. Na Song. We
   would like to give special thanks to Dr. Christopher Niyibizi for
   valuable guidance and Dr. Feng Li assistance with the experiments.
CR Akin S, 2012, CLIN ENDOCRINOL, V77, P852, DOI 10.1111/j.1365-2265.2012.04341.x
   Akiyama T, 2010, BIOCHEM BIOPH RES CO, V391, P789, DOI 10.1016/j.bbrc.2009.11.139
   Al-Jallad H, 2015, BONE, V76, P115, DOI 10.1016/j.bone.2015.04.008
   Amano S, 2005, MICROVASC RES, V69, P45, DOI 10.1016/j.mvr.2004.11.001
   Barnstable CJ, 2004, PROG RETIN EYE RES, V23, P561, DOI 10.1016/j.preteyeres.2004.05.002
   Belinsky G.S., 2016, ORPHANET J RARE DIS, V4
   Belinsky GS, 2016, FASEB J, V30, P2837, DOI 10.1096/fj.201500027R
   Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M5074401200
   Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012
   Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501
   Gattu AK, 2013, FASEB J, V27, P4384, DOI 10.1096/fj.13-232900
   Hofbauer LC, 2007, J BONE MINER RES, V22, P1317, DOI 10.1359/JBMR.070510
   Hu K, 2016, J CLIN INVEST, V126, P509, DOI 10.1172/JCI82585
   Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047
   Li F, 2015, J CELL PHYSIOL, V230, P1243, DOI 10.1002/jcp.24859
   Li F, 2013, STEM CELLS, V31, P2714, DOI 10.1002/stem.1505
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rauch F, 2012, J CLIN ENDOCR METAB, V97, pE1550, DOI 10.1210/jc.2012-1827
   Shanbhogue VV, 2016, LANCET DIABETES ENDO, V4, P159, DOI 10.1016/S2213-8587(15)00283-1
   Shanbhogue VV, 2015, J BONE MINER RES, V30, P2188, DOI 10.1002/jbmr.2573
   Song N, 2014, TISSUE ENG PT A, V20, P239, DOI [10.1089/ten.tea.2013.0197, 10.1089/ten.TEA.2013.0197]
   Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9
   Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504
   TOMBRANTINK J, 1991, EXP EYE RES, V53, P411, DOI 10.1016/0014-4835(91)90248-D
   Valverde P, 2008, J BONE MINER RES, V23, P1775, DOI 10.1359/JBMR.080605
   Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4
   Wang JY, 2017, CALCIFIED TISSUE INT, V100, P55, DOI 10.1007/s00223-016-0201-z
   Xie B, 2012, INVEST OPHTH VIS SCI, V53, P1023, DOI 10.1167/iovs.11-8695
   Zhang LP, 2009, ACTA DIABETOL, V46, P119, DOI 10.1007/s00592-008-0068-1
   Zhang SX, 2006, J MOL ENDOCRINOL, V37, P1, DOI 10.1677/jme.1.02008
   Zheng Z, 2010, INVEST OPHTH VIS SCI, V51, P64, DOI 10.1167/iovs.09-3511
NR 31
TC 1
Z9 1
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD SEP 5
PY 2017
VL 627
BP 563
EP 568
DI 10.1016/j.gene.2017.07.018
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA FD6SK
UT WOS:000407658000074
PM 28698158
DA 2018-12-27
ER

PT J
AU Li, ZF
AF Li, Zifeng
TI RETRACTED: Physical Models of Drill String Axial and Torsional
   Vibrations (Retracted article. See vol. 144, 2018)
SO JOURNAL OF ENGINEERING MECHANICS
LA English
DT Editorial Material; Retracted Publication
AB Forum papers are thought-provoking opinion pieces or essays founded in fact, sometimes containing speculation, on a civil engineering topic of general interest and relevance to the readership of the journal. The views expressed in this Forum article do not necessarily reflect the views of ASCE or the Editorial Board of the journal.
C1 [Li, Zifeng] Yanshan Univ, Petr Engn Inst, Qinhuangdao 066004, Hebei, Peoples R China.
RP Li, ZF (reprint author), Yanshan Univ, Petr Engn Inst, Qinhuangdao 066004, Hebei, Peoples R China.
EM zfli@ysu.edu.cn
FU National Natural Science Foundation of China [51374183, 51490653,
   51674220]
FX The paper is supported by the National Natural Science Foundation of
   China (Grant Nos. 51374183, 51490653, and 51674220).
CR Detournay E, 2008, INT J ROCK MECH MIN, V45, P1347, DOI 10.1016/j.ijrmms.2008.01.010
   Li Z., 1996, THEORY WELLBORE TRAJ, P1
   Li Z., 2007, P ROCK MOUNT OIL GAS
   Li ZF, 2017, J PETROL SCI ENG, V151, P194, DOI 10.1016/j.petrol.2016.10.025
   Li ZF, 2016, J SOUND VIB, V384, P356, DOI 10.1016/j.jsv.2016.07.017
   [李子丰 Li Zifeng], 2004, [工程力学, Engineering Mechanics], V21, P203
   Li Zifeng, 2008, TUBULAR MECH OIL GAS, P1
   Nandakumar K, 2013, J SOUND VIB, V332, P2575, DOI 10.1016/j.jsv.2012.12.020
   Nandakumar K, 2013, APPL MATH MODEL, V37, P1705, DOI 10.1016/j.apm.2012.04.038
NR 9
TC 1
Z9 1
U1 10
U2 10
PU ASCE-AMER SOC CIVIL ENGINEERS
PI RESTON
PA 1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA
SN 0733-9399
EI 1943-7889
J9 J ENG MECH
JI J. Eng. Mech.
PD SEP
PY 2017
VL 143
IS 9
AR 02517001
DI 10.1061/(ASCE)EM.1943-7889.0001310
PG 3
WC Engineering, Mechanical
SC Engineering
GA FF0GD
UT WOS:000408579300001
DA 2018-12-27
ER

PT J
AU Hong, SY
   Jun, SY
AF Hong, Sun Yi
   Jun, Soo Young
TI RETRACTED: Community Capacity Building Exercise Maintenance Program for
   Frail Elderly Women (Retracted article. See vol.12, pg.154, 2018)
SO ASIAN NURSING RESEARCH
LA English
DT Article; Retracted Publication
DE elderly; community; exercise; maintenance
ID PHYSICAL-ACTIVITY; OLDER-ADULTS; EFFICACY
AB Purpose: The purpose of this study was to examine the effects of community capacity building exercise maintenance program for frail elderly women.
   Methods: A quasiexperimental pretest-posttest design was used with nonequivalent control group. The experimental group (n = 22) received community capacity building exercise maintenance program, whereas the control group (n = 23) received health physical exercise program for 16 sessions over 8 weeks. The data of physical fitness, body compositions, self-efficacy, and health-related quality of life were collected three times for both group: before the intervention, immediately after the intervention, and 8 weeks after the intervention. Analyses were conducted using c 2 test, t test, Fisher's exact test, and repeated measures analysis of variance.
   Results: Compared to the control group, muscular strength (p = .002), static balance (p = .013), muscular endurance (p = .003), self-efficacy (p <.001), and health-related quality of life (p = .030) were significantly improved in the experimental group. In addition, body fat percentage (p = .005) in this group was significantly decreased after the community capacity building exercise maintenance program.
   Conclusion: Theses results indicated that a community capacity building exercise maintenance program is feasible, and associated with exercise maintenance among frail elderly women. (C) 2017 Korean Society of Nursing Science, Published by Elsevier Korea LLC. This is an open access article under the CC BY-NC-ND license.
C1 [Hong, Sun Yi] Suseong Univ, Dept Nursing, Daegu, South Korea.
   [Jun, Soo Young] Kyungpook Natl Univ, Grad Sch, Coll Nursing, Daegu, South Korea.
RP Jun, SY (reprint author), Kyungpook Natl Univ, Coll Nursing, 680 Kukchaeborangro, Daegu 41944, South Korea.
EM sy0340@naver.com
CR BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037//0033-295X.84.2.191
   Bergamin M, 2013, CLIN INTERV AGING, V8, P1109, DOI 10.2147/CIA.S44198
   Chung LMY, 2012, ASIAN J GERONTOLOGY, V7, P69
   Draper AK, 2010, SOC SCI MED, V71, P1102, DOI 10.1016/j.socscimed.2010.05.016
   Edwards MB, 2015, SPORT MANAG REV, V18, P6, DOI 10.1016/j.smr.2013.08.008
   Filar-Mierzwa K, 2016, J WOMEN AGING, V23, P1
   Geraedts H, 2013, PATIENT EDUC COUNS, V91, P14, DOI 10.1016/j.pec.2012.10.018
   Goytia CN, 2013, PROG COMM HLTH PARTN, V7, P291, DOI 10.1353/cpr.2013.0031
   Greenspan SL, 2015, JAMA INTERN MED, V175, P913, DOI 10.1001/jamainternmed.2015.0747
   Grim M, 2011, AM J HEALTH PROMOT, V25, P227, DOI 10.4278/ajhp.081216-ARB-307
   Heiss VJ, 2016, PSYCHOL HEALTH MED, V21, P92, DOI 10.1080/13548506.2015.1017510
   Kang S.J., 2011, KOREAN J SPORT PSYCH, V22, P113
   Kattenstroth JC, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00005
   Kim SH, 2015, 11135200000028513 KO
   Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142
   Nam H.S., 2007, EQ 5D KOREAN VALUATI
   Oosting E, 2015, PHYSIOTHERAPY, V101, pe1150
   Rikli RE, 2013, SENIOR FITNESS TEST, P85
   Saygin O, 2015, STUD ETHNO-MED, V9, P379
   Sherrington Catherine, 2011, N S W Public Health Bull, V22, P78, DOI 10.1071/NB10056
   Silveira P, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2579
   Simmons A, 2011, PREV MED, V52, P193, DOI [10.1015/j.ypmed.2011.02.003, 10.1016/j.ypmed.2011.02.003]
   Song MS, 2013, ASIAN NURS RES, V7, P1, DOI 10.1016/j.anr.2012.11.001
   Stolee P, 2012, WORK, V41, P339, DOI 10.3233/WOR-2012-1304
   Verrusio W, 2014, COMPLEMENT THER MED, V22, P614, DOI 10.1016/j.ctim.2014.05.012
   Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39
   WILLIAMS A, 1990, HEALTH POLICY, V16, P199
   Zgibor JC, 2016, PROG COMM HLTH PARTN, V10, P123, DOI 10.1353/cpr.2016.0001
   박순미, 2016, [Health and Social Welfare Review, 보건사회연구], V36, P97, DOI 10.15709/hswr.2016.36.4.97
   김명배, 2016, [The Korean Society of Sports Science, 한국체육과학회지], V25, P1303
NR 30
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1976-1317
EI 2093-7482
J9 ASIAN NURS RES
JI Asian Nurs. Res.
PD SEP
PY 2017
VL 11
IS 3
BP 166
EP 173
DI 10.1016/j.anr.2017.06.001
PG 8
WC Nursing
SC Nursing
GA FL4VO
UT WOS:000414229800002
PM 28991596
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Cheong, MY
   Abu Hassan, H
   Ismail, R
   Hasan, ZAA
AF Cheong, Mei Yee
   Abu Hassan, Hazimah
   Ismail, Rosnah
   Hasan, Zafarizal Aldrin Azizul
TI RETRACTED: Preparation and characterization of zinc glycerolate: UV
   protection, biological activity and permeation study (Retracted article.
   See vol. 22, pg. 886, 2018)
SO JOURNAL OF SAUDI CHEMICAL SOCIETY
LA English
DT Article; Retracted Publication
DE Zinc complex; Zinc glycerolate; Antimicrobial; Permeation study
ID SLOW-RELEASE SOURCE; IN-VITRO; ASPERGILLUS-NIGER; IRON ALKOXIDE;
   MONOGLYCEROLATE; GROWTH; IONS; METALS; ADIPOCYTES; INFECTION
AB Zinc glycerolate, has been reported to be beneficial in the treatment of many medical ailments but its properties for skincare application are not explored. Zinc glycerolate has been successfully synthesized by heating zinc oxide and glycerol in 240 degrees C via microwave irradiation. The characterization and properties of zinc glycerolate were discussed including scanning electron micro-scopy (SEM), laser diffraction particle size analysis, in vitro irritancy potential, UV protection, antibacterial and permeation properties via Franz diffusion cell of the zinc glycerolate. Zinc glycerolate is classified as non-irritant when used in dermal application. It has SPF of 1.007 +/- 0.004 and ultraviolet A to B (UVA/UVB) ratio of 0.7 +/- 0.019 which is considered good for UVA protection under Boot's star rating. The antimicrobial properties of zinc glycerolate were expressed as the minimum inhibitory concentration (MIC); the minimum bactericidal concentration (MBC) and the time needed to eliminate 99.9% of the bacteria population (time-kill). Zinc glycerolate has better bactericidal properties than zinc oxide particularly towards Staphylococcus epidermis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Propionibacterium acnes while no effect was observed for Candida albicans and Aspergillus niger. The concentration of zinc ions that has diffused through polysulfone membrane installed in a vertical diffusion cell was determined through atomic absorption spectroscopy (AAS). The highest concentration of zinc ion diffused was found from incorporation of zinc glycerolate in oil-in-water (O/W) cream-based excipient. The obtained results indicated that zinc glycerolate has a good potential for applications in the cosmetics and pharmaceutical products. (C) 2015 King Saud University. Production and hosting by Elsevier B.V.
C1 [Cheong, Mei Yee; Abu Hassan, Hazimah; Ismail, Rosnah; Hasan, Zafarizal Aldrin Azizul] MPOB, AOTD, 6 Persiaran Inst, Kajang 43000, Selangor, Malaysia.
RP Cheong, MY (reprint author), MPOB, AOTD, 6 Persiaran Inst, Kajang 43000, Selangor, Malaysia.
EM cheongmy@mpob.gov.my
OI Cheong, Mei Yee/0000-0003-2732-020X
FU MPOB
FX This research was supported by a Grant from the MPOB. The authors are
   grateful to Prof. Howard A. Barnes for his assistance in editing this
   manuscript.
CR ABELSON PH, 1950, J BACTERIOL, V60, P401
   [Anonymous], 1996, IRRITECTION ASSAY SY, P1
   [Anonymous], SPF ANAL SUNSCREENS, P1
   APISARIYAKULM A, 1990, MED J AUSTRALIA, V152, P54
   Atmaca S, 1998, TURK J MED SCI, V28, P595
   Azam A, 2012, INT J NANOMED, V7, P3527, DOI 10.2147/IJN.S29020
   BABICH H, 1978, APPL ENVIRON MICROB, V36, P906
   BARTLETT L, 1974, WATER RES, V8, P179, DOI 10.1016/0043-1354(74)90041-4
   Bos M.A., 1995, U. S. Patent, Patent No. 5475123
   Bos M. A., 2006, U. S. Patent, Patent No. [7074949B2, 7074949]
   Boyd D, 2006, J MATER SCI-MATER M, V17, P489, DOI 10.1007/s10856-006-8930-6
   BROWN MRW, 1971, INHIBITION DESTRUCTI, P307
   BRUYLANTS P, 1980, J INORG NUCL CHEM, V42, P1603, DOI 10.1016/0022-1902(80)80324-1
   CARTER JW, 1973, WATER RES, V7, P951, DOI 10.1016/0043-1354(73)90177-2
   COULSTON L, 1980, DIABETES, V29, P665, DOI 10.2337/diabetes.29.8.665
   CUMMINS D, 1991, J CLIN PERIODONTOL, V18, P455, DOI 10.1111/j.1600-051X.1991.tb02316.x
   EAGON RG, 1965, CAN J MICROBIOL, V11, P1041, DOI 10.1139/m65-144
   FAIRLIE DP, 1992, AGENTS ACTIONS, V36, P152, DOI 10.1007/BF01991243
   Foley J, 2003, CARIES RES, V37, P416, DOI 10.1159/000073393
   FRANTZ SW, 1990, METHODS SKIN ABSORPT, P35
   FULS PF, 1970, CLAY CLAY MINER, V18, P53, DOI 10.1346/CCMN.1970.0180107
   HAMBLEY TW, 1983, AUST J CHEM, V36, P1249, DOI 10.1071/CH9831249
   Hazimah A. H., 2001, PALM OIL DEV, V35, P8
   IZAGUIRREFERNANDEZ EJ, 1989, CARIES RES, V23, P18, DOI 10.1159/000261149
   Jain J, 2009, MOL PHARMACEUT, V6, P1388, DOI 10.1021/mp900056g
   KORANT BD, 1974, NATURE, V248, P588, DOI 10.1038/248588a0
   LABOREY F, 1973, CR ACAD SCI D NAT, V276, P529
   MAGO R, 1994, APPL ENVIRON MICROB, V60, P2367
   Matkin D.A., 1997, U. S. Patent, Patent No. 5646324
   MAY JM, 1982, J BIOL CHEM, V257, P4362
   MENDELOVICI E, 1986, THERMOCHIM ACTA, V107, P75, DOI 10.1016/0040-6031(86)85036-5
   Monti D, 2015, INT J COSMETIC SCI, V37, P298, DOI 10.1111/ics.12199
   Moore S. L., 2004, RUSSELL HUGO AYLIFFE, P8, DOI [10.1002/9780470755884.ch2, DOI 10.1002/9780470755884.CH2]
   NAGY L, 1986, INORG CHIM A-BIOINOR, V124, P55, DOI 10.1016/S0020-1693(00)82085-X
   NICKERSON WJ, 1946, SCIENCE, V103, P484, DOI 10.1126/science.103.2677.484
   Osinaga PWR, 2003, DENT MATER, V19, P212, DOI 10.1016/S0109-5641(02)00032-5
   OU JT, 1972, J BACTERIOL, V11, P177
   Padmavathy N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/035004
   Phan TN, 2004, ORAL MICROBIOL IMMUN, V19, P31, DOI 10.1046/j.0902-0055.2003.00109.x
   Poulter N, 2011, NEW J CHEM, V35, P1477, DOI 10.1039/c1nj20091g
   QAIYUMI S, 2007, ANTIMICROBIAL SUSCEP, P75
   RADKE LL, 1994, CLIN IMMUNOL IMMUNOP, V73, P344, DOI 10.1006/clin.1994.1208
   RADOSLOVICH EW, 1970, AUST J CHEM, V23, P1963, DOI 10.1071/CH9701963
   Rostan EF, 2002, INT J DERMATOL, V41, P606, DOI 10.1046/j.1365-4362.2002.01567.x
   RUTHVEN JA, 1973, J PROTOZOOL, V20, P127, DOI 10.1111/j.1550-7408.1973.tb06015.x
   SHISHEVA A, 1992, DIABETES, V41, P982, DOI 10.2337/diabetes.41.8.982
   SINA JF, 1995, FUND APPL TOXICOL, V26, P20, DOI 10.1006/faat.1995.1071
   SMITH WH, 1978, T BRIT MYCOL SOC, V70, P29, DOI 10.1016/S0007-1536(78)80166-1
   SODERBERG TA, 1990, SCAND J PLAST RECONS, V24, P193
   SOMERS E, 1961, ANN APPL BIOL, V49, P246, DOI 10.1111/j.1744-7348.1961.tb03612.x
   Stickler D, 2004, RUSSELL HUGO AYLIFFE, p[154, 169]
   SUGARMAN B, 1983, REV INFECT DIS, V5, P137
   Taylor R.M., 1990, U. S. Patent, Patent No. 4943316
   Taylor R. M., 1989, U. S. Patent, Patent No. 4876278
   Taylor R. M., 1988, U. S. Patent, Patent No. 4789701
   Taylor R.M., 1985, Pharmaceutical Compound Zinc Glycerolate Complex Prepared by Reacting Zinc Oxide and Glycerol, Patent No. [4.544.761, 4544761, U54544761 A]
   Taylor R. M., 2006, U. S. Patent, Patent No. [US 2006173073A1, 2006173073]
   TZAGOLOFF H, 1964, VIROLOGY, V24, P372, DOI 10.1016/0042-6822(64)90174-6
   WALSH CT, 1994, ENVIRON HEALTH PERSP, V102, P5, DOI 10.2307/3431820
   WHITEHOUSE MW, 1990, AGENTS ACTIONS, V31, P47, DOI 10.1007/BF02003221
   WILSON DO, 1977, SOIL BIOL BIOCHEM, V9, P277, DOI 10.1016/0038-0717(77)90035-9
   Winslow CEA, 1931, J BACTERIOL, V22, P49
   WOLD WSM, 1976, CAN J MICROBIOL, V22, P1083, DOI 10.1139/m76-159
   Yan H, 2008, OPHTHALMOLOGICA, V222, P245, DOI 10.1159/000131104
   Yee CM, 2012, J OIL PALM RES, V24, P1287
NR 65
TC 1
Z9 1
U1 4
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1319-6103
EI 2212-4640
J9 J SAUDI CHEM SOC
JI J. Saudi Chem. Soc.
PD SEP
PY 2017
VL 21
IS 6
BP 643
EP 655
DI 10.1016/j.jscs.2015.09.002
PG 13
WC Chemistry, Multidisciplinary
SC Chemistry
GA FL4PW
UT WOS:000414214000002
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Crepeaux, G
   Exley, C
   Shaw, CA
   Gherardi, RK
AF Crepeaux, Guillemette
   Exley, Christopher
   Shaw, Christopher A.
   Gherardi, Romain K.
TI RETRACTED: Scientific and ethical obligations to publish tobacco
   industry-funded research on nicotine delivery systems of reduced risk
   (Retracted article. See vol. 410, pg. 170, 2018)
SO TOXICOLOGY
LA English
DT Letter; Retracted Publication
C1 [Crepeaux, Guillemette; Gherardi, Romain K.] Univ Paris Est Creteil UPEC, INSERM, U955 E10, Creteil, France.
   [Crepeaux, Guillemette] Ecole Natl Vet Alfort, Maisons Alfort, France.
   [Exley, Christopher] Keele Univ, Birchall Ctr, Keele, Staffs, England.
   [Shaw, Christopher A.] Univ British Columbia, Dept Ophthalmol, Vancouver, BC, Canada.
RP Crepeaux, G (reprint author), Univ Paris Est Creteil UPEC, INSERM, U955 E10, Creteil, France.
EM guillemette.crepeaux@gmail.com
OI Exley, Christopher/0000-0002-5116-7607; Crepeaux,
   Guillemette/0000-0001-7624-3904
CR Crepeaux G, 2017, TOXICOLOGY, V375, P48, DOI [10.1016/j.tox.201611.018, 10.1016/j.tox.2016.11.018]
   Hawkes D, 2017, TOXICOLOGY, V389, P53, DOI 10.1016/j.tox.2017.06.009
NR 2
TC 2
Z9 2
U1 3
U2 6
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0300-483X
J9 TOXICOLOGY
JI Toxicology
PD SEP 1
PY 2017
VL 390
BP 159
EP 159
DI 10.1016/j.tox.2017.09.010
PG 1
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA FK6JV
UT WOS:000413610900018
PM 28928034
DA 2018-12-27
ER

PT J
AU Xu, C
   Li, M
   Wang, C
   Li, K
   Liu, H
AF Xu, C.
   Li, M.
   Wang, C.
   Li, K.
   Liu, H.
TI RETRACTED: Ankle-hindfoot after calcaneal fractures: A biomechanical
   study (Retracted article. See vol. 104, pg. 547, 2018)
SO ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH
LA English
DT Article; Retracted Publication
DE Ankle-hindfoot; Calcaneal fractures; Biomechanics; Experimental; Finite
   element
ID INTRAARTICULAR FRACTURES; CONTACT CHARACTERISTICS; NONOPERATIVE
   TREATMENT; INTERNAL-FIXATION; SUBTALAR JOINT; OPEN REDUCTION; BONE
AB Introduction: Both the overall shape of the calcaneus and anatomical reduction of joint congruity are important prognostic factors. However, there is a significant lack of biomechanical data supporting the clinical importance of calcaneus height, length and heel width. The objective of this study was to determine the effects of abnormal calcaneus morphology on ankle-hindfoot biomechanics.
   Hypothesis :The normal biomechanics of the ankle-hindfoot would be severely disrupted by the abnormal calcaneus morphology.
   Materials and methods: Fifteen human cadaveric feet were evaluated intact and post-osteotomy after application of a 20 N load. The kinematics of the ankle-hindfoot were compared between normal and simulated calcaneal fractures with reductions in calcaneal height, widening of the heel and shortening of the calcaneal length. In finite element analysis, static loading was simulated at an axial load with the subtalar joint in a neutral position, and the effects of the injured calcaneus on the contact characteristics of the subtalar joints were evaluated in terms of the contact areas, peak contact pressures and pressure distributions.
   Results: The increases in calcaneal width somewhat limited subtalar motion, and the reductions in length mainly limited external rotation and plantar flexion of the subtalar joint. However, the reductions in height mainly resulted in subtalar rotatory instability. The increases in width somewhat broadened the contact area but more notably increased the high-pressure contact zone. With height loss, the overall contact area decreased, and the contact pressure center shifted to the anteroinferior portion of articulation. However, the contact pressure peak remained almost constant.
   Discussion: The normal biomechanics of the ankle-hindfoot were severely disrupted by the abnormal calcaneus morphology, and reestablishment of the geometric parameters of the calcaneus could restore the relative positions of the 3 superior calcaneal facets and minimize subtalar pain associated with the development of arthrosis and stiffness. Therefore, the 3D calcaneus anatomy should be carefully restored in patients with no risk factors. (C) 2017 Elsevier Masson SAS. All rights reserved.
C1 [Xu, C.; Li, M.; Wang, C.; Li, K.; Liu, H.] Cent S Univ, Xiangya Hosp, Dept Orthpaed, Changsha, Hunan, Peoples R China.
RP Liu, H (reprint author), Cent S Univ, Xiangya Hosp, Dept Orthpaed, Changsha, Hunan, Peoples R China.
EM liuhua345@163.com
FU Research Fund for National Natural Science Foundation of China
   [81301543]; Natural Science Foundation of Hunan Province [2016JJ4108]
FX This work was supported by the Research Fund for National Natural
   Science Foundation of China (Grant No. 81301543) and Natural Science
   Foundation of Hunan Province (Grant No. 2016JJ4108).
CR Anderson AE, 2010, J BIOMECH, V43, P1351, DOI 10.1016/j.jbiomech.2010.01.010
   Anderson AE, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2953472
   Barei DP, 2002, ORTHOP CLIN N AM, V33, P263, DOI 10.1016/S0030-5898(03)00084-1
   Basile A, 2010, J FOOT ANKLE SURG, V49, P25, DOI 10.1053/j.jfas.2009.08.001
   Buckley R, 2002, J BONE JOINT SURG AM, V84A, P1733, DOI 10.2106/00004623-200210000-00001
   Funk JR, 2000, J BIOMECH ENG-T ASME, V122, P15, DOI 10.1115/1.429623
   Golano P, 2010, KNEE SURG SPORT TR A, V18, P557, DOI 10.1007/s00167-010-1100-x
   Guerado E, 2012, INJURY, V43, P1640, DOI 10.1016/j.injury.2012.05.011
   Hetsroni I, 2011, J TRAUMA, V70, P1234, DOI 10.1097/TA.0b013e3181dbe5f7
   Imhauser CW, 2008, J BIOMECH, V41, P1341, DOI 10.1016/j.jbiomech.2007.12.017
   JANZEN DL, 1992, AM J ROENTGENOL, V158, P1271, DOI 10.2214/ajr.158.6.1590122
   KELLER TS, 1994, J BIOMECH, V27, P1159, DOI 10.1016/0021-9290(94)90056-6
   Loucks C, 1999, J ORTHOP TRAUMA, V13, P554, DOI 10.1097/00005131-199911000-00007
   Mitchell M J, 2009, Foot (Edinb), V19, P197, DOI 10.1016/j.foot.2009.05.001
   Morgan EF, 2003, J BIOMECH, V36, P897, DOI 10.1016/S0021-9290(03)00071-X
   Mulcahy DM, 1998, FOOT ANKLE INT, V19, P842, DOI 10.1177/107110079801901209
   PALEY D, 1993, J BONE JOINT SURG AM, V75A, P342, DOI 10.2106/00004623-199303000-00005
   Rammelt S, 2004, J BONE JOINT SURG BR, V86B, P659, DOI 10.1302/0301-620X.86B5.14205
   Rammelt S, 2003, ZBL CHIR, V128, P517
   Sanders R, 2014, J ORTHOP TRAUMA, V28, P551, DOI 10.1097/BOT.0000000000000169
   SANGEORZAN BJ, 1995, J ORTHOP TRAUMA, V9, P251
   Sharr PJ, 2016, FOOT ANKLE SURG, V22, P1, DOI 10.1016/j.fas.2015.10.003
   Sugimoto K, 2005, ARTHROSCOPY, V21, P401, DOI 10.1016/j.arthro.2004.12.005
   [Wang Yimin 王一民], 2014, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V18, P6742
   Wirtz DC, 2000, J BIOMECH, V33, P1325, DOI 10.1016/S0021-9290(00)00069-5
NR 25
TC 1
Z9 1
U1 5
U2 10
PU ELSEVIER MASSON, CORPORATION OFFICE
PI PARIS
PA 65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE
SN 1877-0568
J9 ORTHOP TRAUMATOL-SUR
JI Orthop. Traumatol.-Surg. Res.
PD SEP
PY 2017
VL 103
IS 5
BP 709
EP 716
DI 10.1016/j.otsr.2017.05.013
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA FG6WW
UT WOS:000410540000015
PM 28619268
DA 2018-12-27
ER

PT J
AU Roy, E
   Patra, S
   Madhuri, R
   Sharma, PK
AF Roy, Ekta
   Patra, Santanu
   Madhuri, Rashmi
   Sharma, Prashant K.
TI RETRACTED: Anisotropic Gold Nanoparticle Decorated Magnetopolymersome:
   An Advanced Nanocarrier for Targeted Photothermal Therapy and Dual Mode
   Responsive T-1 MRI Imaging (Retracted article. See vol. 4, pg. 1112,
   2018)
SO ACS BIOMATERIALS SCIENCE & ENGINEERING
LA English
DT Article; Retracted Publication
DE magnetopolymersome; anisotropic gold nanoparticle; photothermal therapy;
   targeted drug delivery; stimuli-responsive T-1-contrast agent
ID SENSITIVE POLYMERSOMES; CONTROLLED DELIVERY; DRUG-DELIVERY; VESICLES;
   COPOLYMER; DOXORUBICIN; ULTRASOUND; CHEMISTRY; LIPOSOMES; DIAGNOSIS
AB Herein, we report the advanced polymer vesicle [made up of triblock polymer: poly(ethylene oxide)-co-poly(Cys-AuNP@FA)-copoly(3-methoxypropylacrylamide] having encapsulated magnetic nano particle capable of targeted methotrexate delivery (having folic acid as tagging agent), photothermal therapy [anisotropic gold nanoparticle (AuNPs)] and stimuli-responsive T-1-imaging (as MRI contrast agent). The prepared polymersome, called as magnetopolymersome (MPS), after encapsulation of magnetic nanoparticle (Gd-doped) is not only high yield and simple in synthesis but also possess very high biocompatibility, more than 95% drug encapsulation efficiency and effective near-infrared (NIR) responsive photothermal therapy. The MPS is highly stable under normal physiological environments and other extreme end conditions (like presence of serum or Triton-X 100) and have excellent stimuli-responsive (temperature and NIR) T-1-contrast effect in vitro conditions (60.57 mM(-1)) s(-1)). To explore the role of shape of AuNPs on the photothermal therapy and drug delivery behavior of prepared nanocarrier, herein, we have synthesized four different shapes of AuNPs, i.e., spherical, triangle, rod, and flower. It was found that nanoflower-conjugated MPS shows the most efficient NIR responsive behavior in comparison to their other colleagues, which broke the ancient myth that spherical nanoparticle are the best candidate for drug delivery process. These features make nanoflower or other anisotropic nanoparticle-based polymersome a very promising and efficient nanocarrier for drug loading, delivery, imaging, and photothermal therapy.
C1 [Roy, Ekta; Patra, Santanu; Madhuri, Rashmi] Indian Inst Technol, Indian Sch Mines, Dept Appl Chem, Dhanbad 826004, Jharkhand, India.
   [Sharma, Prashant K.] Indian Inst Technol, Indian Sch Mines, Dept Appl Phys, Funct Nanomat Res Lab, Dhanbad 826004, Bihar, India.
RP Madhuri, R (reprint author), Indian Inst Technol, Indian Sch Mines, Dept Appl Chem, Dhanbad 826004, Jharkhand, India.
EM rshmmadhuri@gmail.com
FU DST [SERB/F/2798/2016-17, SB/FT/CS-155/2012, FRS/43/2013-2014/AC,
   34/14/21/2014-BRNS, SR/FTP/PS-157/2011, FRS/34/2012-2013/APH]; BRNS
   [SERB/F/2798/2016-17, SB/FT/CS-155/2012, FRS/43/2013-2014/AC,
   34/14/21/2014-BRNS, SR/FTP/PS-157/2011, FRS/34/2012-2013/APH]; ISM
   [SERB/F/2798/2016-17, SB/FT/CS-155/2012, FRS/43/2013-2014/AC,
   34/14/21/2014-BRNS, SR/FTP/PS-157/2011, FRS/34/2012-2013/APH]
FX The authors are thankful to DST, BRNS, and ISM for sponsoring the
   research projects to R.M. (ref no.: SERB/F/2798/2016-17;
   SB/FT/CS-155/2012; FRS/43/2013-2014/AC; 34/14/21/2014-BRNS) and P.K.S.
   (ref no.: SERB/F/2798/2016-17; SR/FTP/PS-157/2011; FRS/34/2012-2013/APH;
   34/14/21/2014-BRNS). The authors are also thankful to Dr. D. Kumar
   (Indian Institute of Science, Bangalore) for his kind assistance and
   help in recording the MRI data and cell related studies.
CR Alibolandi M, 2016, INT J PHARMACEUT, V500, P162, DOI 10.1016/j.ijpharm.2016.01.040
   Asadi H, 2016, RSC ADV, V6, P83963, DOI 10.1039/c6ra20398a
   Attarwala Husain, 2010, J Nat Sci Biol Med, V1, P53, DOI 10.4103/0976-9668.71675
   Bain J, 2015, POLYMERS-BASEL, V7, P2558, DOI 10.3390/polym7121529
   Bartenstein JE, 2016, COLLOID SURFACE A, V506, P739, DOI 10.1016/j.colsurfa.2016.07.032
   Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]
   Che HL, 2016, J MATER CHEM B, V4, P4632, DOI 10.1039/c6tb01163b
   Chi XD, 2015, J AM CHEM SOC, V137, P1440, DOI 10.1021/ja512978n
   de Hoog HPM, 2012, POLYM CHEM-UK, V3, P302, DOI 10.1039/c1py00413a
   Gaitzsch J, 2011, CHEM COMMUN, V47, P3466, DOI 10.1039/c0cc05355d
   Gao WW, 2013, J MATER CHEM B, V1, P6569, DOI [10.1039/c3tb21238f, 10.1039/C3TB21238F]
   Gao XQ, 2017, EUR J MED CHEM, V125, P372, DOI 10.1016/j.ejmech.2016.09.047
   He J, 2013, CHEM COMMUN, V49, P576, DOI 10.1039/c2cc37322j
   Huang GM, 2014, NANOSCALE, V6, P10404, DOI 10.1039/c4nr02680b
   Huang L, 2016, NANOSCALE, V8, P4922, DOI 10.1039/c5nr08596a
   Krystofiak E. S., 2012, J NANOMATER, V2012, P1
   Lee J, 2014, J MATER CHEM B, V2, P8338, DOI 10.1039/c4tb01631a
   Li YX, 2016, RSC ADV, V6, P86717, DOI 10.1039/c6ra17260a
   Lin J, 2013, ACS NANO, V7, P5320, DOI 10.1021/nn4011686
   Liu F, 2015, CHEM MATER, V27, P7945, DOI 10.1021/acs.chemmater.5b03048
   Liu ZY, 2014, ACS APPL MATER INTER, V6, P2393, DOI 10.1021/am404734c
   Luk BT, 2014, ACS APPL MATER INTER, V6, P21859, DOI 10.1021/am5036225
   Malinova V, 2012, FEBS LETT, V586, P2146, DOI 10.1016/j.febslet.2012.05.033
   Park JY, 2009, ACS NANO, V3, P3663, DOI 10.1021/nn900761s
   Patra S, 2016, RSC ADV, V6, P85473, DOI 10.1039/c6ra14584a
   Patra S, 2015, ACS APPL MATER INTER, V7, P9235, DOI 10.1021/acsami.5b01786
   Popescu MT, 2013, ACS MACRO LETT, V2, P222, DOI 10.1021/mz300637c
   Qin JY, 2015, ACS APPL MATER INTER, V7, P14043, DOI 10.1021/acsami.5b03222
   Rohrer M, 2005, INVEST RADIOL, V40, P715, DOI 10.1097/01.rli.0000184756.66360.d3
   Roy E, 2016, COLLOID SURFACE B, V142, P248, DOI 10.1016/j.colsurfb.2016.02.053
   Shen LH, 2013, NANOSCALE, V5, P2133, DOI 10.1039/c2nr33840h
   Simon-Gracia L, 2016, BIOMATERIALS, V104, P247, DOI 10.1016/j.biomaterials.2016.07.023
   van Dongen SFM, 2010, ANGEW CHEM INT EDIT, V49, P7213, DOI 10.1002/anie.201002655
   Wang H, 2015, BIOMATERIALS, V53, P117, DOI 10.1016/j.biomaterials.2015.02.087
   Wang XR, 2014, ANGEW CHEM INT EDIT, V53, P3138, DOI 10.1002/anie.201310589
   Wang ZP, 2014, CHEM COMMUN, V50, P14550, DOI 10.1039/c4cc07048h
   Yu M, 2015, J CONTROL RELEASE, V215, P91, DOI 10.1016/j.jconrel.2015.08.003
NR 37
TC 2
Z9 2
U1 11
U2 42
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-9878
J9 ACS BIOMATER SCI ENG
JI ACS Biomater. Sci. Eng.
PD SEP
PY 2017
VL 3
IS 9
SI SI
BP 2120
EP 2135
DI 10.1021/acsbiomaterials.7b00089
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA FG8VO
UT WOS:000410716100025
DA 2018-12-27
ER

PT J
AU Mkaddem, A
   Zain-Ul-Abdein, M
   Demirci, I
   Bin Mahfouz, A
AF Mkaddem, A.
   Zain-ul-Abdein, M.
   Demirci, I
   Bin Mahfouz, A.
TI RETRACTED: A pure thermal model to evaluate heat-affected zone when
   milling E-glass fiber-reinforced polyester composites (vol 51, pg 3227,
   2016) (Retracted article. See vol. 52, pg. 3699, 2018)
SO JOURNAL OF COMPOSITE MATERIALS
LA English
DT Correction; Retracted Publication
CR Mkaddem A, 2017, J COMPOS MATER, V51, P3227, DOI 10.1177/0021998316640059
NR 1
TC 1
Z9 1
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0021-9983
EI 1530-793X
J9 J COMPOS MATER
JI J. Compos Mater.
PD SEP
PY 2017
VL 51
IS 23
BP 3351
EP 3351
DI 10.1177/0021998317727906
PG 1
WC Materials Science, Composites
SC Materials Science
GA FG8UB
UT WOS:000410712000011
DA 2018-12-27
ER

PT J
AU Ananthan, A
   Jape, GA
   Du Plessis, J
   Annear, P
   Page, R
   Rao, S
AF Ananthan, Anitha
   Jape, Gayatri Athalye
   Du Plessis, Jean
   Annear, Peter
   Page, Rohan
   Rao, Shripada
TI RETRACTED: Amniotic Band Syndrome With Pseudoarthrosis of Tibia and
   Fibula: A Case Report (Retracted article. See vol. 57, pg. 432, 2018)
SO JOURNAL OF FOOT & ANKLE SURGERY
LA English
DT Article; Retracted Publication
DE amniotic band; pseudoarthrosis; preterm infant; rudimentary digit;
   Syme's amputation
ID BODY-WALL COMPLEX; VASCULAR COMPROMISE; IMPENDING GANGRENE; SEQUENCE;
   PSEUDOARTHROSIS; POPULATION; MANAGEMENT; ADHESION
AB Constriction of the lower limb by a congenital amniotic band has been proposed to explain the development of pseudoarthrosis of the tibia and fibula. We report a case of amniotic band syndrome in a preterm female infant with pseudoarthrosis of the tibia and fibula. She was born at 29 weeks of gestation with congenital amniotic bands and was noted to have a severely edematous left foot distal to the constricting band with rudimentary digits. The skin was pink and well perfused with palpable pulses. Radiography demonstrated pseudoarthrosis of the tibia and fibula. The limb deformities were managed with splints, positioning, and physiotherapy. She underwent Z-plasty with soft tissue release on the left lower leg on day 7 of life. At 36 weeks of postmenstrual age, a repeat radiograph showed markedly improved growth of the tibia and fibula with mature new bone formation, which avoided the need for further surgical intervention. During the follow-up period, she underwent left Syme's amputation at 18 months. At 29 months of age, the child was able to walk and run without support. The findings from our case confirm the potential for bone growth in patients with amniotic band syndrome, once the constricting band has been released. Simple release of the constriction band with Z-plasty resulted in growth of mature bone, replacing the pseudoarthrosis and, hence, the patient did not require surgical amputation. Thus, one should be cautious when deciding on surgical amputation, even in the presence of pseudoarthrosis, especially in preterm infants. Early limb preserving surgery with release of the constricting band with an intention to salvage the limb appears appropriate. (C) 2017 by the American College of Foot and Ankle Surgeons. All rights reserved.
C1 [Ananthan, Anitha; Jape, Gayatri Athalye; Du Plessis, Jean] Princess Margaret Hosp Children, Dept Neonatal Paediat, Perth, WA, Australia.
   [Annear, Peter] Princess Margaret Hosp Children, Dept Orthopaed, Perth, WA, Australia.
   [Page, Rohan] Princess Margaret Hosp Children, Dept Plast Surg, Perth, WA, Australia.
   [Rao, Shripada] Univ Western Australia, Ctr Neonatal Res & Educ, Crawley, WA, Australia.
RP Ananthan, A (reprint author), Princess Margaret Hosp Children, Dept Neonatal Paediat, Roberts Road, Subiaco, WA 6008, Australia.
EM ani.gem81@gmail.com
CR Bodamer OAF, 2001, AM J MED GENET, V100, P100, DOI 10.1002/1096-8628(20010422)100:2<100::AID-AJMG1234>3.0.CO;2-E
   FROSTER UG, 1993, AM J MED GENET, V46, P497, DOI 10.1002/ajmg.1320460507
   Ho CA, 2014, J PEDIATR ORTHOPED, V34, pE14, DOI 10.1097/BPO.0000000000000241
   Khan T, 2013, BONE JOINT J, V95B, P1027, DOI 10.1302/0301-620X.95B8.31434
   Lauwers G, 1997, ANN VASC SURG, V11, P178, DOI 10.1007/s100169900031
   Lehman WB, 2000, J PEDIATR ORTHOP B, V9, P103, DOI 10.1097/01202412-200004000-00005
   MartinotDuquennoy V, 1995, EUR J PEDIATR SURG, V5, P380, DOI 10.1055/s-2008-1066250
   MOERMAN P, 1992, AM J MED GENET, V42, P470, DOI 10.1002/ajmg.1320420412
   Orioli IM, 2003, AM J MED GENET A, V118A, P135, DOI 10.1002/ajmg.a.10194
   RAJOO RD, 1991, S AFR J SURG, V29, P27
   Robin NH, 2005, AM J MED GENET A, V137A, P298, DOI 10.1002/ajmg.a.30885
   Romero-Valdovinos M, 2014, MED HYPOTHESES, V83, P306, DOI 10.1016/j.mehy.2014.06.002
   TANG TT, 1991, AM J MED GENET, V41, P21, DOI 10.1002/ajmg.1320410107
   ten Donkelaar HJ, 2002, CLIN DYSMORPHOL, V11, P9, DOI 10.1097/00019605-200201000-00002
   WEINZWEIG N, 1995, PLAST RECONSTR SURG, V96, P972, DOI 10.1097/00006534-199509001-00033
   Welsh J B, 2000, J Perinatol, V20, P387, DOI 10.1038/sj.jp.7200394
   ZIONTS LE, 1984, J BONE JOINT SURG AM, V66A, P450, DOI 10.2106/00004623-198466030-00020
   ZYCH GA, 1983, J BONE JOINT SURG AM, V65, P410, DOI 10.2106/00004623-198365030-00024
NR 18
TC 1
Z9 1
U1 1
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1067-2516
EI 1542-2224
J9 J FOOT ANKLE SURG
JI J. Foot Ankle Surg.
PD SEP-OCT
PY 2017
VL 56
IS 5
BP 1121
EP 1124
DI 10.1053/j.jfas.2017.04.023
PG 4
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA FG3FY
UT WOS:000410023400042
PM 28623060
DA 2018-12-27
ER

PT J
AU Li, WJ
   Lang, M
   Wang, J
AF Li, Wenjun
   Lang, Ming
   Wang, Jian
TI RETRACTED: Access to Cyclobutadienes via an Organocatalytic
   Dienamine-Iminium-Allenamine Cascade Approach (Retracted article. See
   vol. 20, pg. 316, 2018)
SO ORGANIC LETTERS
LA English
DT Article; Retracted Publication
ID DIELS-ALDER REACTION; ALPHA-BRANCHED ENALS; ONE-POT ACCESS;
   ALPHA,BETA-UNSATURATED ALDEHYDES; ENANTIOSELECTIVE ORGANOCATALYSIS;
   ASYMMETRIC ORGANOCATALYSIS; GAMMA-ALKYLATION; CATALYSIS; CYCLOADDITION;
   STATES
AB A new organocatalytic route to cyclobutadienes from alpha,beta-unsaturated aldehydes and ynals is described. This protocol allows a broad substrate scope and mild conditions. Furthermore, a proposed mechanism of a dienamine-iminium-allenamine cascade process is discussed.
C1 [Li, Wenjun; Lang, Ming; Wang, Jian] Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China.
RP Wang, J (reprint author), Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China.
EM wangjian2012@tsinghua.edu.cn
FU National Natural Science Foundation of China [21672121]; "Thousand Plan"
   Youth program of China
FX Generous financial support is provided by the National Natural Science
   Foundation of China (21672121), the "Thousand Plan" Youth program of
   China, and the Bayer Investigator fellow.
CR Albrecht L, 2012, ANGEW CHEM INT EDIT, V51, P13109, DOI 10.1002/anie.201207122
   Albrecht L, 2012, J AM CHEM SOC, V134, P2543, DOI 10.1021/ja211878x
   Aleman J, 2012, ADV SYNTH CATAL, V354, P1665, DOI 10.1002/adsc.201200033
   BALKOVA A, 1994, J CHEM PHYS, V101, P8972, DOI 10.1063/1.468025
   Beeson TD, 2007, SCIENCE, V316, P582, DOI 10.1126/science. 1142696
   Benaglia M, 2003, CHEM REV, V103, P3401, DOI 10.1021/cr010440o
   Bencivenni G, 2010, P NATL ACAD SCI USA, V107, P20642, DOI 10.1073/pnas.1001150107
   Bergonzini G, 2010, ANGEW CHEM INT EDIT, V49, P9685, DOI 10.1002/anie.201004761
   Berkessel A, 2005, ASYMMETRIC ORGANOCATALYSIS: FROM BIOMIMETIC CONCEPTS TO APPLICATIONS IN ASYMMETRIC SYNTHESIS, P1, DOI 10.1002/3527604677
   Berkessel A., 2004, METAL FREE ORGANIC C
   Bonaga LVR, 2005, J AM CHEM SOC, V127, P3473, DOI 10.1021/ja045001w
   Cai XR, 2012, ADV SYNTH CATAL, V354, P359, DOI 10.1002/adsc.201100351
   Cassani C, 2012, ORG LETT, V14, P5590, DOI 10.1021/ol302711w
   CRAM DJ, 1991, ANGEW CHEM INT EDIT, V30, P1024, DOI 10.1002/anie.199110241
   Dalko P. I., 2007, ENANTIOSELECTIVE ORG
   Dalko PI, 2001, ANGEW CHEM INT EDIT, V40, P3726, DOI 10.1002/1521-3773(20011015)40:20<3726::AID-ANIE3726>3.0.CO;2-D
   Dalko PI, 2004, ANGEW CHEM INT EDIT, V43, P5138, DOI 10.1002/anie.200400650
   Dong LJ, 2013, ORG LETT, V15, P204, DOI 10.1021/ol3032285
   EMERSON GF, 1965, J AM CHEM SOC, V87, P131, DOI 10.1021/ja01079a032
   Erkkila A, 2007, CHEM REV, V107, P5416, DOI 10.1021/cr068388p
   Filatov M, 1999, J CHEM PHYS, V110, P116, DOI 10.1063/1.477941
   GLUKHOVTSEV MN, 1995, J PHYS CHEM-US, V99, P6828, DOI 10.1021/j100018a012
   Gogonea V, 1998, ANGEW CHEM INT EDIT, V37, P1945, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1945::AID-ANIE1945>3.0.CO;2-E
   Han B, 2009, ANGEW CHEM INT EDIT, V48, P5474, DOI 10.1002/anie.200902216
   Han B, 2008, ANGEW CHEM INT EDIT, V47, P9971, DOI 10.1002/anie.200804183
   Hong BC, 2007, J ORG CHEM, V72, P8459, DOI 10.1021/jo701477v
   Hong BC, 2007, TETRAHEDRON, V63, P2840, DOI 10.1016/j.tet.2007.01.039
   Hong BC, 2006, ORG LETT, V8, P2217, DOI 10.1021/ol060486+
   Houk KN, 2004, ACCOUNTS CHEM RES, V37, P487, DOI 10.1021/ar040216w
   IRNGARTINGER H, 1980, ANGEW CHEM INT EDIT, V19, P211, DOI 10.1002/anie.198002111
   Jia ZJ, 2011, J AM CHEM SOC, V133, P5053, DOI 10.1021/ja1112194
   Jones SB, 2009, J AM CHEM SOC, V131, P13606, DOI 10.1021/ja906472m
   Kampen D, 2009, TOP CURR CHEM, V291, P395, DOI 10.1007/128_2009_1
   KOLLMAR H, 1977, J AM CHEM SOC, V99, P3583, DOI 10.1021/ja00453a009
   Lee CC, 2006, J ORG CHEM, V71, P8417, DOI 10.1021/jo061334v
   Li WJ, 2014, GREEN CHEM, V16, P3003, DOI 10.1039/c4gc00406j
   Li WJ, 2014, CHEM-EUR J, V20, P6592, DOI 10.1002/chem.201402089
   Limanto J, 2000, J AM CHEM SOC, V122, P8071, DOI 10.1021/ja001946b
   Liu CL, 2010, ORG LETT, V12, P4948, DOI 10.1021/ol102096s
   Liu KG, 2008, ANGEW CHEM INT EDIT, V47, P5827, DOI 10.1002/anie.200801765
   MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367
   Mohr JT, 2008, NATURE, V455, P323, DOI 10.1038/nature07370
   Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016
   Nielsen M, 2011, CHEM COMMUN, V47, P632, DOI 10.1039/c0cc02417a
   Orue A, 2012, ORG LETT, V14, P3740, DOI 10.1021/ol301602h
   Ramachary DB, 2012, EUR J ORG CHEM, P865, DOI 10.1002/ejoc.201101157
   Redington RL, 1998, J CHEM PHYS, V109, P10781, DOI 10.1063/1.477776
   Reetz M. T., 2007, ORGANOCATALYSIS
   ROSENBLUM M, 1967, J AM CHEM SOC, V89, P5074, DOI 10.1021/ja00995a064
   Sekiguchi A, 2001, ANGEW CHEM INT EDIT, V40, P1675, DOI 10.1002/1521-3773(20010504)40:9<1675::AID-ANIE16750>3.0.CO;2-G
   Song AG, 2013, ORG LETT, V15, P2510, DOI 10.1021/ol400988e
   Stiller J, 2011, ORG LETT, V13, P70, DOI 10.1021/ol102559f
   Talavera G, 2012, ANGEW CHEM INT EDIT, V51, P4104, DOI 10.1002/anie.201200269
   WATTS L, 1965, J AM CHEM SOC, V87, P3253, DOI 10.1021/ja01092a049
   Zhang X. S., 2010, ANGEW CHEM, V122, P1523
   Zhang XS, 2012, ANGEW CHEM INT EDIT, V51, P7282, DOI 10.1002/anie.201202161
   Zhang XS, 2010, ANGEW CHEM INT EDIT, V49, P1481, DOI 10.1002/anie.200906050
   Zilberg S, 1998, J PHYS CHEM A, V102, P10843, DOI 10.1021/jp9831029
NR 58
TC 4
Z9 4
U1 3
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1523-7060
EI 1523-7052
J9 ORG LETT
JI Org. Lett.
PD SEP 1
PY 2017
VL 19
IS 17
BP 4564
EP 4567
DI 10.1021/acs.orglett.7b02161
PG 4
WC Chemistry, Organic
SC Chemistry
GA FG1OU
UT WOS:000409566400039
PM 28816461
DA 2018-12-27
ER

PT J
AU Ding, ZC
   Yuan, J
   Luo, H
   Long, XW
AF Ding, Zhi-Chao
   Yuan, Jie
   Luo, Hui
   Long, Xing-Wu
TI RETRACTED: Optical pumping nuclear magnetic resonance system rotating in
   a plane parallel to the quantization axis (Retracted article. See vol.
   26, 2017)
SO CHINESE PHYSICS B
LA English
DT Article; Retracted Publication
DE optical pumping; nuclear magnetic resonance; spin polarization
AB A model of an optical pumping nuclear magnetic resonance system rotating in a plane parallel to the quantization axis is presented. Different coordinate frames for nuclear spin polarization vector are introduced, and theoretical calculation is conducted to analyze this model. We demonstrate that when the optical pumping nuclear magnetic resonance system rotates in a plane parallel to the quantization axis, it will maintain a steady state with respect to the quantization axis which is independent of rotational speed and direction.
C1 [Ding, Zhi-Chao; Yuan, Jie; Luo, Hui; Long, Xing-Wu] Natl Univ Def Technol, Coll Optoelect Sci & Engn, Changsha 410073, Hunan, Peoples R China.
RP Yuan, J; Long, XW (reprint author), Natl Univ Def Technol, Coll Optoelect Sci & Engn, Changsha 410073, Hunan, Peoples R China.
EM jieyuan@nudt.edu.cn; xwlong110@sina.com
FU National Natural Science Foundation of China [61475192]
FX Project supported by the National Natural Science Foundation of China
   (Grant No. 61475192).
CR Anjusha VS, 2016, PHYS LETT A, V380, P577, DOI 10.1016/j.physleta.2015.12.011
   BLOCH F, 1946, PHYS REV, V70, P460, DOI 10.1103/PhysRev.70.460
   Bloch F, 1940, PHYS REV, V57, P522, DOI 10.1103/PhysRev.57.522
   Bulatowicz M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.102001
   COHENTANNOUDJI C, 1970, REV PHYS APPL, V5, P95, DOI 10.1051/rphysap:019700050109500
   Donley EA, 2010, IEEE SENSOR, P17, DOI 10.1109/ICSENS.2010.5690983
   Eklund E. J., 2008, THESIS
   Greenspan R. L., 1995, Navigation. Journal of the Institute of Navigation, V42, P165
   Hane FT, 2017, SCI REP-UK, V7, DOI 10.1038/srep41027
   HAPPER W, 1972, REV MOD PHYS, V44, P169, DOI 10.1103/RevModPhys.44.169
   Kammerlander P, 2016, SCI REP-UK, V6, DOI 10.1038/srep22174
   Larsen M, 2012, 2012 IEEE INT FREQ C, P1
   Meyer D., 2014, Gyroscopy and Navigation, V5, P75, DOI 10.1134/S2075108714020060
   Prikhodko I P, 2014, INT S IN SENS SYST I, P1
   Rabi II, 1938, PHYS REV, V53, P318, DOI 10.1103/PhysRev.53.318
   Seltzer S J, 2008, THESIS
   Wagner L, 2016, MEAS SCI TECHNOL, V27, DOI 10.1088/0957-0233/27/10/105501
   Walker TG, 1997, REV MOD PHYS, V69, P629, DOI 10.1103/RevModPhys.69.629
   Wang SF, 2016, CHINESE PHYS B, V25, DOI 10.1088/1674-1056/25/1/018202
   Zhang D.-W., 2017, CHINESE PHYS B, V26
NR 20
TC 2
Z9 2
U1 6
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1674-1056
EI 1741-4199
J9 CHINESE PHYS B
JI Chin. Phys. B
PD SEP
PY 2017
VL 26
IS 9
AR 093301
DI 10.1088/1674-1056/26/9/093301
PG 5
WC Physics, Multidisciplinary
SC Physics
GA FG0PH
UT WOS:000409463200001
DA 2018-12-27
ER

PT J
AU Li, XF
   Zhang, Z
   Chen, ZK
   Cui, ZW
   Zhang, HN
AF Li, Xiao-Fei
   Zhang, Zhao
   Chen, Zhu-Ke
   Cui, Zhao-Wei
   Zhang, Hai-Ning
TI RETRACTED: Piezo1 protein induces the apoptosis of human
   osteoarthritis-derived chondrocytes by activating caspase-12, the
   signaling marker of ER stress (Retracted article. See vol. 42, pg. 3640,
   2018)
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article; Retracted Publication
DE Piezo1; chondrocytes; endoplasmic reticulum; caspase; apoptosis;
   osteoarthritis; mechanical stretch
ID DISTAL ARTHROGRYPOSIS; IN-VITRO; MUTATIONS; BCL-2; CHANNELS; DEATH; BAX;
   INACTIVATION; XEROCYTOSIS; EXPRESSION
AB The present study was carried out to determine whether the mechanically activated cation channel Piezo1 protein plays a role as a signaling pathway which causes the apoptosis of human chondrocytes. The chondrocytes were isolated, cultured, and then subjected to mechanical stretch force for 0, 2, 12, 24 and 48 h, respectively. The expression levels of Piezo1 and the apoptosis-related protein caspase-12 were assessed by reverse transcription-quantitative polymerase chain reaction, as well as the apoptosis-related genes, B cell lymphoma/leukemia-2 (Bcl-2), Bcl-associated X protein (Bax) and Bcl-2-associated death promoter (BAD). Lactate dehydrogenase (LDH) activity was used to discern dead cells. Piezo1 expression was determined by immunofluorescence. In addition, Piezo1 inhibitor, GsMTx4, was used to block the mechanically activated (MA) cation channel Piezo1, and served as a positive control. The results showed that the osteoarthritis (OA)-derived chondrocytes showed a tendency to undergo late-stage apoptosis under compressive loading. Piezo1 and caspase-12 were significantly upregulated under static compressive stimuli and the expression was related to the rate of apoptosis of the OA-derived chondrocytes during compressive loading. The expression of caspase-12 and late-stage apoptosis of the human OA-derived chondrocytes were repressed by GsMTx4, the specific inhibitor of Piezo1, while the expression of Piezo1 and the induction of the apoptosis of the OA-derived chondrocytes during compressive loading was not totally blocked. Thus, we conclude that Piezo1 plays an important role in the apoptosis of human OA-derived chondrocytes through a caspase-12-dependent pathway. The expression of Piezo1 protein was not totally inhibited by GsMTx4.
C1 [Li, Xiao-Fei; Zhang, Zhao; Chen, Zhu-Ke; Cui, Zhao-Wei; Zhang, Hai-Ning] Qingdao Univ, Dept Joint Surg, Affiliated Hosp, 59 Haier Rd, Qingdao 266101, Shandong, Peoples R China.
RP Zhang, HN (reprint author), Qingdao Univ, Dept Joint Surg, Affiliated Hosp, 59 Haier Rd, Qingdao 266101, Shandong, Peoples R China.
EM zhhaining@hotmail.com
FU National Natural Science Foundation of China [81171774, 81272056]
FX The authors thank Ying-Zhen Wang for assistance in providing
   experimental material. This study was supported by the National Natural
   Science Foundation of China (nos. 81171774 and 81272056).
CR Andolfo I, 2013, BLOOD, V121, P3925, DOI 10.1182/blood-2013-02-482489
   Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974
   Bagriantsev SN, 2014, J BIOL CHEM, V289, P31673, DOI 10.1074/jbc.R114.612697
   Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817
   Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1
   Coste B, 2013, P NATL ACAD SCI USA, V110, P4667, DOI 10.1073/pnas.1221400110
   Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812
   Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270
   Demolombe S, 2013, BIOPHYS J, V105, P833, DOI 10.1016/j.bpj.2013.07.018
   Drexler S, 2014, INT J CLIN RHEUMATOL, V9, P155
   Frohlich M, 2016, INT J DEV NEUROSCI, V48, P9, DOI 10.1016/j.ijdevneu.2015.10.004
   Ge JP, 2015, NATURE, V527, P64, DOI 10.1038/nature15247
   Gnanasambandam R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125503
   Gottlieb PA, 2013, BIOPHYS J, V104, p467A, DOI 10.1016/j.bpj.2012.11.2584
   Guilak F, 2011, BEST PRACT RES CL RH, V25, P815, DOI 10.1016/j.berh.2011.11.013
   Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801
   Lee MS, 2002, J ORTHOP RES, V20, P556, DOI 10.1016/S0736-0266(01)00149-8
   Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111
   Liu C, 2015, INT J MOL MED, V36, P1081, DOI 10.3892/ijmm.2015.2295
   Liu JQ, 2009, J CELL BIOCHEM, V107, P834, DOI 10.1002/jcb.22182
   Liu X, 1999, NEUROREPORT, V10, P3087, DOI 10.1097/00001756-199909290-00039
   Martin JA, 2006, BIORHEOLOGY, V43, P517
   Mastroleo L, 2016, DEV WORLD BIOETH, V16, P80
   McMillin MJ, 2014, AM J HUM GENET, V94, P734, DOI 10.1016/j.ajhg.2014.03.015
   Miyamoto T, 2012, NEUROUROL URODYNAM, V31, P1015
   Mocetti P, 2001, TISSUE CELL, V33, P1, DOI 10.1054/tice.2000.0144
   Pannaccione A, 2012, J NEUROSCI, V32, P10609, DOI 10.1523/JNEUROSCI.6429-11.2012
   Rennier Keith, 2013, BMC Res Notes, V6, P10, DOI 10.1186/1756-0500-6-10
   Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451
   Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983
   Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369
   Takamatsu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092699
   Wiren KM, 2006, BONE, V38, P637, DOI 10.1016/j.bone.2005.10.029
   YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5
   Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253
NR 35
TC 6
Z9 7
U1 2
U2 6
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD SEP
PY 2017
VL 40
IS 3
BP 845
EP 853
DI 10.3892/ijmm.2017.3075
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA FE0JS
UT WOS:000407907200026
PM 28731145
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Jia, M
   Gao, Z
   Guo, Q
   Gu, XM
AF Jia, Min
   Gao, Zheng
   Guo, Qing
   Gu, Xuemai
TI RETRACTED: Fast compressive tracking with robust example selection based
   on multiple instance learning in smart and autonomous systems (Retracted
   article. See vol. 76, pg. 761, 2018)
SO PATTERN RECOGNITION
LA English
DT Article; Retracted Publication
DE Smart and autonomous systems; Robust tracking; Fast compressive
   tracking; Multiple instance learning; Training Example
ID VISUAL TRACKING; OBJECT TRACKING; MODEL
AB In Smart and Autonomous Systems (SAS) with a discriminative tracking system, the general way to choose the training examples is to sample the image patches surrounding the tracking object at the current frame and label them manually. However, when the tracking result is not quite accurate, the classifier updates with misaligned examples that bring unexpected noise, which could result in drift. We propose a method of example selection based on multiple instance learning (MIL) using an iterative strategy. The idea is to remove the worst example that has little contributions to the likelihood of bags in the positive bag for each round. The proposed system is built on FCT, a novel tracking algorithm that adopts compressive sensing for image representation. The qualitative and quantitative experimental results show the advantage of the proposed tracker in efficiency and accuracy to current state-of-the-art trackers when objects suffer from deformation and rotation. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Jia, Min; Gao, Zheng; Guo, Qing; Gu, Xuemai] Harbin Inst Technol, Sch Elect Informat Engn, Commun Res Ctr, Harbin 150080, Peoples R China.
RP Jia, M (reprint author), Harbin Inst Technol, Sch Elect Informat Engn, Commun Res Ctr, Harbin 150080, Peoples R China.
EM jiamin@hit.edu.cn
FU National Science Foundations of China [61671183]; Major consulting
   projects of Chinese Academy of Engineering [2016-ZD-05-07]
FX We would like to thank anonymous reviewers and editors for their
   critical suggestions. This work was supported by the National Science
   Foundations of China (No.61671183) and Major consulting projects of
   Chinese Academy of Engineering (2016-ZD-05-07).
CR Avidan S, 2007, IEEE T PATTERN ANAL, V29, P261, DOI 10.1109/TPAMI.2007.35
   Babenko B, 2011, IEEE T PATTERN ANAL, V33, P1619, DOI 10.1109/TPAMI.2010.226
   Babenko B, 2009, PROC CVPR IEEE, P983, DOI 10.1109/CVPRW.2009.5206737
   Collins RT, 2005, IEEE T PATTERN ANAL, V27, P1631, DOI 10.1109/TPAMI.2005.205
   DIACONIS P, 1984, ANN STAT, V12, P793, DOI 10.1214/aos/1176346703
   Dietterich TG, 1997, ARTIF INTELL, V89, P31, DOI 10.1016/S0004-3702(96)00034-3
   Dollar P, 2007, IEEE C COMP VIS PATT, P1
   Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582
   Everingham M, 2010, INT J COMPUT VISION, V88, P303, DOI 10.1007/s11263-009-0275-4
   Gao Y, 2015, IET COMPUT VIS, V9, P857, DOI 10.1049/iet-cvi.2014.0431
   Grabner H., 2006, BRIT MACH VIS C, V1, P47, DOI DOI 10.5244/C.20.6
   Held D., 2015, INT J ROBOT RES, V35, P1
   Henriques JF, 2015, IEEE T PATTERN ANAL, V37, P583, DOI 10.1109/TPAMI.2014.2345390
   Henriques JF, 2012, LECT NOTES COMPUT SC, V7575, P702, DOI 10.1007/978-3-642-33765-9_50
   Hoai M, 2014, PATTERN RECOGN, V47, P1523, DOI 10.1016/j.patcog.2013.09.028
   Jenkins MD, 2016, PATTERN RECOGN LETT, V69, P82, DOI 10.1016/j.patrec.2015.10.014
   Jia X, 2012, PROC CVPR IEEE, P1822, DOI 10.1109/CVPR.2012.6247880
   Li M, 2010, PROC CVPR IEEE, P1395, DOI 10.1109/CVPR.2010.5539805
   Li X, 2013, ACM T INTEL SYST TEC, V4, DOI 10.1145/2508037.2508039
   Mei X., 2011, IEEE C COMP VIS PATT, P1257
   Rifkin R, 2003, NATO SCI SERIES 3, V190, P131
   Salti S, 2012, IEEE T IMAGE PROCESS, V21, P4334, DOI 10.1109/TIP.2012.2206035
   Smith K., 2016, USE ACTIVE TRACK DJI
   Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb
   Viola P.a, 2005, P NIPS, V74, P1769
   Wang G, 2016, IEEE T IMAGE PROCESS, V25, P5104, DOI 10.1109/TIP.2016.2603602
   Wu Y, 2015, IEEE T PATTERN ANAL, V37, P1834, DOI 10.1109/TPAMI.2014.2388226
   Wu Y, 2012, IEEE T IMAGE PROCESS, V21, P2824, DOI 10.1109/TIP.2011.2182521
   Xu Y, 2014, MED IMAGE ANAL, V18, P591, DOI 10.1016/j.media.2014.01.010
   Xue JH, 2008, NEURAL PROCESS LETT, V28, P169, DOI 10.1007/s11063-008-9088-7
   Zhang KH, 2014, IEEE T PATTERN ANAL, V36, P2002, DOI 10.1109/TPAMI.2014.2315808
   Zhang KH, 2013, IEEE T IMAGE PROCESS, V22, P4664, DOI 10.1109/TIP.2013.2277800
   Zhang KH, 2012, LECT NOTES COMPUT SC, V7574, P864, DOI 10.1007/978-3-642-33712-3_62
   Zhang KH, 2013, PATTERN RECOGN, V46, P397, DOI 10.1016/j.patcog.2012.07.013
   Zhong W, 2012, PROC CVPR IEEE, P1838, DOI 10.1109/CVPR.2012.6247882
   Zhu JZ, 2014, IET COMPUT VIS, V8, P740, DOI 10.1049/iet-cvi.2013.0255
NR 36
TC 1
Z9 1
U1 3
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0031-3203
EI 1873-5142
J9 PATTERN RECOGN
JI Pattern Recognit.
PD SEP
PY 2017
VL 69
BP 336
EP 351
DI 10.1016/j.patcog.2017.03.027
PG 16
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA EX3MC
UT WOS:000403135200025
DA 2018-12-27
ER

PT J
AU Lei, X
   Liang, YH
   Chen, J
   Xiao, S
   Lei, J
   Li, JF
   Duanmu, JZ
   Jiang, QG
   Liu, DN
   Tang, C
   Li, TY
AF Lei, Xiong
   Liang, Yahang
   Chen, Jian
   Xiao, Shuai
   Lei, Jian
   Li, Jianfeng
   Duanmu, Jinzhong
   Jiang, Qunguang
   Liu, Dongning
   Tang, Cheng
   Li, Taiyuan
TI RETRACTED: Sorcin Predicts Poor Prognosis and Promotes Metastasis by
   Facilitating Epithelial-mesenchymal Transition in Hepatocellular
   Carcinoma (Retracted article. See vol. 8, art no 11857, 2018)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID CANCER-ASSOCIATED FIBROBLASTS; MICROVASCULAR INVASION; PROTEIN-KINASES;
   IN-VIVO; CELLS; ERK; OVEREXPRESSION; TRANSCRIPTION; RECRUITMENT;
   PATHWAYS
AB Metastasis-associated recurrence is the main cause for the poor prognosis of hepatocellular carcinoma (HCC). However, the detailed molecular mechanisms underlying HCC metastasis remain elusive. Though some data indicated the oncogenic role of Sorcin in tumors, the prognostic value and biological role of Sorcin in HCC is still unknown. In this study, it demonstrated that Sorcin expression levels were significantly upregulated in HCC tumor tissues compared with matched adjacent nontumorous liver tissues and normal liver tissues, and such expression level correlated with HCC metastasis. High Sorcin expression was significantly correlated with aggressive clinicopathological characteristics such as multiple tumor nodules, high Edmondson-Steiner grade, microvascular invasion, advanced TNM stage and advanced BCLC stage (all P < 0.05). HCC patients with high Sorcin expression had both shorter survival and higher recurrence than those with low Sorcin expression (all P < 0.05). Sorcin expression was an independent and significant risk factor for survival and recurrence of HCC patients. Results of functional experiments showed that Sorcin could promote HCC cell proliferation, migration, and invasion in vitro, and facilitate HCC growth and metastasis in vivo. Mechanistically, Sorcin exerted its role by activating extracellular signal-regulated kinase (ERK) pathway and promoted metastasis by facilitating epithelial-mesenchymal transition (EMT) in HCC.
C1 [Lei, Xiong; Liang, Yahang; Li, Jianfeng; Duanmu, Jinzhong; Jiang, Qunguang; Liu, Dongning; Tang, Cheng; Li, Taiyuan] Nanchang Univ, Affiliated Hosp 1, Dept Gen Surg, Nanchang 330006, Jiangxi, Peoples R China.
   [Chen, Jian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Surg, Guangzhou 510080, Guangdong, Peoples R China.
   [Xiao, Shuai] Cent S Univ, Xiangya Hosp, Dept Surg, Liver Canc Lab, Changsha 410008, Hunan, Peoples R China.
   [Lei, Jian] Cent S Univ, Dept Pathol, Affiliated Canc Hosp, Xiangya Sch Med, Changsha 410013, Hunan, Peoples R China.
RP Li, TY (reprint author), Nanchang Univ, Affiliated Hosp 1, Dept Gen Surg, Nanchang 330006, Jiangxi, Peoples R China.
EM jylitaiyuan@sina.com
FU National Natural Science Foundation of China [81172018]; Natural Science
   Foundation of Jiangxi, China [20141511040001]
FX This work was supported by National Natural Science Foundation of China
   (81172018) and also partly supported by the Natural Science Foundation
   of Jiangxi, China (20141511040001).
CR Anderberg C, 2009, CANCER RES, V69, P369, DOI 10.1158/0008-5472.CAN-08-2724
   Andrieux LO, 2007, CANCER RES, V67, P2114, DOI 10.1158/0008-5472.CAN-06-3821
   Bao R., 2016, ONCOTARGET
   Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627
   Cadamuro M, 2013, HEPATOLOGY, V58, P1042, DOI 10.1002/hep.26384
   Chung T. W., 2004, FASEB J
   Dave JM, 2014, MICROCIRCULATION, V21, P333, DOI 10.1111/micc.12111
   Farrell EF, 2003, J BIOL CHEM, V278, P34660, DOI 10.1074/jbc.M305931200
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   He QC, 2011, ONCOL REP, V25, P237, DOI 10.3892/or_00001066
   Hu YH, 2014, BREAST CANCER RES TR, V143, P287, DOI 10.1007/s10549-013-2809-2
   Ichikawa K, 2015, MOL CELL, V58, P35, DOI 10.1016/j.molcel.2015.01.023
   Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9
   Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682
   Moreno-Ortega AJ, 2015, AGING CELL, V14, P1094, DOI 10.1111/acel.12403
   Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877
   Lei X., 2016, ONCOTARGET
   Lei X, 2015, ONCOTARGET, V6, P40622, DOI 10.18632/oncotarget.5872
   Lemieux E, 2009, INT J CANCER, V125, P1575, DOI 10.1002/ijc.24485
   Li L, 2016, CANCER LETT, V379, P191, DOI 10.1016/j.canlet.2015.07.018
   Lin SB, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-3
   Lin Z. H., 2014, INT J ONCOLOGY
   Lokuta AJ, 1997, J BIOL CHEM, V272, P25333, DOI 10.1074/jbc.272.40.25333
   Maluccio M, 2012, CA-CANCER J CLIN, V62, P394, DOI 10.3322/caac.21161
   McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237
   OuYang HY, 2016, HEPATOLOGY, V63, P1227, DOI 10.1002/hep.28397
   Pote N, 2015, J HEPATOL, V62, P848, DOI 10.1016/j.jhep.2014.11.005
   Pote N, 2013, HEPATOLOGY, V58, P983, DOI 10.1002/hep.26433
   Qu YQ, 2010, MED ONCOL, V27, P1303, DOI 10.1007/s12032-009-9379-5
   Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004
   Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021
   Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1
   Tirumuru N, 2011, HEPATOLOGY, V54, p1328A
   Tong WH, 2015, CELL BIOCHEM BIOPHYS, V72, P453, DOI 10.1007/s12013-014-0486-3
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Tsai FC, 2015, BIOMED RES INT, DOI 10.1155/2015/409245
   Wang CL, 2013, CELL BIOCHEM BIOPHYS, V67, P1433, DOI 10.1007/s12013-013-9676-7
   Xie XL, 2001, PROTEIN SCI, V10, P2419, DOI 10.1110/ps.ps.36701
   Xu JF, 2013, CANCER-AM CANCER SOC, V119, P2247, DOI 10.1002/cncr.28023
   Yang LY, 2014, SURGERY, V156, P1177, DOI 10.1016/j.surg.2014.05.012
   Zhong JH, 2014, ANN SURG, V260, P329, DOI 10.1097/SLA.0000000000000236
NR 43
TC 6
Z9 6
U1 3
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD AUG 30
PY 2017
VL 7
AR 10049
DI 10.1038/s41598-017-10365-3
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA FF0WS
UT WOS:000408622400143
PM 28855589
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Ramsay, LC
   Buchan, SA
   Stirling, RG
   Cowling, BJ
   Feng, S
   Kwong, JC
   Warshawsky, BF
AF Ramsay, Lauren C.
   Buchan, Sarah A.
   Stirling, Robert G.
   Cowling, Benjamin J.
   Feng, Shuo
   Kwong, Jeffrey C.
   Warshawsky, Bryna F.
TI RETRACTED: The impact of repeated vaccination on influenza vaccine
   effectiveness: a systematic review and meta-analysis (Retracted article.
   See vol. 16, art 133, 2018)
SO BMC MEDICINE
LA English
DT Review; Retracted Publication
DE Influenza; Vaccine effectiveness; Repeated vaccination
ID TEST-NEGATIVE DESIGN; PREVENTING INFLUENZA; SERIAL VACCINATION; SEASON
   PROTECTION; UNITED-STATES; CROSS-SEASON; VIRUS; CHILDREN; A(H3N2);
   A(H1N1)PDM09
AB Background: Conflicting results regarding the impact of repeated vaccination on influenza vaccine effectiveness (VE) may cause confusion regarding the benefits of receiving the current season's vaccine.
   Methods: We systematically searched MEDLINE, Embase, PubMed, and Cumulative Index to Nursing and Allied Health Literature from database inception to August 17, 2016, for observational studies published in English that reported VE against laboratory-confirmed influenza for four vaccination groups, namely current season only, prior season only, both seasons, and neither season. We pooled differences in VE (Delta VE) between vaccination groups by influenza season and type/subtype using a random effects model. The study protocol is registered with PROSPERO (registration number: CRD42016037241).
   Results: We identified 3435 unique articles, reviewed the full text of 634, and included 20 for meta-analysis. Compared to prior season vaccination only, vaccination in both seasons was associated with greater protection against influenza H1N1 (Delta VE = 26%; 95% CI, 15% to 36%) and B (Delta VE = 24%; 95% CI, 7% to 42%), but not H3N2 (Delta VE = 10%; 95% CI, -6% to 25%). Compared to no vaccination for either season, individuals who received the current season's vaccine had greater protection against H1N1 (Delta VE = 61%; 95% CI, 50% to 70%), H3N2 (Delta VE = 41%; 95% CI, 33% to 48%), and B (Delta VE = 62%; 95% CI, 54% to 68%). We observed no differences in VE between vaccination in both seasons and the current season only for H1N1 (Delta VE = 4%; 95% CI, -7% to 15%), H3N2 (Delta VE = -12%; 95% CI, -27% to 4%), or B (Delta VE = -8%; 95% CI, -17% to 1%).
   Conclusions: From the patient perspective, our results support current season vaccination regardless of prior season vaccination. We found no overall evidence that prior season vaccination negatively impacts current season VE. It is important that future VE studies include vaccination history over multiple seasons in order to evaluate repeated vaccination in more detail.
C1 [Ramsay, Lauren C.; Kwong, Jeffrey C.; Warshawsky, Bryna F.] Publ Hlth Ontario, 480 Univ Ave Suite 300, Toronto, ON M5G 1V2, Canada.
   [Buchan, Sarah A.; Stirling, Robert G.; Kwong, Jeffrey C.] Univ Toronto, Dalla Lana Sch Publ Hlth, 155 Coll St, Toronto, ON M5T 3M7, Canada.
   [Stirling, Robert G.] Publ Hlth Agcy Canada, 130 Colonnade Rd, Ottawa, ON K1A 0K9, Canada.
   [Cowling, Benjamin J.; Feng, Shuo] Univ Hong Kong, Li Ka Shing Fac Med, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Sch Publ Hlth, Pokfulam, Hong Kong, Peoples R China.
   [Kwong, Jeffrey C.] Inst Clin Evaluat Sci, Vet Hill Trail,2075 Bayview Ave G1 06, Toronto, ON M4N 3M5, Canada.
   [Kwong, Jeffrey C.] Univ Toronto, Dept Family Community Med, 155 Coll St, Toronto, ON M5T 3M7, Canada.
   [Kwong, Jeffrey C.] Univ Hlth Network, 399 Bathurst St, Toronto, ON M5T 2S8, Canada.
   [Warshawsky, Bryna F.] Western Univ, Dept Epidemiol & Biostat, 1151 Richmond St, London, ON N6A 3K7, Canada.
RP Warshawsky, BF (reprint author), Publ Hlth Ontario, 480 Univ Ave Suite 300, Toronto, ON M5G 1V2, Canada.; Warshawsky, BF (reprint author), Western Univ, Dept Epidemiol & Biostat, 1151 Richmond St, London, ON N6A 3K7, Canada.
EM bryna.warshawsky@oahpp.ca
CR [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461
   Belongia Edward A, 2017, Expert Rev Vaccines, V16, P1, DOI 10.1080/14760584.2017.1334554
   Beyer WEP, 1999, ARCH INTERN MED, V159, P182, DOI 10.1001/archinte.159.2.182
   Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F
   Casado I, 2016, EXPERT REV VACCINES, V15, P425, DOI 10.1586/14760584.2016.1134328
   Castilla J, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.22.30243
   Castilla J, 2011, EURO SURVEILL, V16
   Castilla J, 2016, VACCINE, V34, P1350, DOI 10.1016/j.vaccine.2016.01.054
   Domnich A, 2017, VACCINE, V35, P513, DOI 10.1016/j.vaccine.2016.12.011
   Feng S, 2016, VACCINE, V34, P1672, DOI 10.1016/j.vaccine.2016.02.039
   Francis T, 1960, P AM PHILOS SOC, V104, P572
   Fu CX, 2015, VACCINE, V33, P2917, DOI 10.1016/j.vaccine.2015.04.063
   Gaglani M, 2016, J INFECT DIS, V213, P1546, DOI 10.1093/infdis/jiv577
   HOSKINS TW, 1979, LANCET, V1, P33
   Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053
   Jimenez-Jorge S, 2012, VACCINE, V30, P3595, DOI 10.1016/j.vaccine.2012.03.048
   Keitel WA, 1997, VACCINE, V15, P1114, DOI 10.1016/S0264-410X(97)00003-0
   Lansbury LE, 2017, VACCINE, V35, P1996, DOI 10.1016/j.vaccine.2017.02.059
   Leung VK, 2016, EUROSURVEILLANCE, V21, P35, DOI 10.2807/1560-7917.ES.2016.21.16.30202
   Martinez-Baz I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-191
   McLean HQ, 2015, J INFECT DIS, V211, P1529, DOI 10.1093/infdis/jiu647
   McLean HQ, 2014, CLIN INFECT DIS, V59, P1375, DOI 10.1093/cid/ciu680
   Mokkink LB, 2010, J CLIN EPIDEMIOL, V63, P737, DOI [10.1136/bmj.b2535, 10.1371/journal.pmed.1000097, 10.1016/j.jclinepi.2010.02.006, 10.1002/14651858.CD008216.pub4, 10.1016/j.jclinepi.2010.03.004, 10.1002/14651858.CD008242.pub3, 10.1136/bmj.c869]
   National Advisory Committee on Immunization (NACI), 2017, CAN IMM GUID CHAPT I
   Ohmit SE, 2016, J INFECT DIS, V213, P1229, DOI 10.1093/infdis/jiv563
   Ohmit SE, 2015, J INFECT DIS, V211, P1519, DOI 10.1093/infdis/jiu650
   Ohmit SE, 2014, CLIN INFECT DIS, V58, P319, DOI 10.1093/cid/cit736
   Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021
   Pebody RG, 2013, EPIDEMIOL INFECT, V141, P620, DOI 10.1017/S0950268812001148
   Petrie JG, 2016, CLIN INFECT DIS, V63, P1017, DOI 10.1093/cid/ciw432
   Rondy M, 2015, EUROSURVEILLANCE, V20, P9, DOI 10.2807/1560-7917.ES2015.20.2.21011
   Savulescu C, 2011, EUROSURVEILLANCE, V16, P5
   Simpson C. R., 2015, Eurosurveillance, V20, P21043
   Skowronski DM, 2017, J INFECT DIS, V215, P1059, DOI 10.1093/infdis/jix074
   Skowronski DM, 2016, CLIN INFECT DIS, V63, P21, DOI 10.1093/cid/ciw176
   Skowronski DM, 2015, J INFECT DIS, V212, P726, DOI 10.1093/infdis/jiv177
   Skowronski DM, 2014, J INFECT DIS, V210, P126, DOI 10.1093/infdis/jiu048
   Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153
   Skowronski DM, 2012, CLIN INFECT DIS, V55, P332, DOI 10.1093/cid/cis431
   Smith DJ, 1999, P NATL ACAD SCI USA, V96, P14001, DOI 10.1073/pnas.96.24.14001
   Smithgall M, 2016, CLIN INFECT DIS, V62, P358, DOI 10.1093/cid/civ867
   Sullivan SG, 2016, AM J EPIDEMIOL, V184, P345, DOI 10.1093/aje/kww064
   Sullivan SG, 2013, CLIN INFECT DIS, V57, P474, DOI 10.1093/cid/cit255
   Syrjanen RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108538
   Thompson MG, 2016, PEDIATR INFECT DIS J, V35, P299, DOI 10.1097/INF.0000000000001006
   Thompson MG, 2014, CLIN INFECT DIS, V58, P449, DOI 10.1093/cid/cit750
   Valenciano M, 2016, EUROSURVEILLANCE, V21, P15, DOI 10.2807/1560-7917.ES.2016.21.7.30139
   Wells G, 2011, NEWCASTLE OTTAWA SCA
NR 48
TC 20
Z9 22
U1 2
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD AUG 21
PY 2017
VL 15
AR 159
DI 10.1186/s12916-017-0919-0
PG 18
WC Medicine, General & Internal
SC General & Internal Medicine
GA FE0RJ
UT WOS:000407927100001
PM 28823248
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Shibuki, T
   Otsuka, T
   Isoda, H
   Araki, N
   Kubotsu, Y
   Kawaguchi, Y
   Nakashita, S
   Yoshioka, W
   Kawazoe, S
   Kawasoe, H
   Ide, Y
   Mizuta, T
AF Shibuki, Taro
   Otsuka, Taiga
   Isoda, Hiroshi
   Araki, Norimasa
   Kubotsu, Yoshihito
   Kawaguchi, Yasunori
   Nakashita, Shunya
   Yoshioka, Wataru
   Kawazoe, Seiji
   Kawasoe, Hiroaki
   Ide, Yasushi
   Mizuta, Toshihiko
TI RETRACTED: Seropositivity and Titers of Anti-Smooth Muscle Actin
   Antibody Are Associated with Relapse of Type 1 Autoimmune Hepatitis
   (Retracted article. See vol. 24, pg. 1768, 2018)
SO MEDICAL SCIENCE MONITOR
LA English
DT Article; Retracted Publication
DE Autoantibodies; Hepatitis Autoimmune; Recurrence
ID JAPAN; WITHDRAWAL; DIAGNOSIS; MARKERS; POINT
AB Background: It is important to avoid relapse in autoimmune hepatitis (AIH) because repeated multiple relapses have been associated with a worse prognosis. However, risk factors for relapse before initiation of treatment are not fully understood. The aim of this study was to find predictive markers for relapse of type 1 AIH.
   Material/Methods: We reviewed the records of 53 patients diagnosed with type 1 AIH based on the revised scoring system proposed by the International Autoimmune Hepatitis Group (IAIHG) between 2009 and 2014 at 4 hospitals belonging to the Saga Study Group of Liver Diseases (SASLD). We analyzed the differences in background characteristics between patients with or without relapse.
   Results: All patients achieved remission after treatment, and 9 (17%) subsequently relapsed. The relapsed patients were significantly younger and had a higher positive rate of anti-smooth muscle antibody (ASMA) than the non-relapsed patients (100% vs. 25%, P=0.0012). Moreover, relapse rate increased with titer of ASMA, while titer of antinuclear antibody was not associated with relapse rate.
   Conclusions: ASMA is a useful predictive marker for relapse of type 1 AIH during or after withdrawal of medical therapy. More careful attention should be paid to immunosuppressive therapy in patients with high titers of ASMA.
C1 [Shibuki, Taro; Kawasoe, Hiroaki; Mizuta, Toshihiko] Imari Arita Kyoritsu Hosp, Dept Internal Med, Saga, Japan.
   [Otsuka, Taiga; Isoda, Hiroshi; Araki, Norimasa; Kubotsu, Yoshihito] Saga Univ Hosp, Hepatol Div, Saga, Japan.
   [Kawaguchi, Yasunori; Nakashita, Shunya; Yoshioka, Wataru; Kawazoe, Seiji] Saga Ken Med Ctr Koseikan, Dept Hepatobiliary & Pancreatol, Saga, Japan.
   [Ide, Yasushi] Karatsu Red Cross Hosp, Dept Internal Med, Saga, Japan.
RP Mizuta, T (reprint author), Imari Arita Kyoritsu Hosp, Dept Internal Med, Saga, Japan.
EM mizuta1221@gmail.com
CR Abe M, 2011, J GASTROENTEROL, V46, P1136, DOI 10.1007/s00535-011-0421-y
   Al-Chalabi T, 2006, J HEPATOL, V45, P575, DOI 10.1016/j.jhep.2006.04.007
   Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9
   Couto CA, 2014, HEPATOLOGY, V59, P592, DOI 10.1002/hep.26666
   Czaja AJ, 2006, HEPATOLOGY, V43, P532, DOI 10.1002/hep.21074
   CZAJA AJ, 1995, AM J GASTROENTEROL, V90, P1206
   Czaja AJ, 2009, J HEPATOL, V51, P161, DOI 10.1016/j.jhep.2009.02.026
   DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
   Gregorio GV, 2002, AUTOIMMUNITY, V35, P515, DOI 10.1080/0891693021000056721
   Kaneko A, 2015, KANZO, V56, P507
   Miyake Y, 2005, J HEPATOL, V43, P951, DOI 10.1016/j.jhep.2005.06.006
   Miyake Y, 2010, DIGEST LIVER DIS, V42, P51, DOI 10.1016/j.dld.2009.04.009
   Montano-Loza AJ, 2007, LIVER INT, V27, P507, DOI 10.1111/j.1478-3231.2007.01444.x
   Montano-Loza AJ, 2007, AM J GASTROENTEROL, V102, P1005, DOI 10.1111/j.1572-0241.2007.01153.x
   Onji M, 2014, HEPATOL RES, V44, P368, DOI 10.1111/hepr.12300
   Takahashi A, 2015, HEPATOL RES, V45, P638, DOI 10.1111/hepr.12397
   Toda G, 1997, J HEPATOL, V26, P1207, DOI 10.1016/S0168-8278(97)80453-9
   van Gerven NMF, 2013, J HEPATOL, V58, P141, DOI 10.1016/j.jhep.2012.09.009
   Yokokawa J, 2011, HEPATOL RES, V41, P641, DOI 10.1111/j.1872-034X.2011.00812.x
   Yoshizawa K, 2012, HEPATOLOGY, V56, P668, DOI 10.1002/hep.25658
NR 20
TC 2
Z9 2
U1 1
U2 2
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD AUG 20
PY 2017
VL 23
DI 10.12659/MSM.902576
PG 6
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA FF8GL
UT WOS:000409254600001
PM 28822993
OA Green Published
DA 2018-12-27
ER

PT J
AU Guo, X
   Sun, W
   Huang, LS
   Wu, LL
   Hou, Y
   Qin, LL
   Liu, TH
AF Guo, Xuan
   Sun, Wen
   Huang, Liansha
   Wu, Lili
   Hou, Yi
   Qin, Lingling
   Liu, Tonghua
TI RETRACTED: Effect of Cinnamaldehyde on Glucose Metabolism and Vessel
   Function (Retracted article. See vol.24, pg.4572, 2018)
SO MEDICAL SCIENCE MONITOR
LA English
DT Article; Retracted Publication
DE Insulin Resistance; Oxidative Stress; Superoxides
ID OXIDATIVE STRESS; CELLS; NRF2; COMPLICATIONS; INFLAMMATION; DISEASE;
   AMPK
AB Background: Cinnamaldehyde has anti-diabetic effects such as blood glucose and lipid regulation, insulin resistance improvement, and antioxidation. However, there have been few related reports published on the effect of cinnamaldehyde in the treatment of diabetic vascular endothelial dysfunction and prevention of diabetic vascular complications. We aimed to explore the effect and mechanism of cinnamaldehyde on glucose metabolism and vessel function in db/db mice.
   Material/Methods: General condition of mice (n= 10 for each group) such as food intake, fasting blood glucose, body weight, and insulin sensitivity was monitored periodically during the intervention time for 12 weeks. Immunofluorescent staining and hematoxylin and eosin staining of the pancreas were employed to observe the effects of cinnamaldehyde on the function and morphology of pancreatic islets. Acetylcholine (Ach) solution was used to observe Ach-induced endothelium-dependent vasodilatation and nitroglycerin (NTG) solution was used to observe NTG-induced endothelium-independent vasodilatation.
   Results: There was significant improvement in general condition of db/db mice, including food intake, fasting blood glucose, body weight, and insulin sensitivity. After cinnamaldehyde intervention, the function and morphology of pancreatic islets was significantly improved in db/db mice compared to the control group. The level of superoxide anion significantly decreased while the level of nitric oxide significantly increased in db/db mice. Cinnamaldehyde had significant effects on endothelium-dependent diastolic function and vascular remodeling.
   Conclusions: Cinnamaldehyde can significantly reduce fasting glucose levels, increase insulin sensitivity, and improve islet morphology and function in db/db mice. Experiments showed that cinnamaldehyde could effectively improve vascular endothelium-dependent diastolic function with antihypertensive trend, which provides experimental evidence for further cinnamaldehyde clinical use.
C1 [Guo, Xuan; Hou, Yi] Beijing Univ Chinese Med, Dept Endocrinol, Beijing, Peoples R China.
   [Sun, Wen; Liu, Tonghua] Beijing Univ Chinese Med, Minist Educ, Key Lab Hlth Cultivat, Beijing, Peoples R China.
   [Huang, Liansha] Chinese Med Hosp Baoan, Prevent Treatment Dis Ctr, Shenzhen, Guangdong, Peoples R China.
   [Wu, Lili] Beijing Univ Chinese Med, Beijing Key Lab Hlth Cultivat, Beijing, Peoples R China.
   [Qin, Lingling] Beijing Univ Chinese Med, Dept Sci & Technol, Beijing, Peoples R China.
RP Liu, TH (reprint author), Beijing Univ Chinese Med, Minist Educ, Key Lab Hlth Cultivat, Beijing, Peoples R China.
EM thliu@vip.163.com
FU National Natural Science Foundation of China [81503550]
FX Research supported by the National Natural Science Foundation of China
   (No. 81503550)
CR Babu PS, 2007, PHYTOMEDICINE, V14, P15, DOI 10.1016/j.phymed.2006.11.005
   Camacho S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07919
   Castela A, 2016, NAT REV UROL, V13, P266, DOI 10.1038/nrurol.2016.23
   Domingueti CP, 2016, J DIABETES COMPLICAT, V30, P738, DOI 10.1016/j.jdiacomp.2015.12.018
   Dong YZ, 2017, DIABETES VASC DIS RE, V14, P14, DOI 10.1177/1479164116666762
   Farrokhfall K, 2014, J FUNCT FOODS, V10, P397, DOI 10.1016/j.jff.2014.07.014
   Ferretti AC, 2016, ONCOTARGET, V7, P17815, DOI 10.18632/oncotarget.7404
   Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545
   Huang B, 2011, J AGR FOOD CHEM, V59, P3666, DOI 10.1021/jf104814t
   Huang JS, 2015, J CELL BIOCHEM, V116, P1028, DOI 10.1002/jcb.25058
   Huang TC, 2011, J AGR FOOD CHEM, V59, P5164, DOI 10.1021/jf200579h
   Lozano I, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0074-1
   Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320
   Migliori M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117530
   Mohammedi K, 2016, DIABETES CARE, V39, P1796, DOI 10.2337/dc16-0588
   Nikzamir A, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.13426
   Ramakrishnan S, 2014, J NEUROIMMUNE PHARM, V9, P142, DOI 10.1007/s11481-014-9531-7
   Saifudin A, 2013, J NAT MED-TOKYO, V67, P264, DOI 10.1007/s11418-012-0674-7
   Srikanth S, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0683-0
   Subash-Babu P, 2014, BIOMOL THER, V22, P47, DOI 10.4062/biomolther.2013.100
   Ullah A, 2016, SAUDI PHARM J, V24, P547, DOI 10.1016/j.jsps.2015.03.013
   Vikram A, 2014, INT J ENDOCRINOL, DOI 10.1155/2014/679754
   Xu RS, 2015, WORLD J DIABETES, V6, P54, DOI 10.4239/wjd.v6.i1.54
   Zheng HT, 2011, DIABETES, V60, P3055, DOI 10.2337/db11-0807
NR 24
TC 4
Z9 4
U1 1
U2 7
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1643-3750
J9 MED SCI MONITOR
JI Med. Sci. Monitor
PD AUG 9
PY 2017
VL 23
BP 3844
EP 3853
DI 10.12659/MSM.906027
PG 10
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA FD1EG
UT WOS:000407279600001
PM 28790298
OA Green Published
DA 2018-12-27
ER

PT J
AU Yuan, HC
   Jiang, CW
   Hou, LY
   Lv, YB
   Feng, XZ
   Guo, LF
   Sun, G
   Liu, K
   Liu, YJ
   Xu, B
   Wang, CY
AF Yuan, H. -C.
   Jiang, C. -W.
   Hou, L. -Y.
   Lv, Y. -B.
   Feng, X. -Z.
   Guo, L. -F.
   Sun, G.
   Liu, K.
   Liu, Y. -J.
   Xu, B.
   Wang, C. -Y.
TI RETRACTED: Effect of VEGF on neuronal degeneration and interaction
   between Alzheimer's disease biomarkers(Retracted article. See
   vol.21,pg.3982,2017)
SO EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
LA English
DT Article; Retracted Publication
DE Vascular endothelial growth factor; Alzheimer's disease; Cognitive
   decline; Amyloid-beta 42; tau protein
ID ENDOTHELIAL GROWTH-FACTOR; COGNITIVE IMPAIRMENT; MOUSE MODEL;
   ASSOCIATION; EXPRESSION; MEMORY; CELLS; ADNI; RATS
AB OBJECTIVE: To explore whether the vascular endothelial growth factor (VEGF) level changes the biological markers of Alzheimer's disease (AD) and discover the relationship between VEGF and the brain aging.
   PATIENTS AND METHODS: The neuroimaging and neuropsychological results on Alzheimer's disease neuroimaging program (ADNI) were analyzed as biomarkers. Participants were all recruited from ADNI including cognitive ability (n= 90), mild cognitive impairment (n= 130) and AD (n= 59). The relationship between VEGF level in cerebrospinal fluid (CSF) and hippocampal volume, episodic memory and executive ability was compared laterally and longitudinally, in order to evaluate whether VEGF was effective. Moreover, the correlation between VEGF levels in CSF and the results of brain aging was detected and evaluated, so as to detect the level of VEGF in CSF and the continuous determination of the relationship with AD biomarkers (A beta 42, total t protein).
   RESULTS: The general linear model and the multiple regression research indicated that the VEGF in CSF was related to the brain aging (hippocampal volume, episodic memory and executive ability). The interaction between AD biomarkers (CSF amyloid beta (A beta-42) and total t protein) and VEGF promoted AD biomarkers to enhance the effect of VEGF on the brain aging. The VEGF correlated with the baseline hippocampal volume (p = 0.009), longitudinal hippocampal atrophy (p = 0.010), longitudinal memory decline (p < 0.0001) and longitudinal executive capacity decline (p = 0.003). In the prediction of longitudinal hippocampal atrophy (p < 0.0001) memory loss (p = 0.010) and implementation capacity (p = 0.0002), the VEGF and t protein interacted with each other. In the prediction of longitudinal memory loss (p = 0.010), the VEGF interacted with amyloid-beta 4.
   CONCLUSIONS: The elevated VEGF in CSF is associated with the brain aging. When AD biomarkers were elevated, the VEGF had the strongest neuro-protective effect. Moreover, in the positive AD biomarkers, especially the individual t protein, the protective effect of VEGF was the strongest. In the prediction of longitudinal changes in the hippocampal volume, the memory and the executive ability, the interactions of VEGF and t protein were observed. VEGF and A beta-42 also interacted with each other in case of longitudinal changes in the memory performance.
C1 [Yuan, H. -C.; Xu, B.] Qingdao Cent Hosp, Dept Neurol, Qingdao, Shandong, Peoples R China.
   [Jiang, C. -W.; Sun, G.; Liu, K.] Jinan Mil Gen Hosp, Dept Intervent Radiol, Jinan, Shandong, Peoples R China.
   [Jiang, C. -W.; Hou, L. -Y.] Qingdao Hiser Med Ctr, Dept Intervent Radiol, Qingdao, Shandong, Peoples R China.
   [Lv, Y. -B.; Feng, X. -Z.; Guo, L. -F.] Shandong Med Imaging Res Inst, Dept Intervent Radiol, Jinan, Shandong, Peoples R China.
   [Liu, Y. -J.] Qingdao Hiser Med Ctr, Dept Neurosurg, Qingdao, Shandong, Peoples R China.
   [Wang, C. -Y.] China Japan Friendship Hosp, Dept Head & Neck Surg, Beijing, Peoples R China.
RP Xu, B (reprint author), Qingdao Cent Hosp, Dept Neurol, Qingdao, Shandong, Peoples R China.; Wang, CY (reprint author), China Japan Friendship Hosp, Dept Head & Neck Surg, Beijing, Peoples R China.
EM p0268255xietao5@163.com
CR Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008
   Chen H, 2015, EUR REV MED PHARMACO, V19, P3569
   Crane PK, 2012, BRAIN IMAGING BEHAV, V6, P502, DOI 10.1007/s11682-012-9186-z
   Fakhoury M, 2016, J NEUROL, V263, P1683, DOI 10.1007/s00415-016-8052-0
   Falk T, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-49
   Guo LH, 2013, EUR ARCH PSY CLIN N, V263, P553, DOI 10.1007/s00406-013-0405-4
   Liguori C, 2016, CNS NEUROL DISORD DR
   Mattsson N, 2014, NEUROBIOL AGING, V35, P614, DOI 10.1016/j.neurobiolaging.2013.08.027
   Meng QY, 2010, CHINESE MED J-PEKING, V123, P471, DOI 10.3760/cma.j.issn.0366-6999.2010.04.016
   Ng T, 2014, EXPERT OPIN DRUG SAF, V13, P83, DOI 10.1517/14740338.2013.828034
   Ota M, 2017, PSYCHIAT RES-NEUROIM, V259, P54, DOI 10.1016/j.pscychresns.2016.11.002
   PROVIA J, 2014, CURR NEUROVASC RES, V11, P1
   Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084
   Sargent KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116332
   Shulman MB, 2013, NEUROLOGY, V81, P1114, DOI 10.1212/WNL.0b013e3182a55f4a
   Spuch C, 2010, BIOMATERIALS, V31, P5608, DOI 10.1016/j.biomaterials.2010.03.042
   Tang Hui, 2015, Nan Fang Yi Ke Da Xue Xue Bao, V35, P1552
   Tang HD, 2013, NEUROBIOL AGING, V34, P1412, DOI 10.1016/j.neurobiolaging.2012.10.029
   Wang DH, 2015, NAT NEUROSCI, V18, P1853, DOI 10.1038/nn.4164
   Wang P, 2011, BIOCHEM BIOPH RES CO, V411, P620, DOI 10.1016/j.bbrc.2011.07.003
   Wang ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126310
   Wozney JL, 2014, CANCER METAST REV, V33, P1
   Zetterberg H, 2015, CURR OPIN PSYCHIATR, V28, P402, DOI 10.1097/YCO.0000000000000179
   Zhang JB, 2016, EUR J NEUROL, V23, P1337, DOI 10.1111/ene.13030
   Zhu XZ, 2015, EUR REV MED PHARMACO, V19, P4362
NR 25
TC 1
Z9 1
U1 5
U2 6
PU VERDUCI PUBLISHER
PI ROME
PA VIA GREGORIO VII, ROME, 186-00165, ITALY
SN 1128-3602
J9 EUR REV MED PHARMACO
JI Eur. Rev. Med. Pharmacol. Sci.
PD AUG
PY 2017
VL 21
IS 16
BP 3649
EP 3657
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FH9AY
UT WOS:000411499700019
PM 28925478
DA 2018-12-27
ER

PT J
AU Song, Y
   Zhang, RF
   Liu, Y
AF Song, Yi
   Zhang, Rui-Fang
   Liu, Yu
TI RETRACTED: 2D-STI combined with gated Tc-99(m)-MIBI MPI for the
   diagnosis of myocardial ischemia in hypercholesterolemia patients
   (Retracted article. See vol. 15, pg. 4594, 2018)
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article; Retracted Publication
DE echocardiography; homozygous familial hypercholesterolemia; speckle
   tracking imaging; MPI; myocardial ischemia
ID HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; TOMOGRAPHY
   CORONARY-ANGIOGRAPHY; TC-99(M)-TETROFOSMIN SPECT; CARDIOVASCULAR
   FEATURES; ARTERY-DISEASE; WALL-MOTION; ECHOCARDIOGRAPHY; GUIDANCE;
   HEART; ASSOCIATION
AB This study aimed to investigate the reliability of ultrasound two-dimensional speckle tracking imaging (2D-STI) for the evaluation of myocardial ischemia in familial hypercholesterolemia (FH) patients. We recruited 28 patients clinically diagnosed with homozygous familial hypercholesterolemia (HoFH) and subjected them to 2D-STI, gated transthoracic Doppler echocardiography (TTDE), and Tc-99(m)-methoxyisobutylisonitrile myocardial perfusion imaging (Tc-99(m)-MIBI MPI). The sensitivity, specificity and diagnostic accordance rate of TTDE and 2D-STI for myocardial ischemia in HoFH patients were compared with the Tc-99(m)-MIBI scores. According to the diagnosis of ischemia in the three main coronary arteries (LAD, LCX, and RCA) by MPI, patients were further divided into different groups for comparing segmental strain by 2D-STI. The total correlation between TTDE and Tc-99(m)-MIBI MPI for evaluation of myocardial ischemia was r=0.483 and between 2D-STI and Tc-99(m)-MIBI MPI was 0.786. The total correlation index for ejection fraction (EF) between TTDE and 99Tcm-MIBI MPI was r=0.606 and for 2D-STI and Tc-99(m)-MIBI MPI was r=0.919. TTDE indicated that differences among LVDd, LVDs, IVS, LVPW, AO Vmax, PG, E/e', and DT were statistically significant. STI indicated that the total strain of the ischemia group was lower than that of the non-ischemia group. The total systolic strain and total early diastolic strain of the ischemia group were lower than that of the non-ischemia group. TTDE can be used for primary observation and evaluation of ventricular wall ischemia for HoFH patients. Ultrasound 2D-STI is better than TTDE in the evaluation of myocardial ischemia in HoFH patients. Ultrasound 2D-STI shows the same effectiveness as Tc-99(m)-MIBI MPI for the detection of myocardial ischemia, serving as good tool for prognosis and treatment evaluation in HoFH patients.
C1 [Song, Yi; Zhang, Rui-Fang] Zhengzhou Univ, Affiliated Hosp 1, Dept Med Ultrason, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China.
   [Liu, Yu] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China.
RP Zhang, RF (reprint author), Zhengzhou Univ, Affiliated Hosp 1, Dept Med Ultrason, 1 Jianshe East Rd, Zhengzhou 450052, Henan, Peoples R China.
EM bo0763914qiaop@163.com
CR Al-Sarraf A, 2013, CAN J CARDIOL, V29, P6, DOI 10.1016/j.cjca.2012.04.019
   Anderson RH, 2005, EUR J CARDIO-THORAC, V28, P517, DOI 10.1016/j.ejcts.2005.06.043
   BROOK GJ, 1989, CLIN CARDIOL, V12, P333, DOI 10.1002/clc.4960120608
   Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975
   Cuchel M, 2014, EUR HEART J, V35, P2146, DOI 10.1093/eurheartj/ehu274
   GERMANO G, 1995, J NUCL MED, V36, P2138
   Goldberg AC, 2011, J CLIN LIPIDOL, V5, P133, DOI 10.1016/j.jacl.2011.03.001
   Huang Y, 2016, EUR REV MED PHARMACO, V20, P2673
   Kadokami T, 2012, NUCL MED COMMUN, V33, P60, DOI 10.1097/MNM.0b013e32834d3bde
   Leung DY, 2010, HEART LUNG CIRC, V19, P161, DOI 10.1016/j.hlc.2009.11.006
   Li G, 2015, EUR REV MED PHARMACO, V19, P4139
   Liyanage KE, 2011, CRIT REV CL LAB SCI, V48, P1, DOI 10.3109/10408363.2011.565585
   Modesto KM, 2006, EUR J ECHOCARDIOGR, V7, P315, DOI 10.1016/j.euje.2005.07.003
   MOURATIDIS B, 1992, AM J CARDIOL, V70, P1109, DOI 10.1016/0002-9149(92)90038-Z
   Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273
   Perk G, 2007, J AM SOC ECHOCARDIOG, V20, P234, DOI 10.1016/j.echo.2006.08.023
   Rynkiewicz A, 2013, J CLIN LIPIDOL, V7, P217, DOI 10.1016/j.jacl.2013.01.005
   Santana CA, 2009, J NUCL CARDIOL, V16, P201, DOI 10.1007/s12350-008-9019-z
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358
   Shimoni S, 2002, CIRCULATION, V106, P950, DOI 10.1161/01.CIR.0000026395.19594.43
   SPRECHER DL, 1984, AM J CARDIOL, V54, P20, DOI 10.1016/0002-9149(84)90298-4
   Wahba FFM, 2001, NUCL MED COMMUN, V22, P175, DOI 10.1097/00006231-200102000-00009
   Wahba FFM, 2001, NUCL MED COMMUN, V22, P663, DOI 10.1097/00006231-200106000-00010
   [王蒨 WANG Qian], 2006, [中华核医学杂志, Chinese Journal of Nuclear Medicine], V26, P81
NR 24
TC 2
Z9 2
U1 4
U2 5
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD AUG
PY 2017
VL 14
IS 2
BP 981
EP 994
DI 10.3892/etm.2017.4602
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA FB7BY
UT WOS:000406297300013
PM 28810550
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Razavi, SMJ
   Ferro, P
   Berto, F
AF Razavi, Seyed-Mohammad-Javad
   Ferro, Paolo
   Berto, Filippo
TI RETRACTED: Fatigue Assessment of Ti-6Al-4V Circular Notched Specimens
   Produced by Selective Laser Melting (Retracted article. See vol. 46,
   artn. 291, 2017)
SO METALS
LA English
DT Article; Retracted Publication
DE additive manufacturing; circular notch; fatigue; selective laser melting
   (SLM); titanium alloy
ID MICROSTRUCTURE; STRENGTH
AB Additive manufacturing (AM) offers the potential to economically produce customized components with complex geometries in a shorter design-to-manufacture cycle. However, the basic understanding of the fatigue behavior of these materials must be substantially improved at all scale levels before the unique features of this rapidly developing technology can be used in critical load bearing applications. This work aims to assess the fatigue strength of Ti-6Al-4V smooth and circular notched samples produced by selective laser melting (SLM). Scanning Electron Microscopy (SEM) was used to investigate the fracture surface of the broken samples in order to identify crack initiation points and fracture mechanisms. Despite the observed fatigue strength reduction induced by circular notched specimens compared to smooth specimens, notched samples showed a very low notch sensitivity attributed both to hexagonal crystal lattice characteristics of tempered alpha prime grains and to surface defects induced by the SLM process itself.
C1 [Razavi, Seyed-Mohammad-Javad; Berto, Filippo] Norwegian Univ Sci & Technol NTNU, Dept Mech & Ind Engn, Richard Birkelands Vei 2b, N-7491 Trondheim, Norway.
   [Ferro, Paolo] Univ Padua, Dept Engn & Management, Stradella San Nicola 3, I-36100 Vicenza, Italy.
RP Berto, F (reprint author), Norwegian Univ Sci & Technol NTNU, Dept Mech & Ind Engn, Richard Birkelands Vei 2b, N-7491 Trondheim, Norway.
EM javad.razavi@ntnu.no; ferro@gest.unipd.it; filippo.berto@ntnu.no
OI Razavi, Seyed Mohamad Javad/0000-0002-2574-065X
CR Ayatollahi Majid Reza, 2017, Materials Science Forum, V879, P3, DOI 10.4028/www.scientific.net/MSF.879.3
   Berto F, 2014, MATER DESIGN, V54, P57, DOI 10.1016/j.matdes.2013.08.013
   Berto F, 2013, CARBON, V63, P101, DOI 10.1016/j.carbon.2013.06.045
   Berto F, 2011, MATER DESIGN, V32, P822, DOI 10.1016/j.matdes.2010.07.017
   Blattmeier M, 2012, RAPID PROTOTYPING J, V18, P161, DOI 10.1108/13552541211212140
   Cherolis NE, 2008, J FAIL ANAL PREV, V8, P255, DOI 10.1007/s11668-008-9146-5
   de Lacalle LNL, 2002, J MATER PROCESS TECH, V123, P292
   Domashenkov A, 2017, ADDIT MANUF, V15, P66, DOI 10.1016/j.addma.2017.03.008
   Hosseini S., 2012, BIOMEDICAL ENG TECHN
   Kasperovich G, 2015, J MATER PROCESS TECH, V220, P202, DOI 10.1016/j.jmatprotec.2015.01.025
   Kruth JP, 2005, RAPID PROTOTYPING J, V11, P26, DOI 10.1108/13552540510573365
   Lee YS, 2016, ADDIT MANUF, V12, P178, DOI 10.1016/j.addma.2016.05.003
   Leuders S., 2013, INT J FATIGUE, V48, P300, DOI DOI 10.1016/J.IJFATIGUE.2012.11.011
   Lindgren LE, 2016, ADDIT MANUF, V12, P144, DOI 10.1016/j.addma.2016.05.005
   Krahmer DM, 2016, EXP TECHNIQUES, V40, P1555, DOI 10.1007/s40799-016-0134-5
   Razavi SMJ, 2017, ENG FRACT MECH, V169, P226, DOI 10.1016/j.engfracmech.2016.11.013
   Song X, 2014, MAT SCI ENG A-STRUCT, V619, P112, DOI 10.1016/j.msea.2014.09.069
   Sun Z, 2014, IOP CONF SER-MAT SCI, V63, DOI 10.1088/1757-899X/63/1/012021
   Todai M, 2017, ADDIT MANUF, V13, P61, DOI 10.1016/j.addma.2016.11.001
   Vaithilingam J., 2012, P SOL FREEF FABR SFF
   Vilaro T, 2011, METALL MATER TRANS A, V42A, P3190, DOI 10.1007/s11661-011-0731-y
   Vrancken B, 2012, J ALLOY COMPD, V541, P177, DOI 10.1016/j.jallcom.2012.07.022
   Wu XH, 2004, MATER DESIGN, V25, P137, DOI 10.1016/j.matdes.2003.09.009
   Wycisk E, 2015, FRONT MATER, DOI 10.3389/fmats.2015.00072
   Yadroitsev I, 2011, PHYSCS PROC, V12, P264, DOI 10.1016/j.phpro.2011.03.034
   Yang L., 2014, PROCEEDINGS OF THE S
NR 26
TC 3
Z9 3
U1 13
U2 24
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2075-4701
J9 METALS-BASEL
JI Metals
PD AUG
PY 2017
VL 7
IS 8
AR UNSP 291
DI 10.3390/met7080291
PG 10
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA FF3TQ
UT WOS:000408843200010
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Lu, T
AF Lu, Tao
TI RETRACTED: Bayesian inference on mixed-effects location scale models
   with skew-t distribution and mismeasured covariates for longitudinal
   data (Retracted article. See vol. 37, pg. 3707, 2018)
SO STATISTICS IN MEDICINE
LA English
DT Article; Retracted Publication
DE AIDS study; Bayesian inference; longitudinal data; mixed-effects
   location scale models; covariate measurement errors; skew-t distribution
ID MOMENTARY ASSESSMENT DATA; MEASUREMENT ERRORS; MISSING RESPONSES
AB In AIDS studies, heterogeneous between and within subject variations are often observed on longitudinal end-points. To accommodate heteroscedasticity in the longitudinal data, statistical methods have been developed to model the mean and variance jointly. Most of these methods assume (conditional) normal distributions for random errors, which is not realistic in practice. In this article, we propose a Bayesian mixed-effects location scale model with skew-t distribution and mismeasured covariates for heterogeneous longitudinal data with skewness. The proposed model captures the between-subject and within-subject (WS) heterogeneity by modeling the between-subject and WS variations with covariates as well as a random effect at subject level in the WS variance. Further, the proposed model also takes into account the covariate measurement errors, and commonly assumed normal distributions for model errors are substituted by skew-t distribution to account for skewness. Parameter estimation is carried out in a Bayesian framework. The proposed method is illustrated with a Multicenter AIDS Cohort Study. Simulation studies are performed to assess the performance of the proposed method. Copyright (C) 2017 JohnWiley & Sons, Ltd.
C1 [Lu, Tao] Univ Nevada, Dept Math & Stat, Reno, NV 89557 USA.
RP Lu, T (reprint author), Univ Nevada, Dept Math & Stat, Reno, NV 89557 USA.
EM stat.lu11@gmail.com
CR Arellano-Valle RB, 2005, J MULTIVARIATE ANAL, V96, P93, DOI 10.1016/j.jmva.2004.10.002
   Azzalini A, 2003, J ROY STAT SOC B, V65, P367, DOI 10.1111/1467-9868.00391
   Azzalini A, 2008, INT STAT REV, V76, P106, DOI 10.1111/j.1751-5823.2007.00016.x
   Elliott MR, 2007, BIOSTATISTICS, V8, P756, DOI 10.1093/biostatistics/kxm003
   Fonseca TCO, 2008, BIOMETRIKA, V95, P325, DOI 10.1093/biomet/asn001
   Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136
   Gelman A. E., 2003, BAYESIAN DATA ANAL
   Hedeker D, 2008, BIOMETRICS, V64, P627, DOI 10.1111/j.1541-0420.2007.00924.x
   Ho HJ, 2010, BIOMETRICAL J, V52, P449, DOI 10.1002/bimj.200900184
   Huang YX, 2012, INT J BIOSTAT, V8, DOI 10.1515/1557-4679.1426
   Huang YX, 2012, BIOMETRICS, V68, P943, DOI 10.1111/j.1541-0420.2011.01719.x
   Huang YX, 2011, BIOMETRICS, V67, P260, DOI 10.1111/j.1541-0420.2010.01425.x
   Jara A, 2008, COMPUT STAT DATA AN, V52, P5033, DOI 10.1016/j.csda.2008.04.027
   Kapur K, 2015, STAT MED, V34, P630, DOI 10.1002/sim.6345
   Lachos VH, 2011, BIOMETRICS, V67, P1594, DOI 10.1111/j.1541-0420.2011.01586.x
   Leng CL, 2010, J AM STAT ASSOC, V105, P181, DOI 10.1198/jasa.2009.tm08485
   Li X, 2012, STAT MED, V31, P3192, DOI 10.1002/sim.5393
   Liu W, 2007, BIOMETRICS, V63, P342, DOI 10.1111/j.1541-0420.2006.00687.x
   Lu T, 2015, STAT METHOD IN PRESS
   Lu XS, 2016, COMPUT STAT DATA AN, V93, P119, DOI 10.1016/j.csda.2014.04.003
   Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011
   Pourahmadi M, 1999, BIOMETRIKA, V86, P677, DOI 10.1093/biomet/86.3.677
   Pugach O, 2014, NICOTINE TOB RES, V16, pS151, DOI 10.1093/ntr/ntt143
   Sahu SK, 2003, CAN J STAT, V31, P129, DOI 10.2307/3316064
   Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Verbeke G, 1996, J AM STAT ASSOC, V91, P217, DOI 10.2307/2291398
   Villa C, 2014, BAYESIAN ANAL, V9, P197, DOI 10.1214/13-BA854
   Wu L, 2002, J AM STAT ASSOC, V97, P955, DOI 10.1198/016214502388618744
   Yao WX, 2013, J R STAT SOC B, V75, P123, DOI 10.1111/j.1467-9868.2012.01038.x
   Zhang WP, 2015, J R STAT SOC B, V77, P219, DOI 10.1111/rssb.12065
NR 30
TC 1
Z9 1
U1 2
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0277-6715
EI 1097-0258
J9 STAT MED
JI Stat. Med.
PD JUL 20
PY 2017
VL 36
IS 16
BP 2614
EP 2629
DI 10.1002/sim.7315
PG 16
WC Mathematical & Computational Biology; Public, Environmental &
   Occupational Health; Medical Informatics; Medicine, Research &
   Experimental; Statistics & Probability
SC Mathematical & Computational Biology; Public, Environmental &
   Occupational Health; Medical Informatics; Research & Experimental
   Medicine; Mathematics
GA EY6BH
UT WOS:000404067000011
PM 28421622
DA 2018-12-27
ER

PT J
AU Gao, XH
   Zhang, SS
   Chen, H
   Wang, YH
   Yuan, CH
   Wang, FB
AF Gao, Xing-hui
   Zhang, Shuang-shuang
   Chen, Hao
   Wang, Yu-Hui
   Yuan, Chun-Hui
   Wang, Fu-Bing
TI RETRACTED: Systemic Hepatic-Damage Index for Predicting the Prognosis of
   Hepatocellular Carcinoma after Curative Resection (Retracted article.
   See vol. 8, art no 1137, 2018)
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article; Retracted Publication
DE system hepatic-damageindex; hepatocellularcar cinoma; recurrence;
   prognosis; survival
ID NON-HODGKIN-LYMPHOMA; ACUTE-INFLAMMATION; ALPHA-FETOPROTEIN; TOTAL
   CHOLESTEROL; CANCER; RISK; HDL; BIOMARKER
AB Purpose: We have developed a systemic hepatic-damage index (SHI) based on serum total cholesterol (TC) and high density lipoprotein levels (HDL) and determined its prognostic significance in hepatocellular carcinoma (HCC) patients undergoing resection.
   Experimental Design: The SHI was analyzed in the training cohort of 188 HCC patients and in the validation cohort of 177 HCC patients. The systemic immune-inflammation index (SII) scores in the validation cohorts were also measured. Area under the receiver operating characteristic curve (AUC) was used to explore the prediction accuracy in HCC patients.
   Results: An optimal cutoff point for the SHI of 2.84 stratified the HCC patients into high SHI (>2.84) and low SHI (?2.84) groups in the training cohort. Univariate and multivariate analyses revealed the SHI was an independent predictor for overall survival and relapse-free survival, and prognostic for patients with negative ?-fetoprotein and Barcelona Clinic Liver Cancer stage 0+A. The AUCs of the SHI for survival and recurrence were higher than other conventional clinical indices. Low SHI significantly correlated with vascular invasion. The SII scores were significantly higher in patients with low SHI compared with those with high SHI. HCC patients in SHI ? 2.84 group had shorter recurrence time and lower survival rate than HCC patients in SHI > 2.84 group.
   Conclusions: The SHI was a potential biomarker for assessing HCC prognosis, and improving SHI level in HCC patients may be a promising therapeutic strategy decision. The poor outcome in HCC patients with low SHI scores might increase SII scores, increasing the possibility of recurrence and metastasis.
C1 [Gao, Xing-hui; Wang, Yu-Hui; Yuan, Chun-Hui; Wang, Fu-Bing] Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Wuhan, Peoples R China.
   [Zhang, Shuang-shuang] Tongji Univ, Shanghai Dermatol Hosp, Dept Dermatol, Shanghai, Peoples R China.
   [Chen, Hao] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan, Peoples R China.
RP Wang, FB (reprint author), Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Wuhan, Peoples R China.
EM wfb20042002@sina.com
FU Applied Basic Research Program of Science and Technology Bureau
   Foundation of Wuhan [2016060101010054]; Science and Technology
   Innovation Fostering Foundation of Zhongnan Hospital of Wuhan University
   [cxpy20160025]; "351 talent project (Luojia Young Scholars)" of Wuhan
   University; National Natural Science Foundation of China [81672114]
FX The authors thank the participating patients for the source of
   clinicalblood samples. This work was supported by Applied Basic Research
   Program of Science and Technology Bureau Foundation of Wuhan (No.
   2016060101010054) and Science and Technology Innovation Fostering
   Foundation of Zhongnan Hospital of Wuhan University (cxpy20160025). This
   work was also funded by "351 talent project (Luojia Young Scholars)" of
   Wuhan University and National Natural Science Foundation of China (grant
   No. 81672114).
CR Baecklund E, 2006, ARTHRITIS RHEUM, V54, P692, DOI 10.1002/art.21675
   Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199
   Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713
   Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543
   Cockerill GW, 2001, CIRCULATION, V103, P108
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Forner A, 2011, LIVER INT, V31, P1419, DOI 10.1111/j.1478-3231.2011.02605.x
   Gardini AC, 2016, ONCOTARGET, V7, P67142, DOI 10.18632/oncotarget.11565
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Hu B, 2014, CLIN CANCER RES, V20, P6212, DOI 10.1158/1078-0432.CCR-14-0442
   Irshad M, 2007, MED PRIN PRACT, V16, P310, DOI 10.1159/000102155
   Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282
   Johnson P J, 2001, Clin Liver Dis, V5, P145, DOI 10.1016/S1089-3261(05)70158-6
   Lee YL, 2016, ONCOTARGET, V7, P22948, DOI 10.18632/oncotarget.8312
   Li X, 2017, BREAST, V32, P1, DOI [10.1016/j.breast.2016.08.014, 10.1016/j.breast.2016.11.024]
   Lim U, 2007, CANCER RES, V67, P5569, DOI 10.1158/0008-5472.CAN-07-0212
   Nofer JR, 2002, ATHEROSCLEROSIS, V161, P1, DOI 10.1016/S0021-9150(01)00651-7
   Papageorgiou N, 2016, EXPERT OPIN THER TAR, V20, P907, DOI 10.1517/14728222.2016.1152264
   Pote N, 2015, J HEPATOL, V62, P848, DOI 10.1016/j.jhep.2014.11.005
   SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502
   Smedby KE, 2006, JNCI-J NATL CANCER I, V98, P51, DOI 10.1093/jnci/dj004
   Tietge UJF, 2003, AM J PHYSIOL-ENDOC M, V285, pE403, DOI 10.1152/ajpendo.00576.2002
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Vere CC, 2012, MED PRIN PRACT, V21, P566, DOI 10.1159/000339206
   Wang Q, 2014, SURGERY, V155, P263, DOI 10.1016/j.surg.2013.08.017
   Wang Y, 2016, ONCOTARGET, V7, P57290, DOI 10.18632/oncotarget.10145
   Wittekind C, 2006, PATHOLOGE, V27, P289, DOI 10.1007/s00292-006-0834-1
   Zhang YW, 2017, INT J CANCER, V140, P1645, DOI 10.1002/ijc.30581
NR 28
TC 1
Z9 1
U1 3
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD JUL 18
PY 2017
VL 8
AR UNSP 480
DI 10.3389/fphys.2017.00480
PG 9
WC Physiology
SC Physiology
GA FA7TZ
UT WOS:000405651100001
PM 28769812
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Sinha, R
   Mukhopadhyay, AK
AF Sinha, Rahul
   Mukhopadhyay, Alok Kumar
TI RETRACTED: Load Dependent Wear Analysis of Manganese Steels - Influence
   of Al Content (Retracted article. See vol. 20, pg. 1160, 2017)
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article; Retracted Publication
DE Wear; Mn-steel; hardness; Wear transition; Field emission scanning
   electron microscope
ID STACKING-FAULT ENERGY; ABRASIVE WEAR; SLIDING WEAR; RESISTANCE; SIZE;
   ALUMINUM; BEHAVIOR
AB In this paper influence of load on change in weight loss (mg), hardness and wear transition of 0.12 wt.% Al-Mn-steel (Steel A), 0.35 wt.% Al-Mn-steel (Steel B) and Mn-steel (Steel C) has been examined. With the increase in load these steels shows remarkable decrease in weight loss due to change in surface microstructure from austenite to epsilon or alpha - martensite which results in increase in hardness of material. With the increase in hardness transition in wear mechanism has been noticed. In future aspect these steel would prove to be better material as wear resistant liner in many industrial application.
C1 [Sinha, Rahul; Mukhopadhyay, Alok Kumar] Indian Inst Technol, Dept Min Machinery Engn, Dhanbad, Bihar, India.
RP Sinha, R (reprint author), Indian Inst Technol, Dept Min Machinery Engn, Dhanbad, Bihar, India.
EM rahulsinha@mme.ism.ac.in
CR Acselrad O, 2004, WEAR, V257, P999, DOI 10.1016/j.wear.2004.07.004
   ASHBY MF, 1991, TRIBOL T, V34, P577, DOI 10.1080/10402009108982074
   Bayraktar E, 2004, J MATER PROCESS TECH, V147, P145, DOI 10.1016/j.jmatprotec.2003.10.007
   Chaudhuri DK, 1997, WEAR, V209, P140, DOI 10.1016/S0043-1648(97)00010-0
   CHILDS THC, 1988, P I MECH ENG C-J MEC, V202, P379, DOI 10.1243/PIME_PROC_1988_202_140_02
   Coronado JJ, 2013, WEAR, V301, P82, DOI 10.1016/j.wear.2012.12.016
   Coronado JJ, 2011, WEAR, V271, P1794, DOI 10.1016/j.wear.2011.01.078
   Desch CH, 1941, BIOGRAPHICAL MEMOIRS, V3, P647
   Dumay A, 2008, MAT SCI ENG A-STRUCT, V483-84, P184, DOI 10.1016/j.msea.2006.12.170
   FELLER HG, 1989, WEAR, V132, P1, DOI 10.1016/0043-1648(89)90198-1
   GARRISON WM, 1987, WEAR, V114, P239, DOI 10.1016/0043-1648(87)90090-1
   Gutierrez-Urrutia I, 2012, SCRIPTA MATER, V66, P992, DOI 10.1016/j.scriptamat.2012.01.037
   Kim H, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/014205
   KITSUNAI H, 1990, WEAR, V135, P237, DOI 10.1016/0043-1648(90)90028-9
   Saeed-Akbari A, 2009, METALL MATER TRANS A, V40A, P3076, DOI 10.1007/s11661-009-0050-8
   SIN H, 1979, WEAR, V55, P163, DOI 10.1016/0043-1648(79)90188-1
   Song WW, 2014, ACTA METALL SIN-ENGL, V27, P546, DOI 10.1007/s40195-014-0084-9
   WERT JJ, 1983, WEAR, V91, P253, DOI 10.1016/0043-1648(83)90071-6
   ZUIDEMA BK, 1987, METALL TRANS A, V18, P1629, DOI 10.1007/BF02646146
NR 19
TC 1
Z9 1
U1 3
U2 5
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD JUL-AUG
PY 2017
VL 20
IS 4
BP 1153
EP 1159
DI 10.1590/1980-5373-MR-2017-0169
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA FG7TR
UT WOS:000410628100037
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Sriram, R
   Sapthagiri, R
   Ilavarasan, L
   Ravi, A
AF Sriram, R.
   Sapthagiri, R.
   Ilavarasan, L.
   Ravi, A.
TI RETRACTED: Microwave Assisted Synthesis of Trifluoro Substituted
   2-Aminobenzimidazole Derivatives via Iodoacetic Acid Mediated One-pot
   Condensation (Retracted article. See vol. 55, pg. 366, 2018)
SO JOURNAL OF HETEROCYCLIC CHEMISTRY
LA English
DT Article; Retracted Publication
ID PALLADIUM-CATALYZED AMINATION; BENZIMIDAZOLE DERIVATIVES;
   BIOLOGICAL-ACTIVITY; ANTAGONISTS; INHIBITORS; DISCOVERY; HETEROCYCLES;
   EFFICIENT; DESIGN; KINASE
AB Microwave-assisted efficient one-pot syntheses of trifluoro substituted 2-aminobenzimidazole derivative were synthesized using iodoacetic acid mediated cyclodesulfurization of thioureas. This method eliminates need to handle preformed substituted thioureas, requires lesser reaction time and temperature, is facile, and also gives higher yields of the target molecules.
C1 [Sriram, R.; Sapthagiri, R.; Ilavarasan, L.; Ravi, A.] Thiruvalluvar Univ, Govt Arts Coll, PG & Res Dept Chem, Vellore 606603, Tamil Nadu, India.
RP Ravi, A (reprint author), Thiruvalluvar Univ, Govt Arts Coll, PG & Res Dept Chem, Vellore 606603, Tamil Nadu, India.
EM draravigac@gmail.com
CR Abdel-Mohsen HT, 2010, EUR J MED CHEM, V45, P2336, DOI 10.1016/j.ejmech.2010.02.011
   Alamgir M, 2007, TOP HETEROCYCL CHEM, V9, P87, DOI 10.1007/7081_2007_088
   Beaulieu C, 2004, BIOORG MED CHEM LETT, V14, P3195, DOI 10.1016/j.bmcl.2004.04.005
   Boiani M, 2005, MINI-REV MED CHEM, V5, P409, DOI 10.2174/1389557053544047
   Cai J, 2015, BIOORGAN MED CHEM, V23, P657, DOI 10.1016/j.bmc.2015.01.003
   Cee VJ, 2006, TETRAHEDRON LETT, V47, P3747, DOI 10.1016/j.tetlet.2006.03.112
   Deng XH, 2009, J ORG CHEM, V74, P5742, DOI 10.1021/jo900912h
   Evindar G, 2003, ORG LETT, V5, P133, DOI 10.1021/ol027061h
   Ghosh H, 2008, EUR J ORG CHEM, P6189, DOI 10.1002/ejoc.200800901
   Gill C, 2008, BIOORG MED CHEM LETT, V18, P6244, DOI 10.1016/j.bmcl.2008.09.096
   Hayes ME, 2008, BIOORG MED CHEM LETT, V18, P1573, DOI 10.1016/j.bmcl.2008.01.074
   Heinelt U, 2004, TETRAHEDRON, V60, P9883, DOI 10.1016/j.tet.2004.08.031
   Hong YP, 1998, TETRAHEDRON LETT, V39, P3121, DOI 10.1016/S0040-4039(98)00517-6
   Hong YP, 1997, TETRAHEDRON LETT, V38, P5607, DOI 10.1016/S0040-4039(97)01273-2
   Hooper MW, 2003, J ORG CHEM, V68, P2861, DOI 10.1021/jo0266339
   Horton DA, 2003, CHEM REV, V103, P893, DOI 10.1021/cr020033s
   JANSSENS F, 1985, J MED CHEM, V28, P1925, DOI 10.1021/jm00150a028
   Kling A, 2003, BIOORGAN MED CHEM, V11, P1319, DOI 10.1016/S0968-0896(02)00616-8
   Lv X, 2009, J ORG CHEM, V74, P5618, DOI 10.1021/jo900743y
   Nofal ZM, 2002, ARCH PHARM RES, V25, P250, DOI 10.1007/BF02976622
   Omar A.-M. M. E., 1974, SYNTHESIS, V41
   Omar A.-M. M. E., 1977, SYNTHESIS, V864
   OMAR AMME, 1976, PHARMAZIE, V31, P348
   Perkins JJ, 1999, TETRAHEDRON LETT, V40, P1103, DOI 10.1016/S0040-4039(98)02592-1
   Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.0.20
   Saha P, 2009, J ORG CHEM, V74, P8719, DOI 10.1021/jo901813g
   Snow RJ, 2002, J MED CHEM, V45, P3394, DOI 10.1021/jm020113o
   Ts Mavrova A., 2015, BIOORGAN MED CHEM, V23, P6317
   Wang JM, 2010, J CHEM INF MODEL, V50, P55, DOI 10.1021/ci900398f
   Wang XJ, 2004, TETRAHEDRON LETT, V45, P7167, DOI 10.1016/j.tetlet.2004.07.042
   Wang XQ, 2005, BIOORGAN MED CHEM, V13, P4667, DOI 10.1016/j.bmc.2005.04.060
   Zheng YG, 2013, BIOORG MED CHEM LETT, V23, P3523, DOI 10.1016/j.bmcl.2013.04.039
NR 32
TC 1
Z9 1
U1 4
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-152X
EI 1943-5193
J9 J HETEROCYCLIC CHEM
JI J. Heterocycl. Chem.
PD JUL
PY 2017
VL 54
IS 4
BP 2440
EP 2446
DI 10.1002/jhet.2841
PG 7
WC Chemistry, Organic
SC Chemistry
GA FB1FJ
UT WOS:000405888800035
DA 2018-12-27
ER

PT J
AU Vahed, SZ
   Zonouzi, AP
   Ghanbarian, H
   Ghojazadeh, M
   Samadi, N
   Ardalan, M
AF Vahed, Sepideh Zununi
   Zonouzi, Ahmad Poursadegh
   Ghanbarian, Hossein
   Ghojazadeh, Moteza
   Samadi, Nasser
   Ardalan, Mohammadreza
TI RETRACTED: Upregulated Expression of Circulating MicroRNAs in Kidney
   Transplant Recipients With Interstitial Fibrosis and Tubular Atrophy
   (Retracted article. See vol. 11, pg. 393, 2017)
SO IRANIAN JOURNAL OF KIDNEY DISEASES
LA English
DT Article; Retracted Publication
DE kidney transplantation; circulating microRNAs; interstitial fibrosis and
   tubular atrophy
ID CHRONIC ALLOGRAFT DYSFUNCTION; RENAL-TRANSPLANT; MEDIATED REJECTION;
   MIR-21; INJURY; INFLAMMATION; NEPHROPATHY; MIR-142-3P; PROFILES;
   BIOPSIES
AB Introduction. The discovery of circulating microRNAs (miRNAs), as potential noninvasive diagnostic biomarkers, has opened new avenues of research for identifying transplant patients with chronic allograft dysfunction. The present study aimed to investigate the expression levels of 4 immune-related miRNAs, miR-21, miR-31, miR-142-3p, and miR-155, in plasma samples of kidney allograft recipients.
   Materials and Methods. The plasma expression levels of the miRNAs were evaluated by quantitative real-time polymerase chain reaction in 53 kidney recipients with long-term stable allograft function (n = 27), biopsy-proven interstitial fibrosis and tubular atrophy (n = 26), and healthy controls (n = 15). The possible correlation between clinical parameters and the circulating miRNAs and the receiver-operating characteristic analysis were performed.
   Results. Significantly upregulated expressions of miR-21 (P = .02), miR-142-3p (P = .048), and miR-155 (P = .005) were observed in plasma samples of recipients with interstitial fibrosis and tubular atrophy in comparison to the stable allograft function and healthy control groups. Expression level of the miR-21 in plasma was correlated with creatinine (r = -0.432, P = .03) and estimated glomerular filtration rate (r = 0.423, P = .031). Multivariable analysis indicated that miR-21, miR-142-3p, and miR-155 in plasma samples could discriminate almost most of the patients with interstitial fibrosis and tubular atrophy (area under curve, 0.802; sensitivity, 81%; specificity, 92%).
   Conclusions. Our data suggested that altered expression of miR-21, miR-142-3p, and miR-155 in plasma samples might be associated with kidney allograft dysfunction and could be used for graft monitoring in kidney transplantation.
C1 [Vahed, Sepideh Zununi; Ardalan, Mohammadreza] Tabriz Univ Med Sci, Kidney Res Ctr, Tabriz, Iran.
   [Vahed, Sepideh Zununi; Samadi, Nasser] Tabriz Univ Med Sci, Sch Adv Biomed Sci, Tabriz, Iran.
   [Zonouzi, Ahmad Poursadegh] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran.
   [Ghanbarian, Hossein] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Tehran, Iran.
   [Ghojazadeh, Moteza] Tabriz Univ Med Sci, Liver & Gastrointestinal Dis Res Ctr, Tabriz, Iran.
RP Ardalan, M (reprint author), Tabriz Univ Med Sci, Kidney Res Ctr, Tabriz, Iran.
EM ardalan34@yahoo.com
FU Kidney Research Center of Tabriz University of Medical Sciences
FX This work was financially supported by Kidney Research Center of Tabriz
   University of Medical Sciences. The authors gratefully acknowledge the
   Research Center for Pharmaceutical Nanotechnology, Tabriz University of
   Medical Sciences, for technical support.
CR Abedini S, 2009, CLIN J AM SOC NEPHRO, V4, P1246, DOI 10.2215/CJN.00930209
   Aguado-Fraile E, 2013, NEFROLOGIA, V33, P826, DOI 10.3265/Nefrologia.pre2013.Aug.12198
   Anglicheau D, 2009, P NATL ACAD SCI USA, V106, P5330, DOI 10.1073/pnas.0813121106
   Arias M, 2011, TRANSPLANTATION, V91, pS4, DOI 10.1097/TP.0b013e31821792fd
   Ben-Dov IZ, 2012, TRANSPLANTATION, V94, P1086, DOI 10.1097/TP.0b013e3182751efd
   Bunnag S, 2008, AM J TRANSPLANT, V8, P1423, DOI 10.1111/j.1600-6143.2008.02268.x
   Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463
   Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903
   Danger R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060702
   Danger R, 2012, J AM SOC NEPHROL, V23, P597, DOI 10.1681/ASN.2011060543
   Ganji MR, 2012, IRAN J KIDNEY DIS, V6, P88
   Glowacki F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058014
   Hassan R, 2014, IRAN J KIDNEY DIS, V8, P93
   Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224
   Huang YQ, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-142
   Jelencsics K, 2015, ADV EXP MED BIOL, V888, P271, DOI 10.1007/978-3-319-22671-2_14
   Kang K, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-4
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Li YF, 2013, PROTEIN CELL, V4, P813, DOI 10.1007/s13238-013-3085-y
   Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111
   Maluf DG, 2014, KIDNEY INT, V85, P439, DOI 10.1038/ki.2013.338
   Moreso F, 2006, AM J TRANSPLANT, V6, P747, DOI 10.1111/j.1600-6143.2005.01230.x
   Scian MJ, 2011, AM J TRANSPLANT, V11, P2110, DOI 10.1111/j.1600-6143.2011.03666.x
   Sheedy FJ, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00019
   Soltaninejad E, 2015, IRAN J ALLERGY ASTHM
   Soltaninejad E, 2015, TRANSPL IMMUNOL, V33, P1, DOI 10.1016/j.trim.2015.05.002
   Sui WG, 2008, TRANSPL IMMUNOL, V19, P81, DOI [10.1016/j.trim.2008.01.007, 10.1016/j.trim.2009.01.007]
   Trionfini P, 2015, NAT REV NEPHROL, V11, P23, DOI 10.1038/nrneph.2014.202
   Vahed SZ, 2017, CLIN BIOCHEM, V50, P32, DOI 10.1016/j.clinbiochem.2016.08.007
   Vahed SZ, 2016, IRAN J KIDNEY DIS, V10, P1
   Vahed SZ, 2015, BIOIMPACTS, V5, P45, DOI 10.15171/bi.2015.12
   Vahed SZ, 2014, IRAN J KIDNEY DIS, V8, P4
   Zhong X, 2011, J AM SOC NEPHROL, V22, P1668, DOI 10.1681/ASN.2010111168
   Zununi Sepide, 2013, Nephrourol Mon, V5, P783, DOI 10.5812/numonthly.12722
   Zununi Vahed Sepide, 2013, Nephrourol Mon, V5, P946, DOI 10.5812/numonthly.16179
NR 35
TC 1
Z9 1
U1 0
U2 1
PU IRANIAN SOC NEPHROLGY
PI TEHRAN
PA APT 12, NO 63, SHAHEED TOUSI ST, DR GHARIB ST, KESHAVARZ BLVD, TEHRAN,
   1419783311, IRAN
SN 1735-8582
EI 1735-8604
J9 IRAN J KIDNEY DIS
JI Iran. J. Kidney Dis.
PD JUL
PY 2017
VL 11
IS 4
BP 309
EP 318
PG 10
WC Urology & Nephrology
SC Urology & Nephrology
GA FE2GY
UT WOS:000408036000008
DA 2018-12-27
ER

PT J
AU Dhawan, I
   Choudhury, M
   Hote, MP
   Gupta, A
   Malhotra, P
   Mani, KV
AF Dhawan, Ira
   Choudhury, Minati
   Hote, Milind P.
   Gupta, Anushree
   Malhotra, Poonam
   Mani, Kalaivani V.
TI RETRACTED: Is Endothelin Gene Polymorphism Associated with Postoperative
   Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass
   Grafting? (Retracted article. See vol. 21, pg. 222, 2018)
SO ANNALS OF CARDIAC ANAESTHESIA
LA English
DT Article; Retracted Publication
DE Atrial fibrillation; coronary artery disease; endothelin; endothelin
   gene polymorphism
ID SURGERY; MUTATION; PROPHYLAXIS
AB Background: The mechanism of development of atrial fibrillation (AF) in patients undergoing coronary artery bypass grafting (CABG) has not been clearly defined, and the involvement of multiple factors such as advanced age, withdrawal of beta-blockers, inadequate atrial protection, and electrolyte imbalance, particularly hypomagnesemia has been documented by several authors. Despite all the available pharmacologic prophylaxis, incidence of AF still remains high in this group of patients. This unexplained cause could be genetic inheritance of endothelin-1 (ET-1) gene which is thought to have a pro-arrhythmogenic effect. Aim: This study aims to investigate the relationship between plasma ET-1 concentrations, ET-1 gene polymorphisms in loci -1370 T/G, -134 (3A/4A) Ins/del, Lys198Asn (G/T), and occurrence of AF in patients undergoing CABG. Methodology: Ninety-eight nonrelated, nondiabetic patients over a period of 4 years undergoing routine CABG were selected for the present study. All patients were genotyped for three single nucleotide polymorphisms (SNPs) in loci -1370 T/G, -134 (3A/4A) Ins/del, and Lys198Asn (G/T) in the ET-1 gene by gene sequencing. The plasma ET-1 concentrations were measured using an ET immunoassay. Results: Plasma ET-1 concentrations were higher in AF+ group (P = 0.001) as compared to AF group. The allele frequencies between AF+ and AF group were significantly different only with respect to the Lys198Asn (G/T) SNP of the ET-1 gene. Conclusion: The study described the possible correlation of polymorphism of ET gene in CABG population from India. The ET-1 gene might play a disease-modifying role in atrial fibrillation.
C1 [Dhawan, Ira; Choudhury, Minati; Malhotra, Poonam] All India Inst Med Sci, Dept Cardiac Anaesthesia, Cardiothorac Sci Ctr, New Delhi, India.
   [Hote, Milind P.] All India Inst Med Sci, Dept Cardiothorac Vasc Surg, Cardiothorac Sci Ctr, New Delhi, India.
   [Gupta, Anushree] All India Inst Med Sci, Dept Biotechnol, New Delhi, India.
   [Mani, Kalaivani V.] All India Inst Med Sci, Dept Biostat, New Delhi, India.
RP Choudhury, M (reprint author), All India Inst Med Sci, Dept Cardiac Anaesthesia, Cardiothorac Sci Ctr, New Delhi, India.
EM minatichoudhury2002@yahoo.co.in
FU ICMR
FX IEC is supported by grant from the ICMR.
CR Ahmed M, 2016, CURR CLIN PHARMACOL, V11, P191, DOI 10.2174/1574884711666160701000900
   ANDREWS TC, 1991, CIRCULATION, V84, P236
   Aranki SF, 1996, CIRCULATION, V94, P390, DOI 10.1161/01.CIR.94.3.390
   Bedi M, 2006, HEART RHYTHM, V3, P808, DOI 10.1016/j.hrthm.2006.03.002
   Boos CJ, 2005, INT J CLIN PRACT, V59, P870, DOI 10.1111/j.1368-5031.2005.0599b.x
   Chen LY, 2007, CLIN PHARMACOL THER, V81, P35, DOI 10.1038/sj.clpt.6100016
   Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771
   Christophersen IE, 2016, J HUM GENET, V61, P61, DOI 10.1038/jhg.2015.44
   Daoud EG, 1997, NEW ENGL J MED, V337, P1785, DOI 10.1056/NEJM199712183372501
   Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300
   Kaplan M, 2003, J THORAC CARDIOV SUR, V125, P344, DOI 10.1067/mtc.2003.108
   Kato K, 2007, INT J MOL MED, V19, P933
   Kilickesmez KO, 2015, CORONARY ARTERY DIS, V26, P37, DOI 10.1097/MCA.0000000000000175
   Kohno H, 2005, ANN THORAC SURG, V79, P117, DOI 10.1016/j.athoracsur.2004.06.062
   LAUER MS, 1989, PROG CARDIOVASC DIS, V31, P367, DOI 10.1016/0033-0620(89)90031-5
   Lubitz SA, 2009, CARDIOL CLIN, V27, P25, DOI 10.1016/j.ccl.2008.09.007
   Nyberg MT, 2007, CLIN CHIM ACTA, V375, P87, DOI 10.1016/j.cca.2006.06.020
   Otway R, 2007, J AM COLL CARDIOL, V49, P578, DOI 10.1016/j.jacc.2006.09.044
   Qing P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142458
   Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26
   Volders PGA, 2007, HEART RHYTHM, V4, P469, DOI 10.1016/j.hrthm.2006.12.023
   Wolff L, 1943, NEW ENGL J MED, V229, P396, DOI 10.1056/NEJM194309022291002
   YANAGISAWA M, 1989, TRENDS PHARMACOL SCI, V10, P374
NR 23
TC 2
Z9 2
U1 0
U2 1
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0971-9784
EI 0974-5181
J9 ANN CARD ANAESTH
JI Ann. Card. Anaesth.
PD JUL-SEP
PY 2017
VL 20
IS 3
BP 341
EP 347
DI 10.4103/aca.ACA_264_16
PG 7
WC Anesthesiology
SC Anesthesiology
GA FB2JC
UT WOS:000405969100013
PM 28701603
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Malekpour, L
   Rahali, S
   Potage, D
   Duparc, F
   Dujardin, F
   Roussignol, X
AF Malekpour, Louis
   Rahali, Said
   Potage, Damien
   Duparc, Fabrice
   Dujardin, Franck
   Roussignol, Xavier
TI RETRACTED: Posterior Arthroscopic Tibiotalar Arthrodesis: Anatomic
   Feasibility Study (Retracted article. See vol. 57, pg. 433, 2018)
SO JOURNAL OF FOOT & ANKLE SURGERY
LA English
DT Article; Retracted Publication
DE arthroscopy; cadaveric; safety; tibiotalar fusion
ID ANKLE ARTHRODESIS
AB Anterior arthroscopic tibiotalar arthrodesis has been well codified. A posterior approach with the patient in prone position is indicated when the anterior approach is precluded by soft tissue issues or for a 1-step procedure associated with posterior subtalar fusion. In an anatomic study, we assessed the feasibility of posterior arthroscopic tibiotalar fusion and sought to determine the arthroscopy entry points, mortise cartilage freshening quality, and risk of osseous, tendinous, vascular, and neural complications. We mapped 22 zones of the fibular tibiotalar mortise from 10 specimens. Medial and lateral pars-Achilles arthroscopic approaches were used, with a 4-mm arthroscope at 30. For chondral resection, we used a motorized burr, curette, and osteotome. The entire plafond of the tibial mortise could be freshened in all cases, but the talar dome could be freshened in its entirety in only 20% of cases. In 80%, only the posterior two thirds could be treated, because the anterior portion descending to the neck of the talus was poorly accessible. More than 50% of the area of the malleolar grooves was freshened. One medial malleolar fracture and one posterior fibular artery lesion developed. Thus, the technique was shown to be feaSible, if no frontal hindfoot deformity or tibiotalar equinus is present, which would prevent satisfactory resection of the posterior and anterior talar cartilage. The procedure allows for single-step associated subtalar fusion, requiring 2 complementary arthroscopic approaches, 1 cm distally. (C) 2017 by the American College of Foot and Ankle Surgeons. All rights reserved.
C1 [Malekpour, Louis; Rahali, Said; Potage, Damien; Dujardin, Franck; Roussignol, Xavier] Rouen Univ Hosp, Dept Orthopaed Surg & Traumatol, 1 Rue Germont, F-76031 Rouen, France.
   [Duparc, Fabrice] Rouen Univ, Fac Med, Anat Lab, Rouen, France.
RP Roussignol, X (reprint author), Rouen Univ Hosp, Dept Orthopaed Surg & Traumatol, 1 Rue Germont, F-76031 Rouen, France.
EM xavier.roussignol@chu-rouen.fr
OI duparc, fabrice/0000-0002-7131-7692
CR Albert E, 1879, WIEN MED PRESS, V20, P705
   Allegra F, 2010, ARTHROSCOPY, V26, P26
   Bevernage BD, 2010, ORTHOP TRAUMATOL-SUR, V96, P469, DOI 10.1016/j.otsr.2010.03.012
   CORSO SJ, 1995, ARTHROSCOPY, V11, P585, DOI 10.1016/0749-8063(95)90136-1
   De Vriese L, 1994, Acta Orthop Belg, V60, P389
   DENT CM, 1993, J BONE JOINT SURG BR, V75, P830
   DiDomenico LA, 2011, J FOOT ANKLE SURG, V50, P626, DOI 10.1053/j.jfas.2011.05.007
   Ferkel RD, 2005, FOOT ANKLE INT, V26, P275, DOI 10.1177/107110070502600402
   FREY C, 1994, FOOT ANKLE INT, V15, P581, DOI 10.1177/107110079401501102
   Glick JM, 1996, ARTHROSCOPY, V12, P428, DOI 10.1016/S0749-8063(96)90036-5
   Guhl JF, 1993, FOOT ANKLE ARTHROSCO
   HELM R, 1990, J BONE JOINT SURG BR, V72, P141
   HOLT ES, 1991, CLIN ORTHOP RELAT R, P21
   Lijoi F, 2003, ARTHROSCOPY, V19, P62, DOI 10.1053/jars.2003.50003
   MOECKEL BH, 1991, CLIN ORTHOP RELAT R, P78
   Mouilhade F, 2011, ORTHOP TRAUMATOL-SUR, V97, P396, DOI 10.1016/j.otsr.2011.02.008
   MYERSON MS, 1991, CLIN ORTHOP RELAT R, P84
   O'Brien TS, 1999, FOOT ANKLE INT, V20, P368, DOI 10.1177/107110079902000605
   PARISIEN JS, 1987, CLIN ORTHOP RELAT R, P228
   Pierre A, 2003, REV CHIR ORTHOP, V89, P144
   Shi Zhongmin, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P781
   van Dijk CN, 2009, J BONE JOINT SURG AM, V91A, P287, DOI 10.2106/JBJS.I.00445
   van Dijk C Niek, 2006, Foot Ankle Clin, V11, P391, DOI 10.1016/j.fcl.2006.03.002
   van Dijk CN, 2000, ARTHROSCOPY, V16, P871, DOI 10.1053/jars.2000.19430
NR 24
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1067-2516
EI 1542-2224
J9 J FOOT ANKLE SURG
JI J. Foot Ankle Surg.
PD JUL-AUG
PY 2017
VL 56
IS 4
BP 704
EP 707
DI 10.1053/j.jfas.2017.01.005
PG 4
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA EZ6KQ
UT WOS:000404827200002
PM 28410782
DA 2018-12-27
ER

PT J
AU Zou, YJ
   Xi, XY
   Zhang, CY
AF Zou, Youjia
   Xi, Xiangying
   Zhang, Chaoyang
TI RETRACTED: Southward migrations of the Atlantic Equatorial Currents
   during the Younger Dryas (Retracted article. See vol. 62, pg. 2338,
   2017)
SO LIMNOLOGY AND OCEANOGRAPHY
LA English
DT Article; Retracted Publication
ID INTERTROPICAL CONVERGENCE ZONE; LAST GLACIAL MAXIMUM; OXYGEN ISOTOPIC
   COMPOSITION; WESTERN TROPICAL ATLANTIC; ABRUPT CLIMATE-CHANGE;
   OVERTURNING CIRCULATION; NORTHEASTERN BRAZIL; BIPOLAR SEESAW; OCEAN;
   MOVEMENT
AB Previous studies suggested that a weakened Gulf Stream may have contributed to the Younger Dryas (YD) cold event, however the physical mechanism of the Gulf Stream weakening is unclear. Here, we utilize paired Mg/Ca and delta O-18 measurements of planktonic foraminifera from the northerly and southerly marine sediments in the middle Atlantic Ocean to reconstruct past changes in tropical surface ocean temperature and salinity over the past 14 ka. We demonstrate that during the YD the sea surface temperature (SST) at the northerly core (0 degrees 16'S) was up to 2.1-2.78 degrees C cooler whereas the SST at the southerly core (14 degrees 53'S) was up to 0.8-1.68 degrees C warmer than modern temperatures. The delta O-18, salinity values, accumulation rates, and other hydrological elements at the northerly core all exhibit opposite patterns with those at the southerly core. The anti-phased variations of the paleohydrological elements at the northerly and southerly cores suggest that the Atlantic Equatorial Currents shifted southward significantly from its present-day position during the YD, possibly resulting in a decrease of the Gulf Stream, in turn a cool Northern Hemisphere.
C1 [Zou, Youjia] Shanghai Maritime Univ, Dept Meteorol & Oceanog, Shanghai, Peoples R China.
   [Xi, Xiangying] Wuhan Univ Technol, Sch Management, Wuhan, Peoples R China.
   [Zhang, Chaoyang] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.
RP Xi, XY (reprint author), Wuhan Univ Technol, Sch Management, Wuhan, Peoples R China.
EM xxy9898@aliyun.com
CR Arbuszewski JA, 2013, NAT GEOSCI, V6, P959, DOI [10.1038/NGEO1961, 10.1038/ngeo1961]
   Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992
   Arz HW, 1999, EARTH PLANET SC LETT, V167, P105, DOI 10.1016/S0012-821X(99)00025-4
   Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770
   Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070
   Biasutti M, 2003, J CLIMATE, V16, P2491, DOI 10.1175/1520-0442(2003)016<2491:TACOTT>2.0.CO;2
   Bohm E, 2015, NATURE, V517, P73, DOI 10.1038/nature14059
   Broccoli AJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024546
   Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707
   Broecker WS, 2006, SCIENCE, V312, P1146, DOI 10.1126/science.1123253
   Chiang JCH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000916
   Dekens PS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000200
   Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725
   Henry LG, 2016, SCIENCE, V353, P470, DOI 10.1126/science.aaf5529
   Kaplan MR, 2010, NATURE, V467, P194, DOI 10.1038/nature09313
   KOLLA V, 1979, QUATERNARY RES, V11, P261, DOI 10.1016/0033-5894(79)90008-5
   Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719
   Levitus S, 1994, WORLD OCEAN ATLAS 19, V3, P99
   Levitus S., 1994, NOAA ATLAS NESDIS, V4, P117
   Lutjeharms JRE, 1996, SOUTH ATLANTIC, P125
   Lynch-Stieglitz J, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002032
   Madsen JD, 2001, HYDROBIOLOGIA, V444, P71, DOI 10.1023/A:1017520800568
   Niebler HS, 1998, MAR MICROPALEONTOL, V34, P213, DOI 10.1016/S0377-8398(98)00009-7
   PETERSON RG, 1991, PROG OCEANOGR, V26, P1, DOI 10.1016/0079-6611(91)90006-8
   Poore RZ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019940
   Rahmstorf S, 2015, NAT CLIM CHANGE, V5, P475, DOI [10.1038/nclimate2554, 10.1038/NCLIMATE2554]
   Razik S, 2013, PALAEOGEOGR PALAEOCL, V374, P28, DOI 10.1016/j.palaeo.2012.12.022
   Rind D, 2001, J GEOPHYS RES-ATMOS, V106, P27355, DOI 10.1029/2001JD000954
   Ruhlemann C, 2001, PALEOCEANOGRAPHY, V16, P293, DOI 10.1029/1999PA000474
   Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554
   Schmidt G. A., 1999, GLOBAL SEAWATER OXYG
   Schmidt MW, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002284
   Schmidt MW, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002157
   Schmidt W. J., 1991, DEEP-SEA RES, V38, P379, DOI DOI 10.1016/S0198-0149(12)80018-5
   Schott FA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014786
   Schrag DP, 2002, QUATERNARY SCI REV, V21, P331, DOI 10.1016/S0277-3791(01)00110-X
   Spero HJ, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000814
   Stansell ND, 2010, EARTH PLANET SC LETT, V293, P154, DOI 10.1016/j.epsl.2010.02.040
   Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707
   Stramma L, 1999, J GEOPHYS RES-OCEANS, V104, P20863, DOI 10.1029/1999JC900139
   STRAMMA L, 1995, DEEP-SEA RES PT I, V42, P773, DOI 10.1016/0967-0637(95)00014-W
   Stuiver M, 1998, RADIOCARBON, V40, P1041
   Vink A, 2001, PALEOCEANOGRAPHY, V16, P479, DOI 10.1029/2000PA000582
   Wang XF, 2006, QUATERNARY SCI REV, V25, P3391, DOI 10.1016/j.quascirev.2006.02.009
   Xie SP, 2001, J CLIMATE, V14, P1262, DOI 10.1175/1520-0442(2001)014<1262:FAVOAN>2.0.CO;2
   Zou YJ, 2014, DYNAM ATMOS OCEANS, V67, P29, DOI 10.1016/j.dynatmoce.2014.04.001
NR 46
TC 1
Z9 1
U1 4
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0024-3590
EI 1939-5590
J9 LIMNOL OCEANOGR
JI Limnol. Oceanogr.
PD JUL
PY 2017
VL 62
IS 4
BP 1732
EP 1741
DI 10.1002/lno.10529
PG 10
WC Limnology; Oceanography
SC Marine & Freshwater Biology; Oceanography
GA EZ8QY
UT WOS:000404993100028
DA 2018-12-27
ER

PT J
AU Simpson, EA
   Jaring, MRF
   Andronikou, S
AF Simpson, Ewan A.
   Jaring, Matthew R. F.
   Andronikou, Savvas
TI RETRACTED: Massive Mesenteric Lymphadenopathy Causing Protein-losing
   Enteropathy in Gaucher Disease (Retracted article. See vol. 39, pg.
   E302, 2017)
SO JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
LA English
DT Article; Retracted Publication
DE Gaucher disease; mesenteric lymphadenopathy; protein-losing enteropathy;
   radiology; imaging
AB Protein-losing enteropathy due to massive mesenteric lymphadenopathy is a rare complication of Gaucher disease which is generally refractory to treatment with enzyme replacement and substrate reduction therapies. It is postulated that lymph nodes may act as a "sanctuary site" into which these treatments cannot penetrate. We present the case of a male child with Gaucher disease who developed massive mesenteric lymph nodes despite otherwise successful treatment with enzyme replacement therapy, and subsequently developed protein-losing enteropathy. The sonographic and magnetic resonance appearances of this complication are shown. Large volume lymphadenopathy inevitably provokes concern about the possibility of malignancy, but in a patient with Gaucher disease-particularly with significant ascites and clinical features of protein-losing enteropathy-this rare complication should be considered.
C1 [Simpson, Ewan A.; Jaring, Matthew R. F.; Andronikou, Savvas] Univ Bristol, Univ Hosp Bristol NHS Fdn Trust, Dept Paediat Radiol, Bristol Royal Hosp Children, Bristol, Avon, England.
   [Andronikou, Savvas] Univ Bristol, CRIC Bristol, Bristol, Avon, England.
RP Simpson, EA (reprint author), Bristol Royal Hosp Children, Dept Paediat Radiol, Upper Maudlin St, Bristol BS2 8BJ, Avon, England.
EM ewan_9@hotmail.com
CR Lim AKP, 2002, PEDIATR RADIOL, V32, P674, DOI 10.1007/s00247-002-0761-0
   Mhanni AA, 2016, MOLEC GENET METAB RE, V6, P13, DOI 10.1016/j.ymgmr.2015.12.001
   Mistry PK, 2011, AM J HEMATOL, V86, P110, DOI 10.1002/ajh.21888
   Patlas M, 2002, EUR RADIOL, V12, P397, DOI 10.1007/s003300101031
NR 4
TC 1
Z9 1
U1 1
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1077-4114
EI 1536-3678
J9 J PEDIAT HEMATOL ONC
JI J. Pediatr. Hematol. Oncol.
PD JUL
PY 2017
VL 39
IS 5
BP E300
EP E301
DI 10.1097/MPH.0000000000000763
PG 2
WC Oncology; Hematology; Pediatrics
SC Oncology; Hematology; Pediatrics
GA EY6VO
UT WOS:000404121900015
PM 28060125
DA 2018-12-27
ER

PT J
AU Malvajerdi, SS
   Elahi, AS
AF Malvajerdi, S. Sharifi
   Elahi, A. Salar
TI RETRACTED: A Review on Nanoporous Gallium Nitride (NPGaN) Formation on
   P-Type Silicon Substrate with the Mather-type Plasma Focus Device
   (MPFD)(Retracted article. See vol. 28, pg. 1671, 2018)
SO JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS
LA English
DT Review; Retracted Publication
DE GaN; Photoluminescence; Plasma focus device; Porous; Semiconductors
ID LIGHT-EMITTING-DIODES; OPTOELECTRONIC DEVICES; GAN; SI; FABRICATION
AB A Mather-type plasma focus device (MPFD) was unitized to fabricated porous gallium nitride (GaN) on p-type silicon (Si) substrate with a < 100 > crystal orientation for the first time in a deposition process. GaN was deposited on Si with four and seven shots. The samples went through a three phase annealing procedure. First, the semiconductors were annealed in the PFD with nitrogen plasma shots after their deposition, second, a thermal chemical vapor deposition (TCVD) annealed the samples for 1 at 1050 A degrees C by nitrogen gas at 1 Pa pressure. Finally, an electric furnace annealed the samples for 1 h at 1150 A degrees C with continues flow of nitrogen. Porous GaN structures were observed by field emission scanning electron microscopy (FE-SEM) and atomic force microscopy (AFM). Furthermore, X-ray diffraction (XRD) analyze was carried out to determine the crystallinity of GaN after the samples were annealed. Energy-dispersive X-ray spectroscopy (EDX) indicated the amount of gallium, nitrogen, and oxygen due to self-oxidation of the samples. Photoluminescence (PL) spectroscopy revealed emissions at 2.94 and 3.39 eV which shows hexagonal wurtzite crystal structures was formed.
C1 [Malvajerdi, S. Sharifi; Elahi, A. Salar] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
EM Salari_phy@yahoo.com
CR Abdullah QN, 2014, ADV MATER RES-SWITZ, V925, P450, DOI 10.4028/www.scientific.net/AMR.925.450
   Ahmad M, 2013, J FUSION ENERG, V32, P471, DOI 10.1007/s10894-013-9596-y
   Argoitia A, 1997, APPL PHYS LETT, V70, P179, DOI 10.1063/1.118350
   Bayram C, 2014, ADV FUNCT MATER, V24, P4492, DOI 10.1002/adfm.201304062
   Benykhlef S, 2016, COLLOID POLYM SCI, V294, P1877, DOI 10.1007/s00396-016-3955-y
   Calderon A, 1997, PHYS REV LETT, V79, P5022, DOI 10.1103/PhysRevLett.79.5022
   Chang JR, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4731629
   Choi HJ, 2003, J PHYS CHEM B, V107, P8721, DOI 10.1021/jp034734k
   Chouli F., 2015, POLYM COMPOSITE, V34, P468
   Christie VA, 2004, CURR APPL PHYS, V4, P225, DOI 10.1016/j.cap.2003.11.015
   Eastman LF, 2002, IEEE SPECTRUM, V39, P28, DOI 10.1109/6.999791
   Fujii T, 2004, APPL PHYS LETT, V84, P855, DOI 10.1063/1.1645992
   Goldberger J, 2003, NATURE, V422, P599, DOI 10.1038/nature01551
   Habibi M, 2016, PHYS LETT A, V380, P439, DOI 10.1016/j.physleta.2015.10.048
   Han J, 1998, APPL PHYS LETT, V73, P1688, DOI 10.1063/1.122246
   KHAN MA, 1992, APPL PHYS LETT, V60, P2917, DOI 10.1063/1.106819
   Lanyon YH, 2007, ANAL CHEM, V79, P3048, DOI 10.1021/ac061878x
   Levinshtein M., 2001, PROPERTIES ADV SEMIC
   Li JY, 2000, J CRYST GROWTH, V213, P408, DOI 10.1016/S0022-0248(00)00390-0
   Li YB, 2006, NANOTECHNOLOGY, V17, P5101, DOI 10.1088/0957-4484/17/20/010
   Malvajerdi SS, 2017, INT J HYDROGEN ENERG, V42, P6876, DOI 10.1016/j.ijhydene.2016.12.040
   Mangla O., 2013, J MATER SCI, V48, P1
   Mangla O, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6010004
   Moustakas T.D., 1998, SEMICONDUCTORS SEMIM, V50
   Mynbaeya M., 1999, MRS INTERNET J N S R, V4, P67
   Nakamura S., 2000, BLUE LASER DIODE
   Neufeld J C, 2008, APPL PHYS LETT, V93
   Omrani M., 2016, INT J HYDROGEN ENERG, V41, P9
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Qiu HL, 2007, MAT SCI ENG B-SOLID, V136, P33, DOI 10.1016/j.mseb.2006.08.062
   Radja I, 2015, SYNTHETIC MET, V202, P25, DOI 10.1016/j.synthmet.2015.01.028
   Schmidt A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.205003
   Shin MJ, 2013, MATER LETT, V91, P191, DOI 10.1016/j.matlet.2012.10.002
   Simoes F.R., 2014, MACROMOL RES, V22, P26
   Sohrabi M., 2014, PHYS LETT A, V378, P48
   Stepniewski R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.226404
   Suda Y, 1998, PHYS REV LETT, V80, P3559, DOI 10.1103/PhysRevLett.80.3559
   Umeno M, 2001, MAT SCI SEMICON PROC, V4, P459, DOI 10.1016/S1369-8001(02)00003-3
   Wang WK, 2016, JPN J APPL PHYS, V55, DOI 10.7567/JJAP.55.095503
   Wang YD, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2147716
   Wang YD, 2004, APPL PHYS LETT, V85, P816, DOI 10.1063/1.1774273
   Wierer JJ, 2016, LASER PHOTONICS REV, V10, P612, DOI 10.1002/lpor.201500332
NR 42
TC 1
Z9 1
U1 3
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1574-1443
EI 1574-1451
J9 J INORG ORGANOMET P
JI J. Inorg. Organomet. Polym. Mater.
PD JUL
PY 2017
VL 27
IS 4
BP 948
EP 954
DI 10.1007/s10904-017-0541-9
PG 7
WC Polymer Science
SC Polymer Science
GA EY1EC
UT WOS:000403706000012
DA 2018-12-27
ER

PT J
AU Cvetkovic, M
   Cvetkovic, S
AF Cvetkovic, Milan
   Cvetkovic, Slavica
TI RETRACTED: Theoretical research of self-excited oscillations in
   transmitters for auxiliary motion of a tool machine using a nonlinear
   model (Retracted article. See vol. 39, pg. 4249, 2017)
SO JOURNAL OF THE BRAZILIAN SOCIETY OF MECHANICAL SCIENCES AND ENGINEERING
LA English
DT Article; Retracted Publication
DE Tool machines; Auxiliary motion transmitter; Self-exciting oscillations
AB Starting from the general model of dynamic characteristic of a transmitter for rectilinear motion of a tool machine for cutting, this work sets forward a nonlinear mathematical model which will be used for the theoretical research of oscillations. During this process, all the most important factors of oscillatory movement were taken into consideration, including the frictional force which changes depending on the relative speed of the system, i.e., the sliding speed, as well as the speed of the transmitter motion (speed of transmittance). The result of the appropriate frictional force functional dependency on the relative speed calculated based on experimental research after it is implemented into the model is a nonlinear differential equation which, generally speaking, has no solution. The resulting nonlinear equation was solved using an approximation method of slowly changing coefficients, with the assumption of the system having weak nonlinear characteristics and relatively small attenuation. After calculating the law and speed of motion for the initial non-stationary phase of oscillation, two different ways were used to determine the amplitude of the stationary oscillations, which is an important characteristic of the system. The main equations of motion for the stationary motion regime were set forward based on the acquired amplitude. In this manner, the self-exciting oscillations of the problem set forth were completely defined, i.e., described. In the same way, it was proven that their character depended on the character of the frictional force. At the end of the paper, the derived relations were used to determine the condition of the stability of the self-exciting oscillations and qualitatively analyze the acquired results with a special focus on the effects of specific factors on the observed oscillatory process.
C1 [Cvetkovic, Milan] ETH, Quantit Finance, Zurich, Switzerland.
   [Cvetkovic, Milan] Univ Zurich, Zurich, Switzerland.
   [Cvetkovic, Slavica] Univ Pristina, Fac Mech Engn, Pristina, Kosovo, Serbia.
RP Cvetkovic, M (reprint author), ETH, Quantit Finance, Zurich, Switzerland.; Cvetkovic, M (reprint author), Univ Zurich, Zurich, Switzerland.
EM smijoc@yahoo.com
CR Acerkan NS, 1993, METALOREZUSCE STANKA, V2
   Acerkan NS, 1993, METALOREZUSCE STANKA, V1
   Blaquiere A, 1986, NONLINEAR SYSTEM ANA
   Blaskovic P, 1995, TRIBOLOGIA
   Bulgakov BV, 1984, KOLEBANIJA
   Butenin N. V, 1972, ELEMENTI TEORII NELI
   Crichos N, 1988, TRIBOLOGY
   Granier M, 1967, SYSTEMES OSCILLAMS
   Horst C, 1982, TRIBOLOGY
   Krageljskie IV, 1992, KOEFICIJENT TRENIA
   Krageljskij UB, 1972, TRENIE IZNOS
   Krilov NM, 1967, VREDENIE NELINEJNUJU
   Kudinov AV, 1997, DINAMIKA STRUKOV
   Milacic RV, 1985, MASINE ALATKE 1 2
   Mitrinovic DS, 1990, DIFERENCIJALNE JEDNA
   Opitz H, 1991, MODERNE PRODUKTIONST
   Pronikov SA, 1987, RASCET KONSTRUKVANIE
   Smirnov VI, 1988, KNOS VISSEI MATEMATI, VII
   Smirnov VI, 1988, KNOS VISSEI MATEMATI, VI
   Stoker DZ, 1982, NELINEJNIE KOLEBANIJ
   Tepunkicien BK, 1983, METALOREZUSCIE STANK
   Tobias AS, 1985, MECHINE TOOL VIBRATI
   Week M, 1989, WERKZENGMASHINER, V5
NR 23
TC 1
Z9 1
U1 2
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1678-5878
EI 1806-3691
J9 J BRAZ SOC MECH SCI
JI J. Braz. Soc. Mech. Sci. Eng.
PD JUL
PY 2017
VL 39
IS 7
BP 2677
EP 2686
DI 10.1007/s40430-017-0737-5
PG 10
WC Engineering, Mechanical
SC Engineering
GA EX7SJ
UT WOS:000403448300025
DA 2018-12-27
ER

PT J
AU Kandavel, P
   Selewski, D
   Shah, M
AF Kandavel, Prashanthi
   Selewski, David
   Shah, Meera
TI RETRACTED: Poor Feeding, Weight Loss, and Electrolyte Abnormalities in a
   Term Infant(Retracted article.See vol.56, pg.NP1-NP1, 2017)
SO CLINICAL PEDIATRICS
LA English
DT Editorial Material; Retracted Publication
C1 [Kandavel, Prashanthi; Selewski, David; Shah, Meera] Univ Michigan Hlth Syst, CS Mott Childrens Hosp, 1500 East Med Ctr Dr,D3230 MPB,SPC 5718, Ann Arbor, MI 48109 USA.
RP Kandavel, P (reprint author), Univ Michigan Hlth Syst, CS Mott Childrens Hosp, 1500 East Med Ctr Dr,D3230 MPB,SPC 5718, Ann Arbor, MI 48109 USA.
EM pkandave@med.umich.edu
CR Amin N, 2013, ENDOCRINOL DIABETES, V2013, DOI [DOI 10.1530/EDM-13-0010, 10.1530/edm-13-0010]
   Greenberg JH, 2015, AM J KIDNEY DIS, V65, P513, DOI 10.1053/j.ajkd.2014.10.024
   Riepe FG, 2013, ENDOCR DEV, V24, P86, DOI 10.1159/000342508
   Riepe FG, 2009, HORM RES, V72, P1, DOI 10.1159/000224334
NR 4
TC 1
Z9 1
U1 3
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0009-9228
EI 1938-2707
J9 CLIN PEDIATR
JI Clin. Pediatr.
PD JUL
PY 2017
VL 56
IS 8
BP 789
EP 791
DI 10.1177/0009922816649591
PG 3
WC Pediatrics
SC Pediatrics
GA EX2TC
UT WOS:000403078500015
PM 27184398
DA 2018-12-27
ER

PT J
AU Pankratyev, EY
AF Pankratyev, Evgeniy Yu.
TI RETRACTED: Ab initio study of AlBu3i self-association (Retracted
   article. See vol. 1130, pg. 175, 2018)
SO COMPUTATIONAL AND THEORETICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID MONOMER-DIMER EQUILIBRIA; LIQUID ALUMINUM ALKYLS; OLEFIN
   HYDROALUMINATION; METALLORGANISCHE VERBINDUNGEN; MAGNETIC-RESONANCE;
   TRANSITION-STATES; GAS-PHASE; MECHANISM; CP2ZRCL2; XALBU2I
AB By the methods of the Density Functional Theory and second-order Moller-Plesset perturbation theory calculations the self-association process of triisobutylaluminum AIBu(3)(i) in the temperature range of 203-403 K is studied. The effects of solvation were studied using COSMO polarized continuum salvation model. Thermodynamic parameters of AlBu3i monomer and dimer were calculated and the data obtained were used to obtain their equilibrium concentrations. It has been shown for the first time that in the gas phase and non-polar solvents AlBu3i predominately exists as a dimer. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Pankratyev, Evgeniy Yu.] Russian Acad Sci, Inst Phys Mol & Crystals, Ufa Sci Ctr, Prosp Oktyabrya 151, Ufa 450075, Russia.
   [Pankratyev, Evgeniy Yu.] Ufa State Petr Technol Univ, Kosmonavtov 1, Ufa 450062, Russia.
RP Pankratyev, EY (reprint author), Russian Acad Sci, Inst Phys Mol & Crystals, Ufa Sci Ctr, Prosp Oktyabrya 151, Ufa 450075, Russia.
EM evgeniy@pankratyev.com
RI Pankratyev, Evgeniy/I-6798-2012
OI Pankratyev, Evgeniy/0000-0001-5373-9085
CR [Anonymous], 2004, GAUSSIAN 03 REVISION
   Besedin D. V., 2005, QCC FRONT END 2 09
   BUNDENS JW, 1993, ORGANOMETALLICS, V12, P1608, DOI 10.1021/om00029a019
   Bundens JW, 1999, ORGANOMETALLICS, V18, P3913, DOI 10.1021/om990350y
   Egger K.W., 1969, INT J CHEM KINET, V1, P459
   EGGER KW, 1972, HELV CHIM ACTA, V55, P1502, DOI 10.1002/hlca.19720550515
   EGGER KW, 1969, J AM CHEM SOC, V91, P2867, DOI 10.1021/ja01039a007
   FRISCH MJ, 1990, CHEM PHYS LETT, V166, P275, DOI 10.1016/0009-2614(90)80029-D
   HENRICKSON CH, 1967, INORG CHEM, V6, P1461, DOI 10.1021/ic50054a006
   HOFFMANN EG, 1960, LIEBIGS ANN CHEM, V629, P104
   Laikov D. N., 2000, THESIS
   Laikov DN, 2005, CHEM PHYS LETT, V416, P116, DOI 10.1016/j.cplett.2005.09.046
   Laikov DN, 2005, RUSS CHEM B+, V54, P820, DOI 10.1007/s11172-005-0329-x
   Laikov DN, 1997, CHEM PHYS LETT, V281, P151, DOI 10.1016/S0009-2614(97)01206-2
   Mole T., 1972, ORGANOALUMINUM COMPO, P465
   Moller C, 1934, PHYS REV, V46, P0618, DOI 10.1103/PhysRev.46.618
   Pankratyev E.Y., 2010, BASHKIRSKIY KHIMICHE, V17, P28
   Pankratyev EY, 2012, DOKL CHEM, V443, P67, DOI 10.1134/S0012500812030019
   Pankratyev EY, 2011, J STRUCT CHEM+, V52, P27
   Pankratyev E.Yu., 2008, VESTNIK BASHKIRSKOGO, V13, P802
   Pankratyev E.Yu., 2010, THESIS
   Pankratyev EY, 2012, J ORGANOMET CHEM, V718, P117, DOI 10.1016/j.jorganchem.2012.07.027
   Pankratyev EY, 2011, ORGANOMETALLICS, V30, P6078, DOI 10.1021/om200518h
   Pankratyev EY, 2009, ORGANOMETALLICS, V28, P968, DOI 10.1021/om800393j
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   POOLE CP, 1965, J PHYS CHEM-US, V69, P3663, DOI 10.1021/j100894a512
   Rusakov SV, 2001, RUSS CHEM B+, V50, P2336, DOI 10.1023/A:1015019109791
   SMITH MB, 1972, J ORGANOMET CHEM, V46, P31, DOI 10.1016/S0022-328X(00)90473-X
   SMITH MB, 1970, J ORGANOMET CHEM, V22, P273, DOI 10.1016/S0022-328X(00)86043-X
   YAMAMOTO O, 1968, J PHYS CHEM-US, V72, P822, DOI 10.1021/j100849a600
   Zhurko G.A., 2009, CHEMCRAFT, V1, P6
   Zhygach A.F., 1962, ORGANOALUMINUM COMPO, P320
   ZIEGLER K, 1954, LIEBIGS ANN CHEM, V589, P91
   ZIEGLER K, 1960, LIEBIGS ANN CHEM, V629, P53
NR 34
TC 1
Z9 1
U1 2
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2210-271X
EI 1872-7999
J9 COMPUT THEOR CHEM
JI Comput. Theor. Chem.
PD JUL 1
PY 2017
VL 1111
BP 27
EP 32
DI 10.1016/j.comptc.2017.04.004
PG 6
WC Chemistry, Physical
SC Chemistry
GA EV6JZ
UT WOS:000401877000004
DA 2018-12-27
ER

PT J
AU Mota, CM
   Chen, AL
   Wang, K
   Nadipuram, S
   Vashisht, AA
   Wohlschlegel, JA
   Mineo, TWP
   Bradley, PJ
AF Mota, Caroline M.
   Chen, Allan L.
   Wang, Kevin
   Nadipuram, Santhosh
   Vashisht, Ajay A.
   Wohlschlegel, James A.
   Mineo, Tiago W. P.
   Bradley, Peter J.
TI RETRACTED: New molecular tools in Neospora caninum for studying
   apicomplexan parasite proteins (Retracted article. See vol.8, artn.
   10964. 2018)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID DENSE GRANULE PROTEIN; TOXOPLASMA-GONDII; GENE; INFECTION;
   IDENTIFICATION; TRANSMISSION; EXPRESSION; ORGANELLES; SECRETION;
   INVASION
AB The development of molecular genetics has greatly enhanced the study of the biology and pathology associated with parasites of the phylum Apicomplexa. We have established a system specifically designed for Neospora caninum, and used this system as a heterologous platform for the expression of foreign genes. Plasmid constructs containing fluorescent proteins or targeted genes of Toxoplasma gondii, driven by N. caninum promoters, have yielded robust expression and correct trafficking of target gene products as assessed by immunofluorescence assays and Western blot analyses. Using this approach, we here demonstrated that N. caninum expressing T. gondii's GRA15 and ROP16 kinase are biologically active and induced immunological phenotypes consistent with T. gondii strains. N. caninum expressing TgGRA15 differentially disturbed the NF-kappa B pathway, inducing an increased IL-12 production. On the other hand, N. caninum expressing TgROP16 induced host STAT3 phosphorylation and consequent reduction of IL-12 synthesis. These results indicate that heterologous gene expression in N. caninum is a useful tool for the study of specific gene functions and may allow the identification of antigenic targets responsible for the phenotypic differences observed between these two closely related apicomplexan parasites. Additionally, these observations may prove to be useful for the development of vaccine protocols to control toxoplasmosis and/or neosporosis.
C1 [Mota, Caroline M.; Mineo, Tiago W. P.] Univ Fed Uberlandia, Inst Biomed Sci, Lab Immunoparasitol Dr Mario Endsfeldz Camargo, Uberlandia, MG, Brazil.
   [Chen, Allan L.; Wang, Kevin; Nadipuram, Santhosh; Bradley, Peter J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA.
   [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90024 USA.
   [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, Inst Genom & Proteom, Los Angeles, CA USA.
   [Bradley, Peter J.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.
RP Mineo, TWP (reprint author), Univ Fed Uberlandia, Inst Biomed Sci, Lab Immunoparasitol Dr Mario Endsfeldz Camargo, Uberlandia, MG, Brazil.; Bradley, PJ (reprint author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA.; Bradley, PJ (reprint author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.
EM tiago.mineo@ufu.br; pbradley@ucla.edu
RI Mineo, Tiago/B-4153-2009
OI Mineo, Tiago/0000-0002-2339-2743
FU Brazilian Funding Agency CNPq; Brazilian Funding Agency FAPEMIG;
   Brazilian Funding Agency CAPES
FX The authors thank to Marley Dantas Barbosa, Zilda Mendonca da Silva and
   Ana Claudia Pajuaba for their technical assistance. This work was
   supported by Brazilian Funding Agencies (CNPq, FAPEMIG and CAPES).
CR Beckers CJM, 1997, MOL BIOCHEM PARASIT, V89, P209, DOI 10.1016/S0166-6851(97)00120-5
   Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200
   Butcher B., 2011, PLOS PATHOG, V9
   Buxton D, 2002, TRENDS PARASITOL, V18, P546, DOI 10.1016/S1471-4922(02)02414-5
   Cardoso MRD, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-76
   Carruthers VB, 1997, EUR J CELL BIOL, V73, P114
   Chen AL, 2015, MBIO, V6, DOI 10.1128/mBio.02357-14
   De Craeye S, 2011, VET PARASITOL, V178, P64, DOI 10.1016/j.vetpar.2010.12.016
   Dlugonska H, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/632424
   Donahoe SL, 2015, INT J PARASITOL-PAR, V4, P216, DOI 10.1016/j.ijppaw.2015.04.002
   Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010
   Dubremetz JF, 2007, CELL MICROBIOL, V9, P841, DOI 10.1111/j.1462-5822.2007.00909.x
   Goodswen SJ, 2015, INT J PARASITOL, V45, P305, DOI 10.1016/j.ijpara.2015.01.006
   Hecker YP, 2015, VET PARASITOL, V214, P247, DOI 10.1016/j.vetpar.2015.10.015
   Howe DK, 1997, METHODS, V13, P123, DOI 10.1006/meth.1997.0505
   Jensen KDC, 2013, INFECT IMMUN, V81, P2156, DOI 10.1128/IAI.01185-12
   Lei T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099744
   Li WS, 2015, PARASITOL RES, V114, P2893, DOI 10.1007/s00436-015-4490-3
   Marugan-Hernandez V, 2011, VACCINE, V29, P7867, DOI 10.1016/j.vaccine.2011.07.091
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   Mota CM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01456
   Mota CM, 2014, VET PARASITOL, V205, P14, DOI 10.1016/j.vetpar.2014.07.020
   Nadipuram SM, 2016, MBIO, V7, DOI 10.1128/mBio.00808-16
   Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290
   Pereira LM, 2014, MOL BIOCHEM PARASIT, V196, P75, DOI 10.1016/j.molbiopara.2014.08.001
   Pereira LM, 2014, EXP PARASITOL, V138, P40, DOI 10.1016/j.exppara.2014.01.004
   Rome ME, 2008, INFECT IMMUN, V76, P4865, DOI 10.1128/IAI.00782-08
   Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717
   Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576
   Turetzky JM, 2010, INT J PARASITOL, V40, P1037, DOI 10.1016/j.ijpara.2010.02.014
   Virreira Winter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024434
   Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703
   Yan C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1432-6
   Yuan ZG, 2011, CLIN VACCINE IMMUNOL, V18, P119, DOI 10.1128/CVI.00312-10
   Zhang GH, 2010, VACCINE, V28, P7243, DOI 10.1016/j.vaccine.2010.08.096
NR 35
TC 3
Z9 3
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 19
PY 2017
VL 7
AR 3768
DI 10.1038/s41598-017-03978-1
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EY0LT
UT WOS:000403650300011
PM 28630403
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Lawrence, K
   Hyde, J
AF Lawrence, Kate
   Hyde, Jeannette
TI RETRACTED: Microbiome restoration diet improves digestion, cognition and
   physical and emotional wellbeing (Retracted article. See vol. 13, art no
   E0194851, 2018)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID IRRITABLE-BOWEL-SYNDROME; GUT MICROBIOTA; PROBIOTIC SUPPLEMENTATION;
   ALZHEIMERS-DISEASE; CONTROLLED-TRIAL; ENERGY HARVEST; HEALTHY-ADULTS;
   DOUBLE-BLIND; IMPACT; CONSEQUENCES
AB Manipulating gut bacteria in the microbiome, through the use of probiotics and prebiotics, has been found to have an influence on both physical and emotional wellbeing. This study uses a dietary manipulation 'The Gut Makeover' designed to elicit positive changes to the gut bacteria within the microbiome. 21 healthy participants undertook 'The Gut Makeover' for a four week period. Weight and various aspects of health were assessed pre and post intervention using the Functional Medicine Medical Symptoms Questionnaire (MSQ). Paired sample t-tests revealed a significant reduction in self-reported weight at the end of the intervention. Adverse medical symptoms related to digestion, cognition and physical and emotional wellbeing, were also significantly reduced during the course of the dietary intervention. The intervention, designed to manipulate gut bacteria, had a significant impact on digestion, reducing IBS type symptoms in this non-clinical population. There was also a striking reduction in negative symptoms related to cognition, memory and emotional wellbeing, including symptoms of anxiety and depression. Dietary gut microbiome manipulations may have the power to exert positive physical and psychological health benefits, of a similar nature to those reported in studies using pre and probiotics. The small sample size and lack of control over confounding variables means that it will be important to replicate these findings in larger-scale controlled, prospective, clinical trials. This dietary microbiome intervention has the potential to improve physical and emotional wellbeing in the general population but also to be investigated as a treatment option for individuals with conditions as diverse as IBS, anxiety, depression and Alzheimer's disease.
C1 [Lawrence, Kate] St Marys Univ, Dept Psychol, Twickenham, England.
   [Hyde, Jeannette] Nutr Therapy CNHC mBANT, Twickenham, England.
RP Lawrence, K (reprint author), St Marys Univ, Dept Psychol, Twickenham, England.
EM Kate.lawrence@stmarys.ac.uk
CR Beaumont M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1052-7
   Bennet SMP, 2015, GUT LIVER, V9, P318, DOI 10.5009/gnl14344
   Benton D, 2007, EUR J CLIN NUTR, V61, P355, DOI 10.1038/sj.ejcn.1602546
   Bredesen DE, 2016, AGING-US, V8, P1250, DOI 10.18632/aging.100981
   Bredesen DE, 2014, AGING-US, V6, P707, DOI 10.18632/aging.100690
   Breton J, 2016, CELL METAB, V23, P324, DOI 10.1016/j.cmet.2015.10.017
   Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001
   Clarke Siobhan F, 2012, Gut Microbes, V3, P186, DOI 10.4161/gmic.20168
   Collins SM, 2014, NAT REV GASTRO HEPAT, V11, P497, DOI 10.1038/nrgastro.2014.40
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Despres JP, 2012, CIRCULATION, V126, P1301, DOI 10.1161/CIRCULATIONAHA.111.067264
   Didari T, 2015, WORLD J GASTROENTERO, V21, P3072, DOI 10.3748/wjg.v21.i10.3072
   DRISSI F, 2016, MICROB PATHOG
   Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06
   Flint HJ, 2012, NUTR REV, V70, pS10, DOI 10.1111/j.1753-4887.2012.00499.x
   Furukawa TA, 2016, LANCET PSYCHIAT, V3, P1059, DOI 10.1016/S2215-0366(16)30307-8
   Gargari G, 2016, APPL ENVIRON MICROB, V82, P5850, DOI 10.1128/AEM.01753-16
   Goffredo M, 2016, J CLIN ENDOCR METAB, V101, P4367, DOI 10.1210/jc.2016-1797
   Gwiazdowska D, 2015, ACTA BIOCHIM POL, V62, P895, DOI 10.18388/abp.2015_1154
   Hoban AE, 2016, NEUROSCIENCE, V339, P463, DOI 10.1016/j.neuroscience.2016.10.003
   Holscher HD, 2015, AM J CLIN NUTR, V101, P55, DOI 10.3945/ajcn.114.092064
   Hu X, 2016, SCI CHINA LIFE SCI, V59, P1006, DOI 10.1007/s11427-016-5083-9
   Hyde J., 2015, THE GUT MAKEOVER
   Jones DQS., 2006, TXB FUNCTIONAL MED
   Kristensen NB, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0300-5
   Lambeth Stacey M, 2015, J Diabetes Obes, V2, P1
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Luczynski P, 2016, EUR J NEUROSCI, V44, P2654, DOI 10.1111/ejn.13291
   Maffei VJ, 2017, J GERONTOL A BIOL SC
   Mezzasalma V, 2016, BIOMED RES INT, DOI 10.1155/2016/4740907
   Midha A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00144
   Monnikes H, 2011, J CLIN GASTROENTEROL, V45, pS98, DOI 10.1097/MCG.0b013e31821fbf44
   Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x
   Pedersen C, 2016, BRIT J NUTR, V116, P1869, DOI 10.1017/S0007114516004086
   Pirbaglou M, 2016, NUTR RES, V36, P889, DOI 10.1016/j.nutres.2016.06.009
   Plumed-Ferrer C, 2008, APPL ENVIRON MICROB, V74, P5349, DOI 10.1128/AEM.00324-08
   Ranganathan N. J. G. R, 2012, GASTROENTEROLOGY RES, P1, DOI DOI 10.1155/2012/872716
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Shi Lye Huey, 2016, Trop Life Sci Res, V27, P73, DOI 10.21315/tlsr2016.27.2.6
   Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003
   Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846
   Tomas-Aragones L, 2016, ACTA DERM-VENEREOL, V96, P47, DOI 10.2340/00015555-2368
   Tun HM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0254-x
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Ursell LK, 2012, J ALLERGY CLIN IMMUN, V129, P1204, DOI 10.1016/j.jaci.2012.03.010
   Vanamala JKP, 2015, CELL METAB, V22, P960, DOI 10.1016/j.cmet.2015.11.009
   Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118
   Whorwell PJ, 2006, AM J GASTROENTEROL, V101, P1581, DOI 10.1111/j.1572-0241.2006.00734.x
   Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783
   Zarrinpar A, 2014, CELL METAB, V20, P1006, DOI 10.1016/j.cmet.2014.11.008
   Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001
NR 52
TC 8
Z9 9
U1 3
U2 40
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 14
PY 2017
VL 12
IS 6
AR e0179017
DI 10.1371/journal.pone.0179017
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EX5KN
UT WOS:000403280900029
PM 28614379
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Li, JP
   Xu, ZN
AF Li, Jianping
   Xu, Zhennan
TI RETRACTED: Simultaneous dual-color light sheet fluorescence imaging flow
   cytometry for high-throughput marine phytoplankton analysis (Retracted
   article. See vol. 25, pg. 20033, 2017)
SO OPTICS EXPRESS
LA English
DT Article; Retracted Publication
ID IN-FLOW; MICROSCOPY; CELL; DISCRIMINATION; CLASSIFICATION;
   MICROPLANKTON; ENUMERATION; FLOWCYTOBOT
AB This paper reports the development of a dual-color light sheet fluorescence imaging flow cylometer exclusively designed for rapid phytoplankton analysis. By simultaneously exciting chlorophyll and phycoerythrin fluorescence, the system is enabled to discriminate phycoerythrin-containing and phycoerythrin-lacking phytoplankton groups through simultaneous two-channel spectral imaging-in-flow. It is demonstrated the system has good sensitivity and resolution to detect picophytoplankton down to the size of similar to 1 mu m high throughput of 1.3 x 10(5) cells/s and 5 x 10(3) cells/s at 100 mu/min and 3mL/min volume flow rates for cultured picophytoplankton and nanophytoplankton detection, respectively, and a broad imaging range from similar to 1 mu m up to 300nm covering most marine phytoplankton cell sizes with just one 40 x objective. The simultaneous realization of high resolution, high sensitivity and high throughput with spectral resolving power of the system is expected to promote the technology towards more practical applications that demand automated phytoplankton analysis. (C) 2017 Optical Society of America
C1 [Li, Jianping] Chinese Acad Sci, Shenzhen Inst Adv Technol, 1068 Xueyuan Blvd, Shenzhen 518055, Peoples R China.
   [Li, Jianping; Xu, Zhennan] Hong Kong Baptist Univ, Dept Phys, 224 Waterloo Rd, Kowloon Tong, Hong Kong, Peoples R China.
RP Li, JP (reprint author), Chinese Acad Sci, Shenzhen Inst Adv Technol, 1068 Xueyuan Blvd, Shenzhen 518055, Peoples R China.; Li, JP (reprint author), Hong Kong Baptist Univ, Dept Phys, 224 Waterloo Rd, Kowloon Tong, Hong Kong, Peoples R China.
EM jianping_li@live.cn
FU Research Grants Council of the Hong Kong SAR of PR. China
   [HKBU12201214]; Hong Kong Baptist University [FRG2/14-15/098]; National
   Key Research and Development Program of China [2016YFC1400700]
FX Research Grants Council of the Hong Kong SAR of PR. China
   (HKBU12201214); Hong Kong Baptist University (FRG2/14-15/098); National
   Key Research and Development Program of China (2016YFC1400700).
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   [Anonymous], 2017, AFFINE TRANSFORMATIO
   Basiji D, 2007, I S BIOMED IMAGING, P1100, DOI 10.1109/ISBI.2007.357048
   Chen W, 2009, J MICROBIOL METH, V77, P41, DOI 10.1016/j.mimet.2009.01.001
   Cloern JE, 1996, REV GEOPHYS, V34, P127, DOI 10.1029/96RG00986
   Collier JL, 2000, J PHYCOL, V36, P628, DOI 10.1046/j.1529-8817.2000.99215.x
   Dashkova V, 2017, METHODS, V112, P188, DOI 10.1016/j.ymeth.2016.05.007
   Dubelaar GBJ, 1999, CYTOMETRY, V37, P247, DOI 10.1002/(SICI)1097-0320(19991201)37:4<247::AID-CYTO1>3.0.CO;2-9
   Erickson JS, 2012, ANAL CHEM, V84, P839, DOI 10.1021/ac201623k
   EVANS GT, 1988, LIMNOL OCEANOGR, V33, P1027, DOI 10.4319/lo.1988.33.5.1027
   George TC, 2004, CYTOM PART A, V59A, P237, DOI 10.1002/cyto.a.20048
   Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024
   Gualda EJ, 2017, CYTOM PART A, V91A, P144, DOI 10.1002/cyto.a.23046
   Hecke K. v., 2016, NEW CAMERA UPGRADE P
   Hildebrand M, 2016, METHODS MOL BIOL, P47, DOI 10.1007/978-1-4939-3302-0_4
   Lai QTK, 2016, OPT EXPRESS, V24, P28170, DOI 10.1364/OE.24.028170
   Lebaron P, 1998, APPL ENVIRON MICROB, V64, P1725
   Lei C, 2016, BIOMED OPT EXPRESS, V7, P2703, DOI 10.1364/BOE.7.002703
   Millipore Merk, 2017, IMAGESTREAM 10 MARK
   Olson RJ, 2003, DEEP-SEA RES PT I, V50, P301, DOI 10.1016/S0967-0637(03)00003-7
   OLSON RJ, 1989, CYTOMETRY, V10, P636, DOI 10.1002/cyto.990100520
   Olson RJ, 2007, LIMNOL OCEANOGR-METH, V5, P195, DOI 10.4319/lom.2007.5.195
   Ortyn WE, 2007, CYTOM PART A, V71A, P215, DOI 10.1002/cyto.a.20370
   Paie P, 2016, LAB CHIP, V16, P1556, DOI 10.1039/c6lc00084c
   PHINNEY DA, 1989, CYTOMETRY, V10, P511, DOI 10.1002/cyto.990100506
   Reynaud EG, 2015, NAT METHODS, V12, P30, DOI 10.1038/nmeth.3222
   Sage D, 2017, METHODS, V115, P28, DOI 10.1016/j.ymeth.2016.12.015
   SCHUBERT H, 1989, J PLANKTON RES, V11, P353, DOI 10.1093/plankt/11.2.353
   Sieracki CK, 1998, MAR ECOL PROG SER, V168, P285, DOI 10.3354/meps168285
   Singh AP, 2013, OPT EXPRESS, V21, P8652, DOI 10.1364/OE.21.008652
   Troussellier M, 1999, FEMS MICROBIOL ECOL, V29, P319, DOI 10.1016/S0168-6496(99)00026-4
   Wang JJ, 2014, DEEP-SEA RES PT II, V101, P120, DOI 10.1016/j.dsr2.2013.09.020
   Wu JL, 2013, OPT EXPRESS, V21, P23921, DOI 10.1364/OE.21.023921
   Wu JL, 2013, OPT EXPRESS, V21, P14474, DOI 10.1364/OE.21.014474
   Yourassowsky C, 2014, OPT EXPRESS, V22, P6661, DOI 10.1364/OE.22.006661
   Zetsche EM, 2014, LIMNOL OCEANOGR-METH, V12, P757, DOI 10.4319/lom.2014.12.757
   Zubkov M, 2007, J PLANKTON RES, V29, P79
NR 37
TC 2
Z9 2
U1 4
U2 9
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD JUN 12
PY 2017
VL 25
IS 12
BP 13602
EP 13616
DI 10.1364/OE.25.013602
PG 15
WC Optics
SC Optics
GA EY4IX
UT WOS:000403942300070
PM 28788903
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Grilli, G
   Longo, S
   Huais, PY
   Pereyra, M
   Verga, E
   Urcelay, C
   Galetto, L
AF Grilli, G.
   Longo, S.
   Huais, P. Y.
   Pereyra, M.
   Verga, E.
   Urcelay, C.
   Galetto, L.
TI RETRACTED: Fungal diversity is negatively affected by habitat
   fragmentation: a meta-analysis (Retracted article. See vol. 37, pg. R1,
   2017)
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review; Retracted Publication
ID MYCORRHIZAL FUNGI; ECTOMYCORRHIZAL FUNGI; FOREST FRAGMENTATION; CENTRAL
   ARGENTINA; BOREAL FORESTS; COMMUNITIES; BIODIVERSITY; LANDSCAPE;
   CONSERVATION; ABUNDANCE
AB Fungi are ubiquitous organisms around the world with important roles in ecosystem functioning and services, but knowledge about how habitat fragmentation affect fungal diversity is spread in different trophic groups, studied regions and experimental approaches. We performed a meta-analysis to synthesize the available information to glimpse general patterns of habitat fragmentation effects on fungal diversity. The habitat fragmentation process consistently affect fungal diversity through isolation, area size and increasing edge proportion, albeit this trend may differ between both the type of response variable and fungal groups with different nutritional habits. Together, this knowledge may allow designing accurate strategies for sustainable land uses and landscape management in face of worldwide habitat fragmentation.
C1 [Grilli, G.; Longo, S.; Huais, P. Y.; Pereyra, M.; Verga, E.; Urcelay, C.; Galetto, L.] Univ Nacl Cordoba, CONICET, FCEFyN, Inst Multidisciplinario Biol Vegetal, Velez Sarsfield 1611,CC 495, Cordoba, Argentina.
RP Grilli, G (reprint author), Univ Nacl Cordoba, CONICET, FCEFyN, Inst Multidisciplinario Biol Vegetal, Velez Sarsfield 1611,CC 495, Cordoba, Argentina.
EM ggrilli@imbiv.unc.edu.ar
FU Fondo para la Investigation Cientifica y Tecnologica (FONCyT);
   Secretaria de Ciencia y Tecnica or the Universidad Nacional de Cordoba
   (SECyT - UNC); Consejo Nacional de Investigaciones Centificas y Tecnicas
   (CONICET)
FX We thank M C. Silva-Filho & J. Vivanco for the invitation to write this
   review. This work was funded by Fondo para la Investigation Cientifica y
   Tecnologica (FONCyT), Secretaria de Ciencia y Tecnica or the Universidad
   Nacional de Cordoba (SECyT - UNC) and Consejo Nacional de
   Investigaciones Centificas y Tecnicas (CONICET).
CR Abrego N, 2015, FUNGAL ECOL, V15, P82, DOI 10.1016/j.funeco.2015.01.005
   Abrego N, 2014, FUNGAL ECOL, V8, P18, DOI 10.1016/j.funeco.2013.12.007
   Avelino J, 2012, ECOL APPL, V22, P584, DOI 10.1890/11-0869.1
   Crockatt Martha E., 2012, Fungal Biology Reviews, V26, P94, DOI 10.1016/j.fbr.2012.08.002
   Davison J, 2015, SCIENCE, V349, P970, DOI 10.1126/science.aab1161
   De Casenave JL, 1998, AUK, V115, P425, DOI 10.2307/4089201
   Didham RK, 2012, OIKOS, V121, P161, DOI 10.1111/j.1600-0706.2011.20273.x
   Drinnan IN, 2005, BIOL CONSERV, V124, P339, DOI 10.1016/j.biocon.2005.01.040
   Grez A.A., 2011, CONSERVACION BIOL PE, P63
   Grilli G, 2014, PLANT ECOL, V215, P1513, DOI 10.1007/s11258-014-0410-3
   Grilli G, 2013, FOREST ECOL MANAG, V310, P442, DOI 10.1016/j.foreco.2013.08.052
   Grilli G, 2015, ENVIRON MICROBIOL, V17, P2709, DOI 10.1111/1462-2920.12623
   Grilli G, 2012, PLANT ECOL, V213, P155, DOI 10.1007/s11258-011-9966-3
   Gurevitch J, 2001, DESIGN ANAL ECOLOGIC, P347
   Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052
   Helander M, 2007, NEW PHYTOL, V175, P547, DOI 10.1111/j.1469-8137.2007.02110.x
   Hottola J, 2009, J ECOL, V97, P1320, DOI 10.1111/j.1365-2745.2009.01583.x
   Keinath DA, 2017, GLOBAL ECOL BIOGEOGR, V26, P115, DOI 10.1111/geb.12509
   Kranabetter JM, 2013, FUNGAL ECOL, V6, P430, DOI 10.1016/j.funeco.2013.05.001
   Lindenmayer D. B., 2013, HABITAT FRAGMENTATIO
   Longo S, 2016, FUNG BIOL-US, P81, DOI 10.1007/978-3-319-24355-9_7
   Mengersen K., 2013, HDB METAANALYSIS ECO, P89
   Moora M, 2014, FEMS MICROBIOL ECOL, V90, P609, DOI 10.1111/1574-6941.12420
   Mueller GM, 2011, BIODIVERSITY FUNGI I
   Nguyen NH, 2016, FUNGAL ECOL, V20, P241, DOI 10.1016/j.funeco.2015.06.006
   Norden J, 2013, J ECOL, V101, P701, DOI 10.1111/1365-2745.12085
   NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x
   Olsson J, 2011, BIOL CONSERV, V144, P1100, DOI 10.1016/j.biocon.2010.12.029
   Peay KG, 2007, ECOL LETT, V10, P470, DOI 10.1111/j.1461-0248.2007.01035.x
   Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138
   Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005
   Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770
   Siitonen P, 2005, CONSERV BIOL, V19, P250, DOI 10.1111/j.1523-1739.2005.00232.x
   Team R. C., 2016, R LANG ENV STAT COMP
   Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x
   Vannette RL, 2016, ECOLOGY, V97, P2374, DOI 10.1002/ecy.1472
   Viechtbauer W, 2010, METAFOR METAANALYSIS
   Watson JEM, 2004, BIOL CONSERV, V120, P311, DOI 10.1016/j.biocon.2004.03.004
   Ylisirnio AL, 2016, FOREST ECOL MANAG, V373, P138, DOI 10.1016/j.foreco.2016.04.042
NR 39
TC 1
Z9 1
U1 4
U2 15
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
EI 1879-0364
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD JUN
PY 2017
VL 37
BP 61
EP 66
DI 10.1016/j.mib.2017.03.015
PG 6
WC Microbiology
SC Microbiology
GA FO1EM
UT WOS:000416499500012
PM 28578292
DA 2018-12-27
ER

PT J
AU Askri, H
   Gharbi, F
   Rejeb, S
   Mliki, A
   Ghorbel, A
AF Askri, Hend
   Gharbi, Fatma
   Rejeb, Saloua
   Mliki, Ahmed
   Ghorbel, Abdelwahed
TI RETRACTED: Physiological comparative study of six wild grapevine (Vitis
   sylvestris) accession responses to salinity (Retracted article. See vol.
   10, Artn 402, 2017)
SO ARABIAN JOURNAL OF GEOSCIENCES
LA English
DT Article; Retracted Publication
DE Grapevine; Saline irrigation; Physiological mechanisms; Crop tolerance
ID VINIFERA L.; GROWTH; ROOTSTOCKS; PLANTS; TOLERANCE; STRESS; NACL
AB Salinity problems for vineyards are in concerns, especially in coastal areas where several aquifers are reported to be affected by seawater intrusion and agricultural contamination. Saline irrigation affects growth, yield, and fruit quality of grapevines. Exploring germplasm base through wild ancestors of the target species is a novel adopted strategy to increase crop tolerance to irrigation with saline water. The effects of salt on growth, organic and inorganic solute accumulations, and chlorophyll florescence were studied on 3-month-old plants of six Tunisian wild grapevines with the objective to identify salt tolerance mechanisms and select tolerant genotypes. Potted plants were grown under controlled conditions and irrigated for 14 days with 0, 100, and 150 mM NaCl nutrient solution. Parameters analyzed were related to growth, water relations, mineral nutrition, and chlorophyll fluorescence. Several processes are operating either at the whole plant or at cell level. They appear to be involved in salt tolerance of wild grapevines and are more efficient in tolerant accessions. Salt adversely affects plant growth and plant nutrition. Reductions of shoot growth rate (relative growth rate, day(-1)) reached 49% of control since 100 mM NaCl. They were assigned to stomatal closure and alteration of potassium nutrition and photochemistry. There were significant differences (P < 0.05) within accessions, Tebaba was the most tolerant and Houamdia the most sensitive, while the others were intermediate.
C1 [Askri, Hend; Rejeb, Saloua] Eaux & Forets INRGREF, Inst Natl Rech Genie Rural, BP 10, Ariana 2080, Tunisia.
   [Gharbi, Fatma] Fac Sci Tunis, Tunis 2092, Tunisia.
   [Mliki, Ahmed; Ghorbel, Abdelwahed] CBBC, BP 901, Hammam Iif 2050, Tunisia.
RP Askri, H (reprint author), Eaux & Forets INRGREF, Inst Natl Rech Genie Rural, BP 10, Ariana 2080, Tunisia.
EM askri.hend@yahoo.fr
CR Ashraf M, 1999, ANN APPL BIOL, V135, P509, DOI 10.1111/j.1744-7348.1999.tb00881.x
   Askri H, 2012, ACTA PHYSIOL PLANT, V34, P957, DOI 10.1007/s11738-011-0892-8
   Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196
   BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060
   BINZEL ML, 1988, PLANT PHYSIOL, V86, P607, DOI 10.1104/pp.86.2.607
   Bjorkman O, 1994, ECOPHYSIOLOGY PHOTOS, P17
   CHARTZOULAKIS KS, 1995, IRRIGATION SCI, V16, P23
   Chone X, 2001, ANN BOT-LONDON, V87, P477, DOI 10.1006/anbo.2000.1361
   Daldoul S, 2010, PLANT SCI, V179, P489, DOI 10.1016/j.plantsci.2010.07.017
   Dardeniz A, 2006, BANGLADESH J BOTANY, V35, P143
   Fisarakis I, 2001, AGR WATER MANAGE, V51, P13, DOI 10.1016/S0378-3774(01)00115-9
   GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9
   Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463
   Hunt R, 1990, BASIC GROWTH ANAL
   Jiang QZ, 2006, FIELD CROP RES, V96, P269, DOI 10.1016/j.fcr.2005.07.010
   JOHANSEN C, 1970, PLANT PHYSIOL, V45, P601, DOI 10.1104/pp.45.5.601
   Moutinho-Pereira JM, 2001, VITIS, V40, P117
   Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911
   SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185
   Schreiber U, 1995, ECOPHYSIOLOGY PHOTOS, P49, DOI DOI 10.1007/978-3-642-79354-7_3
   Serraj R, 2002, PLANT CELL ENVIRON, V25, P333, DOI 10.1046/j.1365-3040.2002.00754.x
   Shani U, 2005, AM J ENOL VITICULT, V56, P148
   SHARP RE, 1979, PLANTA, V147, P43, DOI 10.1007/BF00384589
   Staub AM, 1963, TECHNIQUES LAB, V1, P1307
   Upreti KK, 2010, BIOL PLANTARUM, V54, P730, DOI 10.1007/s10535-010-0130-z
   Urdanoz V, 2009, PLANT SOIL, V324, P219, DOI 10.1007/s11104-009-9948-6
NR 26
TC 1
Z9 1
U1 7
U2 18
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1866-7511
EI 1866-7538
J9 ARAB J GEOSCI
JI Arab. J. Geosci.
PD JUN
PY 2017
VL 10
IS 11
AR 246
DI 10.1007/s12517-017-3041-x
PG 8
WC Geosciences, Multidisciplinary
SC Geology
GA EY1IQ
UT WOS:000403720000015
DA 2018-12-27
ER

PT J
AU Salminen, M
   Vire, J
   Viikari, L
   Vahlberg, T
   Isoaho, H
   Lehtonen, A
   Viitanen, M
   Arve, S
   Eloranta, S
AF Salminen, Marika
   Vire, Jenni
   Viikari, Laura
   Vahlberg, Tero
   Isoaho, Hannu
   Lehtonen, Aapo
   Viitanen, Matti
   Arve, Seija
   Eloranta, Sini
TI RETRACTED: Predictors of institutionalization among home-dwelling older
   Finnish people: a 22-year follow-up study (Retracted article. See vol.
   29, pg. 507, 2017)
SO AGING CLINICAL AND EXPERIMENTAL RESEARCH
LA English
DT Article; Retracted Publication
DE Institutionalization; Predictor; Older people; Elderly
ID HIGHLY EDUCATED INDIVIDUALS; MINI-MENTAL-STATE; BODY-MASS INDEX;
   NURSING-HOME; DEMENTIA; ADULTS; RISK; DIAGNOSIS; MORTALITY; ADMISSION
AB Background Identification of predictive factors on institutionalization provides the basis for the development and application of preadmission assessment. There is a lack of evidence for predictors of institutionalization for older people.
   Aims To examine the effect of predictive factors on institutionalization in home-dwelling 70-year-old people.
   Methods The data were collected in 1991 by the clinical examinations, a postal questionnaire, and an interview from the residents of Turku, Finland, born in 1920 (n = 1032). Institutionalization was defined as entry into a nursing home or sheltered housing at any time during a 22-year follow-up.
   Results A rate of institutionalization was 22.0%. In multivariable Cox regression analysis, impaired cognitive function (MMSE 18-26) (hazard ratio 1.71, confidence interval 1.24-2.36) and low BMI (< 25 kg/m(2)) (compared to both BMI of 25-29.9 and that of >= 30, respectively, 1.88, 1.32-2.67, and 1.66, 1.05-2.60), having several falls during the previous year (2.50, 1.28-4.90).
   Conclusions We conclude that impaired cognitive function, low BMI, and frequent falling predicted institutionalization during the 22-year follow-up. To reduce or postpone institutionalization, interventions should target risk factors, such as frailty, physical limitations, and falling. In addition, community-based services according to the needs and functional ability of the home-dwelling older people should be developed.
C1 [Salminen, Marika] Univ Turku, Fac Med, Unit Family Med, Lemminkaisenkatu 1, Turku 20014, Finland.
   [Salminen, Marika] City Turku, Div Welf, Yliopistonkatu 30, Turku, Finland.
   [Vire, Jenni; Viikari, Laura; Lehtonen, Aapo; Viitanen, Matti] Univ Turku, Dept Geriatr, Fac Med, Kunnallissairaalantie 20, Turku, Finland.
   [Vahlberg, Tero] Univ Turku, Inst Clin Med, Biostat, Turku, Finland.
   [Isoaho, Hannu] Statcon Ltd, Savenvalajankatu 3 B 25, Turku, Finland.
   [Viitanen, Matti] Karolinska Inst, Div Clin Geriatr, Karolinska Univ Hosp, S-14186 Stockholm, Sweden.
   [Arve, Seija; Eloranta, Sini] Univ Turku, Dept Nursing Sci, Fac Med, Lemminkaisenkatu 1, Turku, Finland.
   [Eloranta, Sini] Hosp Dist Southwest Finland, Kiinanmyllynkatu 4-8, Turku, Finland.
RP Salminen, M (reprint author), Univ Turku, Fac Med, Unit Family Med, Lemminkaisenkatu 1, Turku 20014, Finland.; Salminen, M (reprint author), City Turku, Div Welf, Yliopistonkatu 30, Turku, Finland.
EM majosa@utu.fi
FU EVO funding of the city of Turku/Welfare Division; Red Feather Campaign
   of the Nordic Lions Club; King Gustav V and Queen Victoria Foundation
FX The study was financially supported by EVO funding of the city of
   Turku/Welfare Division, Red Feather Campaign of the Nordic Lions Club,
   and King Gustav V and Queen Victoria Foundation.
CR Aguero-Torres H, 2001, J CLIN EPIDEMIOL, V54, P795, DOI 10.1016/S0895-4356(00)00371-1
   Alley DE, 2008, J GERONTOL A-BIOL, V63, P1257, DOI 10.1093/gerona/63.11.1257
   Andel R, 2007, J AGING HEALTH, V19, P213, DOI 10.1177/0898264307299359
   Auyeung TW, 2010, J GERONTOL A-BIOL, V65, P99, DOI 10.1093/gerona/glp099
   Bravell ME, 2009, AGING CLIN EXP RES, V21, P329
   Channon A, 2006, WILL THERE BE ENOUGH
   Dunn J E, 1993, J Aging Health, V5, P194, DOI 10.1177/089826439300500203
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13
   Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3
   Gnjidic D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046061
   Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x
   Jefferis BJ, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-114
   Kendrick D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009848.pub2
   Locher JL, 2007, J GERONTOL A-BIOL, V62, P1389, DOI 10.1093/gerona/62.12.1389
   Luppa M, 2008, DEMENT GERIATR COGN, V26, P65, DOI 10.1159/000144027
   Luppa M, 2012, SOC PSYCH PSYCH EPID, V47, P263, DOI 10.1007/s00127-010-0333-9
   Luppa M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-186
   Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202
   Mahler M, 2014, SCAND J PUBLIC HEALT, V42, P36, DOI 10.1177/1403494814556648
   McTigue KM, 2006, OBESITY, V14, P1485, DOI 10.1038/oby.2006.171
   Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022
   O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963
   Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891
   Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0
   Spering CC, 2012, J GERONTOL A-BIOL, V67, P890, DOI 10.1093/gerona/gls006
   Tilastokeskus, 2014, SUOM TIL VUOS 2014
   Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806
   von Bonsdorff M, 2006, GERONTOLOGY, V52, P359, DOI 10.1159/000094985
   ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63
NR 30
TC 5
Z9 5
U1 2
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1594-0667
EI 1720-8319
J9 AGING CLIN EXP RES
JI Aging Clin. Exp. Res.
PD JUN
PY 2017
VL 29
IS 3
BP 499
EP 505
DI 10.1007/s40520-016-0722-3
PG 7
WC Geriatrics & Gerontology
SC Geriatrics & Gerontology
GA EW1HY
UT WOS:000402241800020
PM 28213740
DA 2018-12-27
ER

PT J
AU Maquart, G
   Astier, A
   Ducoin, C
   Guinet, D
   Stezowski, O
   Augey, L
   Chaix, L
   Companis, I
   Dudouet, J
   Lehaut, G
   Mancuso, C
   Redon, N
   Vancraeyenest, A
AF Maquart, G.
   Astier, A.
   Ducoin, C.
   Guinet, D.
   Stezowski, O.
   Augey, L.
   Chaix, L.
   Companis, I.
   Dudouet, J.
   Lehaut, G.
   Mancuso, C.
   Redon, N.
   Vancraeyenest, A.
TI RETRACTED: Backbending in the Th-223(90) nucleus: presentation of the
   consistency of two different experiments (Retracted article. See vol.
   93, artn. 039701, 2018)
SO PHYSICA SCRIPTA
LA English
DT Article; Retracted Publication
DE nuclear structure; nuclear deformations; collective models
ID REFLECTION-ASYMMETRIC SHAPES; OCTUPOLE DEFORMATION; HIGH-SPIN; PARITY
   DOUBLETS; GE DETECTORS; TH-ISOTOPES; CONSEQUENCES; TH-222
AB The detailed level structure of (223)th has been investigated in measurements of gamma radiations following the fusion-evaporation channel of the Pb-208(O-18, 3n) Th-223 reaction at 85MeV beam energy. The present data are extracted from two different experiments performed with the EUROBALL IV and JUROGAM II gamma-ray detector array, respectively. The level structure has been extended up to spin 49 2 and 33 new gamma-rays have been added using triple-gamma coincidence data. The spins and parities of the newly observed states have been confirmed by angular distribution ratios. In addition to the two known yrast bands based on a K = 5/2 configuration, a non-yrast band has been established up to spin 35/2. This observation has brought to light a sharp backbending occuring at the highest spins promoting the Th-223 as the heavier thorium isotope having an accident observed in its moment of inertia at high spin. We interpret this new structure as based on the same configuration as the yrast band in Th-221 having dominant K = 1/2 contribution. At the highest spin a backbending occurs around a rotational frequency of hw= 0.23 MeV, very close to the one predicted in the Th-222 where a sharp transition to a reflection-symmetric shape is expected.
C1 [Maquart, G.; Ducoin, C.; Guinet, D.; Stezowski, O.; Augey, L.; Chaix, L.; Companis, I.; Dudouet, J.; Lehaut, G.; Mancuso, C.; Redon, N.; Vancraeyenest, A.] Univ Lyon, UCBL, CNRS, IPNL,IN2P3, F-69622 Villeurbanne, France.
   [Astier, A.] Univ Paris 11, CNRS, CSNSM, IN2P3, F-91405 Orsay, France.
   [Augey, L.; Lehaut, G.] Univ Caen, CNRS, IN2P3, LPC,ENSICAEN, F-14050 Caen, France.
   [Chaix, L.] Stanford Univ, Stanford, CA 94305 USA.
RP Maquart, G (reprint author), Univ Lyon, UCBL, CNRS, IPNL,IN2P3, F-69622 Villeurbanne, France.
EM g.maquart@ipnl.in2p3.fr
FU EU [HPRI-CT-1999-00078]; EU-FP7 Integrating Activities Project ENSAR
   [262010]; Academy of Finland; University of Jyvaskyla within the Centre
   of Excellence program
FX The authors thank all the persons having participated in the EB-02/17
   EUROBALL IV experiment devoted to the fission fragments, in which the
   data on <SUP>223</SUP>Th were recorded. The EUROBALL project was a
   collaboration between France, United Kingdom, Germany, Italy, Denmark
   and Sweden. This work was supported in part by the EU contract
   HPRI-CT-1999-00078. We thank also all the persons having participated in
   the JUROGAM II experiment labelled as J16 whose first aim was to study
   the 'alpha + <SUP>208</SUP>Pb' structure. We Acknowledge F Azaiez, S
   Courtin, D Curien, I Deloncle, O Dorvaux, G Duchene, B Gall, T Grahn, P
   Greenlees, A Herzan, K Hauschild, U Jakobsson, P Jones, R Julin, S
   Juutinen, S Ketelhut, M Leino, A Lopez-Martens, P Nieminen, P Petkov, P
   Peura, M-G Porquet, P Rahkila, S Rinta-Antila, M Rousseau, P
   Ruotsalainen, M Sandzelius, J Saren, C Scholey, J Sorri, S Stolze and J
   Uusitalo for their participation in the J16/EB-02 experiment. If it were
   not for the first results on <SUP>223</SUP>Th found in the J16
   experiment, we would have not worked on the EUROBALL IV dataset. The
   authors also thank the GAMMAPOOL European Spectroscopy Resource for the
   loan of the detectors for the JUROGAM II array. This work was partially
   supported by the EU-FP7 Integrating Activities Project ENSAR (No.
   262010), by the Academy of Finland and University of Jyvaskyla within
   the Centre of Excellence program.
CR Agbemava SE, 2016, PHYS REV C, V93, DOI 10.1103/PhysRevC.93.044304
   AHMAD SA, 1983, PHYS LETT B, V133, P47, DOI 10.1016/0370-2693(83)90103-X
   Amzal N, 1999, ACTA PHYS POL B, V30, P681
   Astier A, 2010, EUR PHYS J A, V46, P165, DOI 10.1140/epja/i2010-11053-6
   Astier A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.042701
   Astier A, 2011, IMAGES PHYS, P81
   BENGTSSON R, 1979, NUCL PHYS A, V327, P139, DOI 10.1016/0375-9474(79)90322-1
   Butler PA, 2016, J PHYS G NUCL PARTIC, V43, DOI 10.1088/0954-3899/43/7/073002
   Butler PA, 1996, REV MOD PHYS, V68, P349, DOI 10.1103/RevModPhys.68.349
   CHASMAN RR, 1980, PHYS LETT B, V96, P7, DOI 10.1016/0370-2693(80)90199-9
   CWIOK S, 1989, PHYS LETT B, V224, P5, DOI 10.1016/0370-2693(89)91039-3
   CWIOK S, 1991, NUCL PHYS A, V529, P95, DOI 10.1016/0375-9474(91)90787-7
   DAHLINGER M, 1988, NUCL PHYS A, V484, P337, DOI 10.1016/0375-9474(88)90076-0
   Duchene G, 1999, NUCL INSTRUM METH A, V432, P90, DOI 10.1016/S0168-9002(99)00277-6
   Eberth J, 1996, NUCL INSTRUM METH A, V369, P135, DOI 10.1016/0168-9002(95)00794-6
   FERNANDEZNIELLO J, 1991, NUCL PHYS A, V531, P164, DOI 10.1016/0375-9474(91)90575-Q
   Frauendorf S, 2008, PHYS REV C, V77, DOI 10.1103/PhysRevC.77.021304
   Frauendorf S, 2001, REV MOD PHYS, V73, P463, DOI 10.1103/RevModPhys.73.463
   Gaffney LP, 2013, NATURE, V497, P199, DOI 10.1038/nature12073
   HUGHES JR, 1990, NUCL PHYS A, V512, P275, DOI 10.1016/0375-9474(90)93272-8
   Kalaninova Z, 2015, PHYS REV C, V92, DOI 10.1103/PhysRevC.92.014321
   Li ZP, 2016, J PHYS G NUCL PARTIC, V43, DOI 10.1088/0954-3899/43/2/024005
   Li ZP, 2013, PHYS LETT B, V726, P866, DOI 10.1016/j.physletb.2013.09.035
   Naviliat-Cuncic O, 1991, J PHYS G, V17, P145
   NAZAREWICZ W, 1985, NUCL PHYS A, V441, P420, DOI 10.1016/0375-9474(85)90154-X
   NAZAREWICZ W, 1987, NUCL PHYS A, V467, P437, DOI 10.1016/0375-9474(87)90539-2
   NAZAREWICZ W, 1984, PHYS REV LETT, V52, P1272, DOI 10.1103/PhysRevLett.52.1272
   RADFORD DC, 1995, NUCL INSTRUM METH A, V361, P297, DOI 10.1016/0168-9002(95)00183-2
   Reviol W, 2014, PHYS REV C, V90, DOI 10.1103/PhysRevC.90.044318
   Reviol W, 2009, PHYS REV C, V80, DOI 10.1103/PhysRevC.80.011304
   SCHULER P, 1986, PHYS LETT B, V174, P241, DOI 10.1016/0370-2693(86)91091-9
   Simpson J, 1997, Z PHYS A-HADRON NUCL, V358, P139, DOI 10.1007/s002180050290
   SMITH JF, 1995, PHYS REV LETT, V75, P1050, DOI 10.1103/PhysRevLett.75.1050
   Tandel SK, 2013, PHYS REV C, V87, DOI 10.1103/PhysRevC.87.034319
   Urban W, 2001, ACTA PHYS POL B, V32, P2527
   von Brentano P, 2004, PHYS REV C, V69, DOI 10.1103/PhysRevC.69.044314
NR 36
TC 0
Z9 0
U1 1
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0031-8949
EI 1402-4896
J9 PHYS SCRIPTA
JI Phys. Scr.
PD JUN
PY 2017
VL 92
IS 6
AR 064004
DI 10.1088/1402-4896/aa6e8b
PG 11
WC Physics, Multidisciplinary
SC Physics
GA EW5GO
UT WOS:000402534000001
DA 2018-12-27
ER

PT J
AU Schaefer, KA
   Wu, WH
   Colgan, DF
   Tsang, SH
   Bassuk, AG
   Mahajan, VB
AF Schaefer, Kellie A.
   Wu, Wen-Hsuan
   Colgan, Diana F.
   Tsang, Stephen H.
   Bassuk, Alexander G.
   Mahajan, Vinit B.
TI RETRACTED: Unexpected mutations after CRISPR-Cas9 editing in vivo
   (Retracted article. See vol. 14, pg. 547, 2017)
SO NATURE METHODS
LA English
DT Letter; Retracted Publication
C1 [Schaefer, Kellie A.; Colgan, Diana F.] Stanford Univ, Omics Lab, Palo Alto, CA 94304 USA.
   [Schaefer, Kellie A.] Univ Iowa, Interdisciplinary Grad Program Genet, Iowa City, IA USA.
   [Wu, Wen-Hsuan; Tsang, Stephen H.] Columbia Univ, Coll Phys & Surg, Inst Human Nutr, Jonas Childrens Vis Care, New York, NY USA.
   [Wu, Wen-Hsuan; Tsang, Stephen H.] Columbia Univ, Coll Phys & Surg, Inst Human Nutr, Dept Ophthalmol,Bernard & Shirlee Brown Glaucoma, New York, NY USA.
   [Wu, Wen-Hsuan; Tsang, Stephen H.] Columbia Univ, Coll Phys & Surg, Inst Human Nutr, Dept Pathol & Cell Biol, New York, NY USA.
   [Wu, Wen-Hsuan; Tsang, Stephen H.] New York Presbyterian Hosp, Edward S Harkness Eye Inst, New York, NY USA.
   [Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.
   [Bassuk, Alexander G.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.
   [Mahajan, Vinit B.] Stanford Univ, Byers Eye Inst, Palo Alto, CA 94304 USA.
RP Bassuk, AG (reprint author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.; Bassuk, AG (reprint author), Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.; Mahajan, VB (reprint author), Stanford Univ, Byers Eye Inst, Palo Alto, CA 94304 USA.
EM alexander-bassuk@uiowa.edu; vinit.mahajan@stanford.edu
FU NIH [F31EY026789, R01EY026682, R01EY024665, R01EY025225, R01EY024698,
   R01NS098590, R21AG050437, 5P30EY019007, R01EY018213, 5P30CA013696];
   Research to Prevent Blindness (RPB), New York, New York; RPB
   Physician-Scientist Award; RPB, New York, New York, USA; Tistou and
   Charlotte Kerstan Foundation; Schneeweiss Stem Cell Fund, New York State
   [C029572]; Crowley Family Fund; Gebroe Family Foundation
FX We acknowledge the efforts and expertise of the New York Genome Center.
   S. Wu assisted with data analysis. K.A.S. is supported by NIH grant
   F31EY026789. V.B.M. and A.G.B. are supported by NIH grants (R01EY026682,
   R01EY024665, R01EY025225, R01EY024698, R01NS098590 and R21AG050437) and
   Research to Prevent Blindness (RPB), New York, New York. The Bernard &
   Shirlee Brown Glaucoma Laboratory is supported by NIH grants
   (5P30EY019007, R01EY018213). The National Cancer Institute Core is
   supported by an NIH grant (5P30CA013696), the RPB Physician-Scientist
   Award, and unrestricted funds from RPB, New York, New York, USA. S.H.T.
   is a member of the RD-CURE Consortium and is supported by the Tistou and
   Charlotte Kerstan Foundation, the Schneeweiss Stem Cell Fund, New York
   State (grant C029572), the Crowley Family Fund, and the Gebroe Family
   Foundation.
CR Iyer V, 2015, NAT METHODS, V12, P479, DOI 10.1038/nmeth.3408
   Koo T, 2015, MOL CELLS, V38, P475, DOI 10.14348/molcells.2015.0103
   Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046
   Nachman MW, 2000, GENETICS, V156, P297
   Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802
   Wu WH, 2016, MOL THER, V24, P1388, DOI 10.1038/mt.2016.107
NR 6
TC 100
Z9 111
U1 8
U2 57
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1548-7091
EI 1548-7105
J9 NAT METHODS
JI Nat. Methods
PD JUN
PY 2017
VL 14
IS 6
BP 547
EP 548
DI 10.1038/nmeth.4293
PG 2
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA EW1YK
UT WOS:000402291800005
PM 28557981
DA 2018-12-27
ER

PT J
AU Xu, B
   Tallini, G
   Ghossein, RA
AF Xu, Bin
   Tallini, Giovanni
   Ghossein, Ronald A.
TI RETRACTED: Noninvasive Follicular Thyroid Neoplasm with Papillary-Like
   Nuclear Features: Historical Context, Diagnosis, and Future Challenges
   (Retracted article. See vol. 29, pg. 300, 2018)
SO ENDOCRINE PATHOLOGY
LA English
DT Review; Retracted Publication
DE Papillary thyroid carcinoma; Follicular variant; Noninvasive follicular
   thyroid neoplasm with papillary-like nuclear features; RAS; BRAF
ID YOUNG INVESTIGATOR CHALLENGE; INDETERMINATE CYTOLOGY; OBSERVER
   VARIATION; DISTINCT BRAF; CARCINOMA; VARIANT; CANCER; TUMORS;
   EXPRESSION; NODULES
AB The encapsulated/well-demarcated non-invasive form of follicular variant of papillary thyroid carcinoma (FVPTC) that occurs annually in 45,000 patients worldwide was thought for 30 years to be a carcinoma. Many studies have now shown almost no recurrence in these non-invasive tumors, even in patients treated by surgery without radioactive iodine therapy. The categorization of the tumor as cancer has led to aggressive forms of treatment, with their side effects, financial costs, and the psychological and social impact of a cancer diagnosis. Recently, the encapsulated/well-demarcated non-invasive, FVPTC was renamed as noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) by an international group of experts. The new terminology lacks the carcinoma label enabling clinicians to avoid aggressive therapy. By taking the reader through the history of FVPTC, this article explains how diagnostic criteria for thyroid carcinoma of follicular cells have evolved over the last 60 years. It discusses the steps that led to the labeling of FVPTC as cancer and highlights the various studies that helped reclassify and rename this tumor. It also sheds light on the impact of this reclassification on cytologic diagnosis and focuses on the studies needed to refine and expand the histologic criteria of NIFTP. By understanding the history of this change in nomenclature, future classification of tumors will be greatly improved.
C1 [Xu, Bin] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada.
   [Tallini, Giovanni] Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimenta, Dept Med, Sch Med,Anat Pathol,Osped Bellaria, Via Altura 3, I-40139 Bologna, Italy.
   [Ghossein, Ronald A.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.
RP Ghossein, RA (reprint author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.
EM bin1.xu@sunnybrook.ca; giovanni.tallini@unibo.it; ghosseir@mskcc.org
OI Xu, Bin/0000-0003-4638-9835
FU Italian Government-Ministero Della Salute [RF-2011-02350857]
FX This study was supported in part by an Italian Government-Ministero
   Della Salute Grant No. RF-2011-02350857 to G.T.
CR Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050
   Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208
   Ali SZ, 2010, BETHESDA SYSTEM REPO
   Baloch ZW, 2016, CANCER CYTOPATHOL, V124, P616, DOI 10.1002/cncy.21744
   Baloch ZW, 2000, MODERN PATHOL, V13, P861, DOI 10.1038/modpathol.3880153
   Bizzarro T, 2016, CANCER CYTOPATHOL, V124, P699, DOI 10.1002/cncy.21777
   Buchmann L, 2015, OTOLARYNG HEAD NECK, V152, P644, DOI 10.1177/0194599814565761
   CARCANGIU ML, 1985, CANCER, V55, P805, DOI 10.1002/1097-0142(19850215)55:4<805::AID-CNCR2820550419>3.0.CO;2-Z
   Chan JKC, 2002, AM J CLIN PATHOL, V117, P16
   CHEN KTK, 1977, AM J SURG PATHOL, V1, P123, DOI 10.1097/00000478-197706000-00003
   Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110
   DELELLIS RA, 1993, AM J SURG PATHOL, V17, P1067, DOI 10.1097/00000478-199310000-00014
   Edge SB BD, 2010, AJCC CANC STAGING MA
   Elsheikh TM, 2008, AM J CLIN PATHOL, V130, P736, DOI 10.1309/AJCPKP2QUVN4RCCP
   Esserman LJ, 2014, LANCET ONCOL, V15, pE234, DOI 10.1016/S1470-2045(13)70598-9
   Faquin WC, 2016, CANCER CYTOPATHOL, V124, P181, DOI 10.1002/cncy.21631
   Farhat N, 2017, USCAP 2017
   Ganly I, 2015, HUM PATHOL, V46, P657, DOI 10.1016/j.humpath.2015.01.010
   Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822
   Hahn SY, 2016, CLIN ENDOCRINOL
   Hauch A, 2014, ANN SURG ONCOL, V21, P3844, DOI 10.1245/s10434-014-3846-8
   Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020
   Hirokawa M, 2002, AM J SURG PATHOL, V26, P1508, DOI 10.1097/00000478-200211000-00014
   Howitt BE, 2015, AM J CLIN PATHOL, V144, P850, DOI 10.1309/AJCPEIE12POICULI
   Howitt BE, 2013, THYROID, V23, P1256, DOI 10.1089/thy.2013.0018
   Ibrahim AA, 2016, AM J CLIN PATHOL, V146, P373, DOI [10.1093/ajcp/aqw126, 10.1093/AJCP/AQW126]
   Iyer NG, 2011, CANCER-AM CANCER SOC, V117, P4439, DOI 10.1002/cncr.26070
   Jiang XY, 2016, CANCER CYTOPATHOL, V124, P893, DOI 10.1002/cncy.21802
   Krane JF, 2016, CANCER CYTOPATHOL, V124, P767, DOI 10.1002/cncy.21769
   Likhterov I, 2016, THYROID, V26, P1167, DOI 10.1089/thy.2016.0212
   Lindsay S, 1960, CARCINOMA THYROID GL
   Liu J, 2006, CANCER-AM CANCER SOC, V107, P1255, DOI 10.1002/cncr.22138
   LIVOLSI VA, 1994, THYROID, V4, P233, DOI 10.1089/thy.1994.4.233
   Lloyd RV, 2004, AM J SURG PATHOL, V28, P1336, DOI 10.1097/01.pas.0000135519.34847.f6
   Lubitz CC, 2014, CANCER-AM CANCER SOC, V120, P1345, DOI 10.1002/cncr.28562
   Maletta F, 2016, HUM PATHOL, V54, P134, DOI 10.1016/j.humpath.2016.03.014
   Monchik JM, 2001, SURGERY, V129, P429, DOI 10.1067/msy.2001.112965
   Nikiforov YE, 2016, JAMA ONCOLOGY
   Nikiforova MN, 2013, J CLIN ENDOCR METAB, V98, pE1852, DOI 10.1210/jc.2013-2292
   Papotti M, 2005, MODERN PATHOL, V18, P541, DOI 10.1038/modpathol.3800321
   Piana S, 2010, AM J SURG PATHOL, V34, P868, DOI 10.1097/PAS.0b013e3181dbee07
   Renshaw AA, 2002, AM J CLIN PATHOL, V117, P19
   Rivera M, 2010, MODERN PATHOL, V23, P1191, DOI 10.1038/modpathol.2010.112
   Rivera M, 2009, THYROID, V19, P119, DOI 10.1089/thy.2008.0303
   Roerink SHPP, 2013, ACTA ONCOL, V52, P128, DOI 10.3109/0284186X.2012.723822
   Rosai J, 2010, ENDOCR PATHOL, V21, P7, DOI 10.1007/s12022-009-9103-1
   Rosario PW, 2014, CLIN ENDOCRINOL, V81, P630, DOI 10.1111/cen.12387
   Shi XG, 2016, J CLIN ENDOCR METAB, V101, P263, DOI 10.1210/jc.2015-2917
   Strickland KC, 2016, THYROID, V26, P1466, DOI 10.1089/thy.2016.0280
   Tallini G, 2016, J CLIN ENDOCR METAB
   Thompson LDR, 2016, MODERN PATHOL, V29, P698, DOI 10.1038/modpathol.2016.65
   TIELENS ET, 1994, CANCER, V73, P424, DOI 10.1002/1097-0142(19940115)73:2<424::AID-CNCR2820730230>3.0.CO;2-I
   Valderrabano P, 2017, ENDOCR-RELAT CANCER, V24, P127, DOI 10.1530/ERC-16-0512
   VICKERY AL, 1985, SEMIN DIAGN PATHOL, V2, P90
   Vivero M, 2013, THYROID, V23, P273, DOI 10.1089/thy.2012.0369
   WARREN S, 1953, TUMORS THYROID GLAND
   Widder S, 2008, SURGERY, V144, P80, DOI 10.1016/j.surg.2007.11.014
   Williams ED, 2000, INT J SURG PATHOL, V8, P181, DOI 10.1177/106689690000800304
   Wong KS, 2016, THYROID, V26, P911, DOI 10.1089/thy.2015.0644
   WOOLNER LB, 1961, AM J SURG, V102, P354, DOI 10.1016/0002-9610(61)90527-X
   Wreesmann VB, 2004, GENE CHROMOSOME CANC, V40, P355, DOI 10.1002/gcc.20049
   Xu B, 2017, THYROID OFFICIAL J A
   Zhao L, 2017, CANCER
   Zhu ZW, 2003, AM J CLIN PATHOL, V120, P71, DOI 10.1309/ND8D9LAJTRCTG6QD
   Zidan J, 2003, CANCER, V97, P1181, DOI 10.1002/cncr.11175
NR 65
TC 8
Z9 8
U1 0
U2 0
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1046-3976
EI 1559-0097
J9 ENDOCR PATHOL
JI Endocr. Pathol.
PD JUN
PY 2017
VL 28
IS 2
BP 128
EP 138
DI 10.1007/s12022-017-9478-3
PG 11
WC Endocrinology & Metabolism; Pathology
SC Endocrinology & Metabolism; Pathology
GA EU5NA
UT WOS:000401077400005
PM 28361392
DA 2018-12-27
ER

PT J
AU Chu, MH
   Nguyen, VD
   Nguyen, DH
   Nguyen, VH
AF Manh Hung Chu
   Van Duy Nguyen
   Duc Hoa Nguyen
   Van Hieu Nguyen
TI RETRACTED: Investigation of Co-Doped ZnO Nanowires by X-ray Absorption
   Spectroscopy and Ab Initio Simulation (Retracted article. See vol.46,
   pg.4695, 2017)
SO JOURNAL OF ELECTRONIC MATERIALS
LA English
DT Article; Retracted Publication
DE Co-implanted ZnO; nanowires; x-ray absorption near-edge structure;
   simulation; photoluminescence
ID SINGLE; DEVICES
AB The local structure of single room- and high-temperature Co-implanted ZnO nanowires with subsequent thermal annealing has been studied using hard-x-ray techniques in combination with ab initio Zn K-edge x-ray absorption near-edge structure (XANES) simulations. X-ray fluorescence data reveal a homogeneous distribution of Co atoms/ions with concentration of about 0.1 at.% to 0.3 at.% in the nanowires. XANES data indicate substitutional incorporation of Co2+ ions at Zn sites in both types of nanowire. Improved structural order around Co atoms is obtained in nanowires with high-temperature ion implantation followed by thermal annealing. The ab initio Zn K-edge simulations not only confirm recovery of implantation-induced damage in the ZnO host lattice by the thermal annealing process, but also assist in studying the effect of oxygen vacancies in the Zn K-edge XANES spectra. Microphotoluminescence data certify that high-temperature ion implantation with subsequent thermal annealing is an effective approach to achieve the strongest optical activation of Co ions and good energy transfer to Co ions from the ZnO host matrix.
C1 [Manh Hung Chu; Van Duy Nguyen; Duc Hoa Nguyen; Van Hieu Nguyen] Hanoi Univ Sci & Technol, Int Training Inst Mat Sci, 1 Dai Co Viet, Hanoi, Vietnam.
RP Chu, MH (reprint author), Hanoi Univ Sci & Technol, Int Training Inst Mat Sci, 1 Dai Co Viet, Hanoi, Vietnam.
EM mhchu@itims.edu.vn
FU Hanoi University of Science and Technology (HUST) [T2016-PC-131]
FX The authors thank G. Martinez Criado and J. Segura-Ruiz at the ID22 of
   the ESRF for help with experimental setup and valuable discussions. We
   thank C. Ronning from Jena University for sample support. This work was
   financially supported by Hanoi University of Science and Technology
   (HUST) under Project No. T2016-PC-131.
CR Borschel C, 2011, NUCL INSTRUM METH B, V269, P2133, DOI 10.1016/j.nimb.2011.07.004
   Bunau O, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/34/345501
   Chen IJ, 2008, J PHYS CHEM C, V112, P9168, DOI 10.1021/jp711775r
   Chu MH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824117
   Chu MH, 2011, PHYS STATUS SOLIDI-R, V5, P283, DOI 10.1002/pssr.201105291
   Chu MH, 2016, CRYST GROWTH DES, V16, P5339, DOI 10.1021/acs.cgd.6b00844
   Cui JB, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2058222
   Dietl T, 2010, NAT MATER, V9, P965, DOI [10.1038/nmat2898, 10.1038/NMAT2898]
   Geburt S, 2013, PHYS STATUS SOLIDI-R, V7, P886, DOI 10.1002/pssr.201307230
   Geburt S, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/36/365204
   Iwanaga H, 2000, J MATER SCI, V35, P2451, DOI 10.1023/A:1004709500331
   Kempa TJ, 2008, NANO LETT, V8, P3456, DOI 10.1021/nl8023438
   Li MJ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.115309
   Lide D. R., 1996, CRC HDB CHEM PHYS
   Minot ED, 2007, NANO LETT, V7, P367, DOI 10.1021/nl062483w
   Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360
   Muller S, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/13/135704
   Perea DE, 2009, NAT NANOTECHNOL, V4, P315, DOI [10.1038/NNANO.2009.51, 10.1038/nnano.2009.51]
   Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719
   Ronning C, 2010, MAT SCI ENG R, V70, P30, DOI 10.1016/j.mser.2010.07.002
   Segura-Ruiz J, 2011, NANO LETT, V11, P5322, DOI 10.1021/nl202799e
   Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002
   Yang PD, 2010, NANO LETT, V10, P1529, DOI 10.1021/nl100665r
NR 23
TC 2
Z9 2
U1 2
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0361-5235
EI 1543-186X
J9 J ELECTRON MATER
JI J. Electron. Mater.
PD JUN
PY 2017
VL 46
IS 6
BP 3317
EP 3322
DI 10.1007/s11664-016-5264-0
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied
SC Engineering; Materials Science; Physics
GA ET8OY
UT WOS:000400560400007
DA 2018-12-27
ER

PT J
AU Kumar, SN
   Mohandas, C
AF Kumar, S. N.
   Mohandas, C.
TI RETRACTED: An Antifungal Mechanism of Protolichesterinic Acid from the
   Lichen Usnea albopunctata Lies in the Accumulation of Intracellular ROS
   and Mitochondria-Mediated Cell Death Due to Apoptosis in Candida
   tropicalis (Retracted article. See vol. 8, art no 882, 2017)
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article; Retracted Publication
DE protolichesterinic acid; Candida; mechanism of action; apoptosis; ROS
ID CANCER-CELLS; CETRARIA-ISLANDICA; PLASMA-MEMBRANE; HIBICUSLIDE C;
   ESSENTIAL OIL; ALBICANS; FLUCONAZOLE; PHOSPHATIDYLSERINE; INFECTIONS;
   PROPERTY
AB Candida species causes superficial and life-threatening systemic infections and are difficult to treat due to the resistance of these organism to various clinically used drugs. Protolichesterinic acid is a well-known lichen compound. Although the antibacterial activity of protolichesterinic acid has been reported earlier, the antifungal property and its mechanism of action are still largely unidentified. The goal of the present investigation is to explore the anticandidal activity and mechanism of action of protolichesterinic acid, especially against Candida tropicalis. The Minimum Inhibitory Concentration (MIC) value was established through microdilution techniques against four Candida species and out of four species tested, C. tropicalis showed a significant effect (MIC: 2 mu g/ml). In the morphological interference assay, we observed the enhanced inhibition of hyphae when the cells were treated with protolichesterinic acid. Time-kill assay demonstrated that the maximum rate of killing was recorded between 2 and 6 h. C. tropicalis exposed to protolichesterinic acid exhibited an increased ROS production, which is one of the key factors of fungal death. The rise in ROS was due to the dysfunction of mitochondria caused by protolichesterinic acid. We confirmed that protolichesterinic acid-induced dysfunction of mitochondria in C. tropicalis. The damage of cell membrane due to protolichesterinic acid treatment was confirmed by the influx of propidium iodide and was further confirmed by the release of potassium ions. The treatment of protolichesterinic acid also triggered calcium ion signaling. Moreover, it commenced apoptosis which is clearly evidenced by Annexin V and propidium iodide staining. Interestingly protolichesterinic acid recorded excellent immunomodulatory property when tested against lymphocytes. Finally protolichesterinic acid showed low toxicity toward a normal human cell line Foreskin (FS) normal fibroblast. In in vivo test, protolichesterinic acid significantly enhanced the survival of C. tropicalis infected Caenorhabditis elegans. This investigation proposes that the protolichesterinic acid induces apoptosis in C. tropicalis via the enhanced accumulation of intracellular ROS and mitochondrial damage, which leads fungal cell death via apoptosis. Our work revealed a new key aspect of mechanisms of action of protolichesterinic acid in Candida species. This article is the first study on the antifungal and mechanism of action of protolichesterinic acid in Candida species.
C1 [Kumar, S. N.; Mohandas, C.] Cent Tuber Crops Res Inst, Div Crop Protect, Sreekariyam, India.
RP Kumar, SN (reprint author), Cent Tuber Crops Res Inst, Div Crop Protect, Sreekariyam, India.
EM nishanthctcri@gmail.com
FU ICMR, New Delhi
FX SK thanks, ICMR, New Delhi for providing Senior Research fellowship.
CR Abad MJ, 2007, ARKIVOC, P116
   Ahmadiani A, 1998, J ETHNOPHARMACOL, V61, P229, DOI 10.1016/S0378-8741(98)00043-9
   Alves CT, 2014, FUTURE MICROBIOL, V9, P139, DOI 10.2217/fmb.13.147
   Leite MCA, 2015, MED MYCOL, V53, P275, DOI 10.1093/mmy/myu078
   Aravind SR, 2014, RSC ADV, V4, P34632, DOI 10.1039/c4ra04137b
   Barroso G, 2006, FERTIL STERIL, V85, P149, DOI 10.1016/j.fertnstert.2005.06.046
   Bessadottir M, 2015, PROSTAG LEUKOTR ESS, V98, P39, DOI 10.1016/j.plefa.2015.04.009
   Bhattacharya AK, 2015, EUR J MED CHEM, V94, P1, DOI 10.1016/j.ejmech.2015.02.054
   Bishnu Joshi, 2011, Journal of Microbiology and Antimicrobials, V3, P1
   Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343
   Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404
   Chang WQ, 2015, BBA-GEN SUBJECTS, V1850, P1762, DOI 10.1016/j.bbagen.2015.05.005
   Chang WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041624
   Chen XF, 2016, OXID MED CELL LONGEV, DOI 10.1155/2016/1580967
   Chen YX, 2013, J MED MICROBIOL, V62, P1175, DOI 10.1099/jmm.0.055467-0
   Chen Z, 2008, INVEST OPHTH VIS SCI, V49, P539, DOI 10.1167/iovs.07-0569
   Choi H, 2015, BIOCHIMIE, V115, P108, DOI 10.1016/j.biochi.2015.05.009
   Choi H, 2012, BBA-BIOMEMBRANES, V1818, P1648, DOI 10.1016/j.bbamem.2012.02.026
   Clinical and Laboratory Standards Institute [CLSI], 2005, M27S4 CLSI
   Cos P, 2006, J ETHNOPHARMACOL, V106, P290, DOI 10.1016/j.jep.2006.04.003
   da Silva CR, 2014, ANTIMICROB AGENTS CH, V58, P1468, DOI 10.1128/AAC.00651-13
   Dayan F. E., 2001, Pesticide Outlook, V12, P229, DOI 10.1039/b110543b
   de Castro PA, 2013, FUNGAL GENET BIOL, V60, P74, DOI 10.1016/j.fgb.2013.07.001
   Ding YJ, 2016, RSC ADV, V6, P30895, DOI 10.1039/c5ra26092b
   Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016
   Hildeman DA, 1999, IMMUNITY, V10, P735, DOI 10.1016/S1074-7613(00)80072-2
   Hwang B, 2011, BIOCHEM BIOPH RES CO, V405, P267, DOI 10.1016/j.bbrc.2011.01.026
   Hwang JH, 2014, J APPL MICROBIOL, V117, P1400, DOI 10.1111/jam.12633
   Hwang JH, 2013, BIOCHIMIE, V95, P1917, DOI 10.1016/j.biochi.2013.06.019
   Hwang JH, 2012, BIOCHIMIE, V94, P1784, DOI 10.1016/j.biochi.2012.04.010
   Ingolfsdottir K, 1997, ANTIMICROB AGENTS CH, V41, P215, DOI 10.1128/AAC.41.1.215
   Khan A, 2014, RES MICROBIOL, V165, P411, DOI 10.1016/j.resmic.2014.05.031
   Khodavandi A, 2014, PHARM BIOL, V52, P1505, DOI 10.3109/13880209.2014.900808
   Kingston DGI, 2011, J NAT PROD, V74, P496, DOI 10.1021/np100550t
   Kothavade RJ, 2010, J MED MICROBIOL, V59, P873, DOI 10.1099/jmm.0.013227-0
   Kumar S. N., 2014, INT J ANTIBIOT, V2014
   Lee J, 2014, FEMS MICROBIOL LETT, V355, P36, DOI 10.1111/1574-6968.12450
   Lee W, 2014, IUBMB LIFE, V66, P780, DOI 10.1002/iub.1326
   Li Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128693
   Liu SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150859
   Ma CY, 2015, MOLECULES, V20, P17913, DOI 10.3390/molecules201017913
   Machida K, 1999, FEBS LETT, V462, P108, DOI 10.1016/S0014-5793(99)01506-9
   Mitrovic T, 2011, BIOL NYSSANA, V2, P1
   Muller K, 2001, APPL MICROBIOL BIOT, V56, P9, DOI 10.1007/s002530100684
   Nguyen TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111575
   Nissapatorn V, 2003, JPN J INFECT DIS, V56, P187
   Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218
   Russo A, 2012, CHEM-BIOL INTERACT, V195, P1, DOI 10.1016/j.cbi.2011.10.005
   Sharma M, 2015, J CLIN DIAGN RES, V9, pDC20, DOI 10.7860/JCDR/2015/10094.5494
   Shrestha G, 2013, PHYTOCHEM REV, V12, P229, DOI 10.1007/s11101-013-9283-7
   Smrz D, 2007, J BIOL CHEM, V282, P10487, DOI 10.1074/jbc.M611090200
   Srivastava Priya, 2013, Interdiscip Perspect Infect Dis, V2013, P709348, DOI 10.1155/2013/709348
   Suzuki MT, 2016, APPL MICROBIOL BIOT, V100, P583, DOI 10.1007/s00253-015-7114-z
   Suzuki T, 1997, J HISTOCHEM CYTOCHEM, V45, P49, DOI 10.1177/002215549704500107
   Thorsteinsdottir UA, 2016, PHYTOTHER RES, V30, P97, DOI 10.1002/ptr.5507
   Turk AO, 2003, Z NATURFORSCH C, V58, P850
   Wang XJ, 2014, APPL MICROBIOL BIOT, V98, P7387, DOI 10.1007/s00253-014-5784-6
   Weghuber J, 2010, CELL BIOL INT, V34, P1109, DOI 10.1042/CBI20100408
   Yoon MJ, 2012, CANCER LETT, V324, P197, DOI 10.1016/j.canlet.2012.05.018
   Yu QL, 2015, CHEM-BIOL INTERACT, V227, P1, DOI 10.1016/j.cbi.2014.12.014
   Yu QL, 2014, FEMS YEAST RES, V14, P633, DOI 10.1111/1567-1364.12150
   Yun J, 2015, BBA-BIOMEMBRANES, V1848, P695, DOI 10.1016/j.bbamem.2014.11.019
NR 62
TC 1
Z9 1
U1 2
U2 13
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD MAY 29
PY 2017
VL 8
AR 301
DI 10.3389/fphar.2017.00301
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EW1QO
UT WOS:000402267300001
PM 28611662
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Zhang, WJ
   Aguila, B
   Ma, SQ
AF Zhang, Weijie
   Aguila, Briana
   Ma, Shengqian
TI RETRACTED: Potential applications of functional porous organic polymer
   materials (Retracted article. See vol. 5, pg. 18896, 2017)
SO JOURNAL OF MATERIALS CHEMISTRY A
LA English
DT Review; Retracted Publication
ID CONJUGATED MICROPOROUS POLYMERS; GRAPHITIC CARBON NITRIDE; MIXED-MATRIX
   MEMBRANES; HIGH CO2 ADSORPTION; ASYMMETRIC HETEROGENEOUS CATALYSIS;
   HYDROGEN-PEROXIDE PRODUCTION; TRIAZINE-BASED FRAMEWORKS; CROSS-LINKED
   POLYMERS; SMALL GAS-STORAGE; LOCAL DIPOLE-PI
AB Porous materials are important in established processes, such as catalysis and molecular separations, and in emerging technologies for energy and health. Porous organic polymers (POPs), a class of highly crosslinked, amorphous polymers possessing nanopores, have recently emerged as a versatile platform for potential applications. As an emerging material, POPs offer high flexibility for the molecular design and post-synthetic modification of their conjugated skeletons and nanopores. They have shown great potential for challenging energy and environmental issues, as exemplified by their excellent performance in gas storage/ separation, catalysis, environmental remediation, and sensing. This review article summarizes the recent frontiers of functional exploration and potential applications of porous organic polymers.
C1 [Zhang, Weijie; Aguila, Briana; Ma, Shengqian] Univ S Florida, Dept Chem, 4202 East Fowler Ave, Tampa, FL 33620 USA.
RP Ma, SQ (reprint author), Univ S Florida, Dept Chem, 4202 East Fowler Ave, Tampa, FL 33620 USA.
EM sqma@usf.edu
OI Ma, Shengqian/0000-0002-1897-7069
FU USF; DOE Office of Nuclear Energy's Nuclear Energy University Program
   [DE-NE0008281]
FX The authors acknowledge the USF and DOE Office of Nuclear Energy's
   Nuclear Energy University Program (Grant No. DE-NE0008281) for financial
   support of this work.
CR Aguila B, 2016, CHEM COMMUN, V52, P5940, DOI 10.1039/c6cc00843g
   Alkordi MH, 2015, J MATER CHEM A, V3, P22584, DOI 10.1039/c5ta05297a
   Alsbaiee A, 2016, NATURE, V529, P190, DOI 10.1038/nature16185
   An WK, 2014, CHEM-EUR J, V20, P11019, DOI 10.1002/chem.201403002
   Arab P, 2015, J MATER CHEM A, V3, P20586, DOI 10.1039/c5ta04308e
   Arab P, 2014, CHEM MATER, V26, P1385, DOI 10.1021/cm403161e
   Bai Y, 2016, CHEM SOC REV, V45, P2327, DOI 10.1039/c5cs00837a
   Bandyopadhyay S, 2016, ACS APPL MATER INTER, V8, P27669, DOI 10.1021/acsami.6b08331
   Bandyopadhyay S, 2015, POLYM CHEM-UK, V6, P3775, DOI 10.1039/c5py00235d
   Banerjee D, 2016, CHEM-EUR J, V22, P17581, DOI 10.1002/chem.201603908
   Ben T, 2009, ANGEW CHEM INT EDIT, V48, P9457, DOI 10.1002/anie.200904637
   Bleschke C, 2011, ADV SYNTH CATAL, V353, P3101, DOI 10.1002/adsc.201100674
   Bonillo B, 2016, CHEM MATER, V28, P3469, DOI 10.1021/acs.chemmater.6b01195
   Brauer TM, 2016, ANGEW CHEM INT EDIT, V55, P7698, DOI 10.1002/anie.201602382
   Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006
   Budd PM, 2003, J MATER CHEM, V13, P2721, DOI 10.1039/b303996j
   Byun J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13377
   Cai R, 2017, ACS CATAL, V7, P1087, DOI 10.1021/acscatal.6b03211
   Chakrabarty R, 2011, CHEM REV, V111, P6810, DOI 10.1021/cr200077m
   Chang CJ, 2004, J AM CHEM SOC, V126, P10013, DOI 10.1021/ja049115j
   Chang GJ, 2016, POLYM CHEM-UK, V7, P5768, DOI 10.1039/c6py01154c
   Chang GJ, 2016, J MATER CHEM A, V4, P2517, DOI 10.1039/c5ta08705h
   Chang Z, 2013, PHYS CHEM CHEM PHYS, V15, P5430, DOI 10.1039/c3cp50517k
   Chen DY, 2016, POLYM CHEM-UK, V7, P3416, DOI 10.1039/c6py00278a
   Chen L, 2011, ADV MATER, V23, P3149, DOI 10.1002/adma.201100974
   Chen RR, 2009, J PHYS CHEM C, V113, P20689, DOI 10.1021/jp906408y
   Choi HS, 2015, NANOSCALE, V7, P18923, DOI 10.1039/c5nr05696a
   Chu S, 2013, ACS CATAL, V3, P912, DOI 10.1021/cs4000624
   Chun J, 2014, J AM CHEM SOC, V136, P6786, DOI 10.1021/ja500362w
   Cohen SM, 2012, CHEM REV, V112, P970, DOI 10.1021/cr200179u
   Cooper AI, 2009, ADV MATER, V21, P1291, DOI 10.1002/adma.200801971
   Coperet C, 2016, CHEM REV, V116, P323, DOI 10.1021/acs.chemrev.5b00373
   Corey E. J., 1989, LOGIC CHEM SYNTHESIS
   Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411
   Cui SS, 2016, CHEMSUSCHEM, V9, P2365, DOI 10.1002/cssc.201600452
   Cullen W, 2016, NAT CHEM, V8, P231, DOI [10.1038/NCHEM.2452, 10.1038/nchem.2452]
   Dang QQ, 2016, POLYM CHEM-UK, V7, P643, DOI 10.1039/c5py01671a
   Das G, 2016, J MATER CHEM A, V4, P15361, DOI 10.1039/c6ta06439f
   Dawson R, 2009, MACROMOLECULES, V42, P8809, DOI 10.1021/ma901801s
   Dey S, 2016, J MATER CHEM A, V4, P6259, DOI 10.1039/c6ta00638h
   Dhanalaxmi K, 2016, CHEM-EUR J, V22, P15639, DOI 10.1002/chem.201603419
   Ding ML, 2016, CHEM COMMUN, V52, P12294, DOI 10.1039/c6cc07149j
   Ding SY, 2013, CHEM SOC REV, V42, P548, DOI 10.1039/c2cs35072f
   Ding XS, 2015, ANGEW CHEM INT EDIT, V54, P6536, DOI 10.1002/anie.201501732
   Dong GX, 2013, J MATER CHEM A, V1, P4610, DOI 10.1039/c3ta00927k
   Dong GH, 2016, ACS CATAL, V6, P6511, DOI 10.1021/acscatal.6b01657
   Dong JQ, 2014, CHEM COMMUN, V50, P14949, DOI 10.1039/c4cc07648f
   Du NY, 2012, ENERG ENVIRON SCI, V5, P7306, DOI 10.1039/c1ee02668b
   Eddaoudi M, 2015, CHEM SOC REV, V44, P228, DOI 10.1039/c4cs00230j
   El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915
   ELDRIDGE RB, 1993, IND ENG CHEM RES, V32, P2208, DOI 10.1021/ie00022a002
   Fan XQ, 2015, ACS CATAL, V5, P5008, DOI 10.1021/acscatal.5b01155
   Feng X, 2012, CHEM SOC REV, V41, P6010, DOI 10.1039/c2cs35157a
   Fischer S, 2013, ANGEW CHEM INT EDIT, V52, P12174, DOI 10.1002/anie.201303045
   Flouraki C, 2016, POLYM CHEM-UK, V7, P3026, DOI 10.1039/c6py00296j
   Furukawa S, 2011, ACS CATAL, V1, P1150, DOI 10.1021/cs200318n
   Gao H, 2016, J MATER CHEM A, V4, P16490, DOI 10.1039/c6ta07033g
   Gao H, 2016, ACS MACRO LETT, V5, P377, DOI 10.1021/acsmacrolett.6b00015
   Gao WY, 2014, CHEM SOC REV, V43, P5841, DOI 10.1039/c4cs00001c
   Germain ME, 2009, CHEM SOC REV, V38, P2543, DOI 10.1039/b809631g
   Ghosh S, 2015, NAT MATER, V14, P505, DOI [10.1038/NMAT4220, 10.1038/nmat4220]
   Gu C, 2016, ANGEW CHEM INT EDIT, V55, P3049, DOI 10.1002/anie.201510723
   Gu C, 2015, ANGEW CHEM INT EDIT, V54, P13594, DOI 10.1002/anie.201506570
   Gu C, 2014, ANGEW CHEM INT EDIT, V53, P4850, DOI 10.1002/anie.201402141
   Gu CY, 2015, POLYM CHEM-UK, V6, P7410, DOI 10.1039/c5py01090j
   Han M., 2016, ANGEW CHEM, V128, P456
   Han Q, 2016, ANGEW CHEM INT EDIT, V55, P10849, DOI 10.1002/anie.201605591
   Han SS, 2009, CHEM SOC REV, V38, P1460, DOI 10.1039/b802430h
   Hawker CJ, 2005, SCIENCE, V309, P1200, DOI 10.1126/science.1109778
   He YB, 2014, CHEM SOC REV, V43, P5618, DOI 10.1039/c4cs00041b
   Hei ZH, 2016, POLYM CHEM-UK, V7, P770, DOI 10.1039/c5py01682g
   Hijazi I, 2014, J AM CHEM SOC, V136, P6348, DOI 10.1021/ja500984k
   Hong S, 2015, ANGEW CHEM INT EDIT, V54, P13241, DOI 10.1002/anie.201505531
   Hua C, 2016, J MATER CHEM C, V4, P2535, DOI 10.1039/c6tc00132g
   Huang YB, 2016, J AM CHEM SOC, V138, P10104, DOI [10.1021/jacs.6606185, 10.1021/jacs.6b06185]
   Hugar KM, 2015, J AM CHEM SOC, V137, P8730, DOI 10.1021/jacs.5b02879
   Islamoglu T, 2016, ACS APPL MATER INTER, V8, P14648, DOI 10.1021/acsami.6b05326
   Izzet G, 2016, J AM CHEM SOC, V138, P5093, DOI 10.1021/jacs.6b00972
   Jahan M, 2012, J AM CHEM SOC, V134, P6707, DOI 10.1021/ja211433h
   Ji GP, 2016, ANGEW CHEM INT EDIT, V55, P9685, DOI 10.1002/anie.201602667
   Jia HX, 2016, CHEM COMMUN, V52, P13483, DOI 10.1039/c6cc06972j
   Jia HX, 2015, CHEM MATER, V27, P4586, DOI 10.1021/acs.chemmater.5b00882
   Jiang JX, 2008, ANGEW CHEM INT EDIT, V47, P1167, DOI 10.1002/anie.200701595
   Jiang JX, 2011, ANGEW CHEM INT EDIT, V50, P1072, DOI 10.1002/anie.201005864
   Jiang JX, 2010, TOP CURR CHEM, V293, P1, DOI 10.1007/128_2009_5
   Jiang JC, 2015, CHEM REV, V115, P6966, DOI 10.1021/acs.chemrev.5b00221
   Jin T, 2016, CHEM COMMUN, V52, P4454, DOI 10.1039/c6cc00573j
   Jones JTA, 2011, NATURE, V474, P367, DOI 10.1038/nature10125
   Kadish KM, 2005, J AM CHEM SOC, V127, P5625, DOI 10.1021/ja0501060
   Kailasam K, 2016, ENERGY TECHNOL-GER, V4, P744, DOI 10.1002/ente.201500478
   Kang N., 2013, ANGEW CHEM, V125, P6348
   Kaphan DM, 2015, SCIENCE, V350, P1235, DOI 10.1126/science.aad3087
   Karkas MD, 2014, CHEM REV, V114, P11863, DOI 10.1021/cr400572f
   Karmakar A, 2016, ANGEW CHEM INT EDIT, V55, P10667, DOI 10.1002/anie.201604534
   Katsoulidis A. P., 2011, CHEM MAT
   Kaur P, 2011, ACS CATAL, V1, P819, DOI 10.1021/cs200131g
   Keskin S, 2010, CHEMSUSCHEM, V3, P879, DOI 10.1002/cssc.201000114
   Klumpen C, 2016, CHEM MATER, V28, P5461, DOI 10.1021/acs.chemmater.6b01949
   Ko JH, 2015, CHEM COMMUN, V51, P8781, DOI 10.1039/c5cc02144h
   Kofuji Y, 2016, ACS CATAL, V6, P7021, DOI 10.1021/acscatal.6b02367
   Kofuji Y, 2016, J AM CHEM SOC, V138, P10019, DOI 10.1021/jacs.6b05806
   Kou Y, 2011, ANGEW CHEM INT EDIT, V50, P8753, DOI 10.1002/anie.201103493
   Kundu DS, 2012, ANGEW CHEM INT EDIT, V51, P5456, DOI 10.1002/anie.201109072
   Lee JSM, 2016, J MATER CHEM A, V4, P7665, DOI 10.1039/c6ta02319c
   Lee S, 2016, J AM CHEM SOC, V138, P7603, DOI 10.1021/jacs.6b02515
   Lee Y, 2012, J PHYS CHEM LETT, V3, P399, DOI 10.1021/jz2016507
   Leng YJ, 2012, J AM CHEM SOC, V134, P9054, DOI 10.1021/ja302439z
   Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103
   Li A, 2011, ENERG ENVIRON SCI, V4, P2062, DOI 10.1039/c1ee01092a
   Li BY, 2016, CHEM SCI, V7, P2138, DOI 10.1039/c5sc04507j
   Li BY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6537
   Li BY, 2014, J AM CHEM SOC, V136, P8654, DOI 10.1021/ja502119z
   Li BY, 2014, J MATER CHEM A, V2, P11930, DOI 10.1039/c4ta01081g
   Li CY, 2016, GREEN CHEM, V18, P2995, DOI 10.1039/c6gc00728g
   Li GY, 2016, J MATER CHEM A, V4, P11453, DOI 10.1039/c6ta04337b
   Li GY, 2016, CHEM COMMUN, V52, P1143, DOI 10.1039/c5cc08195e
   Li H, 2016, CHEM-EUR J, V22, P11863, DOI 10.1002/chem.201602337
   Li LW, 2016, J AM CHEM SOC, V138, P7681, DOI 10.1021/jacs.6b03472
   Li LY, 2015, NANO RES, V8, P709, DOI 10.1007/s12274-014-0554-4
   Li LY, 2014, ACS NANO, V8, P5352, DOI 10.1021/nn501853g
   Li R, 2016, ACS CATAL, V6, P1113, DOI 10.1021/acscatal.5b02490
   Li ZP, 2015, CHEM-EUR J, V21, P17355, DOI [10.1002/chem.2015022111, 10.1002/chem.201502241]
   Liang YR, 2011, J MATER CHEM, V21, P14424, DOI 10.1039/c1jm13077c
   Lin S, 2015, SCIENCE, V349, P1208, DOI 10.1126/science.aac8343
   Lin ZJ, 2014, CHEM SOC REV, V43, P5867, DOI 10.1039/c3cs60483g
   Liras M, 2016, MACROMOLECULES, V49, P1666, DOI 10.1021/acs.macromol.5b02511
   Liu DP, 2013, ACS MACRO LETT, V2, P522, DOI 10.1021/mz4001699
   Liu JW, 2014, CHEM SOC REV, V43, P6011, DOI 10.1039/c4cs00094c
   Liu JK, 2013, ANGEW CHEM INT EDIT, V52, P3241, DOI 10.1002/anie.201209363
   Liu J, 2015, SCIENCE, V347, P970, DOI 10.1126/science.aaa3145
   Liu L, 2016, ACS APPL MATER INTER, V8, P4651, DOI 10.1021/acsami.5b11519
   Liu XM, 2013, POLYM CHEM-UK, V4, P2445, DOI 10.1039/c3py00083d
   Liu XM, 2013, CHEM COMMUN, V49, P3233, DOI 10.1039/c3cc41082j
   Liu XM, 2012, J AM CHEM SOC, V134, P8738, DOI [10.1021/ja303445r, 10.1021/ja303448r]
   Lu GL, 2015, NANOSCALE, V7, P18271, DOI 10.1039/c5nr05324b
   Lu WG, 2014, CHEM MATER, V26, P4589, DOI 10.1021/cm501922h
   Lu WG, 2010, CHEM MATER, V22, P5964, DOI 10.1021/cm1021068
   Luo J, 2015, ACS CATAL, V5, P2250, DOI 10.1021/acscatal.5b00025
   Luo YL, 2013, POLYM CHEM-UK, V4, P1126, DOI 10.1039/c2py20914d
   Ma H, 2016, ACS MACRO LETT, V5, P1039, DOI 10.1021/acsmacrolett.6b00567
   Ma LQ, 2011, ACS CATAL, V1, P691, DOI 10.1021/cs2001303
   Ma SQ, 2010, CHEM COMMUN, V46, P44, DOI 10.1039/b916295j
   Mackintosh HJ, 2008, J MATER CHEM, V18, P573, DOI 10.1039/b715660j
   Makal TA, 2012, CHEM SOC REV, V41, P7761, DOI 10.1039/c2cs35251f
   Maly KE, 2009, J MATER CHEM, V19, P1781, DOI 10.1039/b816089a
   Mason JA, 2015, NATURE, V527, P357, DOI 10.1038/nature15732
   McCrum NG, 1997, PRINCIPLES POLYM ENG
   McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294
   McKeown NB, 2010, MACROMOLECULES, V43, P5163, DOI 10.1021/ma1006396
   McTiernan CD, 2014, ACS CATAL, V4, P4034, DOI 10.1021/cs501030f
   Mitra T, 2016, CHEM COMMUN, V52, P5581, DOI 10.1039/c6cc00261g
   Modak A, 2012, CHEM COMMUN, V48, P248, DOI 10.1039/c1cc14275e
   Mohanty P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1405
   Mondal S, 2015, J MATER CHEM A, V3, P23577, DOI 10.1039/c5ta06939d
   Monnereau L, 2016, CHEM COMMUN, V52, P571, DOI 10.1039/c5cc06790a
   Morozan A, 2011, CARBON, V49, P4839, DOI 10.1016/j.carbon.2011.07.004
   Msayib KJ, 2016, J MATER CHEM A, V4, P10110, DOI 10.1039/c6ta03257e
   Nandi S, 2015, J MATER CHEM A, V3, P21116, DOI 10.1039/c5ta04241k
   Nocera DG, 2009, INORG CHEM, V48, P10001, DOI 10.1021/ic901328v
   Ong WJ, 2016, CHEM REV, V116, P7159, DOI 10.1021/acs.chemrev.6b00075
   Oveisi AR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10621
   Palkovits R, 2009, ANGEW CHEM INT EDIT, V48, P6909, DOI 10.1002/anie.200902009
   Palma-Cando A, 2015, MACROMOLECULES, V48, P6816, DOI 10.1021/acs.macromol.5b01821
   Patel HA, 2017, CHEMSUSCHEM, V10, P1303, DOI 10.1002/cssc.201601545
   Patel HA, 2014, CHEM-EUR J, V20, P772, DOI 10.1002/chem.201303493
   Patel HA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2359
   Patel HA, 2012, J MATER CHEM, V22, P8431, DOI [10.1039/c2jm30761h, 10.1039/c2jm30761]
   Perry JJ, 2009, CHEM SOC REV, V38, P1400, DOI 10.1039/b807086p
   Popp N, 2015, J MATER CHEM A, V3, P18492, DOI 10.1039/c5ta02504d
   Puthiaraj P, 2014, GREEN CHEM, V16, P4223, DOI 10.1039/c4gc00412d
   Qiao YP, 2016, ANGEW CHEM INT EDIT, V55, P12778, DOI 10.1002/anie.201606847
   Qin L, 2016, POLYM CHEM-UK, V7, P4599, DOI 10.1039/c6py00666c
   Rabbani MG, 2011, CHEM MATER, V23, P1650, DOI 10.1021/cm200411p
   Rabbani MG, 2012, CHEM MATER, V24, P1511, DOI 10.1021/cm300407h
   Rabbani MG, 2012, CHEM COMMUN, V48, P1141, DOI 10.1039/c2cc16986j
   Ramsay WJ, 2016, J AM CHEM SOC, V138, P7264, DOI 10.1021/jacs.6b03858
   Rao KV, 2012, CHEM-EUR J, V18, P4505, DOI 10.1002/chem.201103750
   Rege SU, 1998, AICHE J, V44, P799, DOI 10.1002/aic.690440405
   Ren F, 2016, CHEM COMMUN, V52, P9797, DOI 10.1039/c6cc05188j
   Richter FH, 2016, CHEM-EUR J, V22, P13563, DOI 10.1002/chem.201603069
   Rios P, 2016, ANGEW CHEM INT EDIT, V55, P3387, DOI 10.1002/anie.201510611
   Rizzuto FJ, 2016, ANGEW CHEM INT EDIT, V55, P7958, DOI 10.1002/anie.201602135
   Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030
   Robinson R, 1917, J CHEM SOC, V111, P762, DOI 10.1039/ct9171100762
   Roque-Malherbe R. M. A., 2011, POROUS POLYM SURFACE, P173
   Rose M, 2008, CHEM COMMUN, P2462, DOI 10.1039/b718925g
   Safarik DJ, 1998, IND ENG CHEM RES, V37, P2571, DOI 10.1021/ie970897h
   Sai H, 2013, SCIENCE, V341, P530, DOI 10.1126/science.1238159
   Sang NN, 2015, J MATER CHEM A, V3, P92, DOI 10.1039/c4ta04903a
   Schoedel A, 2016, CHEM REV, V116, P12466, DOI 10.1021/acs.chemrev.6b00346
   Schuch F., 2002, HDB POROUS SOLIDS
   Schulze M, 2016, NAT CHEM, V8, P577, DOI [10.1038/NCHEM.2503, 10.1038/nchem.2503]
   Schwab MG, 2009, J AM CHEM SOC, V131, P7216, DOI 10.1021/ja902116f
   Segura JL, 2016, CHEM SOC REV, V45, P5635, DOI 10.1039/c5cs00878f
   Seida Y, 2000, WATER RES, V34, P1487, DOI 10.1016/S0043-1354(99)00295-X
   Sekizkardes AK, 2016, CHEM COMMUN, V52, P11768, DOI 10.1039/c6cc04811k
   Sekizkardes AK, 2014, J MATER CHEM A, V2, P12492, DOI 10.1039/c4ta01281j
   Shen CJ, 2014, CHEM COMMUN, V50, P11238, DOI 10.1039/c4cc05021e
   Shiraishi Y, 2015, ACS CATAL, V5, P3058, DOI 10.1021/acscatal.5b00408
   Shiraishi Y, 2014, ANGEW CHEM INT EDIT, V53, P13454, DOI 10.1002/anie.201407938
   Shultz AM, 2011, CHEM SCI, V2, P686, DOI 10.1039/c0sc00339e
   Slater AG, 2017, NAT CHEM, V9, P17, DOI [10.1038/nchem.2663, 10.1038/NCHEM.2663]
   Slater AG, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8075
   Sorokin AB, 2013, CHEM REV, V113, P8152, DOI 10.1021/cr4000072
   Sperling LH, 2006, INTRODUCTION TO PHYSICAL POLYMER SCIENCE, 4TH EDITION, P1
   Stock N, 2012, CHEM REV, V112, P933, DOI 10.1021/cr200304e
   Strathmann H, 2013, IND ENG CHEM RES, V52, P10364, DOI 10.1021/ie4002102
   Su CL, 2016, ACS CATAL, V6, P3594, DOI [10.1021/acscatal.6b00443, 10.1021/acscatal.6b02303]
   Su FZ, 2011, ANGEW CHEM INT EDIT, V50, P657, DOI 10.1002/anie.201004365
   Su YQ, 2016, ACS APPL MATER INTER, V8, P18904, DOI 10.1021/acsami.6b05918
   Sun B, 2014, INORG CHEM, V53, P8600, DOI 10.1021/ic501210t
   Sun CJ, 2016, POLYM CHEM-UK, V7, P5031, DOI 10.1039/c6py00725b
   Sun LB, 2013, POLYM CHEM-UK, V4, P1932, DOI 10.1039/c2py21034g
   Sun Q, 2016, CHEM-US, V1, P628, DOI 10.1016/j.chempr.2016.09.008
   Sun Q, 2015, J MATER CHEM A, V3, P23871, DOI 10.1039/c5ta07267k
   Sun Q, 2015, CHEM SOC REV, V44, P6018, DOI 10.1039/c5cs00198f
   Sun Q, 2015, J AM CHEM SOC, V137, P5204, DOI 10.1021/jacs.5b02122
   Sun Q, 2012, CHEM COMMUN, V48, P10505, DOI 10.1039/c2cc35192g
   Sung S, 2014, J MATER CHEM A, V2, P13245, DOI 10.1039/c4ta02861a
   Suresh VM, 2014, ACS APPL MATER INTER, V6, P4630, DOI 10.1021/am500057z
   Talapaneni SN, 2016, CHEM MATER, V28, P4460, DOI 10.1021/acs.chemmater.6b01667
   Talapaneni SN, 2015, CHEM MATER, V27, P6818, DOI 10.1021/acs.chemmater.5b03104
   Tan MX, 2013, ENERG ENVIRON SCI, V6, P3254, DOI 10.1039/c3ee42216j
   Tao LM, 2016, J MATER CHEM A, V4, P11812, DOI 10.1039/c6ta05107c
   Thirion D, 2016, CHEM MATER, V28, P5592, DOI 10.1021/acs.chemmater.6b02152
   Thomas A, 2010, ANGEW CHEM INT EDIT, V49, P8328, DOI 10.1002/anie.201000167
   Thorum MS, 2009, ANGEW CHEM INT EDIT, V48, P165, DOI 10.1002/anie.200803554
   Totten RK, 2013, ACS CATAL, V3, P1454, DOI 10.1021/cs4001738
   Totten RK, 2013, J AM CHEM SOC, V135, P11720, DOI 10.1021/ja405495u
   Tranchemontagne DJL, 2008, ANGEW CHEM INT EDIT, V47, P5136, DOI 10.1002/anie.200705008
   Uchida S, 2008, J AM CHEM SOC, V130, P12370, DOI 10.1021/ja801453c
   Verde-Sesto E, 2014, CHEM-EUR J, V20, P5111, DOI 10.1002/chem.201304163
   Vilela F, 2012, ENERG ENVIRON SCI, V5, P7819, DOI 10.1039/c2ee22002d
   Vyas VS, 2016, CHEM MATER, V28, P5191, DOI 10.1021/acs.chemmater.6b01894
   Wang CA, 2012, CHEM-EUR J, V18, P6718, DOI 10.1002/chem.201200753
   Wang C, 2012, CHEM REV, V112, P1084, DOI 10.1021/cr200252n
   Wang QQ, 2016, NAT CHEM, V8, P225, DOI [10.1038/NCHEM.2425, 10.1038/nchem.2425]
   Wang WL, 2016, ACS CATAL, V6, P6091, DOI 10.1021/acscatal.6b01142
   Wang XS, 2014, CHEM MATER, V26, P1639, DOI 10.1021/cm403860t
   Wang XS, 2013, CHEM COMMUN, V49, P1533, DOI 10.1039/c2cc38067f
   Wang XY, 2016, MACROMOL RAPID COMM, V37, P323, DOI 10.1002/marc.201500615
   Wang XC, 2009, NAT MATER, V8, P76, DOI 10.1038/NMAT2317
   Wang YJ, 2013, CHEM SOC REV, V42, P5768, DOI 10.1039/c3cs60053j
   Wang YX, 2016, J MATER CHEM A, V4, P12554, DOI 10.1039/c6ta03516g
   Wang Z, 2012, MACROMOLECULES, V45, P7413, DOI 10.1021/ma301426e
   Wang ZJ, 2015, ADV MATER, V27, P6265, DOI 10.1002/adma.201502735
   Wen T, 2016, POLYM CHEM-UK, V7, P785, DOI 10.1039/c5py01721a
   Weston MH, 2014, J MATER CHEM A, V2, P299, DOI 10.1039/c3ta12999c
   Weston MH, 2013, CHEM COMMUN, V49, P2995, DOI 10.1039/c3cc40475g
   Wong YL, 2016, J MATER CHEM A, V4, P18677, DOI 10.1039/c6ta07697a
   Wood CD, 2008, ADV MATER, V20, P1916, DOI 10.1002/adma.200702397
   Wood CD, 2007, CHEM MATER, V19, P2034, DOI 10.1021/cm070356a
   Wu DC, 2012, CHEM REV, V112, P3959, DOI 10.1021/cr200440z
   Wu DC, 2011, MACROMOLECULES, V44, P5846, DOI 10.1021/ma2013207
   Wu KY, 2016, ANGEW CHEM INT EDIT, V55, P6013, DOI 10.1002/anie.201600891
   Wu WT, 2016, ACS CATAL, V6, P3365, DOI 10.1021/acscatal.6b00879
   Wu ZS, 2014, ADV MATER, V26, P1450, DOI 10.1002/adma.201304147
   Xiang ZH, 2015, J AM CHEM SOC, V137, P13301, DOI 10.1021/jacs.5b06266
   Xiang ZH, 2014, ANGEW CHEM INT EDIT, V53, P2433, DOI 10.1002/anie.201308896
   Xiang ZH, 2012, MACROMOL RAPID COMM, V33, P1184, DOI 10.1002/marc.201100865
   Xie LH, 2013, CHEM-EUR J, V19, P11590, DOI 10.1002/chem.201301822
   Xie Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2960
   Xu F, 2014, CHEM COMMUN, V50, P4788, DOI 10.1039/c4cc01002g
   Xu F, 2011, J MATER CHEM, V21, P1970, DOI 10.1039/c0jm02044c
   Xu YH, 2013, CHEM SOC REV, V42, P8012, DOI 10.1039/c3cs60160a
   Yang X, 2014, J MATER CHEM A, V2, P15139, DOI 10.1039/c4ta02782e
   Yang YW, 2016, J MATER CHEM A, V4, P15072, DOI 10.1039/c6ta05226f
   Yang ZJ, 2016, ANGEW CHEM INT EDIT, V55, P11499, DOI 10.1002/anie.201605916
   Yang ZZ, 2016, ACS CATAL, V6, P1268, DOI 10.1021/acscatal.5b02583
   Yao SW, 2014, J MATER CHEM A, V2, P8054, DOI 10.1039/c4ta00375f
   Yoon M, 2012, CHEM REV, V112, P1196, DOI 10.1021/cr2003147
   Yuan DQ, 2011, ADV MATER, V23, P3723, DOI 10.1002/adma.201101759
   Yuan K, 2015, CHEM MATER, V27, P7403, DOI 10.1021/acs.chemmater.5b03290
   Yuan Y, 2016, CHEM SCI, V7, P3751, DOI 10.1039/c6sc00134c
   Yuan Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5260
   Yue YF, 2013, ANGEW CHEM INT EDIT, V52, P13458, DOI 10.1002/anie.201307825
   Yun S, 2016, ACS CATAL, V6, P2435, DOI 10.1021/acscatal.5b02613
   Zeng LH, 2016, J MATER CHEM A, V4, P8328, DOI 10.1039/c6ta01035k
   Zhang JY, 2015, J MATER CHEM A, V3, P10990, DOI 10.1039/c5ta00557d
   Zhang JS, 2012, ANGEW CHEM INT EDIT, V51, P3183, DOI 10.1002/anie.201106656
   Zhang K, 2013, CHEM COMMUN, V49, P11158, DOI 10.1039/c3cc45597a
   Zhang K, 2013, ANGEW CHEM INT EDIT, V52, P1432, DOI 10.1002/anie.201207163
   Zhang YM, 2014, CHEM COMMUN, V50, P8507, DOI 10.1039/c4cc04012k
   Zhang YG, 2012, CHEM SOC REV, V41, P2083, DOI 10.1039/c1cs15227k
   Zhao MT, 2016, NATURE, V539, P76, DOI 10.1038/nature19763
   Zhao WX, 2013, J MATER CHEM A, V1, P13878, DOI 10.1039/c3ta13334f
   Zhong H, 2016, CHEM-EUR J, V22, P12533, DOI 10.1002/chem.201601956
   Zhong H, 2016, CHEM SCI, V7, P2188, DOI 10.1039/c5sc04351d
   Zhou HC, 2012, CHEM REV, V112, P673, DOI 10.1021/cr300014x
   Zhou HC, 2014, CHEM SOC REV, V43, P5415, DOI 10.1039/c4cs90059f
   Zhu X, 2016, J AM CHEM SOC, V138, P11497, DOI 10.1021/jacs.6b07644
   Zhu X, 2014, CHEM COMMUN, V50, P15055, DOI 10.1039/c4cc07255c
   Zhu X, 2014, CHEM COMMUN, V50, P7933, DOI 10.1039/c4cc01588f
   Zhu X, 2012, J AM CHEM SOC, V134, P10478, DOI 10.1021/ja304879c
   Zhu YL, 2013, CHEM MATER, V25, P1630, DOI 10.1021/cm400019f
   Zimmerman CM, 1997, J MEMBRANE SCI, V137, P145, DOI 10.1016/S0376-7388(97)00194-4
   Zou C, 2010, J MATER CHEM, V20, P731, DOI 10.1039/b917960g
   Zulfiqar S, 2016, J MATER CHEM A, V4, P8190, DOI 10.1039/c6ta01457g
   Zulfiqar S, 2011, ENERG ENVIRON SCI, V4, P4528, DOI 10.1039/c1ee02264d
NR 299
TC 28
Z9 29
U1 35
U2 331
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-7488
EI 2050-7496
J9 J MATER CHEM A
JI J. Mater. Chem. A
PD MAY 21
PY 2017
VL 5
IS 19
BP 8795
EP 8824
DI 10.1039/c6ta11168h
PG 30
WC Chemistry, Physical; Energy & Fuels; Materials Science,
   Multidisciplinary
SC Chemistry; Energy & Fuels; Materials Science
GA EU8VH
UT WOS:000401316100001
DA 2018-12-27
ER

PT J
AU Son, YO
   Pratheeshkumar, P
   Divya, SP
   Zhang, Z
   Shi, XL
AF Son, Young-Ok
   Pratheeshkumar, Poyil
   Divya, Sasidharan Padmaja
   Zhang, Zhuo
   Shi, Xianglin
TI RETRACTED: Nuclear factor erythroid 2-related factor 2 enhances
   carcinogenesis by suppressing apoptosis and promoting autophagy in
   nickel-transformed cells (Retracted article. See vol. 293, pg. 15457,
   2018)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID ROS-DEPENDENT ACTIVATION; DOUBLE-EDGED-SWORD; OXIDATIVE STRESS;
   CANCER-CELLS; SIGNALING PATHWAY; BEAS-2B CELLS; STEM-CELLS; NRF2;
   RESISTANCE; PROTEIN
AB Nickel-containing compounds are widely used in industry. Nickel is a known human carcinogen that primarily affects the lungs. Proposed mechanisms of nickel-induced carcinogenesis include disruption of cellular iron homeostasis, generation of reactive oxygen species (ROS), and induction of hypoxia signaling. However, the precise molecular mechanisms of nickel-induced malignant transformation and tumor development remain unclear. This study shows that the transcription factor Nrf2 is highly expressed in lung tumor tissue and in nickel-transformed human lung bronchial epithelial BEAS-2B cells (NiT cells). Additionally, constitutively high levels of Nrf2 play a critical role in apoptosis resistance in NiT cells. Basal ROS levels were extremely low in NiT cells and were correlated with elevated expression levels of both antioxidant enzymes (e.g. catalase and superoxide dismutases) and antiapoptotic proteins (e.g. Bcl-2 and Bcl-xL). These processes are tightly controlled by Nrf2. Autophagy inhibition, induced pharmacologically or genetically, enhanced Ni2+-induced apoptosis, indicating that the induction of autophagy is the cause of apoptosis resistance in NiT cells. Using similar approaches, we show that in NiT cells the inhibition of apoptosis decreases autophagy. Wehave shown that Stat3, which is up-regulated by Nrf2, controls autophagy induction in NiT cells. Colony formation and tumor growth were significantly attenuated by knockdown of Nrf2 or Bcl-2. Taken together, this study demonstrates that in NiT cells constitutively high Nrf2 expression inhibits apoptosis by up-regulating antioxidant enzymes and antiapoptotic proteins to increase autophagy via Stat3 signaling. These findings indicate that the Nrf2-mediated suppression of apoptosis and promotion of autophagy contribute to nickel-induced transformation and tumorigenesis.
C1 [Son, Young-Ok; Pratheeshkumar, Poyil; Shi, Xianglin] Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40536 USA.
   [Son, Young-Ok; Pratheeshkumar, Poyil; Divya, Sasidharan Padmaja; Zhang, Zhuo; Shi, Xianglin] Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.
   [Son, Young-Ok] Gwangju Inst Sci & Technol, Natl Creat Res Initiat Ctr Osteoarthritis Pathoge, Gwangju 61005, South Korea.
   [Son, Young-Ok] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 61005, South Korea.
RP Shi, XL (reprint author), Univ Kentucky, Coll Med, Ctr Res Environm Dis, Lexington, KY 40536 USA.; Shi, XL (reprint author), Univ Kentucky, Coll Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA.; Son, YO (reprint author), Gwangju Inst Sci & Technol, Natl Creat Res Initiat Ctr Osteoarthritis Pathoge, Gwangju 61005, South Korea.; Son, YO (reprint author), Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 61005, South Korea.
EM sounagi@gist.ac.kr; xshi5@email.uky.edu
OI Son, Youngok/0000-0003-0154-4061
FU National Institutes of Health [R01 ES015518, R01 CA119028, R01 ES015375,
   R01 CA116697]; Biospecimen and Tissue Procurement Shared Resource
   Facility; Cytometry and Cell Sorting Core Facility of the University of
   Kentucky Markey Cancer Center [P30CA177558]; Basic Science Research
   Program through the National Research Foundation of Korea
   [2016R1D1A1B03930327]
FX This work was supported in part by National Institutes of Health Grants
   R01 ES015518, R01 CA119028, R01 ES015375, and R01 CA116697, the
   Biospecimen and Tissue Procurement Shared Resource Facility, and
   Cytometry and Cell Sorting Core Facility of the University of Kentucky
   Markey Cancer Center Grant P30CA177558. The authors declare that they
   have no conflicts of interest with the contents of this article. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.; Supported by Basic Science Research Program through the
   National Research Foundation of Korea Grant 2016R1D1A1B03930327. To whom
   correspondence may be addressed: National Creative Research Initiatives
   Center for Osteoarthritis Pathogenesis and School of Life Sciences,
   Gwangju Institute of Science and Technology, Gwangju 61005, South Korea.
   Tel.: 82-62-715-2545; Fax: 82-62-715-2516; E-mail: sounagi@gist.ac.kr.
CR Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220
   Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200
   Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098
   Chen X, 2016, FREE RADICAL RES, V50, P744, DOI 10.3109/10715762.2016.1173689
   Costa M, 2005, MUTAT RES-FUND MOL M, V592, P79, DOI 10.1016/j.mrfmmm.2005.06.008
   COSTA M, 1991, ANNU REV PHARMACOL, V31, P321
   Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733
   DOLL R, 1970, BRIT J CANCER, V24, P623, DOI 10.1038/bjc.1970.76
   Edwards MR, 2014, CELL REP, V6, P1017, DOI 10.1016/j.celrep.2014.01.043
   Ellen TP, 2009, BIOCHEMISTRY-US, V48, P4626, DOI 10.1021/bi900246h
   Greenhill CJ, 2011, J IMMUNOL, V186, P1199, DOI 10.4049/jimmunol.1002971
   Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724
   He XQ, 2008, CHEM RES TOXICOL, V21, P1375, DOI 10.1021/tx800019a
   INT AGCY RES CANC, 1990, IARC MONOG EVAL CARC, V49, P257
   Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023
   Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713
   Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Ke QD, 2006, CARCINOGENESIS, V27, P1481, DOI 10.1093/carcin/bgl004
   Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723
   Komatsu M, 2011, AUTOPHAGY, V7, P1088, DOI 10.4161/auto.7.9.16474
   Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150
   Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257
   Liu CW, 2016, FREE RADICAL BIO MED, V95, P180, DOI 10.1016/j.freeradbiomed.2016.03.019
   Luwor RB, 2013, J CLIN NEUROSCI, V20, P907, DOI 10.1016/j.jocn.2013.03.006
   Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239
   McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200
   Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657
   MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926
   Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966
   Niture SK, 2013, FREE RADICAL BIO MED, V57, P119, DOI 10.1016/j.freeradbiomed.2012.12.014
   Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694
   Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003
   Oller AR, 1997, TOXICOL APPL PHARM, V143, P152, DOI 10.1006/taap.1996.8075
   Orrenius S, 2013, ANNU REV PHARMACOL, V53, P275, DOI 10.1146/annurev-pharmtox-011112-140210
   Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904
   Pan JJ, 2011, INT J ONCOL, V39, P1285, DOI 10.3892/ijo.2011.1157
   Pan JJ, 2010, CHEM RES TOXICOL, V23, P568, DOI 10.1021/tx9003193
   Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002
   Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039
   Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963
   REDDEL RR, 1988, CANCER RES, V48, P1904
   Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a
   Salnikow Konstantin, 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P307
   Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993
   Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420
   Son YO, 2015, J BIOL CHEM, V290, P27090, DOI 10.1074/jbc.M115.675371
   Son YO, 2014, J BIOL CHEM, V289, P28660, DOI 10.1074/jbc.M114.595496
   Son YO, 2012, TOXICOL APPL PHARM, V264, P153, DOI 10.1016/j.taap.2012.07.028
   Son YO, 2011, TOXICOL APPL PHARM, V255, P287, DOI 10.1016/j.taap.2011.06.024
   Son YO, 2011, TOXICOL SCI, V119, P335, DOI 10.1093/toxsci/kfq335
   Son YO, 2010, TOXICOL SCI, V113, P127, DOI 10.1093/toxsci/kfp259
   Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278
   Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430
   Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826
   Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006
   Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095
   Wang Y, 2016, CLIN SCI, V130, P801, DOI 10.1042/CS20150617
   White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023
   Xue H, 2016, AUTOPHAGY, V12, P1129, DOI 10.1080/15548627.2016.1178446
   Yang XH, 2016, NEUROSCI LETT, V626, P6, DOI 10.1016/j.neulet.2016.05.012
   Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100
   Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735
   Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589
   Zhang ZD, 2016, GENE, V584, P75, DOI 10.1016/j.gene.2016.03.012
NR 67
TC 7
Z9 7
U1 1
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 19
PY 2017
VL 292
IS 20
BP 8315
EP 8330
DI 10.1074/jbc.M116.773986
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA EV5FT
UT WOS:000401788600017
PM 28330870
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Lowrie, C
   Pearson, AL
   Thomson, G
AF Lowrie, Christopher
   Pearson, Amber L.
   Thomson, George
TI RETRACTED: Inequities in coverage of smokefree space policies within the
   United States (Retracted article. See vol. 18, art no 799, 2018)
SO BMC PUBLIC HEALTH
LA English
DT Article; Retracted Publication
DE Smoking; Inequalities; Smokefree spaces; Geography
ID LOCAL HEALTH DEPARTMENTS; TOBACCO USE; CIGARETTE-SMOKING; INITIATION;
   BEHAVIORS; SMOKERS; CANADA; ADULTS; US
AB Background: Previous studies have found extensive geographic and demographic differences in tobacco use. These differences have been found to be reduced by effective public policies, including banning smoking in public spaces. Smokefree indoor and outdoor spaces reduce secondhand smoke exposure and denormalize smoking.
   Methods: We evaluated regional and demographic differences in the proportion of the population covered by smokefree policies enacted in the United States prior to 2014, for both adults and children.
   Results: Significant differences in coverage were found by ethnicity, region, income, and education (p < 0.001). Smokefree policy coverage was lower for jurisdictions with higher proportions of poor households, households with no high school diploma and the Southeast region. Increased ethnic heterogeneity was found to be a significant predictor of coverage in indoor "public spaces generally", meaning that diversity is protective, with differential effect by region (p = 0.004) - which may relate to urbanicity. Children had a low level of protection in playgrounds and schools (similar to 10% covered nationwide) - these spaces were found to be covered at lower rates than indoor spaces.
   Conclusions: Disparities in smokefree space policies have potential to exacerbate existing health inequities. A national increase in smokefree policies to protect children in playgrounds and schools is a crucial intervention to reduce such inequities.
C1 [Lowrie, Christopher; Pearson, Amber L.] Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA.
   [Pearson, Amber L.; Thomson, George] Univ Otago, Dept Publ Hlth, Wellington 6021, New Zealand.
   [Pearson, Amber L.] Michigan State Univ, Environm Sci & Policy Program, E Lansing, MI 48824 USA.
RP Pearson, AL (reprint author), Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA.; Pearson, AL (reprint author), Univ Otago, Dept Publ Hlth, Wellington 6021, New Zealand.
EM apearson@msu.edu
FU Michigan State University's Provost Undergraduate Research Initiative
FX This work received funding support from Michigan State University's
   Provost Undergraduate Research Initiative. The funding body was not
   involved in the design of the study, collection of data, analysis or
   interpretation of data or the writing of the manuscript.
CR Albers AB, 2007, TOB CONTROL, V16, P101, DOI 10.1136/tc.2006.017426
   Aloise-Young PA, 2002, J PEDIATR PSYCHOL, V27, P497, DOI 10.1093/jpepsy/27.6.497
   American Lung Association in California, 2014, BEC POL WONK COMPR O
   American Non-Smokers Rights Foundation, 2010, US TOB CONTR LAWS DA
   Baha M, 2010, PUBLIC HEALTH, V124, P225, DOI 10.1016/j.puhe.2010.02.011
   Barnett R, 2009, SOC SCI MED, V68, P876, DOI 10.1016/j.socscimed.2008.12.012
   Bayer R, 2013, HEALTH AFFAIR, V32, P1291, DOI 10.1377/hlthaff.2012.1022
   BOYLE P, 2004, TOBACCO PUBLIC HLTH
   Centers for Disease Control and Prevention, 2016, TOB IND MARK
   Chahine T, 2011, SOC SCI MED, V73, P752, DOI 10.1016/j.socscimed.2011.06.032
   Chaiton M, 2014, TOB CONTROL, P1
   DiFranza JR, 2006, PEDIATRICS, V117, pE1237, DOI 10.1542/peds.2005-1817
   Gonzalez M, 2013, AM J PUBLIC HEALTH, V103, pE62, DOI 10.2105/AJPH.2012.301045
   Grant JD, 2012, ALCOHOL CLIN EXP RES, V36, P1412, DOI 10.1111/j.1530-0277.2012.01752.x
   Hahn EJ, 2010, AM J PREV MED, V39, pS66, DOI 10.1016/j.amepre.2010.08.013
   Harris JK, 2013, J PUBLIC HEALTH MAN, V19, pE1, DOI 10.1097/PHH.0b013e318252ee8c
   Hood NE, 2014, NICOTINE TOB RES, V16, P828, DOI 10.1093/ntr/ntu007
   Hyland A, 2012, TOB CONTROL, V21, P154, DOI 10.1136/tobaccocontrol-2011-050389
   Jamal A, 2016, MMWR-MORBID MORTAL W, V65, P1205, DOI 10.15585/mmwr.mm6544a2
   Klein EG, 2012, HEALTH PLACE, V18, P1042, DOI 10.1016/j.healthplace.2012.06.002
   Kruger J, 2015, PREV MED, V78, P9, DOI 10.1016/j.ypmed.2015.06.004
   Lawrence EM, 2014, ADV LIFE COURSE RES, V22, P27, DOI 10.1016/j.alcr.2014.03.002
   Leonardi-Bee J, 2011, THORAX, V66, P847, DOI 10.1136/thx.2010.153379
   MacFadyen L, 2001, BRIT MED J, V322, P513, DOI 10.1136/bmj.322.7285.513
   Moore S, 2014, J EPIDEMIOL COMMUN H, V68, P233, DOI 10.1136/jech-2013-202996
   Nguyen Kimberly H, 2016, MMWR Morb Mortal Wkly Rep, V65, P1045, DOI 10.15585/mmwr.mm6539a1
   Nykiforuk CIJ, 2008, HEALTH SOC CARE COMM, V16, P64, DOI 10.1111/j.1365-2524.2007.00727.x
   Parkin DM, 2011, BRIT J CANCER, V105, pS2, DOI 10.1038/bjc.2011.474
   Pierce JP, 2012, TOB CONTROL, V21, P258, DOI 10.1136/tobaccocontrol-2011-050359
   Rayens Mary Kay, 2012, Policy Polit Nurs Pract, V13, P90, DOI 10.1177/1527154412456434
   Reid JL, 2010, CAN J PUBLIC HEALTH, V101, P73
   Rosenblatt RA, 2002, AM J PUBLIC HEALTH, V92, P1102, DOI 10.2105/AJPH.92.7.1102
   Satterlund TD, 2011, J COMMUN HEALTH, V36, P616, DOI 10.1007/s10900-010-9350-6
   Thomson G, 2015, TOB CONTROL, P1
   Tung GJ, 2014, AM J PUBLIC HEALTH, V104, pE92, DOI 10.2105/AJPH.2013.301689
   U.S. Department of Health and Human Services, 2014, HLTH CONSMOK 50 YE
   US Department of Health and Human Services, 2012, PREV TOB US YOUTH AD
   Wadsworth T, 2004, CRIMINOLOGY, V42, P647, DOI 10.1111/j.1745-9125.2004.tb00532.x
   Zablocki RW, 2014, PREV MED, V59, P73, DOI 10.1016/j.ypmed.2013.11.018
NR 39
TC 5
Z9 5
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAY 16
PY 2017
VL 17
AR 456
DI 10.1186/s12889-017-4385-6
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA EV6FV
UT WOS:000401866200006
PM 28511682
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Park, S
   Jeon, HJ
   Son, JW
   Kim, H
   Hong, JP
AF Park, Subin
   Jeon, Hong Jin
   Son, Jung Woo
   Kim, Haesoo
   Hong, Jin Pyo
TI RETRACTED: Correlates, comorbidities, and suicidal tendencies of
   problematic game use in a national wide sample of Korean
   adults(Retracted article. See vol. 11, art no 53, 2017)
SO INTERNATIONAL JOURNAL OF MENTAL HEALTH SYSTEMS
LA English
DT Article; Retracted Publication
DE Problematic game use; Comorbidity; Suicide; Korea
ID INTERNET GAMING DISORDER; VIDEO GAME; SUBSTANCE USE;
   PSYCHIATRIC-DISORDERS; PSYCHOLOGICAL TRAUMA; ADDICTIVE BEHAVIORS;
   CHILDHOOD EXPOSURE; NORWEGIAN ADULTS; DSM-5 CRITERIA; RISK-FACTORS
AB Background: This study aimed to investigate the prevalence, correlates, comorbidities, and suicidal tendencies of problematic game use in a nationally representative sample of Korean adults.
   Methods: Of the 6022 subjects who participated in the 2011 Korean Epidemiologic Catchment Area study and completed the Composite International Diagnostic Interview 2.1, 1397 game users were evaluated for problematic game use using 9-item DSM-5 proposed criteria for Internet gaming disorder. Respondents who responded "yes" to five or more of the nine DSM-5 criteria were considered as problematic game users and the reminders were considered as normal game users.
   Results: 4.0% (56/1397) of game users were classified as a problematic game user. Problematic game users were more likely to be in younger age group and live in urban area compared with normal game user. Problematic game use was positively associated with several psychiatric disorders including nicotine use disorder, depressive disorder, and anxiety disorder, but not associated with alcohol use disorder and obsessive-compulsive disorder, after adjusting for age, sex, and residential area. Problematic game use was significantly and positively associated with suicide plans, after controlling for psychiatric disorders as well as socio-demographic factors.
   Conclusion: Problematic game use is relatively prevalent in Korean adult population and highly comorbid with other psychiatric disorders and suicidality. Therefore, preventive strategy for problematic game use is needed for game users who were more likely to be addicted such as young adults in urban area, and mental health screening and appropriate treatment are needed for individuals with problematic game use.
C1 [Park, Subin] Natl Ctr Mental Hlth, Mental Hlth Res Inst, Dept Res Planning, Seoul, South Korea.
   [Jeon, Hong Jin; Kim, Haesoo; Hong, Jin Pyo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, 81 Irwon Ro Gangnam Gu, Seoul 06351, South Korea.
   [Son, Jung Woo] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Psychiat, Sch Med, Cheongju, South Korea.
RP Hong, JP (reprint author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Psychiat, 81 Irwon Ro Gangnam Gu, Seoul 06351, South Korea.
EM suhurhong@gmail.com
FU Korea Healthcare Technology R&D project, Ministry of Health and Welfare,
   Republic of Korea [HI12C0035]; Korean Ministry of Health and Welfare
FX This study was supported by the research grant from the Korean Ministry
   of Health and Welfare and Korea Healthcare Technology R&D project,
   Ministry of Health and Welfare, Republic of Korea. [Grant Number
   HI12C0035].
CR American Psychiatric Association, 2013, DIAGN STAT MAN MENT
   American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Andreassen CS, 2016, PSYCHOL ADDICT BEHAV, V30, P252, DOI 10.1037/adb0000160
   Bakken IJ, 2009, SCAND J PSYCHOL, V50, P121, DOI 10.1111/j.1467-9450.2008.00685.x
   BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x
   Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c
   Carli V, 2013, PSYCHOPATHOLOGY, V46, P1, DOI 10.1159/000337971
   Carra G, 2017, SUBST USE MISUSE, V52, P451, DOI 10.1080/10826084.2016.1240696
   Carra G, 2014, J AFFECT DISORDERS, V167, P125, DOI 10.1016/j.jad.2014.05.066
   Cho MJ, 2015, PSYCHIAT INVEST, V12, P164, DOI 10.4306/pi.2015.12.2.164
   Cho MJ, 2002, J KOREAN NEUROPSYCHI, V41, P123
   Desai RA, 2010, PEDIATRICS, V126, pE1414, DOI 10.1542/peds.2009-2706
   Festl R, 2013, ADDICTION, V108, P592, DOI 10.1111/add.12016
   Gentile DA, 2011, PEDIATRICS, V127, pE319, DOI 10.1542/peds.2010-1353
   Guillot CR, 2016, COMPUT HUM BEHAV, V62, P475, DOI 10.1016/j.chb.2016.04.019
   Haagsma MC, 2012, CYBERPSYCH BEH SOC N, V15, P162, DOI 10.1089/cyber.2011.0248
   Kessler RC, 1999, ARCH GEN PSYCHIAT, V56, P617, DOI 10.1001/archpsyc.56.7.617
   Kim NR, 2016, PSYCHIAT INVEST, V13, P58, DOI 10.4306/pi.2016.13.1.58
   KISA, 2010, SURV INT US
   Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011
   Ko CH, 2009, ARCH PEDIAT ADOL MED, V163, P937, DOI 10.1001/archpediatrics.2009.159
   Kuss DJ, 2011, INT J ENV RES PUB HE, V8, P3528, DOI 10.3390/ijerph8093528
   Lemmens JS, 2015, PSYCHOL ASSESSMENT, V27, P567, DOI 10.1037/pas0000062
   Lemmens JS, 2009, MEDIA PSYCHOL, V12, P77, DOI 10.1080/15213260802669458
   Lo SK, 2005, CYBERPSYCHOL BEHAV, V8, P15, DOI 10.1089/cpb.2005.8.15
   Martinotti G, 2008, AM J DRUG ALCOHOL AB, V34, P177, DOI 10.1080/00952990701877078
   Martinotti G, 2015, HUM PSYCHOPHARM CLIN, V30, P295, DOI 10.1002/hup.2486
   Mentzoni RA, 2011, CYBERPSYCH BEH SOC N, V14, P591, DOI 10.1089/cyber.2010.0260
   Messias E, 2011, SUICIDE LIFE-THREAT, V41, P307, DOI 10.1111/j.1943-278X.2011.00030.x
   Park S, 2015, PSYCHIAT INVEST, V12, P171, DOI 10.4306/pi.2015.12.2.171
   Park S, 2014, PSYCHIAT RES, V219, P443, DOI 10.1016/j.psychres.2014.06.009
   Park S, 2013, AUST NZ J PSYCHIAT, V47, P153, DOI 10.1177/0004867412463613
   Park S, 2010, SOC PSYCH PSYCH EPID, V45, P621, DOI 10.1007/s00127-009-0102-9
   Pearce J, 2008, J EPIDEMIOL COMMUN H, V62, P862, DOI 10.1136/jech.2007.068114
   Petry NM, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0610-0
   Porter G, 2010, AUST NZ J PSYCHIAT, V44, P120, DOI 10.3109/00048670903279812
   Przybylski AK, 2013, COMPUT HUM BEHAV, V29, P1841, DOI 10.1016/j.chb.2013.02.014
   Rehbein F, 2015, ADDICTION, V110, P842, DOI 10.1111/add.12849
   Rehbein F, 2010, CYBERPSYCH BEH SOC N, V13, P269, DOI 10.1089/cyber.2009.0227
   Swing EL, 2010, PEDIATRICS, V126, P214, DOI 10.1542/peds.2009-1508
   Vadlin S, 2016, ADDICT BEHAV, V61, P8, DOI 10.1016/j.addbeh.2016.05.001
   van Rooij AJ, 2014, J BEHAV ADDICT, V3, P157, DOI 10.1556/JBA.3.2014.013
   van Rooij AJ, 2011, ADDICTION, V106, P205, DOI 10.1111/j.1360-0443.2010.03104.x
   Walther B, 2012, EUR ADDICT RES, V18, P167, DOI 10.1159/000335662
   Wenzel HG, 2009, PSYCHOL REP, V105, P1237, DOI 10.2466/PR0.105.F.1237-1247
   *WHO, 1997, PROC DEV NEW LANG VE
   Winer ES, 2016, ARCH SUICIDE RES, V20, P265, DOI 10.1080/13811118.2015.1025119
   World Health Organization, 1990, COMP INT DIAGN INT C
NR 48
TC 3
Z9 4
U1 2
U2 11
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1752-4458
J9 INT J MENT HEALTH SY
JI Int. J. Ment. Health Syst.
PD MAY 11
PY 2017
VL 11
AR 35
DI 10.1186/s13033-017-0143-5
PG 7
WC Psychiatry
SC Psychiatry
GA EU8LB
UT WOS:000401289300001
PM 28503193
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Pritchard, HD
AF Pritchard, Hamish D.
TI RETRACTED: Asia's glaciers are a regionally important buffer against
   drought (Retracted article. See vol. 555, 2018)
SO NATURE
LA English
DT Article; Retracted Publication
ID INDUS BASIN; KARAKORAM-HIMALAYA; PRECIPITATION DATA; RIVER-BASIN; SWAT
   MODEL; MASS-LOSS; CLIMATE; MANAGEMENT; YIELD; INDIA
AB The high mountains of Asia-encompassing the Himalayas, the Hindu Kush, Karakoram, Pamir Alai, Kunlun Shan, and Tian Shan mountains-have the highest concentration of glaciers globally, and 800 million people depend in part on meltwater from them. Water stress makes this region vulnerable economically and socially to drought, but glaciers are a uniquely drought-resilient source of water. Here I show that these glaciers provide summer meltwater to rivers and aquifers that is sufficient for the basic needs of 136 million people, or most of the annual municipal and industrial needs of Pakistan, Tajikistan, Turkmenistan, Uzbekistan and Kyrgyzstan. During drought summers, meltwater dominates water inputs to the upper Indus and Aral river basins. Uncertainties in mountain precipitation are poorly known, but, given the magnitude of this water supply, predicted glacier loss would add considerably to drought-related water stress. Such additional water stress increases the risk of social instability, conflict and sudden, uncontrolled population migrations triggered by water scarcity, which is already associated with the large and rapidly growing populations and hydroeconomies of these basins.
C1 [Pritchard, Hamish D.] British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England.
RP Pritchard, HD (reprint author), British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England.
EM hprit@bas.ac.uk
CR Abbaspour KC, 2007, J HYDROL, V333, P413, DOI 10.1016/j.jhydrol.2006.09.014
   Abeysingha NS, 2015, CURR SCI INDIA, V108, P2202
   [Anonymous], 2016, UNEP ENV DAT EXPL CO
   Arendt A, 2015, RANDOLPH GLACIER INV
   Arnold J.G., 2012, SOIL WATER ASSESSMEN
   Berthier E, 2007, REMOTE SENS ENVIRON, V108, P327, DOI 10.1016/j.rse.2006.11.017
   Bolch T, 2012, SCIENCE, V336, P310, DOI 10.1126/science.1215828
   Bolch T, 2011, CRYOSPHERE, V5, P349, DOI 10.5194/tc-5-349-2011
   Bookhagen B, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001426
   Dahri ZH, 2016, SCI TOTAL ENVIRON, V548, P289, DOI 10.1016/j.scitotenv.2016.01.001
   Dyurgerov M. B., 2005, 58 UNSTAAR U COL
   Farinotti D, 2015, NAT GEOSCI, V8, P716, DOI 10.1038/NGEO2513
   Frey H, 2014, CRYOSPHERE, V8, P2313, DOI 10.5194/tc-8-2313-2014
   Gassert F., 2013, AQUEDUCT GLOBAL MAPS
   George C., 2008, OPEN HYDROL J, V2, P1, DOI DOI 10.2174/1874378100802010001
   Hewitt K, 2011, MT RES DEV, V31, P188, DOI 10.1659/MRD-JOURNAL-D-11-00020.1
   Hijioka Y, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1327
   Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188
   International Monetary Fund, 2015, ISS MAN WAT CHALL PO
   Kaab A, 2015, CRYOSPHERE, V9, P557, DOI 10.5194/tc-9-557-2015
   Kaser G, 2010, P NATL ACAD SCI USA, V107, P20223, DOI 10.1073/pnas.1008162107
   Laghari AN, 2012, HYDROL EARTH SYST SC, V16, P1063, DOI 10.5194/hess-16-1063-2012
   Lehner B, 2011, FRONT ECOL ENVIRON, V9, P494, DOI 10.1890/100125
   Malsy M, 2015, ENVIRON EARTH SCI, V73, P787, DOI 10.1007/s12665-014-3107-y
   National Research Council, 2012, HIM GLAC CLIM CHANG
   New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001
   Qi W, 2016, HYDROL EARTH SYST SC, V20, P903, DOI 10.5194/hess-20-903-2016
   Saha S., 2010, NCEP CLIMATE FORECAS
   Sakai A, 2015, CRYOSPHERE, V9, P865, DOI 10.5194/tc-9-865-2015
   Savoskul O. S., 2013, 149 IWMI
   Schaner N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034029
   Schleussner CF, 2016, P NATL ACAD SCI USA, V113, P9216, DOI 10.1073/pnas.1601611113
   Singh P, 2005, J HYDROL, V300, P140, DOI 10.1016/j.jhydrol.2004.06.005
   Singh P, 2002, HYDROLOG SCI J, V47, P93, DOI 10.1080/02626660209492910
   Srinivasan R, 2010, T ASABE, V53, P1533
   STOCKER T. F, 2013, CLIMATE CHANGE 2013
   Strauch M, 2017, CLIMATIC CHANGE, V141, P547, DOI 10.1007/s10584-016-1706-1
   Trucost, 2013, NAT CAP RISK TOP 100
   Van Liew MW, 2003, J AM WATER RESOUR AS, V39, P413, DOI 10.1111/j.1752-1688.2003.tb04395.x
   World Economic Forum, 2016, GLOB RISKS REP 2016
   Wu KS, 2007, J HYDROL, V337, P187, DOI 10.1016/j.jhydrol.2007.01.030
   Yatagai A, 2012, B AM METEOROL SOC, V93, P1401, DOI 10.1175/BAMS-D-11-00122.1
   Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0
   Zemp M, 2015, J GLACIOL, V61, P745, DOI 10.3189/2015JoG15J017
NR 44
TC 36
Z9 38
U1 11
U2 86
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 11
PY 2017
VL 545
IS 7653
BP 169
EP +
DI 10.1038/nature22062
PG 19
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EU3XG
UT WOS:000400963800024
PM 28492255
DA 2018-12-27
ER

PT J
AU Sarka, K
   Danielache, SO
   Kondorskiy, A
   Nanbu, S
AF Sarka, Karolis
   Danielache, Sebastian O.
   Kondorskiy, Alexey
   Nanbu, Shinkoh
TI RETRACTED: Theoretical study of electronic properties and isotope
   effects in the UV absorption spectrum of disulfur (Retracted article.
   See vol. 508, pg. 61, 2018)
SO CHEMICAL PHYSICS
LA English
DT Article; Retracted Publication
DE Potential energy curves; Absorption cross-section; Photodissociation;
   Isotope effects
ID MASS-INDEPENDENT FRACTIONATION; SULFUR ISOTOPES; ATMOSPHERE; EARTH; S2;
   PHOTOEXCITATION; HISTORY; CLIMATE; METHANE; ORIGIN
AB The electronic structures of triplet S-2 ground and excited states are studied by ab initio molecular orbital and configuration interaction calculation. Potential energy curves correlated with S(P-3) + S(P-3) and S(P-3) + S(D-1) at the dissociation limit are evaluated, and electronic terms for a total of 11 states are assigned. Transition dipole moments, as a function of internuclear distance, are determined for two allowed transitions to 1(3) IIu and 1(3)Sigma(-)(u) excited states. Furthermore, the total absorption cross-sections are computed to estimate isotope-fractionation constants, epsilon, for four most common isotopologues: (SS)-S-32-S-32, (SS)-S-32-S-33, (SS)-S-32-S-34, and (SS)-S-32-S-36 by quantum close-coupling (R-matrix) expansion approach. Zero-point energy based constants epsilon(ZPE) are estimated as well to compare with the obtained isotope effects. Three-isotope plots are shown to express mass-independent fractionation effect; large isotopic effects were found on 365 and S-33 in 230-240 nm range, and only on S-36 in 240-267 nm range. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Sarka, Karolis; Danielache, Sebastian O.; Nanbu, Shinkoh] Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.
   [Kondorskiy, Alexey] Russian Acad Sci, PN Lebedev Phys Inst, 53 Leninskiy Pr, Moscow 119991, Russia.
RP Nanbu, S (reprint author), Sophia Univ, Fac Sci & Technol, Dept Mat & Life Sci, Chiyoda Ku, 7-1 Kioi Cho, Tokyo 1028554, Japan.
EM shinkoh.nanbu@sophia.ac.jp
RI Kondorskiy, Alexey/N-2531-2015
OI Kondorskiy, Alexey/0000-0003-4412-565X; Sarka,
   Karolis/0000-0002-3219-7317
FU Japanese Government (Monbukagakusho: MEXT) Scholarship; The Sophia
   University Special Grant
FX The authors want to thank Prof. Ikuo Tokue for the discussions on
   electronic structure. This work was supported by the Japanese Government
   (Monbukagakusho: MEXT) Scholarship and The Sophia University Special
   Grant for Academic Research, Research on Optional Subjects.
CR BARROW RF, 1969, J PHYS PT B ATOM M P, V2, P413, DOI 10.1088/0022-3700/2/3/312
   BREWER L, 1965, J CHEM PHYS, V42, P1385, DOI 10.1063/1.1696125
   Cockell CS, 2001, PHOTOCHEM PHOTOBIOL, V73, P447, DOI 10.1562/0031-8655(2001)073<0447:THOTUR>2.0.CO;2
   Danielache S. O., J CHEM PHYS, V140
   Danielache S. O., J GEOPHYS RES ATMOS, V113
   Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6
   Gaillard F, 2011, NATURE, V478, P229, DOI 10.1038/nature10460
   Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197
   Hattori S, 2013, P NATL ACAD SCI USA, V110, P17656, DOI 10.1073/pnas.1213153110
   Herzberg G., 1957, MOL SPECTRA MOL STRU
   Irikura KK, 2007, J PHYS CHEM REF DATA, V36, P389, DOI 10.1063/1.2436891
   Kasting JF, 2001, SCIENCE, V293, P819, DOI 10.1126/science.1063811
   KNOWLES PJ, 1985, CHEM PHYS LETT, V115, P259, DOI 10.1016/0009-2614(85)80025-7
   MAEDER R, 1948, NATURE, V161, P393, DOI 10.1038/161393a0
   MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030
   MEAKIN JE, 1962, CAN J PHYS, V40, P377, DOI 10.1139/p62-040
   Ono S, 2003, EARTH PLANET SC LETT, V213, P15, DOI 10.1016/S0012-821X(03)00295-4
   Ono SH, 2009, PRECAMBRIAN RES, V169, P48, DOI 10.1016/j.precamres.2008.10.012
   Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134
   Radzig A. A., 1985, REFERENCE DATA ATOMS
   RICKS JM, 1969, CAN J PHYS, V47, P2423, DOI 10.1139/p69-297
   Shiozaki T, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3528720
   SMITH WH, 1969, J QUANT SPECTROSC RA, V9, P1191, DOI 10.1016/0022-4073(69)90106-X
   Ueno Y, 2009, P NATL ACAD SCI USA, V106, P14784, DOI 10.1073/pnas.0903518106
   Werner H.-J., 2012, MOLPRO
   WERNER HJ, 1988, J CHEM PHYS, V89, P5803, DOI 10.1063/1.455556
   Whitehill AR, 2013, P NATL ACAD SCI USA, V110, P17697, DOI 10.1073/pnas.1306979110
   Whitehill AR, 2012, GEOCHIM COSMOCHIM AC, V94, P238, DOI 10.1016/j.gca.2012.06.014
   Wigner E, 1928, Z PHYS, V51, P859, DOI 10.1007/BF01400247
   Yung YL, 1997, SCIENCE, V278, P1778, DOI 10.1126/science.278.5344.1778
   Zahnle K, 2006, GEOBIOLOGY, V4, P271, DOI 10.1111/j.1472-4669.2006.00085.x
NR 31
TC 2
Z9 2
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-0104
EI 1873-4421
J9 CHEM PHYS
JI Chem. Phys.
PD MAY 11
PY 2017
VL 488
BP 36
EP 42
DI 10.1016/j.chemphys.2017.03.005
PG 7
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA ET3ZD
UT WOS:000400217600006
DA 2018-12-27
ER

PT J
AU Soh, B
   Chan, S
AF Soh, Bryan
   Chan, Steven
TI RETRACTED: The use of super-selective mesenteric embolisation as a
   first-line management of acute lower gastrointestinal bleeding
   (Retracted article. See vol. 26, pg. 43, 2018)
SO ANNALS OF MEDICINE AND SURGERY
LA English
DT Article; Retracted Publication
DE Lower gastrointestinal bleeding; Mesenteric embolisation; Angiography
ID SUPERSELECTIVE EMBOLIZATION; MICROCOIL EMBOLIZATION; CLINICAL-OUTCOMES;
   RISK-FACTORS; HEMORRHAGE; LOCALIZATION; ANGIOGRAPHY; DIAGNOSIS
AB Introduction: In this study, we aim to assess the efficacy and safety of digital subtraction angiography (DSA) and super-selective mesenteric artery embolisation in managing lower gastrointestinal bleeding (LGIB) at a multi-centre health service in Melbourne (Australia).
   Method: A retrospective case series of patients with LGIB treated with superselective embolisation in our area health service. Patients with confirmed active LGIB, on either radionuclide scintigraphy (RS) or contrast-enhanced multi-detector CT angiography (CE-MDCT), were referred for DSA, and subsequently endovascular intervention. Data collected included patient characteristics; screening modality; bleeding territory; embolisation technique; technical and clinical success; short to mediumterm complications and mortality up to 30 days; and the need for surgery related to procedural failure or complications.
   Results: There were 55 hospital admissions with acute unstable lower gastrointestinal bleeding that were demonstrable on CE-MDCT or RS over a 30-month period (from 1 January 2014 to 30 June 2016). Of these, eighteen patients were embolised. Immediate haemostasis was achieved in all embolised cases. Eight patients (44%) had clinical re-bleeding postembolisation and warranted repeated imaging. However, only one case (5.6%) had active bleeding identified and was re-embolised. There was no documented case of bowel ischemia or ischemic-stricture and none progressed on to surgery. 30 day mortality was zero.
   Conclusion: Super-selective mesenteric embolisation is a viable, safe and effective first line management for localised LGIB. Our results overall compare favourably with the published experiences of other institutions. It is now accepted first-line practice at our institution to manage localised LGIB with embolisation. (C) 2017 The Author(s). Published by Elsevier Ltd on behalf of IJS Publishing Group Ltd.
C1 [Soh, Bryan; Chan, Steven] Western Hlth, Dept Surg, 160 Furlong Rd, Melbourne, Vic 3011, Australia.
   [Chan, Steven] Univ Melbourne, Melbourne Med Sch Western Precinct, Western Hlth, Sunshine Hosp, 176 Furlong Rd, Melbourne, Vic 3021, Australia.
RP Soh, B (reprint author), Unit 1,20 Peace St, Melbourne, Vic 3146, Australia.
EM bryansoh@gmail.com
CR Abbas SM, 2005, ANZ J SURG, V75, P953, DOI 10.1111/j.1445-2197.2005.03582.x
   Agha RA, 2016, INT J SURG, V36, P319, DOI 10.1016/j.ijsu.2016.10.025
   Barnert J, 2009, NAT REV GASTRO HEPAT, V6, P637, DOI 10.1038/nrgastro.2009.167
   Beejay U, 2002, CURR OPIN GASTROEN, V18, P87, DOI 10.1097/00001574-200201000-00015
   Burgess AN, 2004, ANZ J SURG, V74, P635, DOI 10.1111/j.1445-1433.2004.03109.x
   d'Othee BJ, 2006, CARDIOVASC INTER RAD, V29, P49, DOI 10.1007/s00270-004-0301-4
   Edelman DA, 2007, SURG ENDOSC, V21, P514, DOI 10.1007/s00464-006-9191-7
   Farrell JJ, 2005, ALIMENT PHARM THER, V21, P1281, DOI 10.1111/j.1365-2036.2005.02485.x
   Foley PT, 2010, J MED IMAG RADIAT ON, V54, P9, DOI 10.1111/j.1754-9485.2010.02131.x
   Funaki B, 2004, ABDOM IMAGING, V29, P434, DOI 10.1007/s00261-003-0150-7
   Green BT, 2005, AM J GASTROENTEROL, V100, P2395, DOI 10.1111/j.1572-0241.2005.00306.x
   GUY GE, 1992, AM J ROENTGENOL, V159, P521, DOI 10.2214/ajr.159.3.1503016
   Joo I, 2009, WORLD J GASTROENTERO, V15, P4023, DOI 10.3748/wjg.15.4023
   Karanicolas PJ, 2008, CAN J SURG, V51, P437
   Karner-Hanusch J., 2002, EUR SURG, V34, P230
   Kim JH, 2009, KOREAN J RADIOL, V10, P384, DOI 10.3348/kjr.2009.10.4.384
   Koh DC, 2009, COLORECTAL DIS, V11, P53, DOI 10.1111/j.1463-1318.2008.01536.x
   Kramer SC, 2000, EUR RADIOL, V10, P802, DOI 10.1007/s003300051007
   Kwak HS, 2009, KOREAN J RADIOL, V10, P391, DOI 10.3348/kjr.2009.10.4.391
   Ledermann HP, 1999, CARDIOVASC INTER RAD, V22, P315, DOI 10.1007/s002709900395
   Lipof T, 2008, DIS COLON RECTUM, V51, P301, DOI 10.1007/s10350-007-9149-4
   Maleux G, 2009, AM J GASTROENTEROL, V104, P2042, DOI 10.1038/ajg.2009.186
   O'Grady Helen L, 2008, Clin Colon Rectal Surg, V21, P188, DOI 10.1055/s-2008-1080998
   Padia SA, 2007, CLEV CLIN J MED, V74, P417, DOI 10.3949/ccjm.74.6.417
   Rider PF, 2009, 2009 ASCRS ANN SCI M
   Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021
   Tan KK, 2008, WORLD J SURG, V32, P2707, DOI 10.1007/s00268-008-9759-6
   Waugh J, 2004, Australas Radiol, V48, P311, DOI 10.1111/j.0004-8461.2004.01313.x
   Weldon DT, 2008, EUR RADIOL, V18, P857, DOI 10.1007/s00330-007-0844-2
   Zink SI, 2008, AM J ROENTGENOL, V191, P1107, DOI 10.2214/AJR.07.3642
NR 30
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2049-0801
J9 ANN MED SURG
JI Ann. Med. Surg.
PD MAY
PY 2017
VL 17
BP 27
EP 32
DI 10.1016/j.amsu.2017.03.022
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA FI0QJ
UT WOS:000411633700006
PM 28392914
OA Other Gold, Green Published
DA 2018-12-27
ER

PT J
AU Shah, AF
   Batra, M
   Qureshi, A
AF Shah, Aasim Farooq
   Batra, Manu
   Qureshi, Ambrina
TI RETRACTED: Evaluation of Impact of Pregnancy on Oral Health Status and
   Oral Health Related Quality of Life among Women of Kashmir Valley
   (Retracted article. See vol. 12, pg. ZZ1-ZZ1, 2018)
SO JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
LA English
DT Article; Retracted Publication
DE Postpartum females; Pregnant women; Periodontal disease
ID HUMAN GINGIVA; POSTPARTUM; GUIDELINES; DISEASE; CARE
AB Introduction: Oral health is a key component of overall health and wellbeing of women throughout life; and particularly important prior to conception and during pregnancy. Pregnancy affects both general health as well as the oral health related quality of life.
   Aim: To assess the difference in oral health status and related quality of life among pregnant, postpartum and non pregnant women of Kashmir valley.
   Materials and Methods: The present cross-sectional study was conducted among a convenient sample of 900 women (2237 years) attending Sheri-Kashmir Institute of Medical Sciences (SKIMS) Maternity Hospital, Srinagar, Jammu and Kashmir, India. Sample included 300 pregnant, 280 postpartum women and 320 non pregnant women of matched age group. Pretested and validated proforma for Oral Health Related Quality of Life (OHRQoL) Questionnaire designed in local language was used. Oral health was assessed using Oral Hygiene Index Simplified Index (OHIS), Gingival Index (GI) and Decayed Missing Filled Teeth/Surface Index (DMFT/DMFS). Mean differences were carried out using Kruskal-Wallis one-way ANOVA. Correlation analysis was performed to analyse their relationship with Oral Health Impact Profile (OHIP-14) score. Post-hoc Tukey test was employed for comparing the means within the three trimesters of the pregnant group.
   Results: Pregnant women presented with significantly higher periodontal disease (p=0.05). Decayed Missing and Filled Teeth index (DMFT) showed no difference within the groups. Comparison for the mean OHIP-14 presented significantly poorer scores among the pregnant women.
   Conclusion: Pregnancy had an influence only on the gingiva and not on periodontal attachment levels. However, oral health status and perceived OHRQoL were poorer among pregnant women. The present study draws attention toward the need for highlighting the importance of conserving oral health during pregnancy.
C1 [Shah, Aasim Farooq] Govt Coll & Hosp, Dept Publ Hlth Dent, Srinagar 190010, Jammu & Kashmir, India.
   [Batra, Manu] UCMS Coll Dent Surg, Dept Community & Prevent Dent, Siddharthanagar, Nepal.
   [Qureshi, Ambrina] Dow Univ Hlth Sci, Dept Community & Prevent Dent, Dr Ishrat ul Ebad Khan Inst Oral Hlth Sci, Karachi, Pakistan.
RP Shah, AF (reprint author), Govt Coll & Hosp, Dept Publ Hlth Dent, Srinagar 190010, Jammu & Kashmir, India.
EM dr_aasimshah@yahoo.com
CR Acharya S, 2009, INT J DENT HYG, V7, P102, DOI 10.1111/j.1601-5037.2008.00351.x
   Atchison K A, 1990, J Dent Educ, V54, P680
   Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
   Cornejo Celina, 2013, Acta odontol. latinoam., V26, P68
   Diwaker G., 2016, EC DENT SCI, V6, P1240
   ELATTAR TMA, 1976, PROSTAG OTH LIPID M, V11, P331, DOI 10.1016/0090-6980(76)90155-6
   GREENE JC, 1964, J AM DENT ASSOC, V68, P7, DOI 10.14219/jada.archive.1964.0034
   Gupta R, 2016, SCIENTIFICA, DOI 10.1155/2016/9860387
   Gupta S, 2015, J CLIN DIAGN RES, V9, pZC26, DOI 10.7860/JCDR/2015/13819.6756
   Hemalatha VT, 2013, J CLIN DIAGN RES, V7, P948, DOI 10.7860/JCDR/2013/5405.2986
   Hullah E, 2008, ARCH GYNECOL OBSTET, V277, P405, DOI 10.1007/s00404-007-0480-8
   Junior Almeido AA, 2005, PESQ BRAS ODONTOPED, V5, P59
   Kandan PM, 2011, J PAK MED ASSOC, V61, P1009
   Kim HY, 2009, COMMUNITY DENT ORAL, V37, P468, DOI 10.1111/j.1600-0528.2009.00489.x
   Kumar S, 2013, J CLIN EXPT DENTISTR, V5, P72
   Lamarca GA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-5
   LOE HARALD, 1963, ACTA ODONTOL SCAND, V21, P533, DOI 10.3109/00016356309011240
   Lu HX, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0267-8
   OJANOTKOHARRI A, 1985, J STEROID BIOCHEM, V23, P1031, DOI 10.1016/0022-4731(85)90063-9
   Onigbinde OO, 2014, ANN MED HEALTH SCI R, V4, P852, DOI 10.4103/2141-9248.144876
   Radnai M, 2007, COMMUNITY DENT HLTH, V24, P111
   Sajjan Parappa, 2015, J Int Oral Health, V7, P1
   Salvado BA, 1999, JBP J ODONTOL BEBE, V2, P96
   Sarlati Fatemeh, 2004, J Int Acad Periodontol, V6, P95
   Slade GD, 1997, COMMUNITY DENT ORAL, V25, P284, DOI 10.1111/j.1600-0528.1997.tb00941.x
   Slade GD, 1996, J DENT RES, V75, P1439, DOI 10.1177/00220345960750070301
   Tilakaratne A, 2000, J CLIN PERIODONTOL, V27, P787, DOI 10.1034/j.1600-051x.2000.027010787.x
   Trindade DR, 2000, ORAL CONDITION PREGN
   Vasiliauskiene I, 2003, STOMATOLOGIJA, V5, P57
   Vasiliauskiene Ingrida, 2007, Stomatologija, V9, P129
   World Health Organization WHO, 1987, OR HLTH SURV BAS MET
   Yalcin F, 2002, J PERIODONTOL, V73, P178, DOI 10.1902/jop.2002.73.2.178
NR 32
TC 1
Z9 1
U1 1
U2 6
PU PREMCHAND SHANTIDEVI RESEARCH FOUNDATION
PI DELHI
PA 71 JAIN COLONY, VEER NAGAR, DELHI, 110 007, INDIA
SN 2249-782X
EI 0973-709X
J9 J CLIN DIAGN RES
JI J. Clin. Diagn. Res.
PD MAY
PY 2017
VL 11
IS 5
AR UNSP ZC01-ZC04
DI 10.7860/JCDR/2017/25862.9769
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA FA1IY
UT WOS:000405194100123
PM 28658896
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Alagkiozidis, I
   Gorelick, C
   Shah, T
   Chen, YJA
   Gupta, V
   Stefanov, D
   Amarnani, A
   Lee, YC
   Abulafia, O
   Sarafraz-Yazdi, E
   Michl, J
AF Alagkiozidis, Ioannis
   Gorelick, Constantine
   Shah, Tana
   Chen, Yi-Ju Amy
   Gupta, Vinita
   Stefanov, Dimitre
   Amarnani, Abhi
   Lee, Yi-Chun
   Abulafia, Ovadia
   Sarafraz-Yazdi, Ehsan
   Michl, Josef
TI RETRACTED: Synergy between Paclitaxel and Anti-Cancer Peptide PNC-27 in
   the Treatment of Ovarian Cancer(Retracted article. See vol.47, pg.0,
   2017)
SO ANNALS OF CLINICAL AND LABORATORY SCIENCE
LA English
DT Article; Retracted Publication
ID CANCER-CELLS; CYTOTOXIC DRUGS; OVARIAN-CANCER; P53; RESISTANCE; BINDING;
   AGENTS; MODEL
AB Objectives. Paclitaxel is widely used in the treatment of gynecologic malignancies. It targets tumor cells in the M phase of the cell cycle. Cells in other phases survive the insult and repopulate the tumor. PNC-27 is a peptide synthesized of amino acids of the p53-MDM-2 binding domain. It kills various cancer cell lines in a dose-dependent manner. The goal of this study is to assess ovarian cancer cells' sensitivity to PNC-27 after surviving exposure to paclitaxel and to investigate the potential for synergy between PNC-27 and paclitaxel in the treatment of ovarian cancer. Methods. The impact of exposure to paclitaxel on the surface expression of MDM-2 was assessed with the use of flow cytometry. For measurement of cytotoxicity in vitro, ID8 cells were exposed to paclitaxel for 12 hours in various concentrations. At 12 hours, the drug containing media was removed and the cells were cultured in media containing various concentrations of PNC-27 for 24 hours. Viability was assessed with the use of an MTT assay. Survival fractions were plotted against drug concentrations and the data were fit to logistic dose-response curves. Isoeffective combinations were used to create isobolograms. The combined treatment with weekly paclitaxel and PNC-27 was tested in an intraperitoneal mouse model of ovarian cancer (ID8). Results. Exposure to paclitaxel rendered incomplete time-dependent killing, while PNC-27 mediated comprehensive, dose-dependent killing of ID8 cells. The cytotoxic effect of PNC-27 was dependent on its binding to MDM-2. Blocking MDM-2 inhibited the killing by PNC-27. ID8 cells surviving paclitaxel demonstrated increased expression of MDM-2 and increased susceptibility to PNC-27. Isobologram for dose combinations that were isoeffective indicates synergistic effect between the 2 agents (Combination index < 1). In an in vivo model of ovarian cancer (ID8), the addition of PNC-27 to weekly paclitaxel administration significantly reduces tumor growth. Conclusions. These data demonstrate synergism between PNC-27 and paclitaxel. PNC-27 could target cells surviving paclitaxel and improve its antitumor effect.
C1 [Alagkiozidis, Ioannis; Gorelick, Constantine; Shah, Tana; Chen, Yi-Ju Amy; Gupta, Vinita; Amarnani, Abhi; Lee, Yi-Chun; Abulafia, Ovadia; Sarafraz-Yazdi, Ehsan; Michl, Josef] Suny Downstate Med Ctr, Dept Gynecol Oncol, Brooklyn, NY 11203 USA.
   [Stefanov, Dimitre] Suny Downstate Med Ctr, Dept Epidemiol & Biostat, Brooklyn, NY 11203 USA.
RP Alagkiozidis, I (reprint author), Bronx Lebanon Hosp Ctr, Dept Obstet & Gynecol, 1650 Grand Concourse, Bronx, NY 10457 USA.
EM alagkiozidis@gmail.com
CR Alagkiozidis I, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-77
   Cho S, 2013, ANTICANCER RES, V33, P1317
   Do TN, 2003, ONCOGENE, V22, P1431, DOI 10.1038/sj.onc.1206258
   Durand R E, 1989, Cancer Commun, V1, P277
   Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884
   Gieseler F, 2003, INT J COLORECTAL DIS, V18, P470, DOI 10.1007/s00384-003-0496-x
   HAMILTON TC, 1983, CANCER RES, V43, P5379
   Horwitz S. B., 1994, ANN ONCOL, V5, pS3
   Kanovsky M, 2001, P NATL ACAD SCI USA, V98, P12438, DOI 10.1073/pnas.211280698
   Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710
   May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285
   Micheau O, 1997, J NATL CANCER I, V89, P783, DOI 10.1093/jnci/89.11.783
   Moll UM, 2003, MOL CANCER RES, V1, P1001
   Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585
   Rosal R, 2004, BIOCHEMISTRY-US, V43, P1854, DOI 10.1021/bi035718g
   Sarafraz-Yazdi E, 2014, CURR MED CHEM, V21, P1618, DOI 10.2174/09298673113209990223
   Sarafraz-Yazdi E, 2010, P NATL ACAD SCI USA, V107, P1918, DOI 10.1073/pnas.0909364107
   Wagenpfeil S, 2006, ARTIF INTELL MED, V37, P65, DOI 10.1016/j.artmed.2005.01.011
   WALLE T, 1995, DRUG METAB DISPOS, V23, P506
NR 19
TC 1
Z9 1
U1 2
U2 4
PU ASSOC CLINICAL SCIENTISTS
PI MIDDLEBURY
PA PO BOX 1287, MIDDLEBURY, VT 05753 USA
SN 0091-7370
EI 1550-8080
J9 ANN CLIN LAB SCI
JI Ann. Clin. Lab. Sci.
PD MAY-JUN
PY 2017
VL 47
IS 3
BP 271
EP 281
PG 11
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA FA5NB
UT WOS:000405489000006
PM 28667027
DA 2018-12-27
ER

PT J
AU Yu, JZ
   Zhao, R
   Shi, W
   Li, H
AF Yu, Jianzhong
   Zhao, Rui
   Shi, Wei
   Li, Hao
TI RETRACTED: Risk factors for the prognosis of pediatric medulloblastoma:
   a retrospective analysis of 40 cases (Retracted article. See vol. 72,
   pg. 790, 2017)
SO CLINICS
LA English
DT Article; Retracted Publication
DE Child; Clinical Factors; Medulloblastoma; Molecular Phenotype; Overall
   Survival Time; Prognosis
ID SURVIVAL; CHILDREN; TUMORS
AB OBJECTIVES: In this study, we evaluated the association of molecular subtypes, clinical characteristics and pathological types with the prognosis of patients with medulloblastoma.
   METHODS: We analyzed forty patients with medulloblastoma who underwent surgical resection at our center between January 2004 and June 2014. Risk factors associated with survival, disease progression and recurrence were analyzed with a univariate Cox regression analysis, and the identified significant risk factors were further analyzed by Kaplan-Meier survival curves.
   RESULTS: Factors associated with overall survival included M stage (p=0.014), calcification (p=0.012), postoperative treatment, postoperative Karnofsky Performance Scale (KPS) score (p=0.015), and molecular subtype (p=0.005 for WNT and p=0.008 for SHH). Number of symptoms (p=0.029), M stage (p<0.001), and postoperative radiotherapy (p=0.033) were associated with disease progression. Patients with the WNT or SHH subtype had better survival outcomes than patients with non-WNT/SHH subtypes. Risk factors for disease progression-free survival were symptoms >2 and >= M1 stage without postoperative radiotherapy. The risk of recurrence increased with advanced M stage. Protective factors for recurrence included M0 stage and a combination of chemotherapy and radiotherapy.
   CONCLUSION: We identified the risk factors associated with survival, disease progression and recurrence of medulloblastoma patients. This information is helpful for understanding the prognostic factors related to medulloblastoma.
C1 [Yu, Jianzhong; Shi, Wei; Li, Hao] Fudan Univ, Childrens Hosp, Dept Neurosurg, Shanghai, Peoples R China.
   [Zhao, Rui] Fudan Univ, Childrens Hosp, Shanghai, Peoples R China.
RP Shi, W; Li, H (reprint author), Fudan Univ, Childrens Hosp, Dept Neurosurg, Shanghai, Peoples R China.
EM happyronan@hotmail.com; lihao7272@163.com
FU Shanghai Municipal Health and Family Planning Commission (NSFS)
   [20164Y0086]; Natural Science Foundation of Shanghai (NSFS)
   [16ZR1403700]
FX We thank Professor Zheng Shan, the vice president of Children's hospital
   of Fudan University, for supporting this study. This study was supported
   by grants from the Shanghai Municipal Health and Family Planning
   Commission (NSFS No. 20164Y0086) and the Natural Science Foundation of
   Shanghai (NSFS No. 16ZR1403700).
CR Bartlett F, 2013, CLIN ONCOL-UK, V25, P36, DOI 10.1016/j.clon.2012.09.008
   Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8
   Gerber NU, 2014, CANCER TREAT REV, V40, P356, DOI 10.1016/j.ctrv.2013.11.010
   Kaur K, 2016, BRAIN PATHOL, V26, P334, DOI 10.1111/bpa.12293
   Khafaga Y, 1996, INT J RADIAT ONCOL, V35, P501, DOI 10.1016/S0360-3016(96)80012-5
   Kiltie AE, 1997, MED PEDIATR ONCOL, V28, P348, DOI 10.1002/(SICI)1096-911X(199705)28:5<348::AID-MPO4>3.0.CO;2-H
   Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8
   Korah MP, 2010, INT J RADIAT ONCOL, V77, P106, DOI 10.1016/j.ijrobp.2009.04.058
   Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1
   Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419
   Modha A, 2000, CHILD NERV SYST, V16, P341, DOI 10.1007/s003810050529
   Northcott PA, 2012, NAT REV NEUROL, V8, P340, DOI 10.1038/nrneurol.2012.78
   Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324
   Padovani L, 2007, INT J RADIAT ONCOL, V68, P433, DOI 10.1016/j.ijrobp.2006.12.030
   Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432
   Pfister SM, 2010, ACTA NEUROPATHOL, V120, P553, DOI 10.1007/s00401-010-0751-5
   Pietsch T, 2014, ACTA NEUROPATHOL, V128, P137, DOI 10.1007/s00401-014-1276-0
   Pogorzala M, 2014, ANTICANCER RES, V34, P323
   Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329
   Rieken S, 2011, INT J RADIAT ONCOL, V81, pE7, DOI 10.1016/j.ijrobp.2010.12.042
   Rutkowski S, 2010, J CLIN ONCOL, V28, P4961, DOI 10.1200/JCO.2010.30.2299
   Wilson M, 2014, CLIN CANCER RES, V20, P4532, DOI 10.1158/1078-0432.CCR-13-2320
   Zeltzer PM, 1999, J CLIN ONCOL, V17, P832, DOI 10.1200/JCO.1999.17.3.832
   Zhang ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099490
NR 24
TC 3
Z9 3
U1 5
U2 7
PU HOSPITAL CLINICAS, UNIV SAO PAULO
PI SAO PAULO
PA FAC MEDICINA, UNIV SAO PAULO, SAO PAULO, SP 00000, BRAZIL
SN 1807-5932
EI 1980-5322
J9 CLINICS
JI Clinics
PD MAY
PY 2017
VL 72
IS 5
BP 294
EP 304
DI 10.6061/clinics/2017(05)07
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA EX5FL
UT WOS:000403263700007
PM 28591342
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Fortuny, J
AF Fortuny, Jordi
TI RETRACTED: Retracted: The Witness Set Constraint (Retracted article. See
   vol. 34, art no e2, 2017)
SO JOURNAL OF SEMANTICS
LA English
DT Article; Retracted Publication
ID NATURAL-LANGUAGE; GENERALIZED QUANTIFIERS; SEMANTICS; DETERMINERS; LOGIC
AB This article is initially concerned with a famous constraint on the class of possible determiners in natural languages: the so-called Conservativity Constraint. We shall briefly illustrate the force of this constraint and informally sketch Keenan & Stavi (1986)'s view according to which the Conservativity Constraint derives from the boolean structure of natural language semantics. We shall proceed to discuss certain well-known linguistic categories that have been argued to be interpreted by non-conservative functions: only and the relative proportional determiners many and few. We shall take the challenge posed by the existence of these categories in order to propose an alternative to the Conservativity Constraint. This alternative will be dubbed the Witness Set Constraint, which is inspired in Barwise & Cooper (1981)' s considerations on the semantic processing of generalized quantifiers. We shall defend that the proposed constraint does not suffer from the empirical shortcomings that have been attributed to the Conservativity Constraint, and indeed, we shall argue in detail that it correctly predicts (i) the existence of conservative determiners, (ii) the non-existence of certain non-conservative determiners, such as inner negations, cardinal comparison determiners and the converses of non-trivial proportional determiners, and most importantly, (iii) the existence of the non-conservative functions denoted by only and the relative proportional determiners many and few. This line of reasoning suggests that the class of functions from properties to sets of properties denoted in natural languages typically by determiners is constrained by a principle that simplifies the semantic processing of generalized quantifiers.
C1 [Fortuny, Jordi] Univ Barcelona, Fac Filol, Dept Filol Catalana, Gran Via Corts Catalanes 585, E-08007 Barcelona, Spain.
RP Fortuny, J (reprint author), Univ Barcelona, Fac Filol, Dept Filol Catalana, Gran Via Corts Catalanes 585, E-08007 Barcelona, Spain.
EM jordifortuny@ub.edu
FU  [FFI2011-23356];  [FFI2013-46987-C3-1-P];  [FFI2014-56258-P]
FX I thank Maribel Romero for her help in revising this article and the two
   anonymous reviewers of Journal of Semantics for their constructive
   comments. This work has been supported by the research projects
   FFI2011-23356, FFI2013-46987-C3-1-P and FFI2014-56258-P.
CR Barbara Partee, 1988, P 5 ESCOL, P383
   BARWISE J, 1981, LINGUIST PHILOS, V4, P159, DOI 10.1007/BF00350139
   Beghelli F., 1997, WAYS SCOPE TAKING, P29
   Berwick RC, 2011, COGNITIVE SCI, V35, P1207, DOI 10.1111/j.1551-6709.2011.01189.x
   CHIERCHIA G, 2000, MEANING GRAMMAR INTR
   Chomsky Noam, 1972, PROBLEMS KNOWLEDGE F
   Cohen A, 2001, NAT LANG SEMANT, V69, P41, DOI DOI 10.1023/A:1017913406219
   Fernando T., 1996, P SALT, P53
   Heim I., 1997, SEMANTICS GENERATIVE
   Herburger Elena, 1997, NAT LANG SEMANT, V5, P53, DOI DOI 10.1023/A:1008222204053
   HIGGINBOTHAM J., 1981, LINGUISTIC REV, V1, P41, DOI DOI 10.1515/TLIR.1981.1.1.41
   Keenan E. L., 2010, HDB LOGIC LANGUAGE, P837
   Keenan E. L, 1996, HDB CONT SEMANTIC TH, P41
   Keenan E. L., 1981, TRUTH INTERPRETATION, P65
   Keenan Edward L, 1985, BOOLEAN SEMANTICS NA
   KEENAN EL, 1986, LINGUIST PHILOS, V9, P253, DOI 10.1007/BF00630273
   Keenan EL, 2002, LINGUIST PHILOS, V25, P627, DOI 10.1023/A:1020803514176
   LAPPIN S, 1988, LINGUISTICS, V26, P977, DOI 10.1515/ling.1988.26.6.977
   Lappin S, 2000, LINGUIST PHILOS, V23, P599, DOI 10.1023/A:1005638918877
   Lappin S., 1993, SOAS WORKING PAPERS, V3, P337
   LINDSTROM P, 1966, THEORIA, V32, P186
   Montague Richard, 1974, FORMAL PHILOS SELECT
   Mostowski A., 1955, FUND MATH, V44, P12
   Partee B., 1990, MATH METHODS LINGUIS
   Peters S., 2006, QUANTIFIERS LANGUAGE
   Robaldo Livio, 2011, Journal of Logic, Language and Information, V20, P233, DOI 10.1007/s10849-010-9131-8
   Robaldo L., 2012, P 8 INT C LANG RES E
   Robaldo L, 2014, J LOGIC LANG INFORM, V23, P53, DOI 10.1007/s10849-014-9197-9
   Robaldo L, 2013, LOG J IGPL, V21, P853, DOI 10.1093/jigpal/jzt018
   Szabolcsi A., 2010, QUANTIFICATION
   Szabolcsi Anna, 1997, WAYS SCOPE TAKING, V65, P1, DOI 10.1007/978-94-011-5814-5_1
   VANBENTHEM J, 1983, LINGUIST PHILOS, V6, P447, DOI 10.1007/BF00636286
   von Fintel K, 2008, LINGUIST REV, V25, P139, DOI 10.1515/TLR.2008.004
   WESTERSTAHL D, 1985, LINGUIST PHILOS, V8, P387, DOI 10.1007/BF00637410
NR 34
TC 2
Z9 2
U1 3
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0167-5133
EI 1477-4593
J9 J SEMANT
JI J. Semant.
PD MAY
PY 2017
VL 34
IS 2
AR UNSP e1
DI 10.1093/jos/ffw009
PG 35
WC Linguistics; Language & Linguistics
SC Linguistics
GA EV9EI
UT WOS:000402087700001
OA Bronze
DA 2018-12-27
ER

PT J
AU Wang, KP
   Tang, ZH
   Wang, JL
   Cao, P
   Li, Q
   Shui, WZ
   Wang, HJ
   Zheng, ZM
   Zhang, Y
AF Wang, Kaiping
   Tang, Zhuohong
   Wang, Jinglin
   Cao, Peng
   Li, Qiang
   Shui, Weizhi
   Wang, Hongjing
   Zheng, Ziming
   Zhang, Yu
TI RETRACTED: Polysaccharide from Angelica sinensis ameliorates high-fat
   diet and STZ-induced hepatic oxidative stress and inflammation in
   diabetic mice by activating the Sirt1-AMPK pathway (Retracted article.
   See vol. 47, pg. 133, 2017)
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article; Retracted Publication
DE Polysaccharide from Angelica sinensis; Type 2 diabetes; Liver injury;
   Sirt1-AMPK signaling pathway; Oxidative stress; Inflammation
ID NF-KAPPA-B; INDUCED LIVER-INJURY; PROTEIN-KINASE; NONALCOHOLIC
   STEATOHEPATITIS; INSULIN-RESISTANCE; ACID; STEATOSIS; THERAPY; GLUCOSE;
   HYPERGLYCEMIA
AB Polysaccharide from Angelica sinensis (Oliv.) Diels (ASP) possesses many bioactivities, such as hematopoiesis, anti-inflammation, antioxidation and metabolism regulation. The aim of this study was to investigate the mechanisms underlying the protection of a combination of high-fat diet and streptozotocininduced liver damage in diabetic Balb/c mice by ASP. Results showed that ASP had beneficial effects on ameliorating hyperglycemia, dyslipidemia and liver injury. Moreover, mechanistic study for the liver-protective role in vivo demonstrated that ASP enhanced the activities of superoxide dismutase and glutathione peroxidase and increased the glutathione content, which resulted in the reduction of hepatic reactive oxygen species (ROS) and malondialdehyde, and reduced the protein expression levels of liver IKK alpha/NF-kappa B/p-I kappa B alpha and the concentrations of serum tumor necrosis factor-alpha/interleukin-6. The antioxidative and antiinflammatory actions of ASP might benefit from activating the Sirtl-AMPK signaling pathway. Furthermore, in vitro experiments using HepG2 cells treated with Sirt1 and AMPK inhibitors or small interfering RNA targeting Sirt1 confirmed that ASP suppressed the nuclear protein NF-kappa B p65 and intracellular ROS via the activation of Sirt1-AMPK signals. Collectively, ASP protects the liver against high-fat diet and streptozotocin-induced injury, which may contribute to the recovery of diabetic symptoms. Our findings strengthen the potential therapeutic role of ASP in nutritional foods or prescription for liver diseases or diabetes. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Wang, Kaiping; Tang, Zhuohong; Cao, Peng; Shui, Weizhi; Wang, Hongjing] Huazhong Univ Sci & Technol, Tongji Med Coll Pharm, Hubei Key Lab Nat Med Chem & Resource Evaluat, Wuhan 430030, Peoples R China.
   [Wang, Jinglin; Li, Qiang; Zheng, Ziming; Zhang, Yu] Huazhong Univ Sci & Technol, Dept Pharm, Union Hosp, 1227 Jiefang Rd, Wuhan 430022, Peoples R China.
RP Zhang, Y (reprint author), Huazhong Univ Sci & Technol, Dept Pharm, Union Hosp, 1227 Jiefang Rd, Wuhan 430022, Peoples R China.
EM zhangwkp@163.com
FU National Natural Science Foundation of China [81274151, 81403205]
FX This study was supported by the National Natural Science Foundation of
   China (Grant No. 81274151 and No. 81403205), and we would like to
   express our thanks to the Analysis and Testing Center of Huazhong
   University of Science and Technology and the General Surgery of Union
   Hospital for providing technical assistance.
CR Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005
   Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347
   Caldwell Stephen H, 2004, Clin Liver Dis, V8, P595, DOI 10.1016/j.cld.2004.04.009
   Cao W, 2010, PHYTOMEDICINE, V17, P598, DOI 10.1016/j.phymed.2009.12.014
   Chitturi S, 2001, SEMIN LIVER DIS, V21, P27, DOI 10.1055/s-2001-12927
   Choi Y, 2013, J NUTR BIOCHEM, V24, P1393, DOI 10.1016/j.jnutbio.2012.11.007
   Davidson EP, 2015, EUR J PHARMACOL, V765, P258, DOI 10.1016/j.ejphar.2015.08.015
   Dong YZ, 2014, J ETHNOPHARMACOL, V152, P201, DOI 10.1016/j.jep.2014.01.001
   Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923
   Gao J, 2015, CARBOHYD POLYM, V124, P25, DOI 10.1016/j.carbpol.2015.01.068
   Gruzman Arie, 2009, Rev Diabet Stud, V6, P13, DOI 10.1900/RDS.2009.6.13
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002
   Guo C, 2013, INT J BIOL MACROMOL, V62, P720, DOI 10.1016/j.ijbiomac.2013.09.022
   Han JY, 2015, J GINSENG RES, V39, P105, DOI 10.1016/j.jgr.2014.09.001
   Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249
   He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183
   Jung TW, 2015, DIABETOLOGIA, V58, P2096, DOI 10.1007/s00125-015-3663-z
   Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482
   Liu GP, 2015, INT J BIOL MACROMOL, V76, P169, DOI 10.1016/j.ijbiomac.2015.01.061
   Majumdar SK, 2013, ENDOCRINE, V44, P47, DOI 10.1007/s12020-013-9884-3
   McGrath JC, 2015, BRIT J PHARMACOL, V172, P2427, DOI 10.1111/bph.12956
   Nagaishi K, 2014, HEPATOLOGY, V59, P1816, DOI 10.1002/hep.26975
   Oggioni C, 2014, NUTR METAB CARDIOVAS, V24, P1105, DOI 10.1016/j.numecd.2014.05.005
   Pu XY, 2015, CAN J PHYSIOL PHARM, V93, P39, DOI 10.1139/cjpp-2014-0331
   Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006
   Ren ZH, 2012, INT IMMUNOPHARMACOL, V14, P698, DOI 10.1016/j.intimp.2012.10.008
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0
   Saravanan S, 2015, EUR J PHARMACOL, V761, P279, DOI 10.1016/j.ejphar.2015.05.034
   Skovso S, 2014, J DIABETES INVEST, V5, P349, DOI 10.1111/jdi.12235
   Song CY, 2013, TOXICOL IN VITRO, V27, P1065, DOI 10.1016/j.tiv.2013.01.020
   Subhasree N, 2015, INDIAN J PHARMACOL, V47, P509, DOI 10.4103/0253-7613.165200
   Suman R K, 2016, ADV PHARM SCI, V2016
   Wang KP, 2016, SCI REP-UK, V6, DOI 10.1038/srep26229
   Wang KP, 2016, INT IMMUNOPHARMACOL, V31, P140, DOI 10.1016/j.intimp.2015.12.021
   Wang KP, 2015, FOOD FUNCT, V6, P902, DOI [10.1039/C4FO00859F, 10.1039/c4fo00859f]
   Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029
   Xu MY, 2014, BBA-MOL BASIS DIS, V1842, P2237, DOI 10.1016/j.bbadis.2014.07.025
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620
   Yu F, 2013, CARBOHYD POLYM, V94, P114, DOI 10.1016/j.carbpol.2013.01.050
   Yu JW, 2013, INT J INFECT DIS, V17, pE539, DOI 10.1016/j.ijid.2013.01.027
   Zhang Y, 2014, FOOD FUNCT, V5, P1381, DOI 10.1039/c4fo00006d
   Zhou J, 2015, J ETHNOPHARMACOL, V164, P229, DOI 10.1016/j.jep.2015.02.026
   Zhou J, 2015, CARBOHYD POLYM, V121, P199, DOI 10.1016/j.carbpol.2014.12.037
   Zhuang XY, 2014, MATH PROBL ENG, DOI 10.1155/2014/179169
NR 46
TC 9
Z9 9
U1 7
U2 56
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD MAY
PY 2017
VL 43
BP 88
EP 97
DI 10.1016/j.jnutbio.2017.02.001
PG 10
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA EU5DV
UT WOS:000401052700010
PM 28279889
DA 2018-12-27
ER

PT J
AU Ergen, O
   Gilbert, SM
   Pham, T
   Turner, SJ
   Tan, MTZ
   Worsley, MA
   Zettl, A
AF Ergen, Onur
   Gilbert, S. Matt
   Thang Pham
   Turner, Sally J.
   Tan, Mark Tian Zhi
   Worsley, Marcus A.
   Zettl, Alex
TI RETRACTED: Graded bandgap perovskite solar cells(Retracted article. See
   vol. 17, pg. 204, 2018)
SO NATURE MATERIALS
LA English
DT Article; Retracted Publication
ID HALIDE PEROVSKITES; PHOTOVOLTAIC PERFORMANCE; CELLS; CH3NH3SNI3;
   EFFICIENT; CATIONS; SILICON; TIN
AB Organic-inorganic halide perovskite materials have emerged as attractive alternatives to conventional solar cell building blocks. Their high light absorption coefficients and long diffusion lengths suggest high power conversion efficiencies(1-5), and indeed perovskite-based single bandgap and tandem solar cell designs have yielded impressive performances(1-16). One approach to further enhance solar spectrum utilization is the graded bandgap, but this has not been previously achieved for perovskites. In this study, we demonstrate graded bandgap perovskite solar cells with steady-state conversion efficiencies averaging 18.4%, with a best of 21.7%, all without reflective coatings. An analysis of the experimental data yields high fill factors of similar to 75% and high short-circuit current densities up to 42.1 mA cm(2). The cells are based on an architecture of two perovskite layers (CH3NH3SnI3 and CH3NH3PbI3-xBrx), incorporating GaN, monolayer hexagonal boron nitride, and graphene aerogel.
C1 [Ergen, Onur; Gilbert, S. Matt; Thang Pham; Turner, Sally J.; Tan, Mark Tian Zhi; Zettl, Alex] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.
   [Ergen, Onur; Gilbert, S. Matt; Thang Pham; Zettl, Alex] Lawrence Berkeley Natl Lab, Div Sci Mat, Berkeley, CA 94720 USA.
   [Ergen, Onur; Gilbert, S. Matt; Thang Pham; Turner, Sally J.; Zettl, Alex] Univ Calif Berkeley, Kavli Energy Nanosci Inst, Berkeley, CA 94720 USA.
   [Ergen, Onur; Gilbert, S. Matt; Thang Pham; Turner, Sally J.; Zettl, Alex] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
   [Turner, Sally J.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.
   [Worsley, Marcus A.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.
RP Zettl, A (reprint author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.; Zettl, A (reprint author), Lawrence Berkeley Natl Lab, Div Sci Mat, Berkeley, CA 94720 USA.; Zettl, A (reprint author), Univ Calif Berkeley, Kavli Energy Nanosci Inst, Berkeley, CA 94720 USA.; Zettl, A (reprint author), Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA.
EM azettl@berkeley.edu
RI LBNL, MSD/R-6830-2017
OI Pham, Thang/0000-0001-5940-6206; Worsley, Marcus/0000-0002-8012-7727
FU Office of Science, Office of Basic Energy Sciences, Materials Sciences
   and Engineering Division of the US Department of Energy
   [DE-AC02-05CH11231, KC2207]; National Science Foundation [1542741];
   Office of Naval Research (MURI) [N00014-16-1-2229]; Lawrence Livermore
   National Laboratory under the US Department of Energy
   [DE-AC52-07NA27344, LDRD 13-LW-099]; NSF Graduate Fellowship Program
FX The authors thank B. Lechene (A. Arias group) and D. Hellebusch, S.
   Hawks and N. Bronstein (P. Alivisatos group) for use of the solar
   simulator, J. Kim and C. Jin (F. Wang group) for PL measurements and
   discussions, E. Cardona (O. Dubon group) for XRD measurements, L.
   Leppert (J. Neaton group) for valuable discussions on investigation of
   bandgap alignment, and T. Moiai and K. Emery (National Renewable Energy
   Laboratory) for valuable technical discussions on calibration, J-V
   measurements, and EQE measurements. This research was supported in part
   by the Director, Office of Science, Office of Basic Energy Sciences,
   Materials Sciences and Engineering Division of the US Department of
   Energy under Contract No. DE-AC02-05CH11231, which provided for PL
   measurements under an LDRD award, and, within the sp<SUP>2</SUP>-bonded
   materials program (KC2207), for the design of the experiment and
   material characterization; the National Science Foundation under Grant
   1542741, which provided for photovoltaic response characterization; and
   by the Office of Naval Research (MURI) under Grant N00014-16-1-2229,
   which provided for h-BN growth. This work was additionally supported by
   Lawrence Livermore National Laboratory under the auspices of the US
   Department of Energy under Contract DE-AC52-07NA27344 through LDRD
   13-LW-099, which provided for graphene aerogel synthesis. S.M.G.
   acknowledges support from the NSF Graduate Fellowship Program.
CR Albrecht S, 2016, ENERG ENVIRON SCI, V9, P81, DOI 10.1039/c5ee02965a
   Bailie CD, 2015, ENERG ENVIRON SCI, V8, P956, DOI 10.1039/c4ee03322a
   Bernal C, 2014, J PHYS CHEM C, V118, P24383, DOI 10.1021/jp509358f
   Bi DQ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501170
   Cai B, 2013, ENERG ENVIRON SCI, V6, P1480, DOI 10.1039/c3ee40343b
   De Wolf S, 2014, J PHYS CHEM LETT, V5, P1035, DOI 10.1021/jz500279b
   Echendu OK, 2014, THIN SOLID FILMS, V556, P529, DOI 10.1016/j.tsf.2014.01.071
   Gibb AL, 2013, J AM CHEM SOC, V135, P6758, DOI 10.1021/ja400637n
   Green MA, 2015, PROG PHOTOVOLTAICS, V23, P805, DOI 10.1002/pip.2637
   Hao F, 2014, NAT PHOTONICS, V8, P489, DOI 10.1038/nphoton.2014.82
   He M, 2014, J MATER CHEM A, V2, P5994, DOI 10.1039/c3ta14160h
   Hoke ET, 2015, CHEM SCI, V6, P613, DOI 10.1039/c4sc03141e
   Jeon NJ, 2015, NATURE, V517, P476, DOI 10.1038/nature14133
   Jiang FY, 2016, J MATER CHEM A, V4, P1208, DOI 10.1039/c5ta08744a
   Li H, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.045204
   Liang KN, 1998, CHEM MATER, V10, P403, DOI 10.1021/cm970568f
   Loper P, 2015, PHYS CHEM CHEM PHYS, V17, P1619, DOI 10.1039/c4cp03788j
   Mailoa JP, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4914179
   Manser JS, 2014, NAT PHOTONICS, V8, P737, DOI [10.1038/nphoton.2014.171, 10.1038/NPHOTON.2014.171]
   McCarthy MA, 2011, ACS NANO, V5, P291, DOI 10.1021/nn102721v
   Noel NK, 2014, ENERG ENVIRON SCI, V7, P3061, DOI 10.1039/c4ee01076k
   Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b
   Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557
   Saliba M, 2016, ENERG ENVIRON SCI, V9, P1989, DOI 10.1039/c5ee03874j
   Stoumpos CC, 2013, INORG CHEM, V52, P9019, DOI 10.1021/ic401215x
   Takahashi Y, 2011, DALTON T, V40, P5563, DOI 10.1039/c0dt01601b
   Umari P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04467
   Werner J, 2015, SOL ENERG MAT SOL C, V141, P407, DOI 10.1016/j.solmat.2015.06.024
   Worsley MA, 2014, ACS NANO, V8, P11013, DOI 10.1021/nn505335u
   Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050
NR 30
TC 51
Z9 52
U1 35
U2 458
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
EI 1476-4660
J9 NAT MATER
JI Nat. Mater.
PD MAY
PY 2017
VL 16
IS 5
BP 522
EP +
DI 10.1038/NMAT4795
PG 5
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA ET1CT
UT WOS:000400004200009
PM 27820812
DA 2018-12-27
ER

PT J
AU Li, WH
   Huang, H
   Su, JH
   Ji, X
   Zhang, XB
   Zhang, ZP
   Wang, H
AF Li, Weihao
   Huang, Hui
   Su, Junhua
   Ji, Xin
   Zhang, Xiaobin
   Zhang, Zhiping
   Wang, Hong
TI RETRACTED: miR-124 Acts as a Tumor Suppressor in Glioblastoma via the
   Inhibition of Signal Transducer and Activator of Transcription 3
   (Retracted article. See vol. 54, pg. 8461, 2017)
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article; Retracted Publication
DE miR-124; STAT3; GBM
ID CONSTITUTIVE ACTIVATION; APOPTOSIS; CANCER; EXPRESSION; MICRORNAS;
   PATHWAYS; CELLS
AB MicroRNAs are important regulators of multiple cellular processes, and aberrant miRNA expression has been observed in human glioblastoma (GBM). The present study was to evaluate the level of miR-124 and signal transducer and activator of transcription 3 (STAT3) in GBM tissues and cells. We further investigated the molecular mechanisms of miR-124 and STAT3 in GBM cell lines U87 and U251. Here, we found that miR-124 expression was downregulated in GBM tissues and U87 and U251 cells (all p < 0.001) but not associated with blood routine (RBC, WBC count, etc.) and liver and renal function indicators (all p > 0.05). By contrast, STAT3 was upregulated. Furthermore, the expression of miR-124 was inversely proportional to that of STAT3 mRNA or protein (p = 0.013, p = 0.015, respectively). In vitro studies demonstrated that the overexpression of miR-124 played a suppressor role in the proliferation of U87 and U251 cells and promoted cell apoptosis. Luciferase reporter assays confirmed that miR-124 binding to the 3'-UTR regions of STAT3 inhibited the expression of STAT3 in U87 and U251 cells. However, the inhibitor of miR-124 promoted the expression of STAT3 and cell proliferation. In conclusion, our data suggest that miR-124 may have a potential role in treatment of GBM patients and that miR-124 is a novel regulator of invasiveness and tumorigenicity in GBM cells by targeting STAT3. The miR-124/STAT3 pathway may be a useful therapeutic agent in GBM patients.
C1 [Li, Weihao; Su, Junhua; Ji, Xin; Zhang, Xiaobin; Zhang, Zhiping] Hebei Med Univ, Dept Lab Med, Hosp 2, 215 Hepingxi Rd, Shijiazhuang 050000, Hebei, Peoples R China.
   [Huang, Hui] Childrens Hosp Hebei Prov, Dept Lab Med, Shijiazhuang, Hebei, Peoples R China.
   [Wang, Hong] Hebei Prov Chest Hosp, Dept Blood Transfus, Shijiazhuang, Hebei, Peoples R China.
RP Li, WH (reprint author), Hebei Med Univ, Dept Lab Med, Hosp 2, 215 Hepingxi Rd, Shijiazhuang 050000, Hebei, Peoples R China.
EM lwhaohebei@163.com
CR Altieri R, 2015, TRANSL MED UNISA, V12, P54
   Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4
   Chabre O, 2013, ENDOCR-RELAT CANCER, V20, P579, DOI 10.1530/ERC-13-0051
   Das SS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00828
   Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940
   Gardiner AS, 2015, BIOMOLECULES, V5, P2903, DOI 10.3390/biom5042903
   Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227
   He JF, 2011, J BIOCHEM MOL TOXIC, V25, P404, DOI 10.1002/jbt.20396
   Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.1002/caac.20073, 10.3322/caac.20073]
   Liao A., 2014, MOL NEUROBIOL
   Liu H, 2015, TUMOUR BIOL, V28
   Lv BY, 2015, MOL NEUROBIOL, V52, P1263, DOI 10.1007/s12035-014-8935-y
   Lv Q, 2015, MOL NEUROBIOL
   Lv SZ, 2015, MOL NEUROBIOL, V52, P1257, DOI 10.1007/s12035-014-8938-8
   Mao JH, 2012, ONCOL LETT, V4, P1125, DOI 10.3892/ol.2012.863
   Yan XJ, 2006, GYNECOL ONCOL, V102, P348, DOI 10.1016/j.ygyno.2005.12.033
   Yanokura M, 2015, EXCLI J, V14, P190, DOI 10.17179/excli2014-590
   Zhao G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073803
NR 19
TC 10
Z9 10
U1 5
U2 8
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD MAY
PY 2017
VL 54
IS 4
BP 2555
EP 2561
DI 10.1007/s12035-016-9852-z
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA ES1QY
UT WOS:000399303300018
PM 26993295
DA 2018-12-27
ER

PT J
AU Zhao, DS
   Wang, RC
   Fang, JK
   Ji, XT
   Li, J
   Chen, XY
   Sun, GF
   Wang, ZJ
   Liu, WP
   Wang, YG
   Cheng, G
   Zhen, HN
   Sun, CH
   Fei, Z
AF Zhao, Dongsheng
   Wang, Rencong
   Fang, Junkang
   Ji, Xituan
   Li, Juan
   Chen, Xiaoyan
   Sun, Gangfeng
   Wang, Zhengjun
   Liu, Weiping
   Wang, Yangang
   Cheng, Guang
   Zhen, Haining
   Sun, Chunhua
   Fei, Zhou
TI RETRACTED: MiR-154 Functions as a Tumor Suppressor in Glioblastoma by
   Targeting Wnt5a (Retracted article. See vol. 54, pg. 8460, 2017)
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article; Retracted Publication
DE MiR-154; Wnt5a; EMT; GBM
ID GLIOMA PATIENTS; CANCER; PROGNOSIS; 14Q32; MICRORNAS; LEUKEMIA
AB Recently, deregulated microRNA (miRNA) expression contributes to the development and progression of human glioblastoma. The aim of the present study was to evaluate the level of miR-154 and Wnt5a in glioblastoma tissues and cells. We further investigated the molecular mechanisms of miR-154 and Wnt5a in glioblastoma cell lines. In the present study, we found that miR-154 expression was downregulated in glioblastoma tissues and U87, U251, and A172 cells (all p < 0.001). By contrast, Wnt5a was upregulated. Furthermore, we found that overexpression of miR-154 suppressed cell migration and invasion of U87 and U251 cells. Mechanically, overexpression of miR-154 inhibited epithelial-to-mesenchymal transition (EMT) of U87 and U251 cells. Importantly, we identified that the 3' untranslated region (3'-UTR) of Wnt5a was a direct target of miR-154. Luciferase reporter assays confirmed that miR-154 binding to the 3'-UTR regions of Wnt5a inhibited the expression of Wnt5a in U87 and U251 cells. At the same time, overexpressed Wnt5a also reversed EMT inhibited by miR-154. In conclusion, this study suggested that high miR-154 expression suppressed glioblastoma cell migration, invasion, and EMT development through targeting Wnt5a, which may be recommended as a therapeutic target for glioblastoma.
C1 [Zhao, Dongsheng; Wang, Rencong; Ji, Xituan; Li, Juan; Chen, Xiaoyan; Sun, Gangfeng; Wang, Zhengjun; Liu, Weiping; Wang, Yangang; Cheng, Guang; Zhen, Haining; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China.
   [Fang, Junkang] Dongyang Peoples Hosp Zhejiang Prov, Dept Neurosurg, Dongyang 322100, Zhejiang, Peoples R China.
   [Sun, Chunhua] Nanjing Med Univ, Dept Oncol, Affiliated Wuxi Hosp 2, Wuxi 214002, Peoples R China.
RP Fei, Z (reprint author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China.; Sun, CH (reprint author), Nanjing Med Univ, Dept Oncol, Affiliated Wuxi Hosp 2, Wuxi 214002, Peoples R China.
EM actively0126@126.com; feizhou@fmmu.edu.cn
FU State Key Program of the National Natural Science of China [81430043]
FX This study is supported by the State Key Program of the National Natural
   Science of China (81430043). We thank all the patients who were willing
   to be recruited in this investigation.
CR Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800
   Dai CX, 2015, MOL NEUROBIOL, V52, P1521, DOI 10.1007/s12035-014-8955-7
   Dai YC, 2005, J CANCER RES CLIN, V131, P94, DOI 10.1007/s00432-004-0622-3
   Dixon-McIver A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002141
   Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840
   Franceschi S, 2015, ONCOL LETT, V10, P3599, DOI 10.3892/ol.2015.3738
   He X, 2016, BIOCHEM BIOPH RES CO, V469, P1041, DOI 10.1016/j.bbrc.2015.12.021
   Jiang D, 2015, TUMOUR BIOL
   Liu GJ, 2015, J TEXT I, V106, P1293, DOI 10.1080/00405000.2014.998011
   Lv SZ, 2015, MOL NEUROBIOL, V52, P1257, DOI 10.1007/s12035-014-8938-8
   Manodoro F, 2014, BLOOD, V123, P2066, DOI 10.1182/blood-2012-12-469833
   Pecuchet N, 2013, INT J CANCER, V133, P2834, DOI 10.1002/ijc.28315
   Tang HL, 2015, J CANCER RES THER, V11, P630, DOI 10.4103/0973-1482.146121
   Wang WZ, 2011, INT J CANCER, V129, P1624, DOI 10.1002/ijc.25818
   Xin CG, 2014, MOL CELL BIOCHEM, V387, P271, DOI 10.1007/s11010-013-1892-3
   Yang XS, 2015, MOL NEUROBIOL, V52, P38, DOI 10.1007/s12035-014-8850-2
   Yang XS, 2014, TUMOR BIOL, V35, P11091, DOI 10.1007/s13277-014-2424-9
   Zhu C, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2012.11.013
   Zhu C, 2013, MOL CELL BIOCHEM, V379, P69, DOI 10.1007/s11010-013-1628-4
NR 20
TC 8
Z9 8
U1 5
U2 9
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD MAY
PY 2017
VL 54
IS 4
BP 2823
EP 2830
DI 10.1007/s12035-016-9867-5
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA ES1QY
UT WOS:000399303300041
PM 27013470
DA 2018-12-27
ER

PT J
AU Ren, XR
   Hall, DL
   Vinciguerra, T
   Benish, SE
   Stratton, PR
   Ahn, D
   Hansford, JR
   Cohen, MD
   Sahu, S
   He, H
   Grimes, C
   Salawitch, RJ
   Ehrman, SH
   Dickerson, RR
AF Ren, Xinrong
   Hall, Dolly L.
   Vinciguerra, Timothy
   Benish, Sarah E.
   Stratton, Phillip R.
   Ahn, Doyeon
   Hansford, Jonathan R.
   Cohen, Mark D.
   Sahu, Sayantan
   He, Hao
   Grimes, Courtney
   Salawitch, Ross J.
   Ehrman, Sheryl H.
   Dickerson, Russell R.
TI RETRACTED: Methane emissions from the Marcellus Shale in southwestern
   Pennsylvania and northern West Virginia based on airborne measurements
   (Retracted article. See vol. 123, pg. 1478, 2018)
SO JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES
LA English
DT Article; Retracted Publication
DE methane; emission; Marcellus; climate impact; atmospheric composition;
   atmospheric chemistry
ID NATURAL-GAS PRODUCTION; VOLATILE ORGANIC-COMPOUNDS; STATES PNEUMATIC
   CONTROLLERS; REGIONAL AIR-QUALITY; UNITED-STATES; PRODUCTION SITES;
   BARNETT SHALE; ATMOSPHERIC METHANE; PROCESS EQUIPMENT; PIPELINE LEAKS
AB Natural gas production in the U.S. has increased rapidly over the past decade, along with concerns about methane (CH4) leakage (total fugitive emissions), and climate impacts. Quantification of CH4 emissions from oil and natural gas (O&NG) operations is important for establishing scientifically sound, cost-effective policies for mitigating greenhouse gases. We use aircraft measurements and a mass balance approach for three flight experiments in August and September 2015 to estimate CH4 emissions from O&NG operations in the southwestern Marcellus Shale region. We estimate the mean1 sigma CH4 emission rate as 36.71.9kgCH(4)s(-1) (or 1.160.06TgCH(4)yr(-1)) with 59% coming from O&NG operations. We estimate the mean1 sigma CH4 leak rate from O&NG operations as 3.9 +/- 0.4% with a lower limit of 1.5% and an upper limit of 6.3%. This leak rate is broadly consistent with the results from several recent top-down studies but higher than the results from a few other observational studies as well as in the U.S. Environmental Protection Agency CH4 emission inventory. However, a substantial source of CH4 was found to contain little ethane (C2H6), possibly due to coalbed CH4 emitted either directly from coalmines or from wells drilled through coalbed layers. Although recent regulations requiring capture of gas from the completion venting step of the hydraulic fracturing appear to have reduced losses, our study suggests that for a 20year time scale, energy derived from the combustion of natural gas extracted from this region will require further controls before it can exert a net climate benefit compared to coal.
C1 [Ren, Xinrong; Hall, Dolly L.; Benish, Sarah E.; Stratton, Phillip R.; He, Hao; Salawitch, Ross J.; Dickerson, Russell R.] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA.
   [Ren, Xinrong; Cohen, Mark D.] NOAA, Air Resources Lab, College Pk, MD 20740 USA.
   [Vinciguerra, Timothy; Ehrman, Sheryl H.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   [Ahn, Doyeon; Sahu, Sayantan; Grimes, Courtney; Salawitch, Ross J.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.
   [Hansford, Jonathan R.] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA.
   [Salawitch, Ross J.; Dickerson, Russell R.] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA.
RP Ren, XR (reprint author), Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA.; Ren, XR (reprint author), NOAA, Air Resources Lab, College Pk, MD 20740 USA.
EM ren@umd.edu
RI Salawitch, Ross/B-4605-2009; Ren, Xinrong/E-7838-2015; Dickerson,
   Russell/F-2857-2010
OI Salawitch, Ross/0000-0001-8597-5832; Ren, Xinrong/0000-0001-9974-1666;
   Dickerson, Russell/0000-0003-0206-3083; Ahn, Doyeon/0000-0003-3906-2199
FU National Science Foundation (NSF) [CBET-1438400]; Maryland Department of
   Environment (MDE) [U00P4401029]; National Institute and Science and
   Technology (NIST) [70NANB14H333]; National Oceanic and Atmospheric
   Administration (NOAA); National Aeronautics and Space Administration
   (NASA) AQAST program
FX This work was supported by National Science Foundation (NSF grant
   CBET-1438400), Maryland Department of Environment (MDE contract
   U00P4401029), National Institute and Science and Technology (NIST
   Cooperative Agreement 70NANB14H333), National Oceanic and Atmospheric
   Administration (NOAA), and the National Aeronautics and Space
   Administration (NASA) AQAST program. The authors are grateful to the
   flight crew at University Research Foundation, Greenbelt, MD, for their
   support to conduct flights and to Winston Luke and Paul Kelley at NOAA
   Air Resources Lab for their technical support. The authors also
   acknowledge Maryland Department of Environment's Air Toxics and PAMS
   Analytical Laboratory, especially Acefaw Belay and David Krask for their
   support to analyze VOC samples, Jerry Rhoderick, Bob Miller, and
   Kimberly Schuldt at NIST for certification of CH<INF>4</INF> and
   CO<INF>2</INF> standards, Anna Karion at NIST, Dana Caulton at Princeton
   University, and Paul Shepson at Purdue University for providing helpful
   comments, and Alexia Chittams and Rahma Zakaria at University of
   Maryland for their help to gather gas well data. Data used in this study
   are available at http://www.atmos.umd.edu/similar to
   rammpp/archives/2015data.html. The scientific results and conclusions,
   as well as any views or opinions expressed herein, are those of the
   authors and do not necessarily reflect the view of NSF, MDE, NIST, NOAA,
   and NASA.
CR Allen DT, 2015, ENVIRON SCI TECHNOL, V49, P3983, DOI 10.1021/acs.est.5b00941
   Allen DT, 2013, P NATL ACAD SCI USA, V110, P17768, DOI 10.1073/pnas.1304880110
   Alvares RA, 2016, ELEMENTA-SCI ANTHROP, V4, DOI 10.12952/journal.elementa.000137
   Alvarez RA, 2012, P NATL ACAD SCI USA, V109, P6435, DOI 10.1073/pnas.1202407109
   American Chemistry Council, 2013, SHAL GAS COMP NEW US
   [Anonymous], 2016, FED REGISTER, V81, P35824
   Brandt AR, 2014, SCIENCE, V343, P733, DOI 10.1126/science.1247045
   Brent LC, 2015, J ATMOS CHEM, V72, P503, DOI 10.1007/s10874-013-9265-6
   Bunch AG, 2014, SCI TOTAL ENVIRON, V468, P832, DOI 10.1016/j.scitotenv.2013.08.080
   Cambaliza MOL, 2014, ATMOS CHEM PHYS, V14, P9029, DOI 10.5194/acp-14-9029-2014
   Cathles LM, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004032
   Caulton DR, 2014, P NATL ACAD SCI USA, V111, P6237, DOI 10.1073/pnas.1316546111
   Colborn T, 2011, HUM ECOL RISK ASSESS, V17, P1039, DOI 10.1080/10807039.2011.605662
   Considine T. J., 2010, PENNSYLVANIA MARCELL
   Draxler R. R., 2016, HYSPLIT HYBRID SINGL
   Environmental Protection Agency, 2012, FED REGISTER, V77, P49490
   Field RA, 2014, ENVIRON SCI-PROC IMP, V16, P954, DOI 10.1039/c4em00081a
   Finkel ML, 2013, PUBLIC HEALTH, V127, P889, DOI 10.1016/j.puhe.2013.07.005
   Gilman JB, 2013, ENVIRON SCI TECHNOL, V47, P1297, DOI 10.1021/es304119a
   Goetz JD, 2015, ENVIRON SCI TECHNOL, V49, P7012, DOI 10.1021/acs.est.5b00452
   Gordalla BC, 2013, ENVIRON EARTH SCI, V70, P3875, DOI 10.1007/s12665-013-2672-9
   Hains JC, 2008, ATMOS ENVIRON, V42, P1727, DOI 10.1016/j.atmosenv.2007.11.052
   He H, 2016, EARTHS FUTURE, V4, P94, DOI 10.1002/2015EF000330
   He H, 2014, ATMOS ENVIRON, V85, P18, DOI 10.1016/j.atmosenv.2013.11.039
   Healey B., 2014, PIPELINE GAS J, V241, P90
   Howard T, 2015, ENERGY SCI ENG, V3, P443, DOI 10.1002/ese3.81
   Howard T, 2015, J AIR WASTE MANAGE, V65, P856, DOI 10.1080/10962247.2015.1025925
   Howard T, 2015, ENVIRON SCI TECHNOL, V49, P3981, DOI 10.1021/acs.est.5b00507
   Howarth R.W., 2015, ENERGY EMISSION CONT, V3, P45, DOI DOI 10.2147/EECT.S61539
   Howarth RW, 2014, ENERGY SCI ENG, V2, P47, DOI 10.1002/ese3.35
   Howarth RW, 2011, CLIMATIC CHANGE, V106, P679, DOI 10.1007/s10584-011-0061-5
   Intergovernmental Panel on Climate Change, 2013, CLIM CHANG 2013 PHYS
   Jackson RB, 2014, ENVIRON SCI TECHNOL, V48, P2051, DOI 10.1021/es404474x
   Janjic ZI, 2003, METEOROL ATMOS PHYS, V82, P271, DOI 10.1007/s00703-001-0587-6
   Janjic ZI, 2001, MON WEATHER REV, V129, P1164, DOI 10.1175/1520-0493(2001)129<1164:AAATNM>2.0.CO;2
   Johnson D, 2016, ATMOS ENVIRON, V144, P1, DOI 10.1016/j.atmosenv.2016.08.065
   Karion A, 2015, ENVIRON SCI TECHNOL, V49, P8124, DOI 10.1021/acs.est.5b00217
   Karion A, 2013, GEOPHYS RES LETT, V40, P4393, DOI 10.1002/grl.50811
   Kim A. G., 1973, 7762 US DEP INT
   Kirchgessner DA, 1997, CHEMOSPHERE, V35, P1365, DOI 10.1016/S0045-6535(97)00236-1
   Lamb BK, 2015, ENVIRON SCI TECHNOL, V49, P5161, DOI 10.1021/es505116p
   Lyon DR, 2015, ENVIRON SCI TECHNOL, V49, P8147, DOI 10.1021/es506359c
   Maasakkers JD, 2016, ENVIRON SCI TECHNOL, V50, P13123, DOI 10.1021/acs.est.6b02878
   Marchese AJ, 2015, ENVIRON SCI TECHNOL, V49, P10718, DOI 10.1021/acs.est.5b02275
   McDermott-Levy R, 2013, AM J NURS, V113, P45, DOI 10.1097/01.NAJ.0000431272.83277.f4
   Omara M, 2016, ENVIRON SCI TECHNOL, V50, P2099, DOI 10.1021/acs.est.5b05503
   Peischl J, 2016, J GEOPHYS RES-ATMOS, V121, P6101, DOI 10.1002/2015JD024631
   Peischl J, 2015, J GEOPHYS RES-ATMOS, V120, P2119, DOI 10.1002/2014JD022697
   Peischl J, 2013, J GEOPHYS RES-ATMOS, V118, P4974, DOI 10.1002/jgrd.50413
   Petron G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016360
   Phillips NG, 2013, ENVIRON POLLUT, V173, P1, DOI 10.1016/j.envpol.2012.11.003
   Rich A, 2014, J AIR WASTE MANAGE, V64, P61, DOI 10.1080/10962247.2013.832713
   Roman-Colon Y. A., 2014, 20141207 US GEOL SUR
   Roy AA, 2014, J AIR WASTE MANAGE, V64, P19, DOI 10.1080/10962247.2013.826151
   Rozell DJ, 2012, RISK ANAL, V32, P1382, DOI 10.1111/j.1539-6924.2011.01757.x
   Schneising O, 2014, EARTHS FUTURE, V2, P548, DOI 10.1002/2014EF000265
   Schwietzke S, 2016, NATURE, V538, P88, DOI 10.1038/nature19797
   Schwietzke S, 2014, ENVIRON SCI TECHNOL, V48, P7714, DOI 10.1021/es501204c
   Smith ML, 2015, ENVIRON SCI TECHNOL, V49, P8158, DOI 10.1021/acs.est.5b00219
   Stein AF, 2015, B AM METEOROL SOC, V96, P2059, DOI 10.1175/BAMS-D-14-00110.1
   Swarthout RF, 2015, ENVIRON SCI TECHNOL, V49, P3175, DOI 10.1021/es504315f
   Taubman BF, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006196
   Townsend-Small A, 2016, GEOPHYS RES LETT, V43, P2283, DOI 10.1002/2015GL067623
   U. S. Energy Information Administration (EIA), 2016, ANN EN OUTL 2016
   U. S. Energy Information Administration (EIA), 2016, US DRY SHAL GAS PROD
   U. S. Energy Information Administration (EIA), 2016, REV EM RES US SHAL G
   United States Environmental Protection Agency, 2016, INV US GREENH GAS EM
   United States Environmental Protection Agency (U.S. EPA), 2015, FED REGISTER, V80, P56593
   Vidic RD, 2013, SCIENCE, V340, DOI 10.1126/science.1235009
   Vinciguerra T, 2015, ATMOS ENVIRON, V110, P144, DOI 10.1016/j.atmosenv.2015.03.056
   Voulgarakis A, 2013, ATMOS CHEM PHYS, V13, P2563, DOI 10.5194/acp-13-2563-2013
   WHITE WH, 1976, SCIENCE, V194, P187, DOI 10.1126/science.959846
   Yuan B, 2015, J GEOPHYS RES-ATMOS, V120, P6271, DOI 10.1002/2015JD023242
   Zimmerle DJ, 2015, ENVIRON SCI TECHNOL, V49, P9374, DOI 10.1021/acs.est.5b01669
NR 74
TC 2
Z9 2
U1 4
U2 21
PU AMER GEOPHYSICAL UNION
PI WASHINGTON
PA 2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA
SN 2169-897X
EI 2169-8996
J9 J GEOPHYS RES-ATMOS
JI J. Geophys. Res.-Atmos.
PD APR 27
PY 2017
VL 122
IS 8
BP 4639
EP 4653
DI 10.1002/2016JD026070
PG 15
WC Meteorology & Atmospheric Sciences
SC Meteorology & Atmospheric Sciences
GA EU6YB
UT WOS:000401180800030
PM 28603681
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Xu, EB
   Cao, HL
   Lin, LM
   Liu, HL
AF Xu, Enbin
   Cao, Hailian
   Lin, Liming
   Liu, Honglong
TI RETRACTED: rs10499194 polymorphism in the tumor necrosis factor-alpha
   inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune
   hepatitis risk in Chinese Han population (Retracted article. See vol.
   13, artn. e0195181, 2018)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; SUSCEPTIBILITY;
   METAANALYSIS; VARIANTS; REGION; CELLS; 6Q23
AB Previous studies have found that the polymorphisms of tumor necrosis factor-a induced protein 3 (TNFAIP3) were associated with several autoimmune diseases. However, the role of TNFAIP3 polymorphisms in type-1 autoimmune hepatitis (AIH-1) remained unclear. The present study aimed to clarify the association of TNFAIP3 polymorphisms with AIH-1 risk in a Chinese Han population. The TaqMan SNP genotyping assay was used to determine the distribution of TNFAIP3 polymorphisms in 432 AIH-1 patients and 500 healthy controls. The association of TNFAIP3 polymorphisms and clinical characteristic was further evaluated. Five TNFAIP3 polymorphisms (rs2230926, rs5029939, rs10499194, rs6920220, rs582757) were analyzed in the present study. No significant association could be observed between rs2230926, rs5029939, rs6920220, rs582757 and the susceptibility to AIH-1 in Chinese Han population. Compared with wild-type genotype CC at rs10499194, individuals carrying CT genotype had a significantly increased risk for developing AIH-1 (OR = 2.32, 95% CI 1.44 - 3.74). Under a dominant model, CT/TT carriers have a 140% increased risk of AIH-1 than CC carriers (OR = 2.40, 95% CI 1.50 - 3.87). The rs10499194 T allele was also found to be significantly associated with AIH-1 risk (OR = 2.41, 95% CI 1.51 - 3.82). In addition, higher serum ALT, AST levels and more common cirrhosis were observed in AIH-1 patients with T allele (CT/TT) than those with CC genotype. In conclusion, TNFAIP3 rs10499194 T allele and CT genotype were associated with an increased risk for AIH-1, suggesting rs10499194 polymorphism as a candidate of susceptibility locus to AIH-1.
C1 [Xu, Enbin; Cao, Hailian; Lin, Liming; Liu, Honglong] 404 Hosp Peoples Liberat Army, Dept Gastroenterol, Weihai, Shandong, Peoples R China.
RP Xu, EB (reprint author), 404 Hosp Peoples Liberat Army, Dept Gastroenterol, Weihai, Shandong, Peoples R China.
EM xueb404@163.com
CR Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9
   Cen H, 2013, MOL IMMUNOL, V56, P643, DOI 10.1016/j.molimm.2013.07.006
   Chen S, 2014, BIOMED RES INT, DOI 10.1155/2014/858496
   Chen S, 2011, HUM IMMUNOL, V72, P69, DOI 10.1016/j.humimm.2010.10.019
   Chu YY, 2011, BLOOD, V117, P2227, DOI 10.1182/blood-2010-09-306019
   Czaja AJ, 2000, IMMUNOL REV, V174, P250, DOI 10.1034/j.1600-0528.2002.017401.x
   Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053
   de Boer YS, 2014, GASTROENTEROLOGY, V147, P443, DOI 10.1053/j.gastro.2014.04.022
   Dieude P, 2010, ANN RHEUM DIS, V69, P1958, DOI 10.1136/ard.2009.127928
   Eskandari-Nasab E, 2015, IMMUNOL INVEST, V44, P331, DOI 10.3109/08820139.2014.1003651
   Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200
   Hao GF, 2014, INT J CLIN EXP PATHO, V7, P8958
   He J, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.22013
   Hoffjan S, 2015, INT J IMMUNOGENET, V42, P106, DOI 10.1111/iji.12183
   Ke X, 2016, IRAN J ALLERGY ASTHM, V15, P46
   Kim SK, 2014, RHEUMATOLOGY, V53, P1009, DOI 10.1093/rheumatology/ket473
   Kool M, 2011, IMMUNITY, V35, P82, DOI 10.1016/j.immuni.2011.05.013
   Krawitt EL, 2006, NEW ENGL J MED, V354, P54, DOI 10.1056/NEJMra050408
   Lee YH, 2012, INFLAMM RES, V61, P411, DOI [10.1007/s00011-012-0447-5, 10.1007/s00011-012-0455-5]
   Lim YS, 2008, J HEPATOL, V48, P133, DOI 10.1016/j.jhep.2007.08.019
   Longhi MS, 2010, J AUTOIMMUN, V34, P7, DOI 10.1016/j.jaut.2009.08.010
   Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874
   Migita K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071382
   Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202
   Nititham J, 2015, GENES IMMUN, V16, P120, DOI 10.1038/gene.2014.75
   Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27
   Qin BD, 2014, DIGEST LIVER DIS, V46, P541, DOI 10.1016/j.dld.2014.02.003
   Strettell MDJ, 1997, GASTROENTEROLOGY, V112, P2028, DOI 10.1053/gast.1997.v112.pm9178696
   Sun F, 2013, J HUM GENET, V58, P475, DOI 10.1038/jhg.2013.26
   Tang J, 2012, HEPATOB PANCREAT DIS, V11, P125, DOI 10.1016/S1499-3872(12)60136-2
   Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007
   Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078
   Yokosawa S, 2007, HEPATOLOGY, V45, P384, DOI 10.1002/hep.21518
   Zhang PP, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0268-6
   Zhang XG, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-56
   Zhu LH, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0566-1
NR 36
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 27
PY 2017
VL 12
IS 4
AR e0176471
DI 10.1371/journal.pone.0176471
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA ET6EL
UT WOS:000400383600085
PM 28448618
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Li, HL
   Chu, JW
   Li, JL
   Cui, PF
   Wang, ZZ
AF Li, Hongliang
   Chu, Jiangwei
   Li, Jialu
   Cui, Pengfei
   Wang, Zhanzhong
TI RETRACTED: Energy recovery data characteristics extraction of flywheel
   energy storage control system for vehicular applications (Retracted
   article. See vol. 10, 2018)
SO ADVANCES IN MECHANICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Electric vehicle; flywheel energy storage; control system; data
   characteristics; regenerative braking
ID MECHANICAL HYBRID POWERTRAIN; ADAPTIVE ROBUST-CONTROL; LITHIUM-ION
   BATTERIES; ELECTRIC-VEHICLE; TECHNOLOGY
AB Flywheel energy storage system seems to be especially well suited to hybrid powertrain, which allows regenerative braking and power augmentation during acceleration in automotive vehicles. This article presents a novel electrical flywheel hybrid system through the analysis of the dynamic response of energy recovery process and the transmission characteristics of flywheel energy storage system. The power transmission process and energy flow of the vehicle with flywheel energy storage system were elaborated during braking. Energy recovery performance evaluation indexes were put forward, and the energy conversion characteristic test was conducted by experimental rig. The experimental result shows that the use of low-power motor speed control for gear ring can reduce the degree of jerk of transmission powertrain during energy recovery process and improve the energy recovery rate, and the net energy recovery rate tends to a stable value of 33%. The research extracts some features for flywheel energy storage control system and provides a theoretical basis for the further vehicular applications research.
C1 [Li, Hongliang; Chu, Jiangwei; Li, Jialu] Northeast Forestry Univ, Transportat Coll, Harbin 150040, Peoples R China.
   [Cui, Pengfei] Northeast Forestry Univ, Coll Sci, Harbin, Peoples R China.
   [Wang, Zhanzhong] Jilin Univ, Coll Transportat, Changchun 130022, Peoples R China.
RP Chu, JW (reprint author), Northeast Forestry Univ, Transportat Coll, Harbin 150040, Peoples R China.; Wang, ZZ (reprint author), Jilin Univ, Coll Transportat, Changchun 130022, Peoples R China.
EM cjw_62@nefu.edu.cn; jdwzzhong@163.com
FU Fundamental Research Funds for the Central Universities [02572015AB17];
   National Natural Science Foundation of China [51405075]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was financially supported by the Fundamental Research Funds for the
   Central Universities under grant no. 02572015AB17 and the National
   Natural Science Foundation of China under grant no. 51405075.
CR Bayindir KC, 2011, ENERG CONVERS MANAGE, V52, P1305, DOI 10.1016/j.enconman.2010.09.028
   Ceraolo M, 2009, 2009240069 SAE, DOI [10.4271/2009-24-0069, DOI 10.4271/2009-24-0069]
   Chang XY, 2015, IEEE T IND ELECTRON, V62, P991, DOI 10.1109/TIE.2014.2336607
   Chen Z, 2016, INT J ROBUST NONLIN, V26, P2708, DOI 10.1002/rnc.3472
   Chen Z, 2013, IEEE-ASME T MECH, V18, P1122, DOI 10.1109/TMECH.2012.2197217
   Christen T, 2000, J POWER SOURCES, V91, P210, DOI 10.1016/S0378-7753(00)00474-2
   Clarke P, 2010, TRANSPORT RES D-TR E, V15, P160, DOI 10.1016/j.trd.2009.11.002
   Gao Y, 2000, 1999012910 SAE
   Hannan MA, 2014, RENEW SUST ENERG REV, V29, P135, DOI 10.1016/j.rser.2013.08.097
   Hansen JG, 2011, OFFICE SCI TECHNICAL
   Hu XS, 2014, IEEE T INTELL TRANSP, V15, P1193, DOI 10.1109/TITS.2013.2294675
   Kuo JK, 2013, FUEL CELLS, V13, P1234, DOI 10.1002/fuce.201300129
   Omar N, 2012, ELECTROCHIM ACTA, V86, P305, DOI 10.1016/j.electacta.2012.03.026
   Pullen K. R., 2006, The Institution of Engineering and Technology Hybrid Vehicle Conference 2006, P91
   Ren GZ, 2015, RENEW SUST ENERG REV, V41, P225, DOI 10.1016/j.rser.2014.08.003
   Stewart SG, 2008, J ELECTROCHEM SOC, V155, pA664, DOI 10.1149/1.2953524
   Sun WC, 2013, IEEE T IND ELECTRON, V60, P3889, DOI 10.1109/TIE.2012.2206340
   Sun WC, 2012, IEEE T IND ELECTRON, V59, P530, DOI 10.1109/TIE.2011.2134057
   Thackeray MM, 2012, ENERG ENVIRON SCI, V5, P7854, DOI 10.1039/c2ee21892e
   Tian GD, 2014, J CLEAN PROD, V85, P419, DOI 10.1016/j.jclepro.2014.09.020
   Tian GD, 2013, IEEE T AUTOM SCI ENG, V10, P1004, DOI 10.1109/TASE.2013.2249663
   van Berkel K, 2014, IEEE T CONTR SYST T, V22, P1241, DOI 10.1109/TCST.2013.2279935
   van Berkel K, 2014, IEEE T VEH TECHNOL, V63, P1555, DOI 10.1109/TVT.2013.2287193
   Yao JY, 2014, IEEE T IND ELECTRON, V61, P6285, DOI 10.1109/TIE.2014.2304912
   Yao JY, 2014, IEEE-ASME T MECH, V19, P633, DOI 10.1109/TMECH.2013.2252360
   [张俊智 Zhang Junzhi], 2014, [汽车工程, Automotive Engineering], V36, P911
NR 26
TC 6
Z9 6
U1 9
U2 36
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1687-8140
J9 ADV MECH ENG
JI Adv. Mech. Eng.
PD APR 18
PY 2017
VL 9
IS 4
AR 1687814017696659
DI 10.1177/1687814017696659
PG 11
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA ET7UE
UT WOS:000400503500001
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Pandey, J
AF Pandey, Jay
TI RETRACTED: Synthesis of FeAlPO-5 doped proton conducting and highly
   stable composite membrane (Retracted article. See vol. 213, pg. 400,
   2018)
SO MATERIALS LETTERS
LA English
DT Article; Retracted Publication
DE Composite membrane; Solution-casting; Proton conductivity
ID FUEL-CELL APPLICATIONS
AB Structurally stable, proton conducting and cost effective composite membrane was synthesized successfully using simple and facile solution casting approach. 4% FeAlPO-5 Showed remarkable compatibility with c-PVA forming uniform and defect-free thin film membrane. 4% FeAlPO-5 doping led to introduce bronsted acidic sites in membrane and thereby drastic improvement in proton conductivity was observed. Synthesized composite membrane revealed excellent water holding capacity with proton conductivity of the order 10(-5) S cm(-1) measured at 80 degrees C under fully hydrated conditions. (C)2017 Elsevier B.V. All rights reserved.
C1 [Pandey, Jay] Univ Amsterdam, Vant Hoff Inst Mol Sci HIMS, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.
RP Pandey, J (reprint author), Univ Amsterdam, Vant Hoff Inst Mol Sci HIMS, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.
EM jay.pandey.iitd@gmail.com
CR Kreuer KD, 2004, CHEM REV, V104, P4637, DOI 10.1021/cr020715f
   Kreuer KD, 1996, CHEM MATER, V8, P610, DOI 10.1021/cm950192a
   Pandey J, 2015, INT J HYDROGEN ENERG, V40, P9410, DOI 10.1016/j.ijhydene.2015.05.117
   Pandey J, 2014, INT J HYDROGEN ENERG, V39, P9473, DOI 10.1016/j.ijhydene.2014.03.237
   Rosdi AN, 2016, DESALIN WATER TREAT, V57, P13, DOI 10.1080/19443994.2015.1006815
   Shiju NR, 2006, CHEM COMMUN, P4955, DOI 10.1039/b608982h
   Slade S, 2002, J ELECTROCHEM SOC, V149, pA1556, DOI 10.1149/1.1517281
   Smitha B, 2005, J MEMBRANE SCI, V259, P10, DOI 10.1016/j.memsci.2005.01.035
   Xu W., 2014, SOLID STATE IONICS, V171, P121
   Zenonos C, 2002, PHYS CHEM CHEM PHYS, V4, P5421, DOI 10.1039/b202155b
   Zhao LP, 2015, J POWER SOURCES, V286, P445, DOI 10.1016/j.jpowsour.2015.04.005
NR 11
TC 1
Z9 1
U1 8
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 15
PY 2017
VL 193
BP 85
EP 88
DI 10.1016/j.matlet.2017.01.078
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA EN2LU
UT WOS:000395842600022
DA 2018-12-27
ER

PT J
AU Yang, Y
   Liu, L
   Zha, JH
   Yuan, NY
AF Yang, Yan
   Liu, Liang
   Zha, Jianhua
   Yuan, Ningyi
TI RETRACTED: Nitrite sensing composite systems based on a core-shell
   emissive-superamagnetic structure: Construction, characterization and
   sensing behavior (Retracted article. See vol. 204, pg. 799, 2018)
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article; Retracted Publication
DE Nitrite ion; Core-shell structure; Rhodamine probe; Emission quenching
ID MAGNETIC NANOPARTICLES; FLUOROMETRIC-DETERMINATION; WATER SAMPLES; ION;
   NITRATE; SENSOR; NANOCOMPOSITES; NITROSAMINES
AB Two recyclable nitrite sensing composite samples were designed and constructed through a core-shell structure, with Fe3O4 nanoparticles as core, silica molecular sieve MCM-41 as shell and two rhodamine derivatives as chemosensors, respectively. These samples and their structure were identified with their electron microscopy images, NZ adsorption/desorption isotherms, magnetic response, IR spectra and thermogravimetric analysis. Their nitrite sensing behavior was discussed based on emission intensity quenching, their limit of detection was found as low as 1.2 mu M. Further analysis suggested a static sensing mechanism between nitrite and chemosensors through an additive reaction between NO+ and chemosensors. After finishing their nitrite sensing, these composite samples and their emission could be recycled and recovered by sulphamic acid. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Yang, Yan; Zha, Jianhua; Yuan, Ningyi] Jiangsu Collaborat Innovat Ctr Photovolta Sci & E, Changzhou 213000, Jiangsu, Peoples R China.
   [Liu, Liang] Changzhou Univ, Sch Environm & Safety Engn, Changzhou 213000, Jiangsu, Peoples R China.
RP Yuan, NY (reprint author), Jiangsu Collaborat Innovat Ctr Photovolta Sci & E, Changzhou 213000, Jiangsu, Peoples R China.
EM nyyuan@cczu.edu.cn
FU Prospective Joint Project for Production and Research of Jiangsu
   Province, China [BY2016029-17]
FX This work was supported by the Prospective Joint Project for Production
   and Research of Jiangsu Province, China (BY2016029-17).
CR AXELROD HD, 1975, ANAL CHEM, V47, P922, DOI 10.1021/ac60356a054
   Barbe C, 2004, ADV MATER, V16, P1959, DOI 10.1002/adma.200400771
   CHOI KK, 1980, ANALYST, V105, P241, DOI 10.1039/an9800500241
   Connolly D, 2001, ANAL CHIM ACTA, V441, P53, DOI 10.1016/S0003-2670(01)01068-6
   Dong YL, 2011, J NANOSCI NANOTECHNO, V11, P10387, DOI 10.1166/jnn.2011.5014
   Dujols V, 1997, J AM CHEM SOC, V119, P7386, DOI 10.1021/ja971221g
   Dyal A, 2003, J AM CHEM SOC, V125, P1684, DOI 10.1021/ja021223n
   Gimeno N, 2008, CHEM-EUR J, V14, P3006, DOI 10.1002/chem.200700412
   He L, 2011, J NANOSCI NANOTECHNO, V11, P2256, DOI 10.1166/jnn.2011.3149
   Helaleh MIH, 2000, MICROCHEM J, V64, P241, DOI 10.1016/S0026-265X(00)00018-7
   Jiao CX, 2004, TALANTA, V64, P637, DOI 10.1016/j.talanta.2004.03.052
   Kim E, 2010, ANALYST, V135, P149, DOI 10.1039/b915975d
   Kim H, 2005, J AM CHEM SOC, V127, P544, DOI 10.1021/ja047107x
   Lei BF, 2006, ADV FUNCT MATER, V16, P1883, DOI 10.1002/adfm.200500737
   LIJINSKY W, 1970, NATURE, V225, P21, DOI 10.1038/225021a0
   Liu LK, 2011, J NANOSCI NANOTECHNO, V11, P10333, DOI 10.1166/jnn.2011.5010
   Mousavi MF, 1998, TALANTA, V45, P1247, DOI 10.1016/S0039-9140(97)00240-3
   OHTA T, 1986, ANAL CHEM, V58, P3132, DOI 10.1021/ac00127a047
   Okemgbo AA, 1999, ANAL CHEM, V71, P2725, DOI 10.1021/ac990198+
   Tada DB, 2007, LANGMUIR, V23, P8194, DOI 10.1021/1a700883y
   Vishnuvardhan V, 2008, ANAL CHIM ACTA, V623, P53, DOI 10.1016/j.aca.2008.05.075
   Wang LL, 2012, SENSOR ACTUAT B-CHEM, V171, P946, DOI 10.1016/j.snb.2012.06.008
   Wang YY, 2012, LANGMUIR, V28, P1657, DOI 10.1021/la204494v
   Wang Y, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/621414
   Wang YH, 2010, NEW J CHEM, V34, P1946, DOI 10.1039/c0nj00039f
   Wen ZH, 2004, TALANTA, V62, P351, DOI 10.1016/j.talanta.2003.08.003
   WOLFF IA, 1972, SCIENCE, V177, P15, DOI 10.1126/science.177.4043.15
   World Health Organization (WHO), 2008, GUID DRINK WAT QUAL
   Zhang LZ, 2003, MOLECULES, V8, P207, DOI 10.3390/80100207
NR 29
TC 1
Z9 1
U1 1
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD APR 15
PY 2017
VL 177
BP 125
EP 134
DI 10.1016/j.saa.2017.01.046
PG 10
WC Spectroscopy
SC Spectroscopy
GA EP0KP
UT WOS:000397076500020
PM 28153809
DA 2018-12-27
ER

PT J
AU Kwoka, M
   Ottaviano, L
   Szuber, J
AF Kwoka, M.
   Ottaviano, L.
   Szuber, J.
TI RETRACTED: Comparative analysis of physico-chemical and gas sensing
   characteristics of two different forms of SnO2 films (Retracted article.
   See vol. 441, pg. 1088, 2018)
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Retracted Publication
DE Tin dioxide; RGTO; L-CVD; Crystallinity; Morphology; Chemistry; XRD;
   SEM; AFM; XPS methods; NO2 gas sensor response
ID THIN-FILMS; SURFACE-MORPHOLOGY; SENSORS; OXIDATION; CVD; CHEMISTRY;
   OXIDE; XPS
AB In this paper the results of studies of comparative studies on the crystallinity, morphology and chemistry combined with the gas sensor response of two different forms of tin dioxide (SnO2) films prepared by the Rheotaxial Growth and Thermal Oxidation (RGTO) and by the Laser-enhanced Chemical Vapour Deposition (L-CVD) methods, respectively, are presented.
   For this purpose the X-ray Diffraction (XRD), Scanning Electron Microscopy (SEM), Atomic Force Microscopy (AFM) and X-ray Photoelectron spectroscopy (XPS) have been used. XRD studies for both samples show the contribution from the crystalline SnO2 in the cassiterite rutile phase without any evident contribution from the tin oxide (SnO) phase. SEM and AFM studies show that the surface morphology of RGTO and L-CVD SnO2 samples are characterized by grains/nanograins of different size and surface roughness.
   In turn XPS studies confirm that for both SnO2 samples a slight nonstoichiometry with a relative [O]/[Sn] concentration of 1.8, and slightly different amount of C contamination at the surface of internal grains with relative [C]/[Sn] concentration of 3.5 and 3.2, respectively. This undesired C contamination cannot be ignored because it creates an uncontrolled barrier for the potential gas adsorption at the internal surface of sensor material. This is confirmed by the gas sensor response in NO2 atmosphere of both SnO2 samples because the sensitivity is evidently smaller for RGTO SnO2 with respect to the L-CVD SnO2 samples, whereas the response time showed a completely opposite tendency. It is probably caused by the smaller extension of internal surface and grain dimension with respect to the Debye length, as well as higher C contamination observed for RGTO SnO2 with respect to L-CVD SnO2 samples. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Kwoka, M.; Szuber, J.] Silesian Tech Univ, Inst Elect, PL-44100 Gliwice, Poland.
   [Ottaviano, L.] Univ Aquila, CNR, SPIN, I-67100 Laquila, Italy.
   [Ottaviano, L.] Univ Aquila, Dept Phys & Chem Sci, I-67100 Laquila, Italy.
RP Kwoka, M (reprint author), Silesian Tech Univ, Inst Elect, PL-44100 Gliwice, Poland.
EM Monika.Kwoka@polsl.pl
OI Kwoka, Monika/0000-0001-6197-1191
FU Institute of Electronics, Silesian University of Technology, Gliwice,
   Poland; Project of European Network on New Sensing Technologies for
   Air-Pollution Control and Environmental Sustainability - EuNetAir,
   within the COST Action [TD1105]
FX This work was partially sponsored by the Statutory Funding of the
   Institute of Electronics, Silesian University of Technology, Gliwice,
   Poland, as well as by the Project of European Network on New Sensing
   Technologies for Air-Pollution Control and Environmental Sustainability
   - EuNetAir, within the COST Action TD1105.
CR Barsan N, 1999, FRESEN J ANAL CHEM, V365, P287, DOI 10.1007/s002160051490
   Carpenter MA, 2013, INTEGR ANAL SYST, P1, DOI 10.1007/978-1-4614-5395-6
   Comini E, 2009, SOLID STATE GAS SENSING, P47, DOI 10.1007/978-0-387-09665-0_2
   Dieguez A, 2000, SENSOR ACTUAT B-CHEM, V66, P40, DOI 10.1016/S0925-4005(99)00359-7
   Eranna G, 2012, SER SENSORS, P1
   GOPEL W, 1995, SENSOR ACTUAT B-CHEM, V26, P1, DOI 10.1016/0925-4005(94)01546-T
   Ihokura K., 1994, STANNIC OXIDE GAS SE
   Kwoka M, 2007, THIN SOLID FILMS, V515, P8328, DOI 10.1016/j.tsf.2007.03.035
   Kwoka M, 2005, THIN SOLID FILMS, V490, P36, DOI 10.1016/j.tsf.2005.04.014
   Larciprete R, 1998, THIN SOLID FILMS, V323, P291, DOI 10.1016/S0040-6090(97)01201-7
   LARCIPRETE R, 1993, J VAC SCI TECHNOL A, V11, P336, DOI 10.1116/1.578734
   Larciprete R, 1997, J VAC SCI TECHNOL A, V15, P2492, DOI 10.1116/1.580916
   Ottaviano L, 2009, THIN SOLID FILMS, V517, P6161, DOI 10.1016/j.tsf.2009.04.011
   Rothschild A, 2004, J APPL PHYS, V95, P6374, DOI 10.1063/1.1728314
   Ruhland B, 1998, SENSOR ACTUAT B-CHEM, V50, P85, DOI 10.1016/S0925-4005(98)00160-9
   SBERVEGLIERI G, 1990, SEMICOND SCI TECH, V5, P1231, DOI 10.1088/0268-1242/5/12/015
   Szuber J, 2005, THIN SOLID FILMS, V490, P54, DOI 10.1016/j.tsf.2005.04.011
   Szuber J, 2001, THIN SOLID FILMS, V391, P198, DOI 10.1016/S0040-6090(01)00982-8
   Wagner C. D., 1979, HDB XRAY PHOTOELECTR
NR 19
TC 1
Z9 1
U1 4
U2 79
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD APR 15
PY 2017
VL 401
BP 256
EP 261
DI 10.1016/j.apsusc.2016.12.205
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA EK6ZH
UT WOS:000394074300031
DA 2018-12-27
ER

PT J
AU Elahi, AS
   Ghoranneviss, M
AF Elahi, A. Salar
   Ghoranneviss, M.
TI RETRACTED: High temperature plasma equilibrium analysis by remote
   magnetic diagnostics in large aspect ratio tokamaks (Retracted article.
   See vol. 43, pg. 3075, 2018)
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article; Retracted Publication
DE Tokamak; Remote diagnostics
ID ENERGY CONFINEMENT TIME; RESONANT HELICAL FIELD; POLOIDAL FLUX LOOPS;
   IR-T1 TOKAMAK; HORIZONTAL DISPLACEMENT; INTERNAL INDUCTANCE; SHAFRANOV
   PARAMETER; VERTICAL FIELD; POSITION; SHIFT
AB In this contribution we have reviewed on remote magnetic techniques for determination of plasma displacement based on poloidal flux in large aspect ratio tokamaks. This instrument consists of a two semicircle loops which installed toroidally on inner and outer sides of tokamak chamber and connected with each other. Really, this instrument detects the difference of poloidal flux on the High Field Side (HFS) and Low Field Side (LFS) of tokamak chamber, which we needed in calculating of the Plasma displacement. Main benefit of our proposed instrument is its simplicity. Based on this technique we determined the plasma position, and to compare the result obtained using this technique, an array of four magnetic probes and two flux loops are also designed, constructed and installed on outer surface of the IR-T1 tokamak and plasma position obtained from them. Results are in good agreement with analytical solution of equilibrium problem. (C) 2016 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [Elahi, A. Salar; Ghoranneviss, M.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
EM Salari_phy@yahoo.com
CR Elahi AS, 2017, INT J HYDROGEN ENERG, V42, P6202, DOI 10.1016/j.ijhydene.2016.10.154
   Elahi AS, 2017, INT J HYDROGEN ENERG, V42, P1048, DOI 10.1016/j.ijhydene.2016.07.273
   Elahi AS, 2010, BRAZ J PHYS, V40, P323, DOI 10.1590/S0103-97332010000300012
   Elahi AS, 2010, FUSION ENG DES, V85, P724, DOI 10.1016/j.fusengdes.2010.04.034
   Elahi AS, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/02/025502
   Elahi AS, 2010, J FUSION ENERG, V29, P279, DOI 10.1007/s10894-010-9275-1
   Elahi AS, 2010, J FUSION ENERG, V29, P209, DOI 10.1007/s10894-009-9260-8
   Elahi AS, 2010, PHYS SCRIPTA, V81, DOI 10.1088/0031-8949/81/05/055501
   Elahi AS, 2010, J FUSION ENERG, V29, P83, DOI 10.1007/s10894-009-9235-9
   Elahi AS, 2010, J FUSION ENERG, V29, P62, DOI 10.1007/s10894-009-9232-z
   Elahi AS, 2010, J FUSION ENERG, V29, P88, DOI 10.1007/s10894-009-9237-7
   Elahi AS, 2010, J FUSION ENERG, V29, P76, DOI 10.1007/s10894-009-9234-x
   Elahi AS, 2010, J FUSION ENERG, V29, P36, DOI 10.1007/s10894-009-9226-x
   Elahi AS, 2010, J FUSION ENERG, V29, P29, DOI 10.1007/s10894-009-9224-z
   Elahi AS, 2010, J FUSION ENERG, V29, P32, DOI 10.1007/s10894-009-9227-9
   Elahi AS, 2010, J FUSION ENERG, V29, P26, DOI 10.1007/s10894-009-9223-0
   Elahi AS, 2010, J FUSION ENERG, V29, P22, DOI 10.1007/s10894-009-9221-2
   Elahi AS, 2010, J FUSION ENERG, V29, P1, DOI 10.1007/s10894-009-9218-x
   Elahi AS, 2009, J FUSION ENERG, V28, P416, DOI 10.1007/s10894-009-9215-0
   Elahi AS, 2009, J FUSION ENERG, V28, P412, DOI 10.1007/s10894-009-9214-1
   Elahi AS, 2009, J FUSION ENERG, V28, P404, DOI 10.1007/s10894-009-9212-3
   Elahi AS, 2009, J FUSION ENERG, V28, P408, DOI 10.1007/s10894-009-9213-2
   Elahi AS, 2009, J FUSION ENERG, V28, P390, DOI 10.1007/s10894-009-9208-z
   Elahi AS, 2009, J FUSION ENERG, V28, P394, DOI 10.1007/s10894-009-9210-5
   Elahi AS, 2009, J FUSION ENERG, V28, P385, DOI 10.1007/s10894-009-9207-0
   Elahi AS, 2009, J FUSION ENERG, V28, P346, DOI 10.1007/s10894-009-9198-x
   Elahi AS, 2009, PHYS SCRIPTA, V80, DOI 10.1088/0031-8949/80/04/045501
   Elahi A Salar, 2016, INT J HYDRO IN PRESS
   Elahi AS, 2013, RADIAT EFF DEFECT S, V168, P636, DOI 10.1080/10420150.2011.650171
   Elahi AS, 2013, RADIAT EFF DEFECT S, V168, P654, DOI 10.1080/10420150.2012.706609
   Elahi AS, 2013, RADIAT EFF DEFECT S, V168, P642, DOI 10.1080/10420150.2012.706607
   Elahi AS, 2012, IEEE T PLASMA SCI, V40, P892, DOI 10.1109/TPS.2012.2182990
   Elahi AS, 2012, J FUSION ENERG, V31, P191, DOI 10.1007/s10894-011-9452-x
   Elahi AS, 2011, J FUSION ENERG, V30, P477, DOI 10.1007/s10894-011-9408-1
   Elahi AS, 2011, FUSION ENG DES, V86, P442, DOI 10.1016/j.fusengdes.2011.03.121
   Elahi AS, 2011, J FUSION ENERG, V30, P116, DOI 10.1007/s10894-010-9359-y
   Elahi AS, 2010, IEEE T PLASMA SCI, V38, P3163, DOI 10.1109/TPS.2010.2066289
   Elahi AS, 2010, J FUSION ENERG, V29, P461, DOI 10.1007/s10894-010-9305-z
   Elahi AS, 2010, J FUSION ENERG, V29, P251, DOI 10.1007/s10894-009-9267-1
   Elahi AS, 2010, IEEE T PLASMA SCI, V38, P181, DOI 10.1109/TPS.2009.2037965
   Elahi ASalar, 2010, PHYS SCR, V82
   Ghanbari MR, 2012, PHYS SCRIPTA, V85, DOI 10.1088/0031-8949/85/05/055502
   Ghanbari MR, 2011, RADIAT EFF DEFECT S, V166, P789, DOI 10.1080/10420150.2011.610320
   Ghanbari MR, 2011, PHYS SCRIPTA, V83, DOI 10.1088/0031-8949/83/05/055501
   Ghasemloo M, 2013, RADIAT EFF DEFECT S, V168, P42, DOI 10.1080/10420150.2012.706610
   Ghoranneviss M, 2012, LASER PART BEAMS, V30, P459, DOI 10.1017/S0263034612000341
   Ghoranneviss M, 2010, J FUSION ENERG, V29, P232, DOI 10.1007/s10894-009-9264-4
   Ghoranneviss M, 2010, J FUSION ENERG, V29, P467, DOI 10.1007/s10894-010-9307-x
   Goodarzi Z, 2013, J FUSION ENERG, V32, P103, DOI 10.1007/s10894-012-9526-4
   Habibian J, 2016, INT J HYDROGEN ENERG, V41, P15266, DOI 10.1016/j.ijhydene.2016.06.178
   Mandavipour B, 2017, INT J HYDROGEN ENERG, V42, P46, DOI 10.1016/j.ijhydene.2016.11.017
   Naghidokht A, 2016, INT J HYDROGEN ENERG, V41, P15272, DOI 10.1016/j.ijhydene.2016.07.026
   Rahimirad A, 2010, J FUSION ENERG, V29, P73, DOI 10.1007/s10894-009-9236-8
   Rahimirad A, 2009, J FUSION ENERG, V28, P420, DOI 10.1007/s10894-009-9216-z
   Roudaki FS, 2017, INT J HYDROGEN ENERG, V42, P5207, DOI 10.1016/j.ijhydene.2016.09.189
   Salar Elahi A, 2009, J PLASMA PHYS, V76, P1
NR 56
TC 2
Z9 2
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD APR 13
PY 2017
VL 42
IS 15
BP 9440
EP 9447
DI 10.1016/j.ijhydene.2016.12.053
PG 8
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA EW6AL
UT WOS:000402587500009
DA 2018-12-27
ER

PT J
AU Filippone, M
   Moca, CP
   von Delft, J
   Mora, C
AF Filippone, Michele
   Moca, Catalin Pascu
   von Delft, Jan
   Mora, Christophe
TI RETRACTED: At which magnetic field, exactly, does the Kondo resonance
   begin to split? A Fermi liquid description of the low-energy properties
   of the Anderson model (Retracted article. See vol. 98, art. 079902,
   2018)
SO PHYSICAL REVIEW B
LA English
DT Article; Retracted Publication
ID RENORMALIZATION-GROUP METHOD; PERTURBATION EXPANSIONS; IMPURITY;
   TEMPERATURES; RESISTIVITY; SYSTEMS; ALLOYS; NOISE; LIMIT; SPIN
AB We extend a recently developed Fermi liquid (FL) theory for the asymmetric single-impurity Anderson model [C. Mora et al., Phys. Rev. B 92, 075120 (2015)] to the case of an arbitrary local magnetic field. To describe the system's low-lying quasiparticle excitations for arbitrary values of the bare Hamiltonian's model parameters, we construct an effective low-energy FL Hamiltonian whose FL parameters are expressed in terms of the local level's spin-dependent ground-state occupations and their derivatives with respect to level energy and local magnetic field. These quantities are calculable with excellent accuracy from the Bethe ansatz solution of the Anderson model. Applying this effective model to a quantum dot in a nonequilibrium setting, we obtain exact results for the curvature of the spectral function, c(A), describing its leading similar to epsilon(2) term, and the transport coefficients c(V) and c(T), describing the leading similar to V-2 and similar to T-2 terms in the nonlinear differential conductance. A sign change in c(A) or cV is indicative of a change from a local maximum to a local minimum in the spectral function or nonlinear conductance, respectively, as is expected to occur when an increasing magnetic field causes the Kondo resonance to split into two subpeaks. Surprisingly, we find that the fields B-A and B-V at which c(A) and c(V) change sign are parametrically different, with B-A of order T-K but B-V much larger. In fact, in the Kondo limit c(V) never vanishes, implying that the conductance retains a (very weak) zero-bias maximum even for strong magnetic field and that the two pronounced finite-bias conductance side peaks caused by the Zeeman splitting of the local level do not emerge from zero-bias voltage.
C1 [Filippone, Michele] Free Univ Berlin, Dahlem Ctr Complex Quantum Syst, Arnimallee 14, D-14195 Berlin, Germany.
   [Filippone, Michele] Free Univ Berlin, Inst Theoret Phys, D-14195 Berlin, Germany.
   [Moca, Catalin Pascu] Budapest Univ Technol & Econ, Inst Phys, BME MTA Exot Quantum Phase Grp, H-1521 Budapest, Hungary.
   [Moca, Catalin Pascu] Univ Oradea, Dept Phys, Oradea 410087, Romania.
   [von Delft, Jan] Ludwig Maximilians Univ Munchen, Arnold Sommerfeld Ctr Theoret Phys, Phys Dept, D-80333 Munich, Germany.
   [von Delft, Jan] Ludwig Maximilians Univ Munchen, Ctr NanoSci, D-80333 Munich, Germany.
   [Mora, Christophe] Univ Paris 06, Univ Paris Diderot, Sorbonne Univ,Lab Pierre Aigrain,Sorbonne Paris C, PSL Res Univ,CNRS,Ecole Normal Super,Lab Pierre A, 24 Rue Lhomond, F-75231 Paris 05, France.
RP Filippone, M (reprint author), Free Univ Berlin, Dahlem Ctr Complex Quantum Syst, Arnimallee 14, D-14195 Berlin, Germany.; Filippone, M (reprint author), Free Univ Berlin, Inst Theoret Phys, D-14195 Berlin, Germany.
RI Mora, Christophe/A-1778-2014
OI von Delft, Jan/0000-0002-8655-0999
FU DFG through the Cluster of Excellence "NanoSystems Initiative Munich"
FX We thank S. Arlt, M. Kiselev, H. Schoeller, D. Schimmel, A.
   Weichselbaum, and L. Weidinger for helpful discussions, and A. Hewson
   for several very helpful exchanges on renormalized perturbation theory.
   This work has been supported by the DFG through the Cluster of
   Excellence "NanoSystems Initiative Munich."
CR AFFLECK I, 1993, PHYS REV B, V48, P7297, DOI 10.1103/PhysRevB.48.7297
   AFFLECK I, 1991, NUCL PHYS B, V360, P641, DOI 10.1016/0550-3213(91)90419-X
   Aligia AA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.125405
   Aligia AA, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/1/015306
   Amasha S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045308
   Anders FB, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.196801
   Anders FB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.066804
   [Anonymous], 2001, J PHYS CONDENS MATTE, V13, P10011
   [Anonymous], 1999, NUCL PHYS B, V546, P585
   [Anonymous], 1993, J PHYS CONDENS MATTE, V5, P6277
   [Anonymous], 1994, ADV PHYS, V43, P543
   Bauer J, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035119
   Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4
   Boulat E, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.033409
   Bulla R, 2008, REV MOD PHYS, V80, P395, DOI 10.1103/RevModPhys.80.395
   Chang AM, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096501
   Cohen G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.146802
   Costi TA, 2000, PHYS REV LETT, V85, P1504, DOI 10.1103/PhysRevLett.85.1504
   da Silva LGGVD, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195317
   Dorda A, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.125145
   Doyon B, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245326
   Eckel J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043042
   Edwards K, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.165128
   Edwards K, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/4/045601
   Filippone M, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.045302
   Freton L, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.216802
   Fujii T, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.044714
   Garst M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205125
   Gezzi R, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.045324
   Glazman L., 2003, NEW DIRECTIONS MESOS
   GLAZMAN LI, 1988, JETP LETT+, V47, P452
   GLAZMAN LI, 2005, NANOPHYSICS COHERENC, V81, P427
   Gogolin AO, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.016602
   Goldhaber-Gordon D, 1998, NATURE, V391, P156
   Golub A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.233310
   Grabert H., 2013, SINGLE CHARGE TUNNEL, V294
   HALDANE FDM, 1978, PHYS REV LETT, V40, P416, DOI 10.1103/PhysRevLett.40.416
   HALDANE FDM, 1978, J PHYS C SOLID STATE, V11, P5015, DOI 10.1088/0022-3719/11/24/030
   Hamad IJ, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.195113
   Hanl M, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.195131
   Hewson A. C., 1993, KONDO PROBLEM HEAVY
   Hewson A. C., COMMUNICATION
   HEWSON AC, 1993, PHYS REV LETT, V70, P4007, DOI 10.1103/PhysRevLett.70.4007
   Hewson AC, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045117
   Hewson AC, 2006, J PHYS-CONDENS MAT, V18, P1815, DOI 10.1088/0953-8984/18/5/032
   Hewson AC, 2005, J PHYS-CONDENS MAT, V17, P5413, DOI 10.1088/0953-8984/17/35/008
   Hewson AC, 2005, J PHYS SOC JPN, V74, P8, DOI 10.1143/JPSJ.74.8
   Hewson AC, 2004, EUR PHYS J B, V40, P177, DOI 10.1140/epjb/e2004-00256-0
   Horig CBM, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.165411
   Houck AA, 2005, NANO LETT, V5, P1685, DOI 10.1021/nl050799i
   Jespersen TS, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.233304
   Kamenev A, 2009, ADV PHYS, V58, P197, DOI 10.1080/00018730902850504
   KAWAKAMI N, 1982, J PHYS SOC JPN, V51, P2043, DOI 10.1143/JPSJ.51.2043
   Kehrein S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.056602
   Kogan A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.166602
   Krasius M., 1974, P 14 INT C LOW TEMP, V5, P339
   Lesage F, 1999, PHYS REV LETT, V82, P4540, DOI 10.1103/PhysRevLett.82.4540
   Liu TM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.026803
   MEIR Y, 1992, PHYS REV LETT, V68, P2512, DOI 10.1103/PhysRevLett.68.2512
   Metzner W, 2012, REV MOD PHYS, V84, P299, DOI 10.1103/RevModPhys.84.299
   MIHALY L, 1978, J PHYS LETT-PARIS, V39, pL483
   Moca CP, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.201303
   Moore JE, 2000, PHYS REV LETT, V85, P1722, DOI 10.1103/PhysRevLett.85.1722
   Mora C, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.075120
   Mora C, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155322
   Mora C, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.125304
   Mora C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.036604
   Munoz E, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.016601
   NG TK, 1988, PHYS REV LETT, V61, P1768, DOI 10.1103/PhysRevLett.61.1768
   NOZIERES P, 1978, J PHYS-PARIS, V39, P1117, DOI 10.1051/jphys:0197800390100111700
   NOZIERES P, 1974, J LOW TEMP PHYS, V17, P31, DOI 10.1007/BF00654541
   Oguri A, 2005, J PHYS SOC JPN, V74, P110, DOI 10.1143/JPSJ.74.110
   Oguri A, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.153305
   Pandis V., 2015, J PHYS CONDENS MATT, V92
   Pletyukhov M, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.260601
   Quay CHL, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245311
   Rosch A, 2005, J PHYS SOC JPN, V74, P118, DOI 10.1143/JPSJ.74.118
   Rosch A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.076804
   Sakano R, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.075440
   Sakano R, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.241301
   Schiller A, 1998, PHYS REV B, V58, P14978, DOI 10.1103/PhysRevB.58.14978
   Schoeller H, 2009, EUR PHYS J-SPEC TOP, V168, P179, DOI 10.1140/epjst/e2009-00962-3
   Sela E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.086601
   Smirnov S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.121302
   TSVELICK AM, 1983, ADV PHYS, V32, P453, DOI 10.1080/00018738300101581
   TSVELICK AM, 1983, J PHYS C SOLID STATE, V16, P2321, DOI 10.1088/0022-3719/16/12/018
   Vitushinsky P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.036603
   Weichselbaum A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165117
   Weichselbaum A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.076402
   Weichselbaum A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.245124
   WIEGMANN PB, 1980, PHYS LETT A, V80, P163, DOI 10.1016/0375-9601(80)90212-1
   WIEGMANN PB, 1983, J PHYS C SOLID STATE, V16, P2281, DOI 10.1088/0022-3719/16/12/017
   WILSON KG, 1975, REV MOD PHYS, V47, P773, DOI 10.1103/RevModPhys.47.773
   Wright CJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.115308
   Yamada K., 1975, J PHYS, V54, P316
   Yamada K., 1975, J PHYS, V53, P970
   YOSHIMORI A, 1976, PROG THEOR PHYS, V55, P67, DOI 10.1143/PTP.55.67
   YOSIDA K, 1975, PROG THEOR PHYS, V53, P1286, DOI 10.1143/PTP.53.1286
   YOSIDA K, 1970, SUP PROG THEOR PHYS, P244, DOI 10.1143/PTPS.46.244
   Zitko R, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/053003
NR 100
TC 8
Z9 8
U1 1
U2 4
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 2469-9950
EI 2469-9969
J9 PHYS REV B
JI Phys. Rev. B
PD APR 5
PY 2017
VL 95
IS 16
AR 165404
DI 10.1103/PhysRevB.95.165404
PG 18
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA FS3GW
UT WOS:000419669800005
DA 2018-12-27
ER

PT J
AU Do, NY
   Shin, HJ
   Lee, JE
AF Do, Nam Yong
   Shin, Hyun-Jae
   Lee, Ji-Eun
TI RETRACTED: Wheatgrass extract inhibits hypoxia-inducible
   factor-l-mediated epithelial-mesenchymal transition in A549 cells
   (Retracted article. See vol. 12, pg. 265, 2018)
SO NUTRITION RESEARCH AND PRACTICE
LA English
DT Article; Retracted Publication
DE Triticum; epithelial-mesenchymal transition; sinusitis; hypoxia
   inducible factor 1; cadherins
ID NASAL POLYPS; CYCLE ARREST; EXPRESSION
AB BACKGROUND/OBJECTIVES: Epithelial-mesenchymal transition (EMT) is involved in not only cancer development and metastasis but also non-cancerous conditions. Hypoxia is one of the proposed critical factors contributing to formation of chronic rhinosinusitis or nasal polyposis. Wheatgrass (Triticum aestivum) has antioxidant, anti-aging, and anti-inflammatory effects. In this study, we analyzed whether wheatgrass has an inhibitory effect on the EMT process in airway epithelial cells.
   MATERIALS/METHODS: A549 human lung adenocarcinoma cells were incubated in hypoxic conditions (CO2 5%/O-2 1%) for 24 h in the presence of different concentrations of wheatgrass extract (50, 75, 100, and 150 mu g/mL) and changes in expression of epithelial or mesenchymal markers were evaluated by immunoblotting and immunofluorescence. Accordingly, associated EMT-related transcriptional factors, Snail and Smad, were also evaluated.
   RESULTS: Hypoxia increased expression of N-cadherin and reduced expression of E-cadherin. Mechanistically, E-cadherin levels were recovered during hypoxia by silencing hypoxia inducible factor (HIF)-1 alpha or administering wheatgrass extract. Wheatgrass inhibited the hypoxia-mediated EMT by reducing the expression of phosphorylated Smad3 (pSmad3) and Snail. It suppressed the hypoxia-mediated EMT processes of airway epithelial cells via HIF-1 alpha and the pSmad3 signaling pathway.
   CONCLUSION: These results suggest that wheatgrass has potential as a therapeutic or supplementary agent for HIF-1-related diseases.
C1 [Do, Nam Yong; Lee, Ji-Eun] Chosun Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 365 Plimundaero, Gwangju 61452, South Korea.
   [Shin, Hyun-Jae] Chosun Univ, Dept Biochem & Polymer Engn, Gwangju 61452, South Korea.
RP Lee, JE (reprint author), Chosun Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, 365 Plimundaero, Gwangju 61452, South Korea.
EM gracelee@chosun.ac.kr
FU Research Fund from Chosun University [K206560003]
FX This study was supported by Research Fund from Chosun University 2016
   (K206560003).
CR Alitheen NB, 2011, PAK J PHARM SCI, V24, P243
   Aydos OS, 2011, TURK J MED SCI, V41, P657, DOI 10.3906/sag-0912-425
   Ben-Arye E, 2002, SCAND J GASTROENTERO, V37, P444, DOI 10.1080/003655202317316088
   Chien CY, 2008, OTOLARYNG HEAD NECK, V139, P206, DOI 10.1016/j.otohns.2008.04.022
   Chiu LCM, 2005, INT J MOL MED, V16, P735
   Das A, 2012, INT J FOOD SCI NUTR, V63, P718, DOI 10.3109/09637486.2011.644769
   Ferruzzi MG, 2007, NUTR RES, V27, P1, DOI 10.1016/j.nutres.2006.12.003
   Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC
   Hsu YC, 2007, AM J OTOLARYNG, V28, P379, DOI 10.1016/j.amjoto.2006.11.004
   Jaya M. S., 2009, Biomed, V4, P262
   Kulkarni SD, 2006, PHYTOTHER RES, V20, P218, DOI 10.1002/ptr.1838
   LAM CR, 1950, AM J SURG, V80, P204, DOI 10.1016/0002-9610(50)90531-9
   Lu X, 2009, ALLERGY, V64, P104, DOI 10.1111/j.1398-9995.2008.01829.x
   Matsune S, 2003, ACTA OTO-LARYNGOL, V123, P519, DOI 10.1080/0036554021000028113
   Shakya G, 2016, TOXICOL IND HEALTH, V32, P1026, DOI 10.1177/0748233714545202
   Shakya G, 2015, PHARMACOGN MAG, V11, pS139, DOI 10.4103/0973-1296.157715
   SHERMER M, 2008, SCI AM, V299, P42
   Shin HW, 2012, AM J RESP CRIT CARE, V185, P944, DOI 10.1164/rccm.201109-1706OC
   Steinke JW, 2008, CURR OPIN ALLERGY CL, V8, P16, DOI 10.1097/ACI.0b013e3282f3f488
   Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835
NR 20
TC 3
Z9 3
U1 0
U2 3
PU KOREAN NUTRITION SOC
PI SEOUL
PA 804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-1457
EI 2005-6168
J9 NUTR RES PRACT
JI Nutr. Res. Pract.
PD APR
PY 2017
VL 11
IS 2
BP 83
EP 89
DI 10.4162/nrp.2017.11.2.83
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA ER5YX
UT WOS:000398882200001
PM 28386380
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Izvolt, L
   Dobes, P
   Hodas, S
AF Izvolt, L.
   Dobes, P.
   Hodas, S.
TI RETRACTED: Experimental monitoring and numerical modeling of thermal
   regime of railway track structure - preliminary results and
   conclusions(Retracted article. See vol. 44, pg. 319, 2017)
SO CANADIAN JOURNAL OF CIVIL ENGINEERING
LA English
DT Article; Retracted Publication
DE railway track; subgrade dimensioning; climatic factors; numerical
   modeling of hermal regime; preliminary design nomogram
ID TEMPERATURE; PAVEMENT
AB The paper presents the obtained results and preliminary conclusions of experimental monitoring and numerical modeling of the thermal regime of railway track structure carried out on experimental stands (railway track models in 1:1). The purpose of the experimentation is to optimize the structural thickness of the protective layer in the subgrade structure. The first part of the paper describes the design of experimental stands and methodology for monitoring heat and moisture variations in the railway track structure. The second part characterizes the results of numerical modeling of the thermal regime of the railway track model using the Canadian SVHEAT software (SoilVision 2016) and subsequently carried out comparison of results of experimental measurements and numerical modeling. The SoilVision system is a modeling software based on the finite element method. The paper also introduces the preliminary design nomogram for determining the structural thickness of the protective layer of subgrade surface.
C1 [Izvolt, L.; Dobes, P.; Hodas, S.] Univ Zilina UNIZA, Fac Civil Engn, Dept Railway Engn & Track Management, Univ 8215-1, Zilina, Slovakia.
RP Hodas, S (reprint author), Univ Zilina UNIZA, Fac Civil Engn, Dept Railway Engn & Track Management, Univ 8215-1, Zilina, Slovakia.
EM stanislav.hodas@fstav.uniza.sk
CR [Anonymous], 2012, 1075612 VEGA U ZIL F
   [Anonymous], SV HEAT 2D 3D FIN EL
   [Anonymous], 2016, 1027516 VEGA U ZIL F
   [Anonymous], 2005, 736312 TNZ ZSR SLOV
   [Anonymous], 2015, TRIME PICO PROFILE M
   Dobes P., 2015, THESIS
   Hodas S., 2016, INT J COMPUTATIONAL, V4, P69, DOI [10.2495/CMEM-V4-N2-69-79, DOI 10.2495/CMEM-V4-N2-69-79]
   Hodas S., 2014, COMPRAIL 14 RAILWAY, P253, DOI 10.2495/CR140201
   Izvolt L., 2017, INT J TRANSPORT DEV, V1, P529, DOI [10.2495/TDI-V1-N3-529-539, DOI 10.2495/TDI-V1-N3-529-539]
   Kupculiak P., 2011, THESIS
   Lebeau M, 2009, COMPUT GEOTECH, V36, P435, DOI 10.1016/j.compgeo.2008.04.005
   Lu S, 2007, SOIL SCI SOC AM J, V71, P8, DOI 10.2136/sssaj2006.0041
   McKenzie JM, 2007, ADV WATER RESOUR, V30, P966, DOI 10.1016/j.advwatres.2006.08.008
   Sherif A, 2004, CAN J CIVIL ENG, V31, P369, DOI 10.1139/L03-107
   Watson DK, 2000, CAN J CIVIL ENG, V27, P44, DOI 10.1139/l99-049
NR 15
TC 0
Z9 0
U1 2
U2 5
PU CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS
PI OTTAWA
PA 65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA
SN 0315-1468
EI 1208-6029
J9 CAN J CIVIL ENG
JI Can. J. Civ. Eng.
PD APR
PY 2017
VL 44
IS 4
DI 10.1139/cjce-2017-0136
PG 43
WC Engineering, Civil
SC Engineering
GA ER8RS
UT WOS:000399090600001
DA 2018-12-27
ER

PT J
AU Fei, X
   Kong, WQ
   Chen, X
   Jiang, XJ
   Shao, ZZ
   Lee, JY
AF Fei, Xiang
   Kong, Wangqing
   Chen, Xin
   Jiang, Xuejiao
   Shao, Zhengzhong
   Lee, Jim Yang
TI RETRACTED: A Recycling-Free Nanocatalyst System: The Stabilization of In
   Situ-Reduced Noble Metal Nanoparticles on Silicone Nanofilaments via a
   Mussel-Inspired Approach (Retracted article. See vol. 8, pg. 5023, 2018)
SO ACS CATALYSIS
LA English
DT Article; Retracted Publication
DE recycling-free; noble-metal nanocatalyst; polydopamine; reusability;
   silicone nanofilament; Heck reaction
ID HETEROGENEOUS CATALYSIS; MAGNETIC NANOPARTICLES; ISOCYANIDE INSERTION;
   MYTILUS-EDULIS; PALLADIUM; CHEMISTRY; COATINGS; COLLOIDS; OXIDATION;
   ADHESIVE
AB The recovery and reuse of costly nanocatalysts is an essential operation in modern nanocatalysis, and improvements in catalyst reusability can contribute significantly to the economic viability and sustainable development of nanocatalysis. Herein, starting with the application of a silicone nanofilament (SNF) coating on a target substrate, a mussel-inspired approach in the form of polydopamine (PDA) deposition on the SNF surface was used to form in situ-reduced Pd nanoparticles (Pd NPs) and to stabilize them on the SNFs. This PDA-mediated approach enabled a high integrity nanocatalyst system to be built on a free-standing SNF support while retaining the porosity in the original SNF architecture. The SNFs-Pd nanocomposites prepared as such were applied to the inside walls of laboratory chemical reactors and used as recycling-free nanocatalyst systems for Pd-catalyzed organic reactions without the laborious conventional catalyst recovery and redispersion processes. The SNFs-Pd catalyst system exhibited high activity and high selectivity in single and successive Heck coupling reactions; and a reusability as high as 90% was still possible in the 20th cycle. This mussel-inspired approach is highly versatile and can be applied to laboratory chemical reactors in different shapes, sizes, and configurations to scale up the nanocatalyst applications. Furthermore, the general utility of the chemistry involved allows this surface modification technique to apply to other supported noble metal (e.g., Ag, Au, and Pt) catalysts, thereby increasing the usability and the performance of nanocatalyst systems.
C1 [Fei, Xiang] Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
   [Kong, Wangqing] Ecole Polytech Fed Lausanne, Lab Synth & Nat Prod, Inst Chem Sci & Engn, SB,ISIC,LSPN, BCH5304, CH-1015 Lausanne, Switzerland.
   [Chen, Xin; Jiang, Xuejiao; Shao, Zhengzhong] Fudan Univ, Dept Macromol Sci, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
   [Chen, Xin; Jiang, Xuejiao; Shao, Zhengzhong] Fudan Univ, Adv Mat Lab, Shanghai 200433, Peoples R China.
   [Fei, Xiang; Lee, Jim Yang] Natl Univ Singapore, Dept Chem & Biomol Engn, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
RP Fei, X (reprint author), Univ Zurich, Dept Chem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.; Fei, X (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
EM chefeix@nus.edu.sg
RI Chen, Xin/F-6802-2015
OI Chen, Xin/0000-0001-7706-4166
FU Swiss National Science Foundation; Alfred-Werner-Legat; University of
   Zurich
FX This work is supported by Swiss National Science Foundation, the
   Alfred-Werner-Legat, and the University of Zurich. The authors thank A.
   Kaech and M. Kirschmann (University of Zurich) for the support in
   FIB-SEM analysis from the Center for Microscopy and Image Analysis. A.
   Sologubenko (ETH Zurich) is gratefully acknowledged for acquiring HRTEM
   data in ScopeM. The authors further thank Prof. S. Seeger (University of
   Zurich) for his valuable discussion.
CR Arpad M, 2011, CHEM REV, V111, P2251, DOI 10.1021/cr100355b
   Artus GRJ, 2006, ADV MATER, V18, P2758, DOI 10.1002/adma.200502030
   Artus GRJ, 2014, ADV COLLOID INTERFAC, V209, P144, DOI 10.1016/j.cis.2014.03.007
   Astruc D., 2008, NANOPARTICLES CATALY
   Bell AT, 2003, SCIENCE, V299, P1688, DOI 10.1126/science.1083671
   Benaglia M, 2009, RECOVERABLE RECYCLAB
   Bhanage BM, 2001, CATAL REV, V43, P315, DOI 10.1081/CR-100107480
   Chng LL, 2013, ACCOUNTS CHEM RES, V46, P1825, DOI 10.1021/ar300197s
   Chu ZL, 2015, ADV MATER, V27, P7775, DOI 10.1002/adma.201503502
   Chu ZL, 2014, CHEM SOC REV, V43, P2784, DOI 10.1039/c3cs60415b
   Dams M, 2002, J CATAL, V209, P225, DOI 10.1006/jcat.2002.3630
   Gao LC, 2006, J AM CHEM SOC, V128, P9052, DOI 10.1021/ja062943n
   Harrington MJ, 2010, SCIENCE, V328, P216, DOI 10.1126/science.1181044
   HECK RF, 1972, J ORG CHEM, V37, P2320, DOI 10.1021/jo00979a024
   Herzing AA, 2008, SCIENCE, V321, P1331, DOI 10.1126/science.1159639
   Humphrey JM, 1997, CHEM REV, V97, P2243, DOI 10.1021/cr950005s
   Jeong U, 2007, ADV MATER, V19, P33, DOI 10.1002/adma.200600674
   Joo SH, 2009, NAT MATER, V8, P126, DOI 10.1038/NMAT2329
   Jun YW, 2008, ACCOUNTS CHEM RES, V41, P179, DOI 10.1021/ar700121f
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   LEWIS LN, 1993, CHEM REV, V93, P2693, DOI 10.1021/cr00024a006
   Li BC, 2014, ACS APPL MATER INTER, V6, P11581, DOI 10.1021/am502313h
   Liu YL, 2014, CHEM REV, V114, P5057, DOI 10.1021/cr400407a
   Lu AH, 2007, ANGEW CHEM INT EDIT, V46, P1222, DOI 10.1002/anie.200602866
   Mehnert CP, 1998, J AM CHEM SOC, V120, P12289, DOI 10.1021/ja971637u
   Meier M, 2017, SMALL, V13, DOI 10.1002/smll.201601072
   Meseck GR, 2015, ADV MATER INTERFACES, V2, DOI 10.1002/admi.201500216
   Meseck GR, 2014, J PHYS CHEM C, V118, P24967, DOI 10.1021/jp506867n
   Meseck GR, 2012, ADV FUNCT MATER, V22, P4433, DOI 10.1002/adfm.201200816
   MIZOROKI T, 1971, B CHEM SOC JPN, V44, P581, DOI 10.1246/bcsj.44.581
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Polshettiwar V, 2011, CHEM REV, V111, P3036, DOI 10.1021/cr100230z
   Qiu GYS, 2013, CHEM SOC REV, V42, P5257, DOI 10.1039/c3cs35507a
   Roucoux A, 2002, CHEM REV, V102, P3757, DOI 10.1021/cr010350j
   Schlogl R, 2004, ANGEW CHEM INT EDIT, V43, P1628, DOI 10.1002/anie.200301684
   Shylesh S, 2010, ANGEW CHEM INT EDIT, V49, P3428, DOI 10.1002/anie.200905684
   Somorjai G. A., 2010, INTRO SURFACE CHEM C
   Turner M, 2008, NATURE, V454, P981, DOI 10.1038/nature07194
   Uchic MD, 2007, MRS BULL, V32, P408, DOI 10.1557/mrs2007.64
   Vlaar T, 2013, ANGEW CHEM INT EDIT, V52, P7084, DOI 10.1002/anie.201300942
   Vlaar T, 2012, ANGEW CHEM INT EDIT, V51, P13058, DOI 10.1002/anie.201207410
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   Wang GH, 2014, NAT MATER, V13, P294, DOI 10.1038/NMAT3872
   Yamada YMA, 2014, ANGEW CHEM INT EDIT, V53, P127, DOI 10.1002/anie.201308541
   Yan JM, 2008, ANGEW CHEM INT EDIT, V47, P2287, DOI 10.1002/anie.200704943
   Yang SL, 2015, ANGEW CHEM INT EDIT, V54, P2661, DOI 10.1002/anie.201410360
   Yin LX, 2007, CHEM REV, V107, P133, DOI 10.1021/cr0505674
   Zhang JP, 2014, ADV FUNCT MATER, V24, P1074, DOI 10.1002/adfm.201301481
   Zhang JP, 2014, POLYM CHEM-UK, V5, P1132, DOI 10.1039/c3py01293j
   Zhang JP, 2011, ADV FUNCT MATER, V21, P4699, DOI 10.1002/adfm.201101090
   Zhang JP, 2011, ANGEW CHEM INT EDIT, V50, P6652, DOI 10.1002/anie.201101008
   Zimmermann J, 2008, ADV FUNCT MATER, V18, P3662, DOI 10.1002/adfm.200800755
NR 53
TC 10
Z9 10
U1 7
U2 64
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2155-5435
J9 ACS CATAL
JI ACS Catal.
PD APR
PY 2017
VL 7
IS 4
BP 2412
EP 2418
DI 10.1021/acscatal.6b03185
PG 7
WC Chemistry, Physical
SC Chemistry
GA ER7IS
UT WOS:000398986700020
DA 2018-12-27
ER

PT J
AU Verbree, CT
   Datwyler, SM
   Meile, S
   Eichenseher, F
   Donovan, DM
   Loessner, MJ
   Schmelcher, M
AF Verbree, Carolin T.
   Datwyler, Steven M.
   Meile, Susanne
   Eichenseher, Fritz
   Donovan, David M.
   Loessner, Martin J.
   Schmelcher, Mathias
TI RETRACTED: Identification of Peptidoglycan Hydrolase Constructs with
   Synergistic Staphylolytic Activity in Cow's Milk (Retracted article. See
   vol. 83, art no E02100, 2017)
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article; Retracted Publication
DE antibiotic resistance; antimicrobial agents; bovine mastitis;
   peptidoglycan hydrolases
ID RESISTANT STAPHYLOCOCCUS-AUREUS; IN-VITRO ACTIVITY; BOVINE MASTITIS;
   BACTERIOPHAGE ENDOLYSINS; MAMMARY-GLANDS; LYTIC ACTIVITY; LYSOSTAPHIN;
   INFECTION; ENZYME; KILL
AB Peptidoglycan hydrolases (PGHs) have been suggested as novel therapeutics for the treatment of bovine mastitis. However, activity in the presence of cow's milk is an important requirement for drugs administered into the bovine udder. We have screened a library of > 170 recombinant PGHs, including engineered bacteriophage endolysins, for enzymes with activity against Staphylococcus aureus in milk, using a microtiter plate-based protocol. Nine suitable PGH constructs were identified by this approach and further compared in time-kill assays for their efficacy against S. aureus in heat-treated milk. The three most active enzymes (lysostaphin, Ami2638A, and CHAPK_CWT-LST) reduced S. aureus in milk to undetectable numbers within minutes at nanomolar concentrations. Due to their different peptidoglycan cleavage sites, these PGH constructs revealed synergistic activity in most combinations, as demonstrated by checkerboard assays, spot assays, and time-kill experiments. Furthermore, they proved active against a selection of staphylococcal mastitis isolates from different geographical regions when applied individually or in synergistic combination. The most effective PGH combination completely eradicated S. aureus from milk, with no more bacteria being detected within 24 h after addition of the enzymes, corresponding to a reduction of > 9 log units compared to the control. Efficacy was also retained at different inoculum levels (3 versus 6 log CFU/ml) and when S. aureus was grown in milk as opposed to broth prior to the experiments. In raw cow's milk, CHAPK_CWT-LST showed reduced efficacy, whereas both Ami2638A and lysostaphin retained their activity, reducing bacterial numbers by > 3.5 log units within 3 h.
   IMPORTANCE Staphylococci and S. aureus in particular are a major cause of bovine mastitis, an inflammation of the mammary gland in cows associated with high costs and risks for consumers of milk products. S. aureus-induced mastitis, commonly treated by intramammary infusion of antibiotics, is characterized by low cure rates and increasing antibiotic resistance in bacteria. Therefore, alternative treatment options are highly desirable. PGHs, including bacteriophage endolysins, rapidly and specifically kill selected pathogens by degrading their cell wall and are refractory to resistance development, therefore holding promise as novel antibacterial agents. This study employed a screening approach to identify PGH constructs with high staphylolytic activity in cow's milk within a large collection of enzymes. Our results suggest that the most promising enzymes identified by this strategy hold potential as novel mastitis therapeutics and support their further characterization in animal models.
C1 [Verbree, Carolin T.; Datwyler, Steven M.; Meile, Susanne; Eichenseher, Fritz; Loessner, Martin J.; Schmelcher, Mathias] ETH, Inst Food Nutr & Hlth, Zurich, Switzerland.
   [Donovan, David M.] ARS, Anim Biosci & Biotechnol Lab, ANRI, NEA,USDA, Beltsville, MD USA.
RP Schmelcher, M (reprint author), ETH, Inst Food Nutr & Hlth, Zurich, Switzerland.
EM mathias.schmelcher@hest.ethz.ch
CR Abaev I, 2013, APPL MICROBIOL BIOT, V97, P3449, DOI 10.1007/s00253-012-4252-4
   Becker SC, 2008, FEMS MICROBIOL LETT, V287, P185, DOI 10.1111/j.1574-6968.2008.01308.x
   Becker SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25063
   Becker SC, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnu019
   Becker SC, 2009, FEMS MICROBIOL LETT, V294, P52, DOI 10.1111/j.1574-6968.2009.01541.x
   Daniel A, 2010, ANTIMICROB AGENTS CH, V54, P1603, DOI 10.1128/AAC.01625-09
   DEHART HP, 1995, APPL ENVIRON MICROB, V61, P1475
   Deluyker HA, 2005, J DAIRY SCI, V88, P604, DOI 10.3168/jds.S0022-0302(05)72724-7
   Djurkovic S, 2005, ANTIMICROB AGENTS CH, V49, P1225, DOI 10.1128/AAC.49.3.1225-1228.2005
   Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002
   Gotz F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P5, DOI 10.1007/0-387-30744-3_1
   Gutierrez D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107307
   HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427
   Hebert A, 2000, FEMS MICROBIOL LETT, V193, P57, DOI 10.1016/S0378-1097(00)00455-9
   Idelevich EA, 2016, ANTIMICROB AGENTS CH, V60, P2551, DOI 10.1128/AAC.02859-15
   Idelevich EA, 2011, ANTIMICROB AGENTS CH, V55, P4416, DOI 10.1128/AAC.00217-11
   Jones R.N., 1985, MANUAL CLIN MICROBIO, P972
   Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540
   Kuang Y, 2009, APPL MICROBIOL BIOT, V84, P135, DOI 10.1007/s00253-009-2008-6
   Kusuma C, 2007, ANTIMICROB AGENTS CH, V51, P475, DOI 10.1128/AAC.00786-06
   Lewis RE, 2002, J ANTIMICROB CHEMOTH, V49, P345, DOI 10.1093/jac/49.2.345
   Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x
   MAMO W, 1987, FEMS MICROBIOL LETT, V48, P195, DOI 10.1111/j.1574-6968.1987.tb02541.x
   Mao JZ, 2013, FEMS MICROBIOL LETT, V342, P30, DOI 10.1111/1574-6968.12104
   NEWBOULD FH, 1974, CAN J COMP MED, V38, P411
   O'Flaherty S, 2005, J BACTERIOL, V187, P7161, DOI 10.1128/JB.187.20.7161-7164.2005
   O'Flaherty S, 2005, LETT APPL MICROBIOL, V41, P274, DOI 10.1111/j.1472-765X.2005.01762.x
   Obeso JM, 2008, INT J FOOD MICROBIOL, V128, P212, DOI 10.1016/j.ijfoodmicro.2008.08.010
   Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301
   Pastagia M, 2013, J MED MICROBIOL, V62, P1506, DOI 10.1099/jmm.0.061028-0
   Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384
   Roach DR, 2015, BACTERIOPHAGE, V5, DOI DOI 10.1080/21597081.2015.1062590
   Rodriguez-Rubio L, 2016, CRIT REV BIOTECHNOL, V36, P542, DOI 10.3109/07388551.2014.993587
   Rodriguez-Rubio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054828
   SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414
   SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407
   Schmelcher M, 2015, APPL MICROBIOL BIOT, V99, P8475, DOI 10.1007/s00253-015-6579-0
   Schmelcher M, 2015, J ANTIMICROB CHEMOTH, V70, P1453, DOI 10.1093/jac/dku552
   Schmelcher M, 2014, METHODS MOL BIOL, V1157, P141, DOI 10.1007/978-1-4939-0703-8_12
   Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/FMB.12.97, 10.2217/fmb.12.97]
   Schmelcher M, 2012, APPL ENVIRON MICROB, V78, P2297, DOI 10.1128/AEM.07050-11
   Sordillo LM, 2002, J MAMMARY GLAND BIOL, V7, P135, DOI 10.1023/A:1020347818725
   Taponen S, 2009, VET MICROBIOL, V134, P29, DOI 10.1016/j.vetmic.2008.09.011
   Vanderhaeghen W, 2010, EPIDEMIOL INFECT, V138, P606, DOI 10.1017/S0950268809991567
   Wall RJ, 2005, NAT BIOTECHNOL, V23, P445, DOI 10.1038/nbt1078
   Whisstock JC, 1999, TRENDS BIOCHEM SCI, V24, P132, DOI 10.1016/S0968-0004(99)01366-3
NR 46
TC 6
Z9 6
U1 2
U2 15
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD APR
PY 2017
VL 83
IS 7
AR UNSP e03445
DI 10.1128/AEM.03445-16
PG 15
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA EP0WL
UT WOS:000397107300028
PM 28159785
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Liao, ZB
   Wu, J
   Wu, MJ
   Yan, Y
   Wang, HQ
   Cheng, CJ
   Tang, WY
AF Liao, Zhengbu
   Wu, Jing
   Wu, Mingjun
   Yan, Yi
   Wang, Haiquan
   Cheng, Chongjie
   Tang, Wenyuan
TI RETRACTED: The Critical Role of SRPK1 in EMT of Human Glioblastoma in
   the Spinal Cord (Retracted article. See vol. 54, pg. 8459, 2017)
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article; Retracted Publication
DE SRPK1; Glioblastoma; EMT
ID PATHWAYS; CARCINOMAS; ACTIVATION; APOPTOSIS; MECHANISM; PI3K/AKT;
   BREAST; TUMORS; ERK
AB Up to now, the serine-arginine protein kinase 1 (SRPK1) has been suggested as an important signal mediator, which is implicated in the development of cancers. Unfortunately, some molecular pathways in SRPK1-mediated epithelial-mesenchymal transition (EMT) in human spinal glioblastoma have been not elucidated. In this work, we detected the expression of SRPK1 in human spinal glioblastoma tissues and GBM cell lines and analyzed the relevant molecular proteins using in vitro experiments, including RT-PCR, gene silencing, and Western blot. In this study, RT-PCR and Western blot revealed that the expression of SRPK1 mRNA and protein became higher in all six spinal glioblastoma specimens; however, its expression was low in matched normal specimens. We also demonstrated SRPK1 expression facilitated the proliferation of U87 and U251 cells and inhibited the apoptosis in U87 and U251 cells. Also, SRPK1 promoted the expression of EMT-regulating markers, involving N-cadherin, Snail, and MMP9 and decreased the expression of mesenchymal marker E-cadherin. Moreover, knockdown of SRPK1 significantly inhibited the expression levels of p-Akt rather than t-Akt. In conclusion, knockdown of SRPK1 inhibited glioblastoma cell proliferation, invasion, and EMT process via suppressing p-Akt signaling pathway. This study also lays a new foundation for the clinically biological treatment.
C1 [Liao, Zhengbu; Yan, Yi; Wang, Haiquan; Cheng, Chongjie; Tang, Wenyuan] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China.
   [Wu, Jing] Chongqing Med Univ, Intens Care Unit, Affiliated Hosp 2, Chongqing 400010, Peoples R China.
   [Wu, Mingjun] Chongqing Med Univ, Inst Mol Biol, Chongqing 400016, Peoples R China.
RP Liao, ZB (reprint author), Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China.
EM liaozhengbu163@163.com
FU Chong Qing Natural Science Foundation [cstc2015jcyjA0526]
FX This study is supported by the Chong Qing Natural Science Foundation
   (cstc2015jcyjA0526).
CR Aubol BE, 2014, BIOCHEMISTRY-US, V53, P4625, DOI 10.1021/bi500483m
   Baleriaux DLF, 1999, EUR RADIOL, V9, P1252, DOI 10.1007/s003300050831
   Cuadrado-Pereira Marianela, 2007, Bol Asoc Med P R, V99, P60
   Gammons MV, 2014, BRIT J CANCER, V111, P477, DOI 10.1038/bjc.2014.342
   Ghosh G, 2011, FEBS J, V278, P587, DOI 10.1111/j.1742-4658.2010.07992.x
   Hayes GM, 2007, CANCER RES, V67, P2072, DOI 10.1158/0008-5472.CAN-06-2969
   Henson JW, 2001, CURR OPIN NEUROL, V14, P679, DOI 10.1097/00019052-200112000-00001
   Houten JK, 2000, J NEURO-ONCOL, V47, P225, DOI 10.1023/A:1006418506213
   Keshwani MM, 2015, BIOCHEM J, V466, P311, DOI 10.1042/BJ20141373
   Li K, 2015, TUMOUR BIOL
   Lin JC, 2014, RNA, V20, P1621, DOI 10.1261/rna.045583.114
   Lv BY, 2015, MOL NEUROBIOL, V52, P1263, DOI 10.1007/s12035-014-8935-y
   Lv SZ, 2015, J MOL NEUROSCI, V55, P519, DOI 10.1007/s12031-014-0375-7
   Niu H, 2015, TUMOUR BIOL
   Pan Y, 2015, MOL NEUROBIOL
   Ren GH, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0654-3
   Townsend N, 2004, PEDIATR BLOOD CANCER, V43, P629, DOI 10.1002/pbc.20082
   Wang F., 2015, INT J DISTRIB SENS N, V2015, P1, DOI DOI 10.1007/S00425-015-2443-9
   Wu J. J., 2015, SCI REP, V5, P14, DOI DOI 10.1038/SREP13477
   Yan J, 2015, TUMOUR BIOL
   Zhou B, 2013, MOL CELL BIOCHEM, V379, P191, DOI 10.1007/s11010-013-1641-7
NR 21
TC 4
Z9 4
U1 4
U2 7
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD APR
PY 2017
VL 54
IS 3
BP 1818
EP 1824
DI 10.1007/s12035-016-9784-7
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA ER0VQ
UT WOS:000398506900020
PM 26887384
DA 2018-12-27
ER

PT J
AU Zhang, TH
   Liang, LZ
   Liu, XL
   Wu, JN
   Su, K
   Chen, JY
   Zheng, QY
   Huang, HZ
   Liao, GQ
AF Zhang, Tong-Han
   Liang, Li-Zhong
   Liu, Xiao-Ling
   Wu, Ji-Nan
   Su, Kui
   Chen, Jue-Yao
   Zheng, Qiao-Yi
   Huang, Hong-Zhang
   Liao, Gui-Qing
TI RETRACTED: Long non-coding RNA MALAT1 interacts with miR-124 and
   modulates tongue cancer growth by targeting JAG1 (Retracted article. See
   vol. 40, pg. 3112, 2018)
SO ONCOLOGY REPORTS
LA English
DT Article; Retracted Publication
DE lncRNA; MALAT1; miR-124; tongue cancer; JAG1
ID BREAST-CANCER; CELL-PROLIFERATION; KIDNEY CANCER; CARCINOMA; EXPRESSION;
   INVASION; ACTIVATION; MIGRATION; POOR; EZH2
AB Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a long non-coding RNA (IncRNA), was the earliest discovered to be correlated with cancer and contributes to the initiation and development of several types of tumors. Dysregulation of MALAT1 expression is frequently observed in many types of cancer such as gastric cancer, esophageal squamous cell carcinoma and glioma. To date, the role of MALAT1 and the underlying mechanisms in tongue cancer development remain unclear. In the present study, we studied the influence of MALAT1 on tongue cancer cell lines and clinical tongue cancer samples so as to detect its function and the underlying mechanism. In the present study, IncRNA-MALAT1 was specifically upregulated in tongue cancer cell lines and overexpression promoted tongue cancer cell growth by targeting miR-124. Knockdown of MALAT1 suppressed the growth and invasion of human tongue cancer cells and inhibited metastasis in vitro and in vivo. In addition, miR-124-dependent jaggedl (JAG1) regulation was required for MALAT1-induced tongue cancer cell growth. Our data revealed that MALAT1 inhibited tongue cancer cell growth and metastasis through miR-124-dependent JAG1 regulation. In conclusion, we revealed that MALAT1 may play an oncogenic role by increasing proliferation and metastasis of tongue cancer and is a potential therapeutic target in human tongue cancer.
C1 [Zhang, Tong-Han; Wu, Ji-Nan; Su, Kui; Chen, Jue-Yao; Zheng, Qiao-Yi] Sun Yat Sen Univ, Affiliated Zhongshan Hosp, Dept Oral & Maxillofacial Surg, Zhongshan 528403, Guangdong, Peoples R China.
   [Liang, Li-Zhong] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Oral & Maxillofacial Surg, Zhuhai 519000, Guangdong, Peoples R China.
   [Liu, Xiao-Ling] Sun Yat Sen Univ, Affiliated Zhongshan Hosp, Dept Med Intens Care Unit, Zhongshan 528403, Guangdong, Peoples R China.
   [Huang, Hong-Zhang; Liao, Gui-Qing] Sun Yat Sen Univ, Hosp Stomatol, Guanghua Sch Stomatol, Dept Oral & Maxillofacial Surg, Guangzhou 510055, Guangdong, Peoples R China.
   [Huang, Hong-Zhang; Liao, Gui-Qing] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510080, Guangdong, Peoples R China.
RP Wu, JN; Su, K (reprint author), Sun Yat Sen Univ, Affiliated Zhongshan Hosp, Dept Stomatol, 73 Hubin Rd, Zhongshan 528403, Guangdong, Peoples R China.
EM gdwujn@163.com; 491781534@qq.com
FU National Natural Science Foundation of China [81302356]; Postdoctoral
   Science Foundation of China [2012M511877]; Scientific Projects of
   Zhongshan City [20122A006]; Natural Science Foundation of Guangdong
   Province [2014A030310076]; Science and Technology Project of Guangdong
   Province [2016A020215031]
FX This study was supported by grants from the National Natural Science
   Foundation of China (81302356), the Postdoctoral Science Foundation of
   China (2012M511877), the Scientific Projects of Zhongshan City
   (20122A006), the Natural Science Foundation of Guangdong Province
   (2014A030310076) and the Science and Technology Project of Guangdong
   Province (2016A020215031).
CR An LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069478
   Chang WH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150355
   Cheng Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1303-0
   Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785
   Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233
   Fang ZY, 2014, OR SURG OR MED OR PA, V117, P89, DOI 10.1016/j.oooo.2013.09.007
   Feng TB, 2016, ONCOTARGET, V7, P16205, DOI 10.18632/oncotarget.7578
   Gao W, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/405860
   Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y
   Han G, 2015, EXP THER MED, V9, P679, DOI 10.3892/etm.2014.2161
   Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931
   Hunt S, 2011, FEBS LETT, V585, P187, DOI 10.1016/j.febslet.2010.11.038
   Liu KJ, 2013, BIOMED RES INT, DOI 10.1155/2013/867537
   Liu MX, 2014, ONCOTARGET, V5, P944, DOI 10.18632/oncotarget.1458
   Liu SK, 2016, TUMOR BIOL, V37, P633, DOI 10.1007/s13277-015-3732-4
   Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003
   Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006
   Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069
   Selcuklu SD, 2012, BIOCHEM BIOPH RES CO, V423, P234, DOI 10.1016/j.bbrc.2012.05.074
   Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013
   Simon DP, 2012, CLIN CANCER RES, V18, P2452, DOI 10.1158/1078-0432.CCR-11-2371
   Taniguchi K, 2015, BBA-MOL BASIS DIS, V1852, P1971, DOI 10.1016/j.bbadis.2015.06.022
   Wang XY, 2016, ONCOL REP, V35, P3115, DOI 10.3892/or.2016.4648
   Wang XY, 2015, J BIOL CHEM, V290, P3925, DOI 10.1074/jbc.M114.596866
   Xiao HB, 2015, ONCOTARGET, V6, P38005, DOI 10.18632/oncotarget.5357
   Xie C, 2014, INT J CLIN EXP PATHO, V7, P6534
   Yang MH, 2015, BBA-MOL BASIS DIS, V1852, P166, DOI 10.1016/j.bbadis.2014.11.013
   Yoshimoto R, 2016, BBA-GENE REGUL MECH, V1859, P192, DOI 10.1016/j.bbagrm.2015.09.012
   Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145
   Zhou SG, 2014, J CANCER RES CLIN, V140, P1989, DOI 10.1007/s00432-014-1699-y
NR 30
TC 23
Z9 24
U1 6
U2 13
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1021-335X
EI 1791-2431
J9 ONCOL REP
JI Oncol. Rep.
PD APR
PY 2017
VL 37
IS 4
BP 2087
EP 2094
DI 10.3892/or.2017.5445
PG 8
WC Oncology
SC Oncology
GA EQ5QY
UT WOS:000398138900020
PM 28260102
OA Bronze
DA 2018-12-27
ER

PT J
AU Zhang, L
   Cui, Y
   Wang, YC
   Yin, H
   Zheng, JM
   Huang, L
   Zhao, ZW
   Li, J
AF Zhang, Lei
   Cui, Ying
   Wang, Ying-chun
   Yin, Hong
   Zheng, Jian-min
   Huang, Lu
   Zhao, Zhen-wei
   Li, Jiang
TI RETRACTED: Exploring the mechanism by which accumbal deep brain
   stimulation attenuates morphine-induced reinstatement through
   manganese-enhanced MRI and pharmacological intervention (Retracted
   article. See vol. 297, pg. 191, 2017)
SO EXPERIMENTAL NEUROLOGY
LA English
DT Article; Retracted Publication
DE Morphine; Addiction; Deep brain stimulation; Conditioned place
   preference; Manganese-enhanced MRI; Rat
ID MEDIAL PREFRONTAL CORTEX; OBSESSIVE-COMPULSIVE-DISORDER; PRIMING-INDUCED
   REINSTATEMENT; CONTEXT-INDUCED REINSTATEMENT; HEROIN-SEEKING BEHAVIORS;
   RESONANCE-IMAGING MEMRI; NUCLEUS-ACCUMBENS; IN-VIVO; COCAINE-SEEKING;
   DRUG-SEEKING
AB Deep brain stimulation (DBS) of the nucleus accumbens (NAc) has been applied to attenuate drug relapses in animal studies and clinical treatments. However, the mechanisms by which DBS produces its therapeutic effects remain largely unknown. This study is the first to combine manganese-enhanced magnetic resonance imaging (MRI) with DBS to explore the effects of accumbal DBS on the relapse pathway of rats. The images suggested that DBS produced an antidromic activation of the cortico-accumbal afferents. To verify the activating effects of DBS, the expression levels of the protein encoded by the immediate early gene c-Fos following DBS were measured using immunochemical methods. Intra-shell DBS increased c-Fos expression at the site of stimulation as well as in the infralimbic prefrontal cortex (IL), and increased c-Fos-expressing GABAergic interneurons in the IL This activity is consistent with a previous study demonstrating that DBS of the NAc shell attenuated cocaine reinstatement via local activation and/or the activation of GABAergic interneurons in the medial prefrontal cortex (mPFC). For further examination, lidocaine was microinjected into the NAc shell to block the fibers during DBS before the reinstatement test. Inactivation of the target fibers attenuated the effects of DBS on the reinstatement of morphine seeking. Moreover, GABA receptor antagonists administered into the IL weakened the effect of DBS, while GABA receptor agonists microinjected into the IL attenuated the reinstatement of morphine seeking. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Zhang, Lei; Huang, Lu; Zhao, Zhen-wei; Li, Jiang] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, 569 Xinsi Rd, Xian 710038, Peoples R China.
   [Cui, Ying] Fourth Mil Med Univ, Tangdu Hosp, Dept Blood Transfus, Xian 710038, Peoples R China.
   [Wang, Ying-chun] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.
   [Yin, Hong; Zheng, Jian-min] Fourth Mil Med Univ, Xing Hosp, Dept Radiol, Xian 710032, Peoples R China.
RP Zhao, ZW; Li, J (reprint author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurosurg, 569 Xinsi Rd, Xian 710038, Peoples R China.
EM zhanglei363@163.com; cylul@163.com; yingchun20002009@163.com;
   yinhong@fmmu.edu.cn; jmzheng1986@126.com; huanglufmmu@163.com;
   zzwzc@sina.com; lijiang@fmmu.edu.cn
FU Natural Scientific Research Funds of China [81101022, 31300830]; Shanxi
   National Science Foundation Project (Electrical stimulation on
   protection of ischemic stroke in rats) [S2016YFJM0704]
FX This project was supported by the Natural Scientific Research Funds of
   China (1. Deep brain stimulation in the nucleus accumbens has a more
   important role in the treatment of heroin addiction, No. 81101022; 2. A
   possible mechanism of stathmin as a potential target for treatment of
   Phobia, No. 31300830) and the Shanxi National Science Foundation Project
   (Electrical stimulation on protection of ischemic stroke in rats, No.
   S2016YFJM0704).
CR Benabid AL, 2015, NATURE, V519, P299, DOI 10.1038/519299a
   Beurrier C, 2001, J NEUROPHYSIOL, V85, P1351
   Bossert JM, 2012, J NEUROSCI, V32, P4982, DOI 10.1523/JNEUROSCI.0005-12.2012
   Chen M, 2015, ELIFE, V4, DOI 10.7554/eLife.09275
   Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776
   Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570
   Dugladze T, 2012, SCIENCE, V336, P1458, DOI 10.1126/science.1222017
   Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6
   Feltenstein MW, 2008, BRIT J PHARMACOL, V154, P261, DOI 10.1038/bjp.2008.51
   Fuchs RA, 2007, EUR J NEUROSCI, V26, P487, DOI 10.1111/j.1460-9568.2007.05674.x
   Goeders NE, 2002, J PHARMACOL EXP THER, V301, P785, DOI 10.1124/jpet.301.3.785
   Graziane NM, 2016, NAT NEUROSCI, V19, P915, DOI 10.1038/nn.4313
   Guo LM, 2013, DRUG ALCOHOL DEPEN, V129, P70, DOI 10.1016/j.drugalcdep.2012.09.012
   Henderson MB, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.4.FOCUS10105
   Huff W, 2010, CLIN NEUROL NEUROSUR, V112, P137, DOI 10.1016/j.clineuro.2009.11.006
   Kantak KM, 2009, BEHAV BRAIN RES, V201, P128, DOI 10.1016/j.bbr.2009.02.002
   Klein J, 2010, BEHAV BRAIN RES, V213, P73, DOI 10.1016/j.bbr.2010.04.036
   Knapp CM, 2009, PHARMACOL BIOCHEM BE, V92, P474, DOI 10.1016/j.pbb.2009.01.017
   Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110
   Koya E, 2009, NEUROPHARMACOLOGY, V56, P177, DOI 10.1016/j.neuropharm.2008.04.022
   Kuhn J, 2007, J NEUROL, V254, P963, DOI 10.1007/s00415-006-0404-8
   LaLumiere RT, 2012, EUR J NEUROSCI, V35, P614, DOI 10.1111/j.1460-9568.2012.07991.x
   Leergaard TB, 2003, NEUROIMAGE, V20, P1591, DOI 10.1016/S1053-8119(03)00459-2
   Liu HY, 2008, ADDICT BIOL, V13, P40, DOI 10.1111/j.1369-1600.2007.00088.x
   Liu ZX, 2014, NEURON, V81, P1360, DOI 10.1016/j.neuron.2014.02.010
   Martinez-Rivera FJ, 2016, BIOL PSYCHIAT, V80, P682, DOI 10.1016/j.biopsych.2016.05.015
   McCracken CB, 2007, J NEUROSCI, V27, P12601, DOI 10.1523/JNEUROSCI.3750-07.2007
   McCracken CB, 2009, J NEUROSCI, V29, P5354, DOI 10.1523/JNEUROSCI.0131-09.2009
   McFarland K, 2001, J NEUROSCI, V21, P8655
   McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6
   McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003
   McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024
   Montgomery EB, 2008, NEUROSCI BIOBEHAV R, V32, P388, DOI 10.1016/j.neubiorev.2007.06.003
   Nowak LG, 1998, EXP BRAIN RES, V118, P477, DOI 10.1007/s002210050304
   Nowak LG, 1998, EXP BRAIN RES, V118, P489, DOI 10.1007/s002210050305
   Parkinson JRC, 2009, NEUROIMAGE, V44, P1022, DOI 10.1016/j.neuroimage.2008.09.047
   Pautler RG, 2004, NMR BIOMED, V17, P595, DOI 10.1002/nbm.942
   Pautler RG, 2002, NEUROIMAGE, V16, P441, DOI 10.1006/nimg.2002.1075
   Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515
   Paxinos G., 2004, RAT BRAIN STEREOTAXI
   Perlmutter JS, 2002, NEUROLOGY, V58, P1388, DOI 10.1212/WNL.58.9.1388
   Perrine SA, 2015, NMR BIOMED, V28, P1480, DOI 10.1002/nbm.3409
   Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008
   Peters J, 2013, TRENDS PHARMACOL SCI, V34, P689, DOI 10.1016/j.tips.2013.10.004
   Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309
   Rattay F, 1998, IEEE T BIO-MED ENG, V45, P766, DOI 10.1109/10.678611
   Schlaepfer TE, 2008, NEUROPSYCHOPHARMACOL, V33, P368, DOI 10.1038/sj.npp.1301408
   Schmidt HD, 2005, EUR J PHARMACOL, V526, P65, DOI 10.1016/j.ejphar.2005.09.068
   Schwarz JM, 2011, J NEUROSCI, V31, P17835, DOI 10.1523/JNEUROSCI.3297-11.2011
   See RE, 2005, EUR J PHARMACOL, V526, P140, DOI 10.1016/j.ejphar.2005.09.034
   Simmons JM, 2008, J NEUROSCI, V28, P7637, DOI 10.1523/JNEUROSCI.1488-08.2008
   Soria G, 2008, NEUROIMAGE, V41, P668, DOI 10.1016/j.neuroimage.2008.03.018
   Spealman RD, 1999, PHARMACOL BIOCHEM BE, V64, P327, DOI 10.1016/S0091-3057(99)00049-0
   Stefani A, 2005, ANN NEUROL, V57, P448, DOI 10.1002/ana.20402
   Stuber GD, 2013, NEURON, V78, P6, DOI 10.1016/j.neuron.2013.03.013
   Sturm V, 2003, J CHEM NEUROANAT, V26, P293, DOI 10.1016/j.jchemneu.2003.09.003
   Taba HA, 2010, J NEUROSURG, V113, P1224, DOI 10.3171/2010.8.JNS10312
   Tung LW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12199
   Vassoler FM, 2008, J NEUROSCI, V28, P8735, DOI 10.1523/JNEUROSCI.5277-07.2008
   Vassoler FM, 2013, J NEUROSCI, V33, P14446, DOI 10.1523/JNEUROSCI.4804-12.2013
   Veerakumar A, 2015, CURR OPIN BEHAV SCI, V4, P48, DOI 10.1016/j.cobeha.2015.02.004
   Vitek JL, 2002, MOVEMENT DISORD, V17, pS69, DOI 10.1002/mds.10144
   Wade CL, 2016, NEUROPSYCHOPHARMACOL
   Wagner FA, 2002, NEUROPSYCHOPHARMACOL, V26, P479, DOI 10.1016/S0893-133X(01)00367-0
   Windels F, 2000, EUR J NEUROSCI, V12, P4141, DOI 10.1046/j.1460-9568.2000.00296.x
   Wyckhuys T, 2010, NEUROIMAGE, V52, P55, DOI 10.1016/j.neuroimage.2010.04.017
   Young CK, 2011, NEUROIMAGE, V56, P35, DOI 10.1016/j.neuroimage.2011.02.023
   Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477
   Zhou HY, 2011, BIOL PSYCHIAT, V69, pE41, DOI 10.1016/j.biopsych.2011.02.012
NR 69
TC 2
Z9 2
U1 4
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4886
EI 1090-2430
J9 EXP NEUROL
JI Exp. Neurol.
PD APR
PY 2017
VL 290
BP 29
EP 40
DI 10.1016/j.expneurol.2016.12.013
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA EM5QR
UT WOS:000395368000003
PM 28038985
DA 2018-12-27
ER

PT J
AU Li, YH
   Oliver, PG
   Lu, WY
   Pathak, V
   Sridharan, S
   Augelli-Szafran, CE
   Buchsbaum, DJ
   Suto, MJ
AF Li, Yonghe
   Oliver, Patsy G.
   Lu, Wenyan
   Pathak, Vibha
   Sridharan, Sivaram
   Augelli-Szafran, Corinne E.
   Buchsbaum, Donald J.
   Suto, Mark J.
TI RETRACTED: SRI36160 is a specific inhibitor of Wnt/beta-catenin
   signaling in human pancreatic and colorectal cancer cells (Retracted
   article. See vol. 422, pg. 131, 2018)
SO CANCER LETTERS
LA English
DT Article; Retracted Publication
DE Wnt signaling; Benzimidazole; Niclosamide; Targeted therapy; Drug
   discovery
ID BETA-CATENIN; COLON-CANCER; WNT PATHWAY; R-SPONDIN; DUCTAL
   ADENOCARCINOMA; DRUG DESIGN; STEM-CELLS; NICLOSAMIDE; ACTIVATION;
   EXPRESSION
AB Activation of Wnt/beta-catenin signaling is associated with pancreatic and colorectal cancer, among others. To-date, there are no FDA-approved small molecule Wnt/beta-catenin inhibitors and many past efforts resulted in compounds with undesirable off-target effects. We recently identified a series of benzimidazole analogs as potent inhibitors of Wnt/beta-catenin signaling. Here, we show that the lead compound SRI36160 displayed selective Wnt inhibition and potent antiproliferative activity in pancreatic and colorectal cancer cells. Moreover, SRI36160 had no effect on, STAT3 and mTORC1 signaling in pancreatic and colorectal cancer cells, and was not effective in inhibiting proliferation of non-cancerous cells. Our findings suggest that this series of benzimidazole analogs presents a novel approach for the treatment of Wnt-dependent cancers such as colorectal and pancreatic cancer. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Li, Yonghe; Lu, Wenyan; Pathak, Vibha; Augelli-Szafran, Corinne E.; Suto, Mark J.] Drug Discovery Div, Southern Res, 2000 Ninth Ave South, Birmingham, AL 35255 USA.
   [Oliver, Patsy G.; Sridharan, Sivaram; Buchsbaum, Donald J.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA.
RP Li, YH (reprint author), Drug Discovery Div, Southern Res, 2000 Ninth Ave South, Birmingham, AL 35255 USA.
EM yli@southernresearch.org
FU National Institutes of Health [R01CA124531, R21CA182056, P50CA101955];
   Alabama Innovation Fund; UAB Comprehensive Cancer Center; UAB School of
   Medicine
FX We thank Janet A. Houghton and Ruowen Zhang for helpful discussion and
   support during the course of this study, and Lynae Hanks for critical
   reading of the manuscript. This work was partially supported by grants
   from the National Institutes of Health R01CA124531, R21CA182056 and
   P50CA101955, the Alabama Innovation Fund, the UAB Comprehensive Cancer
   Center, and the UAB School of Medicine.
CR Al-Aynati MM, 2004, CLIN CANCER RES, V10, P1235, DOI 10.1158/1078-0432.CCR-03-0087
   Al-Hadiya Badraddin M H, 2005, Profiles Drug Subst Excip Relat Methodol, V32, P67, DOI 10.1016/S0099-5428(05)32002-8
   Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419
   ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X
   Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7
   Burgess AW, 2011, EXP CELL RES, V317, P2748, DOI 10.1016/j.yexcr.2011.08.010
   Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012
   de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204
   DENAVA CC, 1983, MUTAT RES, V117, P79, DOI 10.1016/0165-1218(83)90155-6
   di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155
   Dow LE, 2015, CELL, V161, P1539, DOI 10.1016/j.cell.2015.05.033
   Giri AK, 1996, MUTAT RES-GENET TOX, V370, P1, DOI 10.1016/S0165-1218(96)90121-4
   Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109
   Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019
   Ilmer M, 2015, CANCER RES, V75, P1883, DOI 10.1158/0008-5472.CAN-14-1327
   Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002
   Jiang JX, 2015, ONCOTARGET, V6, P2767, DOI 10.18632/oncotarget.3089
   Jiang XM, 2015, MOL CELL, V58, P522, DOI 10.1016/j.molcel.2015.03.015
   Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110
   Jiao YC, 2014, J PATHOL, V232, P428, DOI 10.1002/path.4310
   Jin YL, 2010, CANCER RES, V70, P2516, DOI 10.1158/0008-5472.CAN-09-3950
   Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233
   Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1
   Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308
   Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200
   Li YH, 2014, CANCER LETT, V349, P8, DOI 10.1016/j.canlet.2014.04.003
   Lin CH, 2011, FEBS LETT, V585, P3120, DOI 10.1016/j.febslet.2011.08.046
   Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110
   Londono-Joshi AI, 2014, MOL CANCER THER, V13, P800, DOI 10.1158/1535-7163.MCT-13-0555
   Lu WY, 2012, CELL SIGNAL, V24, P2291, DOI 10.1016/j.cellsig.2012.07.009
   Lu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029290
   Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002
   Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787
   Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899
   Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252
   Nehlsen K, 2006, GENE THER MOL BIOL, V10B, P233
   Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470
   Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978
   OSTROSKYWEGMAN P, 1986, MUTAT RES, V173, P81, DOI 10.1016/0165-7992(86)90015-1
   Pathak V., 2016, J MED CHEM
   Patterson S, 2014, TRENDS PARASITOL, V30, P289, DOI 10.1016/j.pt.2014.04.003
   Saeed M, 2011, J BIOL CHEM, V286, P33872, DOI 10.1074/jbc.M111.275446
   Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282
   STRAUSS MJ, 1979, IND ENG CHEM PROD RD, V18, P158, DOI 10.1021/i360071a002
   VEGA SG, 1988, MUTAT RES, V204, P269, DOI 10.1016/0165-1218(88)90099-7
   Walsh JS, 2011, ANNU REV PHARMACOL, V51, P145, DOI 10.1146/annurev-pharmtox-010510-100514
   Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018
   Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744
   Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108
   Xie Y, 2013, EMBO REP, V14, P1120, DOI 10.1038/embor.2013.167
   Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498
   Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607
   Zhang W, 2016, BIOCHEM J, V473, P1027, DOI 10.1042/BJ20150992
   Zhang YQ, 2013, CANCER RES, V73, P4909, DOI 10.1158/0008-5472.CAN-12-4384
NR 54
TC 6
Z9 7
U1 2
U2 12
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3835
EI 1872-7980
J9 CANCER LETT
JI Cancer Lett.
PD MAR 28
PY 2017
VL 389
BP 41
EP 48
DI 10.1016/j.canlet.2016.12.030
PG 8
WC Oncology
SC Oncology
GA EN2NB
UT WOS:000395846100005
PM 28043913
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Chen, Y
   Zhang, ZD
AF Chen, Yong
   Zhang, Zhendong
TI RETRACTED: Mechanism of flash boiling and spray analysis with gasoline,
   iso-octane, n-pentane and ethanol from a novel heated tip GDI injector
   (Retracted article. See vol. 140, pg. 829. 2018)
SO APPLIED THERMAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Heated tip injector; Mie scattering technique; Flash boiling; Fuel
   property; Spray analysis
ID MULTI-HOLE INJECTOR; IGNITION ENGINE; HYDROCARBONS; ATOMIZATION;
   COMBUSTION; ALCOHOLS; NOZZLE
AB The effects of thermal and fuel properties on the spray characteristics of a novel heated tip GDI injector have been investigated. The novel heated tip injector with an inner heater has been designed and manufactured to study the macroscopic spray characteristics under different conditions. To reveal the effects of injector heated tip temperature on spray characteristics, a six holes novel heated tip injector with different temperature has been studied. Moreover, a model refer to the velocity of a droplet of the flash boiling spray is established to predict the spray angle. A high-speed backlit imaging technique combined with cross-sectional spray patterns based on Mie scattering technique is used to obtain images of transient spray formation. The macroscopic spray formations of gasoline, iso-octane, n-pentane and ethanol were measured and compared under different experimental conditions. Experimental methods were used to validate how temperature effects on macroscopic spray characteristics. The results show that there are two key factors that affect the spray characteristics under the same condition, one is the physical properties and the other is fuel temperature. The spray characteristics is the key factor which has a high sensitive effect on the engine performances. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Chen, Yong] Univ Shanghai Sci & Technol, Sch Energy & Power Engn, Shanghai 200093, Peoples R China.
   [Zhang, Zhendong] Univ Shanghai Sci & Technol, Sch Mech Engn, Shanghai 200093, Peoples R China.
RP Chen, Y (reprint author), Univ Shanghai Sci & Technol, Sch Energy & Power Engn, Shanghai 200093, Peoples R China.
EM chenyong79320@sina.com
FU National Natural Science Foundation of China [51275309]
FX This work is supported by the National Natural Science Foundation of
   China (Grant No. 51275309). The Authors are all indebted to their
   generous support.
CR Aleiferis PG, 2013, FUEL, V105, P143, DOI 10.1016/j.fuel.2012.07.044
   Aleiferis PG, 2010, INT J HEAT MASS TRAN, V53, P4588, DOI 10.1016/j.ijheatmasstransfer.2010.06.033
   Aleiferis PG, 2010, COMBUST FLAME, V157, P735, DOI 10.1016/j.combustflame.2009.12.019
   Anand TNC, 2012, FUEL, V102, P613, DOI 10.1016/j.fuel.2012.06.107
   Battistoni M, 2012, APPL ENERG, V97, P656, DOI 10.1016/j.apenergy.2011.11.080
   Chan QN, 2014, FUEL, V130, P228, DOI 10.1016/j.fuel.2014.04.015
   Lee KH, 2004, FUEL, V83, P971, DOI 10.1016/j.fuel.2003.10.021
   Lee S, 2014, FUEL, V137, P50, DOI 10.1016/j.fuel.2014.07.063
   Park SH, 2013, FUEL PROCESS TECHNOL, V106, P392, DOI 10.1016/j.fuproc.2012.09.004
   Park SH, 2009, INT J HEAT FLUID FL, V30, P1183, DOI 10.1016/j.ijheatfluidflow.2009.07.002
   Sementa P, 2012, FUEL, V96, P204, DOI 10.1016/j.fuel.2011.12.068
   Serras-Pereira J, 2012, FUEL, V91, P264, DOI 10.1016/j.fuel.2011.07.037
NR 12
TC 2
Z9 2
U1 3
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-4311
J9 APPL THERM ENG
JI Appl. Therm. Eng.
PD MAR 25
PY 2017
VL 115
BP 1109
EP 1117
DI 10.1016/j.applthermaleng.2016.12.101
PG 9
WC Thermodynamics; Energy & Fuels; Engineering, Mechanical; Mechanics
SC Thermodynamics; Energy & Fuels; Engineering; Mechanics
GA EM9FV
UT WOS:000395617900099
DA 2018-12-27
ER

PT J
AU Roy, E
   Patra, S
   Tiwari, A
   Madhuri, R
   Sharma, PK
AF Roy, Ekta
   Patra, Santanu
   Tiwari, Ashutosh
   Madhuri, Rashmi
   Sharma, Prashant K.
TI RETRACTED: Single cell imprinting on the surface of Ag-ZnO bimetallic
   nanoparticle modified graphene oxide sheets for targeted detection,
   removal and photothermal killing of E. Coli (Retracted article. See vol.
   112, pg. 216, 2018)
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article; Retracted Publication
DE Bacteria sensing; Removal; Photothermal killing; Imprinted polymer;
   GO-Ag@ZnO nanocomposite
ID WATER; RECOGNITION; PATHOGENS; BACTERIA
AB A very cost-effective, fast, sensitive and specific imprinted polymer modified electrochemical sensor for the targeted detection, removal and destruction of Escherichia coli bacteria was developed onto the surface of Ag-ZnO bimetallic nanoparticle and graphene oxide nanocomposite. The nanocomposite played a dual role in this work, as a platform for imprinting of bacteria as well as a participated in their laser-light induced photo killing. In terms of sensing, our proposed sensor can detect E. Coli as few as 10 CFU mL(-1) and capture 98% of bacterial cells from their very high concentrated solution (10(5) CFU mL(-1)). Similarly to the quantitative detection, we have also investigated the quantitative destruction of E. Coli and found that 16.0 cm(2) area of polymer modified glass plate is sufficient enough to kill 10(5) CFU mL(-1) in the small time span of 5 minutes. The obtained results suggest that our proposed sensor have potential to serve as a promising candidate for specific and quantitative detection, removal as well as the destruction of a variety of bacterial pathogens. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Roy, Ekta; Patra, Santanu; Madhuri, Rashmi] Indian Sch Mines, Dept Appl Chem, Dhanbad 826004, Jharkhand, India.
   [Tiwari, Ashutosh] Linkopings Univ, IFM, Smart Mat & Biodevices Biosensors & Bioelect Ctr, S-58183 Linkoping, Sweden.
   [Sharma, Prashant K.] Indian Sch Mines, Funct Nanomat Res Lab, Dept Appl Phys, Dhanbad 826004, Jharkhand, India.
RP Madhuri, R (reprint author), Indian Sch Mines, Dept Appl Chem, Dhanbad 826004, Jharkhand, India.
EM rshmmadhuri@gmail.com
FU DST; BRNS; ISM [SB/FT/CS-155/2012, FRS/43/2013-2014/AC,
   34/14/21/2014-BRNS, SR/FTP/PS-157/2011, FRS/34/2012-2013/APH]
FX Authors are thankful to DST, BRNS and ISM for sponsoring the research
   projects to Dr. Rashmi Madhuri (Ref. no.: SB/FT/CS-155/2012;
   FRS/43/2013-2014/AC; 34/14/21/2014-BRNS) and Dr. Prashant K. Sharma
   (Ref. no.: SR/FTP/PS-157/2011; FRS/34/2012-2013/APH;
   34/14/21/2014-BRNS).
CR Altintas Z, 2015, BIOSENS BIOELECTRON, V74, P996, DOI 10.1016/j.bios.2015.07.076
   Arya SK, 2012, ANAL CHIM ACTA, V737, P1, DOI 10.1016/j.aca.2012.05.048
   BEJ AK, 1990, MOL CELL PROBE, V4, P353, DOI 10.1016/0890-8508(90)90026-V
   BLACK RE, 1993, PEDIATR INFECT DIS J, V12, P751, DOI 10.1097/00006454-199309000-00010
   Chen JH, 2015, ANALYST, V140, P4991, DOI [10.1039/c5an00637f, 10.1039/C5AN00637F]
   Fei JF, 2015, RSC ADV, V5, P74548, DOI 10.1039/c5ra12491c
   Findeisen A, 2012, SENSOR ACTUAT B-CHEM, V170, P196, DOI 10.1016/j.snb.2011.08.025
   Labib M, 2012, ANAL CHEM, V84, P8966, DOI 10.1021/ac302902s
   Leoni E, 2001, J APPL MICROBIOL, V90, P27, DOI 10.1046/j.1365-2672.2001.01178.x
   Lin YF, 2015, J MATER CHEM B, V3, P3573, DOI 10.1039/c5tb00223k
   Nagata S, 1997, J AOAC INT, V80, P408
   Ondera TJ, 2015, ANALYST, V140, P7902, DOI [10.1039/c5an00497g, 10.1039/C5AN00497G]
   Patra S, 2015, ANAL CHIM ACTA, V853, P271, DOI 10.1016/j.aca.2014.10.030
   Ren KN, 2012, ACS NANO, V6, P4314, DOI 10.1021/nn300901z
   Roy E, 2015, RSC ADV, V5, P95433, DOI 10.1039/c5ra18575k
   Roy E, 2014, TALANTA, V120, P198, DOI 10.1016/j.talanta.2013.11.074
   Wan Y, 2014, J MATER CHEM B, V2, P4818, DOI 10.1039/c4tb00288a
   Xie LL, 2013, COLLOID SURFACE B, V107, P245, DOI 10.1016/j.colsurfb.2013.02.020
   Zhang Y, 2014, J INORG BIOCHEM, V130, P74, DOI 10.1016/j.jinorgbio.2013.10.004
NR 19
TC 17
Z9 17
U1 13
U2 271
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD MAR 15
PY 2017
VL 89
SI SI
BP 620
EP 626
DI 10.1016/j.bios.2015.12.085
PN 1
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA EG5IH
UT WOS:000391077000066
PM 26754865
DA 2018-12-27
ER

PT J
AU Patra, S
   Roy, E
   Choudhary, R
   Tiwari, A
   Madhuri, R
   Sharma, PK
AF Patra, Santanu
   Roy, Ekta
   Choudhary, Raksha
   Tiwari, Ashutosh
   Madhuri, Rashmi
   Sharma, Prashant K.
TI RETRACTED: Graphene quantum dots decorated CdS doped graphene oxide
   sheets in dual action mode: As initiator and platform for designing of
   nimesulide imprinted polymer (Retracted article. See vol.114, pg.89,
   2018)
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article; Retracted Publication
DE CdS-doped graphene oxide; Graphene quantum dots; Nano-iniferter;
   Nimesulide sensing; Imprinted polymer
ID SIMULTANEOUS ELECTROCHEMICAL DETERMINATION; VOLTAMMETRIC DETERMINATION;
   CARBON DOTS; ELECTRODE; BORON; NANOSTRUCTURE; HYDROQUINONE; LUMINESCENT;
   RESORCINOL; COMPOSITE
AB The present work describes the preparation of a nanohybrid by a combination of the 2D graphene sheet and OD graphene quantum dots (GQDs). The GQDs were prepared from natural green precursors i.e. carrot juice by the one-step hydrothermal process. To get the maximum fluorescence property from nanohybrid, the graphene sheets were chemically doped with cadmium sulphide (CdS). The as prepared nanohybrid was characterized by means of X-ray diffraction analysis (XRD), field emission scanning electron microscopy (FE-SEM), transmission electron microscopy (TEM), fluorescence and UV-vis spectroscopic techniques. The nanohybrid was further modified to design a nano-iniferter, which shows dual property i.e. works as polymerization initiator as well as provides platform for synthesis of the nimesulide-imprinted polymer. For designing of imprinted polymer two biocompatible monomers (cystine monomer and N-vinyl caprolactam) were used, which provides biodegradability to the polymer matrix. The imprinted polymer shows a very good selectivity towards the detection of nimesulide with a limit of detection as low as 6.65 ng L-1 (S/N=3). The sensor was also applied for the detection of nimesulide in real samples like human blood serum, plasma and urine samples as well as some pharmaceutical tablets. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Patra, Santanu; Roy, Ekta; Choudhary, Raksha; Madhuri, Rashmi] Indian Sch Mines, Dept Appl Chem, Dhanbad 826004, Jharkhand, India.
   [Tiwari, Ashutosh] Linkopings Univ, IFM, Smart Mat & Biodevices Biosensors & Bioelect Ctr, S-58183 Linkoping, Sweden.
   [Sharma, Prashant K.] Indian Sch Mines, Dept Appl Phys, Funct Nanomat Res Lab, Dhanbad 826004, Jharkhand, India.
RP Madhuri, R (reprint author), Indian Sch Mines, Dept Appl Chem, Dhanbad 826004, Jharkhand, India.
EM rshmmadhuri@gmail.com
FU DST; BRNS; ISM [SB/FT/CS-155/2012, FRS/43/2013-2014/AC,
   34/14/21/2014-BRNS, SR/FTP/PS-157/2011, FRS/34/2012-2013/APH]
FX Authors are thankful to DST, BRNS and ISM for sponsoring the research
   projects to Dr. RashmiMadhuri (Ref. nos.: SB/FT/CS-155/2012;
   FRS/43/2013-2014/AC; 34/14/21/2014-BRNS) and Dr. Prashant K. Sharma
   (Ref. nos.: SR/FTP/PS-157/2011; FRS/34/2012-2013/APH;
   34/14/21/2014-BRNS). We are also thankful to Dr. S. K. Sahu and Mr.
   Angshuman Ray Chowdhury for their kind help in PL study.
CR Altinoz S, 2000, J PHARMACEUT BIOMED, V22, P175, DOI 10.1016/S0731-7085(99)00264-2
   Battu P. R., 2009, INT J PHARM TECH RES, V1, P206
   Chu J, 2011, J MATER CHEM, V21, P11283, DOI 10.1039/c1jm11058f
   Datta KKR, 2014, CHEM COMMUN, V50, P10782, DOI 10.1039/c4cc02637c
   Dewani AP, 2015, ARAB J CHEM, V8, P591, DOI 10.1016/j.arabjc.2013.09.040
   Furlanetto S, 2000, ANAL CHIM ACTA, V413, P229, DOI 10.1016/S0003-2670(00)00735-2
   HOF M, 2005, FLUORESCENCE SPECTRO
   Hu SR, 2015, RSC ADV, V5, P18615, DOI 10.1039/c4ra16268d
   Hu SR, 2014, ELECTROCHIM ACTA, V130, P805, DOI 10.1016/j.electacta.2014.02.150
   Karfa P, 2015, RSC ADV, V5, P58141, DOI 10.1039/c5ra09525e
   Kim YA, 2012, ACS NANO, V6, P6293, DOI 10.1021/nn301728j
   Lee HJ, 2002, APPL PHYS LETT, V81, P4020, DOI 10.1063/1.1517405
   Li LS, 2010, J PHYS CHEM LETT, V1, P2572, DOI 10.1021/jz100862f
   Li LL, 2012, ADV FUNCT MATER, V22, P2971, DOI 10.1002/adfm.201200166
   Li LL, 2013, NANOSCALE, V5, P4015, DOI 10.1039/c3nr33849e
   Li XM, 2014, ACS APPL MATER INTER, V6, P3640, DOI 10.1021/am405927f
   Lu YF, 2013, ACS NANO, V7, P6522, DOI 10.1021/nn402102y
   Malode S.J., 2013, ASIAN J PHARM CLIN R, V6, P71
   Patra S, 2015, ENVIRON SCI TECHNOL, V49, P6117, DOI 10.1021/acs.est.5b00182
   Patra S, 2015, ANAL CHIM ACTA, V853, P271, DOI 10.1016/j.aca.2014.10.030
   Patra S, 2015, BIOSENS BIOELECTRON, V63, P301, DOI 10.1016/j.bios.2014.07.063
   Pereira PF, 2013, DIAM RELAT MATER, V39, P41, DOI 10.1016/j.diamond.2013.07.010
   Rao CNR, 2014, NANO TODAY, V9, P324, DOI 10.1016/j.nantod.2014.04.010
   Roy E, 2015, BIOSENS BIOELECTRON, V68, P726, DOI 10.1016/j.bios.2015.01.072
   Sadhukhan M, 2014, RSC ADV, V4, P4998, DOI 10.1039/c3ra46050a
   Shao LD, 2012, REACT FUNCT POLYM, V72, P407, DOI 10.1016/j.reactfunctpolym.2012.04.002
   Skoog DA, 1998, PRINCIPAL INSTRUMENT
   Song YP, 2015, ELECTROCHEM COMMUN, V56, P38, DOI 10.1016/j.elecom.2015.04.003
   Srivastava M, 2015, NANOSCALE, V7, P4820, DOI 10.1039/c4nr07068b
   Wang CY, 2006, J PHARMACEUT BIOMED, V42, P237, DOI 10.1016/j.jpba.2006.03.038
   Wen YY, 2015, CHEM-EUR J, V21, P80, DOI 10.1002/chem.201404779
   Yan X, 2010, NANO LETT, V10, P1869, DOI 10.1021/nl101060h
   Yang Z, 2012, ACS NANO, V6, P205, DOI 10.1021/nn203393d
   Zhang JL, 2010, ELECTROCHIM ACTA, V55, P2522, DOI 10.1016/j.electacta.2009.12.019
   Zhang W., 2015, SCI REPORTS, V5, P1, DOI DOI 10.1038/SREP10791
   Zhang WX, 2015, ANAL METHODS-UK, V7, P6089, DOI [10.1039/C5AY00848D, 10.1039/c5ay00848d]
NR 36
TC 9
Z9 9
U1 21
U2 335
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD MAR 15
PY 2017
VL 89
SI SI
BP 627
EP 635
DI 10.1016/j.bios.2015.12.053
PN 1
PG 9
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA EG5IH
UT WOS:000391077000067
PM 26718547
DA 2018-12-27
ER

PT J
AU Yamamizu, K
   Iwasaki, M
   Takakubo, H
   Sakamoto, T
   Ikuno, T
   Miyoshi, M
   Kondo, T
   Nakao, Y
   Nakagawa, M
   Inoue, H
   Yamashita, JK
AF Yamamizu, Kohei
   Iwasaki, Mio
   Takakubo, Hitomi
   Sakamoto, Takumi
   Ikuno, Takeshi
   Miyoshi, Mami
   Kondo, Takayuki
   Nakao, Yoichi
   Nakagawa, Masato
   Inoue, Haruhisa
   Yamashita, Jun K.
TI RETRACTED: In Vitro Modeling of Blood-Brain Barrier with Human
   iPSC-Derived Endothelial Cells, Pericytes, Neurons, and Astrocytes via
   Notch Signaling (Retracted article. See vol. 10, pg. 674, 2018)
SO STEM CELL REPORTS
LA English
DT Article; Retracted Publication
ID PLURIPOTENT STEM-CELLS; ALZHEIMERS-DISEASE; DRUG DISCOVERY;
   DIFFERENTIATION; ANGIOGENESIS; CNS; PERMEABILITY; PURIFICATION;
   EXPRESSION; INDUCTION
AB The blood-brain barrier (BBB) is composed of four cell populations, brain endothelial cells (BECs), pericytes, neurons, and astrocytes. Its role is to precisely regulate the microenvironment of the brain through selective substance crossing. Here we generated an in vitro model of the BBB by differentiating human induced pluripotent stem cells (hiPSCs) into all four populations. When the four hiPSC-derived populations were co-cultured, endothelial cells (ECs) were endowed with features consistent with BECs, including a high expression of nutrient transporters (CAT3, MFSD2A) and efflux transporters (ABCA1, BCRP, PGP, MRP5), and strong barrier function based on tight junctions. Neuron-derived Dll1, which activates Notch signaling in ECs, was essential for the BEC specification. We performed in vitro BBB permeability tests and assessed ten clinical drugs by nanoLC-MS/MS, finding a good correlation with the BBB permeability reported in previous cases. This technology should be useful for research on human BBB physiology, pathology, and drug development.
C1 [Yamamizu, Kohei; Takakubo, Hitomi; Ikuno, Takeshi; Miyoshi, Mami; Yamashita, Jun K.] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat CiRA, Lab Stem Cell Differentiat,Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.
   [Iwasaki, Mio; Nakagawa, Masato] Kyoto Univ, Dept Life Sci Frontier, CiRA, Kyoto 6068507, Japan.
   [Sakamoto, Takumi; Nakao, Yoichi] Waseda Univ, Dept Chem & Biochem, Tokyo 1698555, Japan.
   [Kondo, Takayuki; Inoue, Haruhisa] Kyoto Univ, Dept Cell Growth & Differentiat, Lab Stem Cell Med, CiRA, Kyoto 6068507, Japan.
RP Yamamizu, K (reprint author), Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat CiRA, Lab Stem Cell Differentiat,Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.
EM kohei@cira.kyoto-u.ac.jp
FU Ministry of Education, Science, Sports and Culture of Japan [16K19033];
   Japan Agency for Medical Research and Development (AMED); AMED; Takeda
   Science Foundation; iPS Cell Research Fund
FX We thank the Division of Electron Microscopic Study, Center for
   Anatomical Studies, Graduate School of Medicine, Kyoto University for
   helping with the transmission electron microscopy analysis, Dr. A. Ota
   for providing the drugs, and Dr. P. Karagiannis for critical reading of
   the manuscript. This study was supported by grants from the Ministry of
   Education, Science, Sports and Culture of Japan (16K19033), Japan Agency
   for Medical Research and Development (AMED), the Program for Intractable
   Diseases Research Utilizing Disease-Specific iPS Cells from AMED,
   Research Project for Practical Applications of Regenerative Medicine
   from AMED, Core Center for iPS Cell Research, Research Center Network
   for Realization of Regenerative Medicine from AMED, Takeda Science
   Foundation, and iPS Cell Research Fund.
CR Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x
   Aday S, 2016, TRENDS BIOTECHNOL, V34, P382, DOI 10.1016/j.tibtech.2016.01.001
   Alavijeh Mohammad S, 2005, NeuroRx, V2, P554, DOI 10.1602/neurorx.2.4.554
   Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368
   Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106
   Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8
   Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731
   Engelhardt B, 2003, CELL TISSUE RES, V314, P119, DOI 10.1007/s00441-003-0751-z
   Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374
   Hahne H, 2013, NAT METHODS, V10, P989, DOI [10.1038/NMETH.2610, 10.1038/nmeth.2610]
   Hoshi Y, 2013, J PHARM SCI-US, V102, P3343, DOI 10.1002/jps.23575
   Kacem K, 1998, GLIA, V23, P1
   Kageyama R, 2008, NAT NEUROSCI, V11, P1247, DOI 10.1038/nn.2208
   Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009
   Lee SW, 2003, NAT MED, V9, P900, DOI 10.1038/nm889
   Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247
   Masumoto H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06716
   Minami H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128890
   Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002
   Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014
   Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x
   Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261
   RISAU W, 1986, DEV BIOL, V117, P537, DOI 10.1016/0012-1606(86)90321-0
   Saito S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00290
   Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594
   Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007
   Watson PMD, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-59
   Weksler BB, 2005, FASEB J, V19, P1872
   Yamamizu K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03213
   Yamamizu K, 2012, CELL STEM CELL, V10, P759, DOI 10.1016/j.stem.2012.02.022
   Yamamizu K, 2012, STEM CELLS, V30, P687, DOI 10.1002/stem.1041
   Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114
   Yamamizu K, 2009, BLOOD, V114, P3707, DOI 10.1182/blood-2008-12-195750
NR 35
TC 23
Z9 24
U1 2
U2 28
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2213-6711
J9 STEM CELL REP
JI Stem Cell Rep.
PD MAR 14
PY 2017
VL 8
IS 3
BP 634
EP 647
DI 10.1016/j.stemcr.2017.01.023
PG 14
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA EP0VD
UT WOS:000397103900013
PM 28238797
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Shi, DP
   Chu, L
   Guo, JH
   Wang, ZZ
   Liu, RJ
AF Shi, Dapai
   Chu, Liang
   Guo, Jianhua
   Wang, Zhanzhong
   Liu, Ruijun
TI RETRACTED: Energy control strategy of plug-in hybrid electric vehicle
   based on pattern recognition (Retracted article. See vol. 10, 2018)
SO ADVANCES IN MECHANICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Plug-in hybrid electric vehicle; energy control strategy; lever theory;
   pattern recognition; planetary gears
ID POWERTRAIN SYSTEM; ROBUST-CONTROL; MANAGEMENT
AB The article researches on the energy control strategy of the series-parallel plug-in hybrid electric vehicle based on pattern recognition. First, after the dynamic analysis and energy flow directions of the planetary gears, according to the theory of leverage simulation, working conditions of power components are analyzed under various operating models. Second, static parameters and control rules are, respectively, designed under the charge-depleting and charge-sustaining models, and flow charts of the vehicle energy control are established. Third, the switch controller of energy control and charge-depleting/charge-sustaining models are designed by the MATLAB/Simulink. Finally, the whole vehicle simulation model is established and simulated by the Advisor software. Results show that the designed energy control model can effectively improve the fuel economy performance of the plug-in hybrid electric vehicle under the premise of ensuring dynamic performance indexes.
C1 [Shi, Dapai; Chu, Liang; Guo, Jianhua] Jilin Univ, State Key Lab Automot Simulat & Control, Changchun 130025, Peoples R China.
   [Wang, Zhanzhong] Jilin Univ, Transportat Coll, Changchun 130022, Peoples R China.
   [Liu, Ruijun] Shandong Univ Technol, Sch Transportat & Vehicle Engn, Zibo, Peoples R China.
RP Guo, JH (reprint author), Jilin Univ, State Key Lab Automot Simulat & Control, Changchun 130025, Peoples R China.; Wang, ZZ (reprint author), Jilin Univ, Transportat Coll, Changchun 130022, Peoples R China.
EM sdpjlu@163.com; wzhanzh@163.com
CR Al-Alawi BM, 2013, APPL ENERG, V103, P488, DOI 10.1016/j.apenergy.2012.10.009
   Bianchi D, 2011, INT J ELECTR HYBRID, V3, P191, DOI 10.1504/IJEHV.2011.042147
   Borhan H, 2012, IEEE T CONTR SYST T, V20, P593, DOI 10.1109/TCST.2011.2134852
   Chen BC, 2014, APPL ENERG, V113, P1764, DOI 10.1016/j.apenergy.2013.08.018
   Chen SY, 2015, APPL ENERG, V160, P132, DOI 10.1016/j.apenergy.2015.09.047
   Chen Z, 2016, INT J ROBUST NONLIN, V26, P2708, DOI 10.1002/rnc.3472
   Chen Z, 2015, IEEE-ASME T MECH, V20, P1482, DOI 10.1109/TMECH.2014.2369454
   Chen Z, 2013, IEEE T VEH TECHNOL, V62, P1020, DOI 10.1109/TVT.2012.2235474
   Fumarola A, 2011, 2011240071 SAE
   Gao YM, 2010, IEEE T IND ELECTRON, V57, P633, DOI 10.1109/TIE.2009.2027918
   Hofman T, 2007, INT J ELECTR HYBRID, V1, P71, DOI 10.1504/IJEHV.2007.014448
   Li CT, 2012, PROCEEDINGS OF THE ASME 5TH ANNUAL DYNAMIC SYSTEMS AND CONTROL DIVISION CONFERENCE AND JSME 11TH MOTION AND VIBRATION CONFERENCE, DSCC 2012, VOL 2, P857
   Liu RJ, 2014, J APPL MATH, V2014
   Malikopoulos AA, 2014, IEEE T INTELL TRANSP, V15, P1869, DOI 10.1109/TITS.2014.2309674
   Mashadi B, 2010, IEEE T VEH TECHNOL, V59, P3223, DOI 10.1109/TVT.2010.2049870
   Nuesch T, 2014, ENERGIES, V7, P834, DOI 10.3390/en7020834
   Sun WC, 2016, IEEE T CONTR SYST T, V24, P2059, DOI 10.1109/TCST.2016.2519282
   Sun WC, 2011, IEEE T CONTR SYST T, V19, P416, DOI 10.1109/TCST.2010.2042296
   Tian GD, 2014, J CLEAN PROD, V85, P419, DOI 10.1016/j.jclepro.2014.09.020
   Tian GD, 2013, IEEE T AUTOM SCI ENG, V10, P1004, DOI 10.1109/TASE.2013.2249663
   Tulpule P, 2009, P 2009 AM CONTR C ST
   Wang J, 2014, SCI WORLD J, V2014
   Wang J, 2013, AUTHORITATIVE GUIDE, P306
   Wang ZX, 2004, J HUBEI AUTOMOT IND, V18, P15
   Xiong R, 2014, APPL ENERG, V113, P463, DOI 10.1016/j.apenergy.2013.07.061
   Yang FC, 2015, MECH MACH THEORY, V92, P86, DOI 10.1016/j.mechmachtheory.2015.05.003
   Yang H, 2009, INT J AUTOMOT TECHN, V10, P381, DOI 10.1007/s12239-009-0044-y
   Yao JY, 2014, IEEE T IND ELECTRON, V61, P6285, DOI 10.1109/TIE.2014.2304912
   Yao JY, 2014, IEEE-ASME T MECH, V19, P633, DOI 10.1109/TMECH.2013.2252360
   Zeng XH, 2014, SIMULATION DEV ADVIS
   Zhang WT, 2007, LECT NOTES COMPUT SC, V4356, P15
   Zhang XW, 2014, P ASME ANN DYN SYST
NR 32
TC 6
Z9 6
U1 8
U2 35
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1687-8140
J9 ADV MECH ENG
JI Adv. Mech. Eng.
PD MAR 10
PY 2017
VL 9
IS 3
AR 1687814017695049
DI 10.1177/1687814017695049
PG 18
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA ET7XP
UT WOS:000400513100001
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Zhou, L
   Wang, DD
   Wang, XF
   Gu, SP
   Sheng, YB
AF Zhou, Lan
   Wang, Dan -Dan
   Wang, Xing -Fu
   Gu, Shi-Pu
   Sheng, Yu-Bo
TI RETRACTED: Efficient Concentration Protocols for the Single-Photon
   Entanglement State with Polarization Feature(Retracted article. See vol.
   5, Artn no.15, 2017)
SO FRONTIERS IN PHYSICS
LA English
DT Article; Retracted Publication
DE single-photon entanglement; entanglement concentration; cross-Kerr
   nonlinearity; variable beam; splitter
ID DISTANCE QUANTUM COMMUNICATION; CROSS-KERR NONLINEARITY; NOISY CHANNELS;
   LINEAR OPTICS; PURIFICATION; TELEPORTATION; AMPLIFICATION; DISTILLATION;
   GENERATION; REPEATERS
AB We propose two efficient entanglement concentration protocols (ECPs) for arbitrary less-entangled single-photon entanglement state, in which the photon qubit has the polarization feature. The first ECP is in linear optics, and the second ECP is in nonlinear optics. The two ECPs have some attractive advantages. First, they can preserve the polarization feature of the photon qubit, while all the other existing ECPs for single photon state cannot achieve this goal. Second, they only require one pair of less-entangled single-photon entanglement state and some auxiliary single photons. Third, they only require local operations. Especially, the second ECP can be used repeatedly, which can increase its success probability largely. Based on above properties, our two ECPs, especially the second one may be useful in current and future quantum communication.
C1 [Zhou, Lan; Wang, Xing -Fu] Nanjing Univ Posts & Telecommun, Coll Math & Phys, Nanjing, Peoples R China.
   [Zhou, Lan; Sheng, Yu-Bo] Nanjing Univ Posts & Telecommun, Minist Educ, Key Lab Broadband Weless Commun & Sensor Network, Nanjing, Peoples R China.
   [Wang, Dan -Dan; Gu, Shi-Pu] Nanjing Univ Posts & Telecommun, Coll Elect Sci & Engn, Nanjing, Peoples R China.
   [Sheng, Yu-Bo] Nanjing Univ Posts & Telecommun, Inst Signal Proc Transmission, Nanjing, Peoples R China.
RP Sheng, YB (reprint author), Nanjing Univ Posts & Telecommun, Minist Educ, Key Lab Broadband Weless Commun & Sensor Network, Nanjing, Peoples R China.; Sheng, YB (reprint author), Nanjing Univ Posts & Telecommun, Inst Signal Proc Transmission, Nanjing, Peoples R China.
EM shengyb@njupt.edu.cn
FU National Natural Science Foundation of China [11474168, 61401222];
   Natural Science Foundation of Jiangsu [BK20151502]; Qing Lan Project in
   Jiangsu Province; Priority Academic Program Development of Jiangsu
   Higher Education Institutions
FX This work was supported by the National Natural Science Foundation of
   China under Grant Nos. 11474168 and 61401222, the Natural Science
   Foundation of Jiangsu under Grant No. BK20151502, the Qing Lan Project
   in Jiangsu Province, and a Project Funded by the Priority Academic
   Program Development of Jiangsu Higher Education Institutions.
CR Ai Q, 2016, SCI BULL, V61, P110, DOI 10.1007/s11434-015-0986-6
   Barrett SD, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.060302
   BENNETT CH, 1992, PHYS REV LETT, V69, P2881, DOI 10.1103/PhysRevLett.69.2881
   BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895
   Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722
   Bennett CH, 1996, PHYS REV A, V53, P2046, DOI 10.1103/PhysRevA.53.2046
   Bi Q, 2015, FRONT PHYS-BEIJING, V10, P198, DOI 10.1007/s11467-015-0461-5
   Bose S, 1999, PHYS REV A, V60, P194, DOI 10.1103/PhysRevA.60.194
   Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932
   Cai XF, 2014, FRONT PHYS-BEIJING, V9, P646, DOI 10.1007/s11467-014-0432-2
   Cao C, 2016, SCI CHINA PHYS MECH, V59, DOI 10.1007/s11433-016-0253-x
   Cao C, 2015, QUANTUM INF PROCESS, V14, P1265, DOI 10.1007/s11128-015-0924-1
   Cao C, 2015, LASER PHYS LETT, V12, DOI 10.1088/1612-2011/12/3/036001
   Cao C, 2013, OPT EXPRESS, V21, P4093, DOI 10.1364/OE.21.004093
   Cao DY, 2015, SCI BULL, V60, P1128, DOI 10.1007/s11434-015-0801-4
   Chang Y, 2015, CHINESE PHYS B, V24, DOI 10.1088/1674-1056/24/8/080306
   Cheong YW, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042314
   Chou CW, 2007, SCIENCE, V316, P1316, DOI 10.1126/science.1140300
   D'Auria V, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.050504
   Deng FG, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.042317
   Deng FG, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.022311
   Deutsch D, 1996, PHYS REV LETT, V77, P2818, DOI 10.1103/PhysRevLett.77.2818
   Du FF, 2015, SCI CHINA PHYS MECH, V58, DOI 10.1007/s11433-014-5638-3
   Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500
   Dur W, 1999, PHYS REV A, V59, P169, DOI 10.1103/PhysRevA.59.169
   EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661
   Fan LL, 2014, QUANTUM INF PROCESS, V13, P1967, DOI 10.1007/s11128-014-0789-8
   Feizpour A, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133603
   Ferreyrol F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.123603
   Friedler I, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.023803
   Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145
   Gisin N, 2015, FRONT PHYS-BEIJING, V10, DOI 10.1007/s11467-015-0485-x
   Gottesman D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.070503
   Guerreiro T, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.070404
   Guo Q, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.054303
   He B, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.053826
   He B, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.035802
   He YQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19116
   He YQ, 2015, OPT EXPRESS, V23, P21671, DOI 10.1364/OE.23.021671
   He YQ, 2015, J PHYS B-AT MOL OPT, V48, DOI 10.1088/0953-4075/48/5/055501
   Henrich D, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2013.2237936
   Horodecki M, 1999, PHYS REV A, V59, P4206, DOI 10.1103/PhysRevA.59.4206
   Hu JY, 2016, LIGHT-SCI APPL, V5, DOI 10.1038/lsa.2016.144
   Jeong H, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.052320
   Jeong H, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.022104
   Kocsis S, 2013, NAT PHYS, V9, P23, DOI [10.1038/NPHYS2469, 10.1038/nphys2469]
   Li T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15610
   LI X, 2014, J NANOMATER, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0089856
   Li X, 2015, SHOCK VIB, DOI 10.1155/2015/431476
   Li Y, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.015802
   Lin Q, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.022331
   Lin Q, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.062312
   Lin Q, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.042310
   Lin Q, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.022301
   Lita AE, 2008, OPT EXPRESS, V16, P3032, DOI 10.1364/OE.16.003032
   Long GL, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.032302
   Maimaiti W, 2015, SCI CHINA PHYS MECH, V58, DOI 10.1007/s11433-015-5657-8
   Monteiro F, 2016, ARXIV161201802
   Murao M, 1998, PHYS REV A, V57, pR4075, DOI 10.1103/PhysRevA.57.R4075
   Nemoto K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.250502
   Nielsen AEB, 2010, PHYS REV A, V81, DOI [10.1103/PhysRevA.81.043823, DOI 10.1103/PHYSREVA.81.043823]
   Osorio CI, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.023815
   Pan J, 2016, QUANTUM INF PROCESS, V15, P1669, DOI 10.1007/s11128-016-1246-7
   Pan JW, 2001, NATURE, V410, P1067, DOI 10.1038/35074041
   Qu CC, 2015, QUANTUM INF PROCESS, V14, P4131, DOI 10.1007/s11128-015-1113-y
   Ren BC, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.012302
   Sangouard N, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.050301
   Shapiro JH, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.062305
   Sheng YB, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.062325
   Sheng YB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13453
   Sheng YB, 2015, QUANTUM INF PROCESS, V14, P963, DOI 10.1007/s11128-015-0916-1
   Sheng YB, 2015, SCI REP-UK, V5, DOI 10.1038/srep07815
   Sheng YB, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.042302
   Sheng YB, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.012307
   Sheng YB, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.032307
   Sheng YB, 2010, QUANTUM INF COMPUT, V10, P272
   Sheng YB, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.042308
   Sheng YB, 2015, SCI CHINA PHYS MECH, V58, DOI 10.1007/s11433-015-5672-9
   Shi BS, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.054301
   Shukla C, 2015, QUANTUM INF PROCESS, V14, P2077, DOI 10.1007/s11128-015-0948-6
   Simon C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.257901
   Usuga MA, 2010, NAT PHYS, V6, P767, DOI 10.1038/NPHYS1743
   Vitali D, 2000, PHYS REV LETT, V85, P445, DOI 10.1103/PhysRevLett.85.445
   Wang C, 2015, SCI BULL, V60, P2016, DOI 10.1007/s11434-015-0941-6
   Wang C, 2014, QUANTUM INF PROCESS, V13, P1025, DOI 10.1007/s11128-013-0707-5
   Wang CA, 2011, J MOD OPTIC, V58, P21, DOI 10.1080/09500340.2010.538735
   Wang GY, 2015, QUANTUM INF PROCESS, V14, P1305, DOI 10.1007/s11128-015-0938-8
   Wang MY, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/15/155502
   Wang MY, 2016, QUANTUM INF PROCESS, V15, P3383, DOI 10.1007/s11128-016-1341-9
   Wu YL, 2016, SCI BULL, V61, P302, DOI 10.1007/s11434-015-0985-7
   Xiang GY, 2010, NAT PHOTONICS, V4, P316, DOI 10.1038/NPHOTON.2010.35
   Xiong PY, 2016, FRONT PHYS-BEIJING, V11, DOI 10.1007/s11467-016-0553-x
   Yamamoto T, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012304
   Yan X, 2014, FRONT PHYS-BEIJING, V9, P640, DOI 10.1007/s11467-014-0435-z
   Zavatta A, 2011, NAT PHOTONICS, V5, P52, DOI [10.1038/nphoton.2010.260, 10.1038/NPHOTON.2010.260]
   Zhang CM, 2015, SCI CHINA PHYS MECH, V58, DOI 10.1007/s11433-015-5687-2
   Zhao Z, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.014301
   Zhou L, 2016, CHINESE PHYS B, V25, DOI 10.1088/1674-1056/25/2/020308
   Zhou L, 2014, OPT COMMUN, V313, P217, DOI 10.1016/j.optcom.2013.10.041
   Zhou L, 2013, J OPT SOC AM B, V30, P71, DOI 10.1364/JOSAB.30.000071
   Zhu CJ, 2011, OPT EXPRESS, V19, P23364, DOI 10.1364/OE.19.023364
NR 101
TC 0
Z9 0
U1 1
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-424X
J9 FRONT PHYS
JI Front. Physics
PD MAR 10
PY 2017
VL 5
AR 9
DI 10.3389/fphy2017.DOCC9
PG 10
WC Physics, Multidisciplinary
SC Physics
GA EN3ML
UT WOS:000395912500001
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Malvajerdi, SS
   Elahi, AS
   Habibi, M
   Khajehnezhad, A
AF Malvajerdi, S. Sharifi
   Elahi, A. Salar
   Habibi, M.
   Khajehnezhad, A.
TI RETRACTED: Growth and characterization of GaN nanoparticles on P-type Si
   (100) substrate by plasma focus device with nitrogen plasma (Retracted
   article. See vol. 43, pg. 2530, 2018)
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article; Retracted Publication
DE GaN; Nanostructures; Plasma focus device; Semiconductor
ID CHEMICAL-VAPOR-DEPOSITION; MOLECULAR-BEAM EPITAXY; GALLIUM NITRIDE;
   QUANTUM DOTS; NANOWIRES; TRANSISTORS; ZINCBLENDE; NANOTUBES; PHASE
AB A Mather type plasma focus device (PFD) was used to grow semiconductor material gallium nitride nanoparticles on P-type silicon (100) with nitrogen as working gas. Two, four and six amount of plasma focus shots were applied to 3 Silicon substrates, field emission scanning electron microscopy and atomic force microscopy indicated spherical gallium nitride nanoparticles nearly similar to gallium nitride quantum dots on the substrate that was deposited with two shots. Photoluminescence spectrometry shows emission peaks in violet 420 nm (2.95 eV) wavelength in all three samples, additionally as the shots increased small peaks at near ultraviolet 360 nm (3.44 eV) were observed. UV-Vis-NIR shows most reflectance at near ultraviolet for the second sample with four shots, as X-ray diffraction shows only some peaks for the third sample with six shots which indicates the low quality of gallium nitride crystalline formation. (C) 2016 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [Malvajerdi, S. Sharifi; Elahi, A. Salar; Khajehnezhad, A.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
   [Habibi, M.] Amirkabir Univ Technol, Energy Engn & Phys Dept, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
EM Salari_phy@yahoo.com
OI Habibi, Morteza/0000-0001-8091-0917
CR Abdullah QN, 2013, INT J HYDROGEN ENERG, V38, P14085, DOI 10.1016/j.ijhydene.2013.08.014
   Abhishek Motayed, 2006, J APPL PHYS, V100
   Aissat A, 2016, INT J HYDROGEN ENERG, V41, P20867, DOI 10.1016/j.ijhydene.2016.06.028
   Chang JR, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4731629
   CHENG TS, 1995, APPL PHYS LETT, V66, P1509, DOI 10.1063/1.113671
   Chiu SY, 2009, INT J HYDROGEN ENERG, V34, P5604, DOI 10.1016/j.ijhydene.2009.04.073
   Choi HJ, 2003, J PHYS CHEM B, V107, P8721, DOI 10.1021/jp034734k
   Duan XF, 2000, J AM CHEM SOC, V122, P188, DOI 10.1021/ja993713u
   Goldberger J, 2003, NATURE, V422, P599, DOI 10.1038/nature01551
   Goodwin TJ, 1997, APPL PHYS LETT, V70, P3122, DOI 10.1063/1.119109
   Gruzintsev AN, 2004, SEMICONDUCTORS, V38
   Habibi M, 2016, PHYS LETT A, V380, P439, DOI 10.1016/j.physleta.2015.10.048
   Han J, 1998, APPL PHYS LETT, V73, P1688, DOI 10.1063/1.122246
   Han WQ, 2000, APPL PHYS LETT, V76, P652, DOI 10.1063/1.125848
   Hassan M, 2008, APPL PHYS A, V90
   HOVEL HJ, 1972, APPL PHYS LETT, V20, P71, DOI 10.1063/1.1654051
   Hu CW, 2002, APPL PHYS LETT, V81, P3236, DOI 10.1063/1.1514394
   Jeong Shin Min, 2013, MAT LETT, V91
   Jung WS, 2005, B KOREAN CHEM SOC, V26, P131
   Kaufmann U, 1999, PHYS REV B, V59, P5561, DOI 10.1103/PhysRevB.59.5561
   Kawasaki K, 2001, APPL PHYS LETT, V79, P2243, DOI 10.1063/1.1405422
   Kim SS, 2011, INT J HYDROGEN ENERG, V36, P2313, DOI 10.1016/j.ijhydene.2010.11.050
   Kouichi Naniwae, 1990, J CRYST GROWTH, V99
   Lee JW, 2008, SOLID STATE COMMUN, V148, P194, DOI 10.1016/j.ssc.2008.08.022
   Lei M, 2008, APPL SURF SCI, V254
   LEI T, 1992, J APPL PHYS, V71, P4933, DOI 10.1063/1.350642
   Li JY, 2000, J CRYST GROWTH, V213, P408, DOI 10.1016/S0022-0248(00)00390-0
   Lo C, 2012, INT J HYDROGEN ENERG, V37, P18579, DOI 10.1016/j.ijhydene.2012.09.039
   Mangla O, 2016, AIP CONF PROC, V1731, DOI 10.1063/1.4947661
   Mangla O, 2013, J MATER SCI, V48, P304, DOI 10.1007/s10853-012-6746-y
   Mangla O, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6010004
   Marchand H, 2001, J APPL PHYS, V89, P7846, DOI 10.1063/1.1372160
   Matioli E, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3540501
   Morteza Habibi, 2016, PRAMANA J PHYS, V86
   NAKAMURA S, 1991, APPL PHYS LETT, V58, P2021, DOI 10.1063/1.105239
   Narges Fani, 2012, J THEOR APPL PHYS, V6, P30
   PAISLEY MJ, 1989, J VAC SCI TECHNOL A, V7, P701, DOI 10.1116/1.575869
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Qiu Hailin, 2007, MAT SCI ENG B, V136
   Reshchikov MA, 2000, J APPL PHYS, V87, P3351, DOI 10.1063/1.372348
   Saron KMA, 2012, J CRYST GROWTH, V349, P19, DOI 10.1016/j.jcrysgro.2012.03.046
   Shuji Nakamura, 2000, BLUE LASER DIODE COM
   Siddiqui J, 2015, CHINESE PHYS B, V24, DOI 10.1088/1674-1056/24/6/065204
   Tu DH, 2013, INT J HYDROGEN ENERG, V38, P14433, DOI 10.1016/j.ijhydene.2013.08.095
   Wang ZR, 2009, PHYS LETT A, V373, P4169, DOI 10.1016/j.physleta.2009.09.033
   Widmann F, 1998, J APPL PHYS, V83, P7618, DOI 10.1063/1.367878
   Xiao RF, 1996, J APPL PHYS, V80, P4226, DOI 10.1063/1.363302
   Yu Chang-Chin, 2002, JPN J APPL PHYS, V41
   Zhong AH, 2014, INT J HYDROGEN ENERG, V39, P8564, DOI 10.1016/j.ijhydene.2014.03.120
NR 49
TC 5
Z9 5
U1 3
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD MAR 9
PY 2017
VL 42
IS 10
BP 6876
EP 6884
DI 10.1016/j.ijhydene.2016.12.040
PG 9
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA ES5YV
UT WOS:000399623500045
DA 2018-12-27
ER

PT J
AU Elahi, AS
   Ghoranneviss, M
AF Elahi, A. Salar
   Ghoranneviss, M.
TI RETRACTED: Semi-emprical techniques for the specification of Shafranov
   shift in the large aspect ratio tokamaks (Retracted article. See vol.
   43, pg. 2529, 2018)
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article; Retracted Publication
DE Tokamak; Plasma position
ID RESONANT HELICAL FIELD; PLASMA HORIZONTAL POSITION; IR-T1 TOKAMAK;
   EQUILIBRIUM RECONSTRUCTION; RUNAWAY ELECTRONS; POLOIDAL BETA; ENERGY;
   DESIGN; PERSPECTIVE; SYSTEM
AB Equilibrium reconstruction consists in identifying, from experimental measurements, a distribution of the plasma current density that satisfies the pressure balance constraint. Numerous methods exist to solve the Grad-Shafranov equation, describing the equilibrium of plasma confined by an axisymmetric magnetic field. In this research, we have reviewed six techniques for determination of the plasma position in IR-T1 tokamak and the effects of superconducting coils and chamber: an optical, flux loops, magnetic probes, multipole moments techniques, and two methods based on the vertical field coil characteristics and analytical solution of Grad-Shafranov equation. In the first method an image processing technique used for the output signal of CCD camera and plasma emission intensity profile and then plasma position obtained. To compare the plasma position obtained using this method, flux loop method, magnetic probe method, multipole moments method, analytical solution of Grad-Shafranov equation, and a sensor-less method based on vertical field coil characteristics are also experimented on the IR-T1 tokamak. Results were compared and discussed. (C) 2016 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [Elahi, A. Salar; Ghoranneviss, M.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
EM Salari_phy@yahoo.com
CR Agah KM, 2015, J X-RAY SCI TECHNOL, V23, P267, DOI 10.3233/XST-150486
   Amerian Z, 2016, INT J THERM SCI, V110, P299, DOI 10.1016/j.ijthermalsci.2016.07.014
   Elahi AS, 2017, INT J HYDROGEN ENERG, V42, P1048, DOI 10.1016/j.ijhydene.2016.07.273
   Elahi AS, 2010, FUSION ENG DES, V85, P724, DOI 10.1016/j.fusengdes.2010.04.034
   Elahi AS, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/02/025502
   Elahi AS, 2010, PHYS SCRIPTA, V81, DOI 10.1088/0031-8949/81/05/055501
   Elahi AS, 2010, J FUSION ENERG, V29, P22, DOI 10.1007/s10894-009-9221-2
   Elahi AS, 2010, J FUSION ENERG, V29, P1, DOI 10.1007/s10894-009-9218-x
   Elahi AS, 2009, J FUSION ENERG, V28, P416, DOI 10.1007/s10894-009-9215-0
   Elahi AS, 2009, J FUSION ENERG, V28, P412, DOI 10.1007/s10894-009-9214-1
   Elahi AS, 2009, J FUSION ENERG, V28, P404, DOI 10.1007/s10894-009-9212-3
   Elahi AS, 2009, J FUSION ENERG, V28, P408, DOI 10.1007/s10894-009-9213-2
   Elahi AS, 2009, J FUSION ENERG, V28, P390, DOI 10.1007/s10894-009-9208-z
   Elahi AS, 2009, J FUSION ENERG, V28, P394, DOI 10.1007/s10894-009-9210-5
   Elahi AS, 2009, J FUSION ENERG, V28, P385, DOI 10.1007/s10894-009-9207-0
   Elahi AS, 2009, J FUSION ENERG, V28, P346, DOI 10.1007/s10894-009-9198-x
   Elahi AS, 2009, PHYS SCRIPTA, V80, DOI 10.1088/0031-8949/80/04/045501
   Elahi AS, 2010, IEEE T PLASMA SCI, V38, P3163, DOI 10.1109/TPS.2010.2066289
   Elahi AS, 2010, IEEE T PLASMA SCI, V38, P181, DOI 10.1109/TPS.2009.2037965
   Ghanbari K, 2016, J XRAY SCI TECHNOL
   Ghanbari MR, 2016, J FUSION ENERG, V35, P180, DOI 10.1007/s10894-015-9992-6
   Ghoranneviss M, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/03/035502
   Habibian J, 2016, INT J HYDROGEN ENERG, V41, P15266, DOI 10.1016/j.ijhydene.2016.06.178
   Kafi M, 2016, J SYNCHROTRON RADIAT, V23, P1227, DOI 10.1107/S1600577516010262
   MUKHOVATOV VS, 1971, NUCL FUSION, V11, P605, DOI 10.1088/0029-5515/11/6/005
   Naghidokht A, 2016, IEEE T NUCL SCI, V63, P2703, DOI 10.1109/TNS.2016.2598738
   Naghidokht A, 2016, INT J HYDROGEN ENERG, V41, P15272, DOI 10.1016/j.ijhydene.2016.07.026
   Naghidokht A, 2016, FUSION ENG DES, V107, P82, DOI 10.1016/j.fusengdes.2016.04.032
   Naghidokht A, 2016, J FUSION ENERG, V35, P415, DOI 10.1007/s10894-015-0051-0
   Niomiya H, 1982, JPN J APPL PHYS, V21, P1323
   Rahimirad A, 2009, J FUSION ENERG, V28, P420, DOI 10.1007/s10894-009-9216-z
   Roudaki FS, 2015, J FUSION ENERG, V34, P911, DOI 10.1007/s10894-015-9898-3
   Roudaki FS, 2016, INT J HYDROGEN ENERG
   Salar Elahi A, 2009, J PLASMA PHYS, V76, P1
NR 34
TC 2
Z9 2
U1 1
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD MAR 2
PY 2017
VL 42
IS 9
BP 6202
EP 6210
DI 10.1016/j.ijhydene.2016.10.154
PG 9
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA ES4LP
UT WOS:000399507100058
DA 2018-12-27
ER

PT J
AU McTiernan, CD
   Leblanc, X
   Scaiano, JC
AF McTiernan, Christopher D.
   Leblanc, Xavier
   Scaiano, Juan C.
TI RETRACTED: Heterogeneous Titania-Photoredox/Nickel Dual Catalysis:
   Decarboxylative Cross-Coupling of Carboxylic Acids with Aryl Iodides
   (Retracted article. See vol. 8, pg. 9847, 2018)
SO ACS CATALYSIS
LA English
DT Article; Retracted Publication
DE heterogeneous; dual catalysis; nickel; titania; decarboxylative
   cross-coupling; photoredox
ID VISIBLE-LIGHT PHOTOREDOX; SINGLE-ELECTRON TRANSMETALATION; HYDROGEN
   SUBSTITUTION-REACTIONS; TRANSITION-METAL CATALYSIS; NICKEL-PHOSPHINE
   COMPLEXES; CARBON BOND FORMATION; ALPHA-AMINO-ACIDS; C-H ARYLATION;
   PALLADIUM CATALYSIS; GRIGNARD-REAGENTS
AB The efficient, mild, and semiheterogeneous decarboxylative cross-coupling of a variety alkyl carboxylic acids with aryl iodides has been accomplished through a merger of TiO2 photoredox and nickel cross-coupling chemistries. The protocol is tolerant to a wide range of substituted aryl iodides and alkyl carboxylic acids. Through replacement of the commonly employed Ir transition-metal complexes with P25 TiO2 as photocatalyst, we show that these transformations can be heterogenized with little effect on the efficiency of these transformations, while at the same time decreasing the associated costs due to the reusability and inexpensive nature of the TiO2 photocatalyst. KEYWORDS: heterogeneous, dual catalysis, nickel, titania, decarboxylative cross-coupling, photoredox
C1 [Scaiano, Juan C.] Univ Ottawa, Dept Chem & Biomol Sci, 10 Marie Curie, Ottawa, ON K1N 6N5, Canada.
   Univ Ottawa, Ctr Catalysis Res & Innovat, 10 Marie Curie, Ottawa, ON K1N 6N5, Canada.
RP Scaiano, JC (reprint author), Univ Ottawa, Dept Chem & Biomol Sci, 10 Marie Curie, Ottawa, ON K1N 6N5, Canada.
EM titoscaiano@mac.com
OI Scaiano, Juan/0000-0002-4838-7123
FU Natural Sciences and Engineering Research Council of Canada; Canada
   Foundation for Innovation; Canada Research Chairs Program
FX This work was supported by the Natural Sciences and Engineering Research
   Council of Canada, the Canada Foundation for Innovation, and the Canada
   Research Chairs Program
CR BARTLETT PN, 1993, ELECTROCHIM ACTA, V38, P2515, DOI 10.1016/0013-4686(93)80147-R
   Cheng WM, 2015, CHEM-EUR J, V21, P13191, DOI 10.1002/chem.201502286
   Cherevatskaya M, 2012, ANGEW CHEM INT EDIT, V51, P4062, DOI 10.1002/anie.201108721
   Choi S, 2015, ACS CATAL, V5, P4796, DOI 10.1021/acscatal.5b00817
   Chu LL, 2015, ANGEW CHEM INT EDIT, V54, P7929, DOI 10.1002/anie.201501908
   CORRIU JP, 1972, J CHEM SOC CHEM COMM, P144
   DIECK HA, 1974, J AM CHEM SOC, V96, P1133, DOI 10.1021/ja00811a029
   El Khatib M, 2016, ANGEW CHEM INT EDIT, V55, P254, DOI 10.1002/anie.201506147
   GURAM AS, 1995, ANGEW CHEM INT EDIT, V34, P1348, DOI 10.1002/anie.199513481
   Gutierrez O, 2015, J AM CHEM SOC, V137, P4896, DOI 10.1021/ja513079r
   HATANAKA Y, 1988, J ORG CHEM, V53, P918, DOI 10.1021/jo00239a056
   He Y, 2015, CHEM SCI, V6, P1194, DOI 10.1039/c4sc03092c
   HECK RF, 1972, J ORG CHEM, V37, P2320, DOI 10.1021/jo00979a024
   HECK RF, 1968, J AM CHEM SOC, V90, P5518, DOI 10.1021/ja01022a034
   Hopkinson MN, 2014, ADV SYNTH CATAL, V356, P2794, DOI 10.1002/adsc.201400580
   Joe CL, 2016, ANGEW CHEM INT EDIT, V55, P4040, DOI 10.1002/anie.201511438
   Jouffroy M, 2016, ORG LETT, V18, P1606, DOI 10.1021/acs.orglett.6b00466
   Jouffroy M, 2016, ORG LETT, V18, P876, DOI 10.1021/acs.orglett.6b00208
   Jouffroy M, 2016, J AM CHEM SOC, V138, P475, DOI 10.1021/jacs.5b10963
   Juillard J., 1977, PURE APPL CHEM, V49, P885
   Kalyani D, 2011, J AM CHEM SOC, V133, P18566, DOI 10.1021/ja208068w
   Kim S, 2016, CHEM SCI, V7, P85, DOI 10.1039/c5sc03025k
   KING AO, 1977, J CHEM SOC CHEM COMM, P683, DOI 10.1039/c39770000683
   Lang SB, 2015, CHEM-EUR J, V21, P18589, DOI 10.1002/chem.201503644
   Lang SB, 2014, J AM CHEM SOC, V136, P13606, DOI 10.1021/ja508317j
   Leveque C, 2016, ORG CHEM FRONT, V3, P462, DOI 10.1039/c6qo00014b
   LOUIE J, 1995, TETRAHEDRON LETT, V36, P3609, DOI 10.1016/0040-4039(95)00605-C
   Manley DW, 2014, ORG LETT, V16, P5394, DOI 10.1021/ol502625w
   Manley DW, 2014, J ORG CHEM, V79, P1386, DOI 10.1021/jo4027929
   McTiernan CD, 2014, ACS CATAL, V4, P4034, DOI 10.1021/cs501030f
   McTiernan CD, 2014, ADV SYNTH CATAL, V356, P2819, DOI 10.1002/adsc.201400547
   MEISEL D, 1986, J AM CHEM SOC, V108, P4706, DOI 10.1021/ja00276a004
   MILSTEIN D, 1978, J AM CHEM SOC, V100, P3636, DOI 10.1021/ja00479a077
   MIYAURA N, 1979, J CHEM SOC CHEM COMM, P866, DOI 10.1039/c39790000866
   MIZOROKI T, 1971, B CHEM SOC JPN, V44, P581, DOI 10.1246/bcsj.44.581
   MORI K, 1973, B CHEM SOC JPN, V46, P1505, DOI 10.1246/bcsj.46.1505
   NEGISHI E, 1976, J CHEM SOC CHEM COMM, P596, DOI 10.1039/c3976000596b
   NEGISHI E, 1977, J ORG CHEM, V42, P1821, DOI 10.1021/jo00430a041
   Neufeldt SR, 2012, ADV SYNTH CATAL, V354, P3517, DOI 10.1002/adsc.201200738
   Oderinde MS, 2016, J AM CHEM SOC, V138, P1760, DOI 10.1021/jacs.5b11244
   Oderinde MS, 2015, J ORG CHEM, V80, P7642, DOI 10.1021/acs.joc.5b01193
   Pitre SP, 2016, ACS OMEGA, V1, P66, DOI 10.1021/acsomega.6b00058
   Primer DN, 2015, J AM CHEM SOC, V137, P2195, DOI 10.1021/ja512946e
   Rodriguez JL, 2012, J MOL CATAL A-CHEM, V353, P29, DOI 10.1016/j.molcata.2011.11.001
   Ryu D, 2016, CHEM-EUR J, V22, P120, DOI 10.1002/chem.201504079
   Sahoo B, 2013, J AM CHEM SOC, V135, P5505, DOI 10.1021/ja400311h
   SAWYER DT, 1966, J ELECTROANAL CHEM, V12, P90, DOI 10.1016/0022-0728(66)80021-9
   Shang R, 2011, SCI CHINA CHEM, V54, P1670, DOI 10.1007/s11426-011-4381-0
   Shu XZ, 2014, J AM CHEM SOC, V136, P5844, DOI 10.1021/ja500716j
   SONOGASHIRA K, 1975, TETRAHEDRON LETT, P4467
   TAMAO K, 1972, J AM CHEM SOC, V94, P4374, DOI 10.1021/ja00767a075
   TAMAO K, 1972, J AM CHEM SOC, V94, P9268, DOI 10.1021/ja00781a070
   TAMAO K, 1976, B CHEM SOC JPN, V49, P1958, DOI 10.1246/bcsj.49.1958
   Tasker SZ, 2015, J AM CHEM SOC, V137, P9531, DOI 10.1021/jacs.5b05597
   Tellis JC, 2014, SCIENCE, V345, P433, DOI 10.1126/science.1253647
   Tlahuext-Aca A, 2016, CHEM-EUR J, V22, P5909, DOI 10.1002/chem.201600710
   Um J, 2016, ORG LETT, V18, P484, DOI 10.1021/acs.orglett.5b03531
   Xu N, 2016, CHEM-EUR J, V22, P2236, DOI 10.1002/chem.201504530
   Xuan J, 2015, CHEM-EUR J, V21, P4962, DOI 10.1002/chem.201500227
   Xuan J, 2015, ANGEW CHEM INT EDIT, V54, P1625, DOI 10.1002/anie.201409999
   Yamashita Y, 2015, P NATL ACAD SCI USA, V112, P12026, DOI 10.1073/pnas.1509715112
   Ye YD, 2012, J AM CHEM SOC, V134, P9034, DOI 10.1021/ja301553c
   Zhou C, 2015, ORG LETT, V17, P6198, DOI 10.1021/acs.orglett.5b03192
   Zoller J, 2014, ANGEW CHEM INT EDIT, V53, P13264, DOI 10.1002/anie.201405478
   Zuo ZW, 2016, J AM CHEM SOC, V138, P1832, DOI 10.1021/jacs.5b13211
NR 65
TC 16
Z9 17
U1 9
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2155-5435
J9 ACS CATAL
JI ACS Catal.
PD MAR
PY 2017
VL 7
IS 3
BP 2171
EP 2175
DI 10.1021/acscatal.6b03687
PG 5
WC Chemistry, Physical
SC Chemistry
GA EN0UR
UT WOS:000395726500081
DA 2018-12-27
ER

PT J
AU Li, M
   Weinberger, DR
AF Li, Ming
   Weinberger, Daniel R.
TI RETRACTED: Illuminating the dark road from schizophrenia genetic
   associations to disease mechanisms (Retracted Article)
SO NATIONAL SCIENCE REVIEW
LA English
DT Review; Retracted Publication
DE schizophrenia; GWAS; functional genomics; molecular mechanism; disease
   biology
ID CATECHOL-O-METHYLTRANSFERASE; GENOME-WIDE ASSOCIATION; HUMAN BRAIN;
   PREFRONTAL CORTEX; FUNCTION VARIANTS; BIPOLAR DISORDER; RISK VARIATION;
   EXPRESSION; LOCUS; MODEL
AB Recent large-scale genome-wide association studies (GWAS) have enabled the discovery of common genetic variations contributing to risk architectures of schizophrenia in human populations; however, the majority of GWAS-identified variants are located in large genomic regions spanning multiple genes, and recognizing the precise targets and mechanisms of these clinical associations is now the major challenge. Here, we review recent progress in schizophrenia genetics, functional genomics and related neuroscience research, and propose a functional pipeline to translate schizophrenia GWAS risk loci into disease biology and information for drug discovery. The pipeline includes identification of underlying molecular mechanisms using transcriptomic data in human brain, prioritization of putative functional causative variants by the integration of genetic epidemiological and bioinformatics methods as well as molecular approaches, and in vitro and in vivo experimental characterizations of the identified targeted species and causative variants to dissect the relevant disease biology. These approaches will accelerate progress from schizophrenia genetic studies to biological mechanisms and ultimately guide the development of prognostic, preventive and therapeutic measures.
C1 [Li, Ming] Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China.
   [Li, Ming; Weinberger, Daniel R.] Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD 21205 USA.
   [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA.
   [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.
   [Weinberger, Daniel R.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.
   [Weinberger, Daniel R.] Peking Univ, Translat Neuropsychiat Inst, Lieber Inst, Beijing 100191, Peoples R China.
RP Li, M (reprint author), Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Peoples R China.; Li, M; Weinberger, DR (reprint author), Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD 21205 USA.; Weinberger, DR (reprint author), Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA.; Weinberger, DR (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.; Weinberger, DR (reprint author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Weinberger, DR (reprint author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.; Weinberger, DR (reprint author), Peking Univ, Translat Neuropsychiat Inst, Lieber Inst, Beijing 100191, Peoples R China.
EM lim-ingkiz@mail.kiz.ac.cn; drweinberger@libd.org
FU CAS Pioneer Hundred Talents Program; Lieber Institute for Brain
   Development; Maltz Research Laboratories
FX This work was supported by the CAS Pioneer Hundred Talents Program (to
   ML) and funding from the Lieber Institute for Brain Development and the
   Maltz Research Laboratories.
CR [Anonymous], 2015, NEURON, V88, P1078
   Arion D, 2015, MOL PSYCHIATR, V20, P1397, DOI 10.1038/mp.2014.171
   Barkus C, 2016, NEUROPSYCHOPHARMACOL, V41, P3060, DOI 10.1038/npp.2016.119
   Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96
   Birnbaum R, 2015, BIOL PSYCHIAT, V77, pE43, DOI 10.1016/j.biopsych.2014.10.008
   Butter F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002982
   Carr GV, 2016, MOL PSYCHIATR, V21, P1517, DOI 10.1038/mp.2015.219
   Carrera N, 2012, BIOL PSYCHIAT, V71, P169, DOI 10.1016/j.biopsych.2011.09.032
   Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589
   Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214
   Cohen OS, 2016, MOL PSYCHIATR, V21, P975, DOI 10.1038/mp.2015.137
   Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524
   Cooper TA, 2005, METHODS, V37, P331, DOI 10.1016/j.ymeth.2005.07.015
   Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799
   Desviat LR, 2012, METHODS MOL BIOL, V867, P37, DOI 10.1007/978-1-61779-767-5_3
   Duan JB, 2014, AM J HUM GENET, V95, P744, DOI 10.1016/j.ajhg.2014.11.001
   Duarte RRR, 2016, AM J MED GENET B, V171, P806, DOI 10.1002/ajmg.b.32445
   Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598
   Falk A, 2016, MOL PSYCHIATR, V21, P1167, DOI 10.1038/mp.2016.89
   Ferrer I, 2007, J NEUROPATH EXP NEUR, V66, P35, DOI 10.1097/nen.0b013e31802c3e7d
   French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002
   Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929
   Gershon ES, 2014, MOL PSYCHIATR, V19, P890, DOI 10.1038/mp.2013.107
   Guintivano J, 2013, EPIGENETICS-US, V8, P290, DOI 10.4161/epi.23924
   Huang HS, 2006, J NEUROSCI METH, V156, P284, DOI 10.1016/j.jneumeth.2006.02.018
   Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962
   Jaffe AE, 2016, NAT NEUROSCI, V19, P40, DOI 10.1038/nn.4181
   Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898
   Jiang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-42
   Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154
   Kleinman JE, 2011, BIOL PSYCHIAT, V69, P140, DOI 10.1016/j.biopsych.2010.10.032
   Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531
   Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103
   Li M, 2016, NAT MED, V22, P649, DOI 10.1038/nm.4096
   Li M, 2016, SCHIZOPHRENIA BULL, V42, P178, DOI 10.1093/schbul/sbv070
   Li YI, 2016, SCIENCE, V352, P600, DOI 10.1126/science.aad9417
   LOTTA T, 1995, BIOCHEMISTRY-US, V34, P4202, DOI 10.1021/bi00013a008
   Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794
   McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474
   Michels KB, 2013, NAT METHODS, V10, P949, DOI 10.1038/nmeth.2632
   Montano CM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r94
   Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888
   O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201
   O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Paterson C, 2014, AM J PSYCHIAT, V171, P979, DOI 10.1176/appi.ajp.2014.13111518
   Praetorius C, 2013, CELL, V155, P1022, DOI 10.1016/j.cell.2013.10.022
   Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975
   Rhie SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063925
   Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11
   Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595
   Roussos P, 2014, CELL REP, V9, P1417, DOI 10.1016/j.celrep.2014.10.015
   Schubert CR, 2014, NEURON, V84, P537, DOI 10.1016/j.neuron.2014.10.037
   Singh T, 2016, NAT NEUROSCI, V19, P571, DOI 10.1038/nn.4267
   Straub RE, 2006, BIOL PSYCHIAT, V60, P81, DOI 10.1016/j.biopsych.2006.002
   Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187
   Takata A, 2014, NEURON, V82, P773, DOI 10.1016/j.neuron.2014.04.043
   Tao R, 2014, JAMA PSYCHIAT, V71, P1112, DOI 10.1001/jamapsychiatry.2014.1079
   Tunbridge EM, 2004, J NEUROSCI, V24, P5331, DOI 10.1523/JNEUROSCI.1124-04.2004
   Wang WZ, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-69
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   Yoshimizu T, 2015, MOL PSYCHIATR, V20, P162, DOI 10.1038/mp.2014.143
   Yu H, 2016, COMMON VARI IN PRESS
   Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979
NR 64
TC 3
Z9 3
U1 5
U2 13
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2095-5138
EI 2053-714X
J9 NATL SCI REV
JI Natl. Sci. Rev.
PD MAR
PY 2017
VL 4
IS 2
BP 240
EP 251
DI 10.1093/nsr/nww065
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EU1VX
UT WOS:000400815000014
OA Bronze
DA 2018-12-27
ER

PT J
AU Mehta, A
   Goswami, M
   Sinha, R
AF Mehta, Anurag
   Goswami, Malini
   Sinha, Rupal
TI RETRACTED: Histopathological Significance and Prognostic Impact of Tumor
   Budding in Colorectal Cancer (Retracted article. See vol. 48, pg. 688,
   2018)
SO ANNALS OF CLINICAL AND LABORATORY SCIENCE
LA English
DT Article; Retracted Publication
DE Tumor budding; Colorectal cancer
ID HIGH-RISK PATIENTS; STAGE-II; RECURRENCE; MARKER; INDEX
AB Background. Colorectal cancer (CRC) is a heterogeneous disease with complex etiology. New prognostic factors for this group of disease need to be investigated. This study evaluated the histopathological significance and prognostic impact of tumor budding in CRC. Design. A total of 60 treatment naive consecutive patients undergoing surgical resection for CRC during the period of January 2011 to December 2013 were included in the study. Details of each patient related to their demographic and tumor profile were recorded. Pan Cytokeratin immunohistochemistry was applied on chosen sections and tumor budding was assessed. Results. The most frequent site of involvement was rectosigmoid and sigmoid colon (31.6%). The majority of the cases were moderately differentiated (75%) in morphology, and showed tumor invasion into the pericolic/subserosal fat (66.6%), and were stage III (38.3%). Nodal involvement was present in 50% cases. Correlations between tumor budding and nodal involvement (p-value 0.039) and AJCC stage (p-value 0.021) were found to be statistically significant. Conclusion. Tumor budding may be a promising and powerful predictor of lymphnodal metastasis and a higher stage of tumor and can be used as a marker for assessing the aggressiveness of CRC. Routine hemotoxylin-eosin staining supported by cytokeratin immunostain can aid in the grading of tumor budding in CRC.
C1 [Mehta, Anurag; Goswami, Malini] Rajiv Gandhi Canc Inst & Res Ctr, Dept Lab Serv, Delhi, India.
   [Sinha, Rupal] Rajiv Gandhi Canc Inst & Res Ctr, Res Dept, Delhi, India.
RP Mehta, A (reprint author), Rajiv Gandhi Canc Inst & Res Ctr, Dept Lab Serv, Lab Serv, Sect 5, Delhi, India.
EM anumehta11@gmail.com
CR De Smedt L, 2016, VIRCHOWS ARCH, V468, P397, DOI 10.1007/s00428-015-1886-5
   Edge SB, 2010, COLON RECTUM, P173
   El-Gendi S, 2011, J EGYPT NATL CANCER, V23, P1, DOI 10.1016/j.jnci.2011.07.001
   Fukumoto K, 2016, CANCER SCI, V107, P1338, DOI 10.1111/cas.12990
   Guzinska-Ustymowicz K, 2005, ANTICANCER RES, V25, P1269
   HASE K, 1993, DIS COLON RECTUM, V36, P627, DOI 10.1007/BF02238588
   Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106
   Kai K, 2016, PATHOL INT, V66, P75, DOI 10.1111/pin.12374
   Kanazawa H, 2008, COLORECTAL DIS, V10, P41, DOI 10.1111/j.1463-1318.2007.01240.x
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Koelzer VH, 2016, HUM PATHOL, V47, P4, DOI 10.1016/j.humpath.2015.08.007
   Lugli A, 2012, BRIT J CANCER, V106, P1713, DOI 10.1038/bjc.2012.127
   MORODOMI T, 1989, CANCER, V63, P539, DOI 10.1002/1097-0142(19890201)63:3<539::AID-CNCR2820630323>3.0.CO;2-S
   Nakamura T, 2008, DIS COLON RECTUM, V51, P568, DOI 10.1007/s10350-008-9192-9
   Ohtsuki K, 2008, ANTICANCER RES, V28, P1831
   Okuyama T, 2003, DIS COLON RECTUM, V46, P1400, DOI 10.1097/01.DCR.0000084413.78455.89
   Okuyama T, 2003, J SURG ONCOL, V83, P42, DOI 10.1002/jso.10230
   Petrelli F, 2015, J Gastrointest Cancer, V46, P212, DOI 10.1007/s12029-015-9716-1
   Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x
   Rogers AC, 2016, BRIT J CANCER, V115, P831, DOI 10.1038/bjc.2016.274
   Sevda SB, 2012, TURKISH J PATHOLOGY, V28
   Tanaka M, 2003, DIS COLON RECTUM, V46, P1054, DOI 10.1097/01.DCR.0000074867.87213.D1
   Tytherleigh MG, 2008, BRIT J SURG, V95, P409, DOI 10.1002/bjs.6127
   Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/S0016-5085(04)00717-6
   Wang LM, 2009, AM J SURG PATHOL, V33, P134, DOI 10.1097/PAS.0b013e318184cd55
   Zhang SW, 2016, STEM CELLS INT, DOI 10.1155/2016/4810734
NR 26
TC 1
Z9 1
U1 0
U2 0
PU ASSOC CLINICAL SCIENTISTS
PI MIDDLEBURY
PA PO BOX 1287, MIDDLEBURY, VT 05753 USA
SN 0091-7370
EI 1550-8080
J9 ANN CLIN LAB SCI
JI Ann. Clin. Lab. Sci.
PD MAR-APR
PY 2017
VL 47
IS 2
BP 129
EP 135
PG 7
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA ET1EY
UT WOS:000400010900003
PM 28442513
DA 2018-12-27
ER

PT J
AU Garcia, RF
   Carril, JC
   Garcia, SI
AF Ferreiro Garcia, Ramon
   Carbia Carril, Jose
   Iglesias Garcia, Steven
TI RETRACTED: Low-grade heat-based thermal cycles unconstrained by the
   Carnot factor doing work by cooling (Retracted article. See vol. 149,
   pg. 1036, 2018)
SO ENERGY
LA English
DT Article; Retracted Publication
DE Closed processes-based cycles; Cooling-based work; Heating-based work;
   Low-grade heat; Residual heat
ID EXPANSION; SYSTEM
AB The objective of the research is to convert heating and cooling energy into mechanical work capable of yielding high thermal efficiency while surpassing the Carnot factor (CF), even when using low grade heat sources. To achieve the proposed objectives, a closed process-based thermal cycle composed of two isochoric and two adiabatic path functions is studied, where one of the isochoric transformations is dedicated to heat absorption, and the other is dedicated to heat release. The analysis is carried out on the basis of double-acting cylinder-based engine types, operating according to a closed process-based thermal cycle with air, helium and hydrogen as the working fluids, characterised by performing mechanical work both in the expansion phase due to heat addition, and in the contraction phase due to heat extraction. The proposed thermal cycles yield acceptable performance, even at medium and low temperatures (that is, for an exceptionally low ratio of the high to the low temperatures of the heat source and heat sink, respectively). The main results derived from a case study operating between 300 and 340 (K) with air, helium and hydrogen, give an efficiency of 56.32 (%), 78.64 (%) and 56.54 (%) respectively, and while the specific work amounts 12.78 (kJ/kg), 71.24 (kJ/kg) and 182.90 (14/kg) respectively. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Ferreiro Garcia, Ramon; Iglesias Garcia, Steven] Univ A Coruna, Dept Ind Engn, La Coruna, Spain.
   [Carbia Carril, Jose] Univ A Coruna, Energy & Prop Dept, La Coruna, Spain.
RP Garcia, RF (reprint author), Univ A Coruna, Dept Ind Engn, La Coruna, Spain.
OI ferreiro garcia, ramon/0000-0002-9466-8620; Iglesias Garcia,
   Steven/0000-0002-3154-6634
CR Cui X, 2016, ENERGY, V95, P303, DOI 10.1016/j.energy.2015.12.032
   Garcia R, 2016, ENERG CONVERS MANAGE, V119, P49, DOI 10.1016/j.enconman.2016.04.031
   Garcia RF, 2016, ENERG CONVERS MANAGE, V113, P252, DOI 10.1016/j.enconman.2016.01.066
   Garcia R Ferreiro, 2015, BR J APPL SCI TECHNO, V6, P216
   Garcia R Ferreiro, 2015, BR J APPL SCI TECHNO, V8, P448, DOI DOI 10.9734/BJAST/2015/17150
   Garcia R. Ferreiro, 2014, BR J APPL SCI TECHNO, V4, P3840
   Garcia R Ferreiro, 2015, BR J APPL SCI TECHNO, V9, P450, DOI DOI 10.9734/BJAST/2015/18624
   Garcia R Ferreiro, 2014, BR J APPL SCI TECHNO, V4, P2821
   Jani DB, 2016, INT J EXERGY, V20, P517, DOI 10.1504/IJEX.2016.078106
   Kim MH, 2013, ENERGY, V59, P726, DOI 10.1016/j.energy.2013.07.018
   Lemmon E.W., 2007, NIST REFERENCE FLUID
   Li YL, 2016, ENERGY, V109, P180, DOI 10.1016/j.energy.2016.03.127
   Mandegari M, 2015, J THERM SCI ENG APPL, V7
   She XH, 2014, ENERG CONVERS MANAGE, V78, P286, DOI 10.1016/j.enconman.2013.10.057
   Van Den Einde D, 2016, PHYS ESSAYS, V29, P297, DOI 10.4006/0836-1398-29.3.297
   Van den Einde D, 2010, PHYS ESSAYS, V23, P550, DOI 10.4006/1.3481188
NR 16
TC 1
Z9 1
U1 2
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-5442
EI 1873-6785
J9 ENERGY
JI Energy
PD MAR 1
PY 2017
VL 122
BP 204
EP 213
DI 10.1016/j.energy.2017.01.075
PG 10
WC Thermodynamics; Energy & Fuels
SC Thermodynamics; Energy & Fuels
GA ES1DC
UT WOS:000399267100018
DA 2018-12-27
ER

PT J
AU Wu, JH
   Ge, F
   Li, YJ
AF Wu, Junhua
   Ge, Fei
   Li, Yingjie
TI RETRACTED: A Vehicle Exhaust NOx Electrochemical Sensor Based on
   AuYttria Stabilized Zirconia Nanocomposite (Retracted article. See vol.
   12, pg. 8832, 2017)
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article; Retracted Publication
DE NOx electrochemical sensor; Gold; Yttria stabilized zirconia;
   Nanocomposite
ID POTENTIAL-TYPE SENSOR; NIO SENSING ELECTRODE; HIGH-TEMPERATURE; GAS
   SENSOR; YSZ; CELLS; PERFORMANCES; IMPROVEMENT
AB Mixed potential sensor which is built on Yttria Stabilized Zirconia (YSZ) with a plain planar structure Au/YSZ/Pt has actual benefit among different kinds of NOx sensors. To further sensing abilities, au composites electrodes were taken a research on. The fact that adding YSZ into the Au electrode reduced in air the polarization resistance has been demonstrated by electrochemical impedance spectroscopy. The proposed porous Au-YSZ composite electrodes in a YSZ-based sensor have more positive effect than pure gold electrode based on the excellent performance. The proposed YSZ-based sensor could linearly detect NO2 in the concentration between 50 to 400 ppm with a low detection limit of 20 ppm.
C1 [Wu, Junhua; Ge, Fei] Nanjing Forestry Univ, Sch Automot & Traff Engn, Nanjing 210037, Jiangsu, Peoples R China.
   [Li, Yingjie] Shanghai Univ Engn Sci, Coll Chem & Chem Engn, Shanghai 201620, Peoples R China.
RP Wu, JH (reprint author), Nanjing Forestry Univ, Sch Automot & Traff Engn, Nanjing 210037, Jiangsu, Peoples R China.
EM 1103409684@qq.com
CR Bultel L, 2005, SOLID STATE IONICS, V176, P793, DOI 10.1016/j.ssi.2004.09.064
   Capone S, 2003, J OPTOELECTRON ADV M, V5, P1335
   Elumalai P, 2005, SOLID STATE IONICS, V176, P2517, DOI 10.1016/j.ssi.2005.02.031
   Elumalai P, 2005, J ELECTROCHEM SOC, V152, pH95, DOI 10.1149/1.1923707
   Elumalai P, 2009, J ELECTROCHEM SOC, V156, pJ288, DOI 10.1149/1.3174390
   Fee M, 2014, J SOLID STATE ELECTR, V18, P2267, DOI 10.1007/s10008-014-2477-0
   Gao J, 2011, SENSOR ACTUAT B-CHEM, V154, P106, DOI 10.1016/j.snb.2010.01.033
   Guillet N, 2002, MAT SCI ENG C-BIO S, V21, P97, DOI 10.1016/S0928-4931(02)00067-X
   Hua CH, 2016, JPN J APPL PHYS, V55, DOI 10.7567/JJAP.55.080302
   Kleitz M, 1997, J EUR CERAM SOC, V17, P819, DOI 10.1016/S0955-2219(97)89966-9
   Lee MJ, 2014, J EUR CERAM SOC, V34, P1771, DOI 10.1016/j.jeurceramsoc.2013.12.042
   Li Y., 2015, SENSOR ACTUAT B-CHEM, V223, P365
   Miura N, 2002, SENSOR ACTUAT B-CHEM, V83, P222, DOI 10.1016/S0925-4005(01)01044-9
   Pijolat C, 2009, SENSOR ACTUAT B-CHEM, V141, P7, DOI 10.1016/j.snb.2009.06.004
   Plashnitsa VV, 2006, INT J APPL CERAM TEC, V3, P127, DOI 10.1111/j.1744-7402.2006.02066.x
   Rasheed PA, 2016, BIOSENS BIOELECTRON, V83, P361, DOI 10.1016/j.bios.2016.04.057
   Sundaravel S., 2015, IND C BIOM TISS ENG
   Wang T, 2001, SENSOR ACTUAT B-CHEM, V77, P132, DOI 10.1016/S0925-4005(01)00684-0
   Woo L.Y., 2013, ECS T, V45, P19
   Yang JC, 2007, SENSOR ACTUAT B-CHEM, V123, P929, DOI 10.1016/j.snb.2006.10.052
   Yin CG, 2013, SENSOR ACTUAT B-CHEM, V183, P474, DOI 10.1016/j.snb.2013.03.064
   Yu SC, 2014, INT J HYDROGEN ENERG, V39, P562, DOI 10.1016/j.ijhydene.2013.10.090
   Zhang WF, 2004, SOLID STATE IONICS, V169, P121, DOI 10.1016/j.ssi.2003.10.004
   Zhu J., 2014, J MATER RES, V30, P357
   Zosel J, 2008, SENSOR ACTUAT B-CHEM, V130, P326, DOI 10.1016/j.snb.2007.08.008
NR 25
TC 1
Z9 1
U1 7
U2 29
PU ESG
PI BELGRADE
PA BORIVOJA STEVANOVICA 25-7, BELGRADE, 11000, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD MAR
PY 2017
VL 12
IS 3
BP 1734
EP 1741
DI 10.20964/2017.03.52
PG 8
WC Electrochemistry
SC Electrochemistry
GA EP3BE
UT WOS:000397256700006
OA Bronze
DA 2018-12-27
ER

PT J
AU Zhang, GD
   Liu, XZ
   Li, YF
   Wang, Y
   Liang, HK
   Li, KY
   Li, LQ
   Chen, CC
   Sun, WQ
   Ren, SL
   Zhu, PF
   Zhang, LC
AF Zhang, Guodong
   Liu, Xiaozhu
   Li, Yinfeng
   Wang, Yan
   Liang, Huankun
   Li, Kangyan
   Li, Laiqing
   Chen, Cuicui
   Sun, Wenqiao
   Ren, Shoulei
   Zhu, Pengfei
   Zhang, Licheng
TI RETRACTED: EphB3-targeted regulation of miR-149 in the migration and
   invasion of human colonic carcinoma HCT116 and SW620 cells (Retracted
   article. See vol. 109, pg. 483, 2018)
SO CANCER SCIENCE
LA English
DT Article; Retracted Publication
DE EphB3; human colorectal cell; invasion; migration; miR-149
ID COLORECTAL-CANCER; EXPRESSION PROFILES; MICRORNA; APOPTOSIS
AB microRNAs play key roles during various crucial cell processes such as proliferation, migration, invasion and apoptosis. Also, microRNAs have been shown to possess oncogenic and tumor-suppressive functions in human cancers. Here, we describe the regulation and function of miR-149 in colorectal cancer cell lines. miR-149 expression patterns were detected in human colorectal cell lines and tissue samples, and then focused on its role in regulation of cell growth, migration, invasion, and its target gene identification. Furthermore, the function of the target gene of miR-149 was analyzed in vitro and in vivo. miR-149 expression was downregulated in human colorectal cancer HCT116 and SW620 cell lines compared to the normal colon epithelial NCM460 cell line using quantitative real-time polymerase chain reaction methods. Further studies indicated that introduction of miR-149 was able to suppress cell migration and invasion. Then, EphB3 was identified as a direct target gene of miR-149 in colorectal cancer cells. Moreover, experiments in vitro showed that knockdown expression of EphB3 could suppress cell proliferation and invasion, and ectopic expression of EphB3 restored the phenotypes of CRC cell lines transfected with miR149. In addition, silencing of EphB3 significantly affected cycle progression distribution and increased apoptosis in CRC cell lines. Finally, in vivo results demonstrated that knockdown of EphB3 by siRNA inhibited tumor growth. In conclusion, the important role of miR149 in colorectal cancer progression suggesting that miR-149 may serve as a therapeutic target for colorectal cancer treatment.
C1 [Zhang, Guodong] Canc Ctr Guangzhou Med Univ, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China.
   [Liu, Xiaozhu; Li, Yinfeng] Guizhou Inst Technol, Sch Light Ind Engn, Guiyang, Guizhou, Peoples R China.
   [Wang, Yan; Ren, Shoulei] Shangdong Med Tech Coll, Tai An, Shandong, Peoples R China.
   [Liang, Huankun; Li, Kangyan; Li, Laiqing; Chen, Cuicui] Guangzhou Youdi Biotechnol Co, Guangzhou, Guangdong, Peoples R China.
   [Sun, Wenqiao; Zhang, Licheng] Canc Ctr 88 Hosp Peoples Liberat Army, Tai An 271000, Shandong, Peoples R China.
RP Zhang, GD (reprint author), Canc Ctr Guangzhou Med Univ, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China.; Zhang, LC (reprint author), Canc Ctr 88 Hosp Peoples Liberat Army, Tai An 271000, Shandong, Peoples R China.
EM zgddoctor@sina.cn; zhang88cn@sohu.com
FU Guangdong Province Science and Technology Plan Projects [20150119];
   Chinese National Foundation of National Science Grants [81402501]
FX Guangdong Province Science and Technology Plan Projects (20150119);
   Chinese National Foundation of National Science Grants (81402501).
CR Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856
   Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626
   Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038
   Charlotte HM, 2010, J BIOL CHEM, V285, P20541
   Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948
   Chiu ST, 2009, CARCINOGENESIS, V30, P1475, DOI 10.1093/carcin/bgp133
   Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11
   Davidson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012560
   Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760
   Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840
   Hans C, 2006, CANCER RES, V66, P1
   Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681
   Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Li D, 2011, OMICS, V15, P673, DOI 10.1089/omi.2011.0064
   Lin RJ, 2010, MOL CARCINOGEN, V49, P719, DOI 10.1002/mc.20647
   Liu Hui-ping, 2010, BIOMASS CHEM ENG, P51, DOI DOI 10.1093/PCP/PCQ080
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Luo ZH, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-3
   Michael MZ, 2003, MOL CANCER RES, V1, P882
   Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002
   Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827
   SCHMID I, 1994, CYTOMETRY, V15, P12, DOI 10.1002/cyto.990150104
   Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102
   Sung JJY, 2005, LANCET ONCOL, V6, P871, DOI 10.1016/S1470-2045(05)70422-8
   Vinci S, 2011, CLIN CHEM LAB MED, V49, P2073, DOI 10.1515/CCLM.2011.708
   Wang F, 2013, J PATHOL, V229, P12, DOI 10.1002/path.4078
   Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041693
   Wu Z., 2011, ADV ADAPTIVE DATA AN, V1, P1
   Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851
   Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028
NR 31
TC 7
Z9 8
U1 3
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1349-7006
J9 CANCER SCI
JI Cancer Sci.
PD MAR
PY 2017
VL 108
IS 3
BP 408
EP 418
DI 10.1111/cas.13161
PG 11
WC Oncology
SC Oncology
GA EQ4HQ
UT WOS:000398037300016
PM 28370854
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Huang, WJ
   Chen, WW
   Zhang, X
AF Huang, Wen-Juan
   Chen, Wei-Wei
   Zhang, Xia
TI RETRACTED: Proteasome inhibitors in glioblastoma (Retracted article. See
   vol. 14, pg. 6321, 2017)
SO ONCOLOGY LETTERS
LA English
DT Review; Retracted Publication
DE glioblastoma; proteasome inhibition; drugs; nervous system
ID INDUCED PERIPHERAL NEUROPATHY; PANCREATIC TUMOR XENOGRAFTS;
   MULTIPLE-MYELOMA CELLS; HISTONE-DEACETYLASE; INTRATUMORAL HETEROGENEITY;
   HDAC INHIBITORS; 20S PROTEASOME; UNITED-STATES; CANCER-CELLS; STEM-CELLS
AB Glioblastomas (GBM) are the tumors originating from the star shaped supportive cells in brain known as astrocytes. These tumors are highly cancerous as they have the ability to proliferate very quickly. New therapeutic strategies are being developed worldwide to fight against deadly GBM, which has median survival time of just 14 months. Proteasome inhibition is an upcoming strategy for GBM. Proteasome inhibition has shown promising results in cancers such as myeloma. However, in the recent past this form of therapy has also shown positive results in brain tumors in the form of elevated apoptosis. We searched the electronic database PubMed for pre-clinical as well as clinical controlled trials reporting importance of proteasome inhibitors during GBM. It was observed clearly that this approach is evolving and has been observed to be promising therapeutic avenue against GBM. Thus, the present review aims to enlighten the present views on use of proteasome inhibition strategy in the case of GBM.
C1 [Huang, Wen-Juan] Xuzhou Cent Hosp, Dept Neurol, Xuzhou 221009, Jiangsu, Peoples R China.
   [Chen, Wei-Wei] Southeast Univ, Affiliated XuZhou Hosp, Coll Med, Xuzhou 221009, Jiangsu, Peoples R China.
   [Zhang, Xia] Nanjing Univ Chinese Med, Xuzhou Clin Med Coll, 199 South Jiefang Rd, Xuzhou 221009, Jiangsu, Peoples R China.
RP Zhang, X (reprint author), Nanjing Univ Chinese Med, Xuzhou Clin Med Coll, 199 South Jiefang Rd, Xuzhou 221009, Jiangsu, Peoples R China.
EM ftmlb8556215@163.com
CR Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030
   Argyriou AA, 2008, BLOOD, V112, P1593, DOI 10.1182/blood-2008-04-149385
   Asklund T, 2012, ANTICANCER RES, V32, P2407
   Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666
   Balyasnikova IV, 2011, CANCER LETT, V310, P148, DOI 10.1016/j.canlet.2011.06.029
   Belloni D, 2010, EXP CELL RES, V316, P1010, DOI 10.1016/j.yexcr.2009.11.005
   Berkers CR, 2005, NAT METHODS, V2, P357, DOI 10.1038/nmeth759
   Berkowitz A, 2012, CLIN J ONCOL NURS, V16, P86, DOI 10.1188/12.CJON.86-89
   Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009
   Chauhan D, 2005, CANCER CELL, V8, P407, DOI 10.1016/j.ccr.2005.10.013
   Chauhan D, 2006, BRIT J CANCER, V95, P961, DOI 10.1038/sj.bjc.6603406
   Cusack JC, 2001, CANCER RES, V61, P3535
   Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169
   Friday BB, 2012, NEURO-ONCOLOGY, V14, P215, DOI 10.1093/neuonc/nor198
   Fuchs D, 2008, J CELL BIOCHEM, V103, P270, DOI 10.1002/jcb.21405
   Gilbert AN, 2016, JOVE-J VIS EXP, DOI 10.3791/54026
   Groll M, 2006, J AM CHEM SOC, V128, P5136, DOI 10.1021/ja058320b
   Groll M, 2006, STRUCTURE, V14, P451, DOI 10.1016/j.str.2005.11.019
   Hess KR, 2004, CANCER, V101, P2293, DOI 10.1002/cncr.20621
   Hideshima T., 2001, CANCER RES, V61, P2001
   Jagannath S, 2004, BRIT J HAEMATOL, V127, P165, DOI 10.1111/j.1365-2141.2004.05188.x
   Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4
   Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4
   Kuhn DJ, 2009, BLOOD, V113, P4667, DOI 10.1182/blood-2008-07-171637
   Lee EQ, 2013, J CLIN ONCOL, V31
   Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200
   Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67
   Lucio-Eterovic AK, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-243
   Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435
   Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247
   Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272
   Miller CP, 2007, BLOOD, V110, P267, DOI 10.1182/blood-2006-03-013128
   Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978
   Nawrocki ST, 2002, MOL CANCER THER, V1, P1243
   Nawrocki ST, 2004, MOL CANCER THER, V3, P59
   Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257
   Pei XY, 2004, CLIN CANCER RES, V10, P3839, DOI 10.1158/1078-0432.CCR-03-0561
   Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091
   Potts BC, 2011, CURR CANCER DRUG TAR, V11, P254
   Richardson PG, 2007, BLOOD, V110, P3557, DOI 10.1182/blood-2006-08-036947
   Richardson PG, 2011, BLOOD, V118, P302
   Richon VM, 1996, P NATL ACAD SCI USA, V93, P5705, DOI 10.1073/pnas.93.12.5705
   Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592
   Selimovic D, 2013, CELL SIGNAL, V25, P308, DOI 10.1016/j.cellsig.2012.10.004
   Singh AV, 2010, BRIT J HAEMATOL, V149, P550, DOI 10.1111/j.1365-2141.2010.08144.x
   Snuderl M, 2011, CANCER CELL, V20, P810, DOI 10.1016/j.ccr.2011.11.005
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Styczynski J, 2006, ANTICANCER RES, V26, P4499
   Szerlip NJ, 2012, P NATL ACAD SCI USA, V109, P3041, DOI 10.1073/pnas.1114033109
   Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020
   Vlashi E, 2010, TRANSL ONCOL, V3, P50, DOI 10.1593/tlo.09244
   Weniger MA, 2011, CLIN CANCER RES, V17, P5101, DOI 10.1158/1078-0432.CCR-10-3367
   Williams PG, 2005, J ORG CHEM, V70, P6196, DOI 10.1021/jo050511
   Wolf S, 2008, EUR J CANCER, V44, P1507, DOI 10.1016/j.ejca.2008.04.018
   Yao F, 2012, MOL MED REP, V5, P84, DOI 10.3892/mmr.2011.590
   Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225
   Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343
   Zou W, 2006, CLIN CANCER RES, V12, P273, DOI 10.1158/1078-0432.CCR-05-0503
   Zunkeler B, 1996, J NEUROSURG, V85, P1056, DOI 10.3171/jns.1996.85.6.1056
NR 59
TC 3
Z9 3
U1 5
U2 5
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-1074
EI 1792-1082
J9 ONCOL LETT
JI Oncol. Lett.
PD MAR
PY 2017
VL 13
IS 3
BP 1058
EP 1062
DI 10.3892/ol.2017.5585
PG 5
WC Oncology
SC Oncology
GA EO9HA
UT WOS:000396998600004
PM 28454213
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Kabel, AM
   Abd Elmaaboud, MA
   Atef, A
   Baali, MH
AF Kabel, Ahmed M.
   Abd Elmaaboud, Maaly A.
   Atef, Aliaa
   Baali, Mohammed H.
TI RETRACTED: Ameliorative potential of linagliptin and/or calcipotriol on
   bleomycin-induced lung fibrosis: In vivo and in vitro study (Retracted
   article. See vol. 60, pg. 237, 2018)
SO ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
LA English
DT Article; Retracted Publication
DE Study; Linagliptin; Calcipotriol; Bleomycin; Pulmonary fibrosis
ID NF-KAPPA-B; IDIOPATHIC PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; OXIDATIVE
   STRESS; RECEPTOR 4; MYOFIBROBLAST DIFFERENTIATION; DIPEPTIDYL
   PEPTIDASE-4; HEME OXYGENASE-1; KIDNEY FIBROSIS; TGF-BETA
AB Pulmonary fibrosis is a serious medical problem that may significantly compromise respiratory functions. The aim of this work was to study the effect of linagliptin and/or calcipotriol on bleomycininduced pulmonary fibrosis and to explore the possible mechanisms underlying this effect. One hundred and twenty male C57BL/6 mice were divided into 6 equal groups as follows: control group; bleomycin group; bleomycin + carboxymethylcellulose group; bleomycin+ linagliptin group; bleomycin+ calcipotriol group and bleomycin + linagliptin + calcipotriol group. Lung weight/body weight index, lung tissue hydroxyproline, collagen, toll-like receptor 4 (TLR4), nuclear factor-like 2 (Nrf2), heme oxygenase-1 (H0-1), malondialdehyde (MDA), glutathione peroxidase (GPx) and catalase (CAT) were measured. Also, bronchoalveolar lavage fluid (BALF) was analyzed for total and differential leucocytic count, lactate dehydrogenase, tumor necrosis factor-alpha (TNF-a), interleukin-10 (IL-10) and transforming growth factor-beta 1 (TGF-(31). Vascular response to potassium chloride, phenylephrine and carbachol as well as tracheal response to carbachol were measured. Also, lung tissue was subjected to histopathological and immunohistochemical examination. Administration of linagliptin and/or calcipotriol induced significant decrease in the lung weight/body weight index, total leucocytic count, BALF lactate dehydrogenase activity, IL-10, TNF-ot and TGF-I31 associated with significant decrease in lung tissue MDA, Nrf2, HO-1, TLR4, hydroxyproline and collagen content with significant increase in tissue GPx and CAT and improvement of the pulmonary architecture, vascular and tracheal response compared to bleomycin group. These effects were significant in linagliptin/calcipotriol combination group compared to the use of each of these drugs alone. In conclusion, linagliptin/calcipotriol combination may represent an effective therapeutic modality for amelioration of bleomycin-induced pulmonary fibrosis. (C) 2017 Elsevier B.V. All rights reserved.
C1 [Kabel, Ahmed M.; Abd Elmaaboud, Maaly A.] Tanta Univ, Dept Pharmacol, Fac Med, El Geish St, Tanta 31527, Egypt.
   [Kabel, Ahmed M.] Taif Univ, Dept Clin Pharm, Coll Pharm, At Taif, Saudi Arabia.
   [Atef, Aliaa] Tanta Univ, Dept Pathol, Fac Med, Tanta, Egypt.
   [Baali, Mohammed H.] Taif Univ, Fac Med, At Taif, Saudi Arabia.
RP Kabel, AM (reprint author), Tanta Univ, Dept Pharmacol, Fac Med, El Geish St, Tanta 31527, Egypt.
EM drakabel@gmail.com
CR Abdel-Raheem IT, 2016, PAK J PHARM SCI, V29, P685
   AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Anuradha R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004317
   Bagnato G, 2015, EUR RESPIR REV, V24, P102, DOI 10.1183/09059180.00003214
   Baltzis D, 2016, J CLIN ENDOCR METAB, V101, P4205, DOI 10.1210/jc.2016-2655
   Bargagli E, 2009, RESP MED, V103, P1245, DOI 10.1016/j.rmed.2009.04.014
   BERGMAN I, 1963, ANAL CHEM, V35, P1961, DOI 10.1021/ac60205a053
   Bhattacharyya S, 2013, AM J PATHOL, V182, P192, DOI 10.1016/j.ajpath.2012.09.007
   Chitra P, 2013, TOXICOL LETT, V219, P178, DOI 10.1016/j.toxlet.2013.03.009
   Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028
   EMMERSON J, 1979, J PHARM PHARMACOL, V31, P798, DOI 10.1111/j.2042-7158.1979.tb13666.x
   Freudlsperger C, 2013, ONCOGENE, V32, P1549, DOI 10.1038/onc.2012.171
   Guan RJ, 2016, TOXICOL LETT, V262, P161, DOI 10.1016/j.toxlet.2016.10.004
   Gupta S, 2003, J CLIN ONCOL, V21, P106, DOI 10.1200/JCO.2003.03.024
   Henry R.J., 1974, CLIN CHEM PRINCIPLES, P831
   Hoppstadter J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-124
   Hori R, 2002, J BIOL CHEM, V277, P10712, DOI 10.1074/jbc.M107749200
   Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729
   Izquierdo MJ, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-159
   Jin XG, 2014, CHINESE MED J-PEKING, V127, P1304, DOI 10.3760/cma.j.issn.0366-6999.20132749
   Jovanovie M., 2016, BIOMED RES INT, V2016
   Kabel AM, 2016, INT IMMUNOPHARMACOL, V39, P335, DOI 10.1016/j.intimp.2016.08.008
   Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029
   Kliment CR, 2011, INT J CLIN EXP PATHO, V4, P349
   Kodera R, 2014, BIOCHEM BIOPH RES CO, V443, P828, DOI 10.1016/j.bbrc.2013.12.049
   Kottmann RM, 2015, AM J PHYSIOL-LUNG C, V309, pL1305, DOI 10.1152/ajplung.00058.2015
   Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC
   Kovtunovych G, 2014, BLOOD, V124, P1522, DOI 10.1182/blood-2014-02-554162
   Li XX, 2015, GENET MOL RES, V14, P17391, DOI 10.4238/2015.December.21.8
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   Minareci E, 2014, INDIAN J PHARMACOL, V46, P185, DOI 10.4103/0253-7613.129315
   Nagai T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160993
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Peluso I, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0268-x
   Rapti E, 2016, ENDOCRINOL DIAB META, DOI 10.1530/EDM-15-0136
   Rohrborn D, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00386
   ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588
   Savani RC, 2000, AM J PHYSIOL-LUNG C, V279, pL743
   Shi S, 2016, FIBROGENESIS TISSUE, V9, DOI 10.1186/s13069-016-0038-0
   Sun JH, 2015, MOL PHARMACOL, V88, P437, DOI 10.1124/mol.115.098269
   Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801
   Wahsh E, 2016, EUR J PHARMACOL, V789, P362, DOI 10.1016/j.ejphar.2016.07.052
   Walters DM, 2008, ANTIOXID REDOX SIGN, V10, P321, DOI 10.1089/ars.2007.1901
   Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85
   Yang IV, 2015, ANN AM THORAC SOC, V12, pS193, DOI 10.1513/AnnalsATS.201503-110AW
NR 45
TC 4
Z9 5
U1 2
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1382-6689
EI 1872-7077
J9 ENVIRON TOXICOL PHAR
JI Environ. Toxicol. Pharmacol.
PD MAR
PY 2017
VL 50
BP 216
EP 226
DI 10.1016/j.etap.2017.02.008
PG 11
WC Environmental Sciences; Pharmacology & Pharmacy; Toxicology
SC Environmental Sciences & Ecology; Pharmacology & Pharmacy; Toxicology
GA EQ1MF
UT WOS:000397833500026
PM 28192751
DA 2018-12-27
ER

PT J
AU Namazi, H
   Kulish, VV
AF Namazi, Hamidreza
   Kulish, Vladimir V.
TI RETRACTED: Mathematical-based modeling and prediction of the effect of
   external stimuli on human gait (Retracted article. See vol. 33, Artn.
   e2902, 2017)
SO INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE human gait; diffusion; external stimuli; fractality; fractional
   diffusion equation (FDE)
ID HUMAN WALKING; PARKINSONS-DISEASE; STRIDE INTERVAL; DYNAMICS; STROKE
AB Human gait is defined as human locomotion that is achieved through the movement of limbs. Different limb movement patterns result in different gait patterns. Different internal and external stimuli can affect the human gait. During the years, scientists have worked on the analysis of the effect of external stimuli on human gait, but no work has been reported yet that suggests a mathematical model for analysis of this effect by linking to the nervous system. Considering the diffusion of external stimuli to the nervous system on one side and fractality of human gait on another side, in this research, for the first time, we develop a model for prediction of human gait using fractional diffusion equation. Using this model, we will predict the effect of auditory stimuli on human gait. The model developed in this research is useful not only for analysis of the effect of auditory stimuli on human gait but can be used also for analysis of different types of stimuli on subjects with healthy conditions or having some types of diseases. Copyright (c) 2016 John Wiley & Sons, Ltd.
C1 [Namazi, Hamidreza; Kulish, Vladimir V.] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
RP Namazi, H (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
EM m080012@e.ntu.edu.sg
CR Berbyuk VE, 1999, J MATH SCI, V96, P3047
   Bucher D, 2011, PROG NEUROBIOL, V94, P307, DOI 10.1016/j.pneurobio.2011.06.001
   Cai SM, 2007, PHYSICA A, V375, P687, DOI 10.1016/j.physa.2006.10.027
   Fernandez del Olmo M, 2003, Neurol Clin Neurophysiol, V2003, P1
   Ford MP, 2007, GAIT POSTURE, V26, P150, DOI 10.1016/j.gaitpost.2006.08.007
   Freedland RL, 2002, NEUROREHABILITATION, V17, P81
   HAUSDORFF JM, 1995, J APPL PHYSIOL, V78, P349
   Hausdorff JM, 2001, PHYSICA A, V302, P138, DOI 10.1016/S0378-4371(01)00460-5
   Howe TE, 2003, CLIN REHABIL, V17, P363, DOI 10.1191/0269215503cr621oa
   Hunt N, 2014, SCI REP-UK, V4, DOI 10.1038/srep05879
   Kaipust JP, 2013, ANN BIOMED ENG, V41, P1595, DOI 10.1007/s10439-012-0654-9
   Kale M, 2011, J MATH SCI MATH ED, V6, P8
   Kulish V, 2006, J MECH MED BIOL, V6, P175, DOI 10.1142/S021951940600187X
   MARSHALL EA, 1983, MATH MODELLING, V4, P391, DOI 10.1016/0270-0255(83)90045-3
   Michaud TC., 2011, HUMAN LOCOMOTION CON
   Munoz-Diosdado A., 2003, ENG MED BIOL SOC 200, V2, P1792
   Namazi H, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2805
   Namazi H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13583
   Prassas S, 1997, GAIT POSTURE, V6, P218, DOI 10.1016/S0966-6362(97)00010-6
   Ren L, 2007, J BIOMECH, V40, P1567, DOI 10.1016/j.jbiomech.2006.07.017
   Rhea CK, 2014, HUM MOVEMENT SCI, V36, P20, DOI 10.1016/j.humov.2014.04.006
   Schneider S, 2007, J NEUROL, V254, P1339, DOI 10.1007/s00415-006-0523-2
   Sejdic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043104
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   Terrier P, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-12
   West BJ, 1999, CHAOS SOLITON FRACT, V10, P1519, DOI 10.1016/S0960-0779(98)00149-0
   Zhang J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001033
NR 27
TC 4
Z9 4
U1 2
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2040-7939
EI 2040-7947
J9 INT J NUMER METH BIO
JI Int. J. Numer. Meth. Biomed.
PD MAR
PY 2017
VL 33
IS 3
AR e02805
DI 10.1002/cnm.2805
PG 10
WC Engineering, Biomedical; Mathematical & Computational Biology;
   Mathematics, Interdisciplinary Applications
SC Engineering; Mathematical & Computational Biology; Mathematics
GA EM6FJ
UT WOS:000395407900007
PM 27229881
DA 2018-12-27
ER

PT J
AU Cheraghi, M
   Namdari, M
   Negahdari, B
   Eatemadi, A
AF Cheraghi, Mostafa
   Namdari, Mehrdad
   Negahdari, Babak
   Eatemadi, Ali
TI RETRACTED: Recent advances in cardiac regeneration: Stem cell,
   biomaterial and growth factors (Retracted article. See vol. 96, pg.
   1570, 2017)
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Review; Retracted Publication
DE Myocardial infarction; Cell therapy; Protein therapy; Biomaterials;
   Delivery systems
ID ACUTE MYOCARDIAL-INFARCTION; SELF-ASSEMBLING PEPTIDE; BONE-MARROW-CELLS;
   DOUBLE-BLIND; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; PROGENITOR CELLS;
   CLINICAL-TRIAL; HEART-FAILURE; THERAPY
AB Myocardial infarction has been reported to be responsible for about 7.3 million deaths each year globally. Present treatments for myocardial infarction have been more palliative rather than curative. Over the past few years, stem cells have demonstrated its potency in regenerating damaged cardiac tissue, especially after myocardial infarction. However, limited short half-life of the protein and cell therapy and low transplanted cell survival rate as demonstrated via several clinical trials have lead to development of more potent and novel delivery systems like biomaterial delivery system and the use of various growth factors. In this review, we will be enumerating and discussing the recent advances in cardiac regeneration with focus on stem cell, biomaterial and growth factors. (C) 2016 Elsevier Masson SAS. All rights reserved.
C1 [Cheraghi, Mostafa; Namdari, Mehrdad] Lorestan Univ Med Sci, Dept Cardiol, Khorramabad 6997118544, Iran.
   [Negahdari, Babak; Eatemadi, Ali] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Tehran, Iran.
   [Eatemadi, Ali] Lorestan Univ Med Sci, Razi Herbal Med Res Ctr, Khorramabad, Iran.
   [Eatemadi, Ali] Lorestan Univ Med Sci, Sch Med, Dept Med Biotechnol, Lorestan, Iran.
RP Namdari, M (reprint author), Lorestan Univ Med Sci, Dept Cardiol, Khorramabad 6997118544, Iran.; Eatemadi, A (reprint author), Univ Tehran Med Sci, Sch Adv Technol Med, Dept Med Biotechnol, Tehran, Iran.
EM hadisdaraee@gmail.com; a-eatemadi@razi.tums.ac.ir
CR Ahmadvand H., 2015, ARYA, V11, P153
   Ahmadvand H, 2016, ARYA ATHEROSCLER, V12, P87
   Aiyelabegan H. T., 2016, INT J POLYM MAT POLY
   Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Baharvand Ahmadi Babak, 2014, J Tehran Heart Cent, V9, P70
   Baharvand B, 2009, INT J CARDIOL, V135, P187, DOI 10.1016/j.ijcard.2008.03.048
   Bartunek J, 2013, J AM COLL CARDIOL, V61, P2329, DOI 10.1016/j.jacc.2013.02.071
   Beiranvand S, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1520-8
   Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034
   Cheraghi M, 2010, ARYA ATHEROSCLER, V6, P111
   Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233
   Chou SH, 2014, CELL TRANSPLANT, V23, P513, DOI 10.3727/096368914X678436
   Da Silva JS, 2013, METHODS MOL BIOL, V1037, P145, DOI 10.1007/978-1-62703-505-7_8
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Daraee H, 2016, ARTIF CELL NANOMED B, V44, P381, DOI 10.3109/21691401.2014.953633
   Daraee H, 2016, ARTIF CELL NANOMED B, V44, P410, DOI 10.3109/21691401.2014.955107
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Diaz-Herraez P, 2013, EUR J PHARM BIOPHARM, V85, P143, DOI 10.1016/j.ejpb.2013.03.022
   Du X. Z. J., 2013, ENVIRON TOXICOL PHAR, V36, P451
   Eatemadi A., 2016, BIOMED PHARMACOTHER
   Eatemadi A, 2016, ARTIF CELL NANOMED B, V44, P1008, DOI 10.3109/21691401.2015.1008510
   Eatemadi A, 2016, ARTIF CELL NANOMED B, V44, P111, DOI 10.3109/21691401.2014.922568
   Eatemadi A, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-393
   Fedak PWM, 2005, CARDIOVASC PATHOL, V14, P109, DOI 10.1016/j.carpath.2005.03.004
   Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008
   Fernandez-Aviles F, 2004, CIRC RES, V95, P742, DOI 10.1161/01.RES.0000144798.54040.ed
   Fukuhara S, 2005, CIRC J, V69, P850, DOI 10.1253/circj.69.850
   Ghafarzadeh M, 2016, CELL MOL BIOL, V62, P102, DOI 10.14715/cmb/2016.62.6.19
   Ghafarzadeh M, 2010, PAK J MED SCI, V26, P987
   Ghafarzadeh M, 2015, ARCH GYNECOL OBSTET, V292, P321, DOI 10.1007/s00404-015-3645-x
   Ghafarzadeh M, 2016, BIOMED PHARMACOTHER, V84, P1163, DOI 10.1016/j.biopha.2016.10.055
   Ghafarzadeh M, 2010, PAK J MED SCI, V26, P407
   Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
   Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703
   Higashi Y, 2012, J GERONTOL A-BIOL, V67, P626, DOI 10.1093/gerona/gls102
   Holladay CA, 2012, BIOMATERIALS, V33, P1303, DOI 10.1016/j.biomaterials.2011.10.019
   Jaferian S, 2016, BIOMED PHARMACOTHER, V84, P780, DOI 10.1016/j.biopha.2016.10.004
   Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0
   Kastrup J, 2011, EUROINTERVENTION, V6, P813, DOI 10.4244/EIJV6I7A140
   Katritsis DG, 2005, CATHETER CARDIO INTE, V65, P321, DOI 10.1002/ccd.20406
   Khosravi AR, 2011, J RES MED SCI, V16, P640
   Lakshmanan R, 2013, MACROMOL BIOSCI, V13, P1119, DOI 10.1002/mabi.201300223
   Leor J, 2000, CIRCULATION, V102, P56
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Maher KO, 2013, DISCOV MED, V15, P349
   Maleki Ali, 2016, Indian Journal of Physiology and Pharmacology, V60, P30
   Matsudaira K, 2012, CIRC J, V76, P1509, DOI 10.1253/circj.CJ-11-1127
   Mellatyar H, 2014, ASIAN PAC J CANCER P, V15, P8693, DOI 10.7314/APJCP.2014.15.20.8693
   Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118
   Mi K, 2009, MACROMOL BIOSCI, V9, P437, DOI 10.1002/mabi.200800262
   Mohamadi A, 2015, CARDIOLOGY, V132, P281
   Mohammadian F., 2016, ARTIF CELL NANOMED B, P1
   Mohyeddin-Bonab M, 2007, ARCH IRAN MED, V10, P467
   Moradi K, 2015, IRAN J BASIC MED SCI, V18, P563
   Nadri S., 2016, J MICROENCAPSUL, P1
   Namdari M, 2016, CELL MOL BIOL, V62, P1, DOI 10.14715/cmb/2016.62.11.1
   Namdari M, 2011, CARDIOVASC J AFR, V22, P67, DOI CVJ-21.022
   Namdari M, 2016, BIOMED PHARMACOTHER, V84, P1179, DOI 10.1016/j.biopha.2016.10.058
   Namdari P, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1618-z
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Pons J, 2008, BIOCHEM BIOPH RES CO, V376, P419, DOI 10.1016/j.bbrc.2008.09.003
   Pourrajab F, 2014, INT J CARDIOL, V173, P12, DOI 10.1016/j.ijcard.2014.02.006
   Ripa RS, 2006, EUR HEART J, V27, P1785, DOI 10.1093/eurheartj/ehl117
   Ruvinov E., 2012, SYNTH LECT TISSUE EN, V4, P1
   Seidi K., 2014, J AIDS CLIN RES, V2014
   Shah Vinod K, 2007, Indian Heart J, V59, P482
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Srivastava D, 2012, ANN NY ACAD SCI, V1270, P66, DOI 10.1111/j.1749-6632.2012.06696.x
   Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C
   Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053
   Tolabi T., 2012, IJCCN, V5, P53
   Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   Vahabi S., 2016, BIOMED PHARMACOTHER
   Vahabi S, 2017, BIOMED PHARMACOTHER, V86, P1, DOI 10.1016/j.biopha.2016.11.137
   Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang SG, 2005, SEMIN CANCER BIOL, V15, P413, DOI 10.1016/j.semcancer.2005.05.007
   Zisa D, 2009, BIOCHEM BIOPH RES CO, V390, P834, DOI 10.1016/j.bbrc.2009.10.058
NR 82
TC 7
Z9 7
U1 2
U2 33
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD MAR
PY 2017
VL 87
BP 37
EP 45
DI 10.1016/j.biopha.2016.12.071
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA EM7XM
UT WOS:000395525600005
PM 28040596
DA 2018-12-27
ER

PT J
AU Abdullah, RM
   Zukarnain, ZA
   Iqbal, R
AF Abdullah, Radhwan M.
   Zukarnain, Zuriati Ahmad
   Iqbal, Rizwan
TI RETRACTED: Improved fast handover method for multiple node by using
   mobile nodes guide (Retracted article. See vol. 69, pg. 413, 2018)
SO TELECOMMUNICATION SYSTEMS
LA English
DT Article; Retracted Publication
DE Fast mobile IPv6; Mobile IPv6; Handover operation; Mobility management;
   Performance analysis
ID ROUTE OPTIMIZATION; NETWORKS; PERFORMANCE; MANAGEMENT; IP
AB The fast mobile internet protocol version 6 (FMIPv6) was suggested as a fast handover mechanism over the mobile wireless Internets in order to reduce the handover latency of a mobile node (MN). However, FMIPv6 was originally designed to deal with single MN's. In mobile wireless Internet, a multiple MNs may do a handover at the same time as a consequence of its movement from one network to another new one. This will therefore lead to the bandwidth waste and low handover performance. This paper intends to propose a multiple handover-based mobile node (MHB-MN) control method and an enhanced FMIPv6 mechanism in order to resolve the abovementioned problem. The proposal of such an MHB-MN method aims at having one mobile node work as a guide for a group of neighboring MNs. This means that the guide of MN prepares itself for a handover before actually taking the initial steps of the actual handover operation. Based on obtained results, it is plainly observable that by MHB-MN method, the handover initiation time, handover latency and handover control messages can be reduced compared to those of FMIPv6. Furthermore, the contention of the wireless channel for multiple MNs can be improved by the use of fewer control messages. Finally, the paper introduces an analytical model to show that by enabling the MHB-MN method and enhancing the FMIPv6 method, a multiple of nodes can perform rapid handover processes with low handover latency compared to that of the FMIPv6 technique.
C1 [Abdullah, Radhwan M.; Zukarnain, Zuriati Ahmad; Iqbal, Rizwan] Univ Putra Malaysia, Fac Comp Sci & Informat Technol, Serdang 43400, Selangor De, Malaysia.
RP Abdullah, RM (reprint author), Univ Putra Malaysia, Fac Comp Sci & Informat Technol, Serdang 43400, Selangor De, Malaysia.
EM radhwan_mohamed@upm.edu.my; Zuriati@fsktm.upm.edu.my;
   rizwaniqbal@yahoo.com
CR Alnas M, 2010, J SYST SOFTWARE, V83, P1644, DOI 10.1016/j.jss.2010.03.080
   Caldeira JMLP, 2015, TELECOMMUN SYST, V60, P119, DOI 10.1007/s11235-014-9926-z
   Caldeira JMLP, 2013, IEEE SENS J, V13, P4339, DOI 10.1109/JSEN.2013.2267729
   Calderon M, 2006, IEEE J SEL AREA COMM, V24, P1702, DOI 10.1109/JSAC.2006.875109
   Chang IC, 2009, IEEE T VEH TECHNOL, V58, P2942, DOI 10.1109/TVT.2008.2010944
   Chen WE, 2013, IET NETW, V2, P115, DOI 10.1049/iet-net.2012.0084
   Chen X, 2010, PROCEEDINGS OF 2010 INTERNATIONAL CONFERENCE ON RISK AND RELIABILITY MANAGEMENT, P19
   Chung-Ming Huang, 2008, 2008 Fourth Advanced International Conference on Telecommunications (AICT '08), P277, DOI 10.1109/AICT.2008.43
   Devarapalli V., 2005, RFC3963 IETF
   Dimopoulou L, 2005, IEEE NETWORK, V19, P14, DOI 10.1109/MNET.2005.1453394
   Huang CM, 2006, IEEE J SEL AREA COMM, V24, P1682, DOI 10.1109/JSAC.2006.875113
   Jaron A, 2012, IET NETW, V1, P229, DOI 10.1049/iet-net.2011.0009
   Johnson D., 2004, 3775 RFC NOK RES CTR, P3775
   Koodli R., 2009, 5568 RFC
   Lee JH, 2011, IET COMMUN, V5, P2149, DOI 10.1049/iet-com.2011.0015
   Li CS, 2012, IET NETW, V1, P199, DOI 10.1049/iet-net.2012.0144
   Lim HJ, 2009, IEEE T MOBILE COMPUT, V8, P1554, DOI 10.1109/TMC.2009.76
   Ma WC, 2004, IEEE J SEL AREA COMM, V22, P664, DOI 10.1109/JSAC.2004.825968
   Mohanty S, 2007, IEEE T MOBILE COMPUT, V6, P731, DOI 10.1109/TMC.2007.1040
   Moore N., 2006, 4429 IETF RFC
   Oliveira LML, 2011, INT J COMMUN SYST, V24, P1445, DOI 10.1002/dac.1228
   Pack S., 2007, FAST HANDOFF SUPPORT, V9, P212
   Pack S, 2009, IEEE T VEH TECHNOL, V58, P3627, DOI 10.1109/TVT.2009.2015328
   Petander H, 2006, IEEE J SEL AREA COMM, V24, P1671, DOI 10.1109/JSAC.2006.875116
   Radhwan M. A., 2013, ARAB J SCI ENG, V39, P851
   Ramani I, 2005, IEEE INFOCOM SER, P675
   Ruiz P, 2010, 2010 International Conference on High Performance Computing & Simulation (HPCS 2010), P249, DOI 10.1109/HPCS.2010.5547129
   Schmidt TC, 2005, TELECOMMUN SYST, V30, P123, DOI 10.1007/s11235-005-4321-4
   Shahriar AZM, 2010, IEEE COMMUN SURV TUT, V12, P24, DOI 10.1109/SURV.2010.020110.00087
   Silva R., 2011, 2011 IEEE Symposium on Computers and Communications (ISCC 2011), P451, DOI 10.1109/ISCC.2011.5983878
   Silva R, 2012, COMPUT COMMUN, V35, P1200, DOI 10.1016/j.comcom.2012.03.005
   Soliman H., 2008, 5380 IETF RFC
   Tseng YC, 2002, WIREL NETW, V8, P153, DOI 10.1023/A:1013763825347
   Wang LL, 2013, J INTERNET TECHNOL, V14, P723, DOI 10.6138/JIT.2013.14.5.01
   Yan ZW, 2010, J INTERNET TECHNOL, V11, P1
   Yen YS, 2013, TELECOMMUN SYST, V52, P461, DOI 10.1007/s11235-011-9448-x
NR 36
TC 2
Z9 2
U1 1
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1018-4864
EI 1572-9451
J9 TELECOMMUN SYST
JI Telecommun. Syst.
PD MAR
PY 2017
VL 64
IS 3
BP 429
EP 438
DI 10.1007/s11235-016-0183-1
PG 10
WC Telecommunications
SC Telecommunications
GA EL0QV
UT WOS:000394327800001
DA 2018-12-27
ER

PT J
AU Azeem, T
   Abid, SA
   Ahmad, W
   Aslam, A
   Sohail, ML
   Jaleel, S
   Umar, S
AF Azeem, T.
   Abid, S. A.
   Ahmad, W.
   Aslam, A.
   Sohail, M. L.
   Jaleel, S.
   Umar, S.
TI RETRACTED: Host immune responses and vaccination against avian
   pathogenic Escherichia coli(Retracted article. See vol 73, pg 697, 2017)
SO WORLDS POULTRY SCIENCE JOURNAL
LA English
DT Article; Retracted Publication
DE avian pathogenic E. coli; virulence; vaccine; vaccination; chicken
ID COLI O78 STRAIN; ESCHERICHIA-COLI; SALMONELLA-ENTERITIDIS; PERITONITIS
   SYNDROME; ANTIBODY-RESPONSES; RESPIRATORY-TRACT; VIRULENCE; CHICKEN;
   COLIBACILLOSIS; POULTRY
AB Avian pathogenic Escherichia coli (APEC) is one of the most economically damaging diseases affecting the poultry industry. This group of extra-intestinal E. coli causes a variety of clinical conditions including air-sacculitis and cellulitis. The economic impact of APEC is mainly due to mortality, slower growth rates and carcass downgrading. In commercial broiler operations, APEC infections are controlled indirectly by vaccination against other respiratory diseases and minimising stress conditions, and directly by administration of antimicrobial agents to suppress symptoms in infected flocks. Several studies have demonstrated that the most common virulence factors studied in APEC are rarely present in the same isolate, showing that APEC strains constitute a heterogeneous group. Different isolates may harbour different associations of virulence factors, each able to induce colibacillosis. Despite its economical relevance, the pathogenesis of colibacillosis is poorly understood. The O antigen, a component of the surface lipopolysaccharide, has been identified as a promising vaccine target. With the availability of a novel bioconjugation technology it is expected that multivalent O antigen conjugate vaccines can be produced on an industrial scale. Despite the potential for developing an efficacious vaccine to combat this economically important poultry disease, several obstacles hinder such efforts. These include cost, vaccine delivery method and timing of vaccination. The present discusses current knowledge on APEC virulence, host response to infection and various attempts to develop an effective vaccine
C1 [Azeem, T.; Abid, S. A.; Ahmad, W.; Aslam, A.] Univ Vet & Anim Sci, Dept Pathol, Lahore, Pakistan.
   [Sohail, M. L.] Univ Vet & Anim Sci, Dept Clin Med & Surg, Lahore, Pakistan.
   [Jaleel, S.] Coll Vet & Anim Sci, Dept Pathobiol, Jhang, Pakistan.
   [Umar, S.] PMAS Arid Agr Univ, Dept Pathobiol, Rawalpindi, Pakistan.
   [Umar, S.] Natl Vet Sch Toulouse, Toulouse, France.
RP Abid, SA (reprint author), Univ Vet & Anim Sci, Dept Pathol, Lahore, Pakistan.
EM salmanhashmi313@yahoo.com
CR Antao EM, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-22
   ARP LH, 1980, AVIAN DIS, V24, P808, DOI 10.2307/1589958
   Bertrand N, 2010, INFECT IMMUN, V78, P5324, DOI 10.1128/IAI.00452-10
   Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08
   Chouikha I, 2006, J BACTERIOL, V188, P977, DOI 10.1128/JB.188.3.977-987.2006
   CVMP, 2012, COLI EMEA V C 002007
   de Paiva JB, 2015, VET MICROBIOL, V175, P123, DOI 10.1016/j.vetmic.2014.11.015
   DEB JR, 1978, RES VET SCI, V24, P308, DOI 10.1016/S0034-5288(18)33039-X
   Dho-Moulin M, 1999, VET RES, V30, P299
   Dozois CM, 2000, INFECT IMMUN, V68, P4145, DOI 10.1128/IAI.68.7.4145-4154.2000
   Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652
   Dziva F, 2013, INFECT IMMUN, V81, P838, DOI 10.1128/IAI.00585-12
   EMERY DA, 2000, Patent No. 6027736
   Ewers C, 2004, VET MICROBIOL, V104, P91, DOI 10.1016/j.vetmic.2004.09.008
   Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08
   Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102
   Filho T.F., 2013, AVIAN DIS, V57, P671, DOI DOI 10.1637/10456-112612-RESNOTE.1
   Flechard M, 2012, J BACTERIOL, V194, P4550, DOI 10.1128/JB.00089-12
   FROMMER A, 1994, AVIAN PATHOL, V23, P425, DOI 10.1080/03079459408419013
   GAO Q., 2012, BMC MICROBIOL, V12, P1
   Gao QQ, 2015, INFECT GENET EVOL, V30, P267, DOI 10.1016/j.meegid.2014.12.038
   Gao QQ, 2015, INFECT GENET EVOL, V29, P180, DOI 10.1016/j.meegid.2014.11.022
   Ghunaim H, 2014, VET MICROBIOL, V172, P13, DOI 10.1016/j.vetmic.2014.04.019
   GROSS WB, 1957, AM J VET RES, V18, P724
   Guabiraba R, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv118
   Herren CD, 2006, INFECT IMMUN, V74, P4900, DOI 10.1128/IAI.00412-06
   Horn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041031
   Horne SM, 2000, AVIAN DIS, V44, P179, DOI 10.2307/1592522
   Ideses D, 2005, J BACTERIOL, V187, P8164, DOI 10.1128/JB.187.23.8164-8171.2005
   Jansen CA, 2010, DEV COMP IMMUNOL, V34, P759, DOI 10.1016/j.dci.2010.02.009
   Kariyawasam S, 2004, AVIAN DIS, V48, P287, DOI 10.1637/7093
   Kariyawasam S, 2004, VET MICROBIOL, V98, P273, DOI 10.1016/j.vetmic.2003.10.022
   Kariyawasam S, 2002, AVIAN DIS, V46, P668, DOI 10.1637/0005-2086(2002)046[0668:SAMART]2.0.CO;2
   Kariyawasam S, 2009, AVIAN DIS, V53, P255, DOI 10.1637/8519-111708-Reg.1
   Keestra AM, 2010, J IMMUNOL, V185, P460, DOI 10.4049/jimmunol.0901921
   Kogut MH, 2003, J INTERF CYTOK RES, V23, P319, DOI 10.1089/107999003766628160
   Kogut MH, 2001, INFLAMMATION, V25, P7, DOI 10.1023/A:1007067426499
   Kogut Michael H., 2012, Frontiers in Genetics, V3, P121, DOI 10.3389/fgene.2012.00121
   KWAGA JKP, 1994, INFECT IMMUN, V62, P3766
   La Ragione RM, 2000, J MED MICROBIOL, V49, P327, DOI 10.1099/0022-1317-49-4-327
   Lamarche MG, 2005, INFECT IMMUN, V73, P4138, DOI 10.1128/IAI.73.7.4138-4145.2005
   Landman WJM, 2014, AVIAN PATHOL, V43, P345, DOI 10.1080/03079457.2014.935291
   Landman WJM, 2013, AVIAN PATHOL, V42, P157, DOI 10.1080/03079457.2013.775694
   Li G, 2008, MICROBIOL-SGM, V154, P1082, DOI 10.1099/mic.0.2007/015784-0
   Li GW, 2010, INFECT IMMUN, V78, P898, DOI 10.1128/IAI.00513-09
   Lowenthal JW, 2013, DEV COMP IMMUNOL, V41, P307, DOI 10.1016/j.dci.2013.07.012
   Lymberopoulos MH, 2006, J BACTERIOL, V188, P6449, DOI 10.1128/JB.00453-06
   Lynne AM, 2012, AVIAN DIS, V56, P192, DOI 10.1637/9861-072111-Reg.1
   Lynne AM, 2006, AVIAN DIS, V50, P273, DOI 10.1637/7441-092105R.1
   Ma JL, 2014, INFECT IMMUN, V82, P3867, DOI 10.1128/IAI.01769-14
   MELAMED D, 1991, AVIAN DIS, V35, P17, DOI 10.2307/1591289
   Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003
   Mellata M, 2010, INFECT IMMUN, V78, P1528, DOI 10.1128/IAI.00981-09
   Mu XH, 2013, J BACTERIOL, V195, P5064, DOI 10.1128/JB.00628-13
   Naveh M.W., 1985, 35 W POULTR DIS C DA
   NIVAS S, 1985, P P C RES WORK AN DI
   Nolan LK, 2003, VET RES COMMUN, V27, P101, DOI 10.1023/A:1022854902700
   Nolan LK, 2008, DIS POULTRY, P691
   Parreira VR, 2003, INFECT IMMUN, V71, P5087, DOI 10.1128/IAI.71.9.5087-5096.2003
   Peighambari SM, 2002, AVIAN DIS, V46, P287, DOI 10.1637/0005-2086(2002)046[0287:SIAEOT]2.0.CO;2
   Poolman JT, 2016, J INFECT DIS, V213, P6, DOI 10.1093/infdis/jiv429
   Rodriguez-Siek KE, 2005, VET RES, V36, P241, DOI 10.1051/vetres:2004057
   Roland K, 1999, AVIAN DIS, V43, P429, DOI 10.2307/1592640
   Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528
   Sabri M, 2008, INFECT IMMUN, V76, P601, DOI 10.1128/IAI.00789-07
   Sadeyen JR, 2015, VET RES, V46, DOI 10.1186/s13567-014-0132-5
   Salehi TZ, 2012, BRAZ J MICROBIOL, V43, P363, DOI [10.1590/S1517-838220120001000043, 10.1590/S1517-83822012000100043]
   Sandford Erin E, 2012, Results Immunol, V2, P44, DOI 10.1016/j.rinim.2012.02.003
   Sperling B, 2015, DEV COMP IMMUNOL, V50, P121, DOI 10.1016/j.dci.2015.02.004
   Stacy AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086565
   Straub C, 2013, DEV COMP IMMUNOL, V41, P324, DOI 10.1016/j.dci.2013.03.013
   Umar S, 2016, WORLD POULTRY SCI J, V72, P833, DOI 10.1017/S0043933916000738
   Umar S, 2016, WORLD POULTRY SCI J, V72, P49, DOI 10.1017/S0043933915002706
   UMAR S., 2017, WORLDS POUL IN PRESS, V73, pxx
   Vandemaele F, 2006, AVIAN PATHOL, V35, P238, DOI 10.1080/03079450600710997
   Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156
   Zhuang QY, 2014, AVIAN DIS, V58, P297, DOI 10.1637/10709-110113-ResNote.1
NR 77
TC 1
Z9 1
U1 6
U2 20
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0043-9339
EI 1743-4777
J9 WORLD POULTRY SCI J
JI Worlds Poult. Sci. J.
PD MAR
PY 2017
VL 73
IS 1
BP 29
EP 44
DI 10.1017/S0043933916000866
PG 16
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA EK2HK
UT WOS:000393748200004
DA 2018-12-27
ER

PT J
AU Roudaki, FS
   Elahi, AS
   Ghoranneviss, M
AF Roudaki, F. S.
   Elahi, A. Salar
   Ghoranneviss, M.
TI RETRACTED: Mapping models for tokamak magnetic configurations with
   non-axisymmetric MHD and RMP perturbations (Retracted article. See vol.
   43, pg. 2528, 2018)
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article; Retracted Publication
DE Tokamak; Hydrogen energy; Magnetic configurations
ID PLASMA HORIZONTAL POSITION; IR-T1 TOKAMAK; RUNAWAY ELECTRONS; DESIGN;
   SYSTEM; ENERGY
AB Magnetic field lines in plasmas can be regarded as trajectories of Hamiltonian systems. For the field line tracing two methods can be applied: i) integration of the trajectory and ii) mapping of the trajectory. The latter is a modern technique for the Hamiltonian system. It is more than an order of magnitude, faster than the integration. A properly chosen mapping procedure always conserves the main flux preserving property of the magnetic field, which is important for a correct reprOduction of the long term behavior of field lines in stochastic regions. Simplistic maps form any Hamiltonian problems have been extensively used during the last four decades. This paper is devoted to the study of some mapping models for the study of magnetic configurations in tokamaks which exhibit non-axisymmetric MHD or RMP perturbations. The destruction of a transport barrier is described using the transmissivity between the chaotic zones situated of its both sides. (C) 2016 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [Roudaki, F. S.; Elahi, A. Salar; Ghoranneviss, M.] Islamic Azad Univ, Plasma Phys Res Ctr, Sci & Res Branch, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Plasma Phys Res Ctr, Sci & Res Branch, Tehran, Iran.
EM Salari_phy@yahoo.com
CR Agah KM, 2015, J X-RAY SCI TECHNOL, V23, P267, DOI 10.3233/XST-150486
   Amerian Z, 2016, INT J THERM SCI, V110, P299, DOI 10.1016/j.ijthermalsci.2016.07.014
   Araghi Farnaz, 2013, J THEORETICAL APPL P, V7, P1
   BALESCU R, 1988, TRANSPORT PROCESSES
   Constantinescu A, 2008, NUCL FUSION, V48, DOI 10.1088/0029-5515/48/2/024017
   Dorranian O, 2014, J THEOR APPL PHYS, V8, P1
   Elahi AS, 2017, INT J HYDROGEN ENERG, V42, P1048, DOI 10.1016/j.ijhydene.2016.07.273
   Ghanbari MR, 2016, J FUSION ENERG, V35, P180, DOI 10.1007/s10894-015-9992-6
   Habibian J, 2016, INT J HYDROGEN ENERG, V41, P15266, DOI 10.1016/j.ijhydene.2016.06.178
   Kafi M, 2016, J SYNCHROTRON RADIAT, V23, P1227, DOI 10.1107/S1600577516010262
   Manouchehrizadeh M, 2013, J THEOR APPL PHYS, V7, P1
   Naghidokht A, 2016, INT J HYDROGEN ENERG, V41, P15272, DOI 10.1016/j.ijhydene.2016.07.026
   Naghidokht A, 2016, FUSION ENG DES, V107, P82, DOI 10.1016/j.fusengdes.2016.04.032
   Naghidokht A, 2016, J FUSION ENERG, V35, P415, DOI 10.1007/s10894-015-0051-0
   Naghidokht A, 2016, IEEE T NUCL SCI
   Roudaki FS, 2015, J FUSION ENERG, V34, P911, DOI 10.1007/s10894-015-9898-3
   Sabetkar A, 2015, J THEOR APPL PHYS, V9, P141, DOI 10.1007/s40094-015-0172-x
   Solar Elahi A, 2016, J XRAY SCI TECHN AUG
NR 18
TC 2
Z9 2
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD FEB 23
PY 2017
VL 42
IS 8
BP 5207
EP 5212
DI 10.1016/j.ijhydene.2016.09.189
PG 6
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA EY3DU
UT WOS:000403852600048
DA 2018-12-27
ER

PT J
AU Sookhak, M
   Gani, A
   Khan, MK
   Buyya, R
AF Sookhak, Mehdi
   Gani, Abdullah
   Khan, Muhammad Khurram
   Buyya, Rajkumar
TI RETRACTED: Dynamic remote data auditing for securing big data storage in
   cloud computing (Retracted article. See vol. 444, pg. 187, 2018)
SO INFORMATION SCIENCES
LA English
DT Article; Retracted Publication
DE Cloud computing; Remote data auditing; Data dynamic; Data integrity; Big
   data storage
ID SOFTWARE PROTECTION; SCHEME
AB Cloud computing has emerged as a new computing paradigm that offers great potential for storing data remotely. Presently, many organizations have reduced the burden of local data storage and maintenance by outsourcing data storage to the cloud. However, integrity and security of the outsourced data continues to be a matter of major concern for data owners due to the lack of control and physical possession over the data. To deal with this problem, researchers have proposed remote data auditing (RDA) techniques. However, the majority of existing RDA techniques is only applicable for static archived data and is not applicable for auditing or dynamically updating the outsourced data. They are also not applicable to big data storage because of the high computational overhead on the auditor. In this paper, we propose an efficient RDA technique based on algebraic signature properties for a cloud storage system that incurs minimum computational and communication costs. We also present the design of a new data structure-Divide and Conquer Table (DCT) that can efficiently support dynamic data operations such as append, insert, modify, and delete. Our proposed data structure can be applied for large-scale data storage and will incur minimum computational cost. A comparison between our proposed method and other state-of-the-art RDA techniques shows that our method is secure and highly efficient in reducing the computational and communication costs on the server and the auditor. (C) 2015 Elsevier Inc. All rights reserved.
C1 [Sookhak, Mehdi; Gani, Abdullah] Univ Malaya, Ctr Mobile Cloud Comp Res C4MCC, Kuala Lumpur, Malaysia.
   [Khan, Muhammad Khurram] King Saud Univ, Ctr Excellence Informat Assurance CoEIA, Riyadh 12372, Saudi Arabia.
   [Buyya, Rajkumar] Univ Melbourne, Dept Comp & Informat Syst, Melbourne, Vic 3010, Australia.
RP Sookhak, M (reprint author), Univ Malaya, Ctr Mobile Cloud Comp Res C4MCC, Kuala Lumpur, Malaysia.
EM m.sookhak@ieee.org; abdullahgani@ieee.org; mkhurram@ksu.edu.sa;
   rbuyya@unimelb.edu.au
RI KHAN, MUHAMMAD KHURRAM/E-4836-2014; Gani, Abdullah/C-2888-2009; Buyya,
   Rajkumar/C-3424-2009
OI KHAN, MUHAMMAD KHURRAM/0000-0001-6636-0533; Gani,
   Abdullah/0000-0002-4388-020X; Buyya, Rajkumar/0000-0001-9754-6496;
   Sookhak, Mehdi/0000-0001-5822-3432
FU Malaysian Ministry of Higher Education under the University of Malaya
   High Impact Research Grant [UM.C/ HIR/ MOHE/FCSIT/03, CR010-2014];
   Deanship of Scientific Research at King Saud University [PRG-1436-16];
   Melbourne-Chindia Cloud Computing (MC3) Research Network; Australian
   Research Council
FX This work is carried out as part of the Mobile Cloud Computing research
   project funded by the Malaysian Ministry of Higher Education under the
   University of Malaya High Impact Research Grant, reference number UM.C/
   HIR/ MOHE/FCSIT/03, and reference number CR010-2014. We extend our
   sincere appreciation to the Deanship of Scientific Research at King Saud
   University for its funding to Prolific Research Group (PRG-1436-16).
   This collaboration is partially supported by Melbourne-Chindia Cloud
   Computing (MC3) Research Network and Future Fellowship of Australian
   Research Council.
CR Ali M, 2015, IEEE SYSTEMS J, VPP, P1, DOI [10.1109/JSYST.2014.2379646, DOI 10.1109/JSYST.2014.2379646.R.D.PIETR0]
   Ali M, 2015, INFORM SCIENCES, V305, P357, DOI 10.1016/j.ins.2015.01.025
   [Anonymous], 2011, DAT BREACH YEAR REV
   Armbrust M, 2010, COMMUN ACM, V53, P50, DOI 10.1145/1721654.1721672
   Armerding T., 2012, COS SECURITY RISK CS
   Ateniese G., 2008, P 4 INT C SEC PRIV C, P1, DOI DOI 10.1145/1460877.1460889
   Ateniese G, 2007, CCS'07: PROCEEDINGS OF THE 14TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P598
   Ateniese G, 2011, ACM T INFORM SYST SE, V14, DOI 10.1145/1952982.1952994
   Boneh D, 2003, LECT NOTES COMPUT SC, V2656, P416
   Boneh D., 2004, P 11 ACM C COMP COMM, P168
   Broder A., 1993, SEQUENCES, P143
   Buyya R, 2009, FUTURE GENER COMP SY, V25, P599, DOI 10.1016/j.future.2008.12.001
   Cash D, 2012, IACR CRYPTOLOGY EPRI, P550
   Catalano D, 2013, LECT NOTES COMPUT SC, V7785, P680, DOI 10.1007/978-3-642-36594-2_38
   Chen B., 2010, P ACM WORKSH CLOUD C, P31
   Chen K, 2011, IEEE NETWORK, V25, P6, DOI 10.1109/MNET.2011.5958002
   Du W., 2010, 24 INT C DISTR COMP, P30
   Erway CC, 2015, ACM T INFORM SYST SE, V17, DOI 10.1145/2699909
   Erway CC, 2009, CCS'09: PROCEEDINGS OF THE 16TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P213
   Goldreich O, 1996, J ACM, V43, P431, DOI 10.1145/233551.233553
   Goodrich MT, 2001, DISCEX'01: DARPA INFORMATION SURVIVABILITY CONFERENCE & EXPOSITION II, VOL II, PROCEEDINGS, P68, DOI 10.1109/DISCEX.2001.932160
   Huang Q, 2011, INT J INF SECUR, V10, P373, DOI 10.1007/s10207-011-0146-1
   Impagliazzo R., 1989, Proceedings of the Twenty First Annual ACM Symposium on Theory of Computing, P12, DOI 10.1145/73007.73009
   Jiang T., 2015, IEEE T COMPUT, P1
   Juels A, 2007, CCS'07: PROCEEDINGS OF THE 14TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P584
   Khan AN, 2014, J SUPERCOMPUT, V68, P624, DOI 10.1007/s11227-013-1055-z
   Krzywiecki Lukasz, 2012, Network and System Security. 6th International Conference, NSS 2012. Proceedings, P305, DOI 10.1007/978-3-642-34601-9_23
   Li JH, 2015, IEEE ASME INT C ADV, P1, DOI 10.1109/AIM.2015.7222499
   Lifei Wei, 2010, Proceedings 2010 30th International Conference on Distributed Computing Systems Workshops (ICDCS 2010 Workshops), P52, DOI 10.1109/ICDCSW.2010.36
   Litwin W, 2004, PROC INT CONF DATA, P412, DOI 10.1109/ICDE.2004.1320015
   Merkle R. C., 1980, Proceedings of the 1980 Symposium on Security and Privacy, P122
   Nurmi D, 2009, CCGRID: 2009 9TH IEEE INTERNATIONAL SYMPOSIUM ON CLUSTER COMPUTING AND THE GRID, P124, DOI 10.1109/CCGRID.2009.93
   Plank J. S., 2005, P 4 USENIX C FIL STO, P1
   PUGH W, 1990, COMMUN ACM, V33, P668, DOI 10.1145/78973.78977
   Rahimi MR, 2014, MOBILE NETW APPL, V19, P133, DOI 10.1007/s11036-013-0477-4
   Rahimi MR, 2013, IEEE INT CONF CLOUD, P75, DOI 10.1109/CLOUD.2013.100
   Rahimi MR, 2012, INT CONF UTIL CLOUD, P83, DOI 10.1109/UCC.2012.25
   Savas E, 2010, IEEE CIRC SYST MAG, V10, P40, DOI 10.1109/MCAS.2010.936785
   Schwarz T., 2006, 26 IEEE INT C DISTR, P12
   Sebe F, 2008, IEEE T KNOWL DATA EN, V20, P1034, DOI 10.1109/TKDE.2007.190647
   Shacham H, 2008, LECT NOTES COMPUT SC, V5350, P90, DOI 10.1007/978-3-540-89255-7_7
   Shamshirband S, 2013, ENG APPL ARTIF INTEL, V26, P2105, DOI 10.1016/j.engappai.2013.04.010
   Sookhak M, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2764465
   Sookhak M, 2014, J NETW COMPUT APPL, V43, P121, DOI 10.1016/j.jnca.2014.04.011
   Wang BY, 2015, IEEE T SERV COMPUT, V8, P92, DOI 10.1109/TSC.2013.2295611
   [王成玲 Wang Chengling], 2012, [火工品, Initiators & Pyrotechnics], P1
   Wang C, 2012, IEEE T SERV COMPUT, V5, P220, DOI 10.1109/TSC.2011.24
   Wang C, 2010, IEEE NETWORK, V24, P19, DOI 10.1109/MNET.2010.5510914
   Wang H., 2012, IEEE T SERV COMPUT, P1
   Wang L, 2014, INT CON DISTR COMP S, P248, DOI 10.1109/ICDCS.2014.33
   Wang L, 2014, IEEE J SEL AREA COMM, V32, P4, DOI 10.1109/JSAC.2014.140102
   Wang QA, 2011, IEEE T PARALL DISTR, V22, P847, DOI 10.1109/TPDS.2010.183
   Wei GY, 2010, J SUPERCOMPUT, V54, P252, DOI 10.1007/s11227-009-0318-1
   Wei LF, 2014, INFORM SCIENCES, V258, P371, DOI 10.1016/j.ins.2013.04.028
   Wu QH, 2009, LECT NOTES COMPUT SC, V5479, P153
   Xu F, 2014, P IEEE, V102, P11, DOI 10.1109/JPROC.2013.2287711
   Yang K, 2013, IEEE T PARALL DISTR, V24, P1717, DOI 10.1109/TPDS.2012.278
   Yu J, 2015, IEEE T INF FOREN SEC, V10, P1167, DOI 10.1109/TIFS.2015.2400425
   Yu ZW, 2012, SOFTWARE PRACT EXPER, V42, P409, DOI 10.1002/spe.1088
   Yuan JW, 2015, IEEE T INF FOREN SEC, V10, P1717, DOI 10.1109/TIFS.2015.2423264
   Zhang JH, 2008, INFORM SCIENCES, V178, P766, DOI 10.1016/j.ins.2007.07.005
   Zhang X, 2014, IEEE ACM T NETWORK, V22, P1218, DOI 10.1109/TNET.2013.2274662
   Zhang Y, 2012, IACR CRYPTOL EPRINT, P291
   Zhou J, 2015, INFORM SCIENCES, V314, P255, DOI 10.1016/j.ins.2014.09.003
NR 64
TC 35
Z9 37
U1 9
U2 136
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0020-0255
EI 1872-6291
J9 INFORM SCIENCES
JI Inf. Sci.
PD FEB 20
PY 2017
VL 380
BP 101
EP 116
DI 10.1016/j.ins.2015.09.004
PG 16
WC Computer Science, Information Systems
SC Computer Science
GA EF7HU
UT WOS:000390501500007
DA 2018-12-27
ER

PT J
AU Wolfe, AR
   Ernlund, A
   McGuinness, W
   Lehmann, C
   Carl, K
   Balmaceda, N
   Neufeld, KL
AF Wolfe, Andy R.
   Ernlund, Amanda
   McGuinness, William
   Lehmann, Carl
   Carl, Kaitlyn
   Balmaceda, Nicole
   Neufeld, Kristi L.
TI RETRACTED: Suppression of intestinal tumorigenesis in Apc mutant mice
   upon Musashi-1 deletion (Retracted article. See vol. 130, pg. 3776-813,
   2017)
SO JOURNAL OF CELL SCIENCE
LA English
DT Article; Retracted Publication
DE Musashi-1; Msi-1; Adenomatous polyposis coli; Apc; Intestinal
   tumorigenesis; Wnt; Notch
ID STEM-CELL MARKER; BINDING PROTEIN MUSASHI-1; MESSENGER-RNA TRANSLATION;
   IN-VIVO; ADENOMATOUS POLYPOSIS; EXPRESSION; WNT; LGR5; IDENTIFICATION;
   COLON
AB Therapeutic strategies based on a specific oncogenic target are better justified when elimination of that particular oncogene reduces tumorigenesis in a model organism. One such oncogene, Musashi-1 (Msi-1), regulates translation of target mRNAs and is implicated in promoting tumorigenesis in the colon and other tissues. Msi-1 targets include the tumor suppressor adenomatous polyposis coli (Apc), a Wnt pathway antagonist lost in similar to 80% of all colorectal cancers. Cell culture experiments have established that Msi-1 is a Wnt target, thus positioning Msi-1 and Apc as mutual antagonists in a mutually repressive feedback loop. Here, we report that intestines from mice lacking Msi-1 display aberrant Apc and Msi-1 mutually repressive feedback, reduced Wnt and Notch signaling, decreased proliferation, and changes in stem cell populations, features predicted to suppress tumorigenesis. Indeed, mice with germline Apc mutations (Apc(Min)) or with the Apc(1322T) truncation mutation have a dramatic reduction in intestinal polyp number when Msi-1 is deleted. Taken together, these results provide genetic evidence that Msi-1 contributes to intestinal tumorigenesis driven by Apc loss, and validate the pursuit of Msi-1 inhibitors as chemo-prevention agents to reduce tumor burden.
C1 [Wolfe, Andy R.; Ernlund, Amanda; McGuinness, William; Lehmann, Carl; Carl, Kaitlyn; Balmaceda, Nicole; Neufeld, Kristi L.] Univ Kansas, Dept Mol Biosci, 7049 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA.
RP Neufeld, KL (reprint author), Univ Kansas, Dept Mol Biosci, 7049 Haworth Hall,1200 Sunnyside Ave, Lawrence, KS 66045 USA.
EM klneuf@ku.edu
OI /0000-0002-9670-5907
FU Higuchi Biosciences Center, a University of Kansas General Research
   Fund; Kansas Masonic Foundation Pilot Research Program of the KU Cancer
   Center [P30CA168524]; University of Kansas Research Investment Council;
   National Cancer Institute [R01CA178831]; National Institute of General
   Medical Sciences [P20 GM103418]
FX This work was supported by J.R. and Inez Jay fund of the Higuchi
   Biosciences Center, a University of Kansas General Research Fund, the
   Kansas Masonic Foundation Pilot Research Program of the KU Cancer Center
   (P30CA168524), the University of Kansas Research Investment Council, the
   National Cancer Institute (R01CA178831 to K.L.N.) and an IDeA award from
   the National Institute of General Medical Sciences (P20 GM103418).
   Deposited in PMC for release after 12 months.
CR Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200
   Arumugam K, 2012, MOL REPROD DEV, V79, P553, DOI 10.1002/mrd.22060
   Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196
   Cambuli FM, 2015, STEM CELLS, V33, P3621, DOI 10.1002/stem.2202
   Cambuli FM, 2013, STEM CELLS, V31, P2273, DOI 10.1002/stem.1428
   Gagliardi G, 2012, PATHOL RES PRACT, V208, P475, DOI 10.1016/j.prp.2012.05.015
   Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072
   Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200
   Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001
   Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384
   Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004
   Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6
   Lamlum H, 1999, NAT MED, V5, P1071
   Lan L, 2015, MOL ONCOL, V9, P1406, DOI 10.1016/j.molonc.2015.03.014
   Lewis A, 2010, GUT, V59, P1680, DOI 10.1136/gut.2009.193680
   Li N, 2015, CELL REP, V13, P2440, DOI 10.1016/j.celrep.2015.11.022
   Mach N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088515
   MacNicol MC, 2011, CELL CYCLE, V10, P39, DOI 10.4161/cc.10.1.14388
   May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621
   Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166
   Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431
   NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X
   Nishimura S, 2003, DIGEST DIS SCI, V48, P1523, DOI 10.1023/A:1024763723240
   Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951
   Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058
   Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x
   Rezza A, 2010, J CELL SCI, V123, P3256, DOI 10.1242/jcs.065284
   Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499
   Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165
   Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   SHOEMAKER AR, 1995, CANCER RES, V55, P4479
   Smith AR, 2015, ONCOTARGET, V6, P12558, DOI 10.18632/oncotarget.3726
   Spears E, 2011, J BIOL CHEM, V286, P4946, DOI 10.1074/jbc.C110.205922
   Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5
   Sureban SM, 2008, GASTROENTEROLOGY, V134, P1448, DOI 10.1053/j.gastro.2008.02.057
   Takahashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053540
   VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763
   VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047
   Wang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-75
   Zeineldin M, 2012, ONCOGENE, V31, P2423, DOI 10.1038/onc.2011.434
   Zeineldin M., 2012, BIOPROTOCOL, V2, pe292
   Zeineldin M, 2013, CANCER RES, V73, P2389, DOI 10.1158/0008-5472.CAN-12-4607
NR 43
TC 3
Z9 3
U1 4
U2 7
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD FEB 15
PY 2017
VL 130
IS 4
BP 805
EP 813
DI 10.1242/jcs.19757
PG 9
WC Cell Biology
SC Cell Biology
GA EL2NJ
UT WOS:000394456200015
PM 28082422
DA 2018-12-27
ER

PT J
AU Peng, X
   Wei, X
   Chen, TY
AF Peng, Xing
   Wei, Xian
   Chen, Tieyu
TI RETRACTED: Towards recyclable optical nitrite sensing composite
   structures: Design, synthesis, characterization and sensing performance
   (Retracted article. See vol. 208, pg. 349, 2019)
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article; Retracted Publication
DE Nitrite ion; Core-shell structure; Rhodamine probe; Emission quenching
ID FLUOROMETRIC-DETERMINATION; MAGNETIC NANOPARTICLES; WATER SAMPLES; ION;
   NITRATE; SENSOR; NANOCOMPOSITES; NITROSAMINES
AB Two site-specific nanocomposite samples were designed and prepared for nitrite sensing. A core-shell structure was applied in them, using Fe3O4 nanoparticles as core, silica molecular sieve MCM-41 as shell and two rhodamine derivatives as chemosensor, respectively. These two composite samples and their core-shell structure were investigated by electron microscopy images, N-2 adsorption/desorption, magnetic property, IR spectra and thermogravimetric analysis. Nitrite sensing performance of these two composite samples was evaluated with their emission quenching. Limit of detection was determined as 1.1 mu M. Further analysis indicated that our chemosensors followed a static sensing mechanism based on an additive reaction between NO+ and chemosensors. These two composite samples showed recyclability after being quenched by nitrite. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Peng, Xing; Chen, Tieyu] Guangxi Med Univ, Nanning 530021, Guangxi, Peoples R China.
   [Wei, Xian] Youjiang Med Univ Nationalities, Dept Pharm, Baise 533000, Guangxi, Peoples R China.
RP Chen, TY (reprint author), Guangxi Med Univ, Nanning 530021, Guangxi, Peoples R China.
EM tieyuchen362@163.com
CR AXELROD HD, 1975, ANAL CHEM, V47, P922, DOI 10.1021/ac60356a054
   Barbe C, 2004, ADV MATER, V16, P1959, DOI 10.1002/adma.200400771
   CHOI KK, 1980, ANALYST, V105, P241, DOI 10.1039/an9800500241
   Connolly D, 2001, ANAL CHIM ACTA, V441, P53, DOI 10.1016/S0003-2670(01)01068-6
   Dong YL, 2011, J NANOSCI NANOTECHNO, V11, P10387, DOI 10.1166/jnn.2011.5014
   Dujols V, 1997, J AM CHEM SOC, V119, P7386, DOI 10.1021/ja971221g
   Dyal A, 2003, J AM CHEM SOC, V125, P1684, DOI 10.1021/ja021223n
   Gimeno N, 2008, CHEM-EUR J, V14, P3006, DOI 10.1002/chem.200700412
   He L, 2011, J NANOSCI NANOTECHNO, V11, P2256, DOI 10.1166/jnn.2011.3149
   Helaleh MIH, 2000, MICROCHEM J, V64, P241, DOI 10.1016/S0026-265X(00)00018-7
   Jiao CX, 2004, TALANTA, V64, P637, DOI 10.1016/j.talanta.2004.03.052
   Kim E, 2010, ANALYST, V135, P149, DOI 10.1039/b915975d
   Kim H, 2005, J AM CHEM SOC, V127, P544, DOI 10.1021/ja047107x
   Lei BF, 2006, ADV FUNCT MATER, V16, P1883, DOI 10.1002/adfm.200500737
   LIJINSKY W, 1970, NATURE, V225, P21, DOI 10.1038/225021a0
   Liu LK, 2011, J NANOSCI NANOTECHNO, V11, P10333, DOI 10.1166/jnn.2011.5010
   Mousavi MF, 1998, TALANTA, V45, P1247, DOI 10.1016/S0039-9140(97)00240-3
   OHTA T, 1986, ANAL CHEM, V58, P3132, DOI 10.1021/ac00127a047
   Okemgbo AA, 1999, ANAL CHEM, V71, P2725, DOI 10.1021/ac990198+
   Tada DB, 2007, LANGMUIR, V23, P8194, DOI 10.1021/1a700883y
   Vishnuvardhan V, 2008, ANAL CHIM ACTA, V623, P53, DOI 10.1016/j.aca.2008.05.075
   Wang LL, 2012, SENSOR ACTUAT B-CHEM, V171, P946, DOI 10.1016/j.snb.2012.06.008
   Wang YY, 2012, LANGMUIR, V28, P1657, DOI 10.1021/la204494v
   Wang YH, 2011, RSC ADV, V1, P1294, DOI 10.1039/c1ra00488c
   Wang YH, 2010, NEW J CHEM, V34, P1946, DOI 10.1039/c0nj00039f
   Wen ZH, 2004, TALANTA, V62, P351, DOI 10.1016/j.talanta.2003.08.003
   WOLFF IA, 1972, SCIENCE, V177, P15, DOI 10.1126/science.177.4043.15
   World Health Organization (WHO), 2008, GUID DRINK WAT QUAL
   Zhang LZ, 2003, MOLECULES, V8, P207, DOI 10.3390/80100207
NR 29
TC 2
Z9 2
U1 1
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD FEB 15
PY 2017
VL 173
BP 950
EP 959
DI 10.1016/j.saa.2016.10.061
PG 10
WC Spectroscopy
SC Spectroscopy
GA EF7II
UT WOS:000390502900127
PM 27837738
DA 2018-12-27
ER

PT J
AU Pieters, M
   Barnard, SA
   Loots, DT
   Rijken, DC
AF Pieters, Marlien
   Barnard, Sunelle A.
   Loots, Du Toit
   Rijken, Dingeman C.
TI RETRACTED: The effects of residual platelets in plasma on plasminogen
   activator inhibitor-1 and plasminogen activator inhibitor-1-related
   assays (Retracted article. See vol. 13, art. e0202381, 2018)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID FIBRINOLYTIC SYSTEM; VASCULAR-DISEASE; PAI-1; ATHEROSCLEROSIS;
   THROMBOSIS; GENE
AB Due to controversial evidence in the literature pertaining to the activity of plasminogen activator inhibitor-1 in platelets, we examined the effects of residual platelets present in plasma (a potential pre-analytical variable) on various plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays. Blood samples were collected from 151 individuals and centrifuged at 352 and 1500 g to obtain plasma with varying numbers of platelet. In a follow-up study, blood samples were collected from an additional 23 individuals, from whom platelet-poor (2000 g), platelet-containing (352 g) and platelet-rich plasma (200 g) were prepared and analysed as fresh-frozen and after five defrost-refreeze cycles (to determine the contribution of in vitro platelet degradation). Plasminogen activator inhibitor-1 activity, plasminogen activator inhibitor-1 antigen, tissue plasminogen activator/plasminogen activator inhibitor-1 complex, plasma clot lysis time, beta-thromboglobulin and plasma platelet count were analysed. Platelet a-granule release (plasma beta-thromboglobulin) showed a significant association with plasminogen activator inhibitor-1 antigen levels but weak associations with plasminogen activator inhibitor-1 activity and a functional marker of fibrinolysis, clot lysis time. Upon dividing the study population into quartiles based on beta-thromboglobulin levels, plasminogen activator inhibitor-1 antigen increased significantly across the quartiles while plasminogen activator inhibitor-1 activity and clot lysis time tended to increase in the 4(th) quartile only. In the follow-up study, plasma plasminogen activator inhibitor-1 antigen was also significantly influenced by platelet count in a concentration-dependent manner. Plasma plasminogen activator inhibitor-1 antigen levels increased further after complete platelet degradation. Residual platelets in plasma significantly influence plasma plasminogen activator inhibitor-1 antigen levels mainly through release of latent plasminogen activator inhibitor-1 with limited effects on plasminogen activator inhibitor-1 activity, tissue plasminogen activator/plasminogen activator inhibitor-1 complex or plasma clot lysis time. Platelets may however also have functional effects on plasma fibrinolytic potential in the presence of high platelet counts, such as in platelet-rich plasma.
C1 [Pieters, Marlien; Barnard, Sunelle A.] North West Univ, Ctr Excellence Nutr, Potchefstroom, North West Prov, South Africa.
   [Loots, Du Toit] North West Univ, Human Metabol, Potchefstroom, North West Prov, South Africa.
   [Rijken, Dingeman C.] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands.
RP Pieters, M (reprint author), North West Univ, Ctr Excellence Nutr, Potchefstroom, North West Prov, South Africa.
EM marlien.pieters@nwu.ac.za
OI Loots, Du Toit/0000-0002-0339-6237; Pieters, Marlien/0000-0003-2849-6370
FU National Research Foundation (NRF) of South Africa [94213]; South
   African Medical Research Council
FX This work was supported by grants from the National Research Foundation
   (NRF) of South Africa (Grant UID: 94213) (http://www.nrf.ac.za) and the
   South African Medical Research Council (http://www.mrc.ac.za). Opinions
   expressed and conclusions arrived at, are those of the authors and are
   not to be attributed to the NRF. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alessi MC, 1997, DIABETES, V46, P860, DOI 10.2337/diabetes.46.5.860
   Bastard JP, 1999, BIOMED PHARMACOTHER, V53, P455, DOI 10.1016/S0753-3322(00)88103-2
   Bath PMW, 1996, BLOOD COAGUL FIBRIN, V7, P157, DOI 10.1097/00001721-199603000-00011
   Brogren H, 2004, BLOOD, V104, P3943, DOI 10.1182/blood-2004-04-1439
   Brogren H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026762
   DECLERCK PJ, 1988, BLOOD, V71, P220
   ERICKSON LA, 1984, J CLIN INVEST, V74, P1465, DOI 10.1172/JCI111559
   Gils A, 2004, CURR MED CHEM, V11, P2323, DOI 10.2174/0929867043364595
   Gurney D, 2002, AM J HEMATOL, V70, P139, DOI 10.1002/ajh.10097
   HEKMAN CM, 1985, J BIOL CHEM, V260, P11581
   JUHANVAGUE I, 1987, THROMB HAEMOSTASIS, V58, P1096
   Kamath S, 2001, EUR HEART J, V22, P1561, DOI 10.1053/euhj.2000.2515
   KRUITHOF EKO, 1988, ENZYME, V40, P113, DOI 10.1159/000469153
   Lisman T, 2005, BLOOD, V105, P1102, DOI 10.1182/blood-2004-08-3253
   Loskutoff DJ, 1999, APMIS, V107, P54, DOI 10.1111/j.1699-0463.1999.tb01526.x
   LOSKUTOFF DJ, 1990, ANN NY ACAD SCI, V598, P238, DOI 10.1111/j.1749-6632.1990.tb42296.x
   Merolla M, 2012, INT J LAB HEMATOL, V34, P81, DOI 10.1111/j.1751-553X.2011.01360.x
   Nordenhem A, 1997, SCAND J CLIN LAB INV, V57, P453, DOI 10.3109/00365519709084594
   PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x
   Peng YM, 2008, NEPHROLOGY, V13, P579, DOI 10.1111/j.1440-1797.2008.00987.x
   Rifkin DB, 1999, APMIS, V107, P80, DOI 10.1111/j.1699-0463.1999.tb01529.x
   Rijken DC, 2009, J THROMB HAEMOST, V7, P4, DOI 10.1111/j.1538-7836.2008.03220.x
   SALOMAA V, 1995, CIRCULATION, V91, P284, DOI 10.1161/01.CIR.91.2.284
   SANCHO E, 1994, EUR J BIOCHEM, V224, P125, DOI 10.1111/j.1432-1033.1994.tb20003.x
   SERIZAWA K, 1993, THROMB RES, V71, P289, DOI 10.1016/0049-3848(93)90198-W
   Smith A, 2005, CIRCULATION, V112, P3080, DOI 10.1161/CIRCULATIONAHA.105.557132
   SPRENGERS ED, 1987, BLOOD, V69, P381
NR 27
TC 4
Z9 5
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 3
PY 2017
VL 12
IS 2
AR e0171271
DI 10.1371/journal.pone.0171271
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN7DG
UT WOS:000396161700050
PM 28158230
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Pratola, MT
   Harari, O
   Bingham, D
   Flowers, GE
AF Pratola, Matthew T.
   Harari, Ofir
   Bingham, Derek
   Flowers, Gwenn E.
TI RETRACTED: Design and Analysis of Experiments on Nonconvex Regions
   (Retracted article. See vol. 60, pg. 270, 2018)
SO TECHNOMETRICS
LA English
DT Article; Retracted Publication
DE Gaussian Process; Geodesic distance; Glacier stake network; ISOMAP;
   Multidimensional scaling
ID GLACIER MASS CHANGES; COMPUTER EXPERIMENTS; SUBGLACIAL WATER; BALANCE;
   MODELS; FLOW
AB Modeling a response over a nonconvex design region is a common problem in diverse areas such as engineering and geophysics. The tools available to model and design for such responses are limited and have received little attention. We propose a new method for selecting design points over nonconvex regions that is based on the application of multidimensional scaling to the geodesic distance. Optimal designs for prediction are described, with special emphasis on Gaussian process models, followed by a simulation study and an application in glaciology. Supplementary materials for this article are available online.
C1 [Pratola, Matthew T.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.
   [Harari, Ofir; Bingham, Derek] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada.
   [Flowers, Gwenn E.] Simon Fraser Univ, Dept Earth Sci, Burnaby, BC V5A 1S6, Canada.
RP Pratola, MT (reprint author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.
EM mpratola@stat.osu.edu; oharari@sfu.ca; dbingham@stat.sfu.ca;
   gflowers@sfu.ca
FU Natural Sciences and Engineering Research Council of Canada (NSERC);
   NSERC; Canada Research Chairs Program; Canada Foundation for Innovation;
   Polar Continental Shelf Program
FX Dr. Bingham's research was supported by a Natural Sciences and
   Engineering Research Council of Canada (NSERC) Discovery Grant. Dr.
   Flowers's research was supported by NSERC (Discovery Grant and Northern
   Research Supplement), Canada Research Chairs Program, Canada Foundation
   for Innovation and Polar Continental Shelf Program.
CR Agassiz Louis, 1866, GEOLOGICAL SKETCHES
   Arendt AA, 2002, SCIENCE, V297, P382, DOI 10.1126/science.1072497
   Bell RE, 2008, NAT GEOSCI, V1, P297, DOI 10.1038/ngeo186
   Bengio Y, 2004, NEURAL COMPUT, V16, P2197, DOI 10.1162/0899766041732396
   Boisvert JB, 2009, MATH GEOSCI, V41, P585, DOI 10.1007/s11004-009-9229-1
   Boisvert JB, 2011, COMPUT GEOSCI-UK, V37, P495, DOI 10.1016/j.cageo.2010.03.021
   Bornn L, 2012, J AM STAT ASSOC, V107, P281, DOI 10.1080/01621459.2011.646919
   Chen T., 1984, 2ND S TAG METH, P70
   Cormen T. H., 2001, INTRO ALGORITHMS
   Cox T. F, 2001, MULTIDIMENSIONAL SCA
   Cressie NA, 1993, STAT SPATIAL DATA WI
   CUFFEY K. M, 2010, PHYS GLACIERS
   Curriero FC, 2006, MATH GEOL, V38, P907, DOI 10.1007/s11004-006-9055-7
   del Castillo E, 2015, TECHNOMETRICS, V57, P87, DOI 10.1080/00401706.2013.879075
   Fedorov V. V., 1972, THEORY OPTIMAL EXPT
   Fountain AG, 1998, REV GEOPHYS, V36, P299, DOI 10.1029/97RG03579
   Fountain AG, 1999, GEOGR ANN A, V81A, P563
   GLEN JW, 1955, PROC R SOC LON SER-A, V228, P519, DOI 10.1098/rspa.1955.0066
   HAMADA M, 1995, J QUAL TECHNOL, V27, P45
   Huwang L, 2006, LECT NOTES MONOGRAPH, V52, P245
   Huybrechts P, 2007, CLIM PAST DISCUSS, V3, P693, DOI [10.5194/cpd-3-693-2007, DOI 10.5194/CPD-3-693-2007]
   IKEN A, 1981, J GLACIOL, V27, P407, DOI 10.3189/S0022143000011448
   JOHNSON ME, 1990, J STAT PLAN INFER, V26, P131, DOI 10.1016/0378-3758(90)90122-B
   Joughin I, 2013, CRYOSPHERE, V7, P1185, DOI 10.5194/tc-7-1185-2013
   Kaser G, 2010, P NATL ACAD SCI USA, V107, P20223, DOI 10.1073/pnas.1008162107
   Lekivetz R., 2014, QUALITY RELIABILITY, V31, P829
   Linkletter C, 2006, TECHNOMETRICS, V48, P478, DOI 10.1198/004017006000000228
   Loland A, 2003, ENVIRONMETRICS, V14, P307, DOI 10.1002/env.588
   Luthcke SB, 2008, J GLACIOL, V54, P767, DOI 10.3189/002214308787779933
   Marshall SJ, 2005, EARTH PLANET SC LETT, V240, P191, DOI [10.1016/j.epsl.2005.09.016, 10.1016/j.epsl.2005.08.016]
   MEIER MF, 1969, CAN J EARTH SCI, V6, P807, DOI 10.1139/e69-081
   Ostrem G., 1991, GLACIER MASSBALANCE
   Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471
   Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7
   Rathbun SL, 1998, ENVIRONMETRICS, V9, P109, DOI 10.1002/(SICI)1099-095X(199803/04)9:2<109::AID-ENV279>3.0.CO;2-L
   SACKS J, 1989, TECHNOMETRICS, V31, P41, DOI 10.2307/1270363
   Sacks J., 1989, STAT SCI, V4, P409, DOI DOI 10.1214/SS/1177012413
   Santner TJ, 2003, DESIGN ANAL COMPUTER
   Stocker T. F., 2013, INTERGOVERNMENTAL PA
   Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319
   Wheler BA, 2014, ARCT ANTARCT ALP RES, V46, P379, DOI 10.1657/1938-4246-46.2.379
   Zou HX, 2012, INT J GEOGR INF SCI, V26, P667, DOI 10.1080/13658816.2011.609488
NR 42
TC 1
Z9 1
U1 2
U2 5
PU AMER STATISTICAL ASSOC
PI ALEXANDRIA
PA 732 N WASHINGTON ST, ALEXANDRIA, VA 22314-1943 USA
SN 0040-1706
EI 1537-2723
J9 TECHNOMETRICS
JI Technometrics
PD FEB
PY 2017
VL 59
IS 1
BP 36
EP 47
DI 10.1080/00401706.2015.1115674
PG 12
WC Statistics & Probability
SC Mathematics
GA EM1MY
UT WOS:000395082900004
DA 2018-12-27
ER

PT J
AU Misak, A
   Misak, A
   Tomasova, L
   Grman, M
   Ondriasova, E
   Krizanova, O
   Ondrias, K
AF Misak, Anton
   Misak, Anton
   Tomasova, Lenka
   Grman, Marian
   Ondriasova, Elena
   Krizanova, Olga
   Ondrias, Karol
TI RETRACTED: Mathematical relationships and their consequences between rat
   pulse waveform parameters and blood pressure during decreasing NO
   bioavailability(Retracted article.See vol.102, pg.739, 2017)
SO EXPERIMENTAL PHYSIOLOGY
LA English
DT Article; Retracted Publication
ID NITRIC-OXIDE SYNTHASE; HEART-RATE; NONINVASIVE MEASUREMENT; ARTERIAL
   STIFFNESS; ANGIOTENSIN-II; L-NAME; HYPERTENSION
AB Information obtained from the arterial pulse waveform (APW) is useful for characterization of the cardiovascular system in particular (patho) physiological conditions. Our goal was to find out whether the relationships between rat APW parameters could be described by simple mathematical functions and to find mathematical parameters for conditions of hypertension resulting from decreased NO bioavailability. Therefore, we explored details of 14 left carotid APW parameters of anaesthetized male Wistar rats and mathematically characterized their relationship to systolic and diastolic blood pressure (BP) in conditions of a gradual reduction in NO bioavailability after administration of l- NAME. The right jugular vein of anaesthetized Wistar rats was cannulated for l- NAME administration. The left carotid artery was cannulated to detect the APW at high resolution. Here, we show the time- dependent parallel changes of 14 APW parameters before and after i.v. administration of l- NAME and present mathematical functions that approximate the relationships of 12 APW parameters to systolic and diastolic BP. Some APW parameters had minor (e.g. heart rate) or biphasic dependence on BP (e.g. relative level of the maximum rate of ventricular pressure decrease (dP/dt(min))), but all relationships, within a particular range of BP, could be approximated by known regression functions, as a linear function (e.g. pulse BP), exponential decay (e. g. relative level of themaximumrate of ventricular pressure increase (dP/dt(max))), exponential growth (systolic area), exponential rise to a maximum (relative augmentation index) or sigmoid function (e. g. increase of relative level of dP/dt(min)). The mathematical functions may assign APW parameters to decreased NO bioavailability. This may have predictive or diagnostic value.
C1 [Misak, Anton; Misak, Anton; Tomasova, Lenka; Grman, Marian; Krizanova, Olga; Ondrias, Karol] Slovak Acad Sci, Biomed Res Ctr, Inst Clin & Translat Res, Dubravska Cesta 9, Bratislava 84505 4, Slovakia.
   [Misak, Anton] Slovak Acad Sci, Inst Normal & Pathol Physiol, Bratislava, Slovakia.
   [Ondriasova, Elena] Comenius Univ, Fac Pharm, Dept Pharmacol & Toxicol, Bratislava, Slovakia.
RP Misak, A (reprint author), Slovak Acad Sci, Biomed Res Ctr, Inst Clin & Translat Res, Dubravska Cesta 9, Bratislava 84505 4, Slovakia.
EM karol.ondrias@savba.sk
FU Slovak Research and Development Agency [APVV-15-0371]; Scientific Grant
   Agency VEGA [2/0050/13, 2/0019/15, 2/0146/16]
FX This work was supported by the Slovak Research and Development Agency
   under contract no. APVV-15-0371 and by Scientific Grant Agency VEGA
   2/0050/13, 2/0019/15 and 2/0146/16.
CR Avolio AP, 2010, PHYSIOL MEAS, V31, pR1, DOI 10.1088/0967-3334/31/1/R01
   Chowienczyk PJ, 1999, J AM COLL CARDIOL, V34, P2007, DOI 10.1016/S0735-1097(99)00441-6
   Codreanu I, 2011, VASC HEALTH RISK MAN, V7, P365, DOI 10.2147/VHRM.S20845
   Fellet AL, 2003, BRAZ J MED BIOL RES, V36, P669, DOI 10.1590/S0100-879X2003000500015
   Grundy D, 2015, J PHYSIOL-LONDON, V593, P2547, DOI 10.1113/JP270818
   Hu CT, 1997, BRIT J PHARMACOL, V122, P1237, DOI 10.1038/sj.bjp.0701496
   Khazan M, 2015, SCIMETR, V3
   KLEMSDAL O, 1994, CARDIOVASC RES, V28, P1397, DOI 10.1093/cvr/28.9.1397
   Lee SS, 2011, SENSORS-BASEL, V11, P1784, DOI 10.3390/s110201784
   Lekakis JP, 2005, INT J CARDIOL, V102, P391, DOI 10.1016/j.ijcard.2004.04.014
   MARCHAIS SJ, 1993, HYPERTENSION, V22, P876, DOI 10.1161/01.HYP.22.6.876
   Mugabo P, 2014, J ETHNOPHARMACOL, V158, P123, DOI 10.1016/j.jep.2014.10.011
   Nelson MR, 2010, MAYO CLIN PROC, V85, P460, DOI 10.4065/mcp.2009.0336
   Nier BA, 2008, EXP PHYSIOL, V93, P503, DOI 10.1113/expphysiol.2007.041129
   O'Rourke MF, 2001, BRIT J CLIN PHARMACO, V51, P507, DOI 10.1046/j.0306-5251.2001.01400.x
   Oliver JJ, 2003, ARTERIOSCL THROM VAS, V23, P554, DOI 10.1161/01.ATV.0000060460.52916.D6
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Paulis L, 2012, HYPERTENSION, V59, P485, DOI 10.1161/HYPERTENSIONAHA.111.185496
   Shin IW, 2014, INT J BIOL SCI, V10, P367, DOI 10.7150/ijbs.8048
   Shirasaka T, 2013, J ANESTH, V27, P325, DOI 10.1007/s00540-012-1515-2
   Stoner L, 2012, INT J VASC MED, V2012, DOI DOI 10.1155/2012/903107
   Sueta D, 2015, INT J CARDIOL, V189, P244, DOI 10.1016/j.ijcard.2015.03.182
   Tomasova L, 2015, NITRIC OXIDE-BIOL CH, V46, P131, DOI 10.1016/j.niox.2014.12.012
   Totzeck M, 2015, WORLD J CARDIOL, V7, P645, DOI 10.4330/wjc.v7.i10.645
   Vlachopoulos C, 2000, CURR PROB CARDIOLOGY, V25, P301
   Weinberg PD, 2001, BRIT J PHARMACOL, V133, P361, DOI 10.1038/sj.bjp.0704084
   Wilkinson IB, 2001, J PHYSIOL-LONDON, V530, P541, DOI 10.1111/j.1469-7793.2001.0541k.x
   Zhang J, 2015, BRIT J ANAESTH, V115, P392, DOI 10.1093/bja/aev254
NR 28
TC 1
Z9 1
U1 3
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0958-0670
EI 1469-445X
J9 EXP PHYSIOL
JI Exp. Physiol.
PD FEB 1
PY 2017
VL 102
IS 2
BP 164
EP 179
DI 10.1113/EP085958
PG 16
WC Physiology
SC Physiology
GA EP2XR
UT WOS:000397247400003
PM 27862525
DA 2018-12-27
ER

PT J
AU Wang, T
   Wang, H
   Yang, DL
   Jiang, LQ
   Zhang, LJ
   Ding, WY
AF Wang, Tao
   Wang, Hui
   Yang, Da-Long
   Jiang, Li-Qiang
   Zhang, Li-Jun
   Ding, Wen-Yuan
TI RETRACTED: Factors predicting surgical site infection after posterior
   lumbar surgery A multicenter retrospective study (Retracted article. See
   vol. 96, artn no e7102, 2017)
SO MEDICINE
LA English
DT Article; Retracted Publication
DE factors; posterior lumbar surgery; surgical site infection
ID RISK-FACTORS; SPINE SURGERY
AB This is a retrospective study.
   The purpose of this study is to explore incidence and risk factors for surgical site infection (SSI) after posterior lumbar surgery. SSI is a common complication after posterior lumbar surgery, bringing mental and physical pain and prolonging hospital stay. However, predisposing factors, as reported less, remain controversial.
   Patients who underwent posterior lumbar surgery at 3 centers between 2006 and 2016 were included. The possible factors include 3 aspects: demographic variables-age, sex, body mass index (BMI), waist-to-hip radio (WHR), hypertension, diabetes, heart disease, smoking, drinking, steroidal injection, surgical time between June and September, preoperative shower; blood test variables-white blood cell (WBC), neutrophil, red blood cell (RBC), hemoglobin (Hb), total protein (TP), albumin, albumin/globulin (A/G), C-reactive protein (CRP), procalcitonin (PCT), erythrocyte sedimentation rate (ESR) and surgical related variables-operation time, blood loss, operative level, instrumentation, incision length. Factors related with SSI were also performed by multivariate analysis.
   The prevalence of SSI was 3.00% (267 cases of 8879) had a postoperative wound infection. There were significant difference in WHR (0.92 vs 0.83), WBC (4.31 vs 6.69), TP (58.7 vs 65.2), albumin (36.9 vs 43.2), CRP (2.01 vs 0.57), PCT (0.097 vs 0.067), operation time (217.9 vs 195.7), blood loss (997.1 vs 915.3) and operative level (3.05 vs 2.45) and incision length (24.1 vs 20.0) between SSI group and non-SSI group. >60 years old, female, BMI <18.5 and >30.0, diabetes, male smoking, preoperative steroidal injection, surgical time between June and September, no preoperative shower, instrumentation surgery were risk factors for SSI after posterior lumbar surgery.
   Many factors, >60 years old, female, BMI, WHR, diabetes, male smoking, preoperative steroidal injection, surgical time between June and September, preoperative shower, WBC, TP, albumin, CRP, PCT, operation time, blood loss and operative level, instrumentation surgery and incision length, could predict SSI after posterior lumbar surgery. Measure should be taken before surgery to lower incidence of SSI after surgery.
C1 [Wang, Tao; Wang, Hui; Yang, Da-Long; Ding, Wen-Yuan] Hebei Med Univ, Hosp 3, Dept Spinal Surg, 139 Ziqiang Rd, Shijiazhuang 050051, Peoples R China.
   [Jiang, Li-Qiang] HanDan Cent Hosp, Dept Orthopaed, Handan, Peoples R China.
   [Zhang, Li-Jun] First Hosp Shijiazhuang, Dept Orthopaed, Shijiazhuang, Peoples R China.
RP Ding, WY (reprint author), Hebei Med Univ, Hosp 3, Dept Spinal Surg, 139 Ziqiang Rd, Shijiazhuang 050051, Peoples R China.
EM docwangspine@163.com
CR Anderson DJ, 2011, INFECT CONT HOSP EP, V32, P315, DOI 10.1086/658940
   Chen SH, 2015, EUR SPINE J, V24, P561, DOI 10.1007/s00586-014-3636-9
   Dubory A, 2015, EUR SPINE J, V24, P543, DOI 10.1007/s00586-014-3523-4
   Durkin MJ, 2015, J NEUROSURG-SPINE, V23, P128, DOI 10.3171/2014.10.SPINE14559
   Gondo T, 2014, INT J CLIN ONCOL, V19, P935, DOI 10.1007/s10147-013-0646-2
   Klemencsics I, 2016, SPINE J, V16, P1377, DOI 10.1016/j.spinee.2016.08.018
   Lee MJ, 2014, SPINE J, V14, P2112, DOI 10.1016/j.spinee.2013.12.026
   Lieber B, 2016, WORLD NEUROSURG, V89, P517, DOI 10.1016/j.wneu.2015.12.085
   Lim S, 2014, SPINE PHILA PA 1976
   Maruo K, 2014, J ORTHOP SCI, V19, P398, DOI 10.1007/s00776-014-0545-z
   Mehta AI, 2012, SPINE, V37, P1652, DOI 10.1097/BRS.0b013e318241b186
   Molinari Robert W, 2012, Eur Spine J, V21 Suppl 4, pS476, DOI 10.1007/s00586-011-2104-z
   O'Neill KR, 2011, SPINE J, V11, P641, DOI 10.1016/j.spinee.2011.04.025
   Olsen MA, 2008, J BONE JOINT SURG AM, V90A, P62, DOI 10.2106/JBJS.F.01515
   Ousey KJ, 2013, SPINE J, V13, P1393, DOI 10.1016/j.spinee.2013.06.040
   Tominaga H, 2016, EUR SPINE J
   Xing D, 2013, EUR SPINE J, V22, P605, DOI 10.1007/s00586-012-2514-6
NR 17
TC 5
Z9 6
U1 3
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD FEB
PY 2017
VL 96
IS 5
AR e6042
DI 10.1097/MD.0000000000006042
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA EK9OM
UT WOS:000394253800066
PM 28151913
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Yu-qian, G
   Tao, L
   Xiao-ting, W
   Yuan-cheng, Q
   Qing, W
   Jin-wen, S
   Li-you, Q
   Wan-zhi, M
AF Yu-qian, Gao
   Tao, Li
   Xiao-ting, Wang
   Yuan-cheng, Qi
   Qing, Wen
   Jin-wen, Shen
   Li-you, Qiu
   Wan-zhi, Mou
TI RETRACTED: Optical sensing composites for cysteine detection: Combining
   rhodamine-based chemosensors with up-conversion nanocrystals (Retracted
   article. See vol. 272, pg. 662, 2018)
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article; Retracted Publication
DE Up-conversion nanoparticles; Rhodamine chemosensor; Cysteine; Sensing
ID FLUORESCENT-PROBE; EXCITATION SOURCE; HOMOCYSTEINE; GLUTATHIONE;
   NANOPARTICLES; CONJUGATE; PERFORMANCE; BEHAVIOR; DISEASE; SENSOR
AB This paper reported two rhodamine-derived chemosensors for cysteine optical sensing. To minimize their photobleaching, up-conversion NaYF4:Yb3+/Er3+ nanocrystals were prepared and modified with alpha-cyclodextrin, serving as excitation host. Efficient energy transfer between this excitation host and our chemosensors was confirmed by spectral analysis, energy transfer radius analysis and emission decay lifetime comparison. Detailed analysis suggested that our chemosensors followed a simple recognition mechanism towards cysteine with binding stoichiometry of 1:1. Chemosensor emission was increased with increasing cysteine concentration. Good selectivity and linear sensing behavior were obtained. The correlation between sensing performance and chemosensor structure was tentatively discussed. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Yu-qian, Gao; Tao, Li; Xiao-ting, Wang; Yuan-cheng, Qi; Qing, Wen; Jin-wen, Shen; Li-you, Qiu] Henan Agr Univ, Coll Life Sci, 95 Wenhua Rd, Zhengzhou 450002, Peoples R China.
   [Yu-qian, Gao; Tao, Li; Xiao-ting, Wang; Yuan-cheng, Qi; Qing, Wen; Jin-wen, Shen; Li-you, Qiu] Henan Agr Univ, Minist Agr, Key Lab Enzyme Engn Agr Microbiol, Zhengzhou 450002, Henan, Peoples R China.
   [Wan-zhi, Mou] Tsinghua Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China.
RP Li-you, Q (reprint author), Henan Agr Univ, Coll Life Sci, 95 Wenhua Rd, Zhengzhou 450002, Peoples R China.
EM hnnongda161@163.com
FU Key Scientific and Technological Project in Henan Province
   [162102110088]; Foundation of He'nan Educational Committee [16A210027]
FX This work was supported by Key Scientific and Technological Project in
   Henan Province (162102110088), Foundation of He'nan Educational
   Committee (16A210027).
CR Awual MR, 2015, SENSOR ACTUAT B-CHEM, V209, P194, DOI 10.1016/j.snb.2014.11.010
   Boyer JC, 2010, NANOSCALE, V2, P1417, DOI 10.1039/c0nr00253d
   Chu CS, 2015, SENSOR ACTUAT B-CHEM, V209, P94, DOI 10.1016/j.snb.2014.11.084
   Cui X, 2014, J LUMIN, V145, P364, DOI 10.1016/j.jlumin.2013.07.021
   Dujols V, 1997, J AM CHEM SOC, V119, P7386, DOI 10.1021/ja971221g
   Guan YL, 2016, BIOSENS BIOELECTRON, V77, P124, DOI 10.1016/j.bios.2015.09.034
   JOHANSSON LBA, 1993, J CHEM SOC FARADAY T, V89, P49, DOI 10.1039/ft9938900049
   Levine J, 2008, DEPRESS ANXIETY, V25, pE154, DOI 10.1002/da.20400
   Li ZQ, 2006, ANGEW CHEM INT EDIT, V45, P7732, DOI 10.1002/anie.200602975
   Lim SY, 2014, J AM CHEM SOC, V136, P7018, DOI 10.1021/ja500962u
   Liu ZY, 2008, CHEM COMMUN, P694, DOI 10.1039/b715402j
   Peng L, 2014, ACS NANO, V8, P2555, DOI 10.1021/nn4061385
   Saha S, 2012, CHEM COMMUN, V48, P1659, DOI 10.1039/c1cc16554b
   Saha S, 2012, INORG CHEM, V51, P336, DOI 10.1021/ic2017243
   Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613
   Song K, 2016, SPECTROCHIM ACTA A, V155, P81, DOI 10.1016/j.saa.2015.11.009
   Wald DS, 2002, BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202
   Wan P, 2016, SPECTROCHIM ACTA A, V159, P223, DOI 10.1016/j.saa.2016.01.052
   Wang FY, 2014, CHEM-EUR J, V20, P11471, DOI 10.1002/chem.201403450
   Wang HL, 2012, CHEM COMMUN, V48, P8341, DOI 10.1039/c2cc33932c
   Wang X, 2014, CHEM COMMUN, V50, P15439, DOI 10.1039/c4cc06637e
   Wang YH, 2011, RSC ADV, V1, P1294, DOI 10.1039/c1ra00488c
   Xie TT, 2009, CHEM COMMUN, P3190, DOI 10.1039/b823352g
   Zhang GQ, 2007, J AM CHEM SOC, V129, P15728, DOI 10.1021/ja079953o
   Zhang J, 2012, CHEM COMMUN, V48, P4860, DOI 10.1039/c2cc31642k
   Zhang LM, 2010, SENSOR ACTUAT B-CHEM, V143, P595, DOI 10.1016/j.snb.2009.09.056
   Zhao QA, 2010, CHEM SOC REV, V39, P3007, DOI 10.1039/b915340c
   Zhou J, 2012, CHEM SOC REV, V41, P1323, DOI 10.1039/c1cs15187h
   Zou DS, 2014, SPECTROCHIM ACTA A, V118, P1062, DOI 10.1016/j.saa.2013.09.117
NR 29
TC 1
Z9 1
U1 1
U2 44
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD FEB
PY 2017
VL 238
BP 1293
EP 1301
DI 10.1016/j.snb.2016.09.106
PG 9
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA ED6EN
UT WOS:000388948600156
DA 2018-12-27
ER

PT J
AU Gaidai, O
   Ji, CY
   Kalogeri, C
   Gao, JL
AF Gaidai, Oleg
   Ji, Chunyan
   Kalogeri, Christina
   Gao, Junliang
TI RETRACTED: SEM-REV energy site extreme wave prediction (Retracted
   article. See vol. 114, pg. 1447, 2017)
SO RENEWABLE ENERGY
LA English
DT Article; Retracted Publication
DE Wave height statistics; Probability; SEM-REV; Extreme value statistics;
   Gumbel distribution; Wave energy
ID DISTRIBUTIONS; HEIGHT
AB Accurate estimation of extreme wave conditions is critical for offshore renewable energy activities and applications. Wave power is the transport of energy by wind waves, and the capture of that energy to do useful work. Wave energy converter (WEC) devices are designed to sustain the wave-induced loads that they experience during both operational and survival sea states. The extreme values of these forces are often a key cost driver for WEC designs. These extreme loads often occur during severe storms; therefore careful examination of harsh wave conditions during the device design process is needed. Consequently the development of a specific extreme condition modeling method is essential.
   This paper presents a novel method for estimating extreme wave statistics, based on the hourly measured wave height maxima at the location of interest. Wave measurements, analyzed in this paper, were collected at SEM-REV offshore sea station located near the coast of France, during years 2001-2010. Note that applied statistical methodology is general and can be well applied to a measured WEC response, and its technology risk assessment.
   Accurate estimation of extreme wave conditions is critical for offshore renewable energy activities and applications. SEM-REV is known French wave energy test site. The method, referred to as ACER method, is presented in brief detail. ACER method provides an accurate extreme value prediction, utilizing available data efficiently. In this study the estimated return level values, obtained by ACER method, are compared to the corresponding return level values obtained by Gumbel method. Based on the overall performance of the proposed method, it is concluded that the ACER method can provide a robust and accurate prediction of extreme wave height at a given location. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Gaidai, Oleg; Ji, Chunyan; Gao, Junliang] Jiangsu Univ Sci & Technol, Zhenjiang, Peoples R China.
   [Kalogeri, Christina] Univ Athens, Athens, Greece.
RP Ji, CY (reprint author), Jiangsu Univ Sci & Technol, Zhenjiang, Peoples R China.
EM jichunyanjkd@l63.com
OI Kalogeri, Christina/0000-0002-9187-0292
CR Aarnes OJ, 2012, J CLIMATE, V25, P1529, DOI 10.1175/JCLI-D-11-00132.1
   Battjes JA, 2000, COAST ENG, V40, P161, DOI 10.1016/S0378-3839(00)00007-7
   Cook NJ, 2004, STRUCT SAF, V26, P391, DOI 10.1016/j.strusafe.2004.01.002
   Ferreira JA, 2000, COAST ENG, V40, P361, DOI 10.1016/S0378-3839(00)00018-1
   Larsen XG, 2015, RENEW ENERG, V80, P205, DOI 10.1016/j.renene.2015.01.069
   Mai S., 2010, COAST ENG P, V1, P712
   Mazas F, 2011, COAST ENG, V58, P385, DOI 10.1016/j.coastaleng.2010.12.003
   Mouslim H., 2008, P 2 INT C OC EN BRES
   Naess A, 2008, J ENG MECH-ASCE, V134, P628, DOI 10.1061/(ASCE)0733-9399(2008)134:8(628)
   Naess A, 2010, J ENG MECH-ASCE, V136, P290, DOI 10.1061/(ASCE)0733-9399(2010)136:3(290)
   Naess A, 2009, J OFFSHORE MECH ARCT, V131, DOI 10.1115/1.3160652
   Naess A, 2009, STRUCT SAF, V31, P325, DOI 10.1016/j.strusafe.2008.06.021
   Naess A., 2013, STOCHASTIC DYNAMICS
   Rugbjerg M., 2006, 9 INT WORKSH WAV HIN, P24
   Teena NV, 2012, NAT HAZARDS, V64, P223, DOI 10.1007/s11069-012-0229-y
   Yu Y., 2015, P OMAE, V9
NR 16
TC 1
Z9 1
U1 1
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-1481
J9 RENEW ENERG
JI Renew. Energy
PD FEB
PY 2017
VL 101
BP 894
EP 899
DI 10.1016/j.renene.2016.09.053
PG 6
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA ED3VD
UT WOS:000388775700081
DA 2018-12-27
ER

PT J
AU Zothanpuia
   Passari, AK
   Chandra, P
   Leo, VV
   Mishra, VK
   Kumar, B
   Singh, BP
AF Zothanpuia
   Passari, Ajit K.
   Chandra, Preeti
   Leo, Vincent V.
   Mishra, Vineet K.
   Kumar, Brijesh
   Singh, Bhim P.
TI RETRACTED: Production of Potent Antimicrobial Compounds from
   Streptomyces cyaneofuscatus Associated with Fresh Water Sediment
   (Retracted article. See vol. 9, artn no. 1681. 2018)
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article; Retracted Publication
DE Streptomyces cyaneofuscatus; antimicrobial activity; biosynthetic genes;
   GC-MS; UPLC-ESI-MS/MS
ID ENDOPHYTIC ACTINOBACTERIA; ANTIOXIDANT ACTIVITY; BIOSYNTHETIC GENE;
   PLANT-GROWTH; MARINE; ANTIBIOTICS; METABOLITES; SOIL; IDENTIFICATION;
   POLYKETIDE
AB The genus Streptomyces under phylum actinobacteria has been recognized as a prolific source for the production of bioactive secondary metabolites. An actinobacterial strain designated as DST103 isolated from a wetland fresh water sediment of Tamdil Lake, Mizoram, Northeast, India was identified as Streptomyces cyaneofuscatus (KY287599) using 16SrRNA gene sequencing which shares 99.87% sequence similarity with Streptomyces cyaneofuscatus NRRL B-2570(T). The strain showed broad spectrum antimicrobial activities against Gram negative bacteria (Escherichia coli MTCC 739 and Pseudomonas aeruginosa MTCC 2453), Gram positive bacteria (Micrococcus luteus NCIM 2170 and Staphylococcus aureus MTCC 96) and yeast pathogen Candida albicans MTCC 3017). The methanolic extract of the strain DST103 exhibited highest antimicrobial activity against E. coli (IC50 = 2.10 mu g/mL) and minimum activity against S. aureus (IC50 = 43.63 mu g/mL). Five antibiotics [trimethoprim (18 mu g/g), fluconazole (6 mu g/g), ketoconazole (18 mu g/g), nalidixic acid (135 mu g/g), and rifampicin (56 mu g/g)] were detected and quantified using ultra-performance liquid chromatography (UPLC-ESI-MS/MS). Further, biosynthetic potential genes [polyketide synthases type II, non-ribosomal peptide synthetases, and aminodeoxyisochorismate synthase (phzE)] were also detected in strain DST103 which may possibly be responsible for the production of antimicrobial compounds. Additionally, gas chromatography-mass spectrometry analysis showed the presence of four volatile compounds which might be responsible for their diverse biological activity. The present study revealed the presence of bioactive compounds in strain DST103, which may be a promising resource for the discovery of novel bioactive metabolites against wide range of pathogens.
C1 [Zothanpuia; Passari, Ajit K.; Leo, Vincent V.; Mishra, Vineet K.; Singh, Bhim P.] Mizoram Univ, Dept Biotechnol, Mol Microbiol & Systemat Lab, Aizawl, India.
   [Chandra, Preeti; Kumar, Brijesh] CSIR Cent Drug Res Inst, Sophisticated Analyt Instrument Facil, Lucknow, Uttar Pradesh, India.
RP Singh, BP (reprint author), Mizoram Univ, Dept Biotechnol, Mol Microbiol & Systemat Lab, Aizawl, India.
EM bhimpratap@gmail.com
FU Science and Engineering Research Board (SERB), Department of Science and
   Technology (DST), Government of India, New Delhi [SERB/F/2501/2013- 14];
   University Grants Commission (UGC), New Delhi [69/2014 F.No10-11/12]
FX BS is thankful to the Science and Engineering Research Board (SERB),
   Department of Science and Technology (DST), Government of India, New
   Delhi for funding as young scientist project No: SERB/F/2501/2013- 14.
   BS is also thankful to University Grants Commission (UGC), New Delhi for
   research funding as Major Research Project (69/2014 F.No10-11/12).
   Authors are also thankful to Department of Biotechnology, Ministry of
   Science and Technology, India, for establishment of the DBT-BIF Centre
   and the DBT-State Biotech Hub in the Department, which has been used for
   the present study. We are thankful to SAIF, NEHU for FEG-SEM analysis
   and SAIF, CSIR-CDRI for conducting HPLC analysis.
CR Alvan G, 2011, DRUG RESIST UPDATE, V14, P70, DOI 10.1016/j.drup.2011.01.007
   Atta HM, 2015, J SAUDI CHEM SOC, V19, P12, DOI 10.1016/j.jscs.2011.12.011
   Ayuso-Sacido A, 2005, MICROB ECOL, V49, P10, DOI 10.1007/s00248-004-0249-6
   Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1
   Brana AF, 2015, MICROB ECOL, V69, P512, DOI 10.1007/s00248-014-0508-0
   Das S, 2010, AQUACULTURE, V305, P32, DOI 10.1016/j.aquaculture.2010.04.001
   David B, 2015, PHYTOCHEM REV, V14, P299, DOI 10.1007/s11101-014-9367-z
   Procopio RED, 2012, BRAZ J INFECT DIS, V16, P466, DOI 10.1016/j.bjid.2012.08.014
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Eloff JN, 1998, J ETHNOPHARMACOL, V60, P1, DOI 10.1016/S0378-8741(97)00123-2
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Gebreyohannes Gebreselema, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P426, DOI 10.1016/S2221-1691(13)60092-1
   GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201
   Goodfellow M., 1984, BIOL BIOCH BIOMEDICA, P453
   Goodfellow M, 2010, ANTON LEEUW INT J G, V98, P119, DOI 10.1007/s10482-010-9460-2
   Hamedi J, 2015, ANN MICROBIOL, V65, P2047, DOI 10.1007/s13213-015-1043-z
   Idramsa E., 2016, INT J PHARM BIO SCI, V7, P666
   Jog R, 2014, MICROBIOL-SGM, V160, P778, DOI 10.1099/mic.0.074146-0
   Kalaiselvan A., 2012, J PHARM BIOMED SCI, V20, P20
   Kavitha A, 2010, MICROBIOL RES, V165, P199, DOI 10.1016/j.micres.2009.05.002
   Kim KJ, 2008, ARCH PHARM RES, V31, P1572, DOI 10.1007/s12272-001-2153-7
   Kim TU, 2012, J MICROBIOL, V50, P50, DOI 10.1007/s12275-012-1417-x
   KUZNETSOV SI, 1970, MICROFLORA LAKES ITS
   Lazzarini A, 2000, ANTON LEEUW INT J G, V78, P399, DOI 10.1023/A:1010287600557
   Minowa Y, 2007, J MOL BIOL, V368, P1500, DOI 10.1016/j.jmb.2007.02.099
   Mitra A, 2008, APPL MICROBIOL BIOT, V80, P685, DOI 10.1007/s00253-008-1626-8
   Mukai A, 2009, J ANTIBIOT, V62, P613, DOI 10.1038/ja.2009.90
   Passari AK, 2016, RES MICROBIOL, V167, P692, DOI 10.1016/j.resmic.2016.07.001
   Passari AK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00273
   Priyanka Sharma, 2014, African Journal of Microbiology Research, V8, P986
   Radhika S, 2011, J PHARM RES, V4, P2584
   Rajan BM, 2014, INT J MOL CELL MED, V3, P130
   Rifaat HM, 2003, J MEDITER ECOL, V4, P5
   Saadoun I., 2008, CURR TRENDS BIOTECHN, V2, P402
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406
   Saravanan S., 2015, International Journal of Current Microbiology and Applied Sciences, V4, P672
   Saurav K, 2012, SAUDI J BIOL SCI, V19, P81, DOI 10.1016/j.sjbs.2011.07.003
   Schneemann I, 2011, MAR DRUGS, V9, P772, DOI 10.3390/md9050772
   Senbagam D., 2016, PHYTOTHERAPEUTIC CON
   Ser HL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01398
   Sharma P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00347
   Sheoran N, 2015, MICROBIOL RES, V173, P66, DOI 10.1016/j.micres.2015.02.001
   SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313
   Sibanda T, 2010, INT J MOL SCI, V11, P2612, DOI 10.3390/ijms11072612
   Stach JEM, 2003, ENVIRON MICROBIOL, V5, P828, DOI 10.1046/j.1462-2920.2003.00483.x
   Subramani R, 2012, MICROBIOL RES, V167, P571, DOI 10.1016/j.micres.2012.06.005
   Talukdar M, 2012, WORLD J MICROB BIOT, V28, P2703, DOI 10.1007/s11274-012-1080-8
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tan LTH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01316
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Villano M. A., 2007, J RES SCI COMPUTING, V4, P29
   Wang C, 2015, J SIGNAL PROCESS SYS, V79, P1, DOI 10.1007/s11265-013-0819-2
   Wawrik B, 2005, APPL ENVIRON MICROB, V71, P2232, DOI 10.1128/AEM.71.5.2232-2238.2005
   WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/jb.173.2.697-703.1991
   Yuan M, 2014, MAR DRUGS, V12, P1281, DOI 10.3390/md12031281
   Zothanpuia, 2016, PEERJ, V4, DOI 10.7717/peerj.2103
   Zothanpuia, 2015, SCI VIS, V15, P136
NR 57
TC 14
Z9 14
U1 2
U2 20
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JAN 25
PY 2017
VL 8
AR 68
DI 10.3389/fmicb.2017.00068
PG 13
WC Microbiology
SC Microbiology
GA EI5RQ
UT WOS:000392552400001
PM 28179900
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Niu, MS
   Wang, GS
AF Niu Ming-Sheng
   Wang Gui-Shi
TI RETRACTED: The research of delta(CO2)-C-13 by use of wavelet de-noising
   at 2.008 mu m based on tunable diode laser absorption spectroscopy
   (Retracted Article)
SO ACTA PHYSICA SINICA
LA Chinese
DT Article; Retracted Publication
DE isotope measurement; novel multi-pass cell; wavelet denoising;
   measurement precise
ID ATMOSPHERIC CO2; CARBON-DIOXIDE; RATIO; PERFORMANCE; METHANE; WATER
AB Development of optical isotope techniques has provided scientists with a set of powerful tools for investigating the sources and sink of atmospheric CO2. Here we describe a continuous, high precision, compact and portable carbon dioxide isotope ratio laser multi-pass cell spectrometer with a tunable distribute feedback laser at 2.008 mu m based on tunable diode laser absorption spectroscopy and, the spectrometer has good temperature and pressure stability. In order to deduce the noise, drift effect and background changes associated with low level signals, a superior signal processing technique of wavelet denoising, which possesses multi-level analytical resolutions both in time and frequency-domains, is introduced. After evaluating the method, evaluation ability and applicabilities of several common wavelet functions are analyzed and tested, the wavelet function of Haar is selected as an optimal wavelet basis function. Based on the analysis of the optimal decomposition level of Haa wavelet function, the VISU function is selected as an optimal wavelet threshold function. The denoising effect and measurement precision are evaluated by use of the VISU threshold function in the measurement process of carbon dioxide stable isotope ratio. The measurement results of carbon dioxide stable isotope ratio before and after suppressing the noises are compared in the same experiment conditions and, the inconsistent reasons of the measured results are theoretically analyzed. This technique allows the measurement of the delta-value for carbon dioxide isotopic ratios with a precision of -12.5% and the measuremnt results show that the wavelet denoising measuring results have higher measurement accuracy, and the measurement precise of carbon dioxide isotope ratio is 7.3 times the original measurement results. The application of the wavelet denoising to the carbon dioxide isotope ratio measurement for the first time proves that the capability of the new near-infrared direct absorption technique to measure isotope ratio can permit high-frequency, near-continuous isotope measurement and obtain the high precision and accurate real-time stable isotope data directly in the field. This technique provides an important tool for studying the resource and sink of green house gases in the future.
C1 [Niu Ming-Sheng] Qufu Normal Univ, Shandong Prov Key Lab Laser Polarizat & Informat, Laser Inst, Qufu 273165, Peoples R China.
   [Niu Ming-Sheng; Wang Gui-Shi] Chinese Acad Sci, Anhui Inst Opt & Fine Mech, Lab Atmospher Physicochem, Hefei 230031, Peoples R China.
RP Niu, MS (reprint author), Qufu Normal Univ, Shandong Prov Key Lab Laser Polarizat & Informat, Laser Inst, Qufu 273165, Peoples R China.; Niu, MS; Wang, GS (reprint author), Chinese Acad Sci, Anhui Inst Opt & Fine Mech, Lab Atmospher Physicochem, Hefei 230031, Peoples R China.
EM nmsheng@163.com; wulixi2004@126.com
FU National Natural Science Foundation of China [41405022]; Qufu Normal
   University Fundation, China [20130760]
FX Project supported by the National Natural Science Foundation of China
   (Grant No. 41405022) and the Qufu Normal University Fundation, China
   (Grant No. 20130760).
CR Bartlome R, 2009, OPT LETT, V34, P866, DOI 10.1364/OL.34.000866
   BERGAMASCHI P, 1994, APPL OPTICS, V33, P7704, DOI 10.1364/AO.33.007704
   Brass M, 2010, ATMOS MEAS TECH, V3, P1707, DOI 10.5194/amt-3-1707-2010
   Gradolewski D, 2014, COMPUT BIOL MED, V52, P119, DOI 10.1016/j.compbiomed.2014.06.011
   Joseph F B, 1992, APPL OPTICS, V3, P1921
   Joseph F B, 1992, APPL OPTICS, V31, P1921
   Kerstel ERT, 1999, ANAL CHEM, V71, P5297, DOI 10.1021/ac990621e
   Kumar HS, 2013, PROCEDIA ENGINEER, V64, P805, DOI 10.1016/j.proeng.2013.09.156
   Le Quere C, 2013, EARTH SYST SCI DATA, V5, P165, DOI 10.5194/essd-5-165-2013
   Li JS, 2015, APPL SPECTROSC, V69, P496, DOI 10.1366/14-07629
   Li XX, 2013, ACTA PHYS SIN-CH ED, V62, DOI 10.7498/aps.62.180203
   Liu LX, 2014, J GEOPHYS RES-ATMOS, V119, P5602, DOI 10.1002/2013JD019605
   Luisier F, 2009, IEEE INT S BIOM IM, V29, P310
   [马毅 Ma Yi], 2011, [计算机与应用化学, Computers and Applied Chemistry], V28, P303
   Mai Bo-ru, 2014, China Environmental Science, V34, P1098
   Marland G, 2012, NAT CLIM CHANGE, V2, P645, DOI 10.1038/nclimate1670
   McManus JB, 2015, OPT EXPRESS, V23, P6569, DOI 10.1364/OE.23.006569
   Pang JP, 2016, SCI TOTAL ENVIRON, V539, P322, DOI 10.1016/j.scitotenv.2015.08.130
   Rajesh AN, 2012, MEAS SCI REV, V12, P46, DOI 10.2478/v10048-012-0010-0
   Sturm P, 2013, ATMOS MEAS TECH, V6, P1659, DOI 10.5194/amt-6-1659-2013
   Trend W, 2016, NATURE, V531, P281
   Wang C, 2008, APPL PHYS B-LASERS O, V92, P259, DOI 10.1007/s00340-008-3077-4
   Wang Y, 2005, SPECTROSC SPECT ANAL, V25, P124
   Werle P, 2011, APPL PHYS B, V10, P4165
   Wu T, 2010, OPT LETT, V35, P634, DOI 10.1364/OL.35.000634
   Xu JH, 2015, AER ADV ENG RES, V28, P1
   Yang Q, 2011, INT C ELECT OPTOELEC, V3, P129
   Zare RN, 2009, P NATL ACAD SCI USA, V106, P10928, DOI 10.1073/pnas.0904230106
   Zhang TW, 2001, GEOCHIM COSMOCHIM AC, V65, P2723, DOI 10.1016/S0016-7037(01)00601-9
   Zheng CT, 2014, SENSOR ACTUAT B-CHEM, V190, P249, DOI 10.1016/j.snb.2013.08.055
NR 30
TC 1
Z9 1
U1 0
U2 12
PU CHINESE PHYSICAL SOC
PI BEIJING
PA P O BOX 603, BEIJING 100080, PEOPLES R CHINA
SN 1000-3290
J9 ACTA PHYS SIN-CH ED
JI Acta Phys. Sin.
PD JAN 20
PY 2017
VL 66
IS 2
AR 024202
DI 10.7498/aps.66.024202
PG 9
WC Physics, Multidisciplinary
SC Physics
GA EP0WQ
UT WOS:000397107800012
DA 2018-12-27
ER

PT J
AU Mizzaci, CC
   Porfirio, GJM
   Vilela, AT
   Guillhen, JCS
   Riera, R
AF Mizzaci, Carolina C.
   Porfirio, Gustavo J. M.
   Vilela, Andre T.
   Guillhen, Jose Cicero S.
   Riera, Rachel
TI RETRACTED: Ivabradine as adjuvant treatment for chronic heart failure
   (Retracted article. See vol. 247, pg. 55, 2017)
SO INTERNATIONAL JOURNAL OF CARDIOLOGY
LA English
DT Article; Retracted Publication
DE Chronic heart failure; Systolic heart failure; lvabradine; Randomized
   controlled trials
ID IDIOPATHIC DILATED CARDIOMYOPATHY; ASSOCIATION; MANAGEMENT; UL-FS-49;
   SHIFT
AB Background: Heart failure prevalence is rising throughout the world. Despite current multidrug therapy, heart failure is the cause of frequent hospitalizations and high mortality.
   Objectives: To assess the effectiveness and safety of ivabradine in chronic heart failure.
   Methods: We searched the databases: the Cochrane Central Register of Controlled Trials CENTRAL (The Cochrane Library), MEDLINE, EMBASE, CINAHL, Conference Proceedings Citation Index Science and Science Citation Index Expanded on Web of Science and LILACS. Randomized, placebo-controlled studies comparing ivabradine versus placebo, in patients who have symptomatic heart failure. Two authors independently abstracted the data and assessed the eligibility and methodological quality of each trial. Extracted data were analysed by determining the relative risks for dichotomous data, and difference in means for continuous data, of the treated group compared with controls.
   Results: Eight randomized controlled trials with an overall number of 17,812 participants were included in this review. After 12 months, compared with placebo, ivabradine was not associated with reduction in cardiovascular mortality (RR 0.95, 95% CI 0.88 to 1.02), reduction of all-cause mortality (RR 0.98, 95% CI 0.90 to 1.06) and reduction of hospitalization for heart failure (RR 0.87, 95% CI 0.68 to 1.11). It was not found differences in safety considering cardiac adverse events between ivabradine and placebo (RR 0.96, 95% Cl 0.89 to 1.02).
   Conclusions: The available data show that ivabradine did not reduce the risk of death and hospitalization for heart failure compared to placebo. There were no differences in safety considering cardiac adverse events between ivabradine and placebo. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Mizzaci, Carolina C.; Porfirio, Gustavo J. M.; Vilela, Andre T.; Riera, Rachel] Univ Fed Sao Paulo, Dept Med Urgency Med & Evidence Based Med, Sao Paulo, Brazil.
   [Guillhen, Jose Cicero S.] Univ Fed Sao Paulo, Cardiovasc Surg, Sao Paulo, Brazil.
RP Mizzaci, CC (reprint author), Univ Fed Sao Paulo, Rua Botucatu 740, BR-04023062 Sao Paulo, Brazil.
EM carolina.mizzaci@hotmail.com
CR Bohm M, 2010, LANCET, V376, P886, DOI 10.1016/S0140-6736(10)61259-7
   Borer JS, 2012, EUR HEART J, V33, P2813, DOI 10.1093/eurheartj/ehs259
   Chumburidze S, 2013, CARDIOLOGY, V125, P424
   Cook J, 2006, J THORAC CARDIOV SUR, V131, P594, DOI 10.1016/j.jtcvs.2005.10.030
   Dickersin K, 1994, BMJ-BRIT MED J, V309, P1286
   Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309
   DiFrancesco D, 2004, DRUGS, V64, P1757, DOI 10.2165/00003495-200464160-00003
   DIFRANCESCO D, 1994, PFLUG ARCH EUR J PHY, V427, P64, DOI 10.1007/BF00585943
   Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019
   Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8
   Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad
   Hady Y.A. Abdel, 2011, EUR J HEART FAIL S, V10, pS107
   Haldeman GA, 1999, AM HEART J, V137, P352, DOI 10.1053/hj.1999.v137.95495
   Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184
   Higgins JP, 2011, COCHRANE HDB SYSTEMA
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Lefebvre C, 2011, COCHRANE HDB SYSTEMA
   Mann DL, 2005, CIRCULATION, V111, P2837, DOI 10.1161/CIRCULATIONAHA.104.500546
   Mansour S, 2011, EGYPT HEART J, V63, P79, DOI 10.1016/j.ehj.2011.09.001
   McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105
   Opasich C, 2001, AM J CARDIOL, V88, P382, DOI 10.1016/S0002-9149(01)01683-6
   Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555
   Rayan M, 2011, ANADOLU KARDIYOL DER, V11, P402, DOI 10.5152/akd.2011.110
   Riccioni G, 2013, PHARMACOLOGY, V92, P276, DOI 10.1159/000355169
   Sarullo FM, 2010, J CARDIOVASC PHARM T, V15, P349, DOI 10.1177/1074248410370326
   Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1
   Tarlovskaya E., 2011, EUR J HEART FAIL S, V10, pS32
   THOLLON C, 1994, BRIT J PHARMACOL, V112, P37, DOI 10.1111/j.1476-5381.1994.tb13025.x
   Tumasyan L.R., 2011, PHARMACOTHERAPY, P808
   Wang YC, 2007, OBESITY, V15, P2855, DOI 10.1038/oby.2007.339
   Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019
NR 31
TC 2
Z9 2
U1 3
U2 28
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0167-5273
EI 1874-1754
J9 INT J CARDIOL
JI Int. J. Cardiol.
PD JAN 15
PY 2017
VL 227
BP 43
EP 50
DI 10.1016/j.ijcard.2016.11.081
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EF6ZU
UT WOS:000390480700008
PM 27846461
DA 2018-12-27
ER

PT J
AU Kadeerhazi, M
   Ali, A
   Bekhit, AE
AF Kadeerhazi, Muhetaer
   Ali, Azam
   Bekhit, Alaa El-Din
TI RETRACTED: On two site-specific nitrite-sensing nanocomposites having a
   core-shell structure: Construction, characterization and sensing
   performance (Retracted article. See vol. 206, pg. 650, 2019)
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article; Retracted Publication
DE Nitrite ion; Core-shell structure; Rhodamine probe; Emission quenching
ID FLUOROMETRIC-DETERMINATION; MAGNETIC NANOPARTICLES; WATER SAMPLES;
   NITRATE; SENSOR; NITROSAMINES
AB This paper reported two site-specific nitrite-sensing nanocomposite samples having a core-shell structure, where Fe3O4 nanoparticles were used as core, two rhodamine derivatives served as chemosensor and MCM-41 was applied as supporting host, respectively. These composite samples and their structure were analyzed and confirmed SEM/TEM, XRD, N-2 adsorption/desorption, magnetic feature, IR and thermogravimetric analysis. Their nitrite sensing performance was discussed based on emission quenching, with limit of detection as low as 1.2 mu M. Detailed analysis suggested that these composite samples followed a static sensing mechanism based on an additive reaction between NO+ and chemosensors. After being quenched by nitrite, these samples could be recovered by sulphamic acid. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Kadeerhazi, Muhetaer] Xinjiang Agr Univ, Coll Food Sci & Pharm, Urumqi 830052, Peoples R China.
   [Ali, Azam] Univ Otago, Dept Appl Sci, Dunedin 9054, New Zealand.
   [Bekhit, Alaa El-Din] Univ Otago, Dept Food Sci, Dunedin 9054, New Zealand.
RP Bekhit, AE (reprint author), Univ Otago, Dept Food Sci, Dunedin 9054, New Zealand.
EM BekhitAED0710@163.com
CR AXELROD HD, 1975, ANAL CHEM, V47, P922, DOI 10.1021/ac60356a054
   Barbe C, 2004, ADV MATER, V16, P1959, DOI 10.1002/adma.200400771
   CHOI KK, 1980, ANALYST, V105, P241, DOI 10.1039/an9800500241
   Connolly D, 2001, ANAL CHIM ACTA, V441, P53, DOI 10.1016/S0003-2670(01)01068-6
   Dong YL, 2011, J NANOSCI NANOTECHNO, V11, P10387, DOI 10.1166/jnn.2011.5014
   Dyal A, 2003, J AM CHEM SOC, V125, P1684, DOI 10.1021/ja021223n
   Gimeno N, 2008, CHEM-EUR J, V14, P3006, DOI 10.1002/chem.200700412
   He L, 2011, J NANOSCI NANOTECHNO, V11, P2256, DOI 10.1166/jnn.2011.3149
   Helaleh MIH, 2000, MICROCHEM J, V64, P241, DOI 10.1016/S0026-265X(00)00018-7
   Jiao CX, 2004, TALANTA, V64, P637, DOI 10.1016/j.talanta.2004.03.052
   Kim E, 2010, ANALYST, V135, P149, DOI 10.1039/b915975d
   Kim H, 2005, J AM CHEM SOC, V127, P544, DOI 10.1021/ja047107x
   Lei BF, 2006, ADV FUNCT MATER, V16, P1883, DOI 10.1002/adfm.200500737
   LIJINSKY W, 1970, NATURE, V225, P21, DOI 10.1038/225021a0
   Liu LK, 2011, J NANOSCI NANOTECHNO, V11, P10333, DOI 10.1166/jnn.2011.5010
   Mousavi MF, 1998, TALANTA, V45, P1247, DOI 10.1016/S0039-9140(97)00240-3
   OHTA T, 1986, ANAL CHEM, V58, P3132, DOI 10.1021/ac00127a047
   Okemgbo AA, 1999, ANAL CHEM, V71, P2725, DOI 10.1021/ac990198+
   Tada DB, 2007, LANGMUIR, V23, P8194, DOI 10.1021/1a700883y
   Vishnuvardhan V, 2008, ANAL CHIM ACTA, V623, P53, DOI 10.1016/j.aca.2008.05.075
   Wang LL, 2012, SENSOR ACTUAT B-CHEM, V171, P946, DOI 10.1016/j.snb.2012.06.008
   Wang YY, 2012, LANGMUIR, V28, P1657, DOI 10.1021/la204494v
   Wang YH, 2011, RSC ADV, V1, P1294, DOI 10.1039/c1ra00488c
   Wang YH, 2010, NEW J CHEM, V34, P1946, DOI 10.1039/c0nj00039f
   Wen ZH, 2004, TALANTA, V62, P351, DOI 10.1016/j.talanta.2003.08.003
   WOLFF IA, 1972, SCIENCE, V177, P15, DOI 10.1126/science.177.4043.15
   World Health Organization (WHO), 2008, GUID DRINK WAT QUAL
   Zhang LZ, 2003, MOLECULES, V8, P207, DOI 10.3390/80100207
NR 28
TC 1
Z9 1
U1 4
U2 44
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD JAN 15
PY 2017
VL 171
BP 361
EP 368
DI 10.1016/j.saa.2016.08.034
PG 8
WC Spectroscopy
SC Spectroscopy
GA DZ1MA
UT WOS:000385601300046
PM 27569768
DA 2018-12-27
ER

PT J
AU Elahi, AS
   Ghoranneviss, M
AF Elahi, A. Salar
   Ghoranneviss, M.
TI RETRACTED: A new perspective on hydrogen plasma equilibrium calculation
   along with the MHD potential energy (Retracted article. See vol. 43, pg.
   2526, 2018)
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article; Retracted Publication
DE Tokamak; Plasma equilibrium; Relaxation method
ID RESONANT HELICAL FIELD; IR-T1 TOKAMAK; MULTIPOLE MOMENTS; POSITION;
   FUSION; DESIGN; RHF
AB In this contribution we have presented two techniques for determination of plasma equilibrium position in IR-T1 tokamak: Relaxation and optical techniques. An analysis method of tokamak plasma equilibrium by a relaxation method with specified magnetic axis was presented. The degrees of freedom due to designated positions of the magnetic axis are possible by using poloidal field coil currents. Stable steady state tokamak plasma equilibria are calculated along with the Magnetohydrodynamic (MHD) potential energy. The plasma generates a plasma current which partially or fully cancels the magnetic field from the poloidal field coils. For low-temperature plasmas, the plasma current distribution is centrally peaked; for high-temperature plasmas, the plasma current has a hole. A centrally peaked current distribution in a low-temperature plasma is evolved into a current distribution with a hole by increasing the plasma pressure by Ohmic heating, RF heating, or by neutral beam injection heating. In the second technique, an image processing technique is used for the output signal of CCD camera. Then, plasma emission intensity profile and plasma position were obtained. Results were compared and discussed. (C) 2016 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [Elahi, A. Salar; Ghoranneviss, M.] Islam Azad Univ, Plasma Phys Res Ctr, Sci & Res Branch, Tehran, Iran.
RP Elahi, AS (reprint author), Islam Azad Univ, Plasma Phys Res Ctr, Sci & Res Branch, Tehran, Iran.
EM Salari_phy@yahoo.com
CR Badiei S, 2009, INT J HYDROGEN ENERG, V34, P487, DOI 10.1016/j.ijhydene.2008.10.024
   Cheng JB, 2009, INT J HYDROGEN ENERG, V34, P6609, DOI 10.1016/j.ijhydene.2009.06.061
   Elahi AS, 2010, FUSION ENG DES, V85, P724, DOI 10.1016/j.fusengdes.2010.04.034
   Elahi AS, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/02/025502
   Elahi AS, 2010, PHYS SCRIPTA, V81, DOI 10.1088/0031-8949/81/05/055501
   Elahi AS, 2010, J FUSION ENERG, V29, P1, DOI 10.1007/s10894-009-9218-x
   Elahi AS, 2009, J FUSION ENERG, V28, P416, DOI 10.1007/s10894-009-9215-0
   Elahi AS, 2009, J FUSION ENERG, V28, P412, DOI 10.1007/s10894-009-9214-1
   Elahi AS, 2009, J FUSION ENERG, V28, P404, DOI 10.1007/s10894-009-9212-3
   Elahi AS, 2009, J FUSION ENERG, V28, P408, DOI 10.1007/s10894-009-9213-2
   Elahi AS, 2009, J FUSION ENERG, V28, P390, DOI 10.1007/s10894-009-9208-z
   Elahi AS, 2009, J FUSION ENERG, V28, P394, DOI 10.1007/s10894-009-9210-5
   Elahi AS, 2009, J FUSION ENERG, V28, P385, DOI 10.1007/s10894-009-9207-0
   Elahi AS, 2009, J FUSION ENERG, V28, P346, DOI 10.1007/s10894-009-9198-x
   Elahi AS, 2009, PHYS SCRIPTA, V80, DOI 10.1088/0031-8949/80/04/045501
   Elahi AS, 2010, IEEE T PLASMA SCI, V38, P3163, DOI 10.1109/TPS.2010.2066289
   Elahi AS, 2010, IEEE T PLASMA SCI, V38, P181, DOI 10.1109/TPS.2009.2037965
   Elahi ASalar, 2010, PHYS SCR, V82
   Habibian J, 2016, INT J HYDROGEN ENERG, V41, P15266, DOI 10.1016/j.ijhydene.2016.06.178
   Kwon GC, 2000, JPN J APPL PHYS 1, V39, P4188, DOI 10.1143/JJAP.39.4188
   MUKHOVATOV VS, 1971, NUCL FUSION, V11, P605, DOI 10.1088/0029-5515/11/6/005
   Naghidokht A, 2016, INT J HYDROGEN ENERG, V41, P15272, DOI 10.1016/j.ijhydene.2016.07.026
   Naghidokht A, 2016, FUSION ENG DES, V107, P82, DOI 10.1016/j.fusengdes.2016.04.032
   Niomiya H, 1982, JPN J APPL PHYS, V21, P1323
   Ouaras K, 2014, INT J HYDROGEN ENERG, V39, P17422, DOI 10.1016/j.ijhydene.2014.08.021
   Rahimirad A, 2009, J FUSION ENERG, V28, P420, DOI 10.1007/s10894-009-9216-z
   Salar Elahi A, 2009, J PLASMA PHYS, V76, P1
   SHKAROFSKY IP, 1982, PHYS FLUIDS, V25, P89, DOI 10.1063/1.863632
   Watanabe O., 2013, PLASMA FUSION RES, V8
   Zakharov L. E., 1973, Soviet Physics - Technical Physics, V18, P151
NR 30
TC 4
Z9 4
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD JAN 12
PY 2017
VL 42
IS 2
BP 1048
EP 1052
DI 10.1016/j.ijhydene.2016.07.273
PG 5
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA EM3KI
UT WOS:000395213200027
DA 2018-12-27
ER

PT J
AU Alipour, R
   Jafari, A
   Elahi, AS
   Ghoranneviss, M
AF Alipour, R.
   Jafari, A.
   Elahi, A. Salar
   Ghoranneviss, M.
TI RETRACTED: A new approach on morphological features of synthesized
   graphene using the LPCVD technique applicable for fuel cell membrane
   (Retracted article. See vol. 43, pg. 2527, 2018)
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article; Retracted Publication
DE Fuel cell; Graphene; LPCVD
ID CHEMICAL-VAPOR-DEPOSITION; OXYGEN REDUCTION REACTION; ALKALINE MEDIA;
   HIGH-QUALITY; OXIDE; ELECTROOXIDATION; PERFORMANCE; GRAPHITE; METHANOL;
   ETHANOL
AB The one-atom-thick materials such as graphene, once thought to be impermeable, allow protons to pass through them. The result will be more efficient fuel cells and the simplification of the heretofore difficult process of separating hydrogen gas for use as fuel in fuel cells. In this research, a large scale graphene were synthesized by Low Pressure Chemical Vapor Deposition (LPCVD) technique. The effects of temperature growth on morphological features of the synthesized graphene on Cu foils were studied, using only Scanning Electron Microscopy (SEM) analysis. Raman spectrum was used to quantify defects and characteristics of synthesized graphene. Three peaks at similar to 1350, similar to 1580 and similar to 2750 cm(-1) related to the D band, G band and 2D band are shown from Raman analysis. The Mountains Map Premium software and the Gwyddion software were used for investigation on morphological features of synthesized graphene samples. The results show that the defects intensity in graphene decreased and the quality of synthesized graphene increased with increasing growth temperature. The grain size and producing the large area of graphene decreased and increased, respectively with the rise of temperature. At all temperatures growth, the multilayer graphene are grown on Cu substrates. The results of the motifs analysis shows that the synthesized graphene layers are made of oblong grains. On the surface of synthesized samples at 800 and 850 degrees C were dominant of valleys. Also, on the surface of synthesized samples at 900 and 1000 degrees C, the peaks were dominant. Thus, the surfaces of all synthesized samples were spiky and isotropic and have an oriented or periodical structure. All results of this work represent that the defects intensity, quality, grain size and uniformity of synthesized graphene could be controlled by only changing the temperature and keeping the other effective parameters constant. (C) 2016 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [Alipour, R.; Jafari, A.; Elahi, A. Salar; Ghoranneviss, M.] Islamic Azad Univ, Plasma Phys Res Ctr, Sci & Res Branch, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Plasma Phys Res Ctr, Sci & Res Branch, Tehran, Iran.
EM Salari_phy@yahoo.com
CR Akbarnejad E, 2016, J INORG ORGANOMET P, V26, P270, DOI 10.1007/s10904-015-0299-x
   Akbarnejad E, 2015, RADIAT EFF DEFECT S, V170, P541, DOI 10.1080/10420150.2015.1052437
   Alipour R, 2016, J ALLOY COMPD, V687, P72, DOI 10.1016/j.jallcom.2016.06.087
   [Anonymous], 2012, DEF SURF TEXT PAR
   Azadfar P, 2015, J INORG ORGANOMET P, V25, P1040, DOI 10.1007/s10904-015-0207-4
   Azadfar P, 2015, J CRYST GROWTH, V415, P166, DOI 10.1016/j.jcrysgro.2015.01.001
   Bunch JS, 2007, SCIENCE, V315, P490, DOI 10.1126/science.1136836
   Elahi AS, 2016, J INORG ORGANOMET P, V26, P773, DOI 10.1007/s10904-016-0368-9
   Elahi AS, 2016, INT J MATER PROD TEC, V52, P353, DOI 10.1504/IJMPT.2016.075500
   Farazmand P, 2015, J INORG ORGANOMET P, V25, P1470, DOI 10.1007/s10904-015-0263-9
   Farazmand P, 2015, J INORG ORGANOMET P, V25, P942, DOI 10.1007/s10904-015-0196-3
   Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   Firoozbakht S, 2016, J INORG ORGANOMET P, V26, P889, DOI 10.1007/s10904-016-0380-0
   Florez-Montano J, 2016, INT J HYDROGEN ENERG, V41, P19799, DOI 10.1016/j.ijhydene.2016.06.166
   Ghorannevis Z, 2016, J CRYST GROWTH, V447, P62, DOI 10.1016/j.jcrysgro.2016.04.062
   Ghorannevis Z, 2015, J INORG ORGANOMET P, V25, P1486, DOI 10.1007/s10904-015-0265-7
   Ghoranneviss M, 2016, MOL CRYST LIQ CRYST, V629, P158, DOI 10.1080/15421406.2015.1107817
   Ghoranneviss M, 2015, MATER MANUF PROCESS, V30, P1348, DOI 10.1080/10426914.2015.1019103
   Ghoranneviss M, 2015, FUSION ENG DES, V94, P1, DOI 10.1016/j.fusengdes.2015.02.059
   Guermoune A, 2011, CARBON, V49, P4204, DOI 10.1016/j.carbon.2011.05.054
   Huang LH, 2016, INT J HYDROGEN ENERG, V41, P11369, DOI 10.1016/j.ijhydene.2016.05.048
   Jafari A, 2016, J INORG ORGANOMET P, V26, P1095, DOI 10.1007/s10904-016-0430-7
   Jafari A, 2016, J INORG ORGANOMET P, V26, P254, DOI 10.1007/s10904-015-0291-5
   Jafari A, 2015, J ALLOY COMPD, V644, P97, DOI 10.1016/j.jallcom.2015.04.202
   Jafari A, 2015, B MATER SCI, V38, P707, DOI 10.1007/s12034-015-0918-8
   Jiang DE, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3077295
   Juang ZY, 2009, CARBON, V47, P2026, DOI 10.1016/j.carbon.2009.03.051
   Krishna R, 2016, INT J HYDROGEN ENERG, V41, P11811, DOI 10.1016/j.ijhydene.2015.12.034
   Levchenko I, 2010, CARBON, V48, P4570, DOI 10.1016/j.carbon.2010.07.055
   Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245
   Liu YS, 2016, INT J HYDROGEN ENERG, V41, P10354, DOI 10.1016/j.ijhydene.2015.10.109
   Madani SS, 2015, J ALLOY COMPD, V648, P1104, DOI 10.1016/j.jallcom.2015.07.063
   Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003
   Moniri S, 2015, J FUSION ENERG, V34, P449, DOI 10.1007/s10894-014-9822-2
   Nale A, 2016, INT J HYDROGEN ENERG, V41, P11225, DOI 10.1016/j.ijhydene.2016.04.191
   Ozcan S, 2016, INT J HYDROGEN ENERG, V41, P9796, DOI 10.1016/j.ijhydene.2016.02.044
   Pan Y, 2009, ADV MATER, V21, P2777, DOI 10.1002/adma.200800761
   Pearce R, 2011, SENSOR ACTUAT B-CHEM, V155, P451, DOI 10.1016/j.snb.2010.12.046
   Petr Klapetek, 2015, GWYDDION SOFTWARE US
   Qi JL, 2011, APPL SURF SCI, V257, P6531, DOI 10.1016/j.apsusc.2011.02.069
   Qi JL, 2012, CHINESE SCI BULL, V57, P3040, DOI 10.1007/s11434-012-5120-4
   Schedin F, 2007, NAT MATER, V6, P652, DOI 10.1038/nmat1967
   Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]
   Sutter PW, 2008, NAT MATER, V7, P406, DOI 10.1038/nmat2166
   Thomsen C, 2000, PHYS REV LETT, V85, P5214, DOI 10.1103/PhysRevLett.85.5214
   Wei L, 2016, INT J HYDROGEN ENERG, V41, P11692, DOI 10.1016/j.ijhydene.2016.04.030
   Wen CL, 2016, INT J HYDROGEN ENERG, V41, P11099, DOI 10.1016/j.ijhydene.2016.05.051
   Wu ZS, 2009, CARBON, V47, P493, DOI 10.1016/j.carbon.2008.10.031
   Xiao B, 2016, INT J HYDROGEN ENERG, V41, P11537, DOI 10.1016/j.ijhydene.2015.11.166
   Yu QK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2982585
   Zhang DM, 2016, INT J HYDROGEN ENERG, V41, P11593, DOI 10.1016/j.ijhydene.2016.04.106
   Zhang X, 2016, INT J HYDROGEN ENERG, V41, P10776, DOI 10.1016/j.ijhydene.2016.05.053
   Zhao W, 2011, J PHYS CHEM LETT, V2, P759, DOI 10.1021/jz200043p
NR 54
TC 3
Z9 3
U1 2
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD JAN 12
PY 2017
VL 42
IS 2
BP 1161
EP 1169
DI 10.1016/j.ijhydene.2016.08.073
PG 9
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA EM3KI
UT WOS:000395213200039
DA 2018-12-27
ER

PT J
AU Ali, M
   Lin, IN
AF Ali, Mubarak
   Lin, I-Nan
TI RETRACTED: The effect of the electronic structure, phase transition, and
   localized dynamics of atoms in the formation of tiny particles of gold
   (Retracted article. See vol. 19, art no 310, 2017)
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article; Retracted Publication
DE Dynamics; Geometry; Phase transition; Two-dimensional structure;
   Electronic structure; Photons; Smooth elements
ID BUILDING-BLOCKS; NANOPARTICLES; SIZE; NANOCRYSTALS; MOLECULES; SHAPE
AB In addition to self-governing properties, tiny-sized particles of metallic colloids are the building blocks of large-sized particles; thus, their study has been the subject of a large number of publications. In the present work, it has been discussed that geometry structure of tiny particle made through atom-to-atom amalgamation depends on attained dynamics of gold atoms along with protruded orientations. The localized process conditions direct two-dimensional structure of a tiny particle at atomically flat air-solution interface while heating locally dynamically approached atoms, thus, negate the role of van der Waals interactions. At electronphoton-solution interface, impinging electrons stretch or deform atoms of tiny particles depending on the mechanism of impingement. In addition, to strike regular grid of electrons ejected on split of atoms not executing excitations and de-excitations of their electrons, atoms of tiny particles also deform or stretch while occupying various sites depending on the process of synergy. Under suitable impinging electron streams, those tiny particles in monolayer two-dimensional structure electron states of their atoms are diffused in the direction of transferred energy, thus, coincide to the next adjacent atoms in each one-dimensional array dealing the same sort of behavior. Instantaneously, photons of adequate energy propagate on the surfaces of such electronic structures and modify those into smooth elements, thus, disregard the phenomenon of localized surface plasmons. This study highlights the fundamental process of formation of tiny particles where the role of localized dynamics of atoms and their electronic structure along with interaction to light are discussed. Such a tool of processing materials, in nonequilibrium pulse-based process, opens a number of possibilities to develop engineered materials with specific chemical, optical, and electronic properties.
C1 [Ali, Mubarak] COMSATS Inst Informat Technol, Dept Phys, Islamabad 45550, Pakistan.
   [Lin, I-Nan] Tamkang Univ, Dept Phys, Taipei 25137, Taiwan.
RP Ali, M (reprint author), COMSATS Inst Informat Technol, Dept Phys, Islamabad 45550, Pakistan.
EM mubarak74@mail.com
OI /0000-0003-1612-6014
FU Ministry of Science and Technology, Taiwan [NSC-102-2811-M-032-008]
FX This study was funded by the National Science Council, now Ministry of
   Science and Technology, Taiwan (grant number NSC-102-2811-M-032-008)
   (2013-2014).
CR Ali M., 2016, FORMATION TINY PARTI
   Ali M., 2016, SWITCHING DYNAMICS M
   Ali M., 2016, GEOMETRIC STRUCTURE
   Ali M., 2016, STRUCTURE EVOLUTION
   Ali M., 2016, ATOMIC BINDING GEOME
   Ali M., 2016, DYNAMICS COLLOIDAL P
   Ali M., 2016, CONTROLLING MORPHOLO
   Ali M., 2016, PHASE TRANSITIONS CR
   Ali M., 2016, ATOMS DEFORM STRETCH
   Atkinson S, 2014, P NATL ACAD SCI USA, V111, P18436, DOI 10.1073/pnas.1408371112
   Bratescu MA, 2011, J PHYS CHEM C, V115, P24569, DOI 10.1021/jp207447c
   Brown LO, 2001, J PHYS CHEM B, V105, P8911, DOI 10.1021/jp011231a
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   Brust M, 2002, COLLOID SURFACE A, V202, P175, DOI 10.1016/S0927-7757(01)01087-1
   Cho SP, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/45/455701
   DERJAGUIN B, 1993, PROG SURF SCI, V43, P30, DOI 10.1016/0079-6816(93)90013-L
   Glotzer SC, 2005, CURR OPIN COLLOID IN, V10, P287, DOI 10.1016/j.cocis.2005.09.011
   Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949
   Kim J, 2010, J AM CHEM SOC, V132, P4996, DOI 10.1021/ja1009629
   Kisielowski C, 2015, ADV MATER, V27, P5838, DOI 10.1002/adma.201500082
   Kusada K, 2013, J AM CHEM SOC, V135, P5493, DOI 10.1021/ja311261s
   Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889
   Liang X, 2010, NANOSCALE RES LETT, V5, P124, DOI 10.1007/s11671-009-9453-0
   Link S, 2000, INT REV PHYS CHEM, V19, P409, DOI 10.1080/01442350050034180
   Liu YM, 2011, CHEM SOC REV, V40, P2494, DOI 10.1039/c0cs00184h
   Manoharan VN, 2015, SCIENCE, V349, DOI 10.1126/science.1253751
   Moscatelli A, 2015, NATURE NANOTECHNOL, DOI [10.1038/nnano.2015.16, DOI 10.1038/NNANO.2015.16]
   Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711
   Negishi Y, 2015, J AM CHEM SOC, V137, P1206, DOI 10.1021/ja5109968
   Patel J, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/24/245604
   Shaw CP, 2011, J MATER CHEM, V21, P12181, DOI 10.1039/c1jm11945a
   Van der Waals J, 1873, THESIS
   Vanmaekelbergh D, 2011, NANO TODAY, V6, P419, DOI 10.1016/j.nantod.2011.06.005
   Ventra M. D., 2008, ELECT TRANSPORT NANO
   Whetten RL, 1996, ADV MATER, V8, P428, DOI 10.1002/adma.19960080513
   Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899
   Ye L, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.201104
   Zhu YY, 2014, ANGEW CHEM INT EDIT, V53, P10723, DOI 10.1002/anie.201405690
NR 38
TC 1
Z9 1
U1 3
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD JAN 9
PY 2017
VL 19
IS 1
AR 15
DI 10.1007/s11051-016-3710-9
PG 9
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA EI2AT
UT WOS:000392289200002
DA 2018-12-27
ER

PT J
AU Mu, XD
   Yang, YX
   Liu, Y
   Luo, D
   Xu, M
   Wei, H
   Gu, DE
   Song, HM
   Hu, YC
AF Mu, Xidong
   Yang, Yexin
   Liu, Yi
   Luo, Du
   Xu, Meng
   Wei, Hui
   Gu, Dangen
   Song, Hongmei
   Hu, Yinchang
TI RETRACTED: The complete mitochondrial genomes of two freshwater snails
   provide new protein-coding gene rearrangement models and phylogenetic
   implications(Retracted article. See vol. 10, Artn. No. 350, 2017)
SO PARASITES & VECTORS
LA English
DT Article; Retracted Publication
DE Pulmonate; Mitochondrial genome; Gene order; Phylogeny
ID SEQUENCE ALIGNMENT; GASTROPODA; EVOLUTION; DNA; PULMONATA;
   BASOMMATOPHORA; IDENTIFICATION; REPLICATION; INTERFACE; SELECTION
AB Background: Mitochondrial (mt) genome sequences are widely used for species identification and to study the phylogenetic relationships among Gastropoda. However, to date, limited data are available as taxon sampling is narrow. In this study we sequenced the complete mt genomes of the freshwater gastropods Radix swinhoei (Lymnaeidae) and Planorbarius corneus (Planorbidae). Based on these sequences, we investigated the gene rearrangement in these two species and the relationships with respect to the ancestral gene order and assessed their phylogenetic relationships.
   Methods: The complete mt genomes of R. swinhoei and P. corneus were sequenced using Illumina-based paired-end sequencing and annotated by comparing the sequence information with that of related gastropod species. Putative models of mitochondrial gene rearrangements were predicted for both R. swinhoei and P. corneus, using Reishia clavigera mtDNA structure as the ancestral gene order. The phylogenetic relationships were inferred using thirteen protein sequences based on Maximum likelihood and Bayesian inference analyses.
   Results: The complete circular mt genome sequences of R. swinhoei and P. corneus were 14,241 bp and 13,687 bp in length, respectively. Comparison of the gene order demonstrated complex rearrangement events in Gastropoda, both for tRNA genes and protein-coding genes. The phylogenetic analyses showed that the family Lymnaeidae was more closely related to the family Planorbidae, consistent with previous classification. Nevertheless, due to the position recovered for R. swinhoei, the family Lymnaeidae was not monophyletic.
   Conclusion: This study provides the complete mt genomes of two freshwater snails, which will aid the development of useful molecular markers for epidemiological, ecological and phylogenetic studies. Additionally, the predicted models for mt gene rearrangement might provide novel insights into mt genome evolution in gastropods.
C1 [Mu, Xidong; Yang, Yexin; Liu, Yi; Luo, Du; Xu, Meng; Wei, Hui; Gu, Dangen; Song, Hongmei; Hu, Yinchang] Chinese Acad Fishery Sci, Key Lab Trop & Subtrop Fishery Resource Applicat, Minist Agr, Pearl River Fisheries Res Inst, Xingyu Rd 1, Guangzhou 510380, Guangdong, Peoples R China.
RP Hu, YC (reprint author), Chinese Acad Fishery Sci, Key Lab Trop & Subtrop Fishery Resource Applicat, Minist Agr, Pearl River Fisheries Res Inst, Xingyu Rd 1, Guangzhou 510380, Guangdong, Peoples R China.
EM huyc22@163.com
FU Program of the National Science Infrastructure Platform of China
   [DKA30470]; Guangdong Science Technology Project of China
   [2010B060200023]
FX This study was supported by the Program of the National Science
   Infrastructure Platform of China (No. DKA30470) and Guangdong Science
   Technology Project of China (NO. 2010B060200023).
CR Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263
   ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0
   Bernt M, 2007, BIOINFORMATICS, V23, P2957, DOI 10.1093/bioinformatics/btm468
   Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023
   Charif D., 2007, STRUCTURAL APPROACHE, P207, DOI DOI 10.1007/978-3-540-35306-5_10
   Chen YX, 2009, J PATHOGEN BIOL, V4, P211
   Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598
   Dayrat B, 2011, MOL PHYLOGENET EVOL, V59, P425, DOI 10.1016/j.ympev.2011.02.014
   Gaitan-Espitia JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067299
   Feldmeyer B, 2010, MOL PHYLOGENET EVOL, V57, P1329, DOI 10.1016/j.ympev.2010.09.012
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61
   Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Guo Yun-Hai, 2009, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V20, P449
   Houart R, 2015, REISHIA CLAVIGERA
   Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323
   Ki JS, 2010, MOL PHYLOGENET EVOL, V54, P1016, DOI 10.1016/j.ympev.2009.12.003
   Klussmann-Kolb A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-57
   Kocot KM, 2013, MOL PHYLOGENET EVOL, V69, P764, DOI 10.1016/j.ympev.2013.07.001
   Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573
   Lawton SP, 2015, INFECT GENET EVOL, V35, P63, DOI 10.1016/j.meegid.2015.07.021
   Liu GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042172
   Liu YY, 1979, CHINESE EC ANIMAL FR, V1, P54
   Lunt DH, 1997, NATURE, V387, P247, DOI 10.1038/387247a0
   Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706
   McLean MJ, 1998, J MOL EVOL, V47, P691, DOI 10.1007/PL00006428
   Nolan JR, 2014, J MOLLUS STUD, V80, P388, DOI 10.1093/mollus/eyu025
   PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182
   Pfenninger M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-100
   Price MR, 2016, MITOCHONDRIAL DNA B, V1, P175, DOI 10.1080/23802359.2016.1149787
   Rasmussen DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-382
   Romero PE, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0735-8
   Romero PE, 2016, MOL PHYLOGENET EVOL, V97, P43, DOI 10.1016/j.ympev.2015.12.014
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   San Mauro D, 2006, MOL BIOL EVOL, V23, P227, DOI 10.1093/molbev/msj025
   Sharma D, 2004, BIOINFORMATICS, V20, P1405, DOI 10.1093/bioinformatics/bth103
   Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295
   Williams ST, 2014, GENE, V533, P38, DOI 10.1016/j.gene.2013.10.005
   WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5
   Yamazaki N, 1997, GENETICS, V145, P749
   Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576
   Zou SM, 2011, MOL PHYLOGENET EVOL, V61, P425, DOI 10.1016/j.ympev.2011.07.014
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 47
TC 0
Z9 1
U1 2
U2 7
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JAN 6
PY 2017
VL 10
AR 11
DI 10.1186/s13071-016-1956-9
PG 13
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA EN9MA
UT WOS:000396323100001
PM 28061879
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Mandavipour, B
   Elahi, AS
   Ghoranneviss, M
AF Mandavipour, B.
   Elahi, A. Salar
   Ghoranneviss, M.
TI RETRACTED: Electromagnetic flux density simulation for the circular and
   D-shaped cross section superconducting tokamaks (Retracted article. See
   vol. 43, pg. 3073, 2018)
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article; Retracted Publication
DE Tokamak; Electromagnetic flux
ID RESONANT HELICAL FIELD; PLASMA EQUILIBRIUM RECONSTRUCTION; IR-T1
   TOKAMAK; HORIZONTAL POSITION; RUNAWAY ELECTRONS; NUCLEAR-FUSION;
   POLOIDAL BETA; DESIGN; SYSTEM; RHF
AB The primary superconducting coils have a fundamental role in plasma magnetic confinement in tokamaks. The magnetic field which produced by primary coil leads to more magnetic field force and better magnetic confinement. In addition, the primary coil acts as a transformer. In this research we have compared the changes of magnetic field and magnetic flux density in distinct status through COMSOL Multiphysics software. The simulations which performed for air core status and three: 90 degrees, 120 degrees, 180 degrees iron core in D cross section and circular cross section tokamaks, indicated that in both kind of tokamaks, the magnetic confinement occurs in a better status with iron core compared with air core, and 90 degrees iron core is the best status for confinement. Also 25 coils designed in different K and delta which are elongation and triangularity respectively were simulated. The simulation represented that toroidal coils with 1 < K < 1.6 and 0.3<delta<0.6 indicated better magnetic field distribution and confinement. (C) 2016 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [Mandavipour, B.; Elahi, A. Salar; Ghoranneviss, M.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
EM Salari_phy@yahoo.com
CR Agah KM, 2015, J X-RAY SCI TECHNOL, V23, P267, DOI 10.3233/XST-150486
   Amerian Z, 2016, INT J THERM SCI, V110, P299, DOI 10.1016/j.ijthermalsci.2016.07.014
   Elahi AS, 2010, FUSION ENG DES, V85, P724, DOI 10.1016/j.fusengdes.2010.04.034
   Elahi AS, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/02/025502
   Elahi AS, 2010, PHYS SCRIPTA, V81, DOI 10.1088/0031-8949/81/05/055501
   Elahi AS, 2010, J FUSION ENERG, V29, P22, DOI 10.1007/s10894-009-9221-2
   Elahi AS, 2010, J FUSION ENERG, V29, P1, DOI 10.1007/s10894-009-9218-x
   Elahi AS, 2009, J FUSION ENERG, V28, P416, DOI 10.1007/s10894-009-9215-0
   Elahi AS, 2009, J FUSION ENERG, V28, P412, DOI 10.1007/s10894-009-9214-1
   Elahi AS, 2009, J FUSION ENERG, V28, P404, DOI 10.1007/s10894-009-9212-3
   Elahi AS, 2009, J FUSION ENERG, V28, P408, DOI 10.1007/s10894-009-9213-2
   Elahi AS, 2009, J FUSION ENERG, V28, P390, DOI 10.1007/s10894-009-9208-z
   Elahi AS, 2009, J FUSION ENERG, V28, P394, DOI 10.1007/s10894-009-9210-5
   Elahi AS, 2009, J FUSION ENERG, V28, P385, DOI 10.1007/s10894-009-9207-0
   Elahi AS, 2009, J FUSION ENERG, V28, P346, DOI 10.1007/s10894-009-9198-x
   Elahi AS, 2009, PHYS SCRIPTA, V80, DOI 10.1088/0031-8949/80/04/045501
   Elahi A Salar, 2016, J XRAY SCI IN PRESS
   Elahi AS, 2010, IEEE T PLASMA SCI, V38, P3163, DOI 10.1109/TPS.2010.2066289
   Elahi AS, 2010, IEEE T PLASMA SCI, V38, P181, DOI 10.1109/TPS.2009.2037965
   Freidberg JP., 2002, PLASMA PHYS FUSION E
   Ghanbari MR, 2016, J FUSION ENERG, V35, P180, DOI 10.1007/s10894-015-9992-6
   Ghoranneviss M, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/03/035502
   Habibian J, 2016, INT J HYDROGEN ENERG, V41, P15266, DOI 10.1016/j.ijhydene.2016.06.178
   Kafi M, 2016, J SYNCHROTRON RADIAT, V23, P1227, DOI 10.1107/S1600577516010262
   Naghidokht A, 2016, IEEE T NUCL SCI, V63, P2703, DOI 10.1109/TNS.2016.2598738
   Naghidokht A, 2016, INT J HYDROGEN ENERG, V41, P15272, DOI 10.1016/j.ijhydene.2016.07.026
   Naghidokht A, 2016, FUSION ENG DES, V107, P82, DOI 10.1016/j.fusengdes.2016.04.032
   Naghidokht A, 2016, J FUSION ENERG, V35, P415, DOI 10.1007/s10894-015-0051-0
   Rahimirad A, 2009, J FUSION ENERG, V28, P420, DOI 10.1007/s10894-009-9216-z
   Roudaki FS, 2015, J FUSION ENERG, V34, P911, DOI 10.1007/s10894-015-9898-3
   Roudaki FS, 2016, INT J HYDRO IN PRESS
   Salar Elahi A, 2009, J PLASMA PHYS, V76, P1
   Wesson J., 2004, TOKAMAKS
NR 33
TC 3
Z9 3
U1 0
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD JAN 5
PY 2017
VL 42
IS 1
BP 46
EP 59
DI 10.1016/j.ijhydene.2016.11.017
PG 14
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA EL5AW
UT WOS:000394634900003
DA 2018-12-27
ER

PT J
AU Cheng, Q
   Xu, M
   Zhang, ZD
   Xie, NL
AF Cheng, Qiang
   Xu, Min
   Zhang, Zhendong
   Xie, Nailiu
TI RETRACTED: Investigation on the spray characteristics of standard
   gasoline, n-pentane, iso-octane and ethnaol with a novel heated tip SIDI
   injector (Retracted article. See vol. 128, pg. 1673, 2018)
SO APPLIED THERMAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Heated tip SIDI injector; Thermodynamic; Spray characteristics; Mie
   scattering; Flash boiling
AB The present study was conducted to investigate the effects of thermal and fuel properties on the spray characteristics of a novel heated tip SIDI injector, and explore a new fuel injection method which can be widely used. The novel heated tip injector with an inner heater was re-designed in a conventional multi-hole SIDI injector. The heat generation was combined with the injection driver to control the injection and heating. The temperature of the heater and solenoid coil were controlled with a thermostatic system and the transfer of thermal energy to the fuel combined with the sub-atmospheric pressures were observed experimentally. The sprays from an asymmetric multi-hole SIDI injector were systematically investigated utilizing a high-speed Mie scattering imaging system and a Phase Doppler Particle Analyzer (PDPA) system. The macroscopic spray formations and SMD of standard gasoline, n-pentane, iso-octane and ethanol were measured and compared under different conditions. The influences of temperature, fuel properties and ambient pressure on the formation of macroscopic sprays were evaluated. The results indicate that there are to key factors that affect the spray characteristics under the same ambient pressure, one is the physical properties and the other is fuel temperature. The spray characteristics is the core role which has a high sensitive effect on the engine performances, therefore causes the flexible fuels cannot be widely used because of the limitation of the engine configuration. The aims of this investigation is to explore a new method which analyzes the change trends of the spray characteristics of different fuels on a novel heated tip SIDI injector. And then calibrate the spray characteristics under different conditions through adjusting the superheated degree of the flexible fuels to improve the spray characteristics so as to meet the demands of the engines. (C) 2016 Published by Elsevier Ltd.
C1 [Cheng, Qiang; Xu, Min] Shanghai Jiao Tong Univ, Inst Automot Engn, Shanghai 200240, Peoples R China.
   [Zhang, Zhendong; Xie, Nailiu] Univ Shanghai Sci & Technol, Inst Automot Engn, Shanghai 200093, Peoples R China.
RP Cheng, Q (reprint author), Shanghai Jiao Tong Univ, Inst Automot Engn, Shanghai 200240, Peoples R China.
EM jonny_cheng@sjtu.edu.cn; usstzzd@126.com; xnls1025@163.com
FU National Natural Science Foundation of China [51275309]; Postdoctoral
   Science Foundation of China [2015M581611]
FX This work is supported by the National Natural Science Foundation of
   China (Grant No: 51275309) and Postdoctoral Science Foundation of China
   (Grant No: 2015M581611). The Authors are all indebted to their generous
   support.
CR Battistoni M, 2012, APPL ENERG, V97, P656, DOI 10.1016/j.apenergy.2011.11.080
   Chan QN, 2014, FUEL, V130, P228, DOI 10.1016/j.fuel.2014.04.015
   Cheng Q, 2016, INT J HEAT FLUID FL, V59, P87, DOI 10.1016/j.ijheatfluidflow.2016.03.001
   Cheng Q, 2015, APPL THERM ENG, V91, P611, DOI 10.1016/j.applthermaleng.2015.08.053
   Ferrari A, 2015, APPL ENERG, V151, P367, DOI 10.1016/j.apenergy.2015.03.074
   Huong Thu, 2011320582 SAE
   Kabasin Daniel, 2010011265 SAE
   Kabasin Daniel, 2009010615 SAE
   Kaye G.W.C., 1995, TABLES PHYS CHEM CON
   Konigsson Fredrik, 2012010826 SAE
   Krenus Roberto, 2014011369 SAE
   Lefebvre A. H., 1989, ATOMIZATION SPRAYS
   Leuthel R., 2008012760 SAE
   Mangalla Lukas Kano, 2013329126 SAE
   Yamazaki Nobuyuki, 1983, P JSME B, V49, P1810
   Yaws C. L., 2006, AWS HDB THERMODYNAMI
   Zeng W, 2012, FUEL, V95, P287, DOI 10.1016/j.fuel.2011.08.048
   Zhang G., 2012, P FISITA 2012 WORLD, P443
   ZHANG Y, 2003, 2003013115 SAE
NR 19
TC 5
Z9 5
U1 5
U2 15
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-4311
J9 APPL THERM ENG
JI Appl. Therm. Eng.
PD JAN 5
PY 2017
VL 110
BP 539
EP 552
DI 10.1016/j.applthermaleng.2016.07.201
PG 14
WC Thermodynamics; Energy & Fuels; Engineering, Mechanical; Mechanics
SC Thermodynamics; Energy & Fuels; Engineering; Mechanics
GA ED3VC
UT WOS:000388775600054
DA 2018-12-27
ER

PT J
AU Imal, M
   Kaya, A
   Sincar, O
AF Imal, Muharrem
   Kaya, Ahmet
   Sincar, Osman
TI RETRACTED: The Biodiesel of Olive Oil Engine Performance and
   Determination of Impacts on Exhaust Emissions (Retracted Article)
SO KAHRAMANMARAS SUTCU IMAM UNIVERSITY JOURNAL OF NATURAL SCIENCES
LA Turkish
DT Article; Retracted Publication
DE Biodiesel; Diesel engine; Exhaust emissions
ID DIESEL-ENGINE; METHYL-ESTERS; COMBUSTION; INJECTION; FUEL
AB The biodiesel production is gradually increasing due to environmental advantages and reduction in dependence on petroleum based diesel fuels. Biodiesel is an oxygenated alternative diesel fuel obtained from renewable sources such as vegetable oil and animal fats. Therefore, many number of studies have been performed related to the production and the use of biodiesel. In this study, the effect of the use of olive oil, as alternative fuel, on engine performance and exhaust emissions in a single cylinder diesel engine were investigated. Diesel fuel and olive oil were used. In order to determine emission and performance characteristics, the engine was tested with full load-varied speed and constant speed-varied load tests. Chemical and physical properties of the raw olive oil were improved mixing with diesel fuel. Experimental results showed that, when olive oil and mixtures are used, the lower engine performance and NOx, and higher exhaust emissions were detected compared to the diesel fuel used engine performance.
C1 [Imal, Muharrem; Kaya, Ahmet; Sincar, Osman] KSU Muhendislik Mimarlik Fak, Makine Muhendisligi Bolumu, Kahramanmaras, Turkey.
RP Imal, M (reprint author), KSU Muhendislik Mimarlik Fak, Makine Muhendisligi Bolumu, Kahramanmaras, Turkey.
EM muharremimal@ksu.edu.tr
CR Acaroglu M, 2008, 7 UL TEM EN SEMP 17, P17
   Akgun G, 2009, 5 YEN EN SEMP DIYARB
   Aktas A, 2008, J FAC ENG ARCHIT GAZ, V23, P199
   Alpgiray B, 2006, THESIS
   Altin R, 1998, THESIS
   Altun S, 2010, TASIT TEKNOLOJILERI, P9
   Aybek A, 2011, TURK J AGRIC FOR, V35, P103, DOI 10.3906/tar-0907-242
   Demirci G, 2001, BIYOGAZ ATIKLARDAN E
   Elicin AK, 2007, TARIM BILIM DERG, V13, P137
   Erdogan D, 2007, 13 UL K 25 27 EYL KO
   Hasimoglu C., 2005, THESIS
   Hasimoglu C, 2008, J FAC ENG ARCHIT GAZ, V23, P207
   Keskin A, 2007, GAZI U MUH MIM FAK D, V22, P57
   Ozsezen AN, 2009, J FAC ENG ARCHIT GAZ, V24, P275
   Sekmen Y, 2007, TECHNOLOGY, V10, P295
   Sen Z, 2003, TEMIZ ENERJI VE KAYN
   Sugozu I., 2009, MAKINA TEKNOLOJILERI, V6, P49
   Ulusoy Y, 1999, THESIS
NR 18
TC 0
Z9 0
U1 8
U2 8
PU KAHRAMANMARAS SUTCU IMAM UNIV
PI KAHRAMANMARAS
PA ISMET PASA MH, KAHRAMANMARAS, 46100, TURKEY
SN 1309-1743
J9 KAHRAMANMARAS SUTCU
JI Kahramanmaras Sutcu Imam Univ. J. Nat. Sci.
PY 2017
VL 20
IS 3
BP 283
EP 291
DI 10.18016/ksudobil.289473
PG 9
WC Agriculture, Multidisciplinary
SC Agriculture
GA GQ2EI
UT WOS:000441461100014
OA Bronze
DA 2018-12-27
ER

PT J
AU Maltese, A
   Romano, P
   D'Oro, L
   Gallai, B
   Marotta, R
   Lavano, F
   Lavano, SM
   Tripi, G
   Salerno, M
AF Maltese, Agata
   Romano, Palmira
   D'Oro, Lucrezia
   Gallai, Beatrice
   Marotta, Rosa
   Lavano, Francesco
   Lavano, Serena Marianna
   Tripi, Gabriele
   Salerno, Margherita
TI RETRACTED: ANGER IN CHILDREN: A MINIREVIEW (Retracted Article)
SO ACTA MEDICA MEDITERRANEA
LA English
DT Review; Retracted Publication
DE anger; children; emotional control; drawings
ID MIGRAINE; SLEEP; AURA; CARE; IRAN; KERMANSHAH; HOSPITALS; SYNERGISM;
   ENURESIS; EFFICACY
AB Aggressive behavior is a peculiar characteristic of most animal species playing an important role in species preservation and two types have been identified: interspecific and intraspecific aggression. The interspecific refers purely to the instinct of predation, while the intraspecific is the purpose for species preservation. Anger has been found in very young children between the ages of four and seven, is manifested through vocalizations, expressions and global movements affecting the entire body of the child: it is a means of communication privileged to express themselves and communicate. Anger must be considered a positive event, even if it may frighten it has a positive effect: transforming an event that could only be destructive and useless in a constructive process, and channeling the child's anger toward a specific goal.
C1 [Maltese, Agata] Univ Palermo, Dept Psychol Pedag & Educ Sci, Palermo, Italy.
   [Romano, Palmira] Ctr LARS, Sarno, Italy.
   [D'Oro, Lucrezia] Ctr Relax, Benevento, Italy.
   [Gallai, Beatrice] Univ Perugia, Dept Surg & Biomed Sci, Perugia, Italy.
   [Marotta, Rosa; Lavano, Francesco; Lavano, Serena Marianna] Magna Graecia Univ Catanzaro, Dept Med & Surg Sci, Catanzaro, Italy.
   [Tripi, Gabriele] Univ Palermo, Dept PROSAMI, Palermo, Italy.
   [Tripi, Gabriele] CH Chinon, Childhood Psychiat Serv Neurodev Disorders, St Benoit La Foret, France.
   [Salerno, Margherita] Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.
RP Salerno, M (reprint author), Univ Palermo, Sci Mother & Child Hlth Promot, Palermo, Italy.
OI TRIPI, Gabriele/0000-0001-7088-9325
CR Acar YA, 2016, ACTA MEDICA MEDITERR, V32, P75
   Akdam H, 2016, ACTA MEDICA MEDITERR, V32, P685, DOI 10.19193/0393-6384_2016_3_75
   Behnamipour S, 2016, ACTA MEDICA MEDITERR, V32, P1549
   Carotenuto M, 2016, ACTA PAEDIATR, V105, P1079, DOI 10.1111/apa.13472
   Carotenuto M, 2010, MED HYPOTHESES, V75, P120, DOI 10.1016/j.mehy.2010.02.004
   Carotenuto M, 2013, NEUROL SCI, V34, P1905, DOI 10.1007/s10072-013-1403-z
   Carotenuto M, 2013, MED HYPOTHESES, V81, P306, DOI 10.1016/j.mehy.2013.04.023
   Chisari G, 2016, ACTA MEDICA MEDITERR, V32, P865, DOI 10.19193/0393-6384_2016_4_102
   Coppola G, 2004, BRAIN DEV-JPN, V26, P26, DOI 10.1016/S0387-7604(03)00090-1
   Crittenden PM, 2017, CLIN CHILD PSYCHOL P, V22, P436, DOI 10.1177/1359104517716214
   Di Filippo T, 2012, MENT ILLN, V4, P21, DOI 10.4081/mi.2012.e5
   Di Serio F, 2016, ACTA MEDICA MEDITERR, V32, P1911, DOI 10.19193/0393-6384_2016_6_182
   Eksi F, 2017, ACTA MEDICA MEDITERR, V33, P341, DOI 10.19193/0393-6384_2017_2_051
   Epifanio MS, 2013, PEDIATRIC REP, V5, P81, DOI 10.4081/pr.2013.e19
   Eraslan A, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_153
   Es MU, 2016, ACTA MEDICA MEDITERR, V32, P911, DOI 10.19193/0393-6384_2016_4_109
   Esposito M, 2014, J INTELL DISABIL RES, V58, P421, DOI 10.1111/jir.12036
   Esposito M, 2015, J MED FOOD, V18, P916, DOI 10.1089/jmf.2014.0113
   Esposito M, 2014, NEUROPSYCH DIS TREAT, V10, P1897, DOI 10.2147/NDT.S69795
   Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1513, DOI 10.2147/NDT.S52716
   Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1351, DOI 10.2147/NDT.S51554
   Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1187, DOI 10.2147/NDT.S50458
   Esposito M, 2013, NEUROPSYCH DIS TREAT, V9, P1061, DOI 10.2147/NDT.S49364
   Fariba F, 2016, ACTA MEDICA MEDITERR, V32, P2101
   Feghhi F, 2016, ACTA MEDICA MEDITERR, V32, P1011
   George C, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01594
   Jalili Z, 2016, ACTA MEDICA MEDITERR, V32, P915
   Karakas D, 2017, ACTA MEDICA MEDITERR, V33, P811, DOI 10.19193/0393-6384_2017_5_120
   Kargin NC, 2016, ACTA MEDICA MEDITERR, V32, P317
   Khodaii Z, 2017, ACTA MEDICA MEDITERR, V33, P301, DOI 10.19193/0393-6384_2017_2_045
   Kilic B, 2017, ACTA MEDICA MEDITERR, V33, P335, DOI [10.19193/0393-6384_2017_2_050, DOI 10.19193/0393-6384_2017_2_050]
   Kirisci O, 2016, ACTA MEDICA MEDITERR, V32, P1805, DOI 10.19193/0393-6384_2016_6_167
   Li HC, 2016, ACTA MEDICA MEDITERR, V32, P519
   Li Y, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_148
   Li ZX, 2017, ACTA MEDICA MEDITERR, V33, P41, DOI 10.19193/0393-6384_2017_1_006
   Licata M, 2016, ACTA MEDICA MEDITERR, V32, P1569, DOI 10.19193/0393-6384_2016_5_131
   Lin ZH, 2016, ACTA MEDICA MEDITERR, V32, P575
   Liu TG, 2016, ACTA MEDICA MEDITERR, V32, P877, DOI 10.19193/0393-6384_2016_4_104
   Ma H, 2016, ACTA MEDICA MEDITERR, V32, P1155
   Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P777, DOI 10.19193/0393-6384_2017_5_114
   Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P667, DOI 10.19193/03936384_2017_4_100
   Maltese A, 2017, ACTA MEDICA MEDITERR, V33, P675, DOI 10.19193/0393-6384_2017_4_101
   Messina A, 2017, ACTA MEDICA MEDITERR, V33, P833, DOI 10.19193/0393-6384_2017_5_124
   Messina A, 2017, ACTA MEDICA MEDITERR, V33, P641, DOI 10.19193/0393-6384_2017_4_095
   Messina A, 2017, ACTA MEDICA MEDITERR, V33, P645, DOI 10.19193/0393-6384_2017_4_096
   Messina G, 2014, J ANESTH CLIN RES, V5, DOI [10.4172/2155-6148.1000395, DOI 10.4172/2155-6148.1000395]
   Messina G, 2015, BIOL MED, V7, DOI [10.4172/0974-8369.1000S3007, DOI 10.4172/0974-8369.1000S3007]
   Messina G., 2015, BIOL MED, V7, P4, DOI [10.4172/0974-8369.1000248, DOI 10.4172/0974-8369.1000248]
   Mohammadnejad E, 2016, ACTA MEDICA MEDITERR, V32, P1295
   Monda V, 2017, ACTA MEDICA MEDITERR, V33, P581, DOI 10.19193/0393-6384_2017_4_085
   Moscatelli F, 2017, ACTA MEDICA MEDITERR, V33, P423, DOI 10.19193/0393-6384_2017_3_062
   Moscatelli F, 2016, SOMATOSENS MOT RES, V33, P137, DOI 10.1080/08990220.2016.1203305
   Motlagh AH, 2016, ACTA MEDICA MEDITERR, V32, P2065
   Nankaly A, 2016, ACTA MEDICA MEDITERR, V32, P953
   Parisi L, 2016, ACTA MEDICA MEDITERR, V32, P1665, DOI [10.19193/0393-6384_2016_5_147, DOI 10.19193/0393-6384_]
   Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P495, DOI 10.19193/0393-6384_2017_3_074
   Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P49, DOI 10.19193/0393-6384_2017_1_007
   Parisi L, 2017, ACTA MEDICA MEDITERR, V33, P23, DOI 10.19193/0393-6384_2017_1_003
   Pekel NB, 2017, ACTA MEDICA MEDITERR, V33, P101, DOI 10.19193/0393-6384_2017_1_016
   Perciavalle V, 2016, ACTA MEDICA MEDITERR, V32, P23
   Perillo L, 2014, PATIENT PREFER ADHER, V8, P353, DOI 10.2147/PPA.S58971
   Pirsaheb M, 2016, ACTA MEDICA MEDITERR, V32, P967
   Precenzano F, 2017, ACTA MEDICA MEDITERR, V33, P405, DOI 10.19193/0393-6384_2017_3_059
   Precenzano F, 2017, NEUROPSYCH DIS TREAT, V13, P253, DOI 10.2147/NDT.S119648
   Precenzano F, 2016, ACTA MEDICA MEDITERR, V32, P1761, DOI 10.19193/0393-6384_2016_6_160
   Rasouli AS, 2016, ACTA MEDICA MEDITERR, V32, P1063
   Refahi S, 2016, ACTA MEDICA MEDITERR, V32, P1207
   Rinaldi B, 2015, NEURAL PLAST, DOI 10.1155/2015/265967
   Ruberto M, 2016, ACTA MEDICA MEDITERR, V32, DOI 10.19193/0393-6384_2016_5_146
   Salehi M, 2016, ACTA MEDICA MEDITERR, V32, P1933
   Salehi N, 2016, ACTA MEDICA MEDITERR, V32, P1965
   Salerno M, 2017, ACTA MEDICA MEDITERR, V33, P621, DOI 10.19193/0393-6384_2017_4_092
   Santamaria F, 2014, RESPIROLOGY, V19, P570, DOI 10.1111/resp.12273
   Valenzano A, 2016, INT J SPORT PHYSIOL, V11, P407, DOI 10.1123/ijspp.2015-0035
   Valiee S, 2016, ACTA MEDICA MEDITERR, V32, P1021
   van Rosmalen L, 2016, HIST PSYCHOL, V19, P22, DOI 10.1037/hop0000015
   Vazirinejad R, 2016, ACTA MEDICA MEDITERR, V32, P987, DOI 10.19193/0393-6384_2016_4_120
   Viggiano A, 2014, J SPORT SCI, V32, P46, DOI 10.1080/02640414.2013.805236
   Wang GP, 2016, ACTA MEDICA MEDITERR, V32, P599
   Wang H, 2016, ACTA MEDICA MEDITERR, V32, P547
   Wen SJ, 2016, ACTA MEDICA MEDITERR, V32, P481
   Wen SW, 2016, ACTA MEDICA MEDITERR, V32, P303
   Yoon H., 2016, ACTA MEDICA MEDITERR, V32, P1697
   Zohreyi T, 2016, ACTA MEDICA MEDITERR, V32, P1257
NR 84
TC 0
Z9 0
U1 2
U2 2
PU CARBONE EDITORE
PI PALERMO
PA VIA QUINTINO SELLA, 68, PALERMO, 90139, ITALY
SN 0393-6384
EI 2283-9720
J9 ACTA MEDICA MEDITERR
JI Acta Medica Mediterr.
PY 2017
VL 33
SI 2
BP 1233
EP 1240
DI 10.19193/0393-6384_2017_2s_191
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA FV8ZY
UT WOS:000424877700008
DA 2018-12-27
ER

PT J
AU Srikanth, S
AF Srikanth, S.
TI RETRACTED: Histopathological analysis of meningioma and its variants: A
   study of fifty cases (Retracted article. See vol. 54, pg. 490, 2017)
SO INDIAN JOURNAL OF CANCER
LA English
DT Article; Retracted Publication
DE Fibroblastic; meningioma; meningothelial; psammomatous
ID CHORDOID MENINGIOMA; BRAIN
AB BACKGROUND: The study was conducted to know the various histopathological variants of meningiomas, the age incidence and sex ratio. MATERIALS AND METHODS: A retrospective and prospective analysis of all the samples sent for histopathology for 2 years during June 2013-May 2015 was done to diagnose meningioma and its variants. Cases were analyzed in detail about the complete clinical history, exact location, and clinical and radiological diagnosis. The majority of the cases were clinically and radiologically diagnosed as meningioma. RESULTS: Of 50 cases which were diagnosed as meningiomas, 21 were meningothelial variant, 15 were psammomatous, 8 were fibroblastic, 4 were transitional, and 1 case each of anaplastic and atypical variant. The most common age group was between 41 and 50 years. The youngest age group was 16 years and oldest was 70. The male: female ratio was 1: 1.5. CONCLUSION: The majority of the meningiomas have been observed between 41 and 50 years. Their proper recognition is therefore important to allow appropriate treatment. Histopathological study plays a major role by which we can diagnose the lesion. Meningiomas typically develop in middle-aged individuals and occur more frequently in women than men. These lesions may also occur in children.
C1 [Srikanth, S.] Pratima Inst Med Sci, Dept Pathol, Karimnagar, Telangana, India.
RP Srikanth, S (reprint author), Pratima Inst Med Sci, Dept Pathol, Karimnagar, Telangana, India.
EM drshastrysri@yahoo.com
CR Arima T, 2005, J NEUROSURG, V102, P733, DOI 10.3171/jns.2005.102.4.0733
   Campbell BA, 2009, AM J CLIN ONCOL-CANC, V32, P73, DOI 10.1097/COC.0b013e31816fc920
   Liu ZG, 2013, INT J CLIN EXP PATHO, V6, P695
   Modha A, 2005, NEUROSURGERY, V57, P538, DOI 10.1227/01.NEU.0000170980.47582.A5
   Moiyadi AV, 2010, J CLIN NEUROSCI, V17, P397, DOI 10.1016/j.jocn.2009.05.035
   Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151
   Shibui S, 2014, NEUROL MED-CHIR, V54, P1
   Wang P, 2011, GENET MOL RES, V10, P2165, DOI 10.4238/vol10-3gmr1212
NR 8
TC 1
Z9 1
U1 2
U2 3
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0019-509X
EI 1998-4774
J9 INDIAN J CANCER
JI Indian J. Cancer
PD JAN-MAR
PY 2017
VL 54
IS 1
BP 313
EP 315
DI 10.4103/ijc.IJC_119_17
PG 3
WC Oncology
SC Oncology
GA FO7ZC
UT WOS:000417098300063
PM 29199712
DA 2018-12-27
ER

PT J
AU He, Y
   Xu, X
   Zhu, T
   Tang, M
   Mei, J
   Si, Y
AF He, Yi
   Xu, Xin
   Zhu, Ting
   Tang, Min
   Mei, Ju
   Si, Yi
TI RETRACTED: Resident Arterial Cells and Circulating Bone Marrow-Derived
   Cells both Contribute to Intimal Hyperplasia in a Rat Allograft Carotid
   Transplantation Model (Retracted article. See vol. 45, pg. 2577, 2018)
SO CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
LA English
DT Article; Retracted Publication
DE Intimal hyperplasia; Allograft; Carotid transplantation; Bone marrow
   cells
ID SMOOTH-MUSCLE-CELLS; PROGENITOR CELLS; NEOINTIMAL FORMATION;
   ATHEROSCLEROTIC LESIONS; DIVERSE CONTRIBUTION; VASCULAR INJURY;
   DEFICIENT MICE; VEIN GRAFTS; PROLIFERATION; THERAPY
AB Background/Aims: Neointimal formation following vascular injury remains a major mechanism of restenosis, whereas the precise sources of neointimal cells are still uncertain. We tested the hypothesis that both injured arterial cells and non-arterial cells contribute to intimal hyperplasia. Methods: Following allograft transplantation of the balloon-injured carotid common artery (n = 3-6), the cellular composition of the transplant grafts and the origins of neointimal cells were measured by immunohistochemistry and immunofluorescence staining. Results: Smooth muscle actin (SMA)-positive and CD68-positive cells were clearly observed 14 days later in the neointima after allograft transplantation of the balloon-injured carotid common artery, where re-endothelialization was not yet complete. Green fluorescent protein (GFP) and wild-type (WT) allograft transplantation revealed that the majority of the neointima cells were apparently from the recipient (approximate to 85%) versus the donor (approximate to 15%). Both monocyte chemotactic protein-1 (MCP-1)/CCR2 and stromal cell-derived factor-1 (SDF-1)/ CXCR4 signaling were involved in intimal hyperplasia, with bone marrow-derived cells also playing a role. Conclusion: These data support the hypothesis that intimal hyperplasia could develop in our novel rat allograft transplantation model of arterial injury, where neointima is attributable not only to local arterial cells but also non-arterial cells including the bone marrow. (C) 2017 The Author(s) Published by S. Karger AG, Basel
C1 [He, Yi; Tang, Min; Mei, Ju] Shanghai Jiao Tong Univ, Dept Cardiovasc Surg, Xinhua Hosp, Sch Med, Shanghai 200092, Peoples R China.
   [Xu, Xin; Zhu, Ting; Si, Yi] Fudan Univ, Dept Vasc Surg, Zhongshan Hosp, Shanghai 200032, Peoples R China.
RP Mei, J (reprint author), Shanghai Jiao Tong Univ, Dept Cardiovasc Surg, Xinhua Hosp, Sch Med, Shanghai 200092, Peoples R China.; Si, Y (reprint author), Fudan Univ, Dept Vasc Surg, Zhongshan Hosp, Shanghai 200032, Peoples R China.
EM ju_mei63@126.com; sysiy@yahoo.com
FU National Natural Science Foundation of China [81470581, 81541012]
FX This work was supported by the National Natural Science Foundation of
   China (No. 81470581 and 81541012).
CR Campbell JH, 2001, ANN NY ACAD SCI, V947, P18
   Campbell JH, 2001, ANN NY ACAD SCI, V947, P24
   Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327
   Gubert F, 2013, STEM CELL RES, V10, P241, DOI 10.1016/j.scr.2012.11.009
   Hu Q, 2015, CELL PHYSIOL BIOCHEM, V37, P719, DOI 10.1159/000430390
   Hu YH, 2004, J CLIN INVEST, V113, P1258, DOI 10.1172/JCI200419628
   Hu YH, 2002, CIRC RES, V91, pE13, DOI 10.1161/01.RES.0000037090.34760.EE
   Hu YH, 2002, CIRCULATION, V106, P1834, DOI 10.1161/01.CIR.0000031333.86845.DD
   Iwata H, 2008, CIRCULATION, V117, P3060, DOI 10.1161/CIRCULATIONAHA.108.782961
   Kent KC, 2004, ANN VASC SURG, V18, P135, DOI 10.1007/s10016-004-0019-4
   Mao HM, 2016, CELL PHYSIOL BIOCHEM, V40, P1506, DOI 10.1159/000453201
   Mayr M, 2000, FASEB J, V14, P261
   Rodriguez-Menocal L, 2009, CARDIOVASC RES, V81, P46, DOI 10.1093/cvr/cvn265
   Roque M, 2002, ARTERIOSCL THROM VAS, V22, P554, DOI 10.1161/hq0402.105720
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Sahara M, 2007, CIRCULATION, V115, P509, DOI 10.1161/CIRCULATIONAHA.106.655837
   Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844
   Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403
   Schober A, 2003, CIRCULATION, V108, P2491, DOI 10.1161/01.CIR.0000099508.76665.9A
   Schober A, 2008, ARTERIOSCL THROM VAS, V28, P1950, DOI 10.1161/ATVBAHA.107.161224
   Shimizu K, 2001, NAT MED, V7, P738, DOI 10.1038/89121
   Si Y, 2012, ARTERIOSCL THROM VAS, V32, P943, DOI 10.1161/ATVBAHA.111.244921
   Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30
   Tanaka K, 2003, CIRC RES, V93, P783, DOI 10.1161/01.RES.0000096651.13001.B4
   Tang C, 2007, FASEB J, V21, P3777, DOI 10.1096/fj.07-8560rev
   Tsai S, 2009, AM J PHYSIOL-HEART C, V297, pH540, DOI 10.1152/ajpheart.91478.2007
   Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74
   Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8
   Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420
   Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38
NR 30
TC 3
Z9 3
U1 3
U2 5
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1015-8987
EI 1421-9778
J9 CELL PHYSIOL BIOCHEM
JI Cell. Physiol. Biochem.
PY 2017
VL 42
IS 4
BP 1303
EP 1312
DI 10.1159/000478959
PG 10
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA FI8JC
UT WOS:000412247700003
PM 28715799
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Strnadova, G
   Hanus, V
   Kahoun, D
   Semerak, P
   Triska, J
AF Strnadova, Gabriela
   Hanus, Vlastimil
   Kahoun, David
   Semerak, Petr
   Triska, Jan
TI RETRACTED: POSSIBILITY OF MONITORING OF PAHs DISTRIBUTION IN THE
   VERTICAL PROFILE AT THE BACKGROUND METEOROLOGICAL STATION KRESIN
   (Retracted Article)
SO ACTA POLYTECHNICA
LA English
DT Article; Retracted Publication
DE vertical profile; polycyclic aromatic hydrocarbons (PAHs); air quality;
   extraction procedure; HPLC; Meteorological station Kresin
ID POLYCYCLIC AROMATIC-HYDROCARBONS; PERSISTENT ORGANIC POLLUTANTS;
   ATMOSPHERIC BOUNDARY-LAYER; PASSIVE AIR SAMPLER; PARTICULATE MATTER;
   SIZE DISTRIBUTIONS; SEASONAL-VARIATION; SPATIAL VARIATIONS; OUTDOOR AIR;
   URBAN AIR
AB The contaminants present in the atmosphere have a substantial impact on public health. Among contaminants, the most important are polycyclic aromatic hydrocarbons (PAHs).
   This paper is focused on the possibility of continuous PAHs monitoring and the description of their vertical distribution using filters, which serve to purify the air before the determination of the greenhouse gases (CO2, CH4, N2O, CO, ozone) and Hg in air, continuously sampled at 8, 50 and 230m at the atmospheric station Kresn near Pacov and elaboration of a simple and economical method of extraction of these filters.
   The station serves as a point for monitoring the occurrence and remote transport of greenhouse gases and selected atmospheric pollutants and for the measurements of basic meteorological characteristics. In December, 17, 2014, a sampling of 16 priority PAHs started and lasted until December, 9, 2015. Samples were taken approximately once a month. The maximum concentration of Sigma PAHs was 15.905 ng/m(3), measured at the height of 8 meters in the period of 11. 2. 2015-11. 3. 2015, the concentration of benzo[a] pyrene exceeded the immission limit in this period by more than 50 %.
   By the sampling, the hypothesis about decreasing concentration of PAHs with increasing height was confirmed, especially the decrease of heavier PAHs.
   The sampling has shown that it is highly desirable to use the meteorological tower for sampling of PAHs using PTFE filters either by including the active sampler itself, or by using pre-filters for tropospheric ozone and gaseous elemental mercury analysers.
C1 [Strnadova, Gabriela; Semerak, Petr] Czech Tech Univ, Dept Phys, Fac Civil Engn, Thakurova 7, Prague 16629 6, Dejvice, Czech Republic.
   [Strnadova, Gabriela; Kahoun, David; Triska, Jan] Univ South Bohemia Ceske Budejovice, Inst Chem & Biochem, Fac Sci, Branisovska 1760, Ceske Budejovice 37005, Czech Republic.
   [Hanus, Vlastimil; Triska, Jan] Czech Acad Sci, Global Change Res Inst, Vvi, Belidla 4a, Brno 60300, Czech Republic.
RP Strnadova, G (reprint author), Czech Tech Univ, Dept Phys, Fac Civil Engn, Thakurova 7, Prague 16629 6, Dejvice, Czech Republic.; Strnadova, G (reprint author), Univ South Bohemia Ceske Budejovice, Inst Chem & Biochem, Fac Sci, Branisovska 1760, Ceske Budejovice 37005, Czech Republic.
EM gstrnadova@prf.jcu.cz
RI Triska, Jan/H-3094-2014
OI Triska, Jan/0000-0003-3846-2158
FU Czech Technical University grant [SGS16/197/OHK1/3T/11]; Ministry of
   Education, Youth and Sports of CR within the National Sustainability
   Program I (NPU I) [LO1415]; Global Change Research Institute AS CR;
   Faculty of Natural Sciences, University of South Bohemia in Ceske
   Budejovice
FX The article was supported by the Czech Technical University grant
   SGS16/197/OHK1/3T/11 and by the Ministry of Education, Youth and Sports
   of CR within the National Sustainability Program I (NPU I), grant number
   LO1415 and the research was performed in the frame of the contract
   between Global Change Research Institute AS CR and Faculty of Natural
   Sciences, University of South Bohemia in Ceske Budejovice. We also thank
   very much to colleagues from Global Change Research Institute AS CR for
   collecting filters in the tower of Kresin near Pacov, mainly Gabriela
   Vitkova.
CR Aamot E, 1996, ENVIRON POLLUT, V92, P275, DOI 10.1016/0269-7491(95)00114-X
   Anastasopoulos AT, 2012, ATMOS ENVIRON, V59, P272, DOI 10.1016/j.atmosenv.2012.05.004
   [Anonymous], 2015, CESKY HYDROMETEOROLO
   [Anonymous], 2016, KRES NEAR PAC OBS PA
   [Anonymous], 2015, CLOUDS TRAC GAS ACTR
   [Anonymous], 2016, CESKA METEOROLOGICKA
   Bae SY, 2002, ATMOS ENVIRON, V36, P5491, DOI 10.1016/S1352-2310(02)00666-0
   Chen Y, 2017, SCI TOTAL ENVIRON, V586, P255, DOI 10.1016/j.scitotenv.2017.01.214
   Choi SD, 2008, ATMOS CHEM PHYS, V8, P4105, DOI 10.5194/acp-8-4105-2008
   Cupr P, 2006, ENVIRON POLLUT, V144, P406, DOI 10.1016/j.envpol.2005.12.045
   Curtosi A, 2007, SCI TOTAL ENVIRON, V383, P193, DOI 10.1016/j.scitotenv.2007.04.025
   Duan JC, 2005, ATMOS RES, V78, P190, DOI 10.1016/j.atmosres.2005.04.001
   Dunbar JC, 2001, SCI TOTAL ENVIRON, V279, P1, DOI 10.1016/S0048-9697(01)00686-6
   Farrar NJ, 2005, ENVIRON SCI TECHNOL, V39, P42, DOI 10.1021/es048907a
   Gouin T, 2010, ATMOS POLLUT RES, V1, P9, DOI 10.5094/APR.2010.002
   HALSALL CJ, 1994, ENVIRON SCI TECHNOL, V28, P2380, DOI 10.1021/es00062a024
   Halsall CJ, 2001, ATMOS ENVIRON, V35, P255, DOI 10.1016/S1352-2310(00)00195-3
   Harner T, 2006, ENVIRON POLLUT, V144, P361, DOI 10.1016/j.envpol.2005.12.044
   Hassanvand MS, 2015, SCI TOTAL ENVIRON, V527, P100, DOI 10.1016/j.scitotenv.2015.05.001
   Hong H, 2007, ATMOS RES, V85, P429, DOI 10.1016/j.atmosres.2007.03.004
   IARC [International agency for research on cancer], 1976, MON EV CARC RISK CHE
   Jung KH, 2011, ATMOSPHERE-BASEL, V2, P96, DOI 10.3390/atmos2020096
   Kalaiarasan M, 2009, BUILD ENVIRON, V44, P418, DOI 10.1016/j.buildenv.2008.04.003
   Kim KH, 2013, ENVIRON INT, V60, P71, DOI 10.1016/j.envint.2013.07.019
   Klanova J, 2006, ENVIRON POLLUT, V144, P393, DOI 10.1016/j.envpol.2005.12.048
   Levy JI, 2003, J EXPO ANAL ENV EPID, V13, P364, DOI 10.1038/sj.jea.7500289
   Levy JI, 2002, J EXPO ANAL ENV EPID, V12, P104, DOI 10.1038/sj/jea/7500203
   Levy JI, 2001, ENVIRON HEALTH PERSP, V109, P341, DOI 10.2307/3454892
   Li CL, 2005, BUILD ENVIRON, V40, P329, DOI 10.1016/j.buildenv.2004.05.015
   LINHART Igor, 2012, TOXIKOLOGIE INTERAKC
   Masih J, 2012, SUSTAIN CITIES SOC, V3, P30, DOI 10.1016/j.scs.2012.01.001
   Menichini E, 2007, ATMOS ENVIRON, V41, P9518, DOI 10.1016/j.atmosenv.2007.08.041
   Moeinaddini M, 2014, ENVIRON SCI POLLUT R, V21, P7757, DOI 10.1007/s11356-014-2694-1
   Ohura T, 2016, J HAZARD MATER, V312, P254, DOI 10.1016/j.jhazmat.2016.03.072
   Omar NYMJ, 2002, ATMOS ENVIRON, V36, P247, DOI 10.1016/S1352-2310(01)00425-3
   Pehnec G, 2016, ATMOS ENVIRON, V131, P263, DOI 10.1016/j.atmosenv.2016.02.009
   Pongpiachan S, 2013, ASIAN PAC J CANCER P, V14, P1865, DOI 10.7314/APJCP.2013.14.3.1865
   Re-Poppi N, 2005, ATMOS ENVIRON, V39, P2839, DOI 10.1016/j.atmosenv.2004.10.006
   Straif K, 2013, AIR POLLUTION CANC, V161
   Tao S, 2007, ATMOS ENVIRON, V41, P9594, DOI 10.1016/j.atmosenv.2007.08.026
   vanVliet P, 1997, ENVIRON RES, V74, P122, DOI 10.1006/enrs.1997.3757
   Venkataraman C, 1999, J AEROSOL SCI, V30, P759, DOI 10.1016/S0021-8502(98)00761-7
   Viskari EL, 1997, ENVIRON POLLUT, V97, P153, DOI 10.1016/S0269-7491(97)00061-4
   World Meteorological Organization, 2016, GLOB ATM WATCH
   Wu SP, 2006, CHEMOSPHERE, V62, P357, DOI 10.1016/j.chemosphere.2005.04.101
NR 45
TC 0
Z9 0
U1 1
U2 6
PU CZECH TECHNICAL UNIV PRAGUE
PI PRAGUE 6
PA ZIKOVA 4, PRAGUE 6, 16636, CZECH REPUBLIC
SN 1210-2709
J9 ACTA POLYTECH
JI Acta Polytech.
PY 2017
VL 57
IS 4
BP 282
EP 294
DI 10.14311/AP.2017.57.0282
PG 13
WC Engineering, Multidisciplinary
SC Engineering
GA FI0CS
UT WOS:000411589500006
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Harrison, SP
   Kelley, DI
AF Harrison, S. P.
   Kelley, D. I.
TI RETRACTED: Projected changes in Australian fire regimes during the 21st
   century and consequences for ecosystems (Retracted article. See vol. 26,
   pg. 844, 2017)
SO INTERNATIONAL JOURNAL OF WILDLAND FIRE
LA English
DT Article; Retracted Publication
DE biome shifts; CO2 impacts on fire; fire danger; fire-induced vegetation
   changes; fuel limitation; resprouting vegetation
ID GLOBAL VEGETATION MODEL; CLIMATE-CHANGE; DANGER; FREQUENCY; EMISSIONS;
   DYNAMICS; PATTERNS; IMPACTS; SYSTEM; RISK
AB Climate projections show Australia becoming significantly warmer during the 21st century, while precipitation decreases over much of the continent. Such changes are generally considered to increase wildfire risk. Nevertheless, using a process-based model of vegetation dynamics and vegetation-fire interactions, we show that while burnt area increases in southern and central Australia, it decreases in northern Australia. Overall, the projected increase in fire by the end of the 21st century is small (0.7-1.3% of land area, depending on the climate scenario). The direct effects of increasing CO2 on vegetation productivity and water-use efficiency influence simulated fire regimes: CO2 effects tend to increase burnt area in arid regions, but increase vegetation density and reduce burnt area in forested regions. Increases in burnt area promote a shift to more fire-adapted trees in wooded areas and their encroachment into grasslands, with an overall increase in forested area of 3.9-11.9% of land area by the end of the century. The decrease in burnt area in northern Australia leads to an increase in tree cover (similar to 20%) and an expansion of tropical forest. Thus, although the overall change in burnt area is small, it has noticeable consequences for vegetation patterns across the continent.
C1 [Harrison, S. P.; Kelley, D. I.] Macquarie Univ, Sch Biol Sci, N Ryde, NSW 2109, Australia.
   [Harrison, S. P.; Kelley, D. I.] Univ Reading, Sch Archaeol Geog & Environm Sci, Reading RG6 6AH, Berks, England.
RP Harrison, SP (reprint author), Macquarie Univ, Sch Biol Sci, N Ryde, NSW 2109, Australia.; Harrison, SP (reprint author), Univ Reading, Sch Archaeol Geog & Environm Sci, Reading RG6 6AH, Berks, England.
EM s.p.harrison@reading.ac.uk
FU iMQRES scholarship at Macquarie University and postdoctoral funding from
   the University of Reading
FX We acknowledge the World Climate Research Program's Working Group on
   Coupled Modelling, which is responsible for CMIP, and the climate
   modelling groups for producing and making available their model output.
   (For CMIP, the US Department of Energy's Program for Climate Model
   Diagnosis and Intercomparison provides coordinating support and led
   development of software infrastructure in partnership with the Global
   Organisation for Earth System Science Portals.) The analyses and figures
   are based on data archived by 18 June 2013. DIK was supported by an
   iMQRES scholarship at Macquarie University and postdoctoral funding from
   the University of Reading. We thank Colin Prentice for comments on the
   draft manuscript.
CR Archibald S, 2013, P NATL ACAD SCI USA, V110, P6442, DOI 10.1073/pnas.1211466110
   Ashe B, 2009, J RISK RES, V12, P121, DOI 10.1080/13669870802648528
   Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297
   Bistinas I, 2014, BIOGEOSCIENCES, V11, P5087, DOI 10.5194/bg-11-5087-2014
   Booth TH, 2012, ADV CLIM CHANG RES, V3, P12, DOI 10.3724/SP.J.1248.2012.00012
   Bradstock RA, 2012, FLAMMABLE AUSTRALIA: FIRE REGIMES, BIODIVERSITY AND ECOSYSTEMS IN A CHANGING WORLD, P1
   Bradstock RA, 2008, INT J WILDLAND FIRE, V17, P809, DOI 10.1071/WF07153
   Brovkin V, 2012, BIOGEOSCIENCES, V9, P565, DOI 10.5194/bg-9-565-2012
   Calvo MM, 2014, BIOGEOSCIENCES, V11, P6017, DOI 10.5194/bg-11-6017-2014
   Clarke PJ, 2013, NEW PHYTOL, V197, P19, DOI 10.1111/nph.12001
   Collins M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1029
   Crompton RP, 2008, ENVIRON SCI POLICY, V11, P371, DOI 10.1016/j.envsci.2008.01.005
   Deeming JE, 1977, INT39 USDA FOR SERV
   DeFries R, 2009, ISLSCP INITIATIVE 2
   Fox-Hughes P, 2014, INT J WILDLAND FIRE, V23, P309, DOI 10.1071/WF13126
   Geng S, 1988, 204 U CAL DEP AGR RA
   Giglio L, 2013, J GEOPHYS RES-BIOGEO, V118, P317, DOI 10.1002/jgrg.20042
   Gill AM, 2012, FLAMMABLE AUSTRALIA: FIRE REGIMES, BIODIVERSITY AND ECOSYSTEMS IN A CHANGING WORLD, P235
   Groves RH, 1994, AUSTR VEGETATION
   Hantson S, 2016, BIOGEOSCIENCES, V13, P3359, DOI 10.5194/bg-13-3359-2016
   Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711
   Harrison SP, 2010, INT YEAR PLANET EART, P21, DOI 10.1007/978-90-481-8716-4_3
   Haverd V, 2013, BIOGEOSCIENCES, V10, P851, DOI 10.5194/bg-10-851-2013
   Hennessy K, 2005, TECHNICAL REPORT
   Higuera PE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127563
   Hughes L., 2013, BE PREPARED CLIMATE
   Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2
   Kelley DI, 2014, GEOSCI MODEL DEV, V7, P2411, DOI 10.5194/gmd-7-2411-2014
   Kelley DI, 2013, BIOGEOSCIENCES, V10, P3313, DOI 10.5194/bg-10-3313-2013
   Kirtman B, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P953
   Knorr W, 2016, NAT CLIM CHANGE, V6, P781, DOI [10.1038/NCLIMATE2999, 10.1038/nclimate2999]
   Knorr W, 2016, BIOGEOSCIENCES, V13, P267, DOI 10.5194/bg-13-267-2016
   Knorr W, 2014, BIOGEOSCIENCES, V11, P1085, DOI 10.5194/bg-11-1085-2014
   Knutti R, 2010, CLIMATIC CHANGE, V102, P395, DOI 10.1007/s10584-010-9800-2
   Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102
   Lawes MJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00204.1
   Lucas C, 2007, BUSHFIRE WEATHER S E
   Matthews S, 2009, AUST METEOROL OCEAN, V58, P41, DOI 10.22499/2.5801.005
   McArthur A. G., 1973, GRASSLAND FIRE DANGE
   McArthur AG, 1967, FIRE BEHAV EUCALYPT, V107
   McArthur AG, 1966, WEATHER GRASSLAND FI, V100
   Michalon N, 1999, GEOPHYS RES LETT, V26, P3097, DOI 10.1029/1999GL010837
   Moritz MA, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00345.1
   Murphy BP, 2013, J BIOGEOGR, V40, P1048, DOI 10.1111/jbi.12065
   NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x
   Pitman AJ, 2007, CLIMATIC CHANGE, V84, P383, DOI 10.1007/s10584-007-9243-6
   Prentice IC, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003906
   PRICE C, 1994, J GEOPHYS RES-ATMOS, V99, P10823, DOI 10.1029/94JD00019
   Romps DM, 2014, SCIENCE, V346, P851, DOI 10.1126/science.1259100
   Rothermel R., 1972, INTRP115 USDA FOR SE
   Ruesch A., 2008, NEW IPCC TIER 1 GLOB
   Russell-Smith J, 2007, INT J WILDLAND FIRE, V16, P361, DOI 10.1071/WF07018
   Settele J, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P271
   Sitch S, 2003, GLOBAL CHANGE BIOL, V9, P161, DOI 10.1046/j.1365-2486.2003.00569.x
   Steffen W, 2009, AUSTRALIAS BIODIVERS
   Stephenson C, 2013, ENVIRON HAZARDS-UK, V12, P93, DOI 10.1080/17477891.2012.703490
   Stocker T. F., 2013, CLIMATE CHANGE 2013, DOI [10.1017/CBO9781107415324, DOI 10.1017/CBO9781107415324]
   Sturman AP, 2005, WEATHER CLIMATE AUST
   Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1
   Tebaldi C, 2007, PHILOS T R SOC A, V365, P2053, DOI 10.1098/rsta.2007.2076
   Thonicke K, 2001, GLOBAL ECOL BIOGEOGR, V10, P661, DOI 10.1046/j.1466-822x.2001.00175.x
   van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P1, DOI 10.1007/s10584-011-0157-y
   Van Wagner CE, 1987, 35 CAN FOR SERV
   Williams AAJ, 2001, CLIMATIC CHANGE, V49, P171, DOI 10.1023/A:1010706116176
   WILLIAMS ER, 1992, SCIENCE, V256, P1184, DOI 10.1126/science.256.5060.1184
   Williams Richard J., 2009, INTERACTIONS CLIMATE
NR 66
TC 0
Z9 0
U1 6
U2 8
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1049-8001
EI 1448-5516
J9 INT J WILDLAND FIRE
JI Int. J. Wildland Fire
PY 2017
VL 26
IS 9
BP A
EP P
PG 16
WC Forestry
SC Forestry
GA FG7BX
UT WOS:000410563800009
DA 2018-12-27
ER

PT J
AU Li, Z
   Wu, JW
   Zhang, HW
   Topaz, M
   He, F
AF Li, Zhen
   Wu, Jiang-Wen
   Zhang, Hong-Wei
   Topaz, Moris
   He, Fang
TI RETRACTED: Regulated negative pressure wound therapy combined TopClosure
   (R) in treatment of skin defect for open fracture in lower extremity: a
   case report (Retracted article. See vol. 11, pg. 6383, 2018)
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
LA English
DT Article; Retracted Publication
DE Regulated negative pressure wound therapy; Top Closure; open fracture;
   skin defect; treatment
ID VISCOELASTIC PROPERTIES; CLOSURE; MANAGEMENT; INJURY
AB Open fracture in lower extremity is the common trauma. However, some of the wound may easily developed into the skin defect. Regulated negative pressure-assisted wound therapy (RNPT) has been widely used to treat infected wounds and chronic wounds that may decrease bacterial load and promotion of wound healing. TopClosure (R) was used to as an innovative skin extension and wound closure-secure system that reducing tension across wound edges. In this case, RNPT combined with TopClosure (R) were employed to treat the skin defect in lower extremity, which may aid immediate wound closure and downgrade treatment time and the dress changing frequency for a wide range of applications on a global scle.
C1 [Li, Zhen; He, Fang] Shihezi Univ, Coll Med, Minist Xinjiang Endem & Ethn Dis, Dept Pathophysiol,Key Lab Educ, Shihezi, Peoples R China.
   [Li, Zhen] Shihezi Univ, Affiliated Hosp 1, Dept Emergency & Crit Care Med, Shihezi, Peoples R China.
   [Wu, Jiang-Wen; Zhang, Hong-Wei] Shihezi Univ, Affiliated Hosp 1, Dept Gen Surg, Shihezi, Peoples R China.
   [Topaz, Moris] Hillel Yaffe Med Ctr, Plast Surg Unit, Hadera, Israel.
RP He, F (reprint author), Shihezi Univ, Coll Med, Minist Xinjiang Endem & Ethn Dis, Dept Pathophysiol,Key Lab Educ, Shihezi, Peoples R China.
EM fangf2002shz@126.com
CR Abramson DL, 1997, ANN PLAS SURG, V38, P540, DOI 10.1097/00000637-199705000-00019
   Buchholz J, 2000, CHIRURG, V71, P1115, DOI 10.1007/s001040051187
   Chen Shao-Zong, 2005, Asian J Surg, V28, P211, DOI 10.1016/S1015-9584(09)60346-8
   Dumville JC, 2013, HYDROGEL DRESSINGS P
   HIRSHOWITZ B, 1993, PLAST RECONSTR SURG, V92, P260, DOI 10.1097/00006534-199308000-00010
   LAZARUS GS, 1994, ARCH DERMATOL, V130, P489, DOI 10.1001/archderm.130.4.489
   Li JQ, 2013, ANN SURG, V257, P335, DOI 10.1097/SLA.0b013e318269d1ca
   Ma L S, 1992, Zhongguo Zhong Xi Yi Jie He Za Zhi, V12, P524
   Ma LS, 1992, ZHONGGUO ZHONG XI YI, V12, P516
   Marek DJ, 2005, AM J SURG, V190, P123, DOI 10.1016/j.amjsurg.2005.05.038
   Morris GS, 2007, OSTOMY WOUND MANAG, V53, P52
   Rayment EA, 2009, INT J LOW EXTR WOUND, V8, P19, DOI 10.1177/1534734609331596
   Reno F, 2009, CELL ADHES MIGR, V3, P239, DOI 10.4161/cam.3.3.8632
   Santiago GF, 2012, ANN PLAS SURG, V69, P418, DOI 10.1097/SAP.0b013e31824a4584
   Tang JB, 2012, INT J LOW EXTR WOUND, V11, P299, DOI 10.1177/1534734612463697
   Topaz M, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000234
   Topaz M, 2014, J DRUGS DERMATOL, V13, P48
   Topaz M, 2012, INDIAN J PLAST SURG, V45, P291, DOI 10.4103/0970-0358.101301
   WOO SLY, 1981, J BIOMECH ENG-T ASME, V103, P293, DOI 10.1115/1.3138295
   Zhu Jian-xin, 2002, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V16, P42
NR 20
TC 1
Z9 1
U1 1
U2 1
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1940-5901
J9 INT J CLIN EXP MED
JI Int. J. Clin. Exp. Med.
PY 2017
VL 10
IS 8
BP 12659
EP 12662
PG 4
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA FF1EX
UT WOS:000408643700165
DA 2018-12-27
ER

PT J
AU Klayman, D
   Coughlin, J
AF Klayman, Douglas
   Coughlin, Jennifer
TI RETRACTED: Summative evaluation of the Employment First State Leadership
   Mentoring Project 2015 program year (Retracted article. See vol. 47, pg.
   259, 2017)
SO JOURNAL OF VOCATIONAL REHABILITATION
LA English
DT Article; Retracted Publication
DE Capacity building; customized employment; competitive integrated
   employment; individuals with significant disabilities; state
   collaborative teams; systems change; vocational rehabilitation
ID INTELLECTUAL DISABILITIES; SUPPORTED EMPLOYEES; OUTCOMES; ADULTS
AB BACKGROUND: The Employment First State Leadership Mentoring Project (EFSLMP) assists states in identifying and addressing changes in state policies, funding models, and practices to increase access to and outcomes associated with competitive integrated employment.
   OBJECTIVE: The objective of the study was to identify systems change and increases in capacity in nine 2015 EFSLMP states.
   METHODS: Based on the collection and coding of products developed by a purposive sample of nine EFSLMP state collaborative teams, the researchers used an ordinal scale rubric to conduct qualitative assessments of state policies, funding priorities, and practices to determine if they align with the principles of systems change and capacity-building efforts as defined by ODEP (2014).
   RESULTS: Seven of nine states achieved pending or full systems change during the program year through their involvement in EFSLMP. Evidence included: MOUs, organization of conferences, training events, completion of HCBS waivers and modifications, completion of Unified State Plans that changed policy and practices and increased the capacity of state systems to provide competitive integrated employment opportunities for individuals with disabilities.
   CONCLUSION: The study results suggest that EFSLMP efficaciously informs policy and practice and leads to state systems change and increases the capacity of agencies to support competitive integrated employment. Changing the "status quo" and transforming the structure or dynamics of entire state systems depends on a number of factors such as systemic inertia and fiscal and human resource restraints.
C1 [Klayman, Douglas; Coughlin, Jennifer] Social Dynam LLC, 481 North Frederick Ave,Suite 410, Gaithersburg, MD 20877 USA.
RP Klayman, D (reprint author), Social Dynam LLC, 481 North Frederick Ave,Suite 410, Gaithersburg, MD 20877 USA.
EM dklayman@socialdynamicsllc.com
FU EFSLMP Contracting Officer's Representative, Serena Lowe, Ph.D., of the
   United States Department of Labor, Office of Disability Employment
   Policy
FX The authors would like to acknowledge the support of EFSLMP Contracting
   Officer's Representative, Serena Lowe, Ph.D., of the United States
   Department of Labor, Office of Disability Employment Policy. Dr. Lowe
   provided a level of transparency into the EFSLMP that allowed the
   authors to collect detailed information from each state collaborative
   team and a variety of EFSLMP stakeholders. We would also like to thank
   Gary Shaheen, Robert Bartlotta, Ph.D. and Rachel Davidson from Social
   Dynamics for their editorial and policy related expertise that
   contributed to the development of this article.
CR Blanck P., 2008, TEXAS J CIVIL LIBERT, V13, P367
   Butterworth J., 2015, STATEDATA NATL REPOR
   Butterworth P, 2011, OCCUP ENVIRON MED, V68, P806, DOI 10.1136/oem.2010.059030
   Cimera RE, 2010, J VOCAT REHABIL, V33, P123, DOI 10.3233/JVR-2010-0521
   Cimera RE, 2011, J VOCAT REHABIL, V35, P21, DOI 10.3233/JVR-2011-0550
   Cimera RE, 2012, AUTISM, V16, P87, DOI 10.1177/1362361311408129
   IPS Dartmouth Supported Employment Center, 2016, IPS DARTM SUPP EMPL
   Jennings E. T., 2013, REPORT PREPARED KENT
   Klayman D., 2014, REPORT EMPLOYMENT 1
   Lunt N, 1994, DISABIL SOC, V9, P223, DOI DOI 10.1080/09687599466780231
   Migliore A, 2007, J VOCAT REHABIL, V26, P5
   National Association of State Directors of Developmental Disabil-ities Services, 2015, BILL WOULD INC STAT
   National Core Indicators (2013-2014), 2016, PERS COMM PAID JOB
   Nord D., 2014, POLICY RES BRIEF, V24, P1
   State of Tennessee Bureau of TennCare, 2015, TENN HOM COMM BAS SE
   U. S. Bureau of Labor Statistics, 2015, PERS DIS LAB FORC CH
   Walker JS, 2015, J BEHAV HEALTH SER R, V42, P254, DOI 10.1007/s11414-014-9452-5
   White H., 2006, REV STATE IMPACT EVA
NR 18
TC 2
Z9 2
U1 0
U2 0
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1052-2263
EI 1878-6316
J9 J VOCAT REHABIL
JI J. Vocat. Rehabil.
PY 2017
VL 47
IS 1
BP 25
EP 45
DI 10.3233/JVR-170881
PG 21
WC Rehabilitation
SC Rehabilitation
GA FE3PP
UT WOS:000408128400004
DA 2018-12-27
ER

PT J
AU Wu, Q
   Zhao, X
   You, H
AF Wu, Q.
   Zhao, X.
   You, H.
TI RETRACTED: Characteristics of liver fibrosis with different etiologies
   using a fully quantitative fibrosis assessment tool (Retracted article.
   See vol. 50, art no E5234, 2017)
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article; Retracted Publication
DE Liver fibrosis; Quantitative assessment; Etiology
ID INFLAMMATION-BASED SCORES; HEPATOCELLULAR-CARCINOMA; COST-EFFECTIVENESS;
   HEPATITIS-C; CIRRHOSIS; MODELS
AB This study aimed to test the diagnostic performance of a fully quantitative fibrosis assessment tool for liver fibrosis in patients with chronic hepatitis B (CHB), primary biliary cirrhosis (PBC) and non-alcoholic steatohepatitis (NASH). A total of 117 patients with liver fibrosis were included in this study, including 50 patients with CHB, 49 patients with PBC and 18 patients with NASH. All patients underwent liver biopsy (LB). Fibrosis stages were assessed by two experienced pathologists. Histopathological images of LB slices were processed by second harmonic generation (SHG)/two-photon excited fluorescence (TPEF) microscopy without staining, a system called qFibrosis (quantitative fibrosis) system. Altogether 101 quantitative features of the SHG/TPEF images were acquired. The parameters of aggregated collagen in portal, septal and fibrillar areas increased significantly with stages of liver fibrosis in PBC and CHB (P < 0.05), but the same was not found for parameters of distributed collagen (P > 0.05). There was a significant correlation between parameters of aggregated collagen in portal, septal and fibrillar areas and stages of liver fibrosis from CHB and PBC (P < 0.05), but no correlation was found between the distributed collagen parameters and the stages of liver fibrosis from those patients (P > 0.05). There was no significant correlation between NASH parameters and stages of fibrosis (P > 0.05). For CHB and PBC patients, the highest correlation was between septal parameters and fibrosis stages, the second highest was between portal parameters and fibrosis stages and the lowest correlation was between fibrillar parameters and fibrosis stages. The correlation between the septal parameters of the PBC and stages is significantly higher than the parameters of the other two areas (P < 0.05). The qFibrosis candidate parameters based on CHB were also applicable for quantitative analysis of liver fibrosis in PBC patients. Different parameters should be selected for liver fibrosis assessment in different stages of PBC compared with CHB.
C1 [Wu, Q.; Zhao, X.; You, H.] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing Key Lab Translat Med Liver Cirrhosis, Beijing, Peoples R China.
   [Wu, Q.; Zhao, X.; You, H.] Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China.
RP You, H (reprint author), Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing Key Lab Translat Med Liver Cirrhosis, Beijing, Peoples R China.; You, H (reprint author), Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China.
EM hongyou30@sina.com
FU National Science and Technology Major Project [2013ZX10002004]; Key
   Project of Beijing Science and Technology Commission
   [D1211000039120003]; National Science and Technology Support Project
   [2015BAI13B09]
FX This work was supported by the National Science and Technology Major
   Project (grant #2013ZX10002004), the Key Project of Beijing Science and
   Technology Commission (D1211000039120003), and National Science and
   Technology Support Project (#2015BAI13B09).
CR Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762
   Fatourou Evangelia M, 2014, Hepatobiliary Surg Nutr, V3, P415, DOI 10.3978/j.issn.2304-3881.2014.07.01
   Ferrarese A, 2014, J HEPATOL, V61, P449, DOI 10.1016/j.jhep.2014.03.038
   Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006
   Leonard H, 2014, ANN HEPATOL, V13, P555
   Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906
   Manousou P, 2014, GUT, V63, P1005, DOI 10.1136/gutjnl-2013-305606
   Papastergiou V, 2014, ALIMENT PHARM THER, V39, P1341, DOI 10.1111/apt.12757
   Papastergiou V, 2014, ALIMENT PHARM THER, V39, P721, DOI 10.1111/apt.12654
   Parisi I, 2014, LIVER TRANSPLANT, V20, P1529, DOI 10.1002/lt.24017
   Parisi I, 2014, LIVER TRANSPLANT, V20, P1327, DOI 10.1002/lt.23969
   Thayalasekaran S, 2014, ANN GASTROENTEROL, V27, P282
   Tsochatzis E, 2014, J HEPATOL, V60, P948, DOI 10.1016/j.jhep.2013.12.023
   Tsochatzis EA, 2014, HEPATOLOGY, V60, P832, DOI 10.1002/hep.27296
   Tsochatzis EA, 2014, J HEPATOL, V61, P453, DOI 10.1016/j.jhep.2014.04.022
   Tsochatzis EA, 2014, EXPERT REV GASTROENT, V8, P571, DOI 10.1586/17474124.2014.902303
   Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5
   Xu SY, 2014, J HEPATOL, V61, P260, DOI [10.1016/j.jhep.2014.03.006, 10.1016/j.jhep.2014.02.015]
NR 18
TC 1
Z9 1
U1 4
U2 8
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, 00, BRAZIL
SN 0100-879X
EI 1678-4510
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PY 2017
VL 50
IS 6
AR e5234
DI 10.1590/1414-431X20175234
PG 6
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA EV7UQ
UT WOS:000401987500001
PM 28538834
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Ufion, AA
   Zulfiqar, B
   Hassan, A
   Habibi, R
   Boddu, P
AF Ufion, Alvaro Altamirano
   Zulfiqar, Beenish
   Hassan, Abdalla
   Habibi, Roshanak
   Boddu, Prajwal
TI RETRACTED: Subclinical Hypothyroidism and Its Association with Increased
   Cardiovascular Mortality (Retracted article. See art no 9174206, 2018)
SO CARDIOLOGY RESEARCH AND PRACTICE
LA English
DT Review; Retracted Publication
ID CORONARY-HEART-DISEASE; VENTRICULAR DIASTOLIC DYSFUNCTION; PRESERVED
   EJECTION FRACTION; PARTICIPANT DATA-ANALYSIS; THYROID-DYSFUNCTION;
   DILATED CARDIOMYOPATHY; SERUM THYROTROPIN; FAILURE; RISK; HORMONE
AB Thyroid hormones play an important role in regulating different metabolism functions and multiple organs' performance. Changes in the thyroid hormone axis can lead to profound effects on the stability of vital organs and systems, especially the cardiovascular system. Hypothyroidism is classified according to the clinical presentation as overt and subclinical. There is some evidence supporting the benefits of thyroxine hormone replacement for subclinical hypothyroidism on cardiovascular mortality outcomes. However, the clinical relevance of measuring and treating high thyroid-stimulating hormone (TSH) levels in newly diagnosed heart failure patients with preserved ejection fraction requires further study. In this report, we review the current evidence regarding the prognostic significance of subclinical hypothyroidism in heart failure patients with preserved ejection fraction.
C1 [Ufion, Alvaro Altamirano; Zulfiqar, Beenish; Hassan, Abdalla] Advocate Illinois Masonic Med Ctr, Dept Internal Med, Chicago, IL 60657 USA.
   [Habibi, Roshanak] St Francis Hosp, Dept Internal Med, Evanston, IL 60202 USA.
   [Boddu, Prajwal] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
RP Ufion, AA (reprint author), Advocate Illinois Masonic Med Ctr, Dept Internal Med, Chicago, IL 60657 USA.
EM alvaro.altamiranoufion@advocatehealth.com
CR AlGhalayini K, 2015, J PAK MED ASSOC, V65, P1300
   Berezin A. E., 2015, CARDIOVASCULAR MED, V4
   Biondi B, 1999, J CLIN ENDOCR METAB, V84, P2064, DOI 10.1210/jc.84.6.2064
   Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043
   Biondi B, 2012, EUR J ENDOCRINOL, V167, P609, DOI 10.1530/EJE-12-0627
   BRENT GA, 1994, NEW ENGL J MED, V331, P847
   Collet TH, 2014, J CLIN ENDOCR METAB, V99, P3353, DOI 10.1210/jc.2014-1250
   Collet TH, 2012, ARCH INTERN MED, V172, P799, DOI 10.1001/archinternmed.2012.402
   Danzi S, 2012, MED CLIN N AM, V96, P257, DOI 10.1016/j.mcna.2012.01.006
   Frey A, 2013, INT J CARDIOL, V168, P300, DOI 10.1016/j.ijcard.2012.09.064
   Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL
   Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024
   Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231
   Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591
   Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489
   Huber G, 2002, J CLIN ENDOCR METAB, V87, P3221, DOI 10.1210/jc.87.7.3221
   KABADI UM, 1993, ARCH INTERN MED, V153, P957, DOI 10.1001/archinte.153.8.957
   Kenessey A, 2006, J BIOL CHEM, V281, P20666, DOI 10.1074/jbc.M512671200
   Kinugasa Y, 2014, CIRC J, V78, P1333, DOI 10.1253/circj.CJ-14-0436
   Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707
   Li XP, 2014, J CARD FAIL, V20, P506, DOI 10.1016/j.cardfail.2014.05.002
   Masaki M, 2014, CIRC J, V78, P1494, DOI 10.1253/circj.CJ-13-1556
   Monzani F, 2004, J CLIN ENDOCR METAB, V89, P2099, DOI 10.1210/jc.2003-031669
   Ning N, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001159
   Pearce SHS, 2013, EUR THYROID J, V2, P215, DOI 10.1159/000356507
   Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869
   Rhee SS, 2011, REV ESP CARDIOL, V64, P220, DOI 10.1016/j.recesp.2010.10.015
   Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460
   Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361
   ROHRER DK, 1991, J BIOL CHEM, V266, P8638
   Rugge B., 2011, 1112EHC033EF AG HEAL, P24
   SAWIN CT, 1979, JAMA-J AM MED ASSOC, V242, P247, DOI 10.1001/jama.242.3.247
   Selmer C, 2014, J CLIN ENDOCR METAB, V99, P2372, DOI 10.1210/jc.2013-4184
   Selvaraj S, 2012, AM J CARDIOL, V110, P234, DOI 10.1016/j.amjcard.2012.02.068
   Shuvya M, 2009, CARDIOVASC PATHOL, V18, P183, DOI 10.1016/j.carpath.2007.12.015
   Somwaru LL, 2012, J CLIN ENDOCR METAB, V97, P1962, DOI 10.1210/jc.2011-3047
   Surks MI, 2007, J CLIN ENDOCR METAB, V92, P4575, DOI 10.1210/jc.2007-1499
   Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228
   TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x
   Wang WY, 2015, J CLIN ENDOCR METAB, V100, P3210, DOI 10.1210/jc.2014-4159
   Waring AC, 2012, J CLIN ENDOCR METAB, V97, P3944, DOI 10.1210/jc.2012-2481
NR 41
TC 1
Z9 1
U1 0
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-8016
EI 2090-0597
J9 CARDIOL RES PRACT
JI Cardiol. Res. Pract.
PY 2017
AR UNSP 7539735
DI 10.1155/2017/7539735
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EW8XW
UT WOS:000402802400001
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Huang, WY
   Huang, HH
   Wang, L
   Hu, J
   Song, WF
AF Huang, Weiyi
   Huang, Haihua
   Wang, Lei
   Hu, Jiong
   Song, Weifeng
TI RETRACTED: SUN1 silencing inhibits cell growth through G0/G1 phase
   arrest in lung adenocarcinoma (Retracted article. See vol.10, pg.5935,
   2017)
SO ONCOTARGETS AND THERAPY
LA English
DT Article; Retracted Publication
DE SUN1; lung cancer; proliferation
ID NUCLEAR-ENVELOPE; LINC COMPLEXES; KASH; CANCER; LAMINOPATHIES;
   CYTOSKELETON; MIGRATION; PROTEINS; BRIDGES; ELEGANS
AB Purpose: Cytoskeleton is critical for carcinoma cell proliferation, migration, and invasion. Sad-1 and UNC-84 domain containing 1 (SUN1) is one of the core linkers of nucleoskeleton and cytoskeleton. However, the functions of SUN1 in lung adenocarcinoma are largely unknown.
   Methods: In this study, we first transduced the lentivirus delivering the short hairpin RNA (shRNA) against SUN1 to lung adenocarcinoma cells (A549 and 95D cells) with high efficiency. After lentivirus infection, quantitative real-time polymerase chain reaction and Western blotting were used to detect the expressions of SUN1 mRNA and protein. The cell proliferation and colony formation were detected by MTT assay and colony formation assay, respectively. The cell distribution in the cell cycle was analyzed by flow cytometry.
   Results: Both mRNA and protein levels of SUN1 were significantly decreased in A549 and 95D cells after lentivirus infection, as indicated by quantitative real-time polymerase chain reaction and Western blot. Next, we found that cell proliferation and colony formation were markedly reduced in SUN1 silenced cells. Moreover, suppression of SUN1 led to cell cycle arrest at G0/G1 phase. Furthermore, Cyclin D1, CDK6, and CDK2 expressions were obviously reduced in A549 cells after SUN1 silencing.
   Conclusion: These results suggest that SUN1 plays an essential role in proliferation of lung adenocarcinoma cells in vitro and may be used as a potential therapeutic target for the treatment of lung adenocarcinoma in the future.
C1 [Huang, Weiyi; Huang, Haihua; Wang, Lei; Hu, Jiong; Song, Weifeng] Shanghai Jiao Tong Univ, Peoples Hosp 1, Dept Oncol, 100 Haining Rd, Shanghai 200080, Peoples R China.
RP Huang, WY (reprint author), Shanghai Jiao Tong Univ, Peoples Hosp 1, Dept Oncol, 100 Haining Rd, Shanghai 200080, Peoples R China.
EM weiyihuangdr@163.com
CR Chen CY, 2012, CELL, V149, P565, DOI 10.1016/j.cell.2012.01.059
   Collins LG, 2007, AM FAM PHYSICIAN, V75, P56
   Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124
   Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018
   Doherty JA, 2010, CANCER EPIDEM BIOMAR, V19, P245, DOI 10.1158/1055-9965.EPI-09-0729
   Fridolfsson HN, 2010, J CELL BIOL, V191, P115, DOI 10.1083/jcb.201004118
   Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910
   Hiraoka Y, 2009, DEV CELL, V17, P598, DOI 10.1016/j.devcel.2009.10.014
   HORVITZ HR, 1980, GENETICS, V96, P435
   Israels E D, 2000, Oncologist, V5, P510, DOI 10.1634/theoncologist.5-6-510
   Lei K, 2012, CURR BIOL, V22, P1609, DOI 10.1016/j.cub.2012.06.043
   Malone CJ, 1999, DEVELOPMENT, V126, P3171
   Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008
   Marme A, 2008, INT J CANCER, V123, P2048, DOI 10.1002/ijc.23763
   PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653
   Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068
   Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427
   Sosa BA, 2013, CURR OPIN STRUC BIOL, V23, P285, DOI 10.1016/j.sbi.2013.03.005
   Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046
   Starr DA, 2012, CURR BIOL, V22, pR678, DOI 10.1016/j.cub.2012.06.070
   Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037
   Tapley EC, 2013, CURR OPIN CELL BIOL, V25, P57, DOI 10.1016/j.ceb.2012.10.014
   Zhou LX, 2010, FEBS LETT, V584, P3013, DOI 10.1016/j.febslet.2010.05.038
   Zhou ZC, 2012, J BIOL CHEM, V287, P5317, DOI 10.1074/jbc.M111.304543
NR 24
TC 1
Z9 1
U1 5
U2 6
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6930
J9 ONCOTARGETS THER
JI OncoTargets Ther.
PY 2017
VL 10
BP 2825
EP 2833
DI 10.2147/OTT.S79727
PG 9
WC Biotechnology & Applied Microbiology; Oncology
SC Biotechnology & Applied Microbiology; Oncology
GA EW6ZM
UT WOS:000402659300001
PM 28652764
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Liu, JJ
   Tan, C
   Xiao, K
   Wang, BZ
   Liu, XQ
   Du, HJ
AF Liu, Juanjuan
   Tan, Chun
   Xiao, Kan
   Wang, Binzhong
   Liu, Xueqing
   Du, Hejun
TI RETRACTED: The complete mitochondrial genome of Dabry's sturgeon
   (Acipenser dabryanus) (Retracted article. See vol. 2, pg. 372, 2017)
SO MITOCHONDRIAL DNA PART B-RESOURCES
LA English
DT Article; Retracted Publication
DE Acipenser dabryanus; Dabry's sturgeon; mitochondrial genome;
   phylogenetic
AB The complete mitochondrial genome of Dabry's sturgeon (Acipenser dabryanus) was first determined in this study. The mitochondrial DNA is circular molecule (16,437 bp in length) with a typical vertebrate mitochondrial gene arrangement, including 13 protein-coding genes, 2 ribosomal RNA (rRNA) genes, 22 transfer RNA (tRNA) genes, and 1 non-coding control region (D-loop). All genes were encoded on the heavy strain except for ND6 and eight tRNA genes. The overall base composition of the heavy strain was A (30.2%), T (23.7%), C (29.7%), G (16.4%), and with an AT bias of 53.9%. Phylogenetic analysis based on the mitochondrial genomes of 10 related species using MEGA 5.1 indicated that A. dabryanus and A. sinensis are the most closely related species.
C1 [Liu, Juanjuan; Tan, Chun; Xiao, Kan; Wang, Binzhong; Liu, Xueqing; Du, Hejun] China Three Gorges Corp, Inst Chinese Sturgeon Res, Hubei Key Lab Three Gorges Project Conservat Fish, Yichang 443100, Hubei Province, Peoples R China.
RP Liu, JJ (reprint author), China Three Gorges Corp, Inst Chinese Sturgeon Res, Hubei Key Lab Three Gorges Project Conservat Fish, Yichang 443100, Hubei Province, Peoples R China.
EM 05juanjuan@163.com
FU National Science Foundation of China [31372537]
FX This study was supported by the National Science Foundation of
   China(31372537).
CR Broughton RE, 2006, MOL BIOL EVOL, V23, P1516, DOI 10.1093/molbev/msl013
   Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017
   Que YF, 2015, J GENET, V94, pE62, DOI 10.1007/s12041-014-0363-2
   Sambrook J., 2002, MOL CLONING LAB MANU
   Zhang H, 2011, J APPL ICHTHYOL, V27, P181, DOI 10.1111/j.1439-0426.2011.01674.x
NR 5
TC 1
Z9 1
U1 2
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2380-2359
J9 MITOCHONDRIAL DNA B
JI Mitochondrial DNA Part B-Resour.
PY 2017
VL 2
BP 54
EP +
DI 10.1080/23802359.2017.1280698
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA EV8PB
UT WOS:000402042700026
DA 2018-12-27
ER

PT J
AU Mun, G
   Choi, H
   Im, N
   Ahn, J
   Park, J
   Seo, H
   Choi, Y
   Lee, JH
   Jung, JH
AF Mun, Gyuri
   Choi, Heekyoung
   Im, Nayoung
   Ahn, Junho
   Park, Jaehyeon
   Seo, Hyowon
   Choi, Yeonweon
   Lee, Ji Ha
   Jung, Jong Hwa
TI RETRACTED: Spatially resolved mechanical properties of photo-responsive
   azobenzene-based supramolecular gels (Retracted article. See vol. 7, pg.
   53056, 2017)
SO RSC ADVANCES
LA English
DT Article; Retracted Publication
ID MOLECULAR-WEIGHT GELATORS; HELICAL NANOSTRUCTURES; LIGHT; HYDROGELS;
   ISOMERIZATION; FLUORESCENCE; DERIVATIVES; TRANSITION; NANOWIRES;
   CHIRALITY
AB The viscoelastic and stiffness properties of azobenzene-based supramolecular gels have been investigated by rheometry and AFM. Interestingly, the viscoelastic properties of cis-isomers were 8-10 fold enhanced in comparison to the trans-isomer, which was a unique phenomenon. More interestingly, Young's modulus of gels increased linearly with time of UV irradiation. The stiffness of gels was finely controlled in the spatial micro-scale environment. The improved mechanical strength was attributed to electrostatic interaction with the production of radicals of the gelators.
C1 [Mun, Gyuri; Choi, Heekyoung; Im, Nayoung; Ahn, Junho; Park, Jaehyeon; Seo, Hyowon; Choi, Yeonweon; Lee, Ji Ha; Jung, Jong Hwa] Gyeongsang Natl Univ, Dept Chem, Jinju 660701, South Korea.
   [Mun, Gyuri; Choi, Heekyoung; Im, Nayoung; Ahn, Junho; Park, Jaehyeon; Seo, Hyowon; Choi, Yeonweon; Lee, Ji Ha; Jung, Jong Hwa] Gyeongsang Natl Univ, Res Inst Nat Sci, Jinju 660701, South Korea.
   [Lee, Ji Ha] Univ Kitakyushu, Dept Chem & Biochem, Kitakyushu, Fukuoka 808013, Japan.
RP Lee, JH; Jung, JH (reprint author), Gyeongsang Natl Univ, Dept Chem, Jinju 660701, South Korea.; Lee, JH; Jung, JH (reprint author), Gyeongsang Natl Univ, Res Inst Nat Sci, Jinju 660701, South Korea.; Lee, JH (reprint author), Univ Kitakyushu, Dept Chem & Biochem, Kitakyushu, Fukuoka 808013, Japan.
EM l-ji@kitakyu-u.ac.jp; jonghwa@gnu.ac.kr
FU NRF from the Ministry of Education, Science and Technology, Korea
   [2015R1A2A2A05001400, 2012R1A4A1027750]; Next-Generation BioGreen 21
   Program (SSAC), Rural development Administration, Korea
   [PJ011177022016]; Japan Society for the Promotion of Science (JSPS)
   [15F15342]
FX This work was supported by the NRF (2015R1A2A2A05001400 and
   2012R1A4A1027750) from the Ministry of Education, Science and
   Technology, Korea. In addition, this work was partially supported by a
   grant from the Next-Generation BioGreen 21 Program (SSAC, grant#:
   PJ011177022016), Rural development Administration, Korea. And J. H. L.
   thanks the Japan Society for the Promotion of Science (JSPS) for
   research fellowship 15F15342.
CR Ahn J, 2013, CHEM COMMUN, V49, P2109, DOI 10.1039/c2cc37249e
   Armao JJ, 2014, J AM CHEM SOC, V136, P11382, DOI 10.1021/ja5044006
   Balamurugan S, 2014, J PHOTOCH PHOTOBIO A, V278, P19, DOI 10.1016/j.jphotochem.2013.12.013
   Beharry AA, 2011, J AM CHEM SOC, V133, P19684, DOI 10.1021/ja209239m
   Borre E, 2016, ANGEW CHEM INT EDIT, V55, P1313, DOI 10.1002/anie.201508241
   Chung JW, 2008, CHEM MATER, V20, P6750, DOI 10.1021/cm8019186
   Dagdas YS, 2011, SOFT MATTER, V7, P3524, DOI 10.1039/c0sm01089h
   Dawn A, 2011, CHEM-ASIAN J, V6, P266, DOI 10.1002/asia.201000217
   Dokic J, 2009, J PHYS CHEM A, V113, P6763, DOI 10.1021/jp9021344
   Draper ER, 2017, CHEM COMMUN, V53, P1868, DOI 10.1039/c6cc10083j
   Draper ER, 2015, NAT CHEM, V7, P849, DOI [10.1038/NCHEM.2347, 10.1038/nchem.2347]
   Du XW, 2015, CHEM REV, V115, P13165, DOI 10.1021/acs.chemrev.5b00299
   Eastoe J, 2004, CHEM COMMUN, P2608, DOI 10.1039/b410158h
   Edwards W, 2013, J AM CHEM SOC, V135, P5911, DOI 10.1021/ja4017107
   Fan GL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04933
   Faramarzi V, 2012, NAT CHEM, V4, P485, DOI [10.1038/nchem.1332, 10.1038/NCHEM.1332]
   GELLMAN SH, 1991, J AM CHEM SOC, V113, P1164, DOI 10.1021/ja00004a016
   Gopal A, 2012, ANGEW CHEM INT EDIT, V51, P10505, DOI 10.1002/anie.201205332
   Han M, 2016, CHEM-EUR J, V22, P3971, DOI 10.1002/chem.201600227
   Iwaso K, 2016, NAT CHEM, V8, P626, DOI [10.1038/nchem.2513, 10.1038/NCHEM.2513]
   Jung SH, 2016, NEW J CHEM, V40, P7917, DOI 10.1039/c6nj01543c
   Kim HJ, 2014, ACS NANO, V8, P2998, DOI 10.1021/nn5002968
   Kim J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7959
   KishoreaSahoo J., 2014, CHEM COMMUN, V50, P5462
   Lee JH, 2015, CHEM COMMUN, V51, P15184, DOI 10.1039/c5cc06024a
   Lustig S. R., 2011, MACROMOLECULES, V44, P5105
   Mart RJ, 2016, CHEM COMMUN, V52, P12262, DOI 10.1039/c6cc04004g
   Matsuzawa Y, 2007, ADV FUNCT MATER, V17, P1507, DOI 10.1002/adfm.200700052
   Merino E, 2012, BEILSTEIN J ORG CHEM, V8, P1071, DOI 10.3762/bjoc.8.119
   Moulin E, 2012, NANOSCALE, V4, P6748, DOI 10.1039/c2nr32168h
   Norikane Y, 2004, ORG LETT, V6, P2595, DOI 10.1021/ol049082c
   Nyrkova I, 2014, ACS NANO, V8, P10111, DOI 10.1021/nn502863b
   Poutanen M, 2016, MACROMOLECULES, V49, P4095, DOI 10.1021/acs.macromol.6b00562
   Praveen VK, 2014, ANGEW CHEM INT EDIT, V53, P365, DOI 10.1002/anie.201306787
   Quinton C, 2014, RSC ADV, V4, P34332, DOI 10.1039/c4ra02675f
   Raeburn J, 2015, CHEM COMMUN, V51, P5170, DOI 10.1039/c4cc08626k
   Raul P.-R., 2015, SOFT MATTER, V11, P5180
   Roduit C, 2009, BIOPHYS J, V97, P674, DOI 10.1016/j.bpj.2009.05.010
   Rosales AM, 2015, BIOMACROMOLECULES, V16, P798, DOI 10.1021/bm501710e
   Shih H, 2016, J MATER CHEM B, V4, P4969, DOI 10.1039/c6tb00890a
   Tamesue S, 2013, J AM CHEM SOC, V135, P15650, DOI 10.1021/ja408547g
   Tuft BW, 2014, BIOMACROMOLECULES, V15, P3717, DOI 10.1021/bm501019s
   Uchida K, 2009, CHEM COMMUN, P4420, DOI 10.1039/b908303k
   Urner LH, 2015, CHEM COMMUN, V51, P8801, DOI 10.1039/c5cc01488c
   Yamauchi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9936
   Yang K, 2013, NEW J CHEM, V37, P920, DOI 10.1039/c3nj41013g
   Yang XY, 2012, J MATER CHEM, V22, P38, DOI 10.1039/c1jm13205a
   Zhang MM, 2012, ANGEW CHEM INT EDIT, V51, P7011, DOI 10.1002/anie.201203063
   Zhang X, 2016, RSC ADV, V6, P60022, DOI 10.1039/c6ra09701d
   Zhao YL, 2009, LANGMUIR, V25, P8442, DOI 10.1021/la804316u
NR 50
TC 3
Z9 3
U1 3
U2 18
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2017
VL 7
IS 43
BP 26827
EP 26833
DI 10.1039/c7ra03797j
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA EV7QU
UT WOS:000401975700038
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Quy, DV
   Kondo, K
AF Dinh Van Quy
   Kondo, Kazuo
TI RETRACTED: Low Thermal Expansion Coefficient Electrodeposited Copper and
   Its Contraction Mechanism by Annealing (Retracted article. See vol. 164,
   pg. X16, 2017)
SO JOURNAL OF THE ELECTROCHEMICAL SOCIETY
LA English
DT Article; Retracted Publication
ID THROUGH-SILICON
AB Through-silicon via (TSV) filling by copper electrodeposition is the key technology used in 3D packaging. The thermal expansion coefficient (TEC) mismatch between the copper and silicon causes TSV pumping. Electrodeposited copper with a low TEC additive starts to contract at 120 degrees C. The difference in expansion length between conventional copper and electrodeposited copper with the low TEC additive increases with annealing. This difference is about 47 mu m at 400 degrees C. The dark spots that exist in the in-situ SEM annealing stage at 310 degrees C and their number increase with the increasing annealing temperature. Based on an FE-AES analysis, several 100-nm dark spots are carbon precipitates. From the X-ray diffraction, the lattice constant contracts by annealing at 420 degrees C for 1 hour. The as-deposited copper has carbon inclusions in its lattice. This carbon diffuses out at high temperature, hence the lattice contract. This non-equilibrium to equilibrium transformation by annealing causes copper contraction during the annealing. (C) 2017 The Electrochemical Society. All rights reserved.
C1 [Dinh Van Quy; Kondo, Kazuo] Osaka Prefecture Univ, Fine Feature Electrodeposit Res Ctr, Naka Ku, Sakai, Osaka 5998531, Japan.
RP Kondo, K (reprint author), Osaka Prefecture Univ, Fine Feature Electrodeposit Res Ctr, Naka Ku, Sakai, Osaka 5998531, Japan.
EM kkondo828@gmail.com
CR Bleiker SJ, 2015, IEEE T COMP PACK MAN, V5, P21, DOI 10.1109/TCPMT.2014.2369236
   Che FX, 2013, IEEE T COMP PACK MAN, V3, P732, DOI 10.1109/TCPMT.2013.2252955
   De Wolf I, 2011, MICROELECTRON RELIAB, V51, P1856, DOI 10.1016/j.microrel.2011.06.003
   DeMessemaeker J., 2013, 2013 IEEE 63 EL COMP, P586
   Kikuchi H, 2008, JPN J APPL PHYS, V47, P2801, DOI 10.1143/JJAP.47.2801
   Kondo Kazuo, [No title captured], Patent No. [PCT/JP2016/084499, 2016084499]
   Lin YT, 2015, ECS ELECTROCHEM LETT, V4, pD25, DOI 10.1149/2.0031509eel
   Nabiollahi N, 2013, 2013 14 INT C THERM, P1
   Roh MH, 2015, METALL MATER TRANS A, V46A, P2051, DOI 10.1007/s11661-015-2801-z
NR 9
TC 0
Z9 0
U1 4
U2 10
PU ELECTROCHEMICAL SOC INC
PI PENNINGTON
PA 65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA
SN 0013-4651
EI 1945-7111
J9 J ELECTROCHEM SOC
JI J. Electrochem. Soc.
PY 2017
VL 164
IS 4
BP D150
EP D153
DI 10.1149/2.0071704jes
PG 4
WC Electrochemistry; Materials Science, Coatings & Films
SC Electrochemistry; Materials Science
GA EU3VH
UT WOS:000400958600094
DA 2018-12-27
ER

PT J
AU Ciebiera, M
   Ciebiera, M
   Czekanska-Rawska, M
   Jakiel, G
AF Ciebiera, Michal
   Ciebiera, Magdalena
   Czekanska-Rawska, Magdalena
   Jakiel, Grzegorz
TI RETRACTED: Laparoscopic isthmocele treatment - single center experience
   (Retracted article. See vol. 12, pg. 206, 2017)
SO VIDEOSURGERY AND OTHER MINIINVASIVE TECHNIQUES
LA English
DT Article; Retracted Publication
DE isthmocele; cesarean scar defect; cesarean section; laparoscopy
ID PREVIOUS CESAREAN-SECTION; UTERINE SCAR DEHISCENCE; HYSTEROSCOPIC
   TREATMENT; NONPREGNANT WOMEN; SECONDARY INFERTILITY; SURGICAL-TREATMENT;
   VAGINAL REPAIR; RISK-FACTORS; DELIVERY; RUPTURE
AB Introduction: A cesarean section is the most frequently performed surgery in modern obstetrics. In case of an incorrect wound healing process there is a risk of a persistent uterine wall defect. Nowadays, due to the high frequency of cesarean sections, obstetricians have to deal with the threat of uterine rupture due to pathological wound healing. It has been proven that isthmocele can cause abnormal uterine bleeding (AUB), pelvic pain (PP), and secondary infertility (SI), and can be a place of improper pregnancy placement.
   Aim: This article presents our experience with isthmocele treatment. We describe our diagnostic process scheme, method of corrective surgery and main therapeutic outcomes.
   Material and methods: In this manuscript we present a single center's experience in isthmocele therapy. We have operated on 16 patients who suffered from abnormal uterine bleeding, pain disorders or secondary infertility possibly due to a cesarean scar defect.
   Results: The results obtained in our center are promising. In 9 of 11 (81.8%) women with abnormal bleeding we obtained complete resolution of symptoms. We had slightly worse results in the case of pelvic pain. In 4 (66.6%) of 6 patients the pain resolved completely. We have obtained 7 pregnancies in 11 (63.6%) patients operated on due to secondary infertility.
   Conclusions: In our opinion, laparoscopic treatment seems to be currently one of the most effective methods in isthmocele therapy. Further investigation is necessary to determine the indications for surgery, suitable treatment strategies and appropriate care.
C1 [Ciebiera, Michal; Czekanska-Rawska, Magdalena; Jakiel, Grzegorz] Ctr Postgrad Med Educ, Dept Obstet & Gynecol 1, 231 Czerniakowska St, PL-00416 Warsaw, Poland.
   [Ciebiera, Magdalena] Med Univ Warsaw, Dept Obstet & Gynecol 1, Students Sci Assoc, Warsaw, Poland.
RP Ciebiera, M (reprint author), Ctr Postgrad Med Educ, Dept Obstet & Gynecol 1, 231 Czerniakowska St, PL-00416 Warsaw, Poland.
EM michal.ciebiera@gmail.com
CR [Anonymous], 1975, World Health Organ Tech Rep Ser, V582, P1
   Api M, 2015, J MINIM INVAS GYN, V22, P1145, DOI 10.1016/j.jmig.2015.06.013
   Asakura Hirobumi, 2000, Journal of Nippon Medical School, V67, P352, DOI 10.1272/jnms.67.352
   Ash A, 2007, BJOG-INT J OBSTET GY, V114, P253, DOI 10.1111/j.1471-0528.2006.01237.x
   Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x
   Binkowska M, 2015, GINEKOL POL, V86, P396
   Borges LM, 2010, J MINIM INVAS GYN, V17, P361, DOI 10.1016/j.jmig.2010.02.007
   Buhimschi CS, 2005, BJOG-INT J OBSTET GY, V112, P38, DOI 10.1111/j.1471-0528.2004.00300.x
   Bujold E, 2002, AM J OBSTET GYNECOL, V186, P311, DOI 10.1067/mob.2002.119923
   Bujold E, 2010, OBSTET GYNECOL, V116, P43, DOI 10.1097/AOG.0b013e3181e41be3
   Ceci O, 2012, J OBSTET GYNAECOL RE, V38, P1302, DOI 10.1111/j.1447-0756.2012.01872.x
   Chang Y, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.038
   Chen H, 2016, INT J OPTOMECHATRONI, V10, P1, DOI 10.1080/15599612.2015.1095956
   Chen YQ, 2014, MED SCI MONITOR, V20, P1395, DOI 10.12659/MSM.890642
   Ciebiera M, 2013, VIDEOSURGERY MINIINV, V8, P342, DOI 10.5114/wiitm.2013.39514
   de Vaate AJMB, 2014, ULTRASOUND OBST GYN, V43, P372, DOI 10.1002/uog.13199
   Dec M, 2015, VIDEOSURGERY MINIINV, V10, P509, DOI 10.5114/wiitm.2015.56411
   Diaz SD, 2002, SOUTHERN MED J, V95, P431
   Dicle O, 1997, EUR RADIOL, V7, P31, DOI 10.1007/s003300050103
   Donnez O, 2008, FERTIL STERIL, V89, P974, DOI 10.1016/j.fertnstert.2007.04.024
   Ecker JL, 2007, NEW ENGL J MED, V356, P885, DOI 10.1056/NEJMp068290
   Fabres C, 2005, J MINIM INVAS GYN L, V12, P25, DOI 10.1016/j.jmig.2004.12.023
   Fabres C, 2003, J ULTRAS MED, V22, P695, DOI 10.7863/jum.2003.22.7.695
   Fabres C, 1998, J AM ASSOC GYN LAP, V5, P375, DOI 10.1016/S1074-3804(98)80050-9
   Feng YL, 2012, J MINIM INVAS GYN, V19, P498, DOI 10.1016/j.jmig.2012.03.010
   Florio P, 2012, CURR OPIN OBSTET GYN, V24, P180, DOI 10.1097/GCO.0b013e3283521202
   Gubbini G, 2008, J MINIM INVAS GYN, V15, P172, DOI 10.1016/j.jmig.2007.10.004
   Gubbini G, 2011, J MINIM INVAS GYN, V18, P234, DOI 10.1016/j.jmig.2010.10.011
   Guise JM, 2004, BRIT MED J, V329, P19, DOI 10.1136/bmj.329.7456.19
   Gurol-Urganci I, 2013, HUM REPROD, V28, P1943, DOI 10.1093/humrep/det130
   Jastrow N, 2006, ULTRASOUND OBST GYN, V27, P420, DOI 10.1002/uog.2718
   Jeremy B, 2013, GYNECOL OBSTET FERTI, V41, P588, DOI 10.1016/j.gyobfe.2013.08.005
   Kayani SI, 2005, BJOG-INT J OBSTET GY, V112, P451, DOI 10.1111/j.1471-0528.2004.00336.x
   Kennare R, 2007, OBSTET GYNECOL, V109, P270, DOI 10.1097/01.AOG.0000250469.23047.73
   Klemm P, 2005, J PERINAT MED, V33, P324, DOI 10.1515/JPM.2005.058
   Luo L, 2012, J MINIM INVAS GYN, V19, P454, DOI 10.1016/j.jmig.2012.03.012
   MacDorman MF, 2008, CLIN PERINATOL, V35, P293, DOI 10.1016/j.clp.2008.03.007
   Marotta ML, 2013, J MINIM INVAS GYN, V20, P386, DOI 10.1016/j.jmig.2012.12.006
   Mascarenhas MN, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-17
   Monteagudo A, 2001, J ULTRAS MED, V20, P1105, DOI 10.7863/jum.2001.20.10.1105
   Osser OV, 2010, BJOG-INT J OBSTET GY, V117, P1119, DOI 10.1111/j.1471-0528.2010.02631.x
   Osser OV, 2009, ULTRASOUND OBST GYN, V34, P90, DOI 10.1002/uog.6395
   Roberge S, 2011, INT J GYNECOL OBSTET, V115, P5, DOI 10.1016/j.ijgo.2011.04.013
   Schepker N, 2015, ARCH GYNECOL OBSTET, V291, P1417, DOI 10.1007/s00404-014-3582-0
   Sen S, 2004, INT J GYNECOL OBSTET, V87, P215, DOI 10.1016/j.ijgo.2004.07.023
   Tanimura S, 2015, J OBSTET GYNAECOL RE, V41, P1363, DOI 10.1111/jog.12738
   Thurmond AS, 1999, J ULTRAS MED, V18, P13
   Uppal T, 2011, J OBSTET GYNAECOL, V31, P413, DOI 10.3109/01443615.2011.577252
   Van Horenbeeck A, 2003, OBSTET GYNECOL, V102, P1137, DOI 10.1016/S0029-7844(03)00083-8
   Vervoort AJMW, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0260-8
   Wang CB, 2009, ULTRASOUND OBST GYN, V34, P85, DOI 10.1002/uog.6405
   Wilson-Leedy JG, 2016, OBSTET GYNECOL, V128, P145, DOI 10.1097/AOG.0000000000001488
   2006, OBSTET GYNECOL, V108, P465
NR 53
TC 2
Z9 2
U1 1
U2 5
PU TERMEDIA PUBLISHING HOUSE LTD
PI POZNAN
PA KLEEBERGA ST 2, POZNAN, 61-615, POLAND
SN 1895-4588
EI 2299-0054
J9 VIDEOSURGERY MINIINV
JI Videosurgery Miniinvasive Tec.
PY 2017
VL 12
IS 1
BP 88
EP 95
DI 10.5114/wiitm.2017.66025
PG 8
WC Surgery
SC Surgery
GA EQ9TP
UT WOS:000398428400014
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Xu, C
   Zhang, CH
   Wang, HW
   Yang, H
   Li, G
   Fei, ZH
   Li, WF
AF Xu, Chang
   Zhang, Chunhong
   Wang, Haowen
   Yang, Han
   Li, Gang
   Fei, Zhenghua
   Li, Wenfeng
TI RETRACTED: FAM172A expression in circulating tumor cells for prediction
   of high-risk subgroups of colorectal cancer(Retracted article. See vol.
   10, pg. 2411, 2017)
SO ONCOTARGETS AND THERAPY
LA English
DT Article; Retracted Publication
DE colorectal cancer; circulating tumor cells; epithelial-mesenchymal
   transition; FAM172A
ID EPITHELIAL-MESENCHYMAL TRANSITION; METASTATIC COLORECTAL-CANCER;
   FOLLOW-UP; CARCINOMA; SURVIVAL; DISEASE; PROGRESSION; PROGNOSIS; MARKER;
   ISET
AB Objectives: Previous studies used enumerated circulating tumor cells (CTCs) to predict prognosis and therapeutic effect in several types of cancers. However, increasing evidence showed that only enumerated CTCs were not enough to reflect the heterogeneity of tumors. Therefore, we classified different metastasis potentials of CTCs from colorectal cancer (CRC) patients to improve the accuracy of prognosis by CTCs.
   Methods: Blood samples were collected from 45 primary CRC patients. CTCs were enriched by blood filtration, and the RNA in situ hybridization method was used to identify and discriminate subgroups of CTCs. Later, FAM172A expression in individual CTCs was measured.
   Results: Three CTC subgroups (epithelial/biophenotypic/mesenchymal CTCs) were identified using epithelial-mesenchymal transition markers. In our research, mesenchymal CTCs significantly increased along with tumor progression, including developing distant metastasis and vascular invasion. Furthermore, FAM172A expression rate in mesenchymal CTCs was significantly higher than that in epithelial CTCs, which suggested that FAM172A may correlate with tumor malignancy. This hypothesis was further verified by FAM172A expression in mesenchymal CTCs strictly related to tumor aggressiveness factors. Finally, we revealed that mesenchymal CTCs and FAM172A expression may predict high-risk subgroups in stage II CRC.
   Conclusion: Our research proved that CTCs could serve as feasible surrogate samples to detect gene expression as a predictive biomarker for tumor evaluation.
C1 [Xu, Chang; Li, Wenfeng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Colorectal Surg, Wenzhou, Peoples R China.
   [Zhang, Chunhong] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pharm, Wenzhou, Peoples R China.
   [Wang, Haowen; Yang, Han; Li, Gang; Fei, Zhenghua; Li, Wenfeng] Wenzhou Med Univ, Affiliated Hosp 1, Dept Chemoradiotherapy, Wenzhou, Peoples R China.
   [Li, Wenfeng] Wenzhou Med Univ, Affiliated Hosp 1, Inst Translat Med, Lab Interdisciplinary Res, Wenzhou, Peoples R China.
RP Li, WF (reprint author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Chemoradiotherapy, Wenzhou, Peoples R China.
EM wflee_wmu@163.com
CR Ambuj K, 2014, PLOS COMPUT BIOL, V10
   Ambuj K, 2013, INTERDISCIP SCI, V5, P241
   Arya SK, 2013, LAB CHIP, V13, P1995, DOI 10.1039/c3lc00009e
   Bhaumik Panchalee, 2014, ScientificWorldJournal, V2014, P547154, DOI 10.1155/2014/547154
   Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543
   Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338
   Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923
   Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766
   Cui C, 2015, TUMOR BIOL, V37, P1
   Cui CH, 2016, TUMOR BIOL, V37, P6501, DOI 10.1007/s13277-015-4166-8
   de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872
   Chinen LTD, 2013, J THORAC DIS, V5, P593, DOI 10.3978/j.issn.2072-1439.2013.09.18
   Farace F, 2011, BRIT J CANCER, V105, P847, DOI 10.1038/bjc.2011.294
   Feng ZQ, 2013, ONCOL REP, V29, P1154, DOI 10.3892/or.2013.2235
   Hardingham JE, 2015, MOL MED, V21, pS25, DOI 10.2119/molmed.2015.00149
   Koerkamp BG, 2013, ANN SURG ONCOL, V20, P2156, DOI 10.1245/s10434-013-2907-8
   Kumar A, 2013, CELL BIOCHEM BIOPHYS, V67, P837, DOI 10.1007/s12013-013-9572-1
   Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758
   Lecharpentier A, 2011, BRIT J CANCER, V105, P1338, DOI 10.1038/bjc.2011.405
   Li H, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001565
   Li MF, 2016, MOL MED REP, V13, P353, DOI 10.3892/mmr.2015.4548
   Li YM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.347
   Linnekamp JF, 2015, CANCER RES, V75, P245, DOI 10.1158/0008-5472.CAN-14-2240
   Ma YC, 2013, TECHNOL CANCER RES T, V12, P295, DOI 10.7785/tcrt.2012.500328
   Meropol N, 2007, ASCO ANN M P CHIC US
   Paterlini-Brechot P, 2007, CANCER LETT, V253, P180, DOI 10.1016/j.canlet.2006.12.014
   Pearl ML, 2014, GYNECOL ONCOL, V134, P581, DOI 10.1016/j.ygyno.2014.06.013
   Qian K, 2016, ONCOL REP, V35, P1273, DOI 10.3892/or.2015.4485
   Sastre J, 2008, ANN ONCOL, V19, P935, DOI 10.1093/annonc/mdm583
   Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260
   Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391
   Wang JY, 2006, WORLD J SURG, V30, P1007, DOI 10.1007/s00268-005-0485-z
   Wu SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123976
   Yokobori T, 2013, CANCER RES, V73, P2059, DOI 10.1158/0008-5472.CAN-12-0326
   Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522
NR 35
TC 0
Z9 0
U1 7
U2 11
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6930
J9 ONCOTARGETS THER
JI OncoTargets Ther.
PY 2017
VL 10
BP 1933
EP 1939
DI 10.2147/OTT.S118346
PG 7
WC Biotechnology & Applied Microbiology; Oncology
SC Biotechnology & Applied Microbiology; Oncology
GA EQ3CM
UT WOS:000397948600006
PM 28408845
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Huang, JF
   Lin, ZW
AF Huang, Junfei
   Lin, Zhaowen
TI RETRACTED: Group-Aware Delay-Constrained Video Transmission Over
   Multihomed Device-to-Device Networks (Retracted Article)
SO IEEE ACCESS
LA English
DT Article; Retracted Publication
DE Video transmission; delay constraint; multihoming; device-to-device
   communications
ID HETEROGENEOUS WIRELESS NETWORKS; BANDWIDTH
AB The technological advancements in wireless communication systems enable mobile users to leverage different radio interfaces (e.g., cellular and WiFi) for concurrent data transmission. However, the existing transmission schemes do not seriously consider the problem of real-time video multicast to a cluster of co-located multihomed mobile devices. Conventionally, each client fetches the video streaming to the best of its capability, and this results in competing resources that degrade user-perceived video quality. Several literatures investigated the problem of using cellular to obtain video contents from the remote server and sharing them through WiFi. However, the stringent delay constraint of real-time video is not addressed in these solutions. In this paper, a cooperative transmission scheme is proposed to tackle the problem. First, a mathematical framework dubbed (Group-Aware Delay-COnstraint) is developed to formulate the delay-constrained goodput maximization problem of real-time video transmission to a group of multihomed mobiles. Second, a dataflow distribution mechanism is presented to conserve the cellular bandwidth and maximize user experience. Then, a prototype is implemented on the Android platform involving real-time video encoded with H.264 codec. Experimental results show that the proposed scheme achieves appreciable improvements over the reference schemes in video peak signal-to-noise ratio, end-to-end delay, and goodput.
C1 [Huang, Junfei] Beijing Univ Posts & Telecommun, Network & Informat Ctr, Inst Network Technol, Beijing 100876, Peoples R China.
   Natl Engn Lab Mobile Network Secur, Beijing 100876, Peoples R China.
RP Huang, JF (reprint author), Beijing Univ Posts & Telecommun, Network & Informat Ctr, Inst Network Technol, Beijing 100876, Peoples R China.
EM huangjunfei@bupt.edu.cn
OI zhang, xiaoyi/0000-0001-5124-4919
FU National High Technology Research and Development Program of China (863
   Program) [2013AA014702]; Fundamental Research Funds for the Central
   Universities [BUPT2016RC48, 2014ZD03-03]; National Natural Science
   Foundation of China [61601041]
FX This work was supported in part by the National High Technology Research
   and Development Program of China (863 Program) under Grant 2013AA014702,
   in part by the Fundamental Research Funds for the Central Universities
   under Grant BUPT2016RC48 and Grant 2014ZD03-03, and in part by the
   National Natural Science Foundation of China under Grant 61601041.
CR Abedini N., 2013, P 14 ACM INT S MOB A, P197
   Alpcan T, 2009, IEEE T MOBILE COMPUT, V8, P41, DOI 10.1109/TMC.2008.85
   [Anonymous], 2016, CISC VIS NETW IND GL
   AVRIEL M, 2003, NONLINEAR PROGRAMMIN
   Boldrini Chiara, 2008, Pervasive and Mobile Computing, V4, P633, DOI 10.1016/j.pmcj.2008.04.003
   Bui V, 2010, IEEE T PARALL DISTR, V21, P1398, DOI 10.1109/TPDS.2010.13
   Chandra R, 2009, I C NETWORK PROTOCOL, P161, DOI 10.1109/ICNP.2009.5339686
   Chebrolu K, 2006, IEEE T MOBILE COMPUT, V5, P388, DOI 10.1109/TMC.2006.1599407
   Cheshire S., 2005, TCP PERFORMANCE PROB
   Freris NM, 2013, IEEE ACM T NETWORK, V21, P469, DOI 10.1109/TNET.2012.2203608
   GILBERT EN, 1960, BELL SYST TECH J, V39, P1253, DOI 10.1002/j.1538-7305.1960.tb03959.x
   Golubchik L, 2002, PERFORM EVALUATION, V49, P429, DOI 10.1016/S0166-5316(02)00125-6
   Hartman T, 2012, IEEE INFOCOM SER, P828, DOI 10.1109/INFCOM.2012.6195830
   Hui P, 2011, IEEE T MOBILE COMPUT, V10, P1576, DOI 10.1109/TMC.2010.246
   Ioannidis S, 2009, IEEE INFOCOM SER, P1422, DOI 10.1109/INFCOM.2009.5062058
   Ismail M, 2014, IEEE T WIREL COMMUN, V13, P4616, DOI 10.1109/TWC.2014.2320726
   Jain M, 2003, IEEE ACM T NETWORK, V11, P537, DOI 10.1109/TNET.2003.815304
   Jones N., 2014, G00260239 GARTN
   Jurca D, 2007, IEEE T MULTIMEDIA, V9, P1227, DOI 10.1109/TMM.2007.902852
   Katti S, 2008, IEEE ACM T NETWORK, V16, P497, DOI 10.1109/TNET.2008.923722
   Le A, 2016, IEEE ACM T NETWORK, V24, P2705, DOI 10.1109/TNET.2015.2501349
   Ma D, 2012, IEEE T PARALL DISTR, V23, P598, DOI 10.1109/TPDS.2011.216
   Mao SW, 2005, IEEE INFOCOM SER, P2325
   MARTELLO S, 1981, COMPUTING, V27, P93, DOI 10.1007/BF02243544
   Prabhavat S, 2011, IEEE T PARALL DISTR, V22, P1730, DOI 10.1109/TPDS.2011.43
   Prasad R, 2003, IEEE NETWORK, V17, P27, DOI 10.1109/MNET.2003.1248658
   Ribeiro Vinay Joseph, 2003, P PASS ACT MEAS WORK, P1
   Rodriguez Pablo, 2004, P 2 INT C MOB SYST A, P217
   Sarkar UK, 2003, IEEE ACM T NETWORK, V11, P638, DOI 10.1109/TNET.2003.815292
   Seferoglu Hulya, 2011, 2011 49th Annual Allerton Conference on Communication, Control, and Computing (Allerton), P220
   Sen S., 2010, P USENIX S NETW SYST, P191
   Si PB, 2010, WIREL NETW, V16, P1277, DOI 10.1007/s11276-009-0202-1
   Song W, 2012, IEEE T WIREL COMMUN, V11, P1554, DOI 10.1109/TWC.2012.021512.111397
   Soroush H, 2011, ACM SIGCOMM COMP COM, V41, P402, DOI 10.1145/2043164.2018489
   Tsao C. -L., 2009, P 5 INT C EM NETW EX, P337
   Wu JY, 2016, IEEE T COMMUN, V64, P2477, DOI 10.1109/TCOMM.2016.2553138
   Wu JY, 2013, IEEE GLOB COMM CONF, P1723, DOI 10.1109/GLOCOM.2013.6831322
   Wu JY, 2015, IEEE T PARALL DISTR, V26, P2286, DOI 10.1109/TPDS.2014.2347031
   Wu JY, 2015, IEEE T MOBILE COMPUT, V14, P688, DOI 10.1109/TMC.2014.2334592
   Xi G, 2014, 2014 21ST INTERNATIONAL CONFERENCE ON TELECOMMUNICATIONS (ICT), P405, DOI 10.1109/ICT.2014.6845148
   Xu CQ, 2013, IEEE T MOBILE COMPUT, V12, P2193, DOI 10.1109/TMC.2012.189
   Yaacoub E., 2012, P 19 ICT JOUN LEB AP, P1
   Zhang L, 2015, WIRELESS PERS COMMUN, V84, P1797, DOI 10.1007/s11277-015-2784-5
   Zhang Y., 2014, P 5 ACM MULT SYST C, P160
   Zhu XQ, 2009, IEEE T MULTIMEDIA, V11, P752, DOI 10.1109/TMM.2009.2017641
NR 45
TC 1
Z9 1
U1 5
U2 10
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 2169-3536
J9 IEEE ACCESS
JI IEEE Access
PY 2017
VL 5
BP 2651
EP 2664
DI 10.1109/ACCESS.2017.2671900
PG 14
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA EP1HV
UT WOS:000397136900167
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Tan, XL
   Lv, JY
   Zhao, GD
   Zhao, ZM
   Li, CG
   Xu, Y
   Hu, MG
AF Tan, Xianglong
   Lv, Jinyong
   Zhao, Guodong
   Zhao, Zhiming
   Li, Chenggang
   Xu, Yong
   Hu, Minggen
TI RETRACTED: MicroRNA-4656 is a prognostic factor and tumor suppressor in
   human pancreatic cancer through a downstream target of TrkA (Retracted
   article. See vol 19, Artn e2967, 2017)
SO JOURNAL OF GENE MEDICINE
LA English
DT Article; Retracted Publication
DE biomarker; invasion; miR-4656; overall survival; pancreatic cancer;
   proliferation; transplant; TrkA
ID GROWTH-FACTOR RECEPTORS; DUCTAL ADENOCARCINOMA; EXPRESSION; CELLS;
   PROLIFERATION; INVASION
AB Background In the present study, we investigated the expression profile and functional mechanism of microRNA-4656 in human pancreatic cancer (PC).
   Methods MiR-4656 expression in PC tumors was examined using a quantitative reverse transcriptase-polymerase chain reaction in 134 patients. Associations between tumorous miR-4656 expression and clinicopathological parameters of patients, as well as overall survival, were analyzed. MiR-4656 expression was also examined in PC in vitro cell lines. In Capan-1 and AsPC-1 PC cells, lentivirus-induced miR-4656 overexpression or downregulation was applied to investigate its functional regulations on PC in vitro proliferation and invasion, as well as in vivo transplant growth. The association of miR-4656 and its downstream target, the tropomyosin receptor kinase A (TrkA) gene, was investigated in both cell line and clinical pancreatic tumors. In miR-4656-overerxpressed PC cells, TrkA was overexpressed with the aim of investigating its role in miR-4656-induced functional regulation in PC.
   Results MiR-4656 was downregulated in PC. Low tumorous miR-4656 expression was associated with a poor prognosis and overall survival of patients. MiR-4656 was also found to be downregulated in PC cell lines. MiR-4656 overexpression in Capan-1 and AsPC-1 cells significantly inhibited cancer proliferation and invasion in vitro, as well as explant growth in vivo, whereas miR-4656 downregulation had no effect on cancer development. The TrkA gene was directly bound by miR-4656, and reversely expressed in PC tumors as miR-4656. TrkA overexpression reversed the inhibitory effect of miR-4656-overexpression on PC proliferation and invasion.
   Conclusions MiR-4656 is expressed to a low extent and is a potential biomarker in PC. Overexpressing miR-4656 has tumor suppressive effects on PC development both in vitro and in vivo, likely through its downstream target of the TrkA gene.
C1 [Tan, Xianglong; Zhao, Guodong; Zhao, Zhiming; Li, Chenggang; Xu, Yong; Hu, Minggen] Peoples Liberat Army, Dept Surg Oncol 2, Gen Hosp, 28 Fuxing Rd, Beijing 100853, Peoples R China.
   [Lv, Jinyong] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Dept Hepatobiliary, Beijing, Peoples R China.
RP Zhao, ZM (reprint author), Peoples Liberat Army, Dept Surg Oncol 2, Gen Hosp, 28 Fuxing Rd, Beijing 100853, Peoples R China.
EM zhzhm4@aol.com
CR Bhayani MK, 2012, MUTAT RES-FUND MOL M, V731, P14, DOI 10.1016/j.mrfmmm.2011.10.014
   Bilimoria KY, 2007, CANCER, V110, P738, DOI 10.1002/cncr.22852
   Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242
   Chitkara D, 2015, ADV DRUG DELIVER REV, V81, P34, DOI 10.1016/j.addr.2014.09.006
   Dang CX, 2006, J GASTROEN HEPATOL, V21, P850, DOI 10.1111/j.1440-1746.2006.04074.x
   Dunne RF, 2015, HEMATOL ONCOL CLIN N, V29, P595, DOI 10.1016/j.hoc.2015.04.003
   Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467
   Lagadec C, 2009, ONCOGENE, V28, P1960, DOI 10.1038/onc.2009.61
   Lin QJ, 2015, WORLD J GASTROENTERO, V21, P7988, DOI 10.3748/wjg.v21.i26.7988
   Liu DP, 2007, ONCOL REP, V18, P673
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592
   Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4
   Persson H, 2011, CANCER RES, V71, P78, DOI 10.1158/0008-5472.CAN-10-1869
   Sakamoto Y, 2001, ONCOL REP, V8, P477
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332
   Tapia V, 2011, GYNECOL ONCOL, V121, P13, DOI 10.1016/j.ygyno.2010.12.341
   Yabar CS, 2016, GASTROENTEROL CLIN N, V45, P429, DOI 10.1016/j.gtc.2016.04.003
   Zhang Y, 2005, ONCOL REP, V14, P161
NR 19
TC 1
Z9 1
U1 2
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1099-498X
EI 1521-2254
J9 J GENE MED
JI J. Gene. Med.
PD JAN-FEB
PY 2017
VL 19
IS 1-2
AR UNSP e2938
DI 10.1002/jgm.2938
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA EN9XP
UT WOS:000396353200003
PM 27936486
DA 2018-12-27
ER

PT J
AU Chen, RC
   Zhang, MF
   Li, QL
   Xiong, HZ
   Liu, SY
   Fang, WY
   Zhang, QB
   Liu, Z
   Xu, XH
   Jiang, QP
AF Chen, Ruichao
   Zhang, Minfeng
   Li, Qiulian
   Xiong, Hanzhen
   Liu, Shaoyan
   Fang, Weiyi
   Zhang, Qianbing
   Liu, Zhen
   Xu, Xuehu
   Jiang, Qingping
TI RETRACTED: The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to
   promote host cell proliferative and invasive abilities in nasopharyngeal
   carcinoma (Retracted article. See vol. 8, pg. 3130, 2017)
SO JOURNAL OF CANCER
LA English
DT Article; Retracted Publication
DE Nasopharyngeal carcinoma; Epstein-Barr Virus; miRNA; MAP3K5
ID GASTRIC ADENOCARCINOMA; EPITHELIAL-CELLS; VIRAL-DNA; MICRORNAS;
   EXPRESSION; APOPTOSIS; ASK1; TUMORIGENESIS; MODULATION; TUMORS
AB miR-BART22, a new discovered Epstein-Barr virus (EBV) miRNA, is abundant in Nasopharyngeal carcinoma (NPC). It has been reported that miR-BART22 promoted the tumor development by down-modulating EBV LMP2 expression to evade the host immune response. But its cell target genes have still been obscure. We have reported an inverse correlation between the BART-22 and MAP3K5 protein expression in NPC tissues and NPC cell lines. Meanwhile, MAP3K5 protein expression level was significantly decreased in primary NPC tissues compared with nasopharyngitis when MAP3K5 mRNA expression was consistent in two group tissues. According to our data and target prediction by miRnada, we assume MAP3K5 is an important target gene of NPC. MAP3K5, also named apoptosis signal-regulating kinase1 (ASK1), is an important early answer gene in P38MAPK pathway and an apoptosis-related gene. In present study, MAP3K5 was verified the target gene of miR-BART22 by luciferase assay. miRBART-22 decreased MAP3K5 protein level. Moreover, it also decreased MAP3K5 downstream gene MAP2K4 expression in P38MAPK pathway, and even their activated phosphorylation forms. Additionally, we found stable transfection of miR-BAT22 could improve tumor cells' proliferative and invasive abilities in NPC cell line 5-8F. The data highlight the role of the EBV miR-BART22 in regulating genes involving in apoptosis and some important pathways to promote cancer development. And it also raises the possibility that inhibitors of miR-BART22 can be as a therapeutic strategy for NPC and other EBV-infected tumors treatment.
C1 [Chen, Ruichao; Zhang, Minfeng; Li, Qiulian; Xiong, Hanzhen; Liu, Shaoyan; Liu, Zhen; Jiang, Qingping] Guangzhou Med Univ, Affiliated Hosp 3, Dept Pathol, Guangzhou 510150, Guangdong, Peoples R China.
   [Liu, Zhen] Guangzhou Med Univ, Basic Sch, Dept Pathol, Guangzhou 510000, Guangdong, Peoples R China.
   [Fang, Weiyi; Zhang, Qianbing] Southern Med Univ, Canc Res Inst, Guangzhou 510515, Guangdong, Peoples R China.
   [Xu, Xuehu] Guangzhou Med Univ, Affiliated Hosp 3, Gastrointestinal Dept, Guangzhou 510150, Guangdong, Peoples R China.
   [Li, Qiulian] Gannan Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Gannan 341000, Peoples R China.
RP Liu, Z; Jiang, QP (reprint author), Guangzhou Med Univ, Affiliated Hosp 3, Dept Pathol, Guangzhou 510150, Guangdong, Peoples R China.; Liu, Z (reprint author), Guangzhou Med Univ, Basic Sch, Dept Pathol, Guangzhou 510000, Guangdong, Peoples R China.; Xu, XH (reprint author), Guangzhou Med Univ, Affiliated Hosp 3, Gastrointestinal Dept, Guangzhou 510150, Guangdong, Peoples R China.
EM narcissus_jane@163.com; maxtiger@126.com; jiangqingping@gzhmu.edu.cn
FU National Nature Science Fund of China [81102061, 30971438]; Guangdong
   Province Breeding Project Plan [LYM11102]; Guangdong Province Education
   Foundation [2014KTSCX102, 2014KTSCX107]; Fund of Guangdong Science and
   Technology department [2014A020212342]
FX This study was supported by National Nature Science Fund of China (No.
   81102061,30971438,), Guangdong Province Breeding Project Plan (No.
   LYM11102), Guangdong Province Education Foundation (No. 2014KTSCX102,
   No. 2014KTSCX107), The Fund of Guangdong Science and Technology
   department (No. 2014A020212342).
CR Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080
   Chen S., 2010, PLOS ONE, V5
   Chibon F, 2004, GENE CHROMOSOME CANC, V40, P32, DOI 10.1002/gcc.20012
   Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581
   Cosmopoulos K, 2009, J VIROL, V83, P2357, DOI 10.1128/JVI.02104-08
   Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793
   Delecluse HJ, 2007, J CLIN PATHOL, V60, P1358, DOI 10.1136/jcp.2006.044586
   DESGRANGES C, 1975, INT J CANCER, V16, P7, DOI 10.1002/ijc.2910160103
   Edwards RH, 2008, J VIROL, V82, P9094, DOI 10.1128/JVI.00785-08
   EPSTEIN MA, 1964, LANCET, V1, P702
   HARN HJ, 1995, HUM PATHOL, V26, P267, DOI 10.1016/0046-8177(95)90056-X
   Hayakawa Y, 2010, GASTROENTEROLOGY, V138, P1055, DOI 10.1053/j.gastro.2009.11.015
   Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90
   Iriyama T, 2009, EMBO J, V28, P843, DOI 10.1038/emboj.2009.32
   Jiang Qing-ping, 2011, Nan Fang Yi Ke Da Xue Xue Bao, V31, P1146
   John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363
   KARRAN L, 1992, P NATL ACAD SCI USA, V89, P8058, DOI 10.1073/pnas.89.17.8058
   Lo AKF, 2012, J PATHOL, V227, P392, DOI 10.1002/path.4025
   Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104
   Lo AKF, 2006, NEOPLASIA, V8, P173, DOI 10.1593/neo.05625
   Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888
   Marquitz AR, 2011, VIROLOGY, V412, P392, DOI 10.1016/j.virol.2011.01.028
   Pressinotti NC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-130
   Prickett TD, 2014, J INVEST DERMATOL, V134, P452, DOI 10.1038/jid.2013.365
   RAABTRAUB N, 1987, INT J CANCER, V39, P25, DOI 10.1002/ijc.2910390106
   Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1021/rna.5248604
   SHIBATA D, 1992, AM J PATHOL, V140, P769
   Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046
   WEISS LM, 1987, AM J PATHOL, V129, P86
   Wong AMG, 2012, CANCER-AM CANCER SOC, V118, P698, DOI 10.1002/cncr.26309
   Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452
   Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08
NR 33
TC 5
Z9 6
U1 3
U2 7
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1837-9664
J9 J CANCER
JI J. Cancer
PY 2017
VL 8
IS 2
BP 305
EP 313
DI 10.7150/jca.15753
PG 9
WC Oncology
SC Oncology
GA EO3EU
UT WOS:000396578500017
PM 28243335
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Andersson, L
AF Andersson, L.
TI RETRACTED: Hidden authority study data have come to light: besides
   narcolepsy, the swine influenza vaccine Pandemrix caused type 1 diabetes
   (Retracted article. See vol. 284, pg. 328, 2018)
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Letter; Retracted Publication
ID IMMUNE-RELATED DISEASES; PUBLISHED ARTICLE RISKS; REGISTRY-BASED COHORT;
   INCLUDING NARCOLEPSY; CONTRADICTORY DATA; FOLLOW-UP; LARS ANDERSSON
C1 [Andersson, L.] Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Solna, Sweden.
RP Andersson, L (reprint author), Karolinska Inst, Dept Physiol & Pharmacol, SE-17177 Solna, Sweden.
EM lars.andersson2@outlook.com
CR Andersson L, 2015, J INTERN MED, V277, P272, DOI 10.1111/joim.12327
   Andersson L, 2014, J INTERN MED, V276, P414, DOI 10.1111/joim.12246
   Persson I, 2015, J INTERN MED, V277, P274, DOI 10.1111/joim.12323
   Persson I, 2014, J INTERN MED, V276, P413, DOI 10.1111/joim.12245
   Persson I, 2014, J INTERN MED, V275, P172, DOI 10.1111/joim.12150
NR 5
TC 4
Z9 4
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD JAN
PY 2017
VL 281
IS 1
BP 99
EP 101
DI 10.1111/joim.12583
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA EK5EP
UT WOS:000393950000010
PM 27995691
DA 2018-12-27
ER

PT J
AU Li, XL
   Song, C
   Huang, GN
   Sun, SW
   Qiao, JJ
   Zhao, JB
   Zhao, ZW
   Li, M
AF Li, Xuelu
   Song, Chen
   Huang, Gena
   Sun, Siwen
   Qiao, Jingjing
   Zhao, Jinbo
   Zhao, Zuowei
   Li, Man
TI RETRACTED: The coexpression of EphB4 and EphrinB2 is associated with
   poor prognosis in HER2-positive breast cancer(Retracted article. See
   vol. 10, pg. 2425, 2017)
SO ONCOTARGETS AND THERAPY
LA English
DT Article; Retracted Publication
DE breast carcinoma; EphB4; EphrinB2; prognosis
ID TUMOR ADVANCEMENT; CANCERS; OVEREXPRESSION; EXPRESSION; RECEPTOR
AB Objective: HER2 overexpression is associated with aggressive phenotypes in breast cancer, including increased tumor proliferation, greater invasiveness, and reduced overall survival. The overall response rate to HER2-targeted therapies remains,30%. There is an urgent need for the identification of efficient markers to predict patients with a poor prognosis. This study was designed to investigate the correlation between EphB4 and EphrinB2 expression and the clinicopathological characteristics of HER2-positive breast cancer.
   Materials and methods: A total of 111 primary HER2-positive breast cancer patients were enrolled in this study (diagnosed since December 2005 to November 2010 from the Second Hospital of Dalian Medical University). The protein expression of EphB4 and EphrinB2 was examined by immunohistochemistry using paraffin-embedded tumor tissues.
   Results: There was a significant correlation between EphB4 and EphrinB2 expression (P=0.013, r=0.255). Kaplan-Meier analysis showed that the prognosis of patients with a high expression of both EphB4 and EphrinB2 was significantly worse than the prognosis of patients with either EphB4 or EphrinB2 expression and patients with negative expression (hazard ratio [HR] =1.935, P=0.0224). However, high expression of EphB4 or EphrinB2 alone was not an independent prognostic factor to predict worse overall survival. To summarize, HER2-positive breast cancer patients with overexpression of both EphB4 and EphrinB2 were associated with the worst prognosis.
   Conclusion: High expression of EphB4 and EphrinB2 correlated with poor overall survival, which can serve as an independent prognostic indicator in primary HER2-positive breast cancer patients.
C1 [Li, Xuelu; Zhao, Zuowei] Dalian Med Univ, Dept Breast Surg, Hosp 2, Dalian, Peoples R China.
   [Song, Chen; Huang, Gena; Sun, Siwen; Qiao, Jingjing; Zhao, Jinbo; Li, Man] Dalian Med Univ, Hosp 2, Dept Oncol, Dalian 116027, Liaoning Provin, Peoples R China.
RP Li, M (reprint author), Dalian Med Univ, Hosp 2, Dept Oncol, Dalian 116027, Liaoning Provin, Peoples R China.
EM dmuliman@163.com
FU National Natural Science Foundation of China [81071127, 81471751,
   81673762, 81650018]
FX The authors would like to thank all patients enrolled in this study.
   Xuelu Li and Chen Song are co-first authors. This work was supported by
   the National Natural Science Foundation of China (No 81071127, No
   81471751, and No 81673762 to Zuowei Zhao; No 81650018 to Man Li).
CR Alam SM, 2008, BRIT J CANCER, V98, P845, DOI 10.1038/sj.bjc.6604216
   Alam SM, 2007, ANN ONCOL, V18, P485, DOI 10.1093/annonc/mdl414
   Alam SM, 2009, GYNECOL ONCOL, V114, P84, DOI 10.1016/j.ygyno.2009.03.017
   BRAMBILLA R, 1995, EMBO J, V14, P3116, DOI 10.1002/j.1460-2075.1995.tb07314.x
   Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005
   Jin CY, 2016, ONCOTARGETS THER, V9, P5483, DOI 10.2147/OTT.S102386
   Kataoka H, 2002, J CANCER RES CLIN, V128, P343, DOI 10.1007/s00432-002-0355-0
   Kong Y, 2016, J CANCER RES CLIN, V142, P1765
   Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856
   Mundy GR, 2006, CELL, V126, P441, DOI 10.1016/j.cell.2006.07.015
   Sharma GK, 2015, HEAD NECK-J SCI SPEC, V37, P964, DOI 10.1002/hed.23694
   Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281
   Tu YY, 2012, CLIN TRANSL ONCOL, V14, P214, DOI 10.1007/s12094-012-0786-2
   Yang D, 2016, ANGIOGENESIS, V19, P297, DOI 10.1007/s10456-016-9514-9
NR 14
TC 2
Z9 2
U1 4
U2 5
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-6930
J9 ONCOTARGETS THER
JI OncoTargets Ther.
PY 2017
VL 10
BP 1735
EP 1742
DI 10.2147/OTT.S132806
PG 8
WC Biotechnology & Applied Microbiology; Oncology
SC Biotechnology & Applied Microbiology; Oncology
GA EO7ZF
UT WOS:000396907900001
PM 28356761
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Pan, YB
   Zheng, SX
   Liu, YP
   Ke, HT
   Yang, XF
AF Pan, Yangbin
   Zheng, Shixiang
   Liu, Yipeng
   Ke, Hongtin
   Yang, Xuefen
TI RETRACTED: Fbxo3 knockdown attenuates inflammatory responses in lupus
   nephritis(Retracted article. See vol.10, pg.8096, 2017)
SO INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
LA English
DT Article; Retracted Publication
DE FBXO3; Fbxl2; TRAF; lupus nephritis; ubiquitinatio
ID FBXO3-DEPENDENT FBXL2 UBIQUITINATION; MEDIATES NEUROPATHIC ALLODYNIA;
   SKIN INFLAMMATION; TNF-ALPHA; NEPHRITIS; CELLS; SLE; DIFFERENTIATION;
   DEGRADATION; ACTIVATION
AB Objective: The present study was on the research of the effects of Fbxo3 on experimental lupus nephritis induced by aggregated IgG in mice renal mesangial cells. Methods: A lupus nephritis cell model was induced via incubation with aggregated IgG. Soluble AIgG could stimulate the expression of IL-1 beta and IL-6 in mesangial cells and promote MC proliferation. Before the incubation, by transfecting plasmid for Fbxl2 or siRNA for Fbxo3, we regulated Fbxl2 or Fbxo3 level in mice renal mesangial cells. The effect of transfection of Fbxl2 plasmid or Fbxo3 siRNA was evaluated by western blot. Results: The results suggested that, AIgG can cause proliferation of renal mesangial cells and stimulate more production of inflammation factors, such as IL-1 beta and IL-6. Either Fbxo3 plasmid or Fbxl2 siRNA inhibit mesangial cells proliferation and IL-6 secretion. Fbxo3 combines with Fbxl2 and prevents it from targeting TRAF2 for polyubiquitination in mesangial cells. Further we found Fbxo3 inhibitor reduces AIgG -induced inflammation in mesangial cells. In conclusion, we confirmed the role of Fbxo3-Fbxl2-TRAF2 in lupus nephritis-like inflammation in mesangial cells, which provide effective treatment for lupus nephritis.
C1 [Pan, Yangbin; Ke, Hongtin] Fujian Med Univ, Affiliated Hosp 1, Div Nephrol, Fuzhou, Fujian, Peoples R China.
   [Zheng, Shixiang; Liu, Yipeng; Yang, Xuefen] Wuhan Univ, Renmin Hosp, Div Nephrol, Wuhan, Hubei, Peoples R China.
RP Pan, YB (reprint author), Fujian Med Univ, Affiliated Hosp 1, Div Nephrol, Fuzhou, Fujian, Peoples R China.
EM panyb_fujian@126.com
FU National Natural Science Foundation of China [81670635]; General Program
   of Fujian Province Natural Science Foundation [2016J01532]; Young and
   Middle Aged Backbone Personnel Training Program of Fujian Provincial
   Health and Family Planning Commission [2016-ZQN-36]
FX This work was supported in part by grants from the National Natural
   Science Foundation of China (81670635), the General Program of Fujian
   Province Natural Science Foundation (2016J01532) and the Young and
   Middle Aged Backbone Personnel Training Program of Fujian Provincial
   Health and Family Planning Commission (2016-ZQN-36).
CR Bao Y, 2014, NEW PHYTOL, V202, P174, DOI 10.1111/nph.12644
   Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565
   Chen BB, 2012, BLOOD, V119, P3132, DOI 10.1182/blood-2011-06-358911
   Chen BB, 2011, CELL CYCLE, V10, P3487, DOI 10.4161/cc.10.20.17742
   Choojitarom K, 2008, CLIN RHEUMATOL, V27, P345, DOI 10.1007/s10067-007-0721-z
   Dubey RK, 2002, HYPERTENSION, V39, P418, DOI 10.1161/hy0202.103297
   Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124
   Huang L, 2015, MOL MED REP, V12, P4187, DOI 10.3892/mmr.2015.3953
   Kavai M, 2008, AUTOIMMUN REV, V8, P160, DOI 10.1016/j.autrev.2008.06.002
   Lai CY, 2016, J NEUROSCI, V36, P9722, DOI 10.1523/JNEUROSCI.1732-16.2016
   Li LQ, 2016, FEBS LETT, V590, P445, DOI 10.1002/1873-3468.12071
   Li MH, 2015, AM J CHINESE MED, V43, P1401, DOI 10.1142/S0192415X15500792
   Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y
   Lin TB, 2015, J NEUROSCI, V35, P16545, DOI 10.1523/JNEUROSCI.2301-15.2015
   Listopad J, 2007, EXP DERMATOL, V16, P661, DOI 10.1111/j.1600-0625.2007.00581.x
   Moroni G, 2013, LUPUS, V22, P810, DOI 10.1177/0961203313492576
   Prause M, 2016, MOL CELL ENDOCRINOL, V420, P24, DOI 10.1016/j.mce.2015.11.021
   Rajabi P, 2012, INFLAMM RES, V61, P1347, DOI 10.1007/s00011-012-0535-6
   Sabry A, 2006, INT UROL NEPHROL, V38, P731, DOI 10.1007/s11255-006-0047-9
   Seah GT, 2001, J IMMUNOL, V167, P1230, DOI 10.4049/jimmunol.167.3.1230
   Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040
   WOLLINA U, 1984, Allergie und Immunologie (Leipzig), V30, P3
   Zhu LJ, 2010, CYTOKINE, V49, P201, DOI 10.1016/j.cyto.2009.10.004
NR 23
TC 1
Z9 1
U1 2
U2 4
PU E-CENTURY PUBLISHING CORP
PI MADISON
PA 40 WHITE OAKS LN, MADISON, WI 53711 USA
SN 1936-2625
J9 INT J CLIN EXP PATHO
JI Int. J. Clin. Exp. Pathol.
PY 2017
VL 10
IS 2
BP 1423
EP 1428
PG 6
WC Oncology; Pathology
SC Oncology; Pathology
GA EN0ZC
UT WOS:000395739000061
DA 2018-12-27
ER

PT J
AU Mallik, A
   Barik, AK
   Pal, B
AF Mallik, Amit
   Barik, Anil K.
   Pal, Biswajit
TI RETRACTED: Self-limited growth of Pr3+- doped LaF3 nanocrystals in
   oxyfluoride glass and glassceramics (Retracted article. See vol. 7, pg.
   44225, 2017)
SO RSC ADVANCES
LA English
DT Article; Retracted Publication
ID UP-CONVERSION LUMINESCENCE; PHASE-SEPARATION; FIBER AMPLIFIERS;
   CERAMICS; CRYSTALLIZATION; MICROSTRUCTURE; ER3+; YB3+
AB Transparent oxyfluoride glass-ceramics of heavy metals doped with rare earth metal ions are important materials in optoelectronics. In the present study, we report the preparation of a glass and a glassceramic with composition 16.52Al(2)O(3)center dot 1.5 AlF3 center dot 12.65LaF(3)center dot 4.33Na(2)O center dot 64.85 SiO2 (mol%), where both the materials were doped with 1 mol% Pr2O3. All four species were structurally characterized by Transmission Electron Microscopy (TEM). Pr2O3 affected the phase separation in the glass and deferred crystallization compared to the undoped glass. The crystallization mechanism and the location of various components in the glass/glass-ceramics were ascertained through advanced STEM/EDX techniques. The phase separated regions in the mother glass were mostly populated by F and La and also by Pr, Al and Si. The phase separated droplets, after annealing, turned into 10-20 nm LaF3 nanocrystals, which were found to partly include the doping Pr3+ ions in the crystals themselves. The interphase crystal/glassy matrix was thoroughly characterized by EDX. The results suggest that the inner LaF3 crystal core is engulfed by an Al enriched layer that follows a Si enriched surrounding shell as the outer core. This finding also indicates that the crystal surface is too viscous to further enhance the crystal growth, and therefore the overall crystal formation is limited to the nanosize.
C1 [Mallik, Amit] Siliguri Coll, Dept Chem, Darjeeling 734001, India.
   [Barik, Anil K.; Pal, Biswajit] St Pauls Cathedral Mission Coll, Dept Chem, 33-1 Raja Rammohan Roy Sarani, Kolkata 700009, India.
RP Pal, B (reprint author), St Pauls Cathedral Mission Coll, Dept Chem, 33-1 Raja Rammohan Roy Sarani, Kolkata 700009, India.
EM palbiswajit@yahoo.com
CR AHN JH, 1986, ULTRAMICROSCOPY, V19, P375, DOI 10.1016/0304-3991(86)90097-5
   Barros JR, 2010, SOLID STATE SCI, V12, P2086, DOI 10.1016/j.solidstatesciences.2010.09.003
   Bhattacharyya S, 2010, CRYST GROWTH DES, V10, P379, DOI 10.1021/cg9009898
   Bhattacharyya S, 2009, NANO LETT, V9, P2493, DOI 10.1021/nl901283r
   Chen DQ, 2007, MATER CHEM PHYS, V101, P464, DOI 10.1016/j.matchemphys.2006.08.005
   Chen DQ, 2016, J EUR CERAM SOC, V36, P1841, DOI 10.1016/j.jeurceramsoc.2016.01.026
   Chen DQ, 2015, J EUR CERAM SOC, V35, P2129, DOI 10.1016/j.jeurceramsoc.2015.01.021
   de Pablos-Martin A, 2013, J AM CERAM SOC, V96, P447, DOI 10.1111/jace.12120
   de Pablos-Martin A, 2012, INT MATER REV, V57, P165, DOI 10.1179/1743280411Y.0000000004
   de Pablos-Martin A, 2010, OPT MATER, V33, P180, DOI 10.1016/j.optmat.2010.08.004
   de Pablos-Martin A, 2011, J AM CERAM SOC, V94, P2420, DOI 10.1111/j.1551-2916.2011.04547.x
   Dejneka MJ, 1998, MRS BULL, V23, P57
   Dominiak-Dzik G, 2012, J ALLOY COMPD, V511, P189, DOI 10.1016/j.jallcom.2011.09.026
   Dzik G. D., 2010, OPT APPL, VXL, P375
   Dzik G. D., 2009, J NANOSCI NANOTECHNO, V9, P2525
   Fedorov PP, 2015, J FLUORINE CHEM, V172, P22, DOI 10.1016/j.jfluchem.2015.01.009
   Gai SL, 2014, CHEM REV, V114, P2343, DOI 10.1021/cr4001594
   Gao GJ, 2013, OPT MATER EXPRESS, V3, P633, DOI 10.1364/OME.3.000633
   Hu ZJ, 2005, J NON-CRYST SOLIDS, V351, P722, DOI 10.1016/j.jnoncrysol.2005.01.075
   Jha A., 1995, J EUR OPT SOC A, V4, P417
   Karaksina EV, 2016, J LUMIN, V177, P275, DOI 10.1016/j.jlumin.2016.05.005
   Karaksina EV, 2016, J LUMIN, V170, P37, DOI [10.1016/j.jlumin.2015.10.015, 10.1016/j.jlumin.2015.0.015]
   Kawamoto Y, 1998, J MATER SCI, V33, P63, DOI 10.1023/A:1004333310532
   Lin CG, 2016, J PHYS CHEM C, V120, P4556, DOI 10.1021/acs.jpcc.6b00683
   Lin CG, 2015, NANO LETT, V15, P6764, DOI 10.1021/acs.nanolett.5b02605
   Macfarlane RM, 2001, OPT LETT, V26, P429, DOI 10.1364/OL.26.000429
   Munoz F, 2011, J NON-CRYST SOLIDS, V357, P1463, DOI 10.1016/j.jnoncrysol.2010.11.024
   Plsarski W. A., 2006, J OPTOELECTRON ADV M, V8, P1206
   Qiu J, 1998, J MATER SCI LETT, V17, P653, DOI 10.1023/A:1006616223254
   Qiu JR, 1996, J MATER SCI LETT, V15, P1641
   Russel C, 2005, CHEM MATER, V17, P5843, DOI 10.1021/cm051430x
   URQUHART P, 1992, IEEE J QUANTUM ELECT, V28, P1962, DOI 10.1109/3.159502
   Wan ZY, 2015, J EUR CERAM SOC, V35, P3673, DOI 10.1016/j.jeurceramsoc.2015.05.031
   Wang XJ, 2003, MICROELECTRON J, V34, P549, DOI 10.1016/S0026-2692(03)00045-4
   WANG YH, 1993, APPL PHYS LETT, V63, P3268, DOI 10.1063/1.110170
   WEI K, 1995, J NON-CRYST SOLIDS, V182, P257, DOI 10.1016/0022-3093(94)00513-3
   WU X, 1994, PHYS STATUS SOLIDI A, V141, P445, DOI 10.1002/pssa.2211410225
   XU W, 1994, J APPL PHYS, V75, P4180, DOI 10.1063/1.356002
   Zhao JJ, 2016, J PHYS CHEM C, V120, P17726, DOI 10.1021/acs.jpcc.6b05796
NR 39
TC 2
Z9 2
U1 2
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2017
VL 7
IS 24
BP 14824
EP 14831
DI 10.1039/c6ra28084f
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA EN6ZC
UT WOS:000396150900061
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Abdalla, S
   Al-Marzouki, F
   Obaid, A
AF Abdalla, S.
   Al-Marzouki, Fahd
   Obaid, A.
TI RETRACTED: Safety considerations during production and consumption of
   hydrogen using proton exchange membrane electrolysis (Retracted article.
   See vol. 9, Artn. 039903, 2017)
SO JOURNAL OF RENEWABLE AND SUSTAINABLE ENERGY
LA English
DT Article; Retracted Publication
ID CELL
AB Hydrogen (H-2) cross-over through a membrane electrolyte is a critical safety issue in proton exchange membrane (PEM) electrolysis. Permeated H-2 tends to be consumed by oxidation or recombination at the anode. In this study, the contribution of oxidation/recombination to the reduction of the H-2 content in the anode compartment was quantitatively evaluated by measuring the H-2 content during the electrolysis operation of a unitized reversible fuel cell stack in which the anode catalyst layer (CL) contained platinum (Pt). The results of fitting calculation indicated that over 70% of permeated H-2 flux through the membrane was consumed at the anode by oxidation or recombination when the cathode pressure was under 10 bars. Therefore, promoting H-2 consumption due to the addition of Pt in either the CL or current collector is critical for safe PEM electrolysis. Furthermore, optimization of the electrode structure is also important not only to increase the Faraday (current) efficiency but also to reduce the H-2 content in the anode. Published by AIP Publishing.
C1 [Abdalla, S.; Al-Marzouki, Fahd] King Abdulaziz Univ, Dept Phys, Fac Sci, POB 80203, Jeddah 21589, Saudi Arabia.
   [Obaid, A.] King Abdulaziz Univ, Dept Phys Chem, Fac Sci, POB 80203, Jeddah 21589, Saudi Arabia.
RP Abdalla, S (reprint author), King Abdulaziz Univ, Dept Phys, Fac Sci, POB 80203, Jeddah 21589, Saudi Arabia.
EM smabdullah@kau.edu.sa; saobaid@kau.edu.sa
FU King Abdulaziz City of Science and Technology [1435-35-143]
FX This project was supported by the King Abdulaziz City of Science and
   Technology, general direction of research grants-Project No.
   (1435-35-143). The authors also acknowledge with thanks the Deanship of
   Scientific Research, King Abdulaziz University for technical support.
   The authors declare no conflicts of interest.
CR Chen WX, 2001, INT J HYDROGEN ENERG, V26, P603, DOI 10.1016/S0360-3199(00)00119-1
   E4tech Sarl  with Element Energy Ltd, 2014, DEV WAT EL EUR UN
   Gabbasa M., 2012, ADV ENV BIOTECHNOLOG, P163
   Grigoriev SA, 2011, INT J HYDROGEN ENERG, V36, P2721, DOI 10.1016/j.ijhydene.2010.03.058
   Grigoriev SA, 2009, INT J HYDROGEN ENERG, V34, P4968, DOI 10.1016/j.ijhydene.2008.11.056
   Harvey R., 2015, PEM ELECTROLYSIS HYD
   Ioroi T, 2000, J ELECTROCHEM SOC, V147, P2018, DOI 10.1149/1.1393478
   Ito H, 2016, INT J HYDROGEN ENERG, V41, P5803, DOI 10.1016/j.ijhydene.2016.01.150
   Ito H, 2011, INT J HYDROGEN ENERG, V36, P10527, DOI 10.1016/j.ijhydene.2011.05.127
   Kato A, 2009, ECS TRANSACTIONS, V25, P1271, DOI 10.1149/1.3210682
   Renner J., 2015, PEM ELECTROLYSIS HYD
   Schalenbach M, 2016, INT J HYDROGEN ENERG, V41, P729, DOI 10.1016/j.ijhydene.2015.11.009
   Schalenbach M, 2015, J PHYS CHEM C, V119, P25145, DOI 10.1021/acs.jpcc.5b04155
   Schalenbach M, 2013, INT J HYDROGEN ENERG, V38, P14921, DOI 10.1016/j.ijhydene.2013.09.013
NR 14
TC 3
Z9 3
U1 3
U2 12
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1941-7012
J9 J RENEW SUSTAIN ENER
JI J. Renew. Sustain. Energy
PD JAN
PY 2017
VL 9
IS 1
AR 013101
DI 10.1063/1.4973859
PG 11
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA EM0HS
UT WOS:000395000000002
DA 2018-12-27
ER

PT J
AU Elahi, AS
   Ghoranneviss, M
AF Elahi, A. Salar
   Ghoranneviss, M.
TI RETRACTED: A new approach on preparation and characterization of zinc
   oxide deposited carbon nanotubes based materials applicable for
   electronic and optoelectronic devices (Retracted article. See vol. 28,
   pg. 19193, 2017)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN ELECTRONICS
LA English
DT Article; Retracted Publication
ID FIELD-EMISSION PROPERTIES; EMITTERS
AB ZnO is a wide-band-gap semiconductor material that is now being developed for many applications, including ultraviolet (UV) light-emitting diodes, UV photodetectors, transparent thin-film transistors, and gas sensors. It can be grown as boules, as thin films, or as nanostructures of many types and shapes. However, as with any useful semiconductor material, its electrical and optical properties are controlled by impurities and defects. We have reviewed the growth and analysis of carbon molecular crystals by the plasma enhanced chemical vapour deposition method. The three main synthesis methods of Carbon Nanocrystals (CNCs) are the arc discharge, the laser ablation and the chemical vapour deposition with a special regard to the later one. By two different methods ZnO layers were coated on the tubes. RF sputtering was one of the ways to directly deposit ZnO thin layer on the MWCNCs. On the other hand, we used thermally physical vapour deposition for making thin Zn film to oxidize it later. Scanning electron microscopy and also Raman spectroscopy measurements of the prepared samples confirmed the presence of ZnO nanolayers on the CNC bodies.
C1 [Elahi, A. Salar; Ghoranneviss, M.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
EM Salari_phy@yahoo.com
CR Akbarnejad E, 2016, J INORG ORGANOMET P, V26, P270, DOI 10.1007/s10904-015-0299-x
   Alipour R, 2016, J ALLOY COMPD, V687, P72, DOI 10.1016/j.jallcom.2016.06.087
   Azadfar P, 2015, J INORG ORGANOMET P, V25, P1040, DOI 10.1007/s10904-015-0207-4
   Azadfar P, 2015, J CRYST GROWTH, V415, P166, DOI 10.1016/j.jcrysgro.2015.01.001
   Bonard JM, 1999, APPL PHYS A-MATER, V69, P245, DOI 10.1007/s003390050998
   Chen I.C., 2006, APPL PHYS LETT, V88
   Choi WB, 1999, APPL PHYS LETT, V75, P3129, DOI 10.1063/1.125253
   de Jonge N, 2002, NATURE, V420, P393, DOI 10.1038/nature01233
   DEHEER WA, 1995, SCIENCE, V270, P1179, DOI 10.1126/science.270.5239.1179
   Dresselhaus MS, 2001, CARBON NANOTUBES SYN
   Elahi AS, 2016, J INORG ORGANOMET P, V26, P773, DOI 10.1007/s10904-016-0368-9
   Elahi AS, 2016, INT J MATER PROD TEC, V52, P353, DOI 10.1504/IJMPT.2016.075500
   Fan SS, 1999, SCIENCE, V283, P512, DOI 10.1126/science.283.5401.512
   Farazmand P, 2015, J INORG ORGANOMET P, V25, P1470, DOI 10.1007/s10904-015-0263-9
   Firoozbakht S, 2016, J INORG ORGANOMET P, V26, P889, DOI 10.1007/s10904-016-0380-0
   Ghorannevis Z, 2016, J CRYST GROWTH, V447, P62, DOI 10.1016/j.jcrysgro.2016.04.062
   Ghorannevis Z, 2015, J INORG ORGANOMET P, V25, P1486, DOI 10.1007/s10904-015-0265-7
   Ghoranneviss M, 2016, MOL CRYST LIQ CRYST, V629, P158, DOI 10.1080/15421406.2015.1107817
   Ghoranneviss M, 2015, MATER MANUF PROCESS, V30, P1348, DOI 10.1080/10426914.2015.1019103
   Ghoranneviss M, 2015, FUSION ENG DES, V94, P1, DOI 10.1016/j.fusengdes.2015.02.059
   Green JM, 2006, J APPL PHYS, V99, DOI 10.1063/1.2194112
   Huang CS, 2009, DIAM RELAT MATER, V18, P452, DOI 10.1016/j.diamond.2008.10.058
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jafari A, 2016, J CRYST GROWTH, V438, P70, DOI 10.1016/j.jcrysgro.2015.12.038
   Jafari A, 2016, J INORG ORGANOMET P, V26, P254, DOI 10.1007/s10904-015-0291-5
   Jafari A, 2015, J ALLOY COMPD, V644, P97, DOI 10.1016/j.jallcom.2015.04.202
   Jiao J, 2002, MATER RES SOC SYMP P, V706, P113
   Kim H, 2002, APPL PHYS LETT, V81, P2085, DOI 10.1063/1.1504877
   Madani SS, 2015, J ALLOY COMPD, V648, P1104, DOI 10.1016/j.jallcom.2015.07.063
   Martel R, 1998, APPL PHYS LETT, V73, P2447, DOI 10.1063/1.122477
   RINZLER AG, 1995, SCIENCE, V269, P1550, DOI 10.1126/science.269.5230.1550
   Salar Elahi A., 2015, J INORG ORGANOMET P, V25, P942
   Salar Elahi A., 2015, RADIAT EFF DEFECT S, V170, P541
   Salar Elahi A., 2015, J FUSION ENERG, V34, P449
   Sveningsson M, 2001, APPL PHYS A-MATER, V73, P409, DOI 10.1007/s003390100923
   Wang QH, 1997, APPL PHYS LETT, V70, P3308, DOI 10.1063/1.119146
   Wong SS, 1999, CHEM PHYS LETT, V306, P219, DOI 10.1016/S0009-2614(99)00488-1
   Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087
   Zhu W, 1999, APPL PHYS LETT, V75, P873, DOI 10.1063/1.124541
NR 39
TC 2
Z9 2
U1 6
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4522
EI 1573-482X
J9 J MATER SCI-MATER EL
JI J. Mater. Sci.-Mater. Electron.
PD JAN
PY 2017
VL 28
IS 2
BP 1659
EP 1666
DI 10.1007/s10854-016-5709-5
PG 8
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA EK9GR
UT WOS:000394232600066
DA 2018-12-27
ER

PT J
AU Ye, WB
   Zhong, ZM
   Zhu, SY
   Zheng, S
   Xiao, J
   Song, SL
   Yu, H
   Wu, Q
   Lin, Z
   Chen, JT
AF Ye, Wenbin
   Zhong, Zhaoming
   Zhu, Siyuan
   Zheng, Shuai
   Xiao, Jun
   Song, Shaolian
   Yu, Hui
   Wu, Qian
   Lin, Zhen
   Chen, Jianting
TI RETRACTED: Advanced oxidation protein products induce chondrocyte death
   through a redox-dependent, poly (ADP-ribose) polymerase-1-mediated
   pathway (Retracted article. See vol. 22, pg. 885, 2017)
SO APOPTOSIS
LA English
DT Article; Retracted Publication
DE Advanced oxidation protein production (AOPPs); Oxidative stress;
   Apoptosis; PARP-1; Chondrocytes; Rheumatoid arthritis
ID GLYCATION END-PRODUCTS; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; CELL-DEATH;
   ENDOTHELIAL-CELLS; SYNOVIAL-FLUID; NADPH OXIDASE; POLY(ADP-RIBOSE)
   POLYMERASE-1; ARTICULAR CHONDROCYTES; CARTILAGE DEGRADATION
AB This study aimed to investigate the effect of AOPPs on apoptosis in human chondrocytes. Chondrocytes were treated with AOPPs. Cell death, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity, reactive oxygen species (ROS) generation, and the expression of apoptotic proteins were detected in vitro. AOPPs levels were detected by colorimetric method. The results in vitro demonstrated that AOPPs induced cell death in human chondrocyte through a redox-dependent pathway, including RAGE-mediated, NADPH oxidase-dependent ROS generation, and poly (ADP-ribose) polymerase-1 (PARP-1) activation. Targeting AOPPs-induced cellular mechanisms might emerge as a promising therapeutic option for patients with RA.
C1 [Ye, Wenbin] Xiamen Univ, PLA, Dept Orthopaed, Affiliated Dongnan Hosp,Hosp 175, Zhangzhou, Fujian, Peoples R China.
   [Zhong, Zhaoming; Zhu, Siyuan; Zheng, Shuai; Yu, Hui; Wu, Qian; Lin, Zhen; Chen, Jianting] Southern Med Univ, Nanfang Hosp, Dept Orthopaed Spinal Surg, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.
   [Xiao, Jun] Southern Med Univ, Nanfang Hosp, Dept Orthoped Joint Surg, Guangzhou, Guangdong, Peoples R China.
   [Song, Shaolian] Southern Med Univ, Nanfang Hosp, Dept Pharm, Guangzhou, Guangdong, Peoples R China.
RP Chen, JT (reprint author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed Spinal Surg, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.
EM jianting_chen@sina.com
FU National Natural Science Foundation of China [81272042]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. 81272042).
CR Akhtar N, 2010, ARTHRITIS RHEUM-US, V62, P1361, DOI 10.1002/art.27329
   Alderman CJJ, 2002, FREE RADICAL BIO MED, V32, P377, DOI 10.1016/S0891-5849(01)00735-3
   Almenier Hazem A, 2012, Front Biosci (Elite Ed), V4, P1335
   Baskol G, 2006, CELL BIOCHEM FUNCT, V24, P307, DOI 10.1027/cbf.1257
   Bazzichi L, 2002, Clin Exp Rheumatol, V20, P761
   Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840
   Cao W, 2013, ANTIOXID REDOX SIGN, V18, P19, DOI 10.1089/ars.2012.4603
   Chiarugi A, 2002, SCIENCE, V297, P200, DOI 10.1126/science.1074592
   Firuzi O, 2008, J CLIN LAB ANAL, V22, P210, DOI 10.1002/jcla.20243
   Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26
   Gunther C, 2013, GUT, V62, P1062, DOI 10.1136/gutjnl-2011-301364
   Guo ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1699, DOI 10.1089/ars.2007.1999
   Henrotin Y, 2005, OSTEOARTHR CARTILAGE, V13, P643, DOI 10.1016/j.joca.2005.04.002
   Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X
   Hitchon CA, 2004, ARTHRITIS RES THER, V6, P265, DOI 10.1186/ar1447
   Kim HA, 1999, ARTHRITIS RHEUM, V42, P1528, DOI 10.1002/1529-0131(199907)42:7<1528::AID-ANR28>3.0.CO;2-9
   Lo YYC, 1998, J CELL BIOCHEM, V69, P19, DOI 10.1002/(SICI)1097-4644(19980401)69:1<19::AID-JCB3>3.0.CO;2-Y
   Loeser RF, 2005, ARTHRITIS RHEUM, V52, P2376, DOI 10.1002/art.21199
   Loor G, 2010, FREE RADICAL BIO MED, V49, P1925, DOI 10.1016/j.freeradbiomed.2010.09.021
   LUNEC J, 1981, J RHEUMATOL, V8, P233
   Mantle D, 1999, CLIN CHIM ACTA, V284, P45, DOI 10.1016/S0009-8981(99)00055-8
   Meyer JW, 1999, ENDOTHELIUM-NEW YORK, V7, P11, DOI 10.3109/10623329909165308
   NAKAMURA K, 1987, INT J TISSUE REACT, V9, P307
   Polzer K, 2007, AUTOIMMUNITY, V40, P333, DOI 10.1080/08916930701356721
   Schiller J, 2003, CURR MED CHEM, V10, P2123, DOI 10.2174/0929867033456828
   Seven A, 2008, CLIN BIOCHEM, V41, P538, DOI 10.1016/j.clinbiochem.2008.01.029
   Tiku ML, 2003, OSTEOARTHR CARTILAGE, V11, P159, DOI 10.1016/S1063-4584(02)00348-5
   van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021
   Witko-Sarsat W, 2003, KIDNEY INT, V64, P82, DOI 10.1046/j.1523-1755.2003.00044.x
   Wu Q, 2016, APOPTOSIS, V21, P36, DOI 10.1007/s10495-015-1191-4
   Xie F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.542
   Yu H, 2015, ORTHOP SURG, V7, P161, DOI 10.1111/os.12179
   Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221
   Zhang FJ, 2012, TOXICOL SCI, V128, P103, DOI 10.1093/toxsci/kfs142
   Zheng S, 2013, CELL PHYSIOL BIOCHEM, V32, P972, DOI 10.1159/000354500
   Zhong ZM, 2009, CELL PHYSIOL BIOCHEM, V24, P105, DOI 10.1159/000227818
   Zhou LL, 2012, KIDNEY INT, V82, P759, DOI 10.1038/ki.2012.184
   Zhou LL, 2009, KIDNEY INT, V76, P1148, DOI 10.1038/ki.2009.322
NR 38
TC 3
Z9 3
U1 4
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1360-8185
EI 1573-675X
J9 APOPTOSIS
JI Apoptosis
PD JAN
PY 2017
VL 22
IS 1
BP 86
EP 97
DI 10.1007/s10495-016-1314-6
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA EI2IH
UT WOS:000392309800006
PM 27858200
DA 2018-12-27
ER

PT J
AU Su, EP
AF Su, E. P.
TI RETRACTED: Post-operative neuropathy after total hip
   arthroplasty(Retracted article. See vol.99B,pg.702,2017)
SO BONE & JOINT JOURNAL
LA English
DT Article; Retracted Publication
ID TOTAL HIP-ARTHROPLASTY; SCIATIC-NERVE PALSY; REPLACEMENT; KNEE
AB Nerve palsy is a well-described complication following total hip arthroplasty, but is highly distressing and disabling. A nerve palsy may cause difficulty with the post-operative rehabilitation, and overall mobility of the patient. Nerve palsy may result from compression and tension to the affected nerve(s) during the course of the operation via surgical manipulation and retractor placement, tension from limb lengthening or compression from post-operative hematoma. In the literature, hip dysplasia, lengthening of the leg, the use of an uncemented femoral component, and female gender are associated with a greater risk of nerve palsy. We examined our experience at a high-volume, tertiary care referral centre, and found an overall incidence of 0.3% out of 39 056 primary hip arthroplasties. Risk factors found to be associated with the incidence of nerve palsy at our institution included the presence of spinal stenosis or lumbar disc disease, age younger than 50, and smoking. If a nerve palsy is diagnosed, imaging is mandatory and surgical evacuation or compressive haematomas may be beneficial. As palsies are slow to recover, supportive care such as bracing, therapy, and reassurance are the mainstays of treatment.
C1 [Su, E. P.] Hosp Special Surg, Weill Cornell Med Coll, Clin Orthopaed, 535 East 70th St, New York, NY 10021 USA.
   [Su, E. P.] Hosp Special Surg, Adult Reconstruct & Joint Replacement Div, 535 East 70th St, New York, NY 10021 USA.
RP Su, EP (reprint author), Hosp Special Surg, Weill Cornell Med Coll, Clin Orthopaed, 535 East 70th St, New York, NY 10021 USA.; Su, EP (reprint author), Hosp Special Surg, Adult Reconstruct & Joint Replacement Div, 535 East 70th St, New York, NY 10021 USA.
EM sue@hss.edu
CR Bodine SC, 1993, ORTHOPAEDIC BASIC SC, P361
   Borrelli J, 2000, J ORTHOP TRAUMA, V14, P255, DOI 10.1097/00005131-200005000-00005
   EDWARDS BN, 1987, CLIN ORTHOP RELAT R, P136
   Farrell CM, 2005, J BONE JOINT SURG AM, V87A, P2619, DOI 10.2106/JBJS.C.01564
   Fleming P, 2003, J BONE JOINT SURG BR, V85B, P363, DOI 10.1302/0301-620X.85B3.13220
   Hurd JL, 2006, J ARTHROPLASTY, V21, P796, DOI 10.1016/j.arth.2005.08.008
   JOHANSON NA, 1983, CLIN ORTHOP RELAT R, P214
   Lewallen DG, 1998, AAOS INSTR COURS LEC, V47, P275
   Navarro R A, 1995, J Arthroplasty, V10, P1
   Park JH, 2013, J BONE JOINT SURG AM, V95A, DOI 10.2106/JBJS.L.00160
   Pokorny D, 2006, SURG RADIOL ANAT, V28, P88, DOI 10.1007/s00276-005-0056-x
   Schmalzried TP, 1997, CLIN ORTHOP RELAT R, P188
   SCHMALZRIED TP, 1991, J BONE JOINT SURG AM, V73A, P1074, DOI 10.2106/00004623-199173070-00018
   Upadhyay A, 2007, J ARTHROPLASTY, V22, P2, DOI 10.1016/j.artli.2007.05.003
   Wang TI, 2016, J ORTHOP SURG RES, V11, DOI 10.1186/s13018-016-0365-2
   WEBER ER, 1976, J BONE JOINT SURG AM, V58, P66, DOI 10.2106/00004623-197658010-00011
   WILSON JN, 1973, CLIN ORTHOP RELAT R, P239
NR 17
TC 5
Z9 5
U1 2
U2 11
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 2049-4394
J9 BONE JOINT J
JI Bone Joint J.
PD JAN
PY 2017
VL 99B
IS 1
SU A
BP 46
EP 49
DI 10.1302/0301-620X.99B1.BJJ-2016-0430.R1
PG 4
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA EI4KG
UT WOS:000392461900009
PM 28042118
OA Bronze
DA 2018-12-27
ER

PT J
AU Flynt, LK
   Veve, MP
   Samuel, LP
   Tibbetts, RJ
AF Flynt, Lauren K.
   Veve, Michael P.
   Samuel, Linoj P.
   Tibbetts, Robert J.
TI RETRACTED: Comparison of Etest to Broth Microdilution for Testing of
   Susceptibility of Pseudomonas aeruginosa to Ceftolozane-Tazobactam
   (Retracted article. See vol. 56, 2018)
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Letter; Retracted Publication
DE ceftolozane-tazobactam
ID ANTIMICROBIAL TREATMENT
C1 [Flynt, Lauren K.; Veve, Michael P.; Samuel, Linoj P.; Tibbetts, Robert J.] Henry Ford Hosp, Detroit, MI 48202 USA.
   [Veve, Michael P.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Detroit, MI USA.
RP Tibbetts, RJ (reprint author), Henry Ford Hosp, Detroit, MI 48202 USA.
EM rtibbet1@hfhs.org
CR [Anonymous], 2013, ANTIBIOTIC RESISTANC
   Burns JL, 2001, DIAGN MICR INFEC DIS, V39, P257, DOI 10.1016/S0732-8893(01)00234-6
   Clark RB, 2009, CUMITECH 31A VERIFIC
   CLSI, 2015, M07 CLSI
   CLSI. Clinical and Laboratory Standards Institute, 2016, M100S CLSI
   Humphries RM, 2016, CLIN INFECT DIS, V63, P83, DOI 10.1093/cid/ciw201
   Kollef MH, 2000, CLIN INFECT DIS, V31, pS131, DOI 10.1086/314079
   Micek ST, 2005, ANTIMICROB AGENTS CH, V49, P1306, DOI 10.1128/AAC.49.4.1306-1311.2005
   Nathwani D, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-32
   Papp-Wallace KM, 2016, INFECT DIS CLIN N AM, V30, P441, DOI 10.1016/j.idc.2016.02.007
NR 10
TC 11
Z9 11
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JAN
PY 2017
VL 55
IS 1
BP 334
EP 335
DI 10.1128/JCM.01920-16
PG 2
WC Microbiology
SC Microbiology
GA EH7QC
UT WOS:000391966600040
PM 27795348
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Mathlouthi, N
   Al-Bayssari, C
   Bakour, S
   Rolain, JM
   Chouchani, C
AF Mathlouthi, Najla
   Al-Bayssari, Charbel
   Bakour, Sofiane
   Rolain, Jean Marc
   Chouchani, Chedly
TI RETRACTED: Prevalence and emergence of carbapenemases-producing
   Gram-negative bacteria in Mediterranean basin (Retracted article. See
   vol.44, pg. 124, 2018)
SO CRITICAL REVIEWS IN MICROBIOLOGY
LA English
DT Review; Retracted Publication
DE Carbapenemases; Gram-negative bacteria; Mediterranean countries
ID METALLO-BETA-LACTAMASE; RESISTANT ACINETOBACTER-BAUMANNII; AERUGINOSA
   CLINICAL ISOLATE; KLEBSIELLA-PNEUMONIAE ISOLATE; INTENSIVE-CARE-UNIT;
   SEQUENCE TYPE 258; OXA-48-PRODUCING ESCHERICHIA-COLI;
   OXACILLINASE-MEDIATED RESISTANCE; INTEGRON-BORNE GENE; REAL-TIME PCR
AB The emergence and the global spread of carbapenemases concern to health services worldwide. Their celestial rise among Gram-negative bacilli has challenged both the scientific and pharmaceutical sectors. Indeed, infections caused by these bacteria have limited treatment options and have been associated with high mortality and morbidity rates. Carbapenemase producers are mainly identified among Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter baumannii and still mostly in hospital settings and rarely in the community. They are closely related to KPC, VIM, IMP, NDM, and OXA-48 types. The encoding genes are mostly plasmid located and associated with various mobile genetic elements. The Mediterranean area is of interest due to a great diversity and population mixing. The prevalence of carbapenemases is particularly high and variant among countries, partially depending on the population exchange relationship between the regions and the possible reservoirs of each carbapenemase. This review described the epidemiology of carbapenemases in this region of the world highlighting the worrisome situation and the need to screen and detect these enzymes to prevent and control their dissemination especially as it is clear that very few novel antibiotics will be introduced in the next few years, making the dissemination of carbapenem-resistant Gram-negative bacteria of crucial importance worldwide.
C1 [Mathlouthi, Najla; Chouchani, Chedly] Univ Tunis El Manar, Fac Sci Tunis, Lab Microorganismes & Biomol Act, Campus Univ, El Manar, Tunisia.
   [Mathlouthi, Najla; Al-Bayssari, Charbel; Bakour, Sofiane; Rolain, Jean Marc] Aix Marseille Univ, IHU Mediterranee Infect, Fac Med & Pharm, URMITE,UM 63,CNRS 7278,IRD 198,INSERM 1095, Marseille, France.
   [Mathlouthi, Najla; Chouchani, Chedly] Univ Carthage, Inst Super Sci & Technol Environm Borj Cedria, Technopole Borj Cedria,BP 1003, Hammam Lif, Tunisia.
RP Chouchani, C (reprint author), Univ Carthage, ISSTE Borj Cedria, Technopole Borj Cedria,BP 1003, Hammam Lif, Tunisia.
EM chdoula77@yahoo.fr
CR Abdelaziz MO, 2013, MICROBIOL IMMUNOL, V57, P391, DOI 10.1111/1348-0421.12046
   Abdelaziz MO, 2012, J CLIN MICROBIOL, V50, P2489, DOI 10.1128/JCM.06710-11
   Abouddihaj B, 2013, APMIS, V121, P675, DOI 10.1111/apm.12034
   Adler A, 2015, J ANTIMICROB CHEMOTH, V70, P89, DOI 10.1093/jac/dku333
   Adler A, 2011, J ANTIMICROB CHEMOTH, V66, P2763, DOI 10.1093/jac/dkr382
   Agabou A, 2014, EUR J CLIN MICROBIOL, V33, P1641, DOI 10.1007/s10096-014-2122-y
   Agodi A, 2011, J CLIN MICROBIOL, V49, P3986, DOI 10.1128/JCM.01242-11
   Aktas Z, 2006, CLIN MICROBIOL INFEC, V12, P695, DOI 10.1111/j.1469-0691.2006.01480.x
   Al Bayssari C, 2014, ANTIMICROB AGENTS CH, V58, P4966, DOI 10.1128/AAC.02523-13
   Al-Agamy MH, 2014, INT J INFECT DIS, V22, P49, DOI [10.10, 10.1016/j.ijid.2013.12.004]
   Al-Hassan L, 2013, CLIN MICROBIOL INFEC, V19, P1082, DOI 10.1111/1469-0691.12143
   Al-Hassan L, 2015, J GLOB ANTIMICROB RE, V3, P5, DOI 10.1016/j.jgar.2014.10.003
   Altoparlak U, 2005, BURNS, V31, P707, DOI 10.1016/j.burns.2005.02.017
   Ambretti S, 2010, NEW MICROBIOL, V33, P281
   Armand-Lefevre L, 2013, ANTIMICROB AGENTS CH, V57, P1488, DOI 10.1128/AAC.01823-12
   Aschbacher R, 2008, J ANTIMICROB CHEMOTH, V61, P515, DOI 10.1093/jac/dkm508
   Aubron C, 2005, MICROB DRUG RESIST, V11, P254, DOI 10.1089/mdr.2005.11.254
   Bahar G, 2004, J ANTIMICROB CHEMOTH, V54, P282, DOI 10.1093/jac/dkh321
   Bakour S., 2015, New Microbes and New Infections, V3, P34, DOI 10.1016/j.nmni.2014.09.001
   Bakour S, 2015, MICROB DRUG RESIST, V21, P279, DOI 10.1089/mdr.2014.0214
   Bakour S, 2014, J INFECT CHEMOTHER, V20, P696, DOI 10.1016/j.jiac.2014.07.010
   Bakour S, 2012, J MED MICROBIOL, V61, P1341, DOI 10.1099/jmm.0.045807-0
   Barguigua A, 2013, MICROB PATHOGENESIS, V61-62, P16, DOI 10.1016/j.micpath.2013.04.010
   Barguigua A, 2012, DIAGN MICR INFEC DIS, V73, P290, DOI 10.1016/j.diagmicrobio.2012.03.011
   Baroud M, 2013, INT J ANTIMICROB AG, V41, P75, DOI 10.1016/j.ijantimicag.2012.08.010
   Bedenic B, 2012, J CHEMOTHERAPY, V24, P237, DOI 10.1179/1973947812Y.0000000017
   Belotti PT, 2015, J ANTIMICROB CHEMOTH, V70, P2237, DOI 10.1093/jac/dkv103
   Ben Nasr A, 2013, ANTIMICROB AGENTS CH, V57, P4089, DOI 10.1128/AAC.00536-13
   Benouda A, 2010, ANN TROP MED PARASIT, V104, P327, DOI 10.1179/136485910X12743554760108
   Beyrouthy R, 2014, J ANTIMICROB CHEMOTH, V69, P2699, DOI 10.1093/jac/dku181
   Birgy A, 2011, J CLIN MICROBIOL, V49, P3085, DOI 10.1128/JCM.00540-11
   Bogaerts P, 2011, ANTIMICROB AGENTS CH, V55, P3036, DOI 10.1128/AAC.00049-11
   Bonnin RA, 2012, CLIN MICROBIOL INFEC, V18, pE362, DOI 10.1111/j.1469-0691.2012.03928.x
   Bonnin RA, 2012, ANTIMICROB AGENTS CH, V56, P3923, DOI 10.1128/AAC.00257-12
   Bonnin RA, 2011, ANTIMICROB AGENTS CH, V55, P349, DOI 10.1128/AAC.00773-10
   Borer A, 2009, INFECT CONT HOSP EP, V30, P972, DOI 10.1086/605922
   Bosnjak Z, 2010, SCAND J INFECT DIS, V42, P193, DOI 10.3109/00365540903426582
   Boulanger A, 2012, ANTIMICROB AGENTS CH, V56, P2214, DOI 10.1128/AAC.05653-11
   Cakirlar FK, 2015, CLIN LAB, V61, P741, DOI 10.7754/Clin.Lab.2014.141116
   Carbonne A, 2010, EUROSURVEILLANCE, V15, P11
   Carmeli Y, 2010, CLIN MICROBIOL INFEC, V16, P102, DOI 10.1111/j.1469-0691.2009.03115.x
   Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128/AAC.01672-07
   Carrer A, 2010, ANTIMICROB AGENTS CH, V54, P1369, DOI 10.1128/AAC.01312-09
   Castanheira M, 2014, ANTIMICROB AGENTS CH, V58, P7358, DOI 10.1128/AAC.03930-14
   Cendejas E, 2010, CLIN MICROBIOL INFEC, V16, P181, DOI 10.1111/j.1469-0691.2009.02888.x
   Charfi-Kessis K, 2014, MICROB PATHOGENESIS, V74, P20, DOI 10.1016/j.micpath.2014.07.003
   Chouchani C, 2011, APMIS, V119, P725, DOI 10.1111/j.1600-0463.2011.02793.x
   Chouchani C, 2011, CRIT REV MICROBIOL, V37, P167, DOI 10.3109/1040841X.2011.552880
   Ciofi Degli Atti M, 2014, BMC INFECT DIS, V14, P494, DOI DOI 10.1186/1471-2334-14-494
   Compain F, 2014, EMERG INFECT DIS, V20, P1246, DOI 10.3201/eid2007.131638
   Cornaglia G, 1999, LANCET, V353, P899, DOI 10.1016/S0140-6736(98)05954-6
   Cornaglia G, 2000, CLIN INFECT DIS, V31, P1119, DOI 10.1086/317448
   Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1
   Curiao T, 2010, J ANTIMICROB CHEMOTH, V65, P1608, DOI 10.1093/jac/dkq174
   Cuzon G, 2008, ANTIMICROB AGENTS CH, V52, P796, DOI 10.1128/AAC.01180-07
   Cuzon G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061322
   Cuzon G, 2012, INT J ANTIMICROB AG, V39, P448, DOI 10.1016/j.ijantimicag.2012.01.008
   Cuzon G, 2011, ANTIMICROB AGENTS CH, V55, P2420, DOI 10.1128/AAC.01452-10
   Cuzon G, 2010, INT J ANTIMICROB AG, V36, P91, DOI 10.1016/j.ijantimicag.2010.02.014
   DEBOER D, 1990, RAPID COMMUN MASS SP, V4, P181, DOI 10.1002/rcm.1290040604
   Decre D, 2010, EUROSURVEILLANCE, V15, P6
   Denis C, 2012, CLIN MICROBIOL INFEC, V18, pE128, DOI 10.1111/j.1469-0691.2012.03761.x
   Di Carlo P, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-103
   Diab M., 2013, African Journal of Microbiology Research, V7, P4465
   Diene SM, 2011, INT J ANTIMICROB AG, V37, P544, DOI 10.1016/j.ijantimicag.2011.02.006
   Dimude JU, 2013, INT J ANTIMICROB AG, V41, P574, DOI 10.1016/j.ijantimicag.2013.02.012
   Dortet L, 2008, J ANTIMICROB CHEMOTH, V61, P455, DOI 10.1093/jac/dkm455
   El Salabi A, 2013, CRIT REV MICROBIOL, V39, P113, DOI 10.3109/1040841X.2012.691870
   El Salabi A, 2012, ANTIMICROB AGENTS CH, V56, P2241, DOI 10.1128/AAC.05640-11
   El-Herte RI, 2012, J INFECT DEV COUNTR, V6, P457, DOI 10.3855/jidc.2340
   El-Sayed-Ahmed MA, 2015, ANTIMICROB AGENTS CH, V59, P3602, DOI 10.1128/AAC.04412-14
   Fontana Carla, 2010, BMC Res Notes, V3, P40, DOI 10.1186/1756-0500-3-40
   Fouad M, 2013, INT J INFECT DIS, V17, pE1252, DOI 10.1016/j.ijid.2013.07.012
   Franolic-Kukina I, 2011, INT J INFECT DIS, V15, pE706, DOI 10.1016/j.ijid.2011.05.016
   Gaibani P, 2011, EUROSURVEILLANCE, V16, P2
   Gaibani P., 2011, Eurosurveillance, V16, P19800
   Giakkoupi P, 2003, J CLIN MICROBIOL, V41, P822, DOI 10.1128/JCM.41.2.822-825.2003
   Giakkoupi P, 2003, J CLIN MICROBIOL, V41, P3893, DOI 10.1128/JCM.41.8.3893-3896.2003
   Giakkoupi P, 2013, DIAGN MICR INFEC DIS, V77, P382, DOI 10.1016/j.diagmicrobio.2013.09.001
   Giakkoupi P, 2011, J ANTIMICROB CHEMOTH, V66, P1510, DOI 10.1093/jac/dkr166
   Giamarellou H, 2009, DRUGS, V69, P1879, DOI 10.2165/11315690-000000000-00000
   Giani T, 2012, ANTIMICROB AGENTS CH, V56, P2216, DOI 10.1128/AAC.06005-11
   Giani T, 2012, ANTIMICROB AGENTS CH, V56, P2211, DOI 10.1128/AAC.00035-12
   Giani T, 2009, J CLIN MICROBIOL, V47, P3793, DOI 10.1128/JCM.01773-09
   Girlich D, 2014, CLIN MICROBIOL INFEC, V20, P350, DOI 10.1111/1469-0691.12325
   Girlich D, 2015, DIAGN MICR INFEC DIS, V83, P234, DOI 10.1016/j.diagmicrobio.2015.06.023
   Goic-Barisic I, 2007, J CHEMOTHERAPY, V19, P462, DOI 10.1179/joc.2007.19.4.462
   Goic-Barisic I, 2011, J HOSP INFECT, V77, P368, DOI 10.1016/j.jhin.2010.12.003
   Goic-Barisic I, 2009, J CLIN MICROBIOL, V47, P3348, DOI 10.1128/JCM.02394-08
   Grundmann H, 2010, EUROSURVEILLANCE, V18, P15
   Gulmez D, 2008, INT J ANTIMICROB AG, V31, P523, DOI 10.1016/j.ijantimicag.2008.01.017
   Guerrero-Lozano I, 2015, MICROB DRUG RESIST, V21, P215, DOI 10.1089/mdr.2014.0155
   Hammami S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-106
   Hammami Samia, 2011, Tunis Med, V89, P638
   Hammerum AM, 2012, INT J ANTIMICROB AG, V40, P191, DOI 10.1016/j.ijantimicag.2012.05.003
   Hammoudi D, 2014, INT J INFECT DIS, V29, P139, DOI 10.1016/j.ijid.2014.07.017
   Hays C, 2012, INT J ANTIMICROB AG, V39, P545, DOI 10.1016/j.ijantimicag.2012.03.002
   Heydari F, 2015, J MED MICROBIOL, V64, P1027, DOI 10.1099/jmm.0.000132
   Hrabak J, 2012, EUROSURVEILLANCE, V17, P9
   Ikonomidis A, 2005, J CLIN MICROBIOL, V43, P5344, DOI 10.1128/JCM.43.10.5344-5347.2005
   Iraz M, 2014, DIAGN MICR INFEC DIS, V78, P292, DOI 10.1016/j.diagmicrobio.2013.12.003
   ITO H, 1995, ANTIMICROB AGENTS CH, V39, P824, DOI 10.1128/AAC.39.4.824
   Janvier F, 2013, ANTIMICROB AGENTS CH, V57, P3408, DOI 10.1128/AAC.02334-12
   Jeannot K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115452
   Jesudason MV, 2005, INDIAN J MED RES, V121, P780
   Juan C, 2008, ANTIMICROB AGENTS CH, V52, P3589, DOI 10.1128/AAC.00465-08
   Kaase M, 2011, J ANTIMICROB CHEMOTH, V66, P1260, DOI 10.1093/jac/dkr135
   Kassis-Chikhani N, 2006, J ANTIMICROB CHEMOTH, V57, P142, DOI 10.1093/jac/dki389
   Khorsi K, 2015, ASIAN PAC J TROP MED, V8, P439, DOI [10.1016/S1995-7645(14)60357-6, 10.1016/j.apjtm.2015.05.011]
   Kilic A, 2011, ANN CLIN LAB SCI, V41, P161
   Kocsis E, 2013, CLIN MICROBIOL INFEC, V19, pE409, DOI 10.1111/1469-0691.12232
   Kotsakis SD, 2010, ANTIMICROB AGENTS CH, V54, P4864, DOI 10.1128/AAC.00771-10
   Kristof K, 2010, J ANTIMICROB CHEMOTH, V65, P1303, DOI 10.1093/jac/dkq133
   Ktari S, 2006, ANTIMICROB AGENTS CH, V50, P4198, DOI 10.1128/AAC.00663-06
   Ktari S, 2011, J ANTIMICROB CHEMOTH, V66, P1644, DOI 10.1093/jac/dkr181
   Lafeuille E, 2013, MICROB DRUG RESIST, V19, P491, DOI 10.1089/mdr.2012.0219
   Lahlaoui H, 2012, EUR J CLIN MICROBIOL, V31, P937, DOI 10.1007/s10096-011-1389-5
   Lartigue MF, 2004, ANTIMICROB AGENTS CH, V48, P4929, DOI 10.1128/AAC.48.12.4929-4930.2004
   Lauretti L, 1999, ANTIMICROB AGENTS CH, V43, P1584, DOI 10.1128/AAC.43.7.1584
   Levast M, 2011, J ANTIMICROB CHEMOTH, V66, P944, DOI 10.1093/jac/dkq504
   Liakopoulos A, 2012, EUROSURVEILLANCE, V17, P5
   Liakopoulos A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-505
   Loli A, 2008, ANTIMICROB AGENTS CH, V52, P1894, DOI 10.1128/AAC.01414-07
   Luzzaro F, 2004, ANTIMICROB AGENTS CH, V48, P648, DOI 10.1128/AAC.48.2.648-650.2004
   Mammina C, 2010, J CLIN MICROBIOL, V48, P1506, DOI 10.1128/JCM.00315-10
   Mansour W, 2008, MICROB DRUG RESIST, V14, P289, DOI 10.1089/mdr.2008.0838
   Mansour W, 2009, DIAGN MICR INFEC DIS, V64, P458, DOI 10.1016/j.diagmicrobio.2009.04.003
   Marchese A, 2010, J CHEMOTHERAPY, V22, P212, DOI 10.1179/joc.2010.22.3.212
   Mathlouthi N, 2015, MICROB DRUG RESIST, V21, P335, DOI 10.1089/mdr.2014.0235
   Mavroidi A, 2015, J MED MICROBIOL, V64, P993, DOI 10.1099/jmm.0.000127
   Mavroidi A, 2012, INT J ANTIMICROB AG, V39, P247, DOI 10.1016/j.ijantimicag.2011.11.003
   Mazzariol A, 2011, CLIN MICROBIOL INFEC, V17, P722, DOI 10.1111/j.1469-0691.2010.03424.x
   Mesli E, 2013, INT J INFECT DIS, V17, pE739, DOI 10.1016/j.ijid.2013.02.024
   Metwally L, 2013, E MEDITERR HEALTH J, V19, P947
   Mezzatesta ML, 2011, CLIN MICROBIOL INFEC, V17, P1444, DOI 10.1111/j.1469-0691.2011.03572.x
   Migliavacca R, 2013, DIAGN MICR INFEC DIS, V75, P180, DOI 10.1016/j.diagmicrobio.2012.11.002
   Miriagou V, 2010, ANTIMICROB AGENTS CH, V54, P4497, DOI 10.1128/AAC.00665-10
   Miro E, 2010, J ANTIMICROB CHEMOTH, V65, P661, DOI 10.1093/jac/dkp504
   Mugnier P, 2008, CLIN MICROBIOL INFEC, V14, P879, DOI 10.1111/j.1469-0691.2008.02056.x
   Mugnier PD, 2010, EMERG INFECT DIS, V16, P35, DOI 10.3201/eid1601.090852
   NAAS T, 1994, P NATL ACAD SCI USA, V91, P7693, DOI 10.1073/pnas.91.16.7693
   Naas T, 2005, ANTIMICROB AGENTS CH, V49, P4423, DOI 10.1128/AAC.49.10.4423-4424.2005
   NAAS T, 1994, ANTIMICROB AGENTS CH, V38, P1262, DOI 10.1128/AAC.38.6.1262
   Naas T, 2011, ANTIMICROB AGENTS CH, V55, P4038, DOI 10.1128/AAC.01734-10
   Naas T, 2010, J ANTIMICROB CHEMOTH, V65, P1305, DOI 10.1093/jac/dkq117
   Nahid F, 2013, J INFECT PUBLIC HEAL, V6, P487, DOI 10.1016/j.jiph.2013.06.006
   Nazic H, 2005, ANTIMICROB AGENTS CH, V49, P2146, DOI 10.1128/AAC.49.5.2146-2147.2005
   Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003
   Nordmann P, 2012, CLIN INFECT DIS, V54, P150, DOI 10.1093/cid/cir720
   Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655
   Nordmann P, 2011, J ANTIMICROB CHEMOTH, V66, P689, DOI 10.1093/jac/dkq520
   Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4
   Ocampo-Sosa AA, 2015, ANTIMICROB AGENTS CH, V59, P1334, DOI 10.1128/AAC.04639-14
   Oteo J, 2010, PEDIATR INFECT DIS J, V29, P1144, DOI 10.1097/INF.0b013e3181efaa2d
   Pantel A, 2015, EUR J CLIN MICROBIOL, V34, P899, DOI 10.1007/s10096-014-2298-1
   Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412
   Perilli M, 2015, MICROB DRUG RESIST, V21, P97, DOI 10.1089/mdr.2014.0056
   Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005
   Picao RC, 2010, J ANTIMICROB CHEMOTH, V65, P796, DOI 10.1093/jac/dkq024
   Pirs M, 2011, EUROSURVEILLANCE, V16, P12
   Pitart C, 2011, ANTIMICROB AGENTS CH, V55, P4398, DOI 10.1128/AAC.00329-11
   Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P622, DOI 10.1128/AAC.44.3.622-632.2000
   Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004
   Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P891, DOI 10.1128/AAC.44.4.891-897.2000
   Poirel L, 2007, FUTURE MICROBIOL, V2, P501, DOI 10.2217/17460913.2.5.501
   Poirel L, 2013, INT J ANTIMICROB AG, V41, P90, DOI 10.1016/j.ijantimicag.2012.08.015
   Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P2781, DOI 10.1093/jac/dkr384
   Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4937, DOI 10.1128/AAC.00413-11
   Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P1181, DOI 10.1093/jac/dkr023
   Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P1821, DOI 10.1128/AAC.01761-10
   Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P447, DOI 10.1128/AAC.01305-10
   Potron A, 2013, EUROSURVEILLANCE, V18, P9, DOI 10.2807/1560-7917.ES2013.18.31.20549
   Potron A, 2011, CLIN MICROBIOL INFEC, V17, pE24, DOI 10.1111/j.1469-0691.2011.03669.x
   Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4896, DOI 10.1128/AAC.00481-11
   Pournaras S, 2003, J ANTIMICROB CHEMOTH, V51, P1409, DOI 10.1093/jac/dkg239
   Principe L, 2014, J CLIN MICROBIOL, V52, P3004, DOI 10.1128/JCM.00291-14
   Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07
   Rafei R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0441-5
   Riccio ML, 2000, ANTIMICROB AGENTS CH, V44, P1229, DOI 10.1128/AAC.44.5.1229-1235.2000
   Riccio ML, 2001, ANTIMICROB AGENTS CH, V45, P1249, DOI 10.1128/AAC.45.4.1249-1253.2001
   Riccio ML, 2005, ANTIMICROB AGENTS CH, V49, P104, DOI 10.1128/AAC.49.1.104-110.2005
   Richter SN, 2011, J CLIN MICROBIOL, V49, P2040, DOI 10.1128/JCM.00133-11
   Robin F, 2010, ANTIMICROB AGENTS CH, V54, P466, DOI 10.1128/AAC.00017-09
   Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09
   Rodriguez-Martinez JM, 2010, ANTIMICROB AGENTS CH, V54, P471, DOI 10.1128/AAC.00458-09
   Rolain JM, 2010, CLIN MICROBIOL INFEC, V16, P1699, DOI 10.1111/j.1469-0691.2010.03385.x
   Gomez-Gil MR, 2010, J ANTIMICROB CHEMOTH, V65, P2695, DOI 10.1093/jac/dkq352
   Ruppe E, 2011, J CLIN MICROBIOL, V49, P2761, DOI 10.1128/JCM.00055-11
   Saidani M, 2012, J MED MICROBIOL, V61, P1746, DOI 10.1099/jmm.0.045229-0
   Samra Z, 2007, INT J ANTIMICROB AG, V30, P525, DOI 10.1016/j.ijantimicag.2007.07.024
   Samuelsen O, 2009, J ANTIMICROB CHEMOTH, V63, P654, DOI 10.1093/jac/dkp018
   San Millan A, 2015, J ANTIMICROB CHEMOTH, V70, P3000, DOI 10.1093/jac/dkv222
   Sanchez-Romero I, 2012, ANTIMICROB AGENTS CH, V56, P420, DOI 10.1128/AAC.05036-11
   Sardelic S, 2003, EMERG INFECT DIS, V9, P1022
   Sassi A, 2014, ANTIMICROB AGENTS CH, V58, P5606, DOI 10.1128/AAC.02818-13
   Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07
   Scotta C, 2011, ANTIMICROB AGENTS CH, V55, P5376, DOI 10.1128/AAC.00716-11
   Sefraoui I, 2014, MICROB DRUG RESIST, V20, P156, DOI 10.1089/mdr.2013.0161
   Sevillano E, 2009, PATHOL BIOL, V57, P493, DOI 10.1016/j.patbio.2008.05.002
   Sole M, 2011, ANTIMICROB AGENTS CH, V55, P4402, DOI 10.1128/AAC.00642-11
   Sorli L, 2011, EUR J CLIN MICROBIOL, V30, P1551, DOI 10.1007/s10096-011-1259-1
   Souli M, 2008, EUROSURVEILLANCE, V13, P19045
   Souli M, 2010, CLIN INFECT DIS, V50, P364, DOI 10.1086/649865
   Tato M, 2007, CLIN INFECT DIS, V45, P1171, DOI 10.1086/522288
   Tato M, 2010, ANTIMICROB AGENTS CH, V54, P320, DOI 10.1128/AAC.00783-09
   Tortola MT, 2005, ANTIMICROB AGENTS CH, V49, P3492, DOI 10.1128/AAC.49.8.3492-3494.2005
   Touati M, 2013, ANTIMICROB AGENTS CH, V57, P2426, DOI 10.1128/AAC.00032-13
   Touati M, 2012, INT J ANTIMICROB AG, V40, P89, DOI 10.1016/j.ijantimicag.2012.03.017
   Trevino M, 2011, MICROB DRUG RESIST, V17, P433, DOI 10.1089/mdr.2010.0182
   Tsakris A, 2000, J CLIN MICROBIOL, V38, P1290
   Tsakris A, 2008, J ANTIMICROB CHEMOTH, V62, P1257, DOI 10.1093/jac/dkn364
   Vatopoulos A., 2008, Eurosurveillance, V13, P8023
   Vidal-Navarro L, 2010, J ANTIMICROB CHEMOTH, V65, P2455, DOI 10.1093/jac/dkq333
   VIEDMA E, 2013, GENOME ANNOUNCEMENTS, V0001
   Voulgari E, 2014, J ANTIMICROB CHEMOTH, V69, P2091, DOI 10.1093/jac/dku105
   Voulgari E, 2013, J ANTIMICROB CHEMOTH, V68, P84, DOI 10.1093/jac/dks356
   Vourli S, 2004, FEMS MICROBIOL LETT, V234, P209, DOI 10.1016/j.femsle.2004.03.028
   Vranic-Ladavac M, 2014, EUR J CLIN MICROBIOL, V33, P471, DOI 10.1007/s10096-013-1991-9
   Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2
   Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005
   Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226
   Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001
   Zafer MM, 2014, BIOMED RES INT, DOI 10.1155/2014/101635
   Zafer MM, 2014, INT J INFECT DIS, V29, P80, DOI 10.1016/j.ijid.2014.07.008
   Zeka AN, 2014, J ANTIMICROB CHEMOTH, V69, P1145, DOI 10.1093/jac/dkt465
   Zhao WH, 2011, FUTURE MICROBIOL, V6, P317, DOI [10.2217/FMB.11.13, 10.2217/fmb.11.13]
NR 226
TC 9
Z9 10
U1 1
U2 17
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1040-841X
EI 1549-7828
J9 CRIT REV MICROBIOL
JI Crit. Rev. Microbiol.
PY 2017
VL 43
IS 1
BP 43
EP 61
DI 10.3109/1040841X.2016.1160867
PG 19
WC Microbiology
SC Microbiology
GA EH6BH
UT WOS:000391856800003
PM 27387224
DA 2018-12-27
ER

PT J
AU Mogha, KV
   Prajapati, JB
AF Mogha, Kanchan V.
   Prajapati, Jashbhai B.
TI RETRACTED: Evaluation of probiotic cream by in-vitro tests for treatment
   of bacterial vaginosis conditions(Retracted article. See vol. 28, pg.
   89, 2017)
SO REVIEWS IN MEDICAL MICROBIOLOGY
LA English
DT Article; Retracted Publication
DE antibiotics; bacterial vaginosis; cream; hydrogen peroxide;
   hydrophobicity
ID GARDNERELLA-VAGINALIS
AB Probiotic bacteria are used to treat a broad range of gastrointestinal and/or vaginal disorders. A vaginal cream containing probiotic Lactobacillus helveticus (Microbial Type Culture Collection) MTCC 5463 was developed to treat vaginal infections. The effectiveness of probiotic cream was compared with market creams (usually prescribed by doctors) by performing different in-vitro tests, that is hydrophobicity, arginine deiminase assay, inhibition of vaginal pathogens, ability to produce H2O2, lactic acid production, and antibiotic susceptibility against various antibiotics used for treating bacterial vaginosis and reduction in pH. The probiotic cream showed maximum reduction in pH (4.32), amount of H2O2 (87.94 mu M), arginine deiminase activity (1.56), D-lactic acid (3.62 mg/g), and L-lactic acid (2.27 mg/g) compared with all other market creams. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Mogha, Kanchan V.; Prajapati, Jashbhai B.] AAU, SMC Coll Dairy Sci, Dept Dairy Microbiol, Anand 388110, Gujarat, India.
RP Mogha, KV (reprint author), AAU, SMC Coll Dairy Sci, Dept Dairy Microbiol, Anand 388110, Gujarat, India.
EM k_v_mogha@yahoo.co.in
FU Department of Science and Technology
FX Department of Science and Technology is acknowledged for providing
   fellowship for PhD research.
CR Cherpes TL, 2005, CLIN INFECT DIS, V40, P1422, DOI 10.1086/429622
   Cianci A, 2016, J WOMENS HLTH ISSUES, V5, P1
   Clinical Laboratory Standards (CLSI), 2011, PERF STAND ANT DISC
   CROW VL, 1982, J BACTERIOL, V150, P1024
   De Backer E, 2010, CLIN MICROBIOL INFEC, V16, P470, DOI 10.1111/j.1469-0691.2009.02852.x
   Decena DCD, 2006, J OBSTET GYNAECOL RE, V32, P243, DOI 10.1111/j.1447-0756.2006.00383.x
   Goldstein EJC, 2002, ANTIMICROB AGENTS CH, V46, P3068, DOI 10.1128/AAC.46.9.3068-3070.2002
   Guaschino S, 2006, BJOG-INT J OBSTET GY, V113, P46, DOI 10.1111/j.1471-0528.2006.01122.x
   Lee H, 2011, INT J FOOD MICROBIOL, V145, P155, DOI 10.1016/j.ijfoodmicro.2010.12.003
   Mundhey DA, 2015, WORLD J PHARM SCI
   Rossi A, 2010, ARCH GYNECOL OBSTET, V281, P1065, DOI 10.1007/s00404-009-1287-6
   Schwiertz A, 2015, GYNECOL OBSTET, V5, P1
   Senan S, 2012, SOUV 1 ANN C PROB AS, P49
   Senan S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00944
   Talwar GP, 2015, J WOMENS HEALTHCARE, V4, P256
   Togni G, 2011, ANTIMICROB AGENTS CH, V55, P2490, DOI 10.1128/AAC.01623-10
   Tomusiak A, 2011, GINEKOL POL, V82, P900
   Vinderola G, 2008, LWT-FOOD SCI TECHNOL, V41, P1678, DOI 10.1016/j.lwt.2007.10.008
NR 18
TC 1
Z9 1
U1 1
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-139X
EI 1473-5601
J9 REV MED MICROBIOL
JI Rev. Med. Microbiol.
PD JAN
PY 2017
VL 28
IS 1
BP 19
EP 25
DI 10.1097/MRM.0000000000000090
PG 7
WC Microbiology
SC Microbiology
GA EH6AC
UT WOS:000391853500004
DA 2018-12-27
ER

PT J
AU Namazi, H
   Kulish, VV
AF Namazi, Hamidreza
   Kulish, Vladimir V.
TI RETRACTED: Fractal Based Analysis of the Influence of Odorants on Heart
   Activity (Retracted article. See vol. 8, art no 46981, 2018)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID AUTONOMIC NERVOUS-SYSTEM; RATE-VARIABILITY; MOLECULAR COMPLEXITY;
   STIMULI; ENTROPY; STRESS; DIAGNOSIS; SIGNALS; ECG
AB An important challenge in heart research is to make the relation between the features of external stimuli and heart activity. Olfactory stimulation is an important type of stimulation that affects the heart activity, which is mapped on Electrocardiogram (ECG) signal. Yet, no one has discovered any relation between the structures of olfactory stimuli and the ECG signal. This study investigates the relation between the structures of heart rate and the olfactory stimulus (odorant). We show that the complexity of the heart rate is coupled with the molecular complexity of the odorant, where more structurally complex odorant causes less fractal heart rate. Also, odorant having higher entropy causes the heart rate having lower approximate entropy. The method discussed here can be applied and investigated in case of patients with heart diseases as the rehabilitation purpose.
C1 [Namazi, Hamidreza; Kulish, Vladimir V.] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
RP Namazi, H (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore, Singapore.
EM hnamazi@ntu.edu.sg
FU Ministry of Education, Singapore [RG119/15]
FX This work has been supported by the grant from Ministry of Education,
   Singapore. Grant number RG119/15.
CR Acharya R. U., 2004, BIOMED ENG ONLINE, V3, P1, DOI DOI 10.1186/1475-925X-3-24
   Annadhason A., 2012, IRACST, V2, P166
   Baumert M, 2014, ENTROPY-SWITZ, V16, P6384, DOI 10.3390/e16126384
   Bhaduri A, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00044
   Burdock G. A., 2009, FENAROLIS HDB FLAVOR
   Cha JH, 2010, J KOREAN ACAD NURS, V40, P705, DOI 10.4040/jkan.2010.40.5.705
   Chiu HC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13315
   Czogala E, 1998, FUZZY SET SYST, V97, P9, DOI 10.1016/S0165-0114(96)00359-4
   D'addio G, 2014, 2014 8TH CONFERENCE OF THE EUROPEAN STUDY GROUP ON CARDIOVASCULAR OSCILLATIONS (ESGCO), P155, DOI 10.1109/ESGCO.2014.6847566
   DEPASCALIS V, 1995, INT J PSYCHOPHYSIOL, V20, P21, DOI 10.1016/0167-8760(95)00023-L
   Dong S, 2016, PHYSIOL BEHAV, V156, P94, DOI 10.1016/j.physbeh.2016.01.013
   Ghosh D. C., 2013, INT J ENG RES APPL, V3, P129
   Haapaniemi TH, 2001, J NEUROL NEUROSUR PS, V70, P305, DOI 10.1136/jnnp.70.3.305
   HENDRICKSON JB, 1987, J CHEM INF COMP SCI, V27, P63, DOI 10.1021/ci00054a004
   Hongratanaworakit T, 2005, ACTA HORTIC, P75, DOI 10.17660/ActaHortic.2005.679.9
   Huh KH, 2011, IMAGNG SCI DENT, V41, P71, DOI 10.5624/isd.2011.41.2.71
   Joseph P, 2004, ITBM RBM, V25, P40
   Jung DJ, 2013, J EXERC REHABIL, V9, P250, DOI 10.12965/jer.130007
   KAMATH C, 2012, MIDDLE EAST J SCI RE, V12, P1403, DOI DOI 10.5829/idosi.mejsr.2012.12.10.118
   Kermen F, 2011, SCI REP-UK, V1, DOI 10.1038/srep00206
   Kikuchi A., 1992, TOHOKU PSYCHOL, V52, P74
   Krstacic G, 2002, COMPUT CARDIOL, V29, P673, DOI 10.1109/CIC.2002.1166862
   Kulish V. V., 2010, PARTIAL DIFFERENTIAL
   Lin PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087798
   Makikallio TH, 2001, J AM COLL CARDIOL, V37, P1395, DOI 10.1016/S0735-1097(01)01171-8
   Matsumoto T, 2016, BIOPSYCHOSOC MED, V10, DOI 10.1186/s13030-016-0063-7
   Diosdado AM, 2009, IEEE ENG MED BIO, P3453, DOI 10.1109/IEMBS.2009.5334596
   Nagai H., 1991, CHEM SENSES, V16, P198
   Namazi H, 2016, BIOSCI TRENDS, V10, P477, DOI 10.5582/bst.2016.01182
   Namazi H, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2805
   Namazi H, 2016, BIOMED RES INT, DOI 10.1155/2016/5469587
   Namazi H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26948
   Namazi H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26639
   Namazi H, 2016, ONCOTARGET, V7, P342, DOI 10.18632/oncotarget.6341
   Namazi H, 2015, ONCOTARGET, V6, P42623, DOI 10.18632/oncotarget.6003
   Namazi H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13583
   Namazi H, 2015, COMPUT MATH METHOD M, DOI 10.1155/2015/148534
   Nategh M., 2015, IRAN J CRIT CARE NUR, V7, P201
   Palomba D, 2000, INT J PSYCHOPHYSIOL, V36, P45, DOI 10.1016/S0167-8760(99)00099-9
   PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355
   Renyi A., 1906, ACTA MATH HUNG, V6, P145
   Roque AL, 2013, CLINICS, V68, P960, DOI 10.6061/clinics/2013(07)12
   Sayorwan Winai, 2012, Journal of the Medical Association of Thailand, V95, P598
   Schroeder M., 1991, FRACTALS CHAOS POWER
   Sell CS, 2014, CHEMISTRY AND THE SENSE OF SMELL, P1, DOI 10.1002/9781118522981
   Singh M., 2014, INT J BIOSCIENCE BIO, V6, P179
   Siritunga S., 2013, HEALTH, V5, P59, DOI [10.4236/health.2013.54A008, DOI 10.4236/HEALTH.2013.54A008]
   SMITH DBD, 1969, PSYCHOPHYSIOLOGY, V6, P317, DOI 10.1111/j.1469-8986.1969.tb02909.x
   Tahmasbi H, 2012, J URMIA NURS MIDWIFE, V14, P51
   Tapanainen JM, 2002, AM J CARDIOL, V90, P347, DOI 10.1016/S0002-9149(02)02488-8
   Wang H. M., 2014, ADV ELECT ENG, V2014, DOI [10.1155/2014/851796, DOI 10.1155/2014/851796]
   Yeh RG, 2010, J MED BIOL ENG, V30, P277, DOI 10.5405/jmbe.30.5.02
   Zamarron C, 2006, SLEEP BREATH, V10, P83, DOI 10.1007/s11325-005-0049-3
NR 53
TC 4
Z9 4
U1 2
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD DEC 8
PY 2016
VL 6
AR 38555
DI 10.1038/srep38555
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE5QM
UT WOS:000389662800001
PM 27929045
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Ottmann, D
   Grorud-Colvert, K
   Sard, NM
   Huntington, BE
   Banks, MA
   Sponaugle, S
AF Ottmann, Daniel
   Grorud-Colvert, Kirsten
   Sard, Nicholas M.
   Huntington, Brittany E.
   Banks, Michael A.
   Sponaugle, Su
TI RETRACTED: Long-term aggregation of larval fish siblings during
   dispersal along an open coast (Retracted article. See vol.114,
   pg.E11336, 2017)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
DE larval dispersal; kin aggregation; genetic patchiness; marine fish
   recruitment; population connectivity
ID CORAL-REEF FISH; CHAOTIC GENETIC PATCHINESS; ROCKFISHES SEBASTES;
   SOUTHERN-CALIFORNIA; INBREEDING COEFFICIENTS; MICROSATELLITE MARKERS;
   POPULATION-STRUCTURE; KIN AGGREGATION; MARINE RESERVE; RELATEDNESS
AB Pelagic dispersal of most benthic marine organisms is a fundamental driver of population distribution and persistence and is thought to lead to highly mixed populations. However, the mechanisms driving dispersal pathways of larvae along open coastlines are largely unknown. To examine the degree to which early stages can remain spatially coherent during dispersal, we measured genetic relatedness within a large pulse of newly recruited splitnose rockfish (Sebastes diploproa), a live-bearing fish whose offspring settle along the US Pacific Northwest coast after spending up to a year in the pelagic environment. A total of 11.6% of the recruits in a single recruitment pulse were siblings, providing the first evidence for persistent aggregation throughout a long dispersal period. Such protracted aggregation has profound implications for our understanding of larval dispersal, population connectivity, and gene flow within demersal marine populations.
C1 [Ottmann, Daniel; Sard, Nicholas M.; Banks, Michael A.; Sponaugle, Su] Oregon State Univ, Hatfield Marine Sci Ctr, Newport, OR 97365 USA.
   [Ottmann, Daniel; Grorud-Colvert, Kirsten; Sponaugle, Su] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.
   [Sard, Nicholas M.; Banks, Michael A.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.
   [Huntington, Brittany E.] Oregon Dept Fish & Wildlife, Marine Reserves Program, Newport, OR 97365 USA.
RP Ottmann, D (reprint author), Oregon State Univ, Hatfield Marine Sci Ctr, Newport, OR 97365 USA.; Ottmann, D (reprint author), Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.
EM daniel.ottmann.riera@gmail.com
OI Ottmann, Daniel/0000-0002-8955-1946
FU Hatfield Marine Science Center Mamie L. Markham Research Award; Oregon
   Department of Fisheries and Wildlife; la Caixa Foundation; US Army Corps
   of Engineers; National Science Foundation [OCE 1419987]
FX Recruits were collected with the assistance of James Burke, Jerod Sapp,
   Tully Rohrer, Joe Tyburczy, Keith Matteson, and Neal McIntosh. We thank
   Keith Bosley and Aaron Chappell for supplying adult fish samples. David
   Jacobson assisted with the processing of the molecular samples. The
   manuscript was improved with the comments of Robert Cowen and Bruce
   Menge. This project was funded by the Hatfield Marine Science Center
   Mamie L. Markham Research Award and supported in-kind by the Oregon
   Department of Fisheries and Wildlife. This work was supported by la
   Caixa Foundation (D.O.) and the US Army Corps of Engineers (N.M.S.), as
   well as by National Science Foundation Grant OCE 1419987 (to S.S.).
   Samples were collected under National Marine Fisheries Service (NMFS)
   permit 18058, and fish protocols were approved by Oregon State
   University Animal Care and Use Protocol 4183.
CR ALLENDORF FW, 1981, CAN J FISH AQUAT SCI, V38, P1507, DOI 10.1139/f81-203
   Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597
   Ammann AJ, 2004, J EXP MAR BIOL ECOL, V299, P135, DOI 10.1016/j.jembe.2003.08.014
   Barth JA, 2007, P NATL ACAD SCI USA, V104, P3719, DOI 10.1073/pnas.0700462104
   Ben-Tzvi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042672
   Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706
   Bernardi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044953
   Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1046/j.1365-294X.1996.00094.x
   Boehlert G, 1981, EFFECTS PHOTOPERIOD, P789
   BOEHLERT GW, 1977, FISH B-NOAA, V75, P887
   Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645
   Broquet T, 2013, EVOLUTION, V67, P1660, DOI 10.1111/j.1558-5646.2012.01826.x
   Buonaccorsi VP, 2002, CAN J FISH AQUAT SCI, V59, P1374, DOI 10.1139/F02-101
   Caselle JE, 2010, B MAR SCI, V86, P355
   Core Team R, 2015, R LANG ENV STAT COMP
   Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039
   Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757
   Csardi G, 2006, INTERJOURNAL, P1695, DOI DOI 10.1093/NAR/
   Drake PT, 2011, J MAR RES, V69, P1, DOI 10.1357/002224011798147615
   Eldon B, 2016, CURR ZOOL, V62, P551, DOI 10.1093/cz/zow094
   Gaines SD, 2010, P NATL ACAD SCI USA, V107, P18251, DOI 10.1073/pnas.1002098107
   Gertseva V.V., 2009, STATUS US SPLITNOSE
   Gomez-Uchida D, 2003, MOL ECOL NOTES, V3, P387, DOI 10.1046/j.1471-8286.2003.00458.x
   Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627
   Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155
   GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296
   Harrison CS, 2013, MAR ECOL PROG SER, V472, P27, DOI 10.3354/meps10061
   Hedgecock D, 2011, B MAR SCI, V87, P971, DOI 10.5343/bms.2010.1051
   Hyde JR, 2008, MAR ECOL PROG SER, V357, P245, DOI 10.3354/meps07296
   Iacchei M, 2013, MOL ECOL, V22, P3476, DOI 10.1111/mec.12341
   Irisson JO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144060
   Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x
   Johnson DW, 2016, ECOLOGY, V97, P627, DOI 10.1890/15-0914.1
   Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538
   Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x
   Kashef NS, 2014, MAR ECOL PROG SER, V500, P231, DOI 10.3354/meps10669
   Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x
   Leis JM, 2006, ADV MAR BIOL, V51, P57, DOI 10.1016/S0065-2881(06)51002-8
   Levin SA, 2003, ANNU REV ECOL EVOL S, V34, P575, DOI 10.1146/annurev.ecolsys.34.011802.132428
   Love M. S., 2002, ROCKFISHES NE PACIFI
   LYNN RJ, 1987, J GEOPHYS RES-OCEANS, V92, P12947, DOI 10.1029/JC092iC12p12947
   MITCHELL CT, 1970, CALIF FISH GAME, V56, P288
   Planes S, 2002, J FISH BIOL, V61, P1033, DOI 10.1006/jfbi.2002.2123
   Planes S, 2009, P NATL ACAD SCI USA, V106, P5693, DOI 10.1073/pnas.0808007106
   QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x
   RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573
   Richardson DE, 2016, P NATL ACAD SCI USA, V113, P3299, DOI 10.1073/pnas.1525636113
   Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454
   Roques S, 1999, MOL ECOL, V8, P685, DOI 10.1046/j.1365-294x.1999.00770.x
   ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249
   Santure AW, 2010, MOL ECOL, V19, P1439, DOI 10.1111/j.1365-294X.2010.04554.x
   Sekino M, 2000, MOL ECOL, V9, P634, DOI 10.1046/j.1365-294x.2000.00882-3.x
   Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2
   Selwyn JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153381
   Shanks AL, 2009, BIOL BULL-US, V216, P373
   Shima JS, 2016, ECOLOGY, V97, P25, DOI 10.1890/14-2298.1
   Sogard SM, 2008, MAR ECOL PROG SER, V360, P227, DOI 10.3354/meps07468
   Sponaugle S, 2005, LIMNOL OCEANOGR, V50, P1033, DOI 10.4319/lo.2005.50.4.1033
   St-Onge P, 2015, OECOLOGIA, V178, P733, DOI 10.1007/s00442-015-3245-2
   Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533
   Taylor HR, 2015, ECOL EVOL, V5, P3140, DOI 10.1002/ece3.1541
   Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x
   Veliz D, 2006, MOL ECOL, V15, P4193, DOI 10.1111/j.1365-294X.2006.03078.x
   Wang J, 2014, J EVOLUTION BIOL, V27, P518, DOI 10.1111/jeb.12315
   Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214
   Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798
   Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x
   Waples RS, 2016, J FISH BIOL, V89, P2479, DOI 10.1111/jfb.13143
   Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   Wickham H, 2011, J STAT SOFTW, V40, P1
   Wickham H, 2007, J STAT SOFTW, V21, P1
   Wilkinson L, 2012, IEEE T VIS COMPUT GR, V18, P321, DOI 10.1109/TVCG.2011.56
   Wimberger P, 1999, MAR BIOTECHNOL, V1, P311, DOI 10.1007/PL00011780
NR 74
TC 10
Z9 10
U1 1
U2 26
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 6
PY 2016
VL 113
IS 49
BP 14067
EP 14072
DI 10.1073/pnas.1613440113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE3XX
UT WOS:000389536700043
PM 27872302
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Alipour, R
   Hosseinnejad, MT
   Elahi, AS
   Ghoranneviss, M
AF Alipour, R.
   Hosseinnejad, M. T.
   Elahi, A. Salar
   Ghoranneviss, M.
TI RETRACTED: New perspective on morphological features of the zinc oxide
   thin films as a gas sensor (Retracted article. See vol. 746, pg. 740,
   2018)
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article; Retracted Publication
DE ZnO thin films; DC magnetron sputtering; Morphological features
ID ZNO NANOPARTICLES; DEPOSITION; GROWTH; DEVICES; LAYER
AB In this experimental research, the effects of the thermal oxidation time on the morphological characteristics of ZnO thin films and the impact of these features on the gas response of samples were investigated. For this purpose, the thin layers of zinc were deposited on glass substrates by DC magnetron sputtering method. To oxidation the samples and produce zinc oxide thin films the thermal oxidation method was used. The X-ray diffraction analysis is used to specify the deposited thin layers. The results of the Scherrer formula showed that the grain size of the grown ZnO thin films was increased with increasing oxidation time. The efficiency of gas sensor of deposited samples at different thermal oxidation times was investigated. The results show that the increase in the oxidation time (which leads to the increase in ZnO grain size) leads to the reduction of gas response a. Also, To study the effects of the morphological characteristics of synthesized ZnO thin films on the gas response, the atomic force microscopy (AFM) analysis, the Mountains Map Premium 7.3 (64-bit version) software and the Gwyddion software were used. By using the results of motifs analysis and the statistical parameters of samples, it could be concluded that the gas response of the ZnO thin films decreased with increasing the surface roughness, density and intensity of peaks on the surfaces of the samples. Also, the results show that the gas response a increased with increasing temperature and this increase of gas response is more intense at higher temperatures. The results of this paper provide new perspectives for the researcher in this field. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Alipour, R.; Elahi, A. Salar; Ghoranneviss, M.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
   [Hosseinnejad, M. T.] Islamic Azad Univ, Sci & Res Branch, Young Researcher & Elite Club, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
EM Salari_phy@yahoo.com
CR Akbarnejad E, 2016, J INORG ORGANOMET P, V26, P270, DOI 10.1007/s10904-015-0299-x
   [Anonymous], 2012, 251782 ISO
   Ashrafi A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2787957
   Azadfar P, 2015, J INORG ORGANOMET P, V25, P1040, DOI 10.1007/s10904-015-0207-4
   Azadfar P, 2015, J CRYST GROWTH, V415, P166, DOI 10.1016/j.jcrysgro.2015.01.001
   Bahadur H, 2007, INDIAN J PURE AP PHY, V45, P395
   Battez AH, 2008, WEAR, V265, P422, DOI 10.1016/j.wear.2007.11.013
   Cheng AJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2889502
   Cui JB, 2012, MATER CHARACT, V64, P43, DOI 10.1016/j.matchar.2011.11.017
   Devaraj R, 2013, APPL NANOSCI, V3, P37, DOI 10.1007/s13204-012-0072-1
   Elahi AS, 2016, INT J MATER PROD TEC, V52, P353, DOI 10.1504/IJMPT.2016.075500
   Farazmand P, 2015, J INORG ORGANOMET P, V25, P1470, DOI 10.1007/s10904-015-0263-9
   Ghorannevis Z, 2016, J CRYST GROWTH, V447, P62, DOI 10.1016/j.jcrysgro.2016.04.062
   Ghorannevis Z, 2015, J INORG ORGANOMET P, V25, P1486, DOI 10.1007/s10904-015-0265-7
   Ghoranneviss M, 2016, MOL CRYST LIQ CRYST, V629, P158, DOI 10.1080/15421406.2015.1107817
   Ghoranneviss M, 2015, MATER MANUF PROCESS, V30, P1348, DOI 10.1080/10426914.2015.1019103
   Ghoranneviss M, 2015, FUSION ENG DES, V94, P1, DOI 10.1016/j.fusengdes.2015.02.059
   Heo YW, 2004, MAT SCI ENG R, V47, P1, DOI 10.1016/j.mser.2004.09.001
   Hjiri M, 2013, NANOMATERIALS-BASEL, V3, P357, DOI 10.3390/nano3030357
   Hong RY, 2006, CHEM ENG J, V119, P71, DOI 10.1016/j.cej.2006.03.003
   Ibupoto ZH, 2013, MATERIALS, V6, P3584, DOI 10.3390/ma6083584
   Jafari A, 2016, J CRYST GROWTH, V438, P70, DOI 10.1016/j.jcrysgro.2015.12.038
   Jafari A, 2016, J INORG ORGANOMET P, V26, P254, DOI 10.1007/s10904-015-0291-5
   Jafari A, 2015, J ALLOY COMPD, V644, P97, DOI 10.1016/j.jallcom.2015.04.202
   Janotti A, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126501
   Jayah NA, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-014-0715-0
   JCPDS, 1977, POWD DIFFR FIL ALPH
   Kaushal A, 2011, J NANOPART RES, V13, P2485, DOI 10.1007/s11051-010-0141-x
   Kim J, 2011, J PHYS CHEM C, V115, P7218, DOI 10.1021/jp110129f
   Kumar SS, 2013, INT NANO LETT, V3, DOI 10.1186/2228-5326-3-30
   Lethy KJ, 2008, APPL PHYS A-MATER, V91, P637, DOI 10.1007/s00339-008-4492-4
   Lim SJ, 2008, THIN SOLID FILMS, V516, P1523, DOI 10.1016/j.tsf.2007.03.144
   Lin J., 2011, MSR P, V1348, P1456
   Lu L, 2014, IEEE T ELECTRON DEV, V61, P1077, DOI 10.1109/TED.2014.2302431
   Madani SS, 2015, J ALLOY COMPD, V648, P1104, DOI 10.1016/j.jallcom.2015.07.063
   Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Ran FY, 2009, J CRYST GROWTH, V311, P4270, DOI 10.1016/j.jcrysgro.2009.07.008
   Rodnyi PA, 2011, OPT SPECTROSC+, V111, P776, DOI 10.1134/S0030400X11120216
   Rodzi ASM, 2013, ADV MATER RES-SWITZ, V667, P367, DOI 10.4028/www.scientific.net/AMR.667.367
   Salar Elahi A., 2015, J INORG ORGANOMET P, V25, P942
   Salar Elahi A., 2015, RADIAT EFF DEFECT S, V170, P541
   Salar Elahi A., 2016, J INORG ORGANOME MAR
   Salar Elahi A., 2015, J FUSION ENERG, V34, P449
   Shakti N., 2010, ZNO THIN FILM, V2, P19
   Sokolov PS, 2014, SOLID STATE COMMUN, V177, P65, DOI 10.1016/j.ssc.2013.10.006
   Wang LW, 2012, SENSOR ACTUAT B-CHEM, V162, P237, DOI 10.1016/j.snb.2011.12.073
   Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01
   Wu XF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22504
   Yeti David Netas, 2015, DEV IS SUPPORTED CZE
   Zhang J, 2009, CRYST GROWTH DES, V9, P3532, DOI 10.1021/cg900269a
   Zhang YC, 2014, INORG CHEM COMMUN, V43, P138, DOI 10.1016/j.inoche.2014.02.032
NR 52
TC 9
Z9 9
U1 3
U2 112
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD DEC 5
PY 2016
VL 687
BP 72
EP 78
DI 10.1016/j.jallcom.2016.06.087
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA DW3ER
UT WOS:000383525400011
DA 2018-12-27
ER

PT J
AU Lin, L
   Chen, GY
   Xu, CW
   Wang, HY
   Wu, YF
   Fang, MY
AF Lin, Li
   Chen, Guang-yong
   Xu, Chun-wei
   Wang, Hai-yan
   Wu, Yong-fang
   Fang, Mei-yu
TI RETRACTED: Evaluation and identification of factors related to KRAS and
   BRAF gene mutations in colorectal cancer: A meta-analysis (Retracted
   article. See vol. 13, pg. 156, 2017)
SO JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
LA English
DT Article; Retracted Publication
DE BRAF gene; colorectal; CpG island methylator phenotype; KRAS gene;
   microsatellite instability; mutation; tumor
ID ISLAND METHYLATOR PHENOTYPE; MICROSATELLITE INSTABILITY; DNA
   METHYLATION; MOLECULAR-FEATURES; CLINICOPATHOLOGICAL FEATURES; PROMOTER
   METHYLATION; COLON-CANCER; CARCINOMA; HYPERMETHYLATION; CLASSIFICATION
AB Objective: The aim of this meta-analysis is to evaluate the distribution pattern of KRAS and BRAF mutations in colorectal cancer.
   Materials and Methods: The database was searched without language restrictions. Meta-analyses were conducted using the STATA software. We calculated the odds ratio (OR) and its 95% confidence interval (95% CI) to estimate the distribution of and correlation between KRAS and BRAF mutations, CpG island methylator phenotype (CIMP), and microsatellite instability (MSI) in left-and right-sided colorectal cancer.
   Results: The studies were divided into five groups: (1) distribution of KRAS/BRAF mutations in distal and proximal colorectal cancer, the summary OR value was 1.24 versus 4.03, (2) distribution of KRAS/BRAF mutations in CIMP-low/Neg and CIMP-high (CIMP-H) tumors, the summary OR value was 0.77 versus 10.49, (3) distribution of KRAS/BRAF mutations in MSI-low (MSI-L)/microsatellite stable (MSS) and MSI-high (MSI-H) tumors, the summary OR value was 0.51 versus 9.60, (4) proportion of CIMP-H/MSI-H tumors among distal and proximal colorectal tumors, the summary OR value was 3.66 versus 6.54, and (5) proportion of CIMP-H tumors among MSI-L/MSS and MSI-H tumors, the summary OR value was 5.87.
   Conclusion: The meta-analysis reveals that KRAS has a slightly higher mutation rate in MSI-L/MSS tumors. Moreover, BRAF mutations have higher detection rates in right-sided colorectal cancer, which suggests that BRAF mutations are likely in CIMP-H tumors. Therefore, based on these findings, the molecular diagnostic tests to be conducted in colorectal cancer patients can be determined according to the location/clinical features of the tumor.
C1 [Lin, Li] Capital Med Univ, Acad Mil Med Sci, Affiliated Hosp, Dept Gastrointestinal Oncol, Beijing, Peoples R China.
   [Xu, Chun-wei; Wang, Hai-yan; Wu, Yong-fang] Capital Med Univ, Acad Mil Med Sci, Affiliated Hosp, Dept Pathol, Beijing, Peoples R China.
   [Chen, Guang-yong] Capital Med Univ, Beijing Friendship Hosp, Dept Pathol, Beijing, Peoples R China.
   [Fang, Mei-yu] Zhejiang Canc Hosp, Dept Integrated Chinese Tradit Med & Western Med, 38 Guangji Rd, Hangzhou 310022, Zhejiang, Peoples R China.
RP Fang, MY (reprint author), Zhejiang Canc Hosp, Dept Integrated Chinese Tradit Med & Western Med, 38 Guangji Rd, Hangzhou 310022, Zhejiang, Peoples R China.
EM fangjade2004@icloud.com
FU Medical Scientific Research Foundation of Zhejiang Province of China
   [2013KYB051]; Zhejiang Administration of Traditional Chinese Medicine
   Foundation [2013ZQ005]
FX This study is supported by the Medical Scientific Research Foundation of
   Zhejiang Province of China (Grant no. 2013KYB051) and Zhejiang
   Administration of Traditional Chinese Medicine Foundation (Grant no.
   2013ZQ005).
CR Ahlquist T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-94
   Ahn JB, 2011, CANCER-AM CANCER SOC, V117, P1847, DOI 10.1002/cncr.25737
   Ang PW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-227
   Aoyagi H, 2011, ONCOL REP, V25, P789, DOI 10.3892/or.2010.1118
   Asaka S, 2009, CARCINOGENESIS, V30, P494, DOI 10.1093/carcin/bgp017
   Boparai KS, 2011, AM J PATHOL, V178, P2700, DOI 10.1016/j.ajpath.2011.02.023
   Dahlin AM, 2010, CLIN CANCER RES, V16, P1845, DOI 10.1158/1078-0432.CCR-09-2594
   de Maat MFG, 2010, AM J PATHOL, V177, P2347, DOI 10.2353/ajpath.2010.091103
   de Vogel S, 2009, ANN ONCOL, V20, P1216, DOI 10.1093/annonc/mdn782
   Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421
   Gafa R, 2000, CANCER, V89, P2025, DOI 10.1002/1097-0142(20001115)89:10<2025::AID-CNCR1>3.3.CO;2-J
   Gao Jing, 2012, Chinese Journal of Pathology, V41, P579, DOI 10.3760/cma.j.issn.0529-5807.2012.09.002
   Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110
   Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x
   Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671
   Kibriya MG, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-50
   Koinuma K, 2004, INT J CANCER, V108, P237, DOI 10.1002/ijc.11523
   Kominami K, 2009, J INT MED RES, V37, P1038, DOI 10.1177/147323000903700408
   Lee S, 2008, PATHOL INT, V58, P104, DOI 10.1111/j.1440-1827.2007.02197.x
   Li VSW, 2009, GASTROENTEROLOGY, V137, P176, DOI 10.1053/j.gastro.2009.03.005
   Li WQ, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-2
   Min BH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-344
   Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154
   Nagasaka T, 2008, GASTROENTEROLOGY, V134, P1950, DOI 10.1053/j.gastro.2008.02.094
   Nagasaka T, 2010, CANCER RES, V70, P3098, DOI 10.1158/0008-5472.CAN-09-3290
   Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422
   Tanaka H, 2006, INT J CANCER, V118, P2765, DOI 10.1002/ijc.21701
   van Engeland M, 2011, J CLIN ONCOL, V29, P1382, DOI 10.1200/JCO.2010.28.2319
   Vasovcak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024114
   Zhao Yan, 2008, Progress in Modern Biomedicine, V8, P875
   Zhu Xiao-li, 2012, Chinese Journal of Pathology, V41, P584, DOI 10.3760/cma.j.issn.0529-5807.2012.09.003
NR 31
TC 3
Z9 3
U1 3
U2 5
PU MEDKNOW PUBLICATIONS & MEDIA PVT LTD
PI MUMBAI
PA B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075,
   INDIA
SN 0973-1482
EI 1998-4138
J9 J CANCER RES THER
JI J. Canc. Res. Ther.
PD DEC
PY 2016
VL 12
IS 7
SU S
BP C191
EP C198
DI 10.4103/0973-1482.200601
PG 8
WC Oncology
SC Oncology
GA EN5NJ
UT WOS:000396052100012
PM 28230016
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Benferrah, N
   Hammadi, M
   Berthiol, F
AF Benferrah, N.
   Hammadi, M.
   Berthiol, F.
TI RETRACTED: Easy and green synthesis of
   6-(arylvinyl)-4-hydroxy-3-(phenylsulfanyl)-2H-pyran-2-ones in aqueous
   potassium hydroxide (Retracted article. See vol. 88, pg. 1061, 2018)
SO RUSSIAN JOURNAL OF GENERAL CHEMISTRY
LA English
DT Article; Retracted Publication
DE Dehydroacetic acid; 4-hydroxy-6-methyl-2H-pyran-2-one; KOH/H2O;
   6-(arylvinyl)-4-hydroxy-3-(phenylsulfanyl)-2H-pyran-2-one
ID KAVA PIPER-METHYSTICUM; PYRONES; ACID
AB A convenient green procedure have been proposed for the synthesis of 6-(2-arylvinyl)-4-hydroxy-3-(phenylsulfanyl)-2H-pyran-2-ones by condensation of 6-(arylvinyl)-4-hydroxy-2H-pyran-2-ones with S-phenyl benzenesulfonothioate in aqueous potassium hydroxide at room temperature.
C1 [Benferrah, N.; Hammadi, M.] Univ Mhamed Bougara Boumerdes, URMPE Res Unit Mat Proc & Environm, Fac Engn Sci, Boumerdes 35000, Algeria.
   [Benferrah, N.] Ctr Sci & Tech Res Phys Chem Anal CRAPC, Tipasa 42000, Algeria.
   [Berthiol, F.] Univ Joseph Fourier, Dept Mol Chem SERCO, ICMG FR 2607, UMR 5250, 301 Rue Chim,BP 53, F-938041 Grenoble 9, France.
RP Benferrah, N (reprint author), Univ Mhamed Bougara Boumerdes, URMPE Res Unit Mat Proc & Environm, Fac Engn Sci, Boumerdes 35000, Algeria.; Benferrah, N (reprint author), Ctr Sci & Tech Res Phys Chem Anal CRAPC, Tipasa 42000, Algeria.
EM benferrahnassima@gmail.com
CR Altomare C, 1997, CEREAL RES COMMUN, V25, P349
   Amaral PA, 2008, TETRAHEDRON LETT, V49, P6607, DOI 10.1016/j.tetlet.2008.07.102
   BACARDIT R, 1982, J HETEROCYCLIC CHEM, V19, P157, DOI 10.1002/jhet.5570190130
   Beckert C, 1997, PHYTOCHEMISTRY, V44, P275, DOI 10.1016/S0031-9422(96)00543-2
   Bilia AR, 2002, LIFE SCI, V70, P2581, DOI 10.1016/S0024-3205(02)01555-2
   BLOOMER JL, 1974, J ORG CHEM, V39, P3615, DOI 10.1021/jo00938a047
   BULOCK JD, 1960, J CHEM SOC, P502, DOI 10.1039/jr9600000502
   Coolie J.N., 1891, J CHEM SOC, V59, P609, DOI [10.1039/CT8915900607, DOI 10.1039/CT8915900607]
   Dalga R.J., 1995, J MED CHEM, V38, P1884
   DECLERCQ E, 1995, J MED CHEM, V38, P2491, DOI 10.1021/jm00014a001
   Demuner AJ, 2009, MOLECULES, V14, P4973, DOI 10.3390/molecules14124973
   Duarte FS, 2007, PHARMACOL BIOCHEM BE, V86, P150, DOI 10.1016/j.pbb.2006.12.019
   Ernst E, 2007, BRIT J CLIN PHARMACO, V64, P415, DOI 10.1111/j.1365-2125.2007.02932.x
   FINDLAY JA, 1976, CAN J CHEM, V54, P270, DOI 10.1139/v76-040
   Harris R.F., 1976, [US Patent, Chem. Abstr], V84, Patent No. 3931235
   Hideaki O., 1998, J ORG CHEM, V63, P8748, DOI [10.1021/jo980743r, DOI 10.1021/JO980743R]
   ISRAILI ZH, 1976, J ORG CHEM, V41, P4070, DOI 10.1021/jo00888a004
   Kepe V, 1996, J HETEROCYCLIC CHEM, V33, P1707, DOI 10.1002/jhet.5570330626
   Lasme P, 2008, J AGR FOOD CHEM, V56, P4976, DOI 10.1021/jf800439g
   McGlacken GP, 2005, NAT PROD REP, V22, P369, DOI 10.1039/b416651p
   MORENOMANAS M, 1992, ADV HETEROCYCL CHEM, V53, P1, DOI 10.1016/S0065-2725(08)60861-2
   Nagawade RR, 2005, EUR J MED CHEM, V40, P1325, DOI 10.1016/j.ejmech.2005.05.012
   PRASAD JVNV, 1995, J AM CHEM SOC, V117, P11070, DOI 10.1021/ja00150a005
   Scherer I, 1998, ADV THER, V15, P261
   Schnell B, 2000, J HETEROCYCLIC CHEM, V37, P911, DOI 10.1002/jhet.5570370439
   Seitz U, 1997, PLANTA MED, V63, P548, DOI 10.1055/s-2006-957761
   Stephen T., 2012, BIO MED CHEM, V20, P1482, DOI [10.1016/j.bmc.2011.12.053, DOI 10.1016/J.BMC.2011.12.053]
   SUZUKI E, 1975, SYNTHESIS-STUTTGART, P192
   TROST BM, 1977, J AM CHEM SOC, V99, P4405, DOI 10.1021/ja00455a032
NR 29
TC 1
Z9 1
U1 1
U2 3
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1070-3632
EI 1608-3350
J9 RUSS J GEN CHEM+
JI Russ. J. Gen. Chem.
PD DEC
PY 2016
VL 86
IS 12
BP 2881
EP 2886
DI 10.1134/S1070363216120550
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA EP6LU
UT WOS:000397491800055
DA 2018-12-27
ER

PT J
AU Li, SY
   Gao, Y
   Ma, WN
   Cheng, TC
   Liu, YH
AF Li, Shaoyi
   Gao, Yun
   Ma, Weining
   Cheng, Tianci
   Liu, Yunhui
TI RETRACTED: Ginsenoside Rh2 inhibits invasiveness of glioblastoma through
   modulation of VEGF-A (Retracted article. See April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Glioblastoma multiforme (GBM); Ginsenoside Rh2 (GRh2); Vascular
   endothelial growth factorA (VEGF-A); miR-497
ID OVARIAN-CANCER CELLS; DEPENDENT INHIBITION; NUDE-MICE; GROWTH;
   PROLIFERATION; MULTIFORME; RH-2
AB The malignancy of glioblastoma multiforme (GBM) is largely due to its local invasion and the presence of the tumor in the relatively restrained region in the brain. Hence, effective prevention of the cancer cell invasion is substantially critical for controlling the growth and deterioration of GBM. We have recently reported the role of ginsenoside Rh2 (GRh2) in suppressing the growth of GBM through EGFR/PI3k/Akt/mTor signaling pathways. Here, we further showed that GRh2 efficiently inhibited the cancer vascularization in vivo. In vitro, GRh2 dose-dependently inhibited the protein, but not messenger RNA (mRNA) of vascular endothelial growth factor A (VEGF-A) in GBM cells. We then examined the underlying mechanisms and found that GRh2 increased the levels of miR-497, which bound to 3'UTR of VEGF-A mRNA to inhibit its translation. Together, our data demonstrate a previously unappreciated role for GRh2 in inhibition of GBM-associated cancer vascularization, which may contribute to the effects of GRh2 on suppression of GBM cancer growth and invasion.
C1 [Li, Shaoyi; Ma, Weining; Cheng, Tianci; Liu, Yunhui] China Med Univ, Shengjing Hosp, Dept Neurosurg, 36 Sanhaojie, Shenyang 110004, Peoples R China.
   [Gao, Yun] He Univ, Ctr Mol Pathol, 66 Sishui St, Shenyang 110163, Peoples R China.
RP Li, SY (reprint author), China Med Univ, Shengjing Hosp, Dept Neurosurg, 36 Sanhaojie, Shenyang 110004, Peoples R China.
EM lishaoyi2014@163.com
FU Natural Science Foundation of China [30772246, 81072655]; Liaoning
   Provincial Department of Education Science Research Foundation
   [L2010586]; Liaoning Provincial Natural Science Foundation [201202286];
   Shengjing Free Researcher Project
FX This work was supported by the Natural Science Foundation of China (No.
   30772246, No. 81072655), Liaoning Provincial Department of Education
   Science Research Foundation (L2010586), Liaoning Provincial Natural
   Science Foundation (201202286), and Shengjing Free Researcher Project
   (2011).
CR Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Chen J, 2014, TUMOR BIOL, V35, P7195, DOI 10.1007/s13277-014-1913-1
   Choi S, 2009, PHARM RES-DORDR, V26, P2280, DOI 10.1007/s11095-009-9944-9
   Eichmann A, 2012, CURR OPIN CELL BIOL, V24, P188, DOI 10.1016/j.ceb.2012.02.002
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417
   Gong J, 2014, TUMOR BIOL, V35, P11879, DOI 10.1007/s13277-014-2438-3
   KIKUCHI Y, 1991, ANTI-CANCER DRUG, V2, P63, DOI 10.1097/00001813-199102000-00009
   Li BH, 2011, CANCER LETT, V301, P185, DOI 10.1016/j.canlet.2010.11.015
   Li SY, 2015, TUMOR BIOL, V36, P2607, DOI 10.1007/s13277-014-2880-2
   Li SY, 2014, TUMOR BIOL, V35, P5593, DOI 10.1007/s13277-014-1739-x
   Liu J, 2010, FITOTERAPIA, V81, P902, DOI 10.1016/j.fitote.2010.05.020
   Nakata H, 1998, JPN J CANCER RES, V89, P733, DOI 10.1111/j.1349-7006.1998.tb03278.x
   Oh M, 1999, INT J ONCOL, V14, P869
   Tang XP, 2013, WORLD J GASTROENTERO, V19, P1582, DOI 10.3748/wjg.v19.i10.1582
   TODE T, 1993, J CANCER RES CLIN, V120, P24, DOI 10.1007/BF01200720
   Tode T, 1993, Nihon Sanka Fujinka Gakkai Zasshi, V45, P1275
   Wang F, 2014, TUMOR BIOL, V35, P8653, DOI 10.1007/s13277-014-2131-6
   Xiao XW, 2014, DIABETOLOGIA, V57, P991, DOI 10.1007/s00125-014-3179-y
   Xiao XW, 2013, J BIOL CHEM, V288, P8636, DOI 10.1074/jbc.M112.422949
   Ye H, 2014, MOL BIOL REP, V41, P5485, DOI 10.1007/s11033-014-3422-0
   Yu XM, 2015, TUMOR BIOL, V36, P967, DOI 10.1007/s13277-014-2709-z
   Yu YH, 2015, CELL PHYSIOL BIOCHEM, V35, P1756, DOI 10.1159/000373987
NR 23
TC 1
Z9 1
U1 5
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD DEC
PY 2016
VL 37
IS 12
BP 15477
EP 15482
DI 10.1007/s13277-015-3759-6
PG 6
WC Oncology
SC Oncology
GA EJ0ZX
UT WOS:000392941000012
DA 2018-12-27
ER

PT J
AU Shi, Y
   Tan, YJ
   Zeng, DZ
   Qian, F
   Yu, PW
AF Shi, Yan
   Tan, Yong-jia
   Zeng, Dong-zhu
   Qian, Feng
   Yu, Pei-wu
TI RETRACTED: miR-203 suppression in gastric carcinoma promotes
   Slug-mediated cancer metastasis (Retracted article. See April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Gastric carcinoma (GC); Slug; miR-203
ID DOWN-REGULATION; PROLIFERATION; MICRORNAS; GROWTH; INHIBITION;
   ACTIVATION; INVASION; VEGFA; CELLS; MMP7
AB MicroRNAs (miRNAs) play critical roles in tumorigenesis and cancer metastasis. Recently, miR-203 was reported as a tumor suppressor microRNA silenced in different malignancies including hepatocellular carcinoma, prostate cancer, oral cancer, breast cancer, and hematopoietic malignancy, whereas its role in the carcinogenesis of gastric carcinoma (GC) has not been evaluated. Here, we analyzed the levels of miR-203 and Slug in the GC specimen and studied their correlation. We analyzed the binding of miR-203 to the 3'-UTR of Slug messenger RNA (mRNA) and its effects on Slug translation by bioinformatics analysis and by luciferase-reporter assay, respectively. We modified miR-203 levels in GC cells and studied their effects on the cell invasiveness in transwell cell migration assay. We found that in GC, miR-203 levels were significantly decreased and Slug levels were significantly increased. miR-203 and Slug inversely correlated in patients' specimen. Bioinformatic analysis predicted that miR-203 may target the 3'-UTR of Slug mRNA to inhibit its translation, which was confirmed by luciferase-reporter assay. Overexpression of miR-203 inhibited Slug and cell invasiveness, while depletion of miR-203 increased Slug and cell invasiveness. These data suggest that miR-203 suppression in GC promotes Slug-mediated cancer metastasis.
C1 [Shi, Yan; Tan, Yong-jia; Zeng, Dong-zhu; Qian, Feng; Yu, Pei-wu] Third Mil Med Univ, Dept Gen Surg, 30 Gaotanyan St, Chongqing 400038, Peoples R China.
   [Shi, Yan; Tan, Yong-jia; Zeng, Dong-zhu; Qian, Feng; Yu, Pei-wu] Third Mil Med Univ, Southwest Hosp, Ctr Minimal Invas Gastrointestinal Surg, 30 Gaotanyan St, Chongqing 400038, Peoples R China.
RP Shi, Y; Yu, PW (reprint author), Third Mil Med Univ, Dept Gen Surg, 30 Gaotanyan St, Chongqing 400038, Peoples R China.; Shi, Y; Yu, PW (reprint author), Third Mil Med Univ, Southwest Hosp, Ctr Minimal Invas Gastrointestinal Surg, 30 Gaotanyan St, Chongqing 400038, Peoples R China.
EM yan_shi15@163.com; yupeiwu01@vip.sina.com
FU National Science Foundation of China [81472293]
FX The study is supported by National Science Foundation of China (No.:
   81472293).
CR Cui YJ, 2013, CELL PHYSIOL BIOCHEM, V31, P778, DOI 10.1159/000350095
   Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004
   Diao YR, 2014, J BIOL CHEM, V289, P529, DOI 10.1074/jbc.M113.494716
   Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250
   Li LP, 2014, ONCOL LETT, V8, P1533, DOI 10.3892/ol.2014.2370
   Liu G, 2014, TUMOR BIOL, V35, P9801, DOI 10.1007/s13277-014-2273-6
   Mao D, 2014, TUMOR BIOL, V35, P8217, DOI 10.1007/s13277-014-2095-6
   Mei Q, 2014, CANCER SCI, V105, P755, DOI 10.1111/cas.12436
   Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002
   Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619
   Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180
   Wang F, 2014, TUMOR BIOL, V35, P8653, DOI 10.1007/s13277-014-2131-6
   Wang W, 2013, CELL BIOCHEM FUNCT, V31, P82, DOI 10.1002/cbf.2863
   Wu WD, 2015, CELL PHYSIOL BIOCHEM, V35, P1764, DOI 10.1159/000373988
   Xu XY, 2014, CELL PHYSIOL BIOCHEM, V33, P1359, DOI 10.1159/000358703
   Ye YH, 2014, TUMOR BIOL, V35, P10891, DOI 10.1007/s13277-014-2383-1
   Zhao XN, 2013, FRONT BIOSCI-LANDMRK, V18, P803, DOI 10.2741/4144
   Zhou XY, 2014, CELL PHYSIOL BIOCHEM, V33, P1003, DOI 10.1159/000358671
   Zhu XY, 2013, CELL PHYSIOL BIOCHEM, V32, P64, DOI 10.1159/000350125
NR 19
TC 4
Z9 4
U1 4
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD DEC
PY 2016
VL 37
IS 12
BP 15483
EP 15488
DI 10.1007/s13277-015-3765-8
PG 6
WC Oncology
SC Oncology
GA EJ0ZX
UT WOS:000392941000013
DA 2018-12-27
ER

PT J
AU Sun, JW
   Ding, WJ
   Zhi, JJ
   Chen, W
AF Sun, Jiwei
   Ding, Wenjun
   Zhi, Jiajun
   Chen, Wei
TI RETRACTED: MiR-200 suppresses metastases of colorectal cancer through
   ZEB1 (Retracted article. See April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Colorectal cancer; ZEB1; miR-200
ID EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; AKT PHOSPHORYLATION;
   MIRNA-200 FAMILY; CELL-MIGRATION; IN-VITRO; INVASION; PATHWAY; CRC;
   PROGRESSION
AB Poor prognosis of some colorectal cancer (CRC) cases largely results from early metastases of CRC to the distal organs. Thus, suppression of the invasion of CRC appears to be crucial therapy. Since microRNAs (miRNAs) play critical roles in the regulation of cancer metastases, identification of the involved miRNAs may provide novel therapeutic targets for CRC treatment. Here, we showed that the levels of miR-200 were significantly decreased and the levels of ZEB1 were significantly increased in the CRC specimens from patients, compared to the paired non-tumor tissue. Moreover, the levels of miR-200 and ZEB1 are inversely correlated. Bioinformatics analyses showed that miR-200 targeted the 3'-UTR of ZEB1 mRNA to inhibit its translation, which was confirmed by luciferase reporter assay. Moreover, miR-200 overexpression inhibited ZEB1-mediated cell invasiveness, while miR-200 depletion increased ZEB1-mediated cell invasiveness in CRC cells. Together, our data suggest that miR-200 suppression in CRC cells may promote ZEB1-mediated cancer metastasis. Our work thus highlights a novel molecular regulatory machinery that regulates metastases of CRC.
C1 [Sun, Jiwei; Ding, Wenjun; Zhi, Jiajun; Chen, Wei] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal Surg, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.
RP Chen, W (reprint author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Colorectal Surg, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.
EM wei_chen15@163.com
CR Ahn SM, 2012, ONCOGENE, V31, P3051, DOI 10.1038/onc.2011.484
   Chai J, 2015, TUMOR BIOL, V36, P1313, DOI 10.1007/s13277-014-2766-3
   Chu DK, 2014, TUMOR BIOL, V35, P9787, DOI 10.1007/s13277-014-2223-3
   Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004
   East JE, 2013, NAT REV GASTRO HEPAT, V10, P69, DOI 10.1038/nrgastro.2012.245
   Fang YT, 2015, CELL PHYSIOL BIOCHEM, V35, P227, DOI 10.1159/000369690
   Gravgaard KH, 2012, BREAST CANCER RES TR, V134, P207, DOI 10.1007/s10549-012-1969-9
   Guo Y, 2015, CELL PHYSIOL BIOCHEM, V35, P2169, DOI 10.1159/000374022
   Hu QF, 2015, CELL PHYSIOL BIOCHEM, V36, P799, DOI 10.1159/000430139
   Labianca R, 2005, ANN ONCOL, V16, P37, DOI 10.1093/annonc/mdi906
   Lan AP, 2014, CELL PHYSIOL BIOCHEM, V34, P368, DOI 10.1159/000363006
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Liu G, 2014, TUMOR BIOL, V35, P9801, DOI 10.1007/s13277-014-2273-6
   Mei Q, 2014, CANCER SCI, V105, P755, DOI 10.1111/cas.12436
   Paterson EL, 2013, NEOPLASIA, V15, P180, DOI 10.1593/neo.121828
   Paterson EL, 2008, THESCIENTIFICWORLDJO, V8, P901, DOI 10.1100/tsw.2008.115
   Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002
   Sa YL, 2015, CELL PHYSIOL BIOCHEM, V35, P2233, DOI 10.1159/000374028
   Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y
   Tang QC, 2015, TUMOR BIOL, V36, P1701, DOI 10.1007/s13277-014-2771-6
   Teng Y, 2014, CELL PHYSIOL BIOCHEM, V33, P717, DOI 10.1159/000358647
   Van Schaeybroeck S, 2011, NAT REV CLIN ONCOL, V8, P222, DOI 10.1038/nrclinonc.2011.15
   von Kleist S, 1975, J Natl Cancer Inst, V55, P555
   Wang F, 2014, TUMOR BIOL, V35, P8653, DOI 10.1007/s13277-014-2131-6
   Wang X, 2015, TUMOR BIOL, V36, P719, DOI 10.1007/s13277-014-2697-z
   Xu K, 2015, CELL PHYSIOL BIOCHEM, V35, P499, DOI 10.1159/000369715
NR 26
TC 9
Z9 9
U1 5
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD DEC
PY 2016
VL 37
IS 12
BP 15501
EP 15507
DI 10.1007/s13277-015-3822-3
PG 7
WC Oncology
SC Oncology
GA EJ0ZX
UT WOS:000392941000016
DA 2018-12-27
ER

PT J
AU Gao, F
   Wang, T
   Zhang, ZF
   Wang, R
   Guo, Y
   Liu, JF
AF Gao, Feng
   Wang, Tao
   Zhang, Zefeng
   Wang, Rui
   Guo, Yang
   Liu, Junfeng
TI RETRACTED: Regulation of activating protein-4-associated metastases of
   non-small cell lung cancer cells by miR-144 (Retracted article. See
   April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Activating protein-4 (AP4); Non-small cell lung cancer (NSCLC); miR-144
ID EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR; IN-VITRO;
   COLORECTAL-CANCER; DOWN-REGULATION; INHIBITS GROWTH; AP4; PROLIFERATION;
   NSCLC; OSTEOSARCOMA
AB Activating protein-4 (AP4) has been recently shown to regulate the cancer metastases in some cancers including non-small cell lung cancer (NSCLC). Specifically, AP4 regulates mTor/p21 and transforming growth factor beta (TGF beta) receptor signaling pathway to increase an epithelial-mesenchymal transition process to augment cell invasiveness. Nevertheless, how AP4 is regulated in NSCLC has not been studied. Here, we showed that in the specimens from the NSCLC patients, the levels of miR-144 were significantly decreased and the levels of AP4 were significantly increased, compared to the paired non-tumor lung tissue. The levels of miR-144 and AP4 inversely correlated in patients' specimens. Bioinformatics analyses revealed that miR-144 targeted the 3'-UTR of AP4 mRNA to inhibit its translation, confirmed by luciferase-reporter assay. Moreover, miR-144 overexpression inhibited AP4-mediated cell invasiveness, while miR-144 depletion increased AP4-mediated cell invasiveness in NSCLC cells. Together, our data suggest that miR-144 suppression may be the cause of the increased levels of AP4, as well as the augmented cancer metastases, in NSCLC.
C1 [Gao, Feng; Wang, Tao; Zhang, Zefeng; Wang, Rui; Guo, Yang; Liu, Junfeng] Hebei Med Univ, Hosp 4, Dept Thorac Surg, 12 Jiankang Rd, Shijiazhuang 050011, Peoples R China.
RP Liu, JF (reprint author), Hebei Med Univ, Hosp 4, Dept Thorac Surg, 12 Jiankang Rd, Shijiazhuang 050011, Peoples R China.
EM gf0503@126.com
CR Akiyoshi S, 2012, BRIT J CANCER, V107, P1345, DOI 10.1038/bjc.2012.326
   BERNARDINI N, 1993, BRIT J CANCER, V67, P1209, DOI 10.1038/bjc.1993.227
   Cao TJ, 2014, TUMOR BIOL, V35, P10759, DOI 10.1007/s13277-014-2017-7
   Chang YW, 2015, CELL PHYSIOL BIOCHEM, V36, P1186, DOI 10.1159/000430289
   Chiang YA, 2013, ENDOCRINOLOGY, V154, P77, DOI 10.1210/en.2012-1781
   GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417
   Goc A, 2013, J BIOL CHEM, V288, P3025, DOI 10.1074/jbc.M112.424770
   Gong H, 2014, MOL MED REP, V10, P336, DOI 10.3892/mmr.2014.2209
   Guan HY, 2015, ENDOCRINE, V48, P566, DOI 10.1007/s12020-014-0326-7
   Guo YW, 2013, FEBS J, V280, P4531, DOI 10.1111/febs.12417
   Iwaya T, 2012, CARCINOGENESIS, V33, P2391, DOI 10.1093/carcin/bgs288
   Jackstadt R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.282
   Jackstadt R, 2014, ONCOTARGET, V5, P7316, DOI 10.18632/oncotarget.2348
   Jackstadt R, 2013, J EXP MED, V210, P1331, DOI 10.1084/jem.20120812
   Ji D, 2015, CELL PHYSIOL BIOCHEM, V36, P1026, DOI 10.1159/000430276
   Jian H, 2015, CELL SIGNAL, V27, P1208, DOI 10.1016/j.cellsig.2015.02.027
   Jian H, 2014, TUMOR BIOL, V35, P11051, DOI 10.1007/s13277-014-2409-8
   Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105
   Kalimutho M, 2011, J GASTROENTEROL, V46, P1391, DOI 10.1007/s00535-011-0456-0
   Leva G. D., 2013, CURR OPIN GENE DEV, V23, P3
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Liu G, 2015, TUMOR BIOL, V36, P2185, DOI 10.1007/s13277-014-2829-5
   Lv Q, 2015, TUMOR BIOL, V36, P3751, DOI 10.1007/s13277-014-3015-5
   Mei Q, 2014, CANCER SCI, V105, P755, DOI 10.1111/cas.12436
   Mitsudomi T, 2013, NAT REV CLIN ONCOL, V10, P235, DOI 10.1038/nrclinonc.2013.22
   Pallis AG, 2013, LUNG CANCER, V80, P120, DOI 10.1016/j.lungcan.2012.12.025
   Pei J, 2014, TUMOR BIOL, V35, P6673, DOI 10.1007/s13277-014-1850-z
   Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002
   Shi L, 2014, CANCER RES, V74, P532, DOI 10.1158/0008-5472.CAN-13-2203
   Song WF, 2015, CELL PHYSIOL BIOCHEM, V35, P184, DOI 10.1159/000369686
   Wang Q, 2014, TUMOR BIOL, V35, P12743, DOI 10.1007/s13277-014-2600-y
   Wang W, 2015, TUMOR BIOL, V36, P447, DOI 10.1007/s13277-014-2674-6
   Zarogoulidis K, 2013, J THORAC DIS, V5, pS389, DOI 10.3978/j.issn.2072-1439.2013.07.10
   Zhao DP, 2015, TUMOR BIOL, V36, P3637, DOI 10.1007/s13277-014-3001-y
NR 34
TC 2
Z9 2
U1 3
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD DEC
PY 2016
VL 37
IS 12
BP 15535
EP 15541
DI 10.1007/s13277-015-3866-4
PG 7
WC Oncology
SC Oncology
GA EJ0ZX
UT WOS:000392941000020
DA 2018-12-27
ER

PT J
AU Peng, Z
   Xu, TC
   Liao, XF
   He, HJ
   Xu, WS
AF Peng, Zheng
   Xu, Tiancai
   Liao, Xiaofang
   He, Huijuan
   Xu, Wansu
TI RETRACTED: Effects of radiotherapy on nasopharyngeal carcinoma cell
   invasiveness (Retracted article. See April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Nasopharyngeal carcinoma (NPC); Radiotherapy; Snail2; miR-613
ID EPITHELIAL-MESENCHYMAL TRANSITION; AKT PHOSPHORYLATION; TARGETING SLUG;
   LXR-ALPHA; IN-VITRO; CANCER; RADIOSENSITIVITY; OVEREXPRESSION;
   ACTIVATION; EXPRESSION
AB Radiotherapy is widely used in the treatment of nasopharyngeal carcinoma (NPC), whereas its effects on the NPC growth, survival, and metastases have not been completely evaluated. Here, we compared the detected metastatic NPC tissues after radiotherapy (m-NPC) to the resected primary NPC tissues prior to radiotherapy (p-NPC). We detected higher levels of Snail2 protein, but not mRNA in m-NPC, compared to p-NPC. In vitro, a modest irradiation on NPC cells resulted in significant cell death, but increased Snail2 protein, but mRNA levels in the surviving NPC cells. Bioinformatics analyses showed that miR-613, which was significantly decreased in NPC cells after irradiation, targeted the 3'-UTR of Snail2 mRNA to inhibit its translation. Moreover, miR-613 overexpression inhibited Snail2-mediated cell invasiveness, while miR-613 depletion increased Snail2-mediated cell invasiveness in NPC cells. Finally, we detected significantly lower levels of miR-613 in m-NPC, compared to p-NPC. Together our data suggest that although radiotherapy induced NPC cell death, it may increase Snail2-mediated NPC cell invasiveness through downregulating miR-613.
C1 [Peng, Zheng; Xu, Tiancai; Liao, Xiaofang; He, Huijuan; Xu, Wansu] Quzhou People Hosp, Dept Radiat Oncol, Zhongloudi Rd, Quzhou 324000, Peoples R China.
RP Peng, Z (reprint author), Quzhou People Hosp, Dept Radiat Oncol, Zhongloudi Rd, Quzhou 324000, Peoples R China.
EM zheng_peng15@163.com
CR [Anonymous], 1978, Sci Sin, V21, P127
   Deng XZ, 2015, CELL PHYSIOL BIOCHEM, V35, P71, DOI 10.1159/000369676
   Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004
   Guo J, 2014, CELL PHYSIOL BIOCHEM, V33, P1087, DOI 10.1159/000358678
   Kao YC, 2013, TUMOR BIOL, V34, P759, DOI 10.1007/s13277-012-0605-y
   King AD, 2007, CLIN RADIOL, V62, P195, DOI 10.1016/j.crad.2006.10.011
   Lee AWM, 2003, WORLD J SURG, V27, P838, DOI 10.1007/s00268-003-7109-2
   Li WL, 2014, CELL PHYSIOL BIOCHEM, V34, P1466, DOI 10.1159/000366351
   Liu G, 2014, TUMOR BIOL, V35, P9801, DOI 10.1007/s13277-014-2273-6
   Mei Q, 2014, CANCER SCI, V105, P755, DOI 10.1111/cas.12436
   Niu HY, 2014, CELL PHYSIOL BIOCHEM, V34, P2007, DOI 10.1159/000366396
   Ou ZM, 2011, MOL ENDOCRINOL, V25, P584, DOI 10.1210/me.2010-0360
   Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002
   Qi XM, 2015, CELL PHYSIOL BIOCHEM, V36, P1743, DOI 10.1159/000430147
   Qiu YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1331, DOI 10.1159/000354531
   Sacco J, 2012, CURR OPIN LIPIDOL, V23, P220, DOI 10.1097/MOL.0b013e3283534c9f
   Teng Y, 2014, CELL PHYSIOL BIOCHEM, V33, P717, DOI 10.1159/000358647
   Wang F, 2014, TUMOR BIOL, V35, P8653, DOI 10.1007/s13277-014-2131-6
   Win KT, 2013, TUMOR BIOL, V34, P3923, DOI 10.1007/s13277-013-0980-z
   Xie M, 2014, CELL PHYSIOL BIOCHEM, V33, P1475, DOI 10.1159/000358712
   Yang T, 2013, CELL PHYSIOL BIOCHEM, V31, P863, DOI 10.1159/000350104
   Yang X, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1155/2013/319734
   Yang ZL, 2013, MOL MED REP, V8, P1353, DOI 10.3892/mmr.2013.1699
   Zhang L, 2012, CANCER LETT, V323, P1, DOI 10.1016/j.canlet.2012.03.030
   Zhang SX, 2014, CELL PHYSIOL BIOCHEM, V33, P1484, DOI 10.1159/000358713
   Zhang T, 2014, TUMOR BIOL, V35, P12593, DOI 10.1007/s13277-014-2581-x
   Zhao RZ, 2014, BIOCHEM BIOPH RES CO, V448, P329, DOI 10.1016/j.bbrc.2014.04.052
   Zhong D, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-32
NR 28
TC 1
Z9 1
U1 3
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD DEC
PY 2016
VL 37
IS 12
BP 15559
EP 15566
DI 10.1007/s13277-015-3960-7
PG 8
WC Oncology
SC Oncology
GA EJ0ZX
UT WOS:000392941000023
DA 2018-12-27
ER

PT J
AU Liu, W
   An, J
   Li, K
   Hou, HC
AF Liu, Wei
   An, Jie
   Li, Kang
   Hou, Huichi
TI RETRACTED: MiR-429 regulates gastric cancer cell invasiveness through
   ZEB proteins (Retracted article. See April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Gastric carcinoma(GC); ZEB1; ZEB2; miR-429
ID EPITHELIAL-MESENCHYMAL TRANSITION; COLORECTAL-CANCER; AKT
   PHOSPHORYLATION; HUMAN OSTEOSARCOMA; DOWN-REGULATION; E-CADHERIN;
   METASTASIS; PROLIFERATION; INHIBITION; EXPRESSION
AB MicroRNAs (miRNAs) play an essential role in the tumorigenesis of gastric carcinoma (GC). MiR-429 has been recently reported to inhibit GC growth; however, whether miR-429 may also regulate the invasion of GC cells is unknown. Here, we showed that miR-429 levels were significantly decreased and ZEB1 and ZEB2 levels were significantly increased in GC specimens, compared to the paired adjacent non-tumor gastric tissue. Moreover, the levels of miR-429 and ZEB1 or ZEB2 inversely correlated in GC specimens. Bioinformatics analyses showed that miR-429 targeted the 3'-untranslated region of both ZEB1 and ZEB2 mRNA to inhibit their translation, which was confirmed by luciferase reporter assay. Overexpression of miR-429 inhibited ZEB1/2-mediated cell invasiveness, while depletion of miR-429 augmented it. Together, our data suggest that miR-429 suppression in GC promotes ZEB1/2-mediated cancer cell invasion.
C1 [Liu, Wei; Li, Kang; Hou, Huichi] Bethune Int Peace Hosp, Dept Gen Surg, 398 Zhongshan West Rd, Shijiazhuang 050082, Peoples R China.
   [An, Jie] Bethune Int Peace Hosp, Dept Pathol, Shijiazhuang 050082, Peoples R China.
RP Hou, HC (reprint author), Bethune Int Peace Hosp, Dept Gen Surg, 398 Zhongshan West Rd, Shijiazhuang 050082, Peoples R China.
EM hou64huichi@163.com
CR Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339
   Coronnello C, 2013, NUCLEIC ACIDS RES, V41, pW159, DOI 10.1093/nar/gkt379
   Cristobal I, 2014, J SURG ONCOL, V110, P484, DOI 10.1002/jso.23661
   Cui YJ, 2013, CELL PHYSIOL BIOCHEM, V31, P778, DOI 10.1159/000350095
   Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004
   Gao HJ, 2014, BIOMED PHARMACOTHER, V68, P943, DOI 10.1016/j.biopha.2014.09.005
   Guo Y, 2015, CELL PHYSIOL BIOCHEM, V35, P2169, DOI 10.1159/000374022
   Hu QF, 2015, CELL PHYSIOL BIOCHEM, V36, P799, DOI 10.1159/000430139
   Lan AP, 2014, CELL PHYSIOL BIOCHEM, V34, P368, DOI 10.1159/000363006
   Li J, 2013, CANCER LETT, V329, P84, DOI 10.1016/j.canlet.2012.10.019
   Liu G, 2014, TUMOR BIOL, V35, P9801, DOI 10.1007/s13277-014-2273-6
   Liu XZ, 2014, CELL BIOCHEM BIOPHYS, V70, P215, DOI 10.1007/s12013-014-9885-8
   Mao D, 2014, TUMOR BIOL, V35, P8217, DOI 10.1007/s13277-014-2095-6
   Mei Q, 2014, CANCER SCI, V105, P755, DOI 10.1111/cas.12436
   Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002
   Sa YL, 2015, CELL PHYSIOL BIOCHEM, V35, P2233, DOI 10.1159/000374028
   Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y
   Sun TW, 2011, EUR J CANCER, V47, P2552, DOI 10.1016/j.ejca.2011.05.021
   Sun YN, 2014, MOL CELL BIOCHEM, V390, P19, DOI 10.1007/s11010-013-1950-x
   Sun YN, 2014, OMICS, V18, P54, DOI 10.1089/omi.2012.0132
   Teng Y, 2014, CELL PHYSIOL BIOCHEM, V33, P717, DOI 10.1159/000358647
   Wang F, 2014, TUMOR BIOL, V35, P8653, DOI 10.1007/s13277-014-2131-6
   Wang LJ, 2014, GYNECOL ONCOL, V134, P96, DOI 10.1016/j.ygyno.2014.04.055
   Wang YZ, 2013, J NANOMATER, DOI 10.1155/2013/169405
   Wu WD, 2015, CELL PHYSIOL BIOCHEM, V35, P1764, DOI 10.1159/000373988
   Xu XY, 2014, CELL PHYSIOL BIOCHEM, V33, P1359, DOI 10.1159/000358703
   Ye YH, 2014, TUMOR BIOL, V35, P10891, DOI 10.1007/s13277-014-2383-1
   Zhao XN, 2013, FRONT BIOSCI-LANDMRK, V18, P803, DOI 10.2741/4144
   Zhou XY, 2014, CELL PHYSIOL BIOCHEM, V33, P1003, DOI 10.1159/000358671
   Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087780
NR 30
TC 4
Z9 4
U1 4
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD DEC
PY 2016
VL 37
IS 12
BP 15575
EP 15581
DI 10.1007/s13277-015-4094-7
PG 7
WC Oncology
SC Oncology
GA EJ0ZX
UT WOS:000392941000025
DA 2018-12-27
ER

PT J
AU Zhang, ZX
   Zhou, QQ
   Miao, Y
   Tian, H
   Li, Y
   Feng, X
   Song, XF
AF Zhang, Zhenxing
   Zhou, Qingqing
   Miao, Ye
   Tian, He
   Li, Yang
   Feng, Xu
   Song, Xiaofeng
TI RETRACTED: MiR-429 induces apoptosis of glioblastoma cell through Bcl-2
   (Retracted article. See April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Glioblastoma multiforme (GBM); Bcl-2; MiR-429; Chemotherapy
ID PATHWAY IN-VITRO; GASTRIC-CANCER; MALIGNANT-MELANOMA; GINSENOSIDE RH2;
   INHIBITS GROWTH; DOUBLE THERAPY; TEMOZOLOMIDE; METAANALYSIS; MULTIFORME;
   INVASION
AB An essential role of microRNAs (miRNAs) has been acknowledged in the tumorigenesis of glioblastoma multiforme (GBM). Very recently, miR-429 was reported to have a potential of suppressing cancer growth. However, whether miR-429 may similarly regulate growth of GBM remains unknown. Here, we analyzed the levels of miR-429 and anti-apoptotic protein Bcl-2 in GBM specimens. We combined bioinformatics analyses and luciferase reporter assay to determine the relationship between miR-429 and Bcl-2 in GBM cells. Cell survival upon temozolomide treatment was analyzed in a CCK assay. Cell apoptosis was measured by fluorescein isothiocyanate (FITC) Annexin Vapoptosis detection assay. We found that miR-429 levels were significantly decreased and Bcl-2 levels were significantly increased in GBM specimens, compared to the paired adjacent non-tumor brain tissue. Moreover, the levels of miR-429 and Bcl-2 inversely correlated. Low-miR-429 subjects had an overall inferior survival, compared to high-miR-429 subjects. MiR-429 targeted the 3'-UTR of Bcl-2 mRNA to inhibit its translation. Overexpression of miR-429 inhibited Bcl-2-mediated cell survival against temozolomide-induced apoptosis, while depletion of miR-429 augmented it. Together, our data suggest that miR-429 suppression in GBM promotes Bcl-2-mediated cancer cell survival against chemotherapyinduced cell death. Re-expression of miR-429 levels in GBM cells may improve the outcome of chemotherapy.
C1 [Zhang, Zhenxing; Zhou, Qingqing; Miao, Ye; Li, Yang; Feng, Xu] Liaoning Med Univ, Dept Neurosurg, Affiliated Hosp 1, Jinzhou 121001, Peoples R China.
   [Tian, He; Song, Xiaofeng] Liaoning Med Univ, Dept Histol & Embryol, 3-40 Songpo Rd, Jinzhou 121001, Peoples R China.
RP Song, XF (reprint author), Liaoning Med Univ, Dept Histol & Embryol, 3-40 Songpo Rd, Jinzhou 121001, Peoples R China.
EM xiaofeng_song15@163.com
FU Program for Excellent Talents in Liaoning Province in China [LJQ2013088]
FX This work has been supported by Program for Excellent Talents in
   Liaoning Province in China (No. LJQ2013088).
CR Algharabli J, 2012, CELL PHYSIOL BIOCHEM, V30, P33, DOI 10.1159/000339047
   Chen J, 2014, TUMOR BIOL, V35, P6293, DOI 10.1007/s13277-014-1821-4
   Chen J, 2014, TUMOR BIOL, V35, P7195, DOI 10.1007/s13277-014-1913-1
   Coronnello C, 2013, NUCLEIC ACIDS RES, V41, pW159, DOI 10.1093/nar/gkt379
   Cui YJ, 2013, CELL PHYSIOL BIOCHEM, V31, P778, DOI 10.1159/000350095
   Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004
   GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417
   Gong J, 2014, TUMOR BIOL, V35, P11879, DOI 10.1007/s13277-014-2438-3
   Huang XY, 2014, TUMOR BIOL, V35, P6167, DOI 10.1007/s13277-014-1669-7
   Jiang G, 2014, TUMOR BIOL, V35, P315, DOI 10.1007/s13277-013-1042-2
   Li DH, 2014, TUMOR BIOL, V35, P8201, DOI 10.1007/s13277-014-2099-2
   Li SY, 2015, TUMOR BIOL, V36, P2607, DOI 10.1007/s13277-014-2880-2
   Li SY, 2014, TUMOR BIOL, V35, P5593, DOI 10.1007/s13277-014-1739-x
   Li X, 2014, CELL PHYSIOL BIOCHEM, V34, P1227, DOI 10.1159/000366334
   Liu G, 2014, TUMOR BIOL, V35, P9801, DOI 10.1007/s13277-014-2273-6
   Lu ZM, 2014, TUMOR BIOL, V35, P2941, DOI 10.1007/s13277-013-1378-7
   Mei Q, 2014, CANCER SCI, V105, P755, DOI 10.1111/cas.12436
   Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002
   Saleh AM, 2015, CELL PHYSIOL BIOCHEM, V35, P1958, DOI 10.1159/000374004
   Shin D, 2015, CELL PHYSIOL BIOCHEM, V36, P1151, DOI 10.1159/000430286
   Wang F, 2014, TUMOR BIOL, V35, P8653, DOI 10.1007/s13277-014-2131-6
   Wu L, 2014, TUMOR BIOL, V35, P12327, DOI 10.1007/s13277-014-2545-1
   Wu XJ, 2013, TUMOR BIOL, V34, P463, DOI 10.1007/s13277-012-0571-4
   Xie M, 2014, CELL PHYSIOL BIOCHEM, V33, P1475, DOI 10.1159/000358712
   Xiong Y, 2014, CELL PHYSIOL BIOCHEM, V34, P1863, DOI 10.1159/000366385
   Yu XM, 2015, TUMOR BIOL, V36, P967, DOI 10.1007/s13277-014-2709-z
   Yu YH, 2015, CELL PHYSIOL BIOCHEM, V35, P1756, DOI 10.1159/000373987
   Yun M, 2015, CELL PHYSIOL BIOCHEM, V35, P1821, DOI 10.1159/000373993
   Zhou XY, 2014, CELL PHYSIOL BIOCHEM, V33, P1003, DOI 10.1159/000358671
   Zhu YX, 2014, CELL PHYSIOL BIOCHEM, V33, P933, DOI 10.1159/000358665
NR 30
TC 1
Z9 1
U1 3
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD DEC
PY 2016
VL 37
IS 12
BP 15607
EP 15613
DI 10.1007/s13277-015-4291-4
PG 7
WC Oncology
SC Oncology
GA EJ0ZX
UT WOS:000392941000029
DA 2018-12-27
ER

PT J
AU Zhang, ZX
   Song, XF
   Feng, X
   Miao, Y
   Wang, HL
   Li, Y
   Tian, H
AF Zhang, Zhenxing
   Song, Xiaofeng
   Feng, Xu
   Miao, Ye
   Wang, Honglei
   Li, Yang
   Tian, He
TI RETRACTED: Norcantharidin modulates miR-655-regulated SENP6 protein
   translation to suppresses invasion of glioblastoma cells (Retracted
   article. See April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Norcantharidin (NCTD); Glioblastoma multiforme (GBM); SENP6; miR-655
ID INHIBITS TUMOR-GROWTH; CANCER CELLS; IN-VITRO; VASCULOGENIC MIMICRY;
   GALLBLADDER CANCERS; ANTICANCER ACTIVITY; SIGNALING PATHWAY; GINSENOSIDE
   RH2; UP-REGULATION; LUNG-CANCER
AB Norcantharidin (NCTD) is currently used as an anticancer drug for the treatment of some malignant cancers. However, whether it may have therapeutic effects on glioblastoma multiforme (GBM) remains unknown. Moreover, the underlying mechanisms have not been completely elucidated. Recently, SUMO-specific protease 6 (SENP6) has been shown as a tumor suppressor in some cancers. Nevertheless, whether it is involved in the pathogenesis of GBM has not been examined. Here, we studied the effects of NCTD on GBMcells. We found that NCTD dose-dependently increased SENP6 protein, but not messenger RNA (mRNA), in GBM cells, resulting in the suppression of cell invasion. Depletion of SENP6 in GBM cells significantly attenuated the NCTD-induced suppression of GBM cell invasion, while overexpression of SENP6 in GBM cells mimicked the effects of NCTD on cell invasion. Moreover, NCTD dose-dependently decreased the levels of microRNA-655 (miR-655), which bound to 3'-UTR of SENP6 mRNA to inhibit its translation. Overexpression of miR-655 decreased SENP6 in GBMcells, while depletion of miR-655 increased SENP6 protein in GBMcells. Taken together, our data demonstrates a previously unappreciated control of NCTD to suppress GBM cell invasion through modulation of miR-655-regulated SENP6 protein translation.
C1 [Zhang, Zhenxing; Feng, Xu; Miao, Ye; Wang, Honglei; Li, Yang] Liaoning Med Univ, Affiliated Hosp 1, Dept Neurosurg, Jinzhou 121001, Peoples R China.
   [Song, Xiaofeng; Tian, He] Liaoning Med Univ, Dept Histol & Embryol, 3-40 Songpo Rd, Jinzhou 121001, Peoples R China.
RP Song, XF (reprint author), Liaoning Med Univ, Dept Histol & Embryol, 3-40 Songpo Rd, Jinzhou 121001, Peoples R China.
EM xiaofeng_song15@163.com
FU Program for Excellent Talents in Liaoning Province in China [LJQ2013088]
FX This work has been supported by the Program for Excellent Talents in
   Liaoning Province in China (NO. LJQ2013088).
CR Bolshakova A, 2013, CELL BIOL INT, V37, P387, DOI 10.1002/cbin.10053
   Chen J, 2014, TUMOR BIOL, V35, P7195, DOI 10.1007/s13277-014-1913-1
   Chen YJ, 2009, LIFE SCI, V85, P642, DOI 10.1016/j.lfs.2009.09.003
   Coronnello C, 2013, NUCLEIC ACIDS RES, V41, pW159, DOI 10.1093/nar/gkt379
   Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004
   GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417
   Gong J, 2014, TUMOR BIOL, V35, P11879, DOI 10.1007/s13277-014-2438-3
   Harazono Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062757
   He X, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/945169, DOI 10.1155/2014/945169]
   Kim YW, 2014, DRUG DES DEV THER, V8, P293, DOI 10.2147/DDDT.S51969
   Kitamura K, 2014, MOL CANCER THER, V13, P444, DOI 10.1158/1535-7163.MCT-13-0448
   Kok SH, 2003, ORAL ONCOL, V39, P19, DOI 10.1016/S1368-8375(01)00129-4
   Lee YC, 2013, ONCOL REP, V29, P237, DOI 10.3892/or.2012.2118
   Li SY, 2015, TUMOR BIOL, V36, P2607, DOI 10.1007/s13277-014-2880-2
   Li SY, 2014, TUMOR BIOL, V35, P5593, DOI 10.1007/s13277-014-1739-x
   Li XP, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1521-5
   Lin SS, 2015, CELL PHYSIOL BIOCHEM, V35, P2213, DOI 10.1159/000374026
   Liu X, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003480
   Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008
   Pereira DM, 2013, DRUG DISCOV TODAY, V18, P282, DOI 10.1016/j.drudis.2012.10.002
   Qian JX, 2013, CANCER BIOTHER RADIO, V28, P196, DOI 10.1089/cbr.2012.1288
   Shi XX, 2014, CELL PHYSIOL BIOCHEM, V33, P920, DOI 10.1159/000358664
   Shou LM, 2013, ONCOL REP, V30, P1059, DOI 10.3892/or.2013.2601
   Wang XH, 2014, ONCOL REP, V32, P716, DOI 10.3892/or.2014.3228
   Wang YY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-301
   Xie JR, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0592-0
   Xie X, 2015, ONCOL LETT, V9, P837, DOI 10.3892/ol.2014.2711
   Yu XM, 2015, TUMOR BIOL, V36, P967, DOI 10.1007/s13277-014-2709-z
   Yu YH, 2015, CELL PHYSIOL BIOCHEM, V35, P1756, DOI 10.1159/000373987
   Zhang JT, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-193
   Zhang JT, 2012, INT J ONCOL, V40, P1501, DOI 10.3892/ijo.2011.1314
   Zhang S., 2012, PHYS COMMUNICATION, V2012, P1, DOI [10.1016/j.phycom.2012.05.002, DOI 10.1016/J.PHYCOM.2012.05.002]
   Zhi XF, 2015, CELL PHYSIOL BIOCHEM, V35, P571, DOI 10.1159/000369720
   Zhu GW, 2014, CELL PHYSIOL BIOCHEM, V34, P1152, DOI 10.1159/000366328
   Zhu W, 2015, INT J ONCOL, V46, P627, DOI 10.3892/ijo.2014.2753
NR 35
TC 1
Z9 2
U1 4
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD DEC
PY 2016
VL 37
IS 12
BP 15635
EP 15641
DI 10.1007/s13277-015-4447-2
PG 7
WC Oncology
SC Oncology
GA EJ0ZX
UT WOS:000392941000032
DA 2018-12-27
ER

PT J
AU Hou, R
   Jiang, L
   Yang, Z
   Wang, SZ
   Liu, QF
AF Hou, Rui
   Jiang, Luo
   Yang, Zhuo
   Wang, Shizhuo
   Liu, Qifang
TI RETRACTED: Rab14 is overexpressed in ovarian cancers and promotes
   ovarian cancer proliferation through Wnt pathway (retracted article)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Rab14; Ovarian cancer; Wnt; Chemoresistance
ID WNT/BETA-CATENIN PATHWAY; CELL LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE;
   CYCLIN-E; EXPRESSION; GROWTH; GTPASES; RAB25; PROGRESSION; RESISTANCE
AB The Rab GTPase family protein Rab14 has been implicated in cancer development. However, its clinical significance in ovarian cancers and its biological effects have not been examined. The present study aims to examine the clinical significance, biological roles, and molecular mechanism of Rab14 in ovarian cancer progression. We examined expression pattern of Rab14 in 122 cases of ovarian cancer specimens using immunohistochemistry and found Rab14 overexpression correlated with FIGO stage (p = 0.0041). We depleted Rab14 in SKOV3 cells using siRNA and overexpressed Rab14 in SW626 cells. Knockdown of Rab14 inhibited cell growth and invasion while its overexpression facilitated cell growth and invasion. In addition, Rab14 overexpression increased paclitaxel resistance in SW626 cells while its depletion reduced drug resistance. Then, we investigated the role of Rab14 in the regulation of WNT/beta-catenin signaling, demonstrating Rab14 overexpression regulated GSK3 beta phosphorylation and nuclear beta-catenin accumulation. Rab14 depletion inhibited while its overexpression enhanced TCF transcriptional activity with corresponding change of Wnt target genes including MMP7 and c-myc. Wnt inhibitor abolished the effect of Rab14 on cell proliferation and Wnt target genes. In conclusion, the present study demonstrated that Rab14 promotes aggressiveness of ovarian cancer cell through, at least partly, Wnt signaling pathway.
C1 [Hou, Rui; Yang, Zhuo; Wang, Shizhuo; Liu, Qifang] China Med Univ, Dept Obstet & Gynaecol, Shengjing Hosp, Shenyang, Liaoning, Peoples R China.
   [Jiang, Luo] China Med Univ, Dept Ultrasonog, Shengjing Hosp, Shenyang, Liaoning, Peoples R China.
RP Hou, R (reprint author), China Med Univ, Dept Obstet & Gynaecol, Shengjing Hosp, Shenyang, Liaoning, Peoples R China.
EM hourui_sjhos@sina.com
FU China NSFC project [81302272]
FX This study was supported by the China NSFC project (No. 81302272). We
   thank Dr. Y Wang and Dr. Y Liu for technical assistance of results
   evaluation
CR Al-Alem LF, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.112.102327
   Anttila MA, 1999, BRIT J CANCER, V79, P1870, DOI 10.1038/sj.bjc.6690298
   Badiglian L, 2009, ONCOL REP, V21, P313, DOI 10.3892/or_00000223
   Baekelandt M, 1999, CLIN CANCER RES, V5, P2848
   Bedrosian I, 2004, ONCOGENE, V23, P2648, DOI 10.1038/sj.onc.1207408
   Benelli R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-142
   Bodnar L, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-16
   Cheng KW, 2005, CANCER RES, V65, P2516, DOI 10.1158/0008-5472.CAN-05-0573
   Chia WJ, 2009, BBA-REV CANCER, V1795, P110, DOI 10.1016/j.bbcan.2008.10.001
   Darcy KM, 2010, GYNECOL ONCOL, V117, P429, DOI 10.1016/j.ygyno.2010.01.048
   Despierre E, 2010, GYNECOL ONCOL, V117, P358, DOI 10.1016/j.ygyno.2010.02.012
   Dhar KK, 1999, INT J GYNECOL CANCER, V9, P342, DOI 10.1046/j.1525-1438.1999.99048.x
   Fan Y, 2006, PATHOLOGY, V38, P561, DOI 10.1080/00313020601024037
   Fan Y, 2015, MOL MED REP, V11, P2173, DOI 10.3892/mmr.2014.2963
   Fang YY, 2012, TUMOR BIOL, V33, P2299, DOI 10.1007/s13277-012-0492-2
   Ho JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039469
   Jin LX, 2014, MOL CELL PROTEOMICS, V13, P3138, DOI 10.1074/mcp.M113.033217
   Liu YT, 2012, MOL MED REP, V6, P1006, DOI 10.3892/mmr.2012.1052
   Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045
   Marone M, 1998, INT J CANCER, V75, P34, DOI 10.1002/(SICI)1097-0215(19980105)75:1<34::AID-IJC6>3.0.CO;2-2
   Ming ZJ, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0201-0
   Nagaraj AB, 2015, ONCOTARGET, V6, P23720, DOI 10.18632/oncotarget.4690
   Permuth-Wey Jennifer, 2009, V472, P413, DOI 10.1007/978-1-60327-492-0_20
   Psyrri A, 2005, CLIN CANCER RES, V11, P8384, DOI 10.1158/1078-0432.CCR-05-1270
   Schummer M, 2012, GYNECOL ONCOL, V125, P65, DOI 10.1016/j.ygyno.2011.11.050
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Subramani D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-312
   Takai Y, 2001, PHYSIOL REV, V81, P153
   Wang R, 2011, ONCOGENE, V30, P2644, DOI 10.1038/onc.2010.642
   Wang YF, 2013, TUMOR BIOL, V34, P1685, DOI 10.1007/s13277-013-0703-5
   Ye F, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-17
   Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508
   Yoshioka S, 2012, MOL CANCER RES, V10, P469, DOI 10.1158/1541-7786.MCR-11-0177
   Zhao Y., 2014, J WIREL COMMUN NETW, V1, P1, DOI DOI 10.1049/IET-EPA.2014.0058
   Zhao Z, 2010, CANCER SCI, V101, P1454, DOI 10.1111/j.1349-7006.2010.01558.x
NR 35
TC 3
Z9 3
U1 4
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD DEC
PY 2016
VL 37
IS 12
BP 16005
EP 16013
DI 10.1007/s13277-016-5420-4
PG 9
WC Oncology
SC Oncology
GA EJ0ZX
UT WOS:000392941000067
DA 2018-12-27
ER

PT J
AU Glover, BM
   Chen, J
   Hong, KL
   Boveda, S
   Baranchuk, A
   Haugaa, KH
   Dorian, P
   Potpara, TS
   Crystal, E
   Mitchell, B
   Tilz, R
   Leong-Sit, P
   Dagres, N
AF Glover, Benedict M.
   Chen, Jian
   Hong, Kathryn L.
   Boveda, Serge
   Baranchuk, Adrian
   Haugaa, Kristina H.
   Dorian, Paul
   Potpara, Tatjana S.
   Crystal, Eugene
   Mitchell, Brent
   Tilz, Roland
   Leong-Sit, Peter
   Dagres, Nikolaos
TI RETRACTED: Catheter ablation for atrial flutter: a survey by the
   European Heart Rhythm Association and Canadian Heart Rhythm
   Society(Retracted article. See vol. 19, pg. E1-E1, 2017)
SO EUROPACE
LA English
DT Article; Retracted Publication
DE Atrial flutter; Catheter ablation; Anticoagulation; Periprocedural
   management; EHRA survey; EP wire
ID FIBRILLATION; ANTICOAGULANTS; METAANALYSIS
AB The purpose of this EP wire survey was to examine current practice in the management of both cavotricuspid isthmus (CTI)-dependent and non-CTI-dependent atrial flutter (AFL) ablation amongst electrophysiologists in European and Canadian centres and to understand how current opinions vary from guidelines. The results of the survey were collected from a detailed questionnaire that was created by the European Heart Rhythm Association Research Network and the Canadian Heart Rhythm Society. Responses were received from 89 centres in 12 countries. The survey highlighted variability within certain aspects of the management of AFL ablation. The variability in opinion regarding other procedural details suggests a need for further research in this area and consideration of the development of guidelines specific to AFL. Overall, there is reasonable consensus regarding oral anticoagulation and the desired endpoints of ablation for patients with CTI-dependent AFL and for non-CTI-dependent AFL.
C1 [Glover, Benedict M.; Hong, Kathryn L.; Baranchuk, Adrian] Queens Univ, Dept Cardiol, Kingston, ON, Canada.
   [Chen, Jian] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway.
   [Chen, Jian] Univ Bergen, Dept Clin Sci, N-5021 Bergen, Norway.
   [Boveda, Serge] Clin Pasteur, Cardiol Cardiac Arrhythmias Management Dept, Toulouse, France.
   [Haugaa, Kristina H.] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Ctr Cardiol Innovat, Oslo, Norway.
   [Haugaa, Kristina H.] Oslo Univ Hosp, Rikshosp, Inst Surg Res, Oslo, Norway.
   [Haugaa, Kristina H.] Univ Oslo, Oslo, Norway.
   [Dorian, Paul] St Michaels Hosp, Toronto, ON, Canada.
   [Potpara, Tatjana S.] Univ Belgrade, Sch Med, Belgrade 11001, Serbia.
   [Potpara, Tatjana S.] Clin Ctr Serbia, Cardiol Clin, Belgrade, Serbia.
   [Crystal, Eugene] Sunnybrook Med Ctr, Toronto, ON, Canada.
   [Mitchell, Brent] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.
   [Mitchell, Brent] Alberta Hlth Serv, Calgary, AB, Canada.
   [Tilz, Roland] Univ Hosp Schleswig Holstein, Med Clin Cardiol Angiol Intens Care Med 2, Univ Heart Ctr Lubeck, Kiel, Germany.
   [Leong-Sit, Peter] Univ Western Ontario, Div Cardiol, London, ON, Canada.
   [Dagres, Nikolaos] Univ Leipzig, Ctr Heart, Dept Electrophysiol, Leipzig, Germany.
RP Glover, BM (reprint author), Queens Univ, Dept Cardiol, Kingston, ON, Canada.
EM benedict.glover@queensu.ca
CR Ellis K, 2007, J CARDIOVASC ELECTR, V18, P799, DOI 10.1111/j.1540-8167.2007.00885.x
   Heidbuchel H, 2015, EUROPACE, V17, P1467, DOI 10.1093/europace/euv309
   Husser D, 2004, AM J CARDIOL, V94, P666, DOI 10.1016/j.amjcard.2004.05.039
   Katritsis DG, 2016, EUROPACE
   Kirchhof P, 2016, EUROPACE, V18, DOI 10.1093/europace/euw295
   Melo SL, 2007, ARQ BRAS CARDIOL, V88, P273, DOI 10.1590/S0066-782X2007000300004
   Perez FJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P393, DOI 10.1161/CIRCEP.109.871665
   Roberts-Thomson KC, 2006, PACE, V29, P643, DOI 10.1111/j.1540-8159.2006.00413.x
   Spector P, 2009, AM J CARDIOL, V104, P671, DOI 10.1016/j.amjcard.2009.04.040
   Vadmann H, 2016, EUROPACE IN PRESS
   Venier S, 2016, EUROPACE IN PRESS
   Williams KA, 2016, J AM COLL CARDIOL, V67, pE27, DOI 10.1016/j.jacc.2015.08.856
   Wu S, 2016, AM J CARDIOL, V117, P926, DOI 10.1016/j.amjcard.2015.12.027
NR 13
TC 5
Z9 5
U1 2
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1099-5129
EI 1532-2092
J9 EUROPACE
JI Europace
PD DEC
PY 2016
VL 18
IS 12
BP 1880
EP 1885
DI 10.1093/europace/euw402
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EI8HB
UT WOS:000392745700018
PM 28130373
OA Bronze
DA 2018-12-27
ER

PT J
AU Abbas, A
   Abbas, S
   Wang, XL
AF Abbas, Aumber
   Abbas, Saleem
   Wang, Xianli
TI RETRACTED: Nanoporous copper: fabrication techniques and advanced
   electrochemical applications(Retracted article. See vol. 35, pg. 63,
   2017)
SO CORROSION REVIEWS
LA English
DT Review; Retracted Publication
DE electrochemical application; fabrication techniques; nanoporous copper
ID AQUEOUS HYDROGENCARBONATE SOLUTION; SINGLE-CRYSTAL ELECTRODES;
   CARBON-DIOXIDE REDUCTION; BUBBLE DYNAMIC TEMPLATE; TI-CU ALLOYS; CO2
   ELECTROREDUCTION; METAL-ELECTRODES; NANOWIRE ARRAYS; CLICK CHEMISTRY;
   IONIC LIQUID
AB Nanoporous copper (NPC), a representative type of nanostructured materials, holds an extensive ability to generate propitious potential for a broad range of highly promising applications. Especially, with the advancement in fabrication techniques, NPC with numerous special and superior properties, such as unique pore structure, large surface-to-volume ratio, enlarged specific surface area, and high electrical and thermal conductivities, has boosted the interest to explore its electrochemical properties and extended its promising applications in energy, sensing, actuation, and catalytic systems. Therefore, timely updates of such a type of material are highly demanding and appealing for a broad audience. This review summarizes the latest advances in the development of NPC with a special focus on synthesis methods and state-of-the-art electrochemical applications such as electrocatalysts, sensors, and energy conversion/storage systems. The important scientific disputes and future research directions are also presented.
C1 [Abbas, Aumber] Newcastle Univ, Sch Chem Engn & Adv Mat CEAM, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   [Abbas, Aumber] Shandong Univ, Sch Mat Sci & Engn, Key Lab Liquid Solid Struct Evolut & Proc Mat, Minist Educ, Jinan 250061, Peoples R China.
   [Abbas, Saleem] Hebei Univ Technol, Sch Mat Sci & Engn, Tianjin 3000130, Peoples R China.
   [Abbas, Saleem] Hebei Univ Technol, Hebei Key Lab Boron Nitride Micro & Nano Mat, Tianjin 3000130, Peoples R China.
   [Wang, Xianli] Univ Georgia, Coll Engn, Athens, GA 30602 USA.
   [Wang, Xianli] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA.
RP Abbas, A (reprint author), Newcastle Univ, Sch Chem Engn & Adv Mat CEAM, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.; Abbas, A (reprint author), Shandong Univ, Sch Mat Sci & Engn, Key Lab Liquid Solid Struct Evolut & Proc Mat, Minist Educ, Jinan 250061, Peoples R China.
EM engr.aumber@icloud.com
FU National Natural Science Foundation of China (NSFC) [51301096]; Shandong
   Provincial Natural Science Foundation [ZR2013EMQ012]; Fundamental
   Research Funds of Shandong University [2014JC017]
FX This work was supported by the National Natural Science Foundation of
   China (NSFC no. 51301096) and the Shandong Provincial Natural Science
   Foundation (ZR2013EMQ012). The work was also financially supported by
   the Fundamental Research Funds of Shandong University (no. 2014JC017).
CR Abbas A, 2016, GREEN CHEM LETT REV, V9, P166, DOI 10.1080/17518253.2016.1188162
   Aburada T, 2011, CORROS SCI, V53, P1627, DOI 10.1016/j.corsci.2011.01.033
   Appleby A.J., 1988, FUEL CELL HDB
   Asghari E, 2016, THIN SOLID FILMS, V598, P6, DOI 10.1016/j.tsf.2015.12.005
   Ashassi-Sorkhabi H, 2016, CHEM ENG J, V299, P282, DOI 10.1016/j.cej.2016.04.069
   Bae JH, 2012, PHYS CHEM CHEM PHYS, V14, P448, DOI 10.1039/c1cp22927c
   Becker H. I., 1957, LOW VOLTAGE ELECTROL
   BENJACOB E, 1990, NATURE, V343, P523, DOI 10.1038/343523a0
   Benson EE, 2009, CHEM SOC REV, V38, P89, DOI 10.1039/b804323j
   Boo H, 2004, J AM CHEM SOC, V126, P4524, DOI 10.1021/ja0398316
   Bozzini B, 2016, ELECTROCHIM ACTA, V218, P208, DOI 10.1016/j.electacta.2016.09.077
   Braun PV, 1999, NATURE, V402, P603, DOI 10.1038/45137
   Brenna M, 2009, POWERTECH 2009 IEEE
   Burke A, 2000, J POWER SOURCES, V91, P37, DOI 10.1016/S0378-7753(00)00485-7
   Calle-Vallejo F., 2013, ANGEW CHEM, V125, P7423
   CHANDRASEKARAN K, 1987, SURF SCI, V185, P495, DOI 10.1016/S0039-6028(87)80173-5
   Chang JK, 2008, J PHYS CHEM C, V112, P1371, DOI 10.1021/jp0772474
   Chen LY, 2010, ADV FUNCT MATER, V20, P2279, DOI 10.1002/adfm.201000326
   Chen LY, 2009, ADV FUNCT MATER, V19, P1221, DOI 10.1002/adfm.200801239
   Chen YH, 2012, J AM CHEM SOC, V134, P19969, DOI 10.1021/ja309317u
   Chmiola J, 2010, SCIENCE, V328, P480, DOI 10.1126/science.1184126
   Conway B. E., 1999, ELECTROCHEMICAL SUPE
   COOK RL, 1989, J ELECTROCHEM SOC, V136, P1982, DOI 10.1149/1.2097110
   Costentin C, 2013, CHEM SOC REV, V42, P2423, DOI 10.1039/c2cs35360a
   Costentin C, 2012, SCIENCE, V338, P90, DOI 10.1126/science.1224581
   Dan ZH, 2013, J ALLOY COMPD, V557, P166, DOI 10.1016/j.jallcom.2013.01.010
   Dan Z, 2012, INTERMETALLICS, V29, P14, DOI 10.1016/j.intermet.2012.04.016
   DEWULF DW, 1989, J ELECTROCHEM SOC, V136, P1686, DOI 10.1149/1.2096993
   DiMeglio JL, 2013, J AM CHEM SOC, V135, P8798, DOI 10.1021/ja4033549
   Divyashree A, 2015, RSC ADV, V5, P88339, DOI 10.1039/c5ra19392c
   Durand WJ, 2011, SURF SCI, V605, P1354, DOI 10.1016/j.susc.2011.04.028
   Ebbesen SD, 2009, J POWER SOURCES, V193, P349, DOI 10.1016/j.jpowsour.2009.02.093
   Ebrahimi A, 2016, CHEM ENG J, V291, P1, DOI 10.1016/j.cej.2016.01.094
   Erlebacher J, 2004, J ELECTROCHEM SOC, V151, pC614, DOI 10.1149/1.1784820
   Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529
   Erlebacher J, 2009, MRS BULL, V34, P561, DOI 10.1557/mrs2009.155
   Feng QJ, 2012, APPL SURF SCI, V258, P5005, DOI 10.1016/j.apsusc.2012.01.030
   FRIEDRICH JB, 1983, J CATAL, V80, P1, DOI 10.1016/0021-9517(83)90223-3
   Gattrell M, 2007, ENERG CONVERS MANAGE, V48, P1255, DOI 10.1016/j.enconman.2006.09.019
   Goncalves MR, 2013, ELECTROCHIM ACTA, V102, P388, DOI 10.1016/j.electacta.2013.04.015
   Hakamada M, 2016, APPL SURF SCI, V387, P1088, DOI 10.1016/j.apsusc.2016.07.059
   Hayes JR, 2006, J MATER RES, V21, P2611, DOI 10.1557/JMR.2006.0322
   Henne R., 2007, THERM SPRAY TECHNOL, V16, P381
   HORI Y, 1987, J AM CHEM SOC, V109, P5022, DOI 10.1021/ja00250a044
   HORI Y, 1986, CHEM LETT, P897, DOI 10.1246/cl.1986.897
   HORI Y, 1989, J CHEM SOC FARAD T 1, V85, P2309, DOI 10.1039/f19898502309
   Hori Y, 2003, J MOL CATAL A-CHEM, V199, P39, DOI 10.1016/S1381-1169(03)00016-5
   Hori Y, 2008, MOD ASP ELECTROCHEM, P89
   Hori Y, 2002, J PHYS CHEM B, V106, P15, DOI 10.1021/jp013478d
   HORI Y, 1985, CHEM LETT, P1695, DOI 10.1246/cl.1985.1695
   Hori Y, 1997, J PHYS CHEM B, V101, P7075, DOI 10.1021/jp970284i
   Hou C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02878
   Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j
   Hu XL, 2013, J APPL POLYM SCI, V127, P3365, DOI 10.1002/app.37662
   Huang JF, 2004, CHEM MATER, V16, P1829, DOI 10.1021/cm030462m
   Jena BK, 2006, CHEM-EUR J, V12, P2702, DOI 10.1002/chem.200501051
   Jia FL, 2014, J POWER SOURCES, V252, P85, DOI 10.1016/j.jpowsour.2013.12.002
   Jiang HW, 2013, J RARE EARTH, V31, P1119, DOI 10.1016/S1002-0721(12)60414-1
   Jin TN, 2012, CHEMCATCHEM, V4, P1217, DOI 10.1002/cctc.201200193
   Jin T, 2011, ADV SYNTH CATAL, V353, P3095, DOI 10.1002/adsc.201100760
   Khan N, TENCON 2000 P IEEE
   KIM JJ, 1988, J ELECTROANAL CHEM, V245, P223, DOI 10.1016/0022-0728(88)80071-8
   Kotz R, 2000, ELECTROCHIM ACTA, V45, P2483, DOI 10.1016/S0013-4686(00)00354-6
   Krongelb S, 1998, IBM J RES DEV, V42, P575, DOI 10.1147/rd.425.0575
   Kuhl KP, 2012, ENERG ENVIRON SCI, V5, P7050, DOI 10.1039/c2ee21234j
   Kulinowski KM, 2000, ADV MATER, V12, P833, DOI 10.1002/(SICI)1521-4095(200006)12:11<833::AID-ADMA833>3.0.CO;2-X
   Laitar DS, 2005, J AM CHEM SOC, V127, P17196, DOI 10.1021/ja0566679
   Lang XY, 2011, NAT NANOTECHNOL, V6, P232, DOI 10.1038/nnano.2011.13
   Li AP, 1999, ADV MATER, V11, P483, DOI 10.1002/(SICI)1521-4095(199904)11:6<483::AID-ADMA483>3.0.CO;2-I
   Li CW, 2014, NATURE, V508, P504, DOI 10.1038/nature13249
   Li CW, 2012, J AM CHEM SOC, V134, P7231, DOI 10.1021/ja3010978
   Li J, 2015, CORROS SCI, V90, P216, DOI 10.1016/j.corsci.2014.10.014
   Li Y, 2000, APPL PHYS LETT, V76, P2011, DOI 10.1063/1.126238
   Li Y, 2007, CHEM MATER, V19, P5758, DOI 10.1021/cm071738j
   Li Y, 2007, ELECTROCHEM COMMUN, V9, P981, DOI 10.1016/j.elecom.2006.11.035
   Linden D., 1984, HE COURT MASQUE, P1
   Liu DQ, 2013, NANOSCALE, V5, P1917, DOI 10.1039/c2nr33383j
   Liu WB, 2011, CORROS SCI, V53, P809, DOI 10.1016/j.corsci.2010.11.017
   Liu WB, 2015, CORROS SCI, V94, P114, DOI 10.1016/j.corsci.2015.01.043
   Liu Z, 2006, J PHYS CHEM B, V110, P4318, DOI 10.1021/jp056940t
   Liu ZN, 2009, ELECTROCHEM COMMUN, V11, P1365, DOI 10.1016/j.elecom.2009.05.004
   Liu ZW, 2003, ADV MATER, V15, P303, DOI 10.1002/adma.200390073
   Lokhande CD, 2011, CURR APPL PHYS, V11, P255, DOI 10.1016/j.cap.2010.12.001
   Luo XK, 2013, CORROS SCI, V67, P100, DOI 10.1016/j.corsci.2012.10.010
   Luo XK, 2012, MATER LETT, V76, P96, DOI 10.1016/j.matlet.2012.02.028
   Mahon PJ, 2001, AUST J CHEM, V54, P473, DOI 10.1071/CH01142
   Manthiram K, 2014, J AM CHEM SOC, V136, P13319, DOI 10.1021/ja5065284
   Mao R, 2012, CORROS SCI, V60, P231, DOI 10.1016/j.corsci.2012.03.032
   Markiewicz JT, 2010, J ORG CHEM, V75, P4887, DOI 10.1021/jo101002p
   MARSDEN WL, 1980, IND ENG CHEM PROD RD, V19, P551, DOI 10.1021/i360076a014
   Maslyk M, 2016, APPL SURF SCI, V389, P287, DOI 10.1016/j.apsusc.2016.07.098
   Masuda H, 1996, JPN J APPL PHYS 2, V35, pL126, DOI 10.1143/JJAP.35.L126
   McCue I, 2016, ANNU REV MATER RES, V46, P263, DOI 10.1146/annurev-matsci-070115-031739
   McCue I, 2016, ADV ENG MATER, V18, P46, DOI 10.1002/adem.201500219
   Meng FH, 2011, ELECTROCHIM ACTA, V56, P4657, DOI 10.1016/j.electacta.2011.02.105
   Metzger RM, 2000, MAGNET IEEE T, V36, P30
   Mijangos C, 2016, PROG POLYM SCI, V54-55, P148, DOI 10.1016/j.progpolymsci.2015.10.003
   Miller JR, 2008, ELECTROCHEM SOC INTE, V17, P53
   Milles S, 2012, J AM CHEM SOC, V134, P5187, DOI 10.1021/ja210587q
   MOLARES MET, 2001, NUCL INSTRUM METH B, V185, P192
   Montoya JH, 2013, CHEMCATCHEM, V5, P737, DOI 10.1002/cctc.201200564
   Moosavifard SE, 2015, ACS APPL MATER INTER, V7, P4851, DOI 10.1021/am508816t
   Nishino A, 1996, J POWER SOURCES, V60, P137, DOI 10.1016/S0378-7753(96)80003-6
   Ogasawara T, 2006, J AM CHEM SOC, V128, P1390, DOI 10.1021/ja056811q
   Pena DJ, 2000, MRS P
   Peterson AA, 2010, ENERG ENVIRON SCI, V3, P1311, DOI 10.1039/c0ee00071j
   Ponnurangam S, 2016, CHEMELECTROCHEM, V3, P74, DOI 10.1002/celc.201500421
   POSSIN GE, 1970, REV SCI INSTRUM, V41, P772, DOI 10.1063/1.1684640
   Prasad KPS, 2016, SCI TECHNOL ADV MAT, V12
   Qi Z, 2009, J PHYS CHEM C, V113, P6694, DOI 10.1021/jp810742z
   Qi Z, 2009, J ALLOY COMPD, V472, P71, DOI 10.1016/j.jallcom.2008.04.017
   Qiao Y, 2011, J MATER CHEM, V21, P4027, DOI 10.1039/c0jm02871a
   Riveros G, 2005, APPL PHYS A-MATER, V81, P17, DOI 10.1007/s00339-004-3112-1
   Rosen BA, 2011, SCIENCE, V334, P643, DOI 10.1126/science.1209786
   Schetty R, 2001, CIRCUIT WORLD, V27, P17, DOI 10.1108/03056120110367131
   Schouten KJP, 2013, ACS CATAL, V3, P1292, DOI 10.1021/cs4002404
   Schouten KJP, 2012, J AM CHEM SOC, V134, P9864, DOI 10.1021/ja302668n
   Schuchert IU, 2003, J ELECTROCHEM SOC, V150, pC189, DOI 10.1149/1.1554722
   Sen S, 2014, ACS CATAL, V4, P3091, DOI 10.1021/cs500522g
   Shin HC, 2005, ADV FUNCT MATER, V15, P582, DOI 10.1002/adfm.200305165
   Shin HC, 2004, CHEM MATER, V16, P5460, DOI [10.1021/cm048887b, 10.1021/cm04S887b]
   Shin HC, 2003, ADV MATER, V15, P1610, DOI 10.1002/adma.200305160
   Shin HC, 2004, ADV MATER, V16, P237, DOI 10.1002/adma.200305660
   Shukla A, 2001, RESONANCE, V6, P52
   Simon P, 2008, INTERFACE, V17, P38
   Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297
   Smith AJ, 1999, J APPL ELECTROCHEM, V29, P1085, DOI 10.1023/A:1003637410133
   Smith BD, 1997, J ELECTROCHEM SOC, V144, P4288, DOI 10.1149/1.1838180
   Srivastava R, 2011, COLLOID SURFACE A, V392, P271, DOI 10.1016/j.colsurfa.2011.10.004
   Stein A, 2008, CHEM MATER, V20, P649, DOI 10.1021/cm702107n
   Su JB, 2013, MATER LETT, V102, P72, DOI 10.1016/j.matlet.2013.03.114
   Sulka G, 2002, B CERCLE ETUD METAUX, V17, pP1
   Sullivan B.P., 2012, ELECTROCHEMICAL ELEC
   Sun L, 2004, CHEM MATER, V16, P3125, DOI 10.1021/cm0497881
   Tang W, 2012, KEY ENG MATER, V14, P76
   Tang W, 2012, PHYS CHEM CHEM PHYS, V14, P76, DOI 10.1039/c1cp22700a
   Thurn-Albrecht T, 2000, SCIENCE, V290, P2126, DOI 10.1126/science.290.5499.2126
   Tong XL, 2009, J PHYS CHEM C, V113, P13787, DOI 10.1021/jp9029503
   Tornow CE, 2012, J AM CHEM SOC, V134, P19520, DOI 10.1021/ja308217w
   Nguyen T, 2016, ELECTROCHIM ACTA, V202, P166, DOI 10.1016/j.electacta.2016.03.204
   Velev OD, 1999, NATURE, V401, P548, DOI 10.1038/44065
   Verdaguer-Casadevall A, 2015, J AM CHEM SOC, V137, P9808, DOI 10.1021/jacs.5b06227
   Wang GF, 2013, MICROCHIM ACTA, V180, P161, DOI 10.1007/s00604-012-0923-1
   Wang GP, 2012, CHEM SOC REV, V41, P797, DOI 10.1039/c1cs15060j
   Wang R, 2016, MATER LETT, V184, P181, DOI 10.1016/j.matlet.2016.08.049
   Wang XG, 2009, J PHYS CHEM C, V113, P13139, DOI 10.1021/jp902490u
   Wanunu M, 2010, NAT NANOTECHNOL, V5, P807, DOI [10.1038/NNANO.2010.202, 10.1038/nnano.2010.202]
   WATANABE K, 1993, CHEM PHYS LETT, V209, P109, DOI 10.1016/0009-2614(93)87210-T
   WATANABE K, 1994, APPL SURF SCI, V75, P121, DOI 10.1016/0169-4332(94)90147-3
   Winter M, 2004, CHEM REV, V104, P4245, DOI 10.1021/cr020730k
   Wittstock A, 2010, SCIENCE, V327, P319, DOI 10.1126/science.1183591
   Wittstock A, 2010, PHYS CHEM CHEM PHYS, V12, P12919, DOI 10.1039/c0cp00757a
   Yamamoto Y, 2014, TETRAHEDRON, V70, P2305, DOI 10.1016/j.tet.2013.09.065
   Yamauchi Y, 2008, CHEM-ASIAN J, V3, P664, DOI 10.1002/asia.200700350
   Yamauchi Y, 2009, CHEM REC, V9, P321, DOI 10.1002/tcr.200900022
   Zen JM, 2003, ANAL CHEM, V75, P2703, DOI 10.1021/ac020542u
   Zhang JT, 2012, CHEM SOC REV, V41, P7016, DOI 10.1039/c2cs35210a
   Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j
   Zhang MZ, 2004, ADV MATER, V16, P409, DOI 10.1002/adma.200305577
   Zhang Q, 2009, ELECTROCHIM ACTA, V54, P6190, DOI 10.1016/j.electacta.2009.05.089
   Zhang SC, 2011, J POWER SOURCES, V196, P6915, DOI 10.1016/j.jpowsour.2010.12.021
   Zhang XJ, 2011, ACS NANO, V5, P2013, DOI 10.1021/nn1030719
   Zhang YJ, 2014, ACS CATAL, V4, P3742, DOI 10.1021/cs5012298
   Zhang ZH, 2009, J PHYS CHEM C, V113, P12629, DOI 10.1021/jp811445a
   Zhao CC, 2010, CORROS SCI, V52, P3962, DOI 10.1016/j.corsci.2010.08.005
   Zhao CC, 2009, CORROS SCI, V51, P2120, DOI 10.1016/j.corsci.2009.05.043
   Zhao XS, 2006, J MATER CHEM, V16, P637, DOI 10.1039/b513060c
   Zheng JP, 1997, J ELECTROCHEM SOC, V144, P2026, DOI 10.1149/1.1837738
   Zheng XT, 2012, CHEM SOC REV, V41, P2061, DOI 10.1039/c1cs15265c
NR 169
TC 2
Z9 2
U1 11
U2 132
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-6005
EI 2191-0316
J9 CORROS REV
JI Corros. Rev.
PD DEC
PY 2016
VL 34
IS 5-6
BP 249
EP 276
DI 10.1515/corrrev-2016-0023
PG 28
WC Electrochemistry; Metallurgy & Metallurgical Engineering; Materials
   Science, Coatings & Films
SC Electrochemistry; Metallurgy & Metallurgical Engineering; Materials
   Science
GA ED5BD
UT WOS:000388865400001
DA 2018-12-27
ER

PT J
AU Dana, S
   Herdean, A
   Lundin, B
   Spetea, C
AF Dana, Somnath
   Herdean, Andrei
   Lundin, Bjorn
   Spetea, Cornelia
TI RETRACTED: Each of the chloroplast potassium efflux antiporters affects
   photosynthesis and growth of fully developed Arabidopsis rosettes under
   short-day photoperiod(Retracted article. See vol. 160, pg. 124, 2017)
SO PHYSIOLOGIA PLANTARUM
LA English
DT Article; Retracted Publication
ID INTACT CHLOROPLASTS; PROTON EXCHANGE; PHOTOSYSTEM-II; CHLOROPHYLL-A;
   ENVELOPE; PLANTS; ION; PH; MAGNESIUM; TRANSPORT
AB In Arabidopsis thaliana, the chloroplast harbors three potassium efflux antiporters (KEAs), namely KEA1 and KEA2 in the inner envelope and KEA3 in the thylakoid membrane. They may play redundant physiological roles as in our previous analyses of young developing Arabidopsis rosettes under long-day photoperiod (16 h light per day), chloroplast kea single mutants resembled the wild-type plants, whereas kea1kea2 and kea1kea2kea3 mutants were impaired in chloroplast development and photosynthesis resulting in stunted growth. Here, we aimed to study whether chloroplast KEAs play redundant roles in chloroplast function of older Arabidopsis plants with fully developed rosettes grown under short-day photoperiod (8 h light per day). Under these conditions, we found defects in photosynthesis and growth in the chloroplast kea single mutants, and most dramatic defects in the kea1kea2 double mutant. The mechanism behind these defects in the single mutants involves reduction in the electron transport rate (kea1 and kea3), and stomata conductance (kea1, kea2 and kea3), which in turn affect CO2 fixation rates. The kea1kea2 mutant, in addition to these alterations, displayed reduced levels of photosynthetic machinery. Taken together, our data suggest that, in addition to the previously reported roles in chloroplast development in young rosettes, each chloroplast KEA affects photosynthesis and growth of Arabidopsis fully developed rosettes.
C1 [Dana, Somnath; Herdean, Andrei; Lundin, Bjorn; Spetea, Cornelia] Univ Gothenburg, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden.
RP Spetea, C (reprint author), Univ Gothenburg, Dept Biol & Environm Sci, S-40530 Gothenburg, Sweden.
EM cornelia.spetea.wiklund@bioenv.gu.se
FU Swedish Research Council; Enkvists Foundation; Carl Tryggers Foundation
FX This work was supported by the Swedish Research Council, the Enkvists
   Foundation (C. S.), and Carl Tryggers Foundation (B. L.). We thank
   Hans-Henning Kunz (Washington State University, Pullman) for providing
   the kea1-1kea2-1 mutant line and for giving input and comments during
   the editing and writing process of this article.
CR Armbruster U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6439
   Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499
   Carraretto L, 2013, SCIENCE, V342, P114, DOI 10.1126/science.1242113
   Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741
   Hohner R, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00218
   HUBER SC, 1980, PLANT PHYSIOL, V65, P350, DOI 10.1104/pp.65.2.350
   Irigoyen S, 2011, PLANT PHYSIOL, V157, P1765, DOI 10.1104/pp.111.181925
   Karlsson PM, 2015, PLANT J, V84, P99, DOI 10.1111/tpj.12962
   Kunz HH, 2014, P NATL ACAD SCI USA, V111, P7480, DOI 10.1073/pnas.1323899111
   LEIGH RA, 1984, NEW PHYTOL, V97, P1, DOI 10.1111/j.1469-8137.1984.tb04103.x
   Lichtenthaler HK, 1983, BIOCHEM SOC T, V11, P591, DOI DOI 10.1042/BST0110591
   Lundin B, 2007, PLANT J, V49, P528, DOI 10.1111/j.1365-313X.2006.02976.x
   Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646
   MAURY WJ, 1981, PLANT PHYSIOL, V68, P1257, DOI 10.1104/pp.68.6.1257
   Aranda-Sicilia MN, 2012, BBA-BIOMEMBRANES, V1818, P2362, DOI 10.1016/j.bbamem.2012.04.011
   Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740
   Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543
   Sheng PK, 2014, PLANT CELL REP, V33, P1581, DOI 10.1007/s00299-014-1639-y
   Strasser RJ, 2004, ADV PHOTO RESPIRAT, V19, P321
   Wang Y, 2013, ANNU REV PLANT BIOL, V64, P451, DOI 10.1146/annurev-arplant-050312-120153
   Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718
   WU WH, 1992, PLANT PHYSIOL, V98, P666, DOI 10.1104/pp.98.2.666
   Yin L, 2010, PLANT PHYSIOL, V153, P666, DOI 10.1104/pp.110.155804
   Zheng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081463
NR 24
TC 7
Z9 8
U1 3
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0031-9317
EI 1399-3054
J9 PHYSIOL PLANTARUM
JI Physiol. Plant.
PD DEC
PY 2016
VL 158
IS 4
BP 483
EP 491
DI 10.1111/ppl.12452
PG 9
WC Plant Sciences
SC Plant Sciences
GA EC1MK
UT WOS:000387869400009
PM 27080934
DA 2018-12-27
ER

PT J
AU Liu, Y
   Bi, TT
   Dai, W
   Wang, G
   Qian, LQ
   Shen, GH
   Gao, QG
AF Liu, Yan
   Bi, Tingting
   Dai, Wei
   Wang, Gang
   Qian, Liqiang
   Shen, Genhai
   Gao, Quangen
TI RETRACTED: Lupeol Induces Apoptosis and Cell Cycle Arrest of Human
   Osteosarcoma Cells Through PI3K/AKT/mTOR Pathway (Retracted article. See
   vol.16, pg.NP2, 2017)
SO TECHNOLOGY IN CANCER RESEARCH & TREATMENT
LA English
DT Article; Retracted Publication
DE lupeol; osteosarcoma; apoptosis; cell cycle; PI3K/AKT/mTOR
ID INHIBITS PROLIFERATION; PEDIATRIC OSTEOSARCOMA; SIGNALING PATHWAY;
   CANCER-THERAPY; BREAST-CANCER; SURVIVAL; ANTICANCER; TARGET; BCL-2;
   PHOSPHORYLATION
AB Lupeol, a dietary triterpene present in many fruits and medicinal plants, has been reported to possess many pharmacological properties including anticancer effect in vitro and in vivo. However, the activity of lupeol against osteosarcoma remains unclear. The present study is conducted to investigate the anticancer activity and the underlying mechanisms of lupeol on human osteosarcoma cells (MNNG/HOS and MG-63) in vitro and in vivo. MNNG/HOS and MG-63 cells were treated by lupeol and subjected to methyl thiazolyl tetrazolium analysis, Hoechst staining, annexin V/propidium iodide double staining, cell cycle analysis, and Western blot analysis. In addition, MNNG/HOS xenograft tumors were established in female nude BALB/c mice, and lupeol was intravenously administered to evaluate the anticancer capacity in vivo. Our results showed that lupeol induced apoptosis as well as cell cycle arrest in G0/G1 phase of MNNG/HOS and MG-63 cells in a dose-dependent manner in vitro. Furthermore, the protein expression levels of phospho-phosphatidylinositol 3-kinase (p-PI3K), phospho-protein kinase B (p-AKT), p-p70S6K, and cyclin D1 were significantly downregulated, whereas the expression levels of p21 and p27 were upregulated. These protein interactions may play a pivotal role in the regulation of apoptosis and cell cycle arrest. More importantly, our in vivo studies showed that administration of lupeol decreased tumor growth in a dose-dependent manner and has no significant effect on the function of liver and kidney. Taken together, our findings indicated that lupeol can induce apoptosis as well as cell cycle arrest of human osteosarcoma cells through phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway and might offer a promising new approach in the effective treatment of osteosarcoma.
C1 [Liu, Yan; Dai, Wei; Wang, Gang; Qian, Liqiang; Shen, Genhai; Gao, Quangen] Wujiang 1 Peoples Hosp, Dept Gen Surg, Suzhou 215200, Peoples R China.
   [Bi, Tingting] Wujiang 1 Peoples Hosp, Dept Geriatr Ward, Suzhou 215200, Peoples R China.
RP Shen, GH; Gao, QG (reprint author), Wujiang 1 Peoples Hosp, Dept Gen Surg, Suzhou 215200, Peoples R China.
EM wjyysgh@163.com; wjyygqg@sohu.com
FU Program for Young Scientist in Science and Education of Suzhou City
   [KJXW2014053]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was supported by the Program for Young Scientist in Science and
   Education of Suzhou City (No. KJXW2014053).
CR Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24
   Ardiansyah, 2012, BIOSCI BIOTECH BIOCH, V76, P183, DOI 10.1271/bbb.110559
   Chaturvedi PK, 2008, CANCER LETT, V263, P1, DOI 10.1016/j.canlet.2008.01.047
   Citro S, 2015, J MOL CELL BIOL, V7, P132, DOI 10.1093/jmcb/mjv021
   Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014
   Federman N, 2009, CURR TREAT OPTION ON, V10, P82, DOI 10.1007/s11864-009-0087-3
   Huang XF, 2009, OBES REV, V10, P610, DOI 10.1111/j.1467-789X.2009.00607.x
   Imam S, 2007, PAK J PHARM SCI, V20, P125
   Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71
   Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17
   Khan N, 2008, ANTIOXID REDOX SIGN, V10, P475, DOI 10.1089/ars.2007.1740
   Kim JH, 2010, FOOD CHEM TOXICOL, V48, P807, DOI 10.1016/j.fct.2009.12.012
   Kim KM, 2015, CHEM-BIOL INTERACT, V225, P32, DOI 10.1016/j.cbi.2014.10.033
   Lee JA, 2008, PEDIATR BLOOD CANCER, V50, P195, DOI 10.1002/pbe.21446
   Li HZ, 2015, MOL MED REP, V11, P851, DOI 10.3892/mmr.2014.2777
   Liang CZ, 2012, CANCER CHEMOTH PHARM, V69, P317, DOI 10.1007/s00280-011-1699-4
   Liu F, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-108
   Liu J, 2014, TUMOR BIOL, V35, P5409, DOI 10.1007/s13277-014-1705-7
   Liu Y, 2014, CYTOTECHNOLOGY, P1
   Liu Y, 2015, N-S ARCH PHARMACOL, V388, P295, DOI 10.1007/s00210-014-1071-4
   Liu Y, 2014, TUMOR BIOL, V35, P5111, DOI 10.1007/s13277-014-1680-z
   Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005
   Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422
   Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766
   Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121
   Prasad S, 2009, CANCER BIOL THER, V8, P1639, DOI 10.4161/cbt.8.17.9204
   Qu JT, 2012, J CANCER RES CLIN, V138, P819, DOI 10.1007/s00432-012-1149-7
   Salah S, 2014, MOL CLIN ONCOL, V2, P811
   Saleem M, 2004, ONCOGENE, V23, P5203, DOI 10.1038/sj.onc.1207641
   Saleem M, 2009, CANCER LETT, V285, P109, DOI 10.1016/j.canlet.2009.04.033
   Saleem M, 2009, CARCINOGENESIS, V30, P808, DOI 10.1093/carcin/bgp044
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Sun CH, 2011, HISTOPATHOLOGY, V58, P1054, DOI 10.1111/j.1365-2559.2011.03856.x
   Tarapore RS, 2010, CARCINOGENESIS, V31, P1844, DOI 10.1093/carcin/bgq169
   Wang L, 2015, MOL MED REP, V11, P931, DOI 10.3892/mmr.2014.2819
   Wu JH, 2013, CURR CANCER DRUG TAR, V13, P143, DOI 10.2174/1568009611313020004
   You YJ, 2003, PHYTOTHER RES, V17, P341, DOI 10.1002/ptr.1140
   Zhang C, 2015, CELL PHYSIOL BIOCHEM, V35, P419, DOI 10.1159/000369707
NR 40
TC 8
Z9 8
U1 4
U2 13
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1533-0346
EI 1533-0338
J9 TECHNOL CANCER RES T
JI Technol. Cancer Res. Treat.
PD DEC
PY 2016
VL 15
IS 6
BP NP16
EP NP24
DI 10.1177/1533034615609014
PG 9
WC Oncology
SC Oncology
GA EC0AE
UT WOS:000387759000003
PM 26443801
OA Bronze
DA 2018-12-27
ER

PT J
AU Abbasi, M
   Hossieni, M
   Izadmehr, M
   Sharifi, M
AF Abbasi, Mandi
   Hossieni, Mandi
   Izadmehr, Mojtaba
   Sharifi, Mohammad
TI RETRACTED: Tracer transport in naturally fractured reservoirs:
   Analytical solutions for a system of parallel fractures (Retracted
   article. See vol. 113, pg. 1342, 2017)
SO INTERNATIONAL JOURNAL OF HEAT AND MASS TRANSFER
LA English
DT Article; Retracted Publication
DE Fractured reservoir; Mass transfer; Shape factor; Advection; Diffusion
ID MATRIX DIFFUSION-COEFFICIENT; STRUCTURED POROUS-MEDIA; MASS-TRANSFER;
   HYDRODYNAMIC DISPERSION; RADIONUCLIDE TRANSPORT; CONTAMINANT TRANSPORT;
   AGGREGATED MEDIA; SINGLE FRACTURE; FISSURED ROCKS; SCALE
AB In naturally fractured reservoirs, modeling of mass transfer between matrix blocks and fractures is an important subject during gas injection or contaminant transport. This study focuses on developing an exact analytical solution to transient tracer transport problem along a discrete fracture in a porous rock matrix. Using Gauss-Legendre quadrature, an expression was obtained in the form of a double integral which is considered as the general transient solution. This solution has the ability to account the following phenomena: advective transport in fractures and molecular diffusion from the fracture to the matrix block. Certain assumptions are made which allow the problem to be formulated as two coupled, one-dimensional partial differential equations: one for the fracture and one for the porous matrix in a direction perpendicular to the fracture.
   Using the obtained analytical solution, tracer concentration in matrix block and fracture was calculated. The advective-diffusive equation in matrix and fracture was used for evaluation of the mass transfer shape factor. The derived analytical solution was used for analyzing early and late time periods of mass transport phenomenon in fractured porous media. Finally, validation of the analytical solution was done by comparing the obtained results with laboratory data adapted from a column tracer test conducted on a fractured till. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Abbasi, Mandi; Hossieni, Mandi; Sharifi, Mohammad] Amirkabir Univ Technol Polytech Tehran, Dept Petr Engn, POB 15875-4413, Tehran, Iran.
   [Izadmehr, Mojtaba] Sharif Univ Technol, Dept Chem & Petr Engn, Tehran 113659465, Iran.
RP Sharifi, M (reprint author), Amirkabir Univ Technol Polytech Tehran, Dept Petr Engn, POB 15875-4413, Tehran, Iran.
EM m_sharifi@aut.ac.ir
CR Abelin H., 1987, PERFORMED EXPT RESUL, P87
   Adler P. M., 2012, FRACTURED POROUS MED
   Bear Jacob, 2013, DYNAMICS FLUIDS PORO
   Becker MW, 2003, WATER RESOUR RES, V39, DOI 10.1029/2001WR001190
   Belani A. K., 1988, THESIS
   Carrera J, 1998, HYDROGEOL J, V6, P178, DOI 10.1007/s100400050143
   Chen CT, 1997, WASTE MANAGE, V17, P53, DOI 10.1016/S0956-053X(97)00037-8
   Chu M, 2007, ADV WATER RESOUR, V30, P1618, DOI 10.1016/j.advwatres.2006.06.016
   Cihan A., 2011, WATER RESOUR RES, V47
   Dietrich Peter, 2005, FLOW TRANSPORT FRACT
   FEENSTRA S, 1984, GROUND WATER, V22, P307, DOI 10.1111/j.1745-6584.1984.tb01403.x
   Fleming SW, 2001, J CONTAM HYDROL, V48, P253, DOI 10.1016/S0169-7722(00)00182-0
   Freeze R. A, 1979, GROUNDWATER
   Fung L.S.-K., 1993, NUMERICAL SIMULATION
   GILMAN JR, 1988, J PETROL TECHNOL, V40, P60, DOI 10.2118/16010-PA
   GRISAK GE, 1980, WATER RESOUR RES, V16, P719, DOI 10.1029/WR016i004p00719
   GRISAK GE, 1980, WATER RESOUR RES, V16, P731, DOI 10.1029/WR016i004p00731
   Gwo JP, 1998, J HYDROL, V208, P204, DOI 10.1016/S0022-1694(98)00161-9
   Haddad AS, 2012, J CONTAM HYDROL, V133, P94, DOI 10.1016/j.jconhyd.2012.02.008
   HU QH, 1995, WATER RESOUR RES, V31, P1637, DOI 10.1029/95WR01138
   Jardine PM, 1999, WATER RESOUR RES, V35, P2015, DOI 10.1029/1999WR900043
   KAZEMI H, 1976, SOC PETROL ENG J, V16, P317, DOI 10.2118/5719-PA
   LEE CH, 1993, NUCL TECHNOL, V101, P67, DOI 10.13182/NT93-A34768
   Litvak B.L., 1985, P 1985 RES CHAR TECH
   Liu HH, 2004, VADOSE ZONE J, V3, P312
   MALOSZEWSKI P, 1985, J HYDROL, V79, P333, DOI 10.1016/0022-1694(85)90064-2
   MALOSZEWSKI P, 1990, WATER RESOUR RES, V26, P1517, DOI 10.1029/WR026i007p01517
   MALOSZEWSKI P, 1993, WATER RESOUR RES, V29, P2723, DOI 10.1029/93WR00608
   Mathias SA, 2009, Q J ENG GEOL HYDROGE, V42, P237, DOI 10.1144/1470-9236/08-016
   NERETNIEKS I, 1980, J GEOPHYS RES, V85, P4379, DOI 10.1029/JB085iB08p04379
   Oberhettinger F., 2012, TABLES LAPLACE TRANS
   PASSIOURA JB, 1971, SOIL SCI, V111, P339, DOI 10.1097/00010694-197106000-00001
   PASSIOURA JB, 1971, SOIL SCI, V111, P345, DOI 10.1097/00010694-197106000-00003
   RAO PSC, 1980, SOIL SCI SOC AM J, V44, P1139, DOI 10.2136/sssaj1980.03615995004400060003x
   Roberts Paul V., 1987, J CONTAM HYDROL, V14, P375
   Saidi Ali M., 1987, RESERVOIR ENG FRACT
   SKOPP J, 1974, SOIL SCI SOC AM J, V38, P545, DOI 10.2136/sssaj1974.03615995003800040012x
   SUDICKY EA, 1982, WATER RESOUR RES, V18, P1634, DOI 10.1029/WR018i006p01634
   TANG DH, 1981, WATER RESOUR RES, V17, P555, DOI 10.1029/WR017i003p00555
   Taylor Geoffrey, 1953, P ROYAL SOC LOND MAT, V219
   van Golf-Racht T. D., 1982, FUNDAMENTALS FRACTUR, V12
   WARREN JE, 1963, SOC PETROL ENG J, V3, P245, DOI 10.2118/426-PA
   Zhou QL, 2007, J CONTAM HYDROL, V93, P161, DOI 10.1016/j.jconhyd.2007.02.002
NR 43
TC 5
Z9 5
U1 5
U2 16
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0017-9310
EI 1879-2189
J9 INT J HEAT MASS TRAN
JI Int. J. Heat Mass Transf.
PD DEC
PY 2016
VL 103
BP 627
EP 634
DI 10.1016/j.ijheatmasstransfer.2016.07.078
PG 8
WC Thermodynamics; Engineering, Mechanical; Mechanics
SC Thermodynamics; Engineering; Mechanics
GA DY0HL
UT WOS:000384777800060
DA 2018-12-27
ER

PT J
AU Nie, DK
   Xia, L
   Chen, J
   Shi, W
   Sun, G
   Guo, J
AF Nie, Dekang
   Xia, Liang
   Chen, Jian
   Shi, Wei
   Sun, Guan
   Guo, Jun
TI RETRACTED: Teaching NeuroImages: Giant neurocysticercosis with unusual
   imaging manifestations (Retracted article. See vol. 88, pg. 2239, 2017)
SO NEUROLOGY
LA English
DT Editorial Material; Retracted Publication
C1 [Nie, Dekang; Sun, Guan; Guo, Jun] Nantong Univ, Affiliated Hosp 4, Dept Neurosurg, Yancheng, Peoples R China.
   [Xia, Liang] Zhejiang Canc Hosp, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China.
   [Chen, Jian; Shi, Wei] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong, Peoples R China.
RP Sun, G; Guo, J (reprint author), Nantong Univ, Affiliated Hosp 4, Dept Neurosurg, Yancheng, Peoples R China.
EM sunguan2008@sina.com; ycyyguojun@163.com
CR Nash TE, 2004, NEUROLOGY, V62, P1934, DOI 10.1212/01.WNL.0000129481.12067.06
   Takeshita Iwao, 1994, Fukuoka Acta Medica, V85, P29
NR 2
TC 3
Z9 3
U1 2
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD NOV 22
PY 2016
VL 87
IS 21
BP E260
EP E261
DI 10.1212/WNL.0000000000003356
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA EI1LE
UT WOS:000392238000005
PM 27872231
OA Bronze
DA 2018-12-27
ER

PT J
AU Stechschulte, LA
   Ge, CX
   Hinds, TD
   Sanchez, ER
   Franceschi, RT
   Lecka-Czernik, B
AF Stechschulte, Lance A.
   Ge, Chunxi
   Hinds, Terry D.
   Sanchez, Edwin R.
   Franceschi, Renny T.
   Lecka-Czernik, Beata
TI RETRACTED: Protein Phosphatase PP5 Controls Bone Mass and the Negative
   Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPAR
   gamma (Peroxisome Proliferator-activated Receptor gamma) and RUNX2
   (Runt-related Transcription Factor 2) (Retracted article. See vol. 293,
   pg. 8314, 2018)
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article; Retracted Publication
ID TETRATRICOPEPTIDE REPEAT; OSTEOBLAST DIFFERENTIATION;
   GLUCOCORTICOID-RECEPTOR; GENE-EXPRESSION; KINASE; PHOSPHORYLATION; MICE;
   IDENTIFICATION; LOCALIZATION; PPAR-GAMMA-2
AB Peroxisome proliferator-activated receptor gamma (PPAR gamma) and runt-related transcription factor 2 (RUNX2) are key regulators of mesenchymal stem cell (MSC) differentiation toward adipocytes and osteoblasts, respectively. Post-translational modifications of these factors determine their activities. Dephosphorylation of PPAR gamma at Ser-112 is required for its adipocytic activity, whereas phosphorylation of RUNX2 at serine 319 (Ser319) promotes its osteoblastic activity. Here we show that protein phosphatase 5 (PP5) reciprocally regulates each receptor by targeting each serine. Mice deficient in PP5 phosphatase have increased osteoblast numbers and high bone formation, which results in high bone mass in the appendicular and axial skeleton. This is associated with a substantial decrease in lipid-containing marrow adipocytes. Indeed, in the absence of PP5 the MSC lineage allocation is skewed toward osteoblasts and away from lipid accumulating adipocytes, although an increase in beige adipocyte gene expression is observed. In the presence of rosiglitazone, PP5 translocates to the nucleus, binds to PPAR gamma and RUNX2, and dephosphorylates both factors, resulting in activation of PPAR gamma adipocytic and suppression of RUNX2 osteoblastic activities. Moreover, shRNA knockdown of PP5 results in cells refractory to rosiglitazone treatment. Lastly, mice deficient in PP5 are resistant to the negative effects of rosiglitazone on bone, which in wild type animals causes a 50% decrease in trabecular bone mass. In conclusion, PP5 is a unique phosphatase reciprocally regulating PPAR gamma and RUNX2 activities in marrow MSC.
C1 [Stechschulte, Lance A.] Univ Toledo Hlth Sci Campus, Dept Orthopaed Surg, Toledo, OH 43614 USA.
   [Hinds, Terry D.; Sanchez, Edwin R.; Lecka-Czernik, Beata] Univ Toledo Hlth Sci Campus, Dept Physiol & Pharmacol, Toledo, OH 43614 USA.
   [Stechschulte, Lance A.; Sanchez, Edwin R.; Lecka-Czernik, Beata] Univ Toledo Hlth Sci Campus, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA.
   [Ge, Chunxi; Franceschi, Renny T.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.
RP Lecka-Czernik, B (reprint author), Univ Toledo Hlth Sci Campus, MS1008,3000 Arlington Ave, Toledo, OH 43614 USA.
EM beata.leckaczernik@utoledo.edu
OI Stechschulte, Lance/0000-0001-9783-6194; Hinds,
   Terry/0000-0002-7599-1529
FU National Institutes of Health [DK105825, DE11723, DK70127]; American
   Diabetes Association [7-13-BS-089]
FX This work was supported, in whole or in part, by National Institutes of
   Health Grants DK105825 (to B. L.-C.), DE11723 (to R. T. F.), and DK70127
   (to E. R. S.). This work was also supported by the American Diabetes
   Association Grant 7-13-BS-089 (to B. L.-C.). The authors declare that
   they have no conflicts of interest with the contents of this article.
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Banerjee A, 2008, BIOCHEMISTRY-US, V47, P10471, DOI 10.1021/bi8011862
   Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074
   Borthwick EB, 2001, FEBS LETT, V491, P279, DOI 10.1016/S0014-5793(01)02177-9
   Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141
   Camp HS, 1997, J BIOL CHEM, V272, P10811
   Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005
   Davies TH, 2005, BIOCHEMISTRY-US, V44, P2030, DOI 10.1021/bi048503v
   Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200
   Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805
   Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09
   Ge CX, 2016, J CELL PHYSIOL, V231, P587, DOI 10.1002/jcp.25102
   Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561
   Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980
   Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010
   Hinds TD, 2011, J BIOL CHEM, V286, P42911, DOI 10.1074/jbc.M111.311662
   Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270
   Kang H, 2001, BIOCHEMISTRY-US, V40, P10485, DOI 10.1021/bi010999i
   Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318
   Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09
   Lazarenko OP, 2007, ENDOCRINOLOGY, V148, P2669, DOI 10.1210/en.2006-1587
   Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7
   Li Y, 2012, J BONE MINER RES, V27, P1263, DOI 10.1002/jbmr.1574
   Liu LC, 2012, CALCIFIED TISSUE INT, V91, P139, DOI 10.1007/s00223-012-9623-4
   Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]
   McGee-Lawrence ME, 2013, J BIOL CHEM, V288, P5291, DOI 10.1074/jbc.M112.414995
   PEREZ A, 1993, EMBO J, V12, P3171, DOI 10.1002/j.1460-2075.1993.tb05986.x
   Rahman S, 2013, ENDOCRINOLOGY, V154, P2687, DOI 10.1210/en.2012-2162
   Rzonca SO, 2004, ENDOCRINOLOGY, V145, P401, DOI 10.1210/en.2003-0746
   Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994
   Skinner J, 1997, J BIOL CHEM, V272, P22464, DOI 10.1074/jbc.272.36.22464
   Stechschulte LA, 2016, EBIOMEDICINE, V10, P174, DOI 10.1016/j.ebiom.2016.06.040
   Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672
   Yong WD, 2007, J BIOL CHEM, V282, P14690, DOI 10.1074/jbc.C700019200
   ZHENG CF, 1993, J BIOL CHEM, V268, P11435
NR 35
TC 11
Z9 11
U1 1
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 18
PY 2016
VL 291
IS 47
BP 24475
EP 24486
DI 10.1074/jbc.M116.752493
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA ED5EX
UT WOS:000388875500012
PM 27687725
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Hao, NJ
   Li, LF
   Tang, FQ
AF Hao, Nanjing
   Li, Laifeng
   Tang, Fangqiong
TI RETRACTED: Fabrication of Carbohydrate-Conjugated Fingerprintlike
   Mesoporous Silica Net for the Targeted Capture of Bacteria(Retracted
   article. See vol. 9, pg. 5671, 2017)
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article; Retracted Publication
DE carbohydrate; mesoporous silica; fingerprint; targeting bacteria
ID STAPHYLOCOCCUS-EPIDERMIDIS; NANOPARTICLES; ADHERENCE; MYCOBACTERIA;
   NANOFIBERS; SYSTEMS; GROWTH; CELLS
AB Herein, a rapid, straightforward, reliable, and low-cost strategy for targeted capture and detection of bacteria using carbohydrate-conjugated mesoporous silica structure was developed. Fingerprint-like mesoporous silica net (FMSN) with well-defined three-dimensional architecture and ordered morphology was first facilely synthesized by the aid of tetrabutylammonium iodine (TBAI) as cotemplates with cetyltrimethylammonium bromide (CTAB). When conjugated with maltoheptaose as targeting moiety, FMSN showed efficient and selective capturing capability of Staphylococcus epidermidis. This new and unique platform for capturing S. epidermidis is fast (within 18 min), high efficiency (greater than 98.6% from 1 X 10(3) CFU/mL to 1 X 10(8) CFU/mL), specific (compared to M. smegmatis mc(2) 155), and reusable (6 cycles).
C1 [Hao, Nanjing] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.
   [Hao, Nanjing; Li, Laifeng; Tang, Fangqiong] Chinese Acad Sci, Tech Inst Phys & Chem, Beijing 100190, Peoples R China.
RP Hao, NJ (reprint author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.; Hao, NJ; Tang, FQ (reprint author), Chinese Acad Sci, Tech Inst Phys & Chem, Beijing 100190, Peoples R China.
EM nanjing.hao@dartmouth.edu; tangfq@mail.ipc.ac.cn
FU National Science Foundation of China [81171454]
FX The authors thank the financial support from the National Science
   Foundation of China (81171454). Dr. Nanjing Hao thanks Prof. Mingdi Yan
   (University of Massachusetts Lowell, MA, U.S.A.) for her kindly
   discussion and revision of this manuscript. Dr. Nanjing Hao also thanks
   Prof. John Xiaojing Zhang for his support in Dartmouth College, NH,
   U.S.A.
CR CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Dichosa AEK, 2014, NAT PROTOC, V9, P608, DOI 10.1038/nprot.2014.034
   Hao NJ, 2016, ACS APPL MATER INTER, V8, P29208, DOI 10.1021/acsami.6b10051
   Hao NJ, 2016, BIOMATER SCI-UK, V4, P575, DOI 10.1039/c5bm00589b
   Hao NJ, 2015, ADV HEALTHC MATER, V4, P2797, DOI 10.1002/adhm.201500491
   Hao NJ, 2016, BIOMATER SCI-UK, V4, P87, DOI 10.1039/c5bm00197h
   Hao NJ, 2016, BIOSENS BIOELECTRON, V76, P113, DOI 10.1016/j.bios.2015.07.031
   Hao NJ, 2015, ACS APPL MATER INTER, V7, P1040, DOI 10.1021/am508219g
   Hao NJ, 2014, J BIOMED NANOTECHNOL, V10, P2508, DOI 10.1166/jbn.2014.1940
   Jiang XR, 2014, LAB CHIP, V14, P671, DOI 10.1039/c3lc50977j
   JONES D, 1963, J BACTERIOL, V85, P62
   Kleitz F, 2001, CHEM MATER, V13, P3587, DOI 10.1021/cm0110324
   Koo OK, 2009, ANAL CHEM, V81, P3094, DOI 10.1021/ac9000833
   Laurino P, 2011, NANO LETT, V11, P73, DOI 10.1021/nl102821f
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Marradi M, 2013, CHEM SOC REV, V42, P4728, DOI 10.1039/c2cs35420a
   Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182
   Pastore HO, 1999, MICROPOR MESOPOR MAT, V32, P211, DOI 10.1016/S1387-1811(99)00108-0
   Platschek B, 2006, ANGEW CHEM INT EDIT, V45, P1134, DOI 10.1002/anie.200503301
   Ritter TK, 2001, ANGEW CHEM INT EDIT, V40, P3508, DOI 10.1002/1521-3773(20011001)40:19<3508::AID-ANIE3508>3.0.CO;2-I
   RUPP ME, 1992, INFECT IMMUN, V60, P4322
   Safavieh M, 2014, BIOSENS BIOELECTRON, V58, P101, DOI 10.1016/j.bios.2014.02.002
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Tseng YT, 2011, BIOSENS BIOELECTRON, V27, P95, DOI 10.1016/j.bios.2011.06.021
   Wang JF, 2004, CHEM MATER, V16, P5169, DOI 10.1021/cm049028q
   Wang JF, 2003, J AM CHEM SOC, V125, P13966, DOI 10.1021/ja036967v
   Xiao CH, 2012, NATURE, V487, P349, DOI 10.1038/nature11230
   Yang K, 2010, NAT NANOTECHNOL, V5, P579, DOI [10.1038/NNANO.2010.141, 10.1038/nnano.2010.141]
NR 28
TC 2
Z9 2
U1 10
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD NOV 16
PY 2016
VL 8
IS 45
BP 30683
EP 30686
DI 10.1021/acsami.6b10989
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EC8YS
UT WOS:000388429600005
PM 27934250
DA 2018-12-27
ER

PT J
AU Aratani, S
   Fujita, H
   Kuroiwa, Y
   Usui, C
   Yokota, S
   Nakamura, I
   Nishioka, K
   Nakajima, T
AF Aratani, Satoko
   Fujita, Hidetoshi
   Kuroiwa, Yoshiyuki
   Usui, Chie
   Yokota, Shumpei
   Nakamura, Ikuro
   Nishioka, Kusuki
   Nakajima, Toshihiro
TI RETRACTED: Murine hypothalamic destruction with vascular cell apoptosis
   subsequent to combined administration of human papilloma virus vaccine
   and pertussis toxin (Retracted article. See vol. 8, artn. 46971, 2018)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ENHANCER-BINDING PROTEIN;
   BENIGN HEREDITARY CHOREA; LOCOMOTION; BRAIN; WOMEN; GENE; IMMUNIZATION;
   HYPOTENSION; MODULATION
AB Vaccination is the most powerful way to prevent human beings from contracting infectious diseases including viruses. In the case of the human papillomavirus (HPV) vaccine, an unexpectedly novel disease entity, HPV vaccination associated neuro-immunopathetic syndrome (HANS), has been reported and remains to be carefully verified. To elucidate the mechanism of HANS, we applied a strategy similar to the active experimental autoimmune encephalitis (EAE) model - one of the most popular animal models used to induce maximum immunological change in the central nervous system. Surprisingly, mice vaccinated with pertussis toxin showed neurological phenotypes that include low responsiveness of the tail reflex and locomotive mobility. Pathological analyses revealed the damage to the hypothalamus and circumventricular regions around the third ventricle, and these regions contained apoptotic vascular endothelial cells. These data suggested that HPV-vaccinated donners that are susceptible to the HPV vaccine might develop HANS under certain environmental factors. These results will give us the new insight into the murine pathological model of HANS and help us to find a way to treat of patients suffering from HANS.
C1 [Aratani, Satoko; Fujita, Hidetoshi; Yokota, Shumpei; Nishioka, Kusuki; Nakajima, Toshihiro] Tokyo Med Univ, Inst Med Sci, Shinjuku Ku, Tokyo, Japan.
   [Aratani, Satoko; Fujita, Hidetoshi; Nakajima, Toshihiro] Tokyo Med Univ, Dept Future Med Sci, Shinjuku Ku, Tokyo, Japan.
   [Aratani, Satoko] Tokyo Med Univ, Phys Student & Researcher Support Ctr, Tokyo, Japan.
   [Kuroiwa, Yoshiyuki] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Dept Neurol, Kawasaki, Kanagawa, Japan.
   [Kuroiwa, Yoshiyuki] Teikyo Univ, Sch Med, Mizonokuchi Hosp, Stroke Ctr, Kawasaki, Kanagawa, Japan.
   [Usui, Chie] Juntendo Univ, Nerima Hosp, Dept Psychiat, Nerima Ku, Tokyo, Japan.
   [Nakamura, Ikuro] Japan Med Res Fdn, Chiyoda Ku, Tokyo, Japan.
   [Nakajima, Toshihiro] Tokyo Med Univ Hosp, IGES, Shinjuku Ku, Tokyo, Japan.
RP Nakajima, T (reprint author), Tokyo Med Univ, Inst Med Sci, Shinjuku Ku, Tokyo, Japan.; Nakajima, T (reprint author), Tokyo Med Univ, Dept Future Med Sci, Shinjuku Ku, Tokyo, Japan.; Nakajima, T (reprint author), Tokyo Med Univ Hosp, IGES, Shinjuku Ku, Tokyo, Japan.
EM marlin@tokyo-med.ac.jp
FU Health Labour Sciences Research Grant; Japan Society for the Promotion
   of Science KAKENHI [26461476]; Strategic Research Foundation at Private
   Universities [S1411011]; Supporting Positive Activities for Female
   Researchers
FX We thank N. Yagishita and Y. Yamano for discussion and S. Shibata and H.
   Iobe for the technical assistance. We also thank all members of Dr.
   Nakajima's laboratory and Medical Research Center of Tokyo medical
   University Hospital. This work was supported in part by Health Labour
   Sciences Research Grant, Japan Society for the Promotion of Science
   KAKENHI (Grant Number 26461476), the Strategic Research Foundation at
   Private Universities (S1411011) and Supporting Positive Activities for
   Female Researchers.
CR Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0
   Asmus F, 2007, MOVEMENT DISORD, V22, P2104, DOI 10.1002/mds.21692
   Bains JS, 2015, NAT REV NEUROSCI, V16, P377, DOI 10.1038/nrn3881
   Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190
   Bedoui S, 2003, J IMMUNOL, V171, P3451, DOI 10.4049/jimmunol.171.7.3451
   Brinth L, 2015, DAN MED J, V62
   Cerpa-Cruz SS, 2013, IMMUNOL RES, V56, P299, DOI 10.1007/s12026-013-8400-4
   Dafny N, 1996, NEUROSCIENCE, V70, P449, DOI 10.1016/0306-4522(95)00358-4
   de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5
   Deacon Robert M J, 2013, J Vis Exp, DOI 10.3791/2610
   Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2609
   ELDRIDGE FL, 1981, SCIENCE, V211, P844, DOI 10.1126/science.7466362
   HARPER DM, 2010, J VACCINES VACCIN, V1, DOI DOI 10.4172/2157-7560.1000107
   Hinsey JC, 1928, J COMP NEUROL, V46, P461, DOI 10.1002/cne.900460204
   Hirai T., 2016, AUTONOMIC NERVOUS SY, V53, P49
   Hoffmann J, 2013, CURR OPIN NEUROL, V26, P240, DOI 10.1097/WCO.0b013e328360eccc
   Hofstetter HH, 2002, J IMMUNOL, V169, P117, DOI 10.4049/jimmunol.169.1.117
   Jeong Y, 2009, NEUROSCIENCE, V159, P1414, DOI 10.1016/j.neuroscience.2009.02.006
   Kawano H, 2003, EXP NEUROL, V182, P103, DOI 10.1016/S0014-4886(03)00030-X
   Khan MJ, 2005, J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187
   KIKKAWA F, 1990, MOL CELL BIOL, V10, P6216, DOI 10.1128/MCB.10.12.6216
   Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60
   Kinoshita T, 2014, INTERNAL MED, V53, P2185, DOI 10.2169/internalmedicine.53.3133
   Kleiner-Fisman Galit, 2011, Handb Clin Neurol, V100, P199, DOI 10.1016/B978-0-444-52014-2.00012-4
   Kugler S, 2007, CELL MICROBIOL, V9, P619, DOI 10.1111/j.1462-5822.2006.00813.x
   LAMMERS JHCM, 1988, BRAIN RES, V449, P294, DOI 10.1016/0006-8993(88)91045-1
   Langer-Gould A, 2014, JAMA NEUROL, V71, P1506, DOI 10.1001/jamaneurol.2014.2633
   LAZZARO D, 1991, DEVELOPMENT, V113, P1093
   Limaye K, 2016, ACTA NEUROL BELG, V116, P119, DOI 10.1007/s13760-015-0577-y
   Magno L, 2009, BRAIN RES, V1304, P164, DOI 10.1016/j.brainres.2009.09.050
   Malt EA, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00059
   Marin O, 2000, J NEUROSCI, V20, P6063
   Mastronardi C, 2006, J NEUROSCI, V26, P13167, DOI 10.1523/JNEUROSCI.4238-06.2006
   MIZUNO K, 1991, MOL CELL BIOL, V11, P4927, DOI 10.1128/MCB.11.10.4927
   Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534
   Nishioka K, 2014, INT J RHEUM DIS S2, V17, P6
   Palmieri B, 2017, IMMUNOL RES, V65, P106, DOI 10.1007/s12026-016-8820-z
   Schievink WI, 2000, J NEUROSURG, V92, P475, DOI 10.3171/jns.2000.92.3.0475
   Shoenfeld Y, 2011, J AUTOIMMUN, V36, P4, DOI 10.1016/j.jaut.2010.07.003
   SINNAMON HM, 1993, PROG NEUROBIOL, V41, P323, DOI 10.1016/0301-0082(93)90003-B
   Stevens FL, 2011, J NEUROPSYCH CLIN N, V23, P120, DOI 10.1176/appi.neuropsych.23.2.121
   Veneziano L, 2014, CEREBELLUM, V13, P588, DOI 10.1007/s12311-014-0570-7
   Villa LL, 2007, INT J INFECT DIS, V11, pS17, DOI 10.1016/S1201-9712(07)60017-4
   Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
   Yokota S., 2015, JAPAN MED J, V4758, P46
NR 45
TC 11
Z9 11
U1 5
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD NOV 11
PY 2016
VL 6
AR 6943
DI 10.1038/srep36943
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EB7SN
UT WOS:000387590700001
PM 27833142
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Hao, NJ
   Li, LF
   Tang, FQ
AF Hao, Nanjing
   Li, Laifeng
   Tang, Fangqiong
TI RETRACTED: BSA Protein-Mediated Synthesis of Hollow Mesoporous Silica
   Nanotubes, and Their Carbohydrate Conjugates for Targeting Cancer Cells
   and Detecting Mycobacteria (Retracted article. See vol. 9, pg. 5670,
   2017)
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article; Retracted Publication
DE carbohydrate; hollow mesoporous silica; targeting detection;
   mycobacteria
ID ESCHERICHIA-COLI; CELLULAR UPTAKE; NANOPARTICLES; FUNCTIONALIZATION;
   FLUORESCENT; NANODOTS; PATHWAY; GROWTH
AB A straightforward method was developed to synthesize hollow mesoporous silica nanotubes (HMSNTs) using bovine serum protein (BSA) as the protective coating and phosphate buffered saline (PBS) as the etching agent at room temperature. Galactose-grafted HMSNTs significantly reduced phagocytosis by macrophages, and enhanced cellular uptake by A549 cells via caveolae-mediated uptake pathway. Trehalose-conjugated HMSNTs interacted strongly with mycobacteria, showing the linear detection range from 1 x 10(4) to 1 x 10(8) bacteria/mL and the detection limit of 1 x 10(3) bacteria/mL. In all cases, the hollow nanotube structure showed higher cellular uptake, bacterial binding, and detection efficiency than their spherical counterpart.
C1 [Hao, Nanjing; Li, Laifeng; Tang, Fangqiong] Chinese Acad Sci, Tech Inst Phys & Chem, Beijing 100190, Peoples R China.
   [Hao, Nanjing] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.
RP Hao, NJ; Tang, FQ (reprint author), Chinese Acad Sci, Tech Inst Phys & Chem, Beijing 100190, Peoples R China.; Hao, NJ (reprint author), Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA.
EM nanjing.hao@dartmouth.edu; tangfq@mail.ipc.ac.cn
FU National Science Foundation of China [81171454]
FX The authors thank the National Science Foundation of China (81171454)
   for the financial support. Dr. Nanjing Hao thanks Prof. Mingdi Yan
   (University of Massachusetts Lowell, MA, U.S.A.) for her kind discussion
   and revision of this manuscript. Dr. Nanjing Hao also thanks Prof. John
   Xiaojing Zhang for his support at Dartmouth College, NH, U.S.A.
CR Bian SW, 2009, CHEM COMMUN, P1261, DOI 10.1039/b821196e
   Chen CT, 2008, ADV FUNCT MATER, V18, P527, DOI 10.1002/adfm.200700449
   Chen S, 2013, ADV HEALTHC MATER, V2, P1091, DOI 10.1002/adhm.201200374
   Chen XC, 2012, ACS APPL MATER INTER, V4, P2303, DOI 10.1021/am300469r
   Fan Y, 2015, BIOSENS BIOELECTRON, V67, P230, DOI 10.1016/j.bios.2014.08.021
   Garcia I, 2015, J AM CHEM SOC, V137, P3686, DOI 10.1021/jacs.5b01001
   Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007
   Hao N, 2017, INT MATER REV, V62, P57, DOI 10.1080/09506608.2016.1190118
   Hao NJ, 2016, BIOMATER SCI-UK, V4, P575, DOI 10.1039/c5bm00589b
   Hao NJ, 2015, ADV HEALTHC MATER, V4, P2797, DOI 10.1002/adhm.201500491
   Hao NJ, 2016, BIOSENS BIOELECTRON, V76, P113, DOI 10.1016/j.bios.2015.07.031
   Hao NJ, 2015, ACS APPL MATER INTER, V7, P1040, DOI 10.1021/am508219g
   Hao NJ, 2012, MICROPOR MESOPOR MAT, V162, P14, DOI 10.1016/j.micromeso.2012.05.040
   Huang CC, 2009, ANAL CHEM, V81, P875, DOI 10.1021/ac8010654
   Hudson S, 2008, ANGEW CHEM INT EDIT, V47, P8582, DOI 10.1002/anie.200705238
   Indrigo J, 2003, MICROBIOL-SGM, V149, P2049, DOI 10.1099/mic.0.26226-0
   Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106
   Kuo PL, 2012, J BIOL CHEM, V287, P9753, DOI 10.1074/jbc.M111.321190
   Liu L, 2006, ANGEW CHEM INT EDIT, V45, P6207, DOI 10.1002/anie.200602097
   Liu LH, 2010, ACCOUNTS CHEM RES, V43, P1434, DOI 10.1021/ar100066t
   Nan AJ, 2008, NANO LETT, V8, P2150, DOI 10.1021/nl0802741
   Park J, 2013, ACCOUNTS CHEM RES, V46, P181, DOI 10.1021/ar300172h
   SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603
   Trewyn BG, 2008, CHEM ENG J, V137, P23, DOI 10.1016/j.cej.2007.09.045
   Tseng YT, 2011, BIOSENS BIOELECTRON, V27, P95, DOI 10.1016/j.bios.2011.06.021
   Wang X, 2011, CHEM COMMUN, V47, P4261, DOI 10.1039/c0cc05299j
   Yildirim A, 2011, ACS APPL MATER INTER, V3, P4159, DOI 10.1021/am201024w
   Zhang XX, 2011, MOL PHARMACEUT, V8, P758, DOI 10.1021/mp100366h
   Zhang YH, 2011, ACS APPL MATER INTER, V3, P3272, DOI 10.1021/am200908t
NR 29
TC 5
Z9 5
U1 7
U2 47
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD NOV 2
PY 2016
VL 8
IS 43
BP 29208
EP 29212
DI 10.1021/acsami.6b10051
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA EB1FP
UT WOS:000387095300003
PM 27767305
DA 2018-12-27
ER

PT J
AU Wu, ZB
   Fei, AH
   Liu, YB
   Pan, SM
AF Wu, Zengbin
   Fei, Aihua
   Liu, Yingbin
   Pan, Shuming
TI RETRACTED: Conditional Tissue-Specific Foxa2 Ablation in Mouse Pancreas
   Causes Hyperinsulinemic Hypoglycemia(Retracted article. See vol. 24, pg.
   E240, 2017)
SO AMERICAN JOURNAL OF THERAPEUTICS
LA English
DT Article; Retracted Publication
DE hyperinsulinemic hypoglycemia; Foxa2; - and -cell differentiation;
   diabetes control
ID CELLS; PDX1; GENE; DIFFERENTIATION; EXPRESSION; SECRETION
AB The forkhead/winged helix transcription factor Foxa2 is a major upstream regulator of Pdx1, a transcription factor necessary for pancreatic development. In the present study, we conditionally knocked out Foxa2 in Pdx1-expressing domain and further analyzed the contribution of Foxa2 to - and -cell development and the effect of Foxa2 deletion on plasma insulin, glucagon, and glucose levels. Homozygous pdx1(cre/+)Foxa2(FL/FL) mice and heterozygous pdx1(cre/+)Foxa2(FL/+) mice were generated by homologous recombination using a Foxa2 gene-targeting vector. - and -cell mass was examined by immunofluorescence microscopy. Plasma glucose, insulin, and plasma were measured at postnatal day 10. For pdx1 lineage tracing studies, heterozygous pdx1(cre/+)Foxa2(FL/+)EYFP(+/-) and homozygous pdx1(cre/+)Foxa2(FL/FL)EYFP(+/-) mice were used. Our immunofluorescence analysis revealed that in the pancreas sections of the homozygous mutant mice, Foxa2 was virtually absent from non- cells and its expression almost exclusively coincided with remnant cells. The density of both and cells apparently decreased in the pancreas of the heterozygous mutant mice and in the pancreas of the homozygous mutant mice, cells lost its predominance and cells increased proportionally. Direct Pdx1 cell lineage tracing revealed that, on embryonic day 18.5, in the homozygous mutant mice, Pdx1 expression coincided almost exclusively with that of insulin-secreting cells. Chemiluminescence assays revealed that heterozygous pdx1(cre/+)Foxa2(FL/+) mice had significantly lower insulin levels than control mice (P < 0.01). However, no apparent difference was observed between homozygous pdx1(cre/+)Foxa2(FL/FL) mice and control mice (P > 0.05). Chemiluminescence assays also showed that Foxa2 deletion significantly depressed plasma glucagon levels in both homozygous pdx1(cre/+)Foxa2(FL/FL) mice and heterozygous pdx1(cre/+)Foxa2(FL/+) mice (P < 0.01 vs. controls). Plasma glucose on postnatal day 10 was significantly lower in homozygous pdx1(cre/+)Foxa2(FL/FL) mice compared with control mice (P < 0.01). Our study demonstrates that homozygous Foxa2 ablation leads to an imbalance in / ratio, profound hypoglucagonemia, inappropriate hyperinsulinemia, and hypoglycemia in mice. Our conditional tissue-specific Foxa2 ablation mouse model will be useful in elucidating regulation of normal and abnormal - and -cell differentiation and pinpointing novel targets for diabetes control.
C1 [Wu, Zengbin; Fei, Aihua; Pan, Shuming] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Emergency, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.
   [Liu, Yingbin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gen Surg, Shanghai, Peoples R China.
RP Pan, SM (reprint author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Emergency, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.
EM panshuming15801@163.com
CR Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0
   Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200
   Cheng N, 2015, J BIOMED RES, V29, P241, DOI 10.7555/JBR.28.20140033
   Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608
   Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026
   Lee CS, 2002, DIABETES, V51, P2546, DOI 10.2337/diabetes.51.8.2546
   Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012
   Masson MH, 2014, ENDOCRINOLOGY, V155, P3781, DOI 10.1210/en.2013-1843
   OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x
   Oliver-Krasinski JM, 2009, J CLIN INVEST, V119, P1888, DOI 10.1172/JCI37028
   Shih David Q, 2002, Curr Diab Rep, V2, P125, DOI 10.1007/s11892-002-0071-9
   Sund NJ, 2001, GENE DEV, V15, P1706, DOI 10.1101/gad.901601
NR 12
TC 0
Z9 0
U1 5
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1075-2765
EI 1536-3686
J9 AM J THER
JI Am. J. Ther.
PD NOV-DEC
PY 2016
VL 23
IS 6
BP E1442
EP E1448
DI 10.1097/MJT.0000000000000399
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA ED2ST
UT WOS:000388699800024
PM 26882312
DA 2018-12-27
ER

PT J
AU Wang, H
AF Wang, Hui
TI RETRACTED: We Are Not Free to Choose: Class Determinism in Zadie Smith's
   NW (Retracted article. See vol. 53, pg. 199, 2018)
SO ARCADIA
LA English
DT Article; Retracted Publication
DE NW; social class; space; economic position; race
ID CASTE
AB NW by Zadie Smith opens with a multicultural and multiracial scene and revolves around the crises in the lives of four people with longstanding connection to Northwest London. The Northwest London in NW is a besieged city, and the people therein could not see any possibility of getting out because the gate has been latched with the concept of social class. In NW, the social class is materialized as space, economic position and race. Geographically NW features the main areas of London, and considers the role of that city in shaping the consciousness of the major characters, a partly spatial configuring of identity. In addition, the major characters in NW also suffer from occupational exclusion and economic exploitation, which then lead to their lower-class position since social class is constructed in such a way that agents are distributed according to their positions in the statistical distribution based on the economic and cultural capital. Finally the racial discrimination encountered by the characters in NW shows that class relations shape the form that racial oppression takes. The racialization of class issues becomes a politically effective tool for the wealthy to divide and rule the lower classes. In NW, Smith thus has adopted a more political attitude than in her previous books, so the relatively new perspective of her fiction might be the attention she draws to the persistent obstacles to class crossing and the acknowledgment of the rigid lines that still define the social classes.
C1 [Wang, Hui] Dalian Univ Foreign Languages, Sch English Studies, 6 Xiduan, Dalian 116044, Liaoning, Peoples R China.
RP Wang, H (reprint author), Dalian Univ Foreign Languages, Sch English Studies, 6 Xiduan, Dalian 116044, Liaoning, Peoples R China.
EM wanghui2004hh@163.com
CR Adair Vivyan C., 2002, SIGN            WINT, P451
   Bourdieu P., 1996, PHYS SPACE SOCIAL SP
   Brooks MR, 1946, SOC FORCES, V25, P207, DOI 10.2307/2571562
   Cox OC, 1945, AM J SOCIOL, V50, P360, DOI 10.1086/219653
   Cox Oliver Cromwell, 2001, RACISM ESSENTIAL REA, P49
   De Vos George A., 1967, JAPANS INVISIBLE RAC
   Deleuze Gilles, 2004, 1000 PLATEAUS CAPITA
   Driscoll L, 2009, EVADING CLASS IN CONTEMPORARY BRITISH LITERATURE, P61
   Eldridge Michael, 1988, TRANSITION, V74, P32
   Gilroy Paul, 2005, POSTCOLONIAL MELANCH
   Griffin LJ, 2002, AM QUART, V54, P67, DOI 10.1353/aq.2002.0003
   Guillory J., 1993, CULTURAL CAPITAL PRO
   Janowitz Anne, 1994, RETHINKING CLASS LIT, P239
   Jones G, 2003, AM LIT HIST, V15, P765, DOI 10.1093/ALH/AJG047
   Kushnick Louis, 1999, NEW INTRO POVERTY RO, P1
   Marcus D, 2013, DISSENT, V60, P67
   Melville Herman, 1995, PIERRE AMBIGUITIES
   OHara Daniel T., 1995, CRITICAL TERMS LIT S, P406
   Powaza-Kurko Barbara, 2015, PERSPECTIVES ACHIEVE, P141
   Ranney David C., 1999, NEW INTRO POVERTY RO, P39
   Smith Zadie, 2012, NEW YORK OBSERV 0409
   Smith Zadie., 2009, CHANGING MY MIND OCC
   Tew Philip, 2014, ETUDES BRITANNIQUES, V47
   Warner WL, 1936, AM J SOCIOL, V42, P234, DOI 10.1086/217391
   Wells Lynn, 2013, READING ZADIE SMITH, P97
   Wood James, 2012, NEW YORKER
   Zapata Beatriz Perez, 2014, INT STUDIES INTERDIS, V16, P83
NR 27
TC 2
Z9 2
U1 1
U2 3
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0003-7982
EI 1613-0642
J9 ARCADIA
JI Arcadia
PD NOV
PY 2016
VL 51
IS 2
SI SI
BP 385
EP 404
DI 10.1515/arcadia-2016-0029
PG 20
WC Literature
SC Literature
GA EC1QP
UT WOS:000387882200009
DA 2018-12-27
ER

PT J
AU Murana, G
   Cefarelli, M
   Kloppenburg, G
   Morshuis, WJ
   Heijmen, RH
AF Murana, Giacomo
   Cefarelli, Mariano
   Kloppenburg, Geoffrey
   Morshuis, Wim J.
   Heijmen, Robin H.
TI RETRACTED: Surgical exclusion of a saccular aneurysm within a patent
   ductus arteriosus in an adult patient with Ortner's syndrome (Retracted
   article. See vol. 13, pg. 594, 2017)
SO FUTURE CARDIOLOGY
LA English
DT Article; Retracted Publication
DE cough; ductus arteriosus; dyspnea; heart team; hoarseness of voice;
   Ortner's syndrome; pulmonary artery; rheumatic disease; systemic lupus
   erythematosus; thoracic aorta aneurysm
AB In adult the patent ductus arteriosus is a rare condition associated sometimes with lethal complications. We describe the case of a 44-year-old woman with a history of systemic lupus erythematosus admitted to our hospital with hoarseness and severe dyspnea. Clinical imaging examinations indicated a saccular aneurysm within a persistent ductus arteriosus with signs of impending rupture. Patient was not considered suitable for transcatheter closure and therefore she underwent open aortic repair. The procedure was uneventful and any significant complications occurred during postoperative course.
C1 [Murana, Giacomo; Cefarelli, Mariano; Kloppenburg, Geoffrey; Heijmen, Robin H.] St Antonius Hosp, Dept Cardiothorac Surg, Nieuwegein, Netherlands.
   [Murana, Giacomo; Cefarelli, Mariano] Univ Bologna, St Orsola Malpighi Hosp, Dept Cardiac Surg, Bologna, Italy.
   [Morshuis, Wim J.] Radboud Univ Nijmegen, Med Ctr, Dept Cardiac Surg, Nijmegen, Netherlands.
   [Heijmen, Robin H.] Acad Med Ctr, Dept Cardiothorac Surg, Amsterdam, Netherlands.
RP Cefarelli, M (reprint author), St Antonius Hosp, Dept Cardiothorac Surg, Nieuwegein, Netherlands.; Cefarelli, M (reprint author), Univ Bologna, St Orsola Malpighi Hosp, Dept Cardiac Surg, Bologna, Italy.
EM mariano.cefarelli@gmail.com
RI Morshuis, prof.W.J./L-4530-2015
CR CRISFIELD RJ, 1971, J THORAC CARDIOV SUR, V62, P243
   Djukanovic BP, 2014, CONGENIT HEART DIS, V9, P433, DOI 10.1111/chd.12164
   Dyamenahalli U, 2000, J AM COLL CARDIOL, V36, P262, DOI 10.1016/S0735-1097(00)00707-5
   LUND JT, 1991, EUR J CARDIO-THORAC, V5, P566, DOI 10.1016/1010-7940(91)90220-E
   Ohmi M, 2002, Kyobu Geka, V55, P149
NR 5
TC 2
Z9 2
U1 0
U2 0
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1479-6678
EI 1744-8298
J9 FUTUR CARDIOL
JI Futur. Cardiol.
PD NOV
PY 2016
VL 12
IS 6
BP 613
EP 616
DI 10.2217/fca-2016-0034
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA EB3JC
UT WOS:000387259400004
PM 27759427
DA 2018-12-27
ER

PT J
AU Cai, ZY
   Liu, JD
   Bian, HL
   Cai, JL
   Guo, XR
AF Cai, Zhiyong
   Liu, Jindi
   Bian, Hongliang
   Cai, Jinlan
   Guo, Xirong
TI RETRACTED: MiR-455 enhances adipogenic differentiation of 3T3-L1 cells
   through targeting uncoupling protein-1(Retracted article. See vol. 72,
   pg. 192, 2017)
SO PHARMAZIE
LA English
DT Article; Retracted Publication
ID BROWN ADIPOCYTES; PROTEIN-1 UCP1; MICRORNAS; OBESITY; EXPRESSION; CANCER
AB Accumulating evidence suggests that microRNAs (miRNAs) play an important role in regulating the pathways in adipose tissue that control processes such as adipogenesis, insulin resistance, and inflammation. Adipogenic differentiation of preadipocytes is a complex process regulated by various factors including miRNAs and cytokines. MiR-455 is a well-known miRNA that enhances adipogenesis. Uncoupling protein-1 (UCP-1), a heparin binding growth factor, plays a negative role in adipogenesis. In this investigation, we demonstrate that UCP-1 is a target gene of miR-455 during adipogenic differentiation in 3T3-L1 preadipocytes. MiR-455 downregulates UCP-1 expression through interaction with a target site of miR-455 in the coding region of mouse UCP-1. The rare codons upstream of the target site regulate miR-455-induced translational knockdown of UCP-1, which provides more insight into the mechanism of adipogenic differentiation. Thus, these results suggest that the acceerative adipogenic effect of miR-455 in 3T3-L1 cells is due, at least in part, to suppression of UCP-1.
C1 [Cai, Zhiyong; Guo, Xirong] Nanjing Med Univ, Inst Pediat, Nanjing 211166, Jiangsu, Peoples R China.
   [Cai, Zhiyong; Liu, Jindi; Bian, Hongliang; Cai, Jinlan] Yancheng Matern & Child Hlth Care Hosp, Newborn Dept, Yancheng, Peoples R China.
   [Guo, Xirong] Nanjing Med Univ, Nanjing Matern & Child Hlth Care Hosp, Dept Children Hlth Care, Nanjing, Jiangsu, Peoples R China.
RP Guo, XR (reprint author), Nanjing Med Univ, Inst Pediat, Nanjing 211166, Jiangsu, Peoples R China.
EM gxlnjmu@126.com
CR Abente EJ, 2016, ARCH BIOCHEM BIOPHYS, V589, P108, DOI 10.1016/j.abb.2015.09.018
   Alexander R, 2011, EXPERT OPIN THER TAR, V15, P623, DOI 10.1517/14728222.2011.561317
   Brondani LD, 2012, ARQ BRAS ENDOCRINOL, V56, P215, DOI 10.1590/S0004-27302012000400001
   Chai J, 2015, TUMOR BIOL, V36, P1313, DOI 10.1007/s13277-014-2766-3
   Clarke KJ, 2012, BBA-BIOENERGETICS, V1817, P1759, DOI 10.1016/j.bbabio.2012.03.035
   Del Mar Gonzalez-Barroso M, 2000, Obes Rev, V1, P61, DOI 10.1046/j.1467-789x.2000.00009.x
   Giorgino F, 2005, ACTA PHYSIOL SCAND, V183, P13, DOI 10.1111/j.1365-201X.2004.01385.x
   Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098
   Lo KA, 2013, BIOSCIENCE REP, V33, DOI DOI 10.1042/BSR20130046
   Peng LP, 2015, MOL CELL BIOCHEM, V405, P73, DOI 10.1007/s11010-015-2397-z
   Porras A, 2002, FEBS LETT, V520, P58, DOI 10.1016/S0014-5793(02)02762-X
   Shi C., 2016, ONCOTARGET
   Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65
   Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621
   Zhang HB, 2015, EMBO REP, V16, P1378, DOI 10.15252/embr.201540837
NR 15
TC 3
Z9 3
U1 6
U2 11
PU GOVI-VERLAG  PHARMAZEUTISCHER VERLAG GMBH
PI ESCHBORN
PA PHARMAZEUTISCCARL MANNICH STR 26, D-65760 ESCHBORN, GERMANY
SN 0031-7144
J9 PHARMAZIE
JI Pharmazie
PD NOV
PY 2016
VL 71
IS 11
BP 625
EP 628
DI 10.1691/ph.2016.6734
PG 4
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA EB9SM
UT WOS:000387737400002
PM 29441965
DA 2018-12-27
ER

PT J
AU Ye, JC
   Qin, Y
   Wu, YF
   Wang, P
   Tang, Y
   Huang, L
   Ma, MJ
   Zeng, YS
   Shen, HY
AF Ye, J-c
   Qin, Y.
   Wu, Y-f
   Wang, P.
   Tang, Y.
   Huang, L.
   Ma, M-j
   Zeng, Y-s
   Shen, H-y
TI RETRACTED: Using primate neural stem cells cultured in self-assembling
   peptide nanofiber scaffolds to repair injured spinal cords in rats
   (Retracted article. See vol. 56, pg. 90, 2018)
SO SPINAL CORD
LA English
DT Article; Retracted Publication
ID TRANSPLANTATION
AB Study design: Transplanted primates' neural stem cells (NSCs) tissue engineering complex into spinal cord injury (SCI) model rats, analyze and evaluate the long-term effects of repairing.
   Objectives: Primate NSCs were cultured in self-assembling peptide nanofiber scaffolds to repair SCI.
   Setting: Sun Yat-sen Memorial Hospital, Guangzhou, China.
   Methods: Primate NSCs were isolated and cultured in self-assembling peptide nanofiber scaffolds. T10 SCI model was established; the rats were randomly divided into four groups: NSC plus self-assembling peptide scaffold group; NSC group; self-assembling peptide scaffold group; and control group. Immunohistochemical staining and electronic microscope were used to investigate the growth and differentiation of transplanted NSCs. The motor function of the hind limbs of rats was evaluated (P<0.05 was considered as statistically significant).
   Results: NSCs and NSCs cultured in self-assembling peptide nanofiber scaffolds could be induced to differentiation into neurons, glial cells and oligodendrocytes in vitro. The primate NSC culture was established in self-assembling peptide scaffolds. No significant difference was seen in the differentiation rate between primate NSCs cultured in self-assembling peptide nanofiber scaffolds and primate NSCs cultured in regular medium. The motor function of the hind limbs in the NSC plus self-assembling peptide scaffold group was significantly better than that of the other three groups. In addition, the NSCs of the NSC group mainly differentiated into astrocytes.
   Conclusion: Transplantation of primate NSCs cultured in self-assembling peptide scaffolds is efficient for repairing the injured spinal cord and for improving the motor function of spinal cord in rats.
C1 [Ye, J-c; Qin, Y.; Wang, P.; Tang, Y.; Huang, L.; Ma, M-j; Shen, H-y] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, 107 Yanjiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.
   [Qin, Y.] Zhuhai Peoples Hosp, Dept Orthoped, Zhuhai, Peoples R China.
   [Wu, Y-f] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Biotherapy Ctr, Guangzhou, Guangdong, Peoples R China.
   [Zeng, Y-s] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Histol & Embryol, Guangzhou, Guangdong, Peoples R China.
RP Shen, HY (reprint author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, 107 Yanjiang West Rd, Guangzhou 510120, Guangdong, Peoples R China.
EM shyshenhuiyong@163.com
FU National Natural Science Foundation of China [U1301223]; Science and
   Technology Office of Guangdong Province [2011B031800019]
FX This work was supported by grants from the National Natural Science
   Foundation of China (No. U1301223), Science and Technology Office of
   Guangdong Province (No. 2011B031800019).
CR Akiyama Y, 2001, EXP NEUROL, V167, P27, DOI 10.1006/exnr.2000.7539
   Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343
   Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595
   Domingo A, 2012, J NEUROTRAUM, V29, P865, DOI 10.1089/neu.2011.2052
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Kiley P, 2005, PLOS BIOL, V3, P1180, DOI 10.1371/journal.pbio.0030230
   Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341
   Ostenfeld T, 2003, ADV TECH STAND NEUR, V28, P3
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893
NR 14
TC 4
Z9 4
U1 3
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1362-4393
EI 1476-5624
J9 SPINAL CORD
JI Spinal Cord
PD NOV
PY 2016
VL 54
IS 11
BP 933
EP 941
DI 10.1038/sc.2016.36
PG 9
WC Clinical Neurology; Rehabilitation
SC Neurosciences & Neurology; Rehabilitation
GA EC2OO
UT WOS:000387962900004
PM 27001129
OA Bronze
DA 2018-12-27
ER

PT J
AU Protich, Z
   Wong, P
   Santhanam, KSV
AF Protich, Z.
   Wong, P.
   Santhanam, K. S. V.
TI RETRACTED: Composite of Zinc Using Graphene Quantum Dot Bath: A
   Prospective Material For Energy Storage (Retracted article. See vol. 5,
   pg. 8474, 2017)
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article; Retracted Publication
DE Zinc-graphene composite; Graphene quantum dots; XRD; EDAX; Contact
   angle; Cyclic voltammeby; Galvanostatic electrolysis; Fluorescence
ID DIFFUSION-COEFFICIENTS; ZN ELECTRODEPOSITION; MULTIPLE NUCLEATION;
   GLASSY-CARBON; BATTERIES; OXIDE; NANOPARTICLES; ELECTROLYTES; GROWTH;
   CELLS
AB The electrodeposition of a zinc-graphene composite has been achieved for the first time using a -graphene quantum dot (GQD) electrode. At the GQD electrode, the electrochemical reduction of zinc ion is shifted to a lesser negative potential with the complementary anodic peak due to the oxidation of the composite shifted toward a positive potential as compared to zinc ion reduction in the GQD bath. The charge ratio of anodic to cathodic peaks is one that represents a gain of nearly ten percent over the conventional Zn/Zn2+ in the energy storage systems. In galvanostatic electrolysis, the deposition of zinc -graphene composite is carried out under neutral and acidic conditions. The X-ray diffraction of the electrolytically prepared composite shows distinct features of 2 theta reflection at 8 due to (001) plane of -graphene, in addition to the characteristic reflections at 38.9 degrees,43.2 degrees, 54.3 degrees, 70.1 degrees and 90 degrees arising from Zn at (002), (100), (101), (102) and (110). A large scale preparation of the zinc -graphene composite has been achieved with a zinc plate as the working electrode in the GQD bath. The thermogravimetric analysis (TGA) of the composite shows a distinct weight loss that is due to breakdown of the composite. The interaction of GQD with zinc ion has been examined by fluorescence spectroscopy that shows quenching of the fluorescence of GQD. Scanning electron microscopy and energy dispersion X-ray analysis (EDAX) shows a string-like structure with peaks for carbon and zinc in EDAX. The electrochemical data on zinc/zinc-graphene composite reveals that it functions ideally as a charge storage material. Contact angle measurements reveal it to have hydrophilicity.
C1 [Protich, Z.; Wong, P.; Santhanam, K. S. V.] Rochester Inst Technol, Sch Chem & Mat Sci, Rochester, NY 14623 USA.
   [Wong, P.] Rochester Inst Technol, Dept Chem Engn, Rochester, NY 14623 USA.
RP Santhanam, KSV (reprint author), Rochester Inst Technol, Sch Chem & Mat Sci, Rochester, NY 14623 USA.
EM ksssch@rit.edu
FU National Science Foundation [1335927]
FX The authors are thankful to Mr. Tom Murphy of Hoeganaes Corp. for help
   with the interpretation of the SEM and EDAX of the zinc graphene
   composite and Prof. S. K. Gupta for XRD recordings. We also thank Prof.
   S. Williams, Mr. A. Jaikumar, and Prof. S. Kandlikar for their interest
   in this work. The authors gratefully acknowledge the financial support
   provided by the National Science Foundation under Award No. 1335927.
CR ALBRIGHT JG, 1975, J SOLUTION CHEM, V4, P809, DOI 10.1007/BF00650537
   Arabagi V., 2013, 2013 IEEE INT C ROB
   Banik SJ, 2013, J ELECTROCHEM SOC, V160, pD519, DOI 10.1149/2.040311jes
   Bapu GNKR, 1998, J SOLID STATE ELECTR, V3, P48
   Bard A. J., 2000, ELECTROCHEMICAL METH
   CATHRO KJ, 1992, J ELECTROCHEM SOC, V139, P2186, DOI 10.1149/1.2221200
   CATHRO KJ, 1987, J POWER SOURCES, V19, P337, DOI 10.1016/0378-7753(87)87009-X
   CHEN YWD, 1982, J ELECTROCHEM SOC, V129, P61, DOI 10.1149/1.2123793
   Cheng YH, 2014, J POWER SOURCES, V249, P435, DOI 10.1016/j.jpowsour.2013.10.115
   Companys E, 2008, J AGR FOOD CHEM, V56, P8296, DOI 10.1021/jf8013475
   de Leon CP, 2006, J POWER SOURCES, V160, P716, DOI 10.1016/j.jpowsour.2006.02.095
   de Leon C. Ponce, 2009, ENCY ELECTROCHEMICAL, P487, DOI 10.1016/B978-044452745-5.00856-X
   Dong XL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06916
   El-Hallag I.S., 2010, J CHIL CHEM SOC, V55, P3
   Fang XL, 2014, ELECTROCHIM ACTA, V137, P634, DOI 10.1016/j.electacta.2014.06.075
   Fischer H., 1954, ELEKTROLYTISCHE ABSE
   GALUS Z, 1984, PURE APPL CHEM, V56, P635, DOI 10.1351/pac198456050635
   Geduld H. H., 1998, ZINCATE ALKALINE NON, P90
   Gomes A, 2006, ELECTROCHIM ACTA, V52, P863, DOI 10.1016/j.electacta.2006.06.025
   Habiba K, 2013, CARBON, V64, P341, DOI 10.1016/j.carbon.2013.07.084
   Harting K, 2012, Z PHYS CHEM, V226, P151, DOI 10.1524/zpch.2012.0152
   Hromadova M, 2001, J PHYS CHEM A, V105, P104, DOI 10.1021/jp002299d
   HUBBARD AT, 1990, LANGMUIR, V6, P97, DOI 10.1021/la00091a014
   Hyde ME, 2003, J ELECTROANAL CHEM, V549, P1, DOI 10.1016/S0022-0728(03)00250-X
   Jaikumar A., 2015, ECS Transactions, V66, P55, DOI 10.1149/06630.0055ecst
   Jugovic BZ, 2006, ELECTROCHIM ACTA, V51, P6268, DOI 10.1016/j.electacta.2006.04.009
   KOSEK JA, 1988, J POWER SOURCES, V22, P293, DOI 10.1016/0378-7753(88)80024-7
   Leung PK, 2011, ELECTROCHIM ACTA, V56, P6536, DOI 10.1016/j.electacta.2011.04.111
   Li MC, 2007, J SOLID STATE ELECTR, V11, P549, DOI 10.1007/s10008-006-0194-z
   Li PC, 2015, J POWER SOURCES, V298, P102, DOI 10.1016/j.jpowsour.2015.08.051
   Li YG, 2014, CHEM SOC REV, V43, P5257, DOI 10.1039/c4cs00015c
   Liu QH, 2010, ELECTROCHEM COMMUN, V12, P1634, DOI 10.1016/j.elecom.2010.09.013
   Liu XF, 2014, J MATER RES, V29, P1401, DOI 10.1557/jmr.2014.145
   Loto C.A., 1991, CORROS PREV CONTROL, V39, P82
   MADER MJ, 1986, J ELECTROCHEM SOC, V133, P1297, DOI 10.1149/1.2108857
   Mason B., 1952, PRINCIPLES GEOCHEMIS
   MCBREEN J, 1983, J ELECTROCHEM SOC, V130, P1667, DOI 10.1149/1.2120059
   Moron LE, 2009, INT J ELECTROCHEM SC, V4, P1735
   Novak P, 1997, CHEM REV, V97, P207, DOI 10.1021/cr941181o
   Peng F, 2016, INT J ELECTROCHEM, DOI 10.1155/2016/3212703
   Protich Z, 2016, J ELECTROCHEM SOC, V163, pE166, DOI 10.1149/2.0961606jes
   Pushpavanam J., 1986, PLAT SURF FINISH, V73, P47
   Putt R., 1979, EM1059 EPRI
   Rana SB, 2010, J OPTOELECTRON ADV M, V12, P257
   Roding M, 2014, J PHYS CHEM C, V118, P30282, DOI 10.1021/jp510436r
   SANTHANAM KSV, 1993, TRENDS POLYM SCI, V1, P284
   Santhanam SVK, 2016, US Patent Application, Patent No. 20160017502
   SCHARIFKER B, 1983, ELECTROCHIM ACTA, V28, P879, DOI 10.1016/0013-4686(83)85163-9
   Schlesinger M., 2000, ELECTRODEPOSITION ZI, P423
   Shanmugasigamani, 2006, J APPL ELECTROCHEM, V36, P315, DOI 10.1007/s10800-005-9076-9
   Shi XH, 2014, ACS APPL MATER INTER, V6, P2568, DOI 10.1021/am405012k
   Simonin JP, 2016, J MOL LIQ, V215, P69, DOI 10.1016/j.molliq.2015.12.020
   Sun MX, 2015, J CLEAN PROD, V107, P775, DOI 10.1016/j.jclepro.2015.05.081
   Taguchi AD, 2008, J BRAZIL CHEM SOC, V19, P727, DOI 10.1590/S0103-50532008000400017
   Taherian F, 2013, LANGMUIR, V29, P1457, DOI 10.1021/la304645w
   Talam Satyanarayana, 2012, ISRN Nanotechnology, DOI 10.5402/2012/372505
   Wang GG, 2011, MATER LETT, V65, P3095, DOI 10.1016/j.matlet.2011.06.096
   Weber AZ, 2011, J APPL ELECTROCHEM, V41, P1137, DOI 10.1007/s10800-011-0348-2
   Weber AZ, 2004, CHEM REV, V104, P4679, DOI 10.1021/cr020729l
   Wei N, 2014, LANGMUIR, V30, P3572, DOI 10.1021/la500513x
   Wu JL, 2010, APPL SURF SCI, V256, P2826, DOI 10.1016/j.apsusc.2009.11.034
   Xiao XY, 2007, J AM CHEM SOC, V129, P9610, DOI 10.1021/ja072344w
   Yang HT, 2010, LANGMUIR, V26, P12598, DOI 10.1021/la1021643
   Yang ZG, 2011, CHEM REV, V111, P3577, DOI 10.1021/cr100290v
   Yao W, 2016, ELECTROCHIM ACTA, V210, P783, DOI 10.1016/j.electacta.2016.06.002
   Yu JX, 2002, RUSS J ELECTROCHEM+, V38, P321, DOI 10.1023/A:1014751327614
   Zeleny J, 1914, PHYS REV, V3, P69, DOI 10.1103/PhysRev.3.69
   Zheng WT, 2009, J PHYS CHEM C, V113, P9164, DOI 10.1021/jp900881q
   Zhu YW, 2006, ADV MATER, V18, P587, DOI 10.1002/adma.200501918
NR 69
TC 7
Z9 7
U1 6
U2 46
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD NOV
PY 2016
VL 4
IS 11
BP 6177
EP 6185
DI 10.1021/acssuschemeng.6b01794
PG 9
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA EB5PO
UT WOS:000387428700044
DA 2018-12-27
ER

PT J
AU De Aza, PN
   de Val, JEMS
   Baudin, C
   Albacete-Martinez, CP
   Salto, AA
   Calvo-Guirado, JL
AF De Aza, Piedad N.
   Mate-Sanchez de Val, Jose E.
   Baudin, Carmen
   Perez Albacete-Martinez, Carlos
   Armijo Salto, Antonio
   Calvo-Guirado, Jose L.
TI RETRACTED: Bone neoformation of a novel porous resorbable Si-Ca-P-based
   ceramic with osteoconductive properties: physical and mechanical
   characterization, histological and histomorphometric study (Retracted
   article. See vol. 29, pg. 537, 2018)
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Retracted Publication
DE bioceramics; biocompatibility; bone response; calcium silicophosphate;
   histology; mechanical properties
ID ALPHA-TRICALCIUM PHOSPHATE; IN-VITRO BEHAVIOR; DICALCIUM SILICATE;
   SYSTEM CA-3(PO4)(2)-CA2SIO4; ELECTRON-MICROSCOPY; CA2SIO4-CA-3(PO4)(2);
   BIOCERAMICS; VIVO; BIOEUTECTIC(R); PROLIFERATION
AB ObjectiveThe aims of the present work were to study a new porous Nurse's A ceramic (Si-Ca-P-based material) bone substitute and examine its mechanical properties invitro and the biocompatibility, osteoconductivity and resorption process invivo.
   Materials and methodPorous ceramic scaffolds were prepared by solid-state reaction and implanted in critical-sized defect created in 15 NZ rabbits. Strength values were determined by the diametrical compression of disk test. Weibull analyses were performed following the European Standard for technical ceramics EN-843-5: 1996, considering 90% of confidence intervals. Results were correlated with scanning microscope observations of fracture surfaces. Implanted scaffolds were characterized by histological and histomorphometric point of view.
   ResultsThe parameters of the Weibull distribution of strength, determined by diametrical compression of disks, were modulus m=13, and characteristic strength sigma(0)=0.60 MPa (90% confidence limit: m=7.2-17.6, sigma(0)=0.570-0.578). Porous calcium silicophosphate scaffolds showed significantly more bone formation in the pores and in the periphery of the implant than the control group. Histomorphometric analysis revealed that the ceramic scaffold (62.230.34*) produced higher values of bone-to-implant contact (BIC) percentages (higher quality, closer contact); moreover, defect closure was significative in relation with control group.
   ConclusionsThe porous calcium silicophosphate ceramic is biocompatible, partially resorbable and osteoinductive material. This rabbit study provides radiological and histological evidences confirming the suitablity of this new material for bone tissue regeneration on critical defects.
C1 [De Aza, Piedad N.] Univ Miguel Hernandez, Inst Bioingn, Elche 03202, Alicante, Spain.
   [Mate-Sanchez de Val, Jose E.; Perez Albacete-Martinez, Carlos; Armijo Salto, Antonio; Calvo-Guirado, Jose L.] UCAM Univ Catolica San Antonio Murcia, Fac Med & Dent, Catedra Invest Odontol, Murcia, Spain.
   [Baudin, Carmen] ICV CSIC, inst Ceram & Vidrio, Madrid, Spain.
RP De Aza, PN (reprint author), Univ Miguel Hernandez, Inst Bioingn, Elche 03202, Alicante, Spain.
EM piedad@umh.es
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018; De Aza, Piedad/A-7621-2015
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; De Aza,
   Piedad/0000-0001-9316-4407; Baudin, Carmen/0000-0002-9037-0931
FU Spanish Ministry of Economy and Competitiveness (MINECO)
   [MAT2013-48426-C2-1-R, MAT2013-48426-C2-2-R]
FX Part of this work has been supported by a Spanish Ministry of Economy
   and Competitiveness (MINECO); contract grant numbers:
   MAT2013-48426-C2-1-R and MAT2013-48426-C2-2-R.
CR AENOR, 2006, EN84352006 AENOT
   Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P55, DOI 10.1111/j.1600-0501.2009.01854.x
   Bohner M, 2009, BIOMATERIALS, V30, P6403, DOI 10.1016/j.biomaterials.2009.08.007
   Calvo-Guirado JL, 2014, CLIN ORAL IMPLAN RES, V25, P1228, DOI 10.1111/clr.12258
   Calvo-Guirado JL, 2015, CLIN ORAL IMPLAN RES, V26, P1402, DOI 10.1111/clr.12465
   CARLISLE EM, 1980, J NUTR, V110, P352
   CARLISLE EM, 1972, SCIENCE, V178, P619, DOI 10.1126/science.178.4061.619
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Carrodeguas RG, 2008, KEY ENG MATER, V361-363, P237
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   De Aza AH, 2007, J AM CERAM SOC, V90, P1200, DOI 10.1111/j.1551-2916.2007.01534.x
   De Aza PN, 2014, MATERIALS, V7, P2395, DOI 10.3390/ma7042395
   de Aza PN, 2013, MICROSC MICROANAL, V19, P1350, DOI 10.1017/S1431927613001864
   De Aza PN, 2013, MAT SCI ENG C-MATER, V33, P4009, DOI 10.1016/j.msec.2013.05.043
   de Aza PN, 1998, J MICROSC-OXFORD, V189, P145
   DeAza PN, 1997, BIOMATERIALS, V18, P1285, DOI 10.1016/S0142-9612(97)00063-X
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   EGGLI PS, 1988, CLIN ORTHOP RELAT R, P127
   Garcia-Paez IH, 2014, J MECH BEHAV BIOMED, V30, P1, DOI 10.1016/j.jmbbm.2013.10.011
   Gonzalez S, 2005, J AM CERAM SOC, V88, P2645, DOI 10.1111/j.1551-2916.2005.00483.x
   Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus
   Hench LL, 2003, GLASS TECHNOL, V44, P1
   JASTY M, 1989, SCANNING MICROSCOPY, V3, P1051
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Lugo GJ, 2015, J EUR CERAM SOC, V35, P3693, DOI 10.1016/j.jeurceramsoc.2015.04.036
   Lugo GJ, 2015, J AM CERAM SOC, V98, P3042, DOI 10.1111/jace.13747
   Calvo-Guirado JL, 2015, CLIN ORAL IMPLAN RES, V26, P454, DOI 10.1111/clr.12399
   Magallanes-Perdomo M, 2009, ACTA BIOMATER, V5, P3057, DOI 10.1016/j.actbio.2009.04.026
   Martinez IM, 2012, MATER CHARACT, V63, P47, DOI 10.1016/j.matchar.2011.10.013
   Martinez IM, 2010, MATER CHARACT, V61, P761, DOI 10.1016/j.matchar.2010.04.010
   Martinez IM, 2012, J AM CERAM SOC, V95, P1112, DOI 10.1111/j.1551-2916.2011.05031.x
   Martinez IM, 2011, CERAM INT, V37, P2527, DOI 10.1016/j.ceramint.2011.03.062
   Mate-Sanchez de Val J. E., 2010, CERAM INT, V38, P1563
   de Val JEMS, 2012, J BIOMED MATER RES A, V100A, P3446, DOI 10.1002/jbm.a.34259
   Meseguer-Olmo L, 2012, J MATER SCI-MATER M, V23, P3003, DOI 10.1007/s10856-012-4742-z
   Minarelli-Gaspar AM, 2009, KEY ENG MATER, V7-10, P396
   Ono D, 2011, CLIN ORAL IMPLAN RES, V22, P1366, DOI 10.1111/j.1600-0501.2010.02117.x
   Rohanizadeh R, 1998, J BIOMED MATER RES, V42, P530, DOI 10.1002/(SICI)1097-4636(19981215)42:4<530::AID-JBM8>3.0.CO;2-6
   Rubio V., 2013, J AM CERAM SOC, V94, P4459
   SCHWARZ K, 1972, NATURE, V239, P333, DOI 10.1038/239333a0
   Sharifi D, 2012, ACTA CIR BRAS, V27, P256, DOI 10.1590/S0102-86502012000300009
   SKEDROS JG, 1993, J BIOMED MATER RES, V27, P47, DOI 10.1002/jbm.820270107
   Velasquez P, 2013, J BIOMED MATER RES A, V101, P1943, DOI 10.1002/jbm.a.34495
   Villora JM, 2004, J EUR CERAM SOC, V24, P589, DOI 10.1016/S0955-2219(03)00245-0
   WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293
   Wierzchos J, 2008, MICRON, V39, P1363, DOI 10.1016/j.micron.2008.01.022
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
NR 51
TC 6
Z9 6
U1 3
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD NOV
PY 2016
VL 27
IS 11
BP 1368
EP 1375
DI 10.1111/clr.12745
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA EB0YE
UT WOS:000387071900005
PM 26775798
DA 2018-12-27
ER

PT J
AU Wu, J
   Zhang, X
   Yan, Y
   Tang, ZH
   Sun, XC
   Huo, G
   Liao, ZB
AF Wu, Jing
   Zhang, Xin
   Yan, Yi
   Tang, Zhaohua
   Sun, Xiaochuan
   Huo, Gang
   Liao, Zhengbu
TI RETRACTED: The Crucial Role of Cyclin-Dependent
   Kinase-5-Ataxia-Telangiectasia Mutated Axis in ICH-Induced Neuronal
   Injury of Rat Model (Retracted article. See vol. 54, pg. 8458, 2017)
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article; Retracted Publication
DE CDK5; ATM; ICH; Rat
ID INTRACEREBRAL HEMORRHAGE; MESENCHYMAL TRANSITION; ALZHEIMERS-DISEASE;
   BRAIN-DEVELOPMENT; CDK5 ACTIVITY; KINASE; CXCR4; GLIOBLASTOMA
AB Cyclin-dependent kinase 5 (CDK5) and ataxia-telangiectasia mutated (ATM) are involved in normal human neurodevelopment and serves as a switch between neuronal survival and death. However, the molecular mechanisms underlying CDK5-ATM-induced neuronal injury caused by intracerebral hemorrhage (ICH) remain unclear. In this work, we used rat ICH models and thrombin-induced cell models to investigate the potential role of CDK5-ATM signals. Our findings revealed that CDK5 protein levels and kinase activities (p-histone H1 expression) were enforced in hematoma-surrounding neuron tissues following ICH. Besides, the expression of p25, p-ATM, and active caspase-3 protein was also upregulated after ICH. According to in vitro assays, the expression of CDK5, p-ATM, and active caspase-3 was all upregulated in cell viability-decreasing ICH cell models. However, blocking of either CDK5 or ATM suppressed the phosphorylation of ATM and the expression of active caspase-3, and attenuated the inhibition of neuronal survival. When p35/p25 was silenced, CDK5-ATM pathway was further inhibited, and cell viability was obviously ameliorated. In conclusion, this work suggested that ATM could be phosphorylated by CDK5 to induce the active caspase-3 and neuronal injury when intracerebral hemorrhage or ischemia occurred. Thus, the CDK5-AMT signal pathway has an important role in ICH process and may be a therapeutic target to prevent brain injury.
C1 [Wu, Jing] Chongqing Med Univ, Affiliated Hosp 2, Intens Care Unit, Chongqing 400010, Peoples R China.
   [Zhang, Xin] Chongqing Med Univ, Inst Mol Biol, Chongqing 400016, Peoples R China.
   [Yan, Yi; Tang, Zhaohua; Sun, Xiaochuan; Huo, Gang; Liao, Zhengbu] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China.
RP Liao, ZB (reprint author), Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China.
EM liaozhengbu163@163.com
FU Chong Qing Natural Science Foundation [cstc2015jcyjA0526]
FX This study is supported by Chong Qing Natural Science Foundation
   (cstc2015jcyjA0526). We greatly thank other members in our lab for
   valuable suggestions and writing.
CR Arif A, 2012, BIOCHEM PHARMACOL, V84, P985, DOI 10.1016/j.bcp.2012.06.027
   Barnett DGS, 2011, BRAIN RES BULL, V85, P9, DOI 10.1016/j.brainresbull.2010.11.016
   Cordeiro MF, 2015, WORLD J STEM CELLS, V7, P618, DOI 10.4252/wjsc.v7.i3.618
   Dai CX, 2015, MOL NEUROBIOL, V52, P1521, DOI 10.1007/s12035-014-8955-7
   Giese KP, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00036
   Han G, 2015, CYTOKINE, V76, P163, DOI 10.1016/j.cyto.2015.05.009
   He QS, 2015, GENET MOL RES, V14, P9849, DOI 10.4238/2015.August.19.18
   Hua Y, 2002, J CEREBR BLOOD F MET, V22, P55, DOI 10.1097/00004647-200201000-00007
   Jessberger S, 2009, TRENDS NEUROSCI, V32, P575, DOI 10.1016/j.tins.2009.07.002
   Kawauchi T, 2014, DEV GROWTH DIFFER, V56, P335, DOI 10.1111/dgd.12138
   Kawauchi T, 2013, GENES CELLS, V18, P176, DOI 10.1111/gtc.12029
   Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002
   Kotlega D, 2015, NEUROL NEUROCHIR POL, V49, P322, DOI 10.1016/j.pjnns.2015.07.007
   Lopes JP, 2011, PROG NEUROBIOL, V94, P49, DOI 10.1016/j.pneurobio.2011.03.006
   Lv BY, 2015, MOL NEUROBIOL, V52, P1263, DOI 10.1007/s12035-014-8935-y
   Lv SZ, 2015, MOL NEUROBIOL, V52, P555, DOI 10.1007/s12035-014-8894-3
   Mottin M, 2015, J PHYS CHEM B, V119, P8330, DOI 10.1021/acs.jpcb.5b04269
   Rea K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.353
   Shah K, 2014, J CELL SCI, V127, P2391, DOI 10.1242/jcs.147553
   Shi P, 2015, ONCOL REP, V34, P1319, DOI 10.3892/or.2015.4081
   Shukla V, 2012, ARCH MED RES, V43, P655, DOI 10.1016/j.arcmed.2012.10.015
   Song WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136950
   Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023
   Tassin TC, 2015, J BIOL CHEM, V290, P16319, DOI 10.1074/jbc.M115.654897
   Tsuchiyama R, 2009, NEUROL RES, V31, P179, DOI 10.1179/174313209X393609
   Wen Z, 2014, NEUROBIOL AGING, V35, P2870, DOI 10.1016/j.neurobiolaging.2014.05.034
   Wilson D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2484
   Yaghi Shadi, 2015, Clin Pract, V5, P756, DOI 10.4081/cp.2015.756
NR 28
TC 4
Z9 4
U1 4
U2 6
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD NOV
PY 2016
VL 53
IS 9
BP 6301
EP 6308
DI 10.1007/s12035-015-9524-4
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA EB2ZO
UT WOS:000387231300041
PM 26567107
DA 2018-12-27
ER

PT J
AU Zhang, DM
   Xu, ZW
   Tao, T
   Liu, XJ
   Sun, XL
   Ji, YH
   Han, LJ
   Qiu, HY
   Zhu, GZ
   Shen, YF
   Zhu, L
   Shen, AG
AF Zhang, Dongmei
   Xu, Zhiwei
   Tao, Tao
   Liu, Xiaojuan
   Sun, Xiaolei
   Ji, Yuhong
   Han, Lijian
   Qiu, Huiyuan
   Zhu, Guizhou
   Shen, Yifen
   Zhu, Liang
   Shen, Aiguo
TI RETRACTED: Modification of TAK1 by O-linked N-acetylglucosamine
   facilitates TAK1 activation and promotes M1 macrophage polarization
   (Retracted article. See vol. 36, pg. 267, 2017)
SO CELLULAR SIGNALLING
LA English
DT Article; Retracted Publication
DE Macrophage; O-GlcNAcylation; Polarization; TGF beta-activated kinase 1
   (TAK1)
ID KAPPA-B; INTRACEREBRAL HEMORRHAGE; SIGNAL-TRANSDUCTION; GLCNAC
   TRANSFERASE; STRESS; PHOSPHORYLATION; PROTEIN; EXPRESSION; CANCER;
   GLCNACYLATION
AB Macrophages play many different roles in tissue inflammation and immunity, and the plasticity of macrophage polarization is closely associated with acute inflammatory responses. O-GIcNAcylation is an important type of post-translational modification, which subtly modulates inflammation responses. Transforming growth factor (TGF)-beta-activated kinase 1 (TAK1) is a key serine/threonine protein kinase that mediates signals transduced by pro-inflammatory cytokines such as TGF-beta, tumor necrosis factor (TNF), and interleukin-1 (IL-1). It is here reported that TGF beta-activated kinase (TAK1) is modified with N-acetylglucosamine (O-GlcNAc) on 5427. Both IL-1 and osmotic stress, which are known as the TAK1-signaling inducers, significantly trigger the O-GlcNAcylation of TAK1 in macrophages. By overexpressing wild-type (WT) or S427ATAK1 mutant into macrophages, it was determined that O-GlcNAcylation of TAK1 on S427 is required for T187/5192 phosphorylation and full activation of TAK1 upon stimulation with IL-1 alpha and NaCl. Aborting O-GIcNAcylation of TAK1 on 5427 was found to inhibit the downstream JNK and nuclear factor-kappa B activation and reduce the final amount of cytokines produced in activated macrophages to a great extent. Results also showed that overexpression of the O-GlcNAcylation-deficient mutant of TAK1 promotes LPS-mediated apoptosis in macrophages. Importantly, TAK1 O-GlcNAcylation was found to promote M1 macrophage polarization in activated macrophages. Taken together, these data demonstrate that O-GlcNAcylation of TAK1 on 5427 critically regulates the pro-inflammatory activation and M1 polarization of macrophages via modulation of the TAK1/JNK/NF-kappa B signaling pathway. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Zhang, Dongmei; Liu, Xiaojuan; Sun, Xiaolei] Nantong Univ, Dept Pathogen Biol, Coll Med, Nantong 226001, Jiangsu, Peoples R China.
   [Xu, Zhiwei; Tao, Tao; Ji, Yuhong; Zhu, Guizhou; Shen, Yifen] Nantong Univ, Dept Immunol, Coll Med, Nantong 226001, Jiangsu, Peoples R China.
   [Zhang, Dongmei; Xu, Zhiwei; Tao, Tao; Liu, Xiaojuan; Sun, Xiaolei; Han, Lijian; Qiu, Huiyuan; Zhu, Liang; Shen, Aiguo] Nantong Univ, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China.
   [Shen, Aiguo] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.
RP Shen, AG (reprint author), Nantong Univ, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China.
EM shag@ntu.edu.cn
FU National Basic Research Program of China (973 Program) [2012CB822104];
   National Natural Science Foundation of China [31500647, 31440037,
   31670803, 31270802, 81202368]; Natural Science Foundation of the Jiangsu
   Higher Education Institutions of China [15KJA310003]; Natural Science
   Foundation of Jiangsu Province [BK20150408]; Nantong Science and
   Technology Project [MS12015093]; Technology Innovation Program of
   Nantong University [YKC14055]; Priority Academic Program Development of
   Jiangsu Higher Education Institutions (PAPD)
FX This work was supported by the National Basic Research Program of China
   (973 Program, No. 2012CB822104); the National Natural Science Foundation
   of China (31500647, 31440037, 31670803, 31270802, 81202368); the Natural
   Science Foundation of the Jiangsu Higher Education Institutions of China
   (15KJA310003); the Natural Science Foundation of Jiangsu Province
   (BK20150408); the Nantong Science and Technology Project (MS12015093);
   Technology Innovation Program of Nantong University (YKC14055) and a
   project funded by the Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD).
CR Bashir S, 2016, INFLAMM RES, V65, P1, DOI 10.1007/s00011-015-0874-1
   Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937
   Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018
   Gawlowski T, 2012, J BIOL CHEM, V287, P30024, DOI 10.1074/jbc.M112.390682
   Ge H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117463
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Guo B, 2014, NAT CELL BIOL, V16, P1215, DOI 10.1038/ncb3066
   Hayakawa K, 2016, J NEUROCHEM, V136, P900, DOI 10.1111/jnc.13492
   Jang I, 2015, BBA-MOL CELL RES, V1853, P1860, DOI 10.1016/j.bbamcr.2015.04.017
   Li L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16626
   Li P., 2016, CELL STRESS CHAPERON
   Li Y, 2011, ONCOGENE, V30, P3887, DOI 10.1038/onc.2011.112
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Motoyoshi S, 2014, BIOCHEM J, V463, P75, DOI 10.1042/BJ20140084
   Muthusamy S, 2015, J BIOL CHEM, V290, P31013, DOI 10.1074/jbc.M115.677534
   Ogura Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10123
   Ouyang C, 2014, J BIOL CHEM, V289, P24226, DOI 10.1074/jbc.M114.559963
   Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8
   Pekkurnaz G, 2014, CELL, V158, P54, DOI 10.1016/j.cell.2014.06.007
   Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106
   Prickett TD, 2008, J BIOL CHEM, V283, P19245, DOI 10.1074/jbc.M800943200
   Qiu H., 2016, MOL CARCINOG
   Sai K, 2016, J CELL SCI, V129, P1855, DOI 10.1242/jcs.180505
   Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007
   Shirakabe K, 1997, J BIOL CHEM, V272, P8141, DOI 10.1074/jbc.272.13.8141
   Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200
   Slawson C, 2006, J CELL BIOCHEM, V97, P71, DOI 10.1002/jcb.20676
   Swarnkar G, 2015, P NATL ACAD SCI USA, V112, P154, DOI 10.1073/pnas.1415213112
   Sylvain-Prevost S, 2015, J IMMUNOL, V195, P5393, DOI 10.4049/jimmunol.1402752
   Tian S, 2015, MACROPHAGE, V2, DOI 10.14800/macrophage.679
   Van Ginderachter JA, 2006, BLOOD, V108, P525, DOI 10.1182/blood-2005-09-3777
   Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714
   Xu ZW, 2016, CELL MOL NEUROBIOL, V36, P755, DOI 10.1007/s10571-015-0258-7
   Xu ZW, 2016, J MOL NEUROSCI, V58, P16, DOI 10.1007/s12031-015-0644-0
   YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008
   Yu Y, 2008, J BIOL CHEM, V283, P24497, DOI 10.1074/jbc.M802825200
NR 36
TC 6
Z9 6
U1 4
U2 22
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0898-6568
EI 1873-3913
J9 CELL SIGNAL
JI Cell. Signal.
PD NOV
PY 2016
VL 28
IS 11
BP 1742
EP 1752
DI 10.1016/j.cellsig.2016.08.008
PG 11
WC Cell Biology
SC Cell Biology
GA DW8YU
UT WOS:000383942200014
PM 27542620
DA 2018-12-27
ER

PT J
AU Safi, R
   Ghasemi, A
   Shoja-Razavi, R
AF Safi, Rohollah
   Ghasemi, Ali
   Shoja-Razavi, Reza
TI RETRACTED: Factors controlling magnetic properties of CoFe2O4
   nanoparticles synthesized by chemical co-precipitation: Modeling and
   optimization using response surface methodology (Retracted article. See
   vol. 43, pg. 11542, 2017)
SO CERAMICS INTERNATIONAL
LA English
DT Article; Retracted Publication
DE Magnetic materials; Nanoparticles; Chemical synthesis; Cobalt ferrite
ID COBALT FERRITE NANOCRYSTALS; HIGH-COERCIVITY; SIZE; REFINEMENT;
   CHEMISTRY; CATIONS
AB CoFe2O4 nanoparticles were synthesized by a low temperature co-precipitation method. In the present research, size-controlled CoFe2O4 was achieved by systematically tailoring the supersaturation condition during the nucleation and crystal growth processes. In order to investigate the size properties of synthesized particles, the experimental design was done using central composite method (CCD) of response. surface methodology (RSM). For this purpose, the temperature, pH, and feeding rate of reactant solutions were selected as influential factors. Based on designed runs, the various responses such as hydrodynamic size of particles, size distribution, crystallite size, and magnetic size were evaluated by dynamic light scattering (DLS), X-ray diffraction (XRD), and vibrating sample magnetometer (VSM). Based on the results, the quadratic polynomial model was fitted for each response that could predict the response amounts. In following, the study of factors effects was carried out using software that showed the flow rate, temperature, and their interactions had higher effectiveness. Finally, by optimizing, the maximum average crystallite size were gained in maximum amounts of temperature (100 degrees C) and pH (13) value and minimum feeding rate of initial reactant (1 ml/min). The coercivity of cobalt ferrite nanoparticles reached 2029 Oe at optimal synthesis conditions. (C) 2016 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Safi, Rohollah; Ghasemi, Ali; Shoja-Razavi, Reza] Malek Ashtar Univ Technol, Dept Mat Engn, Shahin Shahr, Iran.
RP Safi, R (reprint author), Malek Ashtar Univ Technol, Dept Mat Engn, Shahin Shahr, Iran.
EM r.safi@gmx.com
RI Shoja Razavi, Reza/A-6612-2017
OI Shoja Razavi, Reza/0000-0002-8249-2963
CR Ahmadi M, 2005, J HAZARD MATER, V123, P187, DOI 10.1016/j.jhazmat.2005.03.042
   Ahmadi R, 2011, J MIN METALL B, V47, P211, DOI 10.2298/JMMB110330010A
   Ahmadi S, 2012, POWDER TECHNOL, V228, P163, DOI 10.1016/j.powtec.2012.05.012
   Antonopoulou M, 2013, CLEAN-SOIL AIR WATER, V41, P593, DOI 10.1002/clen.201200405
   Auzans E., 1999, MN ZN FERRITE NANOPA
   Auzans E., 2006, J MATER SCI, V34, P1253
   Ayyappan S, 2010, J PHYS CHEM C, V114, P6334, DOI 10.1021/jp911966p
   Bezerra MA, 2008, TALANTA, V76, P965, DOI 10.1016/j.talanta.2008.05.019
   Cedeno-Mattei Y, 2012, MATER CHEM PHYS, V132, P999, DOI 10.1016/j.matchemphys.2011.12.049
   Cedeno-Mattei Y, 2009, MICROELECTRON J, V40, P673, DOI 10.1016/j.mejo.2008.07.040
   Chinnasamy CN, 2003, J COLLOID INTERF SCI, V263, P80, DOI 10.1016/S0021-9797(03)00258-3
   Chinnasamy CN, 2002, IEEE T MAGN, V38, P2640, DOI 10.1109/TMAG.2002.801972
   Cornejo DR, 2002, J MAGN MAGN MATER, V242, P194, DOI 10.1016/S0304-8853(01)01169-6
   Darling SB, 2005, J MATER CHEM, V15, P4189, DOI 10.1039/b506357d
   Ebrahimi B, 2010, PROCESS BIOCHEM, V45, P81, DOI 10.1016/j.procbio.2009.08.007
   Ghasemi A., 2011, J APPL PHYS, V109
   Ghasemi A, 2014, J MAGN MAGN MATER, V354, P136, DOI 10.1016/j.jmmm.2013.10.022
   Goldman A., 1987, MODERN FERRITE TECHN
   Khataee AR, 2011, ENVIRON TECHNOL, V32, P1669, DOI 10.1080/09593330.2011.597432
   Li Y, 2007, ENZYME MICROB TECH, V40, P1381, DOI 10.1016/j.enzmictec.2006.10.015
   MASSART R, 1995, J MAGN MAGN MATER, V149, P1, DOI 10.1016/0304-8853(95)00316-9
   Rana S, 2010, MATER CHEM PHYS, V124, P264, DOI 10.1016/j.matchemphys.2010.06.029
   RIETVELD HM, 1969, J APPL CRYSTALLOGR, V2, P65, DOI 10.1107/S0021889869006558
   Safi R, 2016, CERAM INT, V42, P6375, DOI 10.1016/j.ceramint.2016.01.032
   Safi R, 2015, J MAGN MAGN MATER, V396, P288, DOI 10.1016/j.jmmm.2015.08.022
   Sakkas VA, 2010, J HAZARD MATER, V175, P33, DOI 10.1016/j.jhazmat.2009.10.050
   Sharifi I, 2012, J MAGN MAGN MATER, V324, P1854, DOI 10.1016/j.jmmm.2012.01.015
   Shu C., 2009, IEEE T MAGN, P1
   Sodaee T, 2016, J CLUST SCI, V27, P1239, DOI 10.1007/s10876-015-0925-3
   Spaldin N. A., 2003, MAGNETIC MAT FUNDAME
   STONER EC, 1991, IEEE T MAGN, V27, P3475, DOI 10.1109/TMAG.1991.1183750
   Turtelli RS, 2008, J MAGN MAGN MATER, V320, pE339, DOI 10.1016/j.jmmm.2008.02.067
   Wang JP, 2007, COLLOID SURFACE A, V302, P204, DOI 10.1016/j.colsurfa.2007.02.023
   Young RA, 1993, RIETVELD METHOD
NR 34
TC 5
Z9 5
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD NOV 1
PY 2016
VL 42
IS 14
BP 15818
EP 15825
DI 10.1016/j.ceramint.2016.07.049
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA DU5RU
UT WOS:000382269800090
DA 2018-12-27
ER

PT J
AU Wang, X
   Jiang, CW
   Li, BS
AF Wang, Xu
   Jiang, Chuanwen
   Li, Bosong
TI RETRACTED: Active robust optimization for wind integrated power system
   economic dispatch considering hourly demand response (Retracted article.
   See vol. 125, pg. 1061, 2018)
SO RENEWABLE ENERGY
LA English
DT Article; Retracted Publication
DE Active robust optimization; Nodal price; Wind power; Demand response;
   Economic dispatch
ID CONSTRAINED UNIT COMMITMENT; STOCHASTIC OPTIMIZATION; GENERATION; PRICE;
   MANAGEMENT; MODEL; SCUC
AB Due to dramatically increased uncertainties caused by wind power (WP) integration and price responsive demand, economic dispatch (ED) in a day-ahead market faces new challenges. With the involvement of price responsive demand response (DR), independent system operator (ISO) has to adapt to the changes of both nodal prices and loads under different WP conditions. Moreover, here the changeable nodal prices are determined by both power generation and load not using a simple deterministic mathematical function. The robustness of dispatch strategies can be enhanced through proper demand side management. Motivated by these, we propose a novel active robust optimization dispatch (AROD) model in this paper. The proposed model amalgamates robust optimization (RO) with dynamic optimization (DO) to reveal the effects of price responsive DR, while considering all possible WP conditions. We present extensive numerical case studies on the modified IEEE 30-bus system and IEEE 118-bus system. Computational results demonstrate the effectiveness of the proposed AROD model for the secure and economic operation of the power system under various uncertainties in a day-ahead market. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Wang, Xu; Jiang, Chuanwen; Li, Bosong] Shanghai Jiao Tong Univ, Sch Elect Informat & Elect Engn, Minist Educ, Key Lab Control Power Transmiss & Convers, Shanghai 200240, Peoples R China.
RP Jiang, CW (reprint author), Shanghai Jiao Tong Univ, Sch Elect Informat & Elect Engn, Minist Educ, Key Lab Control Power Transmiss & Convers, Shanghai 200240, Peoples R China.
EM jiangcw@sjtu.edu.cn
FU National Natural Science Fund [51577116]
FX This work is supported by the National Natural Science Fund (51577116).
CR Bertsimas D, 2004, OPER RES, V52, P35, DOI 10.1287/opre.1030.0065
   Bertsimas D, 2013, IEEE T POWER SYST, V28, P52, DOI 10.1109/TPWRS.2012.2205021
   Billinton R, 2009, IEEE T POWER SYST, V24, P1375, DOI 10.1109/TPWRS.2009.2023263
   Botterud A, 2013, IEEE T SUSTAIN ENERG, V4, P250, DOI 10.1109/TSTE.2012.2215631
   Chen Z, 2012, IEEE T SMART GRID, V3, P1822, DOI 10.1109/TSG.2012.2212729
   Conejo AJ, 2005, IEEE T POWER SYST, V20, P1035, DOI 10.1109/TPWRS.2005.846054
   Dantzig G. B., 2004, MANAGE SCI, V1, P197
   Coelho LD, 2006, IEEE T POWER SYST, V21, P1465, DOI 10.1109/TPWRS.2006.881220
   Elsayed W. T., IEEE T POWE IN PRESS
   Gangammanavar H., IEEE T POWE IN PRESS
   Jabr R. A., IEEE T POWE IN PRESS
   Jabr RA, 2013, IEEE T POWER SYST, V28, P4742, DOI 10.1109/TPWRS.2013.2275013
   Jiang RW, 2013, IEEE T POWER SYST, V28, P2271, DOI 10.1109/TPWRS.2013.2250530
   Jiang RW, 2012, IEEE T POWER SYST, V27, P800, DOI 10.1109/TPWRS.2011.2169817
   Kavousi-Fard A., IEEE T SUST IN PRESS
   Kimball LM, 2003, ELECTR POW COMPO SYS, V31, P1193, DOI 10.1080/15325000390248819
   Lee YY, 2013, IEEE T POWER SYST, V28, P2301, DOI 10.1109/TPWRS.2012.2236108
   Leou RC, 2014, IEEE T POWER SYST, V29, P1055, DOI 10.1109/TPWRS.2013.2291556
   Li ZG, 2013, IEEE T POWER SYST, V28, P4516, DOI 10.1109/TPWRS.2013.2267057
   Liu YY, 2015, IEEE T SUSTAIN ENERG, V6, P443, DOI 10.1109/TSTE.2014.2382122
   Lorca A., IEEE T POWE IN PRESS
   Parvania M, 2010, IEEE T SMART GRID, V1, P89, DOI 10.1109/TSG.2010.2046430
   Rabiee A, 2014, IEEE T POWER DELIVER, V29, P336, DOI 10.1109/TPWRD.2013.2259600
   RAHMAN S, 1989, IEEE T POWER SYST, V4, P184, DOI 10.1109/59.32476
   Wang JH, 2008, IEEE T POWER SYST, V23, P1319, DOI 10.1109/TPWRS.2008.926719
   Wang X, 2015, IEEE T POWER SYST, V30, P1094, DOI 10.1109/TPWRS.2014.2344861
   Wang Y, 2011, IEEE T POWER SYST, V26, P1705, DOI 10.1109/TPWRS.2010.2100050
   Wang Z., 2011, ROADMAP WP DEV CHINA
   Wangdee W, 2006, IEEE T ENERGY CONVER, V21, P734, DOI 10.1109/TEC.2006.875475
   Wong S, 2007, IEEE T POWER SYST, V22, P631, DOI 10.1109/TPWRS.2007.894867
   Wu L, 2007, IEEE T POWER SYST, V22, P800, DOI 10.1109/TPWRS.2007.894843
   Wu L, 2012, IEEE T POWER SYST, V27, P913, DOI 10.1109/TPWRS.2011.2164947
   WWEA, 2012, WORLD WIND EN REP 20
   Xiong P, 2013, IEEE T SMART GRID, V4, P2200, DOI 10.1109/TSG.2013.2278398
   Yorino N, 2012, IEEE T POWER SYST, V27, P621, DOI 10.1109/TPWRS.2011.2169285
   Zhang Y, 2013, IEEE T SUSTAIN ENERG, V4, P944, DOI 10.1109/TSTE.2013.2255135
   Zhao CY, 2013, IEEE T POWER SYST, V28, P2708, DOI 10.1109/TPWRS.2013.2244231
   Zhao L., 2012, P IEEE POW EN SOC GE, P1
NR 38
TC 8
Z9 8
U1 5
U2 34
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-1481
J9 RENEW ENERG
JI Renew. Energy
PD NOV
PY 2016
VL 97
BP 798
EP 808
DI 10.1016/j.renene.2016.06.035
PG 11
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA DS2LH
UT WOS:000380600500072
DA 2018-12-27
ER

PT J
AU Hunter, PR
   Pruss-Ustun, A
AF Hunter, Paul R.
   Pruess-Ustuen, Annette
TI RETRACTED: Have We Substantially Underestimated the Impact of Improved
   Sanitation Coverage on Child Health? A Generalized Additive Model Panel
   Analysis of Global Data on Child Mortality and Malnutrition (Retracted
   article. See vol. 12, art no e0178903, 2017)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID MIDDLE-INCOME SETTINGS; DIARRHEAL DISEASE; DRINKING-WATER; INTERVENTION;
   PROGRAM; TRENDS; BRAZIL; TRIAL; INDIA
AB Background
   Although widely accepted as being one of the most important public health advances of the past hundred years, the contribution that improving sanitation coverage can make to child health is still unclear, especially since the publication of two large studies of sanitation in India which found no effect on child morbidity. We hypothesis that the value of sanitation does not come directly from use of improved sanitation but from improving community coverage. If this is so we further hypothesise that the relationship between sanitation coverage and child health will be non-linear and that most of any health improvement will accrue as sanitation becomes universal.
   Methods
   We report a fixed effects panel analysis of country level data using Generalized Additive Models in R. Outcome variables were under 5 childhood mortality, neonatal mortality, under 5 childhood mortality from diarrhoea, proportion of children under 5 with stunting and with underweight. Predictor variables were % coverage by improved sanitation, improved water source, Gross Domestic Product per capita and Health Expenditure per capita. We also identified three studies reporting incidence of diarrhoea in children under five alongside gains in community coverage in improved sanitation.
   Findings
   For each of the five outcome variables, sanitation coverage was independently associated with the outcome but this association was highly non-linear. Improving sanitation coverage was very strongly associated with under 5 years diarrhoea mortality, under 5years all-cause mortality, and all-cause neonatal mortality. There was a decline as sanitation coverage increased up to about 20% but then no further decline was seen until about 70% (60% for diarrhoea mortality and 80% for neonatal mortality, respectively). The association was less strong for stunting and underweight but a threshold about 50% coverage was also seen. Three large trials of sanitation on diarrhoea morbidity gave results that were similar to what would have been predicted by our model.
   Conclusions
   Improving sanitation coverage may be one of the more effective means to reduce childhood mortality, but only if high levels of community coverage are achieved. Studies of the impact of sanitation that focus on the individual's use of improved sanitation as the predictor variable rather than community coverage is likely to severely underestimate the impact of sanitation.
C1 [Hunter, Paul R.; Pruess-Ustuen, Annette] WHO, Environm & Social Determinants Hlth, Dept Publ Hlth, Geneva, Switzerland.
   [Hunter, Paul R.] Univ East Anglia, Norwich Sch Med, Norwich, Norfolk, England.
   [Hunter, Paul R.] Tshwane Univ Technol, Dept Environm Hlth, Pretoria, South Africa.
RP Hunter, PR (reprint author), WHO, Environm & Social Determinants Hlth, Dept Publ Hlth, Geneva, Switzerland.; Hunter, PR (reprint author), Univ East Anglia, Norwich Sch Med, Norwich, Norfolk, England.; Hunter, PR (reprint author), Tshwane Univ Technol, Dept Environm Hlth, Pretoria, South Africa.
EM Paul.Hunter@uea.ac.uk
FU World Health Organization [001]
CR Abdel-Razik MSM, 2015, EPIDEMIOL BIOSTAT PU, V12, DOI 10.2427/11442
   Allen LJS, 2013, MATH BIOSCI, V243, P99, DOI 10.1016/j.mbs.2013.02.006
   Allison P. D., 2009, FIXED EFFECTS REGRES, V160
   Barreto ML, 2007, LANCET, V370, P1622, DOI 10.1016/S0140-6736(07)61638-9
   Cheng JJ, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-4
   Clasen T, 2014, LANCET GLOB HEALTH, V2, pE645, DOI 10.1016/S2214-109X(14)70307-9
   Ferriman A, 2007, BRIT MED J, V334, P111, DOI 10.1136/bmj.39097.611806.DB
   Fink G, 2011, INT J EPIDEMIOL, V40, P1196, DOI 10.1093/ije/dyr102
   Fuller JA, 2015, TROP MED INT HEALTH, V20, P284, DOI 10.1111/tmi.12441
   Garcia S, 2013, PUBLIC HEALTH NUTR, V16, P1703, DOI 10.1017/S1368980012004090
   Gilmartin AA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0143
   Hastie T, 1986, STAT SCI, V1, P297, DOI DOI 10.1214/SS/1177013604
   Hunter PR, 2012, ENVIRON SCI TECHNOL, V46, P3035, DOI 10.1021/es204500c
   Moraes LRS, 2003, T ROY SOC TROP MED H, V97, P153, DOI 10.1016/S0035-9203(03)90104-0
   Pickering AJ, 2015, LANCET GLOB HEALTH, V3, pE701, DOI 10.1016/S2214-109X(15)00144-8
   Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329
   Rah JH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005180
   Rock K, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/2/026602
   Sahu D, 2015, INDIAN J MED RES, V141, P709
   Sastry N, 2005, SOC SCI MED, V60, P923, DOI 10.1016/j.socscimed.2004.06.051
   Savovic J, 2010, RES SYNTH METHODS, V1, P212, DOI 10.1002/jrsm.18
   SHUVAL HI, 1981, B WORLD HEALTH ORGAN, V59, P243
   Spears D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073784
   Sumeet PR, 2014, PLOS MED, DOI [10.1371/journal.pmed.1001709, DOI 10.1371/JOURNAL.PMED.1001709]
   Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246
   Waddington H, 2009, WATER SANITATION HYG, V31
   WHO, 2013, WORLD MALARIA REPORT 2013, P1
   Wolf J, 2014, TROP MED INT HEALTH, V19, P928, DOI 10.1111/tmi.12331
NR 28
TC 10
Z9 10
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD OCT 26
PY 2016
VL 11
IS 10
AR e0164571
DI 10.1371/journal.pone.0164571
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EE4VE
UT WOS:000389602800045
PM 27783646
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Mao, ZY
   Si, CM
   Liu, YW
   Dong, HQ
   Wei, BG
   Lin, GQ
AF Mao, Zhuo-Ya
   Si, Chang-Mei
   Liu, Yi-Wen
   Dong, Han-Qing
   Wei, Bang-Guo
   Lin, Guo-Qiang
TI RETRACTED: Asymmetric Synthesis of Apratoxin E (Retracted article. See
   vol. 82, pg. 11310, 2017)
SO JOURNAL OF ORGANIC CHEMISTRY
LA English
DT Article; Retracted Publication
ID BIOLOGICAL EVALUATION; CYCLODEPSIPEPTIDE APRATOXIN;
   CONFORMATIONAL-ANALYSIS; OXAZOLINE ANALOG; MARINE CYANOBACTERIA;
   LYNGBYA-BOUILLONII; NATURAL-PRODUCTS; POTENT; LIPODEPSIPEPTIDES;
   TRANSLOCATION
AB An efficient method for asymmetric synthesis of apratoxin E 2 is described in this report. The chiral lactone 8, recycled from the degradation of saponin glycosides, was utilized to prepare the non-peptide fragment 6. In addition to this "from nature to nature" strategy, olefin cross-metathesis (CM) was applied as an alternative approach for the formation of the double bond. Moreover, pentafluorophenyl diphenylphosphinate was found to be an efficient condensation reagent for the macrocyclization.
C1 [Mao, Zhuo-Ya; Si, Chang-Mei; Wei, Bang-Guo; Lin, Guo-Qiang] Fudan Univ, Sch Pharm, Dept Nat Prod Chem, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.
   [Mao, Zhuo-Ya; Liu, Yi-Wen; Dong, Han-Qing; Lin, Guo-Qiang] Fudan Univ, Inst Biomed Sci, 130 Dongan Rd, Shanghai 200032, Peoples R China.
RP Wei, BG (reprint author), Fudan Univ, Sch Pharm, Dept Nat Prod Chem, 826 Zhangheng Rd, Shanghai 201203, Peoples R China.
EM bgwei1974@fudan.edu.cn
FU National Natural Science Foundation of China [21472022, 21272041,
   21072034]
FX We thank the National Natural Science Foundation of China (21472022,
   21272041, 21072034) for financial support. The authors thank Dr. Jing-Yi
   Ma for the preparation of several synthetic intermediates. The authors
   also thank Prof. Wei-Sheng Tian and Prof. Zhen-Ting Du for providing the
   lactone 8.
CR Arndt HD, 2015, CHEM-EUR J, V21, P5311, DOI 10.1002/chem.201500368
   Bionda N, 2011, CROAT CHEM ACTA, V84, P315, DOI 10.5562/cca1819
   CARPINO LA, 1993, J AM CHEM SOC, V115, P4397, DOI 10.1021/ja00063a082
   Chen JH, 2004, P NATL ACAD SCI USA, V101, P12067, DOI 10.1073/pnas.04002752101
   Chen JH, 2003, J AM CHEM SOC, V125, P8734, DOI 10.1021/ja036050w
   Chen QY, 2014, J MED CHEM, V57, P3011, DOI 10.1021/jm4019965
   Chen QY, 2011, ACS MED CHEM LETT, V2, P861, DOI 10.1021/ml200176m
   CHEN SQ, 1991, TETRAHEDRON LETT, V32, P6711, DOI 10.1016/S0040-4039(00)93583-4
   CIOMMER M, 1991, SYNLETT, P593
   Cochrane JR, 2015, J ORG CHEM, V80, P4491, DOI 10.1021/acs.joc.5b00349
   COREY EJ, 1987, J AM CHEM SOC, V109, P5551, DOI 10.1021/ja00252a056
   Dey S, 2015, TETRAHEDRON LETT, V56, P2927, DOI 10.1016/j.tetlet.2015.04.022
   Doi T, 2006, ORG LETT, V8, P531, DOI 10.1021/ol052907d
   Doi T, 2011, CHEM-ASIAN J, V6, P180, DOI 10.1002/asia.201000549
   Elder AM, 1999, ORG LETT, V1, P1443, DOI 10.1021/ol990990x
   Gilles A, 2011, CR CHIM, V14, P437, DOI 10.1016/j.crci.2010.09.002
   Gilles A, 2009, J ORG CHEM, V74, P4298, DOI 10.1021/jo900583j
   Grindberg RV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018565
   Grubbs RH, 1998, TETRAHEDRON, V54, P4413, DOI 10.1016/S0040-4020(97)10427-6
   Gutierrez M, 2008, J NAT PROD, V71, P1099, DOI 10.1021/np800121a
   Hamada Y, 2005, CHEM REV, V105, P4441, DOI 10.1021/cr0406312
   He G, 2007, ORG LETT, V9, P1367, DOI 10.1021/ol070271f
   Hu T, 2002, J AM CHEM SOC, V124, P11368, DOI 10.1021/ja0206700
   Huang KC, 2016, MOL CANCER THER, V15, P1208, DOI 10.1158/1535-7163.MCT-15-0648
   Huang W, 2013, J ORG CHEM, V78, P10747, DOI 10.1021/jo401687s
   INANAGA J, 1979, B CHEM SOC JPN, V52, P1989, DOI 10.1246/bcsj.52.1989
   Izzo I, 2006, ANGEW CHEM INT EDIT, V45, P7557, DOI 10.1002/anie.200602033
   Karmann L, 2015, ANGEW CHEM INT EDIT, V54, P4502, DOI 10.1002/anie.201411212
   Lemmens-Gruber R, 2009, CURR MED CHEM, V16, P1122, DOI 10.2174/092986709787581761
   Liu YX, 2009, MOL PHARMACOL, V76, P91, DOI 10.1124/mol.109.056085
   Luesch H, 2006, NAT CHEM BIOL, V2, P158, DOI 10.1038/nchembio769
   Luesch H, 2002, BIOORGAN MED CHEM, V10, P1973, DOI 10.1016/S0968-0896(02)00014-7
   Luesch H, 2001, J AM CHEM SOC, V123, P5418, DOI 10.1021/ja010453j
   Ma DW, 2006, CHEM-EUR J, V12, P7615, DOI 10.1002/chem.200600599
   Ma JY, 2011, TETRAHEDRON LETT, V52, P4598, DOI 10.1016/j.tetlet.2011.05.107
   Ma JY, 2009, SYNLETT, P1307, DOI 10.1055/s-0029-1217158
   Masuda Y, 2014, J ORG CHEM, V79, P8000, DOI 10.1021/jo501130b
   Matthew S, 2008, J NAT PROD, V71, P1113, DOI 10.1021/np700717s
   Nagaike F, 2006, ORG LETT, V8, P4465, DOI 10.1021/ol0616034
   Numajiri Y, 2009, CHEM-ASIAN J, V4, P111, DOI 10.1002/asia.200800365
   Paatero AO, 2016, CELL CHEM BIOL, V23, P561, DOI 10.1016/j.chembiol.2016.04.008
   Pettit GR, 2015, J NAT PROD, V78, P476, DOI 10.1021/np500925y
   Ren RG, 2015, CHINESE CHEM LETT, V26, P1209, DOI 10.1016/j.cclet.2015.07.023
   Robertson BD, 2012, ORG LETT, V14, P5192, DOI 10.1021/ol302309c
   Salvador-Reyes LA, 2015, NAT PROD REP, V32, P478, DOI 10.1039/c4np00104d
   Samy R, 1999, J ORG CHEM, V64, P2711, DOI 10.1021/jo982145i
   Shen JW, 2015, CHINESE J CHEM, V33, P683, DOI 10.1002/cjoc.201400862
   Shen SS, 2009, J CELL BIOL, V185, P629, DOI 10.1083/jcb.200810183
   Tarsis EM, 2015, TETRAHEDRON, V71, P5029, DOI 10.1016/j.tet.2015.05.047
   Thornburg CC, 2013, J NAT PROD, V76, P1781, DOI 10.1021/np4004992
   Tidgewell K, 2010, CHEMBIOCHEM, V11, P1458, DOI 10.1002/cbic.201000070
   Truchot C, 2005, EUR J ORG CHEM, P1765, DOI 10.1002/ejoc.200400709
   Vijayakumar S, 2016, BIOMED PHARMACOTHER, V83, P362, DOI 10.1016/j.biopha.2016.06.052
   VOLKMANN RA, 1983, J ORG CHEM, V48, P1767, DOI 10.1021/jo00158a037
   Wang ZK, 2007, TETRAHEDRON LETT, V48, P7549, DOI 10.1016/j.tetlet.2007.06.123
   Xu ZS, 2004, TETRAHEDRON-ASYMMETR, V15, P355, DOI 10.1016/j.tetasy.2003.11.026
   Yin RW, 2016, TETRAHEDRON, V72, P3823, DOI 10.1016/j.tet.2016.04.050
   Yokokawa F, 2002, TETRAHEDRON, V58, P8127, DOI 10.1016/S0040-4020(02)00906-7
   Yokokawa F., 2001, SYNLETT, V2001
   Yoshida M, 2016, BIOPOLYMERS, V106, P404, DOI 10.1002/bip.22781
   You SL, 2003, ANGEW CHEM INT EDIT, V42, P83, DOI 10.1002/anie.200390059
   Zhang SJ, 2015, CHINESE J CHEM, V33, P674, DOI 10.1002/cjoc.201400861
   ZHANG W, 2014, CHINESE J ORG CHEM, V34, P475, DOI DOI 10.6023/CJOC201310033
   Zou B, 2003, ORG LETT, V5, P3503, DOI 10.1021/ol035332y
NR 64
TC 9
Z9 9
U1 4
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-3263
J9 J ORG CHEM
JI J. Org. Chem.
PD OCT 21
PY 2016
VL 81
IS 20
BP 9903
EP 9911
DI 10.1021/acs.joc.6b02086
PG 9
WC Chemistry, Organic
SC Chemistry
GA DZ9IC
UT WOS:000386187500040
PM 27648480
DA 2018-12-27
ER

PT J
AU Shi, YX
   Chen, WS
   Li, QH
   Ye, ZM
AF Shi Yongxiang
   Chen Weishan
   Li, Qinghuai
   Ye Zhaoming
TI RETRACTED: Androgen receptor CAG and GGN repeat length variation
   contributes more to the tumorigenesis of Osteosarcoma (Retracted
   article. See vol. 8, pg. 34019, 2017)
SO ONCOTARGET
LA English
DT Article; Retracted Publication
DE osteosarcoma; papillary thyroid cancer; AR; repeat; CAG
ID RESISTANT PROSTATE-CANCER; GENE-EXPRESSION; THYROID-CANCER; AR GENE;
   CELLS; RISK; POLYMORPHISM; ASSOCIATION; PROGRESSION; CYTOSINE
AB The androgen receptor (AR) is involved in the differentiation and growth of many cancers. We hypothesized that two microsatellite polymorphic variants, AR (CAG) n and (GGN) n repeats, were also associated with the development of Papillary thyroid cancer (PTC) and Osteosarcoma. In current study, we conducted two case-control studies in a Chinese population to investigate the possible relationship between these two AR repeat polymorphisms and the risk of PTC and Osteosarcoma. The AR CAG repeat length was significantly associated with both risk of PTC and Osteosarcoma. Subjects with shorter AR CAG repeats had a higher risk of developing PTC (OR = 1.47, 95% CI: 1.17-1.85, P = 0.001) and Osteosarcoma (OR = 1.53, 95% CI: 1.19-1.97, P = 9.2 x 10(-4)). Specifically, shorter GGN repeats also contribute a significant increased risk of Osteosarcoma (OR = 1.35, 95% CI: 1.03-1.77, P = 0.030). Our results contribute to a better understanding of the complex hormone related mechanisms underlying PTC and Osteosarcoma.
C1 [Shi Yongxiang; Chen Weishan; Ye Zhaoming] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed Surg, Hangzhou, Zhejiang, Peoples R China.
   [Li, Qinghuai] 3rd Hosp Henan Prov, Dept Med, Zhengzhou Shi, Henan, Peoples R China.
RP Ye, ZM (reprint author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthopaed Surg, Hangzhou, Zhejiang, Peoples R China.
EM ye_zhaoming@163.com
FU Zhejiang Medicines Health Science and Technology Program General Studies
   Program [2016134432]; Zhejiang Provincial Natural Science Foundation of
   Youth Project [LQ16H060001]
FX The study was supported by 2016 Zhejiang Medicines Health Science and
   Technology Program General Studies Program (Item number: 2016134432),
   and 2016 Zhejiang Provincial Natural Science Foundation of Youth Project
   (Application Item Number: LQ16H060001).
CR Arambepola NK, 1998, J ENDOCRINOL, V156, P43, DOI 10.1677/joe.0.1560043
   Ardiani A, 2014, ONCOTARGET, V5, P9335, DOI 10.18632/oncotarget.2429
   Choong CS, 1996, MOL ENDOCRINOL, V10, P1527, DOI 10.1210/me.10.12.1527
   Dang J, 2015, GENET MOL RES, V14, P10258, DOI 10.4238/2015.August.28.10
   Dohi O, 2008, CANCER SCI, V99, P518, DOI 10.1111/j.1349-7006.2007.00673.x
   Fujimoto J, 1999, STEROIDS, V64, P526, DOI 10.1016/S0039-128X(99)00025-2
   Gillis JL, 2013, ONCOTARGET, V4, P691, DOI 10.18632/oncotarget.975
   Hao YJ, 2010, BREAST CANCER RES TR, V124, P815, DOI 10.1007/s10549-010-0907-y
   Jones D, 2015, ONCOTARGET, V6, P29782, DOI 10.18632/oncotarget.4927
   Lombard AP, 2015, ENDOCR-RELAT CANCER, V22, pR265, DOI 10.1530/ERC-15-0209
   Luo J, 2015, ONCOTARGET, V6, P27555, DOI 10.18632/oncotarget.4515
   Magri F, 2012, ENDOCR-RELAT CANCER, V19, P463, DOI 10.1530/ERC-11-0389
   Mehdipour P, 2011, BREAST J, V17, P39, DOI 10.1111/j.1524-4741.2010.01031.x
   Meng XR, 2016, ONCOTARGET, V7, P2105, DOI 10.18632/oncotarget.6012
   Perner S, 2015, ONCOTARGET, V6, P35542, DOI 10.18632/oncotarget.4689
   Qiu MT, 2015, ONCOTARGET, V6, P31702, DOI 10.18632/oncotarget.5165
   Rossi R, 1996, J ENDOCRINOL, V148, P77, DOI 10.1677/joe.0.1480077
   Shafi AA, 2015, ONCOTARGET, V6, P31997, DOI 10.18632/oncotarget.5585
   SLEDDENS HFBM, 1993, HUM MOL GENET, V2, P493, DOI 10.1093/hmg/2.4.493
   Stanley JA, 2012, J STEROID BIOCHEM, V130, P105, DOI 10.1016/j.jsbmb.2012.02.004
   Stelloo S, 2015, EMBO MOL MED
   TAKEUCHI M, 1994, BIOCHEM BIOPH RES CO, V204, P905, DOI 10.1006/bbrc.1994.2545
   Visvanathan K, 2004, J UROLOGY, V171, P652, DOI 10.1097/01.ju.0000108384.74718.73
   Wagle S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13144
   Wu M, 2015, ONCOTARGET, V6, P6136, DOI 10.18632/oncotarget.3346
   Yoo S, 2014, CANCER EPIDEM BIOMAR, V23, P2027, DOI 10.1158/1055-9965.EPI-14-0020
   Zhang BG, 2014, ONCOTARGET, V5, P10584, DOI 10.18632/oncotarget.2513
   Zhu T, 2015, GENE
NR 28
TC 1
Z9 1
U1 3
U2 5
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD OCT 18
PY 2016
VL 7
IS 42
BP 68151
EP 68155
DI 10.18632/oncotarget.11902
PG 5
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA EB5UT
UT WOS:000387446800036
PM 27626686
OA Other Gold, Green Published
DA 2018-12-27
ER

PT J
AU Huang, ZM
   Huang, WQ
   Dong, TG
   Wang, G
   Wu, XK
AF Huang, Zhong-Mei
   Huang, Wei-Qi
   Dong, Tai-Ge
   Wang, Gang
   Wu, Xue-Ke
TI RETRACTED: Enhanced Emission of Quantum System in Si-Ge Nanolayer
   Structure (Retracted article. See vol. 13, artn 46, 2018)
SO NANOSCALE RESEARCH LETTERS
LA English
DT Article; Retracted Publication
DE Quantum system; Si-Ge nanolayer structure; (100) and (111) direction;
   Super-lattice
ID WELL STRUCTURES; SILICON
AB It is very interesting that the enhanced peaks near 1150 and 1550 nm are observed in the photoluminescence (PL) spectra in the quantum system of Si-Ge nanolayer structure, which have the emission characteristics of a three-level system with quantum dots (QDs) pumping and emission of quasi-direct-gap band, in our experiment. In the preparing process of Si-Ge nanolayer structure by using a pulsed laser deposition method, it is discovered that the nanocrystals of Si and Ge grow in the (100) and (111) directions after annealing or electron beam irradiation. The enhanced PL peaks with multi-longitudinal-mode are measured at room temperature in the super-lattice of Si-Ge nanolayer quantum system on SOI.
C1 [Huang, Zhong-Mei] Fudan Univ, State Key Lab Surface Phys, Key Lab Micro & Nano Photon Struct, Minist Educ, Shanghai 200433, Peoples R China.
   [Huang, Zhong-Mei] Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China.
   [Huang, Zhong-Mei; Huang, Wei-Qi; Dong, Tai-Ge; Wang, Gang; Wu, Xue-Ke] Guizhou Univ, Inst Nanophoton Phys, Guiyang 550025, Peoples R China.
RP Huang, WQ (reprint author), Guizhou Univ, Inst Nanophoton Phys, Guiyang 550025, Peoples R China.
EM wqhuang@gzu.edu.cn
FU National Natural Science Foundation of China [11264007, 61465003]
FX This work was supported by the National Natural Science Foundation of
   China (Grant No.11264007, 61465003).
CR Barbagiovanni EG, 2014, APPL PHYS REV, V1, DOI 10.1063/1.4835095
   Chaisakul P, 2010, OPT LETT, V35, P2913, DOI 10.1364/OL.35.002913
   Das S., J APPL PHYS, V110
   El Kurdi M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3297883
   El Kurdi M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3138155
   Huang WQ, 2015, SCI REP-UK, V4, DOI 10.1038/srep09932
   Huang WQ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4761945
   Kirchain R, 2007, NAT PHOTONICS, V1, P303, DOI 10.1038/nphoton.2007.84
   Kuo YH, 2005, NATURE, V437, P1334, DOI 10.1038/nature04204
   LU ZH, 1995, NATURE, V378, P258, DOI 10.1038/378258a0
   Pavesi L, 2000, NATURE, V408, P440, DOI 10.1038/35044012
   Ren S, 2012, IEEE PHOTONIC TECH L, V24, P461, DOI 10.1109/LPT.2011.2181496
   Sun XC, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3170870
   Tahini H, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/19/195802
   Yang M, 2014, OPT LETT, V39, P343, DOI 10.1364/OL.39.000343
   Zhang Y, 2015, IEEE PHOTONIC TECH L, V27, P1026, DOI 10.1109/LPT.2015.2405555
NR 16
TC 2
Z9 2
U1 2
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1556-276X
J9 NANOSCALE RES LETT
JI Nanoscale Res. Lett.
PD OCT 18
PY 2016
VL 11
AR 462
DI 10.1186/s11671-016-1682-4
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA EA3QP
UT WOS:000386519200004
PM 27757943
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Tabrizi, L
   Chiniforoshan, H
AF Tabrizi, Leila
   Chiniforoshan, Hossein
TI RETRACTED: New platinum(II) complex of CCC-pincer N-heterocyclic carbene
   ligand: Synthesis, characterization and photocatalytic hydrogen
   evolution (Retracted article. See vol. 153, pg. 299, 2018)
SO POLYHEDRON
LA English
DT Article; Retracted Publication
DE Carbene ligand'; Pt(II) complex; Hydrogen evolution; Photocatalytic
   activity; Colloidal platinum
ID VISIBLE-LIGHT IRRADIATION; AQUEOUS-SOLUTIONS; SUPRAMOLECULAR
   PHOTOCATALYST; MOLECULAR DEVICE; H-2 EVOLUTION; WATER; REDUCTION;
   GENERATION; SYSTEM; TIO2
AB New CCC-pincer N-heterocyclic carbene Pt(II) complex, [Pt((CCC)-C-TMP)Cl] (1) ((CCC)-C-TMP = 1,1'-(1,3-phenylene) bis(3-(2,4,6-trimethoxypheny1)-1H-benzo[d]imidazol-2-ylidene)) was synthesized and characterized by elemental analysis, IR, (C-13, H-1) NMR and ESI-MS spectroscopies. The emission quenching by Pt nanopartides and methyl viologen, photophysical and electrochemical properties were studied. Also, the photoinduced electron-transfer reactions were investigated in photocatalytic hydrogen-generating, system containing triethanolamine and colloidal Pt without an extra electron relay. The mixture of the platinum(II) complex and the corresponding electron relay, displayed that intramolecular electron transfer increases the photocatalytic efficiency. Moreover, the addition of methyl viologen has no obvious effects on the hydrogen generating efficiency, demonstrating electron transfer from the excited chromophore (complex 1) to colloidal Pt. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Tabrizi, Leila; Chiniforoshan, Hossein] Isfahan Univ Technol, Dept Chem, Esfahan 8415683111, Iran.
RP Tabrizi, L; Chiniforoshan, H (reprint author), Isfahan Univ Technol, Dept Chem, Esfahan 8415683111, Iran.
EM tabrizi79@gmail.com; Chinif@cc.iut.ac.ir
FU Department of Chemistry, Isfahan University of Technology (IUT)
FX We acknowledge general support from the Department of Chemistry, Isfahan
   University of Technology (IUT).
CR Abe R, 2000, J PHOTOCH PHOTOBIO A, V137, P63, DOI 10.1016/S1010-6030(00)00351-8
   ADAR E, 1986, J AM CHEM SOC, V108, P4696, DOI 10.1021/ja00276a002
   Amao Y, 2008, CATAL COMMUN, V9, P131, DOI 10.1016/j.catcom.2007.05.035
   Bae E, 2006, J PHYS CHEM B, V110, P14792, DOI 10.1021/jp062540+
   Chakraborty S, 2005, INORG CHEM, V44, P6284, DOI 10.1021/ic050688m
   Chianese AR, 2010, ORGANOMETALLICS, V29, P3019, DOI 10.1021/om100302g
   Du PW, 2009, INORG CHEM, V48, P4952, DOI 10.1021/ic900389z
   Du PW, 2006, J AM CHEM SOC, V128, P7726, DOI 10.1021/ja0610683
   Elvington M, 2007, J AM CHEM SOC, V129, P10644, DOI 10.1021/ja073123t
   Esswein AJ, 2007, CHEM REV, V107, P4022, DOI 10.1021/cr050193e
   Han Z., 2012, ANGEW CHEM, V124, P1699, DOI DOI 10.1002/ANIE.201107329
   Han ZJ, 2012, ANGEW CHEM INT EDIT, V51, P1667, DOI 10.1002/anie.201107329
   Hartwig JF, 1999, J ORG CHEM, V64, P5575, DOI 10.1021/jo990408i
   Jarosz P, 2009, INORG CHEM, V48, P9653, DOI 10.1021/ic9001913
   Jarosz P, 2008, ENERG ENVIRON SCI, V1, P573, DOI 10.1039/b807513c
   KALYANASUNDARAM K, 1980, HELV CHIM ACTA, V63, P478, DOI 10.1002/hlca.19800630219
   KALYANASUNDARAM K, 1978, HELV CHIM ACTA, V61, P2720, DOI 10.1002/hlca.19780610740
   KALYANASUNDARAM K, 1983, J CHEM SOC FARAD T 2, V79, P1365, DOI 10.1039/f29837901365
   KELLER P, 1980, NOUV J CHIM, V4, P377
   Khramov DM, 2006, ORG LETT, V8, P1831, DOI 10.1021/ol060349c
   KIRCH M, 1979, HELV CHIM ACTA, V62, P1345, DOI 10.1002/hlca.19790620449
   Komatsu T, 2006, J AM CHEM SOC, V128, P16297, DOI 10.1021/ja0656806
   Kotani H, 2011, CHEM-EUR J, V17, P2777, DOI 10.1002/chem.201002399
   Lai SW, 2010, CHEM-ASIAN J, V5, P60, DOI 10.1002/asia.200900304
   LEHN JM, 1977, NOUV J CHIM, V1, P449
   Li Q, 2014, PHYS CHEM CHEM PHYS, V16, P6550, DOI 10.1039/c4cp00626g
   Luo GG, 2015, PHYS CHEM CHEM PHYS, V17, P9716, DOI 10.1039/c5cp00732a
   Maeda K, 2015, ACS CATAL, V5, P1700, DOI 10.1021/acscatal.5b00040
   MCLENDON G, 1980, J CHEM SOC CHEM COMM, P533, DOI 10.1039/c39800000533
   McNamara WR, 2011, J AM CHEM SOC, V133, P15368, DOI 10.1021/ja207842r
   MORADPOUR A, 1978, NOUV J CHIM, V2, P547
   OKURA I, 1985, INORG CHEM, V24, P451, DOI 10.1021/ic00198a001
   Ozawa H, 2006, J AM CHEM SOC, V128, P4926, DOI 10.1021/ja08087h
   Ozawa H, 2007, DALTON T, P1197, DOI 10.1039/b617617h
   PERSAUD L, 1987, J AM CHEM SOC, V109, P7309, DOI 10.1021/ja00258a011
   Rau S, 2006, ANGEW CHEM INT EDIT, V45, P6215, DOI 10.1002/anie.200600543
   Sabatini RP, 2014, J AM CHEM SOC, V136, P7740, DOI 10.1021/ja503053s
   Sabatini RP, 2011, J PHYS CHEM LETT, V2, P223, DOI 10.1021/jz101697y
   Sadighi JP, 1998, TETRAHEDRON LETT, V39, P5327, DOI 10.1016/S0040-4039(98)00988-5
   Sahai R., 1986, CHEM COMMUN, P1133
   Schneider J, 2009, INORG CHEM, V48, P4306, DOI 10.1021/ic801947v
   Singh W. M., 2012, ANGEW CHEM, V124, P1685
   Singh WM, 2012, ANGEW CHEM INT EDIT, V51, P1653, DOI 10.1002/anie.201106494
   Starha P, 2014, MOLECULES, V19, P3832, DOI 10.3390/molecules19033832
   Teets TS, 2011, CHEM COMMUN, V47, P9268, DOI 10.1039/c1cc12390d
   Teets TS, 2011, J AM CHEM SOC, V133, P8114, DOI 10.1021/ja201972v
   Tschierlei S., 2010, ANGEW CHEM, V122, P4073
   Tschierlei S, 2010, ANGEW CHEM INT EDIT, V49, P3981, DOI 10.1002/anie.200906595
   Xu QQ, 2008, CATAL COMMUN, V10, P49, DOI 10.1016/j.catcom.2008.07.034
   Zhang J, 2007, J AM CHEM SOC, V129, P7726, DOI 10.1021/ja071789h
NR 50
TC 1
Z9 1
U1 4
U2 23
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0277-5387
J9 POLYHEDRON
JI Polyhedron
PD OCT 15
PY 2016
VL 117
BP 209
EP 213
DI 10.1016/j.poly.2016.05.057
PG 5
WC Chemistry, Inorganic & Nuclear; Crystallography
SC Chemistry; Crystallography
GA DX4XN
UT WOS:000384384500025
DA 2018-12-27
ER

PT J
AU Hu, ZX
   Chen, DY
   Dong, JY
   Li, Q
   Chen, ZW
   Yin, DG
   Zhao, B
   Wu, CML
   Shek, CH
AF Hu, Zhixiang
   Chen, Dayong
   Dong, Jingyu
   Li, Qi
   Chen, Zhiwen
   Yin, Dongguang
   Zhao, Bing
   Wu, C. M. Lawrence
   Shek, Chan-Hung
TI RETRACTED: Facile synthesis of hierarchical Mn3O4 superstructures and
   efficient catalytic performance (Retracted article. See vol. 19, pg.
   25221, 2017)
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article; Retracted Publication
ID MAGNETIC-PROPERTIES; NANOCRYSTALS FABRICATION; ORIENTED ATTACHMENT;
   OXIDE NANOCRYSTALS; LASER-ABLATION; NANOPARTICLES; NANOWIRES; NANORODS;
   MN2O3; MNO
AB The development of novel materials with excellent performance depends not only on the constituents but also on their remarkable micro/nanostructures. In this work, manganese oxide (Mn3O4) hausmannite structures with a uniform three-dimensional (3D) flower-like hierarchical architecture have been successfully synthesized by a novel chemical route using surfactants as structure-directing agents. Microstructure analysis indicates that the obtained 3D flower-like Mn3O4 superstructure consists of a large number of two-dimensional (2D) Mn3O4 nanosheets, which is different from the reported 3D Mn3O4 hierarchical structures based on zero-dimensional nanoparticles or one-dimensional nanowires and nanorods. This 3D Mn3O4 hierarchical architecture provides us with another type of manganese oxide with different superstructural characteristics, which may have potential practical applications in the catalytic degradation of organic pollutants. The catalytic performance of this hierarchical Mn3O4 superstructure, which was prepared by three different types of structure-directing agents, including cetyltrimethylammonium bromide (CTAB), poly(vinylpyrrolidone) (PVP), and poly(ethylene oxide)poly( propylene oxide) (P123), was evaluated for the catalytic degradation of organic pollutants, e.g. methylene blue. Interestingly, the hierarchical Mn3O4 superstructure prepared using CTAB as a template showed efficient catalytic degradation. The formation processes and possible growth mechanism of this novel 3D Mn3O4 hierarchical superstructure assembled by 2D Mn3O4 nanosheets are discussed in detail.
C1 [Hu, Zhixiang; Chen, Dayong; Dong, Jingyu; Li, Qi; Chen, Zhiwen; Yin, Dongguang; Zhao, Bing] Shanghai Univ, Sch Environm & Chem Engn, Shanghai 200444, Peoples R China.
   [Chen, Zhiwen; Wu, C. M. Lawrence; Shek, Chan-Hung] City Univ Hong Kong, Dept Phys & Mat Sci, Chee Ave, Kowloon, Hong Kong, Peoples R China.
RP Chen, ZW; Zhao, B (reprint author), Shanghai Univ, Sch Environm & Chem Engn, Shanghai 200444, Peoples R China.; Chen, ZW; Shek, CH (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM zwchen@shu.edu.cn; bzhao@shu.edu.cn; apchshek@cityu.edu.hk
RI Chen, Zhiwen/S-7256-2016; SHEK, Chan Hung/J-3857-2015
OI Chen, Zhiwen/0000-0001-9625-8556; SHEK, Chan Hung/0000-0002-6870-523X
FU National Natural Science Foundation of China [11375111, 11428410,
   11074161, 11575105]; Research Fund for the Doctoral Program of Higher
   Education of China [20133108110021]; Key Innovation Fund of Shanghai
   Municipal Education Commission [14ZZ098, 10ZZ64]; Peak Discipline
   Construction Program of Shanghai Municipal Education Commission
   [N.13-A302-15-L02]; Science and Technology Commission of Shanghai
   Municipality [14JC1402000, 10JC1405400]; Shanghai Pujiang Program
   [10PJ1404100]; Program for Changjiang Scholars and Innovative Research
   Team in University [IRT13078]; Research Grants Council of the Hong Kong
   Special Administrative Region, China [CityU 119212]
FX The work described in this article was financially supported by the
   National Natural Science Foundation of China (11375111, 11428410,
   11074161 and 11575105), the Research Fund for the Doctoral Program of
   Higher Education of China (20133108110021), the Key Innovation Fund of
   Shanghai Municipal Education Commission (14ZZ098 and 10ZZ64), the Peak
   Discipline Construction Program of Shanghai Municipal Education
   Commission (N.13-A302-15-L02), the Science and Technology Commission of
   Shanghai Municipality (14JC1402000 and 10JC1405400), the Shanghai
   Pujiang Program (10PJ1404100), and the Program for Changjiang Scholars
   and Innovative Research Team in University (IRT13078). This work was
   also supported by a grant from the Research Grants Council of the Hong
   Kong Special Administrative Region, China (CityU 119212).
CR Ahmad T, 2004, J MATER CHEM, V14, P3406, DOI 10.1039/b409010a
   Armstrong AR, 1996, NATURE, V381, P499, DOI 10.1038/381499a0
   Chen C, 2012, NANOSCALE, V4, P2590, DOI 10.1039/c2nr12079h
   Chen ZW, 2011, PROG MATER SCI, V56, P901, DOI 10.1016/j.pmatsci.2011.02.001
   Chen ZW, 2012, CHEM REV, V112, P3833, DOI 10.1021/cr2004508
   Chen ZW, 2010, ACS NANO, V4, P1202, DOI 10.1021/nn901635f
   Chen ZW, 1997, J CRYST GROWTH, V180, P280, DOI 10.1016/S0022-0248(97)00215-7
   Du CS, 2008, ACTA MATER, V56, P3516, DOI 10.1016/j.actamat.2008.03.030
   Gong JX, 2012, NANO TODAY, V7, P564, DOI 10.1016/j.nantod.2012.10.008
   Holmes JD, 2000, SCIENCE, V287, P1471, DOI 10.1126/science.287.5457.1471
   Huang MH, 2001, ADV MATER, V13, P113, DOI 10.1002/1521-4095(200101)13:2<113::AID-ADMA113>3.0.CO;2-H
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jiao F, 2007, ADV MATER, V19, P4063, DOI 10.1002/adma.200700336
   Jiao F, 2007, ANGEW CHEM INT EDIT, V46, P3946, DOI 10.1002/anie.200700087
   Kao J, 2013, CHEM SOC REV, V42, P2654, DOI 10.1039/c2cs35375j
   Kodama RH, 1997, PHYS REV LETT, V79, P1393, DOI 10.1103/PhysRevLett.79.1393
   Law M., 2002, ANGEW CHEM, V114, P2511, DOI DOI 10.1002/1521-3757(20020703)114:13<2511::AID-ANGE2511>3.0.CO;2-N
   Lee GH, 2002, J AM CHEM SOC, V124, P12094, DOI 10.1021/ja027558m
   Leite ER, 2002, J NANOSCI NANOTECHNO, V2, P125, DOI 10.1166/jnn.2002.094
   Li J, 1997, APPL PHYS LETT, V70, P3047, DOI 10.1063/1.118745
   Li P, 2010, CHEM MATER, V22, P4232, DOI 10.1021/cm100831q
   Liu B, 2004, J PHYS CHEM B, V108, P2788, DOI 10.1021/jp037129q
   Liu L, 2010, J PHYS CHEM C, V114, P251, DOI 10.1021/jp909014w
   Liu YY, 2014, ACS APPL MATER INTER, V6, P9776, DOI 10.1021/am502191k
   MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961
   Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208
   Nakagawa Y, 2014, J AM CHEM SOC, V136, P3716, DOI 10.1021/ja410183q
   Nayak SK, 1999, J AM CHEM SOC, V121, P644, DOI 10.1021/ja981721p
   Oaki Y, 2007, ANGEW CHEM INT EDIT, V46, P4951, DOI 10.1002/anie.200700244
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120
   Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969
   Rusakova I, 2007, CHEM MATER, V19, P1369, DOI 10.1021/cm062649u
   Salazar-Alvarez G, 2007, J AM CHEM SOC, V129, P9102, DOI 10.1021/ja0714282
   Shanmugam S, 2008, J PHYS CHEM C, V112, P15752, DOI 10.1021/jp806175y
   Shao CL, 2004, J SOLID STATE CHEM, V177, P2628, DOI 10.1016/j.ssc.2004.04.003
   Soler-Illia GJAA, 2011, CHEM SOC REV, V40, P1107, DOI 10.1039/c0cs00208a
   Sun XM, 2006, CHEM-EUR J, V12, P2039, DOI 10.1002/chem.200500660
   Sun YF, 2015, CHEM SOC REV, V44, P623, DOI 10.1039/c4cs00236a
   Tan YW, 2011, CHEM COMMUN, V47, P1172, DOI 10.1039/c0cc00978d
   Tian ZR, 1997, SCIENCE, V276, P926, DOI 10.1126/science.276.5314.926
   WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975
   Wang DS, 2008, CHEM-EUR J, V14, P2507, DOI 10.1002/chem.200701668
   Wang M, 2014, PHYS CHEM CHEM PHYS, V16, P21742, DOI 10.1039/c4cp03407d
   Wang ZH, 2008, J CRYST GROWTH, V310, P4148, DOI 10.1016/j.jcrysgro.2008.06.025
   Xi BJ, 2008, CHEM-EUR J, V14, P9786, DOI 10.1002/chem.200801041
   Xu LP, 2008, CHEM MATER, V20, P308, DOI 10.1021/cm702207w
   Yu DP, 1998, SOLID STATE COMMUN, V105, P403, DOI 10.1016/S0038-1098(97)10143-0
   Yu T, 2009, CHEM MATER, V21, P2272, DOI 10.1021/cm900431b
   Yuan CZ, 2014, ANGEW CHEM INT EDIT, V53, P1488, DOI 10.1002/anie.201303971
   Zhang GQ, 2009, J APPL ELECTROCHEM, V39, P1033, DOI 10.1007/s10800-008-9751-8
   Zhang PQ, 2010, NANO RES, V3, P235, DOI 10.1007/s12274-010-1026-0
   Zhang WX, 2004, J CRYST GROWTH, V263, P394, DOI 10.1016/j.jcrysgro.2003.11.099
NR 52
TC 3
Z9 3
U1 9
U2 50
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD OCT 14
PY 2016
VL 18
IS 38
BP 26602
EP 26608
DI 10.1039/c6cp05004b
PG 7
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA DY5WL
UT WOS:000385175000028
PM 27711699
DA 2018-12-27
ER

PT J
AU Wahab, SS
   Hettige, S
   Mankad, K
   Aquilina, K
AF Wahab, Salima S.
   Hettige, Samantha
   Mankad, Kshtij
   Aquilina, Kristian
TI RETRACTED: Posterior fossa syndrome-a narrative review(Retracted
   article. See vol. 7, pg. 169, 2017)
SO QUANTITATIVE IMAGING IN MEDICINE AND SURGERY
LA English
DT Review; Retracted Publication
DE Posterior fossa syndrome (PFS); posterior fossa tumour; cerebellar
   mutism syndrome (CMS); neuroimaging
ID POSTOPERATIVE CEREBELLAR MUTISM; DIFFUSE CEREBRAL VASOSPASM;
   RISK-FACTORS; SUBSEQUENT DYSARTHRIA; TRANSIENT MUTISM; TUMOR RESECTION;
   CHILDREN; 4TH-VENTRICLE; SURGERY; MEDULLOBLASTOMA
AB Posterior fossa syndrome (PFS), or cerebellar mutism syndrome (CMS), is a collection of neurological symptoms that occur following surgical resection of a posterior fossa tumour, and is characterised by either a reduction or an absence of speech. Some authors suggest that CM is only one symptom of the CMS complex that also includes ataxia, hypotonia and irritability as well as cranial nerve deficits, neurobehavioral changes and urinary retention or incontinence. It is seen almost exclusively in children. In 1985 Rekate et al. published the first work describing CM as a clinical entity, occurring as a consequence of bilateral cerebellar injury. Other associated symptoms include visual impairment, altered mood, impaired swallowing and significant gross and fine motor deficits. The effects of this can have a devastating impact on both the patient and their carers, posing a significant clinical challenge to neurorehabilitation services. The reported incidence was between 8% and 31% of children undergoing surgery for posterior fossa tumour. The underlying pathologies include vasospasm, oedema, and axonal/neuronal injury. Neuroimaging has contributed to a better understanding of the anatomical location of postoperative injury. There have been a number of suggestions for treatment interventions for PFS. However, apart from some individual reports, there have been no clinical trials indicating possible benefit. Occupational therapy, speech and language therapy, as well as neurocognitive support, contribute to the recovery of these patients.
C1 [Wahab, Salima S.; Hettige, Samantha; Aquilina, Kristian] Great Ormond St Hosp NHS Fdn Trust, Dept Neurosurg, London, England.
   [Mankad, Kshtij] Great Ormond St Hosp NHS Fdn Trust, Dept Neuroradiol, London, England.
RP Aquilina, K (reprint author), Great Ormond St Hosp NHS Fdn Trust, Dept Neurosurg, London, England.
EM Kristian.Aquilina@gosh.nhs.uk
CR AGUIAR PH, 1995, CHILD NERV SYST, V11, P306, DOI 10.1007/BF00301766
   Alotaibi NM, 2013, J NEUROINTERV SURG, V5, P413, DOI 10.1136/neurintsurg-2012-010477
   Avula S, 2015, NEURO-ONCOLOGY, V17, P614, DOI 10.1093/neuonc/nou299
   Baron J C, 1981, Trans Am Neurol Assoc, V105, P459
   BARON JC, 1984, J CEREBR BLOOD F MET, V4, P140, DOI 10.1038/jcbfm.1984.22
   Caner H, 1999, SURG NEUROL, V51, P181, DOI 10.1016/S0090-3019(98)00120-7
   Catsman-Berrevoets CE, 1999, J NEUROL NEUROSUR PS, V67, P755, DOI 10.1136/jnnp.67.6.755
   Catsman-Berrevoets CE, 2010, CORTEX, V46, P933, DOI 10.1016/j.cortex.2009.10.007
   De Smet HJ, 2007, EUR J PAEDIATR NEURO, V11, P193, DOI 10.1016/j.ejpn.2007.01.007
   Deshmukh VR, 2006, NEUROSURGERY, V58, P202, DOI 10.1227/01.NEU.0000207373.26614.BF
   Dineen RC, 2012, 36 ESNR ANN M NEUR E, pS77
   Doxey D, 1999, PEDIATR NEUROSURG, V31, P131, DOI 10.1159/000028848
   Ersahin Y, 1998, CHILD NERV SYST, V14, P611, DOI 10.1007/s003810050283
   Ersahin Y, 1996, NEUROSURGERY, V38, P60
   Germano A, 1998, CHILD NERV SYST, V14, P114, DOI 10.1007/s003810050191
   Grill J, 2004, J NEUROSURG, V101, P152, DOI 10.3171/ped.2004.101.2.0152
   Gudrunardottir T, 2011, CHILD NERV SYST, V27, P1361, DOI 10.1007/s00381-011-1509-7
   Gudrunardottir T, 2011, CHILD NERV SYST, V27, P513, DOI 10.1007/s00381-010-1383-8
   Gudrunardottir T, 2011, CHILD NERV SYST, V27, P355, DOI 10.1007/s00381-010-1328-2
   HIRSCH JF, 1979, ACTA NEUROCHIR, V48, P1, DOI 10.1007/BF01406016
   Jacob JT, 2011, NEUROCRIT CARE, V14, P86, DOI 10.1007/s12028-010-9464-9
   Kim J, 2005, AM J NEURORADIOL, V26, P2224
   Korah MP, 2010, INT J RADIAT ONCOL, V77, P106, DOI 10.1016/j.ijrobp.2009.04.058
   Kupeli S, 2011, PEDIATR BLOOD CANCER, V56, P206, DOI 10.1002/pbc.22730
   Law N, 2012, NEURO-ONCOLOGY, V14, P1294, DOI 10.1093/neuonc/nos160
   Lee TT, 1998, PEDIATR NEUROSURG, V29, P300, DOI 10.1159/000028741
   LEROUX PD, 1991, SURG NEUROL, V36, P25, DOI 10.1016/0090-3019(91)90128-V
   MATSUSHIMA T, 1992, NEUROSURGERY, V30, P325, DOI 10.1227/00006123-199203000-00003
   Matsushima T, 2012, NEUROSURG REV, V35, P563, DOI 10.1007/s10143-012-0384-3
   Miller NG, 2010, AM J NEURORADIOL, V31, P288, DOI 10.3174/ajnr.A1821
   Morris EB, 2009, BRAIN, V132, P3087, DOI 10.1093/brain/awp241
   Mussi ACM, 2000, J NEUROSURG, V92, P812, DOI 10.3171/jns.2000.92.5.0812
   Ojemann JG, 2013, CHILD NERV SYST, V29, P2071, DOI 10.1007/s00381-013-2205-6
   Patay Z, 2014, AM J NEURORADIOL, V35, P797, DOI 10.3174/ajnr.A3762
   Patay Z, 2014, CEREBELLUM, V13, P580, DOI 10.1007/s12311-014-0575-2
   POLLACK IF, 1995, NEUROSURGERY, V37, P885, DOI 10.1227/00006123-199511000-00006
   Puget S, 2009, CANCER-AM CANCER SOC, V115, P1338, DOI 10.1002/cncr.24150
   Reed-Berendt R, 2014, CHILD NERV SYST, V30, P375, DOI 10.1007/s00381-014-2356-0
   REKATE HL, 1985, ARCH NEUROL-CHICAGO, V42, P697, DOI 10.1001/archneur.1985.04060070091023
   Robertson PL, 2006, J NEUROSURG, V105, P444, DOI 10.3171/ped.2006.105.6.444
   Sagiuchi T, 2001, ANN NUCL MED, V15, P157, DOI 10.1007/BF02988609
   Sherchan Prativa, 2013, Acta Neurochir Suppl, V118, P129, DOI 10.1007/978-3-7091-1434-6_23
   Siffert J, 2000, J NEURO-ONCOL, V48, P75, DOI 10.1023/A:1006483531811
   Soelva V, 2013, CHILD NERV SYST, V29, P597, DOI 10.1007/s00381-012-1973-8
   Tanriover N, 2004, J NEUROSURG, V101, P484, DOI 10.3171/jns.2004.101.3.0484
   Thomale UW, 2013, CHILD NERV SYST, V29, P717, DOI 10.1007/s00381-013-2074-z
   Tomasello F, 2015, ACTA NEUROCHIR, V157, P607, DOI 10.1007/s00701-015-2358-z
   VANDONGEN HR, 1994, NEUROLOGY, V44, P2040, DOI 10.1212/WNL.44.11.2040
   von Monakow C., 1914, LOKALIZATION GROSS H
   Wells EM, 2010, J NEUROSURG-PEDIATR, V5, P329, DOI 10.3171/2009.11.PEDS09131
NR 50
TC 1
Z9 1
U1 6
U2 11
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2223-4292
EI 2223-4306
J9 QUANT IMAGING MED SU
JI Quant. Imaging Med. Surg.
PD OCT
PY 2016
VL 6
IS 5
BP 582
EP 590
DI 10.21037/qims.2016.10.12
PG 9
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EG9OU
UT WOS:000391389300014
PM 27942479
OA Green Published
DA 2018-12-27
ER

PT J
AU Moaddab, A
   Dildy, GA
   Brown, HL
   Bateni, ZH
   Belfort, MA
   Sangi-Haghpeykar, H
   Clark, SL
AF Moaddab, Amirhossein
   Dildy, Gary A.
   Brown, Haywood L.
   Bateni, Zhoobin H.
   Belfort, Michael A.
   Sangi-Haghpeykar, Haleh
   Clark, Steven L.
TI RETRACTED: Health Care Disparity and State-Specific Pregnancy-Related
   Mortality in the United States, 2005-2014 (Retracted article. See vol.
   131, pg. 746, 2018)
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article; Retracted Publication
ID ADVANCED MATERNAL AGE; OUTCOMES
AB OBJECTIVE:To investigate factors associated with differential state maternal mortality ratios and to quantitate the contribution of various demographic factors to such variation.METHODS:In a population-level analysis study, we analyzed data from the Centers for Disease Control and Prevention National Center for Health Statistics database and the Detailed Mortality Underlying Cause of Death database (CDC WONDER) that contains mortality and population counts for all U.S. counties. Bivariate correlations between maternal mortality ratio and all maternal demographic, lifestyle, health, and medical service utilization characteristics were calculated. We performed a maximum likelihood factor analysis with varimax rotation retaining variables that were significant (P<.05) in the univariate analysis to deal with multicollinearity among the existing variables.RESULTS:The United States has experienced a continued increase in maternal mortality ratio since 2007 with rates of 21-22 per 100,000 live births in 2013 and 2014. This increase in mortality was most dramatic in non-Hispanic black women. There was a significant correlation between state mortality ranking and the percentage of non-Hispanic black women in the delivery population. Cesarean deliveries, unintended births, unmarried status, percentage of non-Hispanic black deliveries, and four or less prenatal visits were significantly (P<.05) associated with increased maternal mortality ratio.CONCLUSION:Interstate differences in maternal mortality ratios largely reflect a different proportion of non-Hispanic black or unmarried patients with unplanned pregnancies. Racial disparities in health care availability, access, or utilization by underserved populations are an important issue faced by states in seeking to decrease maternal mortality.
C1 Baylor Coll Med, Dept Obstet, Houston, TX 77030 USA.
   Baylor Coll Med, Dept Gynecol, Houston, TX 77030 USA.
   Duke Univ, Med Ctr, Durham, NC USA.
RP Clark, SL (reprint author), Baylor Coll Med, Dept Obstet & Gynecol, Texas Childrens Pavil Women,6651 Main St, Houston, TX 77030 USA.
EM Steven.Clark@bcm.edu
OI Dildy, Gary/0000-0003-1586-4357
CR 1. The Organisation for Economic Co- operation and Develop- ment ( OECD), 2016, OECD HLTH DAT HLTH S
   [Anonymous], 2016, URB PERC POP STAT HI
   Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11
   Brown HL, 2011, ANN EPIDEMIOL, V21, P73, DOI 10.1016/j.annepidem.2010.10.009
   Brown HL, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.04.036
   Callaghan WM, 2014, AM J OBSTET GYNECOL, V211, P581, DOI 10.1016/j.ajog.2014.07.041
   Centers for Disease Control and Prevention National Center for Health Statistics, 2016, VITALSTATS
   Clark SL, 2008, AM J OBSTET GYNECOL, V199, DOI [10.1016/j.ajog.2008.03.007, 10.1016/j.ajog.2008.05.009]
   Creanga AA, 2015, OBSTET GYNECOL, V125, P5, DOI 10.1097/AOG.0000000000000564
   Creanga AA, 2014, J WOMENS HEALTH, V23, P3, DOI 10.1089/jwh.2013.4617
   Deneux-Tharaux C, 2005, OBSTET GYNECOL, V106, P684, DOI 10.1097/01.AOG.0000174580.24281.e6
   Dildy GA, 1996, AM J OBSTET GYNECOL, V175, P668
   Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903
   Hamilton Brady E Ph D, 2015, Natl Vital Stat Rep, V64, P1
   Horon IL, 2005, AM J PUBLIC HEALTH, V95, P478, DOI 10.2105/AJPH.2004.040063
   Huh WK, 2004, AM J OBSTET GYNECOL, V190, P1249, DOI 10.1016/j.ajog.2003.12.006
   Kost K, 2015, UNINTENDED PREGNANCY
   Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1
   Martin JA, 2009, NATL VITAL STAT REP, V57, P1
   Martin JW, 2010, NATIVE AMERICANS, CHRISTIANITY, AND THE RESHAPING OF THE AMERICAN RELIGIOUS LANDSCAPE, P1
   Martin Joyce A, 2007, Natl Vital Stat Rep, V56, P1
   Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1
   Martin Joyce A, 2013, Natl Vital Stat Rep, V62, P1
   Martin Joyce A, 2012, Natl Vital Stat Rep, V61, P1
   Martin Joyce A, 2011, Natl Vital Stat Rep, V60, P1
   Martin Joyce A, 2010, Natl Vital Stat Rep, V59, P3
   Richards MK, 2016, J PERINATOL, V36, P272, DOI 10.1038/jp.2015.204
   United States Department of Health and Human Services Cen- ters for Disease Control and Prevention National Center for Health Statistics, 2015, UND CAUS DEATH 1999
   Verstraeten BSE, 2015, CLIN INVEST MED, V38, pE15, DOI 10.25011/cim.v38i1.22410
   Xu J, 2010, DEATHS FINAL DATA 20
   Xu Jiaquan, 2016, Natl Vital Stat Rep, V64, P1
NR 31
TC 15
Z9 15
U1 8
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD OCT
PY 2016
VL 128
IS 4
BP 869
EP 875
DI 10.1097/AOG.0000000000001628
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA DX6VT
UT WOS:000384523600025
PM 27607870
DA 2018-12-27
ER

PT J
AU Wei, P
   Yang, JW
   Lu, HW
   Mao, B
   Yang, WL
   Xu, JF
AF Wei, Ping
   Yang, Jia-Wei
   Lu, Hai-Wen
   Mao, Bei
   Yang, Wen-Lan
   Xu, Jin-Fu
TI RETRACTED: Combined inhaled corticosteroid and long-acting beta
   2-adrenergic agonist therapy for noncystic fibrosis bronchiectasis with
   airflow limitation An observational study(Retracted article. See vol.
   96, art no E6039, 2017)
SO MEDICINE
LA English
DT Article; Retracted Publication
DE inhaled; non-CF bronchiectasis; salmeterol-fluticasone; therapy
ID QUALITY-OF-LIFE; CLINICALLY STABLE BRONCHIECTASIS; CYSTIC-FIBROSIS;
   PSEUDOMONAS-AERUGINOSA; ADULT BRONCHIECTASIS; LUNG-FUNCTION;
   COLONIZATION; FLUTICASONE; INFLAMMATION; MECHANISMS
AB Background and objective: There is presently no clear evidence on the effect of combined treatment for non-cystic fibrosis (non-CF) bronchiectasis with inhaled corticosteroid (ICS) and long-acting beta 2-adrenergic agonist (LABA). The objective of this study is to assess the efficacy and safety of salmeterol-fluticasone combined inhaled therapy for non-CF bronchiectasis with airflow limitation.
   Methods: An observational study was performed in 120 non-CF bronchiectasis patients diagnosed by high-resolution computed tomography (HRCT) scanning of the chest. Patients received either routine therapy or salmeterol-fluticasone (100/500 mu g daily) combined inhaled therapy on the basis of routine therapy. Clinical symptoms, health-related quality of life (HRQL), lung function, short-acting beta 2-adrenergic agonist (SABA) use, and safety were monitored throughout the study.
   Results: OF the 120 subjects, 60 received combined inhaled therapy and 60 received routine therapy. Compared to the control group, the combined inhaled therapy group showed significant improvement in their clinical symptom scores (-2.21 vs. -0.31, P=0.002) and a reduction in number of weekly SABA usage (-4.2 vs. 0.1, P<0.01). In addition, patients in the inhaled therapy group achieved a significant improvement in HRQL based on mMRC (-1.51 vs. -0.31, P<0.005) and SGRQ (-7.83 vs. -2.16, P<0.01) scoring accompanied with no severe adverse events. There were fewer exacerbation frequencies in the combined inhaled therapy group over the 12 months of treatment compared to the control group (1 [0-2] vs. 2 [1-4], P=0.017). Furthermore, stratified analysis indicated that combined inhaled therapy partially improve lung function for patients for whom it is severely impaired and those with pseudomonas aeruginosa isolated.
   Conclusion: Our results show that salmeterol-fluticasone combined inhaled therapy should be effective and safe for non-CF bronchiectasis patients especially for those patients with poor lung function or pseudomonas aeruginosa isolated.
C1 [Wei, Ping; Yang, Jia-Wei; Lu, Hai-Wen; Mao, Bei; Xu, Jin-Fu] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Resp & Crit Care Med, 507 Zhengmin Rd, Shanghai 200433, Peoples R China.
   [Yang, Wen-Lan] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Pulm Funct Test, Shanghai, Peoples R China.
RP Xu, JF (reprint author), Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Resp & Crit Care Med, 507 Zhengmin Rd, Shanghai 200433, Peoples R China.
EM jfxucn@gmail.com
FU National Science Foundation of China [NSFC81370109]; Programs from STCSM
   [134119a6400]; Innovation Program of Shanghai Municipal Education
   Commission [13SG21]
FX This work was financially supported by the National Science Foundation
   of China (NSFC81370109); Programs from STCSM (134119a6400), and
   Innovation Program of Shanghai Municipal Education Commission (13SG21),
   which did not play any role in the study design, literature search,
   study selection, collection and analysis of data, interpretation of
   results, or drafting of the manuscript.
CR Martinez-Garcia MA, 2012, CHEST, V141, P461, DOI 10.1378/chest.11-0180
   Angrill J, 2001, AM J RESP CRIT CARE, V164, P1628, DOI 10.1164/ajrccm.164.9.2105083
   Banov C, 2003, ALLERGY ASTHMA PROC, V24, P129
   Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070
   Chalmers JD, 2013, MOL IMMUNOL, V55, P27, DOI 10.1016/j.molimm.2012.09.011
   Evans SA, 1996, EUR RESPIR J, V9, P1601, DOI 10.1183/09031936.96.09081601
   Finch S, 2015, ANN AM THORAC SOC, V12, P1602, DOI 10.1513/AnnalsATS.201506-333OC
   Fuschillo S, 2008, EUR RESPIR J, V31, P396, DOI 10.1183/09031936.00069007
   Global Initiative for Asthma, 2009, GLOB STRAT ASTHM MAN
   Hassan J A, 1999, Respirology, V4, P423, DOI 10.1046/j.1440-1843.1999.00215.x
   Hernando R, 2012, INT J CLIN PHARM-NET, V34, P644, DOI 10.1007/s11096-012-9659-6
   Kapur N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000996.pub2
   King PT, 2006, RESP MED, V100, P2183, DOI 10.1016/j.rmed.2006.03.012
   Liu YP, 2015, RESPIROLOGY, V20, P312, DOI 10.1111/resp.12452
   MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580
   MAK JCW, 1995, J CLIN INVEST, V96, P99, DOI 10.1172/JCI118084
   Martinez-Garcia MA, 2005, CHEST, V128, P739, DOI 10.1378/chest.128.2.739
   Martinez-Garcia MA, 2006, RESP MED, V100, P1623, DOI 10.1016/j.rmed.2005.12.002
   Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490
   McShane PJ, 2013, AM J RESP CRIT CARE, V188, P647, DOI 10.1164/rccm.201303-0411CI
   Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
   Mostafapour Elyas, 2009, Lijec Vjesn, V131 Suppl 6, P8
   O'Donnell AE, 2008, CHEST, V134, P815, DOI 10.1378/chest.08-0776
   Pang LH, 2000, AM J RESP CELL MOL, V23, P79, DOI 10.1165/ajrcmb.23.1.3985
   Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119
   Tsang KW, 2005, THORAX, V60, P239, DOI 10.1136/thx.2002.003236
   Tsang KWT, 1998, AM J RESP CRIT CARE, V158, P723, DOI 10.1164/ajrccm.158.3.9710090
   Whitters D, 2012, THORAX, V67, P1006, DOI 10.1136/thoraxjnl-2011-200206
   Wilson CB, 1997, AM J RESP CRIT CARE, V156, P536, DOI 10.1164/ajrccm.156.2.9607083
NR 29
TC 4
Z9 5
U1 4
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD OCT
PY 2016
VL 95
IS 42
AR e5116
DI 10.1097/MD.0000000000005116
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA EB0EU
UT WOS:000387017000023
PM 27759640
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Ma, ZR
   Yin, W
   Hu, GH
   Zhu, ZH
   Huang, ZJ
AF Ma, Zhou-rui
   Yin, Wei
   Hu, Guan-hong
   Zhu, Zhen-hong
   Huang, Zhi-jian
TI RETRACTED: Effect of Paris polyphylla extract on second-degree burns in
   rats (Retracted article. See vol. 17, pg. 189, 2018)
SO TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Article; Retracted Publication
DE Paris polyphylla; Second-degree burns; Wound healing; Antibacterial;
   Inflammatory cells; Granulation tissues; Silver sulfadiazine
ID POLYGONUM-CUSPIDATUM
AB Purpose: To investigate the healing effect of Paris polyphylla extract (PPE) on second-degree burns in rats.
   Methods: Male Sprague Dawley (SD) rats, weighing 200 - 220 g, were subjected to deep second-degree skin burns by electrical scald instrument. The animals were divided into three groups as follows: (1) second-degree burn model (control) group, (2) burn model treated with 1 % silver sulfadiazine (SSD) group, and (3) burn model treated with 120 mg.mL(-1) PPE group. On days 3, 7 and 14 following the administration of the drug/extract, wound area and histopathological changes in rat epidermis were evaluated for the three groups. The minimum inhibitory concentration (MIC) of PPE on Staphyloccocus aureus, Pseudomonas aeruginosa and Escherichia coli were also assessed.
   Results: On day 14, the mean wound area of PPE treatment group (0.21 +/- 0.04 cm(2)) was significantly smaller than that of the control rats (2.78 +/- 0.18 cm(2), p < 0.01). Histological results indicate that inflammatory cells disappeared and were replaced by new granulation tissue in the group treated with 120 mg.mL(-1) PPE by day 14. Compared with SSD group rats, the inflammatory cells and fibroblast and granulation tissues of burnt rats with burns and treated with 120 mg.mL(-1) PPE decreased significantly. The antibacterial data revealed that the MIC of PPE against S. aureus, P. aeruginosa and E. coli was 2.35, 8.2 and 4.70 mg.mL(-1), respectively.
   Conclusion: Paris polyphylla is an effective medicinal herb that holds promise for the treatment of second-degree burns.
C1 [Ma, Zhou-rui; Yin, Wei; Hu, Guan-hong; Zhu, Zhen-hong; Huang, Zhi-jian] Soochow Univ, Childrens Hosp, Dept Burn & Plast Surg, Suzhou 215025, Peoples R China.
RP Huang, ZJ (reprint author), Soochow Univ, Childrens Hosp, Dept Burn & Plast Surg, Suzhou 215025, Peoples R China.
EM huangzhijian133@sina.com
FU Natural Science Foundation of Jiangsu Province of China (Youth Project)
   [BK20150295]
FX This study was supported by Natural Science Foundation of Jiangsu
   Province of China (Youth Project, grant no. BK20150295).
CR Burd A, 2007, WOUND REPAIR REGEN, V15, P94, DOI 10.1111/j.1524-475X.2006.00190.x
   Coelho Julice Medeiros, 2010, Rev. Col. Bras. Cir., V37, P045, DOI 10.1590/S0100-69912010000100010
   Edelman LS, 2007, BURNS, V33, P958, DOI 10.1016/j.burns.2007.05.002
   Hsu CY, 2007, BIOL RES, V40, P13, DOI 10.4067/S0716-97602007000100002
   Johnson R Michael, 2003, Adv Skin Wound Care, V16, P178, DOI 10.1097/00129334-200307000-00010
   Khodja AN, 2013, BURNS, V39, P98, DOI 10.1016/j.burns.2012.05.021
   Kopp J, 2003, BURNS, V29, P473, DOI 10.1016/S0305-4179(03)00053-6
   Lee JA, 2011, BURNS, V37, P117, DOI 10.1016/j.burns.2010.07.005
   Li AJ, 2007, AQUAC RES, V38, P1110, DOI 10.1111/j.1365-2109.2007.01745.x
   MASAKI H, 1995, BIOL PHARM BULL, V18, P162
   Pazyar N, 2014, SKIN PHARMACOL PHYS, V27, P303, DOI 10.1159/000357477
   Peng W, 2013, J ETHNOPHARMACOL, V148, P729, DOI 10.1016/j.jep.2013.05.007
   Shanmugasundaram N, 2009, J BIOMED MATER RES A, V89A, P472, DOI 10.1002/jbm.a.31997
NR 13
TC 3
Z9 3
U1 1
U2 8
PU PHARMACOTHERAPY GROUP
PI BENIN CITY
PA UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA
SN 1596-5996
J9 TROP J PHARM RES
JI Trop. J. Pharm. Res.
PD OCT
PY 2016
VL 15
IS 10
BP 2131
EP 2135
DI 10.4314/tjpr.v15i10.11
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EA9HE
UT WOS:000386952600011
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Ren, YM
   Wang, XS
   Wei, ZJ
   Fan, BY
   Lin, W
   Zhou, XH
   Feng, SQ
AF Ren, Yi-Ming
   Wang, Xi-Shan
   Wei, Zhi-Jian
   Fan, Bao-You
   Lin, Wei
   Zhou, Xian-Hu
   Feng, Shi-Qing
TI RETRACTED: Efficacy, safety, and cost of surgical versus nonsurgical
   treatment for carpal tunnel syndrome: A systematic review and
   meta-analysis (Retracted article. See vol. 96, art no e6778, 2017)
SO MEDICINE
LA English
DT Review; Retracted Publication
DE carpal tunnel syndrome; conservative treatment; meta-analysis; surgical
   release; systematic review
ID RANDOMIZED CONTROLLED-TRIAL; LOCAL STEROID INJECTION; SURGERY; THERAPY;
   RELEASE; LASER
AB Background:Carpal tunnel syndrome (CTS) is a common peripheral nerve entrapment disease. Either surgical or conservative intervention for CTS patients is needed to choose. We conducted this systematic review and meta-analysis to compare the clinical efficacy, safety, and cost of surgical versus nonsurgical intervention.Methods:The eligible studies were acquired from PubMed, Medline, Embase, Web of Science, Google, and Cochrane Library. The data were extracted by 2 of the coauthors independently and were analyzed by RevMan5.3. Standardized mean differences (SMDs), odds ratios (ORs), and 95% confidence intervals (CIs) were calculated. Cochrane Collaboration Risk of Bias Tool and Newcastle-Ottawa Scale were used to assess risk of bias.Results:Thirteen studies including 9 randomized controlled trials (RCTs) and 4 observational studies were assessed. The methodological quality of the trials ranged from moderate to high. The difference of clinical efficacy was statistically significant between surgical and nonsurgical intervention, and nonsurgical treatment was more effective (OR=2.35, 95%CI=1.18-4.67, P=0.01). Meanwhile, different results were discovered by subgroup analysis. The pooled results of function improvement, symptom improvement, neurophysiological parameters improvement, and cost of care at different follow-up times showed that the differences were not statistically significant between the 2 interventions. The difference of complications and side-effects was statistically significant and conservative treatment achieved better result than surgery (OR=2.03, 95%CI=1.28-3.22, P=0.003). Sensitivity analysis proved the stability of the pooled results.Conclusion:Both surgical and conservative interventions had benefits in CTS. Nonsurgical treatment was more effective and safety than surgical treatment, but there were no significant differences in function improvement, symptom improvement, neurophysiological parameters improvement, and cost of care. Nonsurgical treatment is recommended as the optical choice for CTS. If conservative treatment fails, surgical release can be taken.
C1 [Ren, Yi-Ming; Wei, Zhi-Jian; Fan, Bao-You; Lin, Wei; Zhou, Xian-Hu; Feng, Shi-Qing] Tianjin Med Univ, Gen Hosp, Dept Orthoped, Anshan Rd 154, Tianjin 300052, Peoples R China.
   [Wang, Xi-Shan] Peoples Hosp Rizhao, Dept Orthoped, Rizhao, Shandong, Peoples R China.
RP Zhou, XH; Feng, SQ (reprint author), Tianjin Med Univ, Gen Hosp, Dept Orthoped, Anshan Rd 154, Tianjin 300052, Peoples R China.
EM zhouxh007@126.com; sqfeng@tmu.edu.cn
FU Program for Research - Health Authority of Binhai New Area of Tianjin,
   China [2012BWKY028]; National Natural Science Foundation of China
   [81371957, 81330042]; Special Program for Sino-Russian Joint Research -
   Ministry of Science and Technology, China [2014DFR31210]; Key Program -
   Tianjin Science and Technology Committee, China [13RCGFSY19000,
   14ZCZDSY00044]
FX This work was supported by the Program for Research Sponsored by the
   Health Authority of Binhai New Area of Tianjin, China (2012BWKY028), the
   State Program of National Natural Science Foundation of China
   (81371957), the State Key Program of the National Natural Science
   Foundation of China (81330042), the Special Program for Sino-Russian
   Joint Research Sponsored by the Ministry of Science and Technology,
   China (2014DFR31210), and the Key Program Sponsored by the Tianjin
   Science and Technology Committee, China (13RCGFSY19000, 14ZCZDSY00044).
CR Aroori Somaiah, 2008, Ulster Med J, V77, P6
   Awan Abdus Saboor, 2015, J Ayub Med Coll Abbottabad, V27, P192
   Ayhan-Ardic FF, 2000, FUNCT NEUROL, V15, P157
   Bakhtiary AH, 2004, AUST J PHYSIOTHER, V50, P147, DOI 10.1016/S0004-9514(14)60152-5
   Bland JDP, 2003, J NEUROL NEUROSUR PS, V74, P1674, DOI 10.1136/jnnp.74.12.1674
   Bland JDP, 2007, BRIT MED J, V335, P343, DOI 10.1136/bmj.39282.623553AD
   Chang MH, 1998, NEUROLOGY, V51, P390, DOI 10.1212/WNL.51.2.390
   Cranford CS, 2007, J AM ACAD ORTHOP SUR, V15, P537, DOI 10.5435/00124635-200709000-00004
   De Angelis MV, 2009, ACTA NEUROL SCAND, V119, P68, DOI 10.1111/j.1600-0404.2008.01072.x
   Demirci S, 2002, RHEUMATOL INT, V22, P33, DOI 10.1007/s00296-002-0184-0
   Elwakil TF, 2007, LASER MED SCI, V22, P265, DOI 10.1007/s10103-007-0448-8
   GARLAND H, 1964, LANCET, V1, P1129
   Gerritsen AAM, 2002, JAMA-J AM MED ASSOC, V288, P1245, DOI 10.1001/jama.288.10.1245
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hui ACF, 2005, NEUROLOGY, V64, P2074, DOI 10.1212/01.WNL.0000169017.79374.93
   Jarvik JG, 2009, LANCET, V374, P1074, DOI 10.1016/S0140-6736(09)61517-8
   Korthals-de Bos IBC, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-86
   Ly-Pen D, 2012, RHEUMATOLOGY, V51, P1447, DOI 10.1093/rheumatology/kes053
   Marshall S, 2000, COCHRANE DB SYST REV, V2
   Martin BI, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-2
   Padua L, 2001, NEUROLOGY, V56, P1459, DOI 10.1212/WNL.56.11.1459
   Piazzini D, 2007, CLIN REHABIL, V21, P299, DOI 10.1177/0269215507077294
   Pomerance J, 2009, J HAND SURG-AM, V34A, P1193, DOI 10.1016/j.jhsa.2009.04.034
   Seradge H., 1993, J HAND SURG-AM A, V18, P704
   Shi QY, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-17
   Shiri R, 2009, OCCUP ENVIRON MED, V66, P368, DOI 10.1136/oem.2008.039719
   Shrier I, 2007, AM J EPIDEMIOL, V166, P1203, DOI 10.1093/aje/kwm189
   SPINNER RJ, 1989, MAYO CLIN PROC, V64, P829, DOI 10.1016/S0025-6196(12)61756-X
   TANAKA S, 1994, AM J PUBLIC HEALTH, V84, P1846, DOI 10.2105/AJPH.84.11.1846
   Ucan H, 2006, RHEUMATOL INT, V27, P45, DOI 10.1007/s00296-006-0163-y
   Verdugo RJ, 2003, COCHRANE DATABASE SY, V47
   Wells G, NEWCASTLE OTTAWA SCA
NR 32
TC 9
Z9 9
U1 4
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD OCT
PY 2016
VL 95
IS 40
AR e4857
DI 10.1097/MD.0000000000004857
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA EA1KL
UT WOS:000386350900021
PM 27749538
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Velez, N
   Escandon, P
AF Velez, Norida
   Escandon, Patricia
TI RETRACTED: Distribution and association between environmental and
   clinical isolates of Cryptococcus neoformans in Bogota-Colombia,
   2012-2015(Retracted article. See vol.112,pg.796,2017)
SO MEMORIAS DO INSTITUTO OSWALDO CRUZ
LA English
DT Article; Retracted Publication
DE Cryptococcus neoformans; cryptococcosis; environment; Colombia
ID HIV-ASSOCIATED CRYPTOCOCCOSIS; SPECIES COMPLEX; TRUNK HOLLOWS; MOLECULAR
   EPIDEMIOLOGY; DECAYING WOOD; LIVING TREES; VAR. GRUBII; GATTII;
   PREVALENCE; GENOTYPE
AB The propagules of the fungal species Cryptococcus neoformans and C. gattii, whose varieties are distributed world wide, are the primary cause of cryptococcosis, a life threatening disease. The study of environmental and clinical isolates of Cryptococcosis is an important contribution to the epidemiology and ecology of the fungus. The aim of this work was to determine the presence of C. neoformans and C. gattii in the environment in Bogota, Colombia's capital city and to establish the relation between clinical and environmental isolates in the period 2012-2015. From a total of 4.116 environmental samples collected between October 2012 - March 2014, 35 were positive for C. neoformans var. grubii. From 55 cryptococcosis cases reported in Bogota during 2012-2015, 49 isolates were recovered. From those, 94% were identified as C. neoformans var. grubii molecular type VNI; 4% as VNII and 1,2% as C. neoformans var neoformans VNIV. The 84 detected clinical and environmental isolates studied had a similarity between 49-100% according with molecular typing. The correlation between environmental and clinical samples confirms the hypothesis that patients acquire the disease from environmental exposure to the fungal propagules.
C1 [Velez, Norida; Escandon, Patricia] Inst Nacl Salud, Grp Microbiol, Bogota, Colombia.
RP Escandon, P (reprint author), Inst Nacl Salud, Grp Microbiol, Bogota, Colombia.
EM pescandon@ins.gov.co
FU Instituto Nacional de Salud, Departamento Administrativo de Ciencia,
   Tecnologia e Innovacion Colciencias [2011-3600115683]
FX Instituto Nacional de Salud, Departamento Administrativo de Ciencia,
   Tecnologia e Innovacion Colciencias (grant no 2011-3600115683).
CR Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306
   Cabral Passoni L F, 1999, Rev Iberoam Micol, V16, P77
   Castaneda A., 2001, Biomedica, V21, P75
   Chau TTH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-199
   Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x
   Cogliati M, 2013, SCIENTIFICA, DOI 10.1155/2013/675213
   ELLIS D, 1992, EUR J EPIDEMIOL, V8, P321, DOI 10.1007/BF00158562
   ELLIS DH, 1990, LANCET, V336, P923, DOI 10.1016/0140-6736(90)92283-N
   Ergin C, 2004, MYCOSES, V47, P431, DOI 10.1111/j.1439-0507.2004.01018.x
   Escandon P, 2006, FEMS YEAST RES, V6, P625, DOI 10.1111/j.1567-1364.2006.00055.x
   Escandon P, 2010, MED MYCOL, V48, P675, DOI 10.3109/13693780903420633
   Escandon P, 2012, BIOMEDICA, V32, P386, DOI [10.1590/S0120-41572012000300009, 10.7705/biomedica.v32i3.707]
   Feng XB, 2008, FEMS YEAST RES, V8, P930, DOI 10.1111/j.1567-1364.2008.00422.x
   Francis X, 2013, INT J CURR MICROBIOL, V11, P404
   Colom MF, 2012, MED MYCOL, V50, P67, DOI 10.3109/13693786.2011.574239
   Granados DP, 2006, FEMS YEAST RES, V6, P636, DOI 10.1111/j.1567-1364.2006.00090.x
   Granados DP, 2005, MICROBIAL ECOL, V49, P282, DOI 10.1007/s00248-004-0236-y
   Grover N, 2007, MYCOPATHOLOGIA, V164, P159, DOI 10.1007/s11046-007-9039-2
   Hagen F, 2015, FUNGAL GENET BIOL, V78, P16, DOI 10.1016/j.fgb.2015.02.009
   Hagen F, 2012, EMERG INFECT DIS, V18, P1618, DOI 10.3201/eid1810.120068
   Hagen F, 2010, MYCOPATHOLOGIA, V170, P209, DOI 10.1007/s11046-010-9313-6
   Heitman J, 2011, CRYPTOCOCCUS HUMAN P, P565
   Hull CM, 2002, ANNU REV GENET, V36, P557, DOI 10.1146/annurev.genet.36.052402.152652
   Jain N, 2005, J CLIN MICROBIOL, V43, P5733, DOI 10.1128/JCM.43.11.5733-5742.2005
   Kuroki M, 2004, YEAST, V21, P809, DOI 10.1002/yea.1112
   KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535
   Lizarazo J, 2014, MEM I OSWALDO CRUZ, V109, P797, DOI 10.1590/0074-0276130537
   Meyer W, 2003, EMERG INFECT DIS, V9, P189
   Ordonez N., 1994, Biomedica, V14, P131
   PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305
   Quintero Elizabeth, 2005, Revista Iberoamericana de Micologia, V22, P93
   Randhawa HS, 2001, MYCOPATHOLOGIA, V151, P63, DOI 10.1023/A:1010906220888
   Refojo N, 2009, MED MYCOL, V47, P177, DOI 10.1080/13693780802227290
   Rosario I, 2008, REV IBEROAM MICOL, V25, pS13, DOI 10.1016/S1130-1406(08)70020-2
   Springer DJ, 2010, EMERG INFECT DIS, V16, P14, DOI 10.3201/eid1601.090369
   Tay ST, 2010, MYCOSES, V53, P509, DOI 10.1111/j.1439-0507.2009.01750.x
   Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008
   Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09
   Viviani MA, 2006, FEMS YEAST RES, V6, P614, DOI 10.1111/j.1567-1364.2006.00081.x
NR 39
TC 2
Z9 3
U1 2
U2 5
PU FUNDACO OSWALDO CRUZ
PI RIO DE JANEIRO, RJ
PA AV BRASIL 4365, 21045-900 RIO DE JANEIRO, RJ, BRAZIL
SN 0074-0276
EI 1678-8060
J9 MEM I OSWALDO CRUZ
JI Mem. Inst. Oswaldo Cruz
PD OCT
PY 2016
VL 111
IS 10
BP 642
EP 648
DI 10.1590/0074-02760160201
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA DZ0FY
UT WOS:000385514100006
PM 27706379
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Zheng, H
   Cheng, HJ
   Zhou, L
   Ye, Y
   Chen, JF
AF Zheng, Hao
   Cheng, Huijun
   Zhou, Lu
   Ye, Ying
   Chen, Jianfang
TI RETRACTED: Intercalated Polyaniline/Halloysite Nanocomposites by a
   Solvent-Free Mechanochemical Method(Retracted article. See
   vol.11,pg.1693001,2016)
SO NANO
LA English
DT Article; Retracted Publication
DE Polyaniline; halloysite; nanocomposites; mechanochemical method
ID IN-SITU POLYMERIZATION; TIO2-HALLOYSITE COMPOSITE NANOTUBES; LIGHT
   PHOTOCATALYTIC ACTIVITY; CLAY NANOCOMPOSITE; CHEMICAL POLYMERIZATION;
   CORROSION PROTECTION; AMPHIPHILIC DOPANTS; HALLOYSITE; PERFORMANCE;
   ANILINE
AB Intercalated polyaniline (PANI)/halloysite nanocomposites were prepared by pretreatment technology and mechanochemical synthesis method under solvent-free condition. X-ray diffraction (XRD) analysis revealed that PANI chains have successfully intercalated into the interlayers of halloysite, which was enlightened by the increased basal spacing of halloysite from 10.0 angstrom to 14.7 angstrom in the as-synthesized nanocomposites. The Fourier transform infrared (FT-IR) and the UV-Vis spectra verified the coexistence of PANI and halloysite in the nanocomposites as well as the interaction between the two components. Results from scanning electron microscopy (SEM) and transmission electron microscopy (TEM) revealed that halloysite in the nanocomposites became expanded, which further indicated the successful intercalation of PANI. The thermal stability of PANI/halloysite nanocomposites was examined using thermogravimetric analysis (TGA) and the results showed improved thermal stability of PANI in the resulting nanocomposites due to the retardation erect of halloysite for the degradation of PANI. Moreover, panel experiment was carried out under simulated marine environment to evaluate the anticorrosion effect of the nanocomposites, which showed a better anticorrosive effect than pure epoxy resin coating.
C1 [Zheng, Hao; Cheng, Huijun; Ye, Ying] Zhejiang Univ, Ocean Coll, Inst Marine Chem & Environm, Zhoushan 316021, Peoples R China.
   [Zhou, Lu] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China.
   [Chen, Jianfang] Second Inst Oceanog SOA, Key Lab Marine Ecosyst & Biogeochem, Hangzhou 310012, Zhejiang, Peoples R China.
RP Cheng, HJ (reprint author), Zhejiang Univ, Ocean Coll, Inst Marine Chem & Environm, Zhoushan 316021, Peoples R China.
EM merine@zju.edu.cn
FU open fund of Key Laboratory of Marine Ecosystem and Biogeochemistry of
   SOA [LMEB201403]; Public Science and Technology Research Program
   Foundation of Ocean [201405036-3]; NSF of China [91128212]
FX This work is financially supported by open fund of Key Laboratory of
   Marine Ecosystem and Biogeochemistry of SOA (LMEB201403) and the Public
   Science and Technology Research Program Foundation of Ocean
   (201405036-3). This work was also supported by the NSF of China
   (91128212).
CR Akbarinezhad E, 2011, PROG ORG COAT, V70, P39, DOI 10.1016/j.porgcoat.2010.09.016
   Armelin E, 2008, CORROS SCI, V50, P721, DOI 10.1016/j.corsci.2007.10.006
   Ates M, 2013, MAT SCI ENG C-MATER, V33, P1853, DOI 10.1016/j.msec.2013.01.035
   Azhar FF, 2014, POLYM BULL, V71, P1591, DOI 10.1007/s00289-014-1143-0
   Bhadra S, 2009, PROG POLYM SCI, V34, P783, DOI 10.1016/j.progpolymsci.2009.04.003
   Cavallaro G, 2011, J PHYS CHEM C, V115, P20491, DOI 10.1021/jp207261r
   Cavallaro G, 2011, LANGMUIR, V27, P1158, DOI 10.1021/la103487a
   Chen XN, 2014, NANOSCALE, V6, P8140, DOI 10.1039/c4nr01738b
   Chiu CW, 2014, PROG POLYM SCI, V39, P443, DOI 10.1016/j.progpolymsci.2013.07.002
   De Azevedo W., 2004, PHYS STATUS SOLIDI C, V1, pS249
   Dong Y, 2015, COMPOS PART A-APPL S, V76, P28, DOI 10.1016/j.compositesa.2015.05.011
   Dong Y, 2013, APPL PHYS A-MATER, V112, P747, DOI 10.1007/s00339-013-7789-x
   Ferrante F, 2015, J PHYS CHEM C, V119, P16700, DOI 10.1021/acs.jpcc.5b04281
   FU YP, 1994, CHEM MATER, V6, P671, DOI 10.1021/cm00041a018
   Ge CY, 2012, J COAT TECHNOL RES, V9, P59, DOI 10.1007/s11998-010-9316-8
   Gui DY, 2014, APPL SURF SCI, V307, P172, DOI 10.1016/j.apsusc.2014.04.007
   Gupta B, 2014, APPL CLAY SCI, V95, P50, DOI 10.1016/j.clay.2014.02.009
   Huang HB, 2016, J MATER SCI, V51, P4047, DOI 10.1007/s10853-016-9724-y
   Huang YF, 2012, POLYMER, V53, P1079, DOI 10.1016/j.polymer.2012.01.025
   Jin YH, 2014, APPL SURF SCI, V308, P333, DOI 10.1016/j.apsusc.2014.04.168
   Joussein E, 2007, APPL CLAY SCI, V35, P17, DOI 10.1016/j.clay.2006.07.002
   Kazim S, 2012, J MATER SCI, V47, P420, DOI 10.1007/s10853-011-5815-y
   Kulhankova L, 2014, THIN SOLID FILMS, V562, P319, DOI 10.1016/j.tsf.2014.05.006
   Lee D, 2003, J MATER CHEM, V13, P2942, DOI 10.1039/b303235c
   Levis SR, 2002, INT J PHARM, V243, P125, DOI 10.1016/S0378-5173(02)00274-0
   Li CP, 2015, RSC ADV, V5, P98482, DOI 10.1039/c5ra20024e
   Li CP, 2015, J COLLOID INTERF SCI, V458, P1, DOI 10.1016/j.jcis.2015.07.025
   Li D, 2009, ACCOUNTS CHEM RES, V42, P135, DOI 10.1021/ar800080n
   Liu CX, 2008, POLYM ADVAN TECHNOL, V19, P1693, DOI 10.1002/pat.1105
   Lu J, 2002, J MATER CHEM, V12, P2603, DOI 10.1039/b203921d
   Luca V, 2000, J MATER CHEM, V10, P2121, DOI 10.1039/b000741m
   Mahla DK, 2015, POLYM COMPOSITE, V36, P445, DOI 10.1002/pc.22959
   Mousavinejad T, 2015, PROG ORG COAT, V79, P90, DOI 10.1016/j.porgcoat.2014.11.009
   Parfitt R. L., 1985, Catena Supplement, P1
   Reena VL, 2009, J APPL POLYM SCI, V113, P4066, DOI 10.1002/app.30525
   Sakhri A, 2010, CORROS SCI, V52, P901, DOI 10.1016/j.corsci.2009.11.010
   Sathiyanarayanan S, 2006, PROG ORG COAT, V55, P5, DOI 10.1016/j.porgcoat.2005.09.002
   Song DH, 2008, J PHYS CHEM SOLIDS, V69, P1383, DOI 10.1016/j.jpcs.2007.10.055
   Sudha JD, 2007, J POLYM SCI POL PHYS, V45, P2664, DOI 10.1002/polb.21273
   Sudha JD, 2007, MACROMOL SYMP, V254, P274, DOI 10.1002/masy.200750841
   Sun X, 2012, REACT FUNCT POLYM, V72, P323, DOI 10.1016/j.reactfunctpolym.2012.03.002
   Tai QD, 2011, ACS NANO, V5, P3795, DOI 10.1021/nn200133g
   Tang QW, 2009, MATER LETT, V63, P540, DOI 10.1016/j.matlet.2008.11.028
   Tang YH, 2011, COMPOS PART A-APPL S, V42, P345, DOI 10.1016/j.compositesa.2010.12.003
   Wang QF, 2012, APPL SURF SCI, V258, P9896, DOI 10.1016/j.apsusc.2012.06.047
   Wijeratne WMKT, 2012, J COMPOS MATER, V46, P1335, DOI 10.1177/0021998311418264
   Wu CS, 2008, J POLYM SCI POL CHEM, V46, P1800, DOI 10.1002/pola.22523
   Yoshimoto S, 2004, MACROMOL RAPID COMM, V25, P1687, DOI 10.1002/marc.200400299
   Yoshimoto S, 2004, SYNTHETIC MET, V145, P265, DOI 10.1016/j.synthmet.2004.05.011
   Zehhaf A, 2013, J INORG ORGANOMET P, V23, P1485, DOI 10.1007/s10904-013-9953-3
   Zhang L, 2008, APPL SURF SCI, V255, P2091, DOI 10.1016/j.apsusc.2008.06.187
   Zhang WL, 2012, COLLOID POLYM SCI, V290, P1743, DOI 10.1007/s00396-012-2719-6
   Zhang ZM, 2002, MACROMOLECULES, V35, P5937, DOI 10.1021/ma020199v
   Zhou C, 2011, J MATER SCI, V46, P446, DOI 10.1007/s10853-010-4909-2
NR 54
TC 2
Z9 2
U1 4
U2 33
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1793-2920
EI 1793-7094
J9 NANO
JI Nano
PD OCT
PY 2016
VL 11
IS 10
AR 1650112
DI 10.1142/S1793292016501125
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA DY9DM
UT WOS:000385433700006
DA 2018-12-27
ER

PT J
AU Tesar, V
   Travnicke, Z
   Peszynski, K
AF Tesar, Vaclav
   Travnicke, Zdenek
   Peszynski, Kazirnierz
TI RETRACTED: Impinging jets controlled by fluidic input signal (Retracted
   article. See vol. 276, pg. 346, 2018)
SO SENSORS AND ACTUATORS A-PHYSICAL
LA English
DT Article; Retracted Publication
DE Fluidics; Jets; Impinging jets; Coanda effect
ID HEAT-TRANSFER; MASS-TRANSFER; GAS; SURFACES
AB Impinging jets are the most effective method of heating, cooling, and drying of objects by fluid. They are generated in nozzles directed towards the object surface. This paper summarises experience obtained in developing a nozzle for the heating purpose. So far unique is its ability of switching between two different flow regimes without action of any mechanical (moved or deformed) components. The change takes place in response to a fluidic signal a small input control flow. Advantages are robustness, no maintenance, long life, resistance to high temperature, vibration, and acceleration. In absence of the control flow the generated jet is narrow, focused on a small central spot on the impingement surface. Admission of the control flow spreads the (less intensive) heat transport to a larger surface area. Because of the fast response (no inertia of moving components), the nozzle can be switched at high frequency thus achieving pulse-width continuous modulation of the heating. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Tesar, Vaclav; Travnicke, Zdenek] Acad Sci Czech Republ, Inst Thermomech, Vvi, Dolejskova Str 5, Prague 18200 8, Czech Republic.
   [Peszynski, Kazirnierz] Univ Technol & Life Sci, Bydgoszcz, Poland.
RP Tesar, V (reprint author), Acad Sci Czech Republ, Inst Thermomech, Vvi, Dolejskova Str 5, Prague 18200 8, Czech Republic.
EM tesar@it.cas.cz
OI Peszynski, Kazimierz/0000-0001-6551-0261
FU GACR - the Czech Science Foundation [13-23046S, 14-08888S]
FX This study was supported by research grants Nr. 13-23046S and Nr.
   14-08888S obtained from GACR - the Czech Science Foundation - and also
   by the institutional support RVO: 61388998.
CR Brouckova Z, 2015, J VISUAL-JAPAN, V18, P581, DOI 10.1007/s12650-014-0256-8
   Coanda H, 1936, U. S. Patent, Patent No. [2,052,869, 2052869, US 2052869A]
   Dyban E.P., 1982, KONVEKTIVNYJ TEPLOOB
   JAMBUNATHAN K, 1992, INT J HEAT FLUID FL, V13, P106, DOI 10.1016/0142-727X(92)90017-4
   Maki H, 1989, EXP HEAT TRANSFER, V2, P1
   MARTIN H, 1977, ADV HEAT TRANSFER, V13, P1
   Mueller T.J., 1983, FLUID MECH MEAS, V331
   NEAL SBHC, 1970, J PHYS E SCI INSTRUM, V3, P636, DOI 10.1088/0022-3735/3/8/312
   Perera P.C., 1983, AM SOC MECH ENG ASME
   Tesaf V., 2004, CHEM ENG RES DES, V82
   Tesaf V., 1998, REV APPL FLUIDODINAM, V39, P216
   Tesaf V., 2001, P 11 INT C REC BYDG
   Tesar V, 2006, SENSOR ACTUAT A-PHYS, V125, P159, DOI 10.1016/j.sna.2005.06.022
   Tesar V, 2005, CHEM ENG RES DES, V83, P1111, DOI 10.1205/cherd.04283
   Tesar V, 2015, TOP PROBL FLUID MECH, P199
   Tesar V, 2009, CHEM ENG RES DES, V87, P817, DOI 10.1016/j.cherd.2008.11.004
   Tesar V, 2016, EPJ WEB CONF, V114, DOI 10.1051/epjconf/201611402122
   Travnicek Z, 2004, INT J HEAT MASS TRAN, V47, P2329, DOI 10.1016/j.ijheatmasstransfer.2003.10.032
   Travnicek Z, 2003, INT J HEAT MASS TRAN, V46, P3291, DOI 10.1016/S0017-9310(03)00119-4
   VISKANTA R, 1993, EXP THERM FLUID SCI, V6, P111, DOI 10.1016/0894-1777(93)90022-B
   Zuckerman N., 2005, ADV HEAT TRANSFER, V39, P565
NR 21
TC 3
Z9 3
U1 1
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-4247
J9 SENSOR ACTUAT A-PHYS
JI Sens. Actuator A-Phys.
PD OCT 1
PY 2016
VL 249
BP 85
EP 92
DI 10.1016/j.sna.2016.08.013
PG 8
WC Engineering, Electrical & Electronic; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA DZ1LQ
UT WOS:000385600300011
DA 2018-12-27
ER

PT J
AU Jia, TZ
   Fahrenbach, AC
   Kamat, NP
   Adamala, KP
   Szostak, JW
AF Jia, Tony Z.
   Fahrenbach, Albert C.
   Kamat, Neha P.
   Adamala, Katarzyna P.
   Szostak, Jack W.
TI RETRACTED: Oligoarginine peptides slow strand annealing and assist
   non-enzymatic RNA replication (Retracted article. See vol. 9, pg. 1286,
   2017)
SO NATURE CHEMISTRY
LA English
DT Article; Retracted Publication
ID AMINO-ACIDS; LIQUID DROPLETS; DNA; ARGININE; BINDING; SYSTEM;
   POLYMERIZATION; PRECURSORS; MODEL; THERMODYNAMICS
AB The non-enzymatic replication of RNA is thought to have been a critical process required for the origin of life. One unsolved difficulty with non-enzymatic RNA replication is that template-directed copying of RNA results in a double-stranded product. After strand separation, rapid strand reannealing outcompetes slow non-enzymatic template copying, which renders multiple rounds of RNA replication impossible. Here we show that oligoarginine peptides slow the annealing of complementary oligoribonucleotides by up to several thousand-fold; however, short primers and activated monomers can still bind to template strands, and template-directed primer extension can still occur, all within a phase-separated condensed state, or coacervate. Furthermore, we show that within this phase, partial template copying occurs even in the presence of full-length complementary strands. This method to enable further rounds of replication suggests one mechanism by which short non-coded peptides could have enhanced early cellular fitness, and potentially explains how longer coded peptides, that is, proteins, came to prominence in modern biology.
C1 [Jia, Tony Z.; Fahrenbach, Albert C.; Kamat, Neha P.; Adamala, Katarzyna P.; Szostak, Jack W.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, 185 Cambridge St, Boston, MA 02114 USA.
   [Jia, Tony Z.; Fahrenbach, Albert C.; Kamat, Neha P.; Adamala, Katarzyna P.; Szostak, Jack W.] Massachusetts Gen Hosp, Howard Hughes Med Inst, Ctr Computat & Integrat Biol, 185 Cambridge St, Boston, MA 02114 USA.
   [Jia, Tony Z.; Szostak, Jack W.] Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.
   [Fahrenbach, Albert C.; Szostak, Jack W.] Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, 2-12-1-IE-1 Ookayama, Tokyo 1528550, Japan.
   [Szostak, Jack W.] Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
   [Adamala, Katarzyna P.] MIT, Dept Biol Engn, MIT Media Lab, Cambridge, MA 02139 USA.
   [Adamala, Katarzyna P.] MIT, Dept Brain & Cognit Sci, MIT Media Lab, Cambridge, MA 02139 USA.
   [Adamala, Katarzyna P.] MIT, McGovern Inst, Cambridge, MA 02139 USA.
RP Szostak, JW (reprint author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, 185 Cambridge St, Boston, MA 02114 USA.; Szostak, JW (reprint author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Ctr Computat & Integrat Biol, 185 Cambridge St, Boston, MA 02114 USA.; Szostak, JW (reprint author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.; Szostak, JW (reprint author), Tokyo Inst Technol, Earth Life Sci Inst, Meguro Ku, 2-12-1-IE-1 Ookayama, Tokyo 1528550, Japan.; Szostak, JW (reprint author), Harvard Med Sch, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.
EM szostak@molbio.mgh.harvard.edu
RI Kamat, Neha/L-2799-2016
OI Adamala, Kate/0000-0003-1066-7207
FU Earth-Life Science Institute at the Tokyo Institute of Technology; NASA;
   Simons Foundation [290363]; NASA [NNX15AL18G]
FX We thank A. E. Engelhart, C. Hentrich, B. D. Heuberger, A. T. Larsen, T.
   J. Olsen, N. Prywes, R. Saganty, L. Zhou and all other members of the
   Szostak Lab for helpful discussions and critical reading of the
   manuscript. We also thank G. Ruvkun and E. Rubin for their support and
   very helpful advice. J.W.S. is an Investigator of the Howard Hughes
   Medical Institute. A.C.F. is supported by a Research Fellowship from the
   Earth-Life Science Institute at the Tokyo Institute of Technology.
   N.P.K. is supported by an appointment to the National Aeronautics and
   Space Administration (NASA) Postdoctoral Program, administered by Oak
   Ridge Associated Universities through a contract with NASA. This work
   was supported by grants from the Simons Foundation (290363) and NASA
   (NNX15AL18G) to J.W.S.
CR Adamala K, 2013, SCIENCE, V342, P1098, DOI 10.1126/science.1241888
   Aumiller WM, 2016, NAT CHEM, V8, P129, DOI [10.1038/nchem.2414, 10.1038/NCHEM.2414]
   BAEZA I, 1991, ORIGINS LIFE EVOL B, V21, P225
   Balhorn R, 2000, MOL REPROD DEV, V56, P230, DOI 10.1002/(SICI)1098-2795(200006)56:2+<230::AID-MRD3>3.3.CO;2-M
   Blain JC, 2014, ANNU REV BIOCHEM, V83, P615, DOI 10.1146/annurev-biochem-080411-124036
   Bowler FR, 2013, NAT CHEM, V5, P383, DOI 10.1038/nchem.1626
   Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046
   Cisse II, 2012, NAT STRUCT MOL BIOL, V19, P623, DOI 10.1038/nsmb.2294
   Danger G, 2012, CHEM SOC REV, V41, P5416, DOI 10.1039/c2cs35064e
   Deck C, 2011, NAT CHEM, V3, P603, DOI [10.1038/nchem.1086, 10.1038/NCHEM.1086]
   DeRouchey J, 2013, BIOCHEMISTRY-US, V52, P3000, DOI 10.1021/bi4001408
   Ehrenfreund P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002097
   Engelhart AE, 2013, NAT CHEM, V5, P390, DOI 10.1038/nchem.1623
   Fasting C, 2012, ANGEW CHEM INT EDIT, V51, P10472, DOI 10.1002/anie.201201114
   Frankel EA, 2016, LANGMUIR, V32, P2041, DOI 10.1021/acs.langmuir.5b04462
   Frederix PWJM, 2015, NAT CHEM, V7, P30, DOI [10.1038/NCHEM.2122, 10.1038/nchem.2122]
   GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0
   Hall KB, 2009, METHOD ENZYMOL, V469, P269, DOI 10.1016/S0076-6879(09)69013-3
   Heuberger BD, 2015, J AM CHEM SOC, V137, P2769, DOI 10.1021/jacs.5b00445
   HUD NV, 1993, BIOCHEM BIOPH RES CO, V193, P1347, DOI 10.1006/bbrc.1993.1773
   Hurwitz S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009463
   Hyman AA, 2011, DEV CELL, V21, P14, DOI 10.1016/j.devcel.2011.06.013
   Imai E, 1999, SCIENCE, V283, P831, DOI 10.1126/science.283.5403.831
   Izgu EC, 2015, J AM CHEM SOC, V137, P6373, DOI 10.1021/jacs.5b02707
   Jia TZ, 2014, ORIGINS LIFE EVOL B, V44, P1, DOI 10.1007/s11084-014-9355-8
   JOYCE GF, 1984, J MOL BIOL, V176, P279, DOI 10.1016/0022-2836(84)90425-X
   Kamat NP, 2015, ANGEW CHEM INT EDIT, V54, P11735, DOI 10.1002/anie.201505742
   Kashiwagi N, 2009, NUCLEIC ACIDS RES, V37, P2574, DOI 10.1093/nar/gkp111
   Kreysing M, 2015, NAT CHEM, V7, P203, DOI [10.1038/nchem.2155, 10.1038/NCHEM.2155]
   Kunin V, 2000, ORIGINS LIFE EVOL B, V30, P459, DOI 10.1023/A:1006672126867
   Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026
   Lambert JF, 2008, ORIGINS LIFE EVOL B, V38, P211, DOI 10.1007/s11084-008-9128-3
   Leman L, 2004, SCIENCE, V306, P283, DOI 10.1126/science.1102722
   Leman LJ, 2015, ASTROBIOLOGY, V15, P709, DOI 10.1089/ast.2015.1314
   Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018
   Liu G, 2001, J BIOL CHEM, V276, P34379, DOI 10.1074/jbc.M105250200
   Liu R, 1998, ORIGINS LIFE EVOL B, V28, P245, DOI 10.1023/A:1006576213220
   Mascotti DP, 1997, BIOCHEMISTRY-US, V36, P7272, DOI 10.1021/bi970272n
   MILLER SL, 1987, COLD SPRING HARB SYM, V52, P17, DOI 10.1101/SQB.1987.052.01.005
   MILLER SL, 1953, SCIENCE, V117, P528, DOI 10.1126/science.117.3046.528
   Mullen LB, 2007, ANGEW CHEM INT EDIT, V46, P8063, DOI 10.1002/anie.200702870
   Orgel LE, 2003, ORIGINS LIFE EVOL B, V33, P211, DOI 10.1023/A:1024616317965
   Patel BH, 2015, NAT CHEM, V7, P301, DOI [10.1038/NCHEM.2202, 10.1038/nchem.2202]
   Pizzarello S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002105
   Plankensteiner K, 2006, MOL DIVERS, V10, P3, DOI 10.1007/s11030-006-7009-0
   PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5
   Powner MW, 2010, J AM CHEM SOC, V132, P16677, DOI 10.1021/ja108197s
   Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013
   Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445
   Ritson DJ, 2013, ANGEW CHEM INT EDIT, V52, P5845, DOI 10.1002/anie.201300321
   Robertson M. P., 2012, COLD SPRING HARB PER, V4, DOI DOI 10.1101/CSHPERSPECT.A003608
   ROSS PD, 1960, P NATL ACAD SCI USA, V46, P1360, DOI 10.1073/pnas.46.10.1360
   Szostak J.W., 2012, J SYST CHEM, V3, DOI [DOI 10.1186/1759-2208-3-2, 10.1186/1759-2208-3-2]
   TAN RY, 1995, P NATL ACAD SCI USA, V92, P5282, DOI 10.1073/pnas.92.12.5282
   Tang TYD, 2014, NAT CHEM, V6, P527, DOI [10.1038/NCHEM.1921, 10.1038/nchem.1921]
   Xin L, 2009, SCI CHINA SER B, V52, P1220, DOI 10.1007/s11426-009-0112-1
   Zaia DAM, 2008, ORIGINS LIFE EVOL B, V38, P469, DOI 10.1007/s11084-008-9150-5
   Ziebarth J, 2009, BIOPHYS J, V97, P1971, DOI 10.1016/j.bpj.2009.03.069
NR 58
TC 12
Z9 13
U1 11
U2 68
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1755-4330
EI 1755-4349
J9 NAT CHEM
JI Nat. Chem.
PD OCT
PY 2016
VL 8
IS 10
BP 915
EP 921
DI 10.1038/NCHEM.2551
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA DX5IA
UT WOS:000384413000009
PM 27657866
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Hayashi, T
   Nagata, N
   Senga, T
   Iwayama, S
   Iwaya, M
   Takeuchi, T
   Kamiyama, S
   Akasaki, I
   Matsumoto, T
AF Hayashi, Takafumi
   Nagata, Noriaki
   Senga, Takashi
   Iwayama, Sho
   Iwaya, Motoaki
   Takeuchi, Tetsuya
   Kamiyama, Satoshi
   Akasaki, Isamu
   Matsumoto, Takahiro
TI RETRACTED: Demonstration of electron beam excitation laser using a
   GaInN-based multiquantum well active layer (Retracted article. See
   vol.9, pg.129201, 2016)
SO APPLIED PHYSICS EXPRESS
LA English
DT Article; Retracted Publication
ID ALGAN; DIODES; QUALITY; BLUE; GAN; NM; EMISSION; ENERGY; GREEN; MG
AB In this study, an electron beam excitation laser using a GaInN-based multiquantum well (MQW) active layer was investigated, and laser emission was observed for the first time from a GaInN-based MQW excited by an electron beam. This technology has the potential to provide access to an expanded wavelength region for the laser action of nitride-semiconductor-based lasers from deep UV to infrared. (C) 2016 The Japan Society of Applied Physics
C1 [Hayashi, Takafumi; Nagata, Noriaki; Senga, Takashi; Iwayama, Sho; Iwaya, Motoaki; Takeuchi, Tetsuya; Kamiyama, Satoshi; Akasaki, Isamu] Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan.
   [Akasaki, Isamu] Nagoya Univ, Akasaki Res Ctr, Nagoya, Aichi 4648603, Japan.
   [Matsumoto, Takahiro] Nagoya City Univ, Grad Sch Design & Architecture, Nagoya, Aichi 4640083, Japan.
RP Hayashi, T (reprint author), Meijo Univ, Fac Sci & Technol, Nagoya, Aichi 4688502, Japan.
EM 163434025@ccalumni.meijo-u.ac.jp
FU Program for the Strategic Research Foundation at Private Universities;
   MEXT [15H02019]
FX This study was partially supported by the Program for the Strategic
   Research Foundation at Private Universities, 2012-2016, supported by
   MEXT and MEXT Grant-in-Aid for Scientific Research A No. 15H02019. The
   authors would like to thank Professor H. Amano and Professor Y. Honda
   from Nagoya University and Mr. J. Matsuda and Mr. N. Matsubara from
   Stanley Electric Co., Ltd. for good discussion and support with these
   results.
CR AKASAKI I, 1995, JPN J APPL PHYS 2, V34, P1517
   Akasaki I, 2006, JPN J APPL PHYS 1, V45, P9001, DOI 10.1143/JJAP.45.9001
   AMANO H, 1989, JPN J APPL PHYS 2, V28, pL2112, DOI 10.1143/JJAP.28.L2112
   AMANO H, 1986, APPL PHYS LETT, V48, P353, DOI 10.1063/1.96549
   Iida K, 2004, JPN J APPL PHYS 2, V43, pL499, DOI 10.1143/JJAP.43.L499
   Kneissl M, 2003, APPL PHYS LETT, V82, P4441, DOI 10.1063/1.1585135
   Kodama M, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.021104
   Koike M, 1997, P SOC PHOTO-OPT INS, V3002, P36, DOI 10.1117/12.271046
   Miyoshi T, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.062201
   Nagamatsu K, 2009, PHYS STATUS SOLIDI C, V6, pS437, DOI 10.1002/pssc.200880810
   Nakamura S, 2000, APPL PHYS LETT, V76, P22, DOI 10.1063/1.125643
   NAKAMURA S, 1995, JPN J APPL PHYS 2, V34, pL797, DOI 10.1143/JJAP.34.L797
   Nakamura S, 1996, JPN J APPL PHYS 2, V35, pL74, DOI 10.1143/JJAP.35.L74
   Okawara S., 2015, 6 INT S GROWTH 3 NIT
   Oto T, 2010, NAT PHOTONICS, V4, P767, DOI [10.1038/nphoton.2010.220, 10.1038/NPHOTON.2010.220]
   Shimahara Y, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.042103
   Takano T, 2004, APPL PHYS LETT, V84, P3567, DOI 10.1063/1.1737061
   Tsuzuki H, 2009, J CRYST GROWTH, V311, P2860, DOI 10.1016/j.jcrysgro.2009.01.031
   Xie J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804598
   Yoshida H, 2008, NAT PHOTONICS, V2, P551, DOI 10.1038/nphoton.2008.135
   Yoshida H, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3050539
   Yoshizumi Y, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.092101
NR 22
TC 2
Z9 2
U1 6
U2 30
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1882-0778
EI 1882-0786
J9 APPL PHYS EXPRESS
JI Appl. Phys. Express
PD OCT
PY 2016
VL 9
IS 10
AR 101001
DI 10.7567/APEX.9.101001
PG 3
WC Physics, Applied
SC Physics
GA DX0PP
UT WOS:000384066000001
DA 2018-12-27
ER

PT J
AU Cetin, Y
   Wai, J
   Altay, C
   Bushman, BJ
AF Cetin, Yakup
   Wai, Jonathan
   Altay, Cengiz
   Bushman, Brad J.
TI RETRACTED: Effects of Violent Media on Verbal Task Performance in Gifted
   and General Cohort Children(Retracted article. See vol. 61, pg. 153,
   2017)
SO GIFTED CHILD QUARTERLY
LA English
DT Article; Retracted Publication
DE violent media; giftedness; IQ; sensitivity; verbal task performance
ID PRECOCIOUS YOUTH; SCIENCE; MEMORY; ACCOMPLISHMENTS; AGGRESSION;
   CREATIVITY; CAPACITY; CHILDREN; STUDENTS
AB Violent media immediately grab our attention. However, violent media also detract attention from other cues. A large body of research shows that violent media impair attention and memory, critical resources for academic performance, such as verbal tasks at school. The present study tested whether gifted children are more insulated or more vulnerable to these violent media effects. Gifted (n = 74) and general cohort (n = 80) 10-year-old children were randomly assigned to watch a 12-minute violent or nonviolent cartoon. A verbal task was completed before and after the video. Results showed that gifted children outperformed general cohort children on the verbal task after watching a nonviolent cartoon, but not after watching a violent cartoon. Thus, the violent video eliminated the typical advantage gifted children have on verbal tasks. These findings suggest that the harmful effects of violent media on verbal tasks are greater for gifted children than for general cohort children.
C1 [Cetin, Yakup; Altay, Cengiz] Fatih Univ, Istanbul, Turkey.
   [Wai, Jonathan] Duke Univ, Durham, NC 27708 USA.
   [Bushman, Brad J.] Ohio State Univ, Columbus, OH 43210 USA.
   [Bushman, Brad J.] Univ Amsterdam, Amsterdam, Netherlands.
RP Bushman, BJ (reprint author), Ohio State Univ, Columbus, OH 43210 USA.; Bushman, BJ (reprint author), Univ Amsterdam, Amsterdam, Netherlands.; Bushman, BJ (reprint author), Ohio State Univ, Sch Commun, 3016 Derby Hall,154 North Oval Mall, Columbus, OH 43210 USA.
EM bushman.20@osu.edu
CR Altman R., 1983, ROEPER REV, V6, P65, DOI DOI 10.1080/02783198309552757
   Belson W., 1978, TELEVISION VIOLENCE
   Bushman BJ, 2006, ARCH PEDIAT ADOL MED, V160, P348, DOI 10.1001/archpedi.160.4.348
   Bushman BJ, 2015, AM BEHAV SCI, V59, P1807, DOI 10.1177/0002764215596554
   Buss D. M., 2006, EVOLUTION SOCIAL PSY, P263
   Cetin Y., 2015, ADV PEDIAT RES, V2, DOI 10.12715/apr.2015.2.6
   Dabrowski K., 1979, ADV DEV, V6, P87
   DAUBER SL, 1990, GIFTED CHILD QUART, V34, P10, DOI 10.1177/001698629003400103
   de Jong T, 2010, INSTR SCI, V38, P105, DOI 10.1007/s11251-009-9110-0
   Delisle J. R., 2005, ONCE MIND STORIES SC
   Echterhoff G, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00057
   Engle RW, 2002, CURR DIR PSYCHOL SCI, V11, P19, DOI 10.1111/1467-8721.00160
   ERON LD, 1972, AM PSYCHOL, V27, P253, DOI 10.1037/h0033721
   Huesmann L. R., 1986, TELEVISION AGGRESSIV
   JANOS PM, 1985, GIFTED TALENTED DEV, P149, DOI DOI 10.1037/10054-006
   Jensen AR, 1998, G FACTOR SCI MENTAL
   Kroesbergen EH, 2016, GIFTED CHILD QUART, V60, P16, DOI 10.1177/0016986215609113
   Lovecky D. V., 2004, DIFFERENT MINDS GIFT
   Lubinski D, 2004, J PERS SOC PSYCHOL, V86, P96, DOI 10.1037/0022-3514.86.1.96
   Lubinski D, 2006, PERSPECT PSYCHOL SCI, V1, P316, DOI 10.1111/j.1745-6916.2006.00019.x
   Lubinski D, 2014, PSYCHOL SCI, V25, P2217, DOI 10.1177/0956797614551371
   Lull RB, 2015, PSYCHOL BULL, V141, P1022, DOI 10.1037/bul0000018
   Lull RB, 2015, J EXP SOC PSYCHOL, V56, P172, DOI 10.1016/j.jesp.2014.10.001
   Makel MC, 2015, GIFTED CHILD QUART, V59, P177, DOI 10.1177/0016986215578746
   Makel MC, 2011, J ADV ACAD, V22, P720, DOI 10.1177/1932202X11424880
   Mandler G., 2014, HDB EMOTION MEMORY R, P93
   MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/0033-295X.101.2.343
   Neihart M., 2002, SOCIAL EMOTIONAL DEV
   Neuberg S. L., 2010, HDB SOCIAL PSYCHOL, V2, P761, DOI DOI 10.1002/9780470561119.S0CPSY002021
   Park G, 2007, PSYCHOL SCI, V18, P948, DOI 10.1111/j.1467-9280.2007.02007.x
   Piechowski M. M., 2006, MELLOW OUT THEY SAY
   Savar I., 1995, WECHSLER COCUKLAR IC
   Siegle D., 2013, UNDERACHIEVING GIFTE
   Silverman LK, 1994, ROEPER REV, V17, P110, DOI DOI 10.1080/02783199409553636
   SINGER JL, 1981, TELEVISION IMAGINATI
   Sprafkin J., 1986, J APPL DEV PSYCHOL, V7, P45, DOI [10.1016/0193-3973(86)90018-3, DOI 10.1016/0193-3973(86)90018-3]
   Subotnik RF, 2011, PSYCHOL SCI PUBL INT, V12, P3, DOI 10.1177/1529100611418056
   Terman L. M., 1947, GENETIC STUDIES GENI, V4
   Terman LM, 1925, GENETIC STUDIES GENI, V1
   Wai J, 2005, J EDUC PSYCHOL, V97, P484, DOI 10.1037/0022-0663.97.3.484
   Wai J., 2015, POLICY INSIGHTS BEHA, V3, P122, DOI [10.1177/2372732215621310, DOI 10.1177/2372732215621310]
   Wai J, 2014, INTELLIGENCE, V45, P74, DOI 10.1016/j.intell.2013.08.009
   Wai J, 2010, J EDUC PSYCHOL, V102, P860, DOI 10.1037/a0019454
   Webb J., 2007, PARENTS GUIDE GIFTED
   Wiegman O., 1986, TELEVISION VIEWING R
   Yeari M, 2017, J RES READ, V40, P365, DOI 10.1111/1467-9817.12072
NR 46
TC 1
Z9 1
U1 1
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0016-9862
EI 1934-9041
J9 GIFTED CHILD QUART
JI Gifted Child Q.
PD OCT
PY 2016
VL 60
IS 4
BP 279
EP 286
DI 10.1177/0016986216660382
PG 8
WC Education, Special; Psychology, Educational
SC Education & Educational Research; Psychology
GA DZ7ID
UT WOS:000386037300003
DA 2018-12-27
ER

PT J
AU Orojloo, M
   Amani, S
AF Orojloo, Masoumeh
   Amani, Saeid
TI RETRACTED: Synthesis and studies of selective chemosensor for naked-eye
   detection of anions and cations based on a new Schiff-base derivative
   (Retracted article. See vol. 186, pg. 584, 2018)
SO TALANTA
LA English
DT Article; Retracted Publication
DE Chemosensor; Schiff-base receptors; Naked-eye detection of F-, H2PO4-
   and Al3+
ID DNA-BINDING; MOLECULAR DOCKING; AQUEOUS-MEDIA; ION; RECEPTORS; SENSOR;
   RECOGNITION; HIGHLIGHTS; ZN2+; HSO4
AB A new chromogenic receptor, 4-((2,4-dichlorophenyl)diazenyl)-2-(3-hydroxypropylimino) methyl) phenol, has been designed and synthesized for quantitative and low-cost detection of various biological anions and cations. The dye was characterized by elemental analyses, infrared, UV-visible spectroscopy, and NMR spectroscopy. Upon the addition of F- and H2PO4- to the solution of chemosensor in DMSO, the dramatic naked eye detectable color changes were observed from yellow to red and orange with a limit of detection (LOD) of 1.66 x 10(-6) mol. L-1 and 1.24 x 10-6 mol. L-1 at room temperature, respectively. The chemosensor showed visual changes towards cations, such as Al3+, Cu2+, Fe3+, and Cr3+, in DMSO/water (9:1). The detection limit of receptor L for the analysis of Al3+ ion was calculated to be 3.02 x 10(-6) mol. L-1. The anion recognition property of the receptor via proton transfer was monitored by UV-visible titration and (HNMR)-H-1 spectroscopy. The binding constant (K-a) and stoichiometry of the host-guest complexes formed were determined by the Benesi-Hildebrand (B-H) plot and Job's method, respectively. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Orojloo, Masoumeh; Amani, Saeid] Arak Univ, Fac Sci, Dept Chem, Dr Beheshti Ave, Arak 3815688349, Iran.
RP Amani, S (reprint author), Arak Univ, Fac Sci, Dept Chem, Dr Beheshti Ave, Arak 3815688349, Iran.
EM s-amani@araku.ac.ir
FU Research Council of Arak University
FX The authors would like to thank the Research Council of Arak University
   for financial support of this research.
CR Ambrosi G, 2009, NEW J CHEM, V33, P171, DOI 10.1039/b810228g
   Anslyn EV, 1993, SUPRAMOL CHEM, V1, P201, DOI 10.1080/10610279308035163
   Arabahmadi R, 2014, ANAL METHODS-UK, V6, P7384, DOI 10.1039/c4ay01564a
   Arabahmadi R, 2014, SUPRAMOL CHEM, V26, P321, DOI 10.1080/10610278.2013.833334
   Arabahmadi R, 2013, J COORD CHEM, V66, P218, DOI 10.1080/00958972.2012.752818
   Arakawa H, 2000, J BIOL CHEM, V275, P10150, DOI 10.1074/jbc.275.14.10150
   Atwood A. J., 1996, COMPREHENSIVE SUPRAM
   Barba-Bon A, 2012, CHEM COMMUN, V48, P3000, DOI 10.1039/c2cc17184h
   BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030
   Bhardwaj VK, 2013, TETRAHEDRON, V69, P1606, DOI 10.1016/j.tet.2012.11.090
   Bondy CR, 2004, J AM CHEM SOC, V126, P5030, DOI 10.1021/ja039712q
   Caltagirone C, 2009, CHEM SOC REV, V38, P520, DOI 10.1039/b806422a
   Chall S, 2014, ORG BIOMOL CHEM, V12, P6447, DOI 10.1039/c4ob00732h
   Cobos O.F.M., 2009, DYNA, V160, P107
   Cragg PJ, 2010, SUPRAMOLECULAR CHEMISTRY: FROM BIOLOGICAL INSPIRATION TO BIOMEDICAL APPLICATIONS, P1, DOI 10.1007/978-90-481-2582-1
   Ding YP, 2011, J HAZARD MATER, V186, P1942, DOI 10.1016/j.jhazmat.2010.12.097
   Fegade U, 2014, RSC ADV, V4, P15288, DOI 10.1039/c3ra47935h
   Gale PA, 2003, COORDIN CHEM REV, V240, P191, DOI 10.1016/S0010-8545(02)00258-8
   Gale PA, 2008, CHEM SOC REV, V37, P151, DOI 10.1039/b715825d
   Gale PA, 2006, COORDIN CHEM REV, V250, P3219, DOI 10.1016/j.ccr.2006.05.020
   Geraldes V, 2009, POL J ENVIRON STUD, V18, P353
   Ghorai A, 2015, DALTON T, V44, P13261, DOI 10.1039/c5dt01376c
   Gunnlaugsson T, 2006, COORDIN CHEM REV, V250, P3094, DOI 10.1016/j.ccr.2006.08.017
   HE JJ, 1991, SCIENCE, V251, P1479, DOI 10.1126/science.1900953
   Ispir E, 2009, DYES PIGMENTS, V82, P13, DOI 10.1016/j.dyepig.2008.09.019
   Jimenez-Sanchez A, 2015, J PHYS CHEM C, V119, P13814, DOI 10.1021/acs.jpcc.5b02884
   Joyce LA, 2010, CHEM SOC REV, V39, P3621, DOI 10.1039/b926224p
   Jung HS, 2009, ORG LETT, V11, P3378, DOI 10.1021/ol901221q
   Kaur P, 2013, ANALYST, V138, P425, DOI 10.1039/c2an36100k
   Khedr AM, 2005, DYES PIGMENTS, V67, P117, DOI 10.1016/j.dyepig.2004.11.004
   Kubik S, 2010, CHEM SOC REV, V39, P3648, DOI 10.1039/b926166b
   Kumar M, 2007, SUPRAMOL CHEM, V19, P511, DOI 10.1080/10610270601145436
   Li ZX, 2011, INORG CHEM COMMUN, V14, P1656, DOI 10.1016/j.inoche.2011.06.032
   LIKUSSAR W, 1971, ANAL CHEM, V43, P1265, DOI 10.1021/ac60304a006
   LUECKE H, 1990, NATURE, V347, P402, DOI 10.1038/347402a0
   Martinez-Manez R, 2003, CHEM REV, V103, P4419, DOI 10.1021/cr010421e
   McKee J. E., 1993, WATER QUALITY CRITER
   Miller J., 2014, STAT CHEMOMETRICS AN
   Moyer B. A., 2006, ADV INORG CHEM, V59, P175, DOI DOI 10.1016/B978-0-12-396462-5.00003-9
   Nayab PS, 2015, J FLUORESC, V25, P1905, DOI 10.1007/s10895-015-1683-1
   Nayab PS, 2015, J FLUORESC, V25, P1763, DOI 10.1007/s10895-015-1664-4
   Nickel AML, 2001, CHEM MATER, V13, P1391, DOI 10.1021/cm0009367
   Nieboer J, 2012, INORG CHEM, V51, P6350, DOI 10.1021/ic3005882
   Nordberg G. F, 2007, HDB TOXICOLOGY METAL, P529
   Park S, 2012, SENSOR ACTUAT B-CHEM, V174, P140, DOI 10.1016/j.snb.2012.08.038
   RICHARDSON HW, 1976, J AM CHEM SOC, V98, P835, DOI 10.1021/ja00419a035
   Sahoo SK, 2012, CHEM SOC REV, V41, P7195, DOI 10.1039/c2cs35152h
   Sarkar D, 2014, RSC ADV, V4, P25341, DOI 10.1039/c4ra02765e
   Schmidtchen FP, 1997, CHEM REV, V97, P1609, DOI 10.1021/cr9603845
   Shaghaghi Z, 2014, SPECTROCHIM ACTA A, V131, P67, DOI 10.1016/j.saa.2014.04.026
   Shao J, 2009, DYES PIGMENTS, V80, P259, DOI 10.1016/j.dyepig.2008.07.012
   Song NR, 2013, CHEM SCI, V4, P1765, DOI 10.1039/c3sc22201b
   Steed JW, 2009, CHEM SOC REV, V38, P506, DOI 10.1039/b810364j
   Susheela AK, 2005, FLUORIDE, V38, P98
   Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g
   Vazquez M, 2004, ANGEW CHEM INT EDIT, V43, P1962, DOI 10.1002/anie.200353148
   Vigato PA, 2007, COORDIN CHEM REV, V251, P1311, DOI 10.1016/j.ccr.2006.11.016
   Wu HM, 2009, NEW J CHEM, V33, P653, DOI 10.1039/b815207a
   Xiong J, 2011, TETRAHEDRON LETT, V52, P6157, DOI 10.1016/j.tetlet.2011.09.042
   Yang ST, 2012, ANALYST, V137, P1553, DOI 10.1039/c2an16315b
NR 60
TC 15
Z9 15
U1 3
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD OCT 1
PY 2016
VL 159
BP 292
EP 299
DI 10.1016/j.talanta.2016.06.042
PG 8
WC Chemistry, Analytical
SC Chemistry
GA DT2PD
UT WOS:000381322000041
PM 27474311
DA 2018-12-27
ER

PT J
AU Wang, QY
   Kobayashi, K
   Wang, WQ
   Ruan, J
   Nakajima, D
   Yagishita, M
   Lu, SL
   Zhang, WC
   Suzuki, M
   Saitou, T
   Sekiguchi, K
   Sankoda, K
   Takao, Y
   Nagae, M
   Terasaki, M
AF Wang, Qingyue
   Kobayashi, Keisuke
   Wang, Weiqian
   Ruan, Jie
   Nakajima, Daisuke
   Yagishita, Mayuko
   Lu, Senlin
   Zhang, Wenchao
   Suzuki, Miho
   Saitou, Tomoya
   Sekiguchi, Kazuhiko
   Sankoda, Kenshi
   Takao, Yuji
   Nagae, Masaki
   Terasaki, Masanori
TI RETRACTED: Size distribution and sources of 37 toxic species of
   particulate polycyclic aromatic hydrocarbons during summer and winter in
   Baoshan suburban area of Shanghai, China (Retracted article. See vol.
   626, pg. 1507, 2018)
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article; Retracted Publication
DE Suspended particulate matter; Size distribution; Polycyclic aromatic
   hydrocarbons (PAHs); High molecular PAHs; Toxicity; Shanghai
ID JAPONICA POLLEN GRAINS; URBAN AIR; AIRBORNE PARTICULATE; SOURCE
   APPORTIONMENT; SEASONAL-VARIATION; CARCINOGENIC RISK; INDUSTRIAL SITES;
   OXYGENATED PAHS; HEALTH-RISK; STREET DUST
AB The objectives of this study were to assess the size-segregated distribution and sources of 37 different species of particulate polycyclic aromatic hydrocarbons (PAHs) in a suburban area of Shanghai metropolitan City, China. The ambient particulate sampling was carried out on the rooftop of a five-stories building in Baoshan campus of Shanghai University. An Andersen high-volume air sampler was employed to collect ambient size-segregated particulate matter during summer of August to September and winter of November to December 2015. The high toxic PAHs were determined by a gas chromatography mass spectrometry. The concentrations of total PAHs in suspended particulate matter (SPM) and PM1.1 (suspended particulate matter below 1.1 mu m in diameter) in the suburban area of Shanghai were 4.58-14.5 ng/m(3) and 1.82-8.56 ng/m(3), respectively in summer, and 43.6-160 ng/m(3) and 23.2-121 ng/m(3), separately in winter. 1,8-Naphthalic anhydride (1,8-NA) showed the highest concentration among 37 different species of PAHs in the suburban area of Shanghai. The concentrations of high molecular PAHs (e.g. 5-6 ring PAHs) followed a nearly unimodal size distribution with the highest peaks in PM1.1. The diagnostic ration qualitatively indicated that PAHs in SPM of Shanghai were mainly derived from motor-vehicle or petroleum combustion in summer and from coal and biomass combustion in winter. According to the calculated toxicity equivalency factors based on the methods of Nisbet and Lagoy and the potency equivalency factors (PEF) recommended by U.S. EPA, the highest contributors in the total carcinogenicity of the PAHs in SPM and PM1.1 were dibenzo[a,h] pyrene (46.2% and 45.0% in summer), benzo[a] pyrene (44.4% and 43.8% in winter) and benz[j] aceanthrylene (80.2% and 83.1% in summer and 83.1% and 84.0% in winter), respectively. Therefore, benzo[a] pyrene seemed to be a lower contributor than other carcinogenic PAHs. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Wang, Qingyue; Kobayashi, Keisuke; Ruan, Jie; Suzuki, Miho; Saitou, Tomoya; Sekiguchi, Kazuhiko; Sankoda, Kenshi] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, 255 Shimo Okubo, Saitama, Saitama 3388570, Japan.
   [Wang, Weiqian; Lu, Senlin; Zhang, Wenchao] Shanghai Univ, Sch Environm & Chem Engn, 99 Shangdalu, Shanghai, Peoples R China.
   [Nakajima, Daisuke; Yagishita, Mayuko] Natl Inst Environm Studies, Res Ctr Environm Risk, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.
   [Takao, Yuji; Nagae, Masaki] Nagasaki Univ, Fac Environm Sci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.
   [Terasaki, Masanori] Iwate Univ, Fac Humanities & Social Sci, 3-18-34 Ueda, Morioka, Iwate 0208550, Japan.
RP Wang, QY (reprint author), Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, 255 Shimo Okubo, Saitama, Saitama 3388570, Japan.; Lu, SL (reprint author), Shanghai Univ, Sch Environm & Chem Engn, 99 Shangdalu, Shanghai, Peoples R China.
EM seiyo@mail.saitama-u.ac.jp; senlinlv@staff.shu.edu.cn
RI Lu, Senlin/C-2668-2018
FU Special Funds for Innovative Area Research [20120015, FY 2008-FY2012];
   Japan Society for the Promotion of Science (JSPS) [23651005, 24310005,
   15H05119]; Japanese Ministry of Education, Culture, Sports, Science and
   Technology (MEXT), Japan; Steel Foundation for Environmental Protection
   Technology of Japan [C-33]; National Natural Science Foundation of China
   (NSFC) [21477073]; Shibata Co., Tokyo of Japan [HV-1000R]
FX We acknowledge the support from the Special Funds for Innovative Area
   Research (No. 20120015, FY 2008-FY2012), Grant-in-Aid for Challenging
   Exploratory Research (No. 23651005, FY 2011-FY2012) and Grant-in-Aid for
   Scientific Research (B) (No. 24310005, FY 2012-FY2014; No. 15H05119, FY
   2015-FY2017) from the Japan Society for the Promotion of Science (JSPS)
   and Japanese Ministry of Education, Culture, Sports, Science and
   Technology (MEXT), Japan and Steel Foundation for Environmental
   Protection Technology of Japan (No. C-33, FY 2015). We also acknowledge
   the support from the National Natural Science Foundation of China (NSFC
   Grant No. 21477073). Air sample collection for suspended particulate
   matter during this study was also kindly supported by Shibata Co., Tokyo
   of Japan with the supplement of a new model of Andersen high-volume air
   sampler (HV-1000R).
CR Airparif, 2011, OR PART IL DE FRANC, P65
   Akyuz M, 2009, J HAZARD MATER, V170, P13, DOI 10.1016/j.jhazmat.2009.05.029
   Albinet A, 2007, SCI TOTAL ENVIRON, V384, P280, DOI 10.1016/j.scitotenv.2007.04.028
   AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1
   Audebert M, 2012, TOXICOL APPL PHARM, V260, P58, DOI 10.1016/j.taap.2012.01.022
   Bai Y., 2007, AEROSOL AIR QUAL RES, V7, P79
   Bourotte C, 2005, ATMOS ENVIRON, V39, P3799, DOI 10.1016/j.atmosenv.2005.02.054
   Callen MS, 2011, FUEL PROCESS TECHNOL, V92, P176, DOI 10.1016/j.fuproc.2010.05.019
   Chen MR, 2008, ENVIRON INT, V34, P971, DOI 10.1016/j.envint.2008.02.008
   Delgado-Saborit JM, 2011, ENVIRON INT, V37, P383, DOI 10.1016/j.envint.2010.10.011
   Durant JL, 1999, MUTAT RES-GEN TOX EN, V446, P1, DOI 10.1016/S1383-5718(99)00135-7
   Eiguren-Fernandez A, 2004, AEROSOL SCI TECH, V38, P447, DOI 10.1080/02786820490449511
   Finlayson-Pitts B. J., 2000, CHEM UPPER LOWER ATM, P969
   Gao B, 2011, ATMOS ENVIRON, V45, P7184, DOI 10.1016/j.atmosenv.2011.09.005
   Guo H, 2003, ATMOS ENVIRON, V37, P5307, DOI 10.1016/j.atmosenv.2003.09.011
   Hassanien MA, 2008, J HAZARD MATER, V151, P247, DOI 10.1016/j.jhazmat.2007.05.079
   He JB, 2014, ATMOS ENVIRON, V89, P207, DOI 10.1016/j.atmosenv.2014.02.042
   Hong H, 2007, ATMOS RES, V85, P429, DOI 10.1016/j.atmosres.2007.03.004
   Hu J, 2012, ATMOS RES, V118, P271, DOI 10.1016/j.atmosres.2012.07.015
   Jiang YF, 2014, ECOTOX ENVIRON SAFE, V106, P11, DOI 10.1016/j.ecoenv.2014.04.031
   Kameda Y, 2005, SCI TOTAL ENVIRON, V340, P71, DOI 10.1016/j.scitotenv.2004.08.009
   KAMENS RM, 1989, ENVIRON SCI TECHNOL, V23, P801, DOI 10.1021/es00065a007
   Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1463, DOI 10.1289/ehp.11290
   Kan HD, 2009, ENVIRON HEALTH PERSP, V117, pA187, DOI 10.1289/ehp.12737
   Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005
   Karar K, 2006, ATMOS RES, V81, P36, DOI 10.1016/j.atmosres.2005.11.003
   Katsoyiannis A, 2007, CHEMOSPHERE, V69, P1337, DOI 10.1016/j.chemosphere.2007.05.084
   KHALILI NR, 1995, ATMOS ENVIRON, V29, P533, DOI 10.1016/1352-2310(94)00275-P
   Kurihara R, 2005, ENVIRON TOXICOL CHEM, V24, P1984, DOI 10.1897/04-310R.1
   Lee BD, 2001, CHEMOSPHERE, V42, P431, DOI 10.1016/S0045-6535(00)00061-8
   LEE WMG, 1994, SCI TOTAL ENVIRON, V145, P163, DOI 10.1016/0048-9697(94)90307-7
   Limu D. L. N. T. L, 2013, AEROSOL AIR QUAL RES, V13, P407, DOI [DOI 10.4209/AAQR.2012.05.0130, 10.4209/aaqr.2012.05.0130]
   Liu M, 2007, ATMOS ENVIRON, V41, P8785, DOI 10.1016/j.atmosenv.2007.07.059
   Liu Y, 2008, ENVIRON POLLUT, V154, P298, DOI 10.1016/j.envpol.2007.10.020
   Lundstedt S, 2007, AMBIO, V36, P475, DOI 10.1579/0044-7447(2007)36[475:SFATHO]2.0.CO;2
   Ma J., 2014, J SHANGHAI U NATURAL, V1007-2861
   Mantis J, 2005, CHEMOSPHERE, V59, P593, DOI 10.1016/j.chemosphere.2004.10.019
   Martuzevicius D, 2011, ATMOS ENVIRON, V45, P310, DOI 10.1016/j.atmosenv.2010.10.026
   Menichini E, 1999, ATMOS ENVIRON, V33, P3739, DOI 10.1016/S1352-2310(99)00114-4
   Nam JJ, 2003, CHEMOSPHERE, V50, P1281, DOI 10.1016/S0045-6535(02)00764-6
   NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X
   Office of Environmental Health Hazard Assessment (OEHHA), 1993, BENZ PYR TOX AIR CON
   Ohmori K, 2013, ENVIRON SCI-PROC IMP, V15, P1031, DOI 10.1039/c3em00076a
   Oliveira C, 2011, CHEMOSPHERE, V83, P1588, DOI 10.1016/j.chemosphere.2011.01.011
   Ravindra K, 2008, ATMOS ENVIRON, V42, P2895, DOI 10.1016/j.atmosenv.2007.12.010
   Ravindra K, 2008, SCI TOTAL ENVIRON, V396, P100, DOI 10.1016/j.scitotenv.2008.02.018
   Reyes C, 1998, J PHOTOCH PHOTOBIO A, V112, P277, DOI 10.1016/S1010-6030(97)00290-6
   Sevastyanova O, 2007, MUTAT RES-FUND MOL M, V620, P123, DOI 10.1016/j.mrfmmm.2007.03.002
   Shi JW, 2010, AEROSOL AIR QUAL RES, V10, P507, DOI 10.4209/aaqr.2010.06.0050
   Sienra MD, 2005, ATMOS RES, V75, P267, DOI 10.1016/j.atmosres.2005.01.003
   Sigman ME, 1996, J PHOTOCH PHOTOBIO A, V94, P149, DOI 10.1016/1010-6030(95)04099-4
   Tian FL, 2009, ATMOS ENVIRON, V43, P2747, DOI 10.1016/j.atmosenv.2009.02.037
   Turpin BJ, 2000, ATMOS ENVIRON, V34, P2983, DOI 10.1016/S1352-2310(99)00501-4
   US EPA, 2010, DEV REL POT FACT RPF
   Valavanidis A, 2006, CHEMOSPHERE, V65, P760, DOI 10.1016/j.chemosphere.2006.03.052
   Wang J, 2014, ENVIRON MONIT ASSESS, V186, P7461, DOI 10.1007/s10661-014-3940-1
   Wang Q., 2014, International Journal of Sustainable Development and Planning, V9, P42
   Wang Q, 2012, AEROBIOLOGIA, V28, P71, DOI 10.1007/s10453-011-9212-4
   Wang QY, 2016, ENVIRON POLLUT, V214, P149, DOI 10.1016/j.envpol.2016.04.002
   Wang QY, 2013, ASIAN J ATMOS ENVIRO, V7, P191, DOI 10.5572/ajae.2013.7.4.191
   Wang Q, 2013, ASIAN J ATMOS ENVIRO, V7, P65, DOI 10.5572/ajae.2013.7.2.065
   Wang QY, 2012, ASIAN J ATMOS ENVIRO, V6, P33, DOI 10.5572/ajae.2012.6.1.033
   Wei C, 2015, SCI TOTAL ENVIRON, V505, P814, DOI 10.1016/j.scitotenv.2014.10.054
   Wei SL, 2012, ATMOS RES, V109, P76, DOI 10.1016/j.atmosres.2012.01.009
   WHO IARC, 2010, MON EV CARC RISKS HU, V92
   Wu XG, 2011, ATMOS ENVIRON, V45, P3750, DOI 10.1016/j.atmosenv.2011.04.012
   Xia ZH, 2013, ENVIRON POLLUT, V173, P150, DOI 10.1016/j.envpol.2012.10.009
   Xu FL, 2013, ECOL MODEL, V252, P246, DOI 10.1016/j.ecolmodel.2012.04.010
   Yagishita M, 2015, ATMOS ENVIRON, V115, P263, DOI 10.1016/j.atmosenv.2015.05.050
   Yang D, 2013, MAR POLLUT BULL, V76, P298, DOI 10.1016/j.marpolbul.2013.08.016
   Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5
   Zhang Y., 2009, ATMOS ENVIRON, V43, P812, DOI DOI 10.1016/J.ATM0SENV.2008.10.050
   Zhang Y, 2011, ATMOS ENVIRON, V45, P2515, DOI 10.1016/j.atmosenv.2011.02.034
   Zhao JP, 2010, J ENVIRON SCI-CHINA, V22, P1014, DOI 10.1016/S1001-0742(09)60212-6
   Zhou JB, 2005, CHEMOSPHERE, V61, P792, DOI 10.1016/j.chemosphere.2005.04.002
   Zhu YH, 2014, SCI TOTAL ENVIRON, V466, P357, DOI 10.1016/j.scitotenv.2013.07.030
NR 76
TC 6
Z9 6
U1 6
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0048-9697
EI 1879-1026
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD OCT 1
PY 2016
VL 566
BP 1519
EP 1534
DI 10.1016/j.scitotenv.2016.06.039
PG 16
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DS8VK
UT WOS:000381060900146
PM 27320739
DA 2018-12-27
ER

PT J
AU Wei, XK
   Wang, CS
   Ma, CH
   Sun, W
   Li, HQ
   Cai, ZD
AF Wei, Xiaokang
   Wang, Chuanshun
   Ma, Chunhui
   Sun, Wei
   Li, Haoqing
   Cai, Zhendong
TI RETRACTED: Long noncoding RNA ANRIL is activated by hypoxia-inducible
   factor-1 alpha and promotes osteosarcoma cell invasion and suppresses
   cell apoptosis upon hypoxia(Retracted article. See vol.17,ART
   NO.60,2017)
SO CANCER CELL INTERNATIONAL
LA English
DT Article; Retracted Publication
DE Osteosarcoma; Long noncoding RNA; Hypoxia; HIF-1 alpha; ANRIL
ID INHIBITING APOPTOSIS; CANCER; METASTASIS; CHEMOTHERAPY; SENSITIVITY;
   MODULATION; EXPRESSION; PATHWAY
AB Background: Osteosarcoma is the most common malignancy of bone. Intratumoral hypoxia occurs in many solid tumors, where it is associated with the development of aggressive phenotype. ANRIL has been shown to be a long noncoding RNA that facilitates the progression of a number of malignancies. Yet, few studies have explored the expression pattern of ANRIL in osteosarcoma and the effect of hypoxia on ANRIL.
   Methods: We evaluated the expression levels of ANRIL in osteosarcoma tissues, adjacent normal tissues and cells with quantitative real-time polymerase chain reaction. Multiple approaches including luciferase reporter assay with nucleotide substitutions, chromatin immunoprecipitation assay and electrophoretic mobility shift assay were used to confirm the direct binding of HIF-1 alpha to the ANRIL promoter region. SiRNA-based knockdown and other molecular biology techniques were employed to measure the effect of HIF-1 alpha on the expression of ANRIL.
   Results: We found that the expression of ANRIL was upregulated in 15 pairs of osteosarcoma compared with adjacent normal tissues. We found that hypoxia is sufficient to upregulate ANRIL expression in osteosarcoma cells (MNNG and U2OS). HIF-1 alpha directly binds to the putative hypoxia response element in the upstream region of ANRIL. What's more, siRNA and small molecular inhibitors-mediated HIF-1 alpha suppression attenuated ANRIL upregulation under hypoxic conditions. Upon hypoxia, ANRIL promoted cancer cell invasion and suppressed cell apoptosis.
   Conclusion: Taken together, these data suggest that HIF-1 alpha may contribute to the upregulation of ANRIL in osteosarcoma under hypoxic conditions. ANRIL is involved in hypoxia-induced aggressive phenotype in osteosarcoma.
C1 [Wei, Xiaokang; Wang, Chuanshun; Ma, Chunhui; Sun, Wei; Li, Haoqing; Cai, Zhendong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Orthopaed, 100 Hanning Rd, Shanghai 200080, Peoples R China.
RP Li, HQ; Cai, ZD (reprint author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Orthopaed, 100 Hanning Rd, Shanghai 200080, Peoples R China.
EM lihaoqing@medmail.com.cn; czd856@vip.163.com
FU National Natural Science Foundation of China [81272747]
FX This work was supported by National Natural Science Foundation of China
   (Grant No. 81272747).
CR Cao J, 2015, CANCER RES, V75, P4839, DOI 10.1158/0008-5472.CAN-15-0711
   Casali PG, 2014, ANN ONCOL, V25, P113, DOI 10.1093/annonc/mdu256
   Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378
   Duchman KR, 2015, CANCER EPIDEMIOL, V39, P593, DOI 10.1016/j.canep.2015.05.001
   El-Naggar AM, 2015, CANCER CELL, V27, P682, DOI 10.1016/j.ccell.2015.04.003
   Hu T, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0135-8
   Isakoff MS, 2015, J CLIN ONCOL, V33, P3029, DOI 10.1200/JCO.2014.59.4895
   Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149
   Jo VY, 2014, PATHOLOGY, V46, P95, DOI 10.1097/PAT.0000000000000050
   Lan J, 2014, FEBS LETT, V588, P3333, DOI 10.1016/j.febslet.2014.07.021
   Ma MZ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.541
   Nie FQ, 2015, MOL CANCER THER, V14, P268, DOI 10.1158/1535-7163.MCT-14-0492
   Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214
   Samanta D, 2014, P NATL ACAD SCI USA, V111, pE5429, DOI 10.1073/pnas.1421438111
   Takahashi K, 2014, J CELL SCI, V127, P1585, DOI 10.1242/jcs.141069
   Wan GH, 2013, CELL SIGNAL, V25, P1086, DOI 10.1016/j.cellsig.2013.02.006
   Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064
   Yang F, 2014, MOL CELL, V53, P88, DOI 10.1016/j.molcel.2013.11.004
   Yang F, 2013, MOL CELL, V49, P1083, DOI 10.1016/j.molcel.2013.01.010
   Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021
   Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010
   Zhang D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.240
   Zhang EB, 2014, ONCOTARGET, V5, P2276, DOI 10.18632/oncotarget.1902
NR 23
TC 21
Z9 23
U1 3
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2867
J9 CANCER CELL INT
JI Cancer Cell Int.
PD SEP 23
PY 2016
VL 16
AR 73
DI 10.1186/s12935-016-0349-7
PG 9
WC Oncology
SC Oncology
GA DX4VU
UT WOS:000384380000001
PM 27688736
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Guo, YJ
   Zhang, B
   Feng, XS
   Ren, HX
   Xu, JR
AF Guo, Yi-jie
   Zhang, Bo
   Feng, Xue-song
   Ren, Hui-xun
   Xu, Ji-ru
TI RETRACTED: Human cathelicidin LL-37 enhance the antibiofilm effect of
   EGCG on Streptococcus mutans(Retracted article. See vol.17, Artn no.102,
   2017)
SO BMC ORAL HEALTH
LA English
DT Article; Retracted Publication
DE LL-37; EGCG; Streptococcus mutans; Biofilm
ID STREPTOCOCCUS-MUTANS BIOFILM; EPIGALLOCATECHIN GALLATE; GREEN TEA;
   ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; TEICHOIC-ACIDS; BACTERIA;
   INFECTIONS; PEPTIDES; CHILDREN
AB Background: Streptococcus mutans forms biofilms as a resistance mechanism against antimicrobial agents in the human oral cavity. We recently showed that human cathelicidin LL-37 exhibits inhibitory effects on biofilm formation of S. mutans through interaction with lipoteichoic acid (LTA), but without antibacterial or biofilm dispersal abilities. (-)-Epigallocatechin gallate (EGCG) is the most abundant constituent of tea catechins that has the greatest anti-infective potential to inhibit the growth of various microorganisms and biofilm formation. Therefore, in this study, we evaluated whether LL-37 interacts with EGCG to enhance the antibiofilm effect of EGCG on S. mutans biofilm formation.
   Methods: Clinical S. mutans strains (n = 10) isolated from children's saliva were tested in a biofilm formation assay. The antibiofilm effect of EGCG with and without LL-37 was analyzed by the minimum biofilm eradication concentration assay and confirmed using field emission-scanning electron microscopy. In addition, the interaction among EGCG, LL-37, and LTA of S. mutans was determined using quartz crystal microbalance analysis.
   Results: EGCG killed 100 % of planktonic S. mutans within 5 h, inhibited biofilm formation within 24 h, and reduced bacteria cells in preformed biofilms within 3 h at a concentration of 0.2 mg/mL. However, EGCG did not appear to interact with LTA. LL-37 effectively enhanced the bactericidal activity of EGCG against biofilm formation and preformed biofilms as determined by quantitative crystal violet staining and field emission- scanning electron microscopy. In addition, quartz crystal microbalance analysis revealed that LL-37 interacted with EGCG and promoted binding between EGCG and LTA of S. mutans.
   Conclusions: We show that LL-37 enhances the antibiofilm effect of EGCG on S. mutans. This finding provides new knowledge for dental treatment by using LL-37 as a potential antibiofilm compound.
C1 [Guo, Yi-jie; Zhang, Bo; Feng, Xue-song; Ren, Hui-xun; Xu, Ji-ru] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pathogen Microbiol & Immunol, Yanta West Rd 76, Xian 710061, Shaanxi, Peoples R China.
   [Zhang, Bo] AnKang City Cent Hosp, Clin Lab, Jinzhou South Rd 85, Ankang 725000, Shaanxi, Peoples R China.
   [Guo, Yi-jie; Feng, Xue-song; Ren, Hui-xun; Xu, Ji-ru] Xi An Jiao Tong Univ, Minist Educ China, Key Lab Environm & Genes Related Dis, Yanta West Rd 76, Xian 710061, Shaanxi, Peoples R China.
RP Guo, YJ; Xu, JR (reprint author), Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Pathogen Microbiol & Immunol, Yanta West Rd 76, Xian 710061, Shaanxi, Peoples R China.
EM yijie_guo@mail.xjtu.edu.cn; xujiru@mail.xjtu.edu.cn
FU China Postdoctoral Science Foundation [2015 M582672]; Natural Science
   Basic Research Plan in Shaanxi Province, China [2016JQ8051]
FX This study was supported by the China Postdoctoral Science Foundation
   (No. 2015 M582672) and Natural Science Basic Research Plan in Shaanxi
   Province, China (No. 2016JQ8051).
CR AGERBERTH B, 1995, P NATL ACAD SCI USA, V92, P195, DOI 10.1073/pnas.92.1.195
   Altman H, 2006, J ANTIMICROB CHEMOTH, V58, P198, DOI 10.1093/jac/dkl181
   Bai LL, 2013, INTJ MED SCI BIOTECH, V1, P56
   Beighton D, 2005, COMMUNITY DENT ORAL, V33, P248, DOI 10.1111/j.1600-0528.2005.00232.x
   Bidlack WR, 2001, J AM COLL NUTR, V20, P656
   Blanco AR, 2005, ANTIMICROB AGENTS CH, V49, P4339, DOI 10.1128/AAC.49.10.4339-4343.2005
   Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598
   Coraca-Huber DC, 2012, J ORTHOP RES, V30, P1176, DOI 10.1002/jor.22065
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Denapaite D, 2012, MICROB DRUG RESIST, V18, P344, DOI 10.1089/mdr.2012.0026
   HAMADA S, 1980, MICROBIOL REV, V44, P331
   HEPTINSTALL S, 1970, NATURE, V225, P519, DOI 10.1038/225519a0
   HIROSE H, 1993, CARIES RES, V27, P292, DOI 10.1159/000261553
   Huber B, 2003, Z NATURFORSCH C, V58, P879
   Isogai E, 2003, ORAL MICROBIOL IMMUN, V18, P329, DOI 10.1034/j.1399-302X.2003.00083.x
   Jazani N Hosseini, 2007, Pak J Biol Sci, V10, P1544
   Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718
   Kohda C, 2008, BIOCHEM BIOPH RES CO, V365, P310, DOI 10.1016/j.bbrc.2007.10.190
   Lahiri J, 1999, ANAL CHEM, V71, P777, DOI 10.1021/ac980959t
   Lee KM, 2009, J FOOD PROTECT, V72, P325, DOI 10.4315/0362-028X-72.2.325
   LOESCHE WJ, 1986, MICROBIOL REV, V50, P353
   Lysenko ES, 2000, INFECT IMMUN, V68, P1664, DOI 10.1128/IAI.68.3.1664-1671.2000
   Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000
   Marcenes W, 2013, J DENT RES, V92, P592, DOI 10.1177/0022034513490168
   Mattos-Graner RO, 2000, J DENT RES, V79, P1371, DOI 10.1177/00220345000790060401
   McNaught JG, 1906, J ROYAL ARMY MED COR, V7, P372
   Perry JA, 2009, FEMS MICROBIOL LETT, V299, P261, DOI 10.1111/j.1574-6968.2009.01758.x
   Ramos LD R, 2011, SCI MICROB PATHOGENS, V9, P915
   ROLLA G, 1980, CARIES RES, V14, P235, DOI 10.1159/000260459
   Sannella AR, 2007, BIOCHEM BIOPH RES CO, V353, P177, DOI 10.1016/j.bbrc.2006.12.005
   Sasaki H, 2004, CARIES RES, V38, P2, DOI 10.1159/000073913
   Takagi S, 2012, ANIM SCI J, V83, P482, DOI 10.1111/j.1740-0929.2011.00979.x
   Taylor Peter W, 2005, Food Sci Technol Bull, V2, P71, DOI 10.1616/1476-2137.14184
   Vacca SAM, 2007, CARIES RES, V41, P445
   Wei GX, 2006, J ANTIMICROB CHEMOTH, V57, P1100, DOI 10.1093/jac/dk1120
   Xu X, 2012, ARCH ORAL BIOL, V57, P678, DOI 10.1016/j.archoralbio.2011.10.021
   Xu X, 2011, ANTIMICROB AGENTS CH, V55, P1229, DOI 10.1128/AAC.01016-10
   Yam TS, 1998, J ANTIMICROB CHEMOTH, V42, P211, DOI 10.1093/jac/42.2.211
NR 38
TC 2
Z9 2
U1 5
U2 13
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6831
J9 BMC ORAL HEALTH
JI BMC Oral Health
PD SEP 22
PY 2016
VL 16
DI 10.1186/s12903-016-0292-y
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA DX4ND
UT WOS:000384357300003
PM 27659310
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Habibian, J
   Elahi, AS
   Ghoranneviss, M
   Salem, MK
   Saviz, S
AF Habibian, J.
   Elahi, A. Salar
   Ghoranneviss, M.
   Salem, M. K.
   Saviz, S.
TI RETRACTED: Plasma equilibrium reconstruction for the nuclear fusion of
   magnetically confined hydrogen isotopes (Retracted article. See vol. 43,
   pg. 2525, 2018)
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article; Retracted Publication
DE Tokamak; Plasma equilibrium; Grad-Shafranov (GS) equation
ID RESONANT HELICAL FIELD; IR-T1 TOKAMAK; POSITION; RHF
AB Analytical solutions of electromagnetism driven Grad-Shafranov equation (GSE) can be used for theoretical studies of plasma equilibrium, transport and Magnetohydrodynamic stability of tokamaks. In this research, an extended analytic solution to the Grad-Shafranov equation was presented. The solution describes standard tokamaks configurations. It allows the simulation magnetic surfaces of plasmas with elongation and triangularity, with an independent choice of pressure and plasma current. We have determined equilibrium magnetic surfaces in IR-T1 tokamak. With applying these solutions to IR-T1 tokamak, a small, air core, low beta and large aspect ratio tokamak with a circular cross section, we have calculated poloidal magnetic flux. Due to the generality and high accuracy of the first exact solution for all of the magnetic configurations of interest, the result of this solution for IR-T1 tokamak is acceptable equilibrium compare to the second one for this tokamak. These analytical solutions can be used as an input of feedback control system. (C) 2016 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [Habibian, J.; Elahi, A. Salar; Ghoranneviss, M.; Salem, M. K.; Saviz, S.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
EM Salari_phy@yahoo.com
CR Badiei S, 2009, INT J HYDROGEN ENERG, V34, P487, DOI 10.1016/j.ijhydene.2008.10.024
   Cheng JB, 2009, INT J HYDROGEN ENERG, V34, P6609, DOI 10.1016/j.ijhydene.2009.06.061
   El-Kharbachi A, 2014, INT J HYDROGEN ENERG, V39, P10525, DOI 10.1016/j.ijhydene.2014.05.023
   Elahi AS, 2010, FUSION ENG DES, V85, P724, DOI 10.1016/j.fusengdes.2010.04.034
   Elahi AS, 2010, PHYS SCRIPTA, V82, DOI 10.1088/0031-8949/82/02/025502
   Elahi AS, 2010, J FUSION ENERG, V29, P1, DOI 10.1007/s10894-009-9218-x
   Elahi AS, 2009, J FUSION ENERG, V28, P416, DOI 10.1007/s10894-009-9215-0
   Elahi AS, 2009, J FUSION ENERG, V28, P412, DOI 10.1007/s10894-009-9214-1
   Elahi AS, 2009, J FUSION ENERG, V28, P404, DOI 10.1007/s10894-009-9212-3
   Elahi AS, 2009, J FUSION ENERG, V28, P408, DOI 10.1007/s10894-009-9213-2
   Elahi AS, 2009, J FUSION ENERG, V28, P390, DOI 10.1007/s10894-009-9208-z
   Elahi AS, 2009, J FUSION ENERG, V28, P394, DOI 10.1007/s10894-009-9210-5
   Elahi AS, 2009, J FUSION ENERG, V28, P385, DOI 10.1007/s10894-009-9207-0
   Elahi AS, 2009, J FUSION ENERG, V28, P346, DOI 10.1007/s10894-009-9198-x
   Elahi AS, 2009, PHYS SCRIPTA, V80, DOI 10.1088/0031-8949/80/04/045501
   Elahi AS, 2010, IEEE T PLASMA SCI, V38, P3163, DOI 10.1109/TPS.2010.2066289
   Elahi AS, 2010, IEEE T PLASMA SCI, V38, P181, DOI 10.1109/TPS.2009.2037965
   Elahi ASalar, 2010, PHYS SCR, V82
   Gheisari R, 2010, INT J HYDROGEN ENERG, V35, P9199, DOI 10.1016/j.ijhydene.2010.05.010
   Holmlid L, 2016, INT J HYDROGEN ENERG, V41, P1080, DOI 10.1016/j.ijhydene.2015.10.072
   KRIKORIAN OH, 1983, INT J HYDROGEN ENERG, V8, P515, DOI 10.1016/0360-3199(83)90004-6
   Naghidokht A, 2016, FUSION ENG DES, V107, P82, DOI 10.1016/j.fusengdes.2016.04.032
   Ouaras K, 2014, INT J HYDROGEN ENERG, V39, P17422, DOI 10.1016/j.ijhydene.2014.08.021
   Ozisik G, 2010, INT J HYDROGEN ENERG, V35, P7357, DOI 10.1016/j.ijhydene.2010.04.171
   Rahimirad A, 2009, J FUSION ENERG, V28, P420, DOI 10.1007/s10894-009-9216-z
   Sahin HM, 2016, INT J HYDROGEN ENERG, V41, P7069, DOI 10.1016/j.ijhydene.2015.11.174
   Salar Elahi A, 2010, PHYS SCR, V81
   Salar Elahi A, 2009, J PLASMA PHYS, V76, P1
NR 28
TC 12
Z9 12
U1 4
U2 20
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD SEP 14
PY 2016
VL 41
IS 34
BP 15266
EP 15271
DI 10.1016/j.ijhydene.2016.06.178
PG 6
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA DV3AI
UT WOS:000382793000017
DA 2018-12-27
ER

PT J
AU Naghidokht, A
   Elahi, AS
   Ghoranneviss, M
   Khodabakhsh, R
AF Naghidokht, A.
   Elahi, A. Salar
   Ghoranneviss, M.
   Khodabakhsh, R.
TI RETRACTED: Feedback controller input design for ignition of
   deuterium-tritium in NSTX tokamak (Retracted article. See vol. 43, pg.
   3072, 2018)
SO INTERNATIONAL JOURNAL OF HYDROGEN ENERGY
LA English
DT Article; Retracted Publication
DE Tokamak; Plasma position; Feedback controller design
ID X-RAY-EMISSION; IR-T1 TOKAMAK; HYDROGEN-PRODUCTION; EDGE PLASMA; BIASED
   ELECTRODE; H-2 PRODUCTION; MHD ACTIVITY; PARAMETERS; SYSTEM; FIELD
AB Nuclear fusion is a nuclear reaction in which two or more atomic nuclei (such as a deuterium tritium) come very close and then collide at a very high speed and join to form a new high energy nucleus (Helium). Determination of accurate plasma horizontal position during plasma discharge is essential to transport it to a control system based on feedback. The solutions of Grad-Shafranov equation (GSE) analytically can be used for theoretical studies of plasma equilibrium, transport and magneto hydrodynamic stability. Here we have presented specific choices for source functions, kinetic pressure and poloidal plasma current, to be quadratic in poloidal magnetic flux and derive an analytical solution for Grad-Shafranov equation. With applying this solution to NSTX tokamak, we calculated poloidal magnetic flux, toroidal current density and normalized pressure profiles for this tokamak. Toroidal and poloidal flows can considerably change the equilibrium parameters of tokamak. These effects on the equilibrium of tokamak plasmas are numerically investigated using the code FLOW. As a comparative approach to equilibrium problem, the code is used to model equilibrium of NSTX tokamak for case pure toroidal flow. Comparison of the results of these two methods for NSTX tokamak shows good agreement between two and that our analytical solution can be served as good benchmark against the equilibrium code FLOW. (C) 2016 Hydrogen Energy Publications LLC. Published by Elsevier Ltd. All rights reserved.
C1 [Naghidokht, A.; Khodabakhsh, R.] Urmia Univ, Dept Phys, Orumiyeh, Iran.
   [Elahi, A. Salar; Ghoranneviss, M.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
EM Salari_phy@yahoo.com
CR Agah KM, 2015, J X-RAY SCI TECHNOL, V23, P267, DOI 10.3233/XST-150486
   Agah KM, 2013, IEEE T PLASMA SCI, V41, P2394, DOI 10.1109/TPS.2013.2260830
   Agah KM, 2013, J FUSION ENERG, V32, P268, DOI 10.1007/s10894-012-9563-z
   Chen PC, 2011, INT J HYDROGEN ENERG, V36, P14608, DOI 10.1016/j.ijhydene.2011.08.039
   Du CM, 2015, INT J HYDROGEN ENERG, V40, P15398, DOI 10.1016/j.ijhydene.2015.09.096
   Elahi AS, 2014, RADIAT EFF DEFECT S, V169, P669, DOI 10.1080/10420150.2014.925897
   Elahi AS, 2014, J FUSION ENERG, V33, P264, DOI 10.1007/s10894-014-9665-x
   Elahi AS, 2014, J FUSION ENERG, V33, P242, DOI 10.1007/s10894-013-9661-6
   Elahi AS, 2014, J FUSION ENERG, V33, P1, DOI 10.1007/s10894-013-9634-9
   Elahi AS, 2013, J FUSION ENERG, V32, P627, DOI 10.1007/s10894-013-9627-8
   Elahi AS, 2013, J FUSION ENERG, V32, P580, DOI 10.1007/s10894-013-9618-9
   Elahi AS, 2014, IEEE T PLASMA SCI, V42, P3397, DOI 10.1109/TPS.2014.2354671
   Elahi AS, 2013, RADIAT EFF DEFECT S, V168, P642, DOI 10.1080/10420150.2012.706607
   Elahi AS, 2013, IEEE T PLASMA SCI, V41, P334, DOI 10.1109/TPS.2012.2235186
   Elahi AS, 2012, IEEE T PLASMA SCI, V40, P892, DOI 10.1109/TPS.2012.2182990
   Elahi AS, 2012, J FUSION ENERG, V31, P191, DOI 10.1007/s10894-011-9452-x
   Ghanbari K, 2015, J PLASMA PHYS, V81, DOI 10.1017/S0022377814000336
   Ghanbari K, 2014, J X-RAY SCI TECHNOL, V22, P777, DOI 10.3233/XST-140462
   Ghanbari MR, 2013, J FUSION ENERG, V32, P543, DOI 10.1007/s10894-013-9611-3
   Ghoranneviss M, 2013, FUSION ENG DES, V88, P94, DOI 10.1016/j.fusengdes.2012.12.001
   Goodarzi Z, 2013, J FUSION ENERG, V32, P103, DOI 10.1007/s10894-012-9526-4
   Izgi MS, 2016, INT J HYDROGEN ENERG, V41, P1600, DOI 10.1016/j.ijhydene.2015.11.004
   Lee H, 2016, INT J HYDROGEN ENERG, V41, P7582, DOI 10.1016/j.ijhydene.2016.02.011
   Lin KJ, 2016, INT J HYDROGEN ENERG, V41, P7622, DOI 10.1016/j.ijhydene.2016.02.008
   Perez PAL, 2015, INT J HYDROGEN ENERG, V40, P17224, DOI 10.1016/j.ijhydene.2015.09.106
   Meshkani S, 2013, J FUSION ENERG, V32, P496, DOI 10.1007/s10894-013-9600-6
   Naghidokht A, 2016, J FUSION ENERG, V35, P415, DOI 10.1007/s10894-015-0051-0
   Pacheco J, 2015, INT J HYDROGEN ENERG, V40, P17165, DOI 10.1016/j.ijhydene.2015.08.062
   Radisavljevic-Gajic V, 2014, INT J HYDROGEN ENERG, V39, P11738, DOI 10.1016/j.ijhydene.2014.05.138
   Roudaki FS, 2015, J FUSION ENERG, V34, P911, DOI 10.1007/s10894-015-9898-3
   Sahin O, 2016, INT J HYDROGEN ENERG, V41, P2539, DOI 10.1016/j.ijhydene.2015.11.094
   Salar Elahi A, 2016, IEEE T IN PRESS  JUN
   Srikanth S, 2014, INT J HYDROGEN ENERG, V39, P10028, DOI 10.1016/j.ijhydene.2014.04.152
NR 33
TC 11
Z9 11
U1 3
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0360-3199
EI 1879-3487
J9 INT J HYDROGEN ENERG
JI Int. J. Hydrog. Energy
PD SEP 14
PY 2016
VL 41
IS 34
BP 15272
EP 15276
DI 10.1016/j.ijhydene.2016.07.026
PG 5
WC Chemistry, Physical; Electrochemistry; Energy & Fuels
SC Chemistry; Electrochemistry; Energy & Fuels
GA DV3AI
UT WOS:000382793000018
DA 2018-12-27
ER

PT J
AU Pastrello, C
   Tsay, M
   McQuaid, R
   Abovsky, M
   Pasini, E
   Shirdel, E
   Angeli, M
   Tokar, T
   Jamnik, J
   Kotlyar, M
   Jurisicova, A
   Kotsopoulos, J
   El-Sohemy, A
   Jurisica, I
AF Pastrello, Chiara
   Tsay, Mike
   McQuaid, Rosanne
   Abovsky, Mark
   Pasini, Elisa
   Shirdel, Elize
   Angeli, Marc
   Tokar, Tomas
   Jamnik, Joseph
   Kotlyar, Max
   Jurisicova, Andrea
   Kotsopoulos, Joanne
   El-Sohemy, Ahmed
   Jurisica, Igor
TI RETRACTED: Circulating plant miRNAs can regulate human gene expression
   in vitro (Retracted article. See vol. 7, 2017)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID CRUCIFEROUS VEGETABLE CONSUMPTION; DETECTABLE ORAL BIOAVAILABILITY;
   LUNG-CANCER; BREAST-CANCER; MICRORNAS; RISK; METAANALYSIS; BROCCOLI;
   TARGETS; MICE
AB While Brassica oleracea vegetables have been linked to cancer prevention, the exact mechanism remains unknown. Regulation of gene expression by cross-species microRNAs has been previously reported; however, its link to cancer suppression remains unexplored. In this study we address both issues. We confirm plant microRNAs in human blood in a large nutrigenomics study cohort and in a randomized dose-controlled trial, finding a significant positive correlation between the daily amount of broccoli consumed and the amount of microRNA in the blood. We also demonstrate that Brassica microRNAs regulate expression of human genes and proteins in vitro, and that microRNAs cooperate with other Brassica-specific compounds in a possible cancer-preventive mechanism. Combined, we provide strong evidence and a possible multimodal mechanism for broccoli in cancer prevention.
C1 [Pastrello, Chiara; Tsay, Mike; Abovsky, Mark; Pasini, Elisa; Shirdel, Elize; Angeli, Marc; Tokar, Tomas; Kotlyar, Max; Jurisica, Igor] Univ Hlth Network, IBM Life Sci Discovery Ctr, Princess Margaret Canc Ctr, Toronto, ON, Canada.
   [McQuaid, Rosanne; Jurisicova, Andrea] Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.
   [McQuaid, Rosanne; Jurisicova, Andrea] Univ Toronto, Dept Obstet & Gynecol, Physiol, Toronto, ON, Canada.
   [Pasini, Elisa] CRO Aviano Natl Canc Inst, Canc Bioimmunotherapy Unit, Aviano, Italy.
   [Jamnik, Joseph; Kotsopoulos, Joanne] Univ Toronto, Dept Nutr Sci, Fac Med, Toronto, ON, Canada.
   [Kotsopoulos, Joanne] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.
   [Kotsopoulos, Joanne] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Jurisica, Igor] Univ Toronto, Dept Med Biophys & Comp Sci, Toronto, ON, Canada.
   [Jurisica, Igor] Slovak Acad Sci, Inst Neuroimmunol, Bratislava, Slovakia.
RP Jurisica, I (reprint author), Univ Hlth Network, IBM Life Sci Discovery Ctr, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Jurisica, I (reprint author), Univ Toronto, Dept Med Biophys & Comp Sci, Toronto, ON, Canada.; Jurisica, I (reprint author), Slovak Acad Sci, Inst Neuroimmunol, Bratislava, Slovakia.
EM juris@ai.utoronto.ca
RI Jurisicova, Andrea/E-4580-2013
OI Jurisica, Igor/0000-0002-2507-946X
FU Ontario Research Fund [GL2-01-030]; Canada Research Chair Program (CRC)
   [203373, 225404]; Canada Foundation for Innovation (CFI) [12301, 29272,
   30865]; IBM; European Community [246549]
FX This work was supported in part by Ontario Research Fund (#GL2-01-030);
   Canada Research Chair Program (CRC #203373 and #225404), Canada
   Foundation for Innovation (CFI #12301, #29272, #30865); and IBM. EP was
   a research fellow from the European Community's 7th Framework Programme
   under Grant agreement no. 246549 - Train 2009. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript. The authors would like to thank Richard
   Lu, Wing Xie and Adrian M. Teisanu for the original development of
   mirDIP and CDIP portals; Drs. Tsao and Park for kindly providing us the
   cell lines for validation. The authors are grateful to DNA Software Inc.
   (Ann Arbor, MI) for in kind access to the Visual OMP software package.
CR Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y
   Cahill L, 2009, AM J EPIDEMIOL, V170, P464, DOI 10.1093/aje/kwp156
   Chen X, 2013, NAT BIOTECHNOL, V31, P967, DOI 10.1038/nbt.2741
   Chin AR, 2016, CELL RES, V26, P217, DOI 10.1038/cr.2016.13
   Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737
   Ferguson LR, 2012, MOL NUTR FOOD RES, V56, P126, DOI 10.1002/mnfr.201100507
   Fowke JH, 2006, CARCINOGENESIS, V27, P2096, DOI 10.1093/carcin/bgl065
   Gasper AV, 2007, J NUTR, V137, P1718
   Gupta P, 2014, MOL NUTR FOOD RES, V58, P1685, DOI 10.1002/mnfr.201300684
   Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838
   Herr I, 2010, CANCER TREAT REV, V36, P377, DOI 10.1016/j.ctrv.2010.01.002
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Lam TK, 2009, CANCER EPIDEM BIOMAR, V18, P184, DOI 10.1158/1055-9965.EPI-08-0710
   Li LY, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0454-4
   Li Y, 2014, NUCLEIC ACIDS RES, V42, pD1070, DOI 10.1093/nar/gkt1023
   Liang Gf, 2014, FOOD SCI NUTR, V2, P380, DOI 10.1002/fsn3.113
   Liu B, 2012, INT J UROL, V19, P134, DOI 10.1111/j.1442-2042.2011.02906.x
   Liu XJ, 2013, BREAST, V22, P309, DOI 10.1016/j.breast.2012.07.013
   Mlotshwa S, 2015, CELL RES, V25, P521, DOI 10.1038/cr.2015.25
   Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128
   Pappa G, 2007, CARCINOGENESIS, V28, P1471, DOI 10.1093/carcin/bgm044
   Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254
   Snow JW, 2013, RNA BIOL, V10, P1107, DOI 10.4161/rna.24909
   STEINMETZ KA, 1991, CANCER CAUSE CONTROL, V2, P325, DOI 10.1007/BF00051672
   Tosar JP, 2014, RNA, V20, P754, DOI 10.1261/rna.044263.114
   Tse G, 2014, NUTR CANCER, V66, P128, DOI 10.1080/01635581.2014.852686
   Wagner AE, 2015, FOOD FUNCT, V6, P714, DOI [10.1039/c4fo01119h, 10.1039/C4FO01119H]
   Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009
   Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246
   Wu QJ, 2013, CANCER SCI, V104, P1067, DOI 10.1111/cas.12195
   Yang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137516
   Yang J, 2015, CELL RES, V25, P517, DOI 10.1038/cr.2015.26
   Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158
   Zhang X, 2014, MOL CANCER RES, V12, P1535, DOI 10.1158/1541-7786.MCR-13-0641
   Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381
   Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818
   Zhou Z, 2015, CELL RES, V25, P39, DOI 10.1038/cr.2014.130
   Zhu CQ, 2009, CLIN LUNG CANCER, V10, P331, DOI 10.3816/CLC.2009.n.045
NR 38
TC 10
Z9 11
U1 3
U2 22
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 8
PY 2016
VL 6
AR 32773
DI 10.1038/srep32773
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DV0WW
UT WOS:000382642300002
PM 27604570
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Sigirci, O
   Rockmore, M
   Wansink, B
AF Sigirci, Ozge
   Rockmore, Marc
   Wansink, Brian
TI RETRACTED: How Traumatic Violence Permanently Changes Shopping Behavior
   (Retracted article. See vol.8,artn.2140,2017)
SO FRONTIERS IN PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE disasters; war; combat; violent crime; trauma; consumer behavior
ID 9/11 TERRORIST ATTACKS; MENTAL-HEALTH; PSYCHOLOGICAL ADJUSTMENT; VIETNAM
   VETERANS; NATURAL DISASTER; RISK-TAKING; US VETERANS; WAR-ZONE; IMPACT;
   CHILDREN
AB Traumatic experiences such as combat, living in a conflict country or war-torn nation, or experiencing a violent crime or natural disaster change social relationships and may also influence a life-time of consumer relationships with brands and shopping. Our focus on this previously overlooked area is centered on an analysis of the long-term shopping habits of 355 combat veterans. We show that those who experienced heavy trauma (e.g., heavy combat) exhibited similar disconnection from brands as others have experienced in social relationships. They became more transactional in that they were more open to switching brands, to trying new products, and buying the least expensive alternative (p < 0.01). In contrast, those who had experienced a light trauma were more influenced by ads and more open to buying brands even when they cost more (p < 0.00). Trauma, such as combat, may change ones decision horizon. Functionality and price become more important, which is consistent with the idea that they are more focused on the present moment than on building on the past or saving for the future.
C1 [Sigirci, Ozge] Kiklareli Univ, Fac Econ & Adm Sci, Istanbul, Turkey.
   [Rockmore, Marc] Clark Univ, Dept Econ, Worcester, MA 01610 USA.
   [Wansink, Brian] Cornell Univ, Cornell Food & Brand Lab, Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA.
RP Wansink, B (reprint author), Cornell Univ, Cornell Food & Brand Lab, Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA.
EM foodandbrandlab@cornell.edu
FU Brian Wansink
FX This research received no specific grant from any funding agency in the
   public, commercial, or not-for-profit sectors. It was self funded by
   Brian Wansink.
CR Al-Krenawi A, 2004, J COMP FAM STUD, V35, P185
   Arias M. A., 2014, 011005 U LOS AND CED
   Baker A, 1999, CLIN PSYCHOL REV, V19, P935, DOI 10.1016/S0272-7358(99)00004-5
   Bland SH, 1996, PSYCHOSOM MED, V58, P18, DOI 10.1097/00006842-199601000-00004
   Bogan VL, 2013, CONTEMP ECON POLICY, V31, P457, DOI 10.1111/j.1465-7287.2012.00319.x
   Bramsen I, 2002, PERS INDIV DIFFER, V32, P747, DOI 10.1016/S0191-8869(01)00077-0
   Callen M, 2014, AM ECON REV, V104, P123, DOI 10.1257/aer.104.1.123
   Deahl M, 2000, BRIT J MED PSYCHOL, V73, P77, DOI 10.1348/000711200160318
   Dohle S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1100
   Dube LF, 2010, INT J CONSUM STUD, V34, P333, DOI 10.1111/j.1470-6431.2009.00813.x
   ELDER GH, 1994, PSYCHOL AGING, V9, P5, DOI 10.1037//0882-7974.9.1.5
   Hager MA, 2003, NONPROF VOLUNT SEC Q, V32, P252, DOI 10.1177/0899764003251617
   JORDAN BK, 1992, J CONSULT CLIN PSYCH, V60, P916, DOI 10.1037/0022-006X.60.6.916
   Kim YI, 2014, J ECON BEHAV ORGAN, V108, P174, DOI 10.1016/j.jebo.2014.09.009
   Malmendier U, 2011, Q J ECON, V126, P373, DOI 10.1093/qje/qjq004
   MCFARLANE AC, 1986, MED J AUSTRALIA, V145, P561
   Neria Y, 2008, PSYCHIATRY, V71, P339, DOI 10.1521/psyc.2008.71.4.339
   NORRIS FH, 1988, AM J COMMUN PSYCHOL, V16, P665, DOI 10.1007/BF00930020
   O'Donnell JC, 2000, MIL MED, V165, P219
   Paardekooper B, 1999, J CHILD PSYCHOL PSYC, V40, P529, DOI 10.1111/1469-7610.00471
   Peltonen K, 2010, INT J BEHAV DEV, V34, P554, DOI 10.1177/0165025410368943
   Punamaki RL, 1997, CHILD DEV, V68, P718, DOI 10.2307/1132121
   Richman JA, 2008, AM J PUBLIC HEALTH, V98, pS113, DOI 10.2105/AJPH.98.Supplement_1.S113
   Rockmore M., 7642 WORLD BANK
   Rockmore M., 2012, 121 HICN
   Roos I, 2008, INT J SERV IND MANAG, V19, P281, DOI 10.1108/09564230810874986
   Scharf M, 2005, J ADOLESCENT RES, V20, P64, DOI 10.1177/0743558404271133
   Smith P, 2002, J TRAUMA STRESS, V15, P147, DOI 10.1023/A:1014812209051
   Sneath JZ, 2009, MARKET LETT, V20, P45, DOI 10.1007/s11002-008-9049-y
   Thabet AA, 2009, INT J SOC PSYCHIATR, V55, P226, DOI 10.1177/0020764008096100
   Updegraff JA, 2008, J PERS SOC PSYCHOL, V95, P709, DOI 10.1037/0022-3514.95.3.709
   Villa VM, 2002, MIL MED, V167, P783
   Vogt DS, 2004, J APPL SOC PSYCHOL, V34, P1797, DOI 10.1111/j.1559-1816.2004.tb02586.x
   Voors MJ, 2012, AM ECON REV, V102, P941, DOI 10.1257/aer.102.2.941
   Wansink B, 2008, LEADERSHIP QUART, V19, P547, DOI 10.1016/j.leaqua.2008.07.010
   Wansink B, 2013, J RELIG HEALTH, V52, P768, DOI 10.1007/s10943-013-9733-y
   Wansink B, 2009, APPETITE, V52, P750, DOI 10.1016/j.appet.2009.01.001
NR 37
TC 1
Z9 1
U1 1
U2 11
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-1078
J9 FRONT PSYCHOL
JI Front. Psychol.
PD SEP 6
PY 2016
VL 7
AR 1298
DI 10.3389/fpsyg.2016.01298
PG 6
WC Psychology, Multidisciplinary
SC Psychology
GA DV1YY
UT WOS:000382719200001
PM 27656152
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Nair, BR
   Moonen-van Loon, JMW
   Parvathy, MS
   van der Veuten, CPM
AF Nair, Balakrishnan (Kichu) R.
   Moonen-van Loon, Joyce M. W.
   Parvathy, Mulavana S.
   van der Veuten, Cees P. M.
TI RETRACTED: Composite reliability of workplace-based assessment for
   international medical graduates(Retracted article. See vol. 206, pg. 29,
   2017)
SO MEDICAL JOURNAL OF AUSTRALIA
LA English
DT Article; Retracted Publication
ID COMPETENCE; PERFORMANCE; PROGRAMS; DOCTORS; GAP
AB The known Workplace-based assessment (WBA) of the performance of doctors has gained increasing attention. The reliability of individual assessment tools has been reported in previous studies.
   The new We analysed the composite reliability of a toolbox of WBA instruments In assessing international medical graduates (IMGs). For five case-based discussions, 12 Mini-Clinical Examination Exercises and six multisource feedback assessments, the composite reliability coefficient was 0.899 (standard error of measurement, 0.125).
   The implications The reliability of WBA for assessing the performance of IMGs is excellent. WBA can also be used for performance assessment in other settings.
C1 [Nair, Balakrishnan (Kichu) R.; Parvathy, Mulavana S.] John Hunter Hosp, Ctr Med Profess Dev, Newcastle, NSW, Australia.
   [Moonen-van Loon, Joyce M. W.; van der Veuten, Cees P. M.] Maastricht Univ, Maastricht, Netherlands.
RP Nair, BR (reprint author), John Hunter Hosp, Ctr Med Profess Dev, Newcastle, NSW, Australia.
EM kichu.nair@newcastle.edu.au
CR Australian Medical Council Limited, AMC CLIN EX
   Bingham CM, 2011, MED J AUSTRALIA, V195, P410, DOI 10.5694/mja11.10109
   Brennan R. L., 2001, GEN THEORY
   Crossley J, 2002, MED EDUC, V36, P972, DOI 10.1046/j.1365-2923.2002.01320.x
   Davies H, 2009, MED EDUC, V43, P74, DOI 10.1111/j.1365-2923.2008.03249.x
   Elkin K, 2012, MED J AUSTRALIA, V197, P448, DOI 10.5694/mja12.10632
   Kogan JR, 2014, ACAD MED, V89, P721, DOI 10.1097/ACM.0000000000000221
   Lefroy J, 2015, MED EDUC, V49, P307, DOI 10.1111/medu.12659
   Miller A, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5064
   Moonen-van Loon JMW, 2013, ADV HEALTH SCI EDUC, V18, P1087, DOI 10.1007/s10459-013-9450-z
   Moonen-van Loon JMW, 2015, ACAD MED, V90, P1093, DOI 10.1097/ACM.0000000000000763
   Nair BR, 2015, ADV MED EDUC PRACT, V6, P317, DOI 10.2147/AMEP.S79968
   Nair BK, 2014, MED J AUSTRALIA, V200, P41, DOI 10.5694/mja13.10849
   Nair BR, 2012, MED J AUSTRALIA, V196, P399, DOI 10.5694/mja11.10709
   Neilson R, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1783
   Norcini JJ, 2003, ANN INTERN MED, V138, P476, DOI 10.7326/0003-4819-138-6-200303180-00012
   Norcini J, 2007, MED TEACH, V29, P855, DOI 10.1080/01421590701775453
   Peile E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2696
   Sabey A, 2010, FOCUS HLTH PROF ED, V11, P42
   Swanson DB, 1987, FURTHER DEV ASSESSIN, P13
   Takahashi SG, 2012, CAN FAM PHYSICIAN, V58, pE408
   ten Cate O, 2007, ACAD MED, V82, P542, DOI 10.1097/ACM.0b013e31805559c7
   Tiffin PA, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2622
   van der Vleuten CPM, 2010, BEST PRACT RES CL OB, V24, P703, DOI 10.1016/j.bpobgyn.2010.04.001
   van der Vleuten CPM, 2005, MED EDUC, V39, P309, DOI 10.1111/j.1365-2929.2005.02094.x
   Wilkinson JR, 2008, MED EDUC, V42, P364, DOI 10.1111/j.1365-2923.2008.03010.x
NR 26
TC 3
Z9 3
U1 2
U2 6
PU AUSTRALASIAN MED PUBL CO LTD
PI PYRMONT
PA LEVEL 2, 26-32 PYRMONT BRIDGE RD, PYRMONT, NSW 2009, AUSTRALIA
SN 0025-729X
EI 1326-5377
J9 MED J AUSTRALIA
JI Med. J. Aust.
PD SEP 5
PY 2016
VL 205
IS 5
BP 212
EP 216
DI 10.5694/mja16.00069
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA DX0FQ
UT WOS:000384037600012
PM 27581267
DA 2018-12-27
ER

PT J
AU Kerai, S
   Sehrawat, L
AF Kerai, Sukhyanti
   Sehrawat, Lalit
TI RETRACTED: Successful epidural anesthesia in a patient of Hurler
   syndrome for hernia repair (Retracted article. See vol. 22, pg. 233,
   2018)
SO ANAESTHESIA PAIN & INTENSIVE CARE
LA English
DT Article; Retracted Publication
DE Mucopolysaccharidosis; Hurler syndrome; Epidural anesthesia; Hernia
   repair
ID MUCOPOLYSACCHARIDOSES
AB Mucopolysaccharidosis is a rare inherited lysosomal storage disease characterized by increasing deposition of unmetabolized glucosaminoglycans. The surgical procedures under general anesthesia in these patients is associated with high mortality due to difficulty in airway management. The regional anesthesia is useful alternative; however, previous case reports describing epidural/spinal anesthesia have reported failure of this technique. We describe a case of mucopolysaccharidosis type I (Hurler syndrome) for repair of umbilical and inguinal hernia repair conducted under epidural anesthesia with sedation, obviating the need of intubation.
C1 [Kerai, Sukhyanti; Sehrawat, Lalit] Maulana Azad Med Coll & Associated Hosp, Dept Anesthesiol & Crit Care, Bahadur Shah Zaffar Marg, New Delhi, India.
RP Kerai, S (reprint author), Maulana Azad Med Coll & Associated Hosp, Dept Anesthesiol & Crit Care, Bahadur Shah Zaffar Marg, New Delhi, India.
EM drsukhi25@gmail.com
CR Arn P, 2012, J PEDIATR SURG, V47, P477, DOI 10.1016/j.jpedsurg.2011.09.042
   Barbosa Fabiano Timbó, 2007, Rev. Bras. Anestesiol., V57, P658, DOI 10.1590/S0034-70942007000600008
   Hermanides J, 2012, BRIT J ANAESTH, V109, P144, DOI 10.1093/bja/aes214
   KING DH, 1984, ANAESTHESIA, V39, P126, DOI 10.1111/j.1365-2044.1984.tb09499.x
   Leone A, 2015, CHILD NERV SYST, V31, P203, DOI 10.1007/s00381-014-2578-1
   Pirigov B. K., 2011, Anesteziologiya i Reanimatologiya, P29
   SJOGREN P, 1986, ACTA ANAESTH SCAND, V30, P484, DOI 10.1111/j.1399-6576.1986.tb02459.x
   Vas L, 2000, PAEDIATR ANAESTH, V10, P95, DOI 10.1046/j.1460-9592.2000.00464.x
   WALKER RWM, 1994, ANAESTHESIA, V49, P1078, DOI 10.1111/j.1365-2044.1994.tb04360.x
   Yalcin S, 2011, PEDIATR ANESTH, V21, P1270, DOI 10.1111/j.1460-9592.2011.03671.x
NR 10
TC 1
Z9 1
U1 0
U2 0
PU ANAESTHESIA PAIN & INTENSIVE CARE
PI ISLAMABAD
PA C/O TARIQ HAYAT KHAN, ED, 60-A, NAZIM-UD-DIN RD, ISLAMABAD, 00000,
   PAKISTAN
SN 1607-8322
EI 2220-5799
J9 ANAESTH PAIN INTENSI
JI Anaesth. Pain Intensive Care
PD SEP
PY 2016
VL 20
IS 3
BP 350
EP 352
PG 3
WC Anesthesiology
SC Anesthesiology
GA EY3DT
UT WOS:000403852500019
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Azeem, E
   Gillani, SW
   Poh, V
   Sulaiman, SAS
AF Azeem, Eman
   Gillani, Syed Wasif
   Poh, Vinci
   Sulaiman, Syed Azhar Syed
TI RETRACTED: Healthcare providers' knowledge, attitude and behaviour
   towards breast cancer diagnosis and treatment in Malaysia - a mini
   systematic review (Retracted article. See vol. 17, pg. 2299, 2018)
SO TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
LA English
DT Article; Retracted Publication
DE Healthcare provider; Breast cancer; Knowledge; Attitude; Behavior;
   Systematic review; Malaysia
AB Breast cancer is the most common cancer among women in Malaysia. Therefore, it is important for the public to be educated on breast cancer and to know the steps that need to be taken to detect it early. Healthcare providers are in a unique position to provide public health education due to their good knowledge of health issues and their roles in healthcare. A systematic review of studies conducted from 2008 till 2015 was undertaken to analyze the knowledge, attitudes and behavior of Malaysian healthcare providers regarding breast cancer, in an attempt to obtain an overall picture of how well-equipped the healthcare providers are to provide optimal breast cancer education, and to ascertain their perceptions and actual involvement in such education. The systematic review was conducted via a primary search of various databases and journal websites, and a secondary search of references cited in eligible studies. Criteria for eligibility include studies conducted in Malaysia and published from the year 2008 to 2015, and written in English language. A total of fifteen articles were identified and reviewed but only two studies were eligible for this review. The findings suggest that future and current Malaysian healthcare providers have moderate knowledge of breast cancer, showed a positive disposition towards involvement in breast cancer education, but displayed poor involvement.
C1 [Azeem, Eman] Taibah Univ, Dept Clin Pharm, POB 30001, Al Madinah Al Munawarrah, Saudi Arabia.
   [Gillani, Syed Wasif] King Abdul Aziz Mil Hosp PSAFH, Tabuk, Saudi Arabia.
   [Poh, Vinci] Monash Univ, Subang Jaya, Selangor, Malaysia.
   [Sulaiman, Syed Azhar Syed] Univ Sains Malaysia, Sch Pharmaceut Sci, Gelugor, Penang, Malaysia.
RP Gillani, SW (reprint author), King Abdul Aziz Mil Hosp PSAFH, Tabuk, Saudi Arabia.
EM wasifgillani@gmail.com
CR American Cancer Society, 2015, BREAST CANC PREV EAR
   [Anonymous], 2012, STAR
   Beshir SA, 2012, ASIAN PAC J CANCER P, V13, P4427, DOI 10.7314/APJCP.2012.13.9.4427
   Lin LP, 2013, MALAYS J MED SCI, V20, P60
   National Cancer Registry Ministry of Health Malaysia, 2006, MAL CANC STAT DAT FI
   PRIDE Foundation, 2014, BREAST CANC
   Yip C H, 2014, Med J Malaysia, V69 Suppl A, P8
NR 7
TC 1
Z9 1
U1 0
U2 3
PU PHARMACOTHERAPY GROUP
PI BENIN CITY
PA UNIV BENIN, FACULTY PHARMACY, BENIN CITY, 00000, NIGERIA
SN 1596-5996
J9 TROP J PHARM RES
JI Trop. J. Pharm. Res.
PD SEP
PY 2016
VL 15
IS 9
BP 2041
EP 2045
DI 10.4314/tjpr.v15i9.32
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA EA9GZ
UT WOS:000386951900032
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Chua, A
   Patel, V
   Perrin, A
   Stern, L
   Ehreth, J
   Omert, L
   Hood, C
   Farley, J
   McGlynn, M
   Huang, LP
AF Chua, Andrew
   Patel, Vishal
   Perrin, Allison
   Stern, Lee
   Ehreth, Jenifer
   Omert, Laurel
   Hood, Christopher
   Farley, Julie
   McGlynn, Michael
   Huang, Liping
TI RETRACTED: NUMBER NEEDED TO TREAT WITH 4-FACTOR PROTHROMBIN COMPLEX
   CONCENTRATE FOR URGENT WARFARIN REVERSAL(Retracted article. See vol. 92,
   pg. E60, 2017)
SO AMERICAN JOURNAL OF HEMATOLOGY
LA English
DT Meeting Abstract; Retracted Publication
C1 LASER Analytica, New York, NY USA.
   CSL Behring, King Of Prussia, PA USA.
NR 0
TC 1
Z9 1
U1 2
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0361-8609
EI 1096-8652
J9 AM J HEMATOL
JI Am. J. Hematol.
PD SEP
PY 2016
VL 91
IS 9
MA F66
BP E427
EP E427
PG 1
WC Hematology
SC Hematology
GA DY6LT
UT WOS:000385237100143
DA 2018-12-27
ER

PT J
AU Westbrook, AM
   Szakmary, A
   Schiestl, RH
AF Westbrook, Aya M.
   Szakmary, Akos
   Schiestl, Robert H.
TI RETRACTED: Mouse models of intestinal inflammation and cancer (Retracted
   article. See vol. 92, pg. 3441, 2018)
SO ARCHIVES OF TOXICOLOGY
LA English
DT Review; Retracted Publication
DE Intestinal inflammation; Intestinal cancer; Mouse models
ID DEXTRAN SODIUM-SULFATE; SMALL-BOWEL ADENOCARCINOMA; CD4(+) T-CELLS;
   NF-KAPPA-B; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SPONTANEOUSLY DEVELOP
   COLITIS; COMBINED IMMUNODEFICIENT MICE; CHRONIC ULCERATIVE-COLITIS;
   INNATE IMMUNE-SYSTEM; CROHNS-DISEASE
AB Chronic inflammation is strongly associated with approximately one-fifth of all human cancers. Arising from combinations of factors such as environmental exposures, diet, inherited gene polymorphisms, infections, or from dysfunctions of the immune response, chronic inflammation begins as an attempt of the body to remove injurious stimuli; however, over time, this results in continuous tissue destruction and promotion and maintenance of carcinogenesis. Here, we focus on intestinal inflammation and its associated cancers, a group of diseases on the rise and affecting millions of people worldwide. Intestinal inflammation can be widely grouped into inflammatory bowel diseases (ulcerative colitis and Crohn's disease) and celiac disease. Long-standing intestinal inflammation is associated with colorectal cancer and small-bowel adenocarcinoma, as well as extraintestinal manifestations, including lymphomas and autoimmune diseases. This article highlights potential mechanisms of pathogenesis in inflammatory bowel diseases and celiac disease, as well as those involved in the progression to associated cancers, most of which have been identified from studies utilizing mouse models of intestinal inflammation. Mouse models of intestinal inflammation can be widely grouped into chemically induced models; genetic models, which make up the bulk of the studied models; adoptive transfer models; and spontaneous models. Studies in these models have lead to the understanding that persistent antigen exposure in the intestinal lumen, in combination with loss of epithelial barrier function, and dysfunction and dysregulation of the innate and adaptive immune responses lead to chronic intestinal inflammation. Transcriptional changes in this environment leading to cell survival, hyperplasia, promotion of angiogenesis, persistent DNA damage, or insufficient repair of DNA damage due to an excess of proinflammatory mediators are then thought to lead to sustained malignant transformation. With regard to extraintestinal manifestations such as lymphoma, however, more suitable models are required to further investigate the complex and heterogeneous mechanisms that may be at play.
C1 [Westbrook, Aya M.; Schiestl, Robert H.] Univ Calif Los Angeles, UCLA Sch Med, Mol Toxicol Interdept Program, Los Angeles, CA 90095 USA.
   [Westbrook, Aya M.; Schiestl, Robert H.] Univ Calif Los Angeles, UCLA Sch Med, Dept Pathol & Lab Med, 650 Charles E Young Dr South,71-295 CHS, Los Angeles, CA 90095 USA.
   [Westbrook, Aya M.; Schiestl, Robert H.] Univ Calif Los Angeles, Sch Publ Hlth, 650 Charles E Young Dr South,71-295 CHS, Los Angeles, CA 90095 USA.
   [Szakmary, Akos] Med Univ Vienna, Inst Canc Res, Vienna, Austria.
RP Schiestl, RH (reprint author), Univ Calif Los Angeles, UCLA Sch Med, Mol Toxicol Interdept Program, Los Angeles, CA 90095 USA.; Schiestl, RH (reprint author), Univ Calif Los Angeles, UCLA Sch Med, Dept Pathol & Lab Med, 650 Charles E Young Dr South,71-295 CHS, Los Angeles, CA 90095 USA.; Schiestl, RH (reprint author), Univ Calif Los Angeles, Sch Publ Hlth, 650 Charles E Young Dr South,71-295 CHS, Los Angeles, CA 90095 USA.
EM Rschiestl@mednet.ucla.edu
FU NIH [ES09519]; Jonsson Comprehensive Cancer Foundation; TRP Grant from
   the FWF [L618-B11]; UCLA-NIEHS
FX This work was supported in part by NIH Grant ES09519 (RS), the Jonsson
   Comprehensive Cancer Foundation (RS), a TRP Grant (L618-B11) from the
   FWF (AS and RS) and a UCLA-NIEHS training grant in Molecular Toxicology
   (AW).
CR Abu-Shakra M, 2001, ANN RHEUM DIS, V60, P433, DOI 10.1136/ard.60.5.433
   AbuShakra M, 1996, ARTHRITIS RHEUM, V39, P1050, DOI 10.1002/art.1780390625
   ABUSHAKRA M, 1993, ARTHRITIS RHEUM, V36, P460, DOI 10.1002/art.1780360405
   Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753
   Altindag O, 2007, CLIN BIOCHEM, V40, P167, DOI 10.1016/j.clinbiochem.2006.10.006
   *AM CANC SOC, 2008, CANC FACTS FIG 2008
   AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258
   Amos-Landgraf JM, 2007, P NATL ACAD SCI USA, V104, P4036, DOI 10.1073/pnas.0611690104
   An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929
   Aranda R, 1997, J IMMUNOL, V158, P3464
   Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102
   Atreya R, 2000, NAT MED, V6, P583
   Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0
   BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964
   Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175
   Beatty PL, 2007, J IMMUNOL, V179, P735, DOI 10.4049/jimmunol.179.2.735
   Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052
   Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819
   Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0
   Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595
   Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929
   Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110
   Brandwein SL, 1997, J IMMUNOL, V159, P44
   Brimnes J, 2005, J IMMUNOL, V174, P5814, DOI 10.4049/jimmunol.174.9.5814
   Brimnes J, 2001, EUR J IMMUNOL, V31, P23, DOI 10.1002/1521-4141(200101)31:1<23::AID-IMMU23>3.0.CO;2-2
   Camoglio L, 2000, EUR J IMMUNOL, V30, P1486, DOI 10.1002/(SICI)1521-4141(200005)30:5<1486::AID-IMMU1486>3.0.CO;2-8
   Canavan C, 2006, ALIMENT PHARM THERAP, V23, P1097, DOI 10.1111/j.1365-2036.2006.02854.x
   Catassi C, 2005, GASTROENTEROLOGY, V128, pS79, DOI 10.1053/j.gastro.2005.02.027
   Chan RCF, 2006, HUM PATHOL, V37, P631, DOI 10.1016/j.humpath.2005.12.013
   Chaux P, 1996, LAB INVEST, V74, P975
   Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272
   Clegg CH, 1997, INT IMMUNOL, V9, P1111, DOI 10.1093/intimm/9.8.1111
   Colussi C, 2001, J NATL CANCER I, V93, P1534, DOI 10.1093/jnci/93.20.1534
   Coombes J, 2007, CONTROL INTESTINAL H
   COOPER HS, 1993, LAB INVEST, V69, P238
   Cooper HS, 2000, CARCINOGENESIS, V21, P757, DOI 10.1093/carcin/21.4.757
   Cotran RS, 1999, ROBBINS PATHOLOGIC B, P50
   Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7
   De Giorgi V, 2009, INT J DERMATOL, V48, P312, DOI 10.1111/j.1365-4632.2009.03916.x
   De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090
   Delaunoit T, 2005, AM J GASTROENTEROL, V100, P703, DOI 10.1111/j.1572-0241.2005.40605.x
   DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6
   Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127
   Dotan Iris, 2007, Expert Rev Gastroenterol Hepatol, V1, P265, DOI 10.1586/17474124.1.2.265
   Eckburg PB, 2007, CLIN INFECT DIS, V44, P256, DOI 10.1086/510385
   Elder DJE, 1999, APOPTOSIS, V4, P365, DOI 10.1023/A:1009696505108
   Elgbratt K, 2007, IMMUNOLOGY, V122, P199, DOI 10.1111/j.1365-2567.2007.02629.x
   Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x
   Engle SJ, 2002, CANCER RES, V62, P6362
   Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1
   Erdman SE, 2001, J IMMUNOL, V166, P1443, DOI 10.4049/jimmunol.166.3.1443
   Esensten JH, 2009, J IMMUNOL, V183, P75, DOI 10.4049/jimmunol.0804154
   Farrell RJ, 2002, GASTROENTEROL CLIN N, V31, P41, DOI 10.1016/S0889-8553(01)00004-8
   Festen Eleonora A. M., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P199
   Fichtner-Feigl S, 2005, J CLIN INVEST, V115, P3057, DOI 10.1172/JCI24792
   Fina D, 2008, GUT, V57, P887, DOI 10.1136/gut.2007.129882
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Funabashi H, 2001, EXP ANIM TOKYO, V50, P41, DOI 10.1538/expanim.50.41
   Garlanda C, 2004, P NATL ACAD SCI USA, V101, P3522, DOI 10.1073/pnas.0303860101
   Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017
   Garrett WS, 2009, CANCER CELL, V16, P208, DOI 10.1016/j.ccr.2009.07.015
   Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3
   Green PHR, 2003, HEMATOL ONCOL CLIN N, V17, P611, DOI 10.1016/S0889-8588(03)00008-X
   Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5
   GREENSTEIN AJ, 1985, CANCER, V56, P2914, DOI 10.1002/1097-0142(19851215)56:12<2914::AID-CNCR2820561232>3.0.CO;2-J
   Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201
   Guldenschuh L, 2001, DIS COLON RECTUM, V44, P1090, DOI 10.1007/BF02234627
   Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.2006.0436
   Hecht SS, 1997, ANN NY ACAD SCI, V833, P91, DOI 10.1111/j.1749-6632.1997.tb48596.x
   Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002
   Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3
   HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203
   Hoffmann J, 2000, PATHOBIOLOGY, V70, P121
   HOLLANDER GA, 1995, IMMUNITY, V3, P27, DOI 10.1016/1074-7613(95)90156-6
   Hovhannisyan Z, 2008, NATURE, V456, P534, DOI 10.1038/nature07524
   Huang TT, 2003, INT IMMUNOL, V15, P1359, DOI 10.1093/intimm/dxg135
   Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107
   Iijima H, 2004, J EXP MED, V199, P471, DOI 10.1084/jem.20030437
   Iqbal N, 2002, J EXP MED, V195, P71, DOI 10.1084/jem.2001889
   Issa JPJ, 2001, CANCER RES, V61, P3573
   Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004
   Jess T, 2005, AM J GASTROENTEROL, V100, P2724, DOI 10.1111/j.1572-0241.2005.00287.x
   Kado S, 2001, CANCER RES, V61, P2395
   Kakazu T, 1999, AM J GASTROENTEROL, V94, P2149
   Kanagarajan N, 2008, INFLAMM RES, V57, P34, DOI 10.1007/s00011-007-6177-4
   Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041
   Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021
   Kastenbauer S, 1999, INFECT IMMUN, V67, P1553
   Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911
   Kobayashi M, 2003, J CLIN INVEST, V111, P1297, DOI 10.1172/JCI200317085
   Kohno H, 2005, CANCER SCI, V96, P69, DOI 10.1111/j.1349-7006.2005.00020.x
   Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2
   Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747
   Kuhnel D, 2009, ARCH TOXICOL, V83, P763, DOI 10.1007/s00204-009-0406-2
   KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P
   KULKARNI AB, 1995, AM J PATHOL, V146, P264
   Kullberg MC, 2003, P NATL ACAD SCI USA, V100, P15830, DOI 10.1073/pnas.2534546100
   Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x
   Laden F, 2007, ENVIRON HEALTH PERSP, V115, P1192, DOI 10.1289/ehp.10027
   Laubitz D, 2008, AM J PHYSIOL-GASTR L, V295, pG63, DOI 10.1152/ajpgi.90207.2008
   Lazarus MN, 2006, RHEUMATOLOGY, V45, P1012, DOI 10.1093/rheumatology/kei281
   Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350
   Lee SH, 2003, J IMMUNOL, V170, P2214, DOI 10.4049/jimmunol.170.4.2214
   Leeds JS, 2007, SCAND J GASTROENTERO, V42, P1214, DOI 10.1080/00365520701365112
   Liao J, 2008, MOL CARCINOGEN, V47, P638, DOI 10.1002/mc.20427
   Mahmud S, 2004, BRIT J CANCER, V90, P93, DOI 10.1038/sj.bjc.6601416
   Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d
   Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3
   Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262
   Matsumoto S, 1998, GUT, V43, P71, DOI 10.1136/gut.43.1.71
   MATTESON EL, 1991, J RHEUMATOL, V18, P809
   McCafferty DM, 2000, AM J PHYSIOL-GASTR L, V279, pG90
   McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402
   McPherson M, 2008, AM J PHYSIOL-GASTR L, V295, pG485, DOI 10.1152/ajpgi.90221.2008
   Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073
   Merritt MA, 2008, INT J CANCER, V122, P170, DOI 10.1002/ijc.23017
   Mizoguchi A, 1999, GASTROENTEROLOGY, V116, P320, DOI 10.1016/S0016-5085(99)70128-9
   MOMBAERTS P, 1993, CELL, V75, P275, DOI 10.1016/0092-8674(93)80069-Q
   Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI12821
   MORI H, 1984, Nutrition and Cancer, V6, P92
   MORRISSEY PJ, 1993, J EXP MED, V178, P237, DOI 10.1084/jem.178.1.237
   MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722
   MUNKHOLM P, 1994, GUT, V35, P68, DOI 10.1136/gut.35.1.68
   Mylonaki M, 2005, INFLAMM BOWEL DIS, V11, P481, DOI 10.1097/01.MIB.0000159663.62651.4f
   Nemetz N, 2008, INT J CANCER, V122, P1803, DOI 10.1002/ijc.23308
   Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698
   Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956
   Neurath MF, 1996, ANN NY ACAD SCI, V795, P368, DOI 10.1111/j.1749-6632.1996.tb52695.x
   O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736
   O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989
   Ohman L, 2000, SCAND J IMMUNOL, V52, P80
   OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H
   Okuda Y, 2003, AM J PATHOL, V162, P263, DOI 10.1016/S0002-9440(10)63817-5
   Panwala CM, 1998, J IMMUNOL, V161, P5733
   Park JW, 2009, J ALLERGY CLIN IMMUN, V123, P479, DOI 10.1016/j.jaci.2008.10.035
   Parke D V, 1996, Int J Occup Med Environ Health, V9, P331
   Peebles KA, 2007, EXPERT REV ANTICANC, V7, P1405, DOI 10.1586/14737140.7.10.1405
   Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339
   Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]
   Potter DD, 2004, CANCER RES, V64, P7073, DOI 10.1158/0008-5472.CAN-04-1096
   POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461
   Prantera C, 2009, CURR OPIN GASTROEN, V25, P329, DOI 10.1097/MOG.0b013e32832b20bf
   Prisciandaro L, 2009, INFLAMM BOWEL DIS, V15, P1906, DOI 10.1002/ibd.20938
   Qiu BS, 1999, NAT MED, V5, P1178
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488
   Rakoff-Nahoum Seth, 2006, Yale J Biol Med, V79, P123
   Rashid A, 1997, GASTROENTEROLOGY, V113, P127, DOI 10.1016/S0016-5085(97)70087-8
   Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295
   Rennick DM, 2000, AM J PHYSIOL-GASTR L, V278, pG829
   Reuter BK, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-19
   Ritland SR, 1999, CARCINOGENESIS, V20, P51, DOI 10.1093/carcin/20.1.51
   RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143
   SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O
   SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x
   Sartor RB, 2007, J CLIN GASTROENTEROL, V41, pS37
   Saurer L, 2009, ALLERGY, V64, P505, DOI 10.1111/j.1398-9995.2009.01965.x
   Scanlan PD, 2006, J CLIN MICROBIOL, V44, P3980, DOI 10.1128/JCM.00312-06
   Schuppler M, 2004, INFECT IMMUN, V72, P1983, DOI 10.1128/IAI.72.4.1983-1990.2004
   Sellon RK, 1998, INFECT IMMUN, V66, P5224
   Seril DN, 2003, CARCINOGENESIS, V24, P353, DOI 10.1093/carcin/24.3.353
   Shekhawat PS, 2007, MOL GENET METAB, V92, P315, DOI 10.1016/j.ymgme.2007.08.002
   Shintani N, 1997, SCAND J IMMUNOL, V46, P581, DOI 10.1046/j.1365-3083.1997.d01-169.x
   Shoenfeld Y, 2000, CANC AUTOIMMUNITY, P1
   SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0
   Siegmund B, 2004, J LEUKOCYTE BIOL, V76, P782, DOI 10.1189/jlb.0404239
   Siemes C, 2006, J CLIN ONCOL, V24, P5216, DOI 10.1200/JCO.2006.07.1381
   Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P538
   Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7
   Soderstrom K, 1996, J IMMUNOL, V156, P2331
   Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571
   SPURZEM JR, 1991, CHEST, V100, P389, DOI 10.1378/chest.100.2.389
   Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352
   Steinhoff U, 1999, IMMUNITY, V11, P349, DOI 10.1016/S1074-7613(00)80110-7
   Stewart BW, 2003, WORLD CANC REPORT, P56
   Stoicov C, 2009, J IMMUNOL, V183, P642, DOI 10.4049/jimmunol.0900511
   Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345
   Strauch UG, 2007, WORLD J GASTROENTERO, V13, P6529
   Sugawara K, 2005, GASTROENTEROLOGY, V128, P351, DOI 10.1053/j.gastro.2004.11.001
   SUNDBERG JP, 1994, GASTROENTEROLOGY, V107, P1726, DOI 10.1016/0016-5085(94)90813-3
   Suzuki R, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-84
   Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294
   Takaki K, 2006, INFLAMM RES, V55, P10, DOI 10.1007/s00011-005-0002-8
   Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0
   Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9
   Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x
   Tlaskalova H, 2000, CANC AUTOIMMUNITY, P105
   Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108
   Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852
   Uronis JM, 2009, MAMM GENOME, V20, P261, DOI 10.1007/s00335-009-9186-5
   Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020
   van Meeteren ME, 2000, SCAND J GASTROENTERO, V35, P517
   Velde AAT, 2006, INFLAMM BOWEL DIS, V12, P995
   Verdu EF, 2008, AM J PHYSIOL-GASTR L, V294, pG217, DOI 10.1152/ajpgi.00225.2007
   Vogelsang H, 1998, DIGEST DIS, V16, P333, DOI 10.1159/000016886
   Watanabe M, 1998, J EXP MED, V187, P389, DOI 10.1084/jem.187.3.389
   Welte T, 2003, P NATL ACAD SCI USA, V100, P1879, DOI 10.1073/PNAS.0237137100
   Westbrook AM, 2010, MUTAT RES-REV MUTAT, V705, P40, DOI 10.1016/j.mrrev.2010.03.001
   Westbrook AM, 2010, CANCER RES, V70, P1875, DOI 10.1158/0008-5472.CAN-09-2584
   Westbrook AM, 2009, CELL CYCLE, V8, P2482, DOI 10.4161/cc.8.16.9274
   Westbrook AM, 2009, CANCER RES, V69, P4827, DOI 10.1158/0008-5472.CAN-08-4416
   Wheeler JMD, 2002, GUT, V50, P218, DOI 10.1136/gut.50.2.218
   WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9
   Wirtz S, 1999, J IMMUNOL, V162, P1884
   Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003
   Xie JL, 2008, WORLD J GASTROENTERO, V14, P378, DOI 10.3748/wjg.14.378
   Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280
   Yang YH, 2009, J EXP MED, V206, P1549, DOI 10.1084/jem.20082584
   Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590
   Zhang MQ, 2006, MODERN PATHOL, V19, P573, DOI 10.1038/modpathol.3800566
NR 212
TC 5
Z9 5
U1 2
U2 14
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD SEP
PY 2016
VL 90
IS 9
BP 2109
EP 2130
DI 10.1007/s00204-016-1747-2
PG 22
WC Toxicology
SC Toxicology
GA DZ2DR
UT WOS:000385653000004
PM 27311821
DA 2018-12-27
ER

PT J
AU Pouya, EA
   Rajabi, AA
AF Pouya, E. Ahmadi
   Rajabi, A. A.
TI RETRACTED: Three-dimensional study of the six-body bound-state for the
   case of effective three-body configuration model(Retracted article. See
   vol. 26, art no 1793001, 2014)
SO INTERNATIONAL JOURNAL OF MODERN PHYSICS E-NUCLEAR PHYSICS
LA English
DT Article; Retracted Publication
DE Six-body bound-state problem; Jacobi momentum space; three-dimensional
   approach; simple potential models
ID ANGULAR-MOMENTUM DECOMPOSITION; MONTE-CARLO CALCULATIONS; GROUND-STATE;
   ALPHA-PARTICLE; IDENTICAL PARTICLES; FADDEEV-EQUATIONS;
   BINDING-ENERGIES; SYSTEMS; NUCLEI; SCATTERING
AB A recently developed three-Dimensional (3D) approach, without Partial-Wave (PW) decomposition is considered to investigate solutions of Faddeev-Yakubovsky (F-Y) integral equations in momentum space representation. The F-Y formulation for six-nucleon bound-state problem leads to five coupled equations in terms of five independent structures, which can be reduced to two coupled ones for considering the effective interactions of the two loosely bound nucleons with respect to the a-core nucleus. In order to study, the effective structure of six-nucleon bound-state in 3D representation, the coupled equations are represented in momentum space as a two coupled 3D integral equations. This is the first step to approach the calculations, of six-nucleon bound-state problem in 3D approach. In our calculations, we considered simple potential models, namely spin-independent two-body (2B) interactions. Our numerical results are fair compatible with results of other methods.
C1 [Pouya, E. Ahmadi; Rajabi, A. A.] Shahrood Univ Technol, Dept Phys, POB 3619995161-316, Shahrood, Iran.
RP Pouya, EA (reprint author), Shahrood Univ Technol, Dept Phys, POB 3619995161-316, Shahrood, Iran.
EM e.ahmady.ph@gmail.com
CR Akaishi Y., 1986, LECTURE NOTES PHYSIC, V273, P324
   Bacca S, 2009, EUR PHYS J A, V42, P553, DOI 10.1140/epja/i2009-10815-5
   BAKER GA, 1962, PHYS REV, V125, P1754, DOI 10.1103/PhysRev.125.1754
   BALLOT JL, 1981, Z PHYS A-HADRON NUCL, V302, P347, DOI 10.1007/BF01414266
   Barnea N, 2000, PHYS REV C, V61, DOI 10.1103/PhysRevC.61.054001
   BISHOP RF, 1990, PHYS REV C, V42, P1341, DOI 10.1103/PhysRevC.42.1341
   CARLSON J, 1981, NUCL PHYS A, V371, P301, DOI 10.1016/0375-9474(81)90069-5
   Elster C, 1998, FEW-BODY SYST, V24, P55, DOI 10.1007/s006010050076
   Elster C, 1999, FEW-BODY SYST, V27, P83, DOI 10.1007/s006010050124
   Elster C, 2008, PHYS REV C, V78, DOI 10.1103/PhysRevC.78.034002
   Epelbaum E, 2002, EUR PHYS J A, V15, P543, DOI 10.1140/epja/i2002-10048-2
   Epelbaum E., 2004, PHYS REV C, V70
   FANTONI S, 1970, NUOVO CIMENTO A, V69, P80, DOI 10.1007/BF02728772
   FONSECA AC, 1984, PHYS REV C, V30, P35, DOI 10.1103/PhysRevC.30.35
   Gattobigio M, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.024001
   Gattobigio M., ARXIVNUCLTH10116154
   GIBSON BF, 1977, PHYS REV C, V15, P2257, DOI 10.1103/PhysRevC.15.2257.2
   GLOCKLE W, 1993, NUCL PHYS A, V560, P541, DOI 10.1016/0375-9474(93)90113-C
   Glockle W, 2011, FEW-BODY SYST, V51, P27, DOI 10.1007/s00601-011-0217-x
   Hadizadeh MR, 2007, FEW-BODY SYST, V40, P171, DOI 10.1007/s00601-006-0169-8
   Hadizadeh MR, 2011, PHYS REV C, V83, DOI 10.1103/PhysRevC.83.054004
   Hagen G, 2007, PHYS LETT B, V656, P169, DOI 10.1016/j.physletb.2007.07.072
   Huber D, 1997, FEW-BODY SYST, V22, P107, DOI 10.1007/s006010050057
   Jurgenson E. D., ARXIVNUCLTH10114085
   Kamada H, 2001, PHYS REV C, V64, DOI 10.1103/PhysRevC.64.044001
   KAMADA H, 1992, NUCL PHYS A, V548, P205, DOI 10.1016/0375-9474(92)90009-9
   KAMIMURA M, 1990, NUCL PHYS A, V508, pC17
   Khaldi K., ARXIVNUCLTH10065705V
   KHARCHENKO VF, 1972, PHYS LETT B, VB 42, P328, DOI 10.1016/0370-2693(72)90499-6
   Kroger H., 1977, THESIS
   Lazauskas R, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.044002
   Lin T, 2008, PHYS LETT B, V660, P345, DOI 10.1016/j.physletb.2008.01.012
   Liu H, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.054003
   Liu H, 2003, FEW-BODY SYST, V33, P241, DOI 10.1007/s00601-003-0019-x
   LOMNITZADLER J, 1981, NUCL PHYS A, V361, P399, DOI 10.1016/0375-9474(81)90642-4
   Luu T. C., ARXIVNUCLTH0412109
   MACHLEIDT R, 1987, PHYS REP, V149, P1, DOI 10.1016/S0370-1573(87)80002-9
   MALFLIET RA, 1969, NUCL PHYS A, VA127, P161, DOI 10.1016/0375-9474(69)90775-1
   MERKURIEV SP, 1984, NUCL PHYS A, V431, P125, DOI 10.1016/0375-9474(84)90057-5
   NARODETS.IM, 1974, NUCL PHYS A, V221, P191, DOI 10.1016/0375-9474(74)90108-0
   Nogga A, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.064002
   Nogga A, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.054003
   Nogga A, 2000, PHYS REV LETT, V85, P944, DOI 10.1103/PhysRevLett.85.944
   OEHM W, 1990, PHYS REV C, V42, P2322, DOI 10.1103/PhysRevC.42.2322
   Platter L, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052101
   PUDLINER BS, 1995, PHYS REV LETT, V74, P4396, DOI 10.1103/PhysRevLett.74.4396
   SCHELLINGERHOUT NW, 1992, PHYS REV C, V46, P1192, DOI 10.1103/PhysRevC.46.1192
   STADLER A, 1991, PHYS REV C, V44, P2319, DOI 10.1103/PhysRevC.44.2319
   TANG YC, 1967, NUCL PHYS A, VA 93, P692, DOI 10.1016/0375-9474(67)90316-8
   VARGA K, 1994, PHYS REV C, V50, P189, DOI 10.1103/PhysRevC.50.189
   Varga K, 1995, PHYS REV C, V52, P2885, DOI 10.1103/PhysRevC.52.2885
   Viviani M, 2005, PHYS REV C, V71, DOI 10.1103/PhysRevC.71.024006
   VOLKOV AB, 1965, NUCL PHYS, V74, P33, DOI 10.1016/0029-5582(65)90244-0
   Witala H, 2009, EUR PHYS J A, V41, P385, DOI 10.1140/epja/i2009-10842-2
   Witala H, 2009, EUR PHYS J A, V41, P369, DOI 10.1140/epja/i2009-10843-1
   YAKUBOVS.OA, 1967, SOV J NUCL PHYS+, V5, P937
   ZABOLITZKY JG, 1981, PHYS LETT B, V100, P5, DOI 10.1016/0370-2693(81)90273-2
NR 57
TC 4
Z9 4
U1 2
U2 4
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-3013
EI 1793-6608
J9 INT J MOD PHYS E
JI Int. J. Mod. Phys. E-Nucl. Phys.
PD SEP
PY 2016
VL 25
IS 9
AR 1650072
DI 10.1142/S0218301316500725
PG 24
WC Physics, Nuclear; Physics, Particles & Fields
SC Physics
GA DY9HJ
UT WOS:000385444200013
DA 2018-12-27
ER

PT J
AU Fegade, SL
AF Fegade, Swapnil L.
TI RETRACTED: Aromatics from 1-tetradecene through conversion over zeolite
   catalysts (Retracted article. See vol. 120, pg. 423, 2017)
SO CHEMICAL ENGINEERING RESEARCH & DESIGN
LA English
DT Article; Retracted Publication
DE Aromatization; Zeolite; HZSM-5; Tetradecene; Olefin
ID NANOSCALE HZSM-5 ZEOLITE; N-OCTENE; AROMATIZATION; 1-HEXENE;
   TETRADECENE; COPOLYMERS; 1-OCTENE; ZSM-5
AB A completely new reaction of conversion of 1-tetradecene to aromatic compounds over HZSM-5 type of zeolites was studied. A full factorial design of experiments (DOE) was used to determine significant reaction conditions (factors) and their interactions. Experiments were conducted in a fixed head bench top batch autoclave reactor. The liquid products were analyzed by GC-FID. Reaction temperature and olefin to catalyst ratio (OCR) were identified as individual factors significantly affecting aromatization. A decrease in the SiO2:Al2O3 ratio of zeolite increased the aromatics selectivity. Formation of C-6 to C-8 aromatic hydrocarbons in one step catalytic conversion process leads to the conclusion that cracking of tetradecene chain is an inevitable first step in the formation of aromatics. (C) 2016 Institution of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Fegade, Swapnil L.] Univ N Dakota, Dept Chem Engn, Grand Forks, ND USA.
RP Fegade, SL (reprint author), Univ N Dakota, Dept Chem Engn, Grand Forks, ND USA.
EM swapnil.und@gmail.com
FU United States Department of Agriculture (USDA); UND SUNRISE
FX This work was financially supported by the United States Department of
   Agriculture (USDA) and UND SUNRISE. The author gratefully acknowledges
   the contributions from Dr. B. Tande, Dr. W. Seames, Dr. Kozliak, Dr.
   Kubatova of the University of North Dakota.
CR AKHMEDOV AI, 1986, CHEM TECH FUELS OIL+, V22, P300, DOI 10.1007/BF00719560
   ASTM Committee D-2 on Petroleum Products and Lubricants American Petroleum Institute Refining Dept. Technical Data Committee Pennsylvania State University Dept. of Chemical Engineering ASTM Committee D-2 on Petroleum Products and Lubricants, 1991, PHYS CONST HYDR NONH
   Bhan A, 2008, CATAL REV, V50, P19, DOI 10.1080/01614940701804745
   Burdick D. L., 2001, PETROCHEMICALS NONTE
   Choudhary VR, 2002, APPL CATAL A-GEN, V231, P243, DOI 10.1016/S0926-860X(02)00061-3
   Fegade S.L., 2011, ACS NAT M
   Fegade S, 2015, IND ENG CHEM RES, V54, P9657, DOI 10.1021/acs.iecr.5b01932
   Fegade SL, 2013, CHEM ENG COMMUN, V200, P1039, DOI 10.1080/00986445.2012.737385
   Koivumaki J, 1996, POLYM BULL, V36, P7, DOI 10.1007/BF00296001
   Kotzabasakis V, 2009, J POLYM SCI POL CHEM, V47, P876, DOI 10.1002/pola.23202
   Krishnamurthy G, 2010, J CATAL, V271, P370, DOI 10.1016/j.jcat.2010.02.026
   Lappin G. R., 1989, ALPHA OLEFINS APPL H
   Li YN, 2008, APPL CATAL A-GEN, V338, P100, DOI 10.1016/j.apcata.2007.12.026
   Li YN, 2009, APPL CATAL A-GEN, V360, P8, DOI 10.1016/j.apcata.2009.02.039
   Long HY, 2008, CATAL LETT, V126, P378, DOI 10.1007/s10562-008-9636-9
   Long HY, 2009, MICROPOR MESOPOR MAT, V119, P18, DOI 10.1016/j.micromeso.2008.09.032
   Nash RJ, 1996, APPL CATAL A-GEN, V134, P285, DOI 10.1016/0926-860X(95)00198-0
   NIWA M, 1986, J PHYS CHEM-US, V90, P6233, DOI 10.1021/j100281a033
   Wittcoff H. A., 2004, IND ORGANIC CHEM
NR 19
TC 1
Z9 1
U1 2
U2 13
PU INST CHEMICAL ENGINEERS
PI RUGBY
PA 165-189 RAILWAY TERRACE, DAVIS BLDG, RUGBY CV21 3HQ, ENGLAND
SN 0263-8762
EI 1744-3563
J9 CHEM ENG RES DES
JI Chem. Eng. Res. Des.
PD SEP
PY 2016
VL 113
BP 182
EP 188
DI 10.1016/j.cherd.2016.07.019
PG 7
WC Engineering, Chemical
SC Engineering
GA DW3FW
UT WOS:000383528500015
OA Other Gold
DA 2018-12-27
ER

PT J
AU Wallensteen, L
   Zimmermann, M
   Sandberg, MT
   Gezelius, A
   Nordenstrom, A
   Hirvikoski, T
   Lajic, S
AF Wallensteen, Lena
   Zimmermann, Marius
   Sandberg, Malin Thomsen
   Gezelius, Anton
   Nordenstrom, Anna
   Hirvikoski, Tatja
   Lajic, Svetlana
TI RETRACTED: Evaluation of behavioral problems after prenatal
   dexamethasone treatment in Swedish adolescents at risk of CAH (Retracted
   article. See vol. 103, pg. 140, 2018)
SO HORMONES AND BEHAVIOR
LA English
DT Article; Retracted Publication
DE Prenatal treatment; Dexamethasone; Congenital adrenal hyperplasia;
   Social functioning
ID CONGENITAL ADRENAL-HYPERPLASIA; SOCIAL-ANXIETY-SCALE; 21-HYDROXYLASE
   DEFICIENCY; GLUCOCORTICOID EXPOSURE; TREATED CHILDREN; CONCURRENT
   VALIDITY; FOLLOW-UP; INVENTORY; PHOBIA; MOTOR
AB Prenatal dexamethasone (DEX) treatment in congenital adrenal hyperplasia (CAH) is effective in reducing virilization in affected girls, but other lasting effects are largely unknown. Here, we explore potential side effects of the treatment that will eventually help to make risk benefit analyses of the treatment. Therefore, we investigated the long-term effects of such prenatal DEX treatment on behavioral problems and temperament in children aged 7-17 years. Standardized parent-completed questionnaires were used to evaluate adaptive functioning, behavioral and emotional problems (using CBCL), social anxiety (SPAI-C-P), and temperament (EAS). Self-reports were used to assess the children's own perception of social anxiety (SASC-R). The study compared 34 DEX-treated children and adolescents who were treated during the first trimester of fetal life and do not have CAH with 66 untreated controls from the Swedish population. No statistically significant differences were found between groups, suggesting that healthy children who were treated with DEX during early fetal life seem to be well adjusted without major behavioral or emotional problems as assessed by their parents. Moreover, self reported social anxiety was not increased in DEX-exposed children and adolescents. In fact, the control group scored higher on items assessing anxiety in new, social situations. Nevertheless, for some of these comparisons, non-significant moderate to large effect sizes were observed, implying that the null findings should be interpreted with caution and require studies on larger, internationally combined cohorts. (C) 2016 Elsevier Inc All rights reserved.
C1 [Wallensteen, Lena; Zimmermann, Marius; Sandberg, Malin Thomsen; Gezelius, Anton; Nordenstrom, Anna; Lajic, Svetlana] Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Karolinska Inst, Pediat Endocrinol Unit Q2 08, SE-17176 Stockholm, Sweden.
   [Hirvikoski, Tatja] Karolinska Univ Hosp, Karolinska Inst, KIND, Dept Womens & Childrens Hlth, SE-17176 Stockholm, Sweden.
RP Lajic, S (reprint author), Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Karolinska Inst, Pediat Endocrinol Unit Q2 08, SE-17176 Stockholm, Sweden.
FU IFCAH/The European Society for Pediatric Endocrinology; Marianne and
   Marcus Wallenberg Foundation; Stockholm County Council (ALF-SLL);
   foundation: Stiftelsen Frimurare Barnhuset; foundation: Samariten;
   foundation: Jerringfonden; foundation: Sallskapet Barnavard; foundation:
   Wera Ekstrom
FX This study was supported by IFCAH/The European Society for Pediatric
   Endocrinology, the Marianne and Marcus Wallenberg Foundation, the
   Stockholm County Council (ALF-SLL), and the foundations: Stiftelsen
   Frimurare Barnhuset, Samariten, Jerringfonden, Sallskapet Barnavard and
   Wera Ekstrom.
CR Achenbach T. M., 1991, MANUAL CHILD BEHAV C
   Alexander N, 2012, J CLIN ENDOCR METAB, V97, P3538, DOI 10.1210/jc.2012-1970
   BEIDEL DC, 1995, PSYCHOL ASSESSMENT, V7, P73, DOI 10.1037/1040-3590.7.1.73
   Buss A.H., 1984, TEMPERAMENT EARLY DE
   Buss C, 2012, P NATL ACAD SCI USA, V109, pE1312, DOI 10.1073/pnas.1201295109
   Cohen J, 1988, STAT POWER ANAL BEHA
   Crudo A, 2012, ENDOCRINOLOGY, V153, P3269, DOI 10.1210/en.2011-2160
   Dalziel SR, 2005, BMJ-BRIT MED J, V331, P665, DOI 10.1136/bmj.38576.494363.E0
   DAVID M, 1984, J PEDIATR-US, V105, P799, DOI 10.1016/S0022-3476(84)80310-8
   Davis EP, 2013, BIOL PSYCHIAT, V74, P647, DOI 10.1016/j.biopsych.2013.03.009
   Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781
   Drake AJ, 2010, ENDOCRINOLOGY, V151, P1581, DOI 10.1210/en.2009-1088
   FOREST MG, 1989, ENDOCR RES, V15, P277, DOI 10.1080/07435808909039101
   Harris A, 2011, HORM BEHAV, V59, P279, DOI 10.1016/j.yhbeh.2010.06.007
   Hauser J, 2008, ENDOCRINOLOGY, V149, P6343, DOI 10.1210/en.2008-0615
   Higa CK, 2006, J CLIN CHILD ADOLESC, V35, P590, DOI 10.1207/s15374424jccp3504_11
   Hirvikoski T, 2008, EUR J ENDOCRINOL, V159, P309, DOI 10.1530/EJE-08-0280
   Hirvikoski T, 2007, J CLIN ENDOCR METAB, V92, P542, DOI 10.1210/jc.2006-1340
   Hirvikoski T, 2011, ACTA PAEDIATR, V100, pE112, DOI 10.1111/j.1651-2227.2011.02260.x
   Iqbal M, 2012, ENDOCRINOLOGY, V153, P3295, DOI 10.1210/en.2012-1054
   Khalife N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081394
   LAGRECA AM, 1988, J CLIN CHILD PSYCHOL, V17, P84, DOI 10.1207/s15374424jccp1701_11
   LAGRECA AM, 1993, J CLIN CHILD PSYCHOL, V22, P17, DOI 10.1207/s15374424jccp2201_2
   Lajic S, 1998, J CLIN ENDOCR METAB, V83, P3872, DOI 10.1210/jc.83.11.3872
   Lajic Svetlana, 2008, V13, P82, DOI 10.1159/000134827
   Lajic S, 2011, ENDOCR DEV, V20, P96, DOI 10.1159/000321228
   Meyer-Bahlburg HFL, 2012, EUR J ENDOCRINOL, V167, P103, DOI 10.1530/EJE-11-0789
   Meyer-Bahlburg HFL, 2004, J CLIN ENDOCR METAB, V89, P610, DOI 10.1210/jc.2002-021129
   Miller WL, 2015, BEST PRACT RES CL EN, V29, P469, DOI 10.1016/j.beem.2015.01.005
   NEW MI, 1990, DEV PHARMACOL THERAP, V15, P200
   Nyirenda MJ, 2006, DIABETOLOGIA, V49, P1412, DOI 10.1007/s00125-006-0188-5
   Sandman CA, 2013, J PSYCHOSOM RES, V75, P327, DOI 10.1016/j.jpsychores.2013.07.009
   Shinwell ES, 2009, SEMIN FETAL NEONAT M, V14, P164, DOI 10.1016/j.siny.2008.12.001
   TRAUTMAN PD, 1995, PSYCHONEUROENDOCRINO, V20, P439, DOI 10.1016/0306-4530(94)00070-0
   Wyrwoll CS, 2012, NEUROENDOCRINOLOGY, V95, P47, DOI 10.1159/000331345
NR 35
TC 4
Z9 4
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0018-506X
EI 1095-6867
J9 HORM BEHAV
JI Horm. Behav.
PD SEP
PY 2016
VL 85
BP 5
EP 11
DI 10.1016/j.yhbeh.2016.06.011
PG 7
WC Behavioral Sciences; Endocrinology & Metabolism
SC Behavioral Sciences; Endocrinology & Metabolism
GA DW7GO
UT WOS:000383819400002
PM 27373757
DA 2018-12-27
ER

PT J
AU Attar, MA
   Xu, HM
AF Attar, Mohammadreza Anbari
   Xu, Hongming
TI RETRACTED: Experimental investigation of impacts of engine hardware,
   operating parameters and combustion performance on particulate emissions
   in a DISI engine (Retracted article. See vol. 215, pg. 809, 2018)
SO APPLIED ENERGY
LA English
DT Article; Retracted Publication
DE Particulate matter; DISI engine; Fuel injection equipment; Valvetrain
   system; Combustion indicators
ID AIR-POLLUTION; PARTICLE EMISSIONS; GDI ENGINE; MATTER EMISSIONS;
   ISCHEMIC-STROKE; PLIF TECHNIQUE; GASOLINE; DISEASE; FUEL; INFLAMMATION
AB With increasing concern over ultrafine Particulate Matter (PM) emissions from Direct Injection Spark Ignition (DISI) engines and ever tightening emissions legislation, substantial research work is required to obtain a better understanding of influence of advanced engine technologies on particulate formation and oxidation. In this work, experimental investigation of engine-out particulate emissions were carried out on a single cylinder spray-guided DISI engine. With regard to effects of engine hardware on PM emissions; impacts of fuel spray angle, fuel flow rate and intake valves' lift and camshaft phasing were examined over a wide start of injection sweep window. Injector tests highlighted a complex relation between injector characteristics and engine operating parameters with PM emissions as a result of fuel impingement and poor mixture preparation. Valvetrain tests indicated some benefits from engine throttling by valve lift and intake camshaft phasing in particulate number concentration reduction at low load. This was associated with increased intake flow turbulence and improved mixture preparation. Number weighted particle size distribution was also affected by intake valve modes at low load. Nevertheless, at high load, impacts of variable valve lift and camshaft phasing on particulate number concentration and size distribution became negligible. Furthermore, combustion phase indicators were studied in order to probe impacts of combustion performance on PM emissions. While no satisfactory correlation of initial flame development with PM emissions was identified; shorter rapid-burning angles were observed with lower particulate number concentrations. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Attar, Mohammadreza Anbari; Xu, Hongming] Univ Birmingham, Vehicle & Engine Technol Res Ctr, Birmingham B15 2TT, W Midlands, England.
   [Attar, Mohammadreza Anbari] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Xu, Hongming] Tsinghua Univ, State Key Lab Automot Safety & Energy, Beijing, Peoples R China.
RP Attar, MA (reprint author), Imperial Coll London, Dept Mech Engn, London SW7 2AZ, England.
EM m.a.attar@imperial.ac.uk
FU laboratory by Jaguar Land Rover plc; Shell Global Solutions (UK)
FX This work was conducted in Future Engines and Fuels Laboratory at
   University of Birmingham. The authors gratefully acknowledge technical
   and financial support of the laboratory by Jaguar Land Rover plc and
   Shell Global Solutions (UK). Great thanks are extended to Mr. Rickie
   Creegan and Mr. Lucas Miles Polglase for their help running engine
   tests.
CR Aleiferis PG, 2013, FUEL, V105, P143, DOI 10.1016/j.fuel.2012.07.044
   Anbari Attar M, 2015, EFFECTS INJECTOR NOZ
   Anbari Attar M, 2015, OPTICAL INVESTIGATIO
   ANDERSSON JD, 2001, 2001013577 SAE
   Attar MA, 2014, EXP THERM FLUID SCI, V59, P96, DOI 10.1016/j.expthermflusci.2014.07.020
   Baumgarten C., 2006, HEAT MASS TRANSFER S
   Behndig AF, 2006, EUR RESPIR J, V27, P359, DOI 10.1183/09031936.06.00136904
   Berndorfer A, 2013010261 SAE
   Bonatesta F, 2014, APPL ENERG, V124, P366, DOI 10.1016/j.apenergy.2014.03.030
   Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171
   Bosteels D, 2006, 2006011516 SAE
   Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1
   Brunt Michael F. J., 1999, 1999010187 SAE
   Cavina N, 2013, 2013240182 SAE
   Chan TW, 2012, SAE INT J FUELS LUBR, V5, P1277, DOI 10.4271/2012-01-1727
   Cho J, 2015, APPL ENERG, V160, P592, DOI 10.1016/j.apenergy.2015.08.010
   Dec J.E., 1997, 970873 SAE
   Desqueyroux H, 2002, ENVIRON RES, V89, P29, DOI 10.1006/enrs.2002.4357
   Eckermann Erik, 2001, WORLD HIST AUTOMOBIL
   Forbes LJL, 2009, EPIDEMIOLOGY, V20, P245, DOI 10.1097/EDE.0b013e318190ea3f
   Gent JF, 2009, ENVIRON HEALTH PERSP, V117, P1168, DOI 10.1289/ehp.0800335
   Giechaskiel B, 2012, SAE INT J ENGINES, V5, P379, DOI 10.4271/2012-01-0443
   Glassman I, 2008, COMBUSTION, 4TH EDITION, P1
   Goss CH, 2004, AM J RESP CRIT CARE, V169, P816, DOI 10.1164/rccm.200306-779OC
   Graskow B, 1998, 980528 SAE
   Greenwood SJ, 1996, 961085 SAE
   Harada J., 1997, 970540 SAE
   Henrotin JB, 2007, OCCUP ENVIRON MED, V64, P439, DOI 10.1136/oem.2006.029306
   Heywood J. B., 1998, INTERNAL COMBUSTION
   Hoffmann B, 2009, ENVIRON HEALTH PERSP, V117, P1302, DOI 10.1289/ehp.0800362
   Hoffmann G, 2015, INFLUENCE GDI MULTIH
   Hoffmann G, 2014, SAE INT J ENGINES, V7, P519, DOI 10.4271/2014-01-1209
   Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158
   Ito Y., 2015, 2015011073 SAE
   Iwamoto Y., 1997, 970541 SAE
   Johansson A, 2013, 2013240052 SAE
   Kayes D, 1999, ENVIRON SCI TECHNOL, V33, P3957, DOI 10.1021/es9810991
   Kazour J, 2014, 2014011441 SAE
   Khalek IA, 2010, SAE INT J FUELS LUBR, V3, P623, DOI 10.4271/2010-01-2250
   Kinoshita M., 1999, 1999013656 SAE
   Kittelson DB, 1998, J AEROSOL SCI, V29, P575, DOI 10.1016/S0021-8502(97)10037-4
   Kleeman MJ, 2008, ENVIRON SCI TECHNOL, V42, P235, DOI 10.1021/es071054c
   Lattimore T, 2016, APPL ENERG, V161, P256, DOI 10.1016/j.apenergy.2015.09.080
   Liu Q, 2014, SAE INT J ENGINES, V7, P500, DOI 10.4271/2014-01-1207
   Luders H, 1998, 981374 SAE
   Mamakos A, 2011, ASSESSMENT PARTICLE
   Mamakos A, 2013, J AEROSOL SCI, V63, P115, DOI 10.1016/j.jaerosci.2013.05.004
   Maricq M M, 1999, 1999011530 SAE
   McAllister M, 2014, SAE INT J FUELS LUBR, V7, P995, DOI 10.4271/2014-01-2848
   Mohr M, 2003, 2003011889 SAE
   O'Donnell MJ, 2011, EPIDEMIOLOGY, V22, P422, DOI 10.1097/EDE.0b013e3182126580
   Ogyu K, 2015, 2015011011 SAE
   Parks J, 2016, 2016010937 SAE
   PILCH M, 1987, INT J MULTIPHAS FLOW, V13, P741, DOI 10.1016/0301-9322(87)90063-2
   Piock W, 2011, SAE INT J ENGINES, V4, P1455, DOI 10.4271/2011-01-1212
   Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F
   Price P., 2006, 2006011263 SAE
   Queiroz C, 1997, 973113 SAE
   Reghunathan Nair A, 2016, 2016010936 SAE
   Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC
   Saito C., 2011, 2011010814 SAE
   Schauer JJ, 2008, AEROSOL SCI TECH, V42, P210, DOI 10.1080/02786820801958742
   Schreiber D, 2007, 2007240123 SAE
   Sher E, 2008, PROG ENERG COMBUST, V34, P417, DOI 10.1016/j.pecs.2007.05.001
   Shibata H, 2015, GASOLINE DIRECT INJE
   Storch M, 2015, APPL ENERG, V156, P783, DOI 10.1016/j.apenergy.2015.06.030
   Sullivan JH, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-3
   Swanson J, 2010, J AEROSOL SCI, V41, P1113, DOI 10.1016/j.jaerosci.2010.09.003
   *US EPA, PART MATT
   Velji A, 2010, 2010010352 SAE
   Wang CM, 2014, APPL ENERG, V132, P178, DOI 10.1016/j.apenergy.2014.06.012
   Wang YS, 2014, APPL ENERG, V130, P33, DOI 10.1016/j.apenergy.2014.05.042
   Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47
   Whitaker P, 2011, SAE INT J ENGINES, V4, P1498, DOI 10.4271/2011-01-1219
   World Health Organization (WHO), 2002, WORLD HLTH REP 2002
   Xu F, 2012, 2012010436 SAE
   Zhan R, 2010, 2010010365 SAE
NR 77
TC 5
Z9 5
U1 5
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0306-2619
EI 1872-9118
J9 APPL ENERG
JI Appl. Energy
PD SEP 1
PY 2016
VL 177
BP 703
EP 715
DI 10.1016/j.apenergy.2016.05.147
PG 13
WC Energy & Fuels; Engineering, Chemical
SC Energy & Fuels; Engineering
GA DS2OR
UT WOS:000380623900059
DA 2018-12-27
ER

PT J
AU de Stefano, G
   Scognamiglio, U
   Di Martino, F
   Parrella, R
   Scarano, F
   Signoriello, G
   Farella, N
AF de Stefano, Giorgio
   Scognamiglio, Umberto
   Di Martino, Filomena
   Parrella, Roberto
   Scarano, Francesco
   Signoriello, Giuseppe
   Farella, Nunzia
TI RETRACTED: The role of ceus in characterization of superficial lymph
   nodes : a single center prospective study (Retracted article. See vol 8,
   pg 43595, 2017)
SO ONCOTARGET
LA English
DT Article; Retracted Publication
DE CEUS; Lymph nodes; contras enhanced ultrasound; metastases
ID CONTRAST-ENHANCED ULTRASOUND; ULTRASONOGRAPHY; LYMPHADENOPATHY; BENIGN;
   SONOGRAPHY; DOPPLER; NECK
AB Accurate lymph node characterization is important in a large number of clinical settings. We evaluated the usefulness of Contrast Enhanced Ultrasound (CEUS) in distinguishing between benign and malignant lymph nodes compared with conventional ultrasonography in the differential diagnosis of superficial lymphadenopathy.
   We present our experience for 111 patients enrolled in a single center.
   111 superficial lymph nodes were selected and only 1 lymph node per patient underwent CEUS. A definitive diagnosis for all lymph nodes was obtained by ultrasonographically guided biopsy and/or excision biopsy.
   The size of the lymph nodes, the site (neck, axilla, inguinal region) being easily accessible for biopsy, and the US and color Doppler US characteristics guided us in selecting the nodes to be evaluated by CEUS.
   In our study we identified different enhancement patterns in benign and malignant lymph nodes, with a high degree of diagnostic accuracy for superficial lymphadenopathy in comparison with conventional US.
C1 [de Stefano, Giorgio; Scognamiglio, Umberto; Farella, Nunzia] UOC Malattie Infett Ad Indrizzo Ecointerventist, AORN Colli, Naples, Italy.
   [Di Martino, Filomena] UOC Infez Sistem & Immunodepresso, AORN Colli, Naples, Italy.
   [Parrella, Roberto; Scarano, Francesco] UOC Malattie Infett Ad Indirizzo Resp, AORN Colli, Naples, Italy.
   [Signoriello, Giuseppe] SUN Napoli, Dipartimento Salute Mentale, Serv Stat Med, Naples, Italy.
RP de Stefano, G (reprint author), UOC Malattie Infett Ad Indrizzo Ecointerventist, AORN Colli, Naples, Italy.
EM giordest1@virgilio.it
CR Ahuja AT, 2008, CANCER IMAGING, V8, P48, DOI 10.1102/1470-7330.2008.0006
   Castelijns JA, 2002, EUR RADIOL, V12, P727, DOI 10.1007/s003300101102
   Cui XW, 2013, WORLD J GASTROENTERO, V19, P4850, DOI 10.3748/wjg.v19.i30.4850
   Dome B, 2007, AM J PATHOL, V170, P1, DOI 10.2353/ajpath.2007.060302
   Dudea SM, 2012, MED ULTRASON, V14, P294
   Esen G, 2006, EUR J RADIOL, V58, P345, DOI 10.1016/j.ejrad.2005.12.039
   Giovagnorio F, 2002, J ULTRAS MED, V21, P403, DOI 10.7863/jum.2002.21.4.403
   Liu GJ, 2008, J ULTRAS MED, V27, P657, DOI 10.7863/jum.2008.27.4.657
   Ouyang QF, 2010, J ULTRAS MED, V29, P343, DOI 10.7863/jum.2010.29.3.343
   Poanta L, 2014, MED ULTRASON, V16, P7, DOI 10.11152/mu.2014.2066.161.lp1os2
   Rubaltelli L, 2004, J ULTRAS MED, V23, P829, DOI 10.7863/jum.2004.23.6.829
   RUBALTELLI L, 1990, AM J ROENTGENOL, V155, P1241, DOI 10.2214/ajr.155.6.2122673
   Rubaltelli L, 2011, AM J ROENTGENOL, V196, pW8, DOI 10.2214/AJR.10.4711
   Slaisova R, 2013, EUR J RADIOL, V82, P693, DOI 10.1016/j.ejrad.2012.12.008
   SOLBIATI L, 1992, RADIOL CLIN N AM, V30, P941
   VASSALLO P, 1992, RADIOLOGY, V183, P215, DOI 10.1148/radiology.183.1.1549675
   Wilson SR, 2009, AM J ROENTGENOL, V193, P55, DOI 10.2214/AJR.09.2553
NR 17
TC 4
Z9 4
U1 2
U2 6
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD AUG 9
PY 2016
VL 7
IS 32
BP 52416
EP 52422
DI 10.18632/oncotarget.9385
PG 7
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA DY9CC
UT WOS:000385429100129
PM 27191746
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Helabad, MB
   Ghane, T
   Reidelbach, M
   Woelke, AL
   Knapp, EW
   Imhof, P
AF Helabad, Mandi Bagherpoor
   Ghane, Tahereh
   Reidelbach, Marco
   Woelke, Anna Lena
   Knapp, Ernst Walter
   Imhof, Petra
TI RETRACTED: Protonation State-Dependent Communication in Cytochrome c
   Oxidase (Retracted article. See vol. 113, pg. 223, 2017)
SO BIOPHYSICAL JOURNAL
LA English
DT Article; Retracted Publication
ID CYTOCHROME-C-OXIDASE; PARACOCCUS-DENITRIFICANS; MOLECULAR-DYNAMICS;
   TRANSFER PATHWAY; LIQUID WATER; K-CHANNEL; SPHAEROIDES; MECHANISM;
   RESPIRATION; RESOLUTION
AB Proton transfer in cytochrome c oxidase from the cellular inside to the binuclear redox center (BNC) can occur through two distinct pathways, the D- and K-channels. For the protein to function as both redox enzyme and proton pump, proton transfer out of either of the channels toward the BNC or into the protein toward a proton loading site, and ultimately through the membrane, must be highly regulated. The O -> E intermediate of cytochrome c oxidase is the first redox state in its catalytic cycle, where proton transfer through the K-channel, from K362 to Y288 at the BNC, is important. Molecular dynamics simulations of this intermediate with 16 different combinations of protonation states of key residues in the D- and K-channel show the mutual impact of the two proton-conducting channels to be protonation state-dependent. Strength as well as means of communication, correlations in positions, or connections along the hydrogen-bonded network, change with the protonation state of the K-channel residue K362. The conformational and hydrogen-bond dynamics of the D-channel residue N139 regulated by an interplay of protonation in the D-channel and K362. N139 thus assumes a gating function by which proton passage through the D-channel toward E286 is likely facilitated for states with protonated K362 and unprotonated E286, which would in principle allow proton transfer to the BNC, but no proton pumping until a proton has reached E286.
C1 [Helabad, Mandi Bagherpoor; Ghane, Tahereh; Reidelbach, Marco; Imhof, Petra] Free Univ Berlin, Inst Theoret Phys, Berlin, Germany.
   [Knapp, Ernst Walter] Free Univ Berlin, Inst Biochem, Berlin, Germany.
   [Woelke, Anna Lena] Free Univ Berlin, Inst Pharm, Berlin, Germany.
RP Imhof, P (reprint author), Free Univ Berlin, Inst Theoret Phys, Berlin, Germany.
EM petra.imhof@fu-berlin.de
RI Knapp, Ernst-Walter/E-4493-2010
OI Knapp, Ernst-Walter/0000-0002-2858-0460
FU Deutsche Forschungsgemeinschaft [SFB 1078]
FX We thank the Deutsche Forschungsgemeinschaft for financial support
   provided to the Sonderforschungsbereich 1078 (grant No. SFB 1078) on
   "Protonation Dynamics in Protein Function".
CR Adelroth P, 1998, BIOCHEMISTRY-US, V37, P2470, DOI 10.1021/bi971813b
   BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0
   Bagga J, 2002, LECT NOTES COMPUT SC, V2265, P459
   BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5
   Belevich I, 2007, P NATL ACAD SCI USA, V104, P2685, DOI 10.1073/pnas.0608794104
   Branden M, 2002, BIOCHEMISTRY-US, V41, P10794, DOI 10.1021/bi026093
   Branden M, 2001, P NATL ACAD SCI USA, V98, P5013, DOI 10.1073/pnas.081088398
   Brzezinski P, 1998, ACTA PHYSIOL SCAND, V163, P7
   Cover TM, 2006, ELEMENTS INFORM THEO, P19
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   de Grotthuss CJT, 2006, BBA-BIOENERGETICS, V1757, P871, DOI 10.1016/j.bbabio.2006.07.004
   Dijkstra Edsger, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390
   Henry RM, 2009, J MOL BIOL, V387, P1165, DOI 10.1016/j.jmb.2009.02.042
   Hofacker I, 1998, PROTEINS, V30, P100, DOI 10.1002/(SICI)1097-0134(199801)30:1<100::AID-PROT9>3.0.CO;2-S
   IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kaila VRI, 2008, P NATL ACAD SCI USA, V105, P6255, DOI 10.1073/pnas.0800770105
   Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q
   Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085
   Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138
   Lange OF, 2006, PROTEINS, V62, P1053, DOI 10.1002/prot.20784
   Lee HJ, 2010, J AM CHEM SOC, V132, P16225, DOI 10.1021/ja107244g
   LEVITT M, 1988, P NATL ACAD SCI USA, V85, P7557, DOI 10.1073/pnas.85.20.7557
   Luzar A, 2000, J CHEM PHYS, V113, P10663, DOI 10.1063/1.1320826
   Luzar A, 1996, NATURE, V379, P55, DOI 10.1038/379055a0
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Namslauer A, 2007, J BIOL CHEM, V282, P15148, DOI 10.1074/jbc.M700348200
   Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547
   Peng YX, 2015, J PHYS CHEM B, V119, P9212, DOI 10.1021/jp5095118
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   RAPAPORT DC, 1983, MOL PHYS, V48, P23, DOI 10.1080/00268978300100031
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Sharpe MA, 2008, J BIOENERG BIOMEMBR, V40, P541, DOI 10.1007/s10863-008-9182-6
   STILLINGER FH, 1980, SCIENCE, V209, P451, DOI 10.1126/science.209.4455.451
   Tomson FL, 2003, BIOCHEMISTRY-US, V42, P1711, DOI 10.1021/bi026750y
   Vygodina TV, 1998, BIOCHEMISTRY-US, V37, P3053, DOI 10.1021/bi971876u
   Wikstrom M, 2015, CHEM REV, V115, P2196, DOI 10.1021/cr500448t
   Woelke AL, 2014, BBA-BIOENERGETICS, V1837, P1998, DOI 10.1016/j.bbabio.2014.08.003
   Xu JC, 2007, J AM CHEM SOC, V129, P2910, DOI 10.1021/ja067360s
   Yamashita T, 2012, J AM CHEM SOC, V134, P1147, DOI 10.1021/ja209176e
NR 40
TC 2
Z9 2
U1 2
U2 21
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD AUG 9
PY 2016
VL 111
IS 3
BP 492
EP 503
DI 10.1016/j.bpj.2016.06.038
PG 12
WC Biophysics
SC Biophysics
GA DT1LC
UT WOS:000381243200005
PM 27508434
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Chuang, PY
   Chuang, CN
   Yu, CC
   Wang, LY
   Hsieh, KH
AF Chuang, Pei-Yu
   Chuang, Ching-Nan
   Yu, Chung-Chiang
   Wang, Lee-Yih
   Hsieh, Kuo-Hung
TI RETRACTED: Enhance the stability and efficiency of perovskite solar cell
   via gel-type polyurethane (Retracted article. See vol. 120, pg. 272,
   2017)
SO POLYMER
LA English
DT Article; Retracted Publication
DE Perovskite solar cell; Gel-polyurethane; Stability
ID SOLUTION-PROCESSED PEROVSKITE; ELECTRON EXTRACTION; TRIHALIDE;
   DEPOSITION
AB Solution process of perovskite solar cell is a very promising novel technology for low cost renewable energy and with fascinating properties in application of organic/inorganic hybrid materials. One of the most common cell structures is FTO/TiO2/CH3NH3PbI3-xClx/spiro-OMeTAD/Au. The main issues of this type of solar cell are the poor surface morphology and interface control of the perovskite CH3NH3PbI3-xClx film on TiO2. We demonstrate that the problems could be easily resolved by using a Gel-like polymer such as, polyurethane additive in perovskite precursor solution during the film fabrication of perovskite solar cell. Nearly 60% increase in power conversion efficiency at a value of 13.2% is achieved by adding 1 wt% of polyurethane in the perovskite layer using a 150 degrees C processed TiO2 nanoparticle layer. The morphology of this new perovskite was carefully studied by SEM, XRD, and AFM. The results reveal that the additive controls the size and aggregation (or segregation) between perovskite crystals and polyurethane linear soft segments which provides the formation of smooth film over TiO2 completely. Thus, the V-oc and J(sc) are greatly increased for a high efficiency solar cell. The small amount of additive is optimized at 1 wt% due to its insulating characteristics. This research provides a facile way to fabricate a high efficiency perovskite solar cell by the low temperature solution process (<150 degrees C), which has the advancement of conserving energy over the traditional high temperature sintering TiO2 compact layer device. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Chuang, Pei-Yu; Chuang, Ching-Nan; Hsieh, Kuo-Hung] Natl Taiwan Univ, Coll Engn, Inst Polymer Sci & Engn, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.
   [Yu, Chung-Chiang; Hsieh, Kuo-Hung] Natl Taiwan Univ, Coll Engn, Dept Chem Engn, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.
   [Wang, Lee-Yih] Natl Taiwan Univ, NTU Ctr Condensed Matter Sci, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.
RP Hsieh, KH (reprint author), Natl Taiwan Univ, Coll Engn, Inst Polymer Sci & Engn, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.
EM khhsieh@ntu.edu.tw
FU National Science Council of Taiwan [MOST 104-2221-E-002-159]
FX The present work was supported by the National Science Council of Taiwan
   (MOST 104-2221-E-002-159-).
CR Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340
   Conings B, 2014, ADV MATER, V26, P2041, DOI 10.1002/adma.201304803
   Docampo P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3761
   Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h
   Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090
   Gao P, 2014, ENERG ENVIRON SCI, V7, P2448, DOI 10.1039/c4ee00942h
   Jeng JY, 2013, ADV MATER, V25, P3727, DOI 10.1002/adma.201301327
   Jeon NJ, 2014, J AM CHEM SOC, V136, P7837, DOI 10.1021/ja502824c
   Jeon NJ, 2013, J AM CHEM SOC, V135, P19087, DOI 10.1021/ja410659k
   Kagan CR, 1999, SCIENCE, V286, P945, DOI 10.1126/science.286.5441.945
   Kim HB, 2014, NANOSCALE, V6, P6679, DOI 10.1039/c4nr00130c
   Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591
   Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r
   Liang PW, 2014, ADV MATER, V26, P3748, DOI 10.1002/adma.201400231
   Liu DY, 2014, NAT PHOTONICS, V8, P133, DOI 10.1038/nphoton.2013.342
   Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509
   Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982
   Wang Q, 2014, ENERG ENVIRON SCI, V7, P2359, DOI 10.1039/c4ee00233d
   Wojciechowski K, 2014, ENERG ENVIRON SCI, V7, P1142, DOI 10.1039/c3ee43707h
   Wolf S. D., 2014, J PHYS CHEM LETT, V5, P1035
   Yella A, 2014, NANO LETT, V14, P2591, DOI 10.1021/nl500399m
   You JB, 2014, ACS NANO, V8, P1674, DOI 10.1021/nn406020d
   Zhu ZL, 2014, J AM CHEM SOC, V136, P3760, DOI 10.1021/ja4132246
   Zuo C., 2015, J MAT CHEM A
NR 24
TC 4
Z9 4
U1 5
U2 130
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD AUG 5
PY 2016
VL 97
BP 196
EP 204
DI 10.1016/j.polymer.2016.05.039
PG 9
WC Polymer Science
SC Polymer Science
GA DR1PC
UT WOS:000379676400022
DA 2018-12-27
ER

PT J
AU Lee, DS
   Nam, TG
   Jeong, BS
   Jeong, GS
AF Lee, Dong-Sung
   Nam, Tae-Gyu
   Jeong, Byeong-Seon
   Jeong, Gil-Saeng
TI RETRACTED: BJ-1103, 6-aminopyridin-3-ol skeletal compound, modulates
   neuroprotective and anti-neuroinflammatory effects in murine hippocampal
   and microglial cells via Nrf2-mediated heme oxygenase-1
   expression(Retracted article. See vol. 641, pg. 107, 2017)
SO NEUROSCIENCE LETTERS
LA English
DT Article; Retracted Publication
DE 6-Aminopyridin-3-ol skeletal BJ-1103; Heme oxygenase-1; Nuclear
   transcription factor erythroid-2 related factor 2; Hippocampal HT22;
   Microglial BV2
ID CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES;
   THERAPEUTIC TARGET; INHIBITS INOS; ANTIOXIDANTS; PATHWAY; INJURY;
   6-AMINO-3-PYRIDINOLS; LIPOPOLYSACCHARIDE
AB BJ-1103, as a 6-aminopyridin-3-ol skeletal compound, was originally developed as an antioxidant against free radicals and oxidative stress was prepared from pyridoxine center dot HCl by the reported procedure. In the present study, we examined the effect of BJ-1103 on neuroprotection and neuroinflammation. Our data showed that BJ-1103 can protect HT22 cells against glutamate-induced cell cytotoxicity. And, BJ-1103 also inhibited LPS-induced inflammatory action. In addition, BJ-1103-induced heme oxygenase-1 (HO-1) expression and elevated HO-1 activities in the two cell lines studied. Additionally, BJ-1103 treatment induced nuclear transcription factor erythroid-2 related factor 2 (Nrf2) and increased the promoter activity of antioxidant response elements (AREs). We have demonstrated using the Nrf2 siRNA, HO inhibitor or HO-1 siRNA that BJ-1103 suppressed neurotoxicity and neuroinflammation through the Nrf2-mediated HO-1 expression. These results demonstrated that BJ-1103 may have good therapeutic agent against neurodegenerative diseases that are induced by oxidative stress and neuroinflammation. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
C1 [Lee, Dong-Sung] Chosun Univ, Coll Pharm, Dept Pharm, Gwangju 61452, South Korea.
   [Nam, Tae-Gyu] Hanyang Univ, Dept Pharm, Ansan 15588, South Korea.
   [Nam, Tae-Gyu] Hanyang Univ, Inst Pharmaceut Sci & Technol, Ansan 15588, South Korea.
   [Jeong, Byeong-Seon] Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea.
   [Jeong, Gil-Saeng] Keimyung Univ, Coll Pharm, Daegu 42601, South Korea.
RP Jeong, BS (reprint author), Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea.; Jeong, GS (reprint author), Keimyung Univ, Coll Pharm, Daegu 42601, South Korea.
EM jeongb@ynu.ac.kr; gsjeong@kmu.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [NRF-2016R1A6A1A03011325,
   NRF-2013R1A1A2021751]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education (No. NRF-2016R1A6A1A03011325 and
   NRF-2013R1A1A2021751).
CR Cao Yang, 2009, MEAS CONTROL, V28, P28
   Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024
   Han IO, 2002, NEUROSCI LETT, V325, P9, DOI 10.1016/S0304-3940(02)00218-5
   Im NK, 2013, BIOL PHARM BULL, V36, P796, DOI 10.1248/bpb.b12-00964
   Immenschuh S, 2000, BIOCHEM PHARMACOL, V60, P1121, DOI 10.1016/S0006-2952(00)00443-3
   Jazwa A, 2010, CURR DRUG TARGETS, V11, P1517, DOI 10.2174/1389450111009011517
   Kirkby KA, 2006, AM J PHYSIOL-RENAL, V290, pF563, DOI 10.1152/ajprenal.00220.2005
   Lee DS, 2014, PHYTOTHER RES, V28, P1216, DOI 10.1002/ptr.5119
   Lee DS, 2014, INT J MOL SCI, V15, P8863, DOI 10.3390/ijms15058863
   Lee DS, 2013, TOXICOL IN VITRO, V27, P874, DOI 10.1016/j.tiv.2013.01.003
   Li B, 2012, EVID-BASED COMPL ALT, DOI 10.1155/2012/128019
   Li HY, 2011, J APPL TOXICOL, V31, P690, DOI 10.1002/jat.1654
   Maher P, 2000, CELL MOL LIFE SCI, V57, P1287, DOI 10.1007/PL00000766
   Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6
   Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200
   Michaelis EK, 1998, PROG NEUROBIOL, V54, P369, DOI 10.1016/S0301-0082(97)00055-5
   Omata Y, 2010, FREE RADICAL BIO MED, V48, P1358, DOI 10.1016/j.freeradbiomed.2010.02.018
   Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1
   Rossler OG, 2004, NEUROSCI LETT, V362, P253, DOI 10.1016/j.neulet.2004.03.033
   Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241
   Serwa R, 2010, CHEM-EUR J, V16, P14106, DOI 10.1002/chem.201001382
   Son Y, 2013, AMINO ACIDS, V45, P393, DOI 10.1007/s00726-013-1518-9
   Syapin PJ, 2008, BRIT J PHARMACOL, V155, P623, DOI 10.1038/bjp.2008.342
   Takahashi T, 2004, CURR MED CHEM, V11, P1545, DOI 10.2174/0929867043365080
   Takahashi T, 2009, J CLIN BIOCHEM NUTR, V44, P28, DOI 10.3164/jcbn.08-210-HO
   Thompson GA, 1996, PHARMACOL THERAPEUT, V72, P25, DOI 10.1016/S0163-7258(96)00097-6
   Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823
   Volti GL, 2007, TRANSPL P, V39, P2986, DOI 10.1016/j.transproceed.2007.09.047
   Volti Giovanni Li, 2003, Hypertension (Baltimore), V41, P715
   Wang WZW, 2004, HEPATOLOGY, V40, P424, DOI 10.1002/hep.20334
   Wijtmans M, 2003, ANGEW CHEM INT EDIT, V42, P4370, DOI 10.1002/anie.200351881
NR 31
TC 1
Z9 1
U1 3
U2 15
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD AUG 3
PY 2016
VL 627
BP 42
EP 50
DI 10.1016/j.neulet.2016.05.056
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA DS1XL
UT WOS:000380418400008
PM 27238747
DA 2018-12-27
ER

PT J
AU Hsia, TC
   Yin, MC
AF Hsia, Te-chun
   Yin, Mei-chin
TI RETRACTED: Post-Intake of S-Ethyl Cysteine and S-Methyl Cysteine
   Improved LPS-Induced Acute Lung Injury in Mice (Retracted article. See
   vol. 9, Art no. 528, 2017)
SO NUTRIENTS
LA English
DT Article; Retracted Publication
DE S-ethyl cysteine; S-methyl cysteine; lung; LPS; inflammation
ID NF-KAPPA-B; MOUSE MODEL; PATHWAYS; MAPK; CYCLOOXYGENASE-2; INHIBITION;
   RATS
AB The effects of S-ethyl cysteine (SEC) and S-methyl cysteine (SMC) on lipopolysaccharide (LPS)-induced acute lung injury in mice were examined. Eight hours after LPS challenge, SEC or SMC was supplied in drinking water at 0.5% or 1% for 3 days. LPS increased lung myeloperoxidase activity, neutrophil counts and edema. SEC or SMC post-intake attenuated these events. SEC or SMC suppressed LPS-induced lung expression of cyclooxygenase-2, nuclear factor-kappa B and mitogen-activated protein kinase, and lowered the generation of tumor necrosis factor-alpha, monocyte chemoattractant protein-1 and prostaglandin E-2. LPS enhanced the expression of p47(phox), gp91(phox), Bax and cleaved caspase-3, and increased the production of reactive oxygen species in the lung. SEC or SMC post-intake reversed these alterations. These findings suggest that these agents could protect the lung through their anti-inflammatory, anti-oxidative and anti-apoptotic activities.
C1 [Hsia, Te-chun] China Med Univ, Dept Resp Therapy, Taichung 40402, Taiwan.
   [Hsia, Te-chun] China Med Univ Hosp, Dept Internal Med, Taichung 40402, Taiwan.
   [Yin, Mei-chin] China Med Univ, Dept Nutr, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.
   [Yin, Mei-chin] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
RP Yin, MC (reprint author), China Med Univ, Dept Nutr, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.; Yin, MC (reprint author), Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung 41354, Taiwan.
EM derrick.hsia@msa.hinet.net; mcyin@mail.cmu.edu.tw
FU China Medical University, Taichung City, Taiwan [CMU103-ASIA-05]
FX This study was partially supported by a grant from China Medical
   University, Taichung City, Taiwan (CMU103-ASIA-05).
CR Aggarwal S, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00161
   ALI SF, 1992, NEUROTOXICOLOGY, V13, P637
   Ang SF, 2011, J IMMUNOL, V187, P4778, DOI 10.4049/jimmunol.1101559
   Britt RD, 2012, CELL PHYSIOL BIOCHEM, V29, P213, DOI 10.1159/000337602
   Carnesecchi S, 2012, CELL MOL LIFE SCI, V69, P2373, DOI 10.1007/s00018-012-1013-6
   Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71
   Chi GF, 2013, INFLAMMATION, V36, P501, DOI 10.1007/s10753-012-9571-1
   Choi SB, 2016, MOL IMMUNOL, V74, P27, DOI 10.1016/j.molimm.2016.04.011
   Chu CJ, 2016, J ETHNOPHARMACOL, V185, P263, DOI 10.1016/j.jep.2016.03.022
   Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138
   Hardy LA, 2004, LAB INVEST, V84, P81, DOI 10.1038/labinvest.3700007
   Hsia TC, 2015, J FOOD SCI, V80, pH2094, DOI 10.1111/1750-3841.12973
   Johnson ER, 2010, J AEROSOL MED PULM D, V23, P243, DOI 10.1089/jamp.2009.0775
   Jones MG, 2004, J EXP BOT, V55, P1903, DOI 10.1093/jxb/erh138
   Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697
   Lee I, 2014, AM J PHYSIOL-LUNG C, V306, pL635, DOI 10.1152/ajplung.00374.2013
   Lv HM, 2016, INT J BIOL SCI, V12, P72, DOI 10.7150/ijbs.13188
   Maijo M, 2012, BRIT J NUTR, V107, P867, DOI 10.1017/S0007114511003655
   Mehla K, 2013, BIOCHIMIE, V95, P2404, DOI 10.1016/j.biochi.2013.08.030
   Mohi El-Din Mouchira M, 2014, BMC Res Notes, V7, P243, DOI 10.1186/1756-0500-7-243
   Mokra D, 2015, RESP PHYSIOL NEUROBI, V209, P52, DOI 10.1016/j.resp.2014.10.006
   Niu XF, 2015, INT IMMUNOPHARMACOL, V24, P432, DOI 10.1016/j.intimp.2014.12.041
   Park GY, 2006, AM J PHYSIOL-LUNG C, V290, pL797, DOI 10.1152/ajplung.00513.2005
   Puneet P, 2005, AM J PHYSIOL-LUNG C, V288, pL3, DOI 10.1152/ajplung.00405.2003
   Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3
   Thangavel J, 2015, J CELL SCI, V128, P3094, DOI 10.1242/jcs.170258
   Wang Q., 2016, MEDIAT INFLAMM, V2016
   Yan SL, 2007, J FOOD SCI, V72, pS511, DOI 10.1111/j.1750-3841.2007.00449.x
   Yeh CH, 2014, FREE RADICAL BIO MED, V69, P249, DOI 10.1016/j.freeradbiomed.2014.01.028
   Yuan Q, 2014, APMIS, V122, P810, DOI 10.1111/apm.12222
NR 30
TC 3
Z9 3
U1 2
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2016
VL 8
IS 8
AR 507
DI 10.3390/nu8080507
PG 12
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA EB8SA
UT WOS:000387660000026
PM 27548215
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Dong, ZY
   Liu, SA
   Yao, YM
   Hu, LQ
   Wang, CX
AF Dong, Zhiyan
   Liu, Shun'an
   Yao, Yongming
   Hu, Linqiang
   Wang, Chunxue
TI RETRACTED: Flexible performance design for the H-infinity loop-shaping
   control based on the linear matrix inequality approach: Application to
   the coaxial rotor helicopter (Retracted article. See vol. 10, 2018)
SO ADVANCES IN MECHANICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Advanced control theory; uncertainty; flight control; coaxial rotor
   helicopter
ID OPTIMIZATION; AIRCRAFT; FORMULAS; SYSTEMS; FLIGHT
AB This article introduces a new H-infinity loop-shaping control to decrease the complexity of the appropriate selection of the required performance for a coaxial rotor helicopter with unpredicted or unknown unstructured uncertainties. Uncertainty models are normally assumed that some knowledge of type is known. And to model a particular uncertainty as a separate model is necessary in the high-performance design of specified applications. But to model each particular uncertainty will increase the complexity of performance design for the extremely complex plant. H-infinity loop-shaping control provides a competitive and flexible choice to simultaneously represent a family of unpredicted and unconsidered unstructured uncertainty bounded by H-infinity norm. Many researches have been conducted to consider some aspects of this method, for example, the nominal stability, robustness to uncertainty, and implementation issues. However, to decrease the complexity of the appropriate selection of the required performance was not considered seriously. Therefore, a sufficient set of stable condition is derived using linear matrix inequality approach to provide the flexible performance design considering unpredicted and unknown unstructured uncertainties. Furthermore, the proposed method is applied to stabilize the attitude subsystem of a reconstructed coaxial rotor helicopter. Simulations indicate the effectiveness of the proposed method in the step response.
C1 [Dong, Zhiyan; Liu, Shun'an; Yao, Yongming; Hu, Linqiang; Wang, Chunxue] Jilin Univ, Sch Mech Sci & Engn, Renmin St 5988, Changchun 130025, Jilin Province, Peoples R China.
RP Yao, YM (reprint author), Jilin Univ, Sch Mech Sci & Engn, Renmin St 5988, Changchun 130025, Jilin Province, Peoples R China.
EM ymyao@jlu.edu.cn
FU National High Technology Research and Development Program 863
   [2013AA063903, 2014AA06A613]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This
   research received funding from National High Technology Research and
   Development Program 863 (Nos. 2013AA063903, 2014AA06A613).
CR Chi Z, 2015, 56 AIAA ASCE AHS ASC
   DOYLE JC, 1989, IEEE T AUTOMAT CONTR, V34, P831, DOI 10.1109/9.29425
   Gahinet P, 1996, AUTOMATICA, V32, P1007, DOI 10.1016/0005-1098(96)00033-7
   GLOVER K, 1989, IEEE T AUTOMAT CONTR, V34, P821, DOI 10.1109/9.29424
   Guoxiang Gu, 1999, IEEE Transactions on Automatic Control, V44, P846, DOI 10.1109/9.754832
   HYDE RA, 1993, IEEE T AUTOMAT CONTR, V38, P1021, DOI 10.1109/9.231458
   Iwasaki T, 2005, IEEE T AUTOMAT CONTR, V50, P41, DOI 10.1109/TAC.2004.840475
   IWASAKI T, 1994, AUTOMATICA, V30, P1307, DOI 10.1016/0005-1098(94)90110-4
   Koehl A, 2012, J INTELL ROBOT SYST, V68, P53, DOI 10.1007/s10846-012-9665-x
   La Civita M, 2006, J GUID CONTROL DYNAM, V29, P485, DOI 10.2514/1.15796
   Leishman JG, 2008, J AM HELICOPTER SOC, V53, P366, DOI 10.4050/JAHS.53.366
   Lim JW, 2009, J AM HELICOPTER SOC, V54, DOI 10.4050/JAHS.54.032005
   Lin F, 2013, UNMANNED SYST, V1, P211, DOI 10.1142/S2301385013400049
   MCFARLANE D, 1992, IEEE T AUTOMAT CONTR, V37, P759, DOI 10.1109/9.256330
   Padfield GD, 2007, HELICOPTER FLIGHT DYNAMICS: THE THEORY AND APPLICATION OF FLYING QUALITIES AND SIMULATION MODELLING, 2ND EDITION, P1, DOI 10.1002/9780470691847
   Patra S, 2008, AUTOMATICA, V44, P2214, DOI 10.1016/j.automatica.2008.01.008
   Prempain E, 2005, AUTOMATICA, V41, P1517, DOI 10.1016/j.automatica.2005.04.001
   Schafroth D, 2010, CONTROL ENG PRACT, V18, P700, DOI 10.1016/j.conengprac.2010.02.004
   Scherer C, 1997, IEEE T AUTOMAT CONTR, V42, P896, DOI 10.1109/9.599969
   Sun WC, 2015, IEEE-ASME T MECH, V20, P675, DOI 10.1109/TMECH.2014.2319355
   Sun WC, 2011, IEEE T CONTR SYST T, V19, P416, DOI 10.1109/TCST.2010.2042296
   Syal M, 2012, J AM HELICOPTER SOC, V57, DOI 10.4050/JAHS.57.042003
   Yao JY, 2015, IEEE-ASME T MECH, V20, P2752, DOI 10.1109/TMECH.2015.2409893
   Yao JY, 2015, IEEE T IND ELECTRON, V62, P6469, DOI 10.1109/TIE.2015.2423660
   Yao JY, 2014, IEEE T IND ELECTRON, V61, P6285, DOI 10.1109/TIE.2014.2304912
   Yao JY, 2014, IEEE-ASME T MECH, V19, P633, DOI 10.1109/TMECH.2013.2252360
   Yeo H, 2009, J AIRCRAFT, V46, P1210, DOI 10.2514/1.40101
   Yuan XL, 2015, J CHEM-NY, DOI 10.1155/2015/853105
   Zeng QH, 2015, ADV MECH ENG, V7, DOI 10.1177/1687814015594569
NR 29
TC 1
Z9 1
U1 6
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1687-8140
J9 ADV MECH ENG
JI Adv. Mech. Eng.
PD AUG
PY 2016
VL 8
IS 8
AR 1687814016661088
DI 10.1177/1687814016661088
PG 9
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA DY6KF
UT WOS:000385216600018
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Tziatzios, G
   Gkolfakis, P
   Triantafyllou, K
AF Tziatzios, Georgios
   Gkolfakis, Paraskevas
   Triantafyllou, Konstantinos
TI RETRACTED: It Is the Anemic and Elderly Patients Who Benefit Most from a
   "Second Pass" Examination of the Right Colon(Retracted article.See
   vol.111,Issue 11,2016)
SO AMERICAN JOURNAL OF GASTROENTEROLOGY
LA English
DT Letter; Retracted Publication
C1 [Tziatzios, Georgios; Gkolfakis, Paraskevas; Triantafyllou, Konstantinos] Univ Athens, Attikon Univ Gen Hosp, Hepatogastroenterol Unit, Res Inst,Dept Internal Med Propaedeut 2, 1,Rimini St, Athens 12462, Greece.
   [Tziatzios, Georgios; Gkolfakis, Paraskevas; Triantafyllou, Konstantinos] Univ Athens, Attikon Univ Gen Hosp, Ctr Diabet, Sch Med, 1,Rimini St, Athens 12462, Greece.
RP Triantafyllou, K (reprint author), Univ Athens, Attikon Univ Gen Hosp, Hepatogastroenterol Unit, Res Inst,Dept Internal Med Propaedeut 2, 1,Rimini St, Athens 12462, Greece.; Triantafyllou, K (reprint author), Univ Athens, Attikon Univ Gen Hosp, Ctr Diabet, Sch Med, 1,Rimini St, Athens 12462, Greece.
EM ktriant@med.uoa.gr
OI Gkolfakis, Paraskevas/0000-0002-9677-4013
CR Clark BT, 2016, GASTROINTEST ENDOSC, V84, P126, DOI 10.1016/j.gie.2015.12.030
   Rex DK, 2016, AM J GASTROENTEROL, V111, P9, DOI 10.1038/ajg.2015.385
   Triantafyllou K, 2016, DIGEST LIVER DIS, V48, P176, DOI 10.1016/j.dld.2015.11.024
NR 3
TC 1
Z9 1
U1 4
U2 5
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0002-9270
EI 1572-0241
J9 AM J GASTROENTEROL
JI Am. J. Gastroenterol.
PD AUG
PY 2016
VL 111
IS 8
BP 1199
EP 1200
DI 10.1038/ajg.2016.125
PG 3
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA DX9MR
UT WOS:000384720000024
PM 27481417
DA 2018-12-27
ER

PT J
AU Abdalla, S
   Al-Aama, N
   Al-Ghamdi, MA
AF Abdalla, Soliman
   Al-Aama, Nabil
   Al-Ghamdi, Maryam A.
TI RETRACTED: A Bio Polymeric Adhesive Produced by Photo Cross-Linkable
   Technique(Retracted article. See vol.9, pg.0, 2017)
SO POLYMERS
LA English
DT Article; Retracted Publication
DE bio-adhesives; photo cross-linkable; polycarprolacton; 2-isocyanatoethyl
   methacrylate; isocyanate functional-groups; degree of cross linking
ID BIOADHESIVE PROPERTIES; TISSUE ADHESIVES; THROMBUS; SURGERY; REPAIR;
   ACID
AB The advantages of photo polymerization methods compared to thermal techniques are: rapid cure reactions, low energy demands, solvent free requirements and room temperature use. In order to form a macromer, polycaprolactone (PCL) was cross-linked via ultraviolet power with 2-isocyanatoethyl methacrylate. Different methods of characterization were carried out: estimation of swelling capacity, adhesive capacity (using aminated substrates), surface energy (by contact angle), and attenuated total reflectance Fourier transform infrared. In addition to these experiments, we carried out dynamical mechanical thermal analysis, thermogravimetry and thermorphology characterizations of PCL. Thus, it has been concluded that the prepared macromer could be transformed into membranes that were effective as a medical adhesive. The degree of cross linking has been estimated using two different techniques: swelling of the samples and photo cross linking of the samples with different periods of irradiation at relatively high UV-power (600 mW/cm(2)).
C1 [Abdalla, Soliman] King Abdulaziz Univ, Dept Med Phys, Fac Sci, POB 80203, Jeddah 21589, Saudi Arabia.
   [Al-Aama, Nabil] King Abdulaziz Univ, Internal Med & Cardiol, Sch Med, Jeddah 21589, Saudi Arabia.
   [Al-Aama, Nabil] CCU, Jeddah 21589, Saudi Arabia.
   [Al-Ghamdi, Maryam A.] King Abdulaziz Univ, Dept Biochem, Fac Sci, POB 80203, Jeddah 21589, Saudi Arabia.
   [Al-Ghamdi, Maryam A.] King Abdulaziz Univ, Vitamin Pharmacogen Res Grp D, P Box 80203, Jeddah 21589, Saudi Arabia.
RP Abdalla, S (reprint author), King Abdulaziz Univ, Dept Med Phys, Fac Sci, POB 80203, Jeddah 21589, Saudi Arabia.
EM smabdullah@kau.edu.sa; drnabilalama@yahoo.com; maaalghamdi3@kau.edu.sa
RI AL-Ghamdi, Maryam/P-7781-2014
OI AL-Ghamdi, Maryam/0000-0003-0861-953X
CR Agarwal A, 2013, J CATARACT REFR SURG, V39, P317, DOI 10.1016/j.jcrs.2013.01.019
   Annabi N, 2015, EUR J PHARM BIOPHARM, V95, P27, DOI 10.1016/j.ejpb.2015.05.022
   Barbarini AL, 2010, GREEN CHEM LETT REV, V3, P231, DOI 10.1080/17518251003730825
   Benedict C.V., 1992, U.S. Patent, Patent No. 5108923
   Bochynska AI, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5694-5
   Cencer M, 2015, BIOMACROMOLECULES, V16, P404, DOI 10.1021/bm5016333
   Cencer M, 2014, BIOMACROMOLECULES, V15, P2861, DOI 10.1021/bm500701u
   Chavda H., 2013, BIOMED RES INT, V2013
   Chen F, 2016, SCI REP-UK, V6, DOI 10.1038/srep20014
   Coelho JFJ, 2006, J POLYM SCI POL CHEM, V44, P2809, DOI 10.1002/pola.21389
   Correia T.R., 2016, INT J BIOL MACROMOL
   Dehdilani N, 2016, CELL J, V17, P629
   Dehne T, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-175
   dos Santos KSCR, 2006, INT J PHARMACEUT, V310, P37, DOI 10.1016/j.ijpharm.2005.11.019
   Dunn CJ, 1999, DRUGS, V58, P863, DOI 10.2165/00003495-199958050-00010
   Ebner FM, 2011, BRIT J ANAESTH, V106, P180, DOI 10.1093/bja/aeq336
   Ferreira P, 2008, INT J PHARMACEUT, V352, P172, DOI 10.1016/j.ijpharm.2007.10.026
   Ferreira P, 2007, J APPL POLYM SCI, V105, P593, DOI 10.1002/app.26206
   Ferreira P, 2007, INT J BIOL MACROMOL, V40, P144, DOI 10.1016/j.ijbiomac.2006.06.023
   Ferreira P., 2011, BIOMEDICAL ENG FRONT
   Flory PJ., 1943, ANN NY ACAD SCI, V44, P419, DOI DOI 10.1111/J.1749-6632.19431B52762.X
   Fu W, 2014, INT J NANOMED, V9, P2335, DOI 10.2147/IJN.S61375
   Guo JS, 2016, BIOMATERIALS, V85, P204, DOI 10.1016/j.biomaterials.2016.01.069
   Han M.-E., 2016, INT J BIOL MACROMOL
   Hrncir E, 1997, PHYSIOL RES, V46, P319
   Karikari AS, 2005, BIOMACROMOLECULES, V6, P2866, DOI 10.1021/bm050375i
   Lally T.J., 2011, U.S. Patent, Patent No. [20120141596 A1, 20120141596]
   LIU Y, 2015, SCIJET, V4, P1
   Marques DS, 2016, MAT SCI ENG C-MATER, V58, P601, DOI 10.1016/j.msec.2015.09.009
   Mehdizadeh M, 2013, MACROMOL BIOSCI, V13, P271, DOI 10.1002/mabi.201200332
   Opperman T., 2014, AM PHARM REV, V17, P42
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Parthasarathy M, 2014, NATURAL AND SYNTHETIC BIOMEDICAL POLYMERS, P33
   Petrie EM, 2014, REV ADHES ADHES, V2, pCP2, DOI 10.7569/RAA.2014.097306
   Quan Y., 2016, Patent No. [WO/2016/043300, 2016043300]
   Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664
   Repka MA, 2000, BIOMATERIALS, V21, P1509, DOI 10.1016/S0142-9612(00)00046-6
   Salzig D, 2016, STEM CELLS INT, DOI 10.1155/2016/5246584
   Schmid M, 2002, CHEM PHYS SOLID SURF, V10, P118
   Scognamiglio F, 2016, J BIOMED MATER RES B, V104, P626, DOI 10.1002/jbm.b.33409
   Shirai M, 2014, POLYM J, V46, P859, DOI 10.1038/pj.2014.79
   Singh B., 2015, AM J POLYM SCI TECHN, V1, P1
   Vangala Manogna Rl, 2016, J Oral Maxillofac Pathol, V20, P20, DOI 10.4103/0973-029X.180911
   VANOSS CJ, 1988, CHEM REV, V88, P927, DOI 10.1021/cr00088a006
   Yari Abazar, 2016, Adv Biomed Res, V5, P22, DOI 10.4103/2277-9175.175911
NR 45
TC 5
Z9 5
U1 5
U2 26
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD AUG
PY 2016
VL 8
IS 8
AR 292
DI 10.3390/polym8080292
PG 18
WC Polymer Science
SC Polymer Science
GA DX6UZ
UT WOS:000384520900008
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Maekawa, H
   Serrone, JC
   Tjahjadi, M
   Hernesniemi, J
AF Maekawa, Hidetsugu
   Serrone, Joseph C.
   Tjahjadi, Mardjono
   Hernesniemi, Juha
TI RETRACTED: The role of estrogen on the pathology of cerebral aneurysms
   (Retracted article. See vol. 16, pg. 1121, 2016)
SO EXPERT REVIEW OF NEUROTHERAPEUTICS
LA English
DT Review; Retracted Publication
DE Cerebral aneurysm; endothelial cell; estrogen; estrogen receptor;
   extracellular matrix; inflammation; selective estrogen receptor
   modulator; subarachnoid hemorrhage; vascular remodeling; vascular smooth
   muscle cell
ID HORMONE REPLACEMENT THERAPY; SMOOTH-MUSCLE-CELLS; UNRUPTURED
   INTRACRANIAL ANEURYSMS; RECEPTOR MODULATOR RALOXIFENE; RANDOMIZED
   CONTROLLED-TRIAL; ABDOMINAL AORTIC-ANEURYSM; CORONARY-HEART-DISEASE;
   NITRIC-OXIDE SYNTHASE; SUBARACHNOID HEMORRHAGE; POSTMENOPAUSAL WOMEN
AB Introduction: Epidemiological studies suggest that postmenopausal estrogen deficiency is responsible for the increased risk of aneurysmal subarachnoid hemorrhage, while menopausal hormone therapy is protective against cerebral aneurysms. These findings indicate the critical role of estrogen in the pathophysiology of cerebral aneurysm.Areas covered: Here, we provide a narrative review for understanding the roles of estrogen and estrogen receptors in the pathogenesis of cerebral aneurysms. A specific selective estrogen receptor modulator is a potential drug for cerebral aneurysms, since it may favorably interact with estrogen receptors while avoiding unwanted side effects related to estrogen therapy.Expert Commentary: Future investigations into the role of estrogen on cerebral aneurysm pathophysiology may lead to the development of a novel drug, which interacts with estrogen receptors to modify the pathological mechanism of cerebral aneurysm formation on postmenopausal women.
C1 [Maekawa, Hidetsugu; Serrone, Joseph C.; Tjahjadi, Mardjono; Hernesniemi, Juha] Univ Helsinki, Dept Neurosurg, Cent Hosp, Helsinki, Finland.
   [Maekawa, Hidetsugu] Univ Tokushima, Inst Biomed Sci, Dept Neurosurg, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.
   [Serrone, Joseph C.] Virginia Mason Med Ctr, Neurosci Inst, Seattle, WA 98101 USA.
   [Tjahjadi, Mardjono] Mitra Keluarga Grp Hosp, Dept Neurosurg, Jakarta, Indonesia.
RP Maekawa, H (reprint author), Univ Tokushima, Inst Biomed Sci, Dept Neurosurg, Grad Sch, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.
EM hidetsugumaekawa@yahoo.co.jp
OI Maekawa, Hidetsugu/0000-0002-5633-4582; Tjahjadi,
   Mardjono/0000-0002-8264-8235
CR Algra AM, 2012, NEUROLOGY, V79, P1230, DOI 10.1212/WNL.0b013e31826aace6
   Ali MS, 2013, J CEREBR BLOOD F MET, V33, P1564, DOI 10.1038/jcbfm.2013.109
   Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701
   [Anonymous], 2012, MENOPAUSE, V19, P257, DOI 10.1097/gme.0b013e31824b970a
   Aoki T, 2007, STROKE, V38, P2337, DOI 10.1161/STROKEAHA.107.481838
   Aoki T, 2009, ARTERIOSCL THROM VAS, V29, P1080, DOI 10.1161/ATVBAHA.108.180760
   Aoki T, 2009, STROKE, V40, P942, DOI 10.1161/STROKEAHA.108.532556
   Arenas IA, 2005, HYPERTENSION, V46, P76, DOI 10.1161/01.HYP.0000168925.98963.ef
   Arnal JF, 2013, STEROIDS, V78, P576, DOI 10.1016/j.steroids.2012.11.011
   Banerjee S, 2014, STEROIDS, V81, P64, DOI 10.1016/j.steroids.2013.11.002
   Barrett-Connor E, 2002, JAMA-J AM MED ASSOC, V287, P847, DOI 10.1001/jama.287.7.847
   Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462
   BARRETTCONNOR E, 1991, JAMA-J AM MED ASSOC, V265, P1861, DOI 10.1001/jama.265.14.1861
   Barton M, 2001, J CARDIOVASC PHARM, V38, pS23, DOI 10.1097/00005344-200111002-00007
   Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395
   Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775
   Bowling MR, 2014, ARTERIOSCL THROM VAS, V34, P1477, DOI 10.1161/ATVBAHA.114.303629
   Burek M, 2010, ARTERIOSCL THROM VAS, V30, P298, DOI 10.1161/ATVBAHA.109.197582
   Chakrabarti S, 2014, CAN J CARDIOL, V30, P705, DOI 10.1016/j.cjca.2013.08.006
   Chalouhi N, 2013, STROKE, V44, P3613, DOI 10.1161/STROKEAHA.113.002390
   Chambliss KL, 2010, J CLIN INVEST, V120, P2319, DOI 10.1172/JCI38291
   Chappell MC, 2003, HYPERTENSION, V42, P781, DOI 10.1161/01.HYP.0000085210.66399.A3
   Chen M, 2011, J NEUROINTERV SURG, V3, P163, DOI 10.1136/jnis.2010.003855
   Clarkson TB, 2007, MENOPAUSE, V14, P373, DOI 10.1097/GME.0b013e31803c764d
   Collins P, 2009, CIRCULATION, V119, P922, DOI 10.1161/CIRCULATIONAHA.108.817577
   de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384
   Dubey RK, 2004, HYPERTENSION, V44, P789, DOI 10.1161/01.HYP.0000145988.95551.28
   Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637
   Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8
   Frosen J, 2004, STROKE, V35, P2287, DOI 10.1161/01.STR.0000140636.30204.da
   Frosen J, 2014, TRANSL STROKE RES, V5, P347, DOI 10.1007/s12975-014-0340-3
   Frosen J, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-71
   Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3
   Gavin KM, 2009, J CLIN ENDOCR METAB, V94, P3513, DOI 10.1210/jc.2009-0278
   GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431
   Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49
   Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008
   Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471
   Haas E, 2007, HYPERTENSION, V49, P1358, DOI 10.1161/HYPERTENSIONAHA.107.089995
   Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892
   Hilliard LM, 2013, CURR HYPERTENS REP, V15, P71, DOI 10.1007/s11906-012-0319-y
   Hodges YK, 2000, CIRCULATION, V101, P1792, DOI 10.1161/01.CIR.101.15.1792
   Hodis HN, 2015, MENOPAUSE, V22, P391, DOI [10.1097/GME.0000000000000343, 10.1097/gme.0000000000000343]
   Hsieh HJ, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-3
   Hu PF, 2006, ATHEROSCLEROSIS, V185, P347, DOI 10.1016/j.atherosclerosis.2005.06.011
   Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605
   Jamous MA, 2005, J NEUROSURG, V103, P1046, DOI 10.3171/jns.2005.103.6.1046
   Jamous MA, 2005, J NEUROSURG, V103, P1052, DOI 10.3171/jns.2005.103.6.1052
   Jamous MA, 2007, J NEUROSURG, V107, P405, DOI 10.3171/JNS-07/08/0405
   Jesmin S, 2003, J CEREBR BLOOD F MET, V23, P181, DOI 10.1097/01.WCB.0000043341.09
   Johnston SC, 1998, NEUROLOGY, V51, P411, DOI 10.1212/WNL.51.2.411
   Khalil RA, 2013, BIOCHEM PHARMACOL, V86, P1627, DOI 10.1016/j.bcp.2013.09.024
   Kolega J, 2011, J VASC RES, V48, P429, DOI 10.1159/000324840
   Korja M, 2014, STROKE, V45, P1958, DOI 10.1161/STROKEAHA.114.005318
   Laser A, 2014, J SURG RES, V186, P467, DOI 10.1016/j.jss.2013.07.050
   Lederle FA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1724
   Leung HS, 2007, EUR J PHARMACOL, V555, P178, DOI 10.1016/j.ejphar.2006.10.035
   LONGSTRETH WT, 1994, ANN INTERN MED, V121, P168, DOI 10.7326/0003-4819-121-3-199408010-00002
   Makrygiannis G, 2014, ANN VASC SURG, V28, P1946, DOI 10.1016/j.avsg.2014.07.008
   Martin-McNulty B, 2003, ARTERIOSCL THROM VAS, V23, P1627, DOI 10.1161/01.ATV.0000085842.20866.6A
   Matsushita N, 2012, HYPERTENSION, V60, P1309, DOI 10.1161/HYPERTENSIONAHA.112.198762
   Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306
   Meng H, 2014, AM J NEURORADIOL, V35, P1254, DOI 10.3174/ajnr.A3558
   Meyer MR, 2010, PHARMACOLOGY, V86, P58, DOI 10.1159/000315497
   Meyer MR, 2009, CARDIOVASC RES, V83, P605, DOI 10.1093/cvr/cvp187
   Meyer MR, 2009, MOL CELL ENDOCRINOL, V308, P9, DOI 10.1016/j.mce.2009.03.009
   Meyer MR, 2006, HYPERTENSION, V47, P1019, DOI 10.1161/01.HYP.0000223064.62762.0b
   Mhurchu CN, 2001, STROKE, V32, P606, DOI 10.1161/01.STR.32.3.606
   Miller AP, 2007, MENOPAUSE, V14, P251, DOI 10.1097/01.gme.0000235366.39726.f6
   Murphy E, 2011, CIRC RES, V109, P687, DOI 10.1161/CIRCRESAHA.110.236687
   Nakajima N, 2000, ACTA NEUROPATHOL, V100, P475, DOI 10.1007/s004010000220
   Nelson HD, 2002, JAMA-J AM MED ASSOC, V288, P872, DOI 10.1001/jama.288.7.872
   Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7
   Novella S, 2012, ARTERIOSCL THROM VAS, V32, P2035, DOI 10.1161/ATVBAHA.112.250308
   Nuki Y, 2009, J CEREBR BLOOD F MET, V29, P495, DOI 10.1038/jcbfm.2008.136
   Orshal JM, 2004, AM J PHYSIOL-REG I, V286, pR233, DOI 10.1152/ajpregu.00338.2003
   Ota R, 2009, J CEREBR BLOOD F MET, V29, P1547, DOI 10.1038/jcbfm.2009.77
   Pedersen AT, 1997, LANCET, V350, P1277, DOI 10.1016/S0140-6736(97)06005-4
   Silva RAP, 2014, HYPERTENSION, V64, P362, DOI 10.1161/HYPERTENSIONAHA.114.03415
   Pendergrass KD, 2008, AM J PHYSIOL-HEART C, V295, pH10, DOI 10.1152/ajpheart.01277.2007
   PETITTI DB, 1978, LANCET, V2, P234
   Pinna C, 2008, HYPERTENSION, V51, P1210, DOI 10.1161/HYPERTENSIONAHA.107.106807
   Punnonen R, 1997, MATURITAS, V27, P231, DOI 10.1016/S0378-5122(97)00040-6
   Qureshi AI, 2016, J NEUROSURG, V124, P45, DOI 10.3171/2014.12.JNS142329
   Raz L, 2014, MOL CELL ENDOCRINOL, V389, P22, DOI 10.1016/j.mce.2014.01.015
   Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219
   Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465
   Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321
   SACK MN, 1994, LANCET, V343, P269, DOI 10.1016/S0140-6736(94)91117-7
   Sandoval KE, 2011, MICROVASC RES, V81, P198, DOI 10.1016/j.mvr.2010.12.007
   Schierbeck LL, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6409
   Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537
   Shimada K, 2015, J CEREBR BLOOD F MET, V35, P1163, DOI 10.1038/jcbfm.2015.30
   Shimada K, 2015, STROKE, V46, P1664, DOI 10.1161/STROKEAHA.114.007722
   Simoncini T, 2002, CIRCULATION, V105, P1368, DOI 10.1161/hc1102.105267
   STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102
   Sudoh N, 2001, CIRCULATION, V103, P724
   Tada Y, 2014, NEUROSURGERY, V75, P690, DOI 10.1227/NEU.0000000000000528
   Tada Y, 2014, HYPERTENSION, V63, P1339, DOI 10.1161/HYPERTENSIONAHA.114.03300
   Tada Y, 2014, STROKE, V45, P579, DOI 10.1161/STROKEAHA.113.003072
   Tada Y, 2010, J HYPERTENS, V28, P1883, DOI [10.1097/HJH.b013e32833c2273, 10.1097/HJH;0b013e32833c2273]
   Tada Y, 2009, HYPERTENSION, V54, P552, DOI 10.1161/HYPERTENSIONAHA.109.134130
   Tamura T, 2009, J HYPERTENS, V27, P1284, DOI 10.1097/HJH.0b013e328329d1a7
   Tarhouni K, 2014, ARTERIOSCL THROM VAS, V34, P1281, DOI 10.1161/ATVBAHA.114.303404
   Taylor HS, 2011, J CLIN ENDOCR METAB, V96, P255, DOI 10.1210/jc.2010-0536
   Tham DM, 2002, PHYSIOL GENOMICS, V11, P21, DOI 10.1152/physiolgenomics.00062.2002
   Tulamo R, 2006, NEUROSURGERY, V59, P1069, DOI 10.1227/01.NEU.0000245598.84698.26
   Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0
   Widder J, 2003, HYPERTENSION, V42, P991, DOI 10.1161/01.HYP.0000098661.37637.89
   Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3
   Wu XF, 2009, AM J SURG, V197, P49, DOI 10.1016/j.amjsurg.2007.11.022
   Xing DQ, 2007, AM J PHYSIOL-HEART C, V292, pH2607, DOI 10.1152/ajpheart.01107.2006
   Yagi K, 2010, NEUROSURGERY, V66, P551, DOI 10.1227/01.NEU.0000365771.89576.77
NR 115
TC 1
Z9 1
U1 2
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1473-7175
EI 1744-8360
J9 EXPERT REV NEUROTHER
JI Expert Rev. Neurother.
PD AUG
PY 2016
VL 16
IS 8
BP 927
EP 935
DI 10.1080/14737175.2016.1189827
PG 9
WC Clinical Neurology; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA DT6EC
UT WOS:000381575200008
PM 27177293
DA 2018-12-27
ER

PT J
AU Al-Lashi, RS
AF Al-Lashi, Raied S.
TI RETRACTED: Toward omnidirectional and automated imaging system for
   measuring oceanic whitecap coverage (Retracted article. See vol. 35, pg.
   514, 2018)
SO JOURNAL OF THE OPTICAL SOCIETY OF AMERICA A-OPTICS IMAGE SCIENCE AND
   VISION
LA English
DT Article; Retracted Publication
ID SEA SPRAY AEROSOL
AB Accurate measurements of oceanic whitecap coverage from whitecap images are required for better understanding air-gas transfer and aerosol production processes. However, this is a challenging task because whitecap patches are formed immediately after a wave breaks and are spread over a wide area. The main challenges in designing whitecaps imaging instrument are the small field of view of the camera lens, processing huge numbers of images, recording data over long time periods, and deployment difficulties in stormy conditions. This paper describes the hardware design of a novel high-resolution optical instrument for imaging oceanic whitecaps and the automated algorithm processing the collected images. The instrument was successfully deployed in 2013 as part of the HiWINGS campaign in the North Atlantic Ocean. The instrument uses a fish-eye camera lens to image the whitecaps in a wide angle of view (180 degrees). (C) 2016 Optical Society of America
C1 [Al-Lashi, Raied S.] Univ Leeds, Fac Math & Phys Sci, Sch Food Sci & Nutr, Leeds, W Yorkshire, England.
RP Al-Lashi, RS (reprint author), Univ Leeds, Fac Math & Phys Sci, Sch Food Sci & Nutr, Leeds, W Yorkshire, England.
EM R.Al-lashi@leeds.ac.uk
FU Natural Environment Research Council (NERC) [NE/J020893/1]; AMSCI
   Funding of Chariot Consortium; Natural Environment Research Council
   [NE/J020893/1]
FX Natural Environment Research Council (NERC) (NE/J020893/1); AMSCI
   Funding of Chariot Consortium.
CR Al-Lashi R. S., IEEE J OCEAN E UNPUB
   Anguelova MD, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003158
   Asher W., 2002, GAS TRANSFER WATER S
   Asher WE, 1996, J GEOPHYS RES-OCEANS, V101, P12027, DOI 10.1029/96JC00121
   Brooks IM, 2009, B AM METEOROL SOC, V90, P629, DOI 10.1175/2008BAMS2578.1
   Callaghan A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036165
   Callaghan AH, 2009, J ATMOS OCEAN TECH, V26, P383, DOI 10.1175/2008JTECHO634.1
   de Leeuw G, 2000, J GEOPHYS RES-ATMOS, V105, P29397, DOI 10.1029/2000JD900549
   Frouin R, 1996, J GEOPHYS RES-OCEANS, V101, P14361, DOI 10.1029/96JC00629
   Frouin R, 2001, GEOPHYS RES LETT, V28, P1523, DOI 10.1029/2000GL012657
   Gonzalez R. C., 2008, DIGITAL IMAGE PROCES
   Kapustin VN, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2004JD005527
   Lafon C, 2007, J MARINE SYST, V66, P38, DOI 10.1016/j.jmarsys.2006.02.013
   MONAHAN EC, 1980, J PHYS OCEANOGR, V10, P2094, DOI 10.1175/1520-0485(1980)010<2094:OPLDOO>2.0.CO;2
   Nixon M, 2002, FEATURE EXTRACTION I
   Norris SJ, 2013, OCEAN SCI, V9, P133, DOI 10.5194/os-9-133-2013
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Pascal RW, 2011, J ATMOS OCEAN TECH, V28, P590, DOI 10.1175/2010JTECHO764.1
   Riley K. F., 2010, MATH METHODS PHYS EN
   Stramska M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001321
   SUZUKI S, 1985, COMPUT VISION GRAPH, V30, P32, DOI 10.1016/0734-189X(85)90016-7
   WENTZ FJ, 1992, IEEE T GEOSCI REMOTE, V30, P960, DOI 10.1109/36.175331
   Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718
NR 23
TC 1
Z9 1
U1 2
U2 3
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1084-7529
EI 1520-8532
J9 J OPT SOC AM A
JI J. Opt. Soc. Am. A-Opt. Image Sci. Vis.
PD AUG 1
PY 2016
VL 33
IS 8
BP 1589
EP 1597
DI 10.1364/JOSAA.33.001589
PG 9
WC Optics
SC Optics
GA DU1XW
UT WOS:000382005000019
PM 27505657
OA Green Published
DA 2018-12-27
ER

PT J
AU Akhavan, S
   Safari, A
   Azizmohammadi, S
   Azizmohammadi, S
   Aslami, M
   Yahaghi, E
   Seifoleslami, M
AF Akhavan, Setareh
   Safari, Aghdas
   Azizmohammadi, Sima
   Azizmohammadi, Susan
   Aslami, Maysam
   Yahaghi, Emad
   Seifoleslami, Mehri
TI RETRACTED: Evaluation of mRNA expression levels of IL-17A and IL-10
   cytokines in cervical cancer (Retracted article. See vol.37, pg. 16397,
   2016)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Cervical; IL-17A and IL-10; Metastasis; Grade; Histological
ID TUMOR-GROWTH; INTERLEUKIN-10; SECRETION; ENVIRONMENT; MECHANISM;
   LESIONS; ALPHA; CELLS
AB In this study, we evaluated mRNA expression levels of interleukin (IL)-10/IL-17A by quantitative real-time PCR and their clinical importance in cervical cancer. The IL-10 mRNA levels were higher in cervical cancer tissues as compared with corresponding normal tissues (p < 0.05). Moreover, IL-17A mRNA was significantly increased in cervical cancer tissues than in normal tissues (p < 0.05). Moreover, the high expression level of IL-10 mRNA was markedly related to International League of Gynecology and Obstetrics (FIGO) stage (p = 0.001), but no significant association was found with other clinical factors including age, tumor size, histological grades, and lymph node metastasis. Moreover, high expression levels of IL-17A were not associated with patients' age, tumor size, FIGO stage, and histological grades while IL-17A expression was strongly linked to lymphatic metastasis (p = 0.001). These findings showed that IL-17A might have a crucial role in cervical cancer metastasis. Taken together, IL-17A expression was strongly linked to lymphatic metastasis, indicating that IL-17A might have a crucial role in cervical cancer metastasis. Moreover, our study suggested the association of IL-10 mRNA expression with clinical stage.
C1 [Akhavan, Setareh] Univ Tehran Med Sci, Sch Med, Dept Obstet & Gynecol, Imam Khomeini Hosp Complex, Tehran, Iran.
   [Akhavan, Setareh] Univ Tehran Med Sci, Vali Asr Hosp, Oncol Ward, Tehran, Iran.
   [Safari, Aghdas] AJA Univ Med Sci, Imam Reza Hosp, Dept Gynecol, Tehran, Iran.
   [Azizmohammadi, Sima; Azizmohammadi, Susan] AJA Univ Med Sci, Hajar Hosp, Dept Gynecol, Tehran, Iran.
   [Aslami, Maysam] Calif State Univ Stanislaus, Dept Biol, Turlock, CA 95382 USA.
   [Yahaghi, Emad] Baqiyatallah Univ Med Sci, Dept Mol Biol, Tehran, Iran.
   [Seifoleslami, Mehri] AJA Univ Med Sci, Khanevadeh Hosp, Dept Gynecol, Tehran, Iran.
RP Seifoleslami, M (reprint author), AJA Univ Med Sci, Khanevadeh Hosp, Dept Gynecol, Tehran, Iran.
EM mehri_seifoleslami@yahoo.com.sg
CR Ali KS, 2012, J IMMUNOTOXICOL, V9, P168, DOI 10.3109/1547691X.2011.642419
   Arany I, 2002, ANTIVIR RES, V55, P331, DOI 10.1016/S0166-3542(02)00070-0
   Azar KK, 2004, HUM PATHOL, V35, P1376, DOI 10.1016/j.humpath.2004.08.012
   Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114
   Bermudez-Morales VH, 2008, CANCER INVEST, V26, P1037, DOI 10.1080/07357900802112693
   Bhairavabhotla RK, 2007, INDIAN J BIOCHEM BIO, V44, P350
   CHASE HB, 1958, BRIT J RADIOL, V31, P65, DOI 10.1259/0007-1285-31-362-65
   CLERICI M, 1987, JNCI-J NATL CANCER I, V89, P185
   El-Sherif AM, 2001, J PATHOL, V195, P179, DOI 10.1002/path.929
   Feng MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108502
   Ji YQ, 2010, CANCER IMMUNOL IMMUN, V59, P979, DOI 10.1007/s00262-010-0849-6
   Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360
   Li M, 2014, COMPUT METHOD BIOMEC, V17, P334, DOI 10.1080/10255842.2012.683428
   Ngiow SF, 2010, BLOOD, V115, P2554, DOI 10.1182/blood-2009-11-254607
   Nishimura Y, 2012, CLIN OPHTHALMOL, V6, P365, DOI 10.2147/OPTH.S30310
   Palomer A, 2002, BIOORG MED CHEM LETT, V12, P533, DOI 10.1016/S0960-894X(01)00800-9
   Peghini BC, 2012, HUM IMMUNOL, V73, P920, DOI 10.1016/j.humimm.2012.06.003
   Souza JM, 2013, EUR J GYNAECOL ONCOL, V34, P466
   Stearns ME, 1999, CLIN CANCER RES, V5, P189
   Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183
   Waugh T R, 1935, Can Med Assoc J, V33, P542
   Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557
   zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046
NR 25
TC 2
Z9 2
U1 1
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD AUG
PY 2016
VL 37
IS 8
BP 10149
EP 10153
DI 10.1007/s13277-016-4882-8
PG 5
WC Oncology
SC Oncology
GA DV1HW
UT WOS:000382672900015
PM 26825983
DA 2018-12-27
ER

PT J
AU Li, J
   Song, ZJ
   Wang, YY
   Yin, Y
   Liu, Y
   Yuan, R
   Nan, X
AF Li, Jun
   Song, Zhangjun
   Wang, Yiyu
   Yin, Yue
   Liu, Ying
   Yuan, Rong
   Nan, Xing
TI RETRACTED: Overexpression of SphK1 enhances cell proliferation and
   invasion in triple-negative breast cancer via the PI3K/AKT signaling
   pathway (Retracted article. See April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Sphingosine kinase 1; Sphingosine-1-phosphate; Triple-negative breast
   cancer; Chemotherapy; AKT; PI3K
ID SPHINGOSINE KINASE 1; THERAPEUTIC TARGET; COLON-CANCER; SURVIVAL;
   1-PHOSPHATE; EXPRESSION; PROGNOSIS; APOPTOSIS
AB Sphingosine kinase 1 (SphK1) expression is elevated in various cancers and is associated with shorter survival times for patients. However, the molecular mechanism of SphK1 up-regulation in triple-negative breast cancer (TNBC) remains unclear. In this study, we assayed the expression level of SphK1 in TNBC tissues by qRT-PCR and immunohistochemistry. The level of S1P was quantified by ELISA in the serum of TNBC patients. Our results found that the levels of SphK1 and S1P were significantly increased in TNBC patients compared with normal control. Furthermore, knockdown of SphK1 with siRNA decreased TNBC cell proliferation and inhibited cell migration/invasion. These data suggest that SphK1 has an important role in TNBC and presents an attractive therapeutic target for the treatment for TNBC.
C1 [Li, Jun; Wang, Yiyu; Yin, Yue; Liu, Ying; Yuan, Rong; Nan, Xing] Shaanxi Prov Tumor Hosp, Tumor Res Ctr, 309 YanTa West Rd, Xian 710061, Peoples R China.
   [Song, Zhangjun] Shaanxi Prov Tumor Hosp, Breast Surg Ctr, Xian 710061, Peoples R China.
RP Li, J (reprint author), Shaanxi Prov Tumor Hosp, Tumor Res Ctr, 309 YanTa West Rd, Xian 710061, Peoples R China.
EM junli16@yeah.net
CR Bansal N, 2015, ONCOTARGET, V6, P34087, DOI 10.18632/oncotarget.6048
   Brenton JD, 2005, J CLIN ONCOL, V23, P7350, DOI 10.1200/JCO.2005.03.3845
   Chen MH, 2015, ONCOTARGET, V6, P23594, DOI 10.18632/oncotarget.4335
   Datta A, 2014, ONCOTARGET, V5, P5920, DOI 10.18632/oncotarget.1874
   Fulford LG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1636
   Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007
   Kassam F, 2009, CLIN BREAST CANCER, V9, P29, DOI 10.3816/CBC.2009.n.005
   Kim HS, 2015, ONCOTARGET, V6, P26746, DOI 10.18632/oncotarget.4818
   Liu SQ, 2012, INT J COLORECTAL DIS, V27, P1569, DOI 10.1007/s00384-012-1510-y
   Liu Y, 2015, ONCOTARGET, V6, P41360, DOI 10.18632/oncotarget.6023
   Malavaud B, 2010, EUR J CANCER, V46, P3417, DOI 10.1016/j.ejca.2010.07.053
   Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093
   Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   Tan SSL, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.21
   Tomao F, 2015, ONCOTARGETS THER, V8, P177, DOI 10.2147/OTT.S67673
   Tsukamoto S, 2015, MOL CANCER THER, V14, P2303, DOI 10.1158/1535-7163.MCT-15-0185
   Xu Y, 2015, ONCOTARGET, DOI 10.18632/oncotarget.6564
   Yang L, 2015, BIOCHEM BIOPH RES CO, V460, P903, DOI 10.1016/j.bbrc.2015.03.114
   Zhu LM, 2015, ONCOL REP, V33, P1257, DOI 10.3892/or.2014.3683
NR 20
TC 18
Z9 20
U1 4
U2 10
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD AUG
PY 2016
VL 37
IS 8
BP 10587
EP 10593
DI 10.1007/s13277-016-4954-9
PG 7
WC Oncology
SC Oncology
GA DV1HW
UT WOS:000382672900059
PM 26857281
DA 2018-12-27
ER

PT J
AU Li, X
   Liao, LM
   Chen, GQ
   Wang, ZX
   Lu, TJ
   Deng, H
   Loeb, GE
AF Li, Xing
   Liao, Li-Min
   Chen, Guo-Qing
   Wang, Zhao-Xia
   Lu, Tian-Ji
   Deng, Han
   Loeb, Gerald-E
TI RETRACTED: Tibial nerve stimulation to inhibit the micturition reflex by
   an implantable wireless driver microstimulator in cats (Retracted
   Article. See vol 95, 2016)
SO MEDICINE
LA English
DT Article; Retracted Publication
DE cat; implantable; microstimulator; micturition reflex; tibial nerve
   stimulation
ID OVERACTIVE BLADDER SYNDROME
AB Background: Traditional tibial nerve stimulation (TNS) has been used to treat overactive bladder syndrome (OAB), but there are some shortcomings. Thus, a novel alternative is needed for the treatment of OAB. The study investigated the effects of a new type of tibial nerve microstimulator on the micturition reflex in cats.
   Methods: An implantable wireless driver microstimulator was implanted around the tibial nerve in 9 alpha-chloralose anesthetized cats. Cystometry was performed by infusing 0.9% normal saline (NS) or 0.25% acetic acid (AA) through a urethral catheter. Multiple cystometrograms were performed before, during, and after TNS to determine the inhibitory effect of the microstimulator on the micturition reflex.
   Results: TNS at 2 threshold (T) intensity significantly increased the bladder capacity (BC) during NS infusion. Bladder overactivity was irritated by the intravesical infusion of 0.25% AA, which significantly reduced the BC compared with the NS infusion. TNS at 2 T intensity suppressed AA-induced bladder overactivity and significantly increased the BC compared with the AA control.
   Conclusion: The implantable wireless driver tibial nerve microstimulator appears to be effective in inhibiting the micturition reflex during physiologic and pathologic conditions. The implantable wireless driver tibial nerve microstimulator could be used to treat OAB.
C1 [Li, Xing; Liao, Li-Min; Chen, Guo-Qing; Wang, Zhao-Xia; Lu, Tian-Ji; Deng, Han] Capital Med Univ, Rehabil Sch, Dept Urol, China Rehabil Res Ctr, Beijing, Peoples R China.
   [Li, Xing; Liao, Li-Min; Chen, Guo-Qing; Wang, Zhao-Xia; Lu, Tian-Ji; Deng, Han] Beijing Key Lab Neural Injury & Rehabil, Beijing, Peoples R China.
   [Li, Xing; Liao, Li-Min; Chen, Guo-Qing; Wang, Zhao-Xia; Lu, Tian-Ji; Deng, Han] Beijing Inst Brain Disorders, Ctr Neural Injury & Repair, Beijing, Peoples R China.
   [Loeb, Gerald-E] Univ Southern Calif, Los Angeles, CA USA.
RP Liao, LM (reprint author), China Rehabil Res Ctr, Dept Urol, Beijing, Peoples R China.
EM lmliao@263.net
FU Natural Science Foundation of China; Beijing Natural Science Foundation
FX The authors would like to thank the Natural Science Foundation of China
   and Beijing Natural Science Foundation for financially supporting this
   research. They also would like to thank Fangping Li, Fangxi Li, and
   Xue-Chen Huang for the supports for this study and the valuable
   discussion and suggestions.
CR Abrams P, 2003, UROLOGY, V61, P37, DOI 10.1016/S0090-4295(02)02243-4
   Abrams Paul, 2009, Neurourol Urodyn, V28, P287, DOI 10.1002/nau.20737
   Chen GQ, 2015, INT UROL NEPHROL, V47, P451, DOI 10.1007/s11255-015-0911-6
   de Seze M, 2011, NEUROUROL URODYNAM, V30, P306, DOI 10.1002/nau.20958
   Gormley EA, 2015, J UROLOGY, V193, P1572, DOI 10.1016/j.juro.2015.01.087
   Manriquez V, 2016, EUR J OBSTET GYN R B, V196, P6, DOI 10.1016/j.ejogrb.2015.09.020
   MCGUIRE EJ, 1983, J UROLOGY, V129, P78, DOI 10.1016/S0022-5347(17)51928-X
   Peters KM, 2013, J UROLOGY, V189, P2194, DOI 10.1016/j.juro.2012.11.175
   Peters KM, 2009, J UROLOGY, V182, P1055, DOI 10.1016/j.juro.2009.05.045
   Ruiz BC, 2004, EUR UROL, V45, P65, DOI 10.1016/j.eururo.2003.08.012
   Tai CF, 2012, AM J PHYSIOL-RENAL, V302, pF1090, DOI 10.1152/ajprenal.00609.2011
   Tai CF, 2011, J UROLOGY, V186, P326, DOI 10.1016/j.juro.2011.04.023
   van Balken MR, 2007, EXPERT REV MED DEVIC, V4, P693, DOI 10.1586/17434440.4.5.693
   van der Pal F, 2006, NEUROMODULATION, V9, P163, DOI 10.1111/j.1525-1403.2006.00056.x
   Van der Pal F, 2006, BJU INT, V97, P547, DOI 10.1111/1464-410X.2006.06055.x
NR 15
TC 1
Z9 1
U1 2
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD AUG
PY 2016
VL 95
IS 33
AR e4537
DI 10.1097/MD.0000000000004537
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA DU5KR
UT WOS:000382251100028
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Yu, F
   Hao, S
   Yang, B
   Zhao, Y
   Yang, J
AF Yu, Fei
   Hao, Shuai
   Yang, Bo
   Zhao, Yue
   Yang, Jun
TI RETRACTED: Low Iron Diet Increases Susceptibility to Noise-Induced
   Hearing Loss in Young Rats(Retracted article. See vol. 9, artn no.42,
   2017)
SO NUTRIENTS
LA English
DT Article; Retracted Publication
DE iron deficiency without anemia; ribbon synapse; spiral ganglion cell
ID CELL RIBBON SYNAPSE; AUDITORY-EVOKED POTENTIALS; YOUNG GUINEA-PIGS;
   DEFICIENCY ANEMIA; MYOSIN VIIA; HAIR-CELLS; EXPRESSION; EXPOSURE; MICE;
   PREVALENCE
AB We evaluated the role of iron deficiency (ID) without anemia on hearing function and cochlear pathophysiology of young rats before and after noise exposure. We used rats at developmental stages as an animal model to induce ID without anemia by dietary iron restriction. We have established this dietary restriction model in the rat that should enable us to study the effects of iron deficiency in the absence of severe anemia on hearing and ribbon synapses. Hearing function was measured on Postnatal Day (PND) 21 after induction of ID using auditory brainstem response (ABR). Then, the young rats were exposed to loud noise on PND 21. After noise exposure, hearing function was again measured. We observed the morphology of ribbon synapses, hair cells and spiral ganglion cells (SGCs), and assessed the expression of myosin VIIa, vesicular glutamate transporter 3 and prestin in the cochlea. ID without anemia did not elevate ABR threshold shifts, but reduced ABR wave I peak amplitude of young rats. At 70, 80, and 90 dB SPL, amplitudes of wave I (3.11 +/- 0.96 mu V, 3.52 +/- 1.31 mu V, and 4.37 +/- 1.08 mu V, respectively) in pups from the ID group were decreased compared to the control (5.92 +/- 1.67 mu V, 6.53 +/- 1.70 mu V, and 6.90 +/- 1.76 mu V, respectively) (p < 0.05). Moreover, ID without anemia did not impair the morphology hair cells and SGCs, but decreased the number of ribbon synapses. Before noise exposure, the mean number of ribbon synapses per inner hair cell (IHC) was significantly lower in the ID group (8.44 +/- 1.21) compared to that seen in the control (13.08 +/- 1.36) (p < 0.05). In addition, the numbers of ribbon synapses per IHC of young rats in the control (ID group) were 6.61 +/- 1.59, 3.07 +/- 0.83, 5.85 +/- 1.63 and 12.25 +/- 1.97 (3.75 +/- 1.45, 2.03 +/- 1.08, 3.81 +/- 1.70 and 4.01 +/- 1.65) at 1, 4, 7 and 14 days after noise exposure, respectively. Moreover, ABR thresholds at 4 and 8 kHz in young rats from the ID group were significantly elevated at 7 and 14 days after noise exposure compared to control (p < 0.05). The average number of young rat SGCs from the ID group were significantly decreased in the basal turn of the cochlea compared to the control (p < 0.05). Therefore, ID without anemia delayed the recovery from noise-induced hearing loss and ribbon synapses damage, increased SGCs loss, and upregulated prestin after noise exposure. Thus, the cochleae in rat pups with ID without anemia were potentially susceptible to loud noise exposure, and this deficit may be attributed to the reduction of ribbon synapses and SGCs.
C1 [Yu, Fei; Zhao, Yue; Yang, Jun] China Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, 77 Puhe Rd, Shenyang 110122, Peoples R China.
   [Hao, Shuai; Yang, Bo] China Med Univ, Affiliated Hosp 1, Dept Otolaryngol, 155 Nanjing North St, Shenyang 110001, Peoples R China.
RP Yu, F (reprint author), China Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, 77 Puhe Rd, Shenyang 110122, Peoples R China.
EM yufei@mail.cmu.edu.cn; kellya@163.com; feigo_dl@163.com;
   ford_cmu@163.com; yangjun@mail.cmu.edu.cn
FU National Natural Science Foundation Committee of China [81372972,
   81400469]
FX This study was supported by the National Natural Science Foundation
   Committee of China (grant number 81372972 and 81400469).
CR Amin SB, 2013, J PEDIATR-US, V163, P1267, DOI 10.1016/j.jpeds.2013.06.020
   Amin SB, 2010, J PEDIATR-US, V156, P377, DOI 10.1016/j.jpeds.2009.09.049
   Bao JX, 2010, HEARING RES, V264, P93, DOI 10.1016/j.heares.2009.10.009
   Brumwell CL, 2000, EXP NEUROL, V162, P121, DOI 10.1006/exnr.2000.7317
   Cameron BM, 2011, NUTR REV, V69, pS49, DOI 10.1111/j.1753-4887.2011.00433.x
   Castiglione A, 2015, BIOMED RES INT, V2015
   Choudhury V, 2015, AM J CLIN NUTR, V102, P1030, DOI 10.3945/ajcn.115.113084
   Dieck S. tom, 2005, J CELL BIOL, V168, P825, DOI DOI 10.1083/JCB.200408157
   Fujita T, 2012, DIABETES, V61, P2980, DOI 10.2337/db11-1845
   Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796
   Hu XN, 2014, NUTR RES, V34, P604, DOI 10.1016/j.nutres.2014.06.007
   JEWETT DL, 1970, SCIENCE, V167, P1517, DOI 10.1126/science.167.3924.1517
   Johnson SL, 2008, J NEUROSCI, V28, P7670, DOI 10.1523/JNEUROSCI.0785-08.2008
   Kalinec GM, 2005, P NATL ACAD SCI USA, V102, P16019, DOI 10.1073/pnas.0508053102
   Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418
   Kurekci AE, 2006, TURKISH J PEDIATR, V48, P334
   Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009
   LeBlanc CP, 2009, J NUTR, V139, P1653, DOI 10.3945/jn.109.106013
   Lee DL, 2012, J NEUROSCI, V32, P5010, DOI 10.1523/JNEUROSCI.0526-12.2012
   Liu K, 2014, ACTA OTO-LARYNGOL, V134, P564, DOI 10.3109/00016489.2014.892631
   Liu K, 2013, MOL NEUROBIOL, V48, P647, DOI 10.1007/s12035-013-8454-2
   Liu XQ, 2013, NEUROTOXICOLOGY, V39, P173, DOI 10.1016/j.neuro.2013.10.002
   McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401
   Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293
   Moser T, 2006, CELL TISSUE RES, V326, P347, DOI 10.1007/s00441-006-0276-3
   Peng Z, 2013, BRAIN RES, V1537, P100, DOI 10.1016/j.brainres.2013.09.019
   Radlowski EC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00585
   REEVES PG, 1993, J NUTR, V123, P1939
   Saluja Satish, 2016, Evid Based Med, V21, P112, DOI 10.1136/ebmed-2015-110379
   Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8
   Scholl TO, 2005, AM J CLIN NUTR, V81, p1218S
   Selander J, 2016, ENVIRON HEALTH PERSP, V124, P855, DOI 10.1289/ehp.1509874
   Shi LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081566
   Wang HL, 2015, INT J CLIN EXP PATHO, V8, P8680
   Werner M, 2012, HEARING RES, V283, P107, DOI 10.1016/j.heares.2011.11.003
   Xia AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082602
   Yu F, 2016, NEUROTOX RES, V29, P594, DOI 10.1007/s12640-016-9609-5
   Yu F, 2015, NEUROSCI LETT, V597, P183, DOI 10.1016/j.neulet.2015.04.049
   Yu F, 2014, ENVIRON TOXICOL PHAR, V37, P291, DOI 10.1016/j.etap.2013.11.024
   Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5
NR 40
TC 5
Z9 5
U1 4
U2 13
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG
PY 2016
VL 8
IS 8
AR 456
DI 10.3390/nu8080456
PG 17
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA DS4QS
UT WOS:000380766500012
PM 27483303
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Calvo-Guirado, JL
   Aguilar-Salvatierra, A
   Ramirez-Fernandez, MP
   de Val, JEMS
   Delgado-Ruiz, RA
   Gomez-Moreno, G
AF Luis Calvo-Guirado, Jose
   Aguilar-Salvatierra, Antonio
   Ramirez-Fernandez, Maria P.
   Mate Sanchez de Val, Jose E.
   Arcesio Delgado-Ruiz, Rafael
   Gomez-Moreno, Gerardo
TI RETRACTED: Bone response to collagenized xenografts of porcine origin
   (mp3((R))) and a bovine bone mineral grafting (4BONE (TM) XBM) grafts in
   tibia defects: experimental study in rabbits (Retracted article. See
   vol. 29, pg. 818, 2018)
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Retracted Publication
DE 4BONE (TM) XBM; biomaterial; bone graft; Mp3; tibia rabbits; xenografts
ID HISTOMORPHOMETRIC ANALYSIS; AUGMENTATION TECHNIQUES; DENTAL IMPLANTS;
   REGENERATION; BIOMATERIALS; SUBSTITUTE; DOGS
AB ObjectivesThis study aimed to carry out the evaluation of bone response of new bone formation to two different xenografts (bovine and porcine) biomaterials inserted in rabbit tibiae.
   Materials and methodsThe study used a total of 20 male New Zealand albino rabbits. They received a total of 40 grafts in the proximal metaphyseal areas of both tibiae. Two biomaterials were evaluated: 20 porcine xenografts, as a bone granulate (OsteoBiol((R)) MP3((R)); Tecnoss srl, Giaveno, Italy), were placed in the proximal metaphyseal area of the right tibia, 20 anorganic bovine bone mineral grafting (4BONE XBM, MIS Implants Inc., BARLEV, Israel) were placed in the left tibia. Following graft insertion, the animals were sacrificed in two groups of 10 animals, after 1 and 4months, respectively. For each group, biomaterials were analyzed: newly formed bone, residual graft materials and the connective tissue. Histomorphometric, EDX analysis and element mapping were performed at 1 and 4months after graft insertion.
   ResultsAt 4months after treatment, the bone defects displayed radiological images that showed complete repair of osseous defects. Histomorphometric evaluation showed that for the porcine xenograft, the study averages for newly formed bone represented 84.232.9%, while bovine matrix was 79.34 +/- 2.1%. For residual graft material, the porcine biomaterial had 11.23 +/- 1.7% and the bovine graft 31.56 +/- 2.3%. Finally, the connective tissue for MP3 was 10.33 +/- 1.8%, while for the 4BONE XBM we obtained 14.34 +/- 2.9%. Element analysis revealed higher percentages of Ca (54 +/- 9%) and P (35 +/- 6%) in the group B than group A and control group (P<0.05).
   ConclusionsDefects of a critical size in a rabbit tibia model can be sealed using a bovine porous biphasic calcium phosphate and MP3 material; this supports new bone formation, creates a bridge between borders, and facilitates bone ingrowth in both biomaterials. Furthermore, this study observed partial dissolution of the mineral phase of four bone graft and complete resorption of porcine MP3 biomaterial and its incorporation into the surrounding bone. Depending on clinical needs, each biomaterial could be useful in daily clinical practice.
C1 [Luis Calvo-Guirado, Jose; Ramirez-Fernandez, Maria P.; Mate Sanchez de Val, Jose E.] Univ Catolica San Antonio Murcia UCAM, Int Dent Res Cathedra, Murcia, Spain.
   [Arcesio Delgado-Ruiz, Rafael] SUNY Stony Brook, Sch Dent Med, Stony Brook, NY 11794 USA.
   [Aguilar-Salvatierra, Antonio; Gomez-Moreno, Gerardo] Univ Granada, Fac Dent, Granada, Spain.
RP Calvo-Guirado, JL (reprint author), C Mozart 4 1 Floor C-D, Murcia 30002, Spain.
EM jlcalvo@ucam.edu
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; calvo guirado,
   jose luis/0000-0002-4067-2253
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Beitlitum I, 2010, CLIN ORAL IMPLAN RES, V21, P1242, DOI 10.1111/j.1600-0501.2010.01936.x
   Boix D, 2004, J PERIODONTOL, V75, P663, DOI 10.1902/jop.2004.75.5.663
   Guirado JLC, 2013, CLIN IMPLANT DENT R, V15, P143, DOI 10.1111/j.1708-8208.2011.00337.x
   Calvo-Guirado JL, 2014, CLIN ORAL IMPLAN RES, V25, P1228, DOI 10.1111/clr.12258
   Calvo-Guirado JL, 2015, CLIN ORAL IMPLAN RES, V26, P399, DOI 10.1111/clr.12364
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   De Santis E, 2015, CLIN ORAL IMPLAN RES, V26, P516, DOI 10.1111/clr.12434
   El-Mekkawi HA, 2012, ORAL SURG ORAL MED S, V114, P179
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Ezirganli S, 2013, CLIN ORAL IMPLAN RES, V24, P312, DOI 10.1111/j.1600-0501.2011.02323.x
   Fan HS, 2007, J NANOSCI NANOTECHNO, V7, P808, DOI 10.1166/jnn.2007.501
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kolerman R, 2012, J ORAL MAXIL SURG, V70, P1835, DOI 10.1016/j.joms.2012.04.034
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Calvo-Guirado JL, 2015, CLIN ORAL IMPLAN RES, V26, P454, DOI 10.1111/clr.12399
   de Val JEMS, 2012, J BIOMED MATER RES A, V100A, P3446, DOI 10.1002/jbm.a.34259
   de Val JEMS, 2014, J BIOMED MATER RES A, V102, P1037, DOI 10.1002/jbm.a.34785
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Murai Masakazu, 2005, J Oral Sci, V47, P209, DOI 10.2334/josnusd.47.209
   Pekkan G, 2012, J CRANIO MAXILL SURG, V40, pE1, DOI 10.1016/j.jcms.2011.01.018
   Ramirez-Fernandez MP, 2011, CLIN ORAL IMPLAN RES, V22, P767, DOI 10.1111/j.1600-0501.2010.02058.x
   Ramirez-Fernandez MP, 2013, CLIN ORAL IMPLAN RES, V24, P523, DOI 10.1111/j.1600-0501.2011.02414.x
   Sanchez M., 2014, CLIN ORAL IMPLAN RES, DOI [10.1111/clr.12420, DOI 10.1111/CLR.12420]
   Schopper C, 2005, J BIOMED MATER RES B, V74B, P458, DOI 10.1002/jbm.b.30199
   Simion M, 2007, CLIN ORAL IMPLAN RES, V18, P86, DOI 10.1111/j.1600-0501.2006.01291.x
   Soardi CM, 2011, CLIN ORAL IMPLAN RES, V22, P560, DOI 10.1111/j.1600-0501.2010.02034.x
   Wang W, 2009, ACTA BIOMATER, V5, P3132, DOI 10.1016/j.actbio.2009.04.036
NR 31
TC 2
Z9 2
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD AUG
PY 2016
VL 27
IS 8
BP 1039
EP 1046
DI 10.1111/clr.12681
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DS7IX
UT WOS:000380958000017
PM 26434645
DA 2018-12-27
ER

PT J
AU Yao, CJ
   Li, PP
   Song, HS
   Song, FX
   Qu, YL
   Ma, XC
   Shi, RR
   Wu, JS
AF Yao, Chengjun
   Li, Panpan
   Song, Huishu
   Song, Fuxi
   Qu, Yalan
   Ma, Xiaochen
   Shi, Ranran
   Wu, Jinsong
TI RETRACTED: CXCL12/CXCR4 Axis Upregulates Twist to Induce EMT in Human
   Glioblastoma (Retracted article. See vol. 54, pg. 7553, 2017)
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article; Retracted Publication
DE CXCR4; Twist; EMT; Human glioblastoma
ID EPITHELIAL-MESENCHYMAL TRANSITION; CANCER PROGRESSION; SIGNALING
   PATHWAY; CELLS; SLUG; PROMOTES; INVASION; EXPRESSION; ADHESION; ABILITY
AB In recent decades, the chemokine receptor CXCR4 and its ligand CXCL12 have been extensively reported to be associated with tumorigenesis. In addition, Twist signaling induces the epithelial-mesenchymal transition (EMT) process in glioblastoma development. In the present study, in vitro assays were used to investigate the role of CXCR4 and Twist in human glioblastoma. We explored the impact of CXCR4 and Twist on human glioblastoma using in vitro protein and gene assays. We found the administration of CXCL12 upregulated the expression of p-ERK, p-AKT, Twist, N-cadherin, and MMP9 in U87 cells, whereas the increase of E-cadherin protein was affected. Subsequently, Twist activity and EMT signaling were directly influenced by PD98059 and LY294002. Most importantly, the genetic silencing of Twist inhibited CXCL12-induced EMT occurrence, including proliferation, migration, and tumor formation of U87 cells. In conclusion, CXCL12/CXCR4 pathway activates ERK and PI3K/AKT signaling to upregulate Twist pathway, leading to the progression of EMT in human glioblastoma. Our study creates a new stage for molecule-targeted therapy of human glioblastoma.
C1 [Yao, Chengjun; Wu, Jinsong] Fudan Univ, Dept Neurol Surg, Glioma Surg Div, Huashan Hosp,Shanghai Med Coll, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.
   [Li, Panpan; Song, Huishu; Song, Fuxi; Qu, Yalan; Ma, Xiaochen; Shi, Ranran] Shandong Univ, Sch Med, Qilu Hosp, Jinan, Shandong, Peoples R China.
RP Wu, JS (reprint author), Fudan Univ, Dept Neurol Surg, Glioma Surg Div, Huashan Hosp,Shanghai Med Coll, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.
EM wujssh@126.com
FU National Key Technology R&D Program of China [2014BAI04B05]; National
   Natural Science Foundation of China [81271517]
FX This study is supported by the National Key Technology R&D Program of
   China (No. 2014BAI04B05), and National Natural Science Foundation of
   China (No. 81271517). We gratefully thank our Lab for their critical
   reading of this paper and valuable suggestions.
CR Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330
   Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005
   Ding W, 2010, HEPATOLOGY, V52, P945, DOI 10.1002/hep.23748
   Eberlein C, 2015, ONCOGENE, V34, P704, DOI 10.1038/onc.2013.600
   Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189
   Haupt S, 2006, CELL DEATH DIFFER, V13, P913, DOI 10.1038/sj.cdd.4401906
   He LC, 2012, ONCOL REP, V28, P1399, DOI 10.3892/or.2012.1946
   Hsu YL, 2013, ONCOGENE, V32, P4436, DOI 10.1038/onc.2012.444
   Ishikawa T, 2013, CANCER SCI, V104, P880, DOI 10.1111/cas.12163
   Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29
   Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215
   Leckband D, 2008, BIOCHEM SOC T, V36, P213, DOI 10.1042/B5T0360213
   Li Y, 2014, CANCER LETT, V355, P130, DOI 10.1016/j.canlet.2014.09.007
   Li YY, 2014, IUBMB LIFE, V66, P507, DOI 10.1002/iub.1285
   Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310
   Mack F, 2014, ONCOLOGY-BASEL, V86, P369, DOI 10.1159/000360295
   NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443
   Suman S, 2014, MOL CARCINOGEN, V53, pE151, DOI 10.1002/mc.22076
   Tirino V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.144
   Umar S, 2014, ONCOTARGET, V5, P6573, DOI 10.18632/oncotarget.2384
   Vehlow A, 2013, BBA-REV CANCER, V1836, P236, DOI 10.1016/j.bbcan.2013.07.001
   Wang Q, 2014, MOL MED REP, V10, P3310, DOI 10.3892/mmr.2014.2583
   Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126
   Woolf Eric C, 2012, CNS Oncol, V1, P7, DOI 10.2217/cns.12.9
   Zheng H, 2014, ONCOGENE, V33, P1755, DOI 10.1038/onc.2013.128
NR 25
TC 18
Z9 19
U1 4
U2 8
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD AUG
PY 2016
VL 53
IS 6
BP 3948
EP 3953
DI 10.1007/s12035-015-9340-x
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA DR2AO
UT WOS:000379707600037
PM 26179613
DA 2018-12-27
ER

PT J
AU Mitrani, JL
AF Mitrani, Judith L.
TI RETRACTED: On Separating One from the Other: Images of a Developing
   Self(Retracted article. See vol. 33, pg. 141, 2017)
SO BRITISH JOURNAL OF PSYCHOTHERAPY
LA English
DT Article; Retracted Publication
DE Bion; Klein; Tustin; Bick; Internal Objects; Transformations; Perinatal;
   Pre-Mature Awareness of Separateness
ID EXPERIENCE
AB Through clinical material from a lengthy analysis, the author reveals how the process of transformations (Bion) - in dreams, fantasies and enactments - enabled one analysand to develop a psychic skin (Bick) made up of mindful understanding and tolerance for the primal dreads of unravelling, crumbling and spilling out (Tustin), which may have been trans-generationally acquired in perinatal life and that may have been inherent in the patient becoming pre-maturely aware of bodily separateness from the (m)other. The author also demonstrates how the patient's creative expression of these developments gradually became liberated during the analytic process and the ways in which this process, not unlike a succession of dreams, evolved and was addressed throughout the therapy, uniquely illustrating the arduous process of separating one's self out from some constricting maternal antecedents and internal objects (Klein).
C1 [Mitrani, Judith L.] Psychoanalyt Ctr Calif, Los Angeles, CA 90064 USA.
   [Mitrani, Judith L.] Frances Tustin Mem Trust, Los Angeles, CA 90025 USA.
RP Mitrani, JL (reprint author), Psychoanalyt Ctr Calif, Los Angeles, CA 90064 USA.; Mitrani, JL (reprint author), Frances Tustin Mem Trust, Los Angeles, CA 90025 USA.
CR BICK E, 1968, INT J PSYCHOANAL, V49, P484
   BION WR, 1962, INT J PSYCHOANAL, V43, P306
   FAIMBERG H, 1988, CONTEMP PSYCHOANAL, V24, P99
   MITRANI JL, 1995, PSYCHOANAL QUART, V64, P68, DOI 10.1080/21674086.1995.11927444
   Oliver M., 2012, A 1000 MORNINGS
   Riviere J, 1936, INT J PSYCHOANAL, V17, P304
   ROSENFELD H, 1971, INT J PSYCHOANAL, V52, P169
   TUSTIN F, 1990, PROTECTIVE SHELL CHI
   Tustin F, 1986, AUTISTIC BARRIERS NE
   Tustin F., 1987, COMMUNICATION
NR 10
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0265-9883
EI 1752-0118
J9 BRIT J PSYCHOTHER
JI Brit. J. Psychother.
PD AUG
PY 2016
VL 32
IS 3
BP 321
EP 337
DI 10.1111/bjp.12227
PG 17
WC Psychiatry
SC Psychiatry
GA DR7HO
UT WOS:000380070800004
DA 2018-12-27
ER

PT J
AU Gumus, I
AF Gumus, Inci
TI RETRACTED: Fiscal Uncertainty and Currency Crises (Retracted article.
   See vol. 21, pg. 212, 2017)
SO REVIEW OF DEVELOPMENT ECONOMICS
LA English
DT Article; Retracted Publication
ID EXCHANGE-RATE REGIMES; ATTACKS
AB Fiscal deficits have been put forward as the main factor in the occurrence of currency crises by the first-generation currency crisis models. While most papers within this framework consider a fiscal deficit that occurs with certainty, in reality an increase in the government's fiscal burden may be an uncertain outcome. This paper introduces a model where there is uncertainty about the occurrence of a fiscal deficit for a finite number of periods, and studies the effects of such uncertainty on the evolution of currency crises. If the fiscal deficit materializes, the government has to abandon the fixed exchange rate regime, as in the standard case. However, the paper shows that the peg becomes unsustainable even if the fiscal deficit never materializes. Therefore, a speculative attack occurs and the fixed exchange rate regime collapses with the mere possibility of a deficit, independently of whether this outcome actually occurs or not.
C1 [Gumus, Inci] Sabanci Univ, Fac Arts & Social Sci, TR-34956 Istanbul, Turkey.
RP Gumus, I (reprint author), Sabanci Univ, Fac Arts & Social Sci, TR-34956 Istanbul, Turkey.
EM incigumus@sabanciuniv.edu
CR BLANCO H, 1986, J POLIT ECON, V94, P148, DOI 10.1086/261366
   Burnside C, 2006, J MONETARY ECON, V53, P401, DOI 10.1016/j.jmoneco.2005.03.012
   Burnside C, 2001, J POLIT ECON, V109, P1155, DOI 10.1086/323271
   Corsetti G, 1999, EUR ECON REV, V43, P1211, DOI 10.1016/S0014-2921(99)00017-3
   Corsetti G, 2006, EUR ECON REV, V50, P1317, DOI 10.1016/j.euroecorev.2005.02.005
   Daniel BC, 2001, INT ECON REV, V42, P969, DOI 10.1111/1468-2354.00142
   DORNBUSCH R, 1987, J DEV ECON, V27, P71, DOI 10.1016/0304-3878(87)90007-1
   Eichler S, 2011, REV DEV ECON, V15, P223, DOI 10.1111/j.1467-9361.2011.00604.x
   FLOOD RP, 1984, J INT ECON, V17, P1, DOI 10.1016/0022-1996(84)90002-3
   GRILLI VU, 1986, J INT ECON, V20, P143, DOI 10.1016/0022-1996(86)90066-8
   KRUGMAN P, 1979, J MONEY CREDIT BANK, V11, P311, DOI 10.2307/1991793
   Ma Y, 2009, REV DEV ECON, V13, P87, DOI 10.1111/j.1467-9361.2008.00464.x
NR 12
TC 2
Z9 2
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1363-6669
EI 1467-9361
J9 REV DEV ECON
JI Rev. Dev. Econ.
PD AUG
PY 2016
VL 20
IS 3
BP 637
EP 650
DI 10.1111/rode.12136
PG 14
WC Economics; Planning & Development
SC Business & Economics; Public Administration
GA DR5MM
UT WOS:000379947100002
DA 2018-12-27
ER

PT J
AU Sorkheh, K
   Amirbakhtiar, N
   Ercisli, S
AF Sorkheh, Karim
   Amirbakhtiar, Nazanin
   Ercisli, Sezai
TI RETRACTED: Potential Start Codon Targeted (SCoT) and
   Inter-retrotransposon Amplified Polymorphism (IRAP) Markers for
   Evaluation of Genetic Diversity and Conservation of Wild Pistacia
   Species Population (Retracted article. See vol. 55, pg. 421, 2017)
SO BIOCHEMICAL GENETICS
LA English
DT Article; Retracted Publication
DE Genetic variation; IRAP; SCoT; Conservation
ID MULTILOCUS GENOTYPE DATA; PHYLOGENETIC-RELATIONSHIPS; PLANTS; RAPD;
   GERMPLASM; SEQUENCES; INFERENCE; ISSR; PCR; L.
AB Wild pistachio species is important species in forests regions Iran and provide protection wind and soil erosion. Even though cultivation and utilization of Pistacia are fully exploited, the evolutionary history of the Pistacia genus and the relationships among the species and accessions is still not well understood. Two molecular marker strategies, SCoT and IRAP markers were analyzed for assessment of 50 accessions of this species accumulated from diverse geographical areas of Iran. A thorough of 115 bands were amplified using eight IRAP primers, of which 104 (90.4 %) have been polymorphic, and 246 polymorphic bands (68.7 %) had been located in 358 bands amplified by way of forty-four SCoT primers. Average PIC for IRAP and SCoT markers became 0.32 and 0.48, respectively. This is exposed that SCoT markers have been extra informative than IRAP for the assessment of variety among pistachio accessions. Primarily based on the two extraordinary molecular markers, cluster evaluation revealed that the 50 accessions taken for the evaluation may be divided into three distinct clusters. Those results recommend that the performance of SCoT and IRAP markers was highly the equal in fingerprinting of accessions. The results affirmed a low genetic differentiation among populations, indicating the opportunity of gene drift most of the studied populations. These findings might render striking information in breeding management strategies for genetic conservation and cultivar improvement.
C1 [Sorkheh, Karim] Shahid Chamran Univ Ahvaz, Dept Agron & Plant Breeding, Fac Agr, POB 61355-144, Ahwaz, Iran.
   [Amirbakhtiar, Nazanin] Agr Nat Resources Res & Educ Ctr, Dept Seed & Plant Improvement, POB 61333-3341, Ahwaz, Iran.
   [Ercisli, Sezai] Ataturk Univ, Fac Agr, Dept Hort, TR-25240 Erzurum, Turkey.
RP Sorkheh, K (reprint author), Shahid Chamran Univ Ahvaz, Dept Agron & Plant Breeding, Fac Agr, POB 61355-144, Ahwaz, Iran.
EM karimsorkheh@gmail.com
FU Shahid Chamran University of Ahwaz, Iran
FX This study was supported by Shahid Chamran University of Ahwaz, Iran. We
   thank the Iranian pistachio research institute, Rafsanjan, Iran. The
   authors would like appreciative much appreciated from Heman Ebrahimi for
   arrangement of the pictures in the site of www.banehpedia.com with let
   authorization to utilize.
CR Alavi-Kia SS, 2008, BIOTECHNOL BIOTEC EQ, V22, P795, DOI 10.1080/13102818.2008.10817555
   Alikhani L, 2014, GENE, V552, P176, DOI 10.1016/j.gene.2014.09.034
   Amirmoradi B, 2012, PLANT SYST EVOL, V298, P1679, DOI 10.1007/s00606-012-0669-6
   Bhattacharyya P, 2013, GENE, V529, P21, DOI 10.1016/j.gene.2013.07.096
   Biswas MK, 2014, SCI HORTIC, V124, P254
   Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153
   Cabo S, 2014, J APPL GENET, V55, P307, DOI 10.1007/s13353-014-0211-3
   Chen Liya, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1343
   Collard BCY, 2009, PLANT MOL BIOL REP, V27, P86, DOI 10.1007/s11105-008-0060-5
   Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.1313/1-92559-287-7:141
   ESMAILPOUR A, 2001, COMPREHENSIVE DOCUME
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x
   FAO, 2006, FAOSTAT DAT
   Gorji AM, 2011, AM J POTATO RES, V88, P226, DOI 10.1007/s12230-011-9187-2
   [何新华 He Xinhua], 2005, [分子植物育种, Molecular Plant Breeding], V3, P829
   Horvath A, 2008, BOTANY, V86, P1311, DOI 10.1139/B08-097
   IPGRI, 1998, DESCR PIST SPP EXCL
   Iranjo P, 2016, J FORESTRY RES, V27, P685, DOI 10.1007/s11676-015-0098-9
   Joshi CP, 1997, PLANT MOL BIOL, V35, P993, DOI 10.1023/A:1005816823636
   Kalendar R, 1999, THEOR APPL GENET, V98, P704, DOI 10.1007/s001220051124
   Karimi HR, 2012, PLANT SYST EVOL, V298, P963, DOI 10.1007/s00606-012-0605-9
   Karimi HR, 2011, PLANT SYST EVOL, V297, P207, DOI 10.1007/s00606-011-0508-1
   Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479
   LANDRY BS, 1994, THEOR APPL GENET, V89, P847, DOI 10.1007/BF00224507
   Luo C, 2011, BIOCHEM SYST ECOL, V39, P676, DOI 10.1016/j.bse.2011.05.023
   MANTEL N, 1967, CANCER RES, V27, P209
   Milbourne D, 1997, MOL BREEDING, V3, P127, DOI 10.1023/A:1009633005390
   Milligan B.G., 1994, MOL ECOL, V12, P844
   Mulpuri S, 2013, PLANT SCI, V207, P117, DOI 10.1016/j.plantsci.2013.02.013
   NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269
   Pazouki L, 2010, CONSERV GENET, V11, P311, DOI 10.1007/s10592-009-9812-5
   Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x
   Poczai P, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-6
   Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200
   Pritchard JK, 2000, GENETICS, V155, P945
   Razavi S, 2006, ACTA HORTIC, P689, DOI 10.17660/ActaHortic.2006.726.118
   Rohlf F. J, 1993, NTSYS PC NUMERICAL T
   Sawant SV, 1999, J GENET, V78, P123, DOI 10.1007/BF02924562
   Schneider S, 2000, ARLEQUIN SOFTWARE PO
   Shanjani PS, 2009, TREE GENET GENOMES, V5, P447, DOI 10.1007/s11295-008-0198-1
   Shimada T, 1999, EUPHYTICA, V109, P143, DOI 10.1023/A:1003728201100
   Shimamura M, 1997, NATURE, V388, P666, DOI 10.1038/41759
   Sneller CH, 1997, CROP SCI, V37, P1595, DOI 10.2135/cropsci1997.0011183X003700050032x
   Soorni A, 2013, BIOCHEM SYST ECOL, V50, P438, DOI 10.1016/j.bse.2013.06.005
   Talebi M, 2012, BIOCHEM SYST ECOL, V44, P179, DOI 10.1016/j.bse.2012.05.013
   Techen N, 2004, CURR MED CHEM, V11, P1391, DOI 10.2174/0929867043365206
   VOYTAS DF, 1992, P NATL ACAD SCI USA, V89, P7124, DOI 10.1073/pnas.89.15.7124
   Xiong FQ, 2011, MOL BIOL REP, V38, P3487, DOI 10.1007/s11033-010-0459-6
   [熊发前 Xiong Faqian], 2009, [分子植物育种, Molecular Plant Breeding], V7, P635
   Yeh F., 1999, POPGENE MICROSOFT WI
   [余琪 YU Qi], 2009, [中草药, Chinese Traditional and Herbal Drugs], V40, P1296
NR 52
TC 13
Z9 13
U1 3
U2 20
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0006-2928
EI 1573-4927
J9 BIOCHEM GENET
JI Biochem. Genet.
PD AUG
PY 2016
VL 54
IS 4
BP 368
EP 387
DI 10.1007/s10528-016-9725-1
PG 20
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA DQ9MH
UT WOS:000379533500004
PM 27056191
DA 2018-12-27
ER

PT J
AU Sosan, R
   Azim, CF
AF Sosan, Raazia
   Azim, Choudhry Fahad
TI RETRACTED: Mobile Cloud Computing: The Taxonomy and Comparison of Mobile
   Cloud Computing Application Models (Retracted Article)
SO WIRELESS PERSONAL COMMUNICATIONS
LA English
DT Correction; Retracted Publication
C1 [Sosan, Raazia] Hamdard Univ, Muhammad Bin Qasim Ave, Karachi, Pakistan.
RP Sosan, R (reprint author), Hamdard Univ, Muhammad Bin Qasim Ave, Karachi, Pakistan.
EM raazia.sosan@hamdard.edu.pk; azim.fahad@gmail.com
CR SOSAN R, 2016, WIRELESS PERS COMMUN
NR 1
TC 2
Z9 3
U1 2
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0929-6212
EI 1572-834X
J9 WIRELESS PERS COMMUN
JI Wirel. Pers. Commun.
PD AUG
PY 2016
VL 89
IS 4
BP 1435
EP 1435
DI 10.1007/s11277-016-3339-0
PG 1
WC Telecommunications
SC Telecommunications
GA DQ6YV
UT WOS:000379354200022
OA Bronze
DA 2018-12-27
ER

PT J
AU Hada, A
   Rawat, S
   Krishnan, V
   Jolly, M
   Jeevaraj, T
   Manickavasagam, M
   Ganapathi, A
   Sachdev, A
   Grover, A
AF Hada, Alkesh
   Rawat, Sandhya
   Krishnan, Veda
   Jolly, Monica
   Jeevaraj, Theboral
   Manickavasagam, Markandan
   Ganapathi, Andy
   Sachdev, Archana
   Grover, Anita
TI RETRACTED: Overexpression of thaumatin gene confers enhanced resistance
   to Alternaria brassicae and tolerance to salinity and drought in
   transgenic Brassica juncea (L.) Czern (Retracted Article)
SO PLANT CELL TISSUE AND ORGAN CULTURE
LA English
DT Correction; Retracted Publication
C1 [Rawat, Sandhya; Grover, Anita] Natl Res Ctr Plant Biotechnol, New Delhi 110012, India.
   [Hada, Alkesh; Krishnan, Veda; Jolly, Monica; Sachdev, Archana] Indian Agr Res Inst, Div Biochem, New Delhi 110012, India.
   [Hada, Alkesh; Krishnan, Veda; Jeevaraj, Theboral; Manickavasagam, Markandan; Ganapathi, Andy] Bharathidasan Univ, Dept Biotechnol & Genet Engn, Tiruchchirappalli 620024, Tamil Nadu, India.
RP Grover, A (reprint author), Natl Res Ctr Plant Biotechnol, New Delhi 110012, India.; Ganapathi, A (reprint author), Bharathidasan Univ, Dept Biotechnol & Genet Engn, Tiruchchirappalli 620024, Tamil Nadu, India.
EM aganapathi2007@gmail.com; anita.plantbt@gmail.com
CR HADA A, PLANT CELL TISS ORGA
NR 1
TC 0
Z9 0
U1 4
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-6857
EI 1573-5044
J9 PLANT CELL TISS ORG
JI Plant Cell Tissue Organ Cult.
PD AUG
PY 2016
VL 126
IS 2
BP 371
EP 371
DI 10.1007/s11240-015-0846-8
PG 1
WC Biotechnology & Applied Microbiology; Plant Sciences
SC Biotechnology & Applied Microbiology; Plant Sciences
GA DQ6XT
UT WOS:000379350600016
OA Bronze
DA 2018-12-27
ER

PT J
AU Ghorannevis, Z
   Akbarnejad, E
   Elahi, AS
   Ghoranneviss, M
AF Ghorannevis, Z.
   Akbarnejad, E.
   Elahi, A. Salar
   Ghoranneviss, M.
TI RETRACTED: Application of RF magnetron sputtering for growth of AZO on
   glass substrate (Retracted article. See vol. 490, pg. 117, 2018)
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article; Retracted Publication
DE AZO; Magnetron sputtering; Transparent; Resistivity
ID PULSED-LASER DEPOSITION; ZNO-AL FILMS; OXIDE
AB Aluminum zinc oxide (AZO), as one of the most promising transparent conducting oxide (TCO) materials, has now been widely used in thin film solar cells. In this study the optimization process of the RF magnetron sputtered AZO films was performed at room temperature by studying its physical properties such as structural, optical, electrical and morphological at different deposition times (10, 20, 40 and 60 min) for its use as a front contact for the Cadmium Telluride (CdTe) based thin film solar cell applications. Influence of the deposition time was investigated on the physical properties of the AZO thin film by X-ray diffraction (XRD), atomic force microscopy (AFM), scanning electron microscopy (SEM), spectrophotometer and four point probes. XRD analysis suggests that the preferred orientation of grains for all the samples prepared at different growth times are along (002) plane having the hexagonal structure. From optical measurements the films show an average transmission over 60%. Moreover it was found that by increasing the growth time, which implies increasing the film thicknesses as well as improving the crystallinity the resistivity of the grown films decrease from the 10(-2) Omega cm to the order of 10(-3) Omega cm. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Ghorannevis, Z.] Islamic Azad Univ, Karaj Branch, Dept Phys, Karaj, Iran.
   [Akbarnejad, E.; Elahi, A. Salar; Ghoranneviss, M.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
RP Elahi, AS (reprint author), Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran.
EM Salari_phy@yahoo.com
FU Iran National Science Foundation (INSF)
FX The author also would like to thank Iran National Science Foundation
   (INSF) for their financial support of the project.
CR Chae GS, 2001, JPN J APPL PHYS 1, V40, P1282, DOI 10.1143/JJAP.40.1282
   Ilican S., 2007, MATER SCI-POLAND, V25, P3
   Kim H, 2001, APPL PHYS LETT, V79, P284, DOI 10.1063/1.1383568
   Klug H.P., 1954, XRAY DIFFRACTION PRO
   Matsubara K, 2003, THIN SOLID FILMS, V431, P369, DOI 10.1016/S0040-6090(03)00243-8
   Miorin E, 2011, J NANOSCI NANOTECHNO, V11, P2191, DOI 10.1166/jnn.2011.3542
   Oh BY, 2005, J CRYST GROWTH, V274, P453, DOI 10.1016/j.jcrysgro.2004.10.026
   Ray J.R., 2011, J NANO ELECT PHYS, P3
   Rozati SM, 2007, MATER CHARACT, V58, P319, DOI 10.1016/j.matchar.2006.05.012
   Schuler T, 2006, THIN SOLID FILMS, V502, P67, DOI 10.1016/j.tsf.2005.07.246
   Song DY, 2002, APPL SURF SCI, V195, P291, DOI 10.1016/S0169-4332(02)00611-6
   SWANEPOEL R, 1983, J PHYS E SCI INSTRUM, V16, P1214, DOI 10.1088/0022-3735/16/12/023
   Wei Wu H., 2013, P INT MULT ENG COMP, P2
   Zhang BP, 2004, THIN SOLID FILMS, V449, P12, DOI [10.1016/S0040-6090(03)01466-4, 10.1016/S0040-6090(03)014664-4]
   Zhu FR, 2000, THIN SOLID FILMS, V363, P314, DOI 10.1016/S0040-6090(99)01003-2
NR 15
TC 13
Z9 15
U1 4
U2 68
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
EI 1873-5002
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD AUG 1
PY 2016
VL 447
BP 62
EP 66
DI 10.1016/j.jcrysgro.2016.04.062
PG 5
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA DN2JQ
UT WOS:000376890300011
DA 2018-12-27
ER

PT J
AU Roy, K
   Sriramoju, B
   Kanwar, RK
   Kanwar, JR
AF Roy, Kislay
   Sriramoju, Bhasker
   Kanwar, Rupinder K.
   Kanwar, Jagat R.
TI RETRACTED: Ophthalmic Combination of SurR9-C84A and Trichostatin-A
   Targeting Molecular Pathogenesis of Alkali Burn(Retracted article.See
   vol.8, Artn No.426, 2017)
SO FRONTIERS IN PHARMACOLOGY
LA English
DT Article; Retracted Publication
DE alkali burn; survivin; trichostatin-A; clathrin; claudin; TGF-beta;
   alpha-SMA; cytokines
ID BURNED CORNEA; MYOFIBROBLAST DIFFERENTIATION; HISTONE DEACETYLASE;
   OCULAR SURFACE; RABBIT CORNEA; MITOMYCIN-C; TGF-BETA; EXPRESSION;
   SURVIVIN; CELLS
AB Background: Alkali burn is a frequently occurring ocular injury that resembles ocular inflammation caused by eye allergies, infection, and refractive surgeries.
   Methods: We investigated the synergistic regenerative potential of dominant negative survivin mutant (SurR9-C84A) and histone deacetylase (HDAC) inhibitor trichostatin-A (TSA) against alkali burn and corneal haze using human keratocytes and rabbit alkali burn model (Female New Zealand white rabbits).
   Results: Combination of SurR9-C84A and TSA suppressed levels of transforming growth factor (TGF)-beta, alpha smooth-muscle actin (alpha-SMA), fibronectin and HDAC1, leading to apoptosis in myofibroblast cells and, showed the potential to clear the corneal haze. An insult with 0.5 N NaOH for 1 min led to neutrophils infiltration and formation of large vacuoles in the stroma. Treatments with TSA and SurR9-C84A for 40 min led to improvement in the conjunctival and corneal tissue integrity, marked by an increase in clathrin, and claudin expressions. An increase in TGF-beta and endogenous survivin confirmed wound healing and cell proliferation in rabbit cornea. The blood analysis revealed a substantial decrease in the RBC, WBC, platelets, or the hemoglobin content post alkali burn. The cytokine array analysis revealed that NaOH induced expressions of IL-1 alpha and MMP-9, which were found to be significantly downregulated (1.8 and 11.5 fold respectively) by the combinatorial treatment of SurR9-C84A and TSA.
   Conclusion: Our results confirmed that combination of SurR9-C84A with TSA worked in synergy to heal ocular injury and inflammations due to alkali burn and led to the regeneration of ocular tissue by increasing clathrin, claudin, survivin, and TGF-beta and reversal of alkali burn by suppressing IL-1 alpha and MMP-9 without inducing haze.
C1 [Roy, Kislay; Sriramoju, Bhasker; Kanwar, Rupinder K.; Kanwar, Jagat R.] Deakin Univ, Fac Hlth, Ctr Mol & Med Res, Nanomed Lab Immunol & Mol Biomed Res,Sch Med, Geelong, Vic, Australia.
RP Kanwar, JR (reprint author), Deakin Univ, Fac Hlth, Ctr Mol & Med Res, Nanomed Lab Immunol & Mol Biomed Res,Sch Med, Geelong, Vic, Australia.
EM jagat.kanwar@deakin.edu.au
FU National Health and Medical Research Council (NHMRC) [APP1050286]
FX The authors would like to thank the National Health and Medical Research
   Council (NHMRC, APP1050286) grant funded to Professor JK, where Dr RK is
   an AI, for providing the funding for this project.
CR Ambrosone L, 2014, BIOMED RES INT, DOI 10.1155/2014/471642
   Anderson C, 2014, JOVE-J VIS EXP, DOI 10.3791/51159
   Baratchi S, 2010, J NEUROIMMUNOL, V227, P120, DOI 10.1016/j.jneuroim.2010.06.024
   Bhasker S, 2015, TOXICOL IN VITRO, V29, P917, DOI 10.1016/j.tiv.2015.01.007
   Biehl JW, 1999, MIL MED, V164, P780
   BROWN SI, 1970, ARCH OPHTHALMOL-CHIC, V83, P205
   BROWN SI, 1969, ARCH OPHTHALMOL-CHIC, V81, P370
   BRUBAKER RF, 1991, INVEST OPHTH VIS SCI, V32, P3145
   Chen M, 2010, MOL THER, V18, P519, DOI 10.1038/mt.2009.263
   Cheung CHA, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-36
   CINTRON C, 1988, INVEST OPHTH VIS SCI, V29, P767
   CINTRON C, 1981, CURR EYE RES, V1, P1, DOI 10.3109/02713688109019966
   Conners MS, 1997, INVEST OPHTH VIS SCI, V38, P1963
   Contreras-Ruiz L, 2012, CURR EYE RES, V37, P971, DOI 10.3109/02713683.2012.700756
   Crowe MJ, 2000, J INVEST DERMATOL, V115, P3, DOI 10.1046/j.1523-1747.2000.00010.x
   DANNENBERG AL, 1992, ARCH OPHTHALMOL-CHIC, V110, P843, DOI 10.1001/archopht.1992.01080180115038
   Fukuda M, 2004, JPN J OPHTHALMOL, V48, P93, DOI 10.1007/S10384-003-0033-z
   GNADINGE.MC, 1969, AM J OPHTHALMOL, V68, P478
   Gukasyan Hovhannes J., 2008, V7, P307
   Gupta R, 2011, VET OPHTHALMOL, V14, P304, DOI 10.1111/j.1463-5224.2011.00877.x
   He JC, 2006, ARCH OPHTHALMOL-CHIC, V124, P70, DOI 10.1001/archopht.124.1.70
   Horowitz JC, 2012, INT J BIOCHEM CELL B, V44, P158, DOI 10.1016/j.biocel.2011.10.011
   Jester JV, 2002, EXP EYE RES, V75, P645, DOI 10.1006/exer.2002.2066
   Kan CY, 2013, J BIOL CHEM, V288, P12032, DOI 10.1074/jbc.M112.447821
   Kanwar JR, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-7
   Kaufman HE, 2013, CORNEA, V32, P211, DOI 10.1097/ICO.0b013e3182541e9a
   Kemp MG, 2005, NUCLEIC ACIDS RES, V33, P325, DOI 10.1093/nar/gki177
   Kenyon K R, 1979, Int Ophthalmol Clin, V19, P169
   Kenyon K R, 1985, Trans Am Ophthalmol Soc, V83, P610
   KENYON KR, 1982, OPHTHALMOLOGY, V89, P44
   Kim YB, 1999, ANN NY ACAD SCI, V886, P200, DOI 10.1111/j.1749-6632.1999.tb09416.x
   Kitano A, 2010, MOL VIS, V16, P2964
   Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399
   Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018
   Kurosaka H, 1998, INVEST OPHTH VIS SCI, V39, P699
   Lefevre C, 1996, BIOCONJUGATE CHEM, V7, P482, DOI 10.1021/bc960034p
   Melki SA, 2001, SURV OPHTHALMOL, V46, P95, DOI 10.1016/S0039-6257(01)00254-5
   Netto MV, 2006, J REFRACT SURG, V22, P562
   NOVOTNY GEK, 1984, VIRCHOWS ARCH A, V404, P393, DOI 10.1007/BF00695223
   Okada Y, 2014, LAB INVEST, V94, P1030, DOI 10.1038/labinvest.2014.85
   Park HYL, 2013, AM J PATHOL, V182, P2147, DOI 10.1016/j.ajpath.2013.02.009
   Pattamatta U, 2013, CURR EYE RES, V38, P1110, DOI 10.3109/02713683.2013.811259
   Peltonen S, 2007, BRIT J DERMATOL, V156, P466, DOI 10.1111/j.1365-2133.2006.07642.x
   Penn JW, 2012, INT J BURNS TRAUMA, V2, P18
   Peponis V, 2010, LUPUS, V19, P675, DOI 10.1177/0961203309360539
   Qaddoumi MG, 2003, MOL VIS, V9, P559
   Querfeld C, 1999, J DERMATOL SCI, V21, P13, DOI 10.1016/S0923-1811(99)00008-0
   Roy K, 2015, RSC ADV, V5, P29008, DOI 10.1039/c5ra03791c
   Roy K, 2015, INT J NANOMED, V10, P1019, DOI 10.2147/IJN.S73916
   SAKAI J, 1991, EXP EYE RES, V52, P237, DOI 10.1016/0014-4835(91)90086-T
   SEREGARD S, 1994, GRAEF ARCH CLIN EXP, V232, P325, DOI 10.1007/BF00175983
   Sharma A, 2009, INVEST OPHTH VIS SCI, V50, P2695, DOI 10.1167/iovs.08-2919
   Sotozono C, 1997, CURR EYE RES, V16, P670, DOI 10.1076/ceyr.16.7.670.5057
   Sotozono C., 1998, CORNEAL HEALING RESP, P29
   Sriramoju B, 2014, INT J NANOMED, V9, P3279, DOI 10.2147/IJN.S60169
   Suzuki A, 2000, ONCOGENE, V19, P3225, DOI 10.1038/sj.onc.1203665
   Tsai TH, 2010, EYE, V24, P909, DOI 10.1038/eye.2009.179
   VRABEC F, 1975, A GRAEF ARCH KLIN EX, V197, P233, DOI 10.1007/BF00410868
   Yang JW, 2015, MOL MED REP, V11, P461, DOI 10.3892/mmr.2014.2722
   Yang LL, 2013, MOL PHARMACOL, V83, P671, DOI 10.1124/mol.112.081059
   Yokoo T, 1996, AM J PHYSIOL-RENAL, V270, pF123
   Zhang XH, 2008, CANCER BIOL THER, V7, P1390
   Zhang ZH, 2005, INVEST OPHTH VIS SCI, V46, P4062, DOI 10.1167/iovs.04-1330
NR 63
TC 2
Z9 2
U1 1
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1663-9812
J9 FRONT PHARMACOL
JI Front. Pharmacol.
PD JUL 28
PY 2016
VL 7
AR 226
DI 10.3389/fphar.2016.00226
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA DS3BP
UT WOS:000380658200001
PM 27516741
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Pouyaa, EA
   Rajabi, AA
AF Pouyaa, E. Ahmadi
   Rajabi, A. A.
TI RETRACTED: Six-body bound system calculations in the case of effective
   alpha-core structure(Retracted article. See vol 132, artn no 419, 2017)
SO EUROPEAN PHYSICAL JOURNAL PLUS
LA English
DT Article; Retracted Publication
ID YAKUBOVSKY EQUATIONS; STATE CALCULATIONS; BINDING-ENERGIES; PARTICLE;
   FORCE; DECOMPOSITION; HE-4
AB The Yakubovsky formalism for the six-nucleon bound-state problem leads to five coupled equations in terms of five independent structures, which can be reduced to two coupled ones, for the case of effective 3-body model, namely alpha-core, and two loosely bound neutrons. In order to calculate the binding energy of the six-nucleon bound system, the reduced coupled Yakubovsky equations are represented in momentum space for a separable nucleon-nucleon interaction. This is the first step toward the calculations of the six-nucleon bound-state problem in the Yakubovsky approach. Comparison of our numerical results for binding energies of six-nucleon and four-nucleon problems with respect to the regarded Yamaguchi separable potential confirms that the six-nucleon bound system, in the case of effective alpha-core structure, is a halo structure.
C1 [Pouyaa, E. Ahmadi; Rajabi, A. A.] Shahrood Univ Technol, Dept Phys, POB 3619995161-316, Shahrood, Iran.
RP Pouyaa, EA (reprint author), Shahrood Univ Technol, Dept Phys, POB 3619995161-316, Shahrood, Iran.
EM E.Ahmady.ph@ut.ac.ir; A.A.Rajabi@shahroodut.ac.ir
CR Bacca S, 2009, EUR PHYS J A, V42, P553, DOI 10.1140/epja/i2009-10815-5
   Elster C, 1999, FEW-BODY SYST, V27, P83, DOI 10.1007/s006010050124
   FONSECA AC, 1984, PHYS REV C, V30, P35, DOI 10.1103/PhysRevC.30.35
   Gattobigio M, 2011, FEW-BODY SYST, V50, P463, DOI 10.1007/s00601-010-0154-0
   GIBSON BF, 1977, PHYS REV C, V15, P2257, DOI 10.1103/PhysRevC.15.2257.2
   GLOCKLE W, 1993, NUCL PHYS A, V560, P541, DOI 10.1016/0375-9474(93)90113-C
   GLOCKLE W, 1993, PHYS REV LETT, V71, P971, DOI 10.1103/PhysRevLett.71.971
   Glockle W, 2011, FEW-BODY SYST, V51, P27, DOI 10.1007/s00601-011-0217-x
   Hadizadeh MR, 2007, FEW-BODY SYST, V40, P171, DOI 10.1007/s00601-006-0169-8
   Hagen G, 2007, PHYS LETT B, V656, P169, DOI 10.1016/j.physletb.2007.07.072
   Huber D, 1997, FEW-BODY SYST, V22, P107, DOI 10.1007/s006010050057
   Jurgenson E. D., 2010, ARXIVNUCLTH10114085
   KAMADA H, 1992, PHYS LETT B, V292, P1, DOI 10.1016/0370-2693(92)90598-X
   Kamada H, 2001, PHYS REV C, V64, DOI 10.1103/PhysRevC.64.044001
   KAMADA H, 1992, NUCL PHYS A, V548, P205, DOI 10.1016/0375-9474(92)90009-9
   Kamada H., 1994, FEW-BODY SYST      S, V7, P217
   KHARCHEN.VF, 1972, NUCL PHYS B, VA018, P606
   Luu T. C., 2004, ARXIVNUCLTH0412109
   NARODETSKY IM, 1973, PHYS LETT B, VB 46, P51, DOI 10.1016/0370-2693(73)90473-5
   Nogga A, 2006, PHYS REV C, V73, DOI 10.1103/PhysRevC.73.064002
   Nogga A, 2002, PHYS REV C, V65, DOI 10.1103/PhysRevC.65.054003
   Nogga A, 2000, PHYS REV LETT, V85, P944, DOI 10.1103/PhysRevLett.85.944
   Nogga A., 2006, ARXIVNUCLTH0611081
   Plater L., 2005, ARXIVNUCLTH0511003V1
   Platter L, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052101
   PUDLINER BS, 1995, PHYS REV LETT, V74, P4396, DOI 10.1103/PhysRevLett.74.4396
   Rozpedzik D, 2006, ACTA PHYS POL B, V37, P2889
   STADLER A, 1991, PHYS REV C, V44, P2319, DOI 10.1103/PhysRevC.44.2319
   VARGA K, 1994, PHYS REV C, V50, P189, DOI 10.1103/PhysRevC.50.189
NR 29
TC 3
Z9 3
U1 2
U2 5
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-5444
J9 EUR PHYS J PLUS
JI Eur. Phys. J. Plus
PD JUL 25
PY 2016
VL 131
IS 7
AR 240
DI 10.1140/epjp/i2016-16240-2
PG 14
WC Physics, Multidisciplinary
SC Physics
GA EN4AW
UT WOS:000395950700002
DA 2018-12-27
ER

PT J
AU Fan, Y
   Wang, YF
   Su, HF
   Fang, N
   Zou, C
   Li, WF
   Fei, ZH
AF Fan, Yu
   Wang, Yan-fen
   Su, Hua-fang
   Fang, Na
   Zou, Chen
   Li, Wen-feng
   Fei, Zheng-hua
TI RETRACTED: Decreased expression of the long noncoding RNA LINC00261
   indicate poor prognosis in gastric cancer and suppress gastric cancer
   metastasis by affecting the epithelial-mesenchymal transition(Retracted
   article. See vol. 11, art no 2, 2018)
SO JOURNAL OF HEMATOLOGY & ONCOLOGY
LA English
DT Article; Retracted Publication
DE LINC00261; Metastasis; Prognosis; Gastric cancer
ID PROSTATE-CANCER; UP-REGULATION; CELLS; TRANSCRIPTS; TRANSITIONS;
   CARCINOMA; APOPTOSIS; PROMOTES; INVASION; FEATURES
AB Background: Recent evidence indicates that long noncoding RNAs (lncRNAs) play pivotal roles in the regulation of cellular processes and are found to be dysregulated in a variety of cancers. LINC00261 is an lncRNA that is aberrantly expressed in gastric cancer (GC). The clinical role of LINC00261 in GC and molecular mechanisms remains to be found.
   Methods: Real-time polymerase chain reaction (PCR) was used to examine LINC00261 expression in GC cell lines/tissues compared with normal epithelial cells/adjacent non-tumorous tissues. Gain and loss of function approaches were used to investigate the biological role of LINC00261 in GC cells. The effects of LINC00261 on cell viability were evaluated by MTT and colony formation assays. Wound healing assay, cell migration and invasion assays, and nude mice were used to examine the effects of LINC00261 on tumor cell metastasis in vitro and in vivo. Protein levels of LINC00261 targets were determined by western blot and immunohistochemistry.
   Results: LINC00261 was downregulated in GC cell lines and cancerous tissues, as compared with normal gastric epithelial cells and adjacent noncancerous tissue samples. Low LINC00261 expression was correlated with deeper tumor invasion (P < 0.001), higher tumor stage (P = 0.013), and lymphatic metastasis (P = 0.006). Univariate and multivariate analyses indicated that low LINC00261 expression predicted poor prognosis. Ectopic expression of LINC00261 impaired cell migration and invasion, leading to the inhibition of metastasis in vitro and in vivo. Knockdown of LINC00261 expression promoted cell migration and invasion in vitro. Overexpression of LINC00261 was found to play a key role in epithelial-mesenchymal transition (EMT) through the regulation of E-cadherin, N-cadherin, and Vimentin expression.
   Conclusions: Low expression of the lncRNA LINC00261 occurs in GC and is associated with poor prognosis. LINC00261 suppresses GC metastasis by regulating EMT. Thus, LINC00261 plays an important role in the progression and metastasis of GC.
C1 [Fan, Yu; Fang, Na; Zou, Chen] Jiangsu Univ, Affiliated Peoples Hosp, Inst Canc, Zhenjiang 212002, Jiangsu, Peoples R China.
   [Wang, Yan-fen] Yangzhou Univ, Clin Med Coll 2, Peoples Hosp Yangzhou 1, Dept Pathol, Yangzhou 225000, Jiangsu, Peoples R China.
   [Su, Hua-fang; Li, Wen-feng; Fei, Zheng-hua] Wenzhou Med Univ, Affiliated Hosp 1, Radiotherapy & Chemotherapy Dept, 2 Fuxue Lane, Wenzhou 325000, Peoples R China.
RP Fei, ZH (reprint author), Wenzhou Med Univ, Affiliated Hosp 1, Radiotherapy & Chemotherapy Dept, 2 Fuxue Lane, Wenzhou 325000, Peoples R China.
EM hui-y@163.com
FU Jiangsu provincial key RD special Fund [BE2015666]
FX The design of the study and collection, analysis, and interpretation of
   data and in writing the manuscript was supported by the Jiangsu
   provincial key R&D special Fund (BE2015666).
CR Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x
   De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447
   Guo F, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-19
   Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931
   Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473
   Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391
   Li T, 2016, ONCOGENE, V35, P1575, DOI 10.1038/onc.2015.223
   Liu F, 2016, ONCOGENE, V35, P5422, DOI 10.1038/onc.2016.80
   Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160
   Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710
   Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x
   Muers M, 2011, NAT REV GENET, V12, DOI 10.1038/nrg3088
   Pang KC, 2007, NUCLEIC ACIDS RES, V35, pD178, DOI 10.1093/nar/gkl926
   Ponting CP, 2010, HUM MOL GENET, V19, pR162, DOI 10.1093/hmg/ddq362
   Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006
   Qi P, 2013, MODERN PATHOL, V26, P155, DOI 10.1038/modpathol.2012.160
   Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221
   Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI 10.3322/caac.21332
   Smith AD, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0070-8
   Srikantan V, 2000, P NATL ACAD SCI USA, V97, P12216, DOI 10.1073/pnas.97.22.12216
   Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967
   Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008
   Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007
   Wang WT, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0086-0
   Wang Xiao-Na, 2010, Chin J Cancer, V29, P369
   Xu TP, 2015, ONCOGENE, V34, P5648, DOI 10.1038/onc.2015.18
   Xu TP, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0063-7
   Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010
   Zhao J, 2015, CELL CYCLE, V14, P3112, DOI 10.1080/15384101.2015.1078034
NR 29
TC 33
Z9 37
U1 5
U2 16
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-8722
J9 J HEMATOL ONCOL
JI J. Hematol. Oncol.
PD JUL 21
PY 2016
VL 9
AR 57
DI 10.1186/s13045-016-0288-8
PG 15
WC Oncology; Hematology
SC Oncology; Hematology
GA DS0WF
UT WOS:000380316800001
PM 27439973
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Bao, YY
   Huang, YZ
   Lam, ML
   Xu, T
   Zhu, NH
   Guo, ZB
   Cui, X
   Lam, RHW
   Chen, TH
AF Bao, Yuanye
   Huang, Yaozhun
   Lam, Miu Ling
   Xu, Ting
   Zhu, Ninghao
   Guo, Zhaobin
   Cui, Xin
   Lam, Raymond H. W.
   Chen, Ting-Hsuan
TI RETRACTED: Substrate Stiffness Regulates the Development of Left-Right
   Asymmetry in Cell Orientation (Retracted article. See vol. 10, pg.
   25831, 2018)
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article; Retracted Publication
DE stiffness; micropatterning; left-right asymmetry; cell chirality; cell
   orientation; migration
ID UNCONVENTIONAL MYOSIN; TISSUE MORPHOGENESIS; SELF-ORGANIZATION;
   MIGRATION; ADHESION; CHIRALITY; ACTIN; STRESS; MATRIX; DIFFERENTIATION
AB Left-right (LR) asymmetry of tissue/organ structure is a morphological feature essential for many tissue functions. The ability to incorporate the LR formation in constructing tissue/organ replacement is important for recapturing the inherent tissue structure and functions. However, how LR asymmetry is formed remains largely underdetermined, which creates significant hurdles to reproduce and regulate the formation of LR asymmetry in an engineering context. Here, we report substrate rigidity functioning as an effective switch that turns on the development of LR asymmetry. Using micropatterned cell-adherent stripes on rigid substrates, we found that cells collectively oriented at a LR-biased angle relative to the stripe boundary. This LR asymmetry was initiated by a LR-biased migration of cells at stripe boundary, which later generated a velocity gradient propagating from stripe boundary to the center. After a series of cell translocations and rotations, ultimately, an LR-biased cell orientation within the micropatterned stripe was formed. Importantly, this initiation and propagation of LR asymmetry was observed only on rigid but not on soft substrates, suggesting that the LR asymmetry was regulated by rigid substrate probably through the organization of actin cytoskeleton. Together, we demonstrated substrate rigidity as a determinant factor that mediates the self-organizing LR asymmetry being unfolded from single cells to multicellular organization. More broadly, we anticipate that our findings would pave the way for rebuilding artificial tissue constructs with inherent LR asymmetry in the future.
C1 [Bao, Yuanye; Huang, Yaozhun; Xu, Ting; Zhu, Ninghao; Guo, Zhaobin; Cui, Xin; Lam, Raymond H. W.; Chen, Ting-Hsuan] City Univ Hong Kong, Dept Mech & Biomed Engn, 83 Tat Chee Ave, Hong Kong, Hong Kong, Peoples R China.
   [Lam, Miu Ling; Chen, Ting-Hsuan] City Univ Hong Kong, Sch Creat Media, 83 Tat Chee Ave, Hong Kong, Hong Kong, Peoples R China.
   [Lam, Miu Ling; Lam, Raymond H. W.; Chen, Ting-Hsuan] City Univ Hong Kong, Ctr Robot & Automat, 83 Tat Chee Ave, Hong Kong, Hong Kong, Peoples R China.
   [Lam, Miu Ling; Lam, Raymond H. W.; Chen, Ting-Hsuan] CityU Shenzhen Res Inst, Shenzhen 518057, Peoples R China.
RP Lam, ML (reprint author), City Univ Hong Kong, Sch Creat Media, 83 Tat Chee Ave, Hong Kong, Hong Kong, Peoples R China.; Lam, ML (reprint author), City Univ Hong Kong, Ctr Robot & Automat, 83 Tat Chee Ave, Hong Kong, Hong Kong, Peoples R China.; Lam, ML (reprint author), CityU Shenzhen Res Inst, Shenzhen 518057, Peoples R China.
EM miu.lam@cityu.edu.hk; thchen@cityu.edu.hk
RI CUI, Xin/M-5331-2016
OI LAM, Miu Ling/0000-0002-5333-7454
FU National Natural Science Foundation of China [51305375]; Hong Kong
   Research Grants Council [21214815]; Croucher Foundation [9500016];
   Science Technology and Innovation Committee of Shenzhen Municipality
   [JCYJ20150601102053061]
FX We acknowledge the support from the National Natural Science Foundation
   of China (Grant No. 51305375), Early Career Scheme of Hong Kong Research
   Grants Council (Grant No. 21214815), Croucher Foundation (Grant No.
   9500016), and the Science Technology and Innovation Committee of
   Shenzhen Municipality (Grant No. JCYJ20150601102053061).
CR Aw S, 2008, DEV DYNAM, V237, P3453, DOI 10.1002/dvdy.21560
   Chen TH, 2012, BIOMATERIALS, V33, P9019, DOI 10.1016/j.biomaterials.2012.08.067
   Chen TH, 2012, CIRC RES, V110, P551, DOI 10.1161/CIRCRESAHA.111.255927
   Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2
   Danilchik MV, 2006, DEVELOPMENT, V133, P4517, DOI 10.1242/dev.02642
   Desai RA, 2009, J CELL SCI, V122, P905, DOI 10.1242/jcs.028183
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dokukina IV, 2010, BIOPHYS J, V98, P2794, DOI 10.1016/j.bpj.2010.03.026
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Even-Ram S, 2006, CELL, V126, P645, DOI 10.1016/j.cell.2006.08.008
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029
   Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093
   Hozumi S, 2006, NATURE, V440, P798, DOI 10.1038/nature04625
   Ishizaki T, 2000, MOL PHARMACOL, V57, P976
   Junkin M, 2011, J CELL SCI, V124, P4213, DOI 10.1242/jcs.088898
   Lam RHW, 2012, LAB CHIP, V12, P1865, DOI 10.1039/c2lc21146g
   Lobikin M, 2012, P NATL ACAD SCI USA, V109, P12586, DOI 10.1073/pnas.1202659109
   Noel ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3754
   Obi S, 2012, AM J PHYSIOL-CELL PH, V303, pC595, DOI 10.1152/ajpcell.00133.2012
   Pohl C, 2010, DEV CELL, V19, P402, DOI 10.1016/j.devcel.2010.08.014
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   Singh AV, 2014, ACS NANO, V8, P2196, DOI 10.1021/nn405253d
   Sniadecki NJ, 2007, P NATL ACAD SCI USA, V104, P14553, DOI 10.1073/pnas.0611613104
   Speder P, 2006, NATURE, V440, P803, DOI 10.1038/nature04623
   STREETER DD, 1969, CIRC RES, V24, P339, DOI 10.1161/01.RES.24.3.339
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Taniguchi K, 2011, SCIENCE, V333, P339, DOI 10.1126/science.1200940
   Tee YH, 2015, NAT CELL BIOL, V17, P445, DOI 10.1038/ncb3137
   Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087
   Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172
   Veerkamp J, 2013, DEV CELL, V24, P660, DOI 10.1016/j.devcel.2013.01.026
   Wan LQ, 2011, P NATL ACAD SCI USA, V108, P12295, DOI 10.1073/pnas.1103834108
   Wang Y, 2012, BURNS, V38, P414, DOI 10.1016/j.burns.2011.09.002
   Worley KE, 2015, INTEGR BIOL-UK, V7, P580, DOI 10.1039/c5ib00073d
   Xu JS, 2007, P NATL ACAD SCI USA, V104, P9296, DOI 10.1073/pnas.0703153104
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 42
TC 6
Z9 6
U1 3
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD JUL 20
PY 2016
VL 8
IS 28
BP 17976
EP 17986
DI 10.1021/acsami.6b06789
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA DS0PE
UT WOS:000380298400025
PM 27359036
OA Bronze
DA 2018-12-27
ER

PT J
AU Kushwah, BS
   Kushwah, AVS
   Singh, V
AF Kushwah, Brajesh Singh
   Kushwah, Aeshwary Vikram Singh
   Singh, Vishwajeet
TI RETRACTED: Towards understanding polyhydroxyalkanoates and their
   use(Retracted article. See vol.24, pg.0, 2017)
SO JOURNAL OF POLYMER RESEARCH
LA English
DT Article; Retracted Publication
DE Polymers; Polyhydroxyalkanoates(PHAs)
ID MECHANICAL-PROPERTIES; THERMAL-DEGRADATION; POLYMER BLENDS;
   POLY(-(D)-BETA-HYDROXYBUTYRIC ACID); BACTERIAL POLY(3-HYDROXYBUTYRATE);
   ALIPHATIC POLYESTERS; RENEWABLE RESOURCES; PHYSICAL-PROPERTIES;
   CELLULOSE-ACETATE; MOLECULAR-WEIGHT
AB It is fact that Polymers and their products have changed the face of the world in all the field of the technology. They are the future of the coming up generation of the research of the world. But this is also fact that these synthetic non biodegradable polymers have created a tough situation for the living being for a healthy life. Polyhydroxyalkanoates are polyesters produced by bacteria as intracellular storage materials in response to a variety of nutritional and environmental conditions, such as nitrogen limitation Polyhydroxyalkanoates (PHAs) are gaining increasing attention in the biodegradable polymer market due to their promising properties such as high biodegradability in different environments, not just in composting plants, and processing versatility. Indeed among biopolymers, these biogenic polyesters represent a potential sustainable replacement for fossil fuel-based thermoplastics. Most commercially available PHAs are obtained with pure microbial cultures grown on renewable feedstocks (i.e.glucose) under sterile conditions but recent research studies focus on the use of wastes as growth media.PHA can be extracted from the bacteria cell and then formulated and processed by extrusion for production of rigid and flexible plastic suitable not just for the most assessed medical applications but also considered for applications including packaging, moulded goods, paper coatings, non-oven fabrics, adhesives, films and performance additives. The present paper reviews the PHAs, their main properties, processing aspects, commercially available ones, as well as limitations and related improvements being researched,with specific focus on potential applications of PHAs in packaging.
C1 [Kushwah, Brajesh Singh] Raja Balwant Singh Engn Tech Campus, Dept Mech Engn, Fac Engn & Technol, Agra, Uttar Pradesh, India.
   [Kushwah, Brajesh Singh] APJ Abdul Kalam Tech Univ, Lucknow, Uttar Pradesh, India.
   [Kushwah, Aeshwary Vikram Singh] Monash Univ, Dept Mech Engn, Melbourne, Vic 3800, Australia.
   [Kushwah, Aeshwary Vikram Singh] New Era Res Fdn, R&D Div, Agra, Uttar Pradesh, India.
   [Singh, Vishwajeet] Raja Balwant Singh Coll, Dept Bot, Agra, Uttar Pradesh, India.
   [Singh, Vishwajeet] Dr BR Ambedkar Univ, Agra, Uttar Pradesh, India.
RP Kushwah, BS (reprint author), Raja Balwant Singh Engn Tech Campus, Dept Mech Engn, Fac Engn & Technol, Agra, Uttar Pradesh, India.; Kushwah, BS (reprint author), APJ Abdul Kalam Tech Univ, Lucknow, Uttar Pradesh, India.
EM b_kushwah@rediffmail.com; aeshwary.kushwah@outlook.com;
   officervishu@gmail.com
FU DST Nanomission
FX Authors acknowledge the financial support from the DST Nanomission and
   to the Director and Principal of RBS College, Agra for facilities.
CR ABE H, 1994, MACROMOLECULES, V27, P6012, DOI 10.1021/ma00099a012
   Ahmed T, 2010, BIOMACROMOLECULES, V11, P2707, DOI 10.1021/bm1007579
   Androsch R, 2008, POLYMER, V49, P4673, DOI 10.1016/j.polymer.2008.08.026
   Avella M, 2000, J MATER SCI, V35, P523, DOI 10.1023/A:1004740522751
   AVELLA M, 1993, POLYMER, V34, P3234, DOI 10.1016/0032-3861(93)90396-R
   Averous L, 2006, CARBOHYD POLYM, V66, P480, DOI 10.1016/j.carbpol.2006.04.004
   Bhatt R, 2011, RSC GREEN CHEM SER, P311
   Biron M, 2013, PDL HANDB SER, P31, DOI 10.1016/B978-1-4557-7898-0.00002-0
   Blandl H, 1990, ADV BIOCHEM ENG BIOT, V41, P77
   Boopathy R, 2000, BIORESOURCE TECHNOL, V74, P63, DOI 10.1016/S0960-8524(99)00144-3
   Bordes P, 2009, POLYM DEGRAD STABIL, V94, P789, DOI 10.1016/j.polymdegradstab.2009.01.027
   Bucci DZ, 2005, POLYM TEST, V24, P564, DOI 10.1016/j.polymertesting.2005.02.008
   Bugnicourt E, 2014, EXPRESS POLYM LETT, V8, P791, DOI 10.3144/expresspolymlett.2014.82
   Bugnicourt E, 2013, ADV MATER SCI ENG, DOI 10.1155/2013/496207
   CABALLERO KP, 1995, INT J BIOL MACROMOL, V17, P86, DOI 10.1016/0141-8130(95)93522-Y
   Calabia BP, 2004, BIOTECHNOL LETT, V26, P15, DOI 10.1023/B:BILE.0000009453.81444.51
   CECCORULLI G, 1993, MACROMOLECULES, V26, P6722, DOI 10.1021/ma00077a005
   Chen GQ, 2011, ADV BIOCHEM ENG BIOT, V125, P29, DOI 10.1007/10_2010_89
   Choi HJ, 1997, MACROMOL SYMP, V119, P149, DOI 10.1002/masy.19971190115
   Choi HJ, 1999, POLYMER, V40, P4135, DOI 10.1016/S0032-3861(98)00627-2
   CHOWDHURY AA, 1963, ARCH MIKROBIOL, V47, P167, DOI 10.1007/BF00422523
   Cinelli P., 2012, PROCEEDINGS OF 3RD I, P8
   Correa MCS, 2012, J POLYM ENVIRON, V20, P283, DOI 10.1007/s10924-011-0379-0
   Dawes E A, 1973, Adv Microb Physiol, V10, P135, DOI 10.1016/S0065-2911(08)60088-0
   de Oliveira PS, 2013, J APPL POLYM SCI, V127, P3613, DOI [10.1002/app.37811, DOI 10.1002/APP.37811]
   DEKONING GJM, 1993, POLYMER, V34, P4089, DOI 10.1016/0032-3861(93)90671-V
   Di Lorenzo ML, 2006, POLYM BULL, V57, P713, DOI 10.1007/s00289-006-0621-4
   Di Lorenzo ML, 2012, MACROMOLECULES, V45, P5684, DOI 10.1021/ma3010907
   Di Lorenzo ML, 2001, J MACROMOL SCI PHYS, VB40, P639
   Dikgang J, 2012, RESOUR CONSERV RECY, V66, P59, DOI 10.1016/j.resconrec.2012.06.009
   DOI Y, 1994, STUD POLYM SCI, V12, P39
   Donth E. J., 1992, RELAXATION THERMODYN
   Duarte Marcia Adriana Tomaz, 2006, Mat. Res., V9, P25, DOI 10.1590/S1516-14392006000100006
   El-Hadi A, 2002, POLYM TEST, V21, P665, DOI 10.1016/S0142-9418(01)00142-8
   Erceg M, 2005, POLYM DEGRAD STABIL, V90, P313, DOI 10.1016/j.polymdegradstab.2005.04.048
   GASSNER F, 1994, POLYMER, V35, P2233, DOI 10.1016/0032-3861(94)90258-5
   Gazzano M, 2012, J POLYM SCI POL PHYS, V50, P1463, DOI 10.1002/polb.23147
   GOGOLEWSKI S, 1993, POLYM DEGRAD STABIL, V40, P313, DOI 10.1016/0141-3910(93)90137-8
   GRASSIE N, 1984, POLYM DEGRAD STABIL, V6, P47, DOI 10.1016/0141-3910(84)90016-8
   GRASSIE N, 1984, POLYM DEGRAD STABIL, V6, P95, DOI 10.1016/0141-3910(84)90075-2
   Harasawa I, 1980, U.S. Patent, Patent No. [4235043 A, USA, 4235043]
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   Hong SG, 2013, J THERM ANAL CALORIM, V111, P1243, DOI 10.1007/s10973-012-2503-3
   Innocentini-Mei LH, 2003, MACROMOL SYMP, V197, P77, DOI 10.1002/masy.200350708
   Johnstone B., 1990, FAR EASTERN ECONOMIC, V147, P62
   Kedia G, 2014, BIOTECHNOL BIOPROC E, V19, P989, DOI 10.1007/s12257-014-0144-z
   Koller M, 2014, CHEM BIOCHEM ENG Q, V28, P65
   Koller Martin, 2015, Bioengineering-Basel, V2, P94, DOI 10.3390/bioengineering2020094
   Kosior E., 2006, LIGHTWEIGHT COMPOSTA
   Koyama N, 1997, POLYMER, V38, P1589, DOI 10.1016/S0032-3861(96)00685-4
   KUMAGAI Y, 1992, POLYM DEGRAD STABIL, V37, P253, DOI 10.1016/0141-3910(92)90167-4
   Laycock B, 2013, PROG POLYM SCI, V38, P536, DOI 10.1016/j.progpolymsci.2012.06.003
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Lee SY, 1996, TRENDS BIOTECHNOL, V14, P431, DOI 10.1016/0167-7799(96)10061-5
   Lepoittevin B, 2002, POLYMER, V43, P4017, DOI 10.1016/S0032-3861(02)00229-X
   Meneses Juliana, 2007, Rev.EIA.Esc.Ing.Antioq, V0, P57
   Mergaert J, 1996, J IND MICROBIOL BIOT, V17, P463, DOI 10.1007/BF01574777
   Miguel O, 1997, J APPL POLYM SCI, V64, P1849
   Misra SK, 2010, ACTA BIOMATER, V6, P735, DOI 10.1016/j.actbio.2009.09.023
   MITOMO H, 1988, POLYM COMMUN, V29, P112
   Modi S. J, 2010, THESIS
   Modi S, 2011, EUR POLYM J, V47, P179, DOI 10.1016/j.eurpolymj.2010.11.010
   Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916
   Mulder KF, 1998, TECHNOL FORECAST SOC, V58, P105, DOI 10.1016/S0040-1625(97)00129-7
   Mutha NH, 2006, RESOUR CONSERV RECY, V47, P222, DOI 10.1016/j.resconrec.2005.09.003
   Nishida H., 1993, J ENV POLYM DEGRADE, V1, P227, DOI DOI 10.1007/BF01458031
   Noda I, 1999, POLYM DATA HDB
   PAGLIA ED, 1993, POLYMER, V34, P996, DOI 10.1016/0032-3861(93)90220-5
   Park JW, 2005, MACROMOLECULES, V38, P2345, DOI 10.1021/ma0481611
   Parra DF, 2006, POLYM DEGRAD STABIL, V91, P1954, DOI 10.1016/j.polymdegradstab.2006.02.008
   PIZZOLI M, 1994, MACROMOLECULES, V27, P4755, DOI 10.1021/ma00095a016
   Qiu YZ, 2005, BIOTECHNOL LETT, V27, P1381, DOI 10.1007/s10529-005-3685-6
   Reddy CSK, 2003, BIORESOURCE TECHNOL, V87, P137, DOI 10.1016/S0960-8524(02)00212-2
   Rizk S, 2013, U.S. patent, Patent No. [20130309166, USA, 20130309166]
   Rodrigues JAFR, 2005, J THERM ANAL CALORIM, V79, P379, DOI 10.1007/s10973-005-0069-z
   Sanchez JG, 2000, BIOTECHNOL LETT, V22, P849, DOI 10.1023/A:1005603112688
   Scaffaro R, 2012, J POLYM ENVIRON, V20, P267, DOI 10.1007/s10924-011-0385-2
   Scandola M, 1997, MACROMOLECULES, V30, P2568, DOI 10.1021/ma961431y
   SCANDOLA M, 1992, MACROMOLECULES, V25, P6441, DOI 10.1021/ma00050a009
   SCANDOLA M, 1990, INT J BIOL MACROMOL, V12, P112, DOI 10.1016/0141-8130(90)90062-F
   Schick C, 2002, THERMOCHIM ACTA, V392, P303, DOI 10.1016/S0040-6031(02)00116-8
   SHARMA R, 1995, J MACROMOL SCI R M C, VC35, P327
   Shen L, 2009, PRODUCT OVERVIEW MAR
   Singh S, 2007, COMPOS SCI TECHNOL, V67, P1753, DOI 10.1016/j.compscitech.2006.11.009
   Suyama T, 1998, APPL ENVIRON MICROB, V64, P5008
   Tan GYA, 2014, POLYMERS-BASEL, V6, P706, DOI 10.3390/polym6030706
   TOKIWA Y, 1992, MAKROMOL CHEM-M SYMP, V57, P273, DOI 10.1002/masy.19920570125
   Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722
   Tseng M, 2007, BIODEGRADATION, V18, P579, DOI 10.1007/s10532-006-9089-z
   Varsha YM, 2011, J MICROBIAL BIOCH TE, V3, P99, DOI [10.4172/1948-5948.1000059, DOI 10.4172/1948-5948.1000059]
   Wang LA, 2008, J APPL POLYM SCI, V107, P166, DOI 10.1002/app.27004
   Whitehouse RSs, 2011, World Patent, Patent No. [WO 2011031558 A3, 2011031558]
   Wunderlich B, 2003, PROG POLYM SCI, V28, P383, DOI 10.1016/S0079-6700(02)00085-0
   Yu L, 2006, PROG POLYM SCI, V31, P576, DOI 10.1016/j.progpolymsci.2006.03.002
   Zhang LL, 1997, POLYMER, V38, P6001, DOI 10.1016/S0032-3861(97)00158-4
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
   Zhu CJ, 2012, POLYM TEST, V31, P579, DOI 10.1016/j.polymertesting.2012.03.004
NR 97
TC 10
Z9 10
U1 3
U2 52
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
EI 1572-8935
J9 J POLYM RES
JI J. Polym. Res.
PD JUL 19
PY 2016
VL 23
IS 8
AR 153
DI 10.1007/s10965-016-0988-3
PG 14
WC Polymer Science
SC Polymer Science
GA DR9SG
UT WOS:000380235800001
DA 2018-12-27
ER

PT J
AU Mohanty, S
   Gianni, C
   Mohanty, P
   Halbfass, P
   Metz, T
   Trivedi, C
   Deneke, T
   Tomassoni, G
   Bai, R
   Al-Ahmad, A
   Bailey, S
   Burkhardt, JD
   Gallinghouse, GJ
   Horton, R
   Hranitzky, PM
   Sanchez, JE
   Di Biase, L
   Natale, A
AF Mohanty, Sanghamitra
   Gianni, Carola
   Mohanty, Prasant
   Halbfass, Philipp
   Metz, Tamara
   Trivedi, Chintan
   Deneke, Thomas
   Tomassoni, Gery
   Bai, Rong
   Al-Ahmad, Amin
   Bailey, Shane
   Burkhardt, John David
   Gallinghouse, G. Joseph
   Horton, Rodney
   Hranitzky, Patrick M.
   Sanchez, Javier E.
   Di Biase, Luigi
   Natale, Andrea
TI RETRACTED: Impact of Rotor Ablation in Nonparoxysmal Atrial Fibrillation
   Patients Results From the Randomized OASIS Trial(Retracted article. See
   vol.68,pg.1608,2016)
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article; Retracted Publication
DE FIRM-guided ablation; nonparoxysmal AF; non-PV triggers; PVAI; rotors
ID PULMONARY VEIN ISOLATION; CATHETER ABLATION; LINEAR ABLATION; FOCAL
   IMPULSE; TRIAL; AF; ELECTROGRAM; OUTCOMES; ANTRUM
AB BACKGROUND Nonrandomized studies have reported focal impulse and rotor modulation (FIRM)-guided ablation to be superior to pulmonary vein antrum isolation (PVAI) for persistent atrial fibrillation and long-standing persistent atrial fibrillation.
   OBJECTIVES This study sought to compare efficacy of FIRM ablation with or without PVAI versus PVAI plus non-PV trigger ablation in randomized persistent atrial fibrillation and long-standing persistent atrial fibrillation patients.
   METHODS Nonparoxysmal atrial fibrillation (AF) patients undergoing first ablation were randomized to FIRM only (group 1), FIRM + PVAI (group 2) or PVAI + posterior wall + non-PV trigger ablation (group 3). Primary endpoint was freedom from atrial tachycardia/AF. The secondary endpoint was acute procedural success, defined as AF termination, >= 10% slowing, or organization into atrial tachycardia.
   RESULTS A total of 113 patients were enrolled at 3 centers; 29 in group 1 and 42 each in groups 2 and 3. Group 1 enrollment was terminated early for futility. Focal drivers or rotors were detected in all group 1 and 2 patients. Procedure time was significantly shorter in group 3 versus groups 1 and 2 (p < 0.001). In groups 1 and 2, acute success after rotor-only ablation was achieved in 12 patients (41%) and 11 (26%), respectively. After 12 +/- 7 months' follow-up, 4 patients (14%), 22 (52.4%), and 32 (76%) in groups 1, 2, and 3, respectively, were AF/atrial tachycardia-free while off antiarrhythmic drugs (log-rank p < 0.0001). Group 3 patients experienced higher success compared with groups 1 (p < 0.001) and 2 (p = 0.02).
   CONCLUSIONS Outcomes were poor with rotor-only ablation. PVAI + rotor ablation had significantly longer procedure time and lower efficacy than PVAI + posterior wall + non-PV trigger-ablation. (C) 2016 by the American College of Cardiology Foundation.
C1 [Mohanty, Sanghamitra; Gianni, Carola; Mohanty, Prasant; Trivedi, Chintan; Bai, Rong; Al-Ahmad, Amin; Bailey, Shane; Burkhardt, John David; Gallinghouse, G. Joseph; Horton, Rodney; Hranitzky, Patrick M.; Sanchez, Javier E.; Di Biase, Luigi; Natale, Andrea] St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, Dept Electrophysiol, Austin, TX USA.
   [Halbfass, Philipp; Metz, Tamara; Deneke, Thomas; Di Biase, Luigi] Ctr Cardiovasc, Dept Cardiol, Bad Neustadt an der Saale, Germany.
   [Tomassoni, Gery; Natale, Andrea] Lexington Cardiol Cent Baptist, Dept Cardiol, Lexington, KY USA.
   [Bai, Rong; Natale, Andrea] Capital Med Univ, Beijing Anzhen Hosp, Dept Electrophysiol, Beijing, Peoples R China.
   [Natale, Andrea] Calif Pacific Med Ctr, Dept Electrophysiol & Arrhythmia Serv, San Francisco, CA USA.
   [Natale, Andrea] Scripps Clin, Intervent Electrophysiol, La Jolla, CA 92037 USA.
   [Natale, Andrea] Case Western Reserve Univ, Sch Med, Metro Hlth Med Ctr, Internal Med, Cleveland, OH USA.
   [Natale, Andrea] Stanford Univ, Div Cardiol, Stanford, CA 94305 USA.
   [Natale, Andrea] Univ Texas Austin, Dell Med Sch, Dept Internal Med, Austin, TX 78712 USA.
RP Natale, A (reprint author), St Davids Med Ctr, Texas Cardiac Arrhythmia Inst, 3000 North IH-35,Suite 720, Austin, TX 78705 USA.
EM dr.natale@gmail.com
OI Halbfass, Philipp/0000-0002-4291-2417; Di Biase,
   Luigi/0000-0001-6508-4047
FU Topera; Biosense Webster; St. Jude Medical
FX Dr. Tomassoni has received speaking and consulting fees from Topera. Dr.
   Burkhardt consults for Biosense Webster and Stereotaxis. Dr. Sanchez has
   received speaking fees from Biosense Webster and St. Jude Medical. Dr.
   Di Biase is a consultant for Biosense Webster, Boston Scientific,
   Stereotaxis, and St. Jude Medical; and has received speaking and travel
   honoraria from Medtronic, Boston Scientific, Atricure, EPiEP, Janssen,
   Pfizer, and Biotronik. Dr. Natale has received speaking honoraria from
   Boston Scientific, Biosense Webster, St. Jude Medical, Biotronik, and
   Medtronic; and consults for Biosense Webster, St. Jude Medical, Janssen,
   and Lifewatch. All other authors have reported that they have no
   relationships relevant to the contents of this paper to disclose.
CR Arbelo E, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000877
   Bai R, 2016, HEART RHYTHM, V13, P132, DOI 10.1016/j.hrthm.2015.08.019
   Brooks AG, 2010, HEART RHYTHM, V7, P835, DOI 10.1016/j.hrthm.2010.01.017
   Burkhardt JD, 2012, J AM COLL CARDIOL, V60, P1930, DOI 10.1016/j.jacc.2012.05.058
   Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016
   Chugh A, 2015, CIRC-ARRHYTHMIA ELEC, V8, P2, DOI 10.1161/CIRCEP.115.002674
   Damiano RJ, 2011, J THORAC CARDIOV SUR, V141, P113, DOI 10.1016/j.jtcvs.2010.08.067
   Di Biase L, 2013, PACE, V36, P1198, DOI 10.1111/pace.12209
   Di Biase L, 2013, CURR OPIN CARDIOL, V28, P26, DOI 10.1097/HCO.0b013e32835b59bb
   Di Biase L, 2010, CIRCULATION, V122, P109, DOI 10.1161/CIRCULATIONAHA.109.928903
   Estner HL, 2011, PACE, V34, P939, DOI 10.1111/j.1540-8159.2011.03100.x
   Gianni C, 2016, HEART RHYTHM, V13, P830, DOI 10.1016/j.hrthm.2015.12.028
   Gokoglan Y, 2016, CIRC ARRHYTHM ELECTR, V9
   Hayase J, 2013, HEART RHYTHM, V10, P1913, DOI 10.1016/j.hrthm.2013.07.049
   Lappe Jason M, 2016, Curr Treat Options Cardiovasc Med, V18, P15, DOI 10.1007/s11936-016-0437-y
   Lin YJ, 2013, CIRC-ARRHYTHMIA ELEC, V6, P851, DOI 10.1161/CIRCEP.113.000318
   Miller JM, 2014, J CARDIOVASC ELECTR, V25, P921, DOI 10.1111/jce.12474
   Miyazaki S, 2011, HEART, V97, P668, DOI 10.1136/hrt.2009.186874
   Mohanty S, 2015, J CARDIOVASC ELECTR, V26, P819, DOI 10.1111/jce.12688
   Mohanty S, 2015, HEART RHYTHM, V12, P477, DOI 10.1016/j.hrthm.2014.11.016
   Mohanty S, 2014, J CARDIOVASC ELECTR, V25, P1057, DOI 10.1111/jce.12467
   Narayan SM, 2014, J AM COLL CARDIOL, V63, P1761, DOI 10.1016/j.jacc.2014.02.543
   Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022
   Natale A, 2010, HEART RHYTHM S, pS206
   Saad E, COMPLETE ISOLATION L
   Sanders P, 2007, EUR HEART J, V28, P1862, DOI 10.1093/eurheartj/ehl548
   Shivkumar K, 2012, J CARDIOVASC ELECTR, V23, P1277, DOI 10.1111/jce.12000
   Sommer P, 2016, J CARDIOVASC ELECTR, V27, P274, DOI 10.1111/jce.12874
   Tomassoni G, 2015, J INNOV CARD RHYTHM, V6, P2145, DOI DOI 10.1016/J.JACEP.2016.10.006
   Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288
   Vogler J, 2015, J AM COLL CARDIOL, V66, P2743, DOI 10.1016/j.jacc.2015.09.088
   Wong KCK, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1316, DOI 10.1161/CIRCEP.114.002504
   Wynn GJ, 2016, HEART RHYTHM, V13, P399, DOI 10.1016/j.hrthm.2015.10.006
   Zhao YH, 2016, HEART RHYTHM, V13, P141, DOI 10.1016/j.hrthm.2015.08.029
NR 34
TC 31
Z9 31
U1 2
U2 9
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
EI 1558-3597
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD JUL 19
PY 2016
VL 68
IS 3
BP 274
EP 282
DI 10.1016/j.jacc.2016.04.015
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA DQ9GO
UT WOS:000379518600007
PM 27163758
OA Bronze
DA 2018-12-27
ER

PT J
AU Lavagno, A
   Gervino, G
AF Lavagno, A.
   Gervino, G.
TI RETRACTED: Neutron detection by large NaI crystal (Retracted article.
   See vol. 884, pg. 162, 2018)
SO NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS
   SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT
LA English
DT Article; Retracted Publication
DE Spectroscopy; Neutron detection; Gamma spectrometer
AB In present days new neutron detection methods are under developed due to the global shortage of He-3 and the toxicity of BF3. Neutrons can be indirectly detected by high-energy photons. The performance of a cylindrical Nal crystal, 4 in. diameter and 8 in. length as an indirect neutron detector has been investigated. Measurements were performed with Cf-252 source with bare and shielded Nal detector. With a proper converter and moderator structure for the Nal detector, the detection efficiencies and the minimum detectable activities are improved, making the method very interesting for security applications. The indirect detection of neutrons by photons has several advantages. First, this method can in principle be suited by any gamma spectrometer with only slight modifications that do not compromise with its gamma spectrometry measurements. Second, fission neutron sources and neutron generators can be discriminated thanks to their different gamma energy spectra, a discrimination easily done by a Nal spectrometer. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Lavagno, A.] Politecn Torino, Dept Appl Sci & Technol, I-10129 Turin, Italy.
   [Gervino, G.] Univ Turin, Dipartimento Fis, I-10124 Turin, Italy.
   [Lavagno, A.; Gervino, G.] Ist Nazl Fis Nucl, Sez Torino, Turin, Italy.
RP Lavagno, A (reprint author), Politecn Torino, Dept Appl Sci & Technol, I-10129 Turin, Italy.
EM andrea.lavagno@polito.it
CR Gervino G, 2013, NUCL INSTRUM METH A, V718, P143, DOI 10.1016/j.nima.2012.08.092
   Holm P., 2012, THESIS AALTO U
   Holm P, 2013, NUCL INSTRUM METH A, V697, P59, DOI 10.1016/j.nima.2012.09.010
   Noguere G, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.054602
NR 4
TC 1
Z9 1
U1 3
U2 35
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-9002
EI 1872-9576
J9 NUCL INSTRUM METH A
JI Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc.
   Equip.
PD JUL 11
PY 2016
VL 824
BP 208
EP 209
DI 10.1016/j.nima.2015.10.107
PG 2
WC Instruments & Instrumentation; Nuclear Science & Technology; Physics,
   Nuclear; Physics, Particles & Fields
SC Instruments & Instrumentation; Nuclear Science & Technology; Physics
GA DL1RD
UT WOS:000375408700072
OA Green Published
DA 2018-12-27
ER

PT J
AU Sarwat, M
   Hashem, A
   Ahanger, MA
   Abd Allah, EF
   Alqarawi, AA
   Alyemeni, MN
   Ahmad, P
   Gucel, S
AF Sarwat, Maryam
   Hashem, Abeer
   Ahanger, Mohammad A.
   Abd Allah, Elsayed F.
   Alqarawi, A. A.
   Alyemeni, Mohammed N.
   Ahmad, Parvaiz
   Gucel, Salih
TI RETRACTED: Mitigation of NaCI Stress by Arbuscular Mycorrhizal Fungi
   through the Modulation of Osmolytes, Antioxidants and Secondary
   Metabolites in Mustard (Brassica juncea L.) Plants(Retracted article.
   See vol.7,2016)
SO FRONTIERS IN PLANT SCIENCE
LA English
DT Article; Retracted Publication
DE AMF; antioxidants; Brassica juncea; flavonoids; lipid peroxidation; NaCI
   stress; osmolytes; phytohormones
ID SALT-STRESS; LIPID-PEROXIDATION; OXIDATIVE STRESS; WATER-STRESS;
   MINERAL-NUTRITION; SALINITY STRESS; LETTUCE PLANTS; MAIZE PLANTS;
   PHOSPHATASE-ACTIVITY; IMPROVED TOLERANCE
AB Present work was carried out to investigate the possible role of arbuscular mycorrhizal fungi (AMF) in mitigating salinity-induced alterations in Brassica juncea L. Exposure to NaCI stress altered the morphological, physio-biochemical attributes, antioxidant activity, secondary metabolites and phytohormones in the mustard seedlings. The growth and biomass yield, leaf water content, and total chlorophyll content were decreased with NaCI stress. However, AMF-inoculated plants exhibited enhanced shoot and root length, elevated relative water content, enhanced chlorophyll content, and ultimately biomass yield. Lipid peroxidation and proline content were increased by 54.53 and 63.47%, respectively with 200 mM NaCI concentration. Further increase in proline content and decrease in lipid peroxidation was observed in NaCI-treated plants inoculated with AMF. The antioxidants, superoxide dismutase, ascorbate peroxidase, glutathione reductase, and reduced glutathione were increased by 48.35, 54.86, 43.85, and 44.44%, respectively, with 200 mM NaCI concentration. Further increase in these antioxidants has been observed in AMF-colonized plants indicating the alleviating role of AMF to salinity stress through antioxidant modulation. The total phenol, flavonoids, and phytohormones increase with NaCI treatment. However, NaCI-treated plants colonized with AMF showed further increase in the above parameters except ABA, which was reduced with NaCI+AMF treatment over the plants treated with NaCI alone. Our results demonstrated that NaCI caused negative effect on a juncea seedlings; however, colonization with AMF enhances the NaCI tolerance by reforming the physic biochemical attributes, activities of antioxidant enzymes, and production of secondary metabolites and phytohormones.
C1 [Sarwat, Maryam] Amity Univ, Dept Pharmaceut Biotechnol, Amity Inst Pharm, Noida, India.
   [Hashem, Abeer] Agr Res Ctr, Plant Pathol Res Inst, Mycol & Plant Dis Survey Dept, Giza, Egypt.
   [Hashem, Abeer; Alyemeni, Mohammed N.; Ahmad, Parvaiz] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia.
   [Ahanger, Mohammad A.] Jiwaji Univ, Stress Physiol Lab, Dept Bot, Gwalior, India.
   [Abd Allah, Elsayed F.; Alqarawi, A. A.] King Saud Univ, Plant Prod Dept, Coll Food & Agr Sci, Riyadh, Saudi Arabia.
   [Ahmad, Parvaiz] Sri Pratap Coll, Dept Bot, Srinagar, Jammu & Kashmir, India.
   [Gucel, Salih] Near East Univ, Environm Res Ctr, Nicosia, Cyprus.
RP Ahmad, P (reprint author), King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh, Saudi Arabia.; Ahmad, P (reprint author), Sri Pratap Coll, Dept Bot, Srinagar, Jammu & Kashmir, India.
EM parvaizbot@yahoo.com
RI Abd_Allah, elsayed/N-6846-2017
OI Abd_Allah, elsayed/0000-0002-8509-8953
FU Deanship of Scientific Research at king Saud University [RG-1435-014]
FX The authors would like to extend their sincere appreciation to the
   Deanship of Scientific Research at king Saud University for its funding
   this Research Group NO (RG-1435-014).
CR Abd Allah EF, 2016, PAK J BOT, V48, P2223
   Ahmad P, 2008, INT J PLANT PROD, V2, P353
   Ahmad P, 2011, S AFR J BOT, V77, P36, DOI 10.1016/j.sajb.2010.05.003
   Ahmad P, 2010, RUSS J PLANT PHYSL+, V57, P509, DOI 10.1134/S1021443710040084
   Ahmad P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00868
   Ahmad P, 2014, J PLANT INTERACT, V9, P1, DOI 10.1080/17429145.2012.747629
   Ahmad Parvaiz, 2010, Archives of Agronomy and Soil Science, V56, P575, DOI 10.1080/03650340903164231
   Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243
   Al-Karaki GN, 2000, MYCORRHIZA, V10, P51, DOI 10.1007/s005720000055
   Al-Karaki GN, 1998, J PLANT NUTR, V21, P263, DOI 10.1080/01904169809365401
   Al-Khaliel AS, 2010, PLANT SOIL ENVIRON, V56, P318, DOI 10.17221/204/2009-PSE
   Alexander M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P815
   Alguacil MM, 2003, PHYSIOL PLANTARUM, V118, P562, DOI 10.1034/j.1399-3054.2003.00149.x
   Ali RM, 2003, PLANT SOIL ENVIRON, V49, P158, DOI 10.17221/4107-PSE
   Alqarawi AA, 2014, ACTA BIOL HUNG, V65, P61, DOI 10.1556/ABiol.65.2014.1.6
   Anjum NA, 2011, RUSS J PLANT PHYSL+, V58, P92, DOI 10.1134/S1021443710061019
   Anjum NA, 2010, ASCORBATE-GLUTATHIONE PATHWAY AND STRESS TOLERANCE IN PLANTS, P1, DOI 10.1007/978-90-481-9404-9
   Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79
   Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701
   Aroca R, 2013, J PLANT PHYSIOL, V170, P47, DOI 10.1016/j.jplph.2012.08.020
   Azooz M. M., 2011, International Journal of Plant Physiology and Biochemistry, V3, P253
   Balliu A, 2015, SUSTAINABILITY-BASEL, V7, P15967, DOI 10.3390/su71215799
   Bartwal A, 2013, J PLANT GROWTH REGUL, V32, P216, DOI 10.1007/s00344-012-9272-x
   BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060
   Beltrano J, 2013, J SOIL SCI PLANT NUT, V13, P123, DOI [10.4067/S0718-95162013005000012, 10.4067/S0718-95162012005000009]
   CARLBERG I, 1985, METHOD ENZYMOL, V113, P484
   Chun OK, 2003, J AGR FOOD CHEM, V51, P8067, DOI 10.1021/jf034740d
   Colla G, 2008, BIOL FERT SOILS, V44, P501, DOI 10.1007/s00374-007-0232-8
   Cuglielminetti L., 1995, PLANT PHYSIOL, V109, P1069
   Dawood MG, 2014, S AFR J BOT, V93, P54, DOI 10.1016/j.sajb.2014.03.002
   Dodd IC, 2012, J EXP BOT, V63, P3415, DOI 10.1093/jxb/ers033
   Doganlar ZB, 2010, AFR J AGR RES, V5, P2056
   Egamberdieva D, 2009, ACTA PHYSIOL PLANT, V31, P861, DOI 10.1007/s11738-009-0297-0
   Ehsanpour A. A., 2003, African Journal of Biotechnology, V2, P133
   El-Tayeb MA, 2005, PLANT GROWTH REGUL, V45, P215, DOI 10.1007/s10725-005-4928-1
   Estrada-Luna AA, 2003, J PLANT PHYSIOL, V160, P1073, DOI 10.1078/0176-1617-00989
   Evelin H, 2009, ANN BOT-LONDON, V104, P1263, DOI 10.1093/aob/mcp251
   Feng G, 2002, MYCORRHIZA, V12, P185, DOI 10.1007/s00572-002-0170-0
   Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003
   Foyer CH, 1997, PHYSIOL PLANTARUM, V100, P241, DOI 10.1034/j.1399-3054.1997.1000205.x
   Fujita Y, 2010, OIKOS, V119, P1665, DOI 10.1111/j.1600-0706.2010.18427.x
   Gengmao Z., 2015, IND CROP PROD, V64, P175, DOI DOI 10.1016/J.INDCR0P.2014.10.058
   GIANINAZZIPEARSON V, 1976, PHYSIOL VEG, V14, P833
   Giri B, 2003, BIOL FERT SOILS, V38, P170, DOI 10.1007/s00374-003-0636-z
   Giri B, 2007, MICROB ECOL, V54, P753, DOI 10.1007/s00248-007-9239-9
   GUPTA AK, 1993, PLANT PHYSIOL BIOCH, V31, P369
   Hajiboland R, 2010, PLANT SOIL, V331, P313, DOI 10.1007/s11104-009-0255-z
   Hameed A, 2014, USE MICROBES ALLEVIA, P139
   Hasanuzzaman M., 2014, AUST J CROP SCI, V8, P631
   Hashem Abeer, 2015, Pakistan Journal of Botany, V47, P327
   Hashem Abeer., 2014, PAK J BOT, V46, P2003
   HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1
   HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163
   Huang CH, 2005, J EXP BOT, V56, P3041, DOI 10.1093/jxb/eri301
   Huang YM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00682
   Jahromi F, 2008, MICROB ECOL, V55, P45, DOI 10.1007/s00248-007-9249-7
   Jaleel CA, 2007, S AFR J BOT, V73, P190, DOI 10.1016/j.sajb.2006.11.001
   Javid MG, 2011, AUST J CROP SCI, V5, P726
   Jia WS, 2002, J EXP BOT, V53, P2201, DOI 10.1093/jxb/erf079
   Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2
   JUNIPER S, 1993, MYCORRHIZA, V4, P45, DOI 10.1007/BF00204058
   KAMPFENKEL K, 1995, PLANT PHYSIOL, V107, P725, DOI 10.1104/pp.107.3.725
   Kennedy BF, 1999, J PLANT PHYSIOL, V155, P746, DOI 10.1016/S0176-1617(99)80092-3
   Khattab H., 2007, AUSTR J BASIC APPL S, V1, P323
   Kim SK, 2006, J ENVIRON BIOL, V27, P181
   Koca H, 2007, ENVIRON EXP BOT, V60, P344, DOI 10.1016/j.envexpbot.2006.12.005
   Kohler J, 2009, ENVIRON EXP BOT, V65, P245, DOI 10.1016/j.envexpbot.2008.09.008
   Kumar A, 2010, J PLANT GROWTH REGUL, V29, P297, DOI 10.1007/s00344-009-9136-1
   Kusaba S, 1998, PLANT PHYSIOL, V116, P471, DOI 10.1104/pp.116.2.471
   Latef AAHA, 2011, SCI HORTIC-AMSTERDAM, V127, P228, DOI 10.1016/j.scienta.2010.09.020
   Levitt J, 1980, RESPONSES PLANT ENV, V2
   LINDERMAN RG, 1994, APS SYMP SER, P1
   Lingua G, 2013, INT J MOL SCI, V14, P16207, DOI 10.3390/ijms140816207
   Luck H., 1974, METHOD ENZYMAT AN, V2, P885
   Ludwig-Muller J, 2000, ARBUSCULAR MYCORRHIZ, P263
   Luo ZB, 2009, PLANT PHYSIOL, V151, P1902, DOI 10.1104/pp.109.143735
   Meenu Thakur, 2005, Journal of Agriculture and Social Sciences, V1, P89
   Mehr Z. S., 2012, International Journal of Agronomy and Plant Production, V3, P710
   MENCONI M, 1995, J EXP BOT, V46, P1123, DOI 10.1093/jxb/46.9.1123
   Michalak A, 2006, POL J ENVIRON STUD, V15, P523
   MONERRI C, 1986, PHYSIOL PLANTARUM, V67, P49, DOI 10.1111/j.1399-3054.1986.tb01261.x
   Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911
   NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867
   Nan R, 2002, J PLANT PHYSIOL, V159, P307, DOI 10.1078/0176-1617-00703
   Nell M, 2009, J SCI FOOD AGR, V89, P1090, DOI 10.1002/jsfa.3561
   Nilsen E, 1996, PHYSL PLANTS STRESS, P118
   Olmos E, 1997, J EXP BOT, V48, P1529, DOI 10.1093/jexbot/48.313.1529
   PAN SM, 1988, BOT BULL ACAD SINICA, V29, P33
   Paradiso A, 2008, PLANT CELL PHYSIOL, V49, P362, DOI 10.1093/pcp/pcn013
   Parvaiz Ahmad, 2012, African Journal of Biotechnology, V11, P2694, DOI 10.5897/AJB11.3203
   Pignocchi C, 2003, CURR OPIN PLANT BIOL, V6, P379, DOI 10.1016/S1369-5266(03)00069-4
   Porcel R, 2012, AGRON SUSTAIN DEV, V32, P181, DOI 10.1007/s13593-011-0029-x
   PRESSEY R, 1980, PLANT PHYSIOL, V65, P136, DOI 10.1104/pp.65.1.136
   Qun H. Z., 2007, COLLOID SURFACE B, V59, P128, DOI [10.1016/j.colsurfb.2007.04.023, DOI 10.1016/J.COLSURFB.2007.04.023]
   Rai AK, 2006, CURR MICROBIOL, V52, P6, DOI 10.1007/s00284-005-0043-9
   Rasool S, 2013, ACTA PHYSIOL PLANT, V35, P1039, DOI 10.1007/s11738-012-1142-4
   Rasool Saiema, 2012, J FUNCTIONAL ENV BOT, V2, P59, DOI DOI 10.5958/J.2231-1742.2.1.006
   Rausch T, 2007, PLANT BIOLOGY, V9, P565, DOI 10.1055/s-2007-965580
   Ruiz-Lozano JM, 2003, MYCORRHIZA, V13, P309, DOI 10.1007/s00572-003-0237-6
   Ruiz-Lozano JM, 2000, MYCORRHIZA, V10, P137, DOI 10.1007/s005720000075
   Ruiz-Lozano JM, 2001, J EXP BOT, V52, P2241, DOI 10.1093/jexbot/52.364.2241
   Sangeetha R., 2013, INT J BASIC LIFE SCI, V1, P1
   Schubert S, 2009, PLANT SCI, V177, P196, DOI 10.1016/j.plantsci.2009.05.011
   Shekoofeh E., 2012, J BIOT, V11, P2223, DOI DOI 10.5897/AJB11.1672
   Sheng M, 2008, MYCORRHIZA, V18, P287, DOI 10.1007/s00572-008-0180-7
   SHEWALE JG, 1978, CAN J MICROBIOL, V24, P1204, DOI 10.1139/m78-195
   SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258
   STEPHEN MG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI DOI 10.1111/J.1399-3054.1994.TB02539.X
   Sultana N, 1999, ENVIRON EXP BOT, V42, P211, DOI 10.1016/S0098-8472(99)00035-0
   Tang M, 2009, SOIL BIOL BIOCHEM, V41, P936, DOI 10.1016/j.soilbio.2008.11.007
   Tomar N. S., 2013, American Journal of Plant Sciences, V4, P1134
   Tuna AL, 2008, ENVIRON EXP BOT, V62, P1, DOI 10.1016/j.envexpbot.2007.06.007
   van Rossum MWPC, 1997, PLANT SCI, V130, P207, DOI 10.1016/S0168-9452(97)00215-X
   Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1
   Wada KC, 2014, J PLANT PHYSIOL, V171, P895, DOI 10.1016/j.jplph.2014.03.008
   Wahid A, 2006, J PLANT PHYSIOL, V163, P723, DOI 10.1016/j.jplph.2005.07.007
   Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5
   Wu QS, 2010, ACTA PHYSIOL PLANT, V32, P297, DOI 10.1007/s11738-009-0407-z
   Zorb C, 2013, J PLANT PHYSIOL, V170, P220, DOI 10.1016/j.jplph.2012.09.012
NR 119
TC 8
Z9 9
U1 4
U2 52
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-462X
J9 FRONT PLANT SCI
JI Front. Plant Sci.
PD JUL 4
PY 2016
VL 7
AR 869
DI 10.3389/fpls.2016.00869
PG 14
WC Plant Sciences
SC Plant Sciences
GA DQ0TI
UT WOS:000378913000001
PM 27458462
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Lu, L
   Hattori, T
   Zhao, HY
   Kawasaki, K
   Sun, LP
   Jin, QY
   Zhang, JJ
   Sun, LT
   He, Y
   Zhao, HW
AF Lu, Liang
   Hattori, Toshiyuki
   Zhao, Huan-Yu
   Kawasaki, Katsunori
   Sun, Lie-Peng
   Jin, Qian-Yu
   Zhang, Jun-Jie
   Sun, Liang-Ting
   He, Yuan
   Zhao, Hong-Wei
TI RETRACTED: High power acceleration of an HSC type injector for cancer
   therapy (Retracted article. See vol. 40, 2016)
SO CHINESE PHYSICS C
LA English
DT Article; Retracted Publication
DE RFQ; drift tube linac; IH structure; heavy ion injector; cancer therapy;
   laser ion source; DPIS
ID SINGLE CAVITY LINAC; DESIGN; HIMAC
AB A hybrid single cavity (HSC) linac, which is formed by combining a radio frequency quadrupole (RFQ) and a drift tube (DT) structure into one interdigital-H (IH) cavity, is fabricated and assembled as a proof of principle injector for cancer therapy synchrotron, based on the culmination of several years of research. The HSC linac adopts a direct plasma injection scheme (DPIS), which can inject a high intensity heavy ion beam produced by a laser ion source (LIS). The input beam current of the HSC is designed to be 20 mA C6+ ions. According to numerical simulations, the HSC linac can accelerate a 6-mA C6+ beam, which meets the requirement of the needed particle number for cancer therapy (10(8-9) ions/pulse). The HSC injector with the DPIS method makes the existing multi turn injection system and stripping system unnecessary, and can also bring down the size of the beam pipe in existing synchrotron magnets, which could reduce the whole cost of synchrotron. The radio frequency (rf) measurements show excellent rf properties for the resonator, with a measured Q equal to 91% of the simulated value. A C6+ ion beam extracted from the LIS was used for the HSC commissioning. In beam testing, we found the measured beam parameters agreed with simulations. More details of the measurements and the results of the high power test are reported in this paper.
C1 [Lu, Liang; Zhao, Huan-Yu; Sun, Lie-Peng; Jin, Qian-Yu; Zhang, Jun-Jie; Sun, Liang-Ting; He, Yuan; Zhao, Hong-Wei] Chinese Acad Sci, Inst Modern Phys, Lanzhou 730000, Peoples R China.
   [Hattori, Toshiyuki] Natl Inst Radiol Sci, Chiba 2638555, Japan.
   [Kawasaki, Katsunori] Tokyo Inst Technol, Tokyo 1528550, Japan.
RP Lu, L (reprint author), IMP, Linear Accelerator Grp, Accelerator Div, 509 Nanchang Rd, Lanzhou 730000, Gansu, Peoples R China.
EM luliang@impcas.ac.cn
FU National Natural Science Foundation of China; One Hundred Person Project
   of CAS
FX Supported by National Natural Science Foundation of China and One
   Hundred Person Project of CAS
CR Hattori T, 1996, FUSION ENG DES, V32-33, P359, DOI 10.1016/S0920-3796(96)00489-9
   HIRAO Y, 1992, NUCL PHYS A, V538, pC541
   Ito T, 2007, NUCL INSTRUM METH B, V261, P17, DOI 10.1016/j.nimb.2007.04.101
   Klinck, 2010, ALPHA DECAY 241 AM T, P123
   LU L., 2010, P 25 INT LIN ACC C, P476
   LU L., 2010, P 1 INT PART C KYOT, P786
   Lu L, 2012, NUCL INSTRUM METH A, V688, P11, DOI 10.1016/j.nima.2012.04.056
   Lu LA, 2010, NUCL INSTRUM METH A, V622, P485, DOI 10.1016/j.nima.2010.07.043
   Noda K, 2006, NUCL INSTRUM METH A, V562, P1038, DOI 10.1016/j.nima.2006.02.090
   Takada E, 2010, NUCL PHYS A, V834, p730C, DOI 10.1016/j.nuclphysa.2010.01.132
   Zhang Z.l., 2011, P 2011 IEEE 5 CIS 20, P128
NR 11
TC 1
Z9 1
U1 4
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1674-1137
EI 2058-6132
J9 CHINESE PHYS C
JI Chin. Phys. C
PD JUL
PY 2016
VL 40
IS 7
AR 077001
DI 10.1088/1674-1137/40/7/077001
PG 7
WC Physics, Nuclear; Physics, Particles & Fields
SC Physics
GA DT8HF
UT WOS:000381730100021
DA 2018-12-27
ER

PT J
AU Pan, J
   Lu, FF
   Xu, HC
   Wang, QF
   Lin, CN
   Zhang, SZ
AF Pan, Jun
   Lu, Fengfei
   Xu, Hongchao
   Wang, Qifu
   Lin, Chunnan
   Zhang, Shizhong
TI RETRACTED: Low p21 level is necessary for the suppressive effects of
   micoRNA-31 on glioma cell migration and invasion (Retracted article. See
   April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Glioma; MicroRNA-31; p21; Invasion; Migration
ID CANCER METASTASIS; MALIGNANT GLIOMA; LUNG-CANCER; MICRORNA; MIR-31;
   EXPRESSION; CARCINOMA; THERAPY; PATHWAY; RADIXIN
AB MicroRNAs (miRNAs), a kind of endogenous non-coding RNAs, regulate gene expression through binding to the 3'-untranslational region (UTR) of target messenger RNAs (mRNAs) and act as endogenous agents of RNA interference, resulting in either mRNA degradation or translational repression. MiR-31 has been demonstrated to be associated with the development and progression of glioma. However, the underlying molecular mechanism remains largely unclear. In the present study, we demonstrated that miR-31 only inhibited the cell migration and invasion, as well as the expression of a known miR-31 target oncogene radixin, in U251 glioma cells that expressed low level of p21; however, miR-31 showed no above effects on glioma SHG44 cells that highly expressed p21. Moreover, upregulation of p21 in U251 cells reversed the suppressive effects of miR-31 on the cell migration and invasion, suggesting that low p21 level is necessary for the miR-31-mediated inhibitory effects on glioma. Furthermore, analysis for 35 glioma specimens showed that the expression of radixin was negatively correlated with the miR-31 level in glioma tissues with low p21 expression; however, no such correlation was found in glioma tissues with high p21 level, further supporting that the low p21 level is necessary for the suppressive effect of miR-31 on the expression of its target oncogenes. In summary, our study demonstrates that the suppressive effect of miR-31 on glioma cell migration and invasion is p21-dependent, and suggests that miR-31 may be used for the treatment of patients with p21-deficent glioma.
C1 [Pan, Jun; Lu, Fengfei; Xu, Hongchao; Wang, Qifu; Lin, Chunnan; Zhang, Shizhong] Neurosurg Inst Guangdong Prov, Natl Key Clin Specialty, Guangzhou 510282, Guangdong, Peoples R China.
   [Pan, Jun; Lu, Fengfei; Xu, Hongchao; Wang, Qifu; Lin, Chunnan; Zhang, Shizhong] Guangdong Prov Key Lab Brain Funct Repair & Regen, Guangzhou 510282, Guangdong, Peoples R China.
   [Pan, Jun; Lu, Fengfei; Xu, Hongchao; Wang, Qifu; Lin, Chunnan; Zhang, Shizhong] Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, 253 Gongye Rd, Guangzhou 510282, Guangdong, Peoples R China.
RP Zhang, SZ (reprint author), Neurosurg Inst Guangdong Prov, Natl Key Clin Specialty, Guangzhou 510282, Guangdong, Peoples R China.; Zhang, SZ (reprint author), Guangdong Prov Key Lab Brain Funct Repair & Regen, Guangzhou 510282, Guangdong, Peoples R China.; Zhang, SZ (reprint author), Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, 253 Gongye Rd, Guangzhou 510282, Guangdong, Peoples R China.
EM zhangszdr@yeah.net
CR Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657
   Afra D, 2002, LANCET, V359, P1011
   Aprelikova O, 2010, CELL CYCLE, V9, P4387, DOI 10.4161/cc.9.21.13674
   Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997
   Choi EJ, 2007, NUTR CANCER, V59, P115, DOI 10.1080/01635580701419030
   Choi Eunhyun, 2013, World J Stem Cells, V5, P172, DOI 10.4252/wjsc.v5.i4.172
   Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875
   Dong Z, 2014, CANCER LETT, V343, P249, DOI 10.1016/j.canlet.2013.09.034
   Garner E, 2008, CELL CYCLE, V7, P277, DOI 10.4161/cc.7.3.5328
   Gartel AL, 1996, P SOC EXP BIOL MED, V213, P138
   Gartel AL, 2009, BIOFACTORS, V35, P161, DOI 10.1002/biof.26
   Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x
   Hua DS, 2012, ONCOL REP, V27, P700, DOI 10.3892/or.2011.1555
   Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864
   Li XH, 2012, ONCOL REP, V28, P77, DOI 10.3892/or.2012.1769
   Liu CJ, 2012, HEAD NECK-J SCI SPEC, V34, P219, DOI 10.1002/hed.21713
   Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291
   Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105
   Moss EG, 2002, CURR BIOL, V12, pR138, DOI 10.1016/S0960-9822(02)00708-X
   Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233
   Ning Zhifeng, 2014, Genes Cancer, V5, P436
   Ono Y, 1997, ACTA NEUROPATHOL, V94, P21, DOI 10.1007/s004010050667
   Pulkkanen KJ, 2005, MOL THER, V12, P585, DOI 10.1016/j.ymthe.2005.07.357
   Sathornsumetee S, 2007, CANCER-AM CANCER SOC, V110, P13, DOI 10.1002/cncr.22741
   Shahi MH, 2015, TUMOR BIOL, V36, P2383, DOI 10.1007/s13277-014-2846-4
   Suhail TV, 2015, EUR J CELL BIOL, V94, P90, DOI 10.1016/j.ejcb.2014.12.001
   Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047
   Vosa U, 2013, INT J CANCER, V132, P2884, DOI 10.1002/ijc.27981
   Wang S, 2014, J NEUROL SCI, V338, P71, DOI 10.1016/j.jns.2013.12.019
   Zhu VF, 2012, CANCER LETT, V316, P139, DOI 10.1016/j.canlet.2011.11.001
NR 30
TC 1
Z9 1
U1 3
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD JUL
PY 2016
VL 37
IS 7
BP 9663
EP 9670
DI 10.1007/s13277-016-4788-5
PG 8
WC Oncology
SC Oncology
GA DU4HU
UT WOS:000382174500117
PM 26801671
DA 2018-12-27
ER

PT J
AU Gao, F
   Shen, XZ
   Jiang, F
   Wu, YQ
   Han, CY
AF Gao, Feng
   Shen, Xiao Z.
   Jiang, Feng
   Wu, Yongqiang
   Han, Chunyu
TI RETRACTED: DNA-guided genome editing using the Natronobacterium gregoryi
   Argonaute (Retracted article. See vol. 35, pg. 797, 2017)
SO NATURE BIOTECHNOLOGY
LA English
DT Article; Retracted Publication
ID CRISPR-CAS9 SYSTEM; FOREIGN DNA; HUMAN-CELLS; CAS9; ENDONUCLEASE;
   SPECIFICITY; NUCLEASE; PROTEINS; CLEAVAGE; REVEALS
AB The RNA-guided endonuclease Cas9 has made genome editing a widely accessible technique. Similar to Cas9, endonucleases from the Argonaute protein family also use oligonucleotides as guides to degrade invasive genomes. Here we report that the Natronobacterium gregoryi Argonaute (NgAgo) is a DNA-guided endonuclease suitable for genome editing in human cells. NgAgo binds 5' phosphorylated single-stranded guide DNA (gDNA) of similar to 24 nucleotides, efficiently creates site-specific DNA double-strand breaks when loaded with the gDNA. The NgAgo-gDNA system does not require a protospacer-adjacent motif (PAM), as does Cas9, and preliminary characterization suggests a low tolerance to guide-target mismatches and high efficiency in editing (G+C)-rich genomic targets.
C1 [Gao, Feng; Jiang, Feng; Wu, Yongqiang; Han, Chunyu] Hebei Univ Sci & Technol, Dept Biosci & Bioengn, Shijiazhuang, Hebei, Peoples R China.
   [Shen, Xiao Z.] Zhejiang Univ, Dept Physiol, Sch Med, Hangzhou, Zhejiang, Peoples R China.
RP Han, CY (reprint author), Hebei Univ Sci & Technol, Dept Biosci & Bioengn, Shijiazhuang, Hebei, Peoples R China.
EM hanchunyu74@aliyun.com
FU National Science Foundation of China [31270950]
FX We thank W. Chao for performing flow cytometry experiment. This work was
   supported by the National Science Foundation of China 31270950 to X.Z.S.
CR Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471
   Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829
   Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Molloy Sheilagh, 2013, Nat Rev Microbiol, V11, P743, DOI 10.1038/nrmicro3150
   Olovnikov I, 2013, MOL CELL, V51, P594, DOI 10.1016/j.molcel.2013.08.014
   Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021
   Salomon WE, 2015, CELL, V162, P84, DOI 10.1016/j.cell.2015.06.029
   Schirle NT, 2014, SCIENCE, V346, P608, DOI 10.1126/science.1258040
   Smalheiser NR, 2014, BIOL DIRECT, V9, DOI 10.1186/s13062-014-0027-4
   Swarts DC, 2015, NUCLEIC ACIDS RES, V43, P5120, DOI 10.1093/nar/gkv415
   Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879
   Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971
   Vogel J, 2014, SCIENCE, V344, P972, DOI 10.1126/science.1252962
   Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981
   Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434
NR 22
TC 87
Z9 108
U1 12
U2 537
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD JUL
PY 2016
VL 34
IS 7
BP 768
EP +
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DT2TT
UT WOS:000381335400032
PM 27136078
DA 2018-12-27
ER

PT J
AU Zhang, F
   Jin, XX
   Wang, LK
   Li, SF
   Wu, S
   Cheng, CZ
   Zhang, TZ
   Guo, WZ
AF Zhang, Feng
   Jin, Xuanxiang
   Wang, Like
   Li, Shufen
   Wu, Shuang
   Cheng, Chaoze
   Zhang, Tianzhen
   Guo, Wangzhen
TI RETRACTED: A Cotton Annexin Affects Fiber Elongation and Secondary Cell
   Wall Biosynthesis Associated with Ca2+ Influx, ROS Homeostasis, and
   Actin Filament Reorganization (Retracted article. See vol. 177, pg.
   1773, 2018)
SO PLANT PHYSIOLOGY
LA English
DT Article; Retracted Publication
ID OXYGEN SPECIES PRODUCTION; POSITIVE FEEDBACK-REGULATION;
   GOSSYPIUM-HIRSUTUM L.; NADPH OXIDASE; CELLULOSE SYNTHASE;
   HYDROGEN-PEROXIDE; UPLAND COTTON; HIGHER-PLANTS; POLLEN-TUBE; IN-VITRO
AB Annexins play pivotal roles in a variety of cellular processes as well as in fiber development; however, the functional mechanisms of their activities are unclear. Here, an annexin gene that is preferentially expressed in fibers, GhFAnnxA, was found to be significantly associated with various cotton (Gossypium hirsutum) fiber traits. Transgenic analysis demonstrated that GhFAnnxA affected cotton fiber elongation and was involved in secondary cell wall (SCW) biosynthesis. Functional studies demonstrated that GhFAnnxA may act as a Ca2+ conductance regulator and that reactive oxygen species (ROS) produced by Rbohs in a Ca2+-dependent manner may determine fiber elongation caused by elevated intracellular turgor and cell wall loosening. However, excessive hydrogen peroxide (H2O2) inhibited cotton fiber elongation in vitro. We speculate that a positive feedback loop involving ROS and Ca2+ is regulated by GhCDPK1 and regulates fiber cell elongation. Furthermore, the convergence of actin filaments is altered by their interaction with GhFAnnxA, and this also may contribute to fiber elongation. Moreover, GhFAnnxA may affect SCW biosynthesis through changes in cell wall components caused by an increase in H2O2 levels. These results not only provide new insights into the signaling pathways of GhFAnnxA in fiber development but also clarify the role of ROS in fiber development.
C1 [Zhang, Feng; Jin, Xuanxiang; Wang, Like; Li, Shufen; Wu, Shuang; Cheng, Chaoze; Zhang, Tianzhen; Guo, Wangzhen] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.
RP Guo, WZ (reprint author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.
EM moelab@njau.edu.cn
OI Guo, Wangzhen/0000-0003-3333-7147
FU National Natural Science Foundation in China [31471539]; Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   [010-809001]; Jiangsu Collaborative Innovation Center for Modern Crop
   Production [10]
FX This work was supported by the National Natural Science Foundation in
   China (grant no. 31471539), the Priority Academic Program Development of
   Jiangsu Higher Education Institutions (grant no. 010-809001), and the
   Jiangsu Collaborative Innovation Center for Modern Crop Production
   (project no. 10).
CR ANDRAWIS A, 1993, PLANT J, V3, P763, DOI 10.1111/j.1365-313X.1993.00763.x
   Avci U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056315
   Vazquez LAB, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.29401
   Bashline L, 2014, MOL PLANT, V7, P586, DOI 10.1093/mp/ssu018
   BEASLEY CA, 1973, AM J BOT, V60, P130, DOI 10.2307/2441099
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   BRENNAN T, 1977, PLANT PHYSIOL, V59, P411, DOI 10.1104/pp.59.3.411
   Cai CP, 2014, J INTEGR PLANT BIOL, V56, P51, DOI 10.1111/jipb.12124
   Calvert CM, 1996, PLANT CELL, V8, P333
   CASSMAN KG, 1990, CROP SCI, V30, P672, DOI 10.2135/cropsci1990.0011183X003000030039x
   Chang M, 2015, PLANT J, V83, P515, DOI 10.1111/tpj.12910
   Cosgrove DJ, 1997, PLANT CELL, V9, P1031, DOI 10.1105/tpc.9.7.1031
   Delmer DP, 1997, CELL MOL LIFE SCI, V53, P546, DOI 10.1007/s000180050070
   DHINDSA RS, 1975, PLANT PHYSIOL, V56, P394, DOI 10.1104/pp.56.3.394
   Divya K, 2010, PLANT MOL BIOL, V73, P293, DOI 10.1007/s11103-010-9615-6
   Dodd AN, 2010, ANNU REV PLANT BIOL, V61, P593, DOI 10.1146/annurev-arplant-070109-104628
   Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485
   Fry SC, 1998, BIOCHEM J, V332, P507, DOI 10.1042/bj3320507
   Fu Y, 2015, CURR OPIN PLANT BIOL, V28, P111, DOI 10.1016/j.pbi.2015.10.004
   Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001
   Gilliland LU, 2003, PLANT J, V33, P319, DOI 10.1046/j.1365-313X.2003.01626.x
   Gilliland LU, 2002, PLANT PHYSIOL, V130, P2199, DOI 10.1104/pp.014068
   Goh HH, 2012, PLANT PHYSIOL, V159, P1759, DOI 10.1104/pp.112.200881
   Gorecka KM, 2005, BIOCHEM BIOPH RES CO, V336, P868, DOI 10.1016/j.bbrc.2005.08.181
   GRAVES DA, 1988, PLANTA, V175, P254, DOI 10.1007/BF00392435
   Guo WZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-314
   Guo WB, 2011, PLANT J, V66, P541, DOI 10.1111/j.1365-313X.2011.04511.x
   Han LB, 2013, PLANT CELL, V25, P4421, DOI 10.1105/tpc.113.116970
   Harmer SE, 2002, MOL GENET GENOMICS, V268, P1, DOI 10.1007/s00438-002-0721-2
   Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x
   Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508
   Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159
   Higaki T, 2010, PLANT J, V61, P156, DOI 10.1111/j.1365-313X.2009.04032.x
   Hoshino D, 2004, PLANTA, V219, P867, DOI 10.1007/s00425-004-1285-7
   Hovav R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040025
   Huang QS, 2008, PLANT CELL REP, V27, P1869, DOI 10.1007/s00299-008-0603-0
   Huang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066160
   Hussey PJ, 2006, ANNU REV PLANT BIOL, V57, P109, DOI 10.1146/annurev.arplant.57.032905.105206
   Ishibashi Y, 2010, PLANT PROD SCI, V13, P45, DOI 10.1626/pps.13.45
   [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166
   Jiang YJ, 2012, PLANT BIOTECHNOL J, V10, P301, DOI 10.1111/j.1467-7652.2011.00662.x
   Kaya H, 2014, PLANT CELL, V26, P1069, DOI 10.1105/tpc.113.120642
   Kim HJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-889
   Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.127.4.1361
   Kimura S, 2012, BBA-MOL CELL RES, V1823, P398, DOI 10.1016/j.bbamcr.2011.09.011
   Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884
   Kong ZS, 2015, MOL PLANT, V8, P1011, DOI 10.1016/j.molp.2015.01.004
   Kost B, 2002, CELL, V108, P9, DOI 10.1016/S0092-8674(01)00634-1
   Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686
   Kurek I, 2002, P NATL ACAD SCI USA, V99, P11109, DOI 10.1073/pnas.162077099
   Laohavisit A, 2012, PLANT CELL, V24, P1522, DOI 10.1105/tpc.112.097881
   Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x
   Laohavisit A, 2009, PLANT CELL, V21, P479, DOI 10.1105/tpc.108.059550
   Lecourieux D, 2002, PLANT CELL, V14, P2627, DOI 10.1105/tpc.005579
   Lee DK, 2003, PLANT PHYSIOL, V131, P985, DOI 10.1104/pp.009902
   Li A, 2013, PLANTA, V237, P1585, DOI 10.1007/s00425-013-1868-2
   Li B, 2013, J INTEGR PLANT BIOL, V55, P902, DOI 10.1111/jipb.12063
   Li FF, 2009, PLANT CELL TISS ORG, V97, P225, DOI 10.1007/s11240-009-9521-2
   Li HB, 2007, NEW PHYTOL, V175, P462, DOI 10.1111/j.1469-8137.2007.02120.x
   Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629
   Li Y, 2016, PLANT BIOTECHNOL J, V14, P951, DOI 10.1111/pbi.12450
   Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784
   Liu T, 2014, CURR BIOL, V24, P2708, DOI 10.1016/j.cub.2014.09.053
   Lloyd C, 2008, CURR OPIN PLANT BIOL, V11, P641, DOI 10.1016/j.pbi.2008.10.007
   Lv FN, 2015, J EXP BOT, V66, P1877, DOI 10.1093/jxb/eru530
   Marino D, 2012, TRENDS PLANT SCI, V17, P9, DOI 10.1016/j.tplants.2011.10.001
   Mei WQ, 2009, J GENET GENOMICS, V36, P141, DOI 10.1016/S1673-8527(08)60101-0
   MEINERT MC, 1977, PLANT PHYSIOL, V59, P1088, DOI 10.1104/pp.59.6.1088
   Mortimer JC, 2008, J EXP BOT, V59, P533, DOI 10.1093/jxb/erm344
   Niu EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145725
   O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9
   Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200
   Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551
   Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637
   Potikha TS, 1999, PLANT PHYSIOL, V119, P849, DOI 10.1104/pp.119.3.849
   Preuss ML, 2004, PLANT PHYSIOL, V136, P3945, DOI 10.1104/pp.104.052340
   Qiao B, 2015, J EXP BOT, V66, P5853, DOI 10.1093/jxb/erv294
   Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010
   Qin YongSheng, 2009, Scientia Agricultura Sinica, V42, P4145
   Qu Xiaolu, 2014, Front Plant Sci, V5, P786, DOI 10.3389/fpls.2014.00786
   Rasmussen CG, 2013, PLANT J, V75, P258, DOI 10.1111/tpj.12177
   Richards SL, 2014, PLANT J, V77, P136, DOI 10.1111/tpj.12372
   Ringli C, 2002, PLANT PHYSIOL, V129, P1464, DOI 10.1104/pp.005777
   Rodriguez AA, 2002, PLANT PHYSIOL, V129, P1627, DOI 10.1104/pp.001222
   Romagnoli S, 2007, PLANT CELL PHYSIOL, V48, P345, DOI 10.1093/pcp/pcm001
   Ruan YL, 2004, PLANT PHYSIOL, V136, P4104, DOI 10.1104/pp.104.051540
   Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108
   Ruan YL, 2001, PLANT CELL, V13, P47, DOI 10.1105/tpc.13.1.47
   Sanchez-Rodriguez C, 2012, PLANT CELL, V24, P589, DOI 10.1105/tpc.111.094672
   Schopfer P, 2001, PLANT J, V28, P679, DOI 10.1046/j.1365-313x.2001.01187.x
   SEAGULL RW, 1990, PROTOPLASMA, V159, P44, DOI 10.1007/BF01326634
   Shin HS, 1999, PLANT PHYSIOL, V119, P925, DOI 10.1104/pp.119.3.925
   Short EF, 2012, PLANT J, V71, P948, DOI 10.1111/j.1365-313X.2012.05043.x
   Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014
   Takahashi S, 2012, J BIOCHEM, V152, P37, DOI 10.1093/jb/mvs044
   Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505
   Tang WX, 2014, PLANT MOL BIOL, V85, P613, DOI 10.1007/s11103-014-0208-7
   Tang WX, 2014, NEW PHYTOL, V202, P509, DOI 10.1111/nph.12676
   Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014
   Waadt R, 2008, CSH PROTOC, V2008
   Wang C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-94
   Wang GF, 2013, INT J MOL SCI, V14, P9440, DOI 10.3390/ijms14059440
   Wang LK, 2010, MOL BIOL REP, V37, P3327, DOI 10.1007/s11033-009-9919-2
   Winship LJ, 2010, TRENDS PLANT SCI, V15, P363, DOI 10.1016/j.tplants.2010.04.005
   Xu T, 2009, BIOCHEM J, V421, P171, DOI 10.1042/BJ20082020
   Zhang DS, 2004, PLANT MOL BIOL, V54, P353, DOI 10.1023/B:PLAN.0000036369.55253.dd
   Zhang F, 2015, PLANT MOL BIOL, V87, P47, DOI 10.1007/s11103-014-0260-3
   Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207
   Zhou L, 2011, J INTEGR PLANT BIOL, V53, P347, DOI 10.1111/j.1744-7909.2011.01034.x
NR 109
TC 16
Z9 19
U1 10
U2 43
PU AMER SOC PLANT BIOLOGISTS
PI ROCKVILLE
PA 15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA
SN 0032-0889
EI 1532-2548
J9 PLANT PHYSIOL
JI Plant Physiol.
PD JUL
PY 2016
VL 171
IS 3
BP 1750
EP 1770
DI 10.1104/pp.16.00597
PG 21
WC Plant Sciences
SC Plant Sciences
GA DT2IF
UT WOS:000381303300020
PM 27255486
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Chang, TY
   Chen, HA
   Chiu, CF
   Chang, YW
   Kuo, TC
   Tseng, PC
   Wang, W
   Hung, MC
   Su, JL
AF Chang, Ting-Yu
   Chen, Hsin-An
   Chiu, Ching-Feng
   Chang, Yi-Wen
   Kuo, Tsang-Chih
   Tseng, Po-Chun
   Wang, Weu
   Hung, Mien-Chie
   Su, Jen-Liang
TI RETRACTED: Dicer Elicits Paclitaxel Chemosensitization and Suppresses
   Cancer Stemness in Breast Cancer by Repressing AXL (Retracted article.
   See vol. 78, pg. 5719, 2018)
SO CANCER RESEARCH
LA English
DT Article; Retracted Publication
ID HEPATOCELLULAR-CARCINOMA CELLS; TRAIL-INDUCED APOPTOSIS;
   DOWN-REGULATION; OVARIAN-CANCER; EXPRESSION; E1A; RESISTANCE; TUMOR;
   SENSITIZATION; DROSHA
AB Paclitaxel is a standard-of-care chemotherapy for breast cancer, despite the increasing recognition of its poor effectiveness in the treatment of patients with advanced disease. Here, we report that adenovirus-type 5 E1A-mediated elevation of the miRNA-processing enzyme Dicer is sufficient to enhance paclitaxel sensitization and reduce cancer stem-like cell properties in this setting. Elevating Dicer expression increased levels of the AXL kinase targeting miRNA miR-494, thereby repressing AXL expression to increase paclitaxel sensitivity. We found that Dicer expression was regulated at the transcription level by E1A, through activation of an MAPK14/CEBP alpha pathway. Our findings define a mechanism of E1A-mediated chemosensitization for paclitaxel, which is based upon the suppression of breast cancer stem-like cells, with potential implications for the diagnosis and treatment of breast cancer patients. (C) 2016 AACR.
C1 [Chang, Ting-Yu; Chiu, Ching-Feng; Chang, Yi-Wen; Su, Jen-Liang] Natl Hlth Res Inst, Natl Inst Canc Res, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.
   [Chen, Hsin-An] Taipei Med Univ, Sch Med, Dept Gen Surg, Coll Med, Taipei, Taiwan.
   [Chen, Hsin-An] Taipei Med Univ, Shuang Ho Hosp, Div Gen Surg, Dept Surg, New Taipei, Taiwan.
   [Chen, Hsin-An] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan.
   [Kuo, Tsang-Chih] Natl Taiwan Univ, Inst Biochem Sci, Coll Life Sci, Taipei, Taiwan.
   [Tseng, Po-Chun; Su, Jen-Liang] Asia Univ, Dept Biotechnol, Taichung, Taiwan.
   [Wang, Weu] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Taipei, Taiwan.
   [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.
   [Hung, Mien-Chie; Su, Jen-Liang] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan.
   [Su, Jen-Liang] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan.
RP Su, JL (reprint author), Natl Hlth Res Inst, Natl Inst Canc Res, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan.
EM jlsu@nhri.org.tw
OI Chiu, Ching-Feng/0000-0001-5591-0288
CR Asuthkar S, 2014, ONCOGENE, V33, P1922, DOI 10.1038/onc.2013.151
   Avery-Kiejda KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-253
   Blandino G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1859
   Chang JJ, 2012, BREAST CANCER RES TR, V134, P969, DOI 10.1007/s10549-012-1994-8
   Cheng CJ, 2015, NATURE, V518, P107, DOI 10.1038/nature13905
   Christodoulatos GS, 2014, WORLD J CLIN ONCOL, V5, P71, DOI 10.5306/wjco.v5.i2.71
   Dedes KJ, 2011, EUR J CANCER, V47, P138, DOI 10.1016/j.ejca.2010.08.007
   Deng J, 1998, ONCOGENE, V17, P2167, DOI 10.1038/sj.onc.1202148
   Flinterman M, 2003, ONCOGENE, V22, P1965, DOI 10.1038/sj.onc.1206190
   Gery S, 2005, CLIN CANCER RES, V11, P3184, DOI 10.1158/1078-0432.CCR-04-2625
   Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847
   Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193
   Helgason GV, 2010, CANCER RES, V70, P4074, DOI 10.1158/0008-5472.CAN-09-2876
   Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017
   Hong J, 2013, CANCER RES, V73, P331, DOI 10.1158/0008-5472.CAN-12-3151
   Iliou MS, 2014, ONCOGENE, V33, P4003, DOI 10.1038/onc.2013.398
   Kawahara K, 2014, J ORAL PATHOL MED, V43, P350, DOI 10.1111/jop.12140
   Khoshnaw SM, 2012, BREAST CANCER RES TR, V135, P403, DOI 10.1007/s10549-012-2169-3
   Kim WK, 2011, CLIN CANCER RES, V17, P7584, DOI 10.1158/1078-0432.CCR-11-0166
   Kojima K, 2010, PROSTATE, V70, P1501, DOI 10.1002/pros.21185
   Kuang Y, 2013, ONCOL LETT, V5, P1149, DOI 10.3892/ol.2013.1158
   Lee WP, 1999, MOL CELL BIOL, V19, P8075
   Lee WP, 2003, CANCER RES, V63, P6229
   Liao Y, 2004, CANCER RES, V64, P5938, DOI 10.1158/0008-5472.CAN-04-1533
   Liao Y, 2004, CANCER GENE THER, V11, P594, DOI 10.1038/sj.cgt.7700743
   Liao Y, 2003, MOL CELL BIOL, V23, P6836, DOI 10.1128/MCB.23.19.6836-6848.2003
   Marupudi NI, 2007, EXPERT OPIN DRUG SAF, V6, P609, DOI 10.1517/14740338.6.5.609
   Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785
   Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155
   Mulrane L, 2013, CANCER RES, V73, P6554, DOI 10.1158/0008-5472.CAN-13-1841
   Murray S, 2012, CANCER TREAT REV, V38, P890, DOI 10.1016/j.ctrv.2012.02.011
   Nemajerova A, 2008, CELL DEATH DIFFER, V15, P1440, DOI 10.1038/cdd.2008.66
   Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699
   Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163
   Qi WX, 2013, CURR MED RES OPIN, V29, P117, DOI 10.1185/03007995.2012.756393
   Romano G, 2012, P NATL ACAD SCI USA, V109, P16570, DOI 10.1073/pnas.1207917109
   Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202
   Sato A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057013
   Shao RP, 2005, MOL CANCER RES, V3, P219
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Su JL, 2010, CANCER RES, V70, P5096, DOI 10.1158/0008-5472.CAN-09-4148
   Tolaney SM, 2015, NEW ENGL J MED, V372, P134, DOI 10.1056/NEJMoa1406281
   Ueno NT, 2000, CLIN CANCER RES, V6, P250
   van den Beucken T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6203
   Yamaguchi H, 2010, ONCOGENE, V29, P5619, DOI 10.1038/onc.2010.295
   Yan H, 2013, PHARMACOLOGY, V92, P167, DOI 10.1159/000354585
   Yan M, 2012, PATHOL ONCOL RES, V18, P343, DOI 10.1007/s12253-011-9450-3
   Yu DH, 1998, CANCER METAST REV, V17, P195, DOI 10.1023/A:1006054421970
   Yu ZR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3812
NR 49
TC 10
Z9 10
U1 1
U2 8
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD JUL 1
PY 2016
VL 76
IS 13
BP 3916
EP 3928
DI 10.1158/0008-5472.CAN-15-2555
PG 13
WC Oncology
SC Oncology
GA DR7HU
UT WOS:000380071400027
PM 27216190
OA Bronze
DA 2018-12-27
ER

PT J
AU Tola, PS
   Kim, DH
   Phan, TL
   Liu, C
   Lee, BW
AF Tola, P. S.
   Kim, D. H.
   Phan, T. L.
   Liu, Chunli
   Lee, B. W.
TI RETRACTED: Magnetic properties and magnetocaloric effect of LaMnO3
   nanoparticles prepared by using the sol-gel method (Retracted article.
   See vol. 71, pg. 126, 2017)
SO JOURNAL OF THE KOREAN PHYSICAL SOCIETY
LA English
DT Article; Retracted Publication
DE Manganite nanoparticles; Sol-gel method; Magnetic properties;
   Magnetocaloric effect
ID MANGANITE THIN-FILMS; FERROMAGNETISM; TRANSITIONS; PARTICLES; POWDERS
AB We synthesized LaMnO3 nanoparticles (NPs) with an average particle size of similar to 25 nm by using a sol-gel method with polyvinyl alcohol (PVA). X-ray diffraction studies revealed that the samples exhibited a rhombohedral single phase. The Curie temperature (T (C)) of the ferromagneticparamagnetic (FM-PM) phase transition increased from 218 K for PVA = 0 ml to 287 K for PVA = 5 ml. Concurrently, the magnetic properties of the sample prepared with PVA were improved remarkably. This was ascribed to the presence of excess oxygen which increased the Mn4+/Mn3+ ratio and the FM interactions in the NPs. Particularly, we found that the samples underwent a second-order magnetic phase transition at the T (C). At H = 10 kOe, although their maximum magnetic-entropy change (Delta S (m) ) was small, 0.2 similar to 0.3 J/kg K, the linewidths of the |Delta S (m) (T)| curves were remarkably large, 50 similar to 70 K, leading to a quite large relative cooling power of similar to 17 J/kg.
C1 [Lee, B. W.] Hankuk Univ Foreign Studies, Dept Phys, Yongin 17035, South Korea.
   Hankuk Univ Foreign Studies, Oxide Res Ctr, Yongin 17035, South Korea.
RP Lee, BW (reprint author), Hankuk Univ Foreign Studies, Dept Phys, Yongin 17035, South Korea.
EM bwlee@hufs.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea - Ministry of Education, Science and Technology
   [NRF-2014R1A2A1A11051245, NRF-2014R1A1A3049826]; International
   Cooperation Program through the National Research Foundation of Korea -
   Ministry of Education, Science and Technology [NRF-2015K2A1A2071001]
FX This research was supported by Basic Science Research Program
   (NRF-2014R1A2A1A11051245, NRF-2014R1A1A3049826) and International
   Cooperation Program (NRF-2015K2A1A2071001) through the National Research
   Foundation of Korea funded by the Ministry of Education, Science and
   Technology.
CR ARROTT A, 1957, PHYS REV, V108, P1394, DOI 10.1103/PhysRev.108.1394
   BANERJEE SK, 1964, PHYS LETT, V12, P16
   Bhowmik RN, 2009, J APPL PHYS, V105, DOI 10.1063/1.3138814
   Biswas A, 2012, J ALLOY COMPD, V545, P157, DOI 10.1016/j.jallcom.2012.08.001
   Biswas A, 2008, J APPL PHYS, V103, DOI 10.1063/1.2832431
   Debye P, 1916, PHYS Z, V17, P277
   Dezanneau G, 2003, J SOLID STATE CHEM, V173, P216, DOI 10.1016/S0022-4596(03)00027-6
   Gschneidner KA, 2008, INT J REFRIG, V31, P945, DOI 10.1016/j.ijrefrig.2008.01.004
   Lu WJ, 2008, J APPL PHYS, V104, DOI 10.1063/1.3037236
   Markovich V, 2008, SUPERLATTICE MICROST, V44, P476, DOI 10.1016/j.spmi.2007.10.006
   Markovich V, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/34/346210
   Mathew SP, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/25/256008
   Millis AJ, 1996, PHYS REV LETT, V77, P175, DOI 10.1103/PhysRevLett.77.175
   Mitchell JF, 1996, PHYS REV B, V54, P6172, DOI 10.1103/PhysRevB.54.6172
   Mukherjee K, 2012, SENSOR ACTUAT B-CHEM, V162, P229, DOI 10.1016/j.snb.2011.12.072
   Nagaev EL, 2001, PHYS REP, V346, P388
   Nam DNH, 2000, PHYS REV B, V62, P1027, DOI 10.1103/PhysRevB.62.1027
   Nam DNH, 1999, PHYS REV B, V59, P4189, DOI 10.1103/PhysRevB.59.4189
   Phan MH, 2007, J MAGN MAGN MATER, V308, P325, DOI 10.1016/j.jmmm.2006.07.025
   Phan MH, 2003, J MAGN MAGN MATER, V262, P407, DOI 10.1016/S0304-8853(03)00071-4
   Prellier W, 2001, J PHYS-CONDENS MAT, V13, pR915, DOI 10.1088/0953-8984/13/48/201
   Sadhu A, 2014, CHEM MATER, V26, P1702, DOI 10.1021/cm4041665
   Shimizu Y, 1997, J AM CERAM SOC, V80, P2702
   Stanley H. E., 1971, INTRO PHASE TRANSITI
   Phan TL, 2014, J ALLOY COMPD, V615, P937, DOI 10.1016/j.jallcom.2014.06.107
   Tishin A. M., 2003, MAGNETOCALORIC EFFEC
   Topfer J, 1997, J SOLID STATE CHEM, V130, P117, DOI 10.1006/jssc.1997.7287
   Thanh TD, 2015, J ALLOY COMPD, V649, P981, DOI 10.1016/j.jallcom.2015.07.216
   VERELST M, 1993, J SOLID STATE CHEM, V104, P74, DOI 10.1006/jssc.1993.1142
   ZENER C, 1951, PHYS REV, V82, P403, DOI 10.1103/PhysRev.82.403
NR 30
TC 1
Z9 1
U1 4
U2 24
PU KOREAN PHYSICAL SOC
PI SEOUL
PA 635-4, YUKSAM-DONG, KANGNAM-KU, SEOUL 135-703, SOUTH KOREA
SN 0374-4884
EI 1976-8524
J9 J KOREAN PHYS SOC
JI J. Korean Phys. Soc.
PD JUL
PY 2016
VL 69
IS 1
BP 65
EP 71
DI 10.3938/jkps.69.65
PG 7
WC Physics, Multidisciplinary
SC Physics
GA DR2BL
UT WOS:000379709900013
DA 2018-12-27
ER

PT J
AU Bai, YQ
   Feng, JK
   Zhang, QF
   Wu, HZ
   Du, YR
   Wei, W
AF Bai, Yong-Qiang
   Feng, Jian-Ke
   Zhang, Qing-Fu
   Wu, Hong-Zhi
   Du, Ya-Ru
   Wei, Wei
TI RETRACTED: Effects of the eukaryotic initiation factor 6 gene on
   expression levels of inflammatory mediators in M2 macrophages during
   scar repair (Retracted article. See vol. 16, pg. 5062, 2017)
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article; Retracted Publication
DE eukaryotic initiation factor 6; macrophage; fibrosis
ID ENDOTHELIAL GROWTH-FACTOR; MATRIX METALLOPROTEINASES; DIFFERENTIAL
   EXPRESSION; EXTRACELLULAR-MATRIX; CELLS; PROLIFERATION; RECRUITMENT;
   FIBROBLAST; CONTRIBUTE; FIBROSIS
AB The aim of the present study was to evaluate the effects of the eukaryotic initiation factor 6 ( eIF6) gene on the secretion of M2 macrophage fibrosis-associated factors and the expression levels of key proteases during scar repair. Male eIF6 wild-type ( eIF6(+/+)) and knockout ( eIF6(+/-)) C57BL/6 mice were intraperitoneally lavaged to obtain macrophages, which were induced to the M2 type using interleukin-4. Differences between the gene expression profiles of these macrophages were compared with gene microarrays, and the results were validated using reverse transcription-quantitative polymerase chain reaction analysis and ELISA. Compared with the eIF6(+/-) mice, the mRNA and protein expression levels of vascular endothelial growth factor ( VEGF) and tissue inhibitor of metalloproteinase-2 ( TIMP-2) in the M2 macrophages of the eIF6(+/+) mice were significantly downregulated ( P<0.05), whereas the mRNA and protein expression levels of matrix metalloproteinase-2 ( MMP-2) were significantly upregulated ( P<0.05). Therefore, the results indicated that eIF6 alleviated cicatrization, possibly by inhibiting the generation of VEGF, in order to prevent overgrowth of blood vessels and granulation tissues, and to regulate the MMP-2/TIMP-2 ratio to balance the degradation and deposition of the extracellular matrix.
C1 [Bai, Yong-Qiang; Feng, Jian-Ke; Zhang, Qing-Fu; Wu, Hong-Zhi; Du, Ya-Ru; Wei, Wei] Hebei Med Univ, Dept Burns & Plast Surg, Hosp 1, 89 Donggang Rd, Shijiazhuang 050031, Hebei, Peoples R China.
RP Wei, W (reprint author), Hebei Med Univ, Dept Burns & Plast Surg, Hosp 1, 89 Donggang Rd, Shijiazhuang 050031, Hebei, Peoples R China.
EM weiweidbps@163.com
CR Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160
   Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236
   Ferrante CJ, 2013, INFLAMMATION, V36, P921, DOI 10.1007/s10753-013-9621-3
   GOTO F, 1993, LAB INVEST, V69, P508
   Hamacher S, 2004, DEUT MED WOCHENSCHR, V129, P1976, DOI 10.1055/s-2004-831836
   Hess CL, 2003, ANN PLAS SURG, V51, P210, DOI 10.1097/01.SAP.0000058513.10033.6B
   John GB, 2011, AM J KIDNEY DIS, V58, P127, DOI 10.1053/j.ajkd.2010.12.027
   Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615
   Li W, 2013, STEM CELL RES, V10, P405, DOI 10.1016/j.scr.2013.01.005
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9
   Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248
   Mori R, 2014, AM J PATHOL, V184, P2465, DOI 10.1016/j.ajpath.2014.05.012
   Nayak BS, 2010, J MED FOOD, V13, P1141, DOI 10.1089/jmf.2009.0214
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   Ploeger DTA, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-29
   Raes G, 2002, J LEUKOCYTE BIOL, V71, P597
   Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196
   Senger DR, 1996, AM J PATHOL, V149, P293
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Swiderski RE, 1998, AM J PATHOL, V152, P821
   van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020
   Wang Z, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-119
   Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354
NR 25
TC 2
Z9 2
U1 3
U2 8
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD JUL
PY 2016
VL 14
IS 1
BP 819
EP 824
DI 10.3892/mmr.2016.5294
PG 6
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA DQ9TH
UT WOS:000379551700109
PM 27220600
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Qu, SX
   Li, HP
   Ma, L
   Song, JD
AF Qu, S. X.
   Li, H. P.
   Ma, L.
   Song, J. D.
TI RETRACTED: Insights Into the Evolution of Chemoreceptor Genes
   Superfamily in Tyrophagus putrescentiae (Acari: Acaridae)(Retracted
   article. See vol. 54, pg. 249, 2017)
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article; Retracted Publication
DE gustatory receptor; OR; ionotropic receptor; olfactory system
ID IONOTROPIC GLUTAMATE RECEPTORS; YELLOW-FEVER MOSQUITO; OLFACTORY
   RECEPTORS; ODORANT-BINDING; AEDES-AEGYPTI; BOMBYX-MORI; DROSOPHILA;
   FAMILY; IDENTIFICATION; ANNOTATION
AB All living organisms, including animals, plants, fungi, and bacteria, use the olfactory system to recognize chemicals or pheromone from their environment. Insects detect a volatile substance using odorant receptors (ORs) or gustatory receptors (GRs) and ionotropic receptors (IRs). The gene families of the olfactory system in Acari are still not clear. In this study, we identified seven ORs, one GR, and five IRs from the transcriptome of the storage mite, Tyrophagus putrescentiae Schrank. No olfactory coreceptor was found in this transcriptome. Phylogenetic analysis of these gene families with other Arthropoda species revealed the conservation of carbon dioxide receptors in all tested flying insects and T. putrescentiae. Most of these ORs and GRs were unique to three mosquitoes (Anopheles gambiae Giles, Culex quinquefasciatus Say, and Aedes aegypti L.), Ixodes scapularis Say and Pediculus humanus L., indicating their involvement in specific aspects of both gustatory and olfactory perception. Some clades contained receptors obtained from all tested insect vector species, indicating a degree of conservation among some vector-dependent OR lineages. IRs family was a highly dynamic and independent original of the chemoreceptor genes subfamily. Our findings would make it possible for future research on the chemosensory recognition mechanism in Acari.
C1 [Qu, S. X.; Li, H. P.; Ma, L.; Song, J. D.] Jiangsu Acad Agr Sci, Inst Vegetable Crops, Jiangsu Key Lab Hort Crop Genet Improvement, 50 Zhongling St, Nanjing 210014, Jiangsu, Peoples R China.
RP Song, JD (reprint author), Jiangsu Acad Agr Sci, Inst Vegetable Crops, Jiangsu Key Lab Hort Crop Genet Improvement, 50 Zhongling St, Nanjing 210014, Jiangsu, Peoples R China.
EM qusx@jaas.ac.cn; lhp211@163.com; malin1590@sina.com; ququzhibao@126.com
FU Modern Agro-industry Technology Research System of China [CARS-24]
FX This work was financially supported by the earmarked fund for Modern
   Agro-industry Technology Research System of China (Number: CARS-24).
CR Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042
   Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075
   Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001
   Choi B, 2010, J ALLERGY CLIN IMMUN, V125, pAB18, DOI 10.1016/j.jaci.2009.12.102
   Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4
   Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064
   de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4
   Duek L, 2001, MYCOSES, V44, P390, DOI 10.1046/j.1439-0507.2001.00684.x
   Hughes A. M., 1976, USDA TECHNICAL B
   Jeong KY, 2007, PROTEIN PEPTIDE LETT, V14, P431
   Kent LB, 2008, CHEM SENSES, V33, P79, DOI 10.1093/chemse/bjm067
   Kheradmand K, 2007, J STORED PROD RES, V43, P276, DOI 10.1016/j.jspr.2006.06.007
   Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107
   Krang AS, 2012, P ROY SOC B-BIOL SCI, V279, P3510, DOI 10.1098/rspb.2012.0596
   Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104
   Latorre-Estivalis J. M., 2015, INSECT BIOCH MOL BIO
   Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529
   Li CP, 2003, WORLD J GASTROENTERO, V9, P874, DOI 10.3748/wjg.v9.i4.874
   Liao EC, 2013, J INVEST ALLERG CLIN, V23, P20
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   Meijerink J, 2001, J MOL DIAGN, V3, P55, DOI 10.1016/S1525-1578(10)60652-6
   Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041
   Missbach C, 2014, ELIFE, V3, DOI 10.7554/eLife.02115
   Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701
   Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101
   Qu SX, 2015, J STORED PROD RES, V61, P70, DOI 10.1016/j.jspr.2014.12.003
   Qu S. X., 2015, PEST MANAG IN PRESS
   Riddiford L. M., 1981, NATURE, V289, P161
   Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100
   Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850
   Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X
   Stensmyr MC, 2012, CELL, V151, P1345, DOI 10.1016/j.cell.2012.09.046
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   Van Zee JP, 2007, INT J PARASITOL, V37, P1297, DOI 10.1016/j.ijpara.2007.05.011
   Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033
   Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481
   Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x
   Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x
   Xia YF, 2006, INSECT BIOCHEM MOLEC, V36, P169, DOI 10.1016/j.ibmb.2005.12.003
   Zhang G., 1960, FOOD SCI TECHNOL COM, V2, P23
   Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x
   Zhou XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002930
NR 42
TC 2
Z9 2
U1 4
U2 29
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2016
VL 53
IS 4
BP 753
EP 759
DI 10.1093/jme/tjv257
PG 7
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA DQ4WL
UT WOS:000379204800002
PM 27113112
DA 2018-12-27
ER

PT J
AU Noor, MJ
   Ahmad, M
   Zafar, M
   Sarfraz, M
   Yusoff, I
   Alias, Y
   Ashraf, MA
AF Noor, Mehwish Jamil
   Ahmad, Mushtaq
   Zafar, Muhammad
   Sarfraz, Maliha
   Yusoff, Ismail
   Alias, Yatimah
   Ashraf, Muhammad Aqeel
TI RETRACTED: Floristic and ethnoecological diversity in various habitats
   of a semi-arid area in the Chakwal district (Pakistan), with special
   emphasis on medicinal plants (Retracted Article)
SO PLANT ECOLOGY
LA English
DT Correction; Retracted Publication
C1 [Noor, Mehwish Jamil] Fatima Jinnah Women Univ, Dept Environm Sci, Rawalpindi 46000, Pakistan.
   [Ahmad, Mushtaq; Zafar, Muhammad] Quaid I Azam Univ, Dept Plant Sci, Islamabad 45320, Pakistan.
   [Sarfraz, Maliha] Univ Agr Faisalabad, Dept Physiol & Pharmacol, Faisalabad 38040, Pakistan.
   [Yusoff, Ismail; Ashraf, Muhammad Aqeel] Univ Malaya, Fac Sci, Dept Geol, Kuala Lumpur 50603, Malaysia.
   [Alias, Yatimah] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur 50603, Malaysia.
RP Ashraf, MA (reprint author), Univ Malaya, Fac Sci, Dept Geol, Kuala Lumpur 50603, Malaysia.
EM aqeelashraf@um.edu.my
RI ALIAS, YATIMAH/C-1074-2010
OI ASHRAF, MUHAMMAD AQEEL/0000-0003-3151-3397
CR NOOR MJ, PLANT ECOL
NR 1
TC 1
Z9 1
U1 1
U2 15
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1385-0237
EI 1573-5052
J9 PLANT ECOL
JI Plant Ecol.
PD JUL
PY 2016
VL 217
IS 7
BP 943
EP 943
DI 10.1007/s11258-014-0384-1
PG 1
WC Plant Sciences; Ecology; Forestry
SC Plant Sciences; Environmental Sciences & Ecology; Forestry
GA DQ4LE
UT WOS:000379174600011
OA Bronze
DA 2018-12-27
ER

PT J
AU Hu, M
   Liu, B
AF Hu, Min
   Liu, Bo
TI RETRACTED: Resveratrol attenuates lipopolysaccharide-induced dysfunction
   of blood-brain barrier in endothelial cells via AMPK
   activation(Retracted article. See vol. 21, pg. 277, 2017)
SO KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
LA English
DT Article; Retracted Publication
DE AMPK; Blood -brain barrier; LPS; NAD(P)H oxidase; Resveratrol
ID ACTIVATED PROTEIN-KINASE; INDUCED OXIDATIVE STRESS; TIGHT-JUNCTION
   DYNAMICS; IN-VIVO; APOPTOSIS; PRESSURE; OXIDASE; HEALTH
AB Resveratrol, a phytoalexin, is reported to activate AMP-activated protein kinase (AMPK) in vascular cells. The blood-brain barrier (BBB), formed by specialized brain endothelial cells that are interconnected by tight junctions, strictly regulates paracellular permeability to maintain an optimal extracellular environment for brain homeostasis. The aim of this study was to elucidate the effects of resveratrol and the role of AMPK in BBB dysfunction induced by lipopolysaccharide (LPS). Exposure of human brain microvascular endothelial cells (HBMECs) to LPS (1 mu g/ml) for 4 to 24 hours week dramatically increased the permeability of the BBB in parallel with lowered expression levels of occluding and claudin-5, which are essential to maintain tight junctions in HBMECs. In addition, LPS significantly increased the reactive oxygen species (ROS) productions. All effects induced by LPS in HBVMCs were reversed by adenoviral overexpression of superoxide dismutase, inhibition of NAD(P)H oxidase by apocynin or gain-function of AMPK by adenoviral overexpression of constitutively active mutant (AMPK-CA) or by resveratrol. Finally, upregulation of AMPK by either AMPK-CA or resveratrol abolished the levels of LPS-enhanced NAD(P) H oxidase subunits protein expressions. We conclude that AMPK activation by resveratrol improves the integrity of the BBB disrupted by LPS through suppressing the induction of NAD(P) H oxidase-derived ROS in HBMECs.
C1 [Hu, Min] Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.
   [Liu, Bo] Cent S Univ, Xiangya Hosp 3, Dept Orthopaed, Changsha 410013, Hunan, Peoples R China.
RP Hu, M (reprint author), Peking Univ, Coll Engn, Dept Biomed Engn, Beijing 100871, Peoples R China.; Liu, B (reprint author), Cent S Univ, Xiangya Hosp 3, Dept Orthopaed, Changsha 410013, Hunan, Peoples R China.
EM hu15084737958@139.com; Liu1367251@163.com
CR Cardoso FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035919
   Cheng PW, 2014, BRIT J PHARMACOL, V171, P2739, DOI 10.1111/bph.12648
   Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009
   Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699
   Guo S, 2015, MOL CELL ENDOCRINOL, V412, P85, DOI 10.1016/j.mce.2015.05.034
   Hamza SM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00292
   Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4
   Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218
   Kim SJ, 2013, KOREAN J PHYSIOL PHA, V17, P331, DOI 10.4196/kjpp.2013.17.4.331
   Lee BH, 2013, KOREAN J PHYSIOL PHA, V17, P175, DOI 10.4196/kjpp.2013.17.2.175
   Li GX, 2015, KOREAN J PHYSIOL PHA, V19, P1, DOI 10.4196/kjpp.2015.19.1.1
   Liu C, 2012, FREE RADICAL BIO MED, V53, P1213, DOI 10.1016/j.freeradbiomed.2012.07.003
   Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x
   Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055
   Pasquier F, 2006, DIABETES METAB, V32, P403, DOI 10.1016/S1262-3636(07)70298-7
   Penumathsa SV, 2008, J CELL MOL MED, V12, P2350, DOI 10.1111/j.1582-4934.2008.00251.x
   Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003
   Rahman MA, 2012, KOREAN J PHYSIOL PHA, V16, P321, DOI 10.4196/kjpp.2012.16.5.321
   Ristow M, 2004, J MOL MED, V82, P510, DOI 10.1007/s00109-004-0552-1
   Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0
   Schreibelt G, 2007, FASEB J, V21, P3666, DOI 10.1096/fj.07-8329com
   Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017
   Song P, 2012, FREE RADICAL BIO MED, V52, P1607, DOI 10.1016/j.freeradbiomed.2012.01.025
   Song P, 2011, CIRC RES, V109, P1230, DOI 10.1161/CIRCRESAHA.111.250423
   Wang SB, 2012, CLIN SCI, V122, P555, DOI 10.1042/CS20110625
   Wang SX, 2008, HYPERTENSION, V52, P484, DOI 10.1161/HYPERTENSIONAHA.108.112094
   Wang SX, 2012, NAT MED, V18, P902, DOI 10.1038/nm.2711
   Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530
   Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267
   Xu Q, 2012, NUTR RES, V32, P648, DOI 10.1016/j.nutres.2012.07.002
   Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015
NR 31
TC 7
Z9 7
U1 4
U2 16
PU KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
PI SEOUL
PA C/O EDITORIAL OFFICE, 448-13 SEOKYO-DONG, SEOUL, SOUTH KOREA
SN 1226-4512
EI 2093-3827
J9 KOREAN J PHYSIOL PHA
JI KOREAN J. PHYSIOL. PHARMACOL.
PD JUL
PY 2016
VL 20
IS 4
BP 325
EP 332
DI 10.4196/kjpp.2016.20.4.325
PG 8
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA DQ0AU
UT WOS:000378860300001
PM 27382348
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Li, J
   Li, HY
   Liu, JH
   Feng, B
   Feng, M
   Lv, BY
   Cheng, SM
   Yang, XS
AF Li, Jing
   Li, Huiying
   Liu, Jihong
   Feng, Bin
   Feng, Man
   Lv, Baoyu
   Cheng, Shaomei
   Yang, Xiangshan
TI RETRACTED: The Clinical Implications of Human Telomerase Reverse
   Transcriptase Expression in Grade and Prognosis of Gliomas: a Systematic
   Review and Meta-analysis (Retracted article. See vol. 54, pg. 7552,
   2017)
SO MOLECULAR NEUROBIOLOGY
LA English
DT Review; Retracted Publication
DE HTERT; Gliomas; Grade; Prognosis; Meta-analysis
ID ASTROCYTIC GLIOMAS; CANCER-CELLS; HTERT; TUMORS; SURVIVAL; BRAIN
AB Human telomerase reverse transcriptase (hTERT), a ribonucleoprotein, is reported as an important complex, which is required for stability of DNA molecular structure at the rear of the chromosome. Until now, hTERT has been linked to cell immortalization and tumorigenesis. A couple of articles have been published about the telomerase function in the gliomas; however, these results are conflicting in some degree. Thus, it is crucial to perform a meta-analysis to identify their real actions. We included eligible articles, and estimated odds ratios (ORs) with 95 % confidence intervals (95 % CIs). In our meta-analysis, all 15 eligible articles included 932 patients. Results from 10 studies on WHO grade showed that high hTERT gene or protein expression in glioma tissues was obviously related to high WHO grade (III + IV) (OR 2.45, 95 % CI 1.92-3.13; p = 0.000). What is more, hTERT expression was not associated with old age (OR 0.91, 95 % CI 0.72-1.16; p = 0.448) as well as gender (OR 1.06, 95 % CI 0.82-1.37; p = 0.664). Importantly, hTERT expression was significantly associated with 5-year overall survival (OS; n = 3; hazard ratio (HR) 2.25, 95 % CI 1.36-3.70; p = 0.002) of glioma patients. No heterogeneity was found in all studies. In conclusion, this meta-analysis suggests that hTERT is significantly associated with high glioma grade and poor 5-year overall survival, and pathological test of hTERT mRNA and protein in glioma tissues should be suggested as criteria of glioma grade in the clinical practice.
C1 [Li, Jing; Feng, Bin] Shandong Acad Med Sci, Affiliated Hosp, Deans Off, Jinan, Shandong, Peoples R China.
   [Li, Huiying] Shandong Acad Med Sci, Affiliated Hosp, Dept Special Inspect, Jinan, Shandong, Peoples R China.
   [Liu, Jihong] Shandong Acad Med Sci, Affiliated Hosp, Dept Intern Med 6, Jinan, Shandong, Peoples R China.
   [Feng, Man; Yang, Xiangshan] Shandong Acad Med Sci, Affiliated Hosp, Dept Pathol, Jinan, Shandong, Peoples R China.
   [Lv, Baoyu] Shandong Acad Med Sci, Affiliated Hosp, Dept Nursing, Jinan, Shandong, Peoples R China.
   [Cheng, Shaomei] Shandong Acad Med Sci, Affiliated Hosp, Dept Gynecol, Jinan, Shandong, Peoples R China.
RP Yang, XS (reprint author), Shandong Acad Med Sci, Affiliated Hosp, Dept Pathol, Jinan, Shandong, Peoples R China.
EM yangxiangshan163@163.com
FU Science and Technology Project of Shandong Province Academy of Medical
   Sciences [2013015]
FX This study was supported by Science and Technology Project of Shandong
   Province Academy of Medical Sciences (2013015). We greatly thank other
   members in Yang Lab for valuable suggestions and writing.
CR BEGG CB, 1989, J NATL CANCER I, V81, P107, DOI 10.1093/jnci/81.2.107
   Boldrini L, 2006, INT J ONCOL, V28, P1555
   Cabuy E, 2001, VIRCHOWS ARCH, V439, P176, DOI 10.1007/s004280100466
   Chaires JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115580
   Chong EYY, 2000, PATHOL RES PRACT, V196, P691, DOI 10.1016/S0344-0338(00)80121-1
   Janknecht R, 2004, FEBS LETT, V564, P9, DOI 10.1016/S0014-5793(04)0356-4
   Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215
   Kotoula V, 2006, ACTA NEUROPATHOL, V111, P569, DOI 10.1007/s00401-006-0036-1
   Kotoula V, 2004, ACTA NEUROPATHOL, V107, P443, DOI 10.1007/s00401-004-0832-4
   Kovalenko N A, 2013, Mol Biol (Mosk), V47, P544
   Li J, 2013, MOL MED REP, V7, P1409, DOI 10.3892/mmr.2013.1376
   Li Y, 2004, QINGDAO U, V1, P12
   Li YH, 2013, INT J ONCOL, V43, P151, DOI 10.3892/ijo.2013.1921
   LIU Y, 2008, SHANDONG MED, V48, P15
   Ma Y, 2008, CHIN NEUROSURG FORUM, V1, P613
   Mack F, 2014, ONCOLOGY-BASEL, V86, P369, DOI 10.1159/000360295
   Padhi S, 2015, J CANCER, V6, P192, DOI 10.7150/jca.9558
   Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
   Ruden M, 2013, CANCER TREAT REV, V39, P444, DOI 10.1016/j.ctrv.2012.06.007
   Steels E, 2001, EUR RESPIR J, V18, P705, DOI 10.1183/09031936.01.00062201
   Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8
   Tchirkov A, 2003, BRIT J CANCER, V88, P516, DOI 10.1038/sj.bjc.6600754
   Wang D, 2006, SHANDONG MED, V46, P6
   Wang Y, 2006, SHANDONG MED, V35, P681
   Wang Y, 2013, ACTA U MED NANJING, V33, P1110
   Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126
   Woolf Eric C, 2012, CNS Oncol, V1, P7, DOI 10.2217/cns.12.9
   Yang W, 2004, CMINS, V9, P29
   [于士柱 Yu Shizhu], 2003, [中华病理学杂志, Chinese Journal of Pathology], V32, P215
   Zhao LiBin, 2009, China Tropical Medicine, V9, P1693
NR 30
TC 3
Z9 3
U1 2
U2 11
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD JUL
PY 2016
VL 53
IS 5
BP 2887
EP 2893
DI 10.1007/s12035-015-9170-x
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA DO7AU
UT WOS:000377935400014
PM 25895660
DA 2018-12-27
ER

PT J
AU Selina, NV
   Tumayev, EN
AF Selina, N. V.
   Tumayev, E. N.
TI RETRACTED: Propagation of Electromagnetic Waves in the Pendry Lens
   (Retracted article. See vol. 11, pg. 842, 2016)
SO NANOTECHNOLOGIES IN RUSSIA
LA English
DT Article; Retracted Publication
ID NEGATIVE REFRACTION
AB The propagation of a monochromatic electromagnetic wave in a periodic stratified medium, the refractive index of which has a stepped profile, is investigated. A method for solving Maxwell equations for a piecewise-homogeneous medium is proposed, via which an analytical solution of the wave equation in a closed form has been obtained. Using the obtained solution, the propagation of an electromagnetic wave in a superlens (Pendry superlens) implemented employing a metal plate of nanosized thickness has been studied. It is proved via calculations that, using a superlens, one can achieve an angular resolution exceeding the diffraction limit. A phenomenon of negative refraction is also shown to take place in such a lens.
C1 [Selina, N. V.; Tumayev, E. N.] Kuban State Univ, Ul Stavropolskaya 149, Krasnodar 350040, Russia.
RP Selina, NV (reprint author), Kuban State Univ, Ul Stavropolskaya 149, Krasnodar 350040, Russia.
EM Selina_Natalia@mail.ru; tumayev@phys.kubsu.ru
CR JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370
   Klimov V. V., 2011, NANOPLASMONICS
   Landau L. D., 1967, COURSE THEORITICAL P, V10, P509
   LANDAU LD, 2003, COURSE THEORETICAL P, V8
   Oulton RF, 2013, NAT PHYS, V9, P323, DOI 10.1038/nphys2645
   Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907
   Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966
   VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699
NR 8
TC 1
Z9 1
U1 1
U2 1
PU PLEIADES PUBLISHING INC
PI MOSCOW
PA PLEIADES PUBLISHING INC, MOSCOW, 00000, RUSSIA
SN 1995-0780
EI 1995-0799
J9 NANOTECHNOL RUSS
JI Nanotechnol. Russ.
PD JUL
PY 2016
VL 11
IS 7-8
BP 491
EP 496
DI 10.1134/S1995078016040145
PG 6
WC Nanoscience & Nanotechnology
SC Science & Technology - Other Topics
GA FG5WF
UT WOS:000410419100014
DA 2018-12-27
ER

PT J
AU Xu, M
   Wang, HF
   Zhang, YY
   Zhuang, HW
AF Xu, Meng
   Wang, Hai-Feng
   Zhang, Ying-Ying
   Zhuang, Hui-Wen
TI RETRACTED: Protection of rats spinal cord ischemia-reperfusion injury by
   inhibition of MiR-497 on inflammation and apoptosis: Possible role in
   pediatrics (Retracted article. See vol. 98, pg. 927, 2018)
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article; Retracted Publication
DE miR-497; Spinal cord ischemia-reperfusion; IRAK1; TLR4; CREB
ID ELEMENT-BINDING PROTEIN; BREAST-CANCER; EXPRESSION; CELLS
AB MicroRNAs are extensively included in the pathogenesis and progression of many diseases by inhibiting target gene expression. Recently, studies have demonstrated that microRNA-497 (miR-497) may be implicated in human breast cancer that miR-497 predicts the prognosis of breast cancer patients from the posttranscriptional level. However, the specific function of miR-497 in spinal cord ischemia-reperfusion (IR) injury is far from clear nowadays. The present study was designed to determine the role of miR-497 in spinal cord IR injury and investigate the underlying spinal cord protective mechanism. The rat spinal cord IR injury model was performed by occluding the left anterior descending coronary artery for 30 min, which is then followed by 12 h reperfusion. As predicted, miR-497 over-expression markedly decreased the expression of IL-1 receptor associated kinase (IRAK1) and Cyclic AMP response element binding protein (CREB). Moreover, Toll-like receptor 4 (TLR4), nuclear factor-kappa B (NF-kappa B) and Caspase-3, as miR-497 potential targets were significantly suppressed after miR-497 transfection, then preventing inflammatory cytokines and factors regulating apoptosis. We also found that tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1 beta) activity, pro-apoptotic related genes, such as extracellular regulated protein kinases (ERK), Bcl-2 Associated X Protein (Bax), Bcl-2, Bcl-xL levels were all decreased associated with the down-regulation of IRAK1 and CREB. In conclusion, our data demonstrate that miR-497 could inhibit inflammation and apoptosis of spinal cord IR through its targets, IRAK1 of TLR4 and CREB signaling pathway. Thus, miR-497 may constitute a new therapeutic target for the prevention of spinal cord IR injury. (C) 2016 Elsevier Masson SAS. All rights reserved.
C1 [Xu, Meng; Wang, Hai-Feng; Zhuang, Hui-Wen] Yishui Cent Hosp, Dept Pediat Surg, Linyi 276400, Shandong, Peoples R China.
   [Zhang, Ying-Ying] Yishui Cent Hosp, Dept Hand & Foot Surg, Linyi 276400, Shandong, Peoples R China.
RP Xu, M; Wang, HF (reprint author), Yishui Cent Hosp, Dept Pediat Surg, Linyi 276400, Shandong, Peoples R China.
EM xumeng276400@sina.com; wang@126.com
FU National Natural Science Foundation of China [51206181]
FX This work was supported in part from the National Natural Science
   Foundation of China (No. 51206181).
CR Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Bell MT, 2013, CIRCULATION, V128, pS152, DOI 10.1161/CIRCULATIONAHA.112.000024
   Fang B, 2013, INT J MOL SCI, V14, P10343, DOI 10.3390/ijms140510343
   Jambal P, 2003, J BIOL CHEM, V278, P23055, DOI 10.1074/jbc.M212450200
   Kahn RA, 2007, SEMIN CARDIOTHORAC V, V11, P205, DOI 10.1177/1089253207306098
   Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800
   Li XQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-62
   Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0
   Luo QF, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-95
   Luxenhofer G, 2014, DEV BIOL, V386, P358, DOI 10.1016/j.ydbio.2013.12.023
   Ni B, 2013, INT J NEUROSCI, V123, P745, DOI 10.3109/00207454.2013.796551
   Nieto-Diaz M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00053
   Ozata DM, 2011, ENDOCR-RELAT CANCER, V18, P643, DOI 10.1530/ERC-11-0082
   Poell JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043569
   Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761
   Rahman AH, 2008, J IMMUNOL, V181, P3804, DOI 10.4049/jimmunol.181.6.3804
   Shafi G, 2010, CAN J NEUROL SCI, V37, P177, DOI 10.1017/S0317167100009902
   Shen L, 2012, EXP THER MED, V3, P475, DOI 10.3892/etm.2011.428
   Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080
   Zhu W, 2012, MED ONCOL, V29, P384, DOI 10.1007/s12032-010-9797-4
NR 20
TC 12
Z9 17
U1 3
U2 9
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUL
PY 2016
VL 81
BP 337
EP 344
DI 10.1016/j.biopha.2016.04.028
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA DN8RO
UT WOS:000377347300042
PM 27261611
DA 2018-12-27
ER

PT J
AU Lamie, PF
AF Lamie, Phoebe F.
TI RETRACTED: Design, synthesis, structure-activity relationship and kinase
   inhibitory activity of substituted
   3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ones (Retracted article.
   See vol. 27, pg. 4220, 2017)
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article; Retracted Publication
DE Cyclin-dependant kinase; Cell cycle; Cancer; Roscovitine
ID CYCLIN-DEPENDENT KINASES; BIOLOGICAL EVALUATION; ANTIPROLIFERATIVE
   ACTIVITY; CELL-LINES; IDENTIFICATION; OPTIMIZATION; EGFR
AB A new series of 3-methyl-1-phenyl-1H-pyrazolo[3,4-d] pyrimidin-4-ones having variable substitutions at N5 and C6 positions has been synthesized and characterized. The synthesized compounds were tested for cytotoxicity against K562 and MCF-7 cancer cell lines and for inhibition of protein kinases CDK1/cyclin B, CDK2/cyclin E and Abl. Compounds 5f and 5h killed both K562 and MCF-7 cell lines with IC50 values 8.2, 9.6 mu M and 15.3, 10.8 mu M, respectively. In addition, 5f and 5h showed antiproliferative effect through arrest in G2/M phase on cell cycle of K562 cancer cell line in a dose-dependant manner. To confirm the mechanism of cell death, activity of caspase-3/7 was measured. Moreover, kinase selectivity profiling of the most potent compound 5f revealed several other sensitive targets, including RSK1 and RIPK2, TrkA and VEGFR. The results provide a starting point for optimization in order to increase their potency against kinases and cancer cell lines. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Lamie, Phoebe F.] Beni Suef Univ, Fac Pharm, Dept Organ Pharmaceut Chem, Bani Suwayf 62514, Egypt.
RP Lamie, PF (reprint author), Beni Suef Univ, Fac Pharm, Dept Organ Pharmaceut Chem, Bani Suwayf 62514, Egypt.
CR Bernardini G, 2014, MOL BIOSYST, V10, P1305, DOI 10.1039/c3mb70328b
   Burchat AF, 2002, BIOORG MED CHEM LETT, V12, P1687, DOI 10.1016/S0960-894X(02)00196-8
   Caligluri M, 2005, CHEM BIOL, V12, P1103, DOI 10.1016/j.chembiol.2005.08.008
   Cavasotto CN, 2006, BIOORG MED CHEM LETT, V16, P1969, DOI 10.1016/j.bmcl.2005.12.067
   Chauhan M, 2013, BIOORGAN MED CHEM, V21, P5657, DOI 10.1016/j.bmc.2013.07.027
   Cozzi M, 2012, CELL CYCLE, V11, P1029, DOI 10.4161/cc.11.5.19519
   Ducray R, 2008, BIOORG MED CHEM LETT, V18, P959, DOI 10.1016/j.bmcl.2007.12.035
   Havlicek L, 1997, J MED CHEM, V40, P408, DOI 10.1021/jm960666x
   Jorda R, 2012, CURR PHARM DESIGN, V18, P2974, DOI 10.2174/138161212800672804
   Jorda R, 2011, J MED CHEM, V54, P2980, DOI 10.1021/jm200064p
   Kandeel MM, 2013, J CHEM SCI, V125, P1029, DOI 10.1007/s12039-013-0485-8
   Kim DC, 2003, EUR J MED CHEM, V38, P525, DOI 10.1016/S00223-5234(03)00065-5
   Kopecky DJ, 2008, BIOORG MED CHEM LETT, V18, P6352, DOI 10.1016/j.bmcl.2008.10.092
   Le Brazidec JY, 2012, BIOORG MED CHEM LETT, V22, P2070, DOI 10.1016/j.bmcl.2012.01.019
   Legraverend M, 2006, BIOORGAN MED CHEM, V14, P3987, DOI 10.1016/j.bmc.2005.12.060
   Markwalder JA, 2004, J MED CHEM, V47, P5894, DOI 10.1021/jm020455u
   Paruch K, 2007, BIOORG MED CHEM LETT, V17, P6220, DOI 10.1016/j.bmc1.2007.09.017
   Peat AJ, 2004, BIOORG MED CHEM LETT, V14, P2121, DOI 10.1016/j.bmcl.2004.02.036
   Radi M, 2013, J MED CHEM, V56, P5382, DOI 10.1021/jm400233w
   Saito Y, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004387
   Santucci MA, 2009, CHEMMEDCHEM, V4, P118, DOI 10.1002/cmdc.200800320
   Sartini S, 2014, J MED CHEM, V57, P1225, DOI 10.1021/jm401358b
   Schenone S, 2014, CHEM REV, V114, P7189, DOI 10.1021/cr400270z
   Soth M, 2011, BIOORG MED CHEM LETT, V21, P3452, DOI 10.1016/j.bmcl.2011.03.098
   Wang GT, 2010, BIOORG MED CHEM LETT, V20, P6067, DOI 10.1016/j.bmcl.2010.08.052
   Zatloukal M, 2013, EUR J MED CHEM, V61, P61, DOI 10.1016/j.ejmech.2012.06.036
NR 26
TC 1
Z9 1
U1 1
U2 14
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD JUL 1
PY 2016
VL 26
IS 13
BP 3093
EP 3097
DI 10.1016/j.bmcl.2016.05.004
PG 5
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA DO0LO
UT WOS:000377470600026
PM 27189674
DA 2018-12-27
ER

PT J
AU Liu, H
   Luo, ZX
   Liu, ZK
   Yang, J
   Kan, SF
AF Liu, Hua
   Luo, Zhengxiang
   Liu, Zhongkun
   Yang, Jian
   Kan, Shifeng
TI RETRACTED: Atorvastatin May Attenuate Recurrence of Chronic Subdural
   Hematoma (Retracted article. See vol.10,pg.465,2016)
SO FRONTIERS IN NEUROSCIENCE
LA English
DT Article; Retracted Publication
DE Chronic subdural hematoma; atorvastatin; recurrence
ID CLOSED-SYSTEM DRAINAGE; BURR-HOLE CRANIOSTOMY; SURGICAL-TREATMENT;
   POSTOPERATIVE RECURRENCE; INDEPENDENT PREDICTORS; BRAIN REEXPANSION;
   ANGIOGENESIS; STATINS; NEUROGENESIS
AB Objective: Chronic subdural hematoma (CSDH) is a common form of intracranial hemorrhage with a substantial recurrence rate. Atorvastatin may reduce CSDH via its anti-inflammatory and pro-angiogenesis effects, but its effectiveness for preventing recurrent CSDH has never been explored. We hypothesized that atorvastatin is effective in reducing recurrence of CSDH after surgery and identified determining factors predictive of hematoma recurrence.
   Methods: A prospective study was conducted in 168 surgical cases of CSDH.All patients were randomly assigned to the group treated with atorvastatin or control group. Clinically relevant data were compared between two groups, and subsequently between the recurrence and non-recurrence patients. Multiple logistic regression analysis of the relationship between atorvastatin treatment and the recurrence using brain atrophy, septated and bilateral hematoma was performed.
   Results: Atorvastatin group conferred an advantage by significantly decreasing the recurrence rate (P = 0.023), and patients managed with atorvastatin also had a longer time-to-recurrence (P = 0.038). Admission brain atrophy and bilateral hematoma differed significantly between the recurrence and non-recurrence patients (P = 0.047 and P = 0.045). The results of logistic regression analysis showed that atorvastatin significantly reduced the probability of recurrence; severe brain atrophy and bilateral hematoma were independent risk factors for recurrent CSDH.
   Conclusions: Atorvastatin administration may decrease the risks of recurrence. Patients with severe brain atrophy and bilateral CSDH are prone to the recurrence.
C1 [Liu, Hua; Yang, Jian] Jiangsu Univ, Dept Neurosurg, Peoples Hosp Kunshan 1, Suzhou, Peoples R China.
   [Luo, Zhengxiang] Nanjing Med Univ, Dept Neurosurg, Affiliated Brain Hosp, Nanjing, Jiangsu, Peoples R China.
   [Liu, Zhongkun] Peoples Hosp AnQiu City, Dept Neurosurg, Weifang, Peoples R China.
   [Kan, Shifeng] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Rehabil Med, Shanghai, Peoples R China.
RP Kan, SF (reprint author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 1, Dept Rehabil Med, Shanghai, Peoples R China.
EM 15850351698@163.com
CR Amirjamshidi A, 2007, BRIT J NEUROSURG, V21, P272, DOI 10.1080/02688690701272232
   Araujo FA, 2010, BIOMED PHARMACOTHER, V64, P29, DOI 10.1016/j.biopha.2009.03.003
   Buttmann M, 2007, J NEUROCHEM, V102, P1001, DOI 10.1111/j.1471-4159.2007.04563.x
   Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555
   Ernestus RI, 1997, SURG NEUROL, V48, P220, DOI 10.1016/S0090-3019(97)80031-6
   Frati A, 2004, J NEUROSURG, V100, P24, DOI 10.3171/jns.2004.100.1.0024
   Fukuhara T, 1996, SURG NEUROL, V45, P570, DOI 10.1016/0090-3019(95)00471-8
   Hohenstein A, 2005, J NEUROTRAUM, V22, P518, DOI 10.1089/neu.2005.22.518
   Javadi A, 2011, WORLD NEUROSURG, V75, P731, DOI 10.1016/j.wneu.2010.11.042
   KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207
   Kung WM, 2012, INJURY, V43, P598, DOI 10.1016/j.injury.2010.07.240
   Kurokawa Y, 2005, SURG NEUROL, V64, P444, DOI 10.1016/j.surneu.2004.12.030
   Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288
   MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390
   Matsumura M, 2009, J ATHEROSCLER THROMB, V16, P319, DOI 10.5551/jat.No026
   Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371
   Nakaguchi H, 2001, J NEUROSURG, V95, P256, DOI 10.3171/jns.2001.95.2.0256
   Penchet G, 1998, NEUROCHIRURGIE, V44, P247
   Pripp AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090149
   PROBST C, 1988, J NEUROSURG, V68, P908, DOI 10.3171/jns.1988.68.6.0908
   ROBINSON RG, 1984, J NEUROSURG, V61, P263, DOI 10.3171/jns.1984.61.2.0263
   SCOTTI G, 1977, J NEUROSURG, V47, P311, DOI 10.3171/jns.1977.47.3.0311
   Stanisic M, 2005, ACTA NEUROCHIR, V147, P1249, DOI 10.1007/s00701-005-0616-1
   Tanikawa M, 2001, ACTA NEUROCHIR, V143, P613, DOI 10.1007/s007010170067
   Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17
   Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8
   WAKAI S, 1990, NEUROSURGERY, V26, P771, DOI 10.1227/00006123-199005000-00006
   Wang D, 2014, J NEUROL SCI, V336, P237, DOI [10.1016/jjns.2013.11.005, 10.1016/j.jns.2013.11.005]
   Yamamoto H, 2003, J NEUROSURG, V98, P1217, DOI 10.3171/jns.2003.98.6.1217
   Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158
NR 30
TC 5
Z9 5
U1 2
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-453X
J9 FRONT NEUROSCI-SWITZ
JI Front. Neurosci.
PD JUN 28
PY 2016
VL 10
AR 303
DI 10.3389/fnins.2016.00303
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA DQ7NU
UT WOS:000379395200001
PM 27445673
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Robertson, IJ
   Bennani, F
   Ryan, RS
   Khan, W
   Barry, MK
AF Robertson, Ian J.
   Bennani, Fadel
   Ryan, Ronan S.
   Khan, Waqar
   Barry, M. Kevin
TI RETRACTED: Paediatric Ewing-like sarcoma arising from the cranium - a
   unique diagnostic challenge(Retracted article. See vol.11,pg.97,2016)
   (Retracted article. See vol. 11, 2016)
SO DIAGNOSTIC PATHOLOGY
LA English
DT Article; Retracted Publication
DE Sarcoma; Ewing; CIC-DUX-4; Scalp
ID ROUND-CELL SARCOMAS; SOFT-TISSUE SARCOMAS; FUSION; TRANSLOCATION;
   TUMORS; TRIAL
C1 [Robertson, Ian J.; Khan, Waqar; Barry, M. Kevin] Mayo Gen Hosp, Dept Surg, Castlebar, Co Mayo, Ireland.
   [Bennani, Fadel] Mayo Gen Hosp, Dept Histopathol, Castlebar, Co Mayo, Ireland.
   [Ryan, Ronan S.] Mayo Gen Hosp, Dept Diagnost Radiol, Castlebar, Co Mayo, Ireland.
   [Barry, M. Kevin] NUIG, Surg, Galway, Ireland.
RP Robertson, IJ (reprint author), Mayo Gen Hosp, Dept Surg, Castlebar, Co Mayo, Ireland.
EM irobertson@me.com
CR Antonescu C, 2014, HISTOPATHOLOGY, V64, P26, DOI 10.1111/his.12281
   CRUSSI FG, 1979, AM J SURG PATHOL, V3, P157
   Davicioni E, 2008, MOL DIAGN THER, V12, P359, DOI 10.2165/1250444-200812060-00003
   Eilber FC, 2008, J SURG ONCOL, V97, P314, DOI 10.1002/jso.20974
   Graham C, 2012, HUM PATHOL, V43, P180, DOI 10.1016/j.humpath.2011.04.023
   Italiano A, 2012, GENE CHROMOSOME CANC, V51, P207, DOI 10.1002/gcc.20945
   Juergens C, 2006, PEDIATR BLOOD CANCER, V47, P22, DOI 10.1002/pbc.20820
   Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136
   Ladenstein R, 2010, J CLIN ONCOL, V28, P3284, DOI 10.1200/JCO.2009.22.9864
   Mackall CL, 2002, CANCER CELL, V2, P175, DOI 10.1016/S1535-6108(02)00132-0
   Meyer WH, 2004, CANCER TREAT REV, V30, P269, DOI 10.1016/j.ctrv.2003.11.001
   Ng TL, 2007, J MOL DIAGN, V9, P459, DOI 10.2353/jmoldx.2007.070009
   Qualman SJ, 1998, PEDIATR DEVEL PATHOL, V1, P550, DOI 10.1007/s100249900076
   Sebire NJ, 2002, PEDIATR DEVEL PATHOL, V5, P579, DOI 10.1007/s10024-002-0022-0
   Somers GR, 2006, PEDIATR DEVEL PATHOL, V9, P132, DOI 10.2350/08-05-0098.1
   van de Rijn M, 2006, ANNU REV PATHOL-MECH, V1, P435, DOI 10.1146/annurev.pathol.1.110304.100052
   Yoshimoto M, 2009, CANCER GENET CYTOGEN, V195, P1, DOI 10.1016/j.cancergencyto.2009.06.015
NR 17
TC 1
Z9 1
U1 5
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1746-1596
J9 DIAGN PATHOL
JI Diagn. Pathol.
PD JUN 24
PY 2016
VL 11
AR 54
DI 10.1186/s13000-016-0502-6
PG 8
WC Pathology
SC Pathology
GA DQ6FB
UT WOS:000379298800002
PM 27342568
OA DOAJ Gold, Green Accepted
DA 2018-12-27
ER

PT J
AU Li, QB
   Wang, CY
   Huo, YQ
   Jia, ZW
   Wang, XQ
AF Li, Qingbo
   Wang, Chuanying
   Huo, Yanqing
   Jia, Zhiwei
   Wang, Xiqian
TI RETRACTED: Minimally invasive versus open surgery for acute Achilles
   tendon rupture: a systematic review of overlapping meta-analyses
   (Retracted article. See vol. 13, art. 156, 2018)
SO JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH
LA English
DT Article; Retracted Publication
DE Achilles tendon rupture; Minimally invasive surgery; Open surgery;
   Systematic review; Meta-analysis
ID METHODOLOGICAL QUALITY; PERCUTANEOUS REPAIR; CONTROLLED-TRIALS;
   MEASUREMENT TOOL; FRACTURES; DEVICE; AMSTAR
AB Background: A number of meta-analyses have been carried out to evaluate the effects of minimally invasive surgery (MIS) versus open surgery (OS) for acute Achilles tendon rupture. However, discordant findings were seen in these meta-analyses. The present study, performing a systematic review of overlapping meta-analyses regarding MIS versus OS of acute Achilles tendon rupture, aimed to assist decision-makers interpret and choose among conflicting meta-analyses, as well as to offer treatment recommendations based on current best evidence.
   Methods: The literature search was performed to identify systematic reviews comparing MIS with OS for Achilles tendon rupture. Meta-analyses only comprising randomized controlled trials (RCTs) were included. Two authors individually evaluated the quality of meta-analysis and extracted data. The Jadad decision algorithm was conducted to ascertain which meta-analysis offered the best evidence.
   Results: A total of four meta-analyses was included. All these meta-analyses comprised RCTs or quasi-RCTs and were determined as Level-II evidence. The scores of the Assessment of Multiple Systematic Reviews (AMSTAR) ranged from 7 to 10 (median 9.5). The Jadad algorithm indicated that the best meta-analysis should be chosen according to the search strategies and application of selection. A high-quality meta-analysis with more RCTs was chosen, which suggested that there was no statistically significant difference between MIS and OS regarding rerupture rate, tissue adhesion, sural nerve injury, deep infection, and deep vein thrombosis. However, MIS could decrease superficial infection rate, and had a better patient satisfaction for good to excellent outcomes in comparison to OS.
   Conclusions: Based on the best available evidence, MIS may be superior to OS for treating acute Achilles tendon rupture. However, due to some limitations, this should be cautiously interpreted, and further high-quality studies are needed.
C1 [Li, Qingbo; Huo, Yanqing; Wang, Xiqian] Shandong Univ, Hosp 2, Dept Orthopaed Trauma, Jinan 250100, Peoples R China.
   [Wang, Chuanying] Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Rehabil, 1 Jingba Rd, Jinan 250001, Peoples R China.
   [Jia, Zhiwei] 306th Hosp Peoples Liberat Army, Dept Orthopaed, Beijing, Peoples R China.
RP Wang, CY (reprint author), Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Rehabil, 1 Jingba Rd, Jinan 250001, Peoples R China.; Jia, ZW (reprint author), 306th Hosp Peoples Liberat Army, Dept Orthopaed, Beijing, Peoples R China.
EM wangchuanyingjinan@163.com; jiazhiwei@139.com
CR Aktas S, 2009, FOOT ANKLE INT, V30, P391, DOI 10.3113/FAI.2009.0391
   Avina Valencia Jorge Arturo, 2009, Acta Ortop Mex, V23, P125
   Carmont MR, 2013, KNEE SURG SPORT TR A, V21, P1361, DOI 10.1007/s00167-013-2423-1
   Del Buono A, 2014, BRIT MED BULL, V109, P45, DOI 10.1093/bmb/ldt029
   Erickson BJ, 2015, ARTHROSCOPY, V31, P1207, DOI 10.1016/j.arthro.2014.11.040
   Gigante A, 2008, KNEE SURG SPORT TR A, V16, P204, DOI 10.1007/s00167-007-0448-z
   Gwynne-Jones DP, 2011, FOOT ANKLE INT, V32, P337, DOI 10.3113/FAI.2011.0337
   Jadad AR, 1997, CAN MED ASSOC J, V156, P1411
   Jones Matthew P, 2012, J Bone Joint Surg Am, V94, pe88, DOI 10.2106/JBJS.J.01829
   Karabinas Panagiotis K, 2014, Eur J Orthop Surg Traumatol, V24, P607, DOI 10.1007/s00590-013-1350-7
   Khan RJ, 2010, COCHRANE DB SYST REV, V9
   Khan RJK, 2005, J BONE JOINT SURG AM, V87A, P2202, DOI 10.2106/JBJS.D.03049
   Leppilahti J, 1996, ACTA ORTHOP SCAND, V67, P277, DOI 10.3109/17453679608994688
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Lim J, 2001, FOOT ANKLE INT, V22, P559, DOI 10.1177/107110070102200705
   Maffulli N, 1999, J BONE JOINT SURG AM, V81A, P1019, DOI 10.2106/00004623-199907000-00017
   Maffulli N, 2003, AM J SPORT MED, V31, P692, DOI 10.1177/03635465030310051001
   Majewski M, 2000, ORTHOPADE, V29, P670
   Mascarenhas R, 2015, ARTHROSCOPY, V31, P561, DOI 10.1016/j.arthro.2014.11.011
   McMahon Samuel E, 2011, Foot Ankle Surg, V17, P211, DOI 10.1016/j.fas.2010.11.001
   Porter KJ, 2014, FOOT ANKLE SURG, V20, P90, DOI 10.1016/j.fas.2013.11.005
   Schroeder D, 1997, AM ORTHOP SOC SPORT, V21, P1228
   Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10
   Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009
   Shea BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001350
   Wilkins R, 2012, AM J SPORT MED, V40, P2154, DOI 10.1177/0363546512453293
   Worth N, 2007, J Orthop Surg (Hong Kong), V15, P311
   Wright JG, 2003, J BONE JOINT SURG AM, V85A, P1
   Zhao JG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001057
   Zhao JG, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000599
NR 30
TC 7
Z9 10
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1749-799X
J9 J ORTHOP SURG RES
JI J. Orthop. Surg. Res.
PD JUN 6
PY 2016
VL 11
AR 65
DI 10.1186/s13018-016-0401-2
PG 7
WC Orthopedics
SC Orthopedics
GA DN7WL
UT WOS:000377290800001
PM 27266275
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Lonnstedt, OM
   Eklov, P
AF Lonnstedt, Oona M.
   Eklov, Peter
TI RETRACTED: Environmentally relevant concentrations of microplastic
   particles influence larval fish ecology (Retracted Article)
SO SCIENCE
LA English
DT Article; Retracted Publication
ID MARINE-ENVIRONMENT; RECRUITMENT; BEHAVIOR; DEBRIS; SEA; EGG
AB The widespread occurrence and accumulation of plastic waste in the environment have become a growing global concern over the past decade. Although some marine organisms have been shown to ingest plastic, few studies have investigated the ecological effects of plastic waste on animals. Here we show that exposure to environmentally relevant concentrations of microplastic polystyrene particles (90 micrometers) inhibits hatching, decreases growth rates, and alters feeding preferences and innate behaviors of European perch (Perca fluviatilis) larvae. Furthermore, individuals exposed to microplastics do not respond to olfactory threat cues, which greatly increases predator-induced mortality rates. Our results demonstrate that microplastic particles operate both chemically and physically on larval fish performance and development.
C1 [Lonnstedt, Oona M.; Eklov, Peter] Uppsala Univ, Dept Ecol & Genet, Limnol, Uppsala, Sweden.
RP Lonnstedt, OM (reprint author), Uppsala Univ, Dept Ecol & Genet, Limnol, Uppsala, Sweden.
EM oona.lonnstedt@ebc.uu.se
FU Uppsala University-Campus Gotland; Swedish Research Council
   Vetenskapsradet
FX This study was financially supported by Uppsala University-Campus
   Gotland and the Swedish Research Council Vetenskapsradet. All work
   reported herein was conducted in accordance with the guidelines for the
   care and use of animals in research of the Swedish Board of Agriculture
   with approval by the Uppsala University Ethics Committee. We thank A.
   Nissling, J. Sundin, G. Rosenqvist, M. Cunha, I. Wallin, R. Gydemo, and
   L. Vallin for logistic support and A. Roswald, I. Lonnstedt, and M.
   McCormick for comments and statistical advice. The data reported in this
   paper are archived at the research database at Uppsala University and
   are also included in the online supplementary materials.
CR Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030
   Andrady AL, 2009, PHILOS T R SOC B, V364, P1977, DOI 10.1098/rstb.2008.0304
   [Anonymous], 2013, PLASTICS FACTS 2013
   BAILEY KM, 1989, ADV MAR BIOL, V25, P1
   Browne MA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2929
   Cedervall T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032254
   Chae DH, 2015, ARCH ENVIRON CON TOX, V69, P269, DOI 10.1007/s00244-015-0173-4
   Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f
   Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x
   LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1
   Ljunggren L, 2010, ICES J MAR SCI, V67, P1587, DOI 10.1093/icesjms/fsq109
   Lonnstedt OM, 2014, J ANIM ECOL, V83, P1178, DOI 10.1111/1365-2656.12209
   Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516
   Mattsson K, 2015, ENVIRON SCI TECHNOL, V49, P553, DOI 10.1021/es5053655
   Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025
   Noren F., 2007, KIMO SWEDEN
   Noren F., 2014, LANS VASTRA GOTAKAND, V52
   Rochman CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14340
   Rochman CM, 2013, ENVIRON SCI TECHNOL, V47, P1646, DOI 10.1021/es303700s
   Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144
   Sundblad G, 2014, ICES J MAR SCI, V71, P672, DOI 10.1093/icesjms/fst056
   Sussarellu R, 2016, P NATL ACAD SCI USA, V113, P2430, DOI 10.1073/pnas.1519019113
   Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559
   TREASURER JW, 1983, ENVIRON BIOL FISH, V8, P3, DOI 10.1007/BF00004941
   Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031
NR 25
TC 66
Z9 79
U1 27
U2 591
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUN 3
PY 2016
VL 352
IS 6290
BP 1213
EP 1216
DI 10.1126/science.aad8828
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN4NY
UT WOS:000377045700041
PM 27257256
DA 2018-12-27
ER

PT J
AU Lee, JC
   Cha, CI
   Kim, D
   Choe, SY
AF Lee, Jae Chul
   Cha, Choong Ik
   Kim, Dongsik
   Choe, Soo Young
TI RETRACTED: Therapeutic effects of umbilical cord blood derived
   mesenchymal stem cell-conditioned medium on pulmonary arterial
   hypertension in rats(Retracted article.See vol.50,pg.325,2016)
SO JOURNAL OF THE ANATOMICAL SOCIETY OF INDIA
LA English
DT Article; Retracted Publication
DE Apoptosis; Conditioned medium; Gene expression; Mesenchymal stem cells;
   Pulmonary artery hypertension
ID ANTAGONIST; DISEASE
AB Introduction: Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) may have multiple therapeutic applications cell based therapy with one being for treatment of pulmonary artery hypertension. As low survival rates and potential tumorigenicity of implanted cells could undermine the mesenchymal stem cell-based therapy, we chose to investigate the use of conditioned medium (CM) from a culture of MSC cells.
   Material and methods: CM was prepared by culturing hUCB-MSCs in three-dimensional spheroids. In a rat model of PAH induced by monocrotaline, we infused CM or the control unconditioned culture media via tail-vein of 6-week-oldSprague-Dawley rats.
   Results: Compared with the control unconditioned media, CM infusion reduced the ventricular pressure, the right ventricle/(left ventricle +interventricular septum) ratio, and maintained respiratory function in the treated animals. Also the number of IL-1 alpha, CCL5 and TIMP-1-positive cells increased in lung samples and the number of TUNEL-positive cells decreased significantly in the CM treated animals.
   Discussion: From our in vivo data in the rat model, the observed decreases in the TUNEL staining point to a potential therapeutic benefit of the CM in ameliorating PAH-mediated lung tissue damage. Increased IL-1 alpha, CCL5 and TIMP-1 levels may play important roles in this regard. (C) 2016 Anatomical Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd. All rights reserved.
C1 [Lee, Jae Chul; Choe, Soo Young] Chungbuk Natl Univ, Sch Life Sci, Dept Biol, Cheongju 361763, South Korea.
   [Lee, Jae Chul; Kim, Dongsik] Korea Univ, Dept Surg, Brain Korea PLUS Project Med Sci & HBP Surg & Liv, Coll Med, Seoul, South Korea.
   [Lee, Jae Chul; Cha, Choong Ik] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea.
   [Lee, Jae Chul] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul, South Korea.
   [Lee, Jae Chul] Seoul Natl Univ, Bundang Hosp, Dept Plast & Reconstruct Surg, 82,Gumi Ro 173 Beon Gil, Songnam 463707, Gyeonggi Do, South Korea.
RP Choe, SY (reprint author), Chungbuk Natl Univ, Dept Biol, Cheongju 361763, South Korea.; Kim, D (reprint author), Korea Univ, Coll Med, Dept HBP Surg & Liver Transplantat, 145 Anam Ro, Seoul 136701, South Korea.
EM 98603@snubh.org; leejc@chungbuk.ac.kr
FU Korea University
FX This work was supported by a Korea University Grant.
CR Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002
   Cho YJ, 2012, J NEUROSCI RES, V90, P1794, DOI 10.1002/jnr.23063
   Fukumoto Y, 2011, CIRC J, V75, P1801, DOI 10.1253/circj.CJ-11-0567
   Golob MJ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12815
   Guo YH, 2014, HEART VESSELS, V29, P520, DOI 10.1007/s00380-013-0395-1
   Jeong SY, 2013, STEM CELLS, V31, P2136, DOI 10.1002/stem.1471
   Jin H, 2013, CELL TRANSPLANT, V22, P1637, DOI 10.3727/096368912X661427
   Kang H, 2015, STEM CELLS DEV, V24, P1658, DOI 10.1089/scd.2014.0496
   Kim AK, 2011, EUR J VASC ENDOVASC, V42, P667, DOI 10.1016/j.ejvs.2011.06.026
   Kim JY, 2012, CELL DEATH DIFFER, V19, P680, DOI 10.1038/cdd.2011.140
   Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568
   Lee EJ, 2012, MOL THER, V20, P1424, DOI 10.1038/mt.2012.58
   Lee JC, 2014, ANAT CELL BIOL, V47, P217, DOI 10.5115/acb.2014.47.4.217
   Lee Kyung-Bok, 2011, Int J Stem Cells, V4, P88
   Lim HC, 2008, NEUROSCI LETT, V435, P175, DOI 10.1016/j.neulet.2008.02.035
   Mori H, 2016, INT J CARDIOL, V221, P122, DOI 10.1016/j.ijcard.2016.06.322
   Nicholls DJ, 2015, J PHARMACOL EXP THER, V353, P340, DOI 10.1124/jpet.114.221358
   Pereira SL, 2013, EUR J PHARMACOL, V702, P316, DOI 10.1016/j.ejphar.2013.01.050
   Pereira T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113769
   Shimamura M, 2013, BIOMED RES INT, DOI 10.1155/2013/186215
   Swaminathan AC, 2015, AM J RESP CELL MOL, V52, P663, DOI 10.1165/rcmb.2014-0438TR
   Zhang Li-jin, 2015, Zhen Ci Yan Jiu, V40, P352
NR 22
TC 0
Z9 0
U1 4
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0003-2778
J9 J ANAT SOC INDIA
JI J. Anat. Soc. India
PD JUN
PY 2016
VL 65
IS 1
BP 15
EP 19
DI 10.1016/j.jasi.2016.07.005
PG 5
WC Anatomy & Morphology
SC Anatomy & Morphology
GA DY3QG
UT WOS:000385008100004
OA Green Published
DA 2018-12-27
ER

PT J
AU Maghsoudloo, M
   Zarandi, HR
AF Maghsoudloo, Mohammad
   Zarandi, Hamid R.
TI RETRACTED: PARALLEL EXECUTION TRACING: AN ALTERNATIVE SOLUTION TO
   EXPLOIT UNDER-UTILIZED RESOURCES IN MULTI-CORE ARCHITECTURES FOR
   CONTROL-FLOW CHECKING (Retracted article. See vol. 31, pg. 155, 2018)
SO FACTA UNIVERSITATIS-SERIES ELECTRONICS AND ENERGETICS
LA English
DT Article; Retracted Publication
DE On-line error detection; control-flow error; error detection coverage;
   multi-core processor; CPU utilization
ID ERROR-DETECTION ENHANCEMENT; PROCESSORS; SOFTWARE
AB In this paper, a software behavior-based technique is presented to detect control-flow errors in multi-core architectures. The analysis of a key point leads to introduction of the proposed technique: employing under-utilized CPU resources in multi-core processors to check the execution flow of the programs concurrently and in parallel with the main executions. To evaluate the proposed technique, a quad-core processor system was used as the simulation environment, and the behavior of SPEC CPU2006 benchmarks were studied as the target to compare with conventional techniques. The experimental results, with regard to both detection coverage and performance overhead, demonstrate that on average, about 94% of the control-flow errors can be detected by the proposed technique, with less performance overhead compared to previous techniques.
C1 [Maghsoudloo, Mohammad; Zarandi, Hamid R.] Amirkabir Univ Technol, Tehran Polytech, 424 Hafez Ave, Tehran, Iran.
RP Maghsoudloo, M (reprint author), Amirkabir Univ Technol, Tehran Polytech, 424 Hafez Ave, Tehran, Iran.
EM m.maghsoudloo@aut.ac.ir
RI Zarandi, Hamid R./M-2409-2018
OI Zarandi, Hamid R./0000-0003-1385-4171
CR Aggarwal N., 2007, P 34 ANN INT S COMP, P340
   Aliee H., 2011, P 9 IEEE INT C HIGH
   BERGER ED, 2009, P 24 ACM SIGPLAN C O, P81
   Blake G., 2010, P 43 ANN INT S MICR
   Fazeli M, 2008, J ELECTRON TEST, V24, P21, DOI 10.1007/s10836-007-5017-3
   Goloubeva O, 2005, P REL MAINT S, P583, DOI 10.1109/RAMS.2005.1408426
   Kumar S., 2009, P 42 ANN INT S MICR
   Maghsoudloo M., 2011, P 14 EUR C DIG SYST
   Manoochehri M., 2011, P 44 ANN INT S MICR
   Meixner A, 2008, I C DEPEND SYS NETWO, P80, DOI 10.1109/DSN.2008.4630073
   Oh N, 2002, IEEE T RELIAB, V51, P111, DOI 10.1109/24.994926
   Patterson D, 2010, IEEE SPECTRUM, V47, P29
   Powell MD, 2009, CONF PROC INT SYMP C, P93, DOI 10.1145/1555815.1555769
   Rajabzadeh A, 2006, MICROELECTRON RELIAB, V46, P124, DOI 10.1016/j.microrel.2004.10.013
   Rajabzadeh A, 2006, MICROELECTRON RELIAB, V46, P959, DOI [10.1016/j.microrel.2005.07.108, 10.1016/j.mcirorel.2005.07.108]
   Rajabzadeh A, 2004, J ELECTRON TEST, V20, P553, DOI 10.1023/B:JETT.0000042519.31454.1b
   Rajabzadeh A., 2011, J IRAN COMPUTER SOC
   Reis GA, 2005, CGO 2005: INTERNATIONAL SYMPOSIUM ON CODE GENERATION AND OPTIMIZATION, P243, DOI 10.1109/CGO.2005.34
   Rimen M., 1995, P 1995 PAC RIM INT S, P238
   Romanescu BF, 2008, PACT'08: PROCEEDINGS OF THE SEVENTEENTH INTERNATIONAL CONFERENCE ON PARALLEL ARCHITECTURES AND COMPILATION TECHNIQUES, P43, DOI 10.1145/1454115.1454124
   Schiffel U, 2010, LECT NOTES COMPUT SC, V6351, P169, DOI 10.1007/978-3-642-15651-9_13
   SCHUETTE MA, 1987, IEEE T COMPUT, V36, P264
   Shi W., 2006, P 33 ANN INT S COMP
   Shye A., 2007, P 37 IEEE IFIP INT C
   Shye A., 2008, IEEE T DEPENDABLE SE
   Slegel TJ, 1999, IEEE MICRO, V19, P12, DOI 10.1109/40.755464
   STANDARD PERFORMANCE EVALUATION CORPORATION, 2006, SPEC CPU2006 BENCHM
   Vemu R., 2007, P IEEE INT TEST C, P1, DOI DOI 10.1109/TEST.2007.4437639
   Vemu R., 2006, P 12 IEEE INT ON LIN, P151
   Wells PM, 2009, ACM SIGPLAN NOTICES, V44, P169, DOI 10.1145/1508284.1508265
   Zarandi H R, 2010, Proceedings 2010 IEEE 16th Pacific Rim International Symposium on Dependable Computing (PRDC 2010), P141, DOI 10.1109/PRDC.2010.10
NR 31
TC 2
Z9 2
U1 0
U2 0
PU UNIV NIS
PI NIS
PA UNIVERZITETSKI TRG 2, PO BOX 123, NIS, 18000, SERBIA
SN 0353-3670
EI 2217-5997
J9 FACTA UNIV-SER ELECT
JI Facta Univ.-Ser. Electron. Energ.
PD JUN
PY 2016
VL 29
IS 2
BP 243
EP 260
DI 10.2298/FUEE1602243M
PG 18
WC Engineering, Electrical & Electronic
SC Engineering
GA DV5DH
UT WOS:000382945700007
DA 2018-12-27
ER

PT J
AU Di Nucci, E
AF Di Nucci, Ezio
TI RETRACTED: Strategic Bombing, Causal Beliefs, and Double Effect
   (Retracted article. See vol. 51, pg. 361, 2017)
SO JOURNAL OF VALUE INQUIRY
LA English
DT Article; Retracted Publication
ID WAR
C1 [Di Nucci, Ezio] Univ Copenhagen, Copenhagen, Denmark.
RP Di Nucci, E (reprint author), Univ Copenhagen, Copenhagen, Denmark.
EM ezio@sund.ku.dk
OI Di Nucci, Ezio/0000-0002-5734-6622
CR BENNETT J, 1980, TANNER LECT HUMAN VA
   Bennett Jonathan, 1995, ACT ITSELF
   BOYLE JM, 1980, ETHICS, V90, P527, DOI 10.1086/292183
   Bratman M., 1987, INTENTION PLANS PRAC
   Cavanaugh Thomas, 2006, DOUBLE EFFECT REASON
   DAVIS N, 1984, PAC PHILOS QUART, V65, P107
   Di Nucci E., 2014, ETHICS INTENTION
   Di Nucci E., 2008, MIND OUT OF ACTION
   Di Nucci E., 2013, MINDLESSNESS
   Di Nucci E., 2014, J ANCIENT PHILOS, V8, P20
   Di Nucci E., 2011, RATIONALITY MARKETS, V2, P179
   Di Nucci E, 2014, EXPERIMENTAL ETHICS: TOWARD AN EMPIRICAL MORAL PHILOSOPHY, P80
   Di Nucci E, 2014, AM J BIOETHICS, V14, P42, DOI 10.1080/15265161.2014.918205
   Di Nucci E, 2013, PHILOS PSYCHOL, V26, P662, DOI 10.1080/09515089.2012.674664
   Di Nucci E, 2013, J MED ETHICS, V39, P537, DOI 10.1136/medethics-2012-101172
   Di Nucci E, 2011, PHILOS EXPLOR, V14, P117, DOI 10.1080/13869795.2011.544233
   Di Nucci E, 2009, ANALYSIS, V69, P69, DOI 10.1093/analys/ann011
   DINUCCI E, 2015, AREL RIV, V2015, P274
   DINUCCI E, 2014, 23 K DTSCH GES FUER
   DINUCCI E, 2013, WAS DURFEN WIR GLAUB
   Fabre C, 2009, ETHICS, V120, P36, DOI 10.1086/649218
   Ford J. C., 1944, THEOL STUD, V5, P261
   FRANKLAND N, 1970, BOMBER OFFENSIVE
   Mangan Joseph, 1949, THEOL STUD, V10, P41
   McIntyre A, 2001, ETHICS, V111, P219, DOI 10.1086/233472
   MCMAHAN JEFF, 2009, KILLING WAR
   RYAN JK, 1933, MODERN WAR BASIC ETH
   Scanlon Thomas M., 2008, MORAL DIMENSIONS
   WALZER M, 1971, PHILOS PUBLIC AFF, V1, P3
   Woodward P. A., 2001, DOCTRINE DOUBLE EFFE
NR 30
TC 1
Z9 1
U1 1
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0022-5363
EI 1573-0492
J9 J VALUE INQUIRY
JI J. Value Inq.
PD JUN
PY 2016
VL 50
IS 2
BP 385
EP 394
DI 10.1007/s10790-015-9518-5
PG 10
WC Ethics; Philosophy
SC Social Sciences - Other Topics; Philosophy
GA DU7OK
UT WOS:000382404200008
DA 2018-12-27
ER

PT J
AU Chiang, HK
   Fang, CC
   Hsu, FJ
AF Chiang, Huann-Keng
   Fang, Chun-Chiang
   Hsu, Feng-Jui
TI RETRACTED: Robust variable air speed control of a nonlinear fan system
   based on backstepping sliding mode control techniques (Retracted
   article. See vol. 10, 2018)
SO ADVANCES IN MECHANICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Modelling uncertainty; backstepping sliding mode control; variable air
   volume; fan system; robustness control; uncertainty
ID VOLUME SYSTEM
AB A backstepping technique combining the sliding mode control method with an integrator and estimator design for variable air speed control is proposed in this article. The self-build fan-plate system is used to derive the mathematical model for air speed control which builds a direct connection between motor rotation and air speed control. Furthermore, the mathematical model also includes effects arising from modelling uncertainties, parameter variations and external disturbances because of modelling errors, load changing and variable loading shifting, respectively. The Lyapunov theory is employed in the controller design procedure that ensures the stability of the system. The experimental results show the great tracking and convergence ability of the proposed controllers even under the time variations and sharply changing commands.
C1 [Chiang, Huann-Keng; Hsu, Feng-Jui] Natl Yunlin Univ Sci & Technol, Dept Elect Engn, Touliu 64002, Yunlin, Taiwan.
   [Fang, Chun-Chiang] Natl Yunlin Univ Sci & Technol, Grad Sch Engn Sci Technol, Touliu 64002, Yunlin, Taiwan.
RP Chiang, HK (reprint author), Natl Yunlin Univ Sci & Technol, Dept Elect Engn, Touliu 64002, Yunlin, Taiwan.
EM chianghk@yuntech.edu.tw
FU Ministry of Science and Technology in Taiwan, R.O.C.
   [MOST104-2221-E-224-019]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship and/or publication of this article: This work
   was supported by the Ministry of Science and Technology in Taiwan,
   R.O.C., through grant MOST104-2221-E-224-019.
CR Chen Z, 2015, IEEE-ASME T MECH, V20, P1482, DOI 10.1109/TMECH.2014.2369454
   Goyal Siddharth, 2013, 2013 IEEE 52nd Annual Conference on Decision and Control (CDC), P4796, DOI 10.1109/CDC.2013.6760641
   Guo CY, 2009, IEEE T CONTR SYST T, V17, P600, DOI 10.1109/TCST.2008.2002036
   Lee JD, 2013, IEEE T IND INFORM, V9, P817, DOI 10.1109/TII.2012.2219062
   LIN CH, 2012, IEEE INT S IND EL, P668
   Lin FJ, 2007, IEEE T MAGN, V43, P2009, DOI 10.1109/TMAG.2006.890325
   Semsar-Kazerooni E, 2008, IEEE T CONTR SYST T, V16, P918, DOI 10.1109/TCST.2007.916344
   Shuai Liu, 2013, 2013 IEEE International Conference on Automation Science and Engineering (CASE), P422, DOI 10.1109/CoASE.2013.6654001
   Song Q, 2003, IEE P-CONTR THEOR AP, V150, P112, DOI 10.1049/ip-cta:20030065
   Sun WC, 2015, IEEE-ASME T MECH, V20, P675, DOI 10.1109/TMECH.2014.2319355
   Tan Y, 2000, P 2000 IEEE INT C CO, P368
   Thosar A, 2006, IEEE C ICIT06, P1569
   Wang YH, 2011, 2011 9TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION (WCICA 2011), P706, DOI 10.1109/WCICA.2011.5970606
   Yang Y, 2014, CHIN CONTR CONF, P65, DOI 10.1109/ChiCC.2014.6896597
   Yao JY, 2015, IEEE-ASME T MECH, V20, P2752, DOI 10.1109/TMECH.2015.2409893
   Yao JY, 2015, IEEE T IND ELECTRON, V62, P6469, DOI 10.1109/TIE.2015.2423660
   Yao JY, 2014, IEEE T IND ELECTRON, V61, P6285, DOI 10.1109/TIE.2014.2304912
   Yao JY, 2014, IEEE-ASME T MECH, V19, P633, DOI 10.1109/TMECH.2013.2252360
   Zou Q, 2015, ADV MECH ENG, V7, DOI 10.1177/1687814015606308
NR 19
TC 3
Z9 3
U1 3
U2 23
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1687-8140
J9 ADV MECH ENG
JI Adv. Mech. Eng.
PD JUN
PY 2016
VL 8
IS 6
AR 1687814016651373
DI 10.1177/1687814016651373
PG 12
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA DR3FD
UT WOS:000379787100041
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Liu, C
   Cai, GW
   Yang, DY
AF Liu, Cheng
   Cai, Guowei
   Yang, Deyou
TI RETRACTED: Design nonlinear robust damping controller for static
   synchronous series compensator based on objective holographic
   feedback-H-infinity (Retracted article. See vol. 10, 2018)
SO ADVANCES IN MECHANICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Power oscillation damping controller; direct feedback linearization;
   objective holographic feedback; H-infinity control; static synchronous
   series compensator
ID ENERGY-STORAGE; POWER-SYSTEMS; OSCILLATIONS
AB Considering the strong nonlinearity of power oscillation in power system containing static synchronous series compensator and nonlinear factors, a novel power oscillation damping controller that exhibits nonlinearity and robustness is proposed to reduce power oscillation in such systems. First, use objective holographic feedback on the system state equation to obtain system model. Second, nonlinear factors and external disturbances are estimated using direct feedback linearization to achieve linearization of the nonlinear model. Third, H-infinity equation should be selected. Finally, a power oscillation damping controller of static synchronous series compensator is designed on direct feedback linearization, objective holographic feedback theory-H-infinity. The controller exhibits good dynamic performance and robustness. Simulations on four-generator two-area system are conducted under various disturbances to prove the effectiveness and robustness of the proposed damping control method.
C1 [Liu, Cheng; Cai, Guowei; Yang, Deyou] Northeast Dianli Univ, Sch Elect Engn, Chuanying 132012, Jilin, Peoples R China.
RP Liu, C (reprint author), Northeast Dianli Univ, Sch Elect Engn, Chuanying 132012, Jilin, Peoples R China.
EM 05dylc@163.com
FU National Natural Science Foundation of China [51377017]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported by National Natural Science Foundation of China (no.
   51377017).
CR Badar R, 2013, ELECTR POW COMPO SYS, V41, P845, DOI 10.1080/15325008.2013.792882
   Balarko C., 2003, IEEE T POWER SYST, V18, P1149
   Beza M, 2015, IEEE T POWER SYST, V30, P484, DOI 10.1109/TPWRS.2014.2320411
   Dong L, 2004, IEEE T POWER SYST, V19, P120, DOI [10.1109/TPWRS.2003.821022, 10.1109/TPWRS.20,03.821022]
   Hashmani AA, 2012, INT J ELEC POWER, V42, P605, DOI 10.1016/j.ijepes.2012.03.049
   KLEIN M, 1991, IEEE T POWER SYST, V6, P914, DOI 10.1109/59.119229
   Kumar IS, 1999, IEEE T POWER DELIVER, V14, P1448, DOI 10.1109/61.796239
   Kundur P. S., 1994, POWER SYSTEM STABILI
   Lei BJ, 2014, CONTROL ENG PRACT, V29, P147, DOI 10.1016/j.conengprac.2014.04.011
   Li J, 2008, POWER SYST TECHNOL, V32, P12
   [李天云 Li Tianyun], 2012, [电网技术, Power System Technology], V36, P131
   Liu Hui, 2007, Proceedings of the CSEE, V27, P21
   Miao ZX, 2009, IEEE T ENERGY CONVER, V24, P415, DOI 10.1109/TEC.2009.2015980
   Ngamroo I, 2003, ELECTR POW SYST RES, V67, P161, DOI 10.1016/S0378-7796(03)00110-X
   Pourboghrat F, 2004, IEEE T POWER SYST, V19, P1123, DOI 10.1109/TPWRS.2003.821462
   Rigby BS, 2002, IEEE T IND APPL, V38, P1105, DOI 10.1109/TIA..2002.800565
   Sui XC, 2014, IEEE T POWER SYST, V29, P2539, DOI 10.1109/TPWRS.2014.2305977
   Sun UQ, 2009, IET CONTROL THEORY A, V69, P641
   Wang H. F., 1999, 1999 IEEE Africon. 5th Africon Conference in Africa (Cat. No.99CH36342), P495, DOI 10.1109/AFRCON.1999.820931
   Wang XF., 2003, MODERN POWER SYSTEM, P1
   Wei Yan, 2003, Proceedings of the CSEE, V23, P65
   Yan Bo, 2012, Journal of Zhejiang University. Engineering Science, V46, P1975, DOI 10.3785/j.issn.1008-973X.2012.11.006
   Yao W, 2014, IEEE T POWER SYST, V29, P318, DOI 10.1109/TPWRS.2013.2280216
   Zhou Shuangxi, 1995, Proceedings of the CSEE, V15, P281
NR 24
TC 1
Z9 1
U1 2
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1687-8140
J9 ADV MECH ENG
JI Adv. Mech. Eng.
PD JUN
PY 2016
VL 8
IS 6
AR 1687814016655681
DI 10.1177/1687814016655681
PG 11
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA DR3FD
UT WOS:000379787100042
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Yang, JW
   Zhao, CQ
   Zhu, AH
   Yao, DC
   Wu, HJ
AF Yang, Jianwei
   Zhao, Chunqing
   Zhu, Aihua
   Yao, Dechen
   Wu, Huijie
TI RETRACTED: The reliability estimation for the braking system of
   high-speed electric multiple units based on Bayes and GO method
   (Retracted article. See vol. 8, 2016)
SO ADVANCES IN MECHANICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE High-speed electric multiple unit braking system; two-parameter
   exponential distribution; Bayes estimation; Markov chain Monte Carlo; GO
   method; small sample
ID EXPONENTIAL-DISTRIBUTION; CENSORED SAMPLES; DISTRIBUTIONS; PARAMETER
AB In order to solve the reliability estimation problem of the braking system of electric multiple units, the models of component and system are evaluated by making use of two kinds of Bayes method and GO method in this article. Starting from cell-level components, the two Bayes methods including multi-Bayes method and Bayes method introducing Markov chain Monte Carlo algorithm are applied to estimate the parameters and the failure rate of component whose lifetime obeys the model of two-parameter exponential distribution. On the basis of component estimation, this article, according to GO method, achieves the quantitative reliability character analysis for the braking system based on the reliability characteristic quantity of the brake system parts and logical relations between system operators. Finally, through the experiment and test data, it proves that the two methods and GO method can solve the reliability evaluation problem of the braking system, which provides a theoretical basis for the safe operation and maintenance of the braking system of electric multiple units.
C1 [Yang, Jianwei; Zhao, Chunqing; Zhu, Aihua; Yao, Dechen; Wu, Huijie] Beijing Univ Civil Engn & Architecture, Sch Mech Elect & Vehicle Engn, 1 Zhanlanguan Rd, Beijing 100044, Peoples R China.
   [Yang, Jianwei; Zhao, Chunqing; Zhu, Aihua; Wu, Huijie] Beijing Univ Civil Engn & Architecture, Beijing Key Lab Performance Guarantee Urban Rail, Beijing, Peoples R China.
RP Yang, JW (reprint author), Beijing Univ Civil Engn & Architecture, Sch Mech Elect & Vehicle Engn, 1 Zhanlanguan Rd, Beijing 100044, Peoples R China.
EM yangjianwei@bucea.edu.cn
FU National Natural Science Foundation of China [51175028]; Great scholars
   training project [CITTCD20150312]; Beijing outstanding talent training
   project [2012D005017000006]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The
   research work was supported by National Natural Science Foundation of
   China under grant no. 51175028, Great scholars training project under
   CIT&TCD20150312, and Beijing outstanding talent training project under
   2012D005017000006.
CR Ahmed AS, 2012, RELIAB ENG SYST SAFE, V100, P48
   Angali KA, 2014, COMMUN STAT-SIMUL C, V43, P31, DOI 10.1080/03610918.2012.697963
   CAI H, 2004, BAYES TEST ANAL EVAL
   Cantone L, 2009, P I MECH ENG F-J RAI, V223, P305, DOI 10.1243/09544097JRRT240
   Chan PS, 2015, METRIKA, V78, P747, DOI 10.1007/s00184-014-0525-5
   Chen W, 2012, P CHIN RAILW SOC VEH, V11, P271
   Cheng JY, 2009, MECH RES APPL, V5, P45
   Cramer E, 2014, COMMUN STAT-THEOR M, V43, P4401, DOI 10.1080/03610926.2012.721912
   Dong J Z, 2012, STUDY URBAN RAIL VEH
   Dong JZ, 2013, URBAN MASS TRANSIT, V4, P28
   Fernando AM, 2013, QUAL ENG, V25, P282
   GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596
   Han M., 1997, OPERATIONS RES MANAG, V6, P31
   Han M, 1998, OPER RES MANAG SCI, V7, P29
   Hu EQ, 2005, STAT INFERENCE 2 PAR
   Krishna H, 2013, J STAT COMPUT SIM, V83, P1007, DOI 10.1080/00949655.2011.647027
   Li JJ, 2007, BAYES STAT INFERENCE
   Li YM, 2008, EMUS BRAKE TECHNOLOG
   Lord D, 2008, SAFETY SCI, V46, P751, DOI 10.1016/j.ssci.2007.03.005
   MAO Shisong, 1984, RELIABILITY STAT
   Ng HKT, 2005, IEEE T RELIAB, V54, P374, DOI 10.1109/TR.2005.853036
   Shen ZM, 2004, GO METHOD PRINCIPLE
   Shen ZP, 2002, NUCL POWER ENG, V21, P456
   Singh S. K., 2014, J DATA SCI, V12, P157
   Upadhyay SK, 2010, J STAT COMPUT SIM, V80, P241, DOI 10.1080/00949650802600730
   Wang J, 2014, COMMUN STAT-SIMUL C, V43, P359, DOI 10.1080/03610918.2012.703359
   Wang L., 1996, MATH STAT APPL PROBA, V11, P64
   Wang LC, 2014, COMPUT STAT DATA AN, V71, P633, DOI 10.1016/j.csda.2013.07.020
   Xiong LH, 2004, STAT ANAL RELIABILIT
   Yu J, 2012, RES RELIABILITY ANAL
   Zhai YM, 2002, BAYES STAT INFERENCE
   Zhang J., 2013, RES MODELING SIMULAT
   Zhang MN, 2014, ROLLING STOCK, V3, P31
   Zhang Z., 2012, RELIABILITY THEORY E
   Zhu Dexin, 2013, Journal of Central South University (Science and Technology), V44, P963
NR 35
TC 1
Z9 1
U1 4
U2 15
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1687-8140
J9 ADV MECH ENG
JI Adv. Mech. Eng.
PD JUN
PY 2016
VL 8
IS 6
AR 1687814016654825
DI 10.1177/1687814016654825
PG 12
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA DR3FD
UT WOS:000379787100032
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Hu, H
   Niu, XB
   Liu, F
AF Hu, Hao
   Niu, Xiaobin
   Liu, Feng
TI RETRACTED: Thermodynamic Self-Limiting Growth of Heteroepitaxial Islands
   Induced by Nonlinear Elastic Effect (Retracted article. See vol. 17, pg.
   2110, 2017)
SO NANO LETTERS
LA English
DT Article; Retracted Publication
DE Quantum dots; nonlinear elastic effect; self-limiting growth;
   nanopatterned substrate
ID ASSEMBLED GE ISLANDS; SHAPE TRANSITION; STRAINED ISLANDS; PATTERNED SI;
   COHERENT; SI(001); PYRAMIDS; NANOCRYSTALS; SILICON; SURFACE
AB We investigate nonlinear elastic effect (NLEF) on the growth of heteroepitaxial islands,,a topic of both scientific and technological significance for their applications as quantum dots: We show that the NLEF induces a thermodynamic self-limiting growth mechanism that hinders' the strain relaxation of coherent island beyond a maximum size, which is in,contrast to indefinite strain relaxation with increasing island size in the linear elastic regime. This,self-limiting growth effect shows a strong dependence on the island facet angle, which applies also to islands inside pits patterned in a substrate surface with an additional dependence on the pit inclination angle. Consequently, primary islands nucleate and grow first in the pits and then secondary islands nucleate at the rim around the pits after the primary islands reach the self-limited maximum size. Our theory sheds new lights on understanding the heteroepitaxial Wand growth and explains a number of past and recent experimental observations.
C1 [Hu, Hao] Xi An Jiao Tong Univ, Frontier Inst Sci & Technol, Xian 710054, Peoples R China.
   [Niu, Xiaobin] Univ Elect Sci & Technol China, State Key Lab Elect Thin Film & Integrated Device, Chengdu 610054, Peoples R China.
   [Liu, Feng] Univ Utah, Dept Mat Sci & Engn, Salt Lake City, UT 84112 USA.
   [Liu, Feng] Collaborat Innovat Ctr Quantum Matter, Beijing 100084, Peoples R China.
RP Liu, F (reprint author), Univ Utah, Dept Mat Sci & Engn, Salt Lake City, UT 84112 USA.; Liu, F (reprint author), Collaborat Innovat Ctr Quantum Matter, Beijing 100084, Peoples R China.
EM fliu@eng.utah.edu
RI Hu, Hao/D-1419-2013
FU NSFC [11404252]; FIST, Xi'an Jiaotong University; UESTC; DOE-BES
   [DE-FG02-04ER46148]
FX The work at Xi'an Jiaotong University was supported by NSFC (Grant
   11404252) and the Startup Funding from FIST, Xi'an Jiaotong University
   (H.H.). The work at University of Electronic Science and Technology of
   China was supported by the Startup Funding from UESTC(X. B.). The work
   at Utah was supported by DOE-BES (Grant DE-FG02-04ER46148) (F.L.).
CR Aqua JN, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.085322
   Bergamaschini R, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.156101
   Floro JA, 1999, PHYS REV B, V59, P1990, DOI 10.1103/PhysRevB.59.1990
   Grydlik M, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/10/105601
   Hackl F, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/16/165302
   Hu H, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106103
   Hu H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.216102
   Ieong Meikei, 2004, Science, V306, P2057, DOI 10.1126/science.1100731
   Jesson DE, 1998, PHYS REV LETT, V80, P5156, DOI 10.1103/PhysRevLett.80.5156
   Jin G, 1999, APPL PHYS LETT, V75, P2752, DOI 10.1063/1.125138
   Johnson HT, 1997, J APPL PHYS, V81, P6081, DOI 10.1063/1.364357
   Kamins TI, 1997, APPL PHYS LETT, V71, P1201, DOI 10.1063/1.119625
   Katsaros G, 2010, NAT NANOTECHNOL, V5, P458, DOI [10.1038/NNANO.2010.84, 10.1038/nnano.2010.84]
   Katsaros G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096103
   LEGOUES FK, 1994, PHYS REV LETT, V73, P300, DOI 10.1103/PhysRevLett.73.300
   Liu F, 1999, PHYS REV LETT, V82, P2528, DOI 10.1103/PhysRevLett.82.2528
   Liu F, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.136101
   Liu F, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.246105
   Liu F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.126103
   Liu P, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085336
   Lu GH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.176103
   Ma X. J., 2014, J PHYS D, V47
   Medeiros-Ribeiro G, 1998, SCIENCE, V279, P353, DOI 10.1126/science.279.5349.353
   MO YW, 1990, PHYS REV LETT, V65, P1020, DOI 10.1103/PhysRevLett.65.1020
   Notzel R, 1998, NATURE, V392, P56, DOI 10.1038/32127
   Pang YY, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075413
   Robinson JT, 2005, NANO LETT, V5, P2070, DOI 10.1021/nl051719d
   Ross FM, 1999, SCIENCE, V286, P1931, DOI 10.1126/science.286.5446.1931
   Schmidt OG, 2007, NANOSCI TECHNOL, P1, DOI 10.1007/978-3-540-46936-0
   SHCHUKIN VA, 1995, PHYS REV LETT, V75, P2968, DOI 10.1103/PhysRevLett.75.2968
   Steinfort AJ, 1996, PHYS REV LETT, V77, P2009, DOI 10.1103/PhysRevLett.77.2009
   Stoffel M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.155326
   Sutter P, 2000, PHYS REV LETT, V84, P4637, DOI 10.1103/PhysRevLett.84.4637
   Tersoff J, 1996, PHYS REV LETT, V76, P1675, DOI 10.1103/PhysRevLett.76.1675
   TERSOFF J, 1993, PHYS REV LETT, V70, P2782, DOI 10.1103/PhysRevLett.70.2782
   Vastola G, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.155415
   Xu X, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/4/045002
   Yang B, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.025502
   Zhang JJ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.166102
   Zhang JJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3514239
   Zhang R, 1998, APPL PHYS LETT, V73, P505, DOI 10.1063/1.121915
   Zhong ZY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.176102
   Zhong ZY, 2003, J APPL PHYS, V93, P6258, DOI 10.1063/1.1566455
   Zinovyev VA, 2006, SURF SCI, V600, P4777, DOI 10.1016/j.susc.2006.07.047
NR 44
TC 5
Z9 5
U1 4
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1530-6984
EI 1530-6992
J9 NANO LETT
JI Nano Lett.
PD JUN
PY 2016
VL 16
IS 6
BP 3919
EP 3924
DI 10.1021/acs.nanolett.6b01525
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA DO2WW
UT WOS:000377642700073
PM 27203611
DA 2018-12-27
ER

PT J
AU Wang, DH
   Xu, NN
   Zhang, ZB
   Yang, SJ
   Qiu, CW
   Li, CY
   Deng, GZ
   Guo, MY
AF Wang, Dehai
   Xu, Niannian
   Zhang, Zhenbiao
   Yang, Shijin
   Qiu, Changwei
   Li, Chengye
   Deng, Ganzhen
   Guo, Mengyao
TI RETRACTED: Sophocarpine displays anti-inflammatory effect via inhibiting
   TLR4 and TLR4 downstream pathways on LPS-induced mastitis in the mammary
   gland of mice (Retracted article. See vol. 50, pg. 370, 2017)
SO INTERNATIONAL IMMUNOPHARMACOLOGY
LA English
DT Article; Retracted Publication
DE Sophocarpine; Mastitis; Toll-like receptor 4 (TLR4); Nuclear
   factor-kappa B (NF-kappa B); p38
ID NF-KAPPA-B; LIPOPOLYSACCHARIDE-INDUCED MASTITIS; MAPKS SIGNALING
   PATHWAYS; ACUTE LUNG INJURY; EPITHELIAL-CELLS; STAPHYLOCOCCUS-AUREUS;
   INFLAMMATORY RESPONSES; TNF-ALPHA; IN-VITRO; ACTIVATION
AB Mastitis is defined as the inflammation of the mammary gland. LPS, which is widely used to induce mastitis models for the study of this disease, triggers similar inflammation as Escherichia coli. Sophocarpine, isolated from Sophora alopecuroides L, exhibits multiple biological properties. The aim of the present study was to determine the anti-inflammatory effect and mechanism of action of sophocarpine on mastitis within an LPS-induced mouse model. ELISA and western blotting were performed to detect protein levels. The qPCR was performed to detect mRNA levels. The ELISA and qRT-PCR results showed that sophocarpine inhibited the expression of TNF-alpha, IL-1 beta and IL-6 in a dose-dependent manner. However, sophocarpine suppressed TLR4 expression. Further study showed that sophocarpine could suppress the phosphorylation of I kappa B alpha, p65 and p38. These results confirm that sophocarpine played an anti-inflammatory role in LPS-induced mastitis by regulating TLR4 and the NF-kappa B and MAPK signaling pathways in mammary gland tissues. Therefore, sophocarpine may be a potential therapeutic drug for the treatment of mastitis. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Wang, Dehai; Xu, Niannian; Zhang, Zhenbiao; Yang, Shijin; Qiu, Changwei; Li, Chengye; Deng, Ganzhen; Guo, Mengyao] Huazhong Agr Univ, Coll Vet Med, Wuhan 430070, Peoples R China.
RP Guo, MY (reprint author), Huazhong Agr Univ, Coll Vet Med, Wuhan 430070, Peoples R China.
EM guomy1985@sohu.com
FU Fundamental Research Funds for the Central Universities [2662014BQ024];
   National Natural Science Foundation of China [31272622, 31502130];
   Undergraduate Special Science and Technology Innovation of Huazhong
   Agricultural University [2015BC009]
FX This work was supported by a grant from the Fundamental Research Funds
   for the Central Universities (No. 2662014BQ024), the National Natural
   Science Foundation of China (No. 31272622 and No. 31502130) and
   Undergraduate Special Science and Technology Innovation of Huazhong
   Agricultural University (No. 2015BC009).
CR Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391
   Asehnoune K, 2005, CELL SIGNAL, V17, P385, DOI 10.1016/j.cellsig.2004.08.005
   Bannerman DD, 2003, J DAIRY SCI, V86, P3128, DOI 10.3168/jds.S0022-0302(03)73914-9
   Boudjellab N, 2000, COMP BIOCHEM PHYS A, V127, P191, DOI 10.1016/S1095-6433(00)00257-9
   Branger J, 2002, J IMMUNOL, V168, P4070, DOI 10.4049/jimmunol.168.8.4070
   Chen YG, 2003, J NEUROSCI RES, V72, P125, DOI 10.1002/jnr.10548
   Chu X, 2010, INT IMMUNOPHARMACOL, V10, P600, DOI 10.1016/j.intimp.2010.02.010
   Fu YH, 2013, VET IMMUNOL IMMUNOP, V151, P20, DOI 10.1016/j.vetimm.2012.09.039
   Gao LY, 2000, TRENDS MICROBIOL, V8, P306, DOI 10.1016/S0966-842X(00)01784-4
   Gao XJ, 2015, INFLAMMATION, V38, P1142, DOI 10.1007/s10753-014-0079-8
   Gao YL, 2012, TOXICOL IN VITRO, V26, P1, DOI 10.1016/j.tiv.2011.09.019
   Gao YL, 2009, J ETHNOPHARMACOL, V125, P324, DOI 10.1016/j.jep.2009.06.036
   Guo MY, 2013, INT IMMUNOPHARMACOL, V16, P125, DOI 10.1016/j.intimp.2013.03.006
   Hogeveen H, 2011, NEW ZEAL VET J, V59, P16, DOI 10.1080/00480169.2011.547165
   Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248
   LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0
   Lee JW, 2006, VET RES, V37, P219, DOI 10.1051/vetres:2005051
   Li B, 2010, INT IMMUNOPHARMACOL, V10, P344, DOI 10.1016/j.intimp.2009.12.006
   Li DP, 2013, EUR J PHARMACOL, V705, P79, DOI 10.1016/j.ejphar.2013.02.021
   Li DP, 2013, INFLAMM RES, V62, P9, DOI 10.1007/s00011-012-0545-4
   Li FY, 2013, INT IMMUNOPHARMACOL, V17, P478, DOI 10.1016/j.intimp.2013.07.010
   Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910
   Lin Z, 2011, BASIC CLIN PHARMACOL, V108, P304, DOI 10.1111/j.1742-7843.2010.00653.x
   Lo Faro ML, 2014, NITRIC OXIDE-BIOL CH, V41, P38, DOI 10.1016/j.niox.2014.05.014
   Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933
   Notebaert S, 2006, VET QUART, V28, P2, DOI 10.1080/01652176.2006.9695201
   O'Sullivan AW, 2009, J SURG RES, V152, P46, DOI 10.1016/j.jss.2008.04.030
   Ohsugi Y., 2015, ENDOCR METAB IMMUNE
   Oviedo-Boyso J, 2007, J INFECTION, V54, P399, DOI 10.1016/j.jinf.2006.06.010
   Qian H, 2014, WORLD J GASTROENTERO, V20, P1822, DOI 10.3748/wjg.v20.i7.1822
   Ren WY, 2015, INFLAMMATION, V38, P384, DOI 10.1007/s10753-014-0042-8
   Rosfjord EC, 1999, J MAMMARY GLAND BIOL, V4, P229, DOI 10.1023/A:1018789527533
   Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333
   Song CY, 2011, J GASTROEN HEPATOL, V26, P765, DOI 10.1111/j.1440-1746.2010.06561.x
   Song XJ, 2014, INFLAMMATION, V37, P1588, DOI 10.1007/s10753-014-9885-2
   Sordillo LM, 2002, J MAMMARY GLAND BIOL, V7, P135, DOI 10.1023/A:1020347818725
   Carneiro DMVF, 2009, CIENC RURAL, V39, P1934, DOI 10.1590/S0103-84782009005000106
   Wang XJ, 2012, INT J COLORECTAL DIS, V27, P575, DOI 10.1007/s00384-011-1352-z
   Yang ZT, 2014, INFLAMMATION, V37, P2047, DOI 10.1007/s10753-014-9937-7
   Zhang W, 2014, INFLAMMATION, V37, P478, DOI 10.1007/s10753-013-9761-5
   Zhang YF, 2008, INT IMMUNOPHARMACOL, V8, P1767, DOI 10.1016/j.intimp.2008.08.008
   Zhong WT, 2013, INFLAMMATION, V36, P529, DOI 10.1007/s10753-012-9574-y
NR 42
TC 7
Z9 9
U1 3
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-5769
EI 1878-1705
J9 INT IMMUNOPHARMACOL
JI Int. Immunopharmacol.
PD JUN
PY 2016
VL 35
BP 111
EP 118
DI 10.1016/j.intimp.2016.03.026
PG 8
WC Immunology; Pharmacology & Pharmacy
SC Immunology; Pharmacology & Pharmacy
GA DM2XX
UT WOS:000376212500013
PM 27039209
DA 2018-12-27
ER

PT J
AU Lehman, D
   Stanton, J
   Alire, D
AF Lehman, D.
   Stanton, J.
   Alire, D.
TI RETRACTED: Seismic Evaluation of Beam-Column Joints in Older Concrete
   Exterior Frames (Retracted Article)
SO JOURNAL OF STRUCTURAL ENGINEERING
LA English
DT Correction; Retracted Publication
CR Lehman D, 2016, J STRUCT ENG, V142, DOI 10.1061/(ASCE)ST.1943-541X.0000463
NR 1
TC 1
Z9 1
U1 4
U2 18
PU ASCE-AMER SOC CIVIL ENGINEERS
PI RESTON
PA 1801 ALEXANDER BELL DR, RESTON, VA 20191-4400 USA
SN 0733-9445
EI 1943-541X
J9 J STRUCT ENG
JI J. Struct. Eng.
PD JUN
PY 2016
VL 142
IS 6
AR 08216002
DI 10.1061/(ASCE)ST.1943-541X.0000463
PG 1
WC Construction & Building Technology; Engineering, Civil
SC Construction & Building Technology; Engineering
GA DM6DK
UT WOS:000376440300021
DA 2018-12-27
ER

PT J
AU Mohammadi, M
   Kaghazian, M
   Rahmani, O
   Ahmadi, K
   Hatami, E
   Ziari, K
   Talebreza, A
AF Mohammadi, Mohsen
   Kaghazian, Maria
   Rahmani, Omid
   Ahmadi, Koorosh
   Hatami, Elham
   Ziari, Katayoun
   Talebreza, Amir
TI RETRACTED: Overexpression of interleukins IL-17 and IL-8 with poor
   prognosis in colorectal cancer induces metastasis (Retracted article.
   See vol.37, pg. 16421, 2016)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE IL-17; IL-8; Colorectal cancer; PCR; Expression
ID ENDOTHELIAL GROWTH-FACTOR; TUMOR-GROWTH; CARCINOMA CELLS;
   PROSTATE-CANCER; OVARIAN-CANCER; HUMAN-MELANOMA; IN-VITRO; KAPPA-B;
   ANGIOGENESIS; EXPRESSION
AB Current evidences indicated that a group of soluble mediators called chemokines is involved in tumor growth and metastasis. The association of IL-8 with tumor cell migration was previously found, and its expression was related to angiogenesis, tumor progression, and metastasis in many kinds of carcinomas in human and animal models. Furthermore, it has been showed that IL-17 plays its role as either a proteome of tumor progression or antitumor indifferent cancer models. To investigate the messenger RNA (mRNA) expressions of IL-8 and IL-17 in patients with colorectal cancer (CRC) and non-tumor tissue, quantitative real-time PCR was used in the study. Our results showed that expression of IL-8 mRNA was significantly increased in tumor tissues (mean +/- SD 3.84 +/- 0.08) compared with adjacent normal mucosa (mean +/- SD 1.17 +/- 0.75, P = 0.001). Furthermore, a higher expression of IL-17 mRNA was found in tumor tissues (mean +/- SD 2.73 +/- 0.69) when compared with normal tissues (mean +/- SD 1.06 +/- 0.07, P = 0.001). Our findings indicated that advanced tumor-node-metastasis (TNM) stage (P = 0.024) and histological grade (poorly differentiated, P = 0.013) and distant metastasis (P = 0.001) were correlated with expression of IL-8. Moreover, high expression of IL-17 showed significant association with early stage CRC (TNM) (P = 0.038). In conclusion, the expression of IL-8 and IL-17 mRNAs was significantly increased in tumor tissues compared with adjacent normal tissues. We found that advanced TNM stage and histological grade and distant metastasis were correlated with expression of IL-8, while high expression of IL-17 showed significant association with early stage CRC (TNM) stage and overexpression of IL-8 may be associated with progression of CRC.
C1 [Mohammadi, Mohsen] Lorestan Univ Med Sci, Fac Pharm, Dept Pharmaceut Biotechnol, Khorramabad, Iran.
   [Kaghazian, Maria] Jundishapur Univ Med Sci, Dept Biol, Ahwaz, Iran.
   [Rahmani, Omid; Ziari, Katayoun] AJA Univ Med Sci, Dept Pathol, Besat Hosp, Tehran, Iran.
   [Ahmadi, Koorosh] Alborz Univ Med Sci, Dept Emergency Med, Karaj, Iran.
   [Hatami, Elham] Loghman Hakim Hosp, Dept Pathol, Sarakhs, Iran.
   [Talebreza, Amir] AJA Univ Med Sci, Dept Surg, Tehran, Iran.
RP Talebreza, A (reprint author), AJA Univ Med Sci, Dept Surg, Tehran, Iran.
EM dr.amirtalebreza@gmail.com
OI Jalallou, Nahid/0000-0003-2142-4526
CR An H, 2015, TUMOUR BIOL
   Baier PK, 2005, ANTICANCER RES, V25, P3581
   Balbay MD, 1999, CLIN CANCER RES, V5, P783
   Brew R, 2000, CYTOKINE, V12, P78, DOI 10.1006/cyto.1999.0518
   Chen X, 2010, LUNG CANCER, V69, P348, DOI 10.1016/j.lungcan.2009.11.013
   Cui GL, 2012, SCAND J GASTROENTERO, V47, P1304, DOI 10.3109/00365521.2012.725089
   Doll D, 2010, INT J COLORECTAL DIS, V25, P573, DOI 10.1007/s00384-010-0901-1
   He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574
   Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965
   Huang SY, 2002, AM J PATHOL, V161, P125, DOI 10.1016/S0002-9440(10)64164-8
   Inoue K, 2000, CLIN CANCER RES, V6, P2104
   Kitadai Y, 2000, CLIN CANCER RES, V6, P2735
   Kryczek I, 2009, BLOOD, V114, P357, DOI 10.1182/blood-2008-09-177360
   Lang K, 2002, INT J CANCER, V99, P673, DOI 10.1002/ijc.10424
   Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794
   Li AH, 2003, J IMMUNOL, V170, P3369, DOI 10.4049/jimmunol.170.6.3369
   Lin Y, 2015, CLIN TRANSL ONCOL, V17, P50, DOI 10.1007/s12094-014-1197-3
   Liu JK, 2011, BIOCHEM BIOPH RES CO, V407, P348, DOI 10.1016/j.bbrc.2011.03.021
   Lurje G, 2010, ANN ONCOL, V21, P78, DOI 10.1093/annonc/mdp280
   Maeda S, 2008, CANCER SCI, V99, P836, DOI 10.1111/j.1349-7006.2008.00763.x
   Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014
   Masuya D, 2001, CANCER, V92, P2628, DOI 10.1002/1097-0142(20011115)92:10<2628::AID-CNCR1616>3.0.CO;2-F
   Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536
   Mian BM, 2003, CLIN CANCER RES, V9, P3167
   Miyahara Y, 2008, P NATL ACAD SCI USA, V105, P15505, DOI 10.1073/pnas.0710686105
   Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562
   Petanidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073616
   RIES L, 2000, SEER CANC STAT REV 1
   Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217
   Rubie C, 2007, WORLD J GASTROENTERO, V13, P4996, DOI 10.3748/wjg.v13.i37.4996
   Schadendorf D, 1996, BRIT J CANCER, V74, P194, DOI 10.1038/bjc.1996.337
   Schultheis AM, 2008, CLIN CANCER RES, V14, P7554, DOI 10.1158/1078-0432.CCR-08-0351
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028
   Steiner GE, 2003, PROSTATE, V56, P171, DOI 10.1002/pros.10238
   Takamori H, 2000, PANCREAS, V21, P52, DOI 10.1097/00006676-200007000-00051
   Tan E, 2007, EUR J CANCER, V43, P2285, DOI 10.1016/j.ejca.2007.06.009
   Terada H, 2005, EUR SURG RES, V37, P166, DOI 10.1159/000085964
   Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050
   Zhang JP, 2009, J HEPATOL, V50, P980, DOI 10.1016/j.jhep.2008.12.033
   Zhu YM, 2004, BRIT J CANCER, V91, P1970, DOI 10.1038/sj.bjc.6602227
NR 41
TC 5
Z9 5
U1 2
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD JUN
PY 2016
VL 37
IS 6
BP 7501
EP 7505
DI 10.1007/s13277-015-4628-z
PG 5
WC Oncology
SC Oncology
GA DM6LT
UT WOS:000376464700048
PM 26678893
DA 2018-12-27
ER

PT J
AU Safaei, HR
   Rostamzadeh, A
   Rahmani, O
   Mohammadi, M
   Ghaderi, O
   Yahaghi, H
   Ahmadi, K
AF Safaei, Hamid Reza
   Rostamzadeh, Ayoob
   Rahmani, Omid
   Mohammadi, Mohsen
   Ghaderi, Omar
   Yahaghi, Hamid
   Ahmadi, Koroosh
TI RETRACTED: Prognostic investigations of B7-H1 and B7-H4 expression
   levels as independent predictor markers of renal cell carcinoma
   (Retracted article. See vol.37, pg. 16423, 2016)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE B7-H1 and B7-H4; Renal cell carcinoma; Analysis; Prognosis;
   Immunohistochemistry
ID B7 FAMILY; POTENTIAL MECHANISM; LUNG-CANCER; BLOCKADE; IMMUNITY;
   MOLECULE; IMMUNOTHERAPY; EVASION; SYSTEM; BREAST
AB In order to evaluate the correlation of B7-H4 and B7-H1 with renal cell carcinoma (RCC), we analyzed B7-H1 and B7-H4 expressions and their clinical significance by immunohistochemical method. Our result indicated that B7-H4-positive staining was detected in 58.13 % of RCC tissues (25 tissues tumors), and there were 18 tissues of patients without detectable B7-H4. Furthermore, 21 cases (48.83 %) were B7-H1-positive. Positive tumor expressions of B7-H4 and B7-H1 were markedly related to advanced TNM stage (P = 0.001; P = 0.014), high grade (P = 0.001; P = 002), and larger tumor size (P = 0.002; P = 024) in RCC tissues than patients with B7-H4-negative and B7-H1-negative in RCC tissues. The patients with B7-H1 and B7-H4-positive expressions were found to be markedly correlated with the overall survival of the patients (P < 0.05) and tended to have an increased risk of death when compared with negative expression groups. Univariate analysis showed that B7-H4 and B7-H1 expressions, TNM stage, high grade, and tumor size were significantly related to the prognosis of RCC. Furthermore, multivariate analysis showed that B7-H4 and B7-H1 expressions decreased overall survival. The adjusted HR for B7-H1 was 2.83 (95 % CI 1.210-2.971; P = 0.031) and also was 2.918 (95 % CI 1.243-3.102; P = 0.006) for B7-H4 that showed these markers were independent prognostic factors in RCC patients. The expressions of B7-H1 and B7-H4 in RCC patients indicate that these markers may be as a predictor of tumor development and death risk. Further investigations can be helpful to confirm B7-H1 and B7-H4 roles as an independent predictor of clinical RCC outcome.
C1 [Safaei, Hamid Reza] AJA Univ Med Sci, Dept Pediat Nephrol, Tehran, Iran.
   [Rostamzadeh, Ayoob] Shahrekord Univ Med Sci, Fac Med, Dept Anat Sci, Shahrekord, Iran.
   [Rahmani, Omid] AJA Univ Med Sci, Besat Hosp, Dept Pathol, Tehran, Iran.
   [Mohammadi, Mohsen] Lorestan Univ Med Sci, Fac Pharm, Dept Pharmaceut Biotechnol, Khorramabad, Iran.
   [Ghaderi, Omar] Univ Tehran Med Sci, Dept Pharmaceut Biotechnol, Tehran, Iran.
   [Yahaghi, Hamid] Baqiyatallah Univ Med Sci, Dept Mol Biol, Tehran, Iran.
   [Ahmadi, Koroosh] Alborz Univ Med Sci, Dept Emergency Med, Karaj, Iran.
RP Ahmadi, K (reprint author), Alborz Univ Med Sci, Dept Emergency Med, Karaj, Iran.
EM ahmadik@mums.ac.ir
OI Safaei, Hamid Reza/0000-0003-0105-162X
CR Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257
   CAMPBELL SC, 2007, CAMPBELL WALSH UROLO, P1567
   Choi IH, 2003, J IMMUNOL, V171, P4650, DOI 10.4049/jimmunol.171.9.4650
   Curiel TJ, 2003, NAT MED, V9, P562, DOI 10.1038/nm863
   Dong HD, 2003, J MOL MED-JMM, V81, P281, DOI 10.1007/s00109-003-0430-2
   Dong HD, 1999, NAT MED, V5, P1365
   Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730
   Dutcher JP, 2013, THER ADV UROL, V5, P338, DOI 10.1177/1756287213505672
   Hirano F, 2005, CANCER RES, V65, P1089
   Howlader N, 2013, SEER CANC STAT REV 1
   Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099
   Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428
   Krambeck AE, 2006, P NATL ACAD SCI USA, V103, P10391, DOI 10.1073/pnas.0600937103
   Kryczek I, 2006, J EXP MED, V203, P871, DOI 10.1084/jem.20050930
   McGuire BB, 2009, CURR OPIN UROL, V19, P441, DOI 10.1097/MOU.0b013e32832f0c68
   Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469
   Salceda S, 2005, EXP CELL RES, V306, P128, DOI 10.1016/j.yexcr.2005.01.018
   Shi SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076012
   Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3
   Strome SE, 2003, CANCER RES, V63, P6501
   Sun YP, 2006, LUNG CANCER-J IASLC, V53, P143, DOI 10.1016/j.lungcan.2006.05.012
   Thompson RH, 2007, CLIN CANCER RES, V13, p709S, DOI 10.1158/1078-0432.CCR-06-1868
   Thompson RH, 2006, CANCER RES, V66, P3381, DOI 10.1158/0008-5472.CAN-05-4303
   Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101
   Tringler B, 2005, CLIN CANCER RES, V11, P1842, DOI 10.1158/1078-0432.CCR-04-1658
   Wintterle S, 2003, CANCER RES, V63, P7462
   Zisman A, 2001, J CLIN ONCOL, V19, P1649, DOI 10.1200/JCO.2001.19.6.1649
NR 27
TC 7
Z9 7
U1 1
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD JUN
PY 2016
VL 37
IS 6
BP 7583
EP 7587
DI 10.1007/s13277-015-4652-z
PG 5
WC Oncology
SC Oncology
GA DM6LT
UT WOS:000376464700057
PM 26687644
DA 2018-12-27
ER

PT J
AU Mohammadi, M
   Goudarzi, PK
   Rahmani, O
   Kaghazian, P
   Yahaghi, E
   Taheriazam, A
   Ahmadi, K
AF Mohammadi, Mohsen
   Goudarzi, Peyman Karimi
   Rahmani, Omid
   Kaghazian, Peyman
   Yahaghi, Emad
   Taheriazam, Afshin
   Ahmadi, Koroosh
TI RETRACTED: Evaluation of gene expression level of CDC5L and MACC1 in
   poor prognosis and progression of osteosarcoma (Retracted article. See
   vol.37, pg. 16425, 2016)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Osteosarcoma; Expression; PCR; CDC5L; MACC1
ID RENAL-CELL CARCINOMA; DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA;
   MESSENGER-RNA; UP-REGULATION; OVEREXPRESSION; METASTASIS; PREDICTS;
   REGULATOR; MIGRATION
AB Current evidences have indicated that osteosarcoma is strongly associated with abnormal genetic and epigenetic changes that lead to the abnormal expression of oncogenes or methylation of tumor suppressor genes. In the present study, MACC1 and CDC5L mRNA levels in the patients with osteosarcoma were evaluated using quantitative real-time PCR. Our results demonstrated that CDC5L mRNA levels were higher in tumor tissues than in adjacent normal tissues (2.713 +/- 0.738 vs. 1.071 +/- 0.629; P < 0.05). Moreover, MACC1 was upregulated in tumor bone tissues than in adjacent normal tissues (3.221 +/- 0. 624 vs. 1.427 +/- 0.456; P < 0.05). Our result demonstrated that high expression of CDC5L was significantly related to advanced TNM stage (P = 0.032). No significant difference was determined between CDC5L mRNA expression and other clinicopathological parameters including age, gender, tumor diameter, location, tumor grade, and histological type. In addition, overexpression of MACC1 was strongly correlated with advanced TNM stage (P = 0.027) and high tumor grade (P = 0.035). Our findings indicated that mRNA level of CDC5L is correlated with advanced TNM stage, and MACC1 may be involved in progression of osteosarcoma.
C1 [Mohammadi, Mohsen] Lorestan Univ Med Sci, Dept Pharmaceut Biotechnol, Fac Pharm, Khorramabad, Iran.
   [Goudarzi, Peyman Karimi] AJA Univ Med Sci, Dept Neurosurg, Tehran, Iran.
   [Rahmani, Omid] AJA Univ Med Sci, Besat Hosp, Dept Pathol, Tehran, Iran.
   [Kaghazian, Peyman] Univ Klinikum Bonn, Dept Orthoped & Traumatol, Bonn, Germany.
   [Yahaghi, Emad] Islamic Azad Univ, North Tehran Branch, Young Researchers & Elite Club, Tehran, Iran.
   [Taheriazam, Afshin] Islamic Azad Univ, Tehran Med Sci Branch, Dept Orthoped Surg, Tehran, Iran.
   [Ahmadi, Koroosh] Alborz Univ Med Sci, Dept Emergency Med, Karaj, Iran.
RP Ahmadi, K (reprint author), Alborz Univ Med Sci, Dept Emergency Med, Karaj, Iran.
EM ahmadik@mums.ac.ir
OI Taheriazam, Afshin/0000-0002-3907-925X
CR Arlt F, 2009, INT J BIOCHEM CELL B, V41, P2356, DOI 10.1016/j.biocel.2009.08.001
   Bernstein HS, 1998, J BIOL CHEM, V273, P4666, DOI 10.1074/jbc.273.8.4666
   Broadhead Matthew L., 2011, Sarcoma, P959248, DOI 10.1155/2011/959248
   Chen WJ, 2016, TUMOR BIOL, V37, P4093, DOI 10.1007/s13277-015-4088-5
   Esmailiejah AA, 2015, TUMOUR BIOL
   Gao J, 2013, MOL CELL BIOCHEM, V376, P21, DOI 10.1007/s11010-012-1545-y
   Hu H, 2012, ONCOL LETT, V4, P1037, DOI 10.3892/ol.2012.866
   Huang YB, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-16
   Jaffe N, 2009, CANC TREAT, V152, P239, DOI 10.1007/978-1-4419-0284-9_12
   Janowitz T, 2013, SEMIN ONCOL, V40, P482, DOI [10.1053/j.seminonco1.2013.05.004, 10.1053/j.seminoncol.2013.05.004]
   Jin Z, 2015, INT J CLIN EXP PATHO, V8, P3857
   Liu LH, 2011, BIOCHEM BIOPH RES CO, V416, P31, DOI 10.1016/j.bbrc.2011.10.117
   Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115
   Martin JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095843
   Mu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.117
   Qu JH, 2012, WORLD J GASTROENTERO, V18, P2995, DOI 10.3748/wjg.v18.i23.2995
   Shimokawa H, 2011, J THORAC CARDIOV SUR, V141, P895, DOI 10.1016/j.jtcvs.2010.09.044
   Shirahata A, 2010, ANTICANCER RES, V30, P3441
   Shirahata A, 2010, ANTICANCER RES, V30, P2689
   Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889
   Taheriazam A, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0422-x
   Taheriazam A, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0400-3
   Thayanithy V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043720
   Zhang K, 2014, TUMOR BIOL, V35, P1343, DOI 10.1007/s13277-013-1180-6
   Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122
NR 25
TC 6
Z9 6
U1 1
U2 12
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD JUN
PY 2016
VL 37
IS 6
BP 8153
EP 8157
DI 10.1007/s13277-015-4726-y
PG 5
WC Oncology
SC Oncology
GA DM6LT
UT WOS:000376464700115
PM 26715275
DA 2018-12-27
ER

PT J
AU Liu, Y
   Bi, TT
   Dai, W
   Wang, G
   Qian, LQ
   Gao, QG
   Shen, GH
AF Liu, Yan
   Bi, Tingting
   Dai, Wei
   Wang, Gang
   Qian, Liqiang
   Gao, Quangen
   Shen, Genhai
TI RETRACTED: Effects of Oxymatrine on the Proliferation and Apoptosis of
   Human Hepatoma Carcinoma Cells (Retracted article. See vol.16, pg.NP1,
   2017)
SO TECHNOLOGY IN CANCER RESEARCH & TREATMENT
LA English
DT Article; Retracted Publication
DE oxymatrine; human hepatoma cells; apoptosis; Bax/Bcl-2; caspase
ID BCL-2 FAMILY PROTEINS; HEPATOCELLULAR-CARCINOMA; CANCER-CELLS; DEPENDENT
   APOPTOSIS; PANCREATIC-CANCER; SIGNALING PATHWAY; EXPRESSION; MATRINE;
   EPIDEMIOLOGY; INHIBITION
AB Oxymatrine, one of the main active components of extracts from the dry roots of Sophora flavescens, has been reported to possess anticancer activities in vitro and in vivo. However, the precise mechanism involved remains largely unknown. The present study is conducted to investigate the anticancer activity and the underlying mechanisms of oxymatrine in human hepatoma cells (Hep-G2 and SMMC-7721) in vitro and in vivo. Hep-G2 and SMMC-7721 cells were treated by oxymatrine and subjected to methyl thiazolyl tetrazolium analysis, Hoechst 33342 staining, annexin V/propidium iodide double staining, reverse transcription polymerase chain reaction, and Western blot analysis. In addition, SMMC-7721 xenograft tumors were established in male nude BALB/c mice, and oxymatrine was intravenously administered to evaluate the anticancer capacity in vivo. Our results showed that oxymatrine inhibited the proliferation and induced apoptosis of Hep-G2 and SMMC-7721 cells in a dose-dependent manner in vitro. Furthermore, the RNA and protein expression of Bax and caspase 3 levels were significantly upregulated, whereas the expression of Bcl-2 was downregulated. These protein interactions may play a pivotal role in the regulation of proliferation and apoptosis. More importantly, our in vivo studies showed that administration of oxymatrine decreased tumor growth in a dose-dependent manner. Immunohistochemistry analysis demonstrated an increase of Bax and caspase 3 and a decrease of Bcl-2 in tumor tissues following oxymatrine treatment which are consistent with the in vitro results. Taken together, our findings indicated that oxymatrine can inhibit cell proliferation and induce apoptosis of human hepatoma Hep-G2 and SMMC-7721 cells and might offer a therapeutic potential advantage for human hepatoma chemoprevention or chemotherapy.
C1 [Liu, Yan; Dai, Wei; Wang, Gang; Qian, Liqiang; Gao, Quangen; Shen, Genhai] Wujiang 1 Peoples Hosp, Dept Gen Surg, Suzhou 215200, Peoples R China.
   [Bi, Tingting] Wujiang 1 Peoples Hosp, Dept Geriatr Ward, Suzhou 215200, Peoples R China.
RP Gao, QG; Shen, GH (reprint author), Wujiang 1 Peoples Hosp, Dept Gen Surg, Suzhou 215200, Peoples R China.
EM wjyygqg@sohu.com; wjyysgh@163.com
FU Program for Young Scientist in Science and Education of Suzhou City
   [KJXW2014053]; Program for Young Scientist in Science and Education of
   Wujiang District [WWK201415]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This study
   was supported by the Program for Young Scientist in Science and
   Education of Suzhou City (No. KJXW2014053), the Program for Young
   Scientist in Science and Education of Wujiang District (No. WWK201415).
CR Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753
   Buendia B, 1999, J CELL SCI, V112, P1743
   Burlacu A, 2003, J CELL MOL MED, V7, P249, DOI 10.1111/j.1582-4934.2003.tb00225.x
   Chen H, 2013, ONCOL REP, V30, P589, DOI 10.3892/or.2013.2529
   Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663
   Cui XY, 2010, BIOSCI TRENDS, V4, P39
   Deng ZY, 2009, CHINESE MED J-PEKING, V122, P1449, DOI 10.3760/cma.j.issn.0366-6999.2009.12.018
   Dhanasekaran R, 2012, HEPATIC MED-EVID RES, V4, P19, DOI [10.1586/egh.09.35, 10.2147/HMER.S16316]
   Fan H., 2009, MEDIAT INFLAMM, V2009, P704
   Guzman JR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01629
   Jin Y, 2008, J HUAZHONG U SCI-MED, V28, P314, DOI 10.1007/s11596-008-0319-y
   Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17
   Kim JH, 2010, FOOD CHEM TOXICOL, V48, P807, DOI 10.1016/j.fct.2009.12.012
   Kojiro M, 2005, BEST PRACT RES CL GA, V19, P39, DOI 10.1016/j.bpg.2004.10.007
   Li Y, 2007, BASIC CLIN PHARMACOL, V101, P1, DOI 10.1111/j.1742-7843.2006.00040.x
   Liang CZ, 2012, CANCER CHEMOTH PHARM, V69, P317, DOI 10.1007/s00280-011-1699-4
   Ling Q, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-66
   Liu J, 2014, TUMOR BIOL, V35, P5409, DOI 10.1007/s13277-014-1705-7
   Park SY, 2005, CANCER LETT, V224, P123, DOI 10.1016/j.canlet.2004.10.009
   Raphael SW, 2012, ISRN ONCOL, V2012, DOI DOI 10.5402/2012/421673
   Saleem M, 2009, CARCINOGENESIS, V30, P808, DOI 10.1093/carcin/bgp044
   Song GB, 2006, COLLOID SURFACE B, V48, P1, DOI 10.1016/j.colsurfb.2005.12.012
   Song MQ, 2007, WORLD J GASTROENTERO, V13, P1788, DOI 10.3748/wjg.v13.i12.1788
   Spencer SL, 2011, CELL, V144, P926, DOI 10.1016/j.cell.2011.03.002
   Stefaniuk P, 2010, WORLD J GASTROENTERO, V16, P418, DOI 10.3748/wjg.v16.i4.418
   Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307
   Wu XS, 2014, ANTI-CANCER DRUG, V25, P1007, DOI 10.1097/CAD.0000000000000124
   Xiang XX, 2002, CHINESE MED J-PEKING, V115, P593
   Yang JD, 2010, INFECT DIS CLIN N AM, V24, P899, DOI 10.1016/j.idc.2010.07.004
   Yong-Gang C, 2010, PHYTOTHER RES, V24, P1844, DOI 10.1002/ptr.3206
   Zhang Y, 2011, MED ONCOL, V28, pS99, DOI 10.1007/s12032-010-9721-y
   Zhang Y, 2009, CYTOTECHNOLOGY, V59, P191, DOI 10.1007/s10616-009-9211-2
   Zhang Y, 2014, TUMOR BIOL, V35, P1619, DOI 10.1007/s13277-013-1223-z
   Zhang ZP, 2012, PHYTOTHER RES, V26, P932, DOI 10.1002/ptr.3657
NR 34
TC 13
Z9 14
U1 2
U2 13
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1533-0346
EI 1533-0338
J9 TECHNOL CANCER RES T
JI Technol. Cancer Res. Treat.
PD JUN
PY 2016
VL 15
IS 3
BP 487
EP 497
DI 10.1177/1533034615587616
PG 11
WC Oncology
SC Oncology
GA DL5VG
UT WOS:000375704500010
PM 26009496
OA Bronze
DA 2018-12-27
ER

PT J
AU Arduino, F
   Santarelli, M
AF Arduino, Francesco
   Santarelli, Massimo
TI RETRACTED: Total cost of ownership of CHP SOFC systems: Effect of
   installation context (Retracted Article. See Vol.97,pg.636,2016)
SO ENERGY POLICY
LA English
DT Article; Retracted Publication
DE SOFC; Impact of location; Economic feasibility; Life cycle cost; Life
   cycle impact assessment; Use phase model
AB Solid oxide fuel cells (SOFC) are one of the most interesting between the emerging technologies for energy production. Although some information about the production cost of these devices are already known, their operational cost has not been studied yet with sufficient accuracy.
   This paper presents a life cycle cost (LCC) analysis of CHP (combined heat and power) SOFC systems performed in hospitals located in various cities of the US and one in Italy. In this study the strong effects of the installation context will be analyzed using a customized use phase model for each location.
   The cost effectiveness of these devices has been proved without credits in Mondovi (IT), New York (NY) and Minneapolis (MN) where the payback time goes from 10 to 7 years. Considering the credits, it is possible to obtain economic feasibility also in Chicago (IL) and reduce the payback for other cities to values from 4 to 6 years. In other cities like Phoenix (AZ) and Houston (TX) the payback can't be reached in any case. The life cycle impact assessment analysis has shown how, even in the cities with cleaner electricity grid, there is a reduction in the emissions of both greenhouse gases and pollutants. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Arduino, Francesco] Politecn Torino, Corso Duca Abruzzi 24, I-10129 Turin, Italy.
   [Santarelli, Massimo] Politecn Torino, Dipartimento Energia, Corso Duca Abruzzi 24, I-10129 Turin, Italy.
RP Arduino, F (reprint author), Politecn Torino, Corso Duca Abruzzi 24, I-10129 Turin, Italy.
EM fra.arduino90@gmail.com; massimo.santarelli@polito.it
CR Deru M, 2011, US DEP ENERGY COMMER
   DOE, 2013, FUEL CELL TECHN MARK
   EIA, 2011, VOL REP GREENH GAS P
   EPA, 2008, TECHN CHAR FUEL CELL
   EPA, 2011, EM FACT GREENH GAS I
   HOOGERS G, 2003, FUEL CELL TECHNOLOGY
   James B. D., 2012, MANUFACTURING COST A
   Muller N. Z., 2006, AIR POLLUTION EMISSI
   Siler-Evans K., 2012, MARGINAL EMISSIONS F
   Van Regemorter Denise, INTEGRATION EXTERNAL
   Wei M, 2014, TOTAL COST OWNERSHIP
   Weimar MR, 2013, COST STUDY MANUFACTU
NR 12
TC 4
Z9 4
U1 5
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-4215
EI 1873-6777
J9 ENERG POLICY
JI Energy Policy
PD JUN
PY 2016
VL 93
BP 213
EP 228
DI 10.1016/j.enpol.2016.02.053
PG 16
WC Economics; Energy & Fuels; Environmental Sciences; Environmental Studies
SC Business & Economics; Energy & Fuels; Environmental Sciences & Ecology
GA DL1AH
UT WOS:000375363800024
DA 2018-12-27
ER

PT J
AU Subramanian, HH
   Arun, M
   Silburn, PA
   Holstege, G
AF Subramanian, Hari H.
   Arun, Mridula
   Silburn, Peter A.
   Holstege, Gert
TI RETRACTED: Motor organization of positive and negative emotional
   vocalization in the cat midbrain periaqueductal gray (Retracted article.
   See vol.526, pg.1991, 2018)
SO JOURNAL OF COMPARATIVE NEUROLOGY
LA English
DT Article; Retracted Publication
DE nucleus retroambiguus; midbrain periaqueductal gray; vocalization; motor
   organization
ID PARABRACHIAL NUCLEUS CONTRIBUTES; ABDUCTOR SPASMODIC DYSPHONIA; RAT
   IN-VIVO; FOOD-INTAKE; LARYNGEAL ELECTROMYOGRAPHY; EFFERENT PROJECTIONS;
   NONLIMBIC COMPONENTS; MUSCLE-ACTIVITY; NEURAL-CONTROL; SPINAL-CORD
AB Neurochemical microstimulation in different parts of the midbrain periaqueductal gray (PAG) in the cat generates four different types of vocalization, mews, howls, cries, and hisses. Mews signify positive vocal expression, whereas howls, hisses, and cries signify negative vocal communications. Mews were generated in the lateral column of the intermediate PAG and howls and hisses in the ventrolateral column of the intermediate PAG. Cries were generated in two regions, the lateral column of the rostral PAG and the ventrolateral column of the caudal PAG. To define the specific motor patterns belonging to mews, howls, and cries, the following muscles were recorded during these vocalizations: larynx (cricothyroid, thyroarytenoid, and posterior cricoarytenoid), tongue (genioglossus), jaw (digastric), and respiration (diaphragm, internal intercostal, external abdominal oblique, and internal abdominal oblique) muscles. Furthermore, the frequency, intensity, activation cascades, and turns and amplitude analyses of the electromyograms (EMGs) during these vocalizations were analyzed. The results show that each type of vocalization consists of a specific, circumscribed motor coordination. The nucleus retroambiguus (NRA) in the caudal medulla serves as the final premotor interneuronal output system for vocalization. NRA neurochemical microstimulation also generated vocalizations (guttural sounds). Analysis of the EMGs demonstrated that these vocalizations consist of only small parts of the emotional voalizations generated by neurochemical stimulation in the PAG. These results demonstrate that motor organization of positive and negative emotional vocal expressions are segregated in the PAG and that the PAG uses the NRA as a tool to gain access to the motoneurons generating vocalization. J. Comp. Neurol. 524:1540-1557, 2016. (c) 2015 Wiley Periodicals, Inc.
C1 [Subramanian, Hari H.; Arun, Mridula; Silburn, Peter A.; Holstege, Gert] Univ Queensland, Queensland Brain Inst, Asia Pacific Ctr Neuromodulat, Brisbane, Qld 4072, Australia.
   [Arun, Mridula] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.
RP Subramanian, HH (reprint author), Univ Queensland, Queensland Brain Inst, Asia Pacific Ctr Neuromodulat, Brisbane, Qld 4072, Australia.
EM h.subramanian@uq.edu.au
FU University of Queensland
FX We are grateful for the laboratory support of Dr. Ron Balnave (School of
   Biomedical Sciences, The University of Sydney) and advice on
   quantitative EMG analysis from Dr. Andrew Bradley (School of Information
   Technology and Electrical Engineering, The University of Queensland).
   M.A. was supported by The University of Queensland summer and winter
   research scholarships.
CR ADAMETZ J, 1959, NEUROLOGY, V9, P636, DOI 10.1212/WNL.9.10.636
   Alexander MP, 2001, NEUROREHAB NEURAL RE, V15, P151, DOI 10.1177/154596830101500208
   Alhadeff AL, 2014, AM J PHYSIOL-REG I, V307, pR1338, DOI 10.1152/ajpregu.00329.2014
   Alhadeff AL, 2014, NEUROPSYCHOPHARMACOL, V39, P2233, DOI 10.1038/npp.2014.74
   BANDLER R, 1988, BRAIN RES, V439, P95, DOI 10.1016/0006-8993(88)91465-5
   Beauchaine TP, 2015, CURR OPIN PSYCHOL, V3, P43, DOI 10.1016/j.copsyc.2015.01.017
   Beaver BV., 2003, FELINE BEHAV GUIDE V
   BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K
   Berman AL., 1968, CYTOARCHITECTONIC AT
   BERNARD JF, 1995, J COMP NEUROL, V353, P480, DOI 10.1002/cne.903530403
   Blitzer A, 2009, OTOLARYNG HEAD NECK, V140, P782, DOI 10.1016/j.otohns.2009.01.026
   Bolser DC, 2013, OTOLARYNG CLIN N AM, V46, P957, DOI 10.1016/j.otc.2013.09.013
   BRADSHAW J, 1992, BEHAV DOMESTIC CAT
   Bradshaw J, 2000, DOMESTIC CAT BIOL IT, P71
   Broniatowski M, 2012, LARYNGOSCOPE, V122, P2015, DOI 10.1002/lary.23464
   Cairns AM, 1998, RESP PHYSIOL, V112, P305, DOI 10.1016/S0034-5687(98)00032-2
   CARRIVE P, 1989, BRAIN RES, V483, P251, DOI 10.1016/0006-8993(89)90169-8
   CARRIVE P, 1993, BEHAV BRAIN RES, V58, P27, DOI 10.1016/0166-4328(93)90088-8
   Carter ME, 2013, NATURE, V503, P111, DOI 10.1038/nature12596
   Chen R, 1996, MUSCLE NERVE, V19, P324, DOI 10.1002/(SICI)1097-4598(199603)19:3<324::AID-MUS7>3.0.CO;2-F
   Chhetri DK, 2014, LARYNGOSCOPE, V124, P2363, DOI 10.1002/lary.24742
   COWIE RJ, 1992, J COMP NEUROL, V319, P536, DOI 10.1002/cne.903190406
   Cyrus CB, 2001, OTOLARYNG HEAD NECK, V124, P23, DOI 10.1067/mhn.2001.112572
   Darwin C, 1872, EXPRESSION EMOTIONS
   Dusterhoft F, 2004, NEUROSCIENCE, V123, P53, DOI 10.1016/j.neuroscience.2003.07.007
   FRIES W, 1974, EXP BRAIN RES, V21, P441
   GOODCHILD AK, 1982, J NEUROSCI METH, V6, P351, DOI 10.1016/0165-0270(82)90036-X
   HAYASHI H, 1984, J NEUROPHYSIOL, V51, P890
   Heman-Ackah YD, 2007, OTOLARYNG CLIN N AM, V40, P1003, DOI 10.1016/j.otc.2007.05.007
   HOLSTEGE G, 1991, PROG BRAIN RES, V87, P307
   HOLSTEGE G, 1988, PROG BRAIN RES, V77, P47
   HOLSTEGE G, 1989, J COMP NEUROL, V284, P242, DOI 10.1002/cne.902840208
   HOLSTEGE G, 1991, NATO ADV SCI I A-LIF, V213, P239
   Holstege G, 2016, J COMP NEUROL, V524, P1558, DOI 10.1002/cne.23898
   Janssens L, 2013, RESP MED, V107, P331, DOI 10.1016/j.rmed.2012.11.019
   Jiang J., 1988, J VOICE, V1, P314, DOI DOI 10.1016/S0892-1997(88)80004-3
   JOHN ER, 1968, SCIENCE, V159, P1489, DOI 10.1126/science.159.3822.1489
   Jurgens U, 2009, J VOICE, V23, P1, DOI 10.1016/j.jvoice.2007.07.005
   Krout KE, 1998, J COMP NEUROL, V401, P437
   KRUKOFF TL, 1993, BRAIN RES BULL, V30, P163, DOI 10.1016/0361-9230(93)90054-F
   Landsberg G, 1996, J AM VET MED ASSOC, V208, P502
   LI YQ, 1993, BRAIN RES, V608, P138, DOI 10.1016/0006-8993(93)90784-K
   LINDESTAD PA, 1991, ACTA OTO-LARYNGOL, V111, P1146, DOI 10.3109/00016489109100770
   Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095
   MANTYH PW, 1982, J COMP NEUROL, V211, P50, DOI 10.1002/cne.902110106
   Nash EA, 1996, LARYNGOSCOPE, V106, P484, DOI 10.1097/00005537-199604000-00017
   Nicastro N, 2003, J COMP PSYCHOL, V117, P44, DOI 10.1037/0735-7036.117.1.44
   Ota R, 2013, NEUROSCIENCE, V254, P260, DOI 10.1016/j.neuroscience.2013.09.036
   Pettersen V, 2005, FOLIA PHONIATR LOGO, V57, P255, DOI 10.1159/000087079
   Richard JE, 2014, ENDOCRINOLOGY, V155, P4356, DOI 10.1210/en.2014-1248
   Road JD, 1998, MOL CELL BIOCHEM, V179, P81, DOI 10.1023/A:1006855819966
   Schmidt MF, 2014, PROG BRAIN RES, V212, P297, DOI 10.1016/B978-0-444-63488-7.00015-X
   SKULTETY FM, 1958, J COMP NEUROL, V110, P337, DOI 10.1002/cne.901100303
   Statham MM, 2010, LARYNGOSCOPE, V120, P2036, DOI 10.1002/lary.21046
   Subramanian HH, 2013, J COMP NEUROL, V521, P3083, DOI 10.1002/cne.23334
   Subramanian HH, 2013, J PHYSIOL-LONDON, V591, P109, DOI 10.1113/jphysiol.2012.245217
   Subramanian HH, 2011, J NEUROPHYSIOL, V105, P2852, DOI 10.1152/jn.00168.2011
   Subramanian HH, 2009, J NEUROSCI, V29, P3824, DOI 10.1523/JNEUROSCI.0607-09.2009
   Subramanian HH, 2008, J NEUROSCI, V28, P12274, DOI 10.1523/JNEUROSCI.4168-08.2008
   Subramanian HH, 2014, PROG BRAIN RES, V212, P352
   Sukhotinsky I, 2006, J CHEM NEUROANAT, V32, P159, DOI 10.1016/j.jchemneu.2006.08.003
   Tawadros PB, 2012, MOVEMENT DISORD, V27, P1811, DOI 10.1002/mds.25262
   WATSON BC, 1991, J SPEECH HEAR RES, V34, P473, DOI 10.1044/jshr.3403.473
   WIBERG M, 1987, J COMP NEUROL, V264, P92, DOI 10.1002/cne.902640108
   WIBERG M, 1992, UPSALA J MED SCI, V97, P37, DOI 10.3109/03009739209179280
   Wu AP, 2015, LARYNGOSCOPE, V125, P904, DOI 10.1002/lary.25004
   Yeon SC, 2011, BEHAV PROCESS, V87, P183, DOI 10.1016/j.beproc.2011.03.003
   ZHANG SP, 1994, J NEUROPHYSIOL, V72, P1337
   Zhang SP, 1996, J NEUROPHYSIOL, V74, P1
NR 69
TC 8
Z9 8
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9967
EI 1096-9861
J9 J COMP NEUROL
JI J. Comp. Neurol.
PD JUN 1
PY 2016
VL 524
IS 8
SI SI
BP 1540
EP 1557
DI 10.1002/cne.23869
PG 18
WC Neurosciences; Zoology
SC Neurosciences & Neurology; Zoology
GA DH9UH
UT WOS:000373140900003
PM 26235936
DA 2018-12-27
ER

PT J
AU Kabeel, AE
   Omara, ZM
   Essa, FA
   Abdullah, AS
AF Kabeel, A. E.
   Omara, Z. M.
   Essa, F. A.
   Abdullah, A. S.
TI RETRACTED: Solar still with condenser - A detailed review (Retracted
   article. See vol. 77, pg. 1403, 2017)
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review; Retracted Publication
DE Solar Still; Solar distillation; Condenser; Review
ID ENHANCED CONDENSATION; EXTERNAL CONDENSER; SEPARATE CONDENSER; PROVIDING
   VACUUM; PERFORMANCE; DISTILLATION; NANOFLUIDS; SYSTEM; EFFICIENCY;
   CHAMBER
AB Access to potable water to the people is narrowing down day after day all over the world. Most of the human diseases are caused by polluted or non-purified water resources. Water purification without affecting the ecosystem is the necessity of the hour. Solar distillation is one of the water purification techniques producing ultrapure distilled water. Solar still distillation systems offer sustainable tools for freshwater production. Numerous environmental and operational parameters attribute to optimize the still design. Different designs were tested by researchers to improve the productivity of solar still. In their experimentations, the solar still integrated with external or internal condenser is deemed to be effective and efficient design. In this detailed survey, we are seeking to introduce, explain and discuss the status of different solar stills integrated with different condensers arrangements. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Kabeel, A. E.; Abdullah, A. S.] Tanta Univ, Fac Engn, Dept Power Mech Engn, Tanta, Egypt.
   [Omara, Z. M.; Essa, F. A.] Kafrelsheikh Univ, Fac Engn, Dept Mech Engn, Kafrelsheikh, Egypt.
   [Abdullah, A. S.] Prince Sattam bin Abdulaziz Univ, Fac Engn, Al Kharj, Saudi Arabia.
RP Kabeel, AE (reprint author), Tanta Univ, Fac Engn, Dept Power Mech Engn, Tanta, Egypt.
EM kabeel6@hotmail.com
CR AbuQudais M, 1996, ENERGY, V21, P851, DOI 10.1016/0360-5442(96)00050-3
   Ahmed H.M, 2012, J ADV SCI ENG RES, V2, P1
   Ahmed S. T., 1988, Solar & Wind Technology, V5, P637, DOI 10.1016/0741-983X(88)90061-6
   Al-Hamadani AAF, 2013, ENERGY J, V28, P6
   Al-Kharabsheh S, 2003, DESALINATION, V156, P323, DOI 10.1016/S0011-9164(03)00363-1
   Al-Nimr MA, 2015, SOL ENERGY, V114, P8, DOI 10.1016/j.solener.2015.01.021
   Belhadj MM, 2015, ENERG CONVERS MANAGE, V94, P245, DOI 10.1016/j.enconman.2015.01.069
   Bhardwaj R, 2015, APPL ENERG, V154, P480, DOI 10.1016/j.apenergy.2015.05.060
   El-Bahi A, 1999, DESALINATION, V123, P79, DOI 10.1016/S0011-9164(99)00061-2
   El-Bahi A, 1999, RENEW ENERG, V17, P509, DOI 10.1016/S0960-1481(98)00768-X
   El-Samadony YAF, 2015, EXP HEAT TRANSFER, V28, P392, DOI 10.1080/08916152.2014.890964
   Emad AA, 2014, J AGR SCI, V6, P48
   FATANI AA, 1994, RENEW ENERG, V4, P377, DOI 10.1016/0960-1481(94)90044-2
   Fatani AA, 1995, INT J SOLAR ENERGY, V17, P1
   FATH HES, 1993, ENERG CONVERS MANAGE, V34, P63, DOI 10.1016/0196-8904(93)90008-X
   Fath HES, 2004, DESALINATION, V169, P129, DOI 10.1016/j.desal.2004.08.014
   Fath HES, 1996, DESALINATION, V107, P223, DOI 10.1016/S0011-9164(96)00164-6
   Fath HES, 2002, DESALINATION, V142, P19, DOI 10.1016/S0011-9164(01)00422-2
   Haddad OM, 2000, RENEW ENERG, V21, P459, DOI 10.1016/S0960-1481(00)00079-3
   Husham MA, 2012, SCI RES ESSAYS, V7, P1444
   Kabeel AE, 2015, RENEW SUST ENERG REV, V46, P178, DOI 10.1016/j.rser.2015.02.053
   Kabeel AE, 2014, ENERG CONVERS MANAGE, V86, P268, DOI 10.1016/j.enconman.2014.05.050
   Kabeel AE, 2014, ENERG CONVERS MANAGE, V78, P493, DOI 10.1016/j.enconman.2013.11.013
   Kerfah R, 2012, MECHANIKA, P49, DOI 10.5755/j01.mech.18.1.1281
   Khalifa AJN, 1999, ENERG CONVERS MANAGE, V40, P1835, DOI 10.1016/S0196-8904(99)00049-7
   Koilraj Gnanadason M, 2012, INT J SCI ENG RES, V3, P2229
   Kudish AI, 2003, ENERG CONVERS MANAGE, V44, P1653, DOI 10.1016/S0196-8904(02)00180-2
   Kumar KV, 2008, DESALINATION, V230, P51, DOI 10.1016/j.desal.2007.11.015
   Madhlopa A, 2009, RENEW ENERG, V34, P1668, DOI 10.1016/j.renene.2008.12.032
   Mahmoudi H, 2010, RENEW SUST ENERG REV, V14, P2182, DOI 10.1016/j.rser.2010.03.024
   Monowe P, 2011, DESALINATION, V280, P332, DOI 10.1016/j.desal.2011.07.031
   Murugavel KK, 2013, RENEW SUST ENERG REV, V20, P364, DOI 10.1016/j.rser.2012.10.047
   NIJEGORODOV N, 1994, RENEW ENERG, V4, P123, DOI 10.1016/0960-1481(94)90074-4
   Omara ZM, 2015, ENERG CONVERS MANAGE, V103, P965, DOI 10.1016/j.enconman.2015.07.035
   Paul R., 2015, DENIM MANUFACTURE FI, P1, DOI [10.1016/B978-0-85709-843-6.00001-9, DOI 10.1016/B978-0-85709-843-6.00001-9]
   Rabah Kerfah, 2015, DESALIN WATER TREAT, P1
   RAHIM NHA, 1995, DESALINATION, V101, P255, DOI 10.1016/0011-9164(95)00028-Z
   REDDY MS, 1983, APPL ENERG, V13, P15, DOI 10.1016/0306-2619(83)90031-4
   Rene T, 1999, ENERG CONVERS MANAGE, V41, P93
   Sampathkumar K, 2010, RENEW SUST ENERG REV, V14, P1503, DOI 10.1016/j.rser.2010.01.023
   Sathyamurthy R, 2015, DESALINATION, V367, P180, DOI 10.1016/j.desal.2015.04.012
   Sivakumar V, 2013, RENEW SUST ENERG REV, V28, P246, DOI 10.1016/j.rser.2013.07.037
   Tiwari GN, 1997, DESALINATION, V114, P153, DOI 10.1016/S0011-9164(98)00007-1
   Tiwari GN, 2003, SOL ENERGY, V75, P367, DOI 10.1016/j.solener.2003.07.005
   Velmurugan V, 2011, RENEW SUST ENERG REV, V15, P1294, DOI 10.1016/j.rser.2010.10.012
   Xiong JY, 2013, ENERG CONVERS MANAGE, V73, P176, DOI 10.1016/j.enconman.2013.04.024
NR 46
TC 17
Z9 17
U1 3
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD JUN
PY 2016
VL 59
BP 839
EP 857
DI 10.1016/j.rser.2016.01.020
PG 19
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA DG3CZ
UT WOS:000371948400057
DA 2018-12-27
ER

PT J
AU Esmaeli, A
AF Esmaeli, Abdolreza
TI RETRACTED: Stability analysis and control of microgrids by sliding mode
   control(Retracted article. See vol 93, pg 506, 2017)
SO INTERNATIONAL JOURNAL OF ELECTRICAL POWER & ENERGY SYSTEMS
LA English
DT Article; Retracted Publication
DE Distributed power generation; Microgrids; Sliding mode control; Voltage
   control
ID DYNAMIC PERFORMANCE; POWER; OPERATION
AB In this paper stability analysis and control of microgrids using sliding mode control are presented. Renewable energy based distributed generation (DG) is increasingly play a dominant role in the generation of electricity. Microgrid consists of cluster of load and distributed generators that operate as a single controllable system. The interconnection of the DG to the grid by power electronic converters has raised concern about safe operation and protection of the equipment. Many control strategy have been proposed for enhancing the stability of microgrid as for proper load sharing. Parallel converters have been proposed to deliver desired real power and reactive power to the system. The active power and reactive power sharing can be achieved by controlling two independent quantities, of frequency and voltage magnitude. In this paper, a sliding mode control (SMC) is proposed to smooth transition between grid connected and islanded modes of operation which this work through converter firing pulses controlled the output voltage magnitude. Finally the simulation results obtained using the MATLAB/SIMULINK software. Simulation results show the effectiveness of using SMC in transient response of load current and in load voltage and current during immediate load variations. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Esmaeli, Abdolreza] Nucl Sci & Technol Res Inst, Plasma & Nucl Fus Res Sch, Tehran, Iran.
RP Esmaeli, A (reprint author), Nucl Sci & Technol Res Inst, Plasma & Nucl Fus Res Sch, Tehran, Iran.
EM aesmaeli@aeoi.org.ir
OI Esmaeli, Abdolreza/0000-0002-2346-273X
CR Aghatehrani R, 2011, P IEEE POW EN SOC GE, V24-29, P1
   Azevedo GMS, 2013, BRAZIL POWER ELECTR, P1008, DOI 10.1109/COBEP.2013.6785238
   Barklund E, 2008, IEEE T POWER ELECTR, V23, P2346, DOI 10.1109/TPEL.2008.2001910
   Furtado EC, 2008, IEEE T CIRCUITS-II, V55, P1061, DOI 10.1109/TCSII.2008.926800
   Gao C, 2013, 2 IET REN POW GEN C, P1
   Ghosh A, 2000, IEEE T POWER DELIVER, V15, P417, DOI 10.1109/61.847283
   Inthamoussou FA, 2013, IEEE T ENERGY CONVER, V28, P690, DOI 10.1109/TEC.2013.2260752
   Katiraei F, 2005, IEEE T POWER DELIVER, V20, P248, DOI 10.1109/TPWRD.2004.835051
   Lasserter R H, 2002, IEEE POW ENG SOC WIN, P305
   Li YW, 2009, IEEE T POWER ELECTR, V24, P2977, DOI 10.1109/TPEL.2009.2022828
   Majumder R, 2010, MODELING STABILITY A
   Milosevic M., 2007, P IEEE POW ENG SOC G, P1
   Mishra S, 2013, IEEE T POWER SYST, V28, P4393, DOI 10.1109/TPWRS.2013.2261098
   Mishra SK, 2009, IEEE T IND ELECTRON, V56, P3704, DOI 10.1109/TIE.2009.2025289
   Nichols DK, 2006, P IEEE POW ENG SOC G
   Nikkhajoei H, 2009, IEEE T POWER DELIVER, V24, P1598, DOI 10.1109/TPWRD.2009.2021040
   Piagi P, 2006, POW ENG SOC GEN M IE
   Reza M, 2006, POW SYST C EXP PSCE, P1423
   Rowe CN, 2012, IEEE ENER CONV, P2727, DOI 10.1109/ECCE.2012.6342384
   Salamah AM, 2008, IET GENER TRANSM DIS, V2, P209, DOI 10.1049/iet-gtd:20070144
   Sao CK, 2008, IEEE T POWER SYST, V23, P1088, DOI 10.1109/TPWRS.2008.922232
   Shahabi M, 2009, IEEE T ENERGY CONVER, V24, P137, DOI 10.1109/TEC.2008.2006556
   Slootweg JG, 2002, POWER ENG SOC SUMMER, V2, P862, DOI DOI 10.1109/PESS.2002.1043465
   Xiao S, 2008, IEEE T POWER ELECTR, V23, P495, DOI 10.1109/TPEL.2007.912947
   Zhang J, 2011, 2011 INT C EL INF CO, P1257
NR 25
TC 16
Z9 17
U1 3
U2 70
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-0615
EI 1879-3517
J9 INT J ELEC POWER
JI Int. J. Electr. Power Energy Syst.
PD JUN
PY 2016
VL 78
BP 22
EP 28
DI 10.1016/j.ijepes.2015.11.068
PG 7
WC Engineering, Electrical & Electronic
SC Engineering
GA DE7RZ
UT WOS:000370835700003
DA 2018-12-27
ER

PT J
AU Namazi, H
   Akrami, A
   Kulish, VV
AF Namazi, Hamidreza
   Akrami, Amin
   Kulish, Vladimir V.
TI RETRACTED: The Analysis of the Influence of Odorant's Complexity on
   Fractal Dynamics of Human Respiration (Retracted article. See vol. 8,
   art no 46982, 2018)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID APPROXIMATE ENTROPY; VARIABILITY; PRESSURE; INTERVAL; BREATH; SLEEP
AB One of the major challenges in olfaction research is to relate the structural features of the odorants to different features of olfactory system. However, no relationship has been yet discovered between the structure of the olfactory stimulus, and the structure of respiratory signal. This study reveals the plasticity of human respiratory signal in relation to 'complex' olfactory stimulus (odorant). We demonstrated that fractal temporal structure of respiration dynamics shifts towards the properties of the odorants used. The results show for the first time that more structurally complex a monomolecular odorant will result in less fractal respiratory signal. On the other hand, odorant with higher entropy will result the respiratory signal with lower entropy. The capability observed in this research can be further investigated and applied for treatment of patients with different respiratory diseases.
C1 [Namazi, Hamidreza; Kulish, Vladimir V.] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
   [Akrami, Amin] Univ Tehran, Sch Met & Mat Engn, Tehran 14174, Iran.
RP Namazi, H (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
EM hnamazi@ntu.edu.sg
FU Ministry of Education, Singapore [RG119/15]
FX This work has been supported by the grant from Ministry of Education,
   Singapore. Grant number RG119/15.
CR Akay Metin, 2003, J Integr Neurosci, V2, P165, DOI 10.1142/S021963520300024X
   Angelini L, 2007, ARTIF INTELL MED, V41, P237, DOI 10.1016/j.artmed.2007.07.012
   Bassingthwaighte J. B, 1994, FRACTAL PHYSL
   Burdock G. A., 2009, FENAROLIS HDB FLAVOR
   Burioka N, 2003, CHEST, V123, P80, DOI 10.1378/chest.123.1.80
   Caldirola D, 2004, AM J PSYCHIAT, V161, P79, DOI 10.1176/appi.ajp.161.1.79
   Edwards R. D, 2012, TECHNICAL ANAL STOCK
   Elder DE, 2012, RESP PHYSIOL NEUROBI, V181, P1, DOI 10.1016/j.resp.2012.01.006
   Fadel PJ, 2004, J APPL PHYSIOL, V97, P2056, DOI 10.1152/japplphysiol.00657.2004
   Goldman LJ, 2008, RESP PHYSIOL NEUROBI, V161, P29, DOI 10.1016/j.resp.2007.11.007
   Gomez C, 2009, MED ENG PHYS, V31, P306, DOI 10.1016/j.medengphy.2008.06.010
   Gupta V, 1997, INT J MED INFORM, V45, P185, DOI 10.1016/S1386-5056(97)00029-4
   HENDRICKSON JB, 1987, J CHEM INF COMP SCI, V27, P63, DOI 10.1021/ci00054a004
   Kaplan V, 2000, EUR RESPIR J, V15, P570, DOI 10.1034/j.1399-3003.2000.15.24.x
   Larsen PD, 2004, RESP PHYSIOL NEUROBI, V139, P263, DOI 10.1016/j.resp.2003.11.001
   Namazi H, 2016, ONCOTARGET, V7, P342, DOI 10.18632/oncotarget.6341
   Namazi H, 2015, COMPUT MATH METHOD M, DOI 10.1155/2015/148534
   Peng CK, 2002, ANN BIOMED ENG, V30, P683, DOI 10.1114/1.1481053
   PINCUS SM, 1991, J CLIN MONITOR, V7, P335, DOI 10.1007/BF01619355
   Sedjelmaci I, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414500559
   Sell CS, 2014, CHEMISTRY AND THE SENSE OF SMELL, P1, DOI 10.1002/9781118522981
   SZETO HH, 1992, AM J PHYSIOL, V263, pR141
   West BJ, 2005, RESP PHYSIOL NEUROBI, V145, P219, DOI 10.1016/j.resp.2004.07.010
   White CE, 2010, J TRAUMA, V68, P1310, DOI 10.1097/TA.0b013e3181da90db
   Wu DWL, 2014, J VISION, V14, DOI 10.1167/14.9.8
NR 25
TC 3
Z9 3
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 31
PY 2016
VL 6
AR 26948
DI 10.1038/srep26948
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DN2GC
UT WOS:000376881100002
PM 27244590
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Heestermans, M
   Salloum-Asfar, S
   Salvatori, D
   Laghmani, E
   Luken, BM
   Zeerleder, SS
   Spronk, HMH
   Korporaal, SJ
   Wagenaar, GTM
   Reitsma, PH
   van Vlijmen, BJM
AF Heestermans, Marco
   Salloum-Asfar, Salam
   Salvatori, Daniela
   Laghmani, El Houari
   Luken, Brenda M.
   Zeerleder, Sacha S.
   Spronk, Henri M. H.
   Korporaal, Suzanne J.
   Wagenaar, Gerry T. M.
   Reitsma, Pieter H.
   van Vlijmen, Bart J. M.
TI RETRACTED: Role of platelets, neutrophils, and factor XII in spontaneous
   venous thrombosis in mice (Retracted article. See vol. 131, pg. 2996,
   2018)
SO BLOOD
LA English
DT Article; Retracted Publication
ID COAGULATION-FACTOR XII; DEEP-VEIN THROMBOSIS; EXTRACELLULAR TRAPS;
   ARTERIAL THROMBOSIS; INTRINSIC PATHWAY; RISK-FACTORS; IN-VIVO;
   THROMBOEMBOLISM; DEFICIENCY; ACTIVATION
AB Recently, platelets, neutrophils, and factor XII (FXII) have been implicated as important players in the pathophysiology of venous thrombosis. Their role became evident in mouse models in which surgical handling was used to provoke thrombosis. Inhibiting anticoagulation in mice by using small interfering RNA (siRNA) targeting Serpinc1 and Proc also results in a thrombotic phenotype, which is spontaneous (no additional triggers) and reproducibly results in clots in the large veins of the head and fibrin deposition in the liver. This thrombotic phenotype is fatal but can be fully rescued by thrombin inhibition. The mouse model was used in this study to investigate the role of platelets, neutrophils, and FXII. After administration of siRNAs targeting Serpinc1 and Proc, antibody-mediated depletion of platelets fully abrogated the clinical features as well as microscopic aspects in the head. This was corroborated by strongly reduced fibrin deposition in the liver. Whereas neutrophils were abundant in siRNA-triggered thrombotic lesions, antibody-mediated depletion of circulating Ly6G-positive neutrophils did not affect onset, severity, or thrombus morphology. In addition, absence of circulating neutrophils did not affect quantitative liver fibrin deposition. Remarkably, siRNA-mediated depletion of plasma FXII accelerated the onset of the clinical phenotype; mice were affected with more severe thrombotic lesions. To summarize, in this study, onset and severity of the thrombotic phenotype are dependent on the presence of platelets but not circulating neutrophils. Unexpectedly, FXII has a protective effect. This study challenges the proposed roles of neutrophils and FXII in venous thrombosis pathophysiology.
C1 [Heestermans, Marco; Salloum-Asfar, Salam; Reitsma, Pieter H.; van Vlijmen, Bart J. M.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands.
   [Heestermans, Marco; Salloum-Asfar, Salam; Reitsma, Pieter H.; van Vlijmen, Bart J. M.] Leiden Univ, Med Ctr, Dept Internal Med, Div Thrombosis & Hemostasis, Leiden, Netherlands.
   [Salvatori, Daniela] Leiden Univ, Med Ctr, Cent Lab Anim Facil, Leiden, Netherlands.
   [Laghmani, El Houari; Wagenaar, Gerry T. M.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands.
   [Luken, Brenda M.; Zeerleder, Sacha S.] Sanquin Acad Med Ctr, Landsteiner Lab, Dept Immunopathol, Amsterdam, Netherlands.
   [Spronk, Henri M. H.] Maastricht Univ, Dept Internal Med & Biochem, NL-6200 MD Maastricht, Netherlands.
   [Korporaal, Suzanne J.] Univ Med Ctr Utrecht, Dept Clin Chem & Hematol, Utrecht, Netherlands.
RP van Vlijmen, BJM (reprint author), Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Dept Internal Med,Div Thrombosis & Hemostasis, Leiden, Netherlands.
EM b.j.m.van_vlijmen@lumc.nl
CR Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238
   Bjorkqvist J, 2015, J CLIN INVEST, V125, P3132, DOI 10.1172/JCI77139
   Brill A, 2011, BLOOD, V117, P1400, DOI 10.1182/blood-2010-05-287623
   Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170
   Cleuren ACA, 2010, J THROMB HAEMOST, V8, P1838, DOI 10.1111/j.1538-7836.2010.03930.x
   Dahlback B, 2008, BLOOD, V112, P19, DOI 10.1182/blood-2008-01-077909
   de Vissei YP, 2010, AM J RESP CRIT CARE, V182, P1239, DOI [10.1164/rccm.200909.1361OC, 10.1164/rccm.200909-1361OC]
   Diaz JA, 2013, THROMB HAEMOSTASIS, V109, P1158, DOI 10.1160/TH12-09-0711
   Gailani D, 2007, ARTERIOSCL THROM VAS, V27, P2507, DOI 10.1161/ATVBAHA.107.155952
   Geddings J, 2014, J THROMB HAEMOST, V12, P571, DOI 10.1111/jth.12510
   Geddings JE, 2014, THROMB HAEMOSTASIS, V111, P570, DOI 10.1160/TH13-10-0812
   Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575
   Kenne E, 2015, J INTERN MED, V278, P571, DOI 10.1111/joim.12430
   Konings J, 2015, THROMB RES, V136, P474, DOI 10.1016/j.thromres.2015.06.028
   Konings J, 2011, BLOOD, V118, P3942, DOI 10.1182/blood-2011-03-339572
   Kooijman S, 2015, J THROMB HAEMOST, V13, P126, DOI 10.1111/jth.12765
   Mangin P, 2006, BLOOD, V107, P4346, DOI 10.1182/blood-2005-10-4244
   Martinelli I, 2001, THROMB HAEMOSTASIS, V86, P395
   Martinod K, 2014, BLOOD, V123, P2768, DOI 10.1182/blood-2013-10-463646
   Muller F, 2011, CURR OPIN HEMATOL, V18, P349, DOI 10.1097/MOH.0b013e3283497e61
   Muller F, 2009, CELL, V139, P1143, DOI 10.1016/j.cell.2009.11.001
   Nielsen VG, 2005, ACTA ANAESTH SCAND, V49, P222, DOI 10.1111/j.1399-6576.2004.00602.x
   Renne T, 2006, BLOOD CELL MOL DIS, V36, P148, DOI 10.1016/j.bcmd.2005.12.014
   Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007
   Safdar H, 2013, BLOOD, V121, P4413, DOI 10.1182/blood-2012-11-465674
   Safdar H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038104
   Savchenko AS, 2014, J THROMB HAEMOST, V12, P860, DOI 10.1111/jth.12571
   Schmaier AH, 2016, J THROMB HAEMOST, V14, P28, DOI 10.1111/jth.13194
   van Montfoort ML, 2013, ARTERIOSCL THROM VAS, V33, P147, DOI 10.1161/ATVBAHA.112.300498
   von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322
   Warkentin TE, 2012, NEW ENGL J MED, V367, P2039, DOI 10.1056/NEJMe1211480
   Zeerleder S, 2007, FEBS LETT, V581, P5382, DOI 10.1016/j.febslet.2007.10.037
NR 32
TC 17
Z9 19
U1 1
U2 12
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD MAY 26
PY 2016
VL 127
IS 21
BP 2630
EP 2637
DI 10.1182/blood-2015-10-672766
PG 8
WC Hematology
SC Hematology
GA DP2QK
UT WOS:000378334400017
PM 26932804
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Mahato, P
   Yanai, N
   Sindoro, M
   Granick, S
   Kimizuka, N
AF Mahato, Prasenjit
   Yanai, Nobuhiro
   Sindoro, Melinda
   Granick, Steve
   Kimizuka, Nobuo
TI RETRACTED: Preorganized Chromophores Facilitate Triplet Energy
   Migration, Annihilation and Upconverted Singlet Energy Collection
   (Retracted article. See vol. 139, pg. 8382, 2017)
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article; Retracted Publication
ID METAL-ORGANIC FRAMEWORKS; LOW-POWER; HIGH-EFFICIENCY; BAND-GAP;
   CONVERSION; OXYGEN; PHASE; AIR; PHOTOCATALYSIS; NANOFIBERS
AB Photon upconversion (UC) based on triplet triplet annihilation (TTA) has the potential to enhance significantly photovoltaic and photocatalytic efficiencies by harnessing sub-bandgap photons, but the progress of this field is held back by the chemistry problem of how to preorganize multiple chromophores for efficient UC under weak solar irradiance. Recently, the first maximization of UC quantum yield at solar irradiance was achieved using fast triplet energy migration (TEM) in metal organic frameworks (MOFs) with ordered acceptor arrays, but at the same time, a trade-off between fast TEM and high fluorescence efficiency was also found. Here, we provide a solution for this trade-off issue by developing a new strategy, triplet energy migration, annihilation and upconverted singlet energy collection (TEM-UPCON). The porous structure of acceptor-based MOF crystals allows triplet donor molecules to be accommodated without aggregation. The surface of donor-doped MOF nanocrystals is modified with highly fluorescent energy collectors through coordination bond formation. Thanks to the higher fluorescence quantum yield of surface-bound collectors than parent MOFs, the implementation of the energy collector greatly improves the total UC quantum yield. The UC quantum yield maximization behavior at ultralow excitation intensity was retained because the TTA events take place only in the MOF acceptors. The TEM-UPCON concept may be generalized to collectors with various functions and would lead to quantitative harvesting of upconverted energy, which is difficult to achieve in common molecular diffusion-based systems.
C1 [Mahato, Prasenjit; Yanai, Nobuhiro; Kimizuka, Nobuo] Kyushu Univ, CMS, Grad Sch Engn, Dept Chem & Biochem,Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan.
   [Yanai, Nobuhiro] JST, PRESTO, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
   [Sindoro, Melinda; Granick, Steve] Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.
   [Granick, Steve] UNIST, IBS Ctr Soft & Living Matter, Ulsan 689798, South Korea.
RP Yanai, N; Kimizuka, N (reprint author), Kyushu Univ, CMS, Grad Sch Engn, Dept Chem & Biochem,Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan.; Yanai, N (reprint author), JST, PRESTO, Honcho 4-1-8, Kawaguchi, Saitama 3320012, Japan.
EM yanai@mail.cstm.kyushu-u.ac.jp; n-kimi@mail.cstm.kyushu-u.ac.jp
OI Sindoro, Melinda/0000-0002-2335-3859
FU JSPS-NSF International Collaborations in Chemistry (ICC) program;
   Ministry of Education, Culture Sports, Science and Technology of Japan
   [25220805, 26810036, 16H00844]; Asahi Glass Foundation; National Science
   Foundation [NSF CHE 13-03757]; Institute for Basic Science [IBS-R020-D1]
FX This work was partly supported by the JSPS-NSF International
   Collaborations in Chemistry (ICC) program, a Grants-in-Aid for
   Scientific Research (S) (25220805), a Grants-in-Aid for Young Scientists
   (B) (26810036), a Grant-in-Aid for Scientific Research on Innovative
   Area (16H00844) from the Ministry of Education, Culture Sports, Science
   and Technology of Japan, and the Asahi Glass Foundation. M.S. was
   supported by the National Science Foundation, Grant NSF CHE 13-03757.
   S.G. acknowledges support from the Institute for Basic Science, Project
   Code IBS-R020-D1.
CR Alkordi MH, 2008, J AM CHEM SOC, V130, P12639, DOI 10.1021/ja804703w
   Askes SHC, 2015, PHYS CHEM CHEM PHYS, V17, P27380, DOI 10.1039/c5cp04352b
   Baluschev S, 2007, J APPL PHYS, V101, DOI 10.1063/1.2409618
   Baluschev S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.143903
   Cheng YY, 2010, J PHYS CHEM LETT, V1, P1795, DOI 10.1021/jz100566u
   Duan PF, 2015, J AM CHEM SOC, V137, P1887, DOI 10.1021/ja511061h
   Duan PF, 2013, J AM CHEM SOC, V135, P19056, DOI 10.1021/ja411316s
   Furukawa S, 2014, CHEM SOC REV, V43, P5700, DOI 10.1039/c4cs00106k
   Gadzikwa T, 2008, CHEM COMMUN, P5493, DOI 10.1039/b805101a
   Gadzikwa T, 2009, J AM CHEM SOC, V131, P13613, DOI 10.1021/ja904189d
   Goudarzi H, 2014, J PHYS CHEM C, V118, P14256, DOI 10.1021/jp5052936
   Gray V, 2014, PHYS CHEM CHEM PHYS, V16, P10345, DOI 10.1039/c4cp00744a
   Haefele A, 2012, J PHYS CHEM LETT, V3, P299, DOI 10.1021/jz300012u
   Hauptvogel IM, 2011, INORG CHEM, V50, P8367, DOI 10.1021/ic200937u
   Hosoyamada M, 2016, CHEM-EUR J, V22, P2060, DOI 10.1002/chem.201503318
   Juan-Alcaniz J, 2012, J MATER CHEM, V22, P10102, DOI 10.1039/c2jm15563j
   Kent CA, 2010, J AM CHEM SOC, V132, P12767, DOI 10.1021/ja102804s
   Khnayzer RS, 2012, CHEM COMMUN, V48, P209, DOI 10.1039/c1cc16015j
   Kim JH, 2014, ACS PHOTONICS, V1, P382, DOI 10.1021/ph500036m
   Kim JH, 2012, J AM CHEM SOC, V134, P17478, DOI 10.1021/ja308789u
   Kim JH, 2012, CHEM MATER, V24, P2250, DOI 10.1021/cm3012414
   Kondo M, 2010, ANGEW CHEM INT EDIT, V49, P5327, DOI 10.1002/anie.201001063
   Liu B, 2011, J AM CHEM SOC, V133, P1734, DOI 10.1021/ja1109826
   Liu JX, 2015, ANGEW CHEM INT EDIT, V54, P7441, DOI 10.1002/anie.201501862
   MAEDA Y, 1987, J POLYM SCI POL PHYS, V25, P1005, DOI 10.1002/polb.1987.090250503
   Mahato P, 2015, NAT MATER, V14, P924, DOI [10.1038/NMAT4366, 10.1038/nmat4366]
   Marsico F, 2014, J AM CHEM SOC, V136, P11057, DOI 10.1021/ja5049412
   Miller KS, 1997, TRENDS FOOD SCI TECH, V8, P228, DOI 10.1016/S0924-2244(97)01051-0
   Monguzzi A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195112
   Monguzzi A, 2013, ADV ENERGY MATER, V3, P680, DOI 10.1002/aenm.201200897
   Monguzzi A, 2012, PHYS CHEM CHEM PHYS, V14, P4322, DOI 10.1039/c2cp23900k
   Morris W, 2014, J AM CHEM SOC, V136, P7261, DOI 10.1021/ja503215w
   Nagata S, 2012, CRYSTENGCOMM, V14, P4137, DOI 10.1039/c2ce06633e
   Ogawa T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10882
   Pope M., 1999, ELECT PROCESSES ORGA
   Schmidt TW, 2014, J PHYS CHEM LETT, V5, P4062, DOI 10.1021/jz501799m
   Schulze TF, 2015, ENERG ENVIRON SCI, V8, P103, DOI 10.1039/c4ee02481h
   Simon YC, 2012, J MATER CHEM, V22, P20817, DOI 10.1039/c2jm33654e
   Sindoro M, 2014, ACCOUNTS CHEM RES, V47, P459, DOI 10.1021/ar400151n
   Singh-Rachford TN, 2010, COORDIN CHEM REV, V254, P2560, DOI 10.1016/j.ccr.2010.01.003
   So MC, 2015, CHEM COMMUN, V51, P3501, DOI 10.1039/c4cc09596k
   Svagan AJ, 2014, ACS NANO, V8, P8198, DOI 10.1021/nn502496a
   Turro N. J., 2010, MODERN MOL PHOTOCHEM
   Vadrucci R, 2014, J MATER CHEM C, V2, P2837, DOI 10.1039/c3tc32473g
   Wang WP, 2015, NANO LETT, V15, P6332, DOI 10.1021/acs.nanolett.5b01325
   Wohnhaas C, 2013, ACS MACRO LETT, V2, P446, DOI 10.1021/mz400100j
   Xu KJ, 2015, CHEM COMMUN, V51, P1803, DOI 10.1039/c4cc09202c
   Yanai N, 2016, CHEM COMMUN, V52, P5354, DOI 10.1039/c6cc00089d
   Yanai N, 2012, ANGEW CHEM INT EDIT, V51, P5638, DOI 10.1002/anie.201109132
   Yoshihara T, 2012, ANGEW CHEM INT EDIT, V51, P4148, DOI 10.1002/anie.201107557
   Zhang T, 2014, CHEM SOC REV, V43, P5982, DOI 10.1039/c4cs00103f
   Zhao JZ, 2011, RSC ADV, V1, P937, DOI 10.1039/c1ra00469g
   Zhou J, 2015, CHEM REV, V115, P395, DOI 10.1021/cr400478f
NR 53
TC 25
Z9 25
U1 24
U2 219
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAY 25
PY 2016
VL 138
IS 20
BP 6541
EP 6549
DI 10.1021/jacs.6b01652
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA DN1KY
UT WOS:000376825900041
PM 27163784
DA 2018-12-27
ER

PT J
AU Namazi, H
   Kulish, VV
   Akrami, A
AF Namazi, Hamidreza
   Kulish, Vladimir V.
   Akrami, Amin
TI RETRACTED: The analysis of the influence of fractal structure of stimuli
   on fractal dynamics in fixational eye movements and EEG signal
   (Retracted article. See vol. 8, art no 46985, 2018)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID DIMENSION; SACCADES
AB One of the major challenges in vision research is to analyze the effect of visual stimuli on human vision. However, no relationship has been yet discovered between the structure of the visual stimulus, and the structure of fixational eye movements. This study reveals the plasticity of human fixational eye movements in relation to the 'complex' visual stimulus. We demonstrated that the fractal temporal structure of visual dynamics shifts towards the fractal dynamics of the visual stimulus (image). The results showed that images with higher complexity (higher fractality) cause fixational eye movements with lower fractality. Considering the brain, as the main part of nervous system that is engaged in eye movements, we analyzed the governed Electroencephalogram (EEG) signal during fixation. We have found out that there is a coupling between fractality of image, EEG and fixational eye movements. The capability observed in this research can be further investigated and applied for treatment of different vision disorders.
C1 [Namazi, Hamidreza; Kulish, Vladimir V.] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
   [Akrami, Amin] Univ Tehran, Sch Mech Engn, Tehran 14174, Iran.
RP Namazi, H (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.
EM hnamazi@ntu.edu.sg
FU Ministry of Education, Singapore [RG119/15]
FX This work has been supported by the grant from Ministry of Education,
   Singapore. Grant number RG119/15.
CR Anandarup M., 2014, INT J COMPUT APPL, V88, DOI [10.5120/15407-3928, DOI 10.5120/15407-3928]
   Astefanoaei Corina, 2013, Rom J Biophys, V23, P81
   Belyaev R. V., 2014, RENSIT, V6, P30
   Billock VA, 2001, PHYSICA D, V148, P136, DOI 10.1016/S0167-2789(00)00174-3
   CORNSWEET TN, 1956, J OPT SOC AM, V46, P987, DOI 10.1364/JOSA.46.000987
   DITCHBURN RW, 1980, VISION RES, V20, P271, DOI 10.1016/0042-6989(80)90112-1
   Foisy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143693
   Foulsham T, 2010, VISION RES, V50, P779, DOI 10.1016/j.visres.2010.01.019
   Hahn HK, 2005, MATH BIOSCI INTERAC, P55, DOI 10.1007/3-7643-7412-8_5
   Huh KH, 2011, IMAGNG SCI DENT, V41, P71, DOI 10.5624/isd.2011.41.2.71
   Hunt N, 2014, SCI REP-UK, V4, DOI 10.1038/srep05879
   Lia J., 2009, PATTERN RECOGN, V42, P2460
   Mandelbrot B., 1983, FRACTAL GEOMETRY NAT
   Marlow CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139379
   Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006
   Nagai M, 2007, IEEE SYS MAN CYBERN, P4014
   Namazi H, 2016, ONCOTARGET, V7, P342, DOI 10.18632/oncotarget.6341
   Namazi H, 2015, ONCOTARGET, V6, P42623, DOI 10.18632/oncotarget.6003
   Namazi H, 2015, COMPUT MATH METHOD M, DOI 10.1155/2015/148534
   Schmeisser ET, 2001, OPTOMETRY VISION SCI, V78, P805, DOI 10.1097/00006324-200111000-00010
   Tan CO, 2009, J PHYSIOL-LONDON, V587, P3929, DOI 10.1113/jphysiol.2009.169219
   Wang Quan, 2014, Proc Eye Track Res Appl Symp, V2014, P67
   Wu DWL, 2014, J VISION, V14, DOI 10.1167/14.9.8
   YOSHIMATSU H, 1992, P IEEE EMBS, V14, P81, DOI 10.1109/IEMBS.1992.5760867
NR 24
TC 7
Z9 9
U1 1
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 24
PY 2016
VL 6
AR 26639
DI 10.1038/srep26639
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DM5LB
UT WOS:000376389400001
PM 27217194
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Delorme, A
   Pierce, A
   Michel, L
   Radin, D
AF Delorme, Arnaud
   Pierce, Alan
   Michel, Leena
   Radin, Dean
TI RETRACTED: Prediction of Mortality Based on Facial Characteristics
   (Retracted article. See vol.10,pg.515,2016)
SO FRONTIERS IN HUMAN NEUROSCIENCE
LA English
DT Article; Retracted Publication
DE face; mortality; intuition; EEG; reading
ID FACES; POTENTIALS; ATTENTION; TOOLBOX; HEALTH; AGE
AB Recent studies have shown that characteristics of the face contain a wealth of information about health, age and chronic clinical conditions. Such studies involve objective measurement of facial features correlated with historical health information. But some individuals also claim to be adept at gauging mortality based on a glance at a person's photograph. To test this claim, we invited 12 such individuals to see if they could determine if a person was alive or dead based solely on a brief examination of facial photographs. All photos used in the experiment were transformed into a uniform gray scale and then counterbalanced across eight categories: gender, age, gaze direction, glasses, head position, smile, hair color, and image resolution. Participants examined 404 photographs displayed on a computer monitor, one photo at a time, each shown for a maximum of 8 s. Half of the individuals in the photos were deceased, and half were alive at the time the experiment was conducted. Participants were asked to press a button if they thought the person in a photo was living or deceased. Overall mean accuracy on this task was 53.8%, where 50% was expected by chance (p < 0.004, two-tail). Statistically significant accuracy was independently obtained in 5 of the 12 participants. We also collected 32-channel electrophysiological recordings and observed a robust difference between images of deceased individuals correctly vs. incorrectly classified in the early event related potential (ERP) at 100 ms post-stimulus onset. Our results support claims of individuals who report that some as-yet unknown features of the face predict mortality. The results are also compatible with claims about clairvoyance warrants further investigation.
C1 [Delorme, Arnaud] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Delorme, Arnaud; Pierce, Alan; Michel, Leena; Radin, Dean] Inst Noet Sci, Petaluma, CA USA.
RP Delorme, A (reprint author), Univ Calif San Diego, La Jolla, CA 92093 USA.; Delorme, A (reprint author), Inst Noet Sci, Petaluma, CA USA.
EM arno@cerco.ups-tlse.fr
FU Bial Foundation [234/12]
FX The authors wish to thank the Bial Foundation (Grant 234/12) for a
   generous grant that supported this study, as well as generous support
   from Lori Grace, Wendy Grace and Alan Hugenot and the donors and members
   of the Institute of Noetic Sciences. The authors also wish to thank
   Harmony Sullala, Mollie Robertson, and Joseph Burnett for their help in
   locating and classifying the photographs and Cassandra Vieten as well as
   the Frontiers referees for their valuable comments on this manuscript.
CR Bourguignon Erika, 1976, POSSESSION
   Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357
   Christoffersen M, 2014, CIRCULATION, V129, P990, DOI 10.1161/CIRCULATIONAHA.113.001696
   DAVIS PW, 1984, SOC SCI MED, V19, P691, DOI 10.1016/0277-9536(84)90241-7
   Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009
   Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007
   Halit H, 2000, NEUROREPORT, V11, P1871, DOI 10.1097/00001756-200006260-00014
   Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781
   Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8
   Ibanez A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00188
   Kelly EW, 2011, J NERV MENT DIS, V199, P11, DOI 10.1097/NMD.0b013e31820439da
   Luck S, 2005, INTRO EVENT RELATED
   Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024
   Okada HC, 2013, PLAST RECONSTR SURG, V132, P1085, DOI 10.1097/PRS.0b013e3182a4c20a
   PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6
   Reither EN, 2009, DEMOGRAPHY, V46, P27, DOI 10.1353/dem.0.0037
   Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010
   Taylor MJ, 1999, CLIN NEUROPHYSIOL, V110, P910, DOI 10.1016/S1388-2457(99)00006-1
   Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28
   Wilson M., 2015, MANHATTAN FORTUNETEL
NR 20
TC 1
Z9 1
U1 2
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5161
J9 FRONT HUM NEUROSCI
JI Front. Hum. Neurosci.
PD MAY 17
PY 2016
VL 10
AR 173
DI 10.3389/fnhum.2016.00173
PG 6
WC Neurosciences; Psychology
SC Neurosciences & Neurology; Psychology
GA DM0TF
UT WOS:000376058000001
PM 27242466
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Praveena, K
   Sadhana, K
   Sandhya, R
   Murthy, SR
   Liu, HL
AF Praveena, K.
   Sadhana, K.
   Sandhya, R.
   Murthy, S. R.
   Liu, Hsiang-Lin
TI RETRACTED: Influence of Ca2+ doping on structural, dielectric and
   magnetic properties of Sr2MgCo2-xCaxFe24O41 for potential antenna
   applications (Retracted article. See vol. 43, pg. 14543, 2017)
SO CERAMICS INTERNATIONAL
LA English
DT Article; Retracted Publication
DE Z-type hexaferrite; Sol-gel route; Dielectric properties; Magnetic
   properties; Low temperature sintering; Low loss
ID CITRATE PRECURSOR METHOD; ROOM-TEMPERATURE; INFRARED SPECTRA; ZINC
   FERRITES; HEXAFERRITE; CERAMICS; CONDUCTIVITY
AB Z-type hexaferrites Sr2MgCo2-xCaxFe24O41 of stoichiometric composition where x=0.0, 0.2, 0.4, 0.6, 0.8 and 1.0 were prepared by sol-gel method. The obtained nanopowders were sintered at 950 degrees C/4 h using conventional sintering method. The samples were characterized by X-ray diffraction (XRD) and field emission scanning electron microscopy (FE-SEM). Phase analysis of Ca-doped Sr2MgCo2-xCaxFe24O41 powders revealed pure Z-type hexaferrites phase. The room temperature dielectric and magnetic properties (epsilon', epsilon '', mu' and mu '') were studied using RF impedance analyzer in the frequency range of 1 MHz to 1.8 GHz. The dielectric responses of these compounds are found to be frequency dependent and show the frequency stability upto 1.4 GHz. The relaxation-type dielectric behavior is dominating in the low frequency region and resonance-type dielectric behavior is found to be dominating above 10(9) Hz. It was inferred that the permeability was sensitively controlled by the substitution of Ca2+. The coercivity (H-c) increased gradually with an increase of calcium content. Frequency variation of AC conductivity is explained in terms of hopping of electrons between Fe2+ and Fe3+. Since loss tangent was kept low with the frequency ranging from 1 MHz to 1.4 GHz, such magneto-dielectric material could be used in this frequency range for antenna miniaturization. (C) 2016 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Praveena, K.] Eternal Univ, Sch Phys, Baru Sahib 173101, Himachal Prades, India.
   [Praveena, K.; Liu, Hsiang-Lin] Natl Taiwan Normal Univ, Dept Phys, Taipei 11677, Taiwan.
   [Sadhana, K.] Osmania Univ, Univ Coll Sci, Dept Phys, Hyderabad 500004, Andhra Pradesh, India.
   [Sandhya, R.; Murthy, S. R.] Osmania Univ, Univ Coll Sci, Dept Phys, Hyderabad 500007, Andhra Pradesh, India.
RP Praveena, K (reprint author), Natl Taiwan Normal Univ, Dept Phys, Taipei 11677, Taiwan.
FU Ministry of Science and Technology of Republic of China [NSC
   102-2112-M-003-002-MY3, MOST 104-2811-M-003-009]
FX Dr K. Praveena acknowledges the Ministry of Science and Technology of
   Republic of China under Grant No. NSC 102-2112-M-003-002-MY3 and MOST
   104-2811-M-003-009 for financial support.
CR [Anonymous], 2006, AGILENT TECHNOLOGIES
   Bhavikatti A. M., 2010, INT J ENG SCI TECHNO, V2, P6532
   Chen IW, 2000, NATURE, V404, P168, DOI 10.1038/35004548
   Chen YJ, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3590771
   Chun SH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.177201
   Cullity B. D., 1978, ELEMENTS XRAY DIFFRA
   Ebnabbasi K, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.024430
   ElHiti MA, 1996, J MAGN MAGN MATER, V164, P187, DOI 10.1016/S0304-8853(96)00368-X
   Hafner S, 1961, Z KRISTALLOGR, V115, P331, DOI 10.1524/zkri.1961.115.5-6.331
   Hashim M, 2013, CERAM INT, V39, P1807, DOI 10.1016/j.ceramint.2012.08.028
   Iqbal MJ, 2008, CHEM ENG J, V136, P383, DOI 10.1016/j.cej.2007.05.046
   JOSYULU OS, 1981, PHYS STATUS SOLIDI A, V65, P479, DOI 10.1002/pssa.2210650209
   Jung YK, 2012, IEEE T ANTENN PROPAG, V60, P786, DOI 10.1109/TAP.2011.2167943
   Kikuchi T, 2011, MATER RES BULL, V46, P1085, DOI 10.1016/j.materresbull.2011.03.004
   Kimura T, 2012, ANNU REV CONDEN MA P, V3, P93, DOI 10.1146/annurev-conmatphys-020911-125101
   Kitagawa Y, 2010, NAT MATER, V9, P797, DOI 10.1038/nmat2826
   Kong LB, 2007, J AM CERAM SOC, V90, P2104, DOI 10.1111/j.1551-2916.2007.01691.x
   KOOPS CG, 1951, PHYS REV, V83, P121, DOI 10.1103/PhysRev.83.121
   Kumar A, 2011, J PHYS CHEM SOLIDS, V72, P1189, DOI 10.1016/j.jpcs.2011.06.006
   Kumar L, 2013, INT NANO LETT, V3, DOI 10.1186/2228-5326-3-8
   Liu XS, 2002, J MAGN MAGN MATER, V238, P207, DOI 10.1016/S0304-8853(01)00914-3
   MURTHY VRK, 1976, PHYS STATUS SOLIDI A, V36, pK133, DOI 10.1002/pssa.2210360247
   Pradeep A, 2008, MATER CHEM PHYS, V112, P572, DOI 10.1016/j.matchemphys.2008.05.090
   Pullar RC, 1998, J MAGN MAGN MATER, V186, P326, DOI 10.1016/S0304-8853(98)00107-3
   Pullar RC, 2012, PROG MATER SCI, V57, P1191, DOI 10.1016/j.pmatsci.2012.04.001
   Rashad MM, 2012, J MAGN MAGN MATER, V324, P4019, DOI 10.1016/j.jmmm.2012.07.010
   Rasly M, 2013, J MAGN MAGN MATER, V337, P58, DOI 10.1016/j.jmmm.2013.02.038
   Reddy MP, 2011, CURR APPL PHYS, V11, P191, DOI 10.1016/j.cap.2010.07.005
   Sindhu S, 2002, B MATER SCI, V25, P599, DOI 10.1007/BF02707892
   Smith J., 1961, FERRITES
   Soda M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.087201
   Su H, 2011, J APPL PHYS, V109, DOI 10.1063/1.3535418
   Takada Y, 2006, J APPL PHYS, V100, DOI 10.1063/1.2204334
   Tang RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13645
   Tokunaga M, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.064713
   Wagner KW, 1913, ANN PHYS-BERLIN, V40, P817
   WALDRON RD, 1955, PHYS REV, V99, P1727, DOI 10.1103/PhysRev.99.1727
   Wang XH, 2005, J AM CERAM SOC, V88, P478, DOI 10.1111/j.1551-2916.2005.00081.x
   Wang XH, 2001, J MAGN MAGN MATER, V234, P255, DOI 10.1016/S0304-8853(01)00376-6
   Wang X, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896326
   Wu JT, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4753973
   Xia Q, 2012, J APPL PHYS, V112, DOI 10.1063/1.4748175
   Xu JJ, 2011, J ALLOY COMPD, V509, P4290, DOI 10.1016/j.jallcom.2011.01.027
   Xu JJ, 2011, J MAGN MAGN MATER, V323, P157, DOI 10.1016/j.jmmm.2010.08.055
   Yanchen Gao, 2010, 2010 IEEE International Conference on Advanced Management Science (ICAMS), P109, DOI 10.1109/ICAMS.2010.5553275
   Zhang X, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3677672
NR 46
TC 5
Z9 5
U1 6
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAY 15
PY 2016
VL 42
IS 7
BP 8869
EP 8877
DI 10.1016/j.ceramint.2016.02.135
PG 9
WC Materials Science, Ceramics
SC Materials Science
GA DJ2ZX
UT WOS:000374075300133
DA 2018-12-27
ER

PT J
AU Park, JH
   Joo, SK
AF Park, Jae Hyo
   Joo, Seung Ki
TI RETRACTED: Impact of an ultra-thin ZrTiO4 buffer layer for long
   retention characteristics of metal-ferroelectric-insulator-semiconductor
   capacitor(Retracted article.See vol.50, Artn No.139701, 2017)
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Article; Retracted Publication
DE ferroelectric field-effect transistor;
   metal-ferroelectric-insulator-semiconductor capacitor; buffer layer;
   ZrTiO4
ID FIELD-EFFECT TRANSISTORS; MEMORY APPLICATIONS; GRAIN-GROWTH; FILMS; FET;
   SI
AB In most ferroelectric field-effect transistors (FeFETs), a thin interfacial layer is inserted between the ferroelectric and semiconductor in order to avoid the interdiffusion of metallic impurities. In this work, we have used ZrTiO4 (ZTO) as an interfacial layer to improve the interface of Pb(Zr, Ti)O-3 (PZT)/Si and prevent the diffusion of metallic impurities of PZT. It was found that optimizing the thickness of ZTO strongly influences the FeFET retention characteristics. Gate leakage current and Pb metallic interdiffusion were effectively suppressed when the ZTO thickness was thicker than 5 nm. However, a self-depolarization field was generated by the charge compensation loss in PZT, caused by the thick ZTO. On the other hand, our sample showed a large gate leakage current and Pb metallic interdiffusion when ZTO was thinner than 2 nm. It was found that 2 nm thick ZTO is the optimum thickness for long retention characteristics in FeFETs.
C1 [Park, Jae Hyo; Joo, Seung Ki] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.
   [Park, Jae Hyo; Joo, Seung Ki] Seoul Natl Univ, Eui San Res Ctr, RIAM, Seoul 151742, South Korea.
RP Joo, SK (reprint author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.; Joo, SK (reprint author), Seoul Natl Univ, Eui San Res Ctr, RIAM, Seoul 151742, South Korea.
EM skjoo@snu.ac.kr
FU Seoul National University, Seoul, Republic of Korea, through the Eui-San
   Research Center; Research Institute of Advanced Materials (RIAM);
   Science Research Program through the National Research Foundation of
   Korea (NRF) - Ministry of Education [0417-20150112]; BK21PLUS SNU
   materials Division for Educating Creative Global Leaders [F15SN02D1702]
FX This work was supported by Seoul National University, Seoul, Republic of
   Korea, through the Eui-San Research Center and Research Institute of
   Advanced Materials (RIAM). In addition, this work was partially
   supported by the Science Research Program through the National Research
   Foundation of Korea (NRF) funded by the Ministry of Education (Grant
   0417-20150112) and in part by BK21PLUS SNU materials Division for
   Educating Creative Global Leaders (Grant F15SN02D1702).
CR Bez R, 2004, MAT SCI SEMICON PROC, V7, P349, DOI 10.1016/j.mssp.2004.09.127
   Carel R, 1996, ACTA MATER, V44, P2479, DOI 10.1016/1359-6454(95)00365-7
   Chen A, 2015, EMERGING NANOELECTRONIC DEVICES, P1
   Chin A, 2001, IEEE ELECTR DEVICE L, V22, P336, DOI 10.1109/55.930683
   Hai LV, 2010, SEMICOND SCI TECH, V25, DOI 10.1088/0268-1242/25/11/115013
   Hoffman J, 2010, ADV MATER, V22, P2957, DOI 10.1002/adma.200904327
   JONES RE, 1995, INTEGR FERROELECTR, V6, P81, DOI 10.1080/10584589508019355
   Juan TPC, 2006, IEEE ELECTR DEVICE L, V27, P217, DOI 10.1109/LED.2006.870414
   Kao K C, 1981, INT SERIES SCI SOLID, P151
   Lin Y, 1998, APPL PHYS LETT, V73, P2781, DOI 10.1063/1.122589
   Lue HT, 2002, IEEE T ELECTRON DEV, V49, P1790, DOI 10.1109/TED.2002.803626
   Ma TP, 2002, IEEE ELECTR DEVICE L, V23, P386, DOI 10.1109/LED.2002.1015207
   Muller J, 2012, IEEE ELECTR DEVICE L, V33, P185, DOI 10.1109/LED.2011.2177435
   Naber RCG, 2006, J PHYS D APPL PHYS, V39, P1984, DOI 10.1088/0022-3727/39/9/N01
   Pan X, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3609323
   Parikh N R, 1990, MRS P, V200, P192
   Park BE, 1998, JPN J APPL PHYS 1, V37, P5145, DOI 10.1143/JJAP.37.5145
   Park JH, 2015, IEEE ELECTR DEVICE L, V36, P1033, DOI 10.1109/LED.2015.2472987
   Petrov I, 2003, J VAC SCI TECHNOL A, V21, pS117, DOI 10.1116/1.1601610
   ROSE A, 1955, PHYS REV, V97, P1538, DOI 10.1103/PhysRev.97.1538
   Sakai S, 2004, IEEE ELECTR DEVICE L, V25, P369, DOI 10.1109/LED.2004.828992
   Sakurai H, 2001, IEEE SEMI INT SEM MA, P163
   Satish B, 2002, J PHYS D APPL PHYS, V35, P2048, DOI 10.1088/0022-3727/35/16/321
   SCOTT JF, 1989, FERROELECTRICS, V93, P31, DOI 10.1080/00150198908017317
   Shih WC, 2008, J APPL PHYS, V103, DOI 10.1063/1.2924434
   Sugiyama H, 2000, JPN J APPL PHYS 1, V39, P2131, DOI 10.1143/JJAP.39.2131
   Sun J, 2011, IEEE T ELECTRON DEV, V58, P3559, DOI 10.1109/TED.2011.2162335
   Takahashi K, 2005, JPN J APPL PHYS 1, V44, P6218, DOI 10.1143/JJAP.44.6218
   Tang MH, 2011, IEEE T ELECTRON DEV, V58, P370, DOI 10.1109/TED.2010.2090883
   THOMPSON CV, 1990, ANNU REV MATER SCI, V20, P245, DOI 10.1146/annurev.ms.20.080190.001333
   Verma RM, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866655
   Xu HS, 2001, APPL PHYS LETT, V78, P2360, DOI 10.1063/1.1358847
   Zavala G, 1997, J APPL PHYS, V81, P7480, DOI 10.1063/1.365350
NR 33
TC 1
Z9 1
U1 2
U2 20
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
EI 1361-6463
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD MAY 11
PY 2016
VL 49
IS 18
AR 185104
DI 10.1088/0022-3727/49/18/185104
PG 6
WC Physics, Applied
SC Physics
GA DK9MU
UT WOS:000375255300011
DA 2018-12-27
ER

PT J
AU Wu, XX
   Chen, XF
   Dan, J
   Cao, Y
   Gao, SH
   Guo, ZY
   Zerbe, P
   Chai, YF
   Diao, Y
   Zhang, L
AF Wu, Xunxun
   Chen, Xiaofei
   Dan, Jia
   Cao, Yan
   Gao, Shouhong
   Guo, Zhiying
   Zerbe, Philipp
   Chai, Yifeng
   Diao, Yong
   Zhang, Lei
TI RETRACTED: Characterization of anti-leukemia components from Indigo
   naturalis using comprehensive two-dimensional K562/cell membrane
   chromatography and in silico target identification(Retracted article.
   See vol. 88, pg. 721, 2017)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID TRADITIONAL CHINESE MEDICINE; CHRONIC MYELOGENOUS LEUKEMIA; INDIRUBIN
   DERIVATIVES; DRUG DISCOVERY; CELL-CYCLE; INDUCE APOPTOSIS; HERBAL
   MEDICINES; CANCER-CELLS; LUNG-CANCER; DNA-DAMAGE
AB Traditional Chinese Medicine (TCM) has been developed for thousands of years and has formed an integrated theoretical system based on a large amount of clinical practice. However, essential ingredients in TCM herbs have not been fully identified, and their precise mechanisms and targets are not elucidated. In this study, a new strategy combining comprehensive two-dimensional K562/cell membrane chromatographic system and in silico target identification was established to characterize active components from Indigo naturalis, a famous TCM herb that has been widely used for the treatment of leukemia in China, and their targets. Three active components, indirubin, tryptanthrin and isorhamnetin, were successfully characterized and their anti-leukemia effects were validated by cell viability and cell apoptosis assays. Isorhamnetin, with undefined cancer related targets, was selected for in silico target identification. Proto-oncogene tyrosine-protein kinase (Src) was identified as its membrane target and the dissociation constant (Kd) between Src and isorhamnetin was 3.81 mu M. Furthermore, anti-leukemia effects of isorhamnetin were mediated by Src through inducing G2/M cell cycle arrest. The results demonstrated that the integrated strategy could efficiently characterize active components in TCM and their targets, which may bring a new light for a better understanding of the complex mechanism of herbal medicines.
C1 [Wu, Xunxun; Guo, Zhiying; Diao, Yong] Huaqiao Univ, Inst Mol Med, Sch Biomed Sci, Quanzhou 362021, Peoples R China.
   [Wu, Xunxun; Chen, Xiaofei; Dan, Jia; Cao, Yan; Gao, Shouhong; Guo, Zhiying; Chai, Yifeng; Zhang, Lei] Second Mil Med Univ, Shanghai Changzheng Hosp, Sch Pharm, Shanghai 200433, Peoples R China.
   [Zerbe, Philipp] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.
RP Diao, Y (reprint author), Huaqiao Univ, Inst Mol Med, Sch Biomed Sci, Quanzhou 362021, Peoples R China.; Zhang, L (reprint author), Second Mil Med Univ, Shanghai Changzheng Hosp, Sch Pharm, Shanghai 200433, Peoples R China.
EM diaoyong@hqu.edu.cn; zhanglei@smmu.edu.cn
FU National Natural Science Foundation of China [U1405215, 81503039];
   "Yang-Fan Project" of the Science and Technology Commission of Shanghai
   Municipality [15YF1400200]; Young Scholar Project of Second Military
   Medical University [2014QN07]
FX The authors thank professor Junping Zhang, Li Su, Xiaoping Huang, Qian
   Ji and Guoquan Wang for their kindly suggestions and help for the
   experiments. The authors also thank the reviewers for their precious
   suggestions in the revised paper. This work was supported by the
   National Natural Science Foundation of China (Grant Number U1405215,
   81503039), the "Yang-Fan Project" of the Science and Technology
   Commission of Shanghai Municipality (Grant No. 15YF1400200), and the
   Young Scholar Project of Second Military Medical University (Grant No.
   2014QN07).
CR Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130
   Cereto-Massague A, 2015, METHODS, V71, P98, DOI 10.1016/j.ymeth.2014.09.006
   Chen XF, 2014, ANAL CHEM, V86, P4748, DOI 10.1021/ac500287e
   Chen XF, 2012, J CHROMATOGR A, V1242, P67, DOI 10.1016/j.chroma.2012.04.034
   Danz H, 2001, PLANTA MED, V67, P411, DOI 10.1055/s-2001-15805
   Davies TG, 2001, STRUCTURE, V9, P389, DOI 10.1016/S0969-2126(01)00598-6
   De Vrieze M, 2013, ANAL BIOANAL CHEM, V405, P6029, DOI 10.1007/s00216-013-7015-x
   Ding X, 2014, J CHROMATOGR A, V1359, P330, DOI 10.1016/j.chroma.2014.07.071
   He HZ, 2012, J PHARMACEUT BIOMED, V62, P196, DOI 10.1016/j.jpba.2011.12.025
   Hoessel R, 1999, NAT CELL BIOL, V1, P60
   Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011
   Kwok HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep18941
   Lee YC, 2010, ONCOGENE, V29, P3196, DOI 10.1038/onc.2010.73
   Liang MJ, 2005, LIFE SCI, V78, P128, DOI 10.1016/j.lfs.2005.04.038
   Liang XM, 2009, J CHROMATOGR A, V1216, P2033, DOI 10.1016/j.chroma.2008.07.026
   Lin CC, 2006, ANTICANCER RES, V26, P1097
   Liu XF, 2010, NUCLEIC ACIDS RES, V38, pW609, DOI 10.1093/nar/gkq300
   Liu X, 2013, TRENDS PHARMACOL SCI, V34, P620, DOI 10.1016/j.tips.2013.09.004
   Loging W, 2007, NAT REV DRUG DISCOV, V6, P220, DOI 10.1038/nrd2265
   Long F, 2015, SCI REP-UK, V5, DOI 10.1038/srep12361
   Miao S, 2011, INT J MOL SCI, V12, P3831, DOI 10.3390/ijms12063831
   Muller P, 2006, J MED CHEM, V49, P6768, DOI 10.1021/jm0606589
   Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102
   Nam S, 2012, MOL ONCOL, V6, P276, DOI 10.1016/j.molonc.2012.02.002
   Patwardhan B, 2005, EVID-BASED COMPL ALT, V2, P465, DOI 10.1093/ecam/neh140
   RESH MD, 1989, CELL, V58, P281, DOI 10.1016/0092-8674(89)90842-8
   Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723
   Saud SM, 2013, CANCER RES, V73, P5473, DOI 10.1158/0008-5472.CAN-13-0525
   Schapira M, 2003, J MED CHEM, V46, P3045, DOI 10.1021/jm0300173
   Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]
   Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594
   SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253
   Song HP, 2015, CHEM COMMUN, V51, P1494, DOI 10.1039/c4cc08728c
   Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410
   Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105
   Wang L, 2010, J PHARMACEUT BIOMED, V51, P1032, DOI 10.1016/j.jpba.2009.11.007
   Wang LR, 2013, AAPS J, V15, P395, DOI 10.1208/s12248-012-9449-z
   Wang Y, 2014, CANCER LETT, V344, P82, DOI 10.1016/j.canlet.2013.10.016
   Wu AG, 2015, SCI REP-UK, V5, DOI 10.1038/srep17199
   Xiao ZJ, 2002, LEUKEMIA LYMPHOMA, V43, P1763, DOI 10.1080/1042819021000006295
   Yang SS, 2013, J MED CHEM, V56, P8321, DOI 10.1021/jm401195n
   Yu R, 2006, J INT MED RES, V34, P231, DOI 10.1177/147323000603400301
   Yu ST, 2007, BIOCHEM BIOPH RES CO, V358, P79, DOI 10.1016/j.bbrc.2007.04.107
   Yuan R, 2000, PHARMACOL THERAPEUT, V86, P191, DOI 10.1016/S0163-7258(00)00039-5
   Zahler S, 2007, CHEM BIOL, V14, P1207, DOI 10.1016/j.chembiol.2007.10.010
   Zhang Q, 2008, FOOD CHEM TOXICOL, V46, P2042, DOI 10.1016/j.fct.2008.01.049
   Zhang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep14633
   Zhao HT, 2014, BIOORG MED CHEM LETT, V24, P1523, DOI 10.1016/j.bmcl.2014.01.083
   Zhen Y, 2007, ONCOGENE, V26, P6372, DOI 10.1038/sj.onc.1210473
NR 49
TC 7
Z9 8
U1 11
U2 41
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 6
PY 2016
VL 6
AR 25491
DI 10.1038/srep25491
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DL1YE
UT WOS:000375428400001
PM 27150638
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Korkmaz, SA
AF Korkmaz, Sevcan Aytac
TI RETRACTED: Diagnosis of cervical cancer cell taken from scanning
   electron and atomic force microscope images of the same patients using
   discrete wavelet entropy energy and Jensen Shannon, Hellinger, Triangle
   Measure classifier(Retracted article. See vol.170,pg.267,2017)
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article; Retracted Publication
DE Scanning electron and atomic force microscope; Cervical cell images;
   Discrete wavelet transform feature extraction; Jensen Shannon
   Divergence; Hellinger and Triangle Measure
ID TEXTURE CLASSIFICATION; UTERINE CERVIX; IN-VITRO; PAP TEST; BIOPHYSICS;
   TRANSFORM; CYTOLOGY; SMEAR; AFM
AB The aim of this article is to provide early detection of cervical cancer by using both Atomic Force Microscope (AFM) and Scanning Electron Microscope (SEM) images of same patient. When the studies in the literature are examined, it is seen that the AFM and SEM images of the same patient are not used together for early diagnosis of cervical cancer. AFM and SEM images can be limited when using only one of them for the early detection of cervical cancer. Therefore, multi-modality solutions which give more accuracy results than single solutions have been realized in this paper. Optimum feature space has been obtained by Discrete Wavelet Entropy Energy (DWEE) applying to the 3 x 180 AFM and SEM images. Then, optimum features of these images are classified with Jensen Shannon, Hellinger, and Triangle Measure (JHT) Classifier for early diagnosis of cervical cancer. However, between classifiers which are Jensen Shannon, Hellinger, and triangle distance have been validated the measures via relationships. Afterwards, accuracy diagnosis of normal, benign, and malign cervical cancer cell was found by combining mean success rates of Jensen Shannon, Hellinger, and Triangle Measure which are connected with each other. Averages of accuracy diagnosis for AFM and SEM images by averaging the results obtained from these 3 classifiers are found as 98.29% and 97.10%, respectively. It has been observed that AFM images for early diagnosis of cervical cancer have higher performance than SEM images. Also in this article, surface roughness of malign AFM images in the result of the analysis made for the AFM images, according to the normal and benign AFM images is observed as larger, If the volume of particles has found as smaller. (C) 2016 Elsevier B.V. All rights reserved.
C1 [Korkmaz, Sevcan Aytac] Firat Univ, Dept Elect Elect Engn, Fac Engn, TR-23100 Elazig, Turkey.
RP Korkmaz, SA (reprint author), Firat Univ, Dept Elect Elect Engn, Fac Engn, TR-23100 Elazig, Turkey.
EM sevcanaytackorkmaz@gmail.com
CR Alessandrini A, 2005, MEAS SCI TECHNOL, V16, pR65, DOI 10.1088/0957-0233/16/6/R01
   Arivazhagan S, 2003, PATTERN RECOGN LETT, V24, P1513, DOI 10.1016/S0167-8655(02)00390-2
   BENOIT AG, 1984, AM J OBSTET GYNECOL, V148, P690, DOI 10.1016/0002-9378(84)90775-0
   Berdyyeva TK, 2005, PHYS MED BIOL, V50, P81, DOI 10.1088/0031-9155/50/1/007
   Cha Sung-Hyuk, 2007, INT J MATH MODEL MET
   Chang T, 1993, IEEE T IMAGE PROCESS, V2, P429, DOI 10.1109/83.242353
   CONNERS RW, 1980, IEEE T PATTERN ANAL, V2, P204, DOI 10.1109/TPAMI.1980.4767008
   Costa Kevin D., 2006, V319, P331
   Costa S, 2007, GYNECOL ONCOL, V106, P170, DOI 10.1016/j.ygyno.2007.03.016
   Dokukin ME, 2012, LANGMUIR, V28, P16060, DOI 10.1021/la302706b
   Garcia JC, 2002, INT C PATT RECOG, P843, DOI 10.1109/ICPR.2002.1048156
   Gopi VP, 2012, COMM COM INF SC, V292, P220
   Grubisic G, 2009, COLLEGIUM ANTROPOL, V33, P1431
   Guz N.V., 2015, NANOMED NANOTECHNOL
   Hanley KZ, 2009, DIAGN CYTOPATHOL, V37, P61, DOI 10.1002/dc.20994
   Hoda RS, 2005, DIAGN CYTOPATHOL, V33, P244, DOI 10.1002/dc.20267
   IKAI A, 2009, ADV BIOCH ENG BIOTEC
   Iyer S, 2009, NAT NANOTECHNOL, V4, P389, DOI [10.1038/nnano.2009.77, 10.1038/NNANO.2009.77]
   Jain Anil K., 1990, SYST MAN CYB C P IEE
   Korkmaz S.A., 2015, OPT INT J LIGHT ELEC
   Korkmaz SA, 2014, J MED SYST, V38, DOI 10.1007/s10916-014-0092-3
   Korkmaz SA, 2016, J NANOELECTRON OPTOE, V11, P551, DOI 10.1166/jno.2016.1917
   Korkmaz Sevcan Aytac, 2015, MED BIOL ENG COMPUT, P1
   Krstovski K., 2013, P C THEOR INF RETR, P22
   Krstovski Kriste, 2013, P 2013 C THEOR INF R
   Lee CC, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-58
   Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009
   Niwas Issac S., 2010, IND INF SYST ICIIS 2
   Niwas S., 2010, COMP INT COMP RES IC
   Niwas S., 2010, IND EL APPL ISIEA 20
   Niwas SI, 2013, SIGNAL PROCESS, V93, P2828, DOI 10.1016/j.sigpro.2012.06.029
   Niwas S. Issac, 2011, IM SYST TECHN 2011 I
   Sahin O, 2007, NAT NANOTECHNOL, V2, P507, DOI 10.1038/nnano.2007.226
   Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342
   Sengur A, 2008, COMPUT BIOL MED, V38, P329, DOI 10.1016/j.compbiomed.2007.11.004
   Sengur A, 2007, EXPERT SYST APPL, V32, P527, DOI 10.1016/j.eswa.2005.12.013
   Sengur A, 2012, J MED SYST, V36, P2649, DOI 10.1007/s10916-011-9740-z
   Sengur A, 2009, EXPERT SYST APPL, V36, P6681, DOI 10.1016/j.eswa.2008.08.066
   Sokolov I., 2007, CANC NANOTECHNOLOGY, P43
   Sokolov I, 2006, NANOMED-NANOTECHNOL, V2, P31, DOI 10.1016/j.nano.2005.12.002
   SOOST HJ, 1991, ACTA CYTOL, V35, P8
   Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002
   Topsoe F, 2000, IEEE T INFORM THEORY, V46, P1602, DOI 10.1109/18.850703
   Tuceryan M., 1993, WORLD SCI, P235
   Yang IH, 2005, BIOMATERIALS, V26, P6599, DOI 10.1016/j.biomaterials.2005.04.024
NR 45
TC 5
Z9 5
U1 2
U2 22
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD MAY 5
PY 2016
VL 160
BP 39
EP 49
DI 10.1016/j.saa.2016.02.004
PG 11
WC Spectroscopy
SC Spectroscopy
GA DH4NB
UT WOS:000372761600006
PM 26921605
DA 2018-12-27
ER

PT J
AU Xu, LP
   Chen, HB
AF Xu, Liping
   Chen, Haibo
TI RETRACTED: Sign-changing solutions to Schrodinger-Kirchhoff-type
   equations with critical exponent (Retracted article. See art no 10,
   2017)
SO ADVANCES IN DIFFERENCE EQUATIONS
LA English
DT Article; Retracted Publication
DE Schrodinger-Kirchhoff-type equations; critical nonlinearity; positive
   solutions; sign-changing solutions; variational methods
ID POSITIVE SOLUTIONS; NONTRIVIAL SOLUTIONS; ELLIPTIC EQUATION; EXISTENCE;
   MULTIPLICITY; R-3
AB In this paper, we study the following Schrodinger-Kirchhoff-type equations:
   {-(a + b integral(R3) vertical bar del u vertical bar(2) dx) Delta u + u = k(x)vertical bar u vertical bar(2*-2)u + mu h(x)u in R-3, u is an element of H-1 (R-3),
   where a, b, mu > 0 are constants, 2* = 6 is the critical Sobolev exponent in three spatial dimensions. Under appropriate assumptions on nonnegative functions k(x) and h(x), we establish the existence of positive and sign-changing solutions by variational methods.
C1 [Xu, Liping] Henan Univ Sci & Technol, Dept Math & Stat, Luoyang 471003, Peoples R China.
   [Chen, Haibo] Cent S Univ, Sch Math & Stat, Changsha 410075, Hunan, Peoples R China.
RP Xu, LP (reprint author), Henan Univ Sci & Technol, Dept Math & Stat, Luoyang 471003, Peoples R China.
EM x.liping@126.com
FU Natural Science Foundation of China [11271372]; Hunan Provincial Natural
   Science Foundation of China [12JJ2004]
FX The authors would like to thank the referees for their valuable
   suggestions and comments which lead to improvement of the manuscript.
   Research supported by Natural Science Foundation of China 11271372 and
   by Hunan Provincial Natural Science Foundation of China 12JJ2004.
CR Alves CO, 2005, COMPUT MATH APPL, V49, P85, DOI 10.1016/j.camwa.2005.01.008
   Ambrosetti A, 2005, PERTURBATION METHODS
   Bartsch T, 2001, J FUNCT ANAL, V186, P117, DOI 10.1006/jfan.2001.3789
   BREZIS H, 1983, P AM MATH SOC, V88, P486, DOI 10.2307/2044999
   Chen JQ, 2009, NONLINEAR ANAL-THEOR, V71, P4739, DOI 10.1016/j.na.2009.03.048
   Cheng BT, 2009, NONLINEAR ANAL-THEOR, V71, P4883, DOI 10.1016/j.na.2009.03.065
   Chipot M, 1997, NONLINEAR ANAL-THEOR, V30, P4619, DOI 10.1016/S0362-546X(97)00169-7
   Correa FJSA, 2004, NONLINEAR ANAL-THEOR, V59, P1147, DOI 10.1016/j.na.2004.08.010
   Gilbarg D., 1983, GRUNDLEHREN MATH WIS, V224
   He XM, 2012, J DIFFER EQUATIONS, V252, P1813, DOI 10.1016/j.jde.2011.08.035
   He XM, 2009, NONLINEAR ANAL-THEOR, V70, P1407, DOI 10.1016/j.na.2008.02.021
   Hirano N, 2007, P ROY SOC EDINB A, V137, P333, DOI 10.1017/S0308210505001277
   Huang L., 2013, COMMUN MATH ANAL, V15, P29
   Huang LR, 2013, J MATH ANAL APPL, V408, P55, DOI 10.1016/j.jmaa.2013.05.071
   Kirchhoff G., 1883, MECHANIK
   Li G, 2013, ARXIV1305677V1MATHAP
   Liang SH, 2014, NONLINEAR ANAL-REAL, V17, P126, DOI 10.1016/j.nonrwa.2013.10.011
   Liu H., 2015, BOUND VALUE PROBL, V2015, P187
   Liu ZS, 2014, MATH METHOD APPL SCI, V37, P571, DOI 10.1002/mma.2815
   Mao AM, 2009, NONLINEAR ANAL-THEOR, V70, P1275, DOI 10.1016/j.na.2008.02.011
   Nie JJ, 2012, NONLINEAR ANAL-THEOR, V75, P3470, DOI 10.1016/j.na.2012.01.004
   Sun JT, 2014, J DIFFER EQUATIONS, V256, P1771, DOI 10.1016/j.jde.2013.12.006
   TARANTELLO G, 1993, MANUSCRIPTA MATH, V81, P57, DOI 10.1007/BF02567844
   Wang J, 2012, J DIFFER EQUATIONS, V253, P2314, DOI 10.1016/j.jde.2012.05.023
   Willem M., 1996, MINIMAX THEOREMS
   Wu XA, 2011, NONLINEAR ANAL-REAL, V12, P1278, DOI 10.1016/j.nonrwa.2010.09.023
   Xu LP, 2016, J MATH ANAL APPL, V433, P455, DOI 10.1016/j.jmaa.2015.07.035
   Zhang ZT, 2006, J MATH ANAL APPL, V317, P456, DOI 10.1016/j.jmaa.2005.06.102
NR 28
TC 1
Z9 1
U1 4
U2 10
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1687-1847
J9 ADV DIFFER EQU-NY
JI Adv. Differ. Equ.
PD MAY 3
PY 2016
AR 121
DI 10.1186/s13662-016-0828-0
PG 14
WC Mathematics, Applied; Mathematics
SC Mathematics
GA DT2DM
UT WOS:000381291000001
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Lee, DS
   Nam, TG
   Jeong, BS
   Jeong, GS
AF Lee, Dong-Sung
   Nam, Tae-Gyu
   Jeong, Byeong-Seon
   Jeong, Gil-Saeng
TI RETRACTED: The Aminopyridinol Derivative BJ-1201 Protects Murine
   Hippocampal Cells against Glutamate-Induced Neurotoxicity via Heme
   Oxygenase-1 (Retracted Article. See vol 21, Art no 1463, 2016)
SO MOLECULES
LA English
DT Article; Retracted Publication
DE aminopyridinol compound BJ-1201; neuroprotection; aminopyridinol HT22;
   heme oxygenase-1; nuclear transcription factor erythroid-2 related
   factor 2
ID OXIDATIVE STRESS; NEUROPROTECTIVE ACTIVITY; THERAPEUTIC TARGET;
   NERVOUS-SYSTEM; HT22 NEURONS; INFLAMMATION; METABOLISM;
   NEUROINFLAMMATION; DIFFERENTIATION; EXCITOTOXICITY
AB Glutamate is the major excitatory neurotransmitter in the brain. It can cause neuronal cell damage in the context of oxidative stress. BJ-1201 is a derivative of the compound aminopyridinol, which is known for its antioxidant activity. In this study, we examined the effect of BJ-1201, a 6-(diphenylamino)-2,4,5-trimethylpyridin-3-ol compound, on neuroprotection in HT22 cells. Our data showed that BJ-1201 can protect HT22 cells against glutamate-induced cell cytotoxicity. In addition, BJ-1201 upregulated heme oxygenase-1 (HO-1) to levels comparable to those of the CoPP-treated group. BJ-1201 treatment induced phosphorylation of JNK, but not p38-MAPK or ERK. It also increased the signal in the reporter assay based on beta-galactosidase activity driven by the nuclear transcription factor erythroid-2 related factor 2 (Nrf2) promoter harboring antioxidant response elements (AREs) and induced the translocation of Nrf2. These results demonstrate that BJ-1201 may be a good therapeutic platform against neurodegenerative diseases induced by oxidative stress.
C1 [Lee, Dong-Sung] Chosun Univ, Coll Pharm, Gwangju 61452, South Korea.
   [Nam, Tae-Gyu] Hanyang Univ, Dept Pharm, Ansan 15588, South Korea.
   [Jeong, Byeong-Seon] Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea.
   [Jeong, Gil-Saeng] Keimyung Univ, Coll Pharm, Daegu 42601, South Korea.
RP Jeong, BS (reprint author), Yeungnam Univ, Coll Pharm, Gyongsan 38541, South Korea.; Jeong, GS (reprint author), Keimyung Univ, Coll Pharm, Daegu 42601, South Korea.
EM dslee2771@chosun.ac.kr; tnam@hanyang.ac.kr; jeongb@ynu.ac.kr;
   gsjeong@kmu.ac.kr
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Education [NRF-2016R1A6A1A03011325]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Education (No. NRF-2016R1A6A1A03011325).
CR Cho N, 2012, FOOD CHEM TOXICOL, V50, P1940, DOI 10.1016/j.fct.2012.03.052
   Chodorowski Zygmunt, 2007, Przegl Lek, V64, P360
   CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6
   Deecher DC, 2005, J CELL BIOCHEM, V95, P302, DOI 10.1002/jcb.20413
   Farombi EO, 2006, J BIOCHEM MOL BIOL, V39, P479
   Flora SJS, 2009, OXID MED CELL LONGEV, V2, P191, DOI 10.4161/oxim.2.4.9112
   Foresti R, 2013, PHARMACOL RES, V76, P132, DOI 10.1016/j.phrs.2013.07.010
   Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001
   Han J, 2014, NEUROCHEM RES, V39, P1292, DOI 10.1007/s11064-014-1311-5
   He MC, 2013, NEURAL REGEN RES, V8, P1297, DOI 10.3969/j.issn.1673-5374.2013.14.006
   Immenschuh S, 2000, BIOCHEM PHARMACOL, V60, P1121, DOI 10.1016/S0006-2952(00)00443-3
   Ishii T, 1999, FREE RADICAL RES, V31, P351, DOI 10.1080/10715769900300921
   Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023
   Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004
   Jazwa A, 2010, CURR DRUG TARGETS, V11, P1517, DOI 10.2174/1389450111009011517
   Jeong GS, 2008, PLANTA MED, V74, P1368, DOI 10.1055/s-2008-1081315
   Johnen G, 1997, P NATL ACAD SCI USA, V94, P13469, DOI 10.1073/pnas.94.25.13469
   Kaizaki A, 2006, BRAIN RES, V1108, P39, DOI 10.1016/j.brainres.2006.06.011
   Kim DG, 2014, EUR J MED CHEM, V78, P126, DOI 10.1016/j.ejmech.2014.03.045
   Lee DS, 2013, TOXICOL IN VITRO, V27, P874, DOI 10.1016/j.tiv.2013.01.003
   Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200
   Lipton SA, 2007, NAT REV NEUROSCI, V8, P803, DOI 10.1038/nrn2229
   Liu J, 2009, LIFE SCI, V84, P267, DOI 10.1016/j.lfs.2008.12.008
   Ma JQ, 2014, FOOD CHEM TOXICOL, V71, P264, DOI 10.1016/j.fct.2014.06.017
   Maher P, 1996, J NEUROSCI, V16, P6394
   Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6
   Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009
   Michaelis EK, 1998, PROG NEUROBIOL, V54, P369, DOI 10.1016/S0301-0082(97)00055-5
   Padgaonkar VA, 2004, EXP EYE RES, V79, P847, DOI 10.1016/j.exer.2004.07.001
   Rossler OG, 2004, NEUROSCI LETT, V362, P253, DOI 10.1016/j.neulet.2004.03.033
   Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004
   Syapin PJ, 2008, BRIT J PHARMACOL, V155, P623, DOI 10.1038/bjp.2008.342
   Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741
   Wijtmans M, 2003, ANGEW CHEM INT EDIT, V42, P4370, DOI 10.1002/anie.200351881
   Yang HJ, 2011, PHARMACOGN MAG, V7, P207, DOI 10.4103/0973-1296.84234
   Youdim KA, 2000, FREE RADICAL BIO MED, V29, P51, DOI 10.1016/S0891-5849(00)00329-4
   Zhao ZY, 2012, NEUROL RES, V34, P38, DOI 10.1179/1743132811Y.0000000057
NR 37
TC 2
Z9 2
U1 1
U2 8
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1420-3049
J9 MOLECULES
JI Molecules
PD MAY
PY 2016
VL 21
IS 5
AR 594
DI 10.3390/molecules21050594
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA DR9UM
UT WOS:000380241600058
PM 27164069
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Cheng, YJ
   Xu, XY
   Wang, SH
   Liu, Y
AF Cheng, Yunjiang
   Xu, Xiangyang
   Wang, Shuhan
   Liu, Yang
TI RETRACTED: Generic control flow for the four types of clutch-to-clutch
   shifts (Retracted article. See vol. 10, 2018)
SO ADVANCES IN MECHANICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Clutch-to-clutch shift; generic control flow; torque ability; automatic
   transmission; dual clutch transmission
ID AUTOMATIC TRANSMISSIONS; DYNAMICS
AB It is known that the clutch-to-clutch shifts in both planetary-type automatic transmission and dual clutch transmission can be divided into four types, which are power-on upshift, power-on downshift, power-off upshift, and power-off downshift. In previous studies, many control methods of clutch-to-clutch shifts are analyzed, but the control flows of the four types are different. In this article, the principle of these shifts is analyzed in detail. The concept of oncoming clutch's torque ability is proposed. A generic control flow is designed, which divides the shift processes of the four types into the same three phases, and the control algorithm in transmission control unit and the calibration process can be simplified. The powertrain system model and the shift controller are established on MATLAB/Simulink platform. The generic control flow is verified by software-in-the-loop simulations. The simulation results show that the proposed generic control flow can control the four types of shifts properly.
C1 [Cheng, Yunjiang; Xu, Xiangyang; Wang, Shuhan; Liu, Yang] Beihang Univ, Sch Transportat Sci & Engn, 37 Xueyuan Rd, Beijing 100191, Peoples R China.
   [Cheng, Yunjiang; Xu, Xiangyang] Beihang Univ, Beijing Key Lab High Efficient Power Transmiss &, Beijing 100191, Peoples R China.
   [Cheng, Yunjiang; Wang, Shuhan] Natl Engn Res Ctr Passenger Car Autotransmiss, Weifang, Shandong, Peoples R China.
RP Wang, SH (reprint author), Beihang Univ, Sch Transportat Sci & Engn, 37 Xueyuan Rd, Beijing 100191, Peoples R China.
EM wsh@buaa.edu.cn
FU Innovation Foundation of BUAA [BY1213114]; Beijing Key Laboratory for
   High-efficient Power Transmission and System Control of New Energy
   Resource Vehicle; Transformation Project of Independent Innovation
   Achievements in Shandong Province [2014CGZH100]; Natural Science
   Foundation of Shandong Province [BS2015ZZ007]; National Natural Science
   Foundation of China [51405010]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The
   Innovation Foundation of BUAA for PhD Graduates (BY1213114), the Beijing
   Key Laboratory for High-efficient Power Transmission and System Control
   of New Energy Resource Vehicle, the Transformation Project of
   Independent Innovation Achievements in Shandong Province (2014CGZH1001),
   the Natural Science Foundation of Shandong Province (BS2015ZZ007), and
   the National Natural Science Foundation of China (51405010).
CR Anlin G., 2013, ADV MECH ENG, V5
   Bai S, 2013, DYNAMIC ANALYSIS AND CONTROL SYSTEM DESIGN OF AUTOMATIC TRANSMISSIONS, P1, DOI 10.4271/R-413
   Bai S, 2002, 2002011252 SAE
   Dong P, 2015, ADV MECH ENG, V7, DOI 10.1177/1687814015590306
   Goetz M, 2005, P I MECH ENG D-J AUT, V219, P951, DOI 10.1243/095440705X34720
   Goetz M, 2004, 2004011637 SAE
   Haj-Fraj A, 2002, INT J VEHICLE DES, V28, P171
   Kim DH, 2003, INT J VEHICLE DES, V32, P250, DOI 10.1504/IJVD.2003.003645
   Kulkarni M, 2007, MECH MACH THEORY, V42, P168, DOI 10.1016/j.mechmachtheory.2006.03.002
   Liu YG, 2014, MECH MACH THEORY, V75, P41, DOI 10.1016/j.mechmachtheory.2014.01.013
   Liu YG, 2009, J MECH DESIGN, V131, DOI 10.1115/1.3125883
   Runde JK, 1986, THESIS MIT CAMBRIDGE
   Society of Automotive Engineers, 1994, DES PRACT PASS CAR A, P18
   Song M, 2014, ADV MECH ENG, V6
   Walker PD, 2013, MECH MACH THEORY, V60, P47, DOI 10.1016/j.mechmachtheory.2012.09.007
   Walker PD, 2011, MECH SYST SIGNAL PR, V25, P1923, DOI 10.1016/j.ymssp.2010.08.018
   Xie CF, 2004, DYNAMICS, P140
   Yoon A, 1999, J DYN SYST-T ASME, V121, P508, DOI 10.1115/1.2802503
NR 18
TC 2
Z9 2
U1 4
U2 37
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1687-8140
J9 ADV MECH ENG
JI Adv. Mech. Eng.
PD MAY
PY 2016
VL 8
IS 5
AR 1687814016644377
DI 10.1177/1687814016644377
PG 16
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA DN9ZG
UT WOS:000377438600006
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Yu, YJ
   Yang, ZH
AF Yu, Yuanjin
   Yang, Zhaohua
TI RETRACTED: A semi-physical simulation platform of attitude determination
   and control system for satellite (Retracted article. See vol. 10, 2018)
SO ADVANCES IN MECHANICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Attitude determination and control system; semi-physical simulation;
   Real-Time Workshop; satellite
AB A semi-physical simulation platform for attitude determination and control system is proposed to verify the attitude estimator and controller on ground. A simulation target, a host PC, many attitude sensors, and actuators compose the simulation platform. The simulation target is composed of a central processing unit board with VxWorks operating system and many input/output boards connected via Compact Peripheral Component Interconnect bus. The executable programs in target are automatically generated from the simulation models in Simulink based on Real-Time Workshop of MATLAB. A three-axes gyroscope, a three-axes magnetometer, a sun sensor, a star tracer, three flywheels, and a Global Positioning System receiver are connected to the simulation target, which formulates the attitude control cycle of a satellite. The simulation models of the attitude determination and control system are described in detail. Finally, the semi-physical simulation platform is used to demonstrate the availability and rationality of the control scheme of a micro-satellite. Comparing the results between the numerical simulation in Simulink and the semi-physical simulation, the semi-physical simulation platform is available and the control scheme successfully achieves three-axes stabilization.
C1 [Yu, Yuanjin] Beihang Univ, Sch Astronaut, Beijing 100191, Peoples R China.
   [Yu, Yuanjin] Shenzhen Univ, Guangdong Key Lab Popular High Performance Comp, Shenzhen, Peoples R China.
   [Yang, Zhaohua] Beihang Univ, Sch Instrumentat Sci & Optoelect Engn, 37 XueYuan Rd, Beijing 100191, Peoples R China.
RP Yang, ZH (reprint author), Beihang Univ, Sch Instrumentat Sci & Optoelect Engn, 37 XueYuan Rd, Beijing 100191, Peoples R China.
EM yangzh@buaa.edu.cn
FU National Natural Science Foundation of China [61374211, 61473022,
   61503015]; China Postdoctoral Science Foundation [2015M580961]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This work
   was supported, in part, by the National Natural Science Foundation of
   China (grant nos 61374211, 61473022, and 61503015) and the China
   Postdoctoral Science Foundation (grant no. 2015M580961).
CR Aleksandrov A, 2014, 2014 INTERNATIONAL CONFERENCE ON COMPUTER TECHNOLOGIES IN PHYSICAL AND ENGINEERING APPLICATIONS (ICCTPEA), P3, DOI 10.1109/ICCTPEA.2014.6893245
   Gao Huayu, 2009, Computer Measurement & Control, V17, P1153
   Kumar YVP, 2014, 2014 INTERNATIONAL CONFERENCE ON CONTROL, INSTRUMENTATION, COMMUNICATION AND COMPUTATIONAL TECHNOLOGIES (ICCICCT), P1217, DOI 10.1109/ICCICCT.2014.6993146
   Kwan Trevor Hocksun, 2015, 2015 IEEE 10th Conference on Industrial Electronics and Applications (ICIEA). Proceedings, P1420, DOI 10.1109/ICIEA.2015.7334330
   [李广兴 Li Guangxing], 2006, [宇航学报, Journal of Chinese Society of Astronautics], V27, P1196
   Li JS, 2004, AEROSP CONTROL, V22, P82
   Liang XF, 2001, J XIAMEN U, V40, P200
   Lin TY, 2014, 2014 CACS INTERNATIONAL AUTOMATIC CONTROL CONFERENCE (CACS 2014), P51, DOI 10.1109/CACS.2014.7097161
   Liu LD, 2003, SATELLITE CONTROL SY
   Quaranta G, 2001, P REALT LIN WORKSH M
   Wang Ning-qiang, 2005, Journal of System Simulation, V17, P1617
   Xu Kai, 2009, Optics and Precision Engineering, V17, P362
   Xu ZG, 2015, IEEE ANN INT CONF CY, P642, DOI 10.1109/CYBER.2015.7288016
   Yang Xu, 2005, Systems Engineering and Electronics, V27, P335
   Yang Zheng-xian, 2009, Journal of System Simulation, V21, P6444
   Zhai K, 2004, AEROSPACE CONTROL, V22, P17
   [张世杰 Zhang Shijie], 2005, [中国空间科学技术, Chinese Space Science and Technology], V25, P43
   Zhang XB, 2000, COMPUTER SIMULATION, V17, P57
NR 18
TC 3
Z9 3
U1 4
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1687-8140
J9 ADV MECH ENG
JI Adv. Mech. Eng.
PD MAY
PY 2016
VL 8
IS 5
AR 1687814016646975
DI 10.1177/1687814016646975
PG 11
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA DN9ZG
UT WOS:000377438600019
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Yao, YY
   Song, JP
   Wang, WP
   Liu, NA
AF Yao, Yanyi
   Song, Jieping
   Wang, Weipeng
   Liu, Nian
TI RETRACTED: Decidual vascular endothelial cells promote maternal-fetal
   immune tolerance by inducing regulatory T cells through canonical Notch1
   signaling (Retracted article. See vol. 95, pg. 416, 2017)
SO IMMUNOLOGY AND CELL BIOLOGY
LA English
DT Article; Retracted Publication
ID HUMAN PLACENTAL MICROVESSELS; PERIPHERAL-BLOOD; SPONTANEOUS-ABORTION;
   ADOPTIVE TRANSFER; HUMAN-PREGNANCY; MOUSE PLACENTA; FETUS; EXPRESSION;
   TRIMESTER; TREGS
AB Adaptation of the maternal immune response to accommodate the semiallogeneic fetus is necessary for pregnancy success. However, the mechanisms by which the fetus avoids rejection despite expression of paternal alloantigens remain incompletely understood. Regulatory T cells (Treg cells) are pivotal for maintaining immune homeostasis, preventing autoimmune disease and fetus rejection. In this study, we found that maternal decidual vascular endothelial cells (DVECs) sustained Foxp3 expression in resting Treg cells in vitro. Moreover, under in vitro Treg cell induction condition with agonistic antibodies and transforming growth factor (TGF)-beta, DVECs promoted Treg cell differentiation from non-Treg conventional T cells. Consistent with the promotion of Treg cell maintenance and differentiation, Treg cell-associated gene expression such as TGF-beta, Epstein-Barr induced gene-3, CD39 and glucocorticoid-induced tumor necrosis factor receptor was also increased in the presence of DVECs. Further study revealed that DVECs expressed Notch ligands such as Jagged-1, Delta-like protein 1 (DLL-1) and DLL-4, while Treg cells expressed Notch1 on their surface. The effects of DVECs on Treg cells was inhibited by siRNA-induced knockdown of expression of Jagged-1 and DLL-1 in DVECs. Downregulation of Notch1 in Treg cells using lentiviral shRNA transduction decreased Foxp3 expression in Treg cells. Adoptive transfer of Notch1-deficient Treg cells increased abortion rate in a murine semiallogeneic pregnancy model. Taken together, our study suggests that maternal DVECs are able to maintain decidual Treg cell identity and promote Treg cell differentiation through activation of Notch1 signal pathway in Treg cells and subsequently inhibit the immune response against semiallogeneic fetuses and preventing spontaneous abortion.
C1 [Yao, Yanyi; Song, Jieping; Wang, Weipeng; Liu, Nian] Maternal & Child Hlth Hosp Hubei Prov, Genet Lab, 745 Wuluo Ave, Wuhan 430070, Hubei Province, Peoples R China.
RP Yao, YY (reprint author), Maternal & Child Hlth Hosp Hubei Prov, Genet Lab, 745 Wuluo Ave, Wuhan 430070, Hubei Province, Peoples R China.
EM yanyiyao@163.com
FU Natural Science Foundation of Hubei Province of China [2013cfc096]
FX This work is supported by the Natural Science Foundation of Hubei
   Province of China (2013cfc096).
CR Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037
   Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755
   Asano N, 2008, J IMMUNOL, V180, P2796, DOI 10.4049/jimmunol.180.5.2796
   Boij R, 2015, AM J REPROD IMMUNOL, V74, P368, DOI 10.1111/aji.12410
   Burghardt S, 2014, J LEUKOCYTE BIOL, V96, P571, DOI 10.1189/jlb.2AB0613-342RR
   Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683
   Carambia A, 2014, J HEPATOL, V61, P594, DOI 10.1016/j.jhep.2014.04.027
   Cobellis L, 2008, J ANAT, V213, P464, DOI 10.1111/j.1469-7580.2008.00963.x
   Dimova T, 2011, AM J REPROD IMMUNOL, V66, P44, DOI 10.1111/j.1600-0897.2011.01046.x
   Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783
   Fu HM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4436
   Gasperowicz M, 2013, GENE EXPR PATTERNS, V13, P249, DOI 10.1016/j.gep.2013.04.006
   Guerin LR, 2009, HUM REPROD UPDATE, V15, P517, DOI 10.1093/humupd/dmp004
   Habbeddine M, 2013, MICROBES INFECT, V15, P928, DOI 10.1016/j.micinf.2013.08.006
   Houser Brandy L., 2012, Yale Journal of Biology and Medicine, V85, P105
   Johnston DA, 2009, GENE, V435, P36, DOI 10.1016/j.gene.2009.01.003
   Kacemi A, 1996, CELL TISSUE RES, V283, P183, DOI 10.1007/s004410050528
   La Rocca C, 2014, IMMUNOL LETT, V162, P41, DOI 10.1016/j.imlet.2014.06.013
   Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306
   Mjosberg J, 2009, J IMMUNOL, V183, P759, DOI 10.4049/jimmunol.0803654
   Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x
   Nancy P, 2014, INT J DEV BIOL, V58, P189, DOI 10.1387/ijdb.140054ae
   Osol G, 2014, MICROCIRCULATION, V21, P38, DOI 10.1111/micc.12080
   Osol G, 2009, PHYSIOLOGY, V24, P58, DOI 10.1152/physiol.00033.2008
   Ou-Yang HF, 2009, MOL CELL BIOCHEM, V320, P109, DOI 10.1007/s11010-008-9912-4
   Ramhorst R, 2012, AM J REPROD IMMUNOL, V67, P17, DOI 10.1111/j.1600-0897.2011.01056.x
   Rogers PAW, 1996, HUM REPROD UPDATE, V2, P57, DOI 10.1093/humupd/2.1.57
   Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597
   Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980
   Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031
   Sanchez-Rodriguez EN, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-8
   Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044
   Sindram-Trujillo AP, 2004, J REPROD IMMUNOL, V62, P125, DOI 10.1016/j.jri.2003.11.007
   Steinborn A, 2008, CLIN IMMUNOL, V129, P401, DOI 10.1016/j.clim.2008.07.032
   Svensson-Arvelund J, 2015, J IMMUNOL, V194, P1534, DOI 10.4049/jimmunol.1401536
   Taflin C, 2011, P NATL ACAD SCI USA, V108, P2891, DOI 10.1073/pnas.1011811108
   Tilburgs T, 2006, PLACENTA, V27, pS47, DOI 10.1016/j.placenta.2005.11.008
   Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737
   Troja W, 2014, PHYSL REP, V2, DOI DOI 10.1002/PHY2.244
   Ugele B, 2001, IN VITRO CELL DEV-AN, V37, P408
   Wang C, 2013, J CLIN INVEST, V123, P1677, DOI 10.1172/JCI66204
   Wang WJ, 2014, HUM REPROD, V29, P946, DOI 10.1093/humrep/deu014
   Xie LK, 2015, EUR J IMMUNOL, V45, P180, DOI 10.1002/eji.201444823
   Yadav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00232
   Zenclussen AC, 2005, AM J PATHOL, V166, P811, DOI 10.1016/S0002-9440(10)62302-4
   Zhao WX, 2012, INT J MED SCI, V9, P447, DOI 10.7150/ijms.4593
NR 46
TC 3
Z9 3
U1 5
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0818-9641
EI 1440-1711
J9 IMMUNOL CELL BIOL
JI Immunol. Cell Biol.
PD MAY-JUN
PY 2016
VL 94
IS 5
BP 458
EP 469
DI 10.1038/icb.2015.119
PG 12
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA DN9TG
UT WOS:000377423000006
PM 26714886
DA 2018-12-27
ER

PT J
AU Schuerger, AC
   Nicholson, WL
AF Schuerger, Andrew C.
   Nicholson, Wayne L.
TI RETRACTED: Twenty-Three Species of Hypobarophilic Bacteria Recovered
   from Diverse Ecosystems Exhibit Growth under Simulated Martian
   Conditions at 0.7 kPa (Retracted Article. See vol.16,pg.736,2016)
SO ASTROBIOLOGY
LA English
DT Article; Retracted Publication
DE Planetary protection; Simulated martian atmosphere; Piezophile;
   Habitability; Extremophilic microorganisms
ID BACILLUS-SUBTILIS; LOW-PRESSURE; SERRATIA-LIQUEFACIENS; PLANETARY
   PROTECTION; MICROBIAL ACTIVITY; ENHANCED GROWTH; 5 KILOPASCALS; MARS;
   SPACECRAFT; PERMAFROST
AB Bacterial growth at low pressure is a new research area with implications for predicting microbial activity in clouds and the bulk atmosphere on Earth, and for modeling the forward contamination of planetary surfaces like Mars. Here, we describe experiments on the recovery and identification of 23 species of bacterial hypobarophiles (def., growth under hypobaric conditions of approximately 1-2 kPa) in 11 genera capable of growth at 0.7 kPa. Hypobarophilic bacteria, but not archaea or fungi, were recovered from soil and non-soil ecosystems. The highest numbers of hypobarophiles were recovered from Arctic soil, Siberian permafrost, and human saliva. Isolates were identified through 16S rRNA sequencing to belong to the genera Carnobacterium, Exiguobacterium, Leuconostoc, Paenibacillus, and Trichococcus. The highest population of culturable hypobarophilic bacteria (5.1 x 10(4) cfu/g) was recovered from Colour Lake soils from Axel Heiberg Island in the Canadian Arctic. In addition, we extend the number of hypobarophilic species in the genus Serratia to six type-strains that include S. ficaria, S. fonticola, S. grimesii, S. liquefaciens, S. plymuthica, and S. quinivorans. Microbial growth at 0.7 kPa suggests that pressure alone will not be growth-limiting on the martian surface or in Earth's atmosphere up to an altitude of 34 km.
C1 [Schuerger, Andrew C.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.
   [Nicholson, Wayne L.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.
RP Schuerger, AC (reprint author), Univ Florida, Space Life Sci Lab, 505 Odyssey Way, Merritt Isl, FL 32953 USA.
EM schuerg@ufl.edu
FU NASA Astrobiology: Exobiology and Evolutionary Biology program
   [NNA08AO15G]; NASA Astrobiology: Planetary Protection Research program
   [NNX 12AJ84G]
FX This study was supported in part by grants from the NASA Astrobiology:
   Exobiology and Evolutionary Biology (NNA08AO15G) and Planetary
   Protection Research (NNX 12AJ84G) programs to A.C.S. and W.L.N. The
   authors would like to acknowledge and thank the following individuals
   for providing soils from diverse ecological niches around the World: K.
   Krivushin (Siberian permafrost soils), C.P. McKay (Antarctica, Arctic,
   Atacama Desert, Mojave Desert), D.J. Smith (Mt. Baker, WA), and V. Parro
   (Rio Tinto, Spain). The authors do not have any conflicts of interests
   with vendors, reviewers, or organizations used in conducting the
   research described herein.
CR Amato P, 2007, ATMOS CHEM PHYS, V7, P4159, DOI 10.5194/acp-7-4159-2007
   Benardini JN, 2003, ASTROBIOLOGY, V3, P709, DOI 10.1089/153110703322736033
   Berry BJ, 2010, APPL ENVIRON MICROB, V76, P2377, DOI 10.1128/AEM.02147-09
   Bruckner J., 2009, ENCY MICROBIOLOGY, P52
   Clarke A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066207
   Coates JD, 2004, NAT REV MICROBIOL, V2, P569, DOI 10.1038/nrmicro926
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Criswell M. E., 2005, NASACP2005213461 AM
   Diehl RH, 2013, TRENDS ECOL EVOL, V28, P377, DOI 10.1016/j.tree.2013.02.015
   Fajardo-Cavazos P, 2012, ASTROBIOLOGY, V12, P258, DOI 10.1089/ast.2011.0728
   Haberle RM, 2001, J GEOPHYS RES-PLANET, V106, P23317, DOI 10.1029/2000JE001360
   La Duc MT, 2003, ENVIRON MICROBIOL, V5, P977, DOI 10.1046/j.1462-2920.2003.00496.x
   La Duc Myron T., 2004, Habitation, V10, P39, DOI 10.3727/154296604774808883
   Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x
   Michiels C, 2008, HIGH-PRESSURE MICROBIOLOGY, P1
   Moissl C., 2007, FEMS MICROBIOL ECOL, DOI [10.1111/j.1574-69.2007.00360.x, DOI 10.1111/J.1574-69.2007.00360.X]
   NASA/NOAA, 1976, NASATMX74335NOAAST76
   Nicholson WL, 2015, INT J SYST EVOL MICR, V65, P556, DOI 10.1099/ijs.0.067983-0
   Nicholson WL, 2013, P NATL ACAD SCI USA, V110, P666, DOI 10.1073/pnas.1209793110
   Nicholson WL, 2012, ICARUS, V220, P904, DOI 10.1016/j.icarus.2012.06.033
   Nicholson WL, 2010, APPL ENVIRON MICROB, V76, P7559, DOI 10.1128/AEM.01126-10
   Novikova ND, 2004, MICROBIAL ECOL, V47, P127, DOI 10.1007/s00248-003-1035-2
   Ojha L, 2015, NAT GEOSCI, V8, P829, DOI [10.1038/NGEO2546, 10.1038/ngeo2546]
   Panikov NS, 2007, FEMS MICROBIOL ECOL, V59, P500, DOI 10.1111/j.1574-6941.2006.00210.x
   Probst A, 2010, APPL ENVIRON MICROB, V76, P2837, DOI 10.1128/AEM.02167-09
   Race MS, 2008, ADV SPACE RES, V42, P1128, DOI 10.1016/j.asr.2008.03.003
   Rivkina EM, 2000, APPL ENVIRON MICROB, V66, P3230, DOI 10.1128/AEM.66.8.3230-3233.2000
   Rummel JD, 2014, ASTROBIOLOGY, V14, P887, DOI 10.1089/ast.2014.1227
   Santl-Temkiv T, 2013, AEROBIOLOGIA, V29, P373, DOI 10.1007/s10453-013-9287-1
   Schuerger A. C., 2006, 37 LUN PLAN SCI C LU
   Schuerger AC, 2015, ASTROBIOLOGY, V15, P478, DOI 10.1089/ast.2015.1289
   Schuerger AC, 2013, ASTROBIOLOGY, V13, P115, DOI 10.1089/ast.2011.0811
   Schuerger AC, 2006, ICARUS, V185, P143, DOI 10.1016/j.icarus.2006.06.014
   Sharma A, 2002, SCIENCE, V295, P1514, DOI 10.1126/science.1068018
   Smith DJ, 2013, ASTROBIOLOGY, V13, P981, DOI 10.1089/ast.2013.1074
   Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/ijs.0.02360-0
   Vaishampayan P, 2010, ASTROBIOLOGY, V10, P499, DOI 10.1089/ast.2009.0443
   Vaitilingom M, 2013, P NATL ACAD SCI USA, V110, P559, DOI 10.1073/pnas.1205743110
   Waters SM, 2014, APPL ENVIRON MICROB, V80, P4788, DOI 10.1128/AEM.00885-14
NR 39
TC 4
Z9 4
U1 4
U2 19
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1531-1074
EI 1557-8070
J9 ASTROBIOLOGY
JI Astrobiology
PD MAY
PY 2016
VL 16
IS 5
BP 335
EP 347
DI 10.1089/ast.2015.1394
PG 13
WC Astronomy & Astrophysics; Biology; Geosciences, Multidisciplinary
SC Astronomy & Astrophysics; Life Sciences & Biomedicine - Other Topics;
   Geology
GA DN6TU
UT WOS:000377210000003
PM 27135839
OA Green Published
DA 2018-12-27
ER

PT J
AU Ziari, K
   Zarea, M
   Gity, M
   Fayyaz, AF
   Yahaghi, E
   Darian, EK
   Hashemian, AM
AF Ziari, Katayoun
   Zarea, Mojtaba
   Gity, Masoumeh
   Fayyaz, Amir Farshid
   Yahaghi, Emad
   Darian, Ebrahim Khodaverdi
   Hashemian, Amir Masoud
TI RETRACTED: Downregulation of miR-148b as biomarker for early detection
   of hepatocellular carcinoma and may serve as a prognostic marker
   (Retracted article. See vol.37, pg. 16401, 2016)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE miRNA; Liver; Pathology; Cancer; PCR
ID CELL LUNG-CANCER; TUMOR-SUPPRESSOR; PANCREATIC-CANCER; GASTRIC-CANCER;
   BREAST-CANCER; MICRORNA; EXPRESSION; BIOGENESIS; ROCK1
AB MicroRNAs (miRNAs) have a large number of various target genes in different cancer types, which may result in many biological functions. Thus, identifying the molecular mechanisms of miRNAs may effect on the complexity of cancer progression via regulation of gene. In the current study, we utilized real-time PCR to quantify the diction of miR-148b in trail hepatocellular carcinoma (HCC) specimen and normal tissues. Furthermore, we evaluated the relationship of miR-148b and clinicopathological features with survival of HCC patients. Therefore, we evaluated the level of miR-148b expression in 101 HCC patients and also in 40 normal control cases. The result suggested lower expression in tumor tissues than normal control tissues (0.96 +/- 0.14; 1.84 +/- 0.20, P< 0.05). Our findings suggest that the declined expression of miR-148b can considerably be linked to tumor node metastasis (TNM) stage (stages III and IV; P=0.021) and vein invasion (P=0.029). Nevertheless, miR-148b expression was not related to sex (P=0.674), age (P=0. 523), size of tumor (P= 0.507), liver cirrhosis, and histologic grade (P=0.734). Survival analysis showed that low expression was remarkably related to overall survival (P=0.012). Furthermore, multivariate survival test suggested that decline of miR-148b diction was linked to poor survival in HCC patients. Our results suggested that miR-148b is decreased in HCC. Therefore, we concluded that miR-148b may play its role in the prognosis of HCC.
C1 [Ziari, Katayoun] AJA Univ Med Sci, Besat Hosp, Dept Pathol, Tehran, Iran.
   [Zarea, Mojtaba] IICT, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India.
   [Gity, Masoumeh] Univ Tehran Med Sci, Med Imaging Ctr, Dept Radiol, Tehran, Iran.
   [Fayyaz, Amir Farshid] AJA Univ Med Sci, Dept Legal Med, Tehran, Iran.
   [Yahaghi, Emad] Baqiyatallah Univ Med Sci, Tehran, Iran.
   [Darian, Ebrahim Khodaverdi] Islamic Azad Univ, Karaj Branch, Young Researchers & Elite Club, Karaj, Iran.
   [Hashemian, Amir Masoud] Mashhad Univ Med Sci, Fac Med, Imam Reza Hosp, Dept Emergency Med, Mashhad, Iran.
RP Hashemian, AM (reprint author), Mashhad Univ Med Sci, Fac Med, Imam Reza Hosp, Dept Emergency Med, Mashhad, Iran.
EM hashemianam@mums.ac.ir
OI Jalallou, Nahid/0000-0003-2142-4526
CR Azizi M, 2014, CANCER BIOL THER, V15, P419, DOI 10.4161/cbt.27630
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997
   Chang H, 2012, MOL MED REP, V5, P1277, DOI 10.3892/mmr.2012.794
   Cimino D, 2013, FASEB J, V27, P1223, DOI 10.1096/fj.12-214692
   Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799
   Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843
   Li L, 2015, MED SCI MONITOR, V21, P1155, DOI 10.12659/MSM.892940
   Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140
   Liu GL, 2014, INT J CLIN EXP MED, V7, P1990
   Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1
   Song YX, 2012, INT J CANCER, V131, P1042, DOI 10.1002/ijc.26485
   Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2
   Wu XJ, 2013, ASIAN PAC J CANCER P, V14, P885, DOI 10.7314/APJCP.2013.14.2.885
   Yang JD, 2010, INFECT DIS CLIN N AM, V24, P899, DOI 10.1016/j.idc.2010.07.004
   Zhang ZY, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0984-6
   Zhao G, 2013, MOL CANCER THER, V12, P83, DOI 10.1158/1535-7163.MCT-12-0534-T
   Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714
NR 18
TC 13
Z9 14
U1 3
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD MAY
PY 2016
VL 37
IS 5
BP 5765
EP 5768
DI 10.1007/s13277-015-3777-4
PG 4
WC Oncology
SC Oncology
GA DM6MC
UT WOS:000376465800012
PM 26206498
DA 2018-12-27
ER

PT J
AU Azam, AT
   Bahador, R
   Hesarikia, H
   Shakeri, M
   Yeganeh, A
AF Azam, Afshin Taheri
   Bahador, Reza
   Hesarikia, Hamid
   Shakeri, Mohammadreza
   Yeganeh, Ali
TI RETRACTED: Downregulation of microRNA-217 and microRNA-646 acts as
   potential predictor biomarkers in progression, metastasis, and
   unfavorable prognosis of human osteosarcoma (Retracted article. See
   vol.37, pg. 16405, 2016)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Osteosarcoma; MiRNAs; Pathology; Metastasis; Patient
ID BREAST-CANCER; PROLIFERATION; EPIDEMIOLOGY; SIGNATURES; EXPRESSION;
   CARCINOMA; ROCK1; ROLES
AB Despite the progress in therapeutic targets, it remains dissatisfactory for most osteosarcoma patients with metastasis or recurrence osteosarcoma. Therefore, it is required to determine the involved mechanisms of osteosarcoma. The aim of this study was to investigate the expression level of MiR-217 and miR-646 and also their association with clinicopathological features in patients with osteosarcoma. Total RNA was purified from patients with osteosarcoma and non-cancerous bone tissues, and then quantitative real-time PCR was applied to evaluate the expression level of microRNAs. Our result suggested that miR-217 expression was remarkably deceased in osteosarcoma bone tissue when compared with non-cancerous bone tissues (mean +/- SD 5.32 +/- 1.231, 2.01 +/- 0.78; P=0.024) and miR-646 expression decreased in osteosarcoma bone tissue in comparison with normal tissues (mean +/- SD 4.56 +/- 1.45, 1.76 +/- 1.24; P=0.041). Our findings indicated that decreased expression of MiR-217 and miR-646 was strongly correlated with high tumor, node, and metastasis (TNM) stage (P=0.015, P=0.002) and large cancer diameter (P=0.041, P=0.053). Kaplan-Meier survival and log-rank analysis indicated that shorter overall survival was strongly linked to decreased expression of miR-217 and miR-646 (log-rank test P=0.034, P=0.026). In terms of miR-217, multivariate Cox proportional hazards model analysis has showed that reduction of miR-217 expression (P=0.001), TNMstage (P=0.046), and lymph node metastasis (P=0.006) were independently linked to a short-time survival of patients. In terms of miR-646, low expression of miR-646 (P=0.021), TNM stage (P=0.052), and tumor size (P=0.043) were independently associated with poor survival of patients as prognostic factors. Our findings suggested that downregulation of MiR-217 and miR-646 was associated with progression of osteosarcoma. MiR-217 and miR-646 may play a key role in suppression of tumor in osteosarcoma and would be applied as a novel therapeutic agent.
C1 [Azam, Afshin Taheri] Islamic Azad Univ, Dept Orthoped Surg, Tehran Med Branch, Tehran, Iran.
   [Bahador, Reza; Shakeri, Mohammadreza] Birjand Univ Med Sci, Dept Orthopaed & Trauma Surg, Birjand, Iran.
   [Hesarikia, Hamid] Baqiyatallah Univ Med Sci, Baqiyatallah Hosp, Dept Orthoped, Trauma Res Ctr, Tehran, Iran.
   [Yeganeh, Ali] Iran Univ Med Sci, Rasoul Akram Hosp, Dept Orthoped Surg, Tehran, Iran.
RP Yeganeh, A (reprint author), Iran Univ Med Sci, Rasoul Akram Hosp, Dept Orthoped Surg, Tehran, Iran.
EM yeganeh471@yahoo.com
CR Bao YP, 2013, ASIAN PAC J CANCER P, V14, P3751, DOI 10.7314/APJCP.2013.14.6.3751
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997
   Cimino D, 2013, FASEB J, V27, P1223, DOI 10.1096/fj.12-214692
   Finnerty JR, 2010, J MOL BIOL, V402, P491, DOI 10.1016/j.jmb.2010.07.051
   Huang JH, 2014, TUMOR BIOL, V35, P1095, DOI 10.1007/s13277-013-1146-8
   Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916
   Li W, 2014, BRIT J CANCER, V111, P1188, DOI 10.1038/bjc.2014.382
   Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257
   Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121
   Ottaviani G, 2009, CANC TREAT, V152, P3, DOI 10.1007/978-1-4419-0284-9_1
   Shen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109138
   Sun XH, 2015, TUMOR BIOL, V36, P2127, DOI 10.1007/s13277-014-2822-z
   Tang MJ, 2013, ONCOTARGETS THER, V6, P833, DOI 10.2147/OTT.S40080
   Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2
   Wu XJ, 2013, ASIAN PAC J CANCER P, V14, P885, DOI 10.7314/APJCP.2013.14.2.885
   Wu XY, 2013, INT J MED SCI, V10, P676, DOI 10.7150/ijms.5528
   Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906
   Zhao WG, 2010, CARCINOGENESIS, V31, P1726, DOI 10.1093/carcin/bgq160
   Zheng BQ, 2011, CLIN CANCER RES, V17, P7574, DOI 10.1158/1078-0432.CCR-11-1714
NR 20
TC 11
Z9 12
U1 1
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD MAY
PY 2016
VL 37
IS 5
BP 5769
EP 5773
DI 10.1007/s13277-015-3821-4
PG 5
WC Oncology
SC Oncology
GA DM6MC
UT WOS:000376465800013
PM 26224480
DA 2018-12-27
ER

PT J
AU Goudarzi, PK
   Taheriazam, A
   Asghari, S
   Jamshidi, M
   Shakeri, M
   Yahaghi, E
   Mirghasemi, A
AF Goudarzi, Peyman Karimi
   Taheriazam, Afshin
   Asghari, Saeid
   Jamshidi, Mohammad
   Shakeri, Mohammadreza
   Yahaghi, Emad
   Mirghasemi, Alireza
TI RETRACTED: Downregulation of miR-185 and upregulation of miR-218
   expression may be potential diagnostic and prognostic biomarkers of
   human chondrosarcoma (Retracted article. See vol.37, pg. 16403, 2016)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Chondrosarcoma; PCR; MicroRNAs; Prognostic; Pathology
ID TUMOR-GROWTH; CANCER; CISPLATIN; CELLS
AB Increasing evidence has confirmed that dysregulation of microRNAs (miRNAs) can contribute to the progression and metastasis of human tumors. Chondrosarcoma is the most common primary malignant bone tumor in adults and has no effective systemic treatment, and patients with this disease have poor survival. Thus, it is important to find new diagnostic markers and improve treatment options. In the current study, we are interested to examine the role of miR-185 and miR-218 expression in patients with chondrosarcoma using real-time PCR. Moreover, the association of the two miRNAs with clinicopathological features and prognosis was evaluated. Survival and Cox proportional hazards analyses were performed to find the association of miR-185 expression and miR-218 levels with prognosis in the patients. Our results indicated that the miR-185 expression was significantly downexpressed in clinical chondrosarcoma bone tissues compared with adjacent normal tissues (P=0.001). MiR-218 expression level was increased in clinical chondrosarcoma bone tissue than those adjacent normal tissues (P=0.001). Decreased expression of miR-185 showed remarkable correlation with advanced tumor stage (P=0.019), tumor grade (P<0.001), and distant metastasis (P=0.001). Moreover, high expression of miR-218 was strongly correlated with advanced tumor stage (P=0.014), tumor grade (P<0.001), and distant metastasis (P=0.002). Kaplan-Meier survival analysis revealed that the low miR-185 expression group and the high miR-218 expression group had remarkably shorter overall survival (log-rank test P=0.007, P=0.004). The multivariate Cox proportional hazards model indicated that decreased expression of miR-185 and increased expression of miR-218 (P=0.017, P=0.012), advanced tumor stage (P=0.006, P=0.012), tumor grade (P=0.032, P=0.016), and distant metastasis (P=0.004, P=0.015) were independently related to overall survival in patients with chondrosarcoma. In conclusion, downregulation of miR-185 and upregulation of miR-218 can be associated with progression of chondrosarcoma and also both of them may act as tumor suppressor genes in chondrosarcoma.
C1 [Goudarzi, Peyman Karimi] AJA Univ Med Sci, Dept Neurosurg, Tehran, Iran.
   [Taheriazam, Afshin] Islamic Azad Univ, Tehran Med Sci Branch, Dept Orthoped Surg, Tehran, Iran.
   [Asghari, Saeid; Shakeri, Mohammadreza] Birjand Univ Med Sci, Dept Orthopaed & Trauma Surg, Birjand, Iran.
   [Jamshidi, Mohammad] Zahedan Univ Med Sci, Cellular & Mol Res Ctr, Zahedan, Iran.
   [Jamshidi, Mohammad] Zahedan Univ Med Sci, Sch Med, Dept Clin Biochem, Zahedan, Iran.
   [Yahaghi, Emad] Baqiyatallah Univ Med Sci, Dept Mol Biol, Tehran, Iran.
   [Mirghasemi, Alireza] Qom Univ Med Sci, Dept Orthoped, Qom, Iran.
RP Mirghasemi, A (reprint author), Qom Univ Med Sci, Dept Orthoped, Qom, Iran.
EM samirghasemi@yahoo.com
OI Taheriazam, Afshin/0000-0002-3907-925X; Mirghasemi,
   Alireza/0000-0001-7569-8456
CR Davidson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012560
   Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x
   Fu PF, 2014, EXP THER MED, V8, P1879, DOI 10.3892/etm.2014.1999
   Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237
   He XQ, 2012, MOL MED, V18, P1491, DOI 10.2119/molmed.2012.00304
   Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P265, DOI 10.1016/j.urolonc.2009.02.002
   Li JR, 2012, INT J MOL SCI, V13, P16053, DOI 10.3390/ijms131216053
   Liu GT, 2015, CANCER LETT, V357, P476, DOI 10.1016/j.canlet.2014.11.015
   Liu W, 2007, WORLD J GASTROENTERO, V13, P497, DOI 10.3748/wjg.v13.i4.497
   Mutlu S, 2015, EUR REV MED PHARMACO, V19, P2384
   Ostling P, 2011, CANCER RES, V71, P1956, DOI 10.1158/0008-5472.CAN-10-2421
   Rozeman LB, 2006, INT ORTHOP, V30, P437, DOI 10.1007/s00264-006-0212-x
   Song LB, 2010, BIOCHEM BIOPH RES CO, V402, P135, DOI 10.1016/j.bbrc.2010.10.003
   Terek RM, 1998, J ORTHOPAED RES, V16, P585, DOI 10.1002/jor.1100160510
   Tian H, 2015, ONCOL REP, V33, P981, DOI 10.3892/or.2014.3657
   Tsai CH, 2015, ONCOTARGET, V6, P258, DOI 10.18632/oncotarget.2724
   Uesugi A, 2011, CANCER RES, V71, P5765, DOI 10.1158/0008-5472.CAN-11-0368
   Xiang Y, 2014, ONCOGENE, V33, P378, DOI 10.1038/onc.2012.575
   Yu H, 2013, INT J CLIN EXP PATHO, V6, P2904
   Zhang XY, 2012, TUMOR BIOL, V33, P1589, DOI 10.1007/s13277-012-0414-3
NR 20
TC 5
Z9 8
U1 3
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD MAY
PY 2016
VL 37
IS 5
BP 5775
EP 5779
DI 10.1007/s13277-015-4090-y
PG 5
WC Oncology
SC Oncology
GA DM6MC
UT WOS:000376465800014
PM 26385770
DA 2018-12-27
ER

PT J
AU Goudarzi, PK
   Mehrabi, F
   Khoshnood, RJ
   Bagheri, AB
   Ahmadi, K
   Yahaghi, E
   Abdolhoseinpour, H
AF Goudarzi, Peyman Karimi
   Mehrabi, Farzad
   Khoshnood, Reza Jalili
   Bagheri, Ali Baradaran
   Ahmadi, Koorosh
   Yahaghi, Emad
   Abdolhoseinpour, Hesam
TI RETRACTED: Expression and prognostic value of the aldehyde dehydrogenase
   1 (ALDH1) and N-myc downstream regulated gene 2 (NDRG2) as potential
   markers in human astrocytomas (Retracted article. See vol. 37, pg.
   16409, 2016)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Astrocytoma; NDRG2; ALDH1; Prognostic; Immunohistochemistry
ID CANCER STEM-CELLS; BREAST-CANCER; DOWN-REGULATION; GLIOBLASTOMA; GLIOMA;
   PROGRESSION; SURVIVAL; THERAPY; CARCINOMA; SLC22A18
AB In this study, immunohistochemical analysis was used to evaluate the expression of ALDH1 and NDRG2 in astrocytoma tissue samples and normal brain tissues. ALDH1 protein staining displayed that AlDH1 expression was not detectable in eight astrocytoma tissues (8/36) and in all of normal brain tissues. There was a significant difference between ALDH1 expression and WHO grades (P=0.03). Furthermore, no correlation was determined between expression levels of ALDH1 and other clinicopathological characteristics including age, sex, and tumor size. Immunohistochemistry showed that a high level of NDRG2 protein expression was markedly detected in normal brain tissues and expression of NDRG2 protein was significantly decreased in astrocytoma tissues. There was a significant association between pathological grading and NDRG2 expression level (P<0.001, Table 1), but no correlation was determined between expression levels of NDRG2 and other clinicopathological characteristics including age, sex, and tumor size. We also obtained detailed follow-up data and evaluated the association of ALDH1/NDRG2 expressions with overall survival. Kaplan-Meier survival and log-rank analysis indicated that the patients with high proportion of ALDH1-positive cells and low proportion of NDRG2-positive had shorter overall survival (P<0.001; P=0.001). Univariate analysis indicated that the high proportion of ALDH1-positive cells (P<0.001), the low proportion of NDRG2-positive cells (P=0.009), and the advanced grade (P<0.005) were markedly linked to the prognosis in patients. Furthermore, in the multivariate analysis, ALDH1 cells' expression (P=0.012), low proportion of NDRG2-positive cells (P=0.025), and advanced grade (P<0.03) were linked to poor overall survival. Our results suggest that NDRG2 expression is related to decreased survival rates and NDRG2 may be a potential marker in the astrocytoma prognosis. NDRG2 may be a potential marker in the astrocytoma prognosis. ALDH1 expression was related to advanced pathological grade and survival rate in astrocytoma patients.
C1 [Goudarzi, Peyman Karimi] AJA Univ Med Sci, Dept Neurosurg, Tehran, Iran.
   [Mehrabi, Farzad] AJA Univ Med Sci, Dept Neurol, Tehran, Iran.
   [Khoshnood, Reza Jalili] Shahid Beheshti Univ Med Sci, Dept Neurosurg, Tehran, Iran.
   [Bagheri, Ali Baradaran] Alborz Univ Med Sci, Dept Neurosurg, Karaj, Iran.
   [Ahmadi, Koorosh] Alborz Univ Med Sci, Dept Emergency Med, Karaj, Iran.
   [Yahaghi, Emad] Baqiyatallah Univ Med Sci, Dept Mol Biol, Tehran, Iran.
   [Abdolhoseinpour, Hesam] Islamic Azad Univ, Tehran Med Sci Branch, Bou Ali Hosp, Dept Neurosurg, Tehran, Iran.
RP Abdolhoseinpour, H (reprint author), Islamic Azad Univ, Tehran Med Sci Branch, Bou Ali Hosp, Dept Neurosurg, Tehran, Iran.
EM abdolhosseinpoor@yahoo.com
CR Awad O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013943
   Balicki D, 2007, CELL STEM CELL, V1, P485, DOI 10.1016/j.stem.2007.10.015
   Carico C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033684
   Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630
   Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048
   Choi SC, 2007, EXP MOL MED, V39, P705, DOI 10.1038/emm.2007.77
   Chu SH, 2012, J CLIN NEUROSCI, V19, P95, DOI 10.1016/j.jocn.2011.04.032
   Chu SH, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-156
   Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315
   Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x
   Deng YC, 2003, INT J CANCER, V106, P342, DOI 10.1002/ijc.11228
   Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281
   Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014
   Hu XL, 2004, WORLD J GASTROENTERO, V10, P3518
   Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418
   Hummerich L, 2006, ONCOGENE, V25, P111, DOI 10.1038/sj.onc.1209016
   Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393
   Kogiku M, 2008, J CLIN NEUROSCI, V15, P1198, DOI 10.1016/j.jocn.2007.11.012
   Li L, 2011, J NEUROL SCI, V308, P77, DOI 10.1016/j.jns.2011.06.007
   Liu DY, 2012, J CLIN NEUROSCI, V19, P1700, DOI 10.1016/j.jocn.2012.01.036
   Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192
   Lorentzen A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-14
   Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4
   Malkoun N, 2012, J NEURO-ONCOL, V106, P127, DOI 10.1007/s11060-011-0643-0
   Moreb JS, 2008, CURR STEM CELL RES T, V3, P237, DOI 10.2174/157488808786734006
   Natsume A, 2012, ONCOGENE, V31, P2715, DOI 10.1038/onc.2011.466
   Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746
   Norden AD, 2006, NEUROLOGIST, V12, P279, DOI 10.1097/01.nrl.0000250928.26044.47
   Patel M, 2008, LUNG CANCER, V59, P340, DOI 10.1016/j.lungcan.2007.08.033
   Schilling SH, 2009, J BIOL CHEM, V284, P25160, DOI 10.1074/jbc.M109.012484
   Shi H, 2009, BIOL PHARM BULL, V32, P968, DOI 10.1248/bpb.32.968
   Stylli SS, 2005, J CLIN NEUROSCI, V12, P389, DOI 10.1016/j.jocn.2005.01.006
   Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865
   Sun BQ, 2009, J NEURO-ONCOL, V94, P213, DOI 10.1007/s11060-009-9859-7
   Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479
   Tepel M, 2008, INT J CANCER, V123, P2080, DOI 10.1002/ijc.23705
   Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8
   Wang YZ, 2012, NEURO-ONCOLOGY, V14, P518, DOI 10.1093/neuonc/nor232
   Zhao HD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-303
NR 39
TC 1
Z9 1
U1 1
U2 4
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD MAY
PY 2016
VL 37
IS 5
BP 6261
EP 6265
DI 10.1007/s13277-015-4491-y
PG 5
WC Oncology
SC Oncology
GA DM6MC
UT WOS:000376465800067
PM 26619843
DA 2018-12-27
ER

PT J
AU Azizmohammadi, S
   Safari, A
   Seifoleslami, M
   Rabati, RG
   Mohammadi, M
   Yahaghi, H
   Azizmohammadi, S
AF Azizmohammadi, Sima
   Safari, Aghdas
   Seifoleslami, Mehri
   Rabati, Rahman Ghaffarzadegan
   Mohammadi, Mohsen
   Yahaghi, Hamid
   Azizmohammadi, Susan
TI RETRACTED: Clinical significance and expression of the PRSS3 and
   Wiskott-Aldrich syndrome protein family verprolin-homologous protein 1
   for the early detection of epithelial ovarian cancer (Retracted article.
   See vol.37, pg. 16399, 2016)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Epithelial ovarian cancer; PRSS3; WAVE1; Tissues; Expression
ID PROSTATE-CANCER; POOR-PROGNOSIS; BREAST-CANCER; STATISTICS; CARCINOMA;
   WASP; TRYPSINOGENS; PROGRESSION; METASTASIS; BIOLOGY
AB In this study, we evaluate the clinical significance of the PRSS3 and Wiskott Aldrich syndrome protein family verprolin-homologous protein 1 (WAVE1) in patients with epithelial ovarian cancer (EOC) by immunohistochemistry. In current study, all adjacent non-cancerous tissues showed absent or low expression of PRSS3. The expression of PRSS3 was significantly increased in the EOCs than adjacent non-cancerous tissues. Moreover, the expression of WAVE1 was significantly observed in all EOC tissues when compared with normal tissues. Furthermore, WAVE1 expression was absent in 35 (89.74 %) adjacent non-cancerous tissues. Our findings showed that high expression of PRSS3 was markedly linked to FIGO stage (P=0.02), advanced grade (P=0.017), and lymph node metastases (P=0.001), but no relationship was determined with other clinicopathological parameters. Furthermore, high expression of WAVE I was significantly correlated with FIGO stage (P=0.001), grade of tumor (P=0.011), and residual tumor size (P=0.041), but no significant associations were found between WAVE1 expression and age, lymph node metastasis, and histological subtypes (all P>0.05). In conclusion, our study showed that increased expression of PRSS3 and. WAVE1 may be involved in development of EOC.
C1 [Azizmohammadi, Sima; Azizmohammadi, Susan] AJA Univ Med Sci, Hajar Hosp, Dept Gynecol, Tehran, Iran.
   [Safari, Aghdas] AJA Univ Med Sci, Imam Reza Hosp, Dept Gynecol, Tehran, Iran.
   [Seifoleslami, Mehri] AJA Univ Med Sci, Khanevadeh Hosp, Dept Gynecol, Tehran, Iran.
   [Rabati, Rahman Ghaffarzadegan] Shahid Mahallati Hosp, Mol Biol Res Ctr, Shahid Abbas Abdollahi, Tabriz, Iran.
   [Mohammadi, Mohsen] Lorestan Univ Med Sci, Fac Pharm, Dept Pharmaceut Biotechnol, Khorramabad, Iran.
   [Yahaghi, Hamid] Baqiyatallah Univ Med Sci, Dept Mol Biol, Tehran, Iran.
RP Azizmohammadi, S (reprint author), AJA Univ Med Sci, Hajar Hosp, Dept Gynecol, Tehran, Iran.
EM dr.azizmohamadi@gmail.com
CR Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644
   Burns S, 2004, BLOOD, V104, P3454, DOI 10.1182/blood-2004-04-1678
   Cai XW, 2009, LUNG CANCER, V65, P299, DOI 10.1016/j.lungcan.2009.06.001
   Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842
   Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004
   Dozmorov MG, 2009, PROSTATE, V69, P1077, DOI 10.1002/pros.20960
   Fernando HS, 2007, ONCOLOGY-BASEL, V73, P376, DOI 10.1159/000136157
   Fernando HS, 2008, J UROLOGY, V180, P1515, DOI 10.1016/j.juro.2008.06.004
   Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15
   He Yu-Lei, 2009, Zhonghua Xue Ye Xue Za Zhi, V30, P237
   Hockla A, 2012, MOL CANCER RES, V10, P1555, DOI 10.1158/1541-7786.MCR-12-0314
   Hockla A, 2010, BREAST CANCER RES TR, V124, P27, DOI 10.1007/s10549-009-0699-0
   Iwaya K, 2007, MODERN PATHOL, V20, P339, DOI 10.1038/modpathol.3800741
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.1002/caac.20073, 10.3322/caac.20073]
   Jiang GZ, 2010, GUT, V59, P1535, DOI 10.1136/gut.2009.200105
   Ma RQ, 2015, GYNECOL ONCOL, V137, P546, DOI 10.1016/j.ygyno.2015.02.022
   Marsit CJ, 2006, CARCINOGENESIS, V27, P112, DOI 10.1093/carcin/bgi172
   Mirandola L, 2011, INT REV IMMUNOL, V30, P127, DOI 10.3109/08830185.2011.572504
   Paju A, 2006, CRIT REV CL LAB SCI, V43, P103, DOI 10.1080/10408360500523852
   Radisky ES, 2010, J MAMMARY GLAND BIOL, V15, P201, DOI 10.1007/s10911-010-9177-x
   Romero I, 2012, ENDOCRINOLOGY, V153, P1593, DOI 10.1210/en.2011-2123
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   Takenawa T, 2001, J CELL SCI, V114, P1801
   Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054
   Yamashita K, 2003, CANCER RES, V63, P6575
   Yang LY, 2006, CLIN CANCER RES, V12, P5673, DOI 10.1158/1078-0432.CCR-06-0022
   Zhang J, 2012, GYNECOL ONCOL, V127, P223, DOI 10.1016/j.ygyno.2012.06.008
NR 27
TC 3
Z9 3
U1 1
U2 6
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD MAY
PY 2016
VL 37
IS 5
BP 6769
EP 6773
DI 10.1007/s13277-015-4586-5
PG 5
WC Oncology
SC Oncology
GA DM6MC
UT WOS:000376465800122
PM 26662304
DA 2018-12-27
ER

PT J
AU Long, JT
   Xie, Y
   Yin, JM
   Lu, W
   Fang, S
AF Long, Jianting
   Xie, Ying
   Yin, Junmei
   Lu, Wei
   Fang, Shi
TI RETRACTED: SphK1 promotes tumor cell migration and invasion in
   colorectal cancer (retracted article)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Colorectal cancer; SphK1; Proliferation; Invasion; EMT; Targeted therapy
ID SPHINGOSINE KINASE 1; PROSTATE-CANCER; ANGIOGENESIS; SURVEILLANCE;
   METASTASIS; INHIBITION; SENSITIZES; PROGNOSIS; APOPTOSIS; CONSENSUS
AB Colorectal cancer (CRC) is one of the most common cancers worldwide. Sphingosine kinase 1 (SphKI), which phosphorylates sphingosine to sphingosine-1-phosphate (SIP), is overexpressed in various types of cancers and may act as an oncogene in tumorigenesis. However, little is known about the role of SphK1 in CRC patients. We studied the expression of SphK1 in 85 cases of CRC tissues by immunohistochemistry, qRT-PCR, and western blot. We also evaluated the effect of SphK1 on cell proliferation and invasion by MTT and transwell invasion assay. SphK1 is overexpressed in CRC tissues and cell lines, and upregulation of SphK1 correlated significantly with the following parameters: lymph node metastasis, liver metastasis, and advanced TNM stage. SphK1 knockdown results in inhibition of cancer cell proliferation. Inhibition of CRC cell migration and invasion is also evident through reversal of EMT by increases in E-cadherin expression and decreases in vimentin expression. In conclusion, SphKI is associated with the proliferation and invasiveness of CRC cells and the SphK1 gene may contribute to a novel therapeutic approach against CRC.
C1 [Long, Jianting] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Med Oncol, Guangzhou 510080, Guangdong, Peoples R China.
   [Xie, Ying; Yin, Junmei; Lu, Wei; Fang, Shi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Clin Nutr, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.
RP Fang, S (reprint author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Clin Nutr, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.
EM fangshi@mail.sysu.edu.cn
FU Science and Technology Planning Project of Guangdong Province
   [2013B021800284]
FX This work is supported by the Science and Technology Planning Project of
   Guangdong Province (2013B021800284)
CR Ader I, 2015, ONCOTARGET, V6, P13803, DOI 10.18632/oncotarget.3144
   Cho SY, 2014, BIOORG MED CHEM LETT, V24, P2560, DOI 10.1016/j.bmcl.2014.03.084
   Datta A, 2014, ONCOTARGET, V5, P5920, DOI 10.18632/oncotarget.1874
   FIDLER IJ, 1982, SCIENCE, V217, P998, DOI 10.1126/science.7112116
   Guillermet-Guibert J, 2009, MOL CANCER THER, V8, P809, DOI 10.1158/1535-7163.MCT-08-1096
   Karimian G, 2013, BBA-MOL BASIS DIS, V1832, P1922, DOI 10.1016/j.bbadis.2013.06.011
   Kobayashi H, 2007, SURGERY, V141, P67, DOI 10.1016/j.surg.2006.07.020
   Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001
   LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C
   Lu ZP, 2015, BIOCHEM BIOPH RES CO, V468, P8, DOI 10.1016/j.bbrc.2015.11.008
   Lufrano M, 2013, MOL MED REP, V8, P645, DOI 10.3892/mmr.2013.1562
   Meng XD, 2014, TUMOR BIOL, V35, P2075, DOI 10.1007/s13277-013-1275-0
   Santulli P, 2012, FERTIL STERIL, V97, P904, DOI 10.1016/j.fertnstert.2011.12.051
   Shi J, 2015, ANN HEPATOL, V14, P198
   Shimada H, 2009, LANGENBECK ARCH SURG, V394, P973, DOI 10.1007/s00423-009-0530-8
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Toiyama Y, 2014, ANN SURG, V259, P735, DOI 10.1097/SLA.0b013e3182a6909d
   Van Cutsem E, 2006, EUR J CANCER, V42, P2212, DOI 10.1016/j.ejca.2006.04.012
   Vettorazzi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8796
   Wang YH, 2014, BIOCHEM BIOPH RES CO, V444, P199, DOI 10.1016/j.bbrc.2014.01.028
   Yang YL, 2012, CANCER SCI, V103, P1538, DOI 10.1111/j.1349-7006.2012.02335.x
   Zhang HW, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-84
   Zhu LM, 2015, ONCOL REP, V33, P1257, DOI 10.3892/or.2014.3683
NR 23
TC 16
Z9 18
U1 2
U2 10
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD MAY
PY 2016
VL 37
IS 5
BP 6831
EP 6836
DI 10.1007/s13277-015-4542-4
PG 6
WC Oncology
SC Oncology
GA DM6MC
UT WOS:000376465800128
PM 26662312
DA 2018-12-27
ER

PT J
AU Fan, JY
   Yang, Y
   Xie, JY
   Lu, YL
   Shi, K
   Huang, YQ
AF Fan, Jia-Ying
   Yang, Yan
   Xie, Jing-Ying
   Lu, Yan-Ling
   Shi, Kun
   Huang, Yan-Qing
TI RETRACTED: MicroRNA-144 mediates metabolic shift in ovarian cancer cells
   by directly targeting Glut1 (Retracted article. See April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Glut1; MicroRNA-144; Ovarian cancer; Warburg effect
ID GLUCOSE-METABOLISM; DOWN-REGULATION; MYC; PROLIFERATION; GLYCOLYSIS;
   BIOGENESIS; CARCINOMA
AB Warburg effect is characterized by an increased utilization of glucose via glycolysis in cancer cells, even when enough oxygen is present to properly respire. Recent studies demonstrate that deregulation of microRNAs contributes to the Warburg effect. In the present study, we show that miR-144 is downregulated while glucose transporter 1 (Glut1) is upregulated in ovarian cancers. In vitro studies further showed that miR-144 inhibits Glut1 expression through targeting its 3'-untranslated region. As a result, cells overexpressing miR-44 exhibited a metabolic shift, including enhanced glucose uptake and lactate production. The altered glucose metabolism induced by miR-144 also leads to a rapid growth of ovarian cancer cells. Taken together, our results indicate that miR-144 may serve as a molecular switch to regulate glycolysis in ovarian cancer by targeting the expression of Glut1.
C1 [Fan, Jia-Ying; Yang, Yan; Xie, Jing-Ying; Lu, Yan-Ling; Shi, Kun; Huang, Yan-Qing] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Gynecol, 9th Jinsui Rd, Guangzhou 510623, Guangdong, Peoples R China.
RP Huang, YQ (reprint author), Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Dept Gynecol, 9th Jinsui Rd, Guangzhou 510623, Guangdong, Peoples R China.
EM fjy0451@163.com; free_jenny@163.com; 13710635907@139.com;
   loo2000@163.com; shikun28@hotmail.com; DrYanqingHuang@163.com
CR Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981
   Chen B, 2015, CANCER LETT, V356, P410, DOI 10.1016/j.canlet.2014.09.028
   Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274
   Foulkes WD, 2014, NAT REV CANCER, V14, P662, DOI 10.1038/nrc3802
   Gonzalez CD, 2014, BIOMED RES INT, DOI 10.1155/2014/926729
   Guo YW, 2013, FEBS J, V280, P4531, DOI 10.1111/febs.12417
   Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838
   Icard P, 2014, BBA-REV CANCER, V1846, P216, DOI 10.1016/j.bbcan.2014.06.002
   Justus CR, 2015, INT J MOL SCI, V16, P11055, DOI 10.3390/ijms160511055
   Kellenberger LD, 2010, J ONCOL, V2010
   Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038
   Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932
   Liu J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0154-5
   Liu L, 2012, BIOCHEM BIOPH RES CO, V425, P368, DOI 10.1016/j.bbrc.2012.07.098
   Mikawa T, 2015, CELL MOL LIFE SCI, V72, P1881, DOI 10.1007/s00018-015-1840-3
   Nie S, 2015, J CRANIOFAC SURG, V26, pE155, DOI 10.1097/SCS.0000000000001385
   Rossing M, 2012, J MOL ENDOCRINOL, V48, P11, DOI 10.1530/JME-11-0039
   Sawayama H, 2014, INT J ONCOL, V45, P1345, DOI 10.3892/ijo.2014.2563
   Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005
   Sun P, 2014, ASIAN PAC J CANCER P, V15, P4245, DOI 10.7314/APJCP.2014.15.10.4245
   Wang G, 2015, ARCH BIOCHEM BIOPHYS, V580, P84, DOI 10.1016/j.abb.2015.07.005
   Yamasaki T, 2013, CANCER SCI, V104, P1411, DOI 10.1111/cas.12240
   Zhang LY, 2013, CARCINOGENESIS, V34, P454, DOI 10.1093/carcin/bgs346
   Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007
NR 24
TC 10
Z9 10
U1 3
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD MAY
PY 2016
VL 37
IS 5
BP 6855
EP 6860
DI 10.1007/s13277-015-4558-9
PG 6
WC Oncology
SC Oncology
GA DM6MC
UT WOS:000376465800131
PM 26662316
DA 2018-12-27
ER

PT J
AU Dayer, L
   Harrington, S
   Martin, B
AF Dayer, Lindsey
   Harrington, Sarah
   Martin, Bradley
TI RETRACTED: Adherence to Adjuvant Neuropathic Pain Medications in a
   Palliative Care Clinic (Retracted article. See vol. 21, pg. 273, 2018)
SO JOURNAL OF PALLIATIVE MEDICINE
LA English
DT Article; Retracted Publication
ID SELF-REPORTED ADHERENCE; PERIPHERAL NEUROPATHY; BREAST-CANCER;
   MANAGEMENT
AB Background: Currently, few studies exist on patient adherence to adjuvant neuropathic pain (NP) medications in the palliative care setting.
   Objectives: We assessed patient adherence rates to NP medications in a palliative care clinic and compared patient self-reported adherence to pharmacy refill records.
   Methods: This was an observational single-site cross-sectional study of patients with NP receiving at least one NP medication for at least three months. Participants who met the inclusion criteria and agreed to participate completed the eight-item Morisky Medication Adherence Scale (MMAS-8) and a seven-day-recall (7DR) adherence measure. Patients gave permission to contact their pharmacy after the visit to collect refill records for the six months prior to the clinic visit. This information was used to calculate the medication possession ratio (MPR).
   Results: We analyzed 32 patients; most (81%) had NP related to a cancer diagnosis. Approximately 87.5% had low or medium adherence using the MMAS-8. The mean self-reported adherence based on 7DR was 94%. The mean MPR was 63%. A majority of patients (88%) had high self-reported adherence (>80%); however only 44% of patients had an MPR >80%.
   Conclusion: Results indicated that the MPR might be a more accurate measure of adherence than patient self-report. More research is needed to assess and improve adherence with NP medications in the outpatient palliative care setting.
C1 [Dayer, Lindsey] Univ Arkansas Med Sci, Coll Pharm, Dept Pharm Practice, Little Rock, AR 72205 USA.
   [Harrington, Sarah] Univ Arkansas Med Sci, Coll Med, Dept Internal Med, Div Hematol Oncol, Little Rock, AR 72205 USA.
   [Martin, Bradley] Univ Arkansas Med Sci, Div Pharmaceut Evaluat & Policy, Little Rock, AR 72205 USA.
RP Dayer, L (reprint author), Univ Arkansas Med Sci, Coll Pharm, 4301 West Markham 522, Little Rock, AR 72205 USA.
EM ledayer@uams.edu
CR Bruera E, 1991, J Palliat Care, V7, P6
   Buga S, 2012, CANCER CONTROL, V19, P154, DOI 10.1177/107327481201900210
   Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891
   Claxton AJ, 2001, CLIN THER, V23, P1296, DOI 10.1016/S0149-2918(01)80109-0
   Coward DD, 2000, CANCER NURS, V23, P101, DOI 10.1097/00002820-200004000-00005
   EISEN SA, 1990, ARCH INTERN MED, V150, P1881, DOI 10.1001/archinte.150.9.1881
   Gharibian D, 2013, CLIN J PAIN, V29, P377, DOI 10.1097/AJP.0b013e31825e45d9
   Groenvold M, 2006, EUR J CANCER, V42, P55, DOI 10.1016/j.ejca.2005.06.022
   Hahn SR, 2008, CURR MED RES OPIN, V24, P2127, DOI 10.1185/03007990802174769 
   Harada S, 2015, AM J HOSP PALLIAT CA
   Hausheer FH, 2006, SEMIN ONCOL, V33, P15, DOI 10.1053/j.seminoncol.2005.12.010
   Hess LM, 2006, ANN PHARMACOTHER, V40, P1280, DOI 10.1345/aph.1H018
   Jacobsen R, 2009, MEDICINA-LITHUANIA, V45, P427, DOI 10.3390/medicina45060055
   Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59
   Mishra S, 2008, AM J HOSP PALLIAT ME, V25, P447, DOI 10.1177/1049909108322288
   Moore S, 2010, CLIN J ONCOL NURS, V14, P41, DOI 10.1188/10.CJON.41-47
   Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x
   Patil PR, 2015, CLIN J PAIN, V31, P414, DOI 10.1097/AJP.0000000000000124
   Rivera E, 2015, CANCER CHEMOTH PHARM, V75, P659, DOI 10.1007/s00280-014-2607-5
   Shi LZ, 2010, PHARMACOECONOMICS, V28, P1097, DOI 10.2165/11537400-000000000-00000
NR 20
TC 1
Z9 1
U1 1
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-6218
EI 1557-7740
J9 J PALLIAT MED
JI J. Palliat. Med.
PD MAY
PY 2016
VL 19
IS 5
BP 538
EP 541
DI 10.1089/jpm.2015.0230
PG 4
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA DL8DZ
UT WOS:000375871600015
PM 26835743
DA 2018-12-27
ER

PT J
AU Rao, JY
   Xie, T
   Liu, YM
AF Rao Jun-ying
   Xie Tao
   Liu Yuan-ming
TI RETRACTED: Fuzzy evaluation model for in-service karst highway tunnel
   structural safety (Retracted article. See vol. 21, pg. 1501, 2017)
SO KSCE JOURNAL OF CIVIL ENGINEERING
LA English
DT Article; Retracted Publication
DE in-service highway tunnel; tunnel structure safety; treated karst cave;
   fuzzy evaluation model
ID SYSTEM
AB To analyze in-service tunnel structure safety, the coupling effect of a multi-factor should be considered. The karst highway tunnel structure safety is classified into five grades based on a railway tunnel health evaluation model. The factors affecting tunnel structure safety are addressed using an analytic hierarchy process. Qualitative indices are classified into five levels according to tunnel safety. A membership function that follows the Gaussian distribution is applied to determine quantitative evaluation indices. Those factors are assigned weights by expert scoring method of system theory, and the treated karst caves are set up as an uncompacted backfill model. A three-grade fuzzy comprehensive evaluation model is finally built for in-service highway tunnel structure safety in the karst area. The safety of Hui-long-shan tunnel is evaluated, and the safety value is judged by the maximum membership law according to the proposed model.
C1 [Rao Jun-ying; Xie Tao; Liu Yuan-ming] Guizhou Univ, Sch Civil Engn, Guiyang 550025, Guizhou, Peoples R China.
RP Rao, JY (reprint author), Guizhou Univ, Sch Civil Engn, Guiyang 550025, Guizhou, Peoples R China.
EM rao-ale@163.com; 8580743@qq.com; 845612605@qq.com
FU Guangdong Provincial Highway Administration Bureau Science Project
   [201114]; Hunan Provincial Innovation Foundation For Postgraduate
   [CX2013B078]; Guizhou Province Outstanding Scientific and Technological
   Education Personnel Governor Special Fund [[2012]43]
FX This paper is sponsored by Guangdong Provincial Highway Administration
   Bureau Science Project (201114), Hunan Provincial Innovation Foundation
   For Postgraduate (CX2013B078), and Guizhou Province Outstanding
   Scientific and Technological Education Personnel Governor Special Fund
   ([2012]43), here thank them.
CR Al-Labadi K. R., 2005, P 10 INT C CIV STRUC, DOI [10.4203/ccp.81.29, DOI 10.4203/CCP.81.29]
   Al-Labadi KR, 2009, J PERFORM CONSTR FAC, V23, P423, DOI 10.1061/(ASCE)CF.1943-5509.0000044
   Chen S, 1998, ENG FUZZY SET THEORY
   Cheng Y, 2007, ROCK SOIL MECH, V28, P1914
   Ebrahim G., 2013, B ENG GEOL ENVIRON, V73, P23, DOI [10.1007/s10064-013-0497-0, DOI 10.1007/S10064-013-0497-0]
   Hong P., 2011, MODERN TUNNELLING TE, V48, P28, DOI [10.3969/j.issn.1009-6582.2011.01.006, DOI 10.3969/J.ISSN.1009-6582.2011.01.006]
   Joo H.M., 2001, PROGR NUCL ENERGY, V39, P345, DOI [10.1016/S0149-1970(01)00019-1, DOI 10.1016/S0149-1970(01)00019-1]
   KAUFMANN A, 1988, FUZZY SET SYST, V28, P295, DOI 10.1016/0165-0114(88)90036-X
   Kazaras K, 2013, CHEM ENGINEER TRANS, V31, P349, DOI 10.3303/CET1331059
   Li F., 1991, FUZZY INFORM PROCESS
   [李术才 Li Shucai], 2013, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V32, P1858
   Li Z. B., 2004, GEOTECHNICAL ENG TEC, V18, P320, DOI [10.3969/j.issn.1007-2993.2004.06.013, DOI 10.3969/J.ISSN.1007-2993.2004.06.013]
   LU L. D, 2003, FLORA CHINA, V9, P46, DOI DOI 10.3321/J.ISSN:1000-131X.2003.09.008
   Panou KD, 2002, TUNN UNDERGR SP TECH, V17, P195, DOI 10.1016/S0886-7798(02)00006-8
   Pei-yin Lv, 1999, J LIAONING I TECHNOL, V19, P42, DOI [10.3969/j.issn.1674-3261.1999.05.011, DOI 10.3969/J.ISSN.1674-3261.1999.05.011]
   Rao J. Y., 2013, ELECT J GEOTECHNICAL, V18, P135
   Wang H. L., 2012, CHINESE J UNDERGROUN, V08, P1389, DOI [10.3969/j.issn.1673-0836.2012.z1.011, DOI 10.3969/J.ISSN.1673-0836.2012.Z1.011]
   Xin M. J., 2001, COMPUTER ENG APPL, V37, P40, DOI [10.3321/j.issn:1002-8331.2001, DOI 10.3321/J.ISSN:1002-8331.2001]
   Yang Y. Q., 2012, STUDY HLTH DIAGNOSIS
NR 19
TC 7
Z9 8
U1 4
U2 42
PU KOREAN SOCIETY OF CIVIL ENGINEERS-KSCE
PI SEOUL
PA 50-7 OGUM-DONG, SONGPA-KU, SEOUL, 138-857, SOUTH KOREA
SN 1226-7988
EI 1976-3808
J9 KSCE J CIV ENG
JI KSCE J. Civ. Eng.
PD MAY
PY 2016
VL 20
IS 4
BP 1242
EP 1249
DI 10.1007/s12205-015-0596-5
PG 8
WC Engineering, Civil
SC Engineering
GA DJ8NI
UT WOS:000374468600012
DA 2018-12-27
ER

PT J
AU Luo, HW
AF Luo, Hong-Wei
TI RETRACTED: Effect of thiols enrichment on Cr(VI) photo-reduction by
   natural organic matter (NOM) (Retracted article. See vol. 161, pg. 564,
   2016)
SO CHEMOSPHERE
LA English
DT Article; Retracted Publication
DE Thiols enrichment; Photo-reduction; Chromium; Natural organic matter
ID HUMIC SUBSTANCES; HEXAVALENT CHROMIUM; ORGANOSULFUR COMPOUNDS;
   FUNCTIONAL-GROUPS; HYDROGEN-SULFIDE; SOIL; ACIDS; ELECTROLYTES;
   COMPLEXATION; SPECTROSCOPY
AB Photochemical redox transformation of Cr(VI)-NOM complexes substantially affects transport and speciation of less toxic Cr(III) in natural waters. However, the underlying mechanisms remain unclear. This study reported photochemical reactions of Cr(VI) with thiol-enriched NOM under acidic condition. More effective thiols enrichment in humic acid (HA) was observed than that in fulvic acid (FA), thereby resulting in a higher reduction capacity and faster rate of Cr(VI) photo-reduction. Chemical addition of sulfide to HA formed a large number of S-containing molecular formulae, which subsequently disappeared following reactions with Cr(VI) under solar irradiation. Cr(VI) photo-reduction in thiol-enriched HA consumed more S-containing formulae. Solar irradiation caused a rapid loss of the reduction capacities and thiol contents in HA and FA. All these findings can provide useful information for understanding the biogeochemical cycles of chromium and sulfur, and are also of environmental significance because they may partially account for photo-transformation of Cr(VI) when chromium enters into the aquatic environment as acidic industrial effluents. (C) 2016 Elsevier Ltd. All rights reserved.
C1 [Luo, Hong-Wei] Univ Sci & Technol China, Dept Chem, Hefei 230026, Peoples R China.
   [Luo, Hong-Wei] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37830 USA.
   [Luo, Hong-Wei] Nanyang Technol Univ, Sch Civil & Environm Engn, Singapore 639798, Singapore.
RP Luo, HW (reprint author), Nanyang Technol Univ, Sch Civil & Environm Engn, Singapore 639798, Singapore.
EM hwluo@ntu.edu.sg
FU China Scholarship Council (CSC);  [201306340082]
FX We gratefully acknowledge financial support provided by China
   Scholarship Council (CSC) and State-Sponsored Scholarship Program for
   Graduate Students (No. 201306340082). We wish to thank Dr. Balaji Rao
   and Dr. Baohua Gu at Oak Ridge National Laboratory for technical
   assistance in analysis of thiol functional groups. Dr. Basanta Kumar
   Biswal and Dr. En-Hua Yang for proofreading and their assistance with
   the FTICR-MS analyses are greatly appreciated.
CR Chen HM, 2014, ENVIRON SCI TECH LET, V1, P399, DOI 10.1021/ez5002598
   Chen SY, 2011, J HAZARD MATER, V197, P337, DOI 10.1016/j.jhazmat.2011.09.091
   Fukushima M, 1995, ANAL CHIM ACTA, V317, P195, DOI 10.1016/0003-2670(95)00410-6
   Gaberell M, 2003, ENVIRON SCI TECHNOL, V37, P4403, DOI 10.1021/es034261v
   Gu BH, 2011, P NATL ACAD SCI USA, V108, P1479, DOI 10.1073/pnas.1008747108
   Gu BH, 2003, GEOCHIM COSMOCHIM AC, V67, P3575, DOI 10.1016/S0016-7037(03)00162-5
   Gustafsson JP, 2014, ENVIRON SCI TECHNOL, V48, P1753, DOI 10.1021/es404557e
   Haitzer M, 2003, ENVIRON SCI TECHNOL, V37, P2436, DOI 10.1021/es026291o
   Heitmann T, 2006, CHEM GEOL, V235, P12, DOI 10.1016/j.chemgeo.2006.05.011
   Hoffmann M, 2012, ENVIRON SCI TECHNOL, V46, P11788, DOI 10.1021/es302590x
   Hsu CL, 2007, ENVIRON SCI TECHNOL, V41, P7907, DOI 10.1021/es0718164
   Jardine PM, 1999, ENVIRON SCI TECHNOL, V33, P2939, DOI 10.1021/es981211v
   Jiang WJ, 2014, ENVIRON SCI TECHNOL, V48, P8078, DOI 10.1021/es405804m
   KACZYNSKI SE, 1993, ENVIRON SCI TECHNOL, V27, P1572, DOI 10.1021/es00045a011
   Kyziol J, 2006, CHEMOSPHERE, V63, P1974, DOI 10.1016/j.che,osphere.2005.09.042
   Leita L, 2009, ENVIRON POLLUT, V157, P1862, DOI 10.1016/j.envpol.2009.01.020
   Lou T, 2006, CHEMOSPHERE, V65, P2333, DOI 10.1016/j.chemosphere.2006.05.001
   Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0
   Luo HW, 2016, CHEMOSPHERE, V147, P20, DOI 10.1016/j.chemosphere.2015.12.092
   Luo HW, 2015, ECOTOXICOLOGY, V24, P2207, DOI 10.1007/s10646-015-1551-4
   Mabbett AN, 2006, ENVIRON SCI TECHNOL, V40, P1015, DOI 10.1021/es0509836
   Nakayasu K, 1999, ENVIRON TOXICOL CHEM, V18, P1085, DOI 10.1897/1551-5028(1999)018<1085:CSOTRB>2.3.CO;2
   Pantsar-Kallio M, 2001, ANAL CHIM ACTA, V439, P9, DOI 10.1016/S0003-2670(01)00840-6
   Peretyazhko T, 2006, GEODERMA, V137, P140, DOI 10.1016/j.geoderma.2006.08.004
   Perlinger JA, 2002, ENVIRON SCI TECHNOL, V36, P2663, DOI 10.1021/es015602c
   Qian Y, 2014, ENVIRON SCI TECH LET, V1, P426, DOI 10.1021/ez500254z
   Rao B, 2014, TALANTA, V119, P240, DOI 10.1016/j.talanta.2013.11.004
   Rickard D, 2005, MAR CHEM, V97, P141, DOI 10.1016/j.marchem.2005.08.004
   SCHOUTEN S, 1993, GEOCHIM COSMOCHIM AC, V57, P5111, DOI 10.1016/0016-7037(93)90613-2
   Sharpless CM, 2014, ENVIRON SCI TECHNOL, V48, P2688, DOI 10.1021/es403925g
   Szulczewski MD, 2001, ENVIRON SCI TECHNOL, V35, P1134, DOI 10.1021/es001301b
   Urban NR, 1999, GEOCHIM COSMOCHIM AC, V63, P837, DOI 10.1016/S0016-7037(98)00306-8
   VAIRAVAMURTHY A, 1987, NATURE, V329, P623, DOI 10.1038/329623a0
   Valencia S, 2013, SCI TOTAL ENVIRON, V442, P207, DOI 10.1016/j.scitotenv.2012.10.058
   Voordeckers JW, 2010, APPL ENVIRON MICROB, V76, P2371, DOI 10.1128/AEM.02250-09
   Wittbrodt PR, 1996, ENVIRON SCI TECHNOL, V30, P2470, DOI 10.1021/es950731c
   Wittbrodt PR, 1997, EUR J SOIL SCI, V48, P151, DOI 10.1111/j.1365-2389.1997.tb00194.x
   WITTBRODT PR, 1995, ENVIRON SCI TECHNOL, V29, P255, DOI 10.1021/es00001a033
NR 38
TC 2
Z9 2
U1 9
U2 50
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
EI 1879-1298
J9 CHEMOSPHERE
JI Chemosphere
PD MAY
PY 2016
VL 151
BP 234
EP 240
DI 10.1016/j.chemosphere.2016.02.103
PG 7
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DJ2YK
UT WOS:000374071000029
PM 26946114
DA 2018-12-27
ER

PT J
AU Chavez-Dozal, AA
   Bernardo, SM
   Lee, SA
AF Chavez-Dozal, Alba A.
   Bernardo, Stella M.
   Lee, Samuel A.
TI RETRACTED: The exocyst in Candida albicans polarized secretion and
   filamentation(Retracted article. See vol.62,pg.911,2016)
SO CURRENT GENETICS
LA English
DT Review; Retracted Publication
DE Exocyst; Filamentation; Polarisome; SEC6; SEC15; Secretion;
   Spitzenkorper
ID SACCHAROMYCES-CEREVISIAE; COMPLEX; EXOCYTOSIS; YEAST; SEC3P
AB The exocyst is an octameric complex that orchestrates the docking and tethering of vesicles to the plasma membrane during exocytosis and is fundamental for key biological processes including growth and establishment of cell polarity. Although components of the exocyst are well conserved among fungi, the specific functions of each component of the exocyst complex unique to Candida albicans biology and pathogenesis are not fully understood. This commentary describes recent findings regarding the role of exocyst subunits Sec6 and Sec15 in C. albicans filamentation and virulence.
C1 [Chavez-Dozal, Alba A.; Bernardo, Stella M.; Lee, Samuel A.] New Mexico VA Healthcare Syst, Infect Dis Sect, 1501 San Pedro SE,Mail Code 111-J, Albuquerque, NM 87108 USA.
   [Chavez-Dozal, Alba A.; Bernardo, Stella M.; Lee, Samuel A.] Univ New Mexico, Hlth Sci Ctr, Div Infect Dis, Albuquerque, NM 87131 USA.
RP Chavez-Dozal, AA (reprint author), New Mexico VA Healthcare Syst, Infect Dis Sect, 1501 San Pedro SE,Mail Code 111-J, Albuquerque, NM 87108 USA.; Chavez-Dozal, AA (reprint author), Univ New Mexico, Hlth Sci Ctr, Div Infect Dis, Albuquerque, NM 87131 USA.
EM albitach@nmsu.edu; SamALee@salud.unm.edu
FU Department of Veterans' Affairs [5I01BX001130]; Biomedical Research
   Institute of New Mexico; NIH (ASERT/IRACDA) [K12GM088021]; NIH
   [T32AI007538, 5 T32 AI007538-13]
FX This work was supported by funding from the Department of Veterans'
   Affairs (Merit Award 5I01BX001130 to SAL), Biomedical Research Institute
   of New Mexico (SAL), NIH Grant T32AI007538 (SMB), NIH Grant K12GM088021
   (ASERT/IRACDA to AAC-D) and NIH Grant 5 T32 AI007538-13 (AAC-D).
CR Bernardo SM, 2014, FEMS YEAST RES, V14, P762, DOI 10.1111/1567-1364.12165
   Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124
   Caballero-Lima D, 2014, MOL BIOL CELL, V25, P1097, DOI 10.1091/mbc.E13-11-0688
   Chavez-Dozal A, 2015, EUKARYOT CELL
   Chavez-Dozal AA, 2015, EUKARYOT CELL, V14, P684, DOI 10.1128/EC.00028-15
   Delic M, 2013, FEMS MICROBIOL REV, V37, P872, DOI 10.1111/1574-6976.12020
   Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811
   Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635
   Heider MR, 2012, TRAFFIC, V13, P898, DOI 10.1111/j.1600-0854.2012.01353.x
   Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861
   Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8
   Jones LA, 2010, EUKARYOT CELL, V9, P1455, DOI 10.1128/EC.00109-10
   Li CR, 2007, J CELL SCI, V120, P1898, DOI 10.1242/jcs.002931
   Luo GG, 2014, MOL BIOL CELL, V25, P3813, DOI 10.1091/mbc.E14-04-0907
   Marash M, 2001, EMBO J, V20, P411, DOI 10.1093/emboj/20.3.411
   Morgan J, 2005, INFECT CONT HOSP EP, V26, P540, DOI 10.1086/502581
   NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7
   Sutton RB, 1998, NATURE, V395, P347
   TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x
   WHITEWAY M, 1992, P NATL ACAD SCI USA, V89, P9410, DOI 10.1073/pnas.89.20.9410
NR 20
TC 1
Z9 1
U1 4
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0172-8083
EI 1432-0983
J9 CURR GENET
JI Curr. Genet.
PD MAY
PY 2016
VL 62
IS 2
BP 343
EP 346
DI 10.1007/s00294-015-0553-3
PG 4
WC Genetics & Heredity
SC Genetics & Heredity
GA DJ1HV
UT WOS:000373954800019
PM 26762634
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Farooq, M
   Kelly, EJ
   Unadkat, JD
AF Farooq, Muhammad
   Kelly, Edward J.
   Unadkat, Jashvant D.
TI RETRACTED: CYP2D6 Is Inducible by Endogenous and Exogenous
   Corticosteroids (Retracted article. See vol. 46, pg. 1360, 2018)
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article; Retracted Publication
ID ADULT-RAT HEPATOCYTES; CYTOCHROME-P450 2D6; DRUG-INTERACTIONS;
   ENZYME-INDUCTION; PROTEASE INHIBITORS; CYP3A ACTIVITY; IN-VITRO;
   PREGNANCY; EXPRESSION; DEXAMETHASONE
AB Although cytochrome P450 (CYP) 2D6 has been widely considered to be noninducible on the basis of human hepatocyte studies, in vivo data suggests that it is inducible by endo-and xenobiotics. Therefore, we investigated if the experimental conditions routinely used in human hepatocyte studies may be a confounding factor in the lack of in vitro induction of CYP2D6. Sandwich cultured human hepatocytes (SCHH) were preincubated with or without dexamethasone (100 nM) for 72 hours before incubation with 1 mu M endogenous (cortisol or corticosterone) or exogenous (dexamethasone or prednisolone) corticosteroids. At 72 hours, CYP2D6 mRNA, protein, and activity were quantified by real-time quantitative polymerase chain reaction, quantitative proteomics, and formation of dextrorphan from dextromethorphan, respectively. In the absence of supplemental dexamethasone, CYP2D6 activity, mRNA, and protein were significantly and robustly (> 10-fold) induced by all four corticosteroids. However, this CYP2D6 induction was abolished in cells preincubated with supplemental dexamethasone. These data show, for the first time, that CYP2D6 is inducible in vitro but the routine presence of 100 nM dexamethasone in the culture medium masks this induction. Our cortisol data are in agreement with the clinical observation that CYP2D6 is inducible during the third trimester of pregnancy when the plasma concentrations of cortisol increase to similar to 1 mu M. These findings, if confirmed in vivo, have implications for predicting CYP2D6-mediated drug-drug interactions and call for re-evaluation of regulatory guidelines on screening for CYP2D6 induction by xenobiotics. Our findings also suggest that cortisol may be a causative factor in the in vivo induction of CYP2D6 during pregnancy.
C1 [Farooq, Muhammad; Kelly, Edward J.; Unadkat, Jashvant D.] Univ Washington, Dept Pharmaceut, Box 357610, Seattle, WA 98195 USA.
RP Unadkat, JD (reprint author), Univ Washington, Dept Pharmaceut, Box 357610, Seattle, WA 98195 USA.
EM jash@uw.edu
FU National Institutes of Health National Institute on Drug Abuse
   [P01DA032507]
FX This work was supported by the National Institutes of Health National
   Institute on Drug Abuse [Grant P01DA032507].
CR ARLOTTO MP, 1987, BIOCHEM PHARMACOL, V36, P3859, DOI 10.1016/0006-2952(87)90450-3
   Benedetti MS, 2000, FUND CLIN PHARMACOL, V14, P301, DOI 10.1111/j.1472-8206.2000.tb00411.x
   Buchanan ML, 2009, DRUG METAB DISPOS, V37, P702, DOI 10.1124/dmd.108.024984
   Claessens AJ, 2010, DRUG METAB DISPOS, V38, P1393, DOI 10.1124/dmd.110.033878
   Dixit V, 2007, DRUG METAB DISPOS, V35, P1853, DOI 10.1124/dmd.107.016089
   EICHELBAUM M, 1986, BRIT J CLIN PHARMACO, V22, P49, DOI 10.1111/j.1365-2125.1986.tb02879.x
   ENGELMANN GL, 1985, ARCH BIOCHEM BIOPHYS, V238, P359, DOI 10.1016/0003-9861(85)90175-4
   GONZALEZ FJ, 1986, MOL CELL BIOL, V6, P2969, DOI 10.1128/MCB.6.8.2969
   GUGUENGUILLOUZO C, 1983, MOL CELL BIOCHEM, V53-4, P35
   GUZELIAN PS, 1977, GASTROENTEROLOGY, V72, P1232
   HOGSTEDT S, 1985, CLIN PHARMACOL THER, V37, P688
   Kirby BJ, 2011, DRUG METAB DISPOS, V39, P2329, DOI 10.1124/dmd.111.038646
   Koh KH, 2014, J BIOL CHEM, V289, P3105, DOI 10.1074/jbc.M113.526798
   Kumar V, 2015, DRUG METAB DISPOS, V43, P284, DOI 10.1124/dmd.114.061614
   LAISHES BA, 1976, IN VITRO CELL DEV B, V12, P821
   LECLERCQ V, 1989, INT J CLIN PHARM TH, V27, P593
   Meunier V, 2000, XENOBIOTICA, V30, P589, DOI 10.1080/004982500406426
   NAWA K, 1986, J BIOL CHEM, V261, P6883
   Ono S, 2002, PSYCHOPHARMACOLOGY, V162, P50, DOI 10.1007/s00213-002-1056-8
   Papageorgiou I, 2013, DRUG METAB DISPOS, V41, P281, DOI 10.1124/dmd.112.049015
   Pascussi JM, 2001, EUR J BIOCHEM, V268, P6346, DOI 10.1046/j.0014-2956.2001.02540.x
   Pitot H C, 1980, Methods Cell Biol, V21B, P441
   Ringel M, 2002, XENOBIOTICA, V32, P653, DOI 10.1080/00498250210144811
   Ryu RJ, 2016, J CLIN PHARMACOL, V56, P581, DOI 10.1002/jcph.631
   Schaefer O, 2012, DRUG METAB DISPOS, V40, P93, DOI 10.1124/dmd.111.042275
   Shirasaka Y, 2013, DRUG METAB DISPOS, V41, P1414, DOI 10.1124/dmd.113.051722
   Spina E, 1996, THER DRUG MONIT, V18, P60, DOI 10.1097/00007691-199602000-00010
   Tracy TS, 2005, AM J OBSTET GYNECOL, V192, P633, DOI 10.1016/j.ajog.2004.08.030
   Ververs FFT, 2009, CLIN PHARMACOKINET, V48, P677, DOI 10.2165/11318050-000000000-00000
   Wadelius M, 1997, CLIN PHARMACOL THER, V62, P400, DOI 10.1016/S0009-9236(97)90118-1
   Wang L, 2015, DRUG METAB DISPOS, V43, P367, DOI 10.1124/dmd.114.061580
   WRIGHTON SA, 1985, BIOCHEMISTRY-US, V24, P2171, DOI 10.1021/bi00330a010
   Yu AM, 2004, DRUG METAB REV, V36, P243, DOI 10.1081/DMR-120034000
   Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2
   Zhang ZF, 2015, DRUG METAB DISPOS, V43, P836, DOI 10.1124/dmd.114.062984
NR 35
TC 8
Z9 8
U1 1
U2 3
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0090-9556
EI 1521-009X
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD MAY 1
PY 2016
VL 44
IS 5
BP 750
EP 757
DI 10.1124/dmd.115.069229
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA FR0KB
UT WOS:000418749300006
PM 26965986
OA Green Published
DA 2018-12-27
ER

PT J
AU Liu, XH
   Wu, HM
   Gong, J
   Wang, T
   Yan, CZ
AF Liu, Xinhong
   Wu, Huamin
   Gong, Jian
   Wang, Tao
   Yan, Chuanzhu
TI RETRACTED: Clinical, pathological and genetic characteristics of
   autosomal dominant inherited dynamin 2 centronuclear myopathy (Retracted
   article. See vol. 14, pg. 613, 2016)
SO MOLECULAR MEDICINE REPORTS
LA English
DT Article; Retracted Publication
DE autosomal dominant inheritance; dynamin 2; centronuclear myopathy
ID MYOTUBULAR MYOPATHY; MUSCLE INVOLVEMENT; NEONATAL ONSET; MUTATIONS;
   PHENOTYPE; FEATURES; MRI
AB The aim of the present study was to report on a family with pathologically and genetically diagnosed autosomal dominant inherited centronuclear myopathy (CNM). In addition, this study aimed to investigate the clinical, pathological and molecular genetic characteristics of the disease. This pedigree was traced back three generations, four patients underwent neurological examination, two patients underwent muscle biopsy, and eight family members were subjected to dynamin 2 (DNM2) gene mutation analysis. DNM2 mutations were detected in seven family members, of which four patients exhibited DNM2 mutation-specific clinical and pathological features. Lower extremity weakness was the predominant symptom of these patients, however, proximal and distal lower extremity involvement was inconsistent. All patients exhibited marked systematic muscle atrophy and various degrees of facial muscle involvement. The patients presented the typical pathological changes of CNM, and their muscle tissues were heavily replaced by adipose tissue, with clustered distribution of muscle fibers as another notable feature. DNM2-CNM patients of this pedigree exhibited heterogeneous clinical and pathological features, providing a basis for further molecular genetic analysis.
C1 [Liu, Xinhong; Yan, Chuanzhu] Shandong Univ, Qilu Hosp, Dept Neurol, 107 Culture West Rd, Jinan 250012, Shandong, Peoples R China.
   [Liu, Xinhong; Wang, Tao] Taian Cent Hosp, Dept Neurol, Tai An 271000, Shandong, Peoples R China.
   [Wu, Huamin] Taian Cent Hosp, Dept Radiol, Tai An 271000, Shandong, Peoples R China.
   [Gong, Jian] Taian Cent Hosp, Dept Digest Syst, Tai An 271000, Shandong, Peoples R China.
RP Yan, CZ (reprint author), Shandong Univ, Qilu Hosp, Dept Neurol, 107 Culture West Rd, Jinan 250012, Shandong, Peoples R China.
EM chuanzhuyancn@163.com
CR Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657
   Bitoun M, 2009, NEUROLOGY, V72, P93, DOI 10.1212/01.wnl.0000338624.25852.12
   Bitoun M, 2007, ANN NEUROL, V62, P666, DOI 10.1002/ana.21235
   Bohm J, 2012, HUM MUTAT, V33, P949, DOI 10.1002/humu.22067
   Catteruccia M, 2013, NEUROMUSCULAR DISORD, V23, P229, DOI 10.1016/j.nmd.2012.12.009
   Finsterer J, 2000, CLIN NEUROPHYSIOL, V111, P1211, DOI 10.1016/S1388-2457(00)00310-2
   Fischer D, 2006, BRAIN, V129, P1463, DOI 10.1093/brain/awl071
   Hanisch F, 2011, J NEUROL, V258, P1085, DOI 10.1007/s00415-010-5889-5
   HORDER M, 1985, SCAND J CLIN LAB INV, V45, P13
   Jeannet PY, 2004, NEUROLOGY, V62, P1484, DOI 10.1212/01.WNL.0000124388.67003.56
   Jungbluth H, 2013, NEUROMUSCULAR DISORD, V23, P1033, DOI 10.1016/j.nmd.2013.08.006
   Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26
   Kerst B, 2000, NEUROMUSCULAR DISORD, V10, P572, DOI 10.1016/S0960-8966(00)00150-4
   Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175
   Melberg A, 2010, NEUROMUSCULAR DISORD, V20, P53, DOI 10.1016/j.nmd.2009.10.006
   Mori-Yoshimura M, 2012, CLIN NEUROL NEUROSUR, V114, P678, DOI 10.1016/j.clineuro.2011.10.040
   Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086
   Romero NB, 2010, NEUROMUSCULAR DISORD, V20, P223, DOI 10.1016/j.nmd.2010.01.014
   Schessl J, 2007, NEUROMUSCULAR DISORD, V17, P28, DOI 10.1016/j.nmd.2006.09.013
   SHER JH, 1967, NEUROLOGY, V17, P727, DOI 10.1212/WNL.17.8.727
   SPIRO AJ, 1966, ARCH NEUROL-CHICAGO, V14, P1, DOI 10.1001/archneur.1966.00470070005001
   Susman RD, 2010, NEUROMUSCULAR DISORD, V20, P229, DOI 10.1016/j.nmd.2010.02.016
NR 22
TC 1
Z9 1
U1 2
U2 5
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1791-2997
EI 1791-3004
J9 MOL MED REP
JI Mol. Med. Rep.
PD MAY
PY 2016
VL 13
IS 5
BP 4273
EP 4278
DI 10.3892/mmr.2016.5047
PG 6
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA DI6BA
UT WOS:000373583000071
PM 27035234
OA Bronze
DA 2018-12-27
ER

PT J
AU Anand, Y
   Gupta, A
   Tyagi, SK
   Anand, S
AF Anand, Y.
   Gupta, A.
   Tyagi, S. K.
   Anand, S.
TI RETRACTED: Computational fluid dynamics, a building simulation tool for
   achieving sustainable buildings (Retracted article. See vol. 64, pg.
   853, 2016)
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review; Retracted Publication
DE Computational fluid dynamics (CFD); Wind driven rain (WDR);
   Contaminants; Reynolds-averaged Navier-Stokes (RANS); and Large Eddy
   Simulation (LES)
ID INDOOR AIR-QUALITY; K-EPSILON MODELS; THERMAL COMFORT; POLLUTANT
   DISPERSION; NUMERICAL-SIMULATION; CFD PREDICTION; URBAN AREA;
   ENVIRONMENTAL-CONDITIONS; CONTAMINANT TRANSPORT; COOPERATIVE PROJECT
AB Buildings use about 40% of the global energy, thus making them the prime consumers and therefore the center of attention. The analysis of most of the building related problems such as the thermal analysis, effects of wind loading, ventilation analysis and the environmental effects etc. were conducted by the wind tunnel tests, earlier. However, now days, all these test can be done effectively with the aid of a mathematical technique called computational fluid dynamics (CFD). This paper is a brief, non-exhaustive overview of the status of application of CFD in building performance simulation for the indoor and outdoor environment. The discussion is focused on the management of the thermal comfort based on the ventilation loss, thermal loss and some other topics like the effect of fire inside the building and the hospital environment along with the discussions on the movement of the pedestrians, effect of rain and wind or wind driven rain (WDR) and pollutants etc. on the buildings especially artifacts. It is seen that CFD technique offers many advantages over the wind tunnel testing and simplified empirical or semi empirical equations. Deficiencies of steady RANS and LES modeling, the need for high-resolution grids and lastly, the requirement of a valid CFD model and its verification poses some limitations. Still efforts are being done and shall continue to focus on alleviating these limitations, but at least equally important is avoiding user errors. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Anand, Y.; Gupta, A.; Anand, S.] Shri Mata Vaishno Devi Univ, Sch Energy Management, Katra, J&K, India.
   [Tyagi, S. K.] Sardar Swaran Singh Natl Inst Renewable Energy, Kapurthala 144601, Punjab, India.
RP Anand, S (reprint author), Shri Mata Vaishno Devi Univ, Sch Energy Management, Katra, J&K, India.
EM anandsanjeev12@gmail.com
CR Albani RAS, 2015, ATMOS ENVIRON, V118, P19, DOI 10.1016/j.atmosenv.2015.07.036
   Anand Y, 2015, J THERM ENG, V1, P433, DOI 10.18186/jte.06871
   Bajc T, 2014, ENERGY BUILD
   Balocco C, 2014, BUILD SIMUL-CHINA, V7, P289, DOI 10.1007/s12273-013-0146-3
   Balocco C, 2011, BUILD SIMUL-CHINA, V4, P5, DOI 10.1007/s12273-011-0019-6
   Baniotopoulos CC, 2011, ENV WIND ENG DESIGN, V531
   Bartak M, 2002, BUILD ENVIRON, V37, P865, DOI 10.1016/S0360-1323(02)00045-8
   Blacken B, 2015, WORKSH TRENDS CHALL, P30
   Blacken BJE, 2009, P 11 IBPSA BUILD SIM, P489
   Blocken B, 2008, WIND STRUCT, V11, P51, DOI 10.12989/was.2008.11.1.051
   Blocken B, 2006, J WIND ENG IND AEROD, V94, P101, DOI 10.1016/j.jweia.2005.11.001
   Blocken B, 2015, BUILD ENVIRON, V84, P170, DOI 10.1016/j.buildenv.2014.11.006
   Blocken B, 2004, J WIND ENG IND AEROD, V92, P849, DOI 10.1016/j.jweia.2004.04.004
   Blocken B, 2009, J WIND ENG IND AEROD, V97, P255, DOI 10.1016/j.jweia.2009.06.007
   Blocken B, 2015, BUILD ENVIRON, V91, P219, DOI 10.1016/j.buildenv.2015.02.015
   Blocken B, 2014, J WIND ENG IND AEROD, V129, P69, DOI 10.1016/j.jweia.2014.03.008
   Boukhris Y, 2014, P 5 INT IEEE REN EN
   Boukhris Y, 2009, BUILD SIMUL-CHINA, V2, P67, DOI 10.1007/S12273-009-9405-8
   Buckmaster DJ, 2015, J THERM ENG, V1, P322, DOI 10.18186/jte.03430
   Buckmaster DJ, 2015, INT J HEAT MASS TRAN, V89, P216, DOI 10.1016/j.ijheatmasstransfer.2015.04.059
   Cai N, 2014, BUILD SIMUL-CHINA, V7, P511, DOI 10.1007/s12273-014-0177-4
   Cao GY, 2014, BUILD ENVIRON, V73, P171, DOI 10.1016/j.buildenv.2013.12.009
   Chen X, 2014, INDOOR BUILT ENVIRON, V23, P640, DOI 10.1177/1420326X13484773
   Chen X, 2012, BUILD SIMUL-CHINA, V5, P371, DOI 10.1007/s12273-012-0078-3
   Ching F D K, 2014, BUILDING CONSTRUCTIO
   CHOI ECC, 1991, P AS PAC C COMP MECH, P1721
   Daghigh R, 2015, RENEW SUST ENERG REV, V48, P681, DOI 10.1016/j.rser.2015.04.017
   Dhaka S, 2015, BUILD ENVIRON, V86, P17, DOI 10.1016/j.buildenv.2014.11.024
   Fan YQ, 2014, BUILD SIMUL-CHINA, V7, P649, DOI 10.1007/s12273-014-0178-3
   Golkarfard V, 2014, ADV POWDER TECHNOL, V25, P389, DOI 10.1016/j.apt.2013.06.008
   Greco D, 2014, AIR POLLUTION, VXXII, p[183, 213]
   Gromke C, 2015, BUILD ENVIRON, V83, P11, DOI 10.1016/j.buildenv.2014.04.022
   Hanna SR, 2006, B AM METEOROL SOC, V87, P1713, DOI 10.1175/BAMS-87-12-1713
   He JM, 1999, J WIND ENG IND AEROD, V81, P295, DOI 10.1016/S0167-6105(99)00025-2
   Hiyama K, 2010, BUILD SIMUL-CHINA, V3, P195, DOI 10.1007/s12273-010-0009-0
   Horikiri K, 2015, ENERG BUILDINGS, V88, P303, DOI 10.1016/j.enbuild.2014.12.015
   Hsieh H.-P., 2015, P 21 ACM SIGKDD INT, P437
   Huang H, 2008, J WIND ENG IND AEROD, V96, P1774, DOI 10.1016/j.jweia.2008.02.010
   Huang KD, 2010, BUILD SIMUL-CHINA, V3, P63, DOI 10.1007/s12273-010-0302-y
   Huang YD, 2015, ENVIRON SCI POLLUT R, V22, P2117, DOI 10.1007/s11356-014-3422-6
   Hunter AM, 2014, ECOL ENG, V63, P102, DOI 10.1016/j.ecoleng.2013.12.021
   Joubert EC, 2015, J WIND ENG IND AEROD, V142, P173, DOI 10.1016/j.jweia.2015.03.019
   Jurelionis A, 2015, ENERG BUILDINGS, V86, P305, DOI 10.1016/j.enbuild.2014.10.014
   Kakate VL, 2014, INT J INNOV RES ELEC, V2
   Kato S, 2014, J ASIAN ARCHIT BUILD, V13, P231, DOI 10.3130/jaabe.13.231
   Khalil E., 2012, CFD LETT, V4, P43
   Kim D, 2015, BUILD ENV
   Kubilay A., THESIS EIDGENOSSISCH, P22371
   Kuo CY, 2015, ENERGIES, V8, P10942, DOI 10.3390/en81010942
   Lateb M, 2014, COMPUT FLUIDS, V100, P308, DOI 10.1016/j.compfluid.2014.05.024
   Lateb M, 2015, ENV POLLUT
   Lei L, 2015, BUILD ENV
   Lei L, 2014, ENERG BUILDINGS, V73, P130, DOI 10.1016/j.enbuild.2013.12.056
   Lohner R, 2008, COMPUT METHOD APPL M, V197, P2173, DOI 10.1016/j.cma.2007.09.010
   Lydon GP, 2014, BUILD SIMUL-CHINA, V7, P277, DOI 10.1007/s12273-013-0145-4
   Manca O, 2014, P 12 BIENN C ENG SYS
   Mavroidis I, 2015, ENVIRON FLUID MECH, V15, P999, DOI 10.1007/s10652-015-9394-3
   Mochida A, 2002, WIND STRUCT, V5, P227, DOI 10.12989/was.2002.5.2_3_4.227
   MURAKAMI S, 1990, J WIND ENG IND AEROD, V33, P139, DOI 10.1016/0167-6105(90)90030-G
   Murakami S., 2014, P 1 INT S COMP WIND
   NEN, 2006, WIND COMF WIND DANG
   Omri M, 2010, BUILD SIMUL-CHINA, V3, P153, DOI 10.1007/s12273-010-0311-x
   Pakkala TA, 2014, BUILD ENVIRON, V82, P27, DOI 10.1016/j.buildenv.2014.07.028
   Park D, 2015, BUILD SIMUL-CHINA, V8, P167, DOI 10.1007/s12273-014-0200-9
   Patnaik G, 2007, J FLUID ENG-T ASME, V129, P1524, DOI 10.1115/1.2801368
   Piscia D, 2015, COMPUT ELECTRON AGR, V115, P129, DOI 10.1016/j.compag.2015.05.005
   Prakash D, 2015, INT J SUSTAIN BUILT
   Prakash D., 2015, AIN SHAMS ENG J
   Ramponi R, 2015, BUILD ENVIRON, V92, P152, DOI 10.1016/j.buildenv.2015.04.018
   Ravikumar P, 2009, BUILD SIMUL-CHINA, V2, P187, DOI 10.1007/s12273-009-9317-7
   Ravikumar P, 2011, BUILD SIMUL-CHINA, V4, P217, DOI 10.1007/s12273-011-0032-9
   Richards PJ, 2002, WIND STRUCT, V5, P151, DOI 10.12989/was.2002.5.2_3_4.151
   Sasamoto T, 2010, BUILD SIMUL-CHINA, V3, P263, DOI 10.1007/s12273-010-0011-6
   Stathopoulos T, 1996, ENG STRUCT, V18, P876, DOI 10.1016/0141-0296(95)00155-7
   Sulaiman H, 2014, RENEW SUST ENERG REV, V40, P171, DOI 10.1016/j.rser.2014.07.162
   Taghinia J, 2015, BUILDING SIMULATION, V8
   TAKAKURA S, 1993, J WIND ENG IND AEROD, V46-7, P765, DOI 10.1016/0167-6105(93)90350-W
   Tominaga Y, 1997, J WIND ENG IND AEROD, V67-8, P827, DOI 10.1016/S0167-6105(97)00122-0
   Tominaga Y, 2007, P 6 INT C IND AIR QU
   Tominaga Y, 2008, J WIND ENG IND AEROD, V96, P389, DOI 10.1016/j.jweia.2008.01.004
   Tuan NA, 2014, INT J ENV SCI, V5, P137
   Turner WJN, 2015, APPL THERM ENG, V77, P142, DOI 10.1016/j.applthermaleng.2014.12.026
   Turner WJN, 2015, BUILD SIMUL-CHINA, V8, P65, DOI 10.1007/s12273-014-0192-5
   Viegas JC, 2015, BUILD SIMUL-CHINA, V8, P189, DOI 10.1007/s12273-014-0202-7
   Villi G, 2009, BUILD SIMUL-CHINA, V2, P215, DOI 10.1007/s12273-009-9414-7
   Wang Y, 2014, BUILD SIMUL-CHINA, V7, P401, DOI 10.1007/s12273-013-0156-1
   Westbury PS, 2002, P WORKSH IMP WIND ST
   Wu WF, 2007, J THERM SCI, V16, P155, DOI 10.1007/s11630-007-0155-6
   Yang CQ, 2010, HVAC&R RES, V16, P813, DOI 10.1080/10789669.2010.10390936
   Yi YK, 2013, BUILD SIMUL-CHINA, V6, P297, DOI 10.1007/s12273-013-0116-9
   Yoshie R, 2007, J WIND ENG IND AEROD, V95, P1551, DOI 10.1016/j.jweia.2007.02.023
   Zhai ZQJ, 2005, ENERG BUILDINGS, V37, P333, DOI 10.1016/j.enbuild.2004.07.001
   Zhang J, 2014, ENVIRON MODELL SOFTW, V58, P71, DOI 10.1016/j.envsoft.2014.04.003
   Zhao K, 2010, BUILD SIMUL-CHINA, V3, P15, DOI 10.1007/s12273-010-0305-8
   Zhuang RN, 2014, BUILD SIMUL-CHINA, V7, P263, DOI 10.1007/s12273-013-0144-5
NR 95
TC 2
Z9 3
U1 5
U2 86
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD MAY
PY 2016
VL 57
BP 1174
EP 1185
DI 10.1016/j.rser.2015.12.198
PG 12
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA DE2KK
UT WOS:000370456000085
DA 2018-12-27
ER

PT J
AU Petkovic, D
   Shamshirband, S
   Kamsin, A
   Lee, M
   Anicic, O
   Nikolic, V
AF Petkovic, Dalibor
   Shamshirband, Shahaboddin
   Kamsin, Amirrudin
   Lee, Malrey
   Anicic, Obrad
   Nikolic, Vlastimir
TI RETRACTED: Survey of the most influential parameters on the wind farm
   net present value (NPV) by adaptive neuro-fuzzy approach (Retracted
   article. See vol. 83, pg. 177, 2018)
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review; Retracted Publication
DE Wind farm; ANFIS; Net present value (NPV); Wind turbine; Variable
   selection
ID TURBINE PLACEMENT; ALGORITHM; OPTIMIZATION; DESIGN; CONTROLLER; PROJECT;
   MODELS; SYSTEM; POWER; PROFITABILITY
AB The main objective of wind farm modeling is to maximize wind farm efficiency. The optimal wind turbine placement on a wind farm could be modified by taking economic aspects into account. The net present value (NPV) is the most important criteria for project investment estimating. The general approach in deciding the distinctive choice for a task through NPV is to treat the money streams as known with conviction. Even little deviations from the decided beforehand values might effectively negate the choice. To assess the investment risk of wind power project, this paper constructed a process that selected the most influential wind farm parameters on the NPV with adaptive neuro-fuzzy (ANFIS) method. This procedure is typically called variable selection, which corresponds to finding a subset of the full set of recorded variables that exhibits good predictive abilities. Variable seeking utilizing the ANFIS system was performed to figure out how the seven wind farm parameters affect the NPV of the wind farm. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Petkovic, Dalibor; Nikolic, Vlastimir] Univ Nis, Dept Mechatron & Control, Fac Mech Engn, Aleksandra Medvedeva 14, Nish 18000, Serbia.
   [Shamshirband, Shahaboddin; Kamsin, Amirrudin] Univ Malaya, Fac Comp Sci & Informat Technol, Dept Comp Syst & Technol, Kuala Lumpur 50603, Malaysia.
   [Lee, Malrey] ChonBuk Natl Univ ChonBuk, Sch Elect & Informat Engn, Res Ctr Adv Image & Informat Technol, Jeonju 561756, South Korea.
   [Anicic, Obrad] Univ Pristina Kosovska Mitrovica, Kneza Milosa 7, Kosovska Mitrovica 38220, Serbia.
RP Lee, M (reprint author), ChonBuk Natl Univ ChonBuk, Sch Elect & Informat Engn, Res Ctr Adv Image & Informat Technol, Jeonju 561756, South Korea.
EM mrlee@chonbuk.ac.kr; oanicic@gmail.com
RI Shamshirband, Shahaboddin/K-2544-2013
OI Shamshirband, Shahaboddin/0000-0002-6605-498X
FU University of Malaya under UMRG [RP006A-14HNE]; Project Grant "Research
   and development of new generation wind turbines of high-energy
   efficiency" - Ministry of Education and Science, Republic of Serbia
   [TP35005]
FX This research is supported by University of Malaya under UMRG grant
   (Project No: RP006A-14HNE). This paper is also supported by Project
   Grant TP35005 "Research and development of new generation wind turbines
   of high-energy efficiency" (2011-2015) financed by Ministry of Education
   and Science, Republic of Serbia.
CR Adankon MM, 2011, PATTERN RECOGN, V44, P2220, DOI 10.1016/j.patcog.2011.02.015
   Afanasyeva S, 2016, ENERG CONVERS MANAGE, V107, P22, DOI 10.1016/j.enconman.2015.09.048
   Akcayol MA, 2004, ADV ENG SOFTW, V35, P129, DOI 10.1016/j.advengsoft.2004.03.005
   Aldair AA, 2011, INT J SMART SENS INT, V4, P224
   Ali AH, 2014, FACTA UNIV-SER MECH, V12, P183
   Areed FG, 2010, AIN SHAMS ENG J, V1, P71, DOI 10.1016/j.asej.2010.09.008
   Banu W., 2011, INT J MODELING OPTIM, V1, P24, DOI DOI 10.7763/IJM0.2011.V1.5
   Bas E, 2013, APPL MATH COMPUT, V219, P5901, DOI 10.1016/j.amc.2012.12.031
   Chan KY, 2011, EXPERT SYST APPL, V38, P9799, DOI 10.1016/j.eswa.2011.02.020
   Chen CK, 2007, APPL MATH COMPUT, V184, P360, DOI 10.1016/j.amc.2006.05.164
   Dastranj MR., 2011, AUST J BASIC APPL SC, V5, P1499
   Dieterle F, 2003, ANAL CHIM ACTA, V490, P71, DOI 10.1016/S0003-2670(03)00338-6
   Donald AS, 2002, P 2002 INT C MACH LE
   Ekonomou L, 2012, SIMUL MODEL PRACT TH, V21, P21, DOI 10.1016/j.simpat.2011.09.009
   Eroglu Y, 2012, RENEW ENERG, V44, P53, DOI 10.1016/j.renene.2011.12.013
   Girard R, 2013, APPL ENERG, V101, P609, DOI 10.1016/j.apenergy.2012.06.064
   Giri BC, 2004, INT J PROD ECON, V92, P157, DOI 10.1016/j.ijpe.2003.10.011
   Gollier C, 2010, J ENVIRON ECON MANAG, V59, P142, DOI 10.1016/j.jeem.2009.11.003
   Grady SA, 2005, RENEW ENERG, V30, P259, DOI 10.1016/j.renene.2004.05.007
   Grigorie TL, 2009, P I MECH ENG G-J AER, V223, P655, DOI 10.1243/09544100JAERO522
   Hanafizadeh P, 2011, MATH COMPUT MODEL, V54, P233, DOI 10.1016/j.mcm.2011.02.005
   Hemmati R, 2016, RENEW ENERG, V85, P620, DOI 10.1016/j.renene.2015.07.019
   Holopainen M, 2010, FOREST POLICY ECON, V12, P377, DOI 10.1016/j.forpol.2010.02.009
   Huang XX, 2008, COMPUT IND ENG, V55, P34, DOI 10.1016/j.cie.2007.11.015
   Huang XX, 2007, J COMPUT APPL MATH, V198, P149, DOI 10.1016/j.cam.2005.11.026
   Ismail, 2015, ENRGY PROCED, V65, P146, DOI 10.1016/j.egypro.2015.01.049
   Ituarte-Villarreal CM, 2011, PROCEDIA COMPUT SCI, V6, DOI 10.1016/j.procs.2011.08.087
   Keswani A, 2006, EUR J OPER RES, V168, P240, DOI 10.1016/j.ejor.2004.02.028
   Kurnaz S, 2010, EXPERT SYST APPL, V37, P1229, DOI 10.1016/j.eswa.2009.06.009
   Lee J, 2015, ENERG CONVERS MANAGE, V100, P90, DOI 10.1016/j.enconman.2015.04.059
   Leng Y, 2013, KNOWL-BASED SYST, V44, P121, DOI 10.1016/j.knosys.2013.01.032
   Lin TT, 2009, EUR J OPER RES, V196, P628, DOI 10.1016/j.ejor.2008.04.004
   Lu K, 2006, PATTERN RECOGN, V39, P717, DOI 10.1016/j.patcog.2005.11.009
   Marmidis G, 2008, RENEW ENERG, V33, P1455, DOI 10.1016/j.renene.2007.09.004
   Mellichamp DA, 2013, COMPUT CHEM ENG, V48, P251, DOI 10.1016/j.compchemeng.2012.08.012
   Moghaddam IG, 2013, RENEW ENERG, V55, P252, DOI 10.1016/j.renene.2012.12.023
   Naim MM, 2007, OMEGA-INT J MANAGE S, V35, P524, DOI 10.1016/j.omega.2005.09.006
   Park J, 2015, APPL ENERG, V151, P320, DOI 10.1016/j.apenergy.2015.03.139
   Pasqual J, 2013, INT J PROD ECON, V142, P205, DOI 10.1016/j.ijpe.2012.11.007
   Petkovic D, 2011, NEURAL COMPUT APPL
   Petkovic D, 2012, EXPERT SYST APPL, V39, P13295, DOI 10.1016/j.eswa.2012.05.072
   Pookpunt S, 2013, RENEW ENERG, V55, P266, DOI 10.1016/j.renene.2012.12.005
   Ravi S, 2011, MOD SIMUL ENG, DOI 10.1155/2011/101437
   Saavedra-Moreno B, 2011, RENEW ENERG, V36, P2838, DOI 10.1016/j.renene.2011.04.018
   Schmit TM, 2009, BIOMASS BIOENERG, V33, P1442, DOI 10.1016/j.biombioe.2009.06.010
   Shamshirband S, 2014, ADV ENG SOFTW, V76, P148, DOI 10.1016/j.advengsoft.2014.06.007
   Shamshirband S, 2014, RENEW SUST ENERG REV, V36, P270, DOI 10.1016/j.rser.2014.04.064
   Shamshirband S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103414
   Shamshirband S, 2014, J NETW COMPUT APPL, V42, P102, DOI 10.1016/j.jnca.2014.03.012
   Shamshirband S, 2014, ENERG CONVERS MANAGE, V80, P229, DOI 10.1016/j.enconman.2014.01.038
   Tian LF, 2005, MECHATRONICS, V15, P1305, DOI 10.1016/j.mechatronics.2005.02.001
   Wagner M, 2013, RENEW ENERG, V51, P64, DOI 10.1016/j.renene.2012.09.008
   Wiesemann W, 2010, EUR J OPER RES, V202, P356, DOI 10.1016/j.ejor.2009.05.045
   Yang M, 2010, ENERG POLICY, V38, P1436, DOI 10.1016/j.enpol.2009.11.024
   Yang Z, 2011, P 29 AIAA APPL AER C, P1
   Yin PY, 2012, RENEW ENERG, V48, P489, DOI 10.1016/j.renene.2012.05.020
NR 56
TC 15
Z9 15
U1 1
U2 17
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD MAY
PY 2016
VL 57
BP 1270
EP 1278
DI 10.1016/j.rser.2015.12.175
PG 9
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA DE2KK
UT WOS:000370456000093
DA 2018-12-27
ER

PT J
AU Bui, HV
   Grillo, F
   Helmer, R
   Goulas, A
   van Ommen, JR
AF Bui, Hao Van
   Grillo, Fabio
   Helmer, Ryan
   Goulas, Aristeidis
   van Ommen, J. Ruud
TI RETRACTED: Controlled Growth of Palladium Nanoparticles on Graphene
   Nanoplatelets via Scalable Atmospheric Pressure Atomic Layer Deposition
   (Retracted article. See vol. 122, pg. 9256, 2018)
SO JOURNAL OF PHYSICAL CHEMISTRY C
LA English
DT Article; Retracted Publication
ID ENHANCED ELECTROCATALYTIC ACTIVITY; FORMIC-ACID OXIDATION; PD
   NANOPARTICLES; SUZUKI-MIYAURA; PARTICLE-SIZE; HETEROGENEOUS CATALYSTS;
   RAMAN-SPECTROSCOPY; COUPLING REACTION; ACTIVE CATALYSTS; GRAPHITE OXIDE
AB We demonstrate the deposition of crystalline palladium nanoparticles on graphene nanoplatelets (Pd/graphene) via atmospheric pressure atomic layer deposition (ALD) carried out in a fluidized bed reactor. The nucleation and growth of Pd nanoparticles on the inert graphene surface was enabled by applying an ozone pretreatment step, without significantly affecting the graphene crystalline structure. Uniform nucleation on both basal planes and edges of the graphene was obtained. The Pd loading and dispersion as well as the average particle size could be controlled by varying the number of ALD cycles. By analyzing the evolution of the particle size distribution and spatial density, we obtained insights into the nucleation and growth of Pd ALD on graphene. Furthermore, by shortening the pretreatment time, selective growth of Pd nanoparticles on the edges of the graphene was achieved. The Pd/graphene fabricated with our method showed a significantly lower level of impurities compared to the Pd/graphene synthesized by wet chemistry routes. Our approach provides a 100% solvent-free, controllable and scalable process for producing the bulk quantities of Pd/graphene required for practical applications in, for example, catalysis.
C1 [Bui, Hao Van; Grillo, Fabio; Helmer, Ryan; van Ommen, J. Ruud] Delft Univ Technol, Dept Chem Engn, NL-2628 BL Delft, Netherlands.
   [Goulas, Aristeidis] Delft IMP BV, NL-2628 BL Delft, Netherlands.
RP Bui, HV (reprint author), Delft Univ Technol, Dept Chem Engn, NL-2628 BL Delft, Netherlands.
EM V.H.Bui@tudelft.nl
RI van Ommen, Ruud/A-4119-2009; Van Bui, Hao/B-7401-2015
OI van Ommen, Ruud/0000-0001-7884-0323; Van Bui, Hao/0000-0001-8460-1409
FU European Research Council under the European Union's Seventh Framework
   Programme (FP)/ERC [279632]
FX The authors acknowledge Bart van der Linden (Catalysis Engineering
   group) and Thang Nguyen (FAME group) for the help and discussion on TGA
   and XRD, respectively, and Meng Yue Wang (National Centre for HREM) for
   the HRTEM images and Baukje Terpstra for the ICP-OES analysis. The
   research leading to these results has received funding from the European
   Research Council under the European Union's Seventh Framework Programme
   (FP/2007-2013)/ERC Grant, Agreement No. 279632.
CR Agostini G, 2009, J PHYS CHEM C, V113, P10485, DOI 10.1021/jp9023712
   Baylet A, 2011, PHYS CHEM CHEM PHYS, V13, P4607, DOI 10.1039/c0cp01331e
   Blandez JF, 2015, CATAL SCI TECHNOL, V5, P2167, DOI 10.1039/c4cy01486c
   Cavanagh AS, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/25/255602
   Chen XM, 2011, J AM CHEM SOC, V133, P3693, DOI 10.1021/ja110313d
   Dasgupta NP, 2013, J AM CHEM SOC, V135, P12932, DOI 10.1021/ja405680p
   Datye AK, 2006, CATAL TODAY, V111, P59, DOI 10.1016/j.cattod.2005.10.013
   Detavernier C, 2011, CHEM SOC REV, V40, P5242, DOI 10.1039/c1cs15091j
   Elam JW, 2006, THIN SOLID FILMS, V515, P1664, DOI 10.1016/j.tsf.2006.05.049
   Feng H, 2011, ACS CATAL, V1, P665, DOI 10.1021/cs2000957
   Feng H, 2010, CHEM MATER, V22, P3133, DOI 10.1021/cm100061n
   Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052
   Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46
   FRITSCHE HG, 1993, Z PHYS D ATOM MOL CL, V26, pS15
   Fu GT, 2013, NANOSCALE, V5, P8007, DOI 10.1039/c3nr02179c
   Gao XQ, 2015, J POWER SOURCES, V280, P491, DOI 10.1016/j.jpowsour.2015.01.131
   George SM, 2010, CHEM REV, V110, P111, DOI 10.1021/cr900056b
   Gong T, 2015, J PHYS CHEM C, V119, P11544, DOI 10.1021/jp5130102
   Goulas A, 2014, KONA POWDER PART J, P234
   Goulas A, 2013, J MATER CHEM A, V1, P4647, DOI 10.1039/c3ta01665j
   Gould TD, 2015, APPL CATAL A-GEN, V492, P107, DOI 10.1016/j.apcata.2014.11.037
   Grillo F, 2015, CHEM ENG J, V268, P384, DOI 10.1016/j.cej.2015.01.067
   Hamalainen J, 2014, CHEM MATER, V26, P786, DOI 10.1021/cm402221y
   Hamalainen J, 2013, THIN SOLID FILMS, V531, P243, DOI 10.1016/j.tsf.2013.01.091
   Huang CC, 2012, ENERG ENVIRON SCI, V5, P8848, DOI 10.1039/c2ee22238h
   Huang YX, 2014, ACS APPL MATER INTER, V6, P15795, DOI 10.1021/am504664r
   Jandhyala S, 2012, ACS NANO, V6, P2722, DOI 10.1021/nn300167t
   Kim K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5781
   King DM, 2007, SURF COAT TECH, V201, P9163, DOI 10.1016/j.surfcoat.2007.05.002
   King DM, 2012, POWDER TECHNOL, V221, P13, DOI 10.1016/j.powtec.2011.12.020
   Leconte N, 2010, ACS NANO, V4, P4033, DOI 10.1021/nn100537z
   Lee BK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2928228
   Lee G, 2009, J PHYS CHEM C, V113, P14225, DOI 10.1021/jp904321n
   Lee HBR, 2013, NANO LETT, V13, P457, DOI 10.1021/nl303803p
   Li HY, 2012, CATAL SCI TECHNOL, V2, P1153, DOI 10.1039/c2cy20099f
   Li Y, 2010, NANO RES, V3, P429, DOI 10.1007/s12274-010-0002-z
   Li YZ, 2012, APPL CATAL B-ENVIRON, V125, P189, DOI 10.1016/j.apcatb.2012.05.023
   Liang YY, 2010, NANO RES, V3, P701, DOI 10.1007/s12274-010-0033-5
   Lin YM, 2009, NANO LETT, V9, P422, DOI 10.1021/nl803316h
   Longrie D, 2014, J VAC SCI TECHNOL A, V32, DOI 10.1116/1.4851676
   Lu JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4264
   Luo LB, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0967-5
   Machado BF, 2012, CATAL SCI TECHNOL, V2, P54, DOI 10.1039/c1cy00361e
   Mackus AJM, 2013, CHEM MATER, V25, P1905, DOI 10.1021/cm400562u
   Miikkulainen V, 2013, J APPL PHYS, V113, DOI 10.1063/1.4757907
   MontejanoCarrizales JM, 1997, NANOSTRUCT MATER, V8, P269, DOI 10.1016/S0965-9773(97)00168-2
   Moser J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205445
   Navalon S, 2014, CHEM REV, V114, P6179, DOI 10.1021/cr4007347
   O'Neill BJ, 2015, ACS CATAL, V5, P1804, DOI 10.1021/cs501862h
   Owens FJ, 2003, INTRO NANOTECHNOLOGY
   Rikkinen E, 2011, J PHYS CHEM C, V115, P23067, DOI 10.1021/jp2083659
   Santra S, 2013, ACS CATAL, V3, P2776, DOI 10.1021/cs400468h
   Scheuermann GM, 2009, J AM CHEM SOC, V131, P8262, DOI 10.1021/ja901105a
   Senkevich JJ, 2003, CHEM VAPOR DEPOS, V9, P258, DOI 10.1002/cvde.200306246
   Seo MH, 2011, ELECTROCHEM COMMUN, V13, P182, DOI 10.1016/j.elecom.2010.12.008
   Sharavath V, 2014, RSC ADV, V4, P48322, DOI 10.1039/c4ra06868h
   Siamaki AR, 2011, J CATAL, V279, P1, DOI 10.1016/j.jcat.2010.12.003
   Singh RN, 2011, CATAL SCI TECHNOL, V1, P778, DOI 10.1039/c1cy00021g
   Sun SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01775
   Sun X, 2014, J MATER CHEM A, V2, P7319, DOI 10.1039/c4ta00589a
   Szori K, 2013, CATAL LETT, V143, P539, DOI 10.1007/s10562-013-1006-6
   Ten Eyck GA, 2006, CHEM VAPOR DEPOS, V12, P290, DOI 10.1002/cvde.200506456
   Upadhyay RK, 2014, RSC ADV, V4, P3823, DOI 10.1039/c3ra45013a
   Valdesueiro D, 2015, MATERIALS, V8, P1249, DOI 10.3390/ma8031249
   van Ommen JR, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0737-4
   VENABLES JA, 1973, PHILOS MAG, V27, P697, DOI 10.1080/14786437308219242
   Vinayan BP, 2013, INT J HYDROGEN ENERG, V38, P2240, DOI 10.1016/j.ijhydene.2012.11.091
   Weber MJ, 2014, J PHYS CHEM C, V118, P8702, DOI 10.1021/jp5009412
   Weber MJ, 2012, CHEM MATER, V24, P2973, DOI 10.1021/cm301206e
   Williams JR, 2007, SCIENCE, V317, P638, DOI 10.1126/science.1144657
   Wu GJ, 2013, APPL CATAL B-ENVIRON, V136, P177, DOI 10.1016/j.apcatb.2013.01.067
   Xi PX, 2012, NANOSCALE, V4, P5597, DOI 10.1039/c2nr31010d
   Xiang QJ, 2012, CHEM SOC REV, V41, P782, DOI 10.1039/c1cs15172j
   Yamamoto S, 2014, NANOSCALE, V6, P6501, DOI 10.1039/c4nr00715h
   Yan H, 2015, J AM CHEM SOC, V137, P10484, DOI 10.1021/jacs.5b06485
   Yang J, 2011, J MATER CHEM, V21, P3384, DOI 10.1039/c0jm03361h
   Yang SD, 2014, SCI REP-UK, V4, DOI 10.1038/srep04501
   Yang SD, 2012, ELECTROCHIM ACTA, V62, P242, DOI 10.1016/j.electacta.2011.12.022
   Yoo E, 2009, NANO LETT, V9, P2255, DOI 10.1021/nl900397t
   Zhang K, 2013, SCI REP-UK, V3, DOI 10.1038/srep03448
   Zhang N, 2012, NANOSCALE, V4, P5792, DOI 10.1039/c2nr31480k
   Zhang ZY, 2015, CHEM COMMUN, V51, P8357, DOI 10.1039/c5cc02715b
   Zhao H, 2011, CHEM COMMUN, V47, P2014, DOI 10.1039/c0cc04432f
   ZINKEALLMANG M, 1992, SURF SCI REP, V16, P377, DOI 10.1016/0167-5729(92)90006-W
NR 84
TC 9
Z9 9
U1 6
U2 68
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1932-7447
J9 J PHYS CHEM C
JI J. Phys. Chem. C
PD APR 28
PY 2016
VL 120
IS 16
BP 8832
EP 8840
DI 10.1021/acs.jpcc.6b02285
PG 9
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA DL3GH
UT WOS:000375521700043
DA 2018-12-27
ER

PT J
AU McGrath-Spangler, EL
AF McGrath-Spangler, E. L.
TI RETRACTED: The impact of a boundary layer height formulation on the
   GEOS-5 model climate (Retracted article. See vol. 121, pg. 5749, 2016)
SO JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES
LA English
DT Article; Retracted Publication
DE planetary boundary layer; turbulence; global modeling; climate
ID BOREAL FOREST; CIRCULATION; CONVECTION; TRANSPORT; DYNAMICS; AGCM
AB Planetary boundary layer (PBL) processes are important for the estimation of surface-atmosphere exchanges that impact global climate. One way of characterizing the strength of these processes is the PBL depth. In the Goddard Earth Observing System (GEOS-5) atmospheric general circulation model, the PBL depth is also used in calculating the turbulent length scale, which, in turn, is used in estimating the turbulence and vertical mixing within the model. Therefore, changing the PBL depth definition directly affects the model climate. This study evaluates the climatological model response of two long-term simulations using different PBL depth definitions. The first definition is based on a bulk Richardson number; the second uses a combination of the same bulk Richardson number definition over land plus a definition based on the turbulent eddy diffusion coefficient over water. The two simulations produce different spatiotemporal patterns of temperature, specific humidity, and wind speed related to the differences in turbulence. The largest differences, as expected, are present over water. Due to differences in atmospheric stability, the relationship between the two PBL depth estimates differ among the majority of the oceans and off the west coasts of continents, affecting the climatic response. Due to its optimization of the climatic response while maintaining a realistic diurnal cycle of PBL depth, the mixed PBL depth configuration is preferred.
C1 [McGrath-Spangler, E. L.] Univ Space Res Assoc, Columbia, MD USA.
   [McGrath-Spangler, E. L.] NASA, Goddard Space Flight Ctr, Global Modeling & Assimilat Off, Greenbelt, MD USA.
RP McGrath-Spangler, EL (reprint author), Univ Space Res Assoc, Columbia, MD USA.; McGrath-Spangler, EL (reprint author), NASA, Goddard Space Flight Ctr, Global Modeling & Assimilat Off, Greenbelt, MD USA.
EM erica.l.mcgrath-spangler@nasa.gov
FU National Aeronautics and Space Administration [NNX15AE62G]
FX The author thanks two anonymous reviewers whose suggestions helped to
   improve this manuscript. The GEOS-5 source code is available from the
   NASA Global Modeling and Assimilation Office. The MERRA-2 data are
   produced by the NASA Global Modeling and Assimilation Office and
   disseminated by the GES DISC with support from NASA's Modeling,
   Analysis, and Prediction program. Computing was supported by allocations
   on the NASA Center for Climate Simulation from Tsengdar Lee. The
   research was supported by Richard Eckman through National Aeronautics
   and Space Administration grant NNX15AE62G.
CR Bacmeister JT, 2006, J ATMOS SCI, V63, P3383, DOI 10.1175/JAS3791.1
   Beljaars A., 1995, P SEM PAR SUBGR SCAL
   Betts AK, 1998, J GEOPHYS RES-ATMOS, V103, P23079, DOI 10.1029/98JD02023
   BLACKADAR AK, 1962, J GEOPHYS RES, V67, P3095, DOI 10.1029/JZ067i008p03095
   Bloom SC, 1996, MON WEATHER REV, V124, P1256, DOI 10.1175/1520-0493(1996)124<1256:DAUIAU>2.0.CO;2
   Chou M. -D., 2001, 19 NASA, V19
   Chou M. -D., 1999, 15 NASA, V15
   Joffre SM, 2001, BOUND-LAY METEOROL, V99, P429, DOI 10.1023/A:1018956525605
   Koster RD, 2000, J GEOPHYS RES-ATMOS, V105, P24809, DOI 10.1029/2000JD900327
   Lin SJ, 2004, MON WEATHER REV, V132, P2293, DOI 10.1175/1520-0493(2004)132<2293:AVLFDC>2.0.CO;2
   Lock AP, 2000, MON WEATHER REV, V128, P3187, DOI 10.1175/1520-0493(2000)128<3187:ANBLMS>2.0.CO;2
   Louis J., 1982, WORKSH PLAN BOUND LA
   McGrath-Spangler EL, 2015, ATMOS CHEM PHYS, V15, P7269, DOI 10.5194/acp-15-7269-2015
   McGrath-Spangler EL, 2014, ATMOS CHEM PHYS, V14, P6717, DOI 10.5194/acp-14-6717-2014
   McGrath-Spangler EL, 2013, J GEOPHYS RES-ATMOS, V118, P1226, DOI 10.1002/jgrd.50198
   Molod A, 2015, GEOSCI MODEL DEV, V8, P1339, DOI 10.5194/gmd-8-1339-2015
   Molod A., 2012, NASA TECH REP SERIES, V28, P115
   MOORTHI S, 1992, MON WEATHER REV, V120, P978, DOI 10.1175/1520-0493(1992)120<0978:RASAPO>2.0.CO;2
   NUMAGUTI A, 1993, J ATMOS SCI, V50, P1874, DOI 10.1175/1520-0469(1993)050<1874:DAEBOT>2.0.CO;2
   Putman WM, 2007, J COMPUT PHYS, V227, P55, DOI 10.1016/j.jcp.2007.07.022
   Rienecker M. M., 2008, NASA TECHNICAL REPOR, V27, P1
   Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1
   Sandu I, 2013, J ADV MODEL EARTH SY, V5, P117, DOI 10.1002/jame.20013
   Seibert P, 2000, ATMOS ENVIRON, V34, P1001, DOI 10.1016/S1352-2310(99)00349-0
   Seidel DJ, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018143
   Seidel DJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013680
   Takacs L. L., 2015, 39 NASA, V39
   TENNEKES H, 1973, J ATMOS SCI, V30, P558, DOI 10.1175/1520-0469(1973)030<0558:AMFTDO>2.0.CO;2
   Vogelezang DHP, 1996, BOUND-LAY METEOROL, V81, P245, DOI 10.1007/BF02430331
NR 29
TC 1
Z9 2
U1 2
U2 13
PU AMER GEOPHYSICAL UNION
PI WASHINGTON
PA 2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA
SN 2169-897X
EI 2169-8996
J9 J GEOPHYS RES-ATMOS
JI J. Geophys. Res.-Atmos.
PD APR 16
PY 2016
VL 121
IS 7
BP 3263
EP 3275
DI 10.1002/2015JD024607
PG 13
WC Meteorology & Atmospheric Sciences
SC Meteorology & Atmospheric Sciences
GA DK7QG
UT WOS:000375120200011
DA 2018-12-27
ER

PT J
AU Samie, N
   Muniandy, S
   Kanthimathi, MS
   Haerian, BS
   Azudin, RER
AF Samie, Nima
   Muniandy, Sekaran
   Kanthimathi, M. S.
   Haerian, Batoul Sadat
   Azudin, Raja Elina Raja
TI RETRACTED: Novel piperazine core compound induces death in human liver
   cancer cells: possible pharmacological properties (Retracted article.
   See vol. 6, pg. 29056, 2016)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID DRUG-INDUCED APOPTOSIS; MEDIATED APOPTOSIS; CYCLE ARREST; PATHWAY;
   ACTIVATION; DERIVATIVES; DNA; INHIBITION; CALCIUM; STRESS
AB The current study evaluates the cytotoxic mechanism of a novel piperazine derivate designated as PCC against human liver cancer cells. In this context, human liver cancer cell lines, SNU-475 and 243, human monocyte/macrophage cell line, CRL-9855, and human B lymphocyte cell line, CCL-156, were used to determine the IC50 of PCC using the standard MTT assay. PCC displayed a strong suppressive effect on SNU-475 and SNU-423 cells with an IC50 value of 6.98 +/- 0.11 mu g/ml and 7.76 +/- 0.45 mu g/ml respectively, after 24 h of treatment. Significant dipping in the mitochondrial membrane potential and elevation in the released of cytochrome c from the mitochondria indicated the induction of the intrinsic apoptosis pathway by PCC. Activation of this pathway was further evidenced by significant activation of caspase 3/7 and 9. PCC was also shown to activate the extrinsic pathways of apoptosis via activation of caspase-8 which is linked to the suppression of NF-kappa B translocation to the nucleus. Cell cycle arrest in the G1 phase was confirmed by flow cytometry and up-regulation of glutathione reductase expression was quantified by qPCR. This study suggests that PCC is a simultaneous inducer of intrinsic and extrinsic pathways of apoptosis in liver cancer cell lines.
C1 [Samie, Nima; Haerian, Batoul Sadat] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.
   [Muniandy, Sekaran; Kanthimathi, M. S.] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia.
   [Kanthimathi, M. S.] Univ Malaya, Fac Med, Ctr Prote Res, Kuala Lumpur 50603, Malaysia.
   [Azudin, Raja Elina Raja] HKL, Dept Pathol, Drug & Res Unit, Kuala Lumpur 50586, Malaysia.
RP Samie, N (reprint author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.; Muniandy, S (reprint author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia.
EM nimasamie@gmail.com; sekaran@um.edu.my
RI MUNIANDY, SEKARAN/B-5345-2010
OI MUNIANDY, SEKARAN/0000-0003-1310-3634
FU Ministry of Higher Education (HIR) [H-20001-00-E00046]; Postgraduate
   Research Grant (PPP) [PG021-2014B]
FX The authors would like to express their ultimate appreciation and
   gratitude to University of Malaya and Ministry of Higher Education (HIR
   Grant H-20001-00-E00046) and Postgraduate Research Grant (PPP)
   PG021-2014B for supporting the current study. We also express our
   deepest appreciation to Nooshin Mohebali which helped us in this work.
CR Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320
   Ahmed W, 2013, CURR HEMATOL MALIG R, V8, P71, DOI 10.1007/s11899-012-0150-1
   Asif M., 2015, INT J ADV SCI RES, V1, P05, DOI 10.18483/IRJSci.73
   Baliga B, 2003, CELL DEATH DIFFER, V10, P16, DOI 10.1038/sj.cdd.4401166
   Baumgartner HK, 2007, AM J PHYSIOL-GASTR L, V293, pG296, DOI 10.1152/ajpgi.00103.2007
   Berkheij M, 2005, TETRAHEDRON LETT, V46, P2369, DOI 10.1016/j.tetlet.2005.02.085
   Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1570
   Cancer I. A. f. R. o. & Organization W. H. GLOBOCAN, 2014, GLOBOCAN EST CANC IN
   Chaudhary P, 2006, BIOORGAN MED CHEM, V14, P1819, DOI 10.1016/j.bmc.2005.10.032
   Chou CC, 2010, ARCH PHARM RES, V33, P1181, DOI 10.1007/s12272-010-0808-y
   Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337
   Festing MFW, 1998, ATLA-ALTERN LAB ANIM, V26, P283
   Friesen C, 1996, NAT MED, V2, P574, DOI 10.1038/nm0596-574
   Garber J., 2011, NATL RES COUNCIL US
   Gasparri F, 2006, J BIOMOL SCREEN, V11, P586, DOI 10.1177/1087057106289406
   Gerasimenko JV, 2002, J CELL SCI, V115, P485
   Gillet R, 1998, CANCER CHEMOTH PHARM, V41, P252
   Giorgi C, 2008, CURR MOL MED, V8, P119
   Guo CC, 2004, BIOORGAN MED CHEM, V12, P2469, DOI 10.1016/j.bmc.2004.01.045
   Hajrezaie M, 2014, SCI WORLD J, DOI 10.1155/2014/540463
   Hatnapure GD, 2012, BIOORG MED CHEM LETT, V22, P6385, DOI 10.1016/j.bmcl.2012.08.071
   Hsu SC, 2010, CRYSTENGCOMM, V12, P3388, DOI 10.1039/c001735c
   Hulme C, 1999, TETRAHEDRON LETT, V40, P5295, DOI 10.1016/S0040-4039(99)00960-0
   Hyer ML, 2008, CANCER RES, V68, P2927, DOI 10.1158/0008-5472.CAN-07-5759
   Kranz D, 2012, CELL CYCLE, V11, P2053, DOI 10.4161/cc.20698
   Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B
   Lee JS, 2012, INT J TOXICOL, V31, P70, DOI 10.1177/1091581811423845
   Ling YH, 2008, MOL PHARMACOL, V74, P793, DOI 10.1124/mol.107.044396
   Liu YJ, 2012, INORG CHIM ACTA, V387, P117, DOI 10.1016/j.ica.2012.01.003
   Lynch K, 2000, ENDOCRINOLOGY, V141, P4209, DOI 10.1210/en.141.11.4209
   OECD Guideline for testing of chemicals, 2005, OECD GUID TEST CHEM
   Park HJ, 2013, FOOD CHEM TOXICOL, V60, P542, DOI 10.1016/j.fct.2013.08.022
   Rahman HS, 2014, INT J NANOMED, V9, P527, DOI 10.2147/IJN.S54346
   Sampson Josiah J 3rd, 2011, Int J Biochem Mol Biol, V2, P78
   Schug ZT, 2011, CELL DEATH DIFFER, V18, P538, DOI 10.1038/cdd.2010.135
   See WL, 2010, ONCOGENE, V29, P1720, DOI 10.1038/onc.2009.465
   Shakibaei M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057218
   Siddiqui N, 2011, J PHARM BIOALLIED SC, V3, P194, DOI 10.4103/0975-7406.80765
   Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254
   Su J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071333
   Tentner AR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.1
   Thangam R, 2014, CARBOHYD POLYM, V107, P138, DOI 10.1016/j.carbpol.2014.02.039
   Tombal B, 1999, CELL CALCIUM, V25, P19, DOI 10.1054/ceca.1998.0005
   Tuncbilek M, 2012, J MED CHEM, V55, P3058, DOI 10.1021/jm3001532
   Upadhayaya RS, 2004, BIOORGAN MED CHEM, V12, P2225, DOI 10.1016/j.bmc.2004.02.014
   Wang L, 2012, CANCER LETT, V324, P75, DOI 10.1016/j.canlet.2012.05.004
   Wang X., 2014, TOXICOL SCI, V1, P141
   Wieder T, 2001, BLOOD, V97, P1378, DOI 10.1182/blood.V97.5.1378
   WILSON WD, 1990, BIOPHYS CHEM, V35, P227, DOI 10.1016/0301-4622(90)80011-U
   Wu GY, 2004, J NUTR, V134, P489
   Yoshida M, 1999, CLIN CANCER RES, V5, P4295
   Yu ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015843
NR 52
TC 4
Z9 4
U1 2
U2 28
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 13
PY 2016
VL 6
AR 24172
DI 10.1038/srep24172
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DJ1LB
UT WOS:000373963200001
PM 27072064
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Karpinski, A
   Yale, M
   Briggs, JC
AF Karpinski, Andrew
   Yale, Miriam
   Briggs, Jessie C.
TI RETRACTED: Unconscious arithmetic processing: A direct
   replication(Retracted article.See vol.47, pg.114, 2017)
SO EUROPEAN JOURNAL OF SOCIAL PSYCHOLOGY
LA English
DT Article; Retracted Publication
DE nonconscious processes; automaticity; arithmetic; CFS; direct
   replication
ID CONTINUOUS FLASH SUPPRESSION; RATIONALITY; INTEGRATION; THOUGHT; CHOICE
AB Across two experiments involving four conditions, Sklar et al. (2012) found that complex subtraction equations can be solved without awareness of the equations. These findings challenge the current position that consciousness is necessary for performing abstract, rule-following tasks. Given the important implications of their work, we directly replicate Sklar's findings using a larger sample (n=94) from a different population. Using Continuous Flash Suppression, we investigated if people were able to solve an equation after subliminal (1300 ms) exposure to it. We found evidence for unconscious addition but not subtraction. The effect of unconscious addition was eliminated when participants reported subjective awareness of the primes. Critical review of our results and implications for further research are discussed.
C1 [Karpinski, Andrew; Yale, Miriam; Briggs, Jessie C.] Temple Univ, Dept Psychol, Weiss Hall,1701 North 13th St, Philadelphia, PA 19122 USA.
RP Karpinski, A (reprint author), Temple Univ, Dept Psychol, Weiss Hall,1701 North 13th St, Philadelphia, PA 19122 USA.
EM andrew.karpinski@temple.edu
CR Bland JM, 1996, BRIT MED J, V312, P1079
   Bland JM, 1996, BMJ-BRIT MED J, V312, P1153
   CAMPBELL JID, 1987, MEM COGNITION, V15, P349, DOI 10.3758/BF03197037
   CHEESMAN J, 1986, CAN J PSYCHOL, V40, P343, DOI 10.1037/h0080103
   Dennett D., 1996, KINDS MINDS UNDERSTA
   Dijksterhuis A, 2006, SCIENCE, V311, P1005, DOI 10.1126/science.1121629
   Dijksterhuis A, 2004, J PERS SOC PSYCHOL, V87, P586, DOI 10.1037/0022-3514.87.5.586
   Dijksterhuis A, 2006, PERSPECT PSYCHOL SCI, V1, P95, DOI 10.1111/j.1745-6916.2006.00007.x
   Evans J.St.B.T, 2009, 2 MINDS DUAL PROCESS
   EVANS JSBT, 1984, BRIT J PSYCHOL, V75, P451, DOI 10.1111/j.2044-8295.1984.tb01915.x
   Faivre N, 2014, PSYCHOL SCI, V25, P2006, DOI 10.1177/0956797614547916
   Gaillard V, 2014, CLIN EEG NEUROSCI, V45, P50, DOI 10.1177/1550059413516757
   Garcia-Orza J, 2009, ATTEN PERCEPT PSYCHO, V71, P471, DOI 10.3758/APP.71.3.471
   GREENWALD AG, 1992, AM PSYCHOL, V47, P766, DOI 10.1037/0003-066X.47.6.766
   Hassin R. R., 2005, NEW UNCONSCIOUS, P196
   Hassin RR, 2013, PERSPECT PSYCHOL SCI, V8, P195, DOI 10.1177/1745691612460684
   Hassin RR, 2009, CONSCIOUS COGN, V18, P665, DOI 10.1016/j.concog.2009.04.003
   Hassin RR, 2009, SOC COGNITION, V27, P20, DOI 10.1521/soco.2009.27.1.20
   Jackson N, 2005, ACTA PSYCHOL, V119, P41, DOI 10.1016/j.actpsy.2004.10.018
   James W, 1913, PRINCIPLES PSYCHOL, VII, P325
   Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697
   Kamii C, 2001, J MATH BEHAV, V20, P33, DOI DOI 10.1016/S0732-3123(01)00060-8
   Kleiman T, 2011, J EXP SOC PSYCHOL, V47, P521, DOI 10.1016/j.jesp.2011.02.007
   Ludwig K, 2015, CONSCIOUS COGN, V35, P251, DOI 10.1016/j.concog.2014.12.010
   Marien H, 2012, J PERS SOC PSYCHOL, V103, P399, DOI 10.1037/a0028955
   Miles WR, 1930, J GEN PSYCHOL, V3, P412, DOI 10.1080/00221309.1930.9918218
   Mudrik L, 2014, TRENDS COGN SCI, V18, P488, DOI 10.1016/j.tics.2014.04.009
   Ric F, 2012, J EXP PSYCHOL GEN, V141, P222, DOI 10.1037/a0024608
   Rusconi E, 2006, COGN NEUROPSYCHOL, V23, P227, DOI 10.1080/13594320500166381
   Sherman J. W., 2014, DUAL PROCESS ORIE
   Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632
   Sklar AY, 2012, P NATL ACAD SCI USA, V109, P19614, DOI 10.1073/pnas.1211645109
   Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3
   Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435
   Strack F, 2015, APA HDB PERSONALITY, P891, DOI DOI 10.1037/14341-028
   Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500
   van Gaal S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0212
   WIDAMAN KF, 1989, J EXP PSYCHOL LEARN, V15, P898, DOI 10.1037/0278-7393.15.5.898
   Wilke M, 2003, NEURON, V39, P1043, DOI 10.1016/j.neuron.2003.08.003
   WILSON TD, 1991, J PERS SOC PSYCHOL, V60, P181, DOI 10.1037//0022-3514.60.2.181
   Yang E, 2012, J VISION, V12, DOI 10.1167/12.3.8
NR 41
TC 4
Z9 4
U1 1
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0046-2772
EI 1099-0992
J9 EUR J SOC PSYCHOL
JI Eur. J. Soc. Psychol.
PD APR
PY 2016
VL 46
IS 3
BP 384
EP 391
DI 10.1002/ejsp.2175
PG 8
WC Psychology, Social
SC Psychology
GA DQ9EN
UT WOS:000379513300010
DA 2018-12-27
ER

PT J
AU Shen, G
   Tang, Y
   Zhao, JS
   Lu, H
   Li, X
   Li, G
AF Shen, Gang
   Tang, Yu
   Zhao, Jinsong
   Lu, Hao
   Li, Xiang
   Li, Ge
TI RETRACTED: Jacobian free monotonic descent algorithm for forward
   kinematics of spatial parallel manipulator (Retracted article. See vol.
   10, 2018)
SO ADVANCES IN MECHANICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Parallel manipulator; forward kinematics; nonlinear equations; Jacobian
   free; real-time system
ID SENSORS
AB In order to efficiently solve a forward kinematics of parallel manipulators for real-time applications, a Jacobian free monotonic descent algorithm is proposed in this article. The system of nonlinear equations of a specified 6-degree-of-freedom parallel manipulator is established using a geometric analysis method. The proposed Jacobian free monotonic descent algorithm is modified using a traditional Newton-Raphson method by employing a first-order Taylor series expansion to numerically approximate a Jacobian matrix. A monotonic descent factor is employed for preventing the iteration from divergence even with poor initial conditions. The proposed algorithm inherits the merits of the Newton-Raphson algorithm and overcomes its drawbacks. The Jacobian free monotonic descent algorithm is programmed in MATLAB/Simulink and then is compiled to a real-time PC system with xPC target technology for implementation. The experimental results demonstrate that the proposed Jacobian free monotonic descent algorithm is effective and feasible for the real-time forward kinematics of parallel manipulators in terms of accuracy, convergence, and execution time.
C1 [Shen, Gang; Tang, Yu; Lu, Hao; Li, Xiang; Li, Ge] China Univ Min & Technol, Sch Mechatron Engn, Jiangsu Key Lab Mine Mech & Elect Equipment, Xuzhou 221116, Peoples R China.
   [Zhao, Jinsong] Yanshan Univ, Key Lab Adv Forging & Stamping Technol & Sci, Minist Educ China, Qinhuangdao, Peoples R China.
RP Lu, H (reprint author), China Univ Min & Technol, Sch Mechatron Engn, Jiangsu Key Lab Mine Mech & Elect Equipment, Xuzhou 221116, Peoples R China.
EM haolucumt@163.com
FU National Natural Science Foundation of China [51575511, 51505412];
   Fundamental Research Funds for the Central Universities in China
   [2015QNA34]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD)
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: This
   research was supported by the National Natural Science Foundation of
   China (grant nos 51575511 and 51505412), the Fundamental Research Funds
   for the Central Universities in China (grant no. 2015QNA34), and the
   Project Funded by the Priority Academic Program Development of Jiangsu
   Higher Education Institutions (PAPD).
CR Chiu YJ, 2001, INT J ROBOT RES, V20, P401, DOI 10.1177/02783640122067462
   Cui HL, 2005, ROBOT CIM-INT MANUF, V21, P497, DOI 10.1016/j.rcim.2004.07.018
   Gan DM, 2009, MECH MACH THEORY, V44, P1640, DOI 10.1016/j.mechmachtheory.2009.01.008
   Gang S, 2013, CONTROL ENG PRACT, V21, P1128, DOI 10.1016/j.conengprac.2013.03.007
   Ghasemi A, 2010, J INTELL ROBOT SYST, V60, P201, DOI 10.1007/s10846-010-9421-z
   Husty ML, 1996, MECH MACH THEORY, V31, P365, DOI 10.1016/0094-114X(95)00091-C
   Kang RJ, 2012, ROBOTICA, V30, P847, DOI 10.1017/S026357471100107X
   Lee TY, 2001, MECH MACH THEORY, V36, P1073, DOI 10.1016/S0094-114X(01)00034-9
   Merlet JP, 2004, INT J ROBOT RES, V23, P221, DOI 10.1177/027836904039809
   Merlet JP, 2006, PARALLEL ROBOTS
   Parenti-Castelli V, 1998, J MECH DESIGN, V120, P549, DOI 10.1115/1.2829313
   Parikh PJ, 2005, IEEE T ROBOT, V21, P18, DOI 10.1109/TRO.2004.833801
   Parikh PJ, 2009, INT J ADV MANUF TECH, V40, P595, DOI 10.1007/s00170-007-1360-x
   Quarteroni A., 2007, NUMERICAL MATH
   Sadjadian H, 2005, J INTELL ROBOT SYST, V44, P225, DOI 10.1007/s10846-005-9006-4
   Shen G, 2016, MECHATRONICS, V33, P49, DOI 10.1016/j.mechatronics.2015.10.009
   Shen G, 2011, J VIB CONTROL, V17, P1611, DOI 10.1177/1077546310380431
   Sommese AJ, 2004, J MECH DESIGN, V126, P262, DOI 10.1115/1.1649965
   Uchida T, 2012, MECH MACH THEORY, V52, P144, DOI 10.1016/j.mechmachtheory.2012.01.015
   WANG LCT, 1993, IEEE T ROBOTIC AUTOM, V9, P272, DOI 10.1109/70.240196
   Yang CF, 2010, J CENT SOUTH UNIV T, V17, P1264, DOI 10.1007/s11771-010-0630-1
   Yao JY, 2014, IEEE T IND ELECTRON, V61, P6285, DOI 10.1109/TIE.2014.2304912
   Zhang D, 2012, ROBOT CIM-INT MANUF, V28, P484, DOI 10.1016/j.rcim.2012.01.003
   Zhang D, 2011, ROBOT CIM-INT MANUF, V27, P157, DOI 10.1016/j.rcim.2010.07.003
   Zhao JS, 2005, INT J ADV MANUF TECH, V27, P112, DOI 10.1007/s00170-004-2160-1
NR 25
TC 5
Z9 6
U1 5
U2 17
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1687-8140
J9 ADV MECH ENG
JI Adv. Mech. Eng.
PD APR
PY 2016
VL 8
IS 4
AR 1687814016645447
DI 10.1177/1687814016645447
PG 8
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA DL4DI
UT WOS:000375583100058
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Haldar, S
AF Haldar, Samadyuti
TI RETRACTED: Effect of electromagnetic field on the stability of
   viscoelastic fluid film flowing down an inclined plane (Retracted
   article. See vol.67,pg.139,2016)
SO ZEITSCHRIFT FUR ANGEWANDTE MATHEMATIK UND PHYSIK
LA English
DT Article; Retracted Publication
DE Thin film; Viscoelastic fluid; Nonlinear stability; Electromagnetic
   field; Weakly nonlinear waves
ID LINEAR TEMPERATURE-VARIATION; MODERATE REYNOLDS-NUMBER; LONG WAVES;
   VISCOUS FILM; LAYER; SURFACE
AB The stability of thin electrically conducting viscoelastic fluid film flowing down on a non-conducting inclined plane in the presence of electromagnetic field is investigated under induction-free approximation. Surface evolution equation is derived by long-wave expansion method. The stabilizing role of Hartman number M (magnetic field) and the destabilizing role of the viscoelastic property G and the electric parameter E on such fluid film are established through the linear stability analysis of the surface evolution equation. Investigation shows that at small values of Hartman number (M), the influence of electric parameter (E) on the viscoelastic parameter (G) is insignificant, while for large values of M, E introduces more destabilizing effect at low values of G than that at high values of G. An interesting result also perceived from our analysis is that the stabilizing effect of Hartman number (M) is decreasing with the increase of the values of G and E, even it gives destabilizing effect after a certain high value of the electric field depending on the high value of G. The weakly nonlinear study reveals that the increase of G decreases the explosive and subcritical unstable zones but increases the supercritical stable zone keeping the unconditional zone almost constant.
C1 [Haldar, Samadyuti] Hooghly Womens Coll, Dept Math, Hooghly 712103, W Bengal, India.
RP Haldar, S (reprint author), Hooghly Womens Coll, Dept Math, Hooghly 712103, W Bengal, India.
EM samdt_h@yahoo.co.in
OI Haldar, Samadyuti/0000-0001-5195-5497
FU UGC (ERO), India [F.PSW-026/09-10(ERO)]
FX I would like to thank the reviewers for their valuable comments and
   suggestions which enabled me to produce an improved presentation of the
   paper. I express my sincere thanks to Dr. Asim Mukhopadhay and Dr.
   Anandamay Mukhopadhyay for their guidances and suggestions. I am very
   much thankful to UGC (ERO), India, for providing me the necessary Grants
   vide Minor Research Project No. F.PSW-026/09-10(ERO) dated 08.11.2009 to
   carry out this research work.
CR Alekseenko S.V., 1994, WAVE FLOW LIQUD FILM
   Andersson H.I., 2000, J PHYS D, V33, P1674
   BEARD DW, 1964, P CAMB PHILOS SOC, V60, P667
   BENJAMIN TB, 1957, J FLUID MECH, V2, P554, DOI 10.1017/S0022112057000373
   BENNEY DJ, 1966, J MATH PHYS CAMB, V45, P150, DOI 10.1002/sapm1966451150
   Chandrasekhar S., 1981, HYDRODYNAMIC HYDROMA
   CHANG HC, 1994, ANNU REV FLUID MECH, V26, P103, DOI 10.1146/annurev.fl.26.010194.000535
   Cheng P.J., 1999, J PHYS D, V32, P1557
   Cheng PJ, 2007, INT J ENG SCI, V45, P905, DOI 10.1016/j.ijengsci.2007.07.001
   Dandapat B. S., 2003, International Journal of Applied Mechanics and Engineering, V8, P379
   Dandapat BS, 2011, INT COMMUN HEAT MASS, V38, P324, DOI 10.1016/j.icheatmasstransfer.2010.11.009
   Dandapat BS, 2010, Z ANGEW MATH PHYS, V61, P685, DOI 10.1007/s00033-010-0074-3
   DANDAPAT BS, 1978, RHEOL ACTA, V17, P492, DOI 10.1007/BF01534276
   Dandapat BS, 1997, RHEOL ACTA, V36, P135, DOI 10.1007/s003970050030
   Fulford G. D., 1964, ADV CHEM ENG, V5, P151, DOI DOI 10.1016/S0065-2377(08)60008-3
   Gordeev Y.N., 1990, APPL MATH THEOR PHYS, V3, P96
   GUPTA AS, 1967, J FLUID MECH, V28, P17, DOI 10.1017/S0022112067001879
   GUPTA AS, 1968, J FLUID MECH, V33, P87, DOI 10.1017/S0022112068002375
   JOO SW, 1994, J NON-NEWTON FLUID, V51, P125, DOI 10.1016/0377-0257(94)85008-9
   KANG F, 1995, J NON-NEWTON FLUID, V57, P243, DOI 10.1016/0377-0257(94)01333-D
   Korsunsky S, 1999, EUR J MECH B-FLUID, V18, P295, DOI 10.1016/S0997-7546(99)80028-4
   LAI W, 1967, PHYS FLUIDS, V10, P844, DOI 10.1063/1.1762198
   Lin S. P., 1986, ENCY FLUID MECHANICS, V1, P931
   LIN SP, 1974, J FLUID MECH, V63, P417, DOI 10.1017/S0022112074001704
   Mukhopadhyay A, 2008, INT J NONLIN MECH, V43, P632, DOI 10.1016/j.ijnonlinmec.2008.02.008
   Mukhopadhyay A, 2010, Z NATURFORSCH A, V65, P618
   Mukhopadhyay A, 2009, INT J HEAT MASS TRAN, V52, P709, DOI 10.1016/j.ijheatmasstransfer.2008.06.043
   O'Brien S. B. G., 2002, ENCY SURFACE COLLOID, P5283, DOI DOI 10.1081/E-ESCS-120000885
   Oron A, 2004, J ENG MATH, V50, P121, DOI 10.1007/s10665-004-2760-7
   Ruyer-Quil C, 2012, J FLUID MECH, V692, P220, DOI 10.1017/jfm.2011.508
   SHAQFEH ESG, 1989, J NON-NEWTON FLUID, V31, P87, DOI 10.1016/0377-0257(89)80015-1
   Shercliff J. A., 1965, TXB MAGNETOHYDRODYNA
   Shit G. C., 2012, INT J APPL MATH MECH, V8, P14
   Uma B, 2006, INT J ENG SCI, V44, P1449, DOI 10.1016/j.ijengsci.2006.08.014
   Uma B, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2896300
   YIH CS, 1963, PHYS FLUIDS, V6, P321, DOI 10.1063/1.1706737
NR 36
TC 1
Z9 1
U1 2
U2 5
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 0044-2275
EI 1420-9039
J9 Z ANGEW MATH PHYS
JI Z. Angew. Math. Phys.
PD APR
PY 2016
VL 67
IS 2
AR UNSP 34
DI 10.1007/s00033-016-0630-6
PG 19
WC Mathematics, Applied
SC Mathematics
GA DJ8RF
UT WOS:000374479500019
DA 2018-12-27
ER

PT J
AU Chu, QD
   Medeiros, KL
   Zhou, MJ
   Peddi, P
   Wu, XC
AF Chu, Quyen D.
   Medeiros, Kaelen L.
   Zhou, Meijiao
   Peddi, Prakash
   Wu, Xiao-Cheng
TI RETRACTED: Impact of Cooperative Trial and Sociodemographic Variation on
   Adjuvant Radiation Therapy Usage in Elderly Women (>= 70 Years) with
   Stage I, Estrogen Receptor-Positive Breast Cancer: Analysis of the
   National Cancer Data Base(Retracted article. See vol.224, pg.1008, 2017)
SO JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
LA English
DT Article; Proceedings Paper; Retracted Publication
CT 127th Annual Meeting of the Southern-Surgical-Association
CY DEC, 2015
CL Hot Springs, VA
SP So Surg Assoc
ID LUMPECTOMY PLUS TAMOXIFEN; CONSERVING SURGERY; FOLLOW-UP; PRACTICE
   PATTERNS; TOTAL MASTECTOMY; OLDER WOMEN; RADIOTHERAPY; IRRADIATION;
   DISPARITIES; ONCOLOGY
AB BACKGROUND: TheCancer and LeukemiaGroup B (CALGB) 9343 trial demonstrated that adjuvant radiation therapy (RT) can be omitted inwomen aged 70 years or older, with small, estrogen receptor (ER)+ breast cancer. We postulated that RT usage after CALGB's publication should have decreased over time.
   STUDY DESIGN: We evaluated a cohort of 205,860 women aged 70 years or older, with stage I, ER+/progesterone receptor (PR)+ breast cancer with lumpectomy, diagnosed between 1998 and 2012, in the National Cancer Data Base. Clinicopathologic and sociodemographic variables were compared between preCALGB and post-CALGB publication (circa 2004). Univariate and multivariate analysis were used.
   RESULTS: Radiation therapy usage decreased by only 2.95% after CALGB publication (68.71% vs 65.76%; p < 0.0001). Almost one-third of women with short life expectancy (>= 85 years) received RT in the post-CALGB group. Significant predictors (p < 0.01) of lowest RT use include advanced age, increased great circle distance, academic research program, East South Central region, rural population < 2,500 not adjacent to a metropolitan area, low income level, high comorbidity index, small tumor, well-differentiated histology, residual tumor, and lack of receipt of anti-hormonal therapy.
   CONCLUSIONS: The CALGB trial had a minimal impact on the rate of adjuvant RT use among elderly women with small, hormone positive breast cancers. Significant variation in RT usage exists across sociodemographic strata. (J Am Coll Surg 2016;222:667-678. (C) 2016 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.)
C1 [Chu, Quyen D.] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Surg, Shreveport, LA 71105 USA.
   [Peddi, Prakash] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Med, Shreveport, LA 71105 USA.
   [Medeiros, Kaelen L.; Zhou, Meijiao; Wu, Xiao-Cheng] Louisiana State Univ, Hlth Sci Ctr Shreveport, Louisiana Tumor Registry, Shreveport, LA 71105 USA.
   [Medeiros, Kaelen L.; Zhou, Meijiao; Wu, Xiao-Cheng] Louisiana State Univ, Hlth Sci Ctr Shreveport, Dept Epidemiol, Shreveport, LA 71105 USA.
   [Chu, Quyen D.; Peddi, Prakash] Louisiana State Univ, Hlth Sci Ctr Shreveport, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA.
   [Medeiros, Kaelen L.; Zhou, Meijiao; Wu, Xiao-Cheng] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA.
RP Chu, QD (reprint author), Louisiana State Univ, Hlth Sci Ctr Shreveport, 1501 Kings Highway, Shreveport, LA 71130 USA.; Chu, QD (reprint author), Feist Weiller Canc Ctr, 1501 Kings Highway, Shreveport, LA 71130 USA.
EM qchu@lsuhsc.edu
CR Bartelink H, 2015, LANCET ONCOL, V16, P47, DOI 10.1016/S1470-2045(14)71156-8
   Bellon JR, 2015, J CLIN ONCOL, V33, P1998, DOI 10.1200/JCO.2015.61.2069
   Blamey RW, 2013, EUR J CANCER, V49, P2294, DOI 10.1016/j.ejca.2013.02.031
   Carlson Robert W, 2005, J Natl Compr Canc Netw, V3, P238
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   ClinicalTrials.gov, 2000, PROSP COH STUD EV RI
   Darby S, 2011, LANCET, V378, P1707, DOI DOI 10.1016/S0140-6736(11)61629-2
   DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8
   FISHER B, 1985, NEW ENGL J MED, V312, P665, DOI 10.1056/NEJM198503143121101
   Fisher B, 2002, NEW ENGL J MED, V347, P567, DOI 10.1056/NEJMoa020128
   Giordano SH, 2012, J CLIN ONCOL, V30, P1577, DOI 10.1200/JCO.2011.40.7007
   Hughes KS, 2015, LANCET ONCOL, V16, P235, DOI 10.1016/S1470-2045(15)70014-8
   Hughes KS, 2013, J CLIN ONCOL, V31, P2382, DOI 10.1200/JCO.2012.45.2615
   Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587
   Kunkler IH, 2015, LANCET ONCOL, V16, P266, DOI 10.1016/S1470-2045(14)71221-5
   Liu FF, 2015, J CLIN ONCOL, V33, P2035, DOI 10.1200/JCO.2014.57.7999
   McCormick B, 2014, J AM COLL SURGEONS, V219, P796, DOI 10.1016/j.jamcollsurg.2014.05.013
   Palta M, 2015, CANCER-AM CANCER SOC, V121, P188, DOI 10.1002/cncr.28937
   Parise CA, 2012, CANCER-AM CANCER SOC, V118, P2516, DOI 10.1002/cncr.26542
   Prat A, 2012, BREAST CANCER RES TR, V135, P301, DOI 10.1007/s10549-012-2143-0
   Smith GL, 2010, CANCER-AM CANCER SOC, V116, P734, DOI 10.1002/cncr.24741
   Soulos PR, 2012, J CLIN ONCOL, V30, P1601, DOI 10.1200/JCO.2011.39.4890
NR 22
TC 9
Z9 9
U1 1
U2 5
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1072-7515
EI 1879-1190
J9 J AM COLL SURGEONS
JI J. Am. Coll. Surg.
PD APR
PY 2016
VL 222
IS 4
BP 667
EP 678
DI 10.1016/j.jamcollsurg.2015.12.018
PG 12
WC Surgery
SC Surgery
GA DK3WL
UT WOS:000374848000062
PM 26831366
DA 2018-12-27
ER

PT J
AU Xu, G
   Qi, FZ
   Zhang, JH
   Xu, JB
   Shi, T
   Miao, Y
AF Xu, Gang
   Qi, Fuzhen
   Zhang, Jianhuai
   Xu, Jianbo
   Shi, Ting
   Miao, Yi
TI RETRACTED: Overexpression of OCT4 contributes to progression of
   hepatocellular carcinoma (Retracted article. See April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Hepatocellular carcinoma; Octamer transcription factor4;
   Epithelial-to-mesenchymal transition; Proliferation; Migration
ID STEM-CELLS; EXPRESSION; CANCER; MARKER
AB The abnormal change of octamer transcription factor 4 (OCT4) is associated with tumor progression; however, its effect on hepatocellular carcinoma (HCC) behavior remains unclear. The purpose of this study was to determine the correlation between HCC and OCT4. In the present study, IHC, western blot analysis, and QRT-PCR were performed to identify differentially expressed OCT4 in a series of HCC tissues and adjacent non-cancerous tissues. In addition, the functions of OCT4 on HCC progression were studied in vitro. Silencing of OCT4 with siRNA was performed in HCC cell lines, and the impact on proliferation, migration, and the EMT marker of HCC was analyzed. Our results found that OCT4 levels were significantly higher in HCC tissues compared with the adjacent non-cancerous tissues. Furthermore, OCT4 siRNA significantly reduced the proliferation rate of SMMC-7721 and HepG2 cells, inhibited the migration and inversion, and could reverse EMT in HCC cells, indicating that OCT4 plays a critical role in HCC progression. Our data suggest that the pathogenesis of human HCC may be mediated by OCT4, and thus, OCT4 could represent selective targets for the molecularly targeted treatments of HCC.
C1 [Xu, Gang; Qi, Fuzhen; Zhang, Jianhuai; Xu, Jianbo; Shi, Ting] Nanjing Med Univ, Huaian Peoples Hosp 1, Dept Gen Surg, Huaian, Jiangsu, Peoples R China.
   [Miao, Yi] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.
RP Miao, Y (reprint author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.
EM dyimiaonjmu@163.com
CR Asadi MH, 2011, INT J CANCER, V128, P2645, DOI 10.1002/ijc.25643
   Atlasi Y, 2007, INT J CANCER, V120, P1598, DOI 10.1002/ijc.22508
   Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426
   Chen Z, 2009, J SURG ONCOL, V99, P414, DOI 10.1002/jso.21270
   Chiappini F, 2012, INT J HEPATOL, V2012, DOI DOI 10.1155/2012/684802
   De Giorgi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056153
   Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800
   Giovannini C, 2014, ONCOTARGET, V5, P10607, DOI 10.18632/oncotarget.2523
   He X., 2014, ONCOTARGET
   Kim Ran-Ju, 2011, Lab Anim Res, V27, P147, DOI 10.5625/lar.2011.27.2.147
   Lahsnig C, 2009, ONCOGENE, V28, P638, DOI 10.1038/onc.2008.418
   Lin SB, 2012, LIVER CANCER, V1, P144, DOI 10.1159/000343828
   Murakami Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-99
   Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9
   Nishikawa H, 2013, J CANCER, V4, P635, DOI 10.7150/jca.7279
   Schreiber C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057465
   Sotomayor P, 2009, PROSTATE, V69, P401, DOI 10.1002/pros.20895
   Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321
   Zhang SM, 2013, J BIOL CHEM, V288, P1469, DOI 10.1074/jbc.M112.438341
   Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581
   Zhou HC, 2014, ONCOTARGET, V5, P12177, DOI 10.18632/oncotarget.2601
NR 21
TC 3
Z9 4
U1 3
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD APR
PY 2016
VL 37
IS 4
BP 4649
EP 4654
DI 10.1007/s13277-015-4285-2
PG 6
WC Oncology
SC Oncology
GA DK4QS
UT WOS:000374904500046
PM 26508029
DA 2018-12-27
ER

PT J
AU Wang, Y
   Xu, P
   Yao, J
   Yang, RN
   Shi, ZG
   Zhu, XJ
   Feng, XS
   Gao, SG
AF Wang, Ying
   Xu, Po
   Yao, Jun
   Yang, Ruina
   Shi, Zhenguo
   Zhu, Xiaojuan
   Feng, Xiaoshan
   Gao, Shegan
TI RETRACTED: MicroRNA-216b is Down-Regulated in Human Gastric
   Adenocarcinoma and Inhibits Proliferation and Cell Cycle Progression by
   Targeting Oncogene HDAC8(Retracted article. See vol.11,pg.839,2016)
SO TARGETED ONCOLOGY
LA English
DT Article; Retracted Publication
ID HISTONE DEACETYLASES; TUMOR-SUPPRESSOR; CANCER INVASION; BREAST-CANCER;
   PROSTATE-CANCER; LUNG-CANCER; TUMORIGENESIS; EXPRESSION; APOPTOSIS;
   GROWTH
AB Accumulating evidence indicates that micro (mi)RNAs play a critical role in carcinogenesis and cancer progression; however, their role in the tumorigenesis of gastric adenocarcinoma remains unclear so the present study investigated this in gastric cancer (GC) tissues and cell lines.
   Human GC specimens (n = 57) and patient-paired non-cancerous specimens were obtained from patients at the First Affiliated Hospital, Henan University of Science and Technology. The AGS and GC9811 gastric cancer cell lines were also used. Expression levels of miR-216b and HDAC8 were examined by quantitative real-time PCR and the expression of HDAC8 was also examined by Western blotting and immunohistochemistry assay. The cell cycle progression was determined by FACS. MiR-216b inhibitor, mimics, and siRNA-HDAC8 transfections were performed to study the loss and gain of function.
   We reported a significantly decreased expression of miR-216b in GC clinical specimens compared with paired non-cancerous tissues. We also observed a significant down-regulation of miR-216b expression in GC cell lines AGS and GC9811 (p < 0.0001). The introduction of miR-216b suppressed GC cell proliferation and cell cycle progression by targeting HDAC8, an oncogene shown to promote malignant tumor development with a potential miR-216b binding site in its 3' untranslated region. HDAC8 expression was shown to be significantly increased in AGS and GC9811 cell lines (p < 0.0001) and GC tissues compared with controls. Moreover, HDAC8 inhibition suppressed cell cycle progression compared with control groups (22 % +/- 1.6 % vs 34 % +/- 2.1), indicating that HDAC8 may function as an oncogene in the development of GC. Furthermore, HDAC8 expression was negatively correlated (p < 0.0001), while miR-216b expression was positively correlated with the clinical outcome of GC patients (p < 0.0001).
   Our data suggest that miR-216b functions as a tumor suppressor in human GC by, at least partially, targeting HDAC8.
C1 [Wang, Ying; Yao, Jun; Yang, Ruina; Zhu, Xiaojuan; Feng, Xiaoshan; Gao, Shegan] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Oncol, 24 Jinghua Rd, Luoyang 471003, Henan, Peoples R China.
   [Xu, Po; Shi, Zhenguo] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Urol Surg, 24 Jinghua Rd, Luoyang 471003, Henan, Peoples R China.
RP Wang, Y; Feng, XS; Gao, SG (reprint author), Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Oncol, 24 Jinghua Rd, Luoyang 471003, Henan, Peoples R China.
EM yingw_215@163.com; 1471511798@qq.com; 949898789@qq.com
FU National Natural Science Foundation of China [81301763, 81572849]; Henan
   provincial key scientific and technological projects [142102310473]
FX This study was supported by the National Natural Science Foundation of
   China (No. 81301763 and No. 81572849) and Henan provincial key
   scientific and technological projects (No. 142102310473).
CR Abbas A, 2008, EPIGENETICS-US, V3, P300, DOI 10.4161/epi.3.6.7273
   Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22
   Chen DQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109578
   Chen DQ, 2014, ONCOTARGET, V5, P3333, DOI 10.18632/oncotarget.1948
   Cheng CY, 2014, CELL REP, V6, P1000, DOI 10.1016/j.celrep.2014.02.023
   Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354
   Deng Min, 2013, Zhonghua Zhong Liu Za Zhi, V35, P645
   Deng M, 2011, J CELL SCI, V124, P2997, DOI 10.1242/jcs.085050
   Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Gu W, 2014, INT J CLIN EXP MED, V7, P2519
   Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485
   Han X, 2015, CANCER GENE THER, V22, P122, DOI 10.1038/cgt.2014.75
   He XX, 2012, ONCOGENE, V31, P3357, DOI 10.1038/onc.2011.500
   Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06
   Hsieh TH, 2015, MOL THER, V23, P656, DOI 10.1038/mt.2014.247
   Ji Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-266
   Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021
   Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003
   Li LP, 2014, ONCOL LETT, V8, P1533, DOI 10.3892/ol.2014.2370
   Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529
   Li Z, 2015, ONCOTARGET, V6, P17559, DOI 10.18632/oncotarget.2755
   Liang JL, 2015, CELL PROLIFERAT, V48, P78, DOI 10.1111/cpr.12159
   Lin CC, 2007, DIS ESOPHAGUS, V20, P365, DOI 10.1111/j.1442-2050.2007.00730.x
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Moser MA, 2014, CHROMOSOMA, V123, P67, DOI 10.1007/s00412-013-0441-x
   Nakagawa M, 2007, ONCOL REP, V18, P769
   Oehme I, 2009, EXPERT OPIN INV DRUG, V18, P1605, DOI 10.1517/14728220903241658
   Oehme I, 2009, CLIN CANCER RES, V15, P91, DOI 10.1158/1078-0432.CCR-08-0684
   Park SY, 2011, ONCOL REP, V25, P1677, DOI 10.3892/or.2011.1236
   Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531
   Romano G, 2012, P NATL ACAD SCI USA, V109, P16570, DOI 10.1073/pnas.1207917109
   Seol HS, 2014, CANCER LETT, V353, P232, DOI 10.1016/j.canlet.2014.07.019
   Shen J, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0659-y
   Tamura G, 2006, WORLD J GASTROENTERO, V12, P192, DOI 10.3748/wjg.v12.i2.192
   Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879
   TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190
   VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5
   Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041693
   Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016
   Xu X, 2013, J BIOL REGUL HOMEOST, V28, P615
   Yang Q, 2014, ONCOGENE, V33, P193, DOI 10.1038/onc.2012.569
   Zheng XS, 2015, J CANCER RES CLIN, V141, P785, DOI 10.1007/s00432-014-1847-4
NR 43
TC 14
Z9 14
U1 3
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1776-2596
EI 1776-260X
J9 TARGET ONCOL
JI Target. Oncol.
PD APR
PY 2016
VL 11
IS 2
BP 197
EP 207
DI 10.1007/s11523-015-0390-9
PG 11
WC Oncology
SC Oncology
GA DI7QA
UT WOS:000373695200008
PM 26408293
DA 2018-12-27
ER

PT J
AU Calvo-Guirado, JL
   Ruiz, RAD
   Ramirez-Fernandez, MP
   Abboud, M
   Janjic, B
   de Val, JEMS
AF Luis Calvo-Guirado, Jose
   Ruiz, Rafael Arcesio Delgado
   Piedad Ramirez-Fernandez, Maria
   Abboud, Marcus
   Janjic, Bojan
   Sanchez de Val, Jose Eduardo Mate
TI RETRACTED: Histological and histomorphometric analyses of narrow
   implants, crestal and subcrestally placed in severe alveolar atrophy: a
   study in foxhound dogs (Retracted article. See vol. 29, pg. 819, 2018)
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Retracted Publication
DE BIC; histomorphometry; ISQ; small-diameter implants; narrow implants;
   MiniSky implants; bluesky implants
ID SURFACE-TREATMENT; TOOTH EXTRACTION; BONE; STABILITY; DIAMETER; GEOMETRY
AB BackgroundNarrow-diameter implants provide an alternative to the horizontal augmentation techniques situations severe bone atrophy. Lack of bone width and interdental space has been regarded as an encumbrance in the case selection for prosthetic rehabilitation using dental implants.
   ObjectiveThe aim of the study was to evaluate bone-to-implant contact and marginal bone loss of two different narrow implants in resorbed ridges at different crestal positions.
   Material and methods48 Bredent Narrow((R)) implants (24 MiniSky((R)) and NarowSky((R))) were placed at crestal and subcrestal levels in healing bone of atrophic alveolar ridge of 6 American foxhounds. Histological and histomorphometric analyses of osseointegration were carried out at 4 and 8weeks.
   ResultsModeling in the marginal defect region was accompanied by marked decreases in the dimensions of both the buccal and the more lingual bone walls. Relative to BIC, significant differences were found in favor of subcrestal group, for both Narrow Sky and MiniSky. Linear measurements showed to be slightly high in the crestal group. With significant differences for PM-IS (peri-implant mucosa to implant shoulder) and IS-BC (implant shoulder to buccal bone crest).
   ConclusionsWithin the limitations of animal study, it can be stated that the NarrowSky(test group) crestal and subcrestal implants showed less crestal bone resorption, higher ISQ values and most BIC at 4 and 8weeks of evaluation compared with MiniSky implants (control group). The design of the implants plays an important role in peri-implant mucosa and crestal bone maintenance at 8-week follow-up period.
C1 [Luis Calvo-Guirado, Jose; Piedad Ramirez-Fernandez, Maria; Sanchez de Val, Jose Eduardo Mate] Univ Murcia, Dept Gen & Implant Dent, Murcia, Spain.
   [Ruiz, Rafael Arcesio Delgado; Abboud, Marcus] SUNY Stony Brook, Dept Prosthodont & Digital Technol, Stony Brook, NY 11794 USA.
   [Janjic, Bojan] Univ Belgrade, Sch Dent Med, Dept Oral Surg, Belgrade, Serbia.
RP Calvo-Guirado, JL (reprint author), Univ Murcia 2, Hosp Morales Meseguer, Fac Med & Dent, Planta Clin Odontol, Calle Marques Velez S-N, Murcia 30007, Spain.
EM joseluis.calvo@um.es
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; RAMIREZ FERNANDEZ,
   MARIA PIEDAD/0000-0003-1913-9902; calvo guirado, jose
   luis/0000-0002-4067-2253
CR Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Barikani Hamidreza, 2014, Dent Res J (Isfahan), V11, P87
   Barros Raquel R. M., 2009, Braz. Dent. J., V20, P91, DOI 10.1590/S0103-64402009000200001
   Bilhan H, 2010, J ORAL REHABIL, V37, P900, DOI 10.1111/j.1365-2842.2010.02117.x
   Calvo-Guirado JL, 2010, CLIN ORAL IMPLAN RES, V21, P308, DOI 10.1111/j.1600-0501.2009.01841.x
   Chung SH, 2008, J ORAL REHABIL, V35, P229, DOI 10.1111/j.1365-2842.2006.01653.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Pontes AEF, 2008, CLIN ORAL IMPLAN RES, V19, P483, DOI 10.1111/j.1600-0501.2007.01506.x
   Javed F, 2010, J DENT, V38, P612, DOI 10.1016/j.jdent.2010.05.013
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137
   Klein MO, 2014, INT J ORAL MAX IMPL, V29, P43, DOI 10.11607/jomi.2014suppl.g1.3
   Calvo-Guirado JL, 2014, CLIN ORAL IMPLAN RES, V25, P1286, DOI 10.1111/clr.12267
   Negri B, 2014, CLIN ORAL IMPLAN RES, V25, pE54, DOI 10.1111/clr.12047
   Negri B, 2013, CLIN IMPLANT DENT R, V15, P799, DOI 10.1111/j.1708-8208.2011.00431.x
   Pagni G, 2012, INT J DENT, DOI 10.1155/2012/151030
   Pal U S, 2011, Natl J Maxillofac Surg, V2, P54, DOI 10.4103/0975-5950.85855
   Sanz M, 2010, CLIN ORAL IMPLAN RES, V21, P13, DOI 10.1111/j.1600-0501.2009.01824.x
   SCHENK DB, 1984, J BIOL CHEM, V259, P14941
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Sencimen M, 2011, J ORAL IMPLANTOL, V37, P411, DOI 10.1563/AAID-JOI-D-09-00130
   Sierra-Sanchez JL, 2014, MED ORAL PATOL ORAL, V19, pE74, DOI 10.4317/medoral.19306
   Tiainen H, 2012, INT J BIOMATERIALS, V2012
   Weng D, 2008, CLIN ORAL IMPLAN RES, V19, P1141, DOI 10.1111/j.1600-0501.2008.01564.x
NR 23
TC 1
Z9 1
U1 1
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD APR
PY 2016
VL 27
IS 4
BP 497
EP 504
DI 10.1111/clr.12569
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA DI7JC
UT WOS:000373674500015
PM 25664845
DA 2018-12-27
ER

PT J
AU Kong, YC
   Sun, B
   Han, QH
   Han, S
   Wang, YC
   Chen, Y
AF Kong, Yichun
   Sun, Bei
   Han, Quanhong
   Han, Shuang
   Wang, Yuchuan
   Chen, Ying
TI RETRACTED: Slit-miR-218-Robo axis regulates retinal neovascularization
   (Retracted article. See vol. 38, pg. 1947, 2016)
SO INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
LA English
DT Article; Retracted Publication
DE retinal neovascularization; oxygen-induced retinopathy; miR-218; Slit2;
   Slit3; Robo1
ID OCULAR NEOVASCULARIZATION; AXON GUIDANCE; MICRORNAS; SLIT; MIGRATION;
   PATHOGENESIS; RETINOPATHY; BIOGENESIS; EXPRESSION; SYSTEM
AB miR-218 is an important intronic microRNA (miRNA or miR) which is known to regulate angiogenesis in tumors. The present study aimed to investigate the effects of miR-218, as well as its host genes, Slit2 and Slit3, on oxygen-induced retinal neovascularization (RNV) and to explore the associated mechanisms of action. For this purpose, a mouse model of oxygen-induced retinopathy (OIR) was established. The expression levels of miR-218-1 and miR-218-2, as well as those of their host genes, Slit2 and Slit3, were determined by RT-qPCR. Fluorescein angiography was performed on the retinas of the mice with OIR, and RNV was quantified by H&E staining in order to evaluate the effect of pCDH-CMV-miR-218 intravitreal injection on RNV in the mouse model of OIR. Roundabout, axon guidance receptor, homolog 1 (Robo1) expression was detected in mouse retinal vascular endothelial cells expressing high or low levels of miR-218 and in retinal tissues from mice with OIR by western blot analysis. Cell migration was evaluated by a scratch wound assay. We noted that in the mice with OIR, the expression level of miR-218 was significantly downregulated. We also noted that Robo1 expression was suppressed by miR-218. Furthermore, in the mice with OIR, the expression level of miR-218 was significantly downregulated, and that of miR-218-1 and its host gene, Slit2, was concomitantly downregulated as well. The restoration of miR-218 inhibited retinal angiogenesis by targeting Robo1. Taken together, our findings suggest that the Slit2-miR-218-Robo1 axis contributes to the inhibition of retinal angiogenesis and that miR-218 may be a new therapeutic target for preventing RNV.
C1 [Kong, Yichun; Han, Quanhong; Han, Shuang; Wang, Yuchuan; Chen, Ying] Tianjin Eye Hosp, 4 Gansu Rd, Tianjin 300020, Peoples R China.
   [Kong, Yichun; Han, Quanhong; Han, Shuang; Wang, Yuchuan; Chen, Ying] Tianjin Key Lab Ophthalmol & Visual Sci, Tianjin 300020, Peoples R China.
   [Kong, Yichun; Han, Quanhong; Han, Shuang; Wang, Yuchuan; Chen, Ying] Tianjin Med Univ, Clin Coll Ophthalmol, Tianjin 300070, Peoples R China.
   [Sun, Bei] Minist Hlth, Key Lab Hormones & Dev, Tianjin 300070, Peoples R China.
   [Sun, Bei] Tianjin Med Univ, Metabol Dis Hosp, Tianjin 300070, Peoples R China.
   [Sun, Bei] Tianjin Med Univ, Tianjin Inst Endocrinol, Tianjin 300070, Peoples R China.
RP Kong, YC (reprint author), Tianjin Eye Hosp, 4 Gansu Rd, Tianjin 300020, Peoples R China.
EM kongyc1942@yahoo.com
OI Wang, Yuchuan/0000-0001-6533-6558
FU Natural Science Foundation of Tianjin City [13JCYBJC22900]
FX This study was supported by the Natural Science Foundation of Tianjin
   City (no. 13JCYBJC22900).
CR Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754
   Avunduk AM, 1997, ACTA OPHTHALMOL SCAN, V75, P441
   Bai YY, 2011, EXP MOL PATHOL, V91, P471, DOI 10.1016/j.yexmp.2011.04.016
   Barik S, 2008, NUCLEIC ACIDS RES, V36, P5232, DOI 10.1093/nar/gkn513
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bauer K, 2011, CARCINOGENESIS, V32, P935, DOI 10.1093/carcin/bgr059
   Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5
   Campochiaro PA, 2013, J MOL MED, V91, P311, DOI 10.1007/s00109-013-0993-5
   Cariboni A, 2012, DEVELOPMENT, V139, P3326, DOI 10.1242/dev.079418
   Chen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095665
   Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165
   Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103
   Fish JE, 2011, DEVELOPMENT, V138, P1409, DOI 10.1242/dev.060046
   Han X, 2010, EXP EYE RES, V90, P742, DOI 10.1016/j.exer.2010.03.007
   Huang LZ, 2009, CURR EYE RES, V34, P1019, DOI 10.3109/02713680903308495
   Huang LZ, 2009, EXP EYE RES, V88, P583, DOI 10.1016/j.exer.2008.11.016
   Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027
   Karamanoukian HL, 2003, ANN THORAC SURG, V75, P1059, DOI 10.1016/S0925-4773(03)00161-8
   Kasinski AL, 2011, NAT REV CANCER, V11, P849, DOI 10.1038/nrc3166
   Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9
   Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632
   Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512
   Kong YC, 2013, CHINESE MED J-PEKING, V126, P1440, DOI 10.3760/cma.j.issn.0366-6999.20130199
   Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006
   Li SQ, 2011, MOL VIS, V17, P3566
   Moravski CJ, 2000, HYPERTENSION, V36, P1099, DOI 10.1161/01.HYP.36.6.1099
   Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849
   Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010
   Schubert T, 2012, INT J MOL MED, V30, P1133, DOI 10.3892/ijmm.2012.1098
   Shen JK, 2008, MOL THER, V16, P1208, DOI 10.1038/mt.2008.104
   Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926
   Smith LEH, 2002, ACTA PAEDIATR, V91, P26, DOI 10.1080/08035250260095771
   Stella MC, 2009, MOL BIOL CELL, V20, P642, DOI 10.1091/mbc.E08-03-0321
   Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879
   van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013
   Wang BS, 2003, ACTA MATH SIN, V19, P29, DOI 10.1007/s10114-002-0221-7
   Zhou WY, 2011, MOL VIS, V17, P1526
NR 37
TC 1
Z9 3
U1 4
U2 11
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1107-3756
EI 1791-244X
J9 INT J MOL MED
JI Int. J. Mol. Med.
PD APR
PY 2016
VL 37
IS 4
BP 1139
EP 1145
DI 10.3892/ijmm.2016.2511
PG 7
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DI4TS
UT WOS:000373492900031
PM 26935869
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Shin, YJ
   Riew, TR
   Park, JH
   Pak, HJ
   Lee, MY
AF Shin, Yoo-Jin
   Riew, Tae-Ryong
   Park, Joo-Hee
   Pak, Ha-Jin
   Lee, Mun-Yong
TI RETRACTED: Expression of SOCS2 mRNA and protein in the ischemic core and
   penumbra after transient focal cerebral ischemia in rats (Retracted
   article. See vol. 364, pg. 681, 2016)
SO CELL AND TISSUE RESEARCH
LA English
DT Article; Retracted Publication
DE Suppressor of cytokine signaling 2; Nestin; Brain macrophages; Reactive
   astrocytes; Focal ischemia
ID GROWTH-FACTOR-I; CYTOKINE SIGNALING SOCS; CENTRAL-NERVOUS-SYSTEM; NESTIN
   EXPRESSION; NEURONAL DIFFERENTIATION; REACTIVE ASTROCYTES; NEURITE
   OUTGROWTH; ARTERY OCCLUSION; PROGENITOR CELLS; TRANSGENIC MICE
AB The suppressor of cytokine signaling 2 (SOCS2) has been reported to be involved in astroglial reactions and adult neurogenesis in the ischemic hippocampus. To elucidate whether SOCS2 is implicated in the pathophysiology of stroke, we investigate spatiotemporal regulation and identification of cell phenotypes expressing SOCS2 after transient focal cerebral ischemia. Weak hybridization signals for SOCS2 mRNA were constitutively observed in striatal neurons and upregulation of SOCS2 mRNA was induced in association with nestin-positive cells in stroke-lesioned rats. Analysis of the characteristics and phenotypes of SOCS2/nestin double-labeled cells revealed spatial differences between infarct and peri-infarct areas. SOCS2/nestin double-labeled cells in the infarct area were associated with the vasculature and were highly proliferative. In contrast, the double-labeled cells in the peri-infarct area were indeed glial fibrillary acidic protein (GFAP)-positive reactive astrocytes forming the glial scar, although nestin-negative reactive astrocytes also exhibited weak SOCS2 expression. In addition, induction of SOCS2 expression was observed in Iba1-positive cells showing a macrophage-like phenotype with amoeboid morphology; these cells were predominantly localized in the infarct area. In the peri-infarct area, only a small proportion of Iba1-positive cells with the morphology of brain macrophages expressed SOCS2 and most activated stellate microglial cells with thick and short processes exhibited weak or negligible SOCS2 expression. Thus, our results revealed the phenotypic and functional heterogeneity of SOCS2-expressing cells within infarct and peri-infarct areas, suggesting the involvement of SOCS2 in astroglial reactions and activation/recruitment of brain macrophages and its potential role in perivascular progenitors/stem cells after ischemic stroke.
C1 [Shin, Yoo-Jin; Riew, Tae-Ryong; Park, Joo-Hee; Pak, Ha-Jin; Lee, Mun-Yong] Catholic Univ Korea, Dept Anat, Catholic Neurosci Inst, Coll Med, Seoul 137701, South Korea.
RP Shin, YJ; Lee, MY (reprint author), Catholic Univ Korea, Dept Anat, Catholic Neurosci Inst, Coll Med, Seoul 137701, South Korea.
EM dbwls612@catholic.ac.kr; munylee@catholic.ac.kr
OI Riew, Tae Ryong/0000-0001-7951-8176
FU Basic Science Research Program through the National Research Foundation
   of Korea (NRF) - Ministry of Science, ICT & Future Planning
   [NRF-2013R1A1A1057485]
FX This research was supported by the Basic Science Research Program
   through the National Research Foundation of Korea (NRF) funded by the
   Ministry of Science, ICT & Future Planning (NRF-2013R1A1A1057485).
CR Abeysinghe HCS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097007
   Barreto GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027881
   BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472
   Campbell IL, 2005, BRAIN RES REV, V48, P166, DOI 10.1016/j.brainresrev.2004.12.006
   Choi JS, 2009, J NEUROTRAUM, V26, P2097, DOI [10.1089/neu.2008.0793, 10.1089/neu.2008-0793]
   Denker SP, 2007, J NEUROCHEM, V100, P893, DOI 10.1111/j.1471-4159.2006.04162.x
   Desland FA, 2014, J CENT NERV SYST DIS, V6, P7, DOI [10.4137/JCNSNSD.S13194, 10.4137/JCNSD.S13194]
   Dey BR, 1998, J BIOL CHEM, V273, P24095, DOI 10.1074/jbc.273.37.24095
   Ding S, 2014, NEURAL REGEN RES, V9, P2048, DOI 10.4103/1673-5374.147929
   Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X
   ERIKSDOTTERNILSSON M, 1986, J NEUROSCI METH, V17, P275, DOI 10.1016/0165-0270(86)90128-7
   Fernandez S, 2007, GROWTH HORM IGF RES, V17, P89, DOI 10.1016/j.ghir.2007.01.006
   Fruchtman S, 2005, AM J PHYSIOL-GASTR L, V289, pG342, DOI 10.1152/ajpgi.00413.2004
   Goldshmit Y, 2004, J BIOL CHEM, V279, P16349, DOI 10.1074/jbc.M312873200
   Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x
   Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0
   Gregorieff A, 2000, J BIOL CHEM, V275, P21596, DOI 10.1074/jbc.M910087199
   Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114
   Hawkes CA, 2013, EXP NEUROL, V250, P270, DOI 10.1016/j.expneurol.2013.09.020
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   Hu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007178
   Ji K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-159
   Kile BT, 2001, CELL MOL LIFE SCI, V58, P1627, DOI 10.1007/PL00000801
   Kofler J, 2011, TOXICOL PATHOL, V39, P103, DOI 10.1177/0192623310387619
   Krebs DL, 2000, J CELL SCI, V113, P2813
   Li Y, 1999, BRAIN RES, V838, P1, DOI 10.1016/S0006-8993(99)01502-4
   LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84
   Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355
   Matsumoto H, 2008, J CEREBR BLOOD F MET, V28, P149, DOI 10.1038/sj.jcbfm.9600519
   MILLER DB, 1995, EXP GERONTOL, V30, P383, DOI 10.1016/0531-5565(94)00064-A
   Nakano-Doi A, 2010, STEM CELLS, V28, P1292, DOI 10.1002/stem.454
   Nakayama D, 2010, EUR J NEUROSCI, V31, P90, DOI 10.1111/j.1460-9568.2009.07043.x
   Noh JS, 2015, J CHEM NEUROANAT, V66-67, P40, DOI 10.1016/j.jchemneu.2015.05.001
   Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006
   Paxinos G, 2006, RAT BRAIN STEREOTAXI
   Penninger JM, 2001, NAT IMMUNOL, V2, P389
   PETITO CK, 1982, J NEUROPATH EXP NEUR, V41, P423, DOI 10.1097/00005072-198207000-00005
   Polizzotto MN, 2000, J COMP NEUROL, V423, P348
   Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356
   Purrello VS, 2002, MECH AGEING DEV, V123, P511, DOI 10.1016/S0047-6374(01)00354-2
   Ransome MI, 2008, MOL CELL NEUROSCI, V38, P537, DOI 10.1016/j.mcn.2008.05.002
   Ransome MI, 2007, J NEUROCHEM, V102, P1953, DOI 10.1111/j.1471-4159.2007.04684.x
   Ransome MI, 2005, NEUROSCIENCE, V132, P673, DOI 10.1016/j.neuroscience.2004.12.041
   Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008
   Rosell DR, 2003, NEUROSCIENCE, V122, P349, DOI 10.1016/S0306-4522(03)00594-3
   Salazar-Colocho P, 2008, NEUROSCI RES, V61, P27, DOI 10.1016/j.neures.2008.01.008
   Schilling M, 2003, EXP NEUROL, V183, P25, DOI 10.1016/S0014-4886(03)00082-7
   Scott HJ, 2006, BRAIN RES, V1067, P138, DOI 10.1016/j.brainres.2005.10.032
   Shin YJ, 2013, CELL TISSUE RES, V351, P383, DOI 10.1007/s00441-012-1538-x
   Shin YJ, 2010, J NEUROIMMUNOL, V229, P81, DOI 10.1016/j.jneuroim.2010.07.008
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206
   Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954
   Uren RT, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmo1.2014.00039, 10.3389/fnmol.2014.00039]
   Uren RT, 2014, J NEUROCHEM, V129, P614, DOI 10.1111/jnc.12671
   Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.cl
   Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6
   Yamashima T, 2004, HIPPOCAMPUS, V14, P861, DOI 10.1002/hipo.20001
   Yamashita T, 2006, BIOCHEM SOC T, V34, P1310, DOI 10.1042/BST0341310
   Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012
   Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200
NR 61
TC 1
Z9 1
U1 1
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD APR
PY 2016
VL 364
IS 1
BP 67
EP 81
DI 10.1007/s00441-015-2319-0
PG 15
WC Cell Biology
SC Cell Biology
GA DI2AL
UT WOS:000373298000007
PM 26563457
DA 2018-12-27
ER

PT J
AU Gopikrishnan, S
   Priakanth, P
AF Gopikrishnan, S.
   Priakanth, P.
TI RETRACTED: HSDA: hybrid communication for secure data aggregation in
   wireless sensor network(Retracted article. See vol.96, pg.3275, 2017)
SO WIRELESS NETWORKS
LA English
DT Article; Retracted Publication
DE Energy efficiency; Data security; Cryptography; Scheduling algorithm;
   Wireless sensor networks
ID KEY DISTRIBUTION; NETWORKS; CHALLENGES; PROTOCOL; INTERNET; THINGS
AB The rapid development of wireless sensor networks motivates the researchers and industries to implement large scale wireless sensor network in highly sensitive applications. Since the data aggregation is the major functionality of the wireless sensor network, the network implementation should avoid data aggregation issues like energy, collision, delay and security. As sensor nodes are deployed in hostile environments, the security of the sensitive information such as authenticity, confidentiality and integrity should be considered. To provide a unique solution that resolve the security and energy issues, this paper proposes a hybrid secure data aggregation (HSDA) to provide high secure data aggregation in an energy efficient way. HSDA implements an end to end symmetric key cryptography for secure authentication using shared public key and it uses hop by hop asymmetric key cryptography with the private keys of each node for data integrity and confidentiality. The proposed model performs the private key generation and encryption at the leaf node to reduce the communication and computation overhead of the sensor nodes. The proposed energy efficient way for achieving the secure data aggregation is proved through simulation results. Compared with existing models, the proposed model provides a new solution that resolves energy as well as security issues in data aggregation.
C1 [Gopikrishnan, S.] Karpagam Coll Engn, Coimbatore 641031, Tamil Nadu, India.
   [Priakanth, P.] Kongu Engn Coll, Perundurai 638052, India.
RP Gopikrishnan, S (reprint author), Karpagam Coll Engn, Coimbatore 641031, Tamil Nadu, India.
EM gopikrishnanme@gmail.com; mypiree@gmail.com
OI Sundaram, Gopikrishnan/0000-0001-9082-9012
CR Alzaid H., 2008, NEW TECHNOLOGIES MOB, P1
   Castelluccia C, 2005, Proceedings of MobiQuitous 2005, P109
   Dhasian HR, 2013, IET INFORM SECUR, V7, P336, DOI 10.1049/iet-ifs.2012.0292
   Feng J, 2012, 2012 IEEE SYMPOSIUM ON COMPUTERS AND COMMUNICATIONS (ISCC), P468, DOI 10.1109/ISCC.2012.6249340
   Ferrer JDI, 1996, INFORM PROCESS LETT, V60, P277, DOI 10.1016/S0020-0190(96)00170-6
   Gupta P, 2000, IEEE T INFORM THEORY, V46, P388, DOI 10.1109/18.825799
   Han K, 2013, IEEE COMMUN MAG, V51, P107, DOI 10.1109/MCOM.2013.6553686
   Hu W, 2009, LECT NOTES COMPUT SC, V5432, P296
   Jailin S., 2011, 2011 International Conference on Recent Trends in Information Technology (ICRTIT 2011), P307, DOI 10.1109/ICRTIT.2011.5972447
   Jing Q, 2014, WIREL NETW, V20, P2481, DOI 10.1007/s11276-014-0761-7
   Kong LH, 2014, IEEE T PARALL DISTR, V25, P2818, DOI 10.1109/TPDS.2013.269
   Niu SF, 2013, COMPUT ELECTR ENG, V39, P1726, DOI 10.1016/j.compeleceng.2012.11.022
   Ozdemir S, 2011, COMPUT NETW, V55, P1735, DOI 10.1016/j.comnet.2011.01.006
   Ozdemir S, 2010, IEEE ACM T NETWORK, V18, P736, DOI 10.1109/TNET.2009.2032910
   Ozdemir S, 2009, COMPUT NETW, V53, P2022, DOI 10.1016/j.comnet.2009.02.023
   Poornima AS, 2013, AD HOC SENS WIREL NE, V17, P193
   Prasad NR, 2006, WIRELESS PERS COMMUN, V37, P455, DOI 10.1007/s11277-006-9044-7
   Rezvani M, 2015, IEEE T DEPEND SECURE, V12, P98, DOI 10.1109/TDSC.2014.2316816
   Roy S, 2014, IEEE T INF FOREN SEC, V9, P681, DOI 10.1109/TIFS.2014.2307197
   Ruj S, 2013, IEEE T COMPUT, V62, P2224, DOI 10.1109/TC.2012.138
   Setia S, 2008, CRYPTOL INF SEC SER, V1, P204
   Sheng ZG, 2013, IEEE WIREL COMMUN, V20, P91, DOI 10.1109/MWC.2013.6704479
   Szewczyk R., 2004, P 2 INT C EMB NETW S, V2, P214, DOI DOI 10.1145/1031495.1031521
   Tahir R., 2008, P WORLD C ENG, V1, P2
   Tseng YC, 2006, COMPUTER, V39, P55, DOI 10.1109/MC.2006.248
   Wang XM, 2010, EURASIP J WIREL COMM, DOI 10.1155/2010/465915
   Wei GY, 2011, COMPUT COMMUN, V34, P793, DOI 10.1016/j.comcom.2010.10.003
   Westhoff D, 2006, IEEE T MOBILE COMPUT, V5, P1417, DOI 10.1109/TMC.2006.144
   Wheeler A, 2007, IEEE COMMUN MAG, V45, P70, DOI 10.1109/MCOM.2007.343615
   Xiao Y, 2012, IEEE T MOBILE COMPUT, V11, P1538, DOI 10.1109/TMC.2011.190
   Xu X, 2015, ACM T SENSOR NETWORK, V11, DOI 10.1145/2700264
   Xu XH, 2011, IEEE T PARALL DISTR, V22, P163, DOI 10.1109/TPDS.2010.80
   Yadav R. B., FRAMEWORK SECURE DAT
   Yan Z., 2015, SECURITY COMMUNICATI
   Yan Z, 2014, J NETW COMPUT APPL, V42, P120, DOI 10.1016/j.jnca.2014.01.014
   Yang HM, 2014, COMPUT NETW, V58, P29, DOI 10.1016/j.comnet.2013.08.020
   Yao YJ, 2013, IEEE INT CONF MOB, P182, DOI 10.1109/MASS.2013.44
   Yu B, 2009, IEEE INFOCOM SER, P2159, DOI 10.1109/INFCOM.2009.5062140
   Zhou J, 2015, IEEE WIREL COMMUN, V22, P136, DOI 10.1109/MWC.2015.7096296
   Zhou Q., 2014, INT J DISTRIBUTED SE
NR 40
TC 2
Z9 2
U1 6
U2 25
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-0038
EI 1572-8196
J9 WIREL NETW
JI Wirel. Netw.
PD APR
PY 2016
VL 22
IS 3
BP 1061
EP 1078
DI 10.1007/s11276-015-1122-x
PG 18
WC Computer Science, Information Systems; Engineering, Electrical &
   Electronic; Telecommunications
SC Computer Science; Engineering; Telecommunications
GA DH6SI
UT WOS:000372921300023
DA 2018-12-27
ER

PT J
AU Serfor-Armah, Y
   Carboo, D
   Akuamoah, RK
   Chatt, A
AF Serfor-Armah, Y.
   Carboo, D.
   Akuamoah, R. K.
   Chatt, A.
TI RETRACTED: Simultaneous preconcentration of Cd, Cr and Hg in seaweed
   samples by cloud point extraction and determination by neutron
   activation (Retracted Article)
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
LA English
DT Correction; Retracted Publication
C1 [Serfor-Armah, Y.; Chatt, A.] Dalhousie Univ, Dept Chem, Trace Anal Res Ctr, Halifax, NS B3H 4J3, Canada.
   [Serfor-Armah, Y.] Ghana Atom Energy Commiss, Dept Chem, POB LG 80, Legon, Accra, Ghana.
   [Serfor-Armah, Y.; Carboo, D.; Akuamoah, R. K.] Univ Ghana, Dept Chem, POB 56, Legon, Accra, Ghana.
RP Chatt, A (reprint author), Dalhousie Univ, Dept Chem, Trace Anal Res Ctr, Halifax, NS B3H 4J3, Canada.
EM a.chatt@dal.ca
CR SERFORARMAH Y, 2016, J RADIOANAL NUCL CHE
NR 1
TC 0
Z9 0
U1 1
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0236-5731
EI 1588-2780
J9 J RADIOANAL NUCL CH
JI J. Radioanal. Nucl. Chem.
PD APR
PY 2016
VL 308
IS 1
BP 379
EP 379
DI 10.1007/s10967-012-1714-1
PG 1
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA DG7MQ
UT WOS:000372268800048
OA Bronze
DA 2018-12-27
ER

PT J
AU Chen, WL
   Zhong, X
   Wei, Y
   Liu, Y
   Yi, Q
   Zhang, GS
   He, LS
   Chen, FJ
   Liu, YP
   Luo, JD
AF Chen, Wenliang
   Zhong, Xiao
   Wei, Yi
   Liu, Yun
   Yi, Quan
   Zhang, Genshui
   He, Lishan
   Chen, Fajiang
   Liu, Yingping
   Luo, Jiandong
TI RETRACTED: TGF-beta Regulates Survivin to Affect Cell Cycle and the
   Expression of EGFR and MMP9 in Glioblastoma (Retracted article. See vol.
   54, pg. 7551, 2017)
SO MOLECULAR NEUROBIOLOGY
LA English
DT Article; Retracted Publication
DE TGF-beta; Survivin; Cell cycle; EGFR; MMP9
ID GROWTH-FACTOR-BETA; LUNG-CANCER CELLS; RADIOTHERAPY; D1; TEMOZOLOMIDE;
   GLIOMAS
AB Transforming growth factor beta (TGF-beta) is suggestive of a molecular target for cancer therapy due to its involvement in cell cycle, differentiation, and morphogenesis. Meanwhile, survivin is identified as an apoptosis inhibitor and involved in tumorgenesis. Here, we aimed to investigate the potential associations between TGF-beta and survivin in glioblastoma U87 cell line. Survivin small interfering RNA (siRNA), Western blotting, and cell cycle analysis were introduced to detect relevant proteins in TGF-beta pathways. In this study, we observed a concentration- and time-dependent increase of survivin expression after treatment with TGF-beta 1. However, the kinase inhibitors U0126 and LY294002 inhibited the upregulation of survivin in comparison with DMSO. In addition, survivin siRNA effectively abrogated survivin expression in U87 cells, therefore affected cells' entry into the S phase of cell cycle, and then repressed the expression of epidermal growth factor receptor (EGFR) and matrix metalloproteinase 9 (MMP9) in comparison with non-transfection. In conclusion, the present study shows that TGF-beta upregulates survivin expression via ERK and PI3K/AKT pathway, leading to glioblastoma cell cycle progression. Thus, the blockade of survivin will allow for the treatment of glioblastoma, partially attributing to the inhibition of EGFR and MMP9 expression.
C1 [Chen, Wenliang; Wei, Yi; Liu, Yun; Yi, Quan; Zhang, Genshui; He, Lishan; Chen, Fajiang; Liu, Yingping; Luo, Jiandong] Guangzhou Med Univ, Dept Pharmacol, Guangzhou 510182, Guangdong, Peoples R China.
   [Zhong, Xiao] Southern Med Univ, Dept Paediat, Affiliated Xiaolan Peoples Hosp, Guangdong 528415, Zhongshan, Peoples R China.
   [Luo, Jiandong] Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Guangzhou Key Lab Cardiovasc Dis, Affiliated Hosp 2, Guangzhou 510182, Guangdong, Peoples R China.
RP Luo, JD (reprint author), Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Guangzhou Key Lab Cardiovasc Dis, Affiliated Hosp 2, Guangzhou 510182, Guangdong, Peoples R China.
EM luojiandong@gzhmu.edu.cn
FU National Natural Science Foundation of China [81402926]; Youth Program
   from Guangzhou City Bureau of Education [2012C204]
FX This work is supported by the National Natural Science Foundation of
   China (grant no. 81402926 to Dr. Wenliang Chen) and Youth Program from
   Guangzhou City Bureau of Education (no. 2012C204 to Dr. Wen-liang Chen).
   We gratefully thank other members of Sandy Lab for their critical
   reading of this paper and valuable suggestions.
CR Ahn SH, 2014, CELL ONCOL, V37, P377, DOI 10.1007/s13402-014-0198-0
   Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807
   Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031
   Cho KH, 2013, CANCER LETT, V336, P167, DOI 10.1016/j.canlet.2013.04.024
   Gao JF, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0072-1
   Garcia I, 2000, INT J BIOL MARKER, V15, P231
   Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189
   Guha M, 2009, CELL CYCLE, V8, P2708, DOI 10.4161/cc.8.17.9457
   Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015
   Kokontis JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109170
   Li D, 2012, ONCOTARGETS THER, V5, P271, DOI 10.2147/OTT.S35322
   Li TY, 2014, CELL PHYSIOL BIOCHEM, V34, P1351, DOI 10.1159/000366342
   Li W, 2013, INT J MOL MED, V32, P271, DOI 10.3892/ijmm.2013.1405
   Liu RY, 2014, INT J ONCOL, V44, P1643, DOI 10.3892/ijo.2014.2310
   Lladser A, 2011, ADV CANCER RES, V111, P1, DOI 10.1016/B978-0-12-385524-4.00001-5
   Nagasawa DT, 2012, NEUROSURG CLIN N AM, V23, P307, DOI 10.1016/j.nec.2012.01.007
   Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517
   Ravikumar G, 2014, J CANCER RES THER, V10, P671, DOI 10.4103/0973-1482.138135
   Rekhi B, 2014, INDIAN J PATHOL MICR, V57, P606, DOI 10.4103/0377-4929.142689
   Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200
   SAROSIEK J, 1988, BIOCHEM BIOPH RES CO, V152, P1421, DOI 10.1016/S0006-291X(88)80444-3
   Soppa U, 2014, CELL CYCLE, V13, P2084, DOI 10.4161/cc.29104
   SPORN MB, 1992, J CELL BIOL, V119, P1017, DOI 10.1083/jcb.119.5.1017
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Takai E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076346
   Travis RC, 2010, LANCET, V375, P2143, DOI 10.1016/S0140-6736(10)60636-8
   WALKER MD, 1978, J NEUROSURG, V49, P333, DOI 10.3171/jns.1978.49.3.0333
   WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303
   Woodworth GE, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00126
NR 29
TC 9
Z9 9
U1 4
U2 27
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD APR
PY 2016
VL 53
IS 3
BP 1648
EP 1653
DI 10.1007/s12035-015-9121-6
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA DG7KQ
UT WOS:000372263600021
PM 25682969
DA 2018-12-27
ER

PT J
AU Long, J
   Liu, Z
   Wu, XD
   Xu, YH
   Ge, CL
AF Long, Jin
   Liu, Zhe
   Wu, Xingda
   Xu, Yuanhong
   Ge, Chunlin
TI RETRACTED: siRNA-Mediated SBF2 Silencing May Inhibit Pancreatic Cancer
   Cells via Attenuation of the TGF-beta Signaling Pathway (Retracted
   article. See vol.16, pg.NP3, 2017)
SO TECHNOLOGY IN CANCER RESEARCH & TREATMENT
LA English
DT Article; Retracted Publication
DE SBF2 gene; pancreatic cancer; cell proliferation; cell apoptosis;
   inhibition
ID GROWTH-FACTOR-BETA; THERAPY; PHOSPHATASES; MECHANISMS; FAMILY
AB Objective: To investigate the effects of small-interfering RNA (siRNA)-mediated silencing of SET binding factor 2 (SBF2) on pancreatic cancer cells and its underlying molecular mechanisms. Methods: Five siRNAs, namely, siRNA-1, siRNA-2, siRNA-3, siRNA-4, and siRNA-5, were designed to silence SBF2 in pancreatic cancer PANC-1 cells. The relative expression levels of SBF2 after siRNA-mediated SBF2 silencing were detected by real-time polymerase chain reaction (RT-PCR). The inhibition and apoptosis of cells were detected by methyl thiazolyl tetrazolium and flow cytometry, respectively. The protein concentrations of SBF2, SMAD-2, phosphorylated-SMAD-2 (p-SMAD-2), SMAD-3, p-SMAD-3, and SMAD-7 were also measured via Western blot. Results: The relative expression levels of SBF2 in the siRNA-mediated SBF2-silenced groups decreased significantly (P < .05), and the proliferation of PANC-1 cells was significantly inhibited (P < .01) after SBF2 silencing using the 5 siRNAs. The relative expression level of SBF2 was the lowest (0.52 +/- 0.05) and the cell inhibition rate was the highest (36.7 +/- 4.0%) in the SBF2-silenced PANC-1 cells using siRNA-3 compared to the 5 siRNA-mediated SBF2-silenced groups. The cell apoptosis rate in the siRNA-3 transfection group was significantly higher than that in the control group (P < .05). The concentrations of p-SMAD-2 and p-SMAD-3 were reduced, while the concentrations of SMAD-2, SMAD-3, and SMAD-7 were increased in the siRNA-3-mediated SBF2-silenced PANC-1 cells. Conclusion: SiRNA-mediated SBF2 silencing could significantly inhibit the proliferation and promote the apoptosis of pancreatic cancer cells possibly via attenuation of transforming growth factor beta/SMAD signaling pathway. And SBF2 silencing can be a potential approach for treatment of pancreatic cancer.
C1 [Long, Jin; Liu, Zhe; Wu, Xingda; Xu, Yuanhong; Ge, Chunlin] China Med Univ, Hosp 1, Dept Gen Surg, 155 Nanjing Bei St, Shenyang 110001, Peoples R China.
RP Long, J (reprint author), China Med Univ, Hosp 1, Dept Gen Surg, 155 Nanjing Bei St, Shenyang 110001, Peoples R China.
EM long_ljin@163.com
CR Arya G, 2011, NANOMED-NANOTECHNOL, V7, P859, DOI 10.1016/j.nano.2011.03.009
   Clague MJ, 2005, TRAFFIC, V6, P1063, DOI 10.1111/j.1600-0854.2005.00338.x
   de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388
   de Visser KE, 1999, LEUKEMIA, V13, P1188, DOI 10.1038/sj.leu.2401477
   Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117
   Dijke P., 2006, SMAD SIGNAL TRANSDUC
   Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23
   Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202
   Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273
   Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652
   Li LS, 2011, CLIN CANCER RES, V17, P275, DOI 10.1158/1078-0432.CCR-10-1983
   Pasche B, 2001, J CELL PHYSIOL, V186, P153, DOI 10.1002/1097-4652(200002)186:2<153::AID-JCP1016>3.0.CO;2-J
   Pittella F, 2012, J CONTROL RELEASE, V161, P868, DOI 10.1016/j.jconrel.2012.05.005
   Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100
   Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X
   Wu C, 2014, GUT, V63, P152, DOI 10.1136/gutjnl-2012-303477
   Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515
   Yongsheng L, 2012, J 3 MILITARY MED U, V34
   Yu JJ, 2013, J BIOL CHEM, V288, P79, DOI 10.1074/jbc.M112.413856
   Yu JJ, 2010, J BIOL CHEM, V285, P8454, DOI 10.1074/jbc.M109.075036
NR 20
TC 1
Z9 2
U1 2
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1533-0346
EI 1533-0338
J9 TECHNOL CANCER RES T
JI Technol. Cancer Res. Treat.
PD APR
PY 2016
VL 15
IS 2
BP 308
EP 313
DI 10.1177/1533034615580724
PG 6
WC Oncology
SC Oncology
GA DG5YR
UT WOS:000372158600011
PM 25882882
OA Bronze
DA 2018-12-27
ER

PT J
AU Su, LX
   Guo, YH
   Wang, YJ
   Wang, DL
   Liu, CT
AF Su, Longxiang
   Guo, Yinghua
   Wang, Yajuan
   Wang, Delong
   Liu, Changting
TI RETRACTED: No effect of artificial gravity on lung function with
   exercise training during head-down bed rest(Retracted article. See vol.
   16, pg. 200, 2017)
SO INTERNATIONAL JOURNAL OF ASTROBIOLOGY
LA English
DT Article; Retracted Publication
DE artificial gravity; ergometric exercise; head-down bed rest; lung
   function
ID PULMONARY GAS-EXCHANGE; SUSTAINED MICROGRAVITY; PHYSIOLOGICAL-CHANGES;
   SLS-1; REST; SPACE; SPACEFLIGHT; ENVIRONMENT; MECHANICS; RESPONSES
AB The aim of this study is to explore the effectiveness of microgravity simulated by head-down bed rest (HDBR) and artificial gravity (AG) with exercise on lung function. Twenty-four volunteers were randomly divided into control and exercise countermeasure (CM) groups for 96 h of 6 degrees HDBR. Comparisons of pulse rate, pulse oxygen saturation (SpO(2)) and lung function were made between these two groups at 0, 24, 48, 72, 96 h. Compared with the sitting position, inspiratory capacity and respiratory reserve volume were significantly higher than before HDBR (0 degrees position) (P < 0.05). Vital capacity, expiratory reserve volume, forced vital capacity, forced expiratory volume in 1 s, forced inspiratory vital capacity, forced inspiratory volume in 1 s, forced expiratory flow at 25, 50, and 75%, maximal mid-expiratory flow and peak expiratory flow were all significantly lower than those before HDBR (P < 0.05). Neither control nor CM groups showed significant differences in pulse rate, SpO(2), pulmonary volume and pulmonary ventilation function over the HDBR observation time. Postural changes can lead to variation in lung volume and ventilation function, but a HDBR model induced no changes in pulmonary function and therefore should not be used to study AG countermeasures.
C1 [Su, Longxiang; Guo, Yinghua; Wang, Yajuan; Wang, Delong; Liu, Changting] Chinese Peoples Liberat Army Gen Hosp, Nanlou Resp Dis Dept, Beijing 100853, Peoples R China.
   [Su, Longxiang] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Crit Care Med, Beijing 100730, Peoples R China.
   [Su, Longxiang] Chinese Acad Med Sci, Beijing 100730, Peoples R China.
RP Su, LX (reprint author), Chinese Peoples Liberat Army Gen Hosp, Nanlou Resp Dis Dept, Beijing 100853, Peoples R China.; Su, LX (reprint author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Crit Care Med, Beijing 100730, Peoples R China.; Su, LX (reprint author), Chinese Acad Med Sci, Beijing 100730, Peoples R China.
EM liuchangt@gmail.com
FU National Basic Research Program of China (973 program) [2014CB744400];
   Key Program of Medical Research in the Military '12th 5-year Plan,'
   China [BWS12J046]; Key Pre-Research Foundation of Military Equipment of
   China [9140A26040312JB10078]; Beijing Novel Program [Z131107000413105];
   program of Manned Spaceflight [040203]
FX The authors are very grateful to Professor Dan Feng of the Department of
   Medical Statistics, Chinese PLA General Hospital, who contributed to the
   data statistical analysis. This study was funded by the National Basic
   Research Program of China (973 program) No. 2014CB744400; Key Program of
   Medical Research in the Military '12th 5-year Plan,' China No.
   BWS12J046; Key Pre-Research Foundation of Military Equipment of China
   No. 9140A26040312JB10078; Beijing Novel Program, No.Z131107000413105;
   and the program of Manned Spaceflight NO.040203.
CR Astakhov D A, 2012, Patol Fiziol Eksp Ter, P70
   Bettinelli D, 2002, J APPL PHYSIOL, V93, P2044, DOI 10.1152/japplphysiol.00492.2002
   ELLIOTT AR, 1994, J APPL PHYSIOL, V77, P2005
   Elliott AR, 1996, J APPL PHYSIOL, V81, P33
   FOWLER JF, 1991, CUTIS, V48, P291
   Grigoriev A I, 1992, Adv Space Biol Med, V2, P43, DOI 10.1016/S1569-2574(08)60017-9
   GRINDELAND RE, 1992, J APPL PHYSIOL, V73, pS1
   Guo YH, 2013, CLIN PHYSIOL FUNCT I, V33, P24, DOI 10.1111/j.1475-097X.2012.01155.x
   Koloteva M I, 2004, J Gravit Physiol, V11, pP101
   Montmerle S, 2002, J APPL PHYSIOL, V92, P75
   PAIVA M, 1989, J APPL PHYSIOL, V67, P1542
   Prisk GK, 2008, EUR J APPL PHYSIOL, V103, P617, DOI 10.1007/s00421-008-0754-2
   Prisk GK, 2006, J APPL PHYSIOL, V101, P439, DOI 10.1152/japplphysiol.01419.2005
   PRISK GK, 1995, J APPL PHYSIOL, V79, P1290
   Prisk GK, 2005, CLIN CHEST MED, V26, P415, DOI 10.1016/j.ccm.2005.05.008
   PRISK GK, 1994, J APPL PHYSIOL, V76, P1730
   Prisk GK, 2002, AVIAT SPACE ENVIR MD, V73, P8
   Riviere D, 2009, B ACAD NAT MED PARIS, V193, P1633
   Sieck GC, 2000, J APPL PHYSIOL, V89, P1
   Trappe T, 2006, J APPL PHYSIOL, V100, P951, DOI 10.1152/japplphysiol.01083.2005
   Venturoli D, 1998, ACTA ASTRONAUT, V42, P185, DOI 10.1016/S0094-5765(98)00116-7
   West JB, 1997, JAMA-J AM MED ASSOC, V277, P1957, DOI 10.1001/jama.277.24.1957
   Wood HE, 2009, AVIAT SPACE ENVIR MD, V80, P395, DOI 10.3357/ASEM.2378.2009
   Yang P, 2007, AVIAT SPACE ENVIR MD, V78, P1035, DOI 10.3357/ASEM.2048.2007
NR 24
TC 0
Z9 1
U1 3
U2 9
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1473-5504
EI 1475-3006
J9 INT J ASTROBIOL
JI Int. J. Astrobiol.
PD APR
PY 2016
VL 15
IS 2
BP 147
EP 153
DI 10.1017/S1473550415000245
PG 7
WC Astronomy & Astrophysics; Biology; Geosciences, Multidisciplinary
SC Astronomy & Astrophysics; Life Sciences & Biomedicine - Other Topics;
   Geology
GA DF9VM
UT WOS:000371710100006
DA 2018-12-27
ER

PT J
AU Narayan, J
   Bhaumik, A
AF Narayan, Jagdish
   Bhaumik, Anagh
TI RETRACTED: Fundamental Discovery of New Phases and Direct Conversion of
   Carbon into Diamond and hBN into cBN and Properties (Retracted article.
   See vol. 47A, pg. 4351, 2016)
SO METALLURGICAL AND MATERIALS TRANSACTIONS A-PHYSICAL METALLURGY AND
   MATERIALS SCIENCE
LA English
DT Article; Retracted Publication
ID CUBIC BORON-NITRIDE; THIN-FILMS; BN; PRESSURE; DIAGRAM; GROWTH; SILICON;
   SOLIDS
AB We review the discovery of new phases of carbon (Q-carbon) and BN (Q-BN) and address critical issues related to direct conversion of carbon into diamond and hBN into cBN at ambient temperatures and pressures in air without any need for catalyst and the presence of hydrogen. The Q-carbon and Q-BN are formed as a result of quenching from super undercooled state by using high-power nanosecond laser pulses. We discuss the equilibrium phase diagram (P vs T) of carbon, and show that by rapid quenching, kinetics can shift thermodynamic graphite/diamond/liquid carbon triple point from 5000 K/12 GPa to super undercooled carbon at atmospheric pressure in air. Similarly, the hBN-cBN-Liquid triple point is shifted from 3500 K/9.5 GPa to as low as 2800 K and atmospheric pressure. It is shown that nanosecond laser heating of amorphous carbon and nanocrystalline BN on sapphire, glass, and polymer substrates can be confined to melt in a super undercooled state. By quenching this super undercooled state, we have created a new state of carbon (Q-carbon) and BN (Q-BN) from which nanocrystals, microcrystals, nanoneedles, microneedles, and thin films are formed depending upon the nucleation and growth times allowed and the presence of growth template. The large-area epitaxial diamond and cBN films are formed, when appropriate planar matching or lattice matching template is provided for growth from super undercooled liquid. The Q-phases have unique atomic structure and bonding characteristics as determined by high-resolution SEM and backscatter diffraction, HRTEM, STEM-Z, EELS, and Raman spectroscopy, and exhibit new and improved mechanical hardness, electrical conductivity, and chemical and physical properties, including room-temperature ferromagnetism and enhanced field emission. The Q-carbon exhibits robust bulk ferromagnetism with estimated Curie temperature of about 500 K and saturation magnetization value of 20 emu g(-1). We have also deposited diamond on cBN by using a novel pulsed laser evaporation of carbon and obtained cBN/diamond composites, where cBN acts as template for diamond growth. Both diamond and cBN grown from super undercooled liquid can be alloyed with both p- and n-type dopants. This process allows carbon to diamond and hBN to cBN conversions and formation of useful nanostructures and microstructures at ambient temperatures in air at atmospheric pressure on practical and heat-sensitive substrates in a controlled way without need for any catalysts and hydrogen to stabilize sp(3) bonding for diamond and cBN phases.
C1 [Narayan, Jagdish; Bhaumik, Anagh] N Carolina State Univ, Dept Mat Sci & Engn, Centennial Campus, Raleigh, NC 27695 USA.
RP Narayan, J (reprint author), N Carolina State Univ, Dept Mat Sci & Engn, Centennial Campus, Raleigh, NC 27695 USA.
EM j_narayan@ncsu.edu
FU National Science Foundation
FX Part of this research was presented at the 2015 MS&T Symposium, honoring
   Professor J. C. M. Li for his 90th birthday celebrations. We are
   grateful to Fan Family Foundation Distinguished Chair Endowment for
   Professor J. Narayan, and this research was partly funded by the
   National Science Foundation. We are also very pleased to acknowledge
   technical help and useful discussions with John Prater, Jim LeBeau,
   Weizong Xu, Roger Narayan, and Jerry Cuomo.
CR ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913
   Basharin AY, 2010, TECH PHYS LETT+, V36, P559, DOI 10.1134/S1063785010060210
   Bundy FP, 1996, CARBON, V34, P141, DOI 10.1016/0008-6223(96)00170-4
   Chen C., 2015, NAT COMMUN, V6, P6327
   CORRIGAN FR, 1975, J CHEM PHYS, V63, P3812, DOI 10.1063/1.431874
   Gogotsi Y, 2001, NATURE, V411, P283, DOI 10.1038/35077031
   Karch K, 1997, PHYS REV B, V56, P7404, DOI 10.1103/PhysRevB.56.7404
   KESTER DJ, 1992, J APPL PHYS, V72, P504, DOI 10.1063/1.351881
   LIU AY, 1989, SCIENCE, V245, P841, DOI 10.1126/science.245.4920.841
   Makarova TL, 2001, NATURE, V413, P716, DOI 10.1038/35099527
   Mao WL, 2003, SCIENCE, V302, P425, DOI 10.1126/science.1089713
   McCulloch DG, 2012, MICRON, V43, P43, DOI 10.1016/j.micron.2011.07.004
   Meng Y, 2004, NAT MATER, V3, P111, DOI 10.1038/nmat1060
   Mirkarimi PB, 1997, MAT SCI ENG R, V21, P47, DOI 10.1016/S0927-796X(97)00009-0
   NARAYAN J, 1981, J APPL PHYS, V52, P1289, DOI 10.1063/1.329753
   Narayan J, 2003, J APPL PHYS, V93, P278, DOI 10.1063/1.1528301
   NARAYAN J, 1991, SCIENCE, V252, P416, DOI 10.1126/science.252.5004.416
   Narayan J, 1997, MAT SCI ENG B-SOLID, V45, P30, DOI 10.1016/S0921-5107(96)01970-8
   Narayan J, 1996, J ELECTRON MATER, V25, P143, DOI 10.1007/BF02666188
   Narayan J., 2015, J APPL PHYS, V118
   Narayan J., 2015, APL MATER, V3
   Narayan J., SCI ADV IN PRESS
   Narayan J., APL MAT UNPUB
   Narayan J., COSSMS, DOI [10.1016/j.cossms.2016.01.001, DOI 10.1016/J.COSSMS.2016.01.001]
   Ohldag H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.187204
   Ovchinnikov A. A., 1991, J MOL STRUC-THEOCHEM, V251, P133
   Prawer S, 2004, PHILOS T ROY SOC A, V362, P2537, DOI 10.1098/rsta.2004.1451
   Reich S, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.205201
   Samantaray CB, 2005, INT MATER REV, V50, P313, DOI 10.1179/174328005X67160
   Sharma AK, 1997, INT MATER REV, V42, P137, DOI 10.1179/imr.1997.42.4.137
   SINGH RK, 1989, MAT SCI ENG B-SOLID, V3, P217, DOI 10.1016/0921-5107(89)90014-7
   Solozhenko V. L., 1995, High Pressure Research, V13, P199, DOI 10.1080/08957959508200884
   Solozhenko VL, 1999, J PHYS CHEM B, V103, P2903, DOI 10.1021/jp984682c
   Yoshimoto M, 1999, NATURE, V399, P340, DOI 10.1038/20653
NR 34
TC 1
Z9 2
U1 6
U2 71
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1073-5623
EI 1543-1940
J9 METALL MATER TRANS A
JI Metall. Mater. Trans. A-Phys. Metall. Mater. Sci.
PD APR
PY 2016
VL 47A
IS 4
BP 1481
EP 1498
DI 10.1007/s11661-015-3312-7
PG 18
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA DF4HA
UT WOS:000371307400001
OA Bronze
DA 2018-12-27
ER

PT J
AU Yilmaz, F
   Balta, MT
   Selbas, R
AF Yilmaz, Fatih
   Balta, M. Tolga
   Selbas, Resat
TI RETRACTED: A review of solar based hydrogen production methods
   (Retracted article. See vol. 83, pg. 176, 2018)
SO RENEWABLE & SUSTAINABLE ENERGY REVIEWS
LA English
DT Review; Retracted Publication
DE Hydrogen; Renewable; Solar; Electrochemical photochemical;
   Thermochemical
ID WATER-SPLITTING CYCLE; PRODUCTION SYSTEM; ENERGY-SYSTEMS; THERMODYNAMIC
   ANALYSIS; THERMOCHEMICAL CYCLES; THERMAL-ENERGY; TECHNOLOGIES;
   PERFORMANCE; GENERATION; CELLS
AB Hydrogen is one of the most promising fuel options for the future and it is considered as a green energy carrier. Nowadays, hydrogen can be produced from several energy resources, including those that are renewable and non-renewable. In this context, solar energy has a significant and unique potential in renewable based hydrogen production methods. The utilization of solar energy for hydrogen production promises to be one of the most viable options to replace fossil-based hydrogen production. In this paper, various solar-based hydrogen production methods are discussed and compared in terms of their pros and cons. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Yilmaz, Fatih] Aksaray Univ, Dept Elect & Energy, Vocat Sch Tech Sci, TR-68100 Aksaray, Turkey.
   [Balta, M. Tolga] Aksaray Univ, Dept Mech Engn, Fac Engn, TR-68100 Aksaray, Turkey.
   [Selbas, Resat] Suleyman Demirel Univ, Dept Energy Syst Engn, Fac Technol, TR-32200 Isparta, Turkey.
RP Yilmaz, F (reprint author), Aksaray Univ, Dept Elect & Energy, Vocat Sch Tech Sci, TR-68100 Aksaray, Turkey.
EM fatihyilmaz@aksaray.edu.tr
RI University, Aksaray/A-1857-2018
CR Abanades S, 2006, SOL ENERGY, V80, P1611, DOI 10.1016/j.solener.2005.12.005
   Abdin Z, 2015, RENEW SUST ENERG REV, V52, P1791, DOI 10.1016/j.rser.2015.08.011
   Agrafiotis C, 2015, RENEW SUST ENERG REV, V42, P54
   Agrafiotis C, 2015, RENEW SUST ENERG REV, V42, P254, DOI 10.1016/j.rser.2014.09.039
   Akyuz E, 2012, INT J HYDROGEN ENERG, V37, P16623, DOI 10.1016/j.ijhydene.2012.02.149
   AlZaharani AA, 2013, INT J HYDROGEN ENERG, V38, P14505, DOI 10.1016/j.ijhydene.2013.09.002
   Androga DD, 2009, THESIS GRADUATE SCH
   Application: photo-electrochemical cell (PEC), 2011, APPL PHOT CELL PEC
   Asada Y, 1999, J BIOSCI BIOENG, V88, P1, DOI 10.1016/S1389-1723(99)80166-2
   Bak T, 2002, INT J HYDROGEN ENERG, V27, P991, DOI 10.1016/S0360-3199(02)00022-8
   Balat M, 2008, INT J HYDROGEN ENERG, V33, P4013, DOI 10.1016/j.ijhydene.2008.05.047
   Balta MT, 2014, INT J HYDROGEN ENERG, V39, P20652, DOI 10.1016/j.ijhydene.2014.06.133
   Balta MT, 2009, INT J HYDROGEN ENERG, V34, P2925, DOI 10.1016/j.ijhydene.2009.01.087
   Balta MO, 2011, EUR PLAN STUD, V19, P1817, DOI 10.1080/09654313.2011.614396
   Barber F, ENV BENEFITS SOLAR H
   Baykara SZ, 2004, INT J HYDROGEN ENERG, V29, P1451, DOI 10.1016/j.ijhydene.2004.02.014
   Benemann JR, 1997, INT J HYDROGEN ENERG, V22, P979, DOI 10.1016/S0360-3199(96)00189-9
   Bhosale RR, 2015, INT J HYDROGEN ENERG, V40, P1639, DOI 10.1016/j.ijhydene.2014.11.118
   Bilgen E, 2001, ENERG CONVERS MANAGE, V42, P1047, DOI 10.1016/S0196-8904(00)00131-X
   Boudries R, 2013, INT J HYDROGEN ENERG, V38, P11507, DOI 10.1016/j.ijhydene.2013.04.136
   Bozoglan E, 2012, ENERGY, V46, P85, DOI 10.1016/j.energy.2012.03.029
   Calderon M, 2011, INT J HYDROGEN ENERG, V36, P5751, DOI 10.1016/j.ijhydene.2011.02.055
   Caliskan H, 2013, INT J HYDROGEN ENERG, V38, P6104, DOI 10.1016/j.ijhydene.2013.01.069
   Cetinkaya E, 2012, INT J HYDROGEN ENERG, V37, P2071, DOI 10.1016/j.ijhydene.2011.10.064
   Chaubey R, 2013, RENEW SUST ENERG REV, V23, P443, DOI 10.1016/j.rser.2013.02.019
   Conibeer GJ, 2007, INT J HYDROGEN ENERG, V32, P2703, DOI [10.1016/j.ijhydene.2006.09.012, 10.1016/.i.ijhydene.2006.09.012]
   Dagdougui H, 2011, INT J HYDROGEN ENERG, V36, P14324, DOI 10.1016/j.ijhydene.2011.08.050
   Dante RC, 2005, INT J HYDROGEN ENERG, V30, P421, DOI 10.1016/j.ijhydene.2004.02.008
   Das D, 2001, INT J HYDROGEN ENERG, V26, P13, DOI 10.1016/S0360-3199(00)00058-6
   Davda RR, 2005, APPL CATAL B-ENVIRON, V56, P171, DOI 10.1016/j.apcatb.2004.04.027
   Dincer I, 1998, ENERG SOURCE, V20, P427, DOI 10.1080/00908319808970070
   Dincer I, 2011, SUSTAINABLE ENERGY S
   Dincer I, 2007, CLEAN-SOIL AIR WATER, V35, P311, DOI 10.1002/clen.200700108
   EC (European Commission), 2003, 20719 EC EUR EN
   El Zayat MY, 1998, INT J HYDROGEN ENERG, V23, P259, DOI 10.1016/S0360-3199(97)00056-6
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Ghandehariun S, 2010, INT J HYDROGEN ENERG, V35, P8511, DOI 10.1016/j.ijhydene.2010.05.028
   Ghribi D, 2013, INT J HYDROGEN ENERG, V38, P8480, DOI 10.1016/j.ijhydene.2012.09.175
   Gonzalez SMA, 2011, P INT C REN EN POW Q
   Guo LJ, 2009, ENERGY, V34, P1073, DOI 10.1016/j.energy.2009.03.012
   Holladay JD, 2009, CATAL TODAY, V139, P244, DOI 10.1016/j.cattod.2008.08.039
   Hollmuller P, 2000, INT J HYDROGEN ENERG, V25, P97, DOI 10.1016/S0360-3199(99)00015-4
   Hong H, 2012, APPL ENERG, V90, P137, DOI 10.1016/j.apenergy.2011.04.050
   Jacobsson TJ, 2014, ENERG ENVIRON SCI, V7, P2056, DOI 10.1039/c4ee00754a
   Joshi AS, 2011, INT J HYDROGEN ENERG, V36, P11246, DOI 10.1016/j.ijhydene.2010.11.122
   Joshi AS, 2010, INT J HYDROGEN ENERG, V35, P4901, DOI 10.1016/j.ijhydene.2009.09.067
   Kelly NA, 2008, INT J HYDROGEN ENERG, V33, P6420, DOI 10.1016/j.ijhydene.2008.08.015
   Khan SUM, 2002, SCIENCE, V297, P2243, DOI 10.1126/science.1075035
   Kotay SM, 2008, INT J HYDROGEN ENERG, V33, P258, DOI 10.1016/j.ijhydene.2007.07.031
   Laurinavichene TV, 2006, INT J HYDROGEN ENERG, V31, P659, DOI 10.1016/j.ijhydene.2005.05.002
   Lehman PA, 1997, INT J HYDROGEN ENERG, V22, P465, DOI 10.1016/S0360-3199(96)00127-9
   Liberatore R, 2012, INT J HYDROGEN ENERG, V37, P9550, DOI 10.1016/j.ijhydene.2012.03.088
   Liu QB, 2009, APPL ENERG, V86, P155, DOI 10.1016/j.apenergy.2008.03.006
   Mallapragada DS, 2014, INT J HYDROGEN ENERG, V39, P62, DOI 10.1016/j.ijhydene.2013.10.075
   Midilli A, 2005, RENEW SUST ENERG REV, V9, P255, DOI 10.1016/j.rser.2004.05.003
   Midilli A, 2007, INT J HYDROGEN ENERG, V32, P511, DOI 10.1016/j.ijhydene.2006.06.050
   Momirlan M, 1999, RENEW SUST ENERG REV, V3, P219, DOI 10.1016/S1364-0321(98)00017-3
   Momirlan M, 2002, RENEW SUST ENERG REV, V6, P141, DOI 10.1016/S1364-0321(02)00004-7
   MORISAKI H, 1976, APPL PHYS LETT, V29, P338, DOI 10.1063/1.89088
   Muradov NZ, 2008, INT J HYDROGEN ENERG, V33, P6804, DOI 10.1016/j.ijhydene.2008.08.054
   Nakada E, 1999, INT J HYDROGEN ENERG, V24, P1053, DOI 10.1016/S0360-3199(98)00141-4
   National Academy of Sciences, 2004, HYDR EC OPP COSTS BA
   Ngoh SK, 2014, SUSTAIN ENERGY TECHN, V7, P279, DOI 10.1016/j.seta.2014.05.002
   Ngoh SK, 2012, RENEW SUST ENERG REV, V16, P6782, DOI 10.1016/j.rser.2012.07.027
   NOZIK AJ, 1976, APPL PHYS LETT, V29, P150, DOI 10.1063/1.89004
   OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0
   Ozcan H, 2014, INT J HYDROGEN ENERG, V39, P15330, DOI 10.1016/j.ijhydene.2014.07.089
   Ozturk M, 2011, P 6 INT ADV TECHN S
   Ozturk M, 2013, APPL THERM ENG, V51, P1235, DOI 10.1016/j.applthermaleng.2012.11.042
   Penner SS, 2006, ENERGY, V31, P33, DOI 10.1016/j.energy.2004.04.060
   Pregger T, 2009, INT J HYDROGEN ENERG, V34, P4256, DOI 10.1016/j.ijhydene.2009.03.025
   Raissi TA, 2003, ANAL SOLAR THERMOCHE
   Ratlamwala TAH, 2015, INT J HYDROGEN ENERG, V40, P7568, DOI 10.1016/j.ijhydene.2014.10.123
   Romagnoli F, 2011, INT J HYDROGEN ENERG, V36, P7866, DOI 10.1016/j.ijhydene.2011.02.004
   Rzayeva MP, 2001, INT J HYDROGEN ENERG, V26, P195, DOI 10.1016/S0360-3199(00)00063-X
   Scamman D, 2014, INT J HYDROGEN ENERG, V39, P19855, DOI 10.1016/j.ijhydene.2014.10.021
   Shamim RO, 2014, INT J HYDROGEN ENERG, V39, P15342, DOI 10.1016/j.ijhydene.2014.07.094
   Shamim RO, 2014, INT J HYDROGEN ENERG, V39, P5546, DOI 10.1016/j.ijhydene.2014.01.135
   Steinfeld A, 2005, SOL ENERGY, V78, P603, DOI 10.1016/j.solener.2003.12.012
   Steinfeld A, 1999, SOL ENERGY, V65, P43, DOI 10.1016/S0038-092X(98)00092-9
   U.S. Department of Energy Hydrogen, 2006, FUEL CELLS INFR TECH
   Veziroglu TN, 1985, SOLAR PRODUCTION HYD, P388
   Villasmil W, 2010, ENERG CONVERS MANAGE, V51, P2353, DOI 10.1016/j.enconman.2010.04.009
   Wang Z, 2012, INT J HYDROGEN ENERG, V37, P16287, DOI 10.1016/j.ijhydene.2012.03.057
   Xiao L, 2012, RENEW ENERG, V41, P1, DOI 10.1016/j.renene.2011.11.023
   Yamada O, 2006, THIN SOLID FILMS, V509, P207, DOI 10.1016/j.tsf.2005.09.174
   Yilanci A, 2009, PROG ENERG COMBUST, V35, P231, DOI 10.1016/j.pecs.2008.07.004
   Zamfirescu C, 2014, SOL ENERGY, V107, P700, DOI 10.1016/j.solener.2014.05.036
   Zeng K, 2010, PROG ENERG COMBUST, V36, P307, DOI 10.1016/j.pecs.2009.11.002
NR 89
TC 58
Z9 59
U1 7
U2 243
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1364-0321
J9 RENEW SUST ENERG REV
JI Renew. Sust. Energ. Rev.
PD APR
PY 2016
VL 56
BP 171
EP 178
DI 10.1016/j.rser.2015.11.060
PG 8
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Energy & Fuels
SC Science & Technology - Other Topics; Energy & Fuels
GA DC8IC
UT WOS:000369462100013
DA 2018-12-27
ER

PT J
AU Bunaciu, AA
   Aboul-Enein, HY
   Hoang, VD
AF Bunaciu, Andrei A.
   Aboul-Enein, Hassan Y.
   Hoang, Vu Dang
TI RETRACTED: Vibrational spectroscopy used in milk products analysis: A
   review (Retracted article. See vol. 209, pg. 367, 2016)
SO FOOD CHEMISTRY
LA English
DT Review; Retracted Publication
DE Milk analysis; Vibrational spectroscopy; Milk composition; Infrared and
   Raman applications
ID TRANSFORM INFRARED-SPECTROSCOPY; TOTAL REFLECTANCE SPECTROSCOPY;
   FATTY-ACID-COMPOSITION; RAMAN-SPECTROSCOPY; POWDERED MILK; RAW-MILK;
   NUTRITIONAL PARAMETERS; CHEMOMETRICS ANALYSIS; FTIR SPECTROSCOPY;
   DAIRY-PRODUCTS
AB Milk is a fluid containing several substances, and its composition depends on several factors. Vibrational spectroscopy is a powerful tool to determine the constituent concentrations and qualitative characteristics of dairy products. Vibrational spectrometry covers a series of well-established analytical methodologies suitable to be employed for both qualitative and quantitative purposes. In the first part of this review, theoretical aspects on vibrational techniques are presented; in the second part, the most important papers, published during the period 2009-2015, related to milk analysis are discussed. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Bunaciu, Andrei A.] CROMATEC PLUS SRL, SCENT Res Ctr Instrumental Anal, Tancabesti, Snagov, Romania.
   [Aboul-Enein, Hassan Y.] Natl Res Ctr, Pharmaceut & Drug Ind Res Div, Pharmaceut & Med Chem Dept, Giza 12622, Egypt.
   [Hoang, Vu Dang] Hanoi Univ Pharm, Dept Analyt Chem & Toxicol, Hanoi, Vietnam.
RP Hoang, VD (reprint author), Hanoi Univ Pharm, Dept Analyt Chem & Toxicol, Hanoi, Vietnam.
EM hoangvd@hup.edu.vn
CR Abbas O., 2012, CHEM ANAL FOOD TECHN
   Afseth NK, 2010, APPL SPECTROSC, V64, P700, DOI 10.1366/000370210791666200
   Almeida MR, 2011, J RAMAN SPECTROSC, V42, P1548, DOI 10.1002/jrs.2893
   Andersen S. K., 2002, HDB VIBRATIONAL SPEC
   Bittante G, 2013, J DAIRY SCI, V96, P5991, DOI 10.3168/jds.2013-6583
   Borin A, 2006, ANAL CHIM ACTA, V579, P25, DOI 10.1016/j.aca.2006.07.008
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bramley A. J., 1992, MACHINE MILKING LACT
   Bunaciu AA, 2014, GAZI U J SCI, V27, P637
   Capuano E, 2014, FOOD RES INT, V60, P59, DOI 10.1016/j.foodres.2013.12.024
   Inacio MRC, 2011, VIB SPECTROSC, V57, P342, DOI 10.1016/j.vibspec.2011.07.002
   Coppa M, 2014, FOOD CHEM, V150, P49, DOI 10.1016/j.foodchem.2013.10.087
   Craig AP, 2015, WOODHEAD PUBL FOOD S, V262, P165, DOI 10.1016/B978-0-85709-801-6.00007-1
   Curley DM, 1998, J DAIRY SCI, V81, P3154, DOI 10.3168/jds.S0022-0302(98)75881-3
   Dagnachew BS, 2013, J DAIRY SCI, V96, P5933, DOI 10.3168/jds.2012-6068
   Dagnachew BS, 2013, J DAIRY SCI, V96, P3973, DOI 10.3168/jds.2012-5972
   DEETH HC, 1983, NEW ZEAL J DAIRY SCI, V18, P13
   Deng YE, 2006, SPECTROSC SPECT ANAL, V26, P636
   Domingo E, 2014, FOOD RES INT, V60, P131, DOI 10.1016/j.foodres.2013.11.006
   El-Abassy RM, 2011, VIB SPECTROSC, V56, P3, DOI 10.1016/j.vibspec.2010.07.001
   Elgersma A, 2006, ANIM FEED SCI TECH, V131, P207, DOI 10.1016/j.anifeedsci.2006.06.012
   Etzion Y, 2004, J DAIRY SCI, V87, P2779, DOI 10.3168/jds.S0022-0302(04)73405-0
   GORNALL AG, 1949, J BIOL CHEM, V177, P751
   GOULDEN JDS, 1964, J DAIRY RES, V31, P273, DOI 10.1017/S0022029900018203
   Griffiths P. R, 1986, CHEM ANAL
   Ingelfinger JR, 2008, NEW ENGL J MED, V359, P2745, DOI 10.1056/NEJMp0808410
   Inon FA, 2004, ANAL CHIM ACTA, V513, P401, DOI 10.1016/j.aca.2004.03.014
   Jawaid S, 2014, ANAL METHODS-UK, V6, P5269, DOI 10.1039/c4ay00558a
   Jung C, 2000, J MOL RECOGNIT, V13, P325, DOI 10.1002/1099-1352(200011/12)13:6<325::AID-JMR507>3.0.CO;2-C
   Karoui R, 2003, INT DAIRY J, V13, P607, DOI 10.1016/S0958-6946(03)00076-1
   Karoui R, 2007, FOOD CHEM, V102, P621, DOI 10.1016/j.foodchem.2006.05.042
   Kasemsumran S, 2007, ANAL SCI, V23, P907, DOI 10.2116/analsci.23.907
   Kawamura S., 2007, Sensing and Instrumentation for Food Quality and Safety, V1, P37, DOI 10.1007/s11694-006-9001-x
   Kher A, 2007, VIB SPECTROSC, V44, P375, DOI 10.1016/j.vibspec.2007.03.006
   Larkin PJ, 2011, INFRARED AND RAMAN SPECTROSCOPY: PRINCIPLES AND SPECTRAL INTERPRETATION, P1
   Liang M, 2006, TALANTA, V69, P1269, DOI 10.1016/j.talanta.2006.01.008
   LIBNAU FO, 1994, VIB SPECTROSC, V7, P243, DOI 10.1016/0924-2031(94)85014-3
   Linker R, 2009, J DAIRY RES, V76, P42, DOI 10.1017/S0022029908003580
   Liu F, 2009, J FOOD ENG, V93, P127, DOI 10.1016/j.jfoodeng.2009.01.004
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   McClure WF, 2002, HDB VIBRATIONAL SPEC
   McGoverin CM, 2009, ANAL METHODS-UK, V1, P29, DOI 10.1039/b9ay00111e
   Meisel S, 2012, APPL ENVIRON MICROB, V78, P5575, DOI 10.1128/AEM.00637-12
   Melfsen A, 2012, J DAIRY SCI, V95, P6465, DOI 10.3168/jds.2012-5388
   Mengshi Lin, 2009, Frontiers of Chemical Engineering in China, V3, P427, DOI 10.1007/s11705-009-0244-z
   Moore JC, 2012, J FOOD SCI, V77, pR118, DOI 10.1111/j.1750-3841.2012.02657.x
   Moros J, 2007, ANAL CHIM ACTA, V593, P30, DOI 10.1016/j.aca.2007.04.036
   Moros J, 2010, TRAC-TREND ANAL CHEM, V29, P578, DOI 10.1016/j.trac.2009.12.012
   MOTTRAM T, 2002, COMP CLIN PATHOL, V11, P50
   Mouazen AM, 2009, BIOSYST ENG, V104, P353, DOI 10.1016/j.biosystemseng.2009.08.001
   Najbjerg H, 2011, ANALYST, V136, P1649, DOI 10.1039/c0an00916d
   Nicolaou N, 2008, ANALYST, V133, P1424, DOI 10.1039/b804439b
   Okazaki S, 2009, FORENSIC TOXICOL, V27, P94, DOI 10.1007/s11419-009-0072-3
   Rodriguez MAP, 2014, FOOD CHEM, V156, P170, DOI 10.1016/j.foodchem.2014.01.092
   Pistorius A, 1995, SPECTROSC EUR, V7, P8
   Rodriguez-Saona LE, 2011, ANNU REV FOOD SCI T, V2, P467, DOI 10.1146/annurev-food-022510-133750
   ROSENTHAL I, 1993, J CHEM EDUC, V70, P480, DOI 10.1021/ed070p480
   Santos PM, 2013, FOOD CHEM, V138, P19, DOI 10.1016/j.foodchem.2012.10.024
   Sharma K, 2010, FOOD SECUR, V2, P97, DOI 10.1007/s12571-009-0048-5
   Stoscheck M., 1990, METHODS ENZYMOLOGY G
   Sun DW, 2009, INFRARED SPECTROSCOPY FOR FOOD QUALITY ANALYSIS AND CONTROL, P1
   Susi H, 1969, STRUCTURE STABILITY, P575
   Trienekens J, 2008, INT J PROD ECON, V113, P107, DOI 10.1016/j.ijpe.2007.02.050
   University of Chicago Medical Center, 2008, SCI DAILY
   Valenti B, 2013, INT DAIRY J, V32, P26, DOI 10.1016/j.idairyj.2013.02.014
   Workman J, 2007, PRACTICAL GUIDE INTE
   Wu D, 2007, J DAIRY SCI, V90, P3613, DOI 10.3168/jds.2007-0164
   Wu D, 2008, J FOOD ENG, V84, P124, DOI 10.1016/j.jfoodeng.2007.04.031
   Yang QQ, 2014, ANAL METHODS-UK, V6, P8388, DOI [10.1039/C4AY00965G, 10.1039/c4ay00965g]
   Zaia DAM, 1999, TALANTA, V49, P373, DOI 10.1016/S0039-9140(98)00385-3
   Zhang LG, 2014, FOOD CHEM, V145, P342, DOI 10.1016/j.foodchem.2013.08.064
NR 71
TC 6
Z9 6
U1 2
U2 98
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD APR 1
PY 2016
VL 196
BP 877
EP 884
DI 10.1016/j.foodchem.2015.10.016
PG 8
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA CY2FI
UT WOS:000366223800111
PM 26593568
DA 2018-12-27
ER

PT J
AU Huang, SH
   Law, CH
   Kuo, PH
   Hu, RY
   Yang, CC
   Chung, TW
   Li, JM
   Lin, LH
   Liu, YC
   Liao, EC
   Tsai, YT
   Wei, YS
   Lin, CC
   Chang, CW
   Chou, HC
   Wang, WC
   Chang, MDT
   Wang, LH
   Kung, HJ
   Chan, HL
   Lyu, PC
AF Huang, Shun-Hong
   Law, Ching-Hsuan
   Kuo, Ping-Hsueh
   Hu, Ren-Yu
   Yang, Ching-Chieh
   Chung, Ting-Wen
   Li, Ji-Min
   Lin, Li-Hsun
   Liu, Yi-Chung
   Liao, En-Chi
   Tsai, Yi-Ting
   Wei, Yu-Shan
   Lin, Chi-Chen
   Chang, Chien-Wen
   Chou, Hsiu-Chuan
   Wang, Wen-Ching
   Chang, Margaret Dah-Tsyr
   Wang, Lu-Hai
   Kung, Hsing-Jien
   Chan, Hong-Lin
   Lyu, Ping-Chiang
TI RETRACTED: MMP-13 is involved in oral cancer cell metastasis (Retracted
   article.See vol.7,pg.48851,2016)
SO ONCOTARGET
LA English
DT Article; Retracted Publication
DE ECM; EMT; IF; MMP-13; OSCC
ID EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; MATRIX
   METALLOPROTEINASES; CYCLE CHECKPOINTS; LUNG-CANCER; EXPRESSION;
   CARCINOMA; STATISTICS; COLLAGEN; ACTIN
AB The oral cancer cell line OC3-I5 with a highly invasive ability was selected and derived from an established OSCC line OC3. In this study, we demonstrated that matrix metalloproteinases protein MMP-13 was up-regulated in OC3-I5 than in OC3 cells. We also observed that expression of epithelial-mesenchymal transition (EMT) markers including Twist, p-Src, Snail1, SIP1, JAM-A, and vinculin were increased in OC3-I5 compared to OC3 cells, whereas E-cadherin expression was decreased in the OC3-I5 cells. Using siMMP-13 knockdown techniques, we showed that siMMP-13 not only reduced the invasion and migration, but also the adhesion abilities of oral cancer cells. In support of the role of MMP-13 in metastasis, we used MMP-13 expressing plasmid-transfected 293T cells to enhance MMP-13 expression in the OC3 cells, transplanting the MMP-13 over expressing OC3 cells into nude mice led to enhanced lung metastasis. In summary, our findings show that MMP-13 promotes invasion and metastasis in oral cancer cells, suggesting altered expression of MMP-13 may be utilized to impede the process of metastasis.
C1 [Huang, Shun-Hong; Law, Ching-Hsuan; Kuo, Ping-Hsueh; Hu, Ren-Yu; Chung, Ting-Wen; Li, Ji-Min; Lin, Li-Hsun; Liu, Yi-Chung; Liao, En-Chi; Tsai, Yi-Ting; Wei, Yu-Shan; Wang, Wen-Ching; Chang, Margaret Dah-Tsyr; Chan, Hong-Lin; Lyu, Ping-Chiang] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan.
   [Huang, Shun-Hong; Law, Ching-Hsuan; Hu, Ren-Yu; Chung, Ting-Wen; Li, Ji-Min; Lin, Li-Hsun; Liu, Yi-Chung; Liao, En-Chi; Tsai, Yi-Ting; Wei, Yu-Shan; Chan, Hong-Lin; Lyu, Ping-Chiang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.
   [Kuo, Ping-Hsueh; Wang, Wen-Ching; Chang, Margaret Dah-Tsyr; Chan, Hong-Lin; Lyu, Ping-Chiang] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.
   [Yang, Ching-Chieh] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan.
   [Yang, Ching-Chieh] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan.
   [Lin, Chi-Chen] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.
   [Lin, Chi-Chen] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.
   [Lin, Chi-Chen] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan.
   [Lin, Chi-Chen] Taichung Vet Gen Hosp, Dept Med Res & Educ, Taichung, Taiwan.
   [Lin, Chi-Chen] Changhua Christian Hosp, Dept Internal Med, Div Chest Med, Changhua, Taiwan.
   [Chang, Chien-Wen] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu 30013, Taiwan.
   [Chou, Hsiu-Chuan] Natl Hsinchu Univ Educ, Dept Appl Sci, Hsinchu, Taiwan.
   [Wang, Lu-Hai; Kung, Hsing-Jien] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Miaoli County, Taiwan.
   [Liu, Yi-Chung] Natl Hlth Res Inst, Inst Populat Sci, Miaoli, Miaoli County, Taiwan.
RP Chan, HL; Lyu, PC (reprint author), Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan.; Chan, HL; Lyu, PC (reprint author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.; Chan, HL; Lyu, PC (reprint author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.
EM hlchan@life.nthu.edu.tw; pclyu@mx.nthu.edu.tw
FU NSC from the National Science Council, Taiwan [MOST103-2311-B-067-008];
   NTHU; CGH from the National Tsing Hua University [100N2723E1]; NTHU from
   the National Tsing Hua University [99N2908E1]; Toward Word-Class
   University project from National Tsing Hua University [100N2051E1];
   VGHUST from the Veteran General Hospitals University System of Taiwan
   [99-P5-22]
FX This work was supported by NSC grant (MOST103-2311-B-067-008) from the
   National Science Council, Taiwan, NTHU and CGH grant (100N2723E1) from
   the National Tsing Hua University, NTHU Booster grant (99N2908E1) from
   the National Tsing Hua University, Toward Word-Class University project
   from National Tsing Hua University (100N2051E1) and VGHUST grant
   (99-P5-22) from the Veteran General Hospitals University System of
   Taiwan.
CR Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873
   Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629
   Billinghurst RC, 1997, J CLIN INVEST, V99, P1534, DOI 10.1172/JCI119316
   Chen J-S, 2012, CARCINOGENESIS
   Engelhardt S, 2014, BRIT J PHARMACOL, V171, P1210, DOI 10.1111/bph.12489
   Farshadpour F, 2011, HEAD NECK-J SCI SPEC, V33, P817, DOI 10.1002/hed.21549
   Fata JE, 2000, CELL MOL LIFE SCI, V57, P77, DOI 10.1007/s000180050500
   Filatova A, 2013, BBA-GEN SUBJECTS, V1830, P2496, DOI 10.1016/j.bbagen.2012.10.008
   Fogh J, 2014, NUDE MOUSE EXPT CLIN, P235
   Hou JM, 2012, J CLIN ONCOL, V30, P525, DOI 10.1200/JCO.2010.33.3716
   Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001
   Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
   Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295
   Kahari V, 2012, GENE THER CANC, V451, P63
   Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530
   Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104
   Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097
   KAWAMATA H, 1995, INT J CANCER, V63, P680, DOI 10.1002/ijc.2910630513
   Kishikawa H, 2014, COLORECTAL DIS, V16, P888, DOI 10.1111/codi.12717
   Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320
   Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200
   Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018
   Li YJ, 2003, J CLIN INVEST, V112, P503, DOI 10.1172/JCI200317913
   Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705
   Lin SC, 2004, J ORAL PATHOL MED, V33, P79, DOI 10.1111/j.1600-0714.2004.00034.x
   Lindy O, 1997, ARTHRITIS RHEUM-US, V40, P1391, DOI 10.1002/art.1780400806
   Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915
   Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027
   Masamune A, 2013, PANCREATOLOGY, V13, P102, DOI 10.1016/j.pan.2012.12.058
   Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506
   Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406
   Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564
   Nissinen LM, 2015, J INVEST DERMATOL, V135, P2350, DOI 10.1038/jid.2015.246
   Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2
   Quan TH, 2013, J INVEST DERMATOL, V133, P1362, DOI 10.1038/jid.2012.509
   Quillard T, 2014, ARTERIOSCL THROM VAS, V34, P1179, DOI 10.1161/ATVBAHA.114.303326
   Radisky DC, 2005, J CELL SCI, V118, P4325, DOI 10.1242/jcs.02552
   Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1
   Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI [10.1056/NEJMoa1311107, 10.1056/NEJMc1404894]
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
   Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420
   Stura EA, 2013, FASEB J, V27, P4395, DOI 10.1096/fj.13-233601
   Wang XR, 2014, TUMOR BIOL, V35, P8715, DOI 10.1007/s13277-014-2147-y
   WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597
   Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7
   Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x
   Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009
   Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0
   Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173
   Zigrino P, 2009, J INVEST DERMATOL, V129, P2686, DOI 10.1038/jid.2009.130
   Zygogianni AG, 2011, HEAD NECK ONCOL, V3, DOI 10.1186/1758-3284-3-2
NR 52
TC 7
Z9 7
U1 3
U2 9
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1949-2553
J9 ONCOTARGET
JI Oncotarget
PD MAR 29
PY 2016
VL 7
IS 13
BP 17144
EP 17161
DI 10.18632/oncotarget.7942
PG 18
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA DL5QW
UT WOS:000375692900139
PM 26958809
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Park, JH
   Kim, HY
   Seok, KH
   Kiaee, Z
   Lee, SK
   Joo, SK
AF Park, Jae Hyo
   Kim, Hyung Yoon
   Seok, Ki Hwan
   Kiaee, Zohreh
   Lee, Sol Kyu
   Joo, Seung Ki
TI RETRACTED: Multibit ferroelectric field-effect transistor with
   epitaxial-like Pb(Zr,Ti)O-3 (Retracted article. See vol. 122, 2017)
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article; Retracted Publication
ID THIN-FILM CAPACITORS; HYDROGEN-INDUCED DEGRADATION; FENAND FLASH MEMORY;
   GRAIN-GROWTH; ELECTRIC-FIELD; FATIGUE; SIZE; MECHANISMS; BOUNDARIES;
   RETENTION
AB Being able to control grain boundaries during the phase transformation when processing a ferroelectric thin-film is crucial for the successful development of practical multibit ferroelectric memory. A novel development of ferroelectric thin-film crystallization processing for realizing epitaxial-like single crystals via artificial nucleation by Pt-seeding is reported here. Dividing the nucleation and growth mechanism by Pt-seeding, it is possible to obtain large and uniform rectangular-shaped ferroelectric grains, large enough to fabricate a field-effect transistor (FET) in the inside of the crystal grain. The fabricated ferroelectric FET, Pt/Pb(Zr,Ti)O-3/ZrTiO4/Si, showed a large memory window (similar to 2.2V), a low operation voltage (similar to 6V), and an ultra-fast program/erase speed (similar to 10(-6) s). Moreover, there was no degradation after 10 15 cycles of bipolar fatigue testing and the sample even showed a long retention time after 1 yr. All of these characteristics correspond to the best performance among all types of ferroelectric field-effect transistors reported thus far. (C) 2016 AIP Publishing LLC.
C1 [Park, Jae Hyo; Kim, Hyung Yoon; Seok, Ki Hwan; Kiaee, Zohreh; Lee, Sol Kyu; Joo, Seung Ki] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.
   [Park, Jae Hyo; Kim, Hyung Yoon; Seok, Ki Hwan; Kiaee, Zohreh; Lee, Sol Kyu; Joo, Seung Ki] Seoul Natl Univ, Eui San Res Ctr, Res Inst Adv Mat, Seoul 151742, South Korea.
RP Park, JH (reprint author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.; Park, JH (reprint author), Seoul Natl Univ, Eui San Res Ctr, Res Inst Adv Mat, Seoul 151742, South Korea.
FU Seoul Nation University, Seoul, Republic of Korea, through the Eui-San
   Research Center; Research Institute of Advanced Materials (RIAM);
   Science Research Program through the National Research Foundation of
   Korea (NRF) - Ministry of Education [0417-20150112]; BK21PLUS SNU
   Materials Division for Educating Creative Global Leaders [F15SN02D1702]
FX The authors would like to thank Dr. Yoonsuk Yoon (LFoundary, Germany)
   for this valuable discussion. This work was supported by Seoul Nation
   University, Seoul, Republic of Korea, through the Eui-San Research
   Center and Research Institute of Advanced Materials (RIAM). In addition,
   this work was partially supported by Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education (Grant No. 0417-20150112) and in part by BK21PLUS SNU
   Materials Division for Educating Creative Global Leaders under (Grant
   No. F15SN02D1702).
CR Ahn CH, 2003, NATURE, V424, P1015, DOI 10.1038/nature01878
   Akinaga H, 2010, P IEEE, V98, P2237, DOI 10.1109/JPROC.2010.2070830
   Carel R, 1996, ACTA MATER, V44, P2479, DOI 10.1016/1359-6454(95)00365-7
   Chu M, 2009, ANNU REV MATER RES, V39, P203, DOI 10.1146/annurev-matsci-082908-145312
   Cross JS, 2001, JPN J APPL PHYS 2, V40, pL346, DOI 10.1143/JJAP.40.L346
   DAUGHTON JM, 1992, THIN SOLID FILMS, V216, P162, DOI 10.1016/0040-6090(92)90888-I
   Desu S. B., 1993, Integrated Ferroelectrics, V3, P365, DOI 10.1080/10584589308216692
   DUIKER HM, 1990, PHYS REV B, V41, P490, DOI 10.1103/PhysRevB.41.490
   Ferain I, 2011, NATURE, V479, P310, DOI 10.1038/nature10676
   Foster CM, 1997, J APPL PHYS, V81, P2349, DOI 10.1063/1.364239
   Fujisawa H, 1997, APPL PHYS LETT, V71, P416, DOI 10.1063/1.119327
   Gelinck GH, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2035324
   Hoffman J, 2010, ADV MATER, V22, P2957, DOI 10.1002/adma.200904327
   Holzlechner G, 2014, SOLID STATE IONICS, V262, P625, DOI 10.1016/j.ssi.2013.08.027
   Hong S, 1999, J APPL PHYS, V86, P607, DOI 10.1063/1.370774
   Horiuchi T, 2010, SEMICOND SCI TECH, V25, DOI 10.1088/0268-1242/25/5/055005
   Ikarashi N, 1998, APPL PHYS LETT, V73, P1955, DOI 10.1063/1.122333
   Kaneko Y, 2011, IEEE T ELECTRON DEV, V58, P1311, DOI 10.1109/TED.2011.2110653
   Kim KW, 2006, J AM CERAM SOC, V89, P1530, DOI 10.1111/j.1551-2916.2006.00934.x
   Kohlstedt H, 2005, MICROELECTRON ENG, V80, P296, DOI 10.1016/j.mee.2005.04.084
   Kowk C. K., 1993, J MATER RES, V8, P339
   Lee JK, 2002, J APPL PHYS, V92, P2724, DOI 10.1063/1.1499976
   Lee JS, 2002, SOLID STATE ELECTRON, V46, P1651, DOI 10.1016/S0038-1101(02)00120-X
   Lee JS, 2002, APPL PHYS LETT, V81, P2602, DOI 10.1063/1.1511280
   Lee ML, 2005, J APPL PHYS, V97, DOI 10.1063/1.1819976
   Ma TP, 2002, IEEE ELECTR DEVICE L, V23, P386, DOI 10.1109/LED.2002.1015207
   Mathews S, 1997, SCIENCE, V276, P238, DOI 10.1126/science.276.5310.238
   MILLER SL, 1992, J APPL PHYS, V72, P5999, DOI 10.1063/1.351910
   Naber RCG, 2005, NAT MATER, V4, P243, DOI 10.1038/nmat1329
   Pan X, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3609323
   Park JH, 2015, IEEE ELECTR DEVICE L, V36, P1033, DOI 10.1109/LED.2015.2472987
   Park JH, 2001, INTEGR FERROELECTR, V40, P1579
   Sagalowicz L., 1999, FERROELECTRIC THIN F, V596, P265
   Sakai S, 2010, MATERIALS, V3, P4950, DOI 10.3390/ma3114950
   Sinnamon LJ, 2002, APPL PHYS LETT, V81, P703, DOI 10.1063/1.1494837
   SPECK JS, 1994, J APPL PHYS, V76, P466, DOI 10.1063/1.357097
   Sun J, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/9/095027
   Tagantsev AK, 2001, J APPL PHYS, V90, P1387, DOI 10.1063/1.1381542
   Takahashi K, 2005, JPN J APPL PHYS 1, V44, P6218, DOI 10.1143/JJAP.44.6218
   Tang MH, 2011, IEEE T ELECTRON DEV, V58, P370, DOI 10.1109/TED.2010.2090883
   Tarui Y, 1997, APPL SURF SCI, V113, P656, DOI 10.1016/S0169-4332(96)00963-4
   THOMPSON CV, 1990, ANNU REV MATER SCI, V20, P245, DOI 10.1146/annurev.ms.20.080190.001333
   Wang SY, 2009, SEMICOND SCI TECH, V24, DOI 10.1088/0268-1242/24/10/105029
   Warren WL, 1996, MRS BULL, V21, P40, DOI 10.1557/S0883769400035909
   WATANABE Y, 1995, APPL PHYS LETT, V66, P1770, DOI 10.1063/1.113362
   WINHOLTZ RA, 1988, AUST J PHYS, V41, P189, DOI 10.1071/PH880189
   Wong HSP, 2010, P IEEE, V98, P2201, DOI 10.1109/JPROC.2010.2070050
   Xiong W, 2006, IEEE ELECTR DEVICE L, V27, P612, DOI 10.1109/LED.2006.877714
   YOO IK, 1992, MAT SCI ENG B-SOLID, V13, P319, DOI 10.1016/0921-5107(92)90135-V
   YOO IK, 1992, PHYS STATUS SOLIDI A, V133, P565, DOI 10.1002/pssa.2211330242
   Zhang W, 2005, ACTA MATER, V53, P199, DOI 10.1016/j.actamat.2004.09.015
   Zhang XZ, 2012, INTEGR FERROELECTR, V132, P114, DOI 10.1080/10584587.2012.660836
   Zhao Z, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.024107
NR 53
TC 6
Z9 6
U1 2
U2 60
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-8979
EI 1089-7550
J9 J APPL PHYS
JI J. Appl. Phys.
PD MAR 28
PY 2016
VL 119
IS 12
AR 124108
DI 10.1063/1.4945002
PG 8
WC Physics, Applied
SC Physics
GA DI6II
UT WOS:000373602000020
DA 2018-12-27
ER

PT J
AU Park, JH
   Kim, HY
   Jang, GS
   Seok, KH
   Chae, HJ
   Lee, SK
   Kiaee, Z
   Joo, SK
AF Park, Jae Hyo
   Kim, Hyung Yoon
   Jang, Gil Su
   Seok, Ki Hwan
   Chae, Hee Jae
   Lee, Sol Kyu
   Kiaee, Zohreh
   Joo, Seung Ki
TI RETRACTED: Integrating Epitaxial-Like Pb(Zr,Ti) O-3 Thin-Film into
   Silicon for Next-Generation Ferroelectric Field-Effect Transistor
   (Retracted article. See vol. 6, 31300, 2016)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID LEAD-ZIRCONATE-TITANATE; DATA RETENTION CHARACTERISTICS; RANDOM-ACCESS
   MEMORY; NUCLEATED LATERAL CRYSTALLIZATION; TRANSMISSION
   ELECTRON-MICROSCOPY; SONOS NONVOLATILE MEMORY; HFO2 BUFFER LAYERS;
   GRAIN-GROWTH; PEROVSKITE FERROELECTRICS; RUTHENIUM OXIDE
AB The development of ferroelectric random-access memory (FeRAM) technology with control of grain boundaries would result in a breakthrough for new nonvolatile memory devices. The excellent piezoelectric and electrical properties of bulk ferroelectrics are degraded when the ferroelectric is processed into thin films because the grain boundaries then form randomly. Controlling the nature of nucleation and growth are the keys to achieving a good crystalline thin-film. However, the sought after high-quality ferroelectric thin-film has so far been thought to be impossible to make, and research has been restricted to atomic-layer deposition which is extremely expensive and has poor reproducibility. Here we demonstrate a novel epitaxial-like growth technique to achieve extremely uniform and large rectangular-shaped grains in thin-film ferroelectrics by dividing the nucleation and growth phases. With this technique, it is possible to achieve 100-mu m large uniform grains, even made available on Si, which is large enough to fabricate a field-effect transistor in each grain. The electrical and reliability test results, including endurance and retention test results, were superior to other FeRAMs reported so far and thus the results presented here constitute the first step toward the development of FeRAM using epitaxial-like ferroelectric thin-films.
C1 [Park, Jae Hyo; Kim, Hyung Yoon; Jang, Gil Su; Seok, Ki Hwan; Chae, Hee Jae; Lee, Sol Kyu; Kiaee, Zohreh; Joo, Seung Ki] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.
   [Park, Jae Hyo; Kim, Hyung Yoon; Jang, Gil Su; Seok, Ki Hwan; Chae, Hee Jae; Lee, Sol Kyu; Kiaee, Zohreh; Joo, Seung Ki] Seoul Natl Univ, Eui San Res Ctr, Res Inst Adv Mat, Seoul 08826, South Korea.
RP Joo, SK (reprint author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.; Joo, SK (reprint author), Seoul Natl Univ, Eui San Res Ctr, Res Inst Adv Mat, Seoul 08826, South Korea.
EM skjoo@snu.ac.kr
FU Seoul Nation University, Seoul, Republic of Korea, through the Eui-San
   Research Center and Research Institute of Advanced Materials (RIAM);
   Science Research Program through the National Research Foundation of
   Korea (NRF) - Ministry of Education [0417-20150112]; BK21PLUS SNU
   Materials Division for Educating Creative Global Leaders [F15SN02D1702]
FX The authors would like to thank Dr. Yoonsuk Yoon (LFoundary, Germany)
   for his valuable discussion. This work was supported by Seoul Nation
   University, Seoul, Republic of Korea, through the Eui-San Research
   Center and Research Institute of Advanced Materials (RIAM). In addition,
   this work was partially supported by Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education (Grant. 0417-20150112) and in part by BK21PLUS SNU
   Materials Division for Educating Creative Global Leaders under (Grant
   F15SN02D1702).
CR Aggarwal S, 1998, APPL PHYS LETT, V73, P1973, DOI 10.1063/1.122339
   Aizawa K, 2004, APPL PHYS LETT, V85, P3199, DOI 10.1063/1.1806274
   Arimoto Y, 2004, MRS BULL, V29, P823, DOI 10.1557/mrs2004.235
   Bae BJ, 2005, INTEGR FERROELECTR, V75, P235, DOI 10.1080/10584580500414564
   Bu JK, 2001, SOLID STATE ELECTRON, V45, P113, DOI 10.1016/S0038-1101(00)00232-X
   CRAWFORD JC, 1971, IEEE T ELECTRON DEV, VED18, P951, DOI 10.1109/T-ED.1971.17309
   DAUGHTON JM, 1992, THIN SOLID FILMS, V216, P162, DOI 10.1016/0040-6090(92)90888-I
   Eitan B, 2000, IEEE ELECTR DEVICE L, V21, P543, DOI 10.1109/55.877205
   Griswold EM, 1995, INTEGR FERROELECTR, V10, P123, DOI 10.1080/10584589508012270
   Groux L., 2005, IEEE T ELECTRON DEV, V52, P447
   Hartmann AJ, 2000, APPL PHYS A-MATER, V70, P239, DOI 10.1007/s003390050041
   Hoffman J, 2010, ADV MATER, V22, P2957, DOI 10.1002/adma.200904327
   Ikarashi N, 1998, APPL PHYS LETT, V73, P1955, DOI 10.1063/1.122333
   Jones RE, 1996, MRS BULL, V21, P55
   Kim K., 2007, P 37 EUR SOL STAT DE, DOI [10.1109/ESSCIRC.2007.4430247, DOI 10.1109/ESSCIRC.2007.4430247]
   KIM K, 2007, PROC EUR SOLID STATE, P47
   Kim KH, 2002, IEEE ELECTR DEVICE L, V23, P82, DOI 10.1109/55.981313
   Kim K, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337361
   KUMAR CVRV, 1991, APPL PHYS LETT, V58, P1161, DOI 10.1063/1.104351
   KUMAR CVRV, 1992, J APPL PHYS, V71, P864, DOI 10.1063/1.351307
   Lee JS, 2000, JPN J APPL PHYS 1, V39, P6343, DOI 10.1143/JJAP.39.6343
   Lee JS, 2002, J APPL PHYS, V92, P2658, DOI 10.1063/1.1496147
   Lee JS, 2002, APPL PHYS LETT, V81, P2602, DOI 10.1063/1.1511280
   Lee JS, 2000, INTEGR FERROELECTR, V31, P149, DOI 10.1080/10584580008215649
   Lee JS, 2001, J KOREAN PHYS SOC, V39, P184
   Lee JS, 2001, JPN J APPL PHYS 1, V40, P229, DOI 10.1143/JJAP.40.229
   Lee YK, 2002, IEEE ELECTR DEVICE L, V23, P664, DOI 10.1109/LED.2002.805001
   Leskela M, 2003, ANGEW CHEM INT EDIT, V42, P5548, DOI 10.1002/anie.200301652
   Lue HT, 2002, IEEE T ELECTRON DEV, V49, P1790, DOI 10.1109/TED.2002.803626
   Ma TP, 2002, IEEE ELECTR DEVICE L, V23, P386, DOI 10.1109/LED.2002.1015207
   Maurice JL, 2006, PHILOS MAG, V86, P2127, DOI 10.1080/14786430600640460
   MILLER SL, 1992, J APPL PHYS, V72, P5999, DOI 10.1063/1.351910
   Morioka H, 2004, APPL PHYS LETT, V85, P3516, DOI 10.1063/1.1795357
   MURGATROYD PN, 1970, J PHYS D APPL PHYS, V3, P151, DOI 10.1088/0022-3727/3/2/308
   Naber RCG, 2005, NAT MATER, V4, P243, DOI 10.1038/nmat1329
   Nakagawara O, 2000, APPL PHYS LETT, V77, P3257, DOI 10.1063/1.1324985
   NAKAMURA T, 1994, APPL PHYS LETT, V65, P1522, DOI 10.1063/1.112031
   Pan X, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3609323
   Pascual R, 1996, J APPL PHYS, V79, P493, DOI 10.1063/1.360856
   Pertsev NA, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.054107
   Raymond MV, 1996, J PHYS CHEM SOLIDS, V57, P1507, DOI 10.1016/0022-3697(96)00020-0
   ROSE A, 1955, PHYS REV, V97, P1538, DOI 10.1103/PhysRev.97.1538
   Scott JF, 2000, APPL PHYS LETT, V76, P3801, DOI 10.1063/1.126786
   Sheikholeslami A, 2000, P IEEE, V88, P667, DOI 10.1109/5.849164
   Shih WC, 2008, J APPL PHYS, V103, DOI 10.1063/1.2924434
   Shin JC, 1999, APPL PHYS LETT, V75, P3411, DOI 10.1063/1.125310
   Song YJ, 2000, APPL PHYS LETT, V76, P451, DOI 10.1063/1.125784
   Sun J, 2011, IEEE T ELECTRON DEV, V58, P3559, DOI 10.1109/TED.2011.2162335
   TABATA H, 1994, APPL PHYS LETT, V65, P1970, DOI 10.1063/1.112837
   Takahashi K, 2005, JPN J APPL PHYS 1, V44, P6218, DOI 10.1143/JJAP.44.6218
   Tan XL, 2002, PHILOS MAG A, V82, P1463, DOI 10.1080/01418610110121067
   Tang MH, 2011, IEEE T ELECTRON DEV, V58, P370, DOI 10.1109/TED.2010.2090883
   THOMPSON CV, 1985, J APPL PHYS, V58, P763, DOI 10.1063/1.336194
   THOMPSON CV, 1990, ANNU REV MATER SCI, V20, P245, DOI 10.1146/annurev.ms.20.080190.001333
   VENABLES JA, 1984, REP PROG PHYS, V47, P399, DOI 10.1088/0034-4885/47/4/002
   Walker Andrew J., 2009, IEEE T ELECTRON DEV, V56, P2703
   White MH, 2000, IEEE CIRCUITS DEVICE, V16, P22, DOI 10.1109/101.857747
   Wong HSP, 2012, P IEEE, V100, P1951, DOI 10.1109/JPROC.2012.2190369
   Wong HSP, 2010, P IEEE, V98, P2201, DOI 10.1109/JPROC.2010.2070050
   WU SY, 1974, IEEE T ELECTRON DEV, VED21, P499
   Xiao YG, 2012, SOLID STATE ELECTRON, V73, P84, DOI 10.1016/j.sse.2012.04.026
   Zhou C, 1997, J APPL PHYS, V82, P3081, DOI 10.1063/1.366147
NR 62
TC 4
Z9 4
U1 1
U2 42
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAR 23
PY 2016
VL 6
AR 23189
DI 10.1038/srep23189
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DH2IZ
UT WOS:000372609900001
PM 27005886
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Gultie, T
   Sebsibie, G
AF Gultie, Teklemariam
   Sebsibie, Girum
TI RETRACTED: Determinants of suboptimal breastfeeding practice in Debre
   Berhan town, Ethiopia: a cross sectional study (Retracted article. See
   vol. 13, Artn. 13, 2018)
SO INTERNATIONAL BREASTFEEDING JOURNAL
LA English
DT Article; Retracted Publication
DE Breastfeeding; Debre Berhan; Community based; Determinants; Weaning
ID CHILD-MORTALITY
AB Background: Optimal breastfeeding is inextricably linked to the achievement of Millennium Development Goals (MDGs) of eradicating extreme poverty and hunger, reducing child mortality and improving maternal health. Breastfeeding is safe, promotes sensory and cognitive development and contains antibodies that protect infants from common childhood illnesses. The objective of this study was to assess suboptimal breastfeeding and its determinants factors among mothers who have children below 23 months old in Debre Berhan, Ethiopia.
   Methods: A community based cross sectional study was conducted from 1 March 2015 until 30 March 2015. Five hundred forty eight mothers were included in the study using a two stage sampling technique. The data was collected by trained data collectors through pretested semi structured questionnaire. The collected data were cleaned, coded, entered and then analyzed using SPSS version 20 windows program. Descriptive statistics, binary and multivariable regression analysis with 95 % confidence interval was carried out and p value less than 0.05 used to determine the significant association. Late initiation of breastfeeding was defined as initiation of breastfeeding after one hour of delivery while early cessation of breastfeeding was to stop breastfeeding before 24 months of age. According to World Health Organization exclusive breastfeeding was defined as the practice of feeding breast milk only, including expressed breast milk, to infants and excluding water, other liquids, breast milk substitutes, and solid foods. Vitamin drops, minerals, oral rehydrating solution (ORS) and medicines may be given.
   Results: The prevalence of late initiation of breastfeeding, not exclusively breastfeeding and early cessation of breastfeeding were 17.5 % (95 % Confidence Interval [CI] 15.2 %, 19.4), 49.8 % (95 % CI 46.3, 50.5) and 12.8 % (95 % CI 11.7, 14.1) respectively. Birth at home was significantly associated with late initiation of breastfeeding (Adjusted Odds Ratio [AOR] 3.0; 95 % CI 1.5, 6.0). No advice during antenatal care was a predictor of not exclusively breastfeeding (AOR1.7; 95 % CI 1.2, 2.5). Being illiterate (AOR 3.2; 95 % CI 1.2, 8.3) and no advice during antenatal care about breastfeeding (AOR 1.9; 95 % CI 1.0. 3.4) were significantly associated with early cessation of breastfeeding.
   Conclusion: Educational status, age, antenatal and postnatal follow up, resident and place of delivery were predictors of suboptimal breastfeeding. Integrated and targeted interventions were recommended to achieve a better outcome in minimizing the late initiation, non-exclusive and early cessation of breastfeeding.
C1 [Gultie, Teklemariam] Arba Minch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arba Minch, Ethiopia.
   [Sebsibie, Girum] Univ Addis Ababa, Coll Hlth Sci, Dept Nursing & Midwifery, Addis Ababa, Ethiopia.
RP Gultie, T (reprint author), Arba Minch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arba Minch, Ethiopia.
EM tekledb2002@gmail.com
OI Gultie, Teklemariam/0000-0001-7266-8569
CR Alemayehu M, 2014, SCI J PPUBLIC HLTH, V2, P394
   Alemayehu T, 2009, ETHIOP J HEALTH DEV, V23, P12
   Alexander R, 2008, DOES SHORTENING TRAI
   [Anonymous], 2003, GLOB STRAT INF YOUNG
   Batal M, 2006, PUBLIC HEALTH NUTR, V9, P313, DOI 10.1079/PHN2006860
   Begum K, 2010, IMPACT EARLY INITIAT
   Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6
   Commission Population counsel, 2008, SUMM STAT REP 2007 P
   Du Plessis D, 2009, HLTH SA GESONDHEID, V14, P1
   Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496.
   Ethiopian central statistics agency, 2001, ETH DEM HLTH SURV 20
   Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303
   Thu HN, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-964
   Imdad A, 2011, BMC PUBLIC HEALTH, V11, pS22, DOI DOI 10.1186/1471-2458-11-S3-S20.PUBMED:21501438
   Kimani EW, 2011, BMC PUBLIC HEALTH, V26, P11
   Nkala TE, 2011, INT BREASTFEED J, V6, DOI 10.1186/1746-4358-6-17
   Ogunlesi TA, 2010, MATERN CHILD HLTH J, V14, P459, DOI 10.1007/s10995-008-0440-3
   Qiu LQ, 2008, INT BREASTFEED J, V3, DOI 10.1186/1746-4358-3-4
   Setegn T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-217
   Tan K L Jr, 2009, Malays J Nutr, V15, P11
   Tawiah-Agyemang C, 2008, J PERINATOL, V28, pS46, DOI 10.1038/jp.2008.173
   UNICEF, 2009, CHILD MON SIT CHILDR
   Veghari Gholamreza, 2011, Oman Med J, V26, P342, DOI 10.5001/omj.2011.84
   Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6
   World Bank, 2006, REP NUTR CENTR DEV S
   World Health Organization, 2004, GUID PRINC COMPL FEE
   World Health Organization, 2012, WORST BREASTF WEEK 1
   World Health Organization, 2013, MAT NEWB CHILD AD HL
   You DZ, 2010, LANCET, V376, P931, DOI 10.1016/S0140-6736(10)61429-8
NR 29
TC 7
Z9 7
U1 1
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1746-4358
J9 INT BREASTFEED J
JI Int. Breastfeed. J.
PD MAR 22
PY 2016
VL 11
AR 5
DI 10.1186/s13006-016-0063-z
PG 8
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA DH1UT
UT WOS:000372571100001
PM 27006686
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Yang, BB
   Yang, X
   Ding, HY
AF Yang, Bin-Bin
   Yang, Xu
   Ding, Huai-Yu
TI RETRACTED: Brain derived neurotrophic factor keep pattern
   electroretinogram from dropping after superior colliculus lesion in mice
   (Retracted article. See vol. 9, pg. 972, 2016)
SO INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
LA English
DT Article; Retracted Publication
DE pattern electroretinogram; optical coherence tomography; brain-derived
   neurotrophic factor; fast Fourier transform; retina; superior colliculus
ID RETINAL GANGLION-CELLS; MOUSE MODEL; IN-VIVO; DYSFUNCTION; RESPONSES;
   DBA/2J; DEATH
AB AIM: To determine if brain derived neurotrophic factor (BDNF) could offer protention to retinal ganglion cells following a superior colliculus (SC) lesion in mice using pattern electroretinogram (PERG) and optical coherence tomography (OCT) as a measures of ganglion cell response and retinal health.
   METHODS: Seven C57BL/6J mice with BDNF protection were tested with PERG and OCT before and after SC lesions.
   RESULTS: Compared with baseline PERG, the amplitude of PERG decreased 11.7% after SC lesions, but not significantly(P>0.05). Through fast Fourier transform (FFT) analysis of the PERGs before and after SC lesions, it was found that dominant frequency of PERGs stayed unchanged, suggesting that the ganglion cells of the retina remained relatively healthy inspite of damage to the ends of the ganglion cell axons. Also, OCT showed no changes in retinal thickness after lesions.
   CONCLUSION: It was concluded that BDNF is essential component of normal retinal and helps retina keeping normal function. While retina lack of BDNF, ex viva resource of BDNF provides protection to the sick retina. It implies that BDNF is a kind therapeutic neurotrophic factor to retina neurodegeneration diseases, such as glaucoma, age related macular degeneration.
C1 [Yang, Bin-Bin] Harbin Med Univ, Dept Ophthalmol, Affiliated Hosp 2, Key Lab, Harbin 150001, Heilongjiang Pr, Peoples R China.
   [Yang, Xu] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.
   [Ding, Huai-Yu] Huaiyin Normal Univ, Life Sci Dept, Huaian 223300, Jiangsu, Peoples R China.
RP Ding, HY (reprint author), Huaiyin Normal Univ, Life Sci Dept, Huaian 223300, Jiangsu, Peoples R China.
EM Huaiya-ding@163.com
FU Department of Science and Technology of Jiangsu Province [BN2009039]
FX Supported by Department of Science and Technology of Jiangsu Province
   (No.BN2009039).
CR ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0
   BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x
   Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308
   CARPENTER P, 1986, J COMP NEUROL, V251, P240, DOI 10.1002/cne.902510208
   COOLEY JW, 1965, MATH COMPUT, V19, P297, DOI 10.2307/2003354
   DRAGER UC, 1975, J NEUROPHYSIOL, V38, P690
   Fernandes CC, 2008, J NEUROSCI, V28, P5611, DOI 10.1523/JNEUROSCI.5378-07.2008
   Ghaffariyeh A, 2011, OPTOMETRY VISION SCI, V88, P80, DOI 10.1097/OPX.0b013e3181fc329f
   Guy J, 2014, INVEST OPHTH VIS SCI, V55, P841, DOI 10.1167/iovs.13-13365
   Herzog KH, 1998, J NEUROSCI, V18, P2891
   Hu Y, 2010, INVEST OPHTH VIS SCI, V51, P1747, DOI 10.1167/iovs.09-4450
   HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   Lom B, 2002, J NEUROSCI, V22, P7639
   Mizoguchi Y, 2009, J IMMUNOL, V183, P7778, DOI 10.4049/jimmunol.0901326
   Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7
   Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8
   Porciatti V, 2007, INVEST OPHTH VIS SCI, V48, P745, DOI 10.1167/iovs.06-0733
   Porciatti V, 2010, MOL VIS, V16, P2939
   Porciatti V, 2010, EXP EYE RES, V90, P452, DOI 10.1016/j.exer.2009.12.005
   Sanchez AL, 2006, DEVELOPMENT, V133, P2477, DOI 10.1242/dev.02409
   Talla V, 2014, INVEST OPHTH VIS SCI, V55, P5214, DOI 10.1167/iovs.14-14688
   Yang X, 2015, INT J OPHTHALMOL-CHI, V8, P1107, DOI 10.3980/j.issn.2222-3959.2015.06.05
   Yang X, 2013, INVEST OPHTH VIS SCI, V54, P1898, DOI 10.1167/iovs.12-11375
NR 24
TC 1
Z9 1
U1 2
U2 7
PU IJO PRESS
PI XI AN
PA NO 269 YOUYI EAST RD, XI AN, 710054, PEOPLES R CHINA
SN 2222-3959
EI 2227-4898
J9 INT J OPHTHALMOL-CHI
JI Int. J. Ophthalmol.
PD MAR 18
PY 2016
VL 9
IS 3
BP 369
EP 372
PG 4
WC Ophthalmology
SC Ophthalmology
GA DG0KB
UT WOS:000371752600007
PM 27158604
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Chu, SJ
   Wang, G
   Zhang, PF
   Zhang, R
   Huang, YX
   Lu, YM
   Da, W
   Sun, Q
   Zhang, J
   Zhu, JS
AF Chu, Shao-Jun
   Wang, Ge
   Zhang, Peng-Fei
   Zhang, Rui
   Huang, Yan-Xia
   Lu, Yun-Min
   Da, Wei
   Sun, Qun
   Zhang, Jing
   Zhu, Jin-Shui
TI RETRACTED: MicroRNA-203 suppresses gastric cancer growth by targeting
   PIBF1/Akt signaling(Retracted article.See vol.36,Article 61,2017)
SO JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
LA English
DT Article; Retracted Publication
DE miRNA-203; Growth; Gastric cancer; PIBF1; Akt
ID INDUCED BLOCKING FACTOR; TUMOR-GROWTH; ESOPHAGEAL CANCER;
   CERVICAL-CANCER; MIR-203; INVASION; METASTASIS; CARCINOMA; CELLS;
   PROLIFERATION
AB Background: MicroRNAs (miRNAs) have been proved involved in many tumorigenic behaviors including tumor growth. But, the clinical significance and functions of miRNA-203 in gastric cancer (GC) remain elusive.
   Results: Decreased expression of miRNA-203 was correlated with tumor size, poor prognosis and recurrence in GC patients. Overexpression of miR-203 or knockdown of its target progesterone immunomodulatory binding factor 1 (PIBF1) inhibited GC growth in vitro and in vivo, while miR-203 knockdown promoted GC proliferation. In addition, PIBF1 overexpression attenuated the inhibitory effects of miR-203 on GC growth and enhanced that effect on p-Akt expression.
   Conclusions: MiR-203 as a tumor biomarker suppresses GC growth through targeting the PIBF1/Akt signaling, suggesting that it may have the important therapeutic potential for the treatment of GC.
C1 [Chu, Shao-Jun] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 6, Dept Gerontol, Shanghai 200233, Peoples R China.
   [Wang, Ge; Zhang, Peng-Fei; Zhang, Rui; Huang, Yan-Xia; Lu, Yun-Min; Da, Wei; Sun, Qun; Zhang, Jing; Zhu, Jin-Shui] Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 6, Dept Gastroenterol, Yishan Rd 600, Shanghai 200233, Peoples R China.
RP Zhang, J; Zhu, JS (reprint author), Shanghai Jiao Tong Univ, Affiliated Shanghai Peoples Hosp 6, Dept Gastroenterol, Yishan Rd 600, Shanghai 200233, Peoples R China.
EM jing5522724@163.com; zhujs1803@163.com
FU National Nature Science Foundation of China [81302093, 81272752,
   81573747]; Hong Kong Scholars Program [XJ2015033]
FX This work is supported by National Nature Science Foundation of China
   (No. 81302093, 81272752 and 81573747) and Hong Kong Scholars Program
   (No. XJ2015033).
CR Cao MJ, 2013, NANOSCALE, V5, P12120, DOI 10.1039/c3nr04056a
   Chang X, 2015, BIOCHEM BIOPH RES CO, V456, P361, DOI 10.1016/j.bbrc.2014.11.087
   Check JH, 2015, CLIN EXP OBSTET GYN, V42, P563
   Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.553
   de Jong MC, 2015, CLIN CANCER RES, V21, P5630, DOI 10.1158/1078-0432.CCR-15-0454
   Deng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072662
   Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095
   Guo LH, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0099-0
   Halasz M, 2013, CELL MOL LIFE SCI, V70, P4617, DOI 10.1007/s00018-013-1404-3
   He JG, 2013, J SURG ONCOL, V108, P121, DOI 10.1002/jso.23315
   Imaoka H., 2015, GASTRIC CANC
   Lachmann M, 2004, INT J CANCER, V112, P51, DOI 10.1002/ijc.20326
   Liu J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0154-5
   Liu SP, 2015, CELL PHYSIOL BIOCHEM, V37, P1956, DOI 10.1159/000438556
   Mao LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117035
   Marano L, 2016, EJSO-EUR J SURG ONC, V42, P18, DOI 10.1016/j.ejso.2015.10.016
   Morandi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049919
   Qu JQ, 2015, MOL CANCER THER, V14, P2653, DOI 10.1158/1535-7163.MCT-15-0461
   Tang R, 2015, CLIN TRANSL ONCOL
   Torre LA, 2012, CA-CANCER J CLIN, V2015, P87, DOI DOI 10.3322/CAAC.21262
   Tsai MM, 2014, CANCER LETT, V351, P222, DOI 10.1016/j.canlet.2014.06.004
   Wan D, 2015, ANTICANCER AGENTS ME
   Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105570
   Wang R, 2015, MOL CELL BIOCHEM, V405, P97, DOI 10.1007/s11010-015-2401-7
   Xiang J, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0125-x
   Yang F., 2015, ONCOL REP
   Yu XY, 2014, STEM CELLS DEV, V23, P576, DOI 10.1089/scd.2013.0308
   Zhang F, 2014, CANCER LETT, V342, P121, DOI 10.1016/j.canlet.2013.08.037
   Zhang J., 2014, INT J DISTRIB SENS N, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0110734
   Zhang K, 2015, J CELL PHYSIOL, V230, P903, DOI 10.1002/jcp.24821
   Zhang L, 2013, CANCER LETT, V332, P94, DOI 10.1016/j.canlet.2013.01.023
   Zhang WP, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0113-6
   Zhao S, 2015, CELL PHYSIOL BIOCHEM, V37, P35, DOI 10.1159/000430331
   Zhao S, 2013, GENET TEST MOL BIOMA, V17, P631, DOI 10.1089/gtmb.2013.0085
   Zhu XY, 2013, CELL PHYSIOL BIOCHEM, V32, P64, DOI 10.1159/000350125
NR 35
TC 14
Z9 14
U1 3
U2 16
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-9966
J9 J EXP CLIN CANC RES
JI J. Exp. Clin. Cancer Res.
PD MAR 15
PY 2016
VL 35
AR 47
DI 10.1186/s13046-016-0323-1
PG 11
WC Oncology
SC Oncology
GA DH1LM
UT WOS:000372545500002
PM 26980572
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Yang, MH
   Li, Y
   Li, JH
   Liu, BX
AF Yang, M. H.
   Li, Y.
   Li, J. H.
   Liu, B. X.
TI RETRACTED: Atomic-scale simulation to study the dynamical properties and
   local structure of Cu-Zr and Ni-Zr metallic glass-forming alloys
   (Retracted article. See vol. 18, pg. 19976, 2016)
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article; Retracted Publication
ID INITIO MOLECULAR-DYNAMICS; MEDIUM-RANGE ORDER; SUPERCOOLED LIQUIDS;
   INTERATOMIC POTENTIALS; TRANSITION; DIFFUSION; MODEL; HETEROGENEITY;
   TEMPERATURE; PARAMETERS
AB Molecular dynamics simulation with well-developed EAM potentials was carried out to investigate the transport properties and local atomic structure of Cu-Zr and Ni-Zr metallic glasses and supercooled liquids. It is found that Cu or Ni atoms have much faster dynamics than Zr atoms in relaxation timescales, while Zr atoms display faster dynamics in the Cu-Zr system than in the Ni-Zr system. A dynamical crossover phenomenon from Arrhenius to super-Arrhenius behavior in the transport properties was observed for the Cu65Zr35 system at T-x approximate to 1250 K and the Ni65Zr35 system at T-x approximate to 1500 K, respectively. Further structural analysis suggests that the dominant interconnected clusters in Cu65Zr35 and Ni65Zr35 systems are < 0, 0, 12, 0 >, < 0, 1, 10, 2 >, < 0, 2, 8, 2 > and < 0, 3, 6, 4 >. To directly characterize and visualize the correlated dynamics, we regard the full icosahedra as the microscopic origin responsible for the formation of metallic glasses in the Cu65Zr35 system, while the metallic glass formation in the Ni65Zr35 system can be attributed to the slow dynamics of < 0, 3, 6, 4 >, < 0, 2, 8, 2 > and < 0, 1, 10, 2 > Ni-centered Voronoi polyhedra. The local atomic order and dynamics for Cu65Zr35 and Ni65Zr35 systems are remarkably different, and these differences are presumed to hinder crystal nucleation and growth, hence promoting the largely different bulk glass-forming ability.
C1 [Yang, M. H.; Li, Y.; Li, J. H.; Liu, B. X.] Tsinghua Univ, Sch Mat Sci & Engn, Key Lab Adv Mat MOE, Beijing 100084, Peoples R China.
RP Li, JH (reprint author), Tsinghua Univ, Sch Mat Sci & Engn, Key Lab Adv Mat MOE, Beijing 100084, Peoples R China.
EM lijiahao@mail.tsinghua.edu.cn
FU National Natural Science Foundation of China [51131003, 51571129];
   Ministry of Science and Technology of China (973 Program)
   [2012CB825700]; Administration of Tsinghua University
FX The authors are grateful for the financial support from the National
   Natural Science Foundation of China (51131003, 51571129), the Ministry
   of Science and Technology of China (973 Program 2012CB825700), and the
   Administration of Tsinghua University.
CR Abe T, 2005, MATER TRANS, V46, P2838, DOI 10.2320/matertrans.46.2838
   Abe T, 2007, J ALLOY COMPD, V434, P152, DOI 10.1016/j.jallcom.2006.08.172
   Abhishek J., 2015, PHYS REV B, V91
   ANGELL CA, 1972, J CHEM PHYS, V57, P470, DOI 10.1063/1.1677987
   Balucani U, 1994, DYNAMICS LIQUID STAT
   Becker SR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.055901
   Berthier L, 2005, EUROPHYS LETT, V69, P320, DOI 10.1209/epl/i2004-10401-5
   Berthier Ludovic, 2011, Physics, V4, DOI 10.1103/Physics.4.42
   Chathoth SM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037801
   Chen SH, 2006, P NATL ACAD SCI USA, V103, P12974, DOI 10.1073/pnas.0603253103
   Cheng YQ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.014207
   Cheng YQ, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2987727
   Chong SH, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/50/504101
   Das SK, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.064208
   Egelstaff P. A, 1967, INTRO LIQUID STATE
   Fernandez-Alonso F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.077801
   Fulcher GS, 1925, J AM CERAM SOC, V8, P339, DOI 10.1111/j.1151-2916.1925.tb16731.x
   Han XJ, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.224201
   Hansen J. P., 2006, THEORY SIMPLE LIQUID
   Hirata A, 2011, NAT MATER, V10, P28, DOI [10.1038/nmat2897, 10.1038/NMAT2897]
   Holland-Moritz D, 2009, J PHYS CONF SER, V144, DOI 10.1088/1742-6596/144/1/012119
   Homsi B. W., 2015, PHYS CHEM CHEM PHYS, V17, P24968
   Huang L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.094118
   Iwashita T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.205504
   Jakse N, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.214204
   Jung YJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061205
   Kaban I, 2013, ACTA MATER, V61, P2509, DOI 10.1016/j.actamat.2013.01.027
   Kelton KF, 2010, NUCL CONDENSED MATTE
   KOB W, 1995, PHYS REV E, V51, P4626, DOI 10.1103/PhysRevE.51.4626
   Kuhn P, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.024309
   Lee M, 2011, ACTA MATER, V59, P159, DOI 10.1016/j.actamat.2010.09.020
   Li JH, 2011, J APPL PHYS, V109, DOI 10.1063/1.3585869
   Liu XJ, 2011, ACTA MATER, V59, P6480, DOI 10.1016/j.actamat.2011.07.012
   LOPEZ JM, 1987, PHYS REV B, V36, P3716, DOI 10.1103/PhysRevB.36.3716
   Mallamace F, 2010, P NATL ACAD SCI USA, V107, P22457, DOI 10.1073/pnas.1015340107
   Mendelev MI, 2012, PHILOS MAG, V92, P4454, DOI 10.1080/14786435.2012.712220
   Mendelev MI, 2009, PHILOS MAG, V89, P967, DOI 10.1080/14786430902832773
   Miracle DB, 2004, NAT MATER, V3, P697, DOI 10.1038/nmat1219
   Ojovan MI, 2008, ENTROPY-SWITZ, V10, P334, DOI 10.3390/e10030334
   PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039
   Salmon PS, 2013, PHYS CHEM CHEM PHYS, V15, P15286, DOI 10.1039/c3cp51741a
   Sastry S, 1998, NATURE, V393, P554, DOI 10.1038/31146
   Schober HR, 2004, PHYS CHEM CHEM PHYS, V6, P3654, DOI 10.1039/b403557g
   Sheng HW, 2006, NATURE, V439, P419, DOI 10.1038/nature04421
   Suryanarayana C., 1998, XRAY DIFFRACTION PRA
   Tammann G., 1926, Z ANORG ALLG CHEM, V156, P245, DOI DOI 10.1002/ZAAC.19261560121
   TURNBULL D, 1969, CONTEMP PHYS, V10, P473, DOI 10.1080/00107516908204405
   Tyrrell H.J.V, 1984, DIFFUSION IN LIQUIDS
   VANHOVE L, 1954, PHYS REV, V95, P249, DOI 10.1103/PhysRev.95.249
   VINEYARD GH, 1958, PHYS REV, V110, P999, DOI 10.1103/PhysRev.110.999
   Vogel H, 1921, PHYS Z, V22, P645
   Voronoi G, 1909, J REINE ANGEW MATH, V136, P67
   Wang WY, 2015, ACTA MATER, V97, P75, DOI 10.1016/j.actamat.2015.07.001
   Widmer-Cooper A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.135701
   Wilson SR, 2015, PHILOS MAG, V95, P224, DOI 10.1080/14786435.2014.995742
   Wu C, 2014, ACTA MATER, V72, P229, DOI 10.1016/j.actamat.2014.03.046
   Wu SQ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3464164
   Xiong LH, 2015, ACTA MATER, V92, P109, DOI 10.1016/j.actamat.2015.03.047
   Xu DH, 2004, ACTA MATER, V52, P2621, DOI 10.1016/j.actamat.2004.02.009
   Yamamoto R, 1998, PHYS REV E, V58, P3515, DOI 10.1103/PhysRevE.58.3515
   Yang MH, 2015, PHYS CHEM CHEM PHYS, V17, P13355, DOI 10.1039/c5cp00512d
   Zaitsev AI, 2002, PHYS CHEM CHEM PHYS, V4, P6047, DOI 10.1039/b201036b
   Zaitsev AI, 2003, PHYS CHEM CHEM PHYS, V5, P4185, DOI 10.1039/b305089k
   Zhang H, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4918807
   Zhang Y, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.180201
   Zhang Y, 2011, ACTA MATER, V59, P4303, DOI 10.1016/j.actamat.2011.03.054
NR 66
TC 5
Z9 5
U1 7
U2 88
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
EI 1463-9084
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD MAR 14
PY 2016
VL 18
IS 10
BP 7169
EP 7183
DI 10.1039/c5cp07676e
PG 15
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA DF8LF
UT WOS:000371608600025
PM 26888279
DA 2018-12-27
ER

PT J
AU Henson, KE
   Jagsi, R
   Cutter, D
   McGale, P
   Taylor, C
   Darby, SC
AF Henson, Katherine E.
   Jagsi, Reshma
   Cutter, David
   McGale, Paul
   Taylor, Carolyn
   Darby, Sarah C.
TI RETRACTED: Inferring the Effects of Cancer Treatment: Divergent Results
   From Early Breast Cancer Trialists' Collaborative Group Meta-Analyses of
   Randomized Trials and Observational Data From SEER Registries (Retracted
   Article. See vol 34, pg 3358, 2016)
SO JOURNAL OF CLINICAL ONCOLOGY
LA English
DT Article; Retracted Publication
ID POSTMASTECTOMY RADIATION-THERAPY; END RESULTS DATABASE; ADJUVANT
   RADIOTHERAPY; CONSERVING SURGERY; SURVIVAL BENEFIT; ELDERLY-WOMEN;
   LUNG-CANCER; CONTRALATERAL BREAST; NCI-SURVEILLANCE; INCREASED RISK
AB Purpose To compare the effect of breast cancer radiotherapy as estimated from observational data with findings from randomized trials.
   Materials and Methods Rate ratios were obtained for selected end points among 13,932 women randomly assigned to receive radiotherapy or not in trials contributing to recent meta-analyses by the Early Breast Cancer Trialists' Collaborative Group. Estimates of the same quantities were derived for 393,840 women registered with breast cancer in the US SEER registries between 1973 and 2008.
   Results In the randomized trials, radiotherapy after breast-conserving surgery reduced mortality from both breast cancer (rate ratio, 0.82; 95% CI, 0.75 to 0.90) and all causes (rate ratio, 0.92; 95% CI, 0.86 to 0.99). Reductions of similar magnitude were seen in the trials of radiotherapy after mastectomy in node-positive disease (rate ratios, breast cancer 0.84; 95% CI, 0.76 to 0.94; all causes, 0.89; 95% CI, 0.81 to 0.97). In the observational data, radiotherapy after breast-conserving surgery was associated with much larger mortality reductions (rate ratios, breast cancer, 0.64; 95% CI, 0.62 to 0.66; all causes, 0.63; 95% CI, 0.62 to 0.65), whereas radiotherapy aftermastectomy in node-positive disease was associated with substantial increases in mortality (rate ratios, breast cancer, 1.34; 95% CI, 1.31 to 1.37; all causes, 1.23; 95% CI, 1.22 to 1.25). Detailed adjustment of the observational data for potential confounders did not reduce the divergence from the randomized data.
   Conclusion This study of mortality after radiotherapy for breast cancer found strikingly divergent results between the Early Breast Cancer Trialists' Collaborative Group meta-analyses of randomized data and the SEER observational data, even when efforts had been made to remove confounding and selection biases. Nonrandomized comparisons are liable to provide misleading estimates of treatment effects. Therefore, they need careful justification every time they are used. (C) 2016 by American Society of Clinical Oncology
C1 [Henson, Katherine E.; Cutter, David; McGale, Paul; Taylor, Carolyn; Darby, Sarah C.] Univ Oxford, Oxford, England.
   Univ Michigan, Ann Arbor, MI 48109 USA.
RP Darby, SC (reprint author), Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.
EM sarah.darby@ctsu.ox.ac.uk
OI Jagsi, Reshma/0000-0001-6562-1228
FU Cancer Research UK; British Heart Foundation; Medical Research Council;
   Nuffield Department of Population Health, University of Oxford;
   Department of Health for England [091/0203]; British Heart Foundation
   Centre for Research Excellence [RE/08/04]
FX Supported by the core funding provided from Cancer Research UK, the
   British Heart Foundation, and the Medical Research Council to the
   Clinical Trial Service Unit, University of Oxford; by the Nuffield
   Department of Population Health, University of Oxford; and by the
   Department of Health for England (Grant No. 091/0203). D.C. was
   supported by the British Heart Foundation Centre for Research Excellence
   (Grant No. RE/08/04).
CR Abe O, 2005, LANCET, V366, P2087
   Abrams M, 2012, INT J RADIAT ONCOL, V84, pS245, DOI 10.1016/j.ijrobp.2012.07.637
   Ademuyiwa FO, 2013, BREAST CANCER RES TR, V138, P241, DOI 10.1007/s10549-013-2425-1
   Agarwal J, 2012, BREAST J, V18, P226, DOI 10.1111/j.1524-4741.2012.01235.x
   Albert JM, 2012, CANCER-AM CANCER SOC, V118, P4642, DOI 10.1002/cncr.27457
   Bao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094815
   Bush D, 2011, BREAST CANCER RES TR, V127, P243, DOI 10.1007/s10549-010-1186-3
   Chakma J, 2014, NEW ENGL J MED, V370, P3, DOI 10.1056/NEJMp1311068
   Cohen RJ, 2013, INT J RADIAT ONCOL, V87, pS232, DOI 10.1016/j.ijrobp.2013.06.601
   Cohen RJ, 2012, INT J RADIAT ONCOL, V84, pS33, DOI 10.1016/j.ijrobp.2012.07.092
   Dai Kubicky C, 2010, INT J RAD ONCOL BI S, V78, pS205
   Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5
   Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8
   Dawood S, 2012, ANN ONCOL, V23, P870, DOI 10.1093/annonc/mdr319
   Dawood SS, 2012, J CLIN ONCOL S, V30
   de Gonzalez AB, 2010, BRIT J CANCER, V102, P220, DOI 10.1038/sj.bjc.6605435
   de Gonzalez AB, 2011, LANCET ONCOL, V12, P353, DOI 10.1016/S1470-2045(11)70061-4
   Delgado D J, 1995, P R Health Sci J, V14, P103
   Doyle JJ, 2007, INT J RADIAT ONCOL, V68, P82, DOI 10.1016/j.ijrobp.2006.12.019
   Du XL, 2002, BREAST CANCER RES TR, V72, P23, DOI 10.1023/A:1014908802632
   Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7
   *EBCTCG, 1990, TREATM EARL BREAST C, V1
   Elmore L, 2014, ANN SURG ONCOL, V21, pS58
   Gaffney DK, 2003, J CLIN ONCOL, V21, P467, DOI 10.1200/JCO.2003.12.047
   Gao X, 2003, INT J RADIAT ONCOL, V56, P1038, DOI 10.1016/S0360-3016(03)00203-7
   Giordano SH, 2005, JNCI-J NATL CANCER I, V97, P419, DOI 10.1093/jnci/dji067
   Giordano SH, 2008, CANCER-AM CANCER SOC, V112, P2456, DOI 10.1002/cncr.23452
   Henson KE, 2013, BRIT J CANCER, V108, P179, DOI 10.1038/bjc.2012.575
   Horowitz DP, 2011, CANC RES S, V71
   Huang J, 2001, CANCER, V92, P172, DOI 10.1002/1097-0142(20010701)92:1<172::AID-CNCR1306>3.0.CO;2-K
   Huang J, 2001, CANCER, V92, P1411, DOI 10.1002/1097-0142(20010915)92:6<1411::AID-CNCR1464>3.0.CO;2-9
   Institute of Medicine, 2010, NAT CANC CLIN TRIALS
   Jagsi R, 2010, J CLIN ONCOL, V28, P2396, DOI 10.1200/JCO.2009.26.8433
   Joslyn SA, 1999, INT J RADIAT ONCOL, V44, P821, DOI 10.1016/S0360-3016(99)00071-1
   Keating NL, 2011, BREAST CANCER RES TR, V125, P803, DOI 10.1007/s10549-010-0865-4
   Korah MP, 2013, INT J RADIAT ONCOL, V87, pS230, DOI 10.1016/j.ijrobp.2013.06.596
   Korah MP, 2012, INT J RADIAT ONCOL, V84, pS34, DOI 10.1016/j.ijrobp.2012.07.094
   Korn EL, 2012, J CLIN ONCOL, V30, P4185, DOI 10.1200/JCO.2012.44.8233
   LIN CCJ, 2013, J CLIN ONCOL S, V31
   Ly BH, 2010, TUMORI, V96, P947
   Lyman GH, 2012, J CLIN ONCOL, V30, P4181, DOI 10.1200/JCO.2012.45.9792
   Martinez SR, 2011, CTS-CLIN TRANSL SCI, V4, P117
   Martinez SR, 2012, MED ONCOL, V29, P1523, DOI 10.1007/s12032-011-0077-8
   Martinez SR, 2012, CANCER-AM CANCER SOC, V118, P196, DOI 10.1002/cncr.26231
   McCammon R, 2008, CANCER-AM CANCER SOC, V113, P683, DOI 10.1002/cncr.23611
   McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8
   Mery CM, 2009, CANCER-AM CANCER SOC, V115, P4055, DOI 10.1002/cncr.24462
   Meyer AM, 2014, SEMIN RADIAT ONCOL, V24, P5, DOI 10.1016/j.semradonc.2013.09.002
   Morgan SC, 2012, CANC RES S, V72
   National Comprehensive Cancer Network (NCCN), 2012, CLIN PRACT GUID ONC
   Neta G, 2012, BREAST CANCER RES TR, V131, P1021, DOI 10.1007/s10549-011-1820-8
   NEUGUT AI, 1993, CANCER, V71, P3054, DOI 10.1002/1097-0142(19930515)71:10<3054::AID-CNCR2820711027>3.0.CO;2-N
   Paszat LF, 1998, J CLIN ONCOL, V16, P2625, DOI 10.1200/JCO.1998.16.8.2625
   Patt DA, 2005, J CLIN ONCOL, V23, P7475, DOI 10.1200/JCO.2005.13.755
   Ravi A, 2012, J CLIN ONCOL S, V30
   Royce M, 2009, CANCER RES, V61, P4134
   Schootman M, 2007, BREAST CANCER RES TR, V103, P77, DOI 10.1007/s10549-006-9354-1
   Smith BD, 2005, J CLIN ONCOL, V23, P1409, DOI 10.1200/JCO.2005.05.100
   Smith BD, 2006, J CLIN ONCOL, V24, P4901, DOI 10.1200/JCO.2006.06.5938
   Smith BD, 2006, JNCI-J NATL CANCER I, V98, P681, DOI 10.1093/jnci/djj186
   Smith GL, 2008, CANCER, V112, P1371, DOI 10.1002/cncr.23307
   Soulos PR, 2012, J CLIN ONCOL, V30, P1601, DOI 10.1200/JCO.2011.39.4890
   StataCorp, 2011, STAT STAT SOFTW REL
   Surapaneni A, 2012, INT J RADIAT ONCOL, V84, pS246, DOI 10.1016/j.ijrobp.2012.07.638
   Taylor BF, 2012, INT J RADIAT ONCOL, V84, pS222, DOI 10.1016/j.ijrobp.2012.07.578
   Valina-Toth AL, 2013, J AM COLL CARDIOL, V61, pE581, DOI 10.1016/S0735-1097(13)60581-1
   Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2
   Vinh-Hung V, 2005, TUMORI, V91, P9
   Vinh-Hung V, 2003, RADIOTHER ONCOL, V67, P147, DOI 10.1016/S0167-8140(03)00002-1
   Vinh-Hung V, 2002, RADIOTHER ONCOL, V64, P281, DOI 10.1016/S0167-8140(02)00105-6
   Vinh-Hung V, 2009, STRAHLENTHER ONKOL, V185, P161, DOI 10.1007/s00066-009-1921-z
   Voordeckers M, 2009, STRAHLENTHER ONKOL, V185, P656, DOI 10.1007/s00066-009-2047-z
   Xie L, 2010, INT J RADIAT ONCOL, V78, pS621, DOI 10.1016/j.ijrobp.2010.07.1445
   Yan W, 2012, INT J RADIAT ONCOL, V84, pS34, DOI 10.1016/j.ijrobp.2012.07.095
   Yan WS, 2013, AM J CLIN ONCOL-CANC, V36, P552, DOI 10.1097/COC.0b013e31825d529b
   Yap J, 2002, INT J RADIAT ONCOL, V52, P1231, DOI 10.1016/S0360-3016(01)02799-7
   Ye JC, 2013, INT J RADIAT ONCOL, V87, pS46, DOI 10.1016/j.ijrobp.2013.06.122
   Yu GP, 2006, CANCER CAUSE CONTROL, V17, P411, DOI 10.1007/s10552-005-0338-y
   Yu JB, 2008, CANCER, V113, P38, DOI 10.1002/cncr.23512
   Zablotska LB, 2005, AM J EPIDEMIOL, V161, P330, DOI 10.1093/aje/kwi050
   Zablotska LB, 2003, CANCER, V97, P1404, DOI 10.1002/cncr.11214
NR 81
TC 16
Z9 16
U1 2
U2 11
PU AMER SOC CLINICAL ONCOLOGY
PI ALEXANDRIA
PA 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA
SN 0732-183X
EI 1527-7755
J9 J CLIN ONCOL
JI J. Clin. Oncol.
PD MAR 10
PY 2016
VL 34
IS 8
BP 803
EP +
DI 10.1200/JCO.2015.62.0294
PG 25
WC Oncology
SC Oncology
GA DJ6OV
UT WOS:000374333700011
PM 26786924
DA 2018-12-27
ER

PT J
AU Riccardi, M
   Pulvento, C
   Patane, C
   Albrizio, R
   Barbieri, G
AF Riccardi, M.
   Pulvento, C.
   Patane, C.
   Albrizio, R.
   Barbieri, G.
TI RETRACTED: Drought stress response in long-storage tomatoes:
   Physiological and biochemical traits(Retracted article.See
   vol.211,pg.459,2016)
SO SCIENTIA HORTICULTURAE
LA English
DT Article; Retracted Publication
DE Tomato; Drought resistance; Re-watering; Leaf gas exchanges; Plant water
   status
ID ABSCISIC-ACID ACCUMULATION; WHEAT TRITICUM-AESTIVUM; LEAF GAS-EXCHANGE;
   XYLEM SAP ABA; WATER-STRESS; STOMATAL CONDUCTANCE; CHLOROPHYLL
   FLUORESCENCE; GENOTYPIC VARIATION; GUARD-CELL; PLANT-RESPONSES
AB Long-storage tomato is traditionally cultivated under no water supply in Mediterranean area and could be considered for cultivation in arid and semi-arid countries. The aim of this work was to identify the main adaptive physiological and biochemical mechanisms of two long-storage tomato landraces (Pizzutello di Sciacca and Locale di Salina), grown under drought conditions with respect to a processing tomato cultivar (Brigade). Before flowering, control plants were irrigated daily, and drought stressed plants did not receive water until stomata conductance reached value near to zero. Recovery of plants was carried out by daily re-irrigation of pots. Pizzutello di Sciacca and Locale di Salina maintained higher values of the leaf photosynthetic rate with fewer reductions in stomatal conductance with respect to Brigade, and they showed a rapid and full recovery of all gas exchange parameters after re-watering, suggesting a good tolerance to water stress. The rates of change in stomatal conductance with abscissic acid were greater for Pizzutello di Sciacca and Locale di Salina compared to Brigade and caused the early stomatal closure, limiting further water loss and subsequent damages. Leaf water status of all genotypes was affected by drought; in particular, Brigade accumulated higher proline contents in the leaves. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Riccardi, M.; Pulvento, C.; Albrizio, R.] Natl Res Council CNR, Inst Agr & Forest Mediterranean Syst ISAFoM, Naples, Italy.
   [Patane, C.] Natl Res Council CNR, Trees & Timber Inst IVALSA, Catania, Sicily, Italy.
   [Barbieri, G.] Univ Naples Federico II, Depatment Agr Sci, Naples, Italy.
RP Riccardi, M (reprint author), Natl Res Council CNR, Inst Agr & Forest Mediterranean Syst ISAFoM, Naples, Italy.
EM maria.riccardi@isafom.cnr
CR Ahuja I, 2010, TRENDS PLANT SCI, V15, P664, DOI 10.1016/j.tplants.2010.08.002
   Alves AAC, 2000, CROP SCI, V40, P131, DOI 10.2135/cropsci2000.401131x
   ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2
   Atkinson CJ, 2000, TREE PHYSIOL, V20, P557
   Bacelar EA, 2009, ACTA PHYSIOL PLANT, V31, P611, DOI 10.1007/s11738-009-0272-9
   Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196
   Balouchi H., 2010, INT J BIOL LIFE SCI, V6, P56
   Bsoul E, 2006, J AM SOC HORTIC SCI, V131, P459
   BULBOTKO GV, 1973, SOV SOIL SCI+, V5, P219
   Cao WX, 2000, ACTA BOT SIN, V42, P1026
   Cellier F, 1998, PLANT PHYSIOL, V116, P319, DOI 10.1104/pp.116.1.319
   CHAVES MM, 1991, J EXP BOT, V42, P1, DOI 10.1093/jxb/42.1.1
   Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076
   Ha CV, 2014, P NATL ACAD SCI USA, V111, P851, DOI 10.1073/pnas.1322135111
   Claussen W, 2005, PLANT SCI, V168, P241, DOI 10.1016/j.plantsci.2004.07.039
   CORREIA MJ, 1995, J EXP BOT, V46, P101, DOI 10.1093/jxb/46.1.101
   CORREIA MJ, 1994, PLANT CELL ENVIRON, V17, P845, DOI 10.1111/j.1365-3040.1994.tb00179.x
   Fedina IS, 1996, PHOTOSYNTHETICA, V32, P213
   FISCHER RA, 1970, J EXP BOT, V21, P371, DOI 10.1093/jxb/21.2.371
   Fischlin A., 2007, CLIMATE CHANGE 2007, P211, DOI DOI 10.1007/S10113-010-0191-8
   Fuchs EE, 1996, PLANT CELL ENVIRON, V19, P1091, DOI 10.1111/j.1365-3040.1996.tb00216.x
   Galmes J, 2011, PLANT CELL ENVIRON, V34, P245, DOI 10.1111/j.1365-3040.2010.02239.x
   Garcia AB, 1997, PLANT PHYSIOL, V115, P159, DOI 10.1104/pp.115.1.159
   GOYAL A, 1985, Indian Journal of Agricultural Research, V19, P215
   GUNASEKERA D, 1994, PLANT SCI, V99, P125, DOI 10.1016/0168-9452(94)90169-4
   Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x
   HARRIS MJ, 1991, PLANT PHYSIOL, V95, P171, DOI 10.1104/pp.95.1.171
   HE JX, 1995, PHYSIOL PLANTARUM, V93, P771, DOI 10.1034/j.1399-3054.1995.930428.x
   Hossain MM, 2014, CROP J, V2, P366, DOI 10.1016/j.cj.2014.08.001
   Jamil M, 2007, SCI AGR, V64, P111, DOI 10.1590/S0103-90162007000200002
   Ji KX, 2012, J PLANT PHYSIOL, V169, P336, DOI 10.1016/j.jplph.2011.10.010
   Jin S, 2000, PLANT CELL ENVIRON, V23, P51, DOI 10.1046/j.1365-3040.2000.00520.x
   KAISER WM, 1987, PHYSIOL PLANTARUM, V71, P142, DOI 10.1111/j.1399-3054.1987.tb04631.x
   KHALIL AAM, 1993, J EXP BOT, V44, P1127, DOI 10.1093/jxb/44.7.1127
   KICHEVA MI, 1994, PHOTOSYNTHETICA, V30, P107
   Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057
   Kocheva K., 2003, Bulgarian Journal of Plant Physiology, P290
   Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300
   Liang J, 1997, PHOTOSYNTH RES, V51, P149, DOI 10.1023/A:1005797410190
   Liang ZS, 2002, BOT BULL ACAD SINICA, V43, P187
   Lichtenthaler HK, 2000, PLANT PHYSIOL BIOCH, V38, P889, DOI 10.1016/S0981-9428(00)01199-2
   Lutts S, 1999, PHYSIOL PLANTARUM, V105, P450, DOI 10.1034/j.1399-3054.1999.105309.x
   Marler TE, 1998, J AM SOC HORTIC SCI, V123, P714
   Massonnet C, 2007, ANN BOT-LONDON, V100, P1347, DOI 10.1093/aob/mcm222
   Medrano H, 2002, ANN BOT-LONDON, V89, P895, DOI 10.1093/aob/mcf079
   Miyashita K, 2005, ENVIRON EXP BOT, V53, P205, DOI 10.1016/j.envexpbot.2004.03.015
   Moseki B., 2011, AFR J PLANT SCI BIOT, V5, P89
   Moseky B., 2000, 26 ANN C S AFR ASS B, P111
   Niinemets U, 2001, ECOLOGY, V82, P453, DOI 10.2307/2679872
   Nishiyama R, 2013, P NATL ACAD SCI USA, V110, P4840, DOI 10.1073/pnas.1302265110
   OBER ES, 1991, PLANT PHYSIOL, V97, P154, DOI 10.1104/pp.97.1.154
   Ort D. R., 1994, PHOTOINHIBITION PHOT, P315
   Osakabe Y, 2011, PHYSIOL PLANTARUM, V142, P105, DOI 10.1111/j.1399-3054.2011.01451.x
   QUARRIE SA, 1979, ANN BOT-LONDON, V44, P323, DOI 10.1093/oxfordjournals.aob.a085736
   Ramanjulu S, 1998, PHOTOSYNTHETICA, V35, P279, DOI 10.1023/A:1006979327921
   Razdan M. K., 2007, GENETIC IMPROVEMENT, P521
   Sapeta H, 2013, ENVIRON EXP BOT, V85, P76, DOI 10.1016/j.envexpbot.2012.08.012
   SHARKEY TD, 1990, PHOTOSYNTHETICA, V24, P651
   SHARP RE, 1994, J EXP BOT, V45, P1743, DOI 10.1093/jxb/45.Special_Issue.1743
   Siddique MRB, 2000, BOT BULL ACAD SINICA, V41, P35
   Somerville C, 2001, SCIENCE, V292, P2217, DOI 10.1126/science.292.5525.2217
   Souza RP, 2004, ENVIRON EXP BOT, V51, P45, DOI 10.1016/S0098-8472(03)00059-5
   Stoll M, 2000, J EXP BOT, V51, P1627, DOI 10.1093/jexbot/51.350.1627
   Tang YL, 2007, PLANT PHYSIOL, V143, P629, DOI 10.1104/pp.106.090712
   Thomas DS, 2001, SCI HORTIC-AMSTERDAM, V90, P93, DOI 10.1016/S0304-4238(00)00260-0
   Vassileva V, 2011, J PLANT RES, V124, P147, DOI 10.1007/s10265-010-0340-7
   Vaz J, 2011, INDIAN J EXP BIOL, V49, P60
   Wang ZL, 2003, J AM SOC HORTIC SCI, V128, P349
   WERY J, 1994, EUPHYTICA, V73, P73, DOI 10.1007/BF00027184
   Wilkinson S, 1997, PLANT PHYSIOL, V113, P559, DOI 10.1104/pp.113.2.559
   Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444
   Yordanov I., 2003, J PLANT PHYSL, V187, P206
   ZHANG J, 1990, PLANT CELL ENVIRON, V13, P277, DOI 10.1111/j.1365-3040.1990.tb01312.x
   ZHANG J, 1987, J EXP BOT, V38, P2015, DOI 10.1093/jxb/38.12.2015
   Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018
   ZHANG JH, 1989, NEW PHYTOL, V113, P167, DOI 10.1111/j.1469-8137.1989.tb04703.x
   Zlatev Z., 2009, BIOTECHNOL, V23, P437
NR 77
TC 4
Z9 4
U1 4
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4238
EI 1879-1018
J9 SCI HORTIC-AMSTERDAM
JI Sci. Hortic.
PD MAR 8
PY 2016
VL 200
BP 25
EP 35
DI 10.1016/j.scienta.2015.12.049
PG 11
WC Horticulture
SC Agriculture
GA DI3QA
UT WOS:000373412300005
DA 2018-12-27
ER

PT J
AU Chanmanee, W
   Islam, MF
   Dennis, BH
   MacDonnell, FM
AF Chanmanee, Wilaiwan
   Islam, Mohammad Fakrul
   Dennis, Brian H.
   MacDonnell, Frederick M.
TI RETRACTED: Solar photothermochemical alkane reverse combustion
   (Retracted article. See vol.115, pg.E557, 2018)
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article; Retracted Publication
DE solar fuel; CO2 reduction; water splitting; photochemistry;
   Fischer-Tropsch
ID FISCHER-TROPSCH SYNTHESIS; CARBON-DIOXIDE; PHOTOCATALYTIC CONVERSION;
   SUPPORTED COBALT; PHOTOELECTROCHEMICAL REDUCTION;
   TEMPERATURE-DEPENDENCE; CONCENTRATED SUNLIGHT; HYDROCARBON FUELS;
   RENEWABLE ENERGY; WATER-VAPOR
AB A one-step, gas-phase photothermocatalytic process for the synthesis of hydrocarbons, including liquid alkanes, aromatics, and oxygenates, with carbon numbers (C-n) up to C-13, from CO2 and water is demonstrated in a flow photoreactor operating at elevated temperatures (180-200 degrees C) and pressures (1-6 bar) using a 5% cobalt on TiO2 catalyst and under UV irradiation. A parametric study of temperature, pressure, and partial pressure ratio revealed that temperatures in excess of 160 degrees C are needed to obtain the higher C-n products in quantity and that the product distribution shifts toward higher C-n products with increasing pressure. In the best run so far, over 13% by mass of the products were C-5+ hydrocarbons and some of these, i.e., octane, are drop-in replacements for existing liquid hydrocarbons fuels. Dioxygen was detected in yields ranging between 64% and 150%. In principle, this tandem photochemical-thermochemical process, fitted with a photocatalyst better matched to the solar spectrum, could provide a cheap and direct method to produce liquid hydrocarbons from CO2 and water via a solar process which uses concentrated sunlight for both photochemical excitation to generate high-energy intermediates and heat to drive important thermochemical carbonchain-forming reactions.
C1 [Chanmanee, Wilaiwan; Islam, Mohammad Fakrul; MacDonnell, Frederick M.] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA.
   [Dennis, Brian H.] Univ Texas Arlington, Dept Mech & Aerosp Engn, Arlington, TX 76019 USA.
RP MacDonnell, FM (reprint author), Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA.; Dennis, BH (reprint author), Univ Texas Arlington, Dept Mech & Aerosp Engn, Arlington, TX 76019 USA.
EM dennisb@uta.edu; macdonn@uta.edu
FU National Science Foundation [CHE-1301332]; Robert A. Welch Foundation
   [Y-1301]; University of Texas at Arlington Center for Renewable Science
   and Technology (CREST)
FX We thank Dr. Upendra Joshi helpful discussions and help with reviewing
   the manuscript. We also thank the reviewers for many helpful comments
   that greatly improved this manuscript. The National Science Foundation
   (CHE-1301332), Robert A. Welch Foundation (Y-1301), and the University
   of Texas at Arlington Center for Renewable Science and Technology
   (CREST) are gratefully acknowledged for financial support.
CR Alibabaei L, 2015, P NATL ACAD SCI USA, V112, P5899, DOI 10.1073/pnas.1506111112
   Alibabaei L, 2013, J MATER CHEM A, V1, P4133, DOI 10.1039/c2ta00935h
   Armaroli N, 2010, ENERGY SUSTAINABLE W, P203
   Ashford DL, 2015, CHEM REV, V115, P13006, DOI 10.1021/acs.chemrev.5b00229
   Barbir F, 2005, SOL ENERGY, V78, P661, DOI 10.1016/j.solener.2004.09.003
   Barton EE, 2008, J AM CHEM SOC, V130, P6342, DOI 10.1021/ja0776327
   Centi G, 2013, ENERG ENVIRON SCI, V6, P1711, DOI 10.1039/c3ee00056g
   Chen XB, 2010, CHEM REV, V110, P6503, DOI 10.1021/cr1001645
   Cole EB, 2010, J AM CHEM SOC, V132, P11539, DOI 10.1021/ja1023496
   Cox CR, 2014, P NATL ACAD SCI USA, V111, P14057, DOI 10.1073/pnas.1414290111
   Dry M. E., 1981, CATALYSIS SCI TECHNO, V1, P159
   FORSS L, 1993, APPL PHYS B-PHOTO, V56, P363, DOI 10.1007/BF00324533
   Gratzel M., 1983, ENERGY RESOURCES PHO
   Guan GQ, 2003, APPL CATAL A-GEN, V249, P11, DOI 10.1016/S0926-860X(03)00205-9
   Guan GQ, 2003, APPL CATAL B-ENVIRON, V41, P387, DOI 10.1016/S0926-3373(02)00174-1
   Habisreutinger SN, 2013, ANGEW CHEM INT EDIT, V52, P7372, DOI 10.1002/anie.201207199
   HALMANN M, 1978, NATURE, V275, P115, DOI 10.1038/275115a0
   Hisatomi T, 2014, CHEM SOC REV, V43, P7520, DOI 10.1039/c3cs60378d
   Hoffmann MR, 2011, DALTON T, V40, P5151, DOI 10.1039/c0dt01777a
   Hwang JS, 2005, TOP CATAL, V35, P311, DOI 10.1007/s11244-005-3839-8
   INOUE T, 1979, NATURE, V277, P637, DOI 10.1038/277637a0
   Izumi Y, 2013, COORDIN CHEM REV, V257, P171, DOI 10.1016/j.ccr.2012.04.018
   James OO, 2012, RSC ADV, V2, P7347, DOI 10.1039/c2ra20519j
   Kamat PV, 2010, CHEM REV, V110, P6664, DOI 10.1021/cr100243p
   Karaca H, 2010, CHEM COMMUN, V46, P788, DOI 10.1039/b920110f
   Khodakov AY, 2007, CHEM REV, V107, P1692, DOI 10.1021/cr050972v
   Khodakov AY, 2009, CATAL TODAY, V144, P251, DOI 10.1016/j.cattod.2008.10.036
   Kubacka A, 2012, CHEM REV, V112, P1555, DOI 10.1021/cr100454n
   Kumar B, 2012, ANNU REV PHYS CHEM, V63, P541, DOI 10.1146/annurev-physchem-032511-143759
   Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103
   Liu C, 2015, NANO LETT, V15, P3634, DOI 10.1021/acs.nanolett.5b01254
   Liu YY, 2009, CATAL COMMUN, V11, P210, DOI 10.1016/j.catcom.2009.10.010
   Mao J, 2013, CATAL SCI TECHNOL, V3, P2481, DOI 10.1039/c3cy00345k
   Mizuno T, 1996, J PHOTOCH PHOTOBIO A, V98, P87, DOI 10.1016/1010-6030(96)04334-1
   Pendyala VRR, 2013, CATAL LETT, V143, P895, DOI 10.1007/s10562-013-1076-5
   Rani S, 2014, APPL SURF SCI, V289, P203, DOI 10.1016/j.apsusc.2013.10.135
   Roy SC, 2010, ACS NANO, V4, P1259, DOI 10.1021/nn9015423
   Saladin F, 1997, J CHEM SOC FARADAY T, V93, P4159, DOI 10.1039/a704801g
   SALADIN F, 1995, J CHEM SOC CHEM COMM, P533, DOI 10.1039/c39950000533
   Schubnell M, 1997, APPL PHYS A-MATER, V64, P109
   Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106
   Solomon S, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P19
   Song WJ, 2013, ENERG ENVIRON SCI, V6, P1240, DOI 10.1039/c3ee24184j
   Song WJ, 2011, PURE APPL CHEM, V83, P749, DOI 10.1351/PAC-CON-10-11-09
   Steinfeld A, 2005, SOL ENERGY, V78, P603, DOI 10.1016/j.solener.2003.12.012
   Subrahmanyam M, 1999, APPL CATAL B-ENVIRON, V23, P169, DOI 10.1016/S0926-3373(99)00079-X
   The Hydrogen Economy, 2004, OPP COSTS BARR R D N, P256
   Torella JP, 2015, P NATL ACAD SCI USA, V112, P2337, DOI 10.1073/pnas.1424872112
   van der Giesen C, 2014, ENVIRON SCI TECHNOL, V48, P7111, DOI 10.1021/es500191g
   VANNICE MA, 1975, J CATAL, V37, P449, DOI 10.1016/0021-9517(75)90181-5
   Varghese OK, 2009, NANO LETT, V9, P731, DOI 10.1021/nl803258p
   Visconti CG, 2013, CATAL TODAY, V214, P61, DOI 10.1016/j.cattod.2012.10.016
   Visconti CG, 2009, APPL CATAL A-GEN, V355, P61, DOI 10.1016/j.apcata.2008.11.027
   VOLLHARDT KPC, 1984, ANGEW CHEM INT EDIT, V23, P539, DOI 10.1002/anie.198405393
   Walter MG, 2010, CHEM REV, V110, P6446, DOI 10.1021/cr1002326
   Xia XH, 2007, CARBON, V45, P717, DOI 10.1016/j.carbon.2006.11.028
   Zennaro R, 2000, CATAL TODAY, V58, P309, DOI 10.1016/S0920-5861(00)00264-9
   Zhang YQ, 2002, CATAL TODAY, V71, P411, DOI 10.1016/S0920-5861(01)00468-0
NR 58
TC 19
Z9 19
U1 3
U2 73
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 8
PY 2016
VL 113
IS 10
BP 2579
EP 2584
DI 10.1073/pnas.1516945113
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG4AW
UT WOS:000372013300023
PM 26903631
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Ge, YX
   Tian, XZ
AF Ge, Yu-Xing
   Tian, Xiang-Zhu
TI RETRACTED: Clc-2 knockout attenuated experimental temporal lobe epilepsy
   in mice by tonic inhibition mediated by GABA(A) receptors (Retracted
   article. See vol. 125, pg. 222, 2016)
SO BRAIN RESEARCH BULLETIN
LA English
DT Article; Retracted Publication
DE Temporal lobe epilepsy; GABA(A) receptors; Chloride channel-2; Tonic
   inhibition
ID CIC-2 CHLORIDE CHANNEL; NITRIC-OXIDE; HIPPOCAMPUS; CLCN2; CELLS;
   MUTATIONS; SEIZURES; VOLTAGE
AB Temporal lobe epilepsy (TLE), the most prevalent form of epilepsy, is often associated with drug-resistant seizures. In TLE, altered function of gamma-aminobutyric acid (GABA)(A) receptors (GABA(A)Rs) results in potentiation of excitatory and/or failure of inhibitory neurotransmission, which contributes to seizure induction and propagation. Our previous study suggested that chloride channel-2 (Clc-2) contributed to chronically elevated tonic inhibition mediated by GABA(A)Rs in a rat model of TLE. In the present study, we used Clc-2 knockout mice to investigate further the role of Clc-2 and its interaction with tonic GABAergic inhibition in a model of TLE. The results revealed that knockout of Clc-2 decreased tonic seizure protection, latency of clonic seizure, seizure threshold and mortality protection in mice. Clc-2 knockout decreased the action potential (AP)(peak) and AP(thresboid), Clc-2 currents and GABA(A)R-mediated tonic inhibition in CA1 pyramidal neurons. Thus, the voltage-gated chloride channel Clc-2, which was functionally upregulated in CA1 pyramidal cells after seizures, may provide protection against TLE by its regulation of action potentials, Clc-2 currents and GABA(A)Rs in the CA1 region of the hippocampus. (C) 2016 Elsevier Inc. All rights reserved.
C1 [Ge, Yu-Xing; Tian, Xiang-Zhu] Tongji Univ, Affiliated Peoples Hosp 10, Dept Neurol, 301 YanChang Rd, Shanghai 200072, Peoples R China.
RP Ge, YX (reprint author), Tongji Univ, Affiliated Peoples Hosp 10, Dept Neurol, 301 YanChang Rd, Shanghai 200072, Peoples R China.
EM yuxing_ge@yeah.net
FU National Natural Science Foundation of China [81301104]
FX This work was supported by grant from the National Natural Science
   Foundation of China (No. 81301104).
CR Blanz J, 2007, J NEUROSCI, V27, P6581, DOI 10.1523/JNEUROSCI.0338-07.2007
   Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220
   Brown JT, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.05.025
   D'Agostino D, 2004, NEUROLOGY, V63, P1500
   Everett K, 2007, EPILEPSY RES, V75, P145, DOI 10.1016/j.eplepsyres.2007.05.004
   Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8
   Galanopoulou AS, 2008, CURR NEUROPHARMACOL, V6, P1, DOI 10.2174/157015908783769653
   Ge YX, 2011, NEUROSCIENCE, V186, P120, DOI 10.1016/j.neuroscience.2011.04.029
   Glykys J, 2008, J NEUROSCI, V28, P1421, DOI 10.1523/JNEUROSCI.4751-07.2008
   Gonzalez MI, 2015, NEUROBIOL DIS, V77, P246, DOI 10.1016/j.nbd.2015.03.001
   GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0
   Gulacsi A, 2003, J NEUROSCI, V23, P8237
   Jordt SE, 1997, EMBO J, V16, P1582, DOI 10.1093/emboj/16.7.1582
   LOSCHER W, 1991, EPILEPSY RES, V8, P171, DOI 10.1016/0920-1211(91)90062-K
   Mladinic M, 1999, P ROY SOC B-BIOL SCI, V266, P1207, DOI 10.1098/rspb.1999.0764
   Moezi L, 2012, EPILEPSY BEHAV, V23, P399, DOI 10.1016/j.yebeh.2012.02.001
   Nehrke K, 2002, J BIOL CHEM, V277, P23604, DOI 10.1074/jbc.M202900200
   Niemeyer MI, 2004, PHYSIOL GENOMICS, V19, P74, DOI 10.1152/physiolgenomics.00070.2004
   Pavlov I, 2013, NEUROPHARMACOLOGY, V69, P55, DOI 10.1016/j.neuropharm.2012.04.003
   Prenosil GA, 2006, J NEUROPHYSIOL, V96, P846, DOI 10.1152/jn.01199.2006
   Rinke I, 2010, J NEUROSCI, V30, P4776, DOI 10.1523/JNEUROSCI.6299-09.2010
   Rivera C, 1999, NATURE, V397, P251
   Ruusuvuori E, 2004, J NEUROSCI, V24, P2699, DOI 10.1523/JNEUROSCI.5176-03.2004
   Shafaroodi H, 2015, EPILEPSY BEHAV, V48, P35, DOI 10.1016/j.yebeh.2015.05.018
   Sik A, 2000, NEUROSCIENCE, V101, P51, DOI 10.1016/S0306-4522(00)00360-2
   THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0
   Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x
NR 27
TC 1
Z9 1
U1 5
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
EI 1873-2747
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD MAR
PY 2016
VL 121
BP 209
EP 214
DI 10.1016/j.brainresbull.2016.02.006
PG 6
WC Neurosciences
SC Neurosciences & Neurology
GA DI3SN
UT WOS:000373418900025
PM 26876934
DA 2018-12-27
ER

PT J
AU Jafer, I
   Stack, P
   MacNamee, K
AF Jafer, Issa
   Stack, Paul
   MacNamee, Kevin
TI RETRACTED: Design of New Power Management Circuit for Light Energy
   Harvesting System (Retracted Article. See vol 16, art no 1831, 2016)
SO SENSORS
LA English
DT Article; Retracted Publication
DE light harvesting; maximum power point tracking and boost converter;
   Wireless Sensors Network
ID WIRELESS SENSOR NETWORKS; NODES; TRACKING
AB Nowadays, it can be observed that Wireless Sensors Networks (WSN) are taking increasingly vital roles in many applications, such as building energy monitoring and control, which is the focus of the work in this paper. However, the main challenging issue with adopting WSN technology is the use of power sources such as batteries, which have a limited lifetime. A smart solution that could tackle this problem is using Energy Harvesting technology. The work in this paper will be focused on proposing a new power management design through harvesting indoor light intensity. The new approach is inspired by the use of the Fractional Open Circuit Voltage based Maximum Power Point tracking (MPPT) concept for sub mw Photo Voltaic (PV) cells. The new design adopts two main features: First, it minimizes the power consumed by the power management section; and second, it maximizes the MPPT-converted output voltage and consequently improves the efficiency of the power conversion in the sub mw power level. The new experimentally-tested design showed an improvement of 81% in the efficiency of MPPT conversion using 0.5 mW input power in comparison with the other presented solutions that showed less efficiency with higher input power.
C1 [Jafer, Issa; Stack, Paul; MacNamee, Kevin] Natl Univ Ireland Univ Coll Cork, Sch Engn, Western Rd, Cork, Ireland.
RP Jafer, I (reprint author), Natl Univ Ireland Univ Coll Cork, Sch Engn, Western Rd, Cork, Ireland.
EM essa.jafer@Campus.ie; Paul_Stack@campus.ie; Kevin.Macnamee@Campus.ie
FU Science Foundation Ireland (SFI); Enterprise Ireland
FX The authors would like to acknowledge the support of Science Foundation
   Ireland (SFI) and Enterprise Ireland for their financial support to this
   work.
CR Akyildiz IF, 2002, COMPUT NETW, V38, P393, DOI 10.1016/S1389-1286(01)00302-4
   Alippi C, 2008, IEEE T CIRCUITS-I, V55, P1742, DOI 10.1109/TCSI.2008.922023
   Arora A, 2004, COMPUT NETW, V46, P605, DOI 10.1016/j.comnet.2004.06.007
   Bassi G, 2013, IET POWER ELECTRON, V6, P1151, DOI 10.1049/iet-pel.2012.0625
   Brunelli D., 2008, P C DES AUT TEST EUR, P104, DOI [10.1.1.301.7015, DOI 10.1109/DATE.2008.4484670]
   Brunelli D, 2009, 2009 1ST INTERNATIONAL CONFERENCE ON WIRELESS COMMUNICATION, VEHICULAR TECHNOLOGY, INFORMATION THEORY AND AEROSPACE & ELECTRONIC SYSTEMS TECHNOLOGY, VOLS 1 AND 2, P11, DOI 10.1109/WIRELESSVITAE.2009.5172413
   Brunelli D, 2009, IEEE T CIRCUITS-I, V56, P2519, DOI 10.1109/TCSI.2009.2015690
   Chini A, 2010, ELECTRON LETT, V46, P296, DOI 10.1049/el.2010.2903
   Dondi D, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON SUSTAINABLE ENERGY TECHNOLOGIES (ICSET), VOLS 1 AND 2, P945, DOI 10.1109/ICSET.2008.4747143
   Dondi D, 2008, IEEE T IND ELECTRON, V55, P2759, DOI 10.1109/TIE.2008.924449
   Esram T, 2007, IEEE T ENERGY CONVER, V22, P439, DOI 10.1109/TEC.2006.874230
   Farhan S., 2006, P 6 ACM C EMB NETW S
   He T., 2004, P 2 INT C MOB SYST A, P270, DOI DOI 10.1145/990064.990096
   JIANG X, 2005, P 4 INT S INF PROC S, P463
   Kori RH, 2009, 2009 INTERNATIONAL CONFERENCE ON ADVANCES IN RECENT TECHNOLOGIES IN COMMUNICATION AND COMPUTING (ARTCOM 2009), P571, DOI 10.1109/ARTCom.2009.232
   Park C., 2006, P 3 ANN IEEE COMM SO, P168
   Park C., 2004, P INT S LOW POW EL D, P168
   Polastre J., 2004, HOT CHIPS, V16, P22
   Raghavendra C. S., 2004, WIRELESS SENSOR NETW
   Raghunathan Vijay, 2005, P 4 INT S INF PROC S
   Richelli A, 2012, IEEE T IND ELECTRON, V59, P2701, DOI 10.1109/TIE.2011.2167890
   Schlyter P., BRIGHT ARE NATURAL L
   Simjee FI, 2008, IEEE T POWER ELECTR, V23, P1526, DOI 10.1109/TPEL.2008.921078
   Stankovic JA, 2008, COMPUTER, V41, P92, DOI 10.1109/MC.2008.441
   Suat U., 2015, J SENS
   Tan YK, 2011, IEEE T POWER ELECTR, V26, P38, DOI 10.1109/TPEL.2010.2056700
   Tan YK, 2011, IEEE T IND ELECTRON, V58, P4424, DOI 10.1109/TIE.2010.2102321
   United States Department of Energy, INT EN OUTL 2011
   Wang Y., 2015, IEEE T COMPUT AID D, V99, P124
   WOLF SMM, 1993, IEEE POWER ELECTRON, P581, DOI 10.1109/PESC.1993.471985
   Yick J, 2008, COMPUT NETW, V52, P2292, DOI 10.1016/j.comnet.2008.04.002
NR 31
TC 2
Z9 2
U1 4
U2 15
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1424-8220
J9 SENSORS-BASEL
JI Sensors
PD MAR
PY 2016
VL 16
IS 3
DI 10.3390/s16030270
PG 20
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA DI7WV
UT WOS:000373713600062
PM 26907300
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Nie, S
   Yue, H
   Xing, D
AF Nie, S.
   Yue, H.
   Xing, D.
TI RETRACTED: A Potential Role for Mitochondrial Produced Reactive Oxygen
   Species in Salicylic Acid-Mediated Plant Acquired Thermotolerance
   (Retracted Article)
SO PLANT PHYSIOLOGY
LA English
DT Correction; Retracted Publication
CR Nie Shengjun, 2015, Plant Physiol, DOI 10.1104/pp.15.00719
NR 1
TC 0
Z9 0
U1 3
U2 15
PU AMER SOC PLANT BIOLOGISTS
PI ROCKVILLE
PA 15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA
SN 0032-0889
EI 1532-2548
J9 PLANT PHYSIOL
JI Plant Physiol.
PD MAR
PY 2016
VL 170
IS 3
BP 1895
EP 1895
DI 10.1104/pp.16.00125
PG 1
WC Plant Sciences
SC Plant Sciences
GA DL1VI
UT WOS:000375420300051
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Bahador, R
   Taheriazam, A
   Mirghasemi, A
   Torkaman, A
   Shakeri, M
   Yahaghi, E
   Goudarzi, PK
AF Bahador, Reza
   Taheriazam, Afshin
   Mirghasemi, Alireza
   Torkaman, Ali
   Shakeri, Mohammadreza
   Yahaghi, Emad
   Goudarzi, Peyman Karimi
TI RETRACTED: Tissue expression levels of miR-29b and miR-422a in children,
   adolescents, and young adults' age groups and their association with
   prediction of poor prognosis in human osteosarcoma (Retracted article.
   See vol.37, pg. 16407, 2016)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE miR-29b and miR-422a; Survival; PCR; Osteosarcoma; Pathology
ID HEPATOCELLULAR-CARCINOMA; MICRORNA; CANCER; PROLIFERATION; EXPERIENCE;
   CELLS
AB Osteosarcoma is the most common type of bone cancer in children and adolescents. MicroRNAs (miRNAs) play important roles in the development, differentiation, and function of different cell types and in the pathogenesis of various human diseases. miRNAs are differentially expressed in normal and cancer cells. The investigation of miRNA expression between healthy subjects and patients with osteosarcoma is crucial for future clinical trials. In this study, the expression levels of miRNAs were detected by qRT-PCR. Correlation between expression levels of tow miRNAs and different clinicopathological characteristics were analyzed using the chi (2) test. Survival rate was detected using the log-rank test and Kaplan-Meier method. qRT-PCR was shown that expression levels of miR-29b and miR-422a were strongly decreased in osteosarcoma bone tissue compared with noncancerous bone tissues. Our result indicated that the low expression levels of miR-29b and miR-422a showed strong correlation with large tumor size (P = 0.20; 0.029), advanced TNM stage (P = 0.001; 0.012), distant metastasis (P = 0.008; 0.019), and grade of tumor (P = 0.009; 0.016). Kaplan-Meier survival analysis showed that the low expressions of miR-29b/miR-422a were correlated with shorter time overall survival (log-rank test, P = 0.009; P = 0.013). Moreover, multivariate Cox proportional hazards model indicated that miR-29b and miR-422a (P = 0.024; P = 0.016) were independent prognostic markers of overall survival of patients. Our result indicated that downregulation of miR-29b and miR-422a may be linked to the prediction of poor prognosis, indicating that miR-29b and miR-422a may be a valuable prognostic marker for osteosarcoma patients.
C1 [Bahador, Reza; Shakeri, Mohammadreza] Birjand Univ Med Sci, Dept Orthopaed & Trauma Surg, Birjand, Iran.
   [Taheriazam, Afshin] Islamic Azad Univ, Dept Orthoped Surg, Tehran Med Sci Branch, Tehran, Iran.
   [Mirghasemi, Alireza] Qom Univ Med Sci, Dept Orthoped, Qom, Iran.
   [Torkaman, Ali] Iran Univ Med Sci, Firoozgar Hosp, Dept Orthoped, Tehran, Iran.
   [Yahaghi, Emad] Baqiyatallah Univ Med Sci, Dept Mol Biol, Tehran, Iran.
   [Goudarzi, Peyman Karimi] AJA Univ Med Sci, Dept Neurosurg, Tehran, Iran.
RP Goudarzi, PK (reprint author), AJA Univ Med Sci, Dept Neurosurg, Tehran, Iran.
EM Pedram_kg@yahoo.com
OI Taheriazam, Afshin/0000-0002-3907-925X; Mirghasemi,
   Alireza/0000-0001-7569-8456
CR Baumhoer D, 2012, CANCER GENET-NY, V205, P212, DOI 10.1016/j.cancergen.2012.03.001
   Broadhead Matthew L., 2011, Sarcoma, P959248, DOI 10.1155/2011/959248
   Cheng JJ, 2013, CELL REP, V5, P471, DOI 10.1016/j.celrep.2013.08.050
   Dai N, 2013, NEOPLASMA, V60, P384, DOI 10.4149/neo_2013_050
   Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x
   Gougelet A, 2011, INT J CANCER, V129, P680, DOI 10.1002/ijc.25715
   Henry JC, 2010, BIOCHEM BIOPH RES CO, V403, P120, DOI 10.1016/j.bbrc.2010.10.130
   Hong QN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0037-1
   Huang JH, 2014, TUMOR BIOL, V35, P1095, DOI 10.1007/s13277-013-1146-8
   Jin J, 2013, ASIAN PAC J CANCER P, V14, P3681, DOI 10.7314/APJCP.2013.14.6.3681
   Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663
   Kager L, 2006, J CLIN ONCOL, V24, P1535, DOI 10.1200/JCO.2005.04.2978
   Kwiecinski M, 2012, LAB INVEST, V92, P978, DOI 10.1038/labinvest.2012.70
   Leary SES, 2013, CANCER-AM CANCER SOC, V119, P2645, DOI 10.1002/cncr.28111
   Ottaviani G, 2009, CANC TREAT, V152, P3, DOI 10.1007/978-1-4419-0284-9_1
   Sandhu R, 2014, INT J ONCOL, V44, P563, DOI 10.3892/ijo.2013.2197
   Sun YH, 2010, BIOCHEM BIOPH RES CO, V396, P501, DOI 10.1016/j.bbrc.2010.04.127
   Wu XJ, 2013, ASIAN PAC J CANCER P, V14, P885, DOI 10.7314/APJCP.2013.14.2.885
   Yan B, 2015, ONCOTARGETS THER, V8, P539, DOI 10.2147/OTT.S75899
   Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906
NR 20
TC 12
Z9 13
U1 4
U2 8
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD MAR
PY 2016
VL 37
IS 3
BP 3091
EP 3095
DI 10.1007/s13277-015-4140-5
PG 5
WC Oncology
SC Oncology
GA DK4QJ
UT WOS:000374903500033
PM 26423405
DA 2018-12-27
ER

PT J
AU Liu, P
   Zhang, M
   Xie, X
   Jin, J
   Holman, CDJ
AF Liu, Ping
   Zhang, Min
   Xie, Xing
   Jin, Jie
   Holman, C. D'Arcy J.
TI RETRACTED: Polymorphisms of 5,10-methylenetetrahydrofolate reductase and
   thymidylate synthase, dietary folate intake, and the risk of leukemia in
   adults (retracted article)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Adult leukemia risk; MTHFR; TS; Dietary folate intake; Gene-environment
   interaction; Case-control study
ID ACUTE LYMPHOBLASTIC-LEUKEMIA; METHYLENETETRAHYDROFOLATE REDUCTASE;
   COMMON MUTATION; MTHFR C677T; CHINESE POPULATION; MYELOID-LEUKEMIA;
   BREAST-CANCER; GENE; DNA; METAANALYSIS
AB The 5,10-methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase (TS) are critical enzymes in folate metabolism. Previous studies have reported conflicting results on the associations between MTHFR/TS polymorphisms and adult leukemia risk, which may due to the lack of information on folate intake. We investigated the risks of adult leukemia with genetic polymorphisms of folate metabolic enzymes (MTHFR C677T, A1298C, and TS) and evaluated if the associations varied by dietary folate intake from a multicenter case-control study conducted in Chinese. This study comprised 442 incident adult leukemia cases and 442 outpatient controls, individually matched to cases by gender, birth quinquennium, and study site. Genotypes were determined by a polymerase chain reaction (PCR) or PCR-based restriction fragment length polymorphism assay. Dietary folate intake was assessed by face-to-face interviews using a validated food-frequency questionnaire. The MTHFR 677TT genotype conferred a significant higher risk of leukemia in males than in females and exhibited an increased risk of acute myeloid leukemia (AML) but a decreased risk of acute lymphoblastic leukemia (ALL). The MTHFR 1298AC genotype appeared to decrease the risks of leukemia in both genders, in AML and ALL. Stratified analysis by dietary folate intake showed the increased risks of leukemia with the MTHFR 677TT and TS 2R3R/2R2R genotypes were only significant in individuals with low folate intake. A significant interaction between TS polymorphism and dietary folate intake was observed (P = 0.03). This study suggests that dietary folate intake and gender may modify the associations between MTHFR/TS polymorphisms and adult leukemia risk.
C1 [Liu, Ping; Zhang, Min; Holman, C. D'Arcy J.] Univ Western Australia, Sch Populat Hlth, M431,35 Stirling Highway, Perth, WA 6009, Australia.
   [Zhang, Min] Macquarie Univ, Australian Inst Hlth Innovat, Ctr Healthcare Resilience & Implementat Sci, Level 6,75 Talavera Rd, Macquarie, NSW 2109, Australia.
   [Xie, Xing] Zhejiang Univ, Sch Med, Womens Hosp, 1 Xueshi Rd, Hangzhou 310006, Zhejiang, Peoples R China.
   [Jin, Jie] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Hematol, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.
RP Liu, P (reprint author), Univ Western Australia, Sch Populat Hlth, M431,35 Stirling Highway, Perth, WA 6009, Australia.
EM ping.liu@research.uwa.edu.au
FU National Health and Medical Research Council (Australia) [572542]
FX This study was funded by the National Health and Medical Research
   Council (Australia) Project Grant (grant number 572542).
CR Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290
   Breslow NE, 1980, STATISTICAL METHODS, V1, P162
   Chen J, 2005, CANCER RES, V65, P1606, DOI 10.1158/0008-5472.CAN-04-2630
   COLE P, 2001, CANC PRINCIPLES PRAC, P228
   Cui YH, 2009, J DIGEST DIS, V10, P118, DOI 10.1111/j.1751-2980.2009.00373.x
   Duthie SJ, 1999, BRIT MED BULL, V55, P578, DOI 10.1258/0007142991902646
   Ferlay JSI, 2013, IARC CANCERBASE
   Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299
   FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111
   Gemmati D, 2009, AM J HEMATOL, V84, P526, DOI 10.1002/ajh.21451
   Gilliland DG, 1998, LEUKEMIA, V12, pS7
   Heijmans BT, 2003, CANCER RES, V63, P1249
   HORIE N, 1995, CELL STRUCT FUNCT, V20, P191, DOI 10.1247/csf.20.191
   Huang LL, 2015, CANCER EPIDEMIOL, V39, P328, DOI 10.1016/j.canep.2015.02.012
   Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4
   Inoue-Choi M, 2012, INT J MOL EPIDEMIOL, V3, P160
   KANEDA S, 1987, NUCLEIC ACIDS RES, V15, P1259, DOI 10.1093/nar/15.3.1259
   Khorshied MM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-013-0794-2
   Kim HN, 2009, LEUKEMIA RES, V33, P82, DOI 10.1016/j.leukres.2008.07.026
   Lehman NL, 2002, EXPERT OPIN INV DRUG, V11, P1775, DOI 10.1517/13543784.11.12.1775
   Li B, 2014, TUMOR BIOL, V35, P4233, DOI 10.1007/s13277-013-1554-9
   Li SY, 2015, MED SCI MONITOR, V21, P740, DOI 10.12659/MSM.892835
   Liu P, 2015, CANCER CAUSE CONTROL, V26, P1141, DOI 10.1007/s10552-015-0608-2
   Lv L, 2010, EUR J HAEMATOL, V84, P506, DOI 10.1111/j.1600-0609.2010.01430.x
   Mason JB, 2005, ALCOHOL, V35, P235, DOI 10.1016/j.alcohol.2005.03.012
   National Institute of Nutrition and Food Safety, 2009, CHIN FOOD COMP BOOK, V1, P3
   National Institute of Nutrition and Food Safety, 2005, CHIN FOOD COMP, V2, P77
   National Institute of Nutrition and Food Safety, 2002, CHIN FOOD COMP BOOK, V1, P326
   Navarro-Peran E, 2005, CANCER RES, V65, P2059, DOI 10.1158/0008-5472.CAN-04-3469
   Oh D, 2007, ANTICANCER RES, V27, P3419
   Qin YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088823
   Robien K, 2003, AM J EPIDEMIOL, V157, P571, DOI 10.1093/aje/kwg024
   Rota M, 2014, CANCER EPIDEMIOL, V38, P339, DOI 10.1016/j.canep.2014.06.001
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P129
   Shrubsole MJ, 2004, CANCER EPIDEM BIOMAR, V13, P190, DOI 10.1158/1055-9965.EPI-03-0273
   Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738
   Skibola CF, 2002, BLOOD, V99, P3786, DOI 10.1182/blood.V99.10.3786
   Skibola CF, 1999, P NATL ACAD SCI USA, V96, P12810, DOI 10.1073/pnas.96.22.12810
   van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825
   Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714
   Weng Y, 2012, LEUKEMIA LYMPHOMA, V53, P1345, DOI 10.3109/10428194.2011.649477
   WICKRAMASINGHE SN, 1994, BLOOD, V83, P1656
   Willett W, 1998, NUTR EPIDEMIOLOGY, P273
   Xiao Y, 2014, ONCOL RES TREAT, V37, P576, DOI 10.1159/000368104
   Yang L, 2011, LEUKEMIA LYMPHOMA, V52, P1770, DOI 10.3109/10428194.2011.578186
   Zhang M, 2005, Asia Pac J Public Health, V17, P29, DOI 10.1177/101053950501700108
   Zhang M, 2002, THESIS CURTIN U TECH
NR 47
TC 1
Z9 2
U1 2
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD MAR
PY 2016
VL 37
IS 3
BP 3265
EP 3275
DI 10.1007/s13277-015-4168-6
PG 11
WC Oncology
SC Oncology
GA DK4QJ
UT WOS:000374903500051
PM 26438060
DA 2018-12-27
ER

PT J
AU Cai, HX
   Huang, YM
   Tang, T
   Wang, Q
   Du, JF
   Zhang, T
AF Cai, Huaxiang
   Huang, Yongmei
   Tang, Tao
   Wang, Qiang
   Du, Junfeng
   Zhang, Tong
TI RETRACTED: Double speed loops control for high-precision position
   tracking of position-controlled actuators involving a harmonic drive
   reducer (Retracted article. See vol. 10, 2018)
SO ADVANCES IN MECHANICAL ENGINEERING
LA English
DT Article; Retracted Publication
DE Harmonic drive; dead zone; nonlinear friction; double speed loops;
   extended state observer; turning error
ID ACTIVE SUSPENSION SYSTEMS; EXTENDED-STATE-OBSERVER; ROBUST-CONTROL;
   TORQUE CONTROL; COMPENSATION; MOTOR; ROBOT
AB In this article, a kind of position control method based on double speed closed loops is proposed to reduce turning error and nonlinear dead zone, which are caused by the flexibility and nonlinear friction in harmonic drive system. The speed loop of motor side is the inner loop and the speed loop of load side is the outer loop. Besides, the robustness performances of double speed loops and single speed loop are analyzed in theory, respectively. And it is stated that the performance of double speed loops is better than the performance of single speed loop. Furthermore, to further reduce the turning error and enhance the precision of system, the article puts forward applying double proportional-integral controllers with double extended state observers in the two speed loops. Extended state observers can transform the nonlinear models into an approximate linear model and eliminate the nonlinear frictions in the system. Finally, a few comparative experimental results show that the proposed control method has better performance for restraining the nonlinear features and enhancing the precision of the harmonic drive system.
C1 [Cai, Huaxiang; Huang, Yongmei; Tang, Tao; Wang, Qiang; Du, Junfeng; Zhang, Tong] Chinese Acad Sci, Inst Opt & Elect, POB 350, Chengdu 610209, Peoples R China.
   [Cai, Huaxiang; Huang, Yongmei; Tang, Tao; Wang, Qiang; Du, Junfeng; Zhang, Tong] Chinese Acad Sci, Key Lab Beam Control, Chengdu, Peoples R China.
   [Cai, Huaxiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China.
RP Cai, HX (reprint author), Chinese Acad Sci, Inst Opt & Elect, POB 350, Chengdu 610209, Peoples R China.
EM chx_ioe@163.com
CR Al-Holou N, 2002, IEEE T FUZZY SYST, V10, P234, DOI 10.1109/91.995124
   Alipouri Y, 2013, ISA T, V52, P291, DOI 10.1016/j.isatra.2012.10.004
   Calvini M, 2015, IEEE T IND ELECTRON, V62, P768, DOI 10.1109/TIE.2014.2349478
   Chen WJ, 2015, IEEE T CONTR SYST T, V23, P164, DOI 10.1109/TCST.2014.2317776
   Fialho I, 2002, IEEE T CONTR SYST T, V10, P43, DOI 10.1109/87.974337
   Gandhi PS, 2002, IEEE T CONTR SYST T, V10, P759, DOI 10.1109/TCST.2002.804119
   Gao HJ, 2006, J SOUND VIB, V290, P654, DOI 10.1016/j.jsv.2005.04.007
   Gao ZQ, 2003, P AMER CONTR CONF, P4989
   Iwasaki M, 2009, IEEE ASME INT C ADV, P662, DOI 10.1109/AIM.2009.5229935
   Kennedy CW, 2005, IEEE-ASME T MECH, V10, P263, DOI 10.1109/TMECH.2005.848290
   Lemmer L., 2006, P IEEE 3 INT C MECH, P369
   Liu HX, 2012, IEEE T IND ELECTRON, V59, P1171, DOI 10.1109/TIE.2011.2162217
   Lu YS, 2007, ELECTR ENG, V90, P95, DOI 10.1007/s00202-006-0057-8
   Montague R, 2012, IEEE-ASME T MECH, V17, P269, DOI 10.1109/TMECH.2010.2096473
   Pizzocaro M, 2013, IEEE T ULTRASON FERR, V60, P273, DOI 10.1109/TUFFC.2013.2563
   Sensinger JW, 2006, IEEE-ASME T MECH, V11, P457, DOI 10.1109/TMECH.2006.878540
   Sharp S., 2012, 2012 UKACC International Conference on Control (CONTROL), P546, DOI 10.1109/CONTROL.2012.6334688
   Smadi IA, 2012, IEEE T IND ELECTRON, V59, P2208, DOI 10.1109/TIE.2011.2148687
   Sun WC, 2012, IEEE T IND ELECTRON, V59, P530, DOI 10.1109/TIE.2011.2134057
   Sun WC, 2011, IEEE T CONTR SYST T, V19, P416, DOI 10.1109/TCST.2010.2042296
   Tadayoni A, 2011, INT J CONTROL AUTOM, V9, P50, DOI 10.1007/s12555-011-0107-5
   Taghirad HD, 1997, IEEE INT CONF ROBOT, P1749, DOI 10.1109/ROBOT.1997.614402
   Tjahjowidodo T, 2013, MECHATRONICS, V23, P497, DOI 10.1016/j.mechatronics.2013.04.002
   Vassileva D, 2011, MECH BASED DES STRUC, V39, P253, DOI 10.1080/15397734.2011.550859
   Yao JY, 2014, IEEE T IND ELECTRON, V61, P6285, DOI 10.1109/TIE.2014.2304912
   Yao JY, 2014, IEEE-ASME T MECH, V19, P633, DOI 10.1109/TMECH.2013.2252360
   Yao JY, 2014, IEEE T IND ELECTRON, V61, P3630, DOI 10.1109/TIE.2013.2281165
   Zhang HW, 2015, IEEE-ASME T MECH, V20, P178, DOI 10.1109/TMECH.2014.2311382
   Zhao ZY, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS I-V, CONFERENCE PROCEEDINGS, P3321, DOI 10.1109/ICMA.2007.4304095
   Zheng Q., 2007, P 46 IEEE C DEC CONT, P3501, DOI DOI 10.1109/CDC.2007.4434676
   Zhu WH, 2007, IEEE INT CONF ROBOT, P3831, DOI 10.1109/ROBOT.2007.364066
   Zhu Z, 2013, IEEE T IND ELECTRON, V60, P5882, DOI 10.1109/TIE.2012.2232254
NR 32
TC 1
Z9 1
U1 10
U2 56
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1687-8140
J9 ADV MECH ENG
JI Adv. Mech. Eng.
PD MAR
PY 2016
VL 8
IS 3
AR 1687814016638785
DI 10.1177/1687814016638785
PG 10
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA DI6KC
UT WOS:000373606600028
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Baughman, BM
   Pattenden, SG
   Norris, JL
   James, LI
   Frye, SV
AF Baughman, Brandi M.
   Pattenden, Samantha G.
   Norris, Jacqueline L.
   James, Lindsey I.
   Frye, Stephen V.
TI RETRACTED: The L3MBTL3 Methyl-Lysine Reader Domain Functions As a Dimer
   (Retracted article. See vol. 13, pg. 281, 2018)
SO ACS CHEMICAL BIOLOGY
LA English
DT Article; Retracted Publication
ID SMALL-MOLECULE LIGANDS; CHROMATIN-STRUCTURE; BINDING-PROTEINS; HISTONE
   H3; ACTIVE GENES; DNA; IDENTIFICATION; RECOGNITION; ANTAGONISTS;
   INHIBITORS
AB L3MBTL3 recognizes mono- and dimethylated lysine residues on histone tails. The recently reported X-ray cocrystal structures of the chemical probe UNC1215 and inhibitor UNC2533 bound to the methyl-lysine reading MBT domains of L3MBTL3 demonstrate a unique and flexible 2:2 dimer mode of recognition. In this study, we describe our in vitro analysis of L3MBTL3 dimerization via its MBT domains and additionally show that this dimerization occurs within a cellular context in the absence of small molecule ligands. Furthermore, mutations to the first and second MBT domains abrogated L3MBTL3 dimerization both in vitro and in cells. These observations are consistent with the hypothesis that L3MBTL3 engages methylated histone tails as a dimer while carrying out its normal function and provides an explanation for the presence of repeated MBT domains within L3MBTL3.
C1 [Baughman, Brandi M.; Pattenden, Samantha G.; Norris, Jacqueline L.; James, Lindsey I.; Frye, Stephen V.] Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, UNC Eshelman Sch Pharm, Chapel Hill, NC 27599 USA.
RP Frye, SV (reprint author), Univ N Carolina, Ctr Integrat Chem Biol & Drug Discovery, Div Chem Biol & Med Chem, UNC Eshelman Sch Pharm, Chapel Hill, NC 27599 USA.
EM svfrye@email.unc.edu
FU National Institute of General Medical Sciences, U.S. National Institutes
   of Health (NIH) [R01GM100919]; Carolina Partnership; University Cancer
   Research Fund
FX We thank the Structural Genomics Consortium for providing the constructs
   and/or plasmids for L3MBTL3 and CBX7. This research was supported by the
   National Institute of General Medical Sciences, U.S. National Institutes
   of Health (NIH, grant R01GM100919), the Carolina Partnership, and the
   University Cancer Research Fund.
CR Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499
   Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010
   Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043
   Camerino MA, 2013, MEDCHEMCOMM, V4, P1501, DOI 10.1039/c3md00197k
   Gao C, 2011, J AM CHEM SOC, V133, P5357, DOI 10.1021/ja110432e
   Herold J Martin, 2011, Curr Chem Genomics, V5, P51, DOI 10.2174/1875397301005010051
   Herold JM, 2011, J MED CHEM, V54, P2504, DOI 10.1021/jm200045v
   James LI, 2013, CLIN PHARMACOL THER, V93, P312, DOI 10.1038/clpt.2013.6
   James LI, 2013, J MED CHEM, V56, P7358, DOI 10.1021/jm400919p
   James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]
   Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127
   Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802
   Knight MJ, 2011, PROTEIN SCI, V20, P1697, DOI 10.1002/pro.703
   KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868
   Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005
   Luger K, 1997, NATURE, V389, P251
   Nady N, 2012, J MOL BIOL, V423, P702, DOI 10.1016/j.jmb.2012.08.022
   Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861
   Paul B, 2012, DRUG DISCOV TODAY, V9, pe101
   Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080
   Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121
   Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981
   Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000
   Simhadri C, 2014, J MED CHEM, V57, P2874, DOI 10.1021/jm401487x
   Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005
   Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412
   Takada Y, 2007, DEVELOPMENT, V134, P579, DOI 10.1242/dev.02747
   Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008
   Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338
   Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048
   Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004
   VANHOLDE KE, 1980, BIOPHYS J, V32, P271, DOI 10.1016/S0006-3495(80)84956-3
   Wagner EK, 2012, BIOCHEMISTRY-US, V51, P8293, DOI 10.1021/bi3009278
   Wang WK, 2003, STRUCTURE, V11, P775, DOI 10.1016/S0969-2126(03)00127-8
   Wigle TJ, 2010, J BIOMOL SCREEN, V15, P62, DOI 10.1177/1087057109352902
   Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301
NR 36
TC 8
Z9 8
U1 3
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1554-8929
EI 1554-8937
J9 ACS CHEM BIOL
JI ACS Chem. Biol.
PD MAR
PY 2016
VL 11
IS 3
BP 722
EP 728
DI 10.1021/acschembio.5b00632
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA DH3CJ
UT WOS:000372664800018
PM 26317848
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Soltani, A
   Bouderbala, W
   Boudjahem, AG
AF Soltani, Abdelhamid
   Bouderbala, Wissam
   Boudjahem, Abdel-ghani
TI RETRACTED: First Principles Study of the Geometries, Relative
   Stabilities and Magnetic Properties of Bimetallic RhnOs (n=1-9) Clusters
   (Retracted article. See vol. 27, pg. 1499, 2016)
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article; Retracted Publication
DE DFT; RhnOs clusters; Relative stability; Magnetic properties
ID RHODIUM NANOPARTICLES; ELECTRONIC-PROPERTIES; CARBON NANOTUBES; OSMIUM
   CLUSTERS; SIZE CONTROL; RH; CATALYSTS; HYDROFORMYLATION; HYDROGENATION;
   DIMERS
AB Using the density functional theory (DFT), the geometries, relative stabilities and magnetic properties of bimetallic RhnOs (n = 1-9) clusters have been investigated. The relative stability was analyzed by examining the binding energy, fragmentation energy, second-order differences of energies and HOMO-LUMO energy gaps. The obtained results indicate that RhOs, Rh3Os, Rh5Os and Rh7Os clusters are more stable than their neighboring clusters. In addition, the doping of the Os atom enhanced the stability of the Rh clusters. The chemical hardness and chemical potential show that RhOs cluster is less reactive, indicating that RhOs cluster is the most stable one among all the clusters. The magnetic properties calculations exhibited that total magnetic moments come mostly from the Rh atoms for RhnOs (n = 3-9) clusters, while the contribution of the Os atom is observed for RhOs and Rh2Os clusters. In addition, the d orbitals plays an important role in the magnetic moments of the RhnOs clusters.
C1 [Soltani, Abdelhamid; Bouderbala, Wissam; Boudjahem, Abdel-ghani] Univ Guelma, Nanomat Chem Grp, Box 401, Guelma 24000, Algeria.
RP Soltani, A (reprint author), Univ Guelma, Nanomat Chem Grp, Box 401, Guelma 24000, Algeria.
EM soltanihamid@yahoo.fr
CR ADAMS RD, 1995, ORGANOMETALLICS, V14, P4167, DOI 10.1021/om00009a019
   Au CT, 1999, J CATAL, V185, P12, DOI 10.1006/jcat.1999.2498
   Behr A, 2012, TETRAHEDRON LETT, V53, P2680, DOI 10.1016/j.tetlet.2012.03.062
   Beltran MR, 2013, EUR PHYS J D, V67, DOI 10.1140/epjd/e2013-30547-2
   Bouderbala W, 2014, MOL PHYS, V112, P1789, DOI 10.1080/00268976.2013.865089
   Bruss AJ, 2006, J MOL CATAL A-CHEM, V252, P212, DOI 10.1016/j.molcata.2006.02.063
   Campos CH, 2015, APPL CATAL A-GEN, V489, P280, DOI 10.1016/j.apcata.2014.10.029
   Chamberlain TW, 2012, CHEM SCI, V3, P1919, DOI 10.1039/c2sc01026g
   Chen MX, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2916588
   Chien CH, 1998, PHYS REV A, V58, P2196, DOI 10.1103/PhysRevA.58.2196
   COTTON FA, 1984, INORG CHIM A-ART LET, V87, P115
   COX AJ, 1993, PHYS REV LETT, V71, P923, DOI 10.1103/PhysRevLett.71.923
   Dennler S, 2003, SURF SCI, V532, P334, DOI 10.1016/S0039-6028(03)00468-0
   Dong CD, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020409
   Du JG, 2008, INT J QUANTUM CHEM, V108, P1505, DOI 10.1002/qua.21684
   Du JA, 2007, J MOL STRUC-THEOCHEM, V817, P47, DOI 10.1016/j.theochem.2007.04.018
   GINGERIC KA, 1972, J CHEM SOC CHEM COMM, P536, DOI 10.1039/c39720000536
   Gopidas KR, 2003, NANO LETT, V3, P1757, DOI 10.1021/nl0348490
   HALPERIN WP, 1986, REV MOD PHYS, V58, P533, DOI 10.1103/RevModPhys.58.533
   Han DF, 2008, J MOL CATAL A-CHEM, V283, P15, DOI 10.1016/j.molcata.2007.12.008
   Izumi Y, 2007, J PHYS CHEM C, V111, P10073, DOI 10.1021/jp072616h
   LEWIS LN, 1993, CHEM REV, V93, P2693, DOI 10.1021/cr00024a006
   Lv J, 2012, PHYSICA B, V407, P14, DOI 10.1016/j.physb.2011.08.102
   Lv J, 2009, CHEM PHYS, V363, P65, DOI 10.1016/j.chemphys.2009.07.011
   Mendes FMT, 1997, APPL CATAL A-GEN, V163, P153, DOI 10.1016/S0926-860X(97)00139-7
   Mokkath JH, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.054407
   MORSE MD, 1986, CHEM REV, V86, P1049, DOI 10.1021/cr00076a005
   PARKS EK, 1990, J CHEM PHYS, V92, P3813, DOI 10.1063/1.457839
   Parr R. G., 1989, DENSITY FUNCTIONAL T
   Reddy BV, 1999, PHYS REV B, V59, P5214, DOI 10.1103/PhysRevB.59.5214
   Sanchez A, 2014, APPL CATAL A-GEN, V477, P117, DOI 10.1016/j.apcata.2014.03.009
   SCHMID G, 1992, CHEM REV, V92, P1709, DOI 10.1021/cr00016a002
   Sidhpuria KB, 2009, APPL CLAY SCI, V42, P386, DOI 10.1016/j.clay.2008.03.010
   Soltani A, 2016, INT J QUANTUM CHEM, V116, P346, DOI 10.1002/qua.25038
   Soltani A, 2014, COMPUT THEOR CHEM, V1047, P6, DOI 10.1016/j.comptc.2014.08.011
   Srivastava AK, 2014, COMPUT THEOR CHEM, V1047, P1, DOI 10.1016/j.comptc.2014.08.008
   STEVENS WJ, 1984, J CHEM PHYS, V81, P6026, DOI 10.1063/1.447604
   TAIT CD, 1989, J AM CHEM SOC, V111, P9072, DOI 10.1021/ja00207a012
   Takahashi K, 2013, CHEM PHYS LETT, V555, P26, DOI 10.1016/j.cplett.2012.10.055
   Teranishi T, 1998, CHEM MATER, V10, P594, DOI 10.1021/cm9705808
   TRUNSCHKE A, 1989, J MOL CATAL, V56, P95, DOI 10.1016/0304-5102(89)80175-0
   Venkataramanan NS, 2008, J MOL STRUC-THEOCHEM, V856, P9, DOI 10.1016/j.theochem.2008.01.012
   Wang HM, 1997, J CHEM PHYS, V106, P2101, DOI 10.1063/1.473344
   Wu ZJ, 2005, CHEM PHYS LETT, V403, P367, DOI 10.1016/j.cplett.2005.01.037
   Xian Y. J., 2010, PHYSICA B, V405, P4892
   Xu XS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.237209
   Yang J X, 2010, PHYSICA B, V405, P4892
   Yang X, 2012, J CATAL, V291, P36, DOI 10.1016/j.jcat.2012.04.003
   Yonezawa T, 2001, LANGMUIR, V17, P4701, DOI 10.1021/la0101954
   Yoon TJ, 2003, INORG CHIM ACTA, V345, P228, DOI 10.1016/S0020-1693(02)01354-3
   Zhang JY, 2003, APPL SURF SCI, V208, P364, DOI 10.1016/S0169-4332(02)01401-0
   Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993
   Zoberbier T, 2012, J AM CHEM SOC, V134, P3073, DOI 10.1021/ja208746z
NR 53
TC 2
Z9 2
U1 3
U2 18
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
PD MAR
PY 2016
VL 27
IS 2
BP 715
EP 731
DI 10.1007/s10876-016-0970-6
PG 17
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA DH7FC
UT WOS:000372956500026
DA 2018-12-27
ER

PT J
AU Yellu, MR
   Engel, JM
   Ghose, A
   Onitilo, AA
AF Yellu, Mahender R.
   Engel, Jessica M.
   Ghose, Abhimanyu
   Onitilo, Adedayo A.
TI RETRACTED: Overview of recent trends in diagnosis and management of
   leptomeningeal multiple myeloma(Retracted article. See vol. 35, pg. 142,
   2017)
SO HEMATOLOGICAL ONCOLOGY
LA English
DT Review; Retracted Publication
DE central nervous system; multiple myeloma; metastasis
ID CENTRAL-NERVOUS-SYSTEM; STEM-CELL TRANSPLANTATION; OF-THE-LITERATURE;
   MULTIPLE-MYELOMA INVASION; MALIGNANT PLASMA-CELLS; FREE LIGHT-CHAINS;
   CEREBROSPINAL-FLUID; CHROMOSOMAL-ABNORMALITIES; CEREBRAL INVOLVEMENT;
   TUMOR-MARKER
AB Neurological complications related to multiple myeloma (MM) are not uncommon; however, direct involvement of the central nervous system (CNS) is extremely rare and represents a diagnostic and therapeutic challenge. Significant survival difference has been noted with the introduction of novel therapy in patients with MM, but their effect on the incidence and their use for management of leptomeningeal myeloma (LMM) is uncertain. Analysis of published data demonstrates its recent increased incidence, median time to CNS presentation, and slight improvement in median survival after diagnosis of LMM. Less common MM isotypes have been overrepresented in LMM. CNS relapse occurred mostly in patients with Durie-Salmon stage III MM. Despite treatments, standard or experimental, the survival rates of LMM remain dismal. Monitoring high risk patients closely, even after achieving complete remission, may be useful in early detection of LMM. As we gain better understanding of LMM, we recommend that future research and clinical care focus on earlier diagnosis and development of more efficient CNS-directed therapy to improve survival in this patient population. Copyright (c) 2014 John Wiley & Sons, Ltd.
C1 [Yellu, Mahender R.; Ghose, Abhimanyu] Univ Cincinnati, Div Hematol Oncol, Stem Cell Transplantat, Cincinnati, OH 45229 USA.
   [Engel, Jessica M.] Marshfield Clin Canc Care St Michaels, Stevens Point, WI USA.
   [Onitilo, Adedayo A.] Marshfield Clin Weston Ctr, Dept Hematol Oncol, Weston, WI USA.
RP Yellu, MR (reprint author), Univ Cincinnati, Dept Hematol Oncol & Stem Cell Transplantat, 234 Goodman St, Cincinnati, OH 45229 USA.
EM yellumr@ucmail.uc.edu
CR Abdallah A, 2014, CL LYMPH MYELOM LEUK, V14, P211, DOI 10.1016/j.clml.2013.11.004
   Alsobhi EM, 2007, SAUDI MED J, V28, P128
   Annibali O, 2009, INT J HEMATOL, V89, P513, DOI 10.1007/s12185-009-0277-6
   Bang HI, 2010, KOREAN J LAB MED, V30, P334, DOI 10.3343/kjlm.2010.30.4.334
   BOUDOURESQUES G, 1983, ANN MED INTERNE, V134, P117
   Brenner H, 2008, BLOOD, V111, P2521, DOI 10.1182/blood-2007-08-104984
   Chamberlain MC, 1998, J NEURO-ONCOL, V38, P135, DOI 10.1023/A:1005982826121
   Chang H, 2006, LEUKEMIA LYMPHOMA, V47, P43, DOI 10.1080/10428190500272549
   Chang H, 2005, BRIT J HAEMATOL, V129, P539, DOI 10.1111/j.1365-2141.2005.05493.x
   Chang H, 2004, BRIT J HAEMATOL, V127, P280, DOI 10.1111/j.1365-2141.2004.05199.x
   Chen CI, 2013, BRIT J HAEMATOL, V162, P483, DOI 10.1111/bjh.12414
   Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086
   Fassas ABT, 2004, LEUKEMIA LYMPHOMA, V45, P291, DOI 10.1080/10428190310001597964
   Fassas ABT, 2002, BRIT J HAEMATOL, V117, P103, DOI 10.1046/j.1365-2141.2002.03401.x
   Fischer C, 2004, CLIN CHEM, V50, P1809, DOI 10.1373/clinchem.2004.033977
   Fonseca Rafael, 2004, Cancer Research, V64, P1546, DOI 10.1158/0008-5472.CAN-03-2876
   Gangatharan SA, 2012, HEMATOL ONCOL, V30, P170, DOI 10.1002/hon.1021
   Giarin MM, 2009, CLIN CHEM, V55, P1510, DOI 10.1373/clinchem.2009.124370
   GIOSEFFI O N, 1992, Sangre (Saragossa), V37, P137
   Gozzetti A, 2012, CANCER-AM CANCER SOC, V118, P1574, DOI 10.1002/cncr.26447
   Harada Kunyu, 1992, Neurological Surgery, V20, P1113
   Hemeryck A, 2007, CANCER CHEMOTH PHARM, V60, P777, DOI 10.1007/s00280-007-0424-9
   Hildebrandt B, 2007, BMC CANCER, V3, P185
   Kang SY, 2005, ANN HEMATOL, V84, P588, DOI 10.1007/s00277-005-1047-z
   Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129
   Leal Ticiana, 2011, Curr Cancer Ther Rev, V7, P319
   Lee D, 2013, BRIT J HAEMATOL, V162, P371, DOI 10.1111/bjh.12404
   LEIFER D, 1992, CANCER-AM CANCER SOC, V70, P1899, DOI 10.1002/1097-0142(19921001)70:7<1899::AID-CNCR2820700716>3.0.CO;2-3
   LICHTENSTEIN A, 1995, CELL IMMUNOL, V162, P248, DOI 10.1006/cimm.1995.1076
   Majid N, 2013, NEUROLOGY, V80
   MCCARTHY J, 1978, J CLIN PATHOL, V31, P259, DOI 10.1136/jcp.31.3.259
   Mendez CE, 2010, CL LYMPH MYELOM LEUK, V10, P220, DOI 10.3816/CLML.2010.n.035
   MORAN CC, 1995, AM J NEURORADIOL, V16, P1501
   Moreau P, 2013, COMBINATION VELCADE
   Moreau P, 2007, LEUKEMIA, V21
   Mourad AR, 2010, AM J MED SCI, V339, P81, DOI 10.1097/MAJ.0b013e3181b61145
   Mussetti A, 2013, LEUKEMIA LYMPHOMA, V54, P864, DOI 10.3109/10428194.2012.718343
   Nahi H, 2014, EUR J HAEMATOL, V92, P454, DOI 10.1111/ejh.12247
   Nieuwenhuizen L, 2008, EUR J HAEMATOL, V80, P1, DOI 10.1111/j.1600-0609.2007.00956.x
   Ochiai N, 2002, LEUKEMIA LYMPHOMA, V43, P641, DOI 10.1080/10428190290012191
   Ohanian M, 2011, BLOOD LYMPHAT CANCER, V1, P9, DOI 10.2147/BLCTT.S22703
   Paludo J, 2013, AM SOC HEM OR SESS 6
   Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442
   Patriarca F, 2001, ANN HEMATOL, V80, P758, DOI 10.1007/s00277-001-0387-6
   Petersen SL, 1999, AM J HEMATOL, V62, P228, DOI 10.1002/(SICI)1096-8652(199912)62:4<228::AID-AJH5>3.0.CO;2-3
   Pika T, 2009, BIOMED PAP, V153, P271, DOI 10.5507/bp.2009.045
   Pontikoglou C, 2005, LEUKEMIA LYMPHOMA, V46, P737, DOI 10.1080/10428190500032661
   Potts BC, 2011, CURR CANCER DRUG TAR, V11, P254
   Qu XY, 2010, CHINESE MED J-PEKING, V123, P1402, DOI 10.3760/cma.j.issn.0366-6999.2010.11.009
   Quach H, 2005, BONE MARROW TRANSPL, V35, P423, DOI 10.1038/sj.bmt.1704777
   Renfrow JJ, 2012, J NEURO-ONCOL, V107, P659, DOI 10.1007/s11060-011-0788-x
   Riley JM, 2011, JPN J RADIOL, V29, P513, DOI 10.1007/s11604-011-0577-7
   Sahin F, 2006, J CLIN NEUROSCI, V13, P259, DOI 10.1016/j.jocn.2005.03.033
   Savage DG, 2002, LEUKEMIA RES, V26, P689, DOI 10.1016/S0145-2126(01)00190-4
   Schluterman KO, 2004, ARCH NEUROL-CHICAGO, V61, P1423, DOI 10.1001/archneur.61.9.1423
   Schroers R, 2010, EUR J HAEMATOL, V85, P236, DOI 10.1111/j.1600-0609.2010.01475.x
   Seftel MD, 2002, LEUKEMIA LYMPHOMA, V43, P2399, DOI 10.1080/1042819021000040125
   Short KD, 2011, LEUKEMIA, V25, P906, DOI 10.1038/leu.2011.29
   Stewart AK, 2009, BLOOD, V114, P5436, DOI 10.1182/blood-2009-07-204651
   Sthaneshwar P, 2009, CLIN CHEM LAB MED, V47, P1101, DOI 10.1515/CCLM.2009.260
   VANCAMP B, 1990, BLOOD, V76, P377
   Veinstein A, 1997, HEMATOL CELL THER, V39, P327, DOI 10.1007/s00282-997-0327-6
   Vermeiren P, 2011, ACTA CLIN BELG, V66, P205, DOI 10.2143/ACB.66.3.2062548
   Yi Ho Jun, 2013, Brain Tumor Res Treat, V1, P103, DOI 10.14791/btrt.2013.1.2.103
NR 64
TC 6
Z9 6
U1 1
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0278-0232
EI 1099-1069
J9 HEMATOL ONCOL
JI Hematol. Oncol.
PD MAR
PY 2016
VL 34
IS 1
BP 2
EP 8
DI 10.1002/hon.2185
PG 7
WC Oncology; Hematology
SC Oncology; Hematology
GA DH2TL
UT WOS:000372639200001
PM 25524637
OA Bronze
DA 2018-12-27
ER

PT J
AU Grujicic, M
   Snipes, JS
   Ramaswami, S
AF Grujicic, M.
   Snipes, J. S.
   Ramaswami, S.
TI RETRACTED: Multi-Length Scale Analysis of the Effect of Fused-Silica
   Pre-shocking on its Tendency for Devitrification(Retracted article. See
   vol. 26, pg. 1979, 2017)
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article; Retracted Publication
DE ballistic-penetration resistance; devitrification; fused silica;
   pre-shocking treatment
ID SODA-LIME GLASS; BALLISTIC-PENETRATION RESISTANCE; MOLECULAR-LEVEL
   ANALYSIS; AMORPHOUS SILICA; FORCE-FIELD; PRESSURE; MODEL; DENSIFICATION;
   POLYUREA; COMPASS
AB Recent studies have suggested that impact-induced devitrification of fused silica, or more specifically formation of high-density stishovite, can significantly improve ballistic-penetration resistance of fused silica, the material which is used in transparent armor. The studies have also shown that in order for stishovite to form during a ballistic impact event, very high projectile kinetic energy normalized by the projectile/fused-silica target-plate contact area must accompany such an event. Otherwise fused-silica devitrification, if taking place, does not substantially improve the material ballistic-penetration resistance. In the present work, all-atom molecular-level computations are carried out in order to establish if pre-shocking of fused-silica target-plates (to form stishovite) and subsequent unloading (to revert stishovite to the material amorphous structure) can increase fused silica's propensity for stishovite formation during a ballistic impact. Towards that end, molecular-level computational procedures are developed to simulate both the pre-shocking treatment of the fused-silica target-plate and its subsequent impact by a solid right-circular cylindrical projectile. The results obtained clearly revealed that when strong-enough shockwaves are used in the fused-silica target-plate pre-shocking procedure, the propensity of fused silica for stishovite formation during the subsequent ballistic impact is increased, as is the associated ballistic-penetration resistance. To rationalize these findings, a detailed post-processing microstructural analysis of the pre-shocked material is employed. The results obtained suggest that fused silica pre-shocked with shockwaves of sufficient strength retain some memory/embryos of stishovite, and these embryos facilitate stishovite formation during the subsequent ballistic impact.
C1 [Grujicic, M.; Snipes, J. S.; Ramaswami, S.] Clemson Univ, Dept Mech Engn, 241 Engn Innovat Bldg, Clemson, SC 29634 USA.
RP Grujicic, M (reprint author), Clemson Univ, Dept Mech Engn, 241 Engn Innovat Bldg, Clemson, SC 29634 USA.
EM gmica@clemson.edu
FU Office of Naval Research (ONR) [N00014-14-1-0286]; ONR
FX The material presented in this paper is based on work supported by the
   Office of Naval Research (ONR) research contract entitled
   "Reactive-Moiety Functionalization of Polyurea for Increased
   Shock-Mitigation Performance", Contract Number N00014-14-1-0286. The
   authors would like to express their appreciation to Dr. Roshdy Barsoum,
   ONR, program sponsor, for many helpful discussions, guidance, and
   continuing interest.
CR Alexander CS, 2008, INT J IMPACT ENG, V35, P1376, DOI 10.1016/j.ijimpeng.2008.07.019
   Amirkhizi AV, 2006, PHILOS MAG, V86, P5847, DOI 10.1080/14786430600833198
   Chakraborty R, 2010, METALL MATER TRANS A, V41A, P1301, DOI 10.1007/s11661-010-0176-8
   Grujicic M, 2008, MAT SCI ENG A-STRUCT, V491, P397, DOI 10.1016/j.msea.2008.02.020
   Grujicic M, 2016, J MATER SCI, V51, P3500, DOI 10.1007/s10853-015-9670-0
   Grujicic M, 2015, J MATER ENG PERFORM, V24, P4890, DOI 10.1007/s11665-015-1775-8
   Grujicic M, 2015, J MATER ENG PERFORM, V24, P2970, DOI 10.1007/s11665-015-1590-2
   Grujicic M, 2014, INT J STRUCT INTEGR, V5, P339, DOI 10.1108/IJSI-01-2014-0001
   Grujicic M, 2012, J MATER ENG PERFORM, V21, P1580, DOI 10.1007/s11665-011-0064-4
   Grujicic M, 2012, J MATER ENG PERFORM, V21, P823, DOI 10.1007/s11665-011-0005-2
   Grujicic M, 2012, P I MECH ENG L-J MAT, V226, P119, DOI 10.1177/1464420711433991
   Grujicic M, 2011, P I MECH ENG L-J MAT, V225, P298, DOI 10.1177/1464420711412849
   Grujicic M, 2011, J MATER ENG PERFORM, V20, P1144, DOI 10.1007/s11665-010-9774-2
   Grujicic M, 2003, APPL SURF SCI, V211, P166, DOI 10.1016/S0169-4332(03)00224-1
   Grujicic M, 2009, J MATER ENG PERFORM, V18, P1012, DOI 10.1007/s11665-008-9343-0
   Grujicic M, 2009, INT J IMPACT ENG, V36, P386, DOI 10.1016/j.ijimpeng.2008.08.001
   Grujicic M, 2014, MULTIDISCIP MODEL MA, V10, P474, DOI 10.1108/MMMS-11-2013-0070
   Grujicic M, 2012, J MATER ENG PERFORM, V21, P837, DOI 10.1007/s11665-011-0004-3
   Kingery W. D., 1976, INTRO CERAMICS, P91
   Kubota A, 2002, P SOC PHOTO-OPT INS, V4679, P108, DOI 10.1117/12.461717
   Mantisi B, 2012, EUR PHYS J B, V85, DOI 10.1140/epjb/e2012-30317-6
   NOSE S, 1991, PROG THEOR PHYS SUPP, P1
   Salleo A, 2003, NAT MATER, V2, P796, DOI 10.1038/nmat1013
   Sun H, 1998, COMPUT THEOR POLYM S, V8, P229, DOI 10.1016/S1089-3156(98)00042-7
   Sun H, 1998, J PHYS CHEM B, V102, P7338, DOI 10.1021/jp980939v
   Tschauner O, 2006, AM MINERAL, V91, P1857, DOI 10.2138/am.2006.2015
   Tu YH, 1998, PHYS REV LETT, V81, P4899, DOI 10.1103/PhysRevLett.81.4899
NR 27
TC 2
Z9 2
U1 2
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD MAR
PY 2016
VL 25
IS 3
BP 995
EP 1009
DI 10.1007/s11665-016-1940-8
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA DG8CD
UT WOS:000372309100030
DA 2018-12-27
ER

PT J
AU Sowa, PM
   Downes, MJ
   Gordon, LG
AF Sowa, Przemyslaw Marcin
   Downes, Martin J.
   Gordon, Louisa G.
TI RETRACTED: Cost-effectiveness of dual energy X-ray absorptiometry (DXA)
   plus anti-resorptive treatment in Australian women with breast cancer
   who receive aromatase inhibitors (Retracted Article)
SO JOURNAL OF BONE AND MINERAL METABOLISM
LA English
DT Correction; Retracted Publication
C1 [Sowa, Przemyslaw Marcin; Downes, Martin J.; Gordon, Louisa G.] Griffith Univ, Menzies Hlth Inst Queensland, Ctr Appl Hlth Econ, Meadowbrook, Qld 4131, Australia.
RP Sowa, PM (reprint author), Griffith Univ, Menzies Hlth Inst Queensland, Ctr Appl Hlth Econ, Meadowbrook, Qld 4131, Australia.
EM m.sowa@griffith.edu.au
RI Gordon, Louisa/P-1427-2016
OI Gordon, Louisa/0000-0002-3159-4249
CR SOWA PM, J BONE MINER METAB, P72337
NR 1
TC 1
Z9 1
U1 2
U2 5
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 0914-8779
EI 1435-5604
J9 J BONE MINER METAB
JI J. Bone Miner. Metab.
PD MAR
PY 2016
VL 34
IS 2
BP 242
EP 242
DI 10.1007/s00774-015-0663-5
PG 1
WC Endocrinology & Metabolism; Medicine, Research & Experimental
SC Endocrinology & Metabolism; Research & Experimental Medicine
GA DG7UO
UT WOS:000372289400014
OA Bronze
DA 2018-12-27
ER

PT J
AU Ji, QJ
   Chen, PJ
   Qin, GR
   Deng, X
   Hao, ZY
   Wawrzak, Z
   Yeo, WS
   Quang, JW
   Cho, H
   Luo, GZ
   Weng, XC
   You, QC
   Luan, CH
   Yang, XJ
   Bae, T
   Yu, KQ
   Jiang, HL
   He, C
AF Ji, Quanjiang
   Chen, Peter J.
   Qin, Guangrong
   Deng, Xin
   Hao, Ziyang
   Wawrzak, Zdzislaw
   Yeo, Won-Sik
   Quang, Jenny Winjing
   Cho, Hoonsik
   Luo, Guan-Zheng
   Weng, Xiaocheng
   You, Qiancheng
   Luan, Chi-Hao
   Yang, Xiaojing
   Bae, Taeok
   Yu, Kunqian
   Jiang, Hualiang
   He, Chuan
TI RETRACTED: Structure and mechanism of the essential two-component
   signal-transduction system WalKR in Staphylococcus aureus (Retracted
   article. See vol. 8, art no 1431, 2017)
SO NATURE COMMUNICATIONS
LA English
DT Article; Retracted Publication
ID RESPONSE REGULATOR; STREPTOCOCCUS-PNEUMONIAE; RNA-SEQ; VIRULENCE;
   EXPRESSION; DOMAINS; PATHWAY; INFECTIONS; COMPLEXES; DISCOVERY
AB Most low GC Gram-positive bacteria possess an essential walKR two-component system (TCS) for signal transduction involved in regulating cell wall homoeostasis. Despite the well-established intracellular regulatory mechanism, the role of this TCS in extracellular signal recognition and factors that modulate the activity of this TCS remain largely unknown. Here we identify the extracellular receptor of the kinase 'WalK' (erWalK) as a key hub for bridging extracellular signal input and intracellular kinase activity modulation in Staphylococcus aureus. Characterization of the crystal structure of erWalK revealed a canonical Per-Arnt-Sim (PAS) domain for signal sensing. Single amino-acid mutation of potential signal-transduction residues resulted in severely impaired function of WalKR. A small molecule derived from structure-based virtual screening against erWalK is capable of selectively activating the walKR TCS. The molecular level characterization of erWalK will not only facilitate exploration of natural signal(s) but also provide a template for rational design of erWalK inhibitors.
C1 [Ji, Quanjiang; Chen, Peter J.; Deng, Xin; Hao, Ziyang; Luo, Guan-Zheng; Weng, Xiaocheng; You, Qiancheng; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Dept Chem, Dept Biochem & Mol Biol, 929 East 57th St, Chicago, IL 60637 USA.
   [Ji, Quanjiang; Chen, Peter J.; Deng, Xin; Hao, Ziyang; Luo, Guan-Zheng; Weng, Xiaocheng; You, Qiancheng; He, Chuan] Univ Chicago, Howard Hughes Med Inst, Inst Biophys Dynam, 929 East 57th St, Chicago, IL 60637 USA.
   [Qin, Guangrong; Yu, Kunqian; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China.
   [Qin, Guangrong] Shanghai Acad Sci & Technol, Shanghai Ctr Bioinformat Technol, Shanghai 201203, Peoples R China.
   [Wawrzak, Zdzislaw] Northwestern Univ, Synchrotron Res Ctr, LS CAT, Argonne, IL 60439 USA.
   [Yeo, Won-Sik; Cho, Hoonsik; Bae, Taeok] Indiana Univ Sch Med Northwest, Gary, IN 46408 USA.
   [Quang, Jenny Winjing; Luan, Chi-Hao] Northwestern Univ, Ctr Struct Genom Infect Dis, Dept Mol Biosci, High Throughput Anal Lab, Evanston, IL 60208 USA.
   [Yang, Xiaojing] Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.
RP He, C (reprint author), Univ Chicago, Howard Hughes Med Inst, Dept Chem, Dept Biochem & Mol Biol, 929 East 57th St, Chicago, IL 60637 USA.; He, C (reprint author), Univ Chicago, Howard Hughes Med Inst, Inst Biophys Dynam, 929 East 57th St, Chicago, IL 60637 USA.; Jiang, HL (reprint author), Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China.
EM hljiang@mail.shcnc.ac.cn; chuanhe@uchicago.edu
OI Bae, Taeok/0000-0002-0576-2851
FU NIH NIAID from the National Institute of Allergy and Infectious Diseases
   [AI074658]; National High Technology Research and Development Program of
   China (863 Program) [2012AA020301, 2012AA01A305]; Chinese Academy of
   Sciences [KSZD-EW-L09-4]; National Natural Science Foundation of China
   grants [81230076, 21210003, 91313000]; US DOE [DE-AC02-06CH11357];
   Michigan Economic Development Corporation; Michigan Technology
   Tri-Corridor [085P1000817]; Indiana University Research Enhancement
   grant
FX We thank S.F. Reichard, MA for editing the manuscript. We thank Theint
   Aung and Dr. Arabela Grigorescu of the Keck Biophysics Facility at
   Northwestern University for assistance in SPR experiments. This work was
   financially supported by NIH NIAID AI074658 from the National Institute
   of Allergy and Infectious Diseases (to C.H.), the National High
   Technology Research and Development Program of China (863 Program) (No.
   2012AA020301 and 2012AA01A305), Chinese Academy of Sciences (Project
   KSZD-EW-L09-4) and the National Natural Science Foundation of China
   grants (81230076, 21210003 and 91313000) (to H.J.). Use of the Advanced
   Photon Source, an Office of Science User Facility operated for the US
   Department of Energy (DOE) Office of Science by Argonne National
   Laboratory, was supported by the US DOE under Contract no.
   DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the
   Michigan Economic Development Corporation and the Michigan Technology
   Tri-Corridor (Grant 085P1000817). C.H. is an investigator of the Howard
   Hughes Medical Institute. This study was, in part, supported by Indiana
   University Research Enhancement grant to T.B.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005
   Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j
   Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662
   Chen PR, 2006, NAT CHEM BIOL, V2, P591, DOI 10.1038/nchembio820
   CHEUNG AL, 1994, J BACTERIOL, V176, P4168
   Cheung J, 2008, J BIOL CHEM, V283, P30256, DOI 10.1074/jbc.M805253200
   Delaune A, 2012, INFECT IMMUN, V80, P3438, DOI 10.1128/IAI.00195-12
   Dosa PI, 2016, J MED CHEM, V59, P810, DOI 10.1021/acs.jmedchem.5b00982
   Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07
   Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fishman N, 2006, AM J INFECT CONTROL, V34, pS64, DOI 10.1016/j.ajic.2006.05.229
   Gotoh Y, 2010, CURR OPIN MICROBIOL, V13, P232, DOI 10.1016/j.mib.2010.01.008
   Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631
   Hosztafi S, 1993, Acta Pharm Hung, V63, P335
   Igarashi M, 2013, J ANTIBIOT, V66, P459, DOI 10.1038/ja.2013.33
   Jansen A, 2007, INT J MED MICROBIOL, V297, P205, DOI 10.1016/j.ijmm.2007.02.002
   Ji QJ, 2012, J BIOL CHEM, V287, P21102, DOI 10.1074/jbc.M112.359737
   Kadioglu A, 2003, INFECT IMMUN, V71, P6676, DOI 10.1128/IAI.71.11.6676-6679.2003
   KARAKAWA WW, 1988, INFECT IMMUN, V56, P1090
   Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x
   Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763
   Liang XD, 2005, J BACTERIOL, V187, P5486, DOI 10.1128/JB.187.15.5486-5492.2005
   Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Martin PK, 1999, J BACTERIOL, V181, P3666
   Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011
   Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x
   Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922
   Rester U, 2008, CURR OPIN DRUG DISC, V11, P559
   Sevvana M, 2008, J MOL BIOL, V377, P512, DOI 10.1016/j.jmb.2008.01.024
   Steinhuber A, 2003, J BACTERIOL, V185, P6278, DOI 10.1128/JB.185.21.6278-6286.2003
   Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603
   Sun F, 2012, P NATL ACAD SCI USA, V109, P9095, DOI 10.1073/pnas.1200603109
   Szurmant H, 2008, P NATL ACAD SCI USA, V105, P5891, DOI 10.1073/pnas.0800247105
   Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019
   Szurmant H, 2007, J BACTERIOL, V189, P3280, DOI 10.1128/JB.01936-06
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493
   WETZEL R, 1994, TRENDS BIOTECHNOL, V12, P193, DOI 10.1016/0167-7799(94)90082-5
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
NR 47
TC 12
Z9 12
U1 9
U2 34
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAR
PY 2016
VL 7
AR 11000
DI 10.1038/ncomms11000
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DG9NG
UT WOS:000372409200001
PM 26987594
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Liu, Y
   Xu, SH
   Wang, X
   Li, KY
   Liu, B
   Wu, H
   Tang, HP
AF Liu, Yong
   Xu, Shenghang
   Wang, Xin
   Li, Kaiyang
   Liu, Bin
   Wu, Hong
   Tang, Huiping
TI RETRACTED: Ultra-High Strength and Ductile Lamellar-Structured Powder
   Metallurgy Binary Ti-Ta Alloys (Retracted article. See vol. 70, pg.
   1349, 2018)
SO JOM
LA English
DT Article; Retracted Publication
ID MECHANICAL-PROPERTIES; BIOMEDICAL APPLICATIONS; CORROSION-RESISTANCE; MO
   ALLOYS; MARTENSITE; TI-6AL-4V; SYSTEM; BIOCOMPATIBILITY;
   SUPERELASTICITY; MICROSTRUCTURE
AB Ultra-high strength and ductile powder metallurgy (PM) binary Ti-20at.%Ta alloy has been fabricated via sintering from elemental Ti and Ta powders and subsequent hot swaging and annealing. The microstructural evolution and mechanical properties in each stage were evaluated. Results show that inhomogeneous microstructures with Ti-rich and Ta-rich areas formed in the as-sintered Ti-Ta alloys due to limited diffusion of Ta. In addition, Kirkendall porosity was observed as a result of the insufficient diffusion of Ta. Annealing at 1000A degrees C for up to 24 h failed to eliminate the pores. Hot swaging eliminated the residual sintering porosity and created a lamellar microstructure, consisting of aligned Ta-enriched and Ti-enriched phases. The hot-swaged and annealed PM Ti-20Ta alloy achieved an ultimate tensile strength of 1600 MPa and tensile elongation of more than 25%, due to its unique lamellar microstructure including the high toughness of Ta-enriched phases, the formation of alpha phase in the beta matrix and the refined lamellae.
C1 [Liu, Yong; Xu, Shenghang; Wang, Xin; Li, Kaiyang; Liu, Bin; Wu, Hong] Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
   [Tang, Huiping] Northwest Inst Nonferrous Met, State Key Lab Porous Met, Xian 710012, Shanxi, Peoples R China.
RP Liu, Y (reprint author), Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
EM yonliu@csu.edu.cn
FU National High Technology Research and Development Program of China (863
   Program) [2013AA031103]; Shenzhen Municipal Science and Technology Plan
   [CXY201107010187A]; Project of Innovation-driven Plan in Central South
   University [2015CX004]
FX The authors gratefully acknowledge the financial support from the
   National High Technology Research and Development Program of China (863
   Program) (No. 2013AA031103), Shenzhen Municipal Science and Technology
   Plan (CXY201107010187A), and the Project of Innovation-driven Plan in
   Central South University (2015CX004).
CR Baheti VA, 2013, INTERMETALLICS, V33, P87, DOI 10.1016/j.intermet.2012.09.020
   Cai MH, 2011, SCRIPTA MATER, V64, P1098, DOI 10.1016/j.scriptamat.2011.02.030
   Correa DRN, 2014, MAT SCI ENG C-MATER, V34, P354, DOI 10.1016/j.msec.2013.09.032
   Delvat E, 2008, J MECH BEHAV BIOMED, V1, P345, DOI 10.1016/j.jmbbm.2008.01.006
   Dong HX, 2011, MAT SCI ENG A-STRUCT, V528, P4849, DOI 10.1016/j.msea.2011.02.014
   Edwards PD, 2015, J MATER PROCESS TECH, V218, P107, DOI 10.1016/j.jmatprotec.2014.11.046
   Gao HY, 2009, INTERMETALLICS, V17, P1041, DOI 10.1016/j.intermet.2009.05.007
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kochmann W, 2004, J ALLOY COMPD, V372, pL15, DOI 10.1016/j.jallcom.2003.10.005
   Liu Y, 2015, J MECH BEHAV BIOMED, V51, P302, DOI 10.1016/j.jmbbm.2015.07.004
   Minho O, 2014, MICROELECTRON ENG, V120, P133, DOI 10.1016/j.mee.2013.09.009
   Park H. S., 2002, MAT SCI ENG A-STRUCT, V50, P329
   Talling RJ, 2009, ACTA MATER, V57, P1188, DOI 10.1016/j.actamat.2008.11.013
   Wangyu H., 1999, J HUNAN U, V26, P10
   Xie FX, 2013, ELECTROCHIM ACTA, V105, P121, DOI 10.1016/j.electacta.2013.04.105
   Xu W, 2015, ACTA MATER, V85, P74, DOI 10.1016/j.actamat.2014.11.028
   Xu XY, 2014, MAT SCI ENG A-STRUCT, V607, P409, DOI 10.1016/j.msea.2014.03.045
   Zhang B, 2013, CALPHAD, V43, P7, DOI 10.1016/j.calphad.2013.08.006
   Zhou SY, 2008, J MEMBRANE SCI, V325, P546, DOI 10.1016/j.memsci.2008.08.024
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 24
TC 3
Z9 3
U1 2
U2 35
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
EI 1543-1851
J9 JOM-US
JI JOM
PD MAR
PY 2016
VL 68
IS 3
BP 899
EP 907
DI 10.1007/s11837-015-1801-1
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA DF4BK
UT WOS:000371292100024
DA 2018-12-27
ER

PT J
AU Gonzalez, S
   Berthelot, J
   Jiner, J
   Perrin-Tricaud, C
   Fernando, R
   Chrast, R
   Lenaers, G
   Tricaud, N
AF Gonzalez, Sergio
   Berthelot, Jade
   Jiner, Jennifer
   Perrin-Tricaud, Claire
   Fernando, Ruani
   Chrast, Roman
   Lenaers, Guy
   Tricaud, Nicolas
TI RETRACTED: Blocking mitochondrial calcium release in Schwann cells
   prevents demyelinating neuropathies (Retracted article. See vol. 127,
   pg. 1115, 2017)
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article; Retracted Publication
ID MARIE-TOOTH DISEASE; AMYOTROPHIC-LATERAL-SCLEROSIS; ACTIVATED
   PROTEIN-KINASES; DEPENDENT ANION CHANNEL; PERMEABILITY TRANSITION;
   DIABETIC-NEUROPATHY; PERIPHERAL NEUROPATHY; AXONAL INTEGRITY;
   CYCLOPHILIN-D; C-JUN
AB Schwann cells produce myelin sheath around peripheral nerve axons. Myelination is critical for rapid propagation of action potentials, as illustrated by the large number of acquired and hereditary peripheral neuropathies, such as diabetic neuropathy or Charcot-Marie-Tooth diseases, that are commonly associated with a process of demyelination. However, the early molecular events that trigger the demyelination program in these diseases remain unknown. Here, we used virally delivered fluorescent probes and in vivo time-lapse imaging in a mouse model of demyelination to investigate the underlying mechanisms of the demyelination process. We demonstrated that mitochondria! calcium released by voltage-dependent anion channel 1 (VDAC1) after sciatic nerve injury triggers Schwann cell demyelination via ERK1/2, p38, JNK, and c-JUN activation. In diabetic mice, VDAC1 activity was altered, resulting in a mitochondria! calcium leak in Schwann cell cytoplasm, thereby priming the cell for demyelination. Moreover, reduction of mitochondria! calcium release, either by shRNA-mediated VDAC1 silencing or pharmacological inhibition, prevented demyelination, leading to nerve conduction and neuromuscular performance recovery in rodent models of diabetic neuropathy and Charcot-Marie-Tooth diseases. Therefore, this study identifies mitochondria as the early key factor in the molecular mechanism of peripheral demyelination and opens a potential opportunity for the treatment of demyelinating peripheral neuropathies.
C1 [Gonzalez, Sergio; Berthelot, Jade; Jiner, Jennifer; Perrin-Tricaud, Claire; Fernando, Ruani; Lenaers, Guy; Tricaud, Nicolas] Univ Montpellier, Inst Neurosci Montpellier, INSERM, U1051, F-34059 Montpellier, France.
   [Chrast, Roman] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.
   [Chrast, Roman] Karolinska Inst, Dept Neurosci, Stockholm, Sweden.
   [Lenaers, Guy] Univ Angers, Mitochondrial Med Res Ctr, Pole Rech & Enseignement Med Mitochondriale, Angers, France.
RP Tricaud, N (reprint author), Inst Neurosci Montpellier, INSERM, U1051, 80 Rue Augustin Fliche, F-34091 Montpellier, France.
EM nicolas.tricaud@inserm.fr
OI lenaers, guy/0000-0003-2736-3349
FU European Research Council [FP7-IDEAS-ERC 311610]; INSERM-AFM Avenir
   grant; StratNeuro program
FX We acknowledge H. Boukhadaoui (Montpellier RIO Imaging Platform), C.
   Cazevieille and A. Caballero-Megido (Centre des Resources en Imagerie
   Cellulaire - TEM platform), and the Animal Facility of the Institute for
   Neurosciences of Montpellier for help and technical assistance. We would
   like to thank J.C. Jonas (Universite Catholique de Louvain, Belgium) for
   the mito-SypHer probe, X. Wang (Peking University, China) for the
   mito-GCaMP2 probe, M. Sereda (Gottingen, Germany) for the CMT1A rat
   model, A.L. Bonnefont (Montpellier, France) for behavior tests
   assistance, W. Joly for critical reading of the manuscript, and P.
   Bomont, M. Teigell, and C. Raoul for technical help. This work was
   supported by European Research Council grant (FP7-IDEAS-ERC 311610 to N.
   Tricaud), an INSERM-AFM Avenir grant (to N. Tricaud), and the StratNeuro
   program (to R. Chrast).
CR Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434
   Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095
   Bordet T, 2007, J PHARMACOL EXP THER, V322, P709, DOI 10.1124/jpet.107.123000
   Chen M, 2011, ACTA BIOCH BIOPH SIN, V43, P822, DOI 10.1093/abbs/gmr075
   Chittoor-Vinod VG, 2015, ASN NEURO, V7, DOI 10.1177/1759091415569909
   Chuderland Dana, 2008, Commun Integr Biol, V1, P4
   Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028
   Cotter L, 2010, SCIENCE, V328, P1415, DOI 10.1126/science.1187735
   De Pinto V, 2010, FEBS LETT, V584, P1793, DOI 10.1016/j.febslet.2010.02.049
   Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803
   Feldman EL, 2003, J CLIN INVEST, V111, P431, DOI 10.1172/JC1200317863
   Fernyhough Paul, 2010, Expert Rev Endocrinol Metab, V5, P39
   Fledrich R, 2014, NAT MED, V20, P1055, DOI 10.1038/nm.3664
   Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007
   Gainutdinov T, 2015, ARCH BIOCHEM BIOPHYS, V579, P40, DOI 10.1016/j.abb.2015.05.009
   Goldin N, 2008, ONCOGENE, V27, P4636, DOI 10.1038/onc.2008.108
   Gonzalez S, 2015, MITOCHONDRION, V23, P32, DOI 10.1016/j.mito.2015.05.004
   Gonzalez S, 2014, NAT PROTOC, V9, P1160, DOI 10.1038/nprot.2014.073
   Hamilton RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065725
   Hantke J, 2014, BRAIN, V137, P2922, DOI 10.1093/brain/awu257
   Hantke J, 2009, EUR J HUM GENET, V17, P1606, DOI 10.1038/ejhg.2009.99
   HARATI Y, 1987, ANN INTERN MED, V107, P546, DOI 10.7326/0003-4819-107-4-546
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   Hughes RAC, 2002, BRIT MED J, V324, P466, DOI 10.1136/bmj.324.7335.466
   Javadov S, 2014, PHARMACOL THERAPEUT, V144, P202, DOI 10.1016/j.pharmthera.2014.05.013
   Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746
   KOLB H, 1987, DIABETES METAB REV, V3, P751, DOI 10.1002/dmr.5610030308
   Lee Hye Jeong, 2014, Exp Neurobiol, V23, P130, DOI 10.5607/en.2014.23.2.130
   Lobsiger CS, 2009, P NATL ACAD SCI USA, V106, P4465, DOI 10.1073/pnas.0813339106
   LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4
   Malik R A, 2014, Handb Clin Neurol, V126, P249, DOI 10.1016/B978-0-444-53480-4.00016-3
   Martin LJ, 2010, IDRUGS, V13, P568
   Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P706, DOI 10.1136/jnnp-2012-302451
   Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614
   Okada T, 2009, HUM GENE THER, V20, P1013, DOI 10.1089/hum.2009.006
   Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013
   Pham K, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E7
   Rigobello MP, 2002, BRIT J PHARMACOL, V136, P1162, DOI 10.1038/sj.bjp.0704823
   RITCHIE JM, 1987, J PHYSIOL-PARIS, V82, P248
   ROBERTSON DM, 1980, DIABETES, V29, P60, DOI 10.2337/diabetes.29.1.60
   Roma LP, 2012, BIOCHEM J, V441, P971, DOI 10.1042/BJ20111770
   Salzer JL, 2008, J CELL BIOL, V181, P575, DOI 10.1083/jcb.200804136
   Fazan VPS, 2010, INT J MORPHOL, V28, P51, DOI 10.4067/S0717-95022010000100007
   Schwartz Michael W, 2013, J Clin Invest, V123, P2344, DOI 10.1172/JCI69346
   Sereda M, 1996, NEURON, V16, P1049, DOI 10.1016/S0896-6273(00)80128-2
   Sharov VG, 2007, J MOL CELL CARDIOL, V42, P150, DOI 10.1016/j.yjmcc.2006.09.013
   Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743
   Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111
   Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279
   SKRE H, 1974, CLIN GENET, V6, P98
   STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0
   Sugimoto K, 2000, DIABETES-METAB RES, V16, P408
   Timmerman V, 2014, GENES-BASEL, V5, P13, DOI 10.3390/genes5010013
   Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012
   Viader A, 2011, J NEUROSCI, V31, P10128, DOI 10.1523/JNEUROSCI.0884-11.2011
   Wang L, 2011, NEUROSCIENCE, V193, P399, DOI 10.1016/j.neuroscience.2011.07.039
   Zenker J, 2012, NEUROSCIENCE, V32, P7493
   Zenker J, 2013, TRENDS NEUROSCI, V36, P439, DOI 10.1016/j.tins.2013.04.008
   Zochodne DW, 2008, CURR OPIN NEUROL, V21, P527, DOI 10.1097/WCO.0b013e32830b84cb
NR 59
TC 10
Z9 11
U1 5
U2 12
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD MAR
PY 2016
VL 126
IS 3
BP 1023
EP 1038
DI 10.1172/JCI84505
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DF2SI
UT WOS:000371193700022
PM 26878172
OA Bronze, Green Published
DA 2018-12-27
ER

PT J
AU Yu, HY
   Artomov, M
   Brahler, S
   Stander, MC
   Shamsan, G
   Sampson, MG
   White, JM
   Kretzler, M
   Miner, JH
   Jain, S
   Winkler, CA
   Mitra, RD
   Kopp, JB
   Daly, MJ
   Shaw, AS
AF Yu, Haiyang
   Artomov, Mykyta
   Braehler, Sebastian
   Stander, M. Christine
   Shamsan, Ghaidan
   Sampson, Matthew G.
   White, J. Michael
   Kretzler, Matthias
   Miner, Jeffrey H.
   Jain, Sanjay
   Winkler, Cheryl A.
   Mitra, Robi D.
   Kopp, Jeffrey B.
   Daly, Mark J.
   Shaw, Andrey S.
TI RETRACTED: A role for genetic susceptibility in sporadic focal segmental
   glomerulosclerosis (Retracted Article. See vol 126, pg 1603, 2016)
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article; Retracted Publication
ID RESISTANT NEPHROTIC SYNDROME; HIV-ASSOCIATED NEPHROPATHY; EMBRYONIC
   STEM-CELLS; PODOCYTE INJURY; CD2-ASSOCIATED PROTEIN;
   GLOMERULAR-DISEASES; AFRICAN-AMERICANS; RNA INTERFERENCE; RENAL-DISEASE;
   MUTATIONS
AB Focal segmental glomerulosclerosis (FSGS) is a syndrome that involves kidney podocyte dysfunction and causes chronic kidney disease. Multiple factors including chemical toxicity, inflammation, and infection underlie FSGS; however, highly penetrant disease genes have been identified in a small fraction of patients with a family history of FSGS. Variants of apolipoprotein 1:1 (APOL1) have been linked to FSGS in African Americans with HIV or hypertension, supporting the proposal that genetic factors enhance FSGS susceptibility. Here, we used sequencing to investigate whether genetics plays a role in the majority of FSGS cases that are identified as primary or sporadic FSGS and have no known cause. Given the limited number of biopsy-proven cases with ethnically matched controls, we devised an analytic strategy to identify and rank potential candidate genes and used an animal model for validation. Nine candidate FSGS susceptibility genes were identified in our patient cohort, and three were validated using a high-throughput mouse method that we developed. Specifically, we introduced a podocyte-specific, doxycycline-inducible transactivator into a murine embryonic stem cell line with an FSGS-susceptible genetic background that allows shRNA-mediated targeting of candidate genes in the adult kidney. Our analysis supports a broader role for genetic susceptibility of both sporadic and familial cases of FSGS and provides a tool to rapidly evaluate candidate FSGS-associated genes.
C1 [Yu, Haiyang; Braehler, Sebastian; Stander, M. Christine; Shamsan, Ghaidan; White, J. Michael; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA.
   [Artomov, Mykyta; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.
   [Artomov, Mykyta; Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA USA.
   [Artomov, Mykyta; Daly, Mark J.] Broad Inst, Cambridge, MA USA.
   [Artomov, Mykyta] Harvard Univ, Dept Chem, 12 Oxford St, Cambridge, MA 02138 USA.
   [Sampson, Matthew G.] Univ Michigan, Pediat Nephrol, Ann Arbor, MI 48109 USA.
   [Kretzler, Matthias] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA.
   [Miner, Jeffrey H.; Jain, Sanjay] Washington Univ, Sch Med, Dept Med, Div Renal, St Louis, MO 63110 USA.
   [Winkler, Cheryl A.] NCI, Mol Genet Epidemiol Studies Sect, Frederick, MD 21701 USA.
   [Mitra, Robi D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.
   [Kopp, Jeffrey B.] NIDDKD, Kidney Dis Sect, Kidney Dis Branch, NIH, Bethesda, MD USA.
   [Shaw, Andrey S.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.
RP Shaw, AS (reprint author), Genentech Inc, One DNA Way,Mail Stop 93B, San Francisco, CA 94080 USA.; Daly, MJ (reprint author), Massachusetts Gen Hosp, Richard B Simches Res Ctr, Analyt & Translat Genet Unit, 185 Cambridge St,CPZN 6818, Boston, MA 02114 USA.
EM mjdaly@atgu.mgh.harvard.edu; shawa6@gene.com
OI jain, sanjay/0000-0003-2804-127X; Artomov, Mykyta/0000-0001-5282-8764;
   Sampson, Matthew/0000-0001-9560-076X
FU NIDDK; HHMI; Intramural Research Programs of the NIDDK; NCI; Deutsche
   Forschungsgemeinschaft (DFG)
FX This project was supported by grants from the NIDDK (to A.S. Shaw, J.H.
   Miner, M. Kretzler, and M.G. Sampson); the HHMI (to A.S. Shaw); and the
   Intramural Research Programs of the NIDDK (to J.B. Kopp), NCI (to C.A.
   Winkler), and the Deutsche Forschungsgemeinschaft (DFG) (to S. Brahler).
   We thank V. Vasioukhin for sharing Dlg5<SUP>+/-</SUP> mice,
   overexpression and RNAi lentiviral plasmids, and histology stainings of
   Dlg5<SUP>-/-</SUP> kidney. We also thank C. Der for sharing the Arhgefl7
   cDNA construct. We also thank R. Kopan and members of the Shaw
   laboratory for critical discussions.
CR Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458
   Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409
   Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000
   Barua M, 2013, KIDNEY INT, V83, P316, DOI 10.1038/ki.2012.349
   Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180
   Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487
   Boute N, 2000, NAT GENET, V24, P349
   Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505
   Brunskill EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024640
   Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779
   D'Agati VD, 2008, KIDNEY INT, V73, P399, DOI 10.1038/sj.ki.5002655
   D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556
   Deller T, 2003, P NATL ACAD SCI USA, V100, P10494, DOI 10.1073/pnas.1832384100
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Friedman DJ, 2011, J AM SOC NEPHROL, V22, P2098, DOI 10.1681/ASN.2011050519
   Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI 10.1172/JCI79504
   Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134
   Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032
   Gigante M, 2009, NEPHROL DIAL TRANSPL, V24, P1858, DOI 10.1093/ndt/gfn712
   Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238
   Huber TB, 2006, J CLIN INVEST, V116, P1337, DOI 10.1172/JCI27400
   Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232
   Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456
   Kasembeli AN, 2015, J AM SOC NEPHROL, V26, P2882, DOI 10.1681/ASN.2014050469
   Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068
   Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x
   Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226
   Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388
   Krendel M, 2009, J AM SOC NEPHROL, V20, P86, DOI 10.1681/ASN.2007111172
   Laurin LP, 2014, NEPHROL DIAL TRANSPL, V29, P2062, DOI 10.1093/ndt/gft532
   Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lin XB, 2014, J AM SOC NEPHROL, V25, P687, DOI 10.1681/ASN.2013070798
   Lindenmeyer MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011545
   Lowik MM, 2007, KIDNEY INT, V72, P1198, DOI 10.1038/sj.ki.5002469
   Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011
   Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322
   Nechiporuk T, 2007, DEV CELL, V13, P338, DOI 10.1016/i.devcel.2007.07.017
   Pollak MR, 2003, SEMIN NEPHROL, V23, P141, DOI 10.1053/snep.2003.50014
   Pollak MR, 2002, J AM SOC NEPHROL, V13, P3016, DOI 10.1097/01.ASN.0000039569.34360.5E
   Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263
   Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012
   Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005
   Rabbani B, 2014, J HUM GENET, V59, P5, DOI 10.1038/jhg.2013.114
   Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592
   Rood IM, 2012, NEPHROL DIAL TRANSPL, V27, P882, DOI 10.1093/ndt/gfr771
   Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489
   Sampson MG, 2015, PEDIATR NEPHROL, V30, P51, DOI 10.1007/s00467-014-2857-9
   Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312
   Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102
   Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111
   Van der Auwera GA, 2013, CURR PROTOC BIOINFOR, V11, DOI DOI 10.1002/0471250953.BI1110S43
   Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444
   Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055
   Wickman L, 2013, J AM SOC NEPHROL, V24, P2081, DOI 10.1681/ASN.2013020173
   Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222
   Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215
   Xu XJ, 2011, NEPHRON EXP NEPHROL, V117, pE39, DOI 10.1159/000320049
   Yu HY, 2013, MOL CELL BIOL, V33, P4755, DOI 10.1128/MCB.00730-13
   Zhou WB, 2012, J AM SOC NEPHROL, V23, P1039, DOI 10.1681/ASN.2011080776
NR 60
TC 18
Z9 18
U1 2
U2 6
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD MAR
PY 2016
VL 126
IS 3
BP 1067
EP 1078
DI 10.1172/JCI82592
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DF2SI
UT WOS:000371193700025
PM 26901816
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Luo, HW
   Xu, F
AF Luo, Hong-Wei
   Xu, Fang
TI RETRACTED: Bioreduction and reoxidation of uranium enhanced by thiol
   functional groups in natural organic matter (Retracted article)
SO CHEMOSPHERE
LA English
DT Article; Retracted Publication
DE Uranium bioremediation; Thiol functional groups; Natural organic matter
ID SHEWANELLA-ONEIDENSIS MR-1; MICROBIAL REDUCTION; SPECTROSCOPIC
   CHARACTERIZATION; ORGANOSULFUR COMPOUNDS; HUMIC SUBSTANCES; U(VI);
   ADSORPTION; COMPLEXATION; FRACTIONS; KINETICS
AB Although natural organic matter (NOM) is known to affect biological reduction of U(VI) and subsequent reoxidation of U(IV), the underlying mechanisms remain unclear. This study investigated the redox reactions of sulfide with NOM to form thiol functional groups, which can greatly enhance U(VI) bioreduction and U(IV) reoxidation. Results showed that humic acid (HA) was found to be more effective than fulvic acid (FA) in producing thiol groups, both U(VI) bioreduction and U(IV) reoxidation rates increased with the increase of thiols content in HA and FA. These findings suggested that among other redox sites, thiol groups in NOM may play an important role in the electron transport between uranium and microbial cells, and are of great environmental implications because they provided direct proof that thiol groups are responsible for bioremediation and immobilization of uranium when it enters into the natural environments such as soil and groundwater. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Luo, Hong-Wei; Xu, Fang] Univ Sci & Technol China, Dept Chem, CAS Key Lab Urban Pollutant Convers, Anhua 230026, Peoples R China.
   [Luo, Hong-Wei] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37830 USA.
   [Luo, Hong-Wei] Nanyang Technol Univ, Sch Civil & Environm Engn, Singapore 639798, Singapore.
RP Luo, HW (reprint author), Nanyang Technol Univ, Sch Civil & Environm Engn, Singapore 639798, Singapore.
EM hwluo@ntu.edu.sg
FU China Scholarship Council (CSC); State-Sponsored Scholarship Program for
   Graduate Students [201306340082]
FX The authors gratefully acknowledge financial support provided by China
   Scholarship Council (CSC) and State-Sponsored Scholarship Program for
   Graduate Students (No. 201306340082). Dr. Baohua Gu and Hui Lin at Oak
   Ridge National Laboratory for technical assistance in analysis of thiol
   functional groups and Dr. En-Hua Yang at Nanyang Technological
   University for proofreading are greatly appreciated.
CR Appiani E, 2014, ENVIRON SCI TECHNOL, V48, P11794, DOI 10.1021/es5021873
   Burgos WD, 2007, ENVIRON ENG SCI, V24, P755, DOI 10.1089/ees.2006.0009
   Chen J, 2002, CHEMOSPHERE, V48, P59, DOI 10.1016/S0045-6535(02)00041-3
   Ding CC, 2015, GEOCHIM COSMOCHIM AC, V165, P86, DOI 10.1016/j.gca.2015.05.036
   Gu BH, 2011, P NATL ACAD SCI USA, V108, P1479, DOI 10.1073/pnas.1008747108
   Gu BH, 2005, ENVIRON SCI TECHNOL, V39, P5268, DOI 10.1021/es050350r
   Gu BH, 2003, GEOCHIM COSMOCHIM AC, V67, P3575, DOI 10.1016/S0016-7037(03)00162-5
   Hoffmann M, 2012, ENVIRON SCI TECHNOL, V46, P11788, DOI 10.1021/es302590x
   Lee SY, 2014, CHEM GEOL, V370, P40, DOI 10.1016/j.chemgeo.2014.01.020
   LOVLEY DR, 1991, NATURE, V350, P413, DOI 10.1038/350413a0
   Luo HW, 2015, ECOTOXICOLOGY, V24, P2207, DOI 10.1007/s10646-015-1551-4
   Moon HS, 2007, ENVIRON SCI TECHNOL, V41, P4587, DOI 10.1021/es063063b
   NASH K, 1981, ENVIRON SCI TECHNOL, V15, P834, DOI 10.1021/es00089a011
   Perlinger JA, 2002, ENVIRON SCI TECHNOL, V36, P2663, DOI 10.1021/es015602c
   Rao B, 2014, TALANTA, V119, P240, DOI 10.1016/j.talanta.2013.11.004
   Roden EE, 2010, NAT GEOSCI, V3, P417, DOI 10.1038/NGEO870
   Schaefer JK, 2009, NAT GEOSCI, V2, P123, DOI 10.1038/NGEO412
   SCHOUTEN S, 1993, GEOCHIM COSMOCHIM AC, V57, P5111, DOI 10.1016/0016-7037(93)90613-2
   Sheng L, 2014, ENVIRON SCI TECHNOL, V48, P3768, DOI 10.1021/es5003692
   Sun YB, 2015, ENVIRON SCI TECHNOL, V49, P4255, DOI 10.1021/es505590j
   Sun YB, 2014, GEOCHIM COSMOCHIM AC, V140, P621, DOI 10.1016/j.gca.2014.06.001
   Sun YB, 2014, J HAZARD MATER, V280, P399, DOI 10.1016/j.jhazmat.2014.08.023
   Szulczewski MD, 2001, ENVIRON SCI TECHNOL, V35, P1134, DOI 10.1021/es001301b
   Urban NR, 1999, GEOCHIM COSMOCHIM AC, V63, P837, DOI 10.1016/S0016-7037(98)00306-8
   VAIRAVAMURTHY A, 1987, NATURE, V329, P623, DOI 10.1038/329623a0
   Yang Y, 2014, CHEM GEOL, V387, P59, DOI 10.1016/j.chemgeo.2014.08.020
NR 26
TC 3
Z9 3
U1 9
U2 60
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0045-6535
EI 1879-1298
J9 CHEMOSPHERE
JI Chemosphere
PD MAR
PY 2016
VL 147
BP 20
EP 24
DI 10.1016/j.chemosphere.2015.12.092
PG 5
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA DE7SD
UT WOS:000370836100004
PM 26751128
DA 2018-12-27
ER

PT J
AU Du, C
   Plummer, AR
   Johnston, DN
AF Du, C.
   Plummer, A. R.
   Johnston, D. N.
TI RETRACTED: Performance analysis of an energy-efficient variable supply
   pressure electro-hydraulic motion control system (Retracted article. See
   vol.60,pg.193,2017)
SO CONTROL ENGINEERING PRACTICE
LA English
DT Article; Retracted Publication
DE Electro-hydraulic system; Energy-efficient fluid power; Robot motion
   control; Variable supply pressure
ID SYSTEM
AB The electro-hydraulic motion control is implemented in diverse applications due to its high power density and good controllability. For a multi-axis system with a single power source, the conventional fixed supply pressure valve-controlled (FPVC) system is a simple but inefficient method due to its dissipating energy via the throttling valves. In this paper, a load-prediction based energy-efficient variable supply pressure valve-controlled (VPVC) method was introduced and implemented on a two-axis robotic arm system. The VPVC system adopts a fixed capacity pump driven by a brushless servomotor. The feed forward part of the VPVC controller predicts the minimum required supply pressure of the system by assuming the control valve of the highest load branch fully open. It is based on the prediction of the required actuation force for a given motion demand, by applying Lagrange's equations of the-second-kind. The feedback control of VPVC is classic proportional (integral) control for the control valves and the motor speed, with measured actuator positions as the feedback signals. Although the VPVC algorithm was demonstrated for a two-axis robotic arm system here, it is applicable to the systems with any number of axes. By using the variable minimum supply pressure together with the maximum valve opening, the energy-efficiency of VPVC is improved compared with a FPVC system. Moreover, due to the feed forward part in VPVC, the dynamic response is much better than a FPVC system with proportional integral position feedback control. The comparison between FPVC and VPVC validated these advantages. The hydraulic power consumption comparison showed that up to 70% saving was achieved by VPVC over FPVC experimentally. If the energy loss via relief valve in FPVC is taken into account, the saving can be increased greatly. In all the comparison tests, the dynamic errors in VPVC were smaller than in FPVC (both were with constant proportional-integral controllers setting). The experimental dynamic errors of VPVC were within 6.5% of the total motion range, compared to 14% for FPVC. And the average dynamic errors of VPVC were within 1.5% of the total motion range. The experiment also showed that the VPVC brought a very quiet operating due to the minimum flow throttling and variable motor speed, which is another significant benefit of VPVC over FPVC. (C) 2015 The Authors. Published by Elsevier Ltd.
C1 [Du, C.; Johnston, D. N.] Univ Bath, Dept Mech Engn, Bath BA2 7AY, Avon, England.
   [Plummer, A. R.] Univ Bath, Dept Mech Engn, Ctr Power Transmiss & Mot Control, Bath BA2 7AY, Avon, England.
RP Du, C (reprint author), Univ Bath, Dept Mech Engn, Bath BA2 7AY, Avon, England.
EM du_can@yeah.net; A.R.Plummer@bath.ac.uk; D.N.Johnston@bath.ac.uk
FU UK Engineering and Physical Sciences Research Council [EP/H024190/1]
FX This work was supported by the UK Engineering and Physical Sciences
   Research Council under grant number EP/H024190/1, together with Instron,
   JCB and Parker Hannifin.
CR Chapple P., 2003, PRINCIPLES HYDRAULIC
   Cheng M., 2014, P 9IFK AACH
   Cleasby K. G., 2008, P FPMC BATH UK, P437
   Djurovic M, 2004, POWER TRANSMISSION AND MOTION CONTROL, P201
   Du C., 2014, THESIS
   Ferreira FJTE, 2011, IEEE T IND ELECTRON, V58, P2117, DOI 10.1109/TIE.2010.2057232
   Guizzo E, 2012, IEEE ROBOT AUTOM MAG, V19, P119, DOI 10.1109/MRA.2012.2184209
   HABIBI SR, 1994, IEEE DECIS CONTR P, P345, DOI 10.1109/CDC.1994.410905
   Has Z, 2013, C IND ELECT APPL, P668
   Helduser S., 2003, P 8 SICFP TAMP FINL
   Hu J, 2012, P I MECH ENG I-J SYS, V226, P466, DOI 10.1177/0959651811425311
   Jansson A., 1990, SAE T, V99, P377
   Khoa LD, 2012, 2012 12TH INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND SYSTEMS (ICCAS), P354
   Liu Y., 2009, P 7 ICFP HANGZH, P257
   Lovrec D, 2009, INT J ADV MANUF TECH, V41, P1066, DOI 10.1007/s00170-008-1553-y
   Mettala K., 2007, P 10 SICFP TAMP FINL
   Minav TA, 2012, IEEE T IND ELECTRON, V59, P2466, DOI 10.1109/TIE.2011.2148682
   Murrenhoff H, 2014, P 9 IFK AACH, P119
   Pan M, 2014, P I MECH ENG I-J SYS, V228, P12, DOI 10.1177/0959651813500952
   Quan ZY, 2014, RENEW SUST ENERG REV, V35, P336, DOI 10.1016/j.rser.2014.04.036
   Semini C., 2011, IMECHE 1, P831
   Van de Ven J. D., 2010, T ASME J DYNAMIC SYS, V133
   Yang H, 2007, IEEE-ASME T MECH, V12, P519, DOI 10.1109/TMECH.2007.905691
   Yang J., 2014, J SYST CONTROL UNPUB
NR 24
TC 9
Z9 9
U1 3
U2 62
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0967-0661
EI 1873-6939
J9 CONTROL ENG PRACT
JI Control Eng. Practice
PD MAR
PY 2016
VL 48
BP 10
EP 21
DI 10.1016/j.conengprac.2015.12.013
PG 12
WC Automation & Control Systems; Engineering, Electrical & Electronic
SC Automation & Control Systems; Engineering
GA DE8SJ
UT WOS:000370906700002
DA 2018-12-27
ER

PT J
AU Frias-Torres, S
   O'Neill, MP
AF Frias-Torres, S.
   O'Neill, M. P.
TI RETRACTED: First observation of spawning of goliath grouper, Epinephelus
   itajara (Retracted Article)
SO CORAL REEFS
LA English
DT Correction; Retracted Publication
C1 [Frias-Torres, S.] Smithsonian Marine Stn, 701 Seaway Dr, Ft Pierce, FL 34949 USA.
   [O'Neill, M. P.] Palm Beach Gardens, POB 32909, Palm Beach Gardens, FL 33420 USA.
RP Frias-Torres, S (reprint author), Smithsonian Marine Stn, 701 Seaway Dr, Ft Pierce, FL 34949 USA.
EM sfriastorres@gmail.com
CR CORAL REEFS
NR 1
TC 0
Z9 0
U1 3
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0722-4028
EI 1432-0975
J9 CORAL REEFS
JI Coral Reefs
PD MAR
PY 2016
VL 35
IS 1
BP 369
EP 369
DI 10.1007/s00338-015-1257-3
PG 1
WC Marine & Freshwater Biology
SC Marine & Freshwater Biology
GA DE9KE
UT WOS:000370955100037
OA Bronze
DA 2018-12-27
ER

PT J
AU Barakat, MI
   Elhady, W
   Gouda, M
   Taha, M
   Metwaly, I
AF Barakat, Mohamed I.
   Elhady, Waleed
   Gouda, Mohamed
   Taha, Mahmoud
   Metwaly, Ibrahim
TI RETRACTED: Surgical management of intractable spasticity (Retracted
   article. See vol. 25, pg. 2676, 2016)
SO EUROPEAN SPINE JOURNAL
LA English
DT Article; Retracted Publication
DE Spasticity; Neurotomy; Rhizotomy
ID SELECTIVE DORSAL RHIZOTOMY; BACLOFEN; NEUROTOMY; CHILDREN
AB Spasticity is motor disorder characterized by a velocity-dependent increase in tonic stretch reflexes (muscle tone) with exaggerated tendon jerks, resulting from hyper-excitability of the stretch reflex, as one component of the upper motor neuron syndrome.
   This study aimed at comparing between spinally based (dorsal rhizotomy) versus peripherally based (selective neurotomy) surgical procedures in management of hypertonia in the lower limbs of pediatrics.
   Over a 3-year period, 50 children with intractable, lower limb spasticity were prospectively treated by selective neurotomy (group A, 35 patients) and dorsal rhizotomy (group B, 15 patients) with 6 months' follow-up period.
   The operative duration was longer with dorsal rhizotomy with mean of 292.2 min versus 76.8 min with neurotomy (P = 0.001) and the hospital stay of dorsal rhizotomy was longer with mean of 6.2 days versus 1.7 days with neurotomy (P = 0.001). Muscles power exhibited significant improvement in 53.3 % of the total rhizotomies (P = 0.001). Following neurotomies; muscle tone showed marked improvement in 69.3 % muscles which had normal tone and 31.9 % of muscles had mild spasticity (P = 0.001). The H/M ratio following dorsal rhizotomies showed marked reduction of the ratio, and the mean was 0.11 versus 0.58 preoperatively.
   Both neurotomies and dorsal rhizotomies were safe surgical procedures and were provided with good improvement in respect of: muscle power, severity of spasticity, patient's ambulation, gait, range of joint movement, associated pain, functional disability, and nerve excitability with no significant difference between both procedures.
C1 [Barakat, Mohamed I.; Elhady, Waleed; Gouda, Mohamed; Taha, Mahmoud; Metwaly, Ibrahim] Zagazig Univ, Fac Med, Neurosurg Dept, Zagazig, Egypt.
RP Barakat, MI (reprint author), Zagazig Univ, Fac Med, Neurosurg Dept, Zagazig, Egypt.
EM mohamedebarakat@hotmail.com; waleedelhadi@hotmail.com;
   drmohamedammar@yahoo.com; mahmoudlotfy72@yahoo.com;
   Ibrahimmetwally@hotmail.com
CR Bhimani R, 2014, REHABIL RES PRACT, V2014
   Buffenoir K, 2013, ACTA NEUROCHIR, V155, P1731, DOI 10.1007/s00701-013-1770-5
   Campistol J, 2003, REV NEUROLOGIA, V37, P70
   Dario A, 2004, DRUG SAFETY, V27, P799, DOI 10.2165/00002018-200427110-00004
   Gaverth J, 2013, J REHABIL MED, V45, P630, DOI 10.2340/16501977-1160
   Kan P, 2008, CHILD NERV SYST, V24, P239, DOI 10.1007/s00381-007-0457-8
   Kheder Ammar, 2012, Pract Neurol, V12, P289, DOI 10.1136/practneurol-2011-000155
   Lazorthes Y, 2002, EUR J NEUROL, V9, P35, DOI 10.1046/j.1468-1331.2002.0090s1035.x
   Maarrawi J, 2006, J NEUROSURG, V104, P215, DOI 10.3171/jns.2006.104.2.215
   Mayer M, 2002, FUNCT NEUROL, V17, P11
   Ozcakir S, 2007, CLIN MED RES, V5, P132, DOI 10.3121/cmr.2007.716
   Reynolds RM, 2014, J NEUROSURG-PEDIATR, V14, P266, DOI 10.3171/2014.5.PEDS13459
   Rode G, 2003, NEUROCHIRURGIE, V49, P247
   Roujeau T, 2008, NEUROCHIRURGIE, V54, P618, DOI 10.1016/j.neuchi.2008.07.010
   Scheinberg A, 2006, J PAEDIATR CHILD H, V42, P715, DOI 10.1111/j.1440-1754.2006.00957.x
   Steinbok P, 2015, DEV MED CHILD NEUROL, V57, P214, DOI 10.1111/dmcn.12609
   Steinbok P, 2013, DEV MED CHILD NEUROL, V55, P586, DOI 10.1111/dmcn.12146
   Taira Takaomi, 2008, Brain and Nerve (Tokyo), V60, P1427
   Taricco M, 2006, Eura Medicophys, V42, P5
NR 19
TC 1
Z9 1
U1 2
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0940-6719
EI 1432-0932
J9 EUR SPINE J
JI Eur. Spine J.
PD MAR
PY 2016
VL 25
IS 3
BP 928
EP 935
DI 10.1007/s00586-015-4326-y
PG 8
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA DE9KX
UT WOS:000370957400036
PM 26667812
DA 2018-12-27
ER

PT J
AU Lee, Y
   Yang, H
   Yin, ZP
AF Lee, Yong
   Yang, Hua
   Yin, Zhouping
TI RETRACTED: A robust vector field correction method via a mixture
   statistical model of PIV signal (Retracted article. See vol. 57, 116,
   2016)
SO EXPERIMENTS IN FLUIDS
LA English
DT Article; Retracted Publication
ID PARTICLE IMAGE VELOCIMETRY; SPURIOUS VECTORS; FLOWS
AB Outlier (spurious vector) is a common problem in practical velocity field measurement using particle image velocimetry technology (PIV), and it should be validated and replaced by a reliable value. One of the most challenging problems is to correctly label the outliers under the circumstance that measurement noise exists or the flow becomes turbulent. Moreover, the outlier's cluster occurrence makes it difficult to pick out all the outliers. Most of current methods validate and correct the outliers using local statistical models in a single pass. In this work, a vector field correction (VFC) method is proposed directly from a mixture statistical model of PIV signal. Actually, this problem is formulated as a maximum a posteriori (MAP) estimation of a Bayesian model with hidden/latent variables, labeling the outliers in the original field. The solution of this MAP estimation, i.e., the outlier set and the restored flow field, is optimized iteratively using an expectation-maximization algorithm. We illustrated this VFC method on two kinds of synthetic velocity fields and two kinds of experimental data and demonstrated that it is robust to a very large number of outliers (even up to 60 %). Besides, the proposed VFC method has high accuracy and excellent compatibility for clustered outliers, compared with the state-of-the-art methods. Our VFC algorithm is computationally efficient, and corresponding Matlab code is provided for others to use it. In addition, our approach is general and can be seamlessly extended to three-dimensional-three-component (3D3C) PIV data.
C1 [Lee, Yong; Yang, Hua; Yin, Zhouping] Huazhong Univ Sci & Technol, State Key Lab Digital Mfg Equipment & Technol, Wuhan 430074, Peoples R China.
RP Yang, H (reprint author), Huazhong Univ Sci & Technol, State Key Lab Digital Mfg Equipment & Technol, Wuhan 430074, Peoples R China.
EM huayang@hust.edu.cn
FU National Natural Science Foundation of China [51327801, 51475193]
FX We thank the anonymous reviewers for their insightful comments. This
   work was supported by National Natural Science Foundation of China
   (Grant Nos. 51327801 and 51475193). The flow fields from Fig. 11a, b and
   d are courtesy of Dr. Wang (Wang et al. 2015).
CR ADRIAN RJ, 1991, ANNU REV FLUID MECH, V23, P261, DOI 10.1146/annurev.fl.23.010191.001401
   Afanasyev YD, 2005, EXP FLUIDS, V39, P828, DOI 10.1007/s00348-005-0017-5
   Bishop C. M., 2006, PATTERN RECOGNITION
   Creutin JD, 2003, J HYDROL, V277, P182, DOI 10.1016/S0022-1694(03)00081-7
   de Baar JH, 2014, EXP FLUIDS, V55, P1
   Deen NG, 2010, EXP FLUIDS, V49, P525, DOI 10.1007/s00348-010-0827-y
   DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1
   Elsinga GE, 2006, EXP FLUIDS, V41, P933, DOI 10.1007/s00348-006-0212-z
   Foucaut J, 2000, P 10 INT S APPL LAS, V16
   Garcia D, 2011, EXP FLUIDS, V50, P1247, DOI 10.1007/s00348-010-0985-y
   Garcia D, 2010, COMPUT STAT DATA AN, V54, P1167, DOI 10.1016/j.csda.2009.09.020
   Griffin J, 2010, EXP FLUIDS, V49, P305, DOI 10.1007/s00348-010-0875-3
   Gunes H, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2740710
   Hart DP, 2000, EXP FLUIDS, V29, P13, DOI 10.1007/s003480050421
   Huang H, 1997, MEAS SCI TECHNOL, V8, P1427, DOI 10.1088/0957-0233/8/12/007
   Liang DF, 2003, EXP FLUIDS, V34, P52, DOI 10.1007/s00348-002-0530-8
   Liu ZL, 2008, CHEM ENG SCI, V63, P1, DOI 10.1016/j.ces.2007.08.080
   Ma JY, 2014, IEEE T IMAGE PROCESS, V23, P1706, DOI 10.1109/TIP.2014.2307478
   Micchelli CA, 2005, NEURAL COMPUT, V17, P177, DOI 10.1162/0899766052530802
   Pereira F, 2006, MEAS SCI TECHNOL, V17, P1680, DOI 10.1088/0957-0233/17/7/006
   Petermeier H, 2007, EXP FLUIDS, V42, P611, DOI 10.1007/s00348-007-0269-3
   Pope S. B., 2000, TURBULENT FLOWS
   Pun CS, 2007, MEAS SCI TECHNOL, V18, P3511, DOI 10.1088/0957-0233/18/11/035
   Raben SG, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/2/025303
   Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0
   Schroeder A., 2008, PARTICLE IMAGE VELOC, V112
   Sciacchitano A, 2013, MEAS SCI TECHNOL, V24, DOI 10.1088/0957-0233/24/4/045302
   Shan F, 2014, INT J HEAT MASS TRAN, V73, P542, DOI 10.1016/j.ijheatmasstransfer.2014.02.039
   Shinneeb AM, 2004, MEAS SCI TECHNOL, V15, P1722, DOI 10.1088/0957-0233/15/9/008
   Stanislas M, 2003, MEAS SCI TECHNOL, V14, pR63, DOI 10.1088/0957-0233/14/10/201
   Steinbuck JV, 2010, J ATMOS OCEAN TECH, V27, P1362, DOI 10.1175/2010JTECHO694.1
   Sugii Y, 2002, PHYSIOL MEAS, V23, P403, DOI 10.1088/0967-3334/23/2/315
   Vennemann P, 2008, PARTICLE IMAGE VELOC
   Vlasenko A, 2015, MEAS SCI TECHNOL, V26, DOI 10.1088/0957-0233/26/6/065301
   Wang HP, 2015, EXP FLUIDS, V56, DOI 10.1007/s00348-015-1894-x
   Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861
   Wereley ST, 2010, ANNU REV FLUID MECH, V42, P557, DOI 10.1146/annurev-fluid-121108-145427
   WESTERWEEL J, 1994, EXP FLUIDS, V16, P236
   Westerweel J, 2005, EXP FLUIDS, V39, P1096, DOI 10.1007/s00348-005-0016-6
   Willert CE, 1997, J FLUID MECH, V345, P227, DOI 10.1017/S0022112097006265
   Yuille AL, 1990, NEURAL COMPUT, V2, P1, DOI 10.1162/neco.1990.2.1.1
   Zhu Y, 2013, MEAS SCI TECHNOL, V24, p[125, 302]
NR 42
TC 3
Z9 3
U1 6
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0723-4864
EI 1432-1114
J9 EXP FLUIDS
JI Exp. Fluids
PD MAR
PY 2016
VL 57
IS 3
AR 31
DI 10.1007/s00348-016-2115-y
PG 20
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA DF0VJ
UT WOS:000371057000003
DA 2018-12-27
ER

PT J
AU Rai, AN
   Tamirisa, S
   Rao, KV
   Kumar, V
   Suprasanna, P
AF Rai, Archana N.
   Tamirisa, Srinath
   Rao, K. V.
   Kumar, Vinay
   Suprasanna, P.
TI RETRACTED: Brassica RNA binding protein ERD4 is involved in conferring
   salt, drought tolerance and enhancing plant growth in
   Arabidopsis(Retracted article. See vol. 93, pg. 547, 2017)
SO PLANT MOLECULAR BIOLOGY
LA English
DT Article; Retracted Publication
DE Early responsive to dehydration (ERD) 4 gene; Brassica juncea;
   Transgenic lines; Abiotic stress tolerance; RNA binding protein; DUF221
   domain
ID MONITORING EXPRESSION PROFILES; ABIOTIC STRESS TOLERANCE;
   GENE-EXPRESSION; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; CHAPERONE ACTIVITY;
   CDNA MICROARRAY; LOW-TEMPERATURE; DEHYDRATION; THALIANA
AB 'Early responsive to dehydration' (ERD) genes are a group of plant genes having functional roles in plant stress tolerance and development. In this study, we have isolated and characterized a Brassica juncea 'ERD' gene (BjERD4) which encodes a novel RNA binding protein. The expression pattern of ERD4 analyzed under different stress conditions showed that transcript levels were increased with dehydration, sodium chloride, low temperature, heat, abscisic acid and salicylic acid treatments. The BjERD4 was found to be localized in the chloroplasts as revealed by Confocal microscopy studies. To study the function, transgenic Arabidopsis plants were generated and analyzed for various morphological and physiological parameters. The overexpressing transgenic lines showed significant increase in number of leaves with more leaf area and larger siliques as compared to wild type plants, whereas RNAi:ERD4 transgenic lines showed reduced leaf number, leaf area, dwarf phenotype and delayed seed germination. Transgenic Arabidopsis plants overexpressing BjERD4 gene also exhibited enhanced tolerance to dehydration and salt stresses, while the knockdown lines were susceptible as compared to wild type plants under similar stress conditions. It was observed that BjERD4 protein could bind RNA as evidenced by the gel-shift assay. The overall results of transcript analysis, RNA gel-shift assay, and transgenic expression, for the first time, show that the BjERD4 is involved in abiotic stress tolerance besides offering new clues about the possible roles of BjERD4 in plant growth and development.
C1 [Rai, Archana N.; Suprasanna, P.] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Plant Stress Physiol & Biotechnol Sect, Bombay 400085, Maharashtra, India.
   [Tamirisa, Srinath; Rao, K. V.] Osmania Univ, Ctr Plant Mol Biol, Hyderabad 500007, Andhra Pradesh, India.
   [Kumar, Vinay] Bhabha Atom Res Ctr, Div Solid State Phys, Bombay 400085, Maharashtra, India.
RP Suprasanna, P (reprint author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Plant Stress Physiol & Biotechnol Sect, Bombay 400085, Maharashtra, India.
EM penna888@yahoo.com
FU BARC
FX This study was funded through the departmental funds provided by BARC.
CR Abel S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004572
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Alves MS, 2013, COMPREHENSIVE SURVEY OF INTERNATIONAL SOYBEAN RESEARCH - GENETICS, PHYSIOLOGY, AGRONOMY AND NITROGEN RELATIONSHIPS, P475, DOI 10.5772/50993
   ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1
   Bohnert HJ, 2006, CURR OPIN PLANT BIOL, V9, P180, DOI 10.1016/j.pbi.2006.01.003
   Cabello JV, 2014, CURR OPIN BIOTECH, V26, P62, DOI 10.1016/j.copbio.2013.09.011
   Camargo SR, 2007, PLANT CELL REP, V26, P2119, DOI 10.1007/s00299-007-0430-8
   Chi YH, 2008, PLANT PHYSIOL, V148, P808, DOI 10.1104/pp.108.123547
   Du YY, 2008, J INTEGR PLANT BIOL, V50, P1318, DOI 10.1111/j.1744-7909.2008.00741.x
   Gutierrez RA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r53
   HODGSON RAJ, 1991, PLANTA, V183, P222, DOI 10.1007/BF00197792
   Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853
   Kim SY, 2010, PLANT CELL REP, V29, P203, DOI 10.1007/s00299-009-0813-0
   KIYOSUE T, 1993, BIOCHEM BIOPH RES CO, V196, P1214, DOI 10.1006/bbrc.1993.2381
   KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874
   Kiyosue T, 1998, BBA-BIOMEMBRANES, V1370, P187, DOI 10.1016/S0005-2736(98)00007-8
   Kiyosue T, 1994, PLANT CELL PHYSL, V106, P35
   Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208
   Lee J, 2011, PLANT CELL, V23, P1588, DOI 10.1105/tpc.110.082230
   Li YS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0653-8
   Lin TP, 2010, INT RES J PLANT SCI, V12, P21
   Liu YH, 2009, PLANT MOL BIOL REP, V27, P542, DOI 10.1007/s11105-009-0119-y
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091
   Mantri N, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P1, DOI 10.1007/978-1-4614-0634-1_1
   McKersie BD, 2000, PLANT PHYSIOL, V122, P1427, DOI 10.1104/pp.122.4.1427
   McQualter R. B., 2007, XXVI Congress, International Society of Sugar Cane Technologists, ICC, Durban, South Africa, 29 July - 2 August, 2007, P878
   Mitschke J, 2009, NEW PHYTOL, V183, P224, DOI 10.1111/j.1469-8137.2009.02832.x
   Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009
   Nakashima K, 1998, PLANT PHYSIOL, V118, P1233, DOI 10.1104/pp.118.4.1233
   Nickelsen J, 2003, CURR GENET, V43, P392, DOI 10.1007/s00294-003-0425-0
   Oono Y, 2003, PLANT J, V34, P868, DOI 10.1046/j.1365-313X.2003.01774.x
   Perez-Clemente RM, 2013, BIOMED RES INT, DOI 10.1155/2013/654120
   Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742
   Rai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032658
   SHEPARD JF, 1975, PLANT PHYSIOL, V55, P689, DOI 10.1104/pp.55.4.689
   Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4
   Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327
   Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164
   Soitamo AJ, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-13
   Taji T, 1999, PLANT CELL PHYSIOL, V40, P119, DOI 10.1093/oxfordjournals.pcp.a029469
   Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092
   ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x
   Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z
   Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156
   Tzin Vered, 2010, Arabidopsis Book, V8, pe0132, DOI 10.1199/tab.0132
   Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002
   Xing Y, 2007, J EXP BOT, V58, P2969, DOI 10.1093/jxb/erm144
   Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901
   Xu T, 2014, J PLANT BIOL, V57, P349, DOI 10.1007/s12374-014-0372-y
   Xu T, 2013, PHYTOCHEMISTRY, V94, P28, DOI 10.1016/j.phytochem.2013.05.019
   Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444
   Yokotani N, 2011, J EXP BOT, V62, P557, DOI 10.1093/jxb/erq290
   Yuan F, 2014, NATURE, V514, P367, DOI 10.1038/nature13593
   Zhang XL, 2005, PLANTA, V222, P494, DOI 10.1007/s00425-005-1564-y
   Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329
NR 56
TC 6
Z9 6
U1 4
U2 34
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0167-4412
EI 1573-5028
J9 PLANT MOL BIOL
JI Plant Mol.Biol.
PD MAR
PY 2016
VL 90
IS 4-5
BP 375
EP 387
DI 10.1007/s11103-015-0423-x
PG 13
WC Biochemistry & Molecular Biology; Plant Sciences
SC Biochemistry & Molecular Biology; Plant Sciences
GA DF2GI
UT WOS:000371160200004
PM 26711633
DA 2018-12-27
ER

PT J
AU Epstein, JI
   Zelefsky, MJ
   Sjoberg, DD
   Nelson, JB
   Egevad, L
   Magi-Galluzzi, C
   Vickers, AJ
   Parwani, AV
   Reuter, VE
   Fine, SW
   Eastham, JA
   Wiklund, P
   Han, M
   Reddy, CA
   Ciezki, JP
   Nyberg, T
   Klein, EA
AF Epstein, Jonathan I.
   Zelefsky, Michael J.
   Sjoberg, Daniel D.
   Nelson, Joel B.
   Egevad, Lars
   Magi-Galluzzi, Cristina
   Vickers, Andrew J.
   Parwani, Anil V.
   Reuter, Victor E.
   Fine, Samson W.
   Eastham, James A.
   Wiklund, Peter
   Han, Misop
   Reddy, Chandana A.
   Ciezki, Jay P.
   Nyberg, Tommy
   Klein, Eric A.
TI RETRACTED: A Contemporary Prostate Cancer Grading System: A Validated
   Alternative to the Gleason Score (Retracted article.See
   vol.66,pg.600,2016)
SO EUROPEAN UROLOGY
LA English
DT Article; Retracted Publication
DE Gleason grade; Gleason score
ID RADICAL PROSTATECTOMY; BIOCHEMICAL RECURRENCE; RADIATION-THERAPY;
   ADENOCARCINOMA; MORTALITY; SURVIVAL; OUTCOMES; DISEASE; RISK; MEN
AB Background: Despite revisions in 2005 and 2014, the Gleason prostate cancer (PCa) grading system still has major deficiencies. Combining of Gleason scores into a three-tiered grouping (6, 7, 8-10) is used most frequently for prognostic and therapeutic purposes. The lowest score, assigned 6, may be misunderstood as a cancer in the middle of the grading scale, and 3 + 4 = 7 and 4 + 3 = 7 are often considered the same prognostic group.
   Objective: To verify that a new grading system accurately produces a smaller number of grades with the most significant prognostic differences, using multi-institutional and multimodal therapy data.
   Design, setting, and participants: Between 2005 and 2014, 20 845 consecutive men were treated by radical prostatectomy at five academic institutions; 5501 men were treated with radiotherapy at two academic institutions.
   Outcome measurements and statistical analysis: Outcome was based on biochemical recurrence (BCR). The log-rank test assessed univariable differences in BCR by Gleason score. Separate univariable and multivariable Cox proportional hazards used four possible categorizations of Gleason scores.
   Results and limitations: In the surgery cohort, we found large differences in recurrence rates between both Gleason 3 + 4 versus 4 + 3 and Gleason 8 versus 9. The hazard ratios relative to Gleason score 6 were 1.9, 5.1, 8.0, and 11.7 for Gleason scores 3 + 4, 4 + 3, 8, and 9-10, respectively. These differences were attenuated in the radiotherapy cohort as a whole due to increased adjuvant or neoadjuvant hormones for patients with high-grade disease but were clearly seen in patients undergoing radiotherapy only. A five-grade group system had the highest prognostic discrimination for all cohorts on both univariable and multivariable analysis. The major limitation was the unavoidable use of prostate-specific antigen BCR as an end point as opposed to cancer-related death.
   Conclusions: The new PCa grading system has these benefits: more accurate grade stratification than current systems, simplified grading system of five grades, and lowest grade is 1, as opposed to 6, with the potential to reduce overtreatment of PCa.
   Patient summary: We looked at outcomes for prostate cancer (PCa) treated with radical prostatectomy or radiation therapy and validated a new grading system with more accurate grade stratification than current systems, including a simplified grading system of five grades and a lowest grade is 1, as opposed to 6, with the potential to reduce overtreatment of PCa. (C) 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.
C1 [Epstein, Jonathan I.; Han, Misop] Johns Hopkins Med Inst, Baltimore, MD 21205 USA.
   [Zelefsky, Michael J.; Sjoberg, Daniel D.; Vickers, Andrew J.; Reuter, Victor E.; Fine, Samson W.; Eastham, James A.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.
   [Nelson, Joel B.; Parwani, Anil V.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA.
   [Egevad, Lars; Wiklund, Peter; Nyberg, Tommy] Karolinska Inst, Stockholm, Sweden.
   [Magi-Galluzzi, Cristina; Reddy, Chandana A.; Ciezki, Jay P.; Klein, Eric A.] Cleveland Clin, Cleveland, OH 44106 USA.
RP Epstein, JI (reprint author), Johns Hopkins Univ Hosp, Weinberg Bldg,Room 2242,401 N Broadway St, Baltimore, MD 21231 USA.
EM jepstein@jhmi.edu
OI Zelefsky, Michael/0000-0002-6090-6424; Nyberg,
   Tommy/0000-0002-9436-0626; Reddy, Chandana/0000-0002-3832-8744
FU NCI NIH HHS [P30 CA008748]
CR Berman DM, 2014, UROL CLIN N AM, V41, P339, DOI 10.1016/j.ucl.2014.01.006
   Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593
   Brockman JA, 2015, EUR UROL, V67, P1160, DOI 10.1016/j.eururo.2014.09.019
   Carter HB, 2012, J CLIN ONCOL, V30, P4294, DOI 10.1200/JCO.2012.44.0586
   Chan TY, 2000, UROLOGY, V56, P823, DOI 10.1016/S0090-4295(00)00753-6
   Cronin AM, 2010, J UROLOGY, V183, P984, DOI 10.1016/j.juro.2009.11.027
   D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969
   Danneman D, 2015, BJU INT, V115, P248, DOI 10.1111/bju.12671
   Epstein JI, 2005, AM J SURG PATHOL, V29, P1228, DOI 10.1097/01.pas.0000173646.99337.b1
   Epstein JI, AM J SURG P IN PRESS
   Epstein JI, 2012, EUR UROL, V61, P1019, DOI 10.1016/j.eururo.2012.01.050
   Esserman LJ, 2014, LANCET ONCOL, V15, pE234, DOI 10.1016/S1470-2045(13)70598-9
   Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433
   GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4
   Kweldam CF, 2015, MODERN PATHOL, V28, P457, DOI 10.1038/modpathol.2014.116
   Lee BH, 2015, EUR UROL, V67, P204, DOI 10.1016/j.eururo.2014.09.017
   McNeal JE, 1996, AM J SURG PATHOL, V20, P802, DOI 10.1097/00000478-199607000-00003
   Mellinger G T, 1977, Recent Results Cancer Res, P61
   Nakabayashi M, 2013, CANCER-AM CANCER SOC, V119, P2990, DOI 10.1002/cncr.28102
   Nelson JB, 2014, J CLIN ONCOL, V32, P1295, DOI 10.1200/JCO.2013.54.2043
   Nielsen ME, 2008, UROLOGY, V72, P389, DOI 10.1016/j.urology.2007.10.053
   Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x
   Resnick MJ, 2013, NEW ENGL J MED, V368, P436, DOI 10.1056/NEJMoa1209978
   Ross HM, 2012, AM J SURG PATHOL, V36, P1346, DOI 10.1097/PAS.0b013e3182556dcd
   Spratt DE, 2014, BJU INT, V114, P360, DOI 10.1111/bju.12514
   Stark JR, 2009, J CLIN ONCOL, V27, P3459, DOI 10.1200/JCO.2008.20.4669
   Trock BJ, 2009, J UROLOGY, V182, P1364, DOI 10.1016/j.juro.2009.06.048
   Tsao CK, 2015, J UROLOGY, V194, P91, DOI 10.1016/j.juro.2015.01.078
   Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162
   Woody NM, 2014, HDB TREATMENT PLANNI
NR 30
TC 310
Z9 320
U1 3
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0302-2838
EI 1873-7560
J9 EUR UROL
JI Eur. Urol.
PD MAR
PY 2016
VL 69
IS 3
BP 428
EP 435
DI 10.1016/j.eururo.2015.06.046
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA DE0ZX
UT WOS:000370356100027
PM 26166626
OA Green Accepted
DA 2018-12-27
ER

PT J
AU Slusarczyk, J
   Trojan, E
   Glombik, K
   Piotrowska, A
   Budziszewska, B
   Kubera, M
   Popiolek-Barczyk, K
   Lason, W
   Mika, J
   Basta-Kaim, A
AF Slusarczyk, Joanna
   Trojan, Ewa
   Glombik, Katarzyna
   Piotrowska, Anna
   Budziszewska, Boguslawa
   Kubera, Marta
   Popiolek-Barczyk, Katarzyna
   Lason, Wladyslaw
   Mika, Joanna
   Basta-Kaim, Agnieszka
TI RETRACTED: Anti-inflammatory properties of tianeptine on
   lipopolysaccharide-induced changes in microglial cells involve toll-like
   receptor-related pathways (Retracted article. See vol. 142, pg. 776,
   2017)
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article; Retracted Publication
DE antidepressant drugs; cytokines; inflammation; intracellular pathways;
   microglia; tianeptine
ID NF-KAPPA-B; PROTEIN-KINASE-C; NITRIC-OXIDE; IN-VITRO; INFLAMMATORY
   ACTIVATION; OXIDATIVE STRESS; INTERFERON-GAMMA; PRENATAL STRESS; RAT;
   CYTOKINES
AB Accumulating evidence suggests that activation of microglia plays a key role in the pathogenesis of depression. Activated microglia produce a wide range of factors whose prolonged or excessive release may lead to brain disorders. Thus, the inhibition of microglial cells may be beneficial in the treatment of depressive diseases. Tianeptine is an atypical antidepressant drug with proven clinical efficacy, but its mechanism of action remains still not fully understood. In the present study, using microglial cultures we investigated whether tianeptine modifies microglial activation after lipopolysaccharide (LPS) stimulation and which intracellular pathways are involved in the activity of this antidepressant. Our study shows that tianeptine attenuated the LPS-evoked inflammatory activation of microglia by decreasing the expression of proinflammatory cytokines such as IL-1, IL-18, IL-6 and tumor necrosis factor (TNF-), the release of nitric oxide (NO) and reactive oxygen species (ROS) as well as the expression of inducible nitric oxide synthase. Analyses of signaling pathways demonstrate that tianeptine led to the suppression of LPS-induced TLR4 expression and ERK1/2 phosphorylation. Furthermore, our study reveals the inhibitory impact of tianeptine on caspase-3-induced PKC degradation and consequently on the activation of NF-B factor in microglial cells. Taken together, present results show anti-inflammatory properties of tianeptine in microglial cultures stimulated by LPS. This study provides evidence that the inhibition of microglial activation may underlie the therapeutic activity of tianeptine.
C1 [Slusarczyk, Joanna; Trojan, Ewa; Glombik, Katarzyna; Budziszewska, Boguslawa; Kubera, Marta; Lason, Wladyslaw; Basta-Kaim, Agnieszka] Polish Acad Sci, Inst Pharmacol, Dept Expt Neuroendocrinol, PL-31343 Krakow, Poland.
   [Piotrowska, Anna; Popiolek-Barczyk, Katarzyna; Mika, Joanna] Polish Acad Sci, Inst Pharmacol, Dept Pharmacol Pain, PL-31343 Krakow, Poland.
RP Basta-Kaim, A (reprint author), Polish Acad Sci, Dept Expt Neuroendocrinol, 12 Smeztna St, PL-31343 Krakow, Poland.
EM basta@if-pan.krakow.pl
OI Mika, Joanna/0000-0003-1986-7205; Budziszewska,
   Boguslawa/0000-0001-9685-5158; Popiolek-Barczyk,
   Katarzyna/0000-0003-4366-6577; Kubera, Marta/0000-0003-4401-5055; Lason,
   Wladyslaw/0000-0001-9640-2159
FU Institute of Pharmacology, Polish Academy of Sciences; National Science
   Centre, Poland [2013/09/B/NZ7/04096]; KNOW - Ministry of Science and
   Higher Education, Poland
FX The authors thank Barbara Korzeniak for her skillful technical
   assistance. We also thank the two anonymous reviewers for their patient
   review and critical reading of our manuscript. This research was
   supported by statutory funds of the Institute of Pharmacology, Polish
   Academy of Sciences and by grant no. 2013/09/B/NZ7/04096, National
   Science Centre, Poland. Joanna Slusarczyk, Ewa Trojan, Anna Piotrowska,
   and Katarzyna Popiolek-Barczyk are holders of scholarships from the
   KNOW, sponsored by the Ministry of Science and Higher Education, Poland.
CR Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7
   Araujo Ines M., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P319, DOI 10.2174/1568007054546126
   Basta-Kaim A, 2011, EUR J PHARMACOL, V650, P586, DOI 10.1016/j.ejphar.2010.09.083
   Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038
   Brown GC, 2003, MOL NEUROBIOL, V27, P325, DOI 10.1385/MN:27:3:325
   Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9
   Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788
   Castanon N, 2004, PSYCHONEUROENDOCRINO, V29, P778, DOI 10.1016/S0306-4530(03)00142-2
   Castanon N, 2003, PSYCHONEUROENDOCRINO, V28, P19, DOI 10.1016/S0306-4530(02)00005-7
   Castanon N, 2001, PSYCHOPHARMACOLOGY, V154, P50, DOI 10.1007/s002130000595
   Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033
   Frick LR, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/608654
   Galecki P, 2010, NEUROENDOCRINOL LETT, V31, P97
   Goldmann T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/208093
   Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0
   Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432
   Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161
   Hashioka S, 2007, EXP NEUROL, V206, P33, DOI 10.1016/j.expneurol.2007.03.022
   Hwang J, 2008, NEUROPHARMACOLOGY, V55, P826, DOI 10.1016/j.neuropharm.2008.06.045
   Jana M, 2007, J IMMUNOL, V179, P4142, DOI 10.4049/jimmunol.179.6.4142
   Janda E, 2011, BRIT J PHARMACOL, V164, P1590, DOI 10.1111/j.1476-5381.2010.01172.x
   Jantas D, 2014, NEUROTOX RES, V25, P208, DOI 10.1007/s12640-013-9430-3
   Jantas D, 2011, NEUROTOXICOLOGY, V32, P845, DOI 10.1016/j.neuro.2011.05.013
   Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0
   Kavanagh E, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.514
   Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010
   Kierdorf K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00044
   Kim BH, 2004, BIOCHEM BIOPH RES CO, V325, P223, DOI 10.1016/j.bbrc.2004.10.026
   Kiss JP, 2000, BRAIN RES BULL, V52, P459, DOI 10.1016/S0361-9230(00)00282-3
   Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003
   Koistinaho M, 2005, BRAIN RES REV, V48, P240, DOI 10.1016/j.brainresrev.2004.12.014
   Kubera M, 2000, POL J PHARMACOL, V52, P481
   Kuipers SD, 2013, NEUROPHARMACOLOGY, V75, P426, DOI 10.1016/j.neuropharm.2013.08.018
   Lee M, 2013, CURR PROTEIN PEPT SC, V14, P21, DOI 10.2174/1389203711314010005
   LEE SC, 1993, J IMMUNOL, V150, P2659
   Lee YY, 2013, INT J MOL SCI, V14, P9820, DOI 10.3390/ijms14059820
   Leskiewicz M, 2008, J NEUROSCI RES, V86, P1361, DOI 10.1002/jnr.21591
   LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105
   Liu DX, 2011, NEUROPHARMACOLOGY, V61, P592, DOI 10.1016/j.neuropharm.2011.04.033
   Liu RP, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-47
   Joca SRL, 2007, STRESS, V10, P227, DOI 10.1080/10253890701223130
   Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1
   Majumder S, 1998, J NEUROSCI RES, V54, P169, DOI 10.1002/(SICI)1097-4547(19981015)54:2<169::AID-JNR5>3.0.CO;2-C
   McEwen BS, 2010, MOL PSYCHIATR, V15, P237, DOI 10.1038/mp.2009.80
   Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529
   MILLER RJ, 2009, HDB EXP PHARM, V194, P417, DOI DOI 10.1007/978-3-540-79090-7_
   Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068
   Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579
   Muniz PS, 2004, AUST NZ J PSYCHIAT, V38, P176, DOI 10.1111/j.1440-1614.2004.01328.x
   Nakagawa Y, 2014, PHARMACEUTICALS, V7, P1028, DOI 10.3390/ph7121028
   Obuchowicz E, 2014, PHARMACOL REP, V66, P34, DOI 10.1016/j.pharep.2013.08.002
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Pannu R, 2006, NEUROCHEM INT, V49, P170, DOI 10.1016/j.neuint.2006.04.010
   Park KW, 2007, EXP MOL MED, V39, P812, DOI 10.1038/emm.2007.88
   Plaisant F, 2003, NEUROPHARMACOLOGY, V44, P801, DOI 10.1016/S0028-3908(03)00066-2
   Polazzi E, 2010, PROG NEUROBIOL, V92, P293, DOI 10.1016/j.pneurobio.2010.06.009
   Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004
   Rousseau MC, 2013, SURGERY, V154, P69, DOI 10.1016/j.surg.2013.03.006
   Ryu J, 2000, J BIOL CHEM, V275, P29955, DOI 10.1074/jbc.M001220200
   Sanchez-Mateo CC, 2003, ARZNEIMITTELFORSCH, V53, P12
   Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200
   Shen SM, 2005, NEUROCHEM INT, V47, P298, DOI 10.1016/j.neuint.2005.03.007
   Slusarczyk J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00082
   Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004
   Stuart MJ, 2014, NEUROSCI BIOBEHAV R, V42, P93, DOI 10.1016/j.neubiorev.2014.02.001
   Suzuki E, 2001, J AFFECT DISORDERS, V63, P221, DOI 10.1016/S0165-0327(00)00164-6
   Szczesny E, 2014, J NEUROIMMUNOL, V276, P37, DOI 10.1016/j.jneuroim.2014.08.001
   Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011
   Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038
   Uzbay TI, 2008, PROG NEURO-PSYCHOPH, V32, P915, DOI 10.1016/j.pnpbp.2007.08.007
   Vancurova I, 2001, J BIOL CHEM, V276, P19746, DOI 10.1074/jbc.M100234200
   Yang GA, 2011, BRAIN PATHOL, V21, P279, DOI 10.1111/j.1750-3639.2010.00445.x
   Zhao H, 2013, CNS NEUROSCI THER, V19, P117, DOI 10.1111/cns.12043
   Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014
NR 74
TC 10
Z9 12
U1 2
U2 20
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD MAR
PY 2016
VL 136
IS 5
BP 958
EP 970
DI 10.1111/jnc.13452
PG 13
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA DE5BT
UT WOS:000370646500007
PM 26640965
OA Bronze
DA 2018-12-27
ER

PT J
AU Kalogeraki, A
   Papadakis, GZ
   Tamiolakis, D
   Karvela-Kalogeraki, I
   Karvelas-Kalogerakis, M
   Segredakis, J
   Papadakis, M
   Moustou, E
   Datseri, G
   Tzardi, M
AF Kalogeraki, Alexandra
   Papadakis, Georgios Z.
   Tamiolakis, Dimitrios
   Karvela-Kalogeraki, Iliana
   Karvelas-Kalogerakis, Mihailos
   Segredakis, John
   Papadakis, Michael
   Moustou, Eleni
   Datseri, Galateia
   Tzardi, Maria
TI RETRACTED: EUS - Fine- Needle Aspiration Biopsy (FNAB) in the Diagnosis
   of Pancreatic Adenocarcinoma: A Review (Retracted article. See vol. 54,
   pg. 255, 2016)
SO ROMANIAN JOURNAL OF INTERNAL MEDICINE
LA English
DT Article; Retracted Publication
DE Pancreas; Pancreatic ductal adenocarcinoma; FNAB; cytology;
   immuno-cytochemistry
ID LINDAU GENE-PRODUCT; DUCTAL ADENOCARCINOMA; CYTOLOGIC CRITERIA; GUIDED
   FNA; IMMUNOHISTOCHEMICAL PANEL; GEMCITABINE SENSITIVITY; CANCER;
   EXPRESSION; S100P; CARCINOMA
AB Solid masses of the pancreas represent a variety of benign and malignant neoplasms of the exocrine and endocrine tissues of the pancreas. A tissue diagnosis is often required to direct therapy in the face of uncertain diagnosis or if the patient is not a surgical candidate either due to advanced disease or comorbidities. Endoscopic ultrasound (EUS) is a relatively new technology that employs endoscopy and high-frequency ultrasound (US). EUS involves imaging of the pancreatic head and the uncinate from the duodenum and imaging of the body and tail from the stomach. It has been shown to be a highly sensitive method for the detection of pancreatic masses. It is superior to extracorporeal US and computed tomographic (CT) scans, especially when the pancreatic tumor is smaller than 2-3 cm. Although EUS is highly sensitive in detecting pancreatic solid masses, its ability to differentiate between inflammatory masses and malignant disease is limited. Endoscopic retrograde cholangiopancreatography (ERCP) brushing, CT-guided biopsies, and transabdominal ultrasound (US) have been the standard nonsurgical methods for obtaining a tissue diagnosis of pancreatic lesions, but a substantial false-negative rate has been reported. Transabdominal US-guided fine-needle aspiration biopsy (US-FNAB) has been used for tissue diagnosis in patients with suspected pancreatic carcinoma. It has been shown to be highly specific, with no false-positive diagnoses. With the advent of curvilinear echoendoscopes, transgastric and transduodenal EUS-FNAB of the pancreas have become a reality EUS with FNAB has revolutionized the ability to diagnose and stage cancers of the gastrointestinal tract and assess the pancreas. Gastrointestinal cancers can be looked at with EUS and their depth of penetration into the intestinal wall can be determined. Any suspicious appearing lymph nodes can be biopsied using EUS/FNAB. The pancreas is another organ that is well visualized with EUS. Abnormalities such as tumors and cysts of the pancreas can be carefully evaluated using EUS and then biopsied with FNAB. There are many new applications of EUS using FNAB. Researchers are looking to deliver chemotherapeutics into small pancreatic cancers and cysts. Nerve blocks using EUS/FNAB to inject numbing medicines into the celiac ganglia, a major nerve cluster, are now routinely performed in patients with pain due to pancreatic cancer. The aim of this study is to perform a review of the literature regarding the usefulness of EUS/FNAB in the diagnosis of pancreatic adenocarcinoma.
C1 [Kalogeraki, Alexandra; Tamiolakis, Dimitrios; Karvela-Kalogeraki, Iliana; Karvelas-Kalogerakis, Mihailos; Segredakis, John; Papadakis, Michael; Moustou, Eleni; Datseri, Galateia; Tzardi, Maria] Univ Crete, Univ Hosp, Sch Med, Dept Pathol Cytopathol, Iraklion, Crete, Greece.
   [Papadakis, Georgios Z.] NIH, Ctr Clin, Dept Radiol & Imaging Sci, Bethesda, MD USA.
RP Kalogeraki, A (reprint author), Univ Crete, Fac Med, POB 1393, Iraklion 71110, Crete, Greece.
EM kalogerakimed@yahoo.gr
CR Afify AM, 2003, ACTA CYTOL, V47, P341
   Agarwal B, 2008, CLIN GASTROENTEROL H, V6, P1425, DOI 10.1016/j.cgh.2008.08.010
   ALKAISI N, 1989, ACTA CYTOL, V33, P145
   Ashida R, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-83
   BECKINGHAM IJ, 2001, ABC LIVER PANCREAS G
   BRANDT KR, 1993, RADIOLOGY, V187, P99, DOI 10.1148/radiology.187.1.8451443
   Bret P M, 1986, Diagn Cytopathol, V2, P221, DOI 10.1002/dc.2840020309
   BRITS CJ, 1976, ACTA CYTOL, V20, P462
   Chu PG, 2005, AM J SURG PATHOL, V29, P359, DOI 10.1097/01.pas.0000149708.12335.6a
   COHEN MB, 1991, DIAGN CYTOPATHOL, V7, P341, DOI 10.1002/dc.2840070404
   De Lott LB, 2005, ARCH PATHOL LAB MED, V129, P1100
   DEMAY RM, 1996, ART SCI CYTOPATHOLOG, P1059
   Deng HB, 2008, AM J CLIN PATHOL, V129, P81, DOI 10.1309/5D76NDE81LE8G545
   Dim DC, 2014, DIAGN CYTOPATHOL, V42, P193, DOI 10.1002/dc.21684
   Eloubeidi MA, 2003, AM J GASTROENTEROL, V98, P2663, DOI 10.1016/S0002-9270(03)01699-X
   Fekete P S, 1986, Diagn Cytopathol, V2, P301, DOI 10.1002/dc.2840020407
   Fritscher-Ravens A, 2000, AM J GASTROENTEROL, V95, P2255
   Fujita H, 2010, NEOPLASIA, V12, P807, DOI 10.1593/neo.10458
   Giorgadze TA, 2006, CANCER CYTOPATHOL, V108, P186, DOI 10.1002/cncr.21913
   Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203
   Goldstein NS, 2001, AM J CLIN PATHOL, V115, P695
   Greenblatt DY, 2011, ANN SURG ONCOL, V18, P2126, DOI 10.1245/s10434-011-1594-6
   Harewood GC, 2002, AM J GASTROENTEROL, V97, P1386, DOI 10.1016/S0002-9270(02)04133-3
   Hassan R, 2005, AM J CLIN PATHOL, V124, P838, DOI 10.1309/F1B64CL7H8VJKEAF
   Hewitt MJ, 2012, GASTROINTEST ENDOSC, V75, P319, DOI 10.1016/j.gie.2011.08.049
   Hosoda W, 2010, PATHOL INT, V60, P358, DOI 10.1111/j.1440-1827.2010.02527.x
   Jhala N, 2006, AM J CLIN PATHOL, V126, P572, DOI 10.1309/CEV30BE088CBDQD9
   Karanjawala ZE, 2008, AM J SURG PATHOL, V32, P188, DOI 10.1097/PAS.0b013e31815701f3
   KOCJAN G, 1989, J CLIN PATHOL, V42, P341, DOI 10.1136/jcp.42.4.341
   Kosarac O, 2011, ACTA CYTOL, V55, P142, DOI 10.1159/000320913
   Kroep JR, 2002, MOL CANCER THER, V1, P371
   KYOKO K, 2008, HEPATOB PANCREAT DIS, V7, P86
   Lau SK, 2002, HUM PATHOL, V33, P1175, DOI 10.1053/hupa.2002.130104
   Lee J G, 1998, Gastrointest Endosc Clin N Am, V8, P221
   Levy M, 2010, HUM PATHOL, V41, P1210, DOI 10.1016/j.humpath.2010.01.014
   Lin F, 2003, CANCER CYTOPATHOL, V99, P44, DOI 10.1002/cncr.11012
   Lin F, 2008, AM J SURG PATHOL, V32, P78, DOI 10.1097/PAS.0b013e31815701d1
   Liu HY, 2012, ARCH PATHOL LAB MED, V136, P601, DOI 10.5858/arpa.2011-0326-OA
   McCarthy DM, 2003, APPL IMMUNOHISTO M M, V11, P238
   MITCHELL ML, 1985, AM J CLIN PATHOL, V83, P171, DOI 10.1093/ajcp/83.2.171
   Nagata K, 2007, J HEPATO-BILIARY-PAN, V14, P243, DOI 10.1007/s00534-006-1169-2
   NIEDERHUBER JE, 1995, CANCER, V76, P1671, DOI 10.1002/1097-0142(19951101)76:9<1671::AID-CNCR2820760926>3.0.CO;2-R
   Noh Kyung W, 2005, MedGenMed, V7, P15
   Paquin SC, 2005, GASTROINTEST ENDOSC, V61, P610, DOI 10.1016/S0016-5107(05)00082-9
   Raut CP, 2003, J GASTROINTEST SURG, V7, P118, DOI 10.1016/S1091-255X(02)00150-6
   ROBINS DB, 1995, ACTA CYTOL, V39, P1
   Takahashi K, 2005, GASTROINTEST ENDOSC, V61, P76, DOI 10.1016/S0016-5107(04)02224-2
   Wachter DL, 2011, AM J SURG PATHOL, V35, P873, DOI 10.1097/PAS.0b013e3182189223
   Ylagan LR, 2002, CANCER CYTOPATHOL, V96, P362, DOI 10.1002/cncr.10759
   Yoshinaga S, 2011, DIGEST ENDOSC, V23, P29, DOI 10.1111/j.1443-1661.2011.01112.x
   Zhao H, 2007, DIAGN CYTOPATHOL, V35, P700, DOI 10.1002/dc.20739
NR 51
TC 5
Z9 5
U1 3
U2 3
PU DE GRUYTER OPEN LTD
PI WARSAW
PA BOGUMILA ZUGA 32A ST, 01-811 WARSAW, POLAND
SN 1582-3296
EI 2501-062X
J9 ROM J INTERN MED
JI Rom. J. Intern. Med.
PD MAR
PY 2016
VL 54
IS 1
BP 24
EP 30
DI 10.1515/rjim-2016-0002
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA ER8XY
UT WOS:000399108000004
PM 27141567
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Buldak, L
   Labuzek, K
   Buldak, RJ
   Machnik, G
   Boldys, A
   Basiak, M
   Boguslaw, O
AF Buldak, Lukasz
   Labuzek, Krzysztof
   Buldak, Rafal Jakub
   Machnik, Grzegorz
   Boldys, Aleksandra
   Basiak, Marcin
   Boguslaw, Okopien
TI RETRACTED: Metformin reduces the expression of NADPH oxidase and
   increases the expression of antioxidative enzymes in human
   monocytes/macrophages cultured in vitro(Retracted article. See vol. 13,
   pg. 794,2017)
SO EXPERIMENTAL AND THERAPEUTIC MEDICINE
LA English
DT Article; Retracted Publication
DE macrophages; metformin; oxidative stress; reactive oxygen species
ID C-REACTIVE PROTEIN; OXIDATIVE STRESS; THERAPY LOWERS; ATHEROSCLEROSIS;
   INFLAMMATION; CATALASE; CELLS; GLUTATHIONE; MONOCYTES; IMPROVES
AB The treatment of diabetes and its complications is a key challenge for healthcare professionals. Accelerated atherosclerosis is associated with progressive diabetes, and it has been indicated that macrophages serve a crucial function in this process. Currently, the first-line treatment of diabetes is based on metformin, which is an inducer of AMP-activated protein kinase (AMPK) and belongs to the biguanide class of pharmaceuticals. It has been previously demonstrated that metformin exhibits more than just hypoglycemic effects. Therefore, the aim of the present study was to investigate the in vitro impact of metformin on cell viability and the expression levels of nicotinamide adenine dinucleotide phosphate (NAPDH) oxidase (p22(phox)), a major enzyme in reactive oxygen species generation, and the three antioxidative enzymes superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) in monocytes/macrophages derived from 10 healthy volunteers. The effects of metformin were observed in the presence or absence of lipopolysaccharide (LPS), which was administered to induce oxidative stress. Furthermore, certain cells were treated with compound C, an inhibitor of AMPK, in order to determine the mechanistic role played by AMPK in the oxidative changes in the macrophages. Cell viability was evaluated using trypan blue and MTT assays. The mRNA and protein expression levels of p22(phox) and the various antioxidative enzymes were determined using polymerase chain reaction and western blot analysis, respectively. The results indicated that metformin, predominantly in LPS-pretreated monocytes/macrophages, reduced the expression levels of p22(phox) and increased those of SOD and GPx, but had only a minor effect on CAT levels. Therefore, metformin appears to alter the oxidative status of macrophages toward increasingly antioxidative activity, which may account for the pleiotropic effects observed during metformin treatment.
C1 [Buldak, Lukasz; Labuzek, Krzysztof; Machnik, Grzegorz; Boldys, Aleksandra; Basiak, Marcin; Boguslaw, Okopien] Med Univ Silesia, Sch Med Katowice, Dept Internal Med & Clin Pharmacol, 18 Medykow, PL-40752 Katowice, Poland.
   [Buldak, Rafal Jakub] Med Univ Silesia, Sch Med, Div Dent Zabrze, Dept Physiol, PL-41808 Zabrze, Poland.
RP Buldak, L (reprint author), Med Univ Silesia, Sch Med Katowice, Dept Internal Med & Clin Pharmacol, 18 Medykow, PL-40752 Katowice, Poland.
EM lbuldak@gmail.com
OI Basiak, Marcin/0000-0003-0674-5612
FU Medical University of Silesia [KNW-1-097/N/4/0, KNW-1-093/N/5/0]
FX This study was supported by statutory grants from the Medical University
   of Silesia (no. KNW-1-097/N/4/0 and KNW-1-093/N/5/0). The authors thank
   Mrs. Jaroslawa Sprada and Mrs. Halina Klimas for their technical
   support.
CR Ari E, 2011, HEMODIAL INT, V15, P453, DOI 10.1111/j.1542-4758.2011.00568.x
   Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8
   Batchuluun B, 2014, ATHEROSCLEROSIS, V232, P156, DOI 10.1016/j.atherosclerosis.2013.10.025
   Buldak L, 2015, N-S ARCH PHARMACOL, V388, P905, DOI 10.1007/s00210-015-1124-3
   Buldak L, 2014, PHARMACOL REP, V66, P418, DOI 10.1016/j.pharep.2013.11.008
   Cheng F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072063
   Costa A, 2014, SEMIN CANCER BIOL, V25, P23, DOI 10.1016/j.semcancer.2013.12.007
   Deo SH, 2012, AM J PHYSIOL-HEART C, V303, pH377, DOI 10.1152/ajpheart.00289.2012
   Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999
   Goth L, 2013, MUTAT RES-REV MUTAT, V753, P147, DOI 10.1016/j.mrrev.2013.08.002
   Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022
   Kaptoge S, 2014, EUR HEART J, V35, P578, DOI 10.1093/eurheartj/eht367
   Kasperczyk A, 2012, TOXICOLOGY, V301, P79, DOI 10.1016/j.tox.2012.07.002
   Krifka S, 2012, BIOMATERIALS, V33, P5177, DOI 10.1016/j.biomaterials.2012.04.013
   Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P171, DOI 10.1007/s00210-009-0477-x
   Lee S, 2014, J DRUG TARGET, V22, P138, DOI 10.3109/1061186X.2013.844158
   Lu Weiqin, 2007, Drug Discov Today Dis Models, V4, P67, DOI 10.1016/j.ddmod.2007.10.005
   Madej A, 2012, POSTEP HIG MED DOSW, V66, P78
   Nivet-Antoine V, 2013, ATHEROSCLEROSIS, V227, P100, DOI 10.1016/j.atherosclerosis.2012.12.015
   Okopien B, 2005, J CARDIOVASC PHARM, V46, P377, DOI 10.1097/01.fjc.0000175455.46245.c8
   Park JG, 2011, BMB REP, V44, P497, DOI 10.5483/BMBRep.2011.44.8.497
   Perrotta I, 2013, CARDIOVASC PATHOL, V22, P428, DOI 10.1016/j.carpath.2013.03.002
   Pignatelli P, 2012, BIOCHEM PHARMACOL, V84, P1635, DOI 10.1016/j.bcp.2012.09.011
   Piwkowska A, 2010, BIOCHEM BIOPH RES CO, V393, P268, DOI 10.1016/j.bbrc.2010.01.119
   Prasad K, 2014, INT J ANGIOL, V23, P217, DOI 10.1055/s-0034-1387169
   Rebelato E, 2012, LIFE SCI, V91, P244, DOI 10.1016/j.lfs.2012.07.004
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813
   Ridker PM, 2008, NEW ENGL J MED, V359, P2195
   Rizos CV, 2013, EUR J PHARMACOL, V705, P96, DOI 10.1016/j.ejphar.2013.02.038
   Savoia C, 2007, CLIN SCI, V112, P375, DOI 10.1042/CS20060247
   Strzalka-Mrozik B, 2013, MOL VIS, V19, P1341
   Szuchman-Sapir A, 2012, BIOCHEM BIOPH RES CO, V423, P884, DOI 10.1016/j.bbrc.2012.06.070
   United Kingdom Prospective Diabetes Study, 1998, LANCET, V352, P854, DOI DOI 10.1016/S0140-6736(98)07037-8
   van Greevenbroek MMJ, 2013, NETH J MED, V71, P174
NR 35
TC 4
Z9 4
U1 2
U2 22
PU SPANDIDOS PUBL LTD
PI ATHENS
PA POB 18179, ATHENS, 116 10, GREECE
SN 1792-0981
EI 1792-1015
J9 EXP THER MED
JI Exp. Ther. Med.
PD MAR
PY 2016
VL 11
IS 3
BP 1095
EP 1103
DI 10.3892/etm.2016.2977
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA DC9PV
UT WOS:000369554400063
PM 26998043
OA Green Published, Bronze
DA 2018-12-27
ER

PT J
AU Watawana, MI
   Jayawardena, N
   Choo, C
   Waisundara, VY
AF Watawana, Mindani I.
   Jayawardena, Nilakshi
   Choo, Candy
   Waisundara, Viduranga Y.
TI RETRACTED: Application of the Kombucha 'tea fungus' for the enhancement
   of antioxidant and starch hydrolase inhibitory properties of ten herbal
   teas (Retracted article. See vol. 209, pg. 366, 2016)
SO FOOD CHEMISTRY
LA English
DT Article; Retracted Publication
DE Acetobacter aceti; Antioxidant activity; Brettanomyces claussenii;
   Starch hydrolases; Zygosaccharomyces bailii
ID FUNGUS METABOLITES; FERMENTATION; POLYPHENOLS; CAPACITY; COMPONENTS;
   EXTRACT; AMYLASE; SAMPLES; ACIDS; ASSAY
AB Ten herbal teas (Acacia arabica, Aegle marmelos flower, A. marmelos root bark, Aerva lanata, Asteracantha longifolia, Cassia auriculata, Hemidesmus indicus, Hordeum vulgare, Phyllanthus emblica, Tinospora cordifolia) were fermented with the Kombucha 'tea fungus'. The pH values of the fermented beverages ranged from 4.0 to 6.0 by day 7, while the titratable acidity ranged from 2.5 to 5.0 g/mL (P <0.05). Gallic acid had statistically significantly increased (P <0.05) in almost all the samples by day 7. The Oxygen radical absorbance capacity assay indicated 5 of the Kombucha beverages to have statistically significant increases (P <0.05) by day 7. The a-amylase inhibitory activities ranged from 52.5 to 67.2 mu g/mL in terms of IC50 values following fermentation, while the a-glucosidase inhibitory activities ranged from 95.2 to 196.1 mu g/mL. In conclusion, an enhancement of the antioxidant and starch hydrolase inhibitory potential of the herbal teas was observed by adding the tea fungus. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Watawana, Mindani I.; Jayawardena, Nilakshi; Waisundara, Viduranga Y.] Natl Inst Fundamental Studies, Kandy 20000, Sri Lanka.
   [Choo, Candy] Temasek Polytech, Temasek Sch Appl Sci, Singapore 529757, Singapore.
RP Waisundara, VY (reprint author), Natl Inst Fundamental Studies, Hantane Rd, Kandy 20000, Sri Lanka.
EM viduranga@gmail.com
FU National Institute of Fundamental Studies, Hantane Road, Kandy, Sri
   Lanka
FX The financial and analytical support provided by the National Institute
   of Fundamental Studies, Hantane Road, Kandy, Sri Lanka and the
   analytical support provided by the Temasek School of Applied Science,
   Temasek Polytechnic, Singapore are acknowledged.
CR Arul V, 2005, J ETHNOPHARMACOL, V96, P159, DOI 10.1016/j.jep.2004.09.013
   Blanc PJ, 1996, BIOTECHNOL LETT, V18, P139, DOI 10.1007/BF00128667
   Chen C, 2000, J APPL MICROBIOL, V89, P834, DOI 10.1046/j.1365-2672.2000.01188.x
   Chu SC, 2006, FOOD CHEM, V98, P502, DOI 10.1016/j.foodchem.2005.05.080
   Crozier A, 2010, MOL ASPECTS MED, V31, P446, DOI 10.1016/j.mam.2010.09.007
   Dufresne CJ, 2001, J NUTR BIOCHEM, V12, P404, DOI 10.1016/S0955-2863(01)00155-3
   FERNANDO MR, 1991, J ETHNOPHARMACOL, V31, P277, DOI 10.1016/0378-8741(91)90012-3
   FOSSUM K, 1974, J NUTR, V104, P930
   Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w
   Gawarammana I. B., 2008, TRADITIONAL HERBAL M, P45
   Goldstein B. J., 2006, LANCET, V371, P2153
   Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920
   Gujral HS, 2004, J FOOD ENG, V65, P89, DOI 10.1016/j.foodchem.2003.12.007
   Haslam E, 2003, PHYTOCHEMISTRY, V64, P61, DOI 10.1016/S0031-9422(03)00355-8
   Huang DJ, 2002, J AGR FOOD CHEM, V50, P1815, DOI 10.1021/jf0113732
   Isabelle M, 2010, FOOD CHEM, V120, P993, DOI 10.1016/j.foodchem.2009.11.038
   Jayabalan R, 2008, FOOD CHEM, V109, P227, DOI 10.1016/j.foodchem.2007.12.037
   Jayabalan R, 2007, FOOD CHEM, V102, P392, DOI 10.1016/j.foodchem.2006.05.032
   Jayabalan R, 2008, J AGR FOOD CHEM, V56, P9064, DOI 10.1021/jf8020893
   Jayabalan R, 2010, FOOD SCI BIOTECHNOL, V19, P843, DOI 10.1007/s10068-010-0119-6
   Khopde SM, 2001, CURR SCI INDIA, V81, P185
   Koh LW, 2009, J AGR FOOD CHEM, V58, P148
   Kovacevic Z., 2014, Macedonian Journal of Medical Sciences, V7, P128
   Lee JC, 2002, J AGR FOOD CHEM, V50, P6490, DOI 10.1021/jf020388c
   Lee Y. H., J FUNCTIONA IN PRESS
   Liu CH, 1996, FOOD MICROBIOL, V13, P407, DOI 10.1006/fmic.1996.0047
   Liu TT, 2011, J AGR FOOD CHEM, V59, P9756, DOI 10.1021/jf202939d
   Madsen Carina, 2007, Ann Nutr Metab, V51, P298, DOI 10.1159/000106804
   Markov SL, 2001, ACTA PERIODICA TECHN, V32, P133
   Marsh AJ, 2014, FOOD MICROBIOL, V38, P171, DOI 10.1016/j.fm.2013.09.003
   Pari L., 2002, SMJ Singapore Medical Journal, V43, P617
   Prior RL, 2000, J AOAC INT, V83, P950
   Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256
   Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044
   REISS J, 1994, Z LEBENSM UNTERS FOR, V198, P258, DOI 10.1007/BF01192606
   RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9
   Smolinske SC, 2005, J PHARM PRACT, V18, P188, DOI 10.1177/0897190005277217
   Sreeramulu G, 2000, J AGR FOOD CHEM, V48, P2589, DOI 10.1021/jf991333m
   SungHee Kole Alison, 2009, J Intensive Care Med, V24, P205, DOI 10.1177/0885066609332963
   Watawana M. I., J FOOD PROC IN PRESS
   Wijeratne SSK, 2006, J AGR FOOD CHEM, V54, P312, DOI 10.1021/jf052692j
   Zhu QY, 1997, J AGR FOOD CHEM, V45, P4624, DOI 10.1021/jf9706080
NR 42
TC 5
Z9 6
U1 6
U2 103
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
EI 1873-7072
J9 FOOD CHEM
JI Food Chem.
PD MAR 1
PY 2016
VL 194
BP 304
EP 311
DI 10.1016/j.foodchem.2015.08.033
PG 8
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA CV4PL
UT WOS:000364248900041
PM 26471559
DA 2018-12-27
ER

PT J
AU Park, JH
   Kim, HY
   Jang, GS
   Ahn, D
   Joo, SK
AF Park, Jae Hyo
   Kim, Hyung Yoon
   Jang, Gil Su
   Ahn, Donghwan
   Joo, Seung Ki
TI RETRACTED: Ultimate multibit 1T-FeRAM with selectively nucleated grown
   single-grain PbZr0.52Ti0.48O3 for very-large-scale-integrated
   memory(Retracted article.See vol.49,pg.379701,2016)
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Article; Retracted Publication
DE 1 transistor-ferroelectric random-access memory (1T-FeRAM); epitaxial
   PZT ferroelectric thin-film; grain-boundary processing; multibit
   nonvolatile memory
ID FIELD-EFFECT TRANSISTOR; TITANATE THIN-FILMS; DATA RETENTION
   CHARACTERISTICS; HYDROGEN-INDUCED DEGRADATION; FERROELECTRIC MEMORY;
   ELECTRICAL-PROPERTIES; LATERAL CRYSTALLIZATION; DIELECTRIC-PROPERTIES;
   DIFFUSION BARRIER; SEED LAYER
AB Controlling the grain-boundary of ferroelectric thin-film is significantly important for realizing ultimate multibit-FeRAM, when a ferroelectric thin-film deposited by radio-frequency reactive magnetron sputtering is integrated into silicon-based devices. A novel crystal-growth process of a ferroelectric thin-film using platinum (Pt)-seed matrix is developed for dividing the nucleation and growth of PbZr0.52Ti0.48O3 (PZT), which cannot be observed in the classical nucleation and growth of PZT. Locating artificial nucleation seeds using Pt-seeds in a desirable position enables one to obtain a large single-grain PZT (similar to 40 mu m) that is large enough to fabricate a field-effect transistor (FET)-type FeRAM. The fabricated FeRAM with a Pt/PZT/ZrTiO4(ZTO)/p-Si structure showed a wide memory window (similar to 1.8 V), low operation voltage (similar to 6 V), ultra-fast Program/Erase (P/E) switching speed (similar to 10(-7) s), and a stable multibit operation controlled by local polarization. In addition, the FeRAM showed no degradation even after cycling the P/E more than 1011 times in all multibit states, and the retention time was expected to have a wide memory window even after 10 years in all multibit states. These characteristics show great potential for the multi-bit FeRAM, which is difficult to expect a reliable operation with large grain-boundaries.
C1 [Park, Jae Hyo; Kim, Hyung Yoon; Jang, Gil Su; Joo, Seung Ki] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.
   [Park, Jae Hyo; Kim, Hyung Yoon; Jang, Gil Su; Joo, Seung Ki] Seoul Natl Univ, Res Inst Adv Mat, Eui San Res Ctr, Seoul 151742, South Korea.
   [Ahn, Donghwan] Kookmin Univ, Dept Adv Mat Engn, Seoul 136702, South Korea.
RP Joo, SK (reprint author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.; Joo, SK (reprint author), Seoul Natl Univ, Res Inst Adv Mat, Eui San Res Ctr, Seoul 151742, South Korea.; Ahn, D (reprint author), Kookmin Univ, Dept Adv Mat Engn, Seoul 136702, South Korea.
EM dhahn@kookmin.ac.kr; skjoo@snu.ac.kr
FU Seoul Nation University, Seoul; Republic of Korea, through the Eui-San
   Research Center; Research Institute of Advanced Materials (RIAM);
   Science Research Program through the National Research Foundation of
   Korea (NRF) - Ministry of Education [0417-20150112]; BK21PLUS SNU
   Materials Division for Educating Creative Global Leaders [F15SN02D1702];
   Kookmin University in Korea
FX The authors would like to thank Dr Yoonsuk Yoon (LFoundary, Germany) for
   this valuable discussion. This work was supported by the Seoul Nation
   University, Seoul, the Republic of Korea, through the Eui-San Research
   Center and the Research Institute of Advanced Materials (RIAM). In
   addition, this work was partially supported by the Science Research
   Program through the National Research Foundation of Korea (NRF) funded
   by the Ministry of Education (Grant. 0417-20150112) and in part by
   BK21PLUS SNU Materials Division for Educating Creative Global Leaders
   under (Grant F15SN02D1702). This work was supported in part by the new
   faculty research program 2013 of Kookmin University in Korea.
CR Ashikaga K, 1999, J APPL PHYS, V85, P7471, DOI 10.1063/1.369381
   Basit NA, 1998, APPL PHYS LETT, V73, P3941, DOI 10.1063/1.122943
   Burfoot J C, 1994, J PHYS C SOLID STATE, V7, P3182
   Cao WW, 1996, J PHYS CHEM SOLIDS, V57, P1499, DOI 10.1016/0022-3697(96)00019-4
   Chadi D J, 1998, PHYS REV B, V47
   Chen SY, 1998, J AM CERAM SOC, V81, P97
   Colla EL, 1998, APPL PHYS LETT, V72, P2763, DOI 10.1063/1.121083
   DUIKER HM, 1990, PHYS REV B, V41, P490, DOI 10.1103/PhysRevB.41.490
   Fukuda Y, 1997, JPN J APPL PHYS 1, V36, P5793, DOI 10.1143/JJAP.36.5793
   George A, 2012, MATER RES BULL, V47, P3141, DOI 10.1016/j.materresbull.2012.08.018
   Ha SM, 1999, THIN SOLID FILMS, V355, P525, DOI 10.1016/S0257-8972(99)00372-2
   Hamedi LH, 2001, J SOLID STATE CHEM, V158, P40, DOI 10.1006/jssc.2000.9054
   Hoffman J, 2010, ADV MATER, V22, P2957, DOI 10.1002/adma.200904327
   Hong S, 1999, J APPL PHYS, V86, P607, DOI 10.1063/1.370774
   HU H, 1993, THIN SOLID FILMS, V223, P327, DOI 10.1016/0040-6090(93)90540-6
   Ikarashi N, 1998, APPL PHYS LETT, V73, P1955, DOI 10.1063/1.122333
   Jones RE, 1996, MRS BULL, V21, P55
   Juan TPC, 2006, IEEE ELECTR DEVICE L, V27, P217, DOI 10.1109/LED.2006.870414
   Kalpat S, 2001, J APPL PHYS, V90, P2703, DOI 10.1063/1.1385580
   Kim K, 2003, MICROELECTRON RELIAB, V43, P385, DOI 10.1016/S0026-2714(02)00285-8
   Kim K, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337361
   KINOSHITA K, 1976, J APPL PHYS, V47, P371, DOI 10.1063/1.322330
   Kurmar C V R V, 1992, J APPL PHYS, V71, P864
   Kurmar C V R V, 1991, APPL PHYS LETT, V58, P1161
   LAMPE DR, 1992, FERROELECTRICS, V133, P61, DOI 10.1080/00150199208217977
   Lee JS, 2000, JPN J APPL PHYS 1, V39, P6343, DOI 10.1143/JJAP.39.6343
   Lee JS, 2002, SOLID STATE ELECTRON, V46, P1651, DOI 10.1016/S0038-1101(02)00120-X
   Lee JS, 2002, J APPL PHYS, V92, P2658, DOI 10.1063/1.1496147
   Lee JS, 2002, APPL PHYS LETT, V81, P3230, DOI 10.1063/1.1516233
   Lee JS, 2000, INTEGR FERROELECTR, V31, P149, DOI 10.1080/10584580008215649
   Lee JS, 2001, J KOREAN PHYS SOC, V39, P184
   Lee JS, 2001, JPN J APPL PHYS 1, V40, P229, DOI 10.1143/JJAP.40.229
   Liu BT, 2002, APPL PHYS LETT, V80, P3599, DOI 10.1063/1.1477281
   Lou XJ, 2009, J APPL PHYS, V105, DOI 10.1063/1.3056603
   Lue HT, 2002, IEEE T ELECTRON DEV, V49, P1790, DOI 10.1109/TED.2002.803626
   Ma TP, 2002, IEEE ELECTR DEVICE L, V23, P386, DOI 10.1109/LED.2002.1015207
   Mhin S, 2015, J AM CERAM SOC, V98, P1407, DOI 10.1111/jace.13468
   MILLER SL, 1992, J APPL PHYS, V72, P5999, DOI 10.1063/1.351910
   Moll J. L., 1963, IEEE T ELECTRON DEV, VED10, P338
   PARIKH NR, 1990, MATER RES SOC SYMP P, V200, P193, DOI 10.1557/PROC-200-193
   Park JH, 2015, IEEE ELECTR DEVICE L, V36, P920, DOI 10.1109/LED.2015.2462745
   Park JH, 2002, INTEGR FERROELECTR, V49, P13, DOI 10.1080/10584580290171720
   Peng X, 2004, MATER LETT, V58, P2073, DOI 10.1016/j.matlet.2004.01.004
   ROBINS JL, 1988, APPL SURF SCI, V33-4, P379, DOI 10.1016/0169-4332(88)90330-3
   Sakai S, 2004, IEEE ELECTR DEVICE L, V25, P369, DOI 10.1109/LED.2004.828992
   Scott JF, 2007, SCIENCE, V315, P954, DOI 10.1126/science.1129564
   Scott JF, 2000, APPL PHYS LETT, V76, P3801, DOI 10.1063/1.126786
   Shimizu M, 2004, J EUR CERAM SOC, V24, P1625, DOI 10.1016/S0955-2219(03)00451-5
   SINHAROY S, 1992, J VAC SCI TECHNOL A, V10, P1554, DOI 10.1116/1.578044
   Son YJ, 2007, J KOREAN PHYS SOC, V51, P701, DOI 10.3938/jkps.51.701
   Song YJ, 2000, APPL PHYS LETT, V76, P451, DOI 10.1063/1.125784
   STOWELL MJ, 1971, THIN SOLID FILMS, V8, P41, DOI 10.1016/0040-6090(71)90095-2
   Suzuki T, 2000, PHILOS MAG A, V80, P621, DOI 10.1080/01418610008212072
   Tanaka H, 2008, JPN J APPL PHYS, V47, P7527, DOI 10.1143/JJAP.47.7527
   Tarui Y, 1997, APPL SURF SCI, V113, P656, DOI 10.1016/S0169-4332(96)00963-4
   Tokumitsu E, 1997, IEEE ELECTR DEVICE L, V18, P160, DOI 10.1109/55.563315
   WILKINSON AP, 1994, CHEM MATER, V6, P750, DOI 10.1021/cm00042a009
   Wu A, 2003, CHEM MATER, V15, P1147, DOI 10.1021/cm020757k
   Wu JS, 2002, J CRYST GROWTH, V234, P603, DOI 10.1016/S0022-0248(01)01734-1
   Wu WB, 2000, J APPL PHYS, V88, P2068, DOI 10.1063/1.1305859
   Zeng JM, 1999, J PHYS-CONDENS MAT, V11, P1139, DOI 10.1088/0953-8984/11/4/021
NR 61
TC 3
Z9 3
U1 3
U2 36
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
EI 1361-6463
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD FEB 25
PY 2016
VL 49
IS 7
AR 075106
DI 10.1088/0022-3727/49/7/075106
PG 6
WC Physics, Applied
SC Physics
GA DC7MG
UT WOS:000369403700014
DA 2018-12-27
ER

PT J
AU Diao, WP
   Snyder, JC
   Wang, SB
   Liu, JB
   Pan, BG
   Guo, GJ
   Wei, G
AF Diao, Wei-Ping
   Snyder, John C.
   Wang, Shu-Bin
   Liu, Jin-Bing
   Pan, Bao-Gui
   Guo, Guang-Jun
   Wei, Ge
TI RETRACTED: Genome-Wide Identification and Expression Analysis of WRKY
   Gene Family in Capsicum annuum L.(Retracted article. See vol. 7,2016)
SO FRONTIERS IN PLANT SCIENCE
LA English
DT Article; Retracted Publication
DE transcriptional factor; WRKY; phylogenetics analysis; expression
   pattern; pepper
ID RALSTONIA-SOLANACEARUM INFECTION; TRANSCRIPTION FACTOR; DEFENSE
   RESPONSE; PLANT DEFENSE; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE;
   PROVIDES INSIGHTS; ABIOTIC STRESSES; BASAL DEFENSE; RICE
AB The WRKY family of transcription factors is one of the most important families of plant transcriptional regulators with members regulating multiple biological processes, especially in regulating defense against biotic and abiotic stresses. However, little information is available about WRKYs in pepper (Capsicum annuum L.). The recent release of completely assembled genome sequences of pepper allowed us to perform a genome-wide investigation for pepper WRKY proteins. In the present study, a total of 71 WRKY genes were identified in the pepper genome. According to structural features of their encoded proteins, the pepper WRKY genes (CaWRKY) were classified into three main groups, with the second group further divided into five subgroups. Genome mapping analysis revealed that CaWRKY were enriched on four chromosomes, especially on chromosome 1, and 15.5% of the family members were tandemly duplicated genes. A phylogenetic tree was constructed depending on WRKY domain' sequences derived from pepper and Arabidopsis. The expression of 21 selected CaWRKY genes in response to seven different biotic and abiotic stresses (salt, heat shock, drought, Phytophtora capsici, SA, MeJA, and ABA) was evaluated by quantitative RT-PCR; Some CaWRKYs were highly expressed and up-regulated by stress treatment. Our results will provide a platform for functional identification and molecular breeding studies of WRKY genes in pepper.
C1 [Diao, Wei-Ping; Wang, Shu-Bin; Liu, Jin-Bing; Pan, Bao-Gui; Guo, Guang-Jun; Wei, Ge] Jiangsu Acad Agr Sci, Inst Vegetable Crops, Nanjing, Jiangsu, Peoples R China.
   [Diao, Wei-Ping] Jiangsu Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China.
   [Snyder, John C.] Univ Kentucky, Coll Agr Food & Environm, Lexington, KY USA.
RP Wang, SB (reprint author), Jiangsu Acad Agr Sci, Inst Vegetable Crops, Nanjing, Jiangsu, Peoples R China.
EM wangsbpep@163.net
FU National Natural Science Foundation of China [31401870]; National
   High-tech Research and Development Program of China [2012AA100103];
   Natural Science Foundation of Jiangsu [BK20141380]; Jiangsu Agricultural
   Science and Technology Innovation Funds [CX (12)1004]; National Natural
   Science Foundation of China [31401870]; National High-tech Research and
   Development Program of China [2012AA100103]; Natural Science Foundation
   of Jiangsu [BK20141380]; Jiangsu Agricultural Science and Technology
   Innovation Funds [CX (12)1004]
FX This research was supported by the National Natural Science Foundation
   of China (31401870), National High-tech Research and Development Program
   of China (863 Program: 2012AA100103), Natural Science Foundation of
   Jiangsu (BK20141380), Jiangsu Agricultural Science and Technology
   Innovation Funds (CX (12)1004).
CR Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Banerjee Aditya, 2015, ScientificWorldJournal, V2015, P807560, DOI 10.1155/2015/807560
   BARKSDALE TH, 1984, PLANT DIS, V68, P506, DOI 10.1094/PD-69-506
   Bin WS, 2012, MOL BREEDING, V30, P1393, DOI 10.1007/s11032-012-9726-7
   Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10
   Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281
   Dang FF, 2013, PLANT CELL ENVIRON, V36, P757, DOI 10.1111/pce.12011
   Dang FF, 2014, PHYSIOL PLANTARUM, V150, P397, DOI 10.1111/ppl.12093
   Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088
   [刁卫平 Diao Weiping], 2014, [华北农学报, Acta Agriculturae Boreali-Sinica], V29, P45
   Ding MQ, 2015, MOL GENET GENOMICS, V290, P151, DOI 10.1007/s00438-014-0904-7
   Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549
   Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9
   Guo M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00806
   Higashi K, 2008, MOL GENET GENOMICS, V279, P303, DOI 10.1007/s00438-007-0315-0
   Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297
   Huang SX, 2012, MOL GENET GENOMICS, V287, P495, DOI 10.1007/s00438-012-0696-6
   ISHIGURO S, 1994, MOL GEN GENET, V244, P563
   Jiang Teng, 2011, Acta Prataculturae Sinica, V20, P211
   Jiang YZ, 2014, J EXP BOT, V65, P6629, DOI 10.1093/jxb/eru381
   Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x
   Kim KC, 2008, PLANT CELL, V20, P2357, DOI 10.1105/tpc.107.055566
   Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877
   Knoth C, 2007, MOL PLANT MICROBE IN, V20, P120, DOI 10.1094/MPMI-20-2-0120
   Lai ZB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-68
   Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325
   Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x
   Li SJ, 2011, PLANTA, V233, P1237, DOI 10.1007/s00425-011-1375-2
   Li ShuMin, 2008, Acta Horticulturae Sinica, V35, P1467
   Ling L., 2011, BMC GENOMICS, V12, P471, DOI [10.1186/1471-2164-12-471, DOI 10.1186/1471-2164-12-471]
   Liu XQ, 2007, J PLANT PHYSIOL, V164, P969, DOI 10.1016/j.jplph.2006.07.006
   Liu XQ, 2005, CELL RES, V15, P593, DOI 10.1038/sj.cr.7290329
   Ma JC, 2015, EVOL BIOINFORM, V11, P47, DOI 10.4137/EBO.S22067
   Pan LJ, 2014, MOL BIOL REP, V41, P1215, DOI 10.1007/s11033-013-2966-8
   Pandey SP, 2010, PLANT J, V64, P912, DOI 10.1111/j.1365-313X.2010.04387.x
   Park CJ, 2006, PLANTA, V223, P168, DOI 10.1007/s00425-005-0067-1
   Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111
   Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492
   Qiu Y. P., 2004, CHINESE SCI BULL, V49, P1860
   Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061
   Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006
   Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1
   Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x
   Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250
   Song Y, 2014, CHINESE SCI BULL, V59, P754, DOI 10.1007/s11434-013-0057-9
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Wang Y. N., 2008, CHINESE AGR SCI B, V24, P93
   Wang YN, 2013, MOL PLANT PATHOL, V14, P131, DOI 10.1111/j.1364-3703.2012.00836.x
   Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9
   [许瑞瑞 Xu Ruirui], 2012, [园艺学报, Acta Horticulturae Sinica], V39, P2049
   Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523
   Zhang C. Q, 2010, THESIS ACAD AAGRICUL
   Zheng ZY, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1171-2229-7-2
   Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x
   Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x
   [邹智 Zou Zhi], 2013, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V35, P36
NR 58
TC 9
Z9 9
U1 5
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-462X
J9 FRONT PLANT SCI
JI Front. Plant Sci.
PD FEB 23
PY 2016
VL 7
DI 10.3389/fpls.2016.00211
PG 15
WC Plant Sciences
SC Plant Sciences
GA DE4IT
UT WOS:000370593100001
PM 26941768
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Khan, K
   Wozniak, SE
   Giannone, AL
   Abdulmassih, ME
AF Khan, Kamran
   Wozniak, Susan E.
   Giannone, Anna Lucia
   Abdulmassih, Maria Elena
TI RETRACTED: A Boy with Relentless Pruritus: Job's Syndrome (Retracted
   article. See vol. 18, pg. 782, 2017)
SO AMERICAN JOURNAL OF CASE REPORTS
LA English
DT Article; Retracted Publication
DE Job Syndrome; Pruritus; Psychotherapy
ID HYPER-IGE SYNDROME; HYPERIMMUNOGLOBULINEMIA-E; ATOPIC-DERMATITIS;
   IMMUNOGLOBULIN; INFECTION; GAMMA
AB Patient: Male, 6
   Final Diagnosis: Job's Syndrome (hyper IgE syndrome)
   Symptoms: Pruritus
   Medication:
   Clinical Procedure: None
   Specialty: Allergology
   Objective: Rare disease
   Background: Job's syndrome (hyper IgE syndrome) is a very rare primary immunodeficiency disease that has an annual approximate incidence of less than 1/1,000,000. This manuscript aims to provide education regarding diagnosis and management strategies of this syndrome worldwide.
   Case Report: A 6-year-old boy was seen at the clinic secondary to persistent pruritus interfering with sleep. At the age of 2 months, the patient developed diffuse eczematous and desquamating skin lesions. He was subsequently diagnosed with atopic dermatitis and managed conservatively. From 2 months to 7 years of age, intermittent exacerbations of dermatitis persisted despite an aggressive treatment regimen. The serum IgE level increased exponentially over a period of 7 years, with a peak value of 57,400 IU/ml. Molecular genetic testing revealed a dominant negative mutation within the SH2 domain of the Signal Transducer and Activator of Transcription (STAT3) gene. The patient was subsequently diagnosed with Job's syndrome. Management included proper skin care, prophylactic antibiotics, immunomodulating agents, and psychotherapy.
   Conclusions: Job's syndrome can often go unrecognized and masquerade as atopic dermatitis. Therefore, genetic testing for this condition should be obtained in all patients with treatment-refractory AD. Additionally, psychotherapy can be a successful management strategy for the grating psychological impact that can be imposed on children with excessive pruritus.
C1 [Khan, Kamran; Wozniak, Susan E.] Sinai Hosp Baltimore, Dept Gen Surg, Baltimore, MD 21215 USA.
RP Khan, K (reprint author), Sinai Hosp Baltimore, Dept Gen Surg, Baltimore, MD 21215 USA.
EM kamkmd92@gmail.com
CR [Anonymous], 2008, JOB SYNDR
   Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081
   Bilora F, 2000, Minerva Med, V91, P113
   BUCKLEY RH, 1972, PEDIATRICS, V49, P59
   Cruz-Portelles A, 2014, REV PORT PNEUMOL, V20, P107, DOI 10.1016/j.rppneu.2013.07.007
   DAVIS SD, 1966, LANCET, V1, P1013
   Farmand S, 2015, CURR OPIN HEMATOL, V22, P12, DOI 10.1097/MOH.0000000000000104
   Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904
   KIMATA H, 1995, J ALLERGY CLIN IMMUN, V95, P771, DOI 10.1016/S0091-6749(95)70185-0
   KING CL, 1989, P NATL ACAD SCI USA, V86, P10085, DOI 10.1073/pnas.86.24.10085
   Massaad MJ, 2013, ANN NY ACAD SCI, V1285, P26, DOI 10.1111/nyas.12049
   Rivers L, 2015, ARCH DIS CHILD, V100, P667, DOI 10.1136/archdischild-2014-306425
   Wakim M, 1998, ANN ALLERG ASTHMA IM, V81, P153, DOI 10.1016/S1081-1206(10)62802-5
NR 13
TC 1
Z9 2
U1 0
U2 1
PU INT SCIENTIFIC LITERATURE, INC
PI SMITHTOWN
PA 361 FOREST LANE, SMITHTOWN, NY 11787 USA
SN 1941-5923
J9 AM J CASE REP
JI Am. J. Case Rep.
PD FEB 21
PY 2016
VL 17
AR 896798
DI 10.12659/AJCR.896798
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA DN4BI
UT WOS:000377007600001
PM 26897360
OA Green Published
DA 2018-12-27
ER

PT J
AU Xiao, Y
   Liu, F
   Zhang, ZG
   Tang, J
   Zou, CG
   Zhang, KQ
AF Xiao, Yi
   Liu, Fang
   Zhang, Zhigang
   Tang, Jie
   Zou, Cheng-Gang
   Zhang, Ke-Qin
TI RETRACTED: Gut-Colonizing Bacteria Promote C-elegans Innate Immunity by
   Producing Nitric Oxide (Retracted article. See vol. 15, pg. 1123, 2016)
SO CELL REPORTS
LA English
DT Article; Retracted Publication
ID CAENORHABDITIS-ELEGANS; LIFE-SPAN; MICROBIOTA; PATHWAY; LONGEVITY;
   PATHOGENS; STRESS
AB Many commensal bacteria in the gut are beneficial to the host immune system, but the underlying mechanisms are largely unclear. Using culture-independent Illumina MiSeq sequencing of the bacterial 16S rRNA gene amplicons, we show that bacterial diversity in the intestine of Caenorhabditis elegans, the freeliving nematode, is distinct from that in soil. Of these bacteria, Bacillus subtilis is the most prominent species in the worm gut. We demonstrate that B. subtilis confers worm resistance to infection by pathogenic bacteria, such as Pseudomonas aeruginosa, Salmonella enterica, and Enterococcus faecalis, by producing nitric oxide (NO). Deletion of the nos gene, which encodes an NO synthase, reduces the protective effect. NO promotes innate immune responses to P. aeruginosa PA14 by activating a conserved p38 mitogen protein kinase (MAPK) in C. elegans. Our work provides an example of antagonism of commensal bacteria against pathogens and illustrates the importance of commensal bacteria in host immunity.
C1 [Xiao, Yi; Liu, Fang; Tang, Jie; Zou, Cheng-Gang; Zhang, Ke-Qin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China.
   [Zhang, Zhigang] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China.
RP Zou, CG; Zhang, KQ (reprint author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China.
EM chgzou@ynu.edu.cn; kqzhang1@aliyun.com
FU NIH Office of Research Infrastructure Programs [P40 OD010440]; National
   Basic Research Program of China (973) [2013CB127500, 2012CB722208];
   National Natural Science Foundation of China [81471916]
FX We are grateful to Dr. J. Xu (McMaster University) for his critical
   reading of this manuscript and Dr. J.L. Song (Kunming Medical
   University) for her technical assistance with electron microscopy. Some
   nematode strains were provided by the Caenorhabditis Genetics Center,
   which is funded by NIH Office of Research Infrastructure Programs (P40
   OD010440). This work was supported by grants 2013CB127500 and
   2012CB722208 from the National Basic Research Program of China (973) (to
   K.-Q.Z.) and by a grant from the National Natural Science Foundation of
   China (81471916) (to C.-G.Z.).
CR Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9
   Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323
   Cabreiro F, 2013, EMBO MOL MED, V5, P1300, DOI 10.1002/emmm.201100972
   Cani PD, 2013, CURR OPIN PHARMACOL, V13, P935, DOI 10.1016/j.coph.2013.09.008
   Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8
   Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59
   Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147
   Gusarov I, 2013, CELL, V152, P818, DOI 10.1016/j.cell.2012.12.043
   Hoeven R, 2011, PLOS PATHOG, V7, DOI DOI 10.1371/JOURNAL.PPAT.1002453
   Iatsenko I, 2014, CURR BIOL, V24, P2720, DOI 10.1016/j.cub.2014.09.055
   Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07
   Kawli T, 2010, P NATL ACAD SCI USA, V107, P13788, DOI 10.1073/pnas.0914715107
   Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759
   Kim Y, 2012, INFECT IMMUN, V80, P2500, DOI 10.1128/IAI.06350-11
   Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339
   Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653
   Lowenstein CJ, 2004, J CELL SCI, V117, P2865, DOI 10.1042/jcs.01166
   MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049
   Montalvo-Katz S, 2013, INFECT IMMUN, V81, P514, DOI 10.1128/IAI.00653-12
   Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
   Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009
   Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106
   Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007
   Ren ZJ, 2015, P NATL ACAD SCI USA, V112, pE2366, DOI 10.1073/pnas.1422858112
   Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103
   Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411
   Thomas CM, 2010, GUT MICROBES, V1, P148, DOI DOI 10.4161/GMIC.1.3.11712
   Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020
   Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183
NR 30
TC 4
Z9 4
U1 6
U2 33
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 16
PY 2016
VL 14
IS 6
BP 1301
EP 1307
DI 10.1016/j.celrep.2016.01.032
PG 7
WC Cell Biology
SC Cell Biology
GA DD8PY
UT WOS:000370190400004
PM 26854225
OA DOAJ Gold
DA 2018-12-27
ER

PT J
AU Francesch-Huidobro, M
AF Francesch-Huidobro, Maria
TI RETRACTED: Climate change and energy policies in Shanghai: A multilevel
   governance perspective (Retracted article. See vol. 215, pg. 808, 2018)
SO APPLIED ENERGY
LA English
DT Article; Retracted Publication
DE Multilevel governance; Climate change; Energy policy; Low carbon
   economy; Carbon capture and storage; Shanghai
ID EXERGY PERFORMANCE; ENVIRONMENTAL GOVERNANCE; RESIDENTIAL APPLICATION;
   POLITICAL-ECONOMY; REDUCTION TARGET; UNITED-STATES; CHINA; CARBON;
   CITIES; STORAGE
AB Despite growing interest in China's response to climate change and energy security, studies undertaken at the subnational level are rare. In the context of the multilevel governance paradigm, this article examines the governance of climate change and energy policy in Shanghai, a rapidly growing Chinese megacity highly vulnerable to the effects of climate change. Although the energy and carbon intensity of Shanghai's economy have fallen significantly since China launched its economic reforms, overall carbon emissions in the municipality continue to rise. Through examining the Shanghai case, this article argues that Chinese subnational climate mitigation policy is dominated by hierarchical governance arrangements. Nevertheless, shifts in national climate and energy policy since 2007 have mandated provincial-level governments, including Shanghai, to develop their own climate and energy policies while offering greater local autonomy for incorporating climate and energy issues into development goals: is this attributable to a decentred form of multilevel governance? The article concludes that Shanghai's climate mitigation and energy policy is dominated by hierarchical governance whereby policies are 'downloaded' from the central government. Perspectives for other cities and insights for policymakers are discussed. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Francesch-Huidobro, Maria] City Univ Hong Kong, Dept Publ Policy, B5718, AC1, Tat Chee Ave, Kowloon Tong, Hong Kong, Peoples R China.
   [Francesch-Huidobro, Maria] City Univ Hong Kong, Sch Energy & Environm, Tat Chee Ave, Kowloon Tong, Hong Kong, Peoples R China.
RP Francesch-Huidobro, M (reprint author), City Univ Hong Kong, Dept Publ Policy, B5718, AC1, Tat Chee Ave, Kowloon Tong, Hong Kong, Peoples R China.; Francesch-Huidobro, M (reprint author), City Univ Hong Kong, Sch Energy & Environm, Tat Chee Ave, Kowloon Tong, Hong Kong, Peoples R China.
EM maria.francesch@cityu.edu.hk
OI FRANCESCH HUIDOBRO, Maria Del Mar/0000-0001-7478-7844
FU City University of Hong Kong Strategic Research Grant [7002813]
FX The research on which this article is based was supported by City
   University of Hong Kong Strategic Research Grant no. 7002813 (SA). I am
   grateful to Applied Energy editors and three anonymous reviewers for
   comments to earlier drafts. The technical support of Alaric Hui and
   Bryan Luk is also acknowledged. I completed the first manuscript while
   on academic attachment to the Energy Studies Institute (ESI-NUS),
   Singapore. I would like to thank Professor SK Chou and ESI colleagues
   for intellectual and personal camaraderie. The usual disclaimers apply.
CR Alber G, 2008, OECD C COMP CIT CLIM
   AndrewsSpeed P, 2012, ENERG CLIM ENVIRON, P1, DOI 10.1057/9781137284037
   [Anonymous], 2015, WORLD BANK REPORT
   [Anonymous], 2007, SHANGH LAUNCH LNG PR
   [Anonymous], 2010, WWF EST VIS LIV PULS
   [Anonymous], 2007, SHANGHAI DAILY  1213
   [Anonymous], 2010, SHANGHAI DAILY  0618
   [Anonymous], 2010, CHINA DAILY
   [Anonymous], 2013, SHANGHAI STAT
   [Anonymous], 2010, PEOPLES DAILY   0709
   [Anonymous], 2014, GUARDIAN
   AUST HP, 2015, EUR J INT LAW, V26, P255
   Bache I., 2004, MULTILEVEL GOVERNANC
   Bailey I, 2011, ANTIPODE, V43, P682, DOI 10.1111/j.1467-8330.2011.00880.x
   Balme R, 2014, ASIA PAC J PUBLIC AM, V36, P167, DOI 10.1080/23276665.2014.942067
   Betsill M, 2007, LOCAL ENVIRON, V12, P447, DOI 10.1080/13549830701659683
   Betsill MM, 2004, INT STUD QUART, V48, P471, DOI 10.1111/j.0020-8833.2004.00310.x
   Betsill MM, 2006, GLOBAL GOV, V12, P12, DOI DOI 10.2307/27800607
   Bulkeley H, 2005, ENVIRON POLIT, V14, P42, DOI 10.1080/0964401042000310178
   Bulkeley H., 2009, 5 URB RES S CIT CLIM
   Bulkeley H, 2010, ANNU REV ENV RESOUR, V35, P229, DOI 10.1146/annurev-environ-072809-101747
   Christoff P, 2010, ENVIRON POLIT, V19, P637, DOI 10.1080/09644016.2010.489718
   Corfee-Morlot J., 2009, OECD ENV WORKING PAP, V14
   Cui LB, 2014, APPL ENERG, V136, P1043, DOI 10.1016/j.apenergy.2014.05.021
   Desideri U, 2002, P ASME ADV EN SYST D
   Francesch-Huidobro M, 2012, ENVIRON POLIT, V21, P791, DOI 10.1080/09644016.2012.686221
   Guo R, 2010, ENERG POLICY, V38, P633, DOI 10.1016/j.enpol.2009.06.074
   Gurney KR, 2009, NATURE, V458, P977, DOI 10.1038/458977a
   Gustavasson E, 2010, ENVIRON PLANN C, V27, P59
   Hao Y, 2015, APPL ENERG, V142, P229, DOI 10.1016/j.apenergy.2014.12.056
   Heggelund G？rild, 2007, Asian Perspective, V31, P155
   Hooghe L, 2003, AM POLIT SCI REV, V97, P233
   Hooghe L., 2001, MULTILEVEL GOVERNANC
   Jordan A, 2001, POLICY POLIT, V29, P193, DOI 10.1332/0305573012501305
   Kern K, 2009, JCMS-J COMMON MARK S, V47, P309, DOI [10.1111/j.1468-5965.2008.00806.x, 10.1111/j.1468-5965.2009.00806.x]
   Koehn PH, 2008, GLOBAL ENVIRON POLIT, V8, P53, DOI 10.1162/glep.2008.8.1.53
   Kooiman J, 2000, DEBATING GOVERNANCE, P138, DOI DOI 10.1017/S000305540281036X
   Lankao PR, 2007, LOCAL ENVIRON, V12, P519, DOI 10.1080/13549830701656887
   Leman E, 2009, WORLD BANK 5 URB RES
   Li F, 2009, SHANGHAI SHI YINGDUI
   Li G, 2015, RENEW SUSTA IN PRESS
   Li G, 2013, THESIS U MARYLAND CO
   Li G, 2015, RENEW SUST ENERG REV, V51, P926, DOI 10.1016/j.rser.2015.06.052
   Li G, 2015, RENEW SUST ENERG REV, V43, P702, DOI 10.1016/j.rser.2014.11.078
   Li G, 2014, INT J REFRIG, V44, P23, DOI 10.1016/j.ijrefrig.2014.05.013
   Li G, 2014, ENERGY, V65, P675, DOI 10.1016/j.energy.2013.12.017
   Li L, 2010, ENERG POLICY, V38, P4797, DOI 10.1016/j.enpol.2009.08.048
   Li W, 2009, PUBLIC ADMIN DEVELOP, V29, P55, DOI 10.1002/pad.501
   Lo AY, 2010, ENVIRON POLIT, V19, P1012, DOI 10.1080/09644016.2010.518689
   Mai Q., 2015, CLIMATE CHANGE GOVER
   Mai Q, 2015, CLIM CHANG GOV CHIN
   National Climate Agency, 2013, COMMUNIQUE
   National Development and Reform Commission (NDRC), 2010, GUOJ FAZH GAIG WEI K
   National Development and Reform Commission (NDRC), ZHONGG YINGD QIH BIA
   Painter M, 2003, HDB PUBLIC ADM
   Pan X, 2010, SHANGHAI DAILY  0810, pB5
   Piattoni S, 2009, WORKING PAPER, P8
   Pierre J., 2000, GOVERNANCE POLITICS
   Qi Ye, 2008, Journal of Environment & Development, V17, P379, DOI 10.1177/1070496508326123
   Richerzhagen C, 2008, WORLD DEV, V36, P308, DOI 10.1016/j.worlddev.2007.06.010
   Schreurs M. A., 2008, Journal of Environment & Development, V17, P343, DOI 10.1177/1070496508326432
   Schreurs MA, 2010, ASIAN ECON POLICY R, V5, P88, DOI 10.1111/j.1748-3131.2010.01150.x
   Shanghai Municipal Government, SAHNGH SHI JIEN JIAN
   Shanghai Municipal Government, 2006, SHANGH SHI JIEN FAZH
   Shanghai Municipal Government, 2010, SHANGH SHI 2010 NIAN
   Shanghai Municipal Government, 2008, SHANGH SHI RENM ZHEN
   Shanghai Municipal Government, 2008, SHANGH YINGD QIH BIA
   Smith A, 2003, HDB PUBLIC ADM
   Tsang S, 2010, ENVIRON POLICY GOV, V20, P180, DOI 10.1002/eet.540
   United Nations Environment Programme (UNEP), 2010, UNEP ENV ASS EXPO 20
   Viebahn P, 2015, APPL ENERG, V157, P229, DOI 10.1016/j.apenergy.2015.07.023
   Wang T, 2010, ENERG POLICY, V38, P3537, DOI 10.1016/j.enpol.2010.02.031
   World Wide Fund, 2009, MEG MEG CLIM VULN RA
   Wu G, 2012, APPL ENERG, V97, P157, DOI 10.1016/j.apenergy.2011.11.061
   WWF, 2009, SHANGH REV ROADM LOW
   Yan J, 2015, APPL ENERGY AIMS SCO
NR 76
TC 13
Z9 13
U1 6
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0306-2619
EI 1872-9118
J9 APPL ENERG
JI Appl. Energy
PD FEB 15
PY 2016
VL 164
BP 45
EP 56
DI 10.1016/j.apenergy.2015.11.026
PG 12
WC Energy & Fuels; Engineering, Chemical
SC Energy & Fuels; Engineering
GA DG9CF
UT WOS:000372379700006
DA 2018-12-27
ER

PT J
AU Liu, HX
   Zhou, JQ
AF Liu, Hongxi
   Zhou, Jianqiu
TI RETRACTED: Atomic-scale analysis of deformation mechanisms of
   nanotwinned polycrystalline Ni nanowires during tension (Retracted
   article. See vol. 126, pg. 529, 2017)
SO COMPUTATIONAL MATERIALS SCIENCE
LA English
DT Article; Retracted Publication
DE Polycrystalline nanowires; Twin boundary spacing; Plastic deformation
   mechanism; Molecular dynamics simulations
ID GOLD NANOWIRES; NANOCRYSTALLINE MATERIALS; GRAIN-SIZE; DISLOCATION
   NUCLEATION; BOUNDARY MIGRATION; ULTRAHIGH-STRENGTH; MAXIMUM STRENGTH;
   NANOSCALE TWINS; THIN-FILMS; METALS
AB Large-scale molecular dynamics simulations have been performed to investigate deformation mechanisms in nanotwinned polycrystalline Ni nanowires (NWs). Atomic-scale dislocation nucleation and propagation activities were captured during tension. Yield stresses were found to decrease with the reduction of twin boundary spacing (TBS) below 3.66 nm, exhibiting an inverse Hall-Petch (HP) relation. Atomic-scale analysis shown that the transition in intra-granular deformation mechanism from partial dislocations nucleation and gliding inclined to the twin boundaries (TBs) to partial dislocations nucleation and gliding parallel to the TBs appeared to be the direct cause of the inverse HP relation. In addition to this, full dislocation and grain boundary migration were also captured. The strain localization during tension was highlighted to understand the atomic mechanisms leading to the catastrophic failure of the nanotwinned polycrystalline NWs. These findings should contribute to the understanding the deformation mechanisms of nanotwinned polycrystalline NWs and provide insights into the possibility of tuning the microstructure to elicit desired mechanical properties. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Liu, Hongxi; Zhou, Jianqiu] Nanjing Tech Univ, Dept Mech Engn, Nanjing 210009, Jiangsu, Peoples R China.
   [Zhou, Jianqiu] Wuhan Inst Technol, Dept Mech Engn, Wuhan 430070, Hubei Province, Peoples R China.
RP Zhou, JQ (reprint author), Nanjing Tech Univ, Dept Mech Engn, Nanjing 210009, Jiangsu, Peoples R China.
EM zhouj@njtech.edu.cn
FU Key Project of Chinese Ministry of Education [211061]; Program for New
   Century Excellent Talents in University; National Natural Science
   Foundation of China [10502025, 10872087, 11272143]; Program for Chinese
   New Century Excellent Talents in university [NCET-12-0712]; Natural
   Science Foundation of Hubei Province [Q20111501]
FX The authors gratefully acknowledge the financial supports of Key Project
   of Chinese Ministry of Education (211061), Program for New Century
   Excellent Talents in University, National Natural Science Foundation of
   China (10502025, 10872087, 11272143), Program for Chinese New Century
   Excellent Talents in university (NCET-12-0712), Natural Science
   Foundation of Hubei Province (Q20111501).
CR Afanasyev KA, 2007, NANO LETT, V7, P2056, DOI 10.1021/nl070959l
   Cahn JW, 2006, ACTA MATER, V54, P4953, DOI 10.1016/j.actamat.2006.08.004
   Cao AJ, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2721367
   Cao AJ, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.214108
   Cao R, 2015, SCRIPTA MATER, V94, P9, DOI 10.1016/j.scriptamat.2014.09.002
   Chen MW, 2003, SCIENCE, V300, P1275, DOI 10.1126/science.1083727
   Deng C, 2009, ACTA MATER, V57, P6090, DOI 10.1016/j.actamat.2009.08.035
   Deng C, 2009, ACS NANO, V3, P3001, DOI 10.1021/nn900668p
   Deng C, 2009, NANO LETT, V9, P1517, DOI 10.1021/nl803553b
   Ganesan Y, 2010, J MICROELECTROMECH S, V19, P675, DOI 10.1109/JMEMS.2010.2046014
   Gianola DS, 2006, ACTA MATER, V54, P2253, DOI 10.1016/j.actamat.2006.01.023
   Gu XW, 2012, NANO LETT, V12, P6385, DOI 10.1021/nl3036993
   Hahn H, 1997, NANOSTRUCT MATER, V9, P603, DOI 10.1016/S0965-9773(97)00135-9
   Jang DC, 2012, NAT NANOTECHNOL, V7, P594, DOI [10.1038/nnano.2012.116, 10.1038/NNANO.2012.116]
   Jang DC, 2011, NANO LETT, V11, P1743, DOI 10.1021/nl2003076
   Jin M, 2004, ACTA MATER, V52, P5381, DOI 10.1016/j.actamat.2004.07.044
   KE M, 1995, NANOSTRUCT MATER, V5, P689, DOI 10.1016/0965-9773(95)00281-I
   Kumar KS, 2003, ACTA MATER, V51, P5743, DOI 10.1016/j.actamat.2003.08.032
   Li XY, 2010, NATURE, V464, P877, DOI 10.1038/nature08929
   Liao XZ, 2003, APPL PHYS LETT, V83, P5062, DOI 10.1063/1.1633975
   Lu L, 2004, SCIENCE, V304, P422, DOI 10.1126/science.1092905
   Lu L, 2009, SCIENCE, V323, P607, DOI 10.1126/science.1167641
   Lu Y, 2010, EXP MECH, V50, P47, DOI 10.1007/s11340-009-9222-0
   Lu Y, 2011, ADV FUNCT MATER, V21, P3982, DOI 10.1002/adfm.201101224
   Masumura RA, 1998, ACTA MATER, V46, P4527, DOI 10.1016/S1359-6454(98)00150-5
   Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003
   Mishin Y, 1999, PHYS REV B, V59, P3393, DOI 10.1103/PhysRevB.59.3393
   Pak OS, 2011, SOFT MATTER, V7, P8169, DOI 10.1039/c1sm05503h
   Pan D, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197289
   Postma HWC, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1929098
   Rupert TJ, 2009, SCIENCE, V326, P1686, DOI 10.1126/science.1178226
   Rupert TJ, 2013, J APPL PHYS, V114, DOI 10.1063/1.4815965
   Seo JH, 2011, NANO LETT, V11, P3499, DOI 10.1021/nl2022306
   Shan DB, 2008, SCRIPTA MATER, V58, P449, DOI 10.1016/j.scriptamat.2007.10.047
   Shan ZW, 2004, SCIENCE, V305, P654, DOI 10.1126/science.1098741
   Shimizu F, 2007, MATER TRANS, V48, P2923, DOI 10.2320/matertrans.MJ200769
   Stukowski A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.224103
   Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012
   Suryanarayana C, 2000, HYPERFINE INTERACT, V130, P5, DOI 10.1023/A:1011026900989
   Tonisch K, 2007, PHYSICA E, V37, P208, DOI 10.1016/j.physe.2006.06.002
   Van Swygenhoven H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024101
   Wang JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2768
   WANG L, 2013, NAT COMMUN, V4
   Wang LH, 2015, ACTA MATER, V90, P194, DOI 10.1016/j.actamat.2015.02.002
   Wang LH, 2013, NPG ASIA MATER, V5, DOI 10.1038/am.2012.70
   Wang YB, 2007, PHIL MAG LETT, V87, P935, DOI 10.1080/09500830701591493
   Wang YB, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2828699
   Weinberger CR, 2012, J MATER CHEM, V22, P3277, DOI 10.1039/c2jm13682a
   Wu B, 2005, NAT MATER, V4, P525, DOI 10.1038/nmat1403
   Wu B, 2006, NANO LETT, V6, P468, DOI 10.1021/nl052427f
   Wu ZX, 2013, ACTA MATER, V61, P5807, DOI 10.1016/j.actamat.2013.06.026
   Wu ZX, 2013, ACTA MATER, V61, P1831, DOI 10.1016/j.actamat.2012.11.053
   Wu ZX, 2012, NANO LETT, V12, P910, DOI 10.1021/nl203980u
   Zhang DF, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/36/365706
   Zhang K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2008377
   Zheng H, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1149
   Zhong S, 2009, SMALL, V5, P2265, DOI 10.1002/smll.200900746
   Zhu LL, 2011, ACTA MATER, V59, P5544, DOI 10.1016/j.actamat.2011.05.027
   Zhu T, 2007, P NATL ACAD SCI USA, V104, P3031, DOI 10.1073/pnas.0611097104
   Zhu Y, 2005, P NATL ACAD SCI USA, V102, P14503, DOI 10.1073/pnas.0506544102
   Zhu YT, 2012, PROG MATER SCI, V57, P1, DOI 10.1016/j.pmatsci.2011.05.001
   Zhu YX, 2013, SCRIPTA MATER, V68, P663, DOI 10.1016/j.scriptamat.2013.01.029
NR 62
TC 5
Z9 5
U1 5
U2 70
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-0256
EI 1879-0801
J9 COMP MATER SCI
JI Comput. Mater. Sci.
PD FEB 15
PY 2016
VL 113
BP 27
EP 37
DI 10.1016/j.commatsci.2015.11.015
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA DA0JC
UT WOS:000367482400004
DA 2018-12-27
ER

PT J
AU Du, CC
   Wu, XY
   Li, J
AF Du, Chuance
   Wu, Xiaoyuan
   Li, Jia
TI RETRACTED: Mutation pattern is an influential factor on functional
   mutation rates in cancer (Retracted article. See vol. 17, Artn. 67,
   2017)
SO CANCER CELL INTERNATIONAL
LA English
DT Article; Retracted Publication
DE Clear-cell renal cell carcinoma; Liver cancer; Lung cancer; Melanoma;
   Mutation pattern; Random forest; Functional variants
ID CANCER GENOMES; METHYLATIONS; ORGANIZATION; ANNOTATION; DISCOVERY;
   SELECTION; PROJECT; GENES
AB Background: Mutation rates are consistently varied in cancer genome and play an important role in tumorigenesis, however, little has been known about their function potential and impact on the distribution of functional mutations. In this study, we investigated genomic features which affect mutation pattern and the function importance of mutation pattern in cancer.
   Methods: Somatic mutations of clear-cell renal cell carcinoma, liver cancer, lung cancer and melanoma and single nucleotide polymorphisms (SNPs) were intersected with 54 distinct genomic features. Somatic mutation and SNP densities were then computed for each feature type. We constructed 2856 1-Mb windows, in which each row (1-Mb window) contains somatic mutation, SNP densities and 54 feature vectors. Correlation analyses were conducted between somatic mutation, SNP densities and each feature vector. We also built two random forest models, namely somatic mutation model (CSM) and SNP model to predict somatic mutation and SNP densities on a 1-Kb scale. The relation of CSM and SNP scores was further analyzed with the distributions of deleterious coding variants predicted by SIFT and Mutation Assessor, non-coding functional variants evaluated with FunSeq 2 and GWAVA and disease-causing variants from HGMD and ClinVar databases.
   Results: We observed a wide range of genomic features which affect local mutation rates, such as replication time, transcription levels, histone marks and regulatory elements. Repressive histone marks, replication time and promoter contributed most to the CSM models, while, recombination rate and chromatin organizations were most important for the SNP model. We showed low mutated regions preferentially have higher densities of deleterious coding mutations, higher average scores of non-coding variants, higher fraction of functional regions and higher enrichment of disease-causing variants as compared to high mutated regions.
   Conclusions: Somatic mutation densities vary largely across cancer genome, mutation frequency is a major indication of function and influence on the distribution of functional mutations in cancer.
C1 [Du, Chuance] Nanchang Univ, Dept Urol, Ganzhou Hosp, Ganzhou, Jiangxi, Peoples R China.
   [Wu, Xiaoyuan] Nanchang Univ, Dept Rehabil, Ganzhou Hosp, Nanchang, Jiangxi, Peoples R China.
   [Li, Jia] Tongji Univ, Shanghai Peoples Hosp 10, Dept Thyroid & Breast, Shanghai 200072, Peoples R China.
RP Du, CC (reprint author), Nanchang Univ, Dept Urol, Ganzhou Hosp, Ganzhou, Jiangxi, Peoples R China.
EM duchuance@126.com
CR Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298
   Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009
   Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701
   Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323
   Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]
   Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111
   Drier Y, 2013, GENOME RES, V23, P228, DOI 10.1101/gr.141382.112
   Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929
   Fox EJ, 2013, CANCER METAST REV, V32, P353, DOI 10.1007/s10555-013-9426-8
   Fu Y., 2014, SCI WORLD J, V2014, P1, DOI DOI 10.1001/JAMANEUR0L.2014.1065
   Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111
   Hoang ML, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006200
   Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987
   Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168
   Khurana E, 2013, SCIENCE, V342, P84, DOI 10.1126/science.1235587
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Landrum MJ, 2013, NUCLEIC ACIDS RES, V2014, P980
   Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912
   Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213
   Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0
   Liu L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2502
   Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Polak P, 2014, NAT BIOTECHNOL, V32, P71, DOI 10.1038/nbt.2778
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Reva B, 2011, NUCLEIC ACIDS RES, V39, P37
   Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832
   Roberts SA, 2014, NAT REV CANCER, V14, P786, DOI 10.1038/nrc3816
   Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172
   Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699
   Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273
   Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048
   Smith MA, 2013, NUCLEIC ACIDS RES, V41, P8220, DOI 10.1093/nar/gkt596
   Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363
   Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13
   Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154
   Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764
   Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982
   Xie BY, 2013, BIOINFORMATICS, V29, P638, DOI 10.1093/bioinformatics/btt014
   Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264
NR 42
TC 1
Z9 1
U1 6
U2 12
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2867
J9 CANCER CELL INT
JI Cancer Cell Int.
PD FEB 9
PY 2016
VL 16
AR 2
DI 10.1186/s12935-016-0278-5
PG 11
WC Oncology
SC Oncology
GA DD2YM
UT WOS:000369788100001
PM 26865835
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Camarasa, MV
   Galvez, VM
AF Vicenta Camarasa, Maria
   Miguel Galvez, Victor
TI RETRACTED: Robust method for TALEN-edited correction of pF508del in
   patient-specific induced pluripotent stem cells (Retracted article. See
   vol. 8, Artn. 123, 2017)
SO STEM CELL RESEARCH & THERAPY
LA English
DT Article; Retracted Publication
DE Homologous recombination; Patient-specific stem cells; Stem cell/genetic
   therapy
ID ZINC-FINGER NUCLEASES; CYSTIC-FIBROSIS GENE; PIGGYBAC TRANSPOSON; GENOME
   MODIFICATION; EFFICIENT; MOUSE; DIFFERENTIATION; CULTURE
AB Cystic fibrosis is one of the most frequent inherited rare diseases, caused by mutations in the cystic fibrosis transmembrane conductance regulator gene. Apart from symptomatic treatments, therapeutic protocols for curing the disease have not yet been established. The regeneration of genetically corrected, disease-free epithelia in cystic fibrosis patients is envisioned by designing a stem cell/genetic therapy in which patient-derived pluripotent stem cells are genetically corrected, from which target tissues are derived. In this framework, we present an efficient method for seamless correction of pF508del mutation in patient-specific induced pluripotent stem cells by gene edited homologous recombination. Gene edition has been performed by transcription activator-like effector nucleases and a homologous recombination donor vector which contains a PiggyBac transposon-based double selectable marker cassette.
   This new method has been designed to partially avoid xenobiotics from the culture system, improve cell culture efficiency and genome stability by using a robust culture system method, and optimize timings. Overall, once the pluripotent cells have been amplified for the first nucleofection, the procedure can be completed in 69 days, and can be easily adapted to edit and change any gene of interest.
C1 [Vicenta Camarasa, Maria; Miguel Galvez, Victor] Hosp Joan March, Caubet Cimera Fdn, Ctra Soller Km 12, Bunyola 07110, Mallorca, Spain.
RP Camarasa, MV (reprint author), Hosp Joan March, Caubet Cimera Fdn, Ctra Soller Km 12, Bunyola 07110, Mallorca, Spain.
EM telomerasi@yahoo.es
CR Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138
   Camarasa MV, 2010, IN VITRO CELL DEV-AN, V46, P386, DOI 10.1007/s11626-010-9291-5
   Camarasa M, 2009, CLONING STEM CELLS, V11, P453, DOI 10.1089/clo.2008.0082
   Camarasa MV, 2015, REC PAT REG MED, V5, P27
   Choi SM, 2013, HEPATOLOGY, V57, P2458, DOI 10.1002/hep.26237
   Crane AM, 2015, STEM CELL REP, V4, P569, DOI 10.1016/j.stemcr.2015.02.005
   Fine EJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1326
   Griesenbach U, 2015, HUM GENE THER, V26, P266, DOI 10.1089/hum.2015.027
   Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927
   Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562
   KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460
   Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686
   Kulinski J, 2000, BIOTECHNIQUES, V29, P44, DOI 10.2144/00291bm07
   Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011
   Lee CM, 2012, BIORESEARCH OPEN ACC, V1, P99, DOI 10.1089/biores.2012.0218
   Li LX, 2012, PLANT MOL BIOL, V78, P407, DOI 10.1007/s11103-012-9875-4
   Lorenzo IM, 2013, STEM CELL REV REP, V9, P435, DOI 10.1007/s12015-012-9412-5
   Mani M, 2005, BIOCHEM BIOPH RES CO, V335, P447, DOI 10.1016/j.bbrc.2005.07.089
   Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749
   Munoz IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109752
   Mussolino C, 2014, NUCLEIC ACIDS RES, V42, P6762, DOI 10.1093/nar/gku305
   Narsinh KH, 2010, MOL THER, V18, P1061, DOI 10.1038/mt.2010.92
   Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01
   Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430
   Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002
   Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/NMETH.2857, 10.1038/nmeth.2857]
   Tanaka M, 2015, SCI REP-UK, V5, DOI 10.1038/srep07826
   Tompkins JD, 2012, P NATL ACAD SCI USA, V109, P12544, DOI 10.1073/pnas.1209620109
   Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105
   Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028
   Ye L, 2014, P NATL ACAD SCI USA, V111, P9591, DOI 10.1073/pnas.1407473111
   Yusa K, 2013, NAT PROTOC, V8, P2061, DOI 10.1038/nprot.2013.126
   Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108
   Zhang LH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016305, 10.1371/journal.pone.0018357]
   Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788
NR 35
TC 9
Z9 10
U1 2
U2 14
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-6512
J9 STEM CELL RES THER
JI Stem Cell Res. Ther.
PD FEB 9
PY 2016
VL 7
AR 26
DI 10.1186/s13287-016-0275-6
PG 12
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA DD1OC
UT WOS:000369690000001
PM 26861665
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Horchani, R
AF Horchani, R.
TI RETRACTED: Asymmetric transport of light in linearly arrayed metallic
   nano-particles(Retracted article. See vol. 131, 2016)
SO EUROPEAN PHYSICAL JOURNAL PLUS
LA English
DT Article; Retracted Publication
ID OPTICAL ISOLATOR; GREENS TENSOR; DIODE
AB A strong asymmetric light transport in a linear chain of spherical and equidistantly spaced silver metal nano-particles (MNPs) located near a substrate is reported. The contrast ratio of the proposed structure is above 0.95. We have studied the propagation of light in the array with respect to the metal and the size of the last nano-particle of the chain and the nature of the substrate. It is shown also that the presence of a copper or gold substrate enhance the guiding properties of the array. This structure opens the possibility to design various optical devices such as broadband antennae and optical diodes.
C1 [Horchani, R.] Dhofar Univ, Coll Arts & Appl Sci, Salalah, Oman.
RP Horchani, R (reprint author), Dhofar Univ, Coll Arts & Appl Sci, Salalah, Oman.
EM horchani@phys.au.dk
CR Bi L, 2011, NAT PHOTONICS, V5, P758, DOI 10.1038/nphoton.2011.270
   Bohren C. F., 1983, ABSORPTION SCATTERIN
   Cicek A, 2012, OPT LETT, V37, P2937, DOI 10.1364/OL.37.002937
   Compaijen PJ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205437
   Evlyukhin AB, 2006, LASER PHYS LETT, V3, P396, DOI 10.1002/lapl.200610014
   Evlyukhin AB, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.134304
   Fan L, 2012, SCIENCE, V335, P447, DOI 10.1126/science.1214383
   Figotin A, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066609
   Gay-Balmaz P, 2002, COMPUT PHYS COMMUN, V144, P111, DOI 10.1016/S0010-4655(01)00471-4
   Giden IH, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4861926
   JACKSON JD, 1998, CLASSICAL ELCTRODYNA
   Jalas D, 2013, NAT PHOTONICS, V7, P579, DOI 10.1038/nphoton.2013.185
   JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370
   Kurt H, 2012, OPT EXPRESS, V20, P20635, DOI 10.1364/OE.20.020635
   Liu V, 2012, OPT EXPRESS, V20, P28388, DOI 10.1364/OE.20.028388
   Maier S A, 2007, PLASMONICS FUNDAMENT
   Mayshev AV, 2008, NANO LETT, V8, P2369, DOI 10.1021/nl8011962
   Novotny L., 2006, PRINCIPLES NANOOPTIC
   Paulus M, 2000, PHYS REV E, V62, P5797, DOI 10.1103/PhysRevE.62.5797
   PETROV A, 2013, SCI REPORTS, V2, P674
   Philip R, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2794015
   Sze Simon M., 2001, SEMICONDUCTOR DEVICE
   Wang C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00674
   Wang C, 2011, OPT EXPRESS, V19, P26948, DOI 10.1364/OE.19.026948
NR 24
TC 0
Z9 0
U1 2
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-5444
J9 EUR PHYS J PLUS
JI Eur. Phys. J. Plus
PD FEB 8
PY 2016
VL 131
IS 2
AR 30
DI 10.1140/epjp/i2016-16030-x
PG 8
WC Physics, Multidisciplinary
SC Physics
GA DD5ZD
UT WOS:000370002600002
DA 2018-12-27
ER

PT J
AU Anguelovski, I
AF Anguelovski, Isabelle
TI RETRACTED: From Toxic Sites to Parks as (Green) LULUs? New Challenges of
   Inequity, Privilege, Gentrification, and Exclusion for Urban
   Environmental Justice(Retracted article. See vol. 16, pg. NP2, 2017)
SO JOURNAL OF PLANNING LITERATURE
LA English
DT Article; Retracted Publication
DE community development; neighborhood greening; environment; land use;
   neighborhood planning; LULUs; recreation and open space; sustainability;
   urban environmental justice; environmental gentrification
ID POLITICAL-ECONOMY; ALTERNATIVE FOOD; SUSTAINABLE DEVELOPMENT;
   SPATIAL-DISTRIBUTION; SMART GROWTH; JUSTICE; COMMUNITY; INEQUALITY;
   ACCESS; CITIES
AB As marginalized neighborhoods benefit from cleanup and environmental amenities often brought by municipal sustainability planning, recent trends of land revaluation, investments, and gentrification are posing a conundrum and paradox for environmental justice (EJ) activists. In this article, I examine the progression of the urban EJ agendafrom fighting contamination to mobilizing for environmental goods and resisting environmental gentrificationand analyze how the EJ scholarship has reflected upon the complexification of this agenda. I argue that locally unwanted land uses can be reconceptualized from contamination sources to new green amenities because of the displacement they seem to trigger or accelerate.
C1 [Anguelovski, Isabelle] Univ Autonoma Barcelona, Inst Environm Sci & Technol, Cerdanyola Del Valles, Spain.
RP Anguelovski, I (reprint author), Univ Autonoma Barcelona, Z Bldg,Z 122, Cerdanyola Del Valles 08193, Spain.
EM Isabelle.Anguelovski@uab.cat
OI Anguelovski, Isabelle/0000-0002-6409-5155
FU ERC Starting Grant program [678034]
FX The author would like to thank Prof. David Pellow, Prof. Erik
   Swyngedouw, and Prof. Giorgos Kallis for their critical comments on an
   earlier version of this paper. She is grateful to the invaluable
   feedback offered by anonymous reviewers from the Journal of Planning
   Literature. She also thanks the ERC Starting Grant program (678034) for
   its support and contribution.
CR Addison C, 2013, J PLAN LIT, V28, P215, DOI 10.1177/0885412212471563
   Agyeman J, 2003, URBAN IND ENVIRON, P1
   Agyeman J, 2015, INCOMPLETE STREETS P
   Agyeman J., 2013, INTRO JUST SUSTAINAB
   Alkon AH, 2011, FOOD HEALTH ENVIRON, P1
   Alkon AH, 2013, ANTIPODE, V45, P663, DOI 10.1111/j.1467-8330.2012.01056.x
   Allen P., 2004, TOGETHER TABLE SUSTA
   Anderson E, 1990, STREETWISE RACE CLAS
   Anguelovski I, 2014, URBAN IND ENVIRON, P1
   Anguelovski I, 2015, GEOFORUM, V58, P184, DOI 10.1016/j.geoforum.2014.10.014
   Anguelovski I, 2013, J PLAN EDUC RES, V33, P160, DOI 10.1177/0739456X13478019
   Anguelovski I, 2013, INT J URBAN REGIONAL, V37, P1012, DOI 10.1111/1468-2427.12054
   Anguelovski I, 2011, CURR OPIN ENV SUST, V3, P169, DOI 10.1016/j.cosust.2010.12.017
   Anguelovski Isabelle, J PLANNING ED RES
   [Anonymous], 2007, TRANSFORMING ENV WAR
   Ash M, 2009, JUSTICE AIR TRACKING
   Bai XM, 2010, ENVIRON SCI POLICY, V13, P312, DOI 10.1016/j.envsci.2010.03.011
   Battaglia Michael, 2014, CITES ENV, V7, P6
   Betancur JJ, 2002, URBAN AFF REV, V37, P780, DOI 10.1177/107874037006002
   Boone Christopher G., 2010, Urban Ecosystems, V13, P255, DOI 10.1007/s11252-009-0118-7
   Boone CG, 2009, ANN ASSOC AM GEOGR, V99, P767, DOI 10.1080/00045600903102949
   Boyd Michelle R., 2008, JIM CROW NOSTALGIA R
   Brand Anna Livia., 2015, INCOMPLETE STREETS P, P245
   Brown Phil, 2013, TOXIC EXPOSURES CONT
   Brownlow Alec, 2006, NATURE CITIES URBAN, V3, P199
   Bryant Bunyan, 1992, RACE INCIDENCE ENV H
   Bryson J, 2013, GEOGR COMPASS, V7, P578, DOI 10.1111/gec3.12056
   Bullard R, 1990, DUMPING DIXIE RACE C
   Bullard R. D., 2005, QUEST ENV JUSTICE HU
   Bullard Robert, 2007, TOXIC WASTES RACE 20
   Cadji Josh, 2015, INCOMPLETE STREETS P, P154
   Campbell HE, 2014, URBAN AFF REV, V50, P521, DOI 10.1177/1078087413505736
   Campbell S, 1996, J AM PLANN ASSOC, V62, P296, DOI 10.1080/01944369608975696
   Chakraborty J, 2012, INT J ENVIRON HEAL R, V22, P165, DOI 10.1080/09603123.2011.628643
   Chambers S, 2007, URBAN AFF REV, V43, P28, DOI 10.1177/1078087407301790
   Checker M, 2008, POLLUTED PROMISES EN
   Checker M, 2011, CITY SOC, V23, P210, DOI 10.1111/j.1548-744X.2011.01063.x
   Collins TW, 2011, HEALTH PLACE, V17, P335, DOI 10.1016/j.healthplace.2010.11.011
   Curran W, 2012, LOCAL ENVIRON, V17, P1027, DOI 10.1080/13549839.2012.729569
   CUTTER SL, 1995, PROG HUM GEOG, V19, P111, DOI 10.1177/030913259501900111
   Dahmann N, 2010, HEALTH PLACE, V16, P431, DOI 10.1016/j.healthplace.2009.11.005
   De Sousa, 2003, LANDSCAPE URBAN PLAN, V62, P181, DOI [10.1016/s0169-2046(02)00149-4, DOI 10.1016/S0169-2046(02)00149-4]
   Dillon L, 2014, ANTIPODE, V46, P1205, DOI 10.1111/anti.12009
   Dobson A., 1998, JUSTICE ENV CONCEPTI
   Dooling S, 2011, J URBANISM, V4, P201, DOI DOI 10.1080/17549175.2011.633346
   Dooling S, 2009, INT J URBAN REGIONAL, V33, P621, DOI 10.1111/j.1468-2427.2009.00860.x
   Downey L, 2008, SOCIOL PERSPECT, V51, P759, DOI 10.1525/sop.2008.51.4.759
   Faber Daniel, 2014, UPROOTING URBAN AM M, P77
   Fitzgerald Joan, 2010, EMERALD CITIES URBAN
   Foster S, 1998, CALIF LAW REV, V86, P775, DOI 10.2307/3481140
   Freudenberg N, 2011, AM J PUBLIC HEALTH, V101, pS123, DOI 10.2105/AJPH.2011.300265
   Fullilove M. T., 2004, ROOT SHOCK TEARING C
   Fullilove MT, 2001, J URBAN HEALTH, V78, P72, DOI 10.1093/jurban/78.1.72
   Gamper-Rabindran Santi, 2011, 16655 NBER
   Gamper-Rabindran S, 2011, AM ECON REV, V101, P620, DOI 10.1257/aer.101.3.620
   Gauna Eileen, 2008, ENVIRON LAW, V38, P457
   Gibbs D., 2007, SUSTAINABLE DEV PARA, P95
   Gibson KJ, 2007, TRANSFORM ANTHROPOL, V15, P3, DOI 10.1525/tran.2007.15.1.03
   Godschalk DR, 2004, J AM PLANN ASSOC, V70, P5, DOI 10.1080/01944360408976334
   Gottlieb R, 2010, FOOD JUSTICE
   Gould K., 2012, WORLD BROOKLYN GENTR, P113
   Guthman J, 2008, CULT GEOGR, V15, P431, DOI 10.1177/1474474008094315
   Guthman J, 2011, FOOD HEALTH ENVIRON, P263
   Hagerman C, 2007, CITIES, V24, P285, DOI 10.1016/j.cities.2006.12.003
   Hamilton T, 2013, URBAN STUD, V50, P1557, DOI 10.1177/0042098012465128
   Hastings A, 2007, ENVIRON PLANN C, V25, P896, DOI 10.1068/c0657
   Hess DJ, 2009, URBAN IND ENVIRON, P1
   Heynen N.C., 2006, NATURE CITIES URBAN, V3
   Heynen N, 2006, URBAN AFF REV, V42, P3, DOI 10.1177/1078087406290729
   Heynen N, 2014, PROG HUM GEOG, V38, P598, DOI 10.1177/0309132513500443
   Hillier AE, 2003, J URBAN HIST, V29, P394, DOI 10.1177/0096144203252003
   Holifield R, 2009, ANTIPODE, V41, P591, DOI 10.1111/j.1467-8330.2009.00690.x
   Hyra Derek S., 2008, NEW URBAN RENEWAL EC
   Jabareen YR, 2006, J PLAN EDUC RES, V26, P38, DOI 10.1177/0739456X05285119
   Jennings J, 2012, COMMUNITY DEV, V43, P464, DOI 10.1080/15575330.2011.645047
   Keil R., 2007, SUSTAINABLE DEV PARA, P41
   Landry SM, 2009, ENVIRON PLANN A, V41, P2651, DOI 10.1068/a41236
   Lerner S, 2010, SACRIFICE ZONES FRON
   Lerner S, 2005, SACRIFICE ZONES FRON
   Loh P., 2010, ENV JUSTICE GREEN EC
   Maantay J, 2002, J LAW MED ETHICS, V30, P572, DOI 10.1111/j.1748-720X.2002.tb00427.x
   Madra YM, 2014, ANTIPODE, V46, P691, DOI 10.1111/anti.12065
   Massey Douglas S, 1993, AM APARTHEID SEGREGA
   McClintock N, 2011, FOOD HEALTH ENVIRON, P89
   McCutcheon P, 2013, GEOFORUM, V49, P61, DOI 10.1016/j.geoforum.2013.05.001
   McCutcheon P, 2011, FOOD HEALTH ENVIRON, P177
   Mohai P, 2009, ANNU REV ENV RESOUR, V34, P405, DOI [10.1146/annurev-environ-082508-094348, 10.1146/annurev.environ.082508-094348]
   Morales A, 2011, FOOD HEALTH ENVIRON, P149
   Morello-Frosch RA, 2002, ENVIRON PLANN C, V20, P477, DOI 10.1068/c03r
   Park L. S., 2011, SLUMS ASPEN IMMIGRAN
   Parson Don, 1982, INT J URBAN REGIONAL, V6, P393, DOI [10.1111/j.1468-2427.1982.tb00387.x, DOI 10.1111/J.1468-2427.1982.TB00387.X]
   Pearsall H., 2008, ENVIRON PLANN C, V28, P872
   Pearsall H, 2012, LOCAL ENVIRON, V17, P1013, DOI 10.1080/13549839.2012.714762
   Pellow D. N., 2002, GARBAGE WARS STRUGGL
   Pellow D. N., 2005, POWER JUSTICE ENV CR
   Pellow DN, 2001, SOCIOL QUART, V42, P47, DOI 10.1525/tsq.2001.42.1.47
   Perkins HA, 2004, CITIES, V21, P291, DOI 10.1016/j.cities.2004.04.002
   Portney KE, 2013, AM COMP ENVIRON POLI, P1
   Pulido L, 2000, ANN ASSOC AM GEOGR, V90, P12, DOI 10.1111/0004-5608.00182
   Pulido L, 1996, ENV EC JUSTICE 2 CHI
   Quastel N, 2009, URBAN GEOGR, V30, P694, DOI 10.2747/0272-3638.30.7.694
   Reynolds K, 2015, ANTIPODE, V47, P240, DOI 10.1111/anti.12098
   Rosan CD, 2012, LOCAL ENVIRON, V17, P959, DOI 10.1080/13549839.2011.627322
   Rosol M, 2013, URBAN STUD, V50, P2238, DOI 10.1177/0042098013478233
   Scheld S, 2005, RETHINKING URBAN PAR
   Schively C, 2007, J PLAN LIT, V21, P255, DOI 10.1177/0885412206295845
   Schlosberg D., 2007, DEFINING ENV JUSTICE
   Schweitzer L, 2007, URBAN STUD, V44, P319, DOI 10.1080/00420980601074961
   Self R O, 2003, AM BABYLON RACE STRU
   Shrader-Frechette K. S., 2002, ENV JUSTICE CREATING
   Slater T, 2006, INT J URBAN REGIONAL, V30, P737, DOI 10.1111/j.1468-2427.2006.00689.x
   Slocum R, 2006, ANTIPODE, V38, P327, DOI 10.1111/j.1467-8330.2006.00582.x
   Small Mario Luis., 2004, VILLA VICTORIA TRANS
   SMITH N, 1987, ANN ASSOC AM GEOGR, V77, P462, DOI 10.1111/j.1467-8306.1987.tb00171.x
   Smith N, 2002, ANTIPODE, V34, P427, DOI 10.1111/1467-8330.00249
   Smith N., 1996, NEW URBAN FRONTIER G
   Smith N., 1986, GENTRIFICATION CITY, P1534
   Song Lily K., 2014, PLANNING THEORY, V14, P152
   Strife S, 2009, ORGAN ENVIRON, V22, P99, DOI 10.1177/1086026609333340
   Sugrue Thomas J., 2005, ORIGINS URBAN CRISIS
   Swyngedouw E., 2007, SUSTAINABLE DEV PARA, P13
   Swyngedouw E, 2009, INT J URBAN REGIONAL, V33, P601, DOI 10.1111/j.1468-2427.2009.00859.x
   Sze J, 2009, ANTIPODE, V41, P807, DOI 10.1111/j.1467-8330.2009.00698.x
   Sze Julie, 2007, NOXIOUS NEW YORK RAC
   Taylor D. E., 2014, TOXIC COMMUNITIES EN
   Pham TTH, 2012, LANDSCAPE URBAN PLAN, V107, P214, DOI 10.1016/j.landurbplan.2012.06.002
   Tretter EM, 2013, INT J URBAN REGIONAL, V37, P297, DOI 10.1111/j.1468-2427.2012.01166.x
   *UN CHURCH CHRIST, 1987, TOX WAST RAC US NAT
   United States General Accounting Office, 1983, GAORCED9584
   Vale L. J., 2013, PURGING POOREST PUBL
   Von Hoffman Alexander, 2003, HOUSE HOUSE BLOCK BL
   Walker G, 2009, ANTIPODE, V41, P614, DOI 10.1111/j.1467-8330.2009.00691.x
   Wheeler SM, 2009, SUSTAINABLE DEV READ
   Wilson SM, 2012, AM J PUBLIC HEALTH, V102, P1974, DOI 10.2105/AJPH.2012.300700
   Winston N, 2010, SUSTAIN DEV, V18, P319, DOI 10.1002/sd.399
   Wolch JR, 2014, LANDSCAPE URBAN PLAN, V125, P234, DOI 10.1016/j.landurbplan.2014.01.017
NR 136
TC 14
Z9 14
U1 1
U2 29
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0885-4122
EI 1552-6593
J9 J PLAN LIT
JI J. Plan. Lit.
PD FEB
PY 2016
VL 31
IS 1
BP 23
EP 36
DI 10.1177/0885412215610491
PG 14
WC Planning & Development; Urban Studies
SC Public Administration; Urban Studies
GA DS0XB
UT WOS:000380319000002
DA 2018-12-27
ER

PT J
AU Niu, HX
   Zhang, XK
   Wang, B
   Zhou, Z
   Wang, J
   Xu, ZF
AF Niu, Hongxin
   Zhang, Xikun
   Wang, Bin
   Zhou, Zhao
   Wang, Jian
   Xu, Zhongfa
TI RETRACTED: The clinical utility of image-guided iodine-125 seed in
   patients with unresectable pancreatic cancer (Retracted article. See
   April, 2017)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Image-guided I-125 seed; Utility; Unresectable pancreatic cancer
ID IMPLANTATION; CARCINOMA; IRRADIATION; STATISTICS; THERAPY; GROWTH
AB In the present study, we investigated the clinical effects of image-guided iodine-125 (I-125) seed on unresectable pancreatic cancer. Twenty-five patients with unresectable pancreatic cancer were enrolled in this study, including 13 patients with seed implantation and 12 patients as control. The survival status, clinical benefits, objective curative effects, and relevant tumor markers were analyzed to assess the feasibility and safety of interstitial I-125 seed implantation. We found that the clinical benefit rate of the seed implantation group is 92.3 % (12/13), compared with 41.7 % (5/12) in the control, and the difference was statistically significant (p < 0.01). Compared with control, patients with seed implantation had significantly shorter operative time, less bleeding, higher albumin, shorter periods to bowel movement, and normal diet as well as lower risk of complications (p < 0.001). The differences of objective curative effects adverse effects, complications, and median survival between these two groups were not significant statistically (p > 0.05). In conclusion, I-125 seed implantation provides a safe and effective method to inhibit the tumor development, relieve pain, and improve quality of life for unresectable pancreatic cancer. These findings need to be validated by conducting further studies with larger cohorts.
C1 [Niu, Hongxin; Zhang, Xikun; Wang, Bin; Zhou, Zhao; Wang, Jian; Xu, Zhongfa] Shandong Acad Med Sci, Affiliated Hosp, Dept Minimally Invas Surg, 38 Wuyingshan Rd, Jinan 250031, Peoples R China.
RP Xu, ZF (reprint author), Shandong Acad Med Sci, Affiliated Hosp, Dept Minimally Invas Surg, 38 Wuyingshan Rd, Jinan 250031, Peoples R China.
EM xuzfshandong@163.com
CR Baron TH, 2010, NEW ENGL J MED, V362, P170, DOI 10.1056/NEJMe0908773
   Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026
   Furuse J, 2003, CANCER-AM CANCER SOC, V97, P1346, DOI 10.1002/cncr.11165
   Ioka T, 2010, INT J RADIAT ONCOL, V78, pS102, DOI 10.1016/j.ijrobp.2010.07.266
   Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.1002/caac.20073, 10.3322/caac.20073]
   Klein AP, 2013, NAT REV CANCER, V13, P66, DOI 10.1038/nrc3420
   Liang J, 2013, CHIN GER J CLIN ONCO, V12, P1245
   Liu K, 2014, INT J MED SCI, V11, P893, DOI 10.7150/ijms.8948
   Ma JX, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-35
   Ma ZH, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-61
   Majumder S, 2012, EXPERT REV GASTROENT, V6, P95, DOI [10.1586/EGH.11.93, 10.1586/egh.11.93]
   Ohorodnyk P, 2009, EUR J CANCER, V45, P2249, DOI 10.1016/j.ejca.2009.05.033
   PERETZ T, 1989, INT J RADIAT ONCOL, V17, P931, DOI 10.1016/0360-3016(89)90138-7
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   SYED AMN, 1983, CANCER, V52, P808, DOI 10.1002/1097-0142(19830901)52:5<808::AID-CNCR2820520510>3.0.CO;2-U
   Wang H, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-106
   Wang JJ, 2009, J EXP CLIN CANC RES, V28, P1
   Wang ZM, 2010, EUR RADIOL, V20, P1786, DOI 10.1007/s00330-009-1703-0
   Zhuang HQ, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-12
NR 19
TC 4
Z9 8
U1 3
U2 7
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD FEB
PY 2016
VL 37
IS 2
BP 2219
EP 2223
DI 10.1007/s13277-015-4045-3
PG 5
WC Oncology
SC Oncology
GA DK0HK
UT WOS:000374593300089
PM 26353858
DA 2018-12-27
ER

PT J
AU Szade, K
   Zukowska, M
   Szade, A
   Collet, G
   Kloska, D
   Kieda, C
   Jozkowicz, A
   Dulak, J
AF Szade, Krzysztof
   Zukowska, Monika
   Szade, Agata
   Collet, Guillaume
   Kloska, Damian
   Kieda, Claudine
   Jozkowicz, Alicja
   Dulak, Jozef
TI RETRACTED: Spheroid-plug model as a tool to study tumor development,
   angiogenesis, and heterogeneity in vivo (retracted article)
SO TUMOR BIOLOGY
LA English
DT Article; Retracted Publication
DE Cancer stem cells; Necrosis; Tumor infiltration; Tumor vascularization;
   B16 melanoma; Lewis lung carcinoma (LLC); Tumor complexity
ID MESENCHYMAL STEM-CELLS; LUNG-CANCER; MULTICELLULAR SPHEROIDS;
   ANIMAL-MODELS; MOUSE MODELS; MELANOMA; GROWTH; THERAPY; INHIBITOR;
   EFFICACY
AB Subcutaneous injection of the tumor cell suspension is a simple and commonly used tool for studying tumor development in vivo. However, subcutaneous models poorly resemble tumor complexity due to the fast growth not reflecting the natural course. Here, we describe an application of the new spheroid-plug model to combine the simplicity of subcutaneous injection with improved resemblance to natural tumor progression. Spheroid-plug model relies on in vitro formation of tumor spheroids, followed by injection of single tumor spheroid subcutaneously in Matrigel matrix. In spheroid-plug model, tumors grow slower in comparison to tumors formed by injection of cell suspension as assessed by 3D ultrasonography (USG) and in vivo bioluminescence measurements. The slower tumor growth rate in spheroid-plug model is accompanied by reduced necrosis. The spheroid-plug model ensures increased and more stable vascularization of tumor than classical subcutaneous tumor model as demonstrated by 3D USG Power Doppler examination. Flow cytometry analysis showed that tumors formed from spheroids have enhanced infiltration of endothelial cells as well as hematopoietic and progenitor cells with stem cell phenotype (c-Kit(+) and Sca-1(+)). They also contain more tumor cells expressing cancer stem cell marker CXCR4. Here, we show that spheroid-plug model allows investigating efficiency of anticancer drugs. Treatment of spheroid-plug tumors with known antiangiogenic agent axitinib decreased their size and viability. The antiangiogenic activity of axitinib was higher in spheroid-plug model than in classical model. Our results indicate that spheroid-plug model imitates natural tumor growth and can become a valuable tool for cancer research.
C1 [Szade, Krzysztof; Zukowska, Monika; Szade, Agata; Kloska, Damian; Jozkowicz, Alicja; Dulak, Jozef] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Krakow, Poland.
   [Szade, Krzysztof; Collet, Guillaume; Kieda, Claudine] CNRS, UPR4301, Ctr Mol Biophys Cell Recognit & Glycobiol, F-45071 Orleans, France.
   [Kieda, Claudine; Dulak, Jozef] Malopolska Ctr Biotechnol, Krakow, Poland.
   [Collet, Guillaume] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Lab Biorespons Mat, San Diego, CA 92103 USA.
RP Jozkowicz, A; Dulak, J (reprint author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Med Biotechnol, Krakow, Poland.; Dulak, J (reprint author), Malopolska Ctr Biotechnol, Krakow, Poland.
EM alicja.jozkowicz@uj.edu.pl; jozef.dulak@uj.edu.pl
OI Zukowska, Monika/0000-0002-2832-2146; Collet,
   Guillaume/0000-0002-0355-563X
FU Foundation for Polish Science [2011-8/9]; Polish National Science Center
   [2012/06/M/NZ1/00008]; National Centre for Research and Development
   [PBS2/B7/0/2013]; FEDER from the European Union [5788/39114]; European
   Union [POIG.02.01.00-12-064/08]; Ministry of Science and Higher
   Education
FX This study was supported by the following grants: Ventures (2011-8/9)
   granted to K.Sz. by Foundation for Polish Science, Harmonia
   (2012/06/M/NZ1/00008) granted to A.J. by Polish National Science Center,
   and National Centre for Research and Development granted to J.D.
   (PBS2/B7/0/2013). Research was conducted in the scope of the MiR-TANGo
   International Associated Laboratory (LIA). The FEDER from the European
   Union grant no. 5788/39114 supported C.K. The Faculty of Biochemistry,
   Biophysics and Biotechnology of the Jagiellonian University was
   beneficiary of the structural funds from the European Union (grant
   POIG.02.01.00-12-064/08). The Faculty of Biochemistry, Biophysics and
   Biotechnology of Jagiellonian University is a partner of the Leading
   National Research Center (KNOW) supported by the Ministry of Science and
   Higher Education. We would like to thank administrative staff Agnieszka
   Andrychowicz-Rog and Joanna Uchto as well as animal facility members
   Janusz Drebot, Karolina Hajduk, Elzbieta Slizewska, and Ewa Werner for
   their valuable help.
CR Ahn GO, 2009, ANGIOGENESIS, V12, P159, DOI 10.1007/s10456-009-9135-7
   Algazi AP, 2015, BR J CANC
   Medina MA, 2007, J CELL MOL MED, V11, P374, DOI 10.1111/j.1582-4934.2007.00056.x
   Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093
   Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106
   Bibby MC, 2004, EUR J CANCER, V40, P852, DOI 10.1016/j.ejca.2003.11.021
   Bose A, 2012, MELANOMA RES, V22, P236, DOI 10.1097/CMR.0b013e3283538293
   Cavallo F, 2006, ADV IMMUNOL, V90, P175, DOI 10.1016/S0065-2776(06)90005-4
   Collet G, 2014, MOL CANCER THER, V13, P165, DOI 10.1158/1535-7163.MCT-13-0637
   CULO F, 1980, BRIT J CANCER, V41, P100, DOI 10.1038/bjc.1980.11
   Davidoff AM, 2001, CLIN CANCER RES, V7, P2870
   Escudier B, 2011, DRUGS R&D, V11, P113, DOI 10.2165/11591240-000000000-00000
   Fang ST, 2011, J MOL CELL CARDIOL, V50, P290, DOI 10.1016/j.yjmcc.2010.10.024
   Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483
   Fruehauf J, 2011, CLIN CANCER RES, V17, P7462, DOI 10.1158/1078-0432.CCR-11-0534
   GILCHRIST KW, 1993, J CLIN ONCOL, V11, P1929, DOI 10.1200/JCO.1993.11.10.1929
   Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731
   Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/j.cell.2011.02.013
   Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012
   Hollingshead MG, 2008, JNCI-J NATL CANCER I, V100, DOI 10.1093/jnci/djn351
   Huang WH, 2013, ONCOGENE, V32, P4343, DOI 10.1038/onc.2012.458
   Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819
   Kerbel RS, 2003, CANCER BIOL THER, V2, pS134
   Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032
   Kim M, 2010, CANCER RES, V70, P10411, DOI 10.1158/0008-5472.CAN-10-2591
   Korff T, 2004, EXP CELL RES, V297, P415, DOI 10.1016/j.yexcr.2004.03.043
   Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341
   LANDRY JM, 1982, CANCER RES, V42, P93
   Lee N, 2014, LAB INVEST, V94, P13, DOI 10.1038/labinvest.2013.116
   Levina V, 2010, CANCER RES, V70, P338, DOI 10.1158/0008-5472.CAN-09-1102
   Liao JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084941
   Mak IWY, 2014, AM J TRANSL RES, V6, P114
   Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045
   Miletic H, 2007, MOL THER, V15, P1373, DOI 10.1038/sj.mt.6300155
   Monzani E, 2007, EUR J CANCER, V43, P935, DOI 10.1016/j.ejca.2007.01.017
   Nian WQ, 2011, MOL CELL BIOCHEM, V355, P241, DOI 10.1007/s11010-011-0860-z
   Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE
   Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925
   Richards CH, 2011, FUTURE ONCOL, V7, P1223, DOI [10.2217/fon.11.99, 10.2217/FON.11.99]
   Richmond A, 2008, DIS MODEL MECH, V1, P78, DOI 10.1242/dmm.000976
   Robertson FM, 2010, J BIOMOL SCREEN, V15, P820, DOI 10.1177/1087057110376541
   Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267
   Singh M, 2012, CANCER RES, V72, P2695, DOI 10.1158/0008-5472.CAN-11-2786
   Studeny M, 2004, J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299
   Suggitt M, 2005, CLIN CANCER RES, V11, P971
   SUTHERLAND RM, 1977, JNCI-J NATL CANCER I, V58, P1849, DOI 10.1093/jnci/58.6.1849
   SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290
   Teicher BA, 2006, MOL CANCER THER, V5, P2435, DOI 10.1158/1535-7163.MCT-06-0391
   Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y
   Venanzi F, 2013, ONCOTARGET, V4, P1829, DOI 10.18632/oncotarget.1397
   Wara AK, 2011, BLOOD, V118, P6461, DOI 10.1182/blood-2011-06-363457
   Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6
   Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537
   Wu JM, 2012, EXPERT OPIN DRUG DIS, V7, P723, DOI 10.1517/17460441.2012.695774
   Wu YJ, 2009, STEM CELLS DEV, V18, P1127, DOI 10.1089/scd.2008.0338
   Zhang XH, 2013, ONCOL LETT, V6, P69, DOI 10.3892/ol.2013.1345
   Zhang XH, 2014, ANTI-CANCER DRUG, V25, P204, DOI 10.1097/CAD.0000000000000033
   Zucchi I, 2007, P NATL ACAD SCI USA, V104, P10476, DOI 10.1073/pnas.0703071104
NR 58
TC 3
Z9 3
U1 2
U2 16
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD FEB
PY 2016
VL 37
IS 2
BP 2481
EP 2496
DI 10.1007/s13277-015-4065-z
PG 16
WC Oncology
SC Oncology
GA DK0HK
UT WOS:000374593300116
PM 26385771
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Zhao, QS
   Hu, LL
   Tian, P
   Wang, ZD
   Li, ZP
   Wang, AW
   Liu, J
AF Zhao, Qing-Sheng
   Hu, Ling-Ling
   Tian, Peng
   Wang, Zhi-Dong
   Li, Zhao-Pei
   Wang, Ai-Wen
   Liu, Jing
TI RETRACTED: Targeted DNA methylation analysis explores association of
   adenocarcinoma and neuroendocrine epitypes with lung cancer (Retracted
   Article)
SO TUMOR BIOLOGY
LA English
DT Correction; Retracted Publication
C1 [Zhao, Qing-Sheng; Wang, Zhi-Dong] Linyi Peoples Hosp, Dept Thorac Surg, Linyi, Peoples R China.
   [Hu, Ling-Ling] Linyi Peoples Hosp, Dept Obstet & Gynecol, Linyi, Peoples R China.
   [Tian, Peng] 456th Hosp Chinese PLA, Dept Cardiothorac Surg, Jinan, Peoples R China.
   [Li, Zhao-Pei] Shandong Univ, Shandong Prov Hosp, Dept Oncol, Jinan 250100, Peoples R China.
   [Wang, Ai-Wen] Lanling Peoples Hosp, Dept Anesthesiol, Lanling, Peoples R China.
   [Liu, Jing] Jilin Univ, Dept Resp Med, Hosp 2, 218 Ziqiang St, Changchun 130041, Jilin, Peoples R China.
RP Liu, J (reprint author), Jilin Univ, Dept Resp Med, Hosp 2, 218 Ziqiang St, Changchun 130041, Jilin, Peoples R China.
EM liujing020901@hotmail.com
CR Zhao QS, 2016, TUMOR BIOL, V37, P2537, DOI 10.1007/s13277-015-3826-z
NR 1
TC 2
Z9 2
U1 3
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1010-4283
EI 1423-0380
J9 TUMOR BIOL
JI Tumor Biol.
PD FEB
PY 2016
VL 37
IS 2
BP 2537
EP 2537
DI 10.1007/s13277-015-3826-z
PG 1
WC Oncology
SC Oncology
GA DK0HK
UT WOS:000374593300121
PM 26386722
OA Bronze
DA 2018-12-27
ER

PT J
AU McGrath, RT
   Donnelly, VC
   Glastras, SJ
   Preda, VA
   Sheriff, N
   Ward, P
   Hocking, SL
   Fulcher, GR
AF McGrath, Rachel T.
   Donnelly, Vanessa C.
   Glastras, Sarah J.
   Preda, Veronica A.
   Sheriff, Nisa
   Ward, Peter
   Hocking, Samantha L.
   Fulcher, Gregory R.
TI RETRACTED: Evaluation of Blood Glucose Meter Efficacy in an Antenatal
   Diabetes Clinic(Retracted article.See vol.19, pg.382, 2017)
SO DIABETES TECHNOLOGY & THERAPEUTICS
LA English
DT Article; Retracted Publication
ID PREGNANCY OUTCOMES; HYPERGLYCEMIA; MELLITUS; RECOMMENDATIONS; ACCURACY;
   SYSTEMS; OBESITY
AB Background: The optimal treatment of diabetes in pregnancy requires accurate measurement of blood glucose levels, in order to minimize adverse outcomes for both mother and neonate. Self-monitoring of blood glucose is routinely used to measure glycemic control and to assess whether treatment targets are being met; however, the accuracy of blood glucose meters in pregnancy is unclear.
   Materials and Methods: Pregnant women with gestational, type 1, or type 2 diabetes mellitus were eligible to participate. Nonfasting capillary blood glucose levels were measured in duplicate using the BGStar (R) (Sanofi, Sydney, Australia) and FreeStyle Lite (R)(Abbott, Sydney) blood glucose meters. Venous blood samples were collected and analyzed for plasma glucose, hematocrit, and glycated hemoglobin. Capillary blood glucose was compared with plasma glucose and further assessed according to International Organization for Standardization (ISO) 15197: 2013 standards.
   Results: One hundred ten women were recruited, providing 96 samples suitable for analysis. The mean-SD laboratory plasma glucose level was 4.6 +/- 1.4 mmol/L; the BGStar and FreeStyle Lite capillary blood glucose values were 5.3 +/- 1.4 mmol/L and 5.0 +/- 1.3 mmol/L, respectively. Both meters showed a positive bias (0.42 mmol/L for the FreeStyle Lite and 0.65 mmol/L for the BGStar). Furthermore, neither meter fulfilled the ISO 15197: 2013 standards, and there was a nonsignificant improvement in meter performance at blood glucose levels of <= 4.2 mmol/L. Hematocrit did not affect the results of either blood glucose meter. Clarke Error Grid analysis demonstrated that approximately 70% of the results of both meters would lead to appropriate clinical action.
   Conclusions: The BGStar and FreeStyle Lite blood glucose meters did not meet ISO 15197: 2013 recommendations for blood glucose monitoring systems when assessed in a population of women with diabetes in pregnancy. Clinicians should consider this difference in blood glucose readings when making diabetes-related treatment decisions.
C1 [McGrath, Rachel T.; Donnelly, Vanessa C.; Glastras, Sarah J.; Preda, Veronica A.; Sheriff, Nisa; Hocking, Samantha L.; Fulcher, Gregory R.] Royal N Shore Hosp, Dept Diabet Endocrinol & Metab, Level 3,Acute Serv Bldg, Sydney, NSW 2065, Australia.
   [McGrath, Rachel T.; Glastras, Sarah J.; Preda, Veronica A.; Hocking, Samantha L.; Fulcher, Gregory R.] Univ Sydney, Royal N Shore Hosp, Northern Clin Sch, St Leonards, NSW 2065, Australia.
   [Ward, Peter] Royal N Shore Hosp, Pathol North Northern Sydney, Chem Pathol, Sydney, NSW, Australia.
RP McGrath, RT (reprint author), Royal N Shore Hosp, Dept Diabet Endocrinol & Metab, Level 3,Acute Serv Bldg, Sydney, NSW 2065, Australia.
EM Rachel.McGrath@health.nsw.gov.au
RI Preda, Vasile/F-2724-2011
OI Preda, Vasile/0000-0003-2115-3113; Hocking,
   Samantha/0000-0002-2514-9392; Glastras, Sarah/0000-0002-9317-1348
CR Alva Shridhara, 2008, J Diabetes Sci Technol, V2, P546
   [Anonymous], 2014, GREN BIOONE VAC INST
   [Anonymous], 2013, 151972013 ISO, VInternational Organization for Standardization
   Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790
   CLARKE WL, 1987, DIABETES CARE, V10, P622, DOI 10.2337/diacare.10.5.622
   Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973
   Dalfra MG, 2011, DIABETES TECHNOL THE, V13, P853, DOI 10.1089/dia.2010.0145
   Diabetes Australia, 2013, GEST DIAB
   Freckmann G, 2014, DIABETES TECHNOL THE, V16, P113, DOI 10.1089/dia.2013.0208
   Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010
   Hoffman L, 1998, MED J AUSTRALIA, V169, P93
   International Diabetes Federation, 2014, GEST DIAB
   *ISO, 2003, 151972003 ISO
   McLean M, 2013, MED J AUSTRALIA, V198, P596, DOI 10.5694/mja12.11326
   Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943
   Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225
   Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848
   Musholt Petra B, 2011, J Diabetes Sci Technol, V5, P1167
   Negrato CA, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-54
   Parwaiz M, 2014, ANN CLIN BIOCHEM, V51, P47, DOI 10.1177/0004563213487893
   Perera NJ, 2011, DIABETES CARE, V34, P335, DOI 10.2337/dc10-1457
   Ramljak Sanja, 2013, J Diabetes Sci Technol, V7, P179
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Teede HJ, 2011, AUST NZ J OBSTET GYN, V51, P499, DOI 10.1111/j.1479-828X.2011.01356.x
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
NR 25
TC 2
Z9 2
U1 3
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1520-9156
EI 1557-8593
J9 DIABETES TECHNOL THE
JI Diabetes Technol. Ther.
PD FEB
PY 2016
VL 18
IS 2
BP 68
EP 74
DI 10.1089/dia.2015.0104
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA DK8EW
UT WOS:000375161000005
PM 26440810
DA 2018-12-27
ER

PT J
AU Nikitin, AG
AF Nikitin, Andrey G.
TI RETRACTED: Manipulating fluorescence color and intensity with regular
   metal nanoparticle-based composite materials (Retracted Article. See
   vol. 109, 129901, 2016)
SO APPLIED PHYSICS LETTERS
LA English
DT Article; Retracted Publication
ID LIGHT-EMITTING-DIODES; EXTRACTION EFFICIENCY; LATTICE RESONANCES;
   ARRAYS; EMISSION
AB This paper first studies the role of structural parameters of ordered metal nanoparticle-based composites in the modification of the spectra and intensity of directional emission from organic molecules. It then investigates the possibilities of white light generation via color conversion using two materials, one emitting in the green and the other one in the red spectral region. The structures under study exhibit enhanced emission within small solid angle in the forward direction due to excitation of the quasiguided modes. These modes modify the angle-dependent local photon density of states and, thus, result in efficient directional outcoupling of radiation. (C) 2016 AIP Publishing LLC.
C1 [Nikitin, Andrey G.] Aix Marseille Univ, UPR CNRS 3118, CINaM, Ctr Interdisciplinaire Nanosci Marseille, Campus Luminy,Case 913, F-13288 Marseille, France.
   [Nikitin, Andrey G.] Al Farabi Kazakh Natl Univ, Fac Phys & Technol, 71 Al Farabi Ave, Alma Ata 050040, Kazakhstan.
RP Nikitin, AG (reprint author), Aix Marseille Univ, UPR CNRS 3118, CINaM, Ctr Interdisciplinaire Nanosci Marseille, Campus Luminy,Case 913, F-13288 Marseille, France.; Nikitin, AG (reprint author), Al Farabi Kazakh Natl Univ, Fac Phys & Technol, 71 Al Farabi Ave, Alma Ata 050040, Kazakhstan.
EM nikitin@cinam.univ-mrs.fr
FU Program of Ministry of Education and Science of Republic of Kazakhstan
   [F.0755/2016]
FX This work was supported by Program F.0755/2016 of the Ministry of
   Education and Science of Republic of Kazakhstan.
CR Abass A, 2014, NANO LETT, V14, P5555, DOI 10.1021/nl501955e
   Abass A, 2014, ACS PHOTONICS, V1, P61, DOI 10.1021/ph400072z
   Auguie B, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.143902
   Christ A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.125113
   Dang SH, 2012, OPT EXPRESS, V20, P23290, DOI 10.1364/OE.20.023290
   Evlyukhin AB, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245411
   Gu XF, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-199
   Guo R, 2015, OPT EXPRESS, V23, P28206, DOI 10.1364/OE.23.028206
   Humphrey AD, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.075404
   Kichin G, 2012, PHYSICA B, V407, P4037, DOI 10.1016/j.physb.2012.01.128
   Kuznetsov AI, 2011, ACS NANO, V5, P4843, DOI 10.1021/nn2009112
   Markel VA, 2005, J PHYS B-AT MOL OPT, V38, pL115, DOI 10.1088/0953-4075/38/7/L02
   Matterson BJ, 2001, ADV MATER, V13, P123, DOI 10.1002/1521-4095(200101)13:2<123::AID-ADMA123>3.0.CO;2-D
   Nakamura S., 1997, BLUE LASER DIODE
   Nikitin A, 2016, ECS J SOLID STATE SC, V5, pR3164, DOI 10.1149/2.0211601jss
   Nikitin AG, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864277
   Nikitin AG, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803535
   Rasskazov IL, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.075405
   Rodriguez SRK, 2013, OPT LETT, V38, P1238, DOI 10.1364/OL.38.001238
   Rodriguez SRK, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.166803
   SAKODA K, 2001, OPTICAL PROPERTIES P
   Schlotter P, 1997, APPL PHYS A-MATER, V64, P417, DOI 10.1007/s003390050498
   Schokker AH, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155452
   Schubert E. F., 2006, LIGHT EMITTING DIODE
   Teperik TV, 2014, J OPT SOC AM B, V31, P223, DOI 10.1364/JOSAB.31.000223
   Tikhodeev SG, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.045102
   Wierer JJ, 2009, NAT PHOTONICS, V3, P163, DOI 10.1038/NPHOTON.2009.21
   Wyszecki Gunter, 2000, COLOR SCI CONCEPTS M
   Yariv A., 2006, PHOTONICS OPTICAL EL
   Zhou W, 2013, NAT NANOTECHNOL, V8, P506, DOI [10.1038/NNANO.2013.99, 10.1038/nnano.2013.99]
   Zhou W, 2012, J PHYS CHEM LETT, V3, P1381, DOI 10.1021/jz300318v
   Zhou W, 2011, NAT NANOTECHNOL, V6, P423, DOI [10.1038/nnano.2011.72, 10.1038/NNANO.2011.72]
   Zhukovsky SV, 2014, APPL PHYS A-MATER, V116, P929, DOI 10.1007/s00339-014-8464-6
   Zhukovsky SV, 2014, PLASMONICS, V9, P283, DOI 10.1007/s11468-013-9621-z
   Zou SL, 2004, J CHEM PHYS, V120, P10871, DOI 10.1063/1.1760740
NR 35
TC 1
Z9 1
U1 3
U2 21
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0003-6951
EI 1077-3118
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD FEB 1
PY 2016
VL 108
IS 5
AR 051112
DI 10.1063/1.4940383
PG 5
WC Physics, Applied
SC Physics
GA DH8PD
UT WOS:000373055700012
DA 2018-12-27
ER

PT J
AU Dou, RJ
   Qiu, SW
   Ju, Y
AF Dou, Renjun
   Qiu, Sawei
   Ju, Yan
TI RETRACTED: Simulation of Effect of Loading Rate on Compression
   Properties in the Two-Dimensional Model of Aluminum Foam Sandwich
   Panels(Retracted article.See vol.57,pg.1857,2016)
SO MATERIALS TRANSACTIONS
LA English
DT Article; Retracted Publication
DE compression property; aluminum foam sandwich panel; ANSYS/LS-DYNA
   software; locking density; locking strain; plastic wave
AB A two-dimensional finite element model of aluminum foam sandwich (AFS) panels was approximated by combing C++ and ANSYS/LS-DYNA software to represent the shapes of the cells and geometric distributions. Under different loading rates, the deformation behavior, shock wave propagation process, inertial effect and stress of the bottom of the model of AFS panels are discussed resulting from simulation. We found that plastic deformation in the model first occurs in a weak section in the quasi-static compression simulation, whereas the local densification is obvious during the high-speed impact process. The results also indicate that the speed of the plastic wave, locking density and locking strain increase respectively with increasing loading rate. In addition, under the loading rate 80 m/s, the model can be compressed after the plastic wave reaches the bottom of the model during the process of deformation due to the reflection of the plastic wave, whereas the plateau stress rises with an increase in the loading rate.
C1 [Dou, Renjun; Qiu, Sawei; Ju, Yan] Kunming Univ Sci & Technol, Fac Mech & Elect Engn, Jingming South Rd, Kunming 650500, Yunnan, Peoples R China.
RP Dou, RJ (reprint author), Kunming Univ Sci & Technol, Fac Mech & Elect Engn, Jingming South Rd, Kunming 650500, Yunnan, Peoples R China.
EM 1320985749@qq.com
CR Chen H. S., 2007, J NINGBO U NATURAL S, V20, P118
   Chen Z., 2012, J SCI U, V44, P84
   [康锦霞 Kang Jinxia], 2015, [振动与冲击, Journal of Vibration and Shock], V34, P189
   Liu Y, 2014, COMP MATER SCI, V91, P223, DOI 10.1016/j.commatsci.2014.05.002
   Nemat-Nasser S, 2007, INT J IMPACT ENG, V34, P1119, DOI 10.1016/j.ijimpeng.2006.05.007
   Pollien A, 2005, MAT SCI ENG A-STRUCT, V404, P9, DOI 10.1016/j.msea.2005.05.096
   Qiu SW, 2015, MATER TRANS, V56, P687, DOI 10.2320/matertrans.M2015008
   Styles M, 2008, COMPOS STRUCT, V86, P227, DOI 10.1016/j.compstruct.2008.03.024
   Su H. B., 2009, SCI TECHNOL ENG, V9, P6991
   Wang LL, 2005, FDN STRESS WAVES
   Xie Z. Y., 2012, COMPOS B, V46, P1
   [于英华 Yu Yinghua], 2010, [计算机仿真, Computer Simulation], V27, P317
   Zhang Jian, 2010, Journal of Xi'an Jiaotong University, V44, P97
   Zhu XL, 2014, COMP MATER SCI, V85, P38, DOI 10.1016/j.commatsci.2013.12.055
NR 14
TC 3
Z9 3
U1 8
U2 32
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD FEB
PY 2016
VL 57
IS 2
BP 99
EP 102
DI 10.2320/matertrans.M2015359
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA DH3EV
UT WOS:000372671200003
OA Bronze
DA 2018-12-27
ER

PT J
AU Imaizumi, A
   Onishi, H
   Yamasaki, A
   Kawamoto, M
   Morisaki, T
   Goto, M
   Iwama, M
   Akaike, T
   Hasumi, K
AF Imaizumi, Akira
   Onishi, Hideya
   Yamasaki, Akio
   Kawamoto, Makoto
   Morisaki, Takashi
   Goto, Mitsuaki
   Iwama, Masamichi
   Akaike, Toshihiro
   Hasumi, Kenichiro
TI RETRACTED: Sugar-carrying Polystyrenes Facilitate Harvesting of APCs
   from MLRs: Possible Application of Sugar-carrying Polystyrenes to
   Immunotherapy (Retracted article. See vol. 36, pg. 6918, 2016)
SO ANTICANCER RESEARCH
LA English
DT Article; Retracted Publication
DE PVGlcNAc; P(VLA-co-SU); antigen-presenting cells; CTL; cancer
   immunotherapy
ID ASIALOGLYCOPROTEIN RECEPTOR EXPRESSION; DENDRITIC CELLS; HEPATOCYTES;
   VIMENTIN; POLYMERS; CANCER
AB Antigen-presenting cells (APCs) play a pivotal role in cancer immunotherapy. APCs in conventionally used flasks are harvested by enzymatic digestion or cell scraping for application to cancer immunotherapy. However, these methods may impair functional molecules expressed on the APC surface and reduce their effects in cancer immunotherapy. Recently, we found that APCs could be harvested by shaking at 4 degrees C in flasks coated with poly[N-p-vinylbenzyl-O-2-acetoamide-2-deoxy-beta-D- glucopyranosyl-(1 -> 4)-2-acetoamide-2-deoxy-beta-Dgluconamide] (PVGlcNAc) or a copolymer consisting of sulfonylurea (SU) linked to poly[N-p-vinyl-benzyl-4-O-beta-D-galactopyranosyl-D-gluconamide] [P(VLA-co-SU)]. In the present study, we compared the functions of cytotoxic Tlymphocytes (CTLs) induced by APCs generated in PVGlcNAcor P(VLA-co-SU)-coated flasks and conventional flasks. APCs from PVGlcNAc- or P(VLA-co-SU)-coated flasks showed higher expression of cluster of differentiation (CD)80/86, CD11c, and major histocompatibility complex class II alloantigen I-A(d), and higher cytotoxicity than APCs from conventional flasks. These results suggest that the use of PVGlcNAc- or P(VLA-co-SU)-coated flasks is optimal for harvesting APCs. The generated APCs also have a higher antigen-presenting ability compared to those generated in conventional flasks. Our results may contribute to the development of effective cancer immunotherapies.
C1 [Imaizumi, Akira; Hasumi, Kenichiro] Shukoukai Inc, Tokyo, Japan.
   [Imaizumi, Akira; Onishi, Hideya; Yamasaki, Akio; Kawamoto, Makoto; Morisaki, Takashi] Kyushu Univ, Grad Sch Med Sci, Dept Canc Therapy & Res, Fukuoka 8128502, Japan.
   [Morisaki, Takashi] Fukuoka Gen Canc Clin, Fukuoka, Japan.
   [Goto, Mitsuaki; Iwama, Masamichi] Celagix Res Ltd, Kanagawa, Japan.
   [Akaike, Toshihiro] Frontier Res Ctr, Tokyo, Japan.
RP Onishi, H (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Canc Therapy & Res, Fukuoka 8128502, Japan.
EM ohnishi@surg1.med.kyushu-u.ac.jp
FU Kakenhi Grant from Japan Society for the Promotion of Science [15K10055]
FX This study was supported by a Kakenhi Grant (15K10055) from the Japan
   Society for the Promotion of Science. The Authors thank Ms Kaori
   Nomiyama for skillful technical assistance.
CR Cho CS, 2006, BIOMATERIALS, V27, P576, DOI 10.1016/j.biomaterials.2005.06.008
   FATHMAN CG, 1977, J IMMUNOL, V118, P1232
   Ise H, 2004, AM J PATHOL, V165, P501, DOI 10.1016/S0002-9440(10)63315-9
   Ise H, 2001, BIOCHEM BIOPH RES CO, V285, P172, DOI 10.1006/bbrc.2001.5139
   Ise H, 2001, J ARTIF ORGANS, V4, P342
   Ise H, 2010, GLYCOBIOLOGY, V20, P843, DOI 10.1093/glycob/cwq039
   Ishihara M, 2000, J BIOMED MATER RES, V50, P144, DOI 10.1002/(SICI)1097-4636(200005)50:2<144::AID-JBM8>3.0.CO;2-S
   Kim SJ, 2012, BIOMATERIALS, V33, P2154, DOI 10.1016/j.biomaterials.2011.11.084
   Onishi H, 2005, ANTICANCER RES, V25, P3445
   Onishi H, 2002, CLIN IMMUNOL, V105, P286, DOI 10.1006/clim.2002.5293
   Onishi H, 2012, ANTICANCER RES, V32, P2385
NR 11
TC 2
Z9 2
U1 4
U2 5
PU INT INST ANTICANCER RESEARCH
PI ATHENS
PA EDITORIAL OFFICE 1ST KM KAPANDRITIOU-KALAMOU RD KAPANDRITI, PO BOX 22,
   ATHENS 19014, GREECE
SN 0250-7005
EI 1791-7530
J9 ANTICANCER RES
JI Anticancer Res.
PD FEB
PY 2016
VL 36
IS 2
BP 673
EP 676
PG 4
WC Oncology
SC Oncology
GA DG7GS
UT WOS:000372253400023
PM 26851023
DA 2018-12-27
ER

PT J
AU van Teeffelen, AJA
   Vos, CC
   Jochem, R
   Baveco, JM
   Meeuwsen, H
   Hilbers, JP
AF van Teeffelen, Astrid J. A.
   Vos, Claire C.
   Jochem, Rene
   Baveco, Johannes M.
   Meeuwsen, Henk
   Hilbers, Jelle P.
TI RETRACTED: The effectiveness of green infrastructure as a climate
   adaptation strategy for intensively-used landscapes: an example of the
   great crested newt (Retracted Article)
SO LANDSCAPE ECOLOGY
LA English
DT Correction; Retracted Publication
C1 [van Teeffelen, Astrid J. A.] Vrije Univ Amsterdam, Inst Environm Studies, Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.
   [van Teeffelen, Astrid J. A.] Wageningen Univ, Land Use Planning Grp, POB 47, NL-6700 AA Wageningen, Netherlands.
   [Vos, Claire C.; Jochem, Rene; Baveco, Johannes M.; Meeuwsen, Henk] Wageningen UR, Alterra, POB 47, NL-6700 AA Wageningen, Netherlands.
   [Hilbers, Jelle P.] Radboud Univ Nijmegen, Fac Sci, Dept Environm Sci, POB 9010, NL-6500 GL Nijmegen, Netherlands.
RP van Teeffelen, AJA (reprint author), Vrije Univ Amsterdam, Inst Environm Studies, Boelelaan 1087, NL-1081 HV Amsterdam, Netherlands.
EM astrid.van.teeffelen@vu.nl
CR VANTEEFFELEN AJA, LANDSCAPE ECOL, P39146
NR 1
TC 2
Z9 2
U1 2
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0921-2973
EI 1572-9761
J9 LANDSCAPE ECOL
JI Landsc. Ecol.
PD FEB
PY 2016
VL 31
IS 2
BP 467
EP 467
DI 10.1007/s10980-014-0079-y
PG 1
WC Ecology; Geography, Physical; Geosciences, Multidisciplinary
SC Environmental Sciences & Ecology; Physical Geography; Geology
GA DG8FR
UT WOS:000372318900019
OA Bronze
DA 2018-12-27
ER

PT J
AU Sun, LF
   Liao, RD
   Lu, W
   Fu, SB
AF Sun, Linfeng
   Liao, Ridong
   Lu, Wei
   Fu, Sibo
TI RETRACTED: Porosity Defect Remodeling and Tensile Analysis of Cast Steel
   (Retracted article. See vol. 9, 488, 2016)
SO MATERIALS
LA English
DT Article; Retracted Publication
DE cast steel; porosity; mapping; radiographic; simulation
ID MECHANICAL-PROPERTIES; DUCTILE RUPTURE; ELASTIC-MODULI; DIE CASTINGS;
   BEHAVIOR; MEDIA; MODEL
AB Tensile properties on ASTM A216 WCB cast steel with centerline porosity defect were studied with radiographic mapping and finite element remodeling technique. Non-linear elastic and plastic behaviors dependent on porosity were mathematically described by relevant equation sets. According to the ASTM E8 tensile test standard, matrix and defect specimens were machined into two categories by two types of height. After applying radiographic inspection, defect morphologies were mapped to the mid-sections of the finite element models and the porosity fraction fields had been generated with interpolation method. ABAQUS input parameters were confirmed by trial simulations to the matrix specimen and comparison with experimental outcomes. Fine agreements of the result curves between simulations and experiments could be observed, and predicted positions of the tensile fracture were found to be in accordance with the tests. Chord modulus was used to obtain the equivalent elastic stiffness because of the non-linear features. The results showed that elongation was the most influenced term to the defect cast steel, compared with elastic stiffness and yield stress. Additional visual explanations on the tensile fracture caused by void propagation were also given by the result contours at different mechanical stages, including distributions of Mises stress and plastic strain.
C1 [Sun, Linfeng; Liao, Ridong] Beijing Inst Technol, Sch Mech Engn, Beijing 100081, Peoples R China.
   [Lu, Wei] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.
   [Fu, Sibo] Eastern Michigan Univ, Art & Sci Sch, Ypsilanti, MI 48197 USA.
RP Liao, RD (reprint author), Beijing Inst Technol, Sch Mech Engn, Beijing 100081, Peoples R China.
EM sunlinfeng1986@163.com; liaordbit@163.com; weilu@umich.edu;
   yli18@emich.edu
FU China Scholarship Council [201306030010]; National Natural Science
   Foundation of China [104010205]
FX This work was supported and funded by China Scholarship Council (File
   No. 201306030010) and National Natural Science Foundation of China
   (Grant No. 104010205).
CR American Society for Testing Materials, 2008, E8E8M08 ASTM
   BERT CW, 1985, J MATER SCI, V20, P2220, DOI 10.1007/BF01112307
   Dassault Systemes, ABAQUS THEOR MAN VER
   Davis JR, 2004, TENSILE TESTING
   DEWEY JM, 1947, J APPL PHYS, V18, P578, DOI 10.1063/1.1697691
   Ghosh S, 2004, COMPUT MECH, V34, P510, DOI 10.1007/s00466-004-0598-5
   GURSON AL, 1977, J ENG MATER-T ASME, V99, P2, DOI 10.1115/1.3443401
   Hangai Y, 2008, MATER TRANS, V49, P782, DOI [10.2320/matertrans.MRA2007314, 10.2320/matertrans.MRA2007314J]
   Hangai Y, 2014, MATERIALS, V7, P2382, DOI 10.3390/ma7032382
   Herakovich CT, 1999, J MATER SCI, V34, P1595, DOI 10.1023/A:1004528600213
   HEULER P, 1993, FATIGUE FRACT ENG M, V16, P115, DOI 10.1111/j.1460-2695.1993.tb00074.x
   NEEDLEMAN A, 1984, J MECH PHYS SOLIDS, V32, P461, DOI 10.1016/0022-5096(84)90031-0
   RAMAKRISHNAN N, 1993, J AM CERAM SOC, V76, P2745, DOI 10.1111/j.1151-2916.1993.tb04011.x
   Rice RW, 2005, J MATER SCI, V40, P983, DOI 10.1007/s10853-005-6517-0
   Ries M., 2007, P APPL MATH MECH, V7
   Roberts AP, 2000, J AM CERAM SOC, V83, P3041, DOI 10.1111/j.1151-2916.2000.tb01680.x
   Sigl KM, 2004, INT J CAST METAL RES, V17, P130, DOI 10.1179/136404604225020588
   Taxer T, 2013, MAT SCI ENG A-STRUCT, V575, P144, DOI 10.1016/j.msea.2013.02.067
   TVERGAARD V, 1981, INT J FRACTURE, V17, P389, DOI 10.1007/BF00036191
   Zhang EL, 2005, INT J MECH SCI, V47, P744, DOI [10.1016/j.ijmecsci.2004.12.011, 10.1016/j.ijmersci.2004.12.011]
NR 20
TC 1
Z9 1
U1 5
U2 13
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD FEB
PY 2016
VL 9
IS 2
AR 119
DI 10.3390/ma9020119
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA DG1KY
UT WOS:000371828100053
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Asrani, VM
   Yoon, HD
   Megill, RD
   Windsor, JA
   Petrov, MS
AF Asrani, Varsha M.
   Yoon, Harry D.
   Megill, Robin D.
   Windsor, John A.
   Petrov, Maxim S.
TI RETRACTED: Interventions That Affect Gastrointestinal Motility in
   Hospitalized Adult Patients A Systematic Review and Meta-Analysis of
   Double-Blind Placebo-Controlled Randomized Trials(Retracted article. See
   vol. 96, 2017)
SO MEDICINE
LA English
DT Review; Retracted Publication
ID CRITICALLY-ILL PATIENTS; IRRITABLE-BOWEL-SYNDROME; GHRELIN RECEPTOR
   AGONIST; MEAL-RELATED SYMPTOMS; FUNCTIONAL DYSPEPSIA;
   ACUTE-PANCREATITIS; CONTROLLED-TRIAL; DIABETIC GASTROPARESIS; COLONIC
   TRANSIT; COLORECTAL SURGERY
AB Gastrointestinal (GI) dysmotility is a common complication in acute, critically ill, postoperative, and chronic patients that may lead to impaired nutrient delivery, poor clinical, and patient-reported outcomes. Several pharmacological and nonpharmacological interventions to treat GI dysmotility were investigated in dozens of clinical studies. However, they often yielded conflicting results, at least in part, because various (nonstandardized) definitions of GI dysmotility were used and methodological quality of studies was poor. While a universally accepted definition of GI dysmotility is yet to be developed, a systematic analysis of data derived from double-blind placebo-controlled randomized trials may provide robust data on absolute and relative effectiveness of various interventions as the study outcome (GI motility) was assessed in the least biased manner.
   To systematically review data from double-blind placebo-controlled randomized trials to determine and compare the effectiveness of interventions that affect GI motility.
   Three electronic databases (MEDLINE, SCOPUS, and EMBASE) were searched. A random effects model was used for meta-analysis. The summary estimates were reported as mean difference (MD) with the corresponding 95% confidence interval (CI).
   A total of 38 double-blind placebo-controlled randomized trials involving 2371 patients were eligible for inclusion in the systematic review. These studies investigated a total of 20 different interventions, of which 6 interventions were meta-analyzed. Of them, the use of dopamine receptor antagonists (MD, -8.99; 95% CI, -17.72 to -0.27; P = 0.04) and macrolides (MD, -26.04; 95% CI, -51.25 to -0.82; P = 0.04) significantly improved GI motility compared with the placebo group. The use of botulism toxin significantly impaired GI motility compared with the placebo group (MD, 5.31; 95% CI, -0.04 to 10.67; P = 0.05). Other interventions (dietary factors, probiotics, hormones) did not affect GI motility.
   Based on the best available data and taking into account the safety profile of each class of intervention, dopamine receptor antagonists and macrolides significantly improve GI motility and are medications of choice in treating GI dysmotility.
C1 [Asrani, Varsha M.; Yoon, Harry D.; Megill, Robin D.; Windsor, John A.; Petrov, Maxim S.] Univ Auckland, Dept Surg, Room 12-085A,Private Bag 92019,Victoria St West, Auckland 1142, New Zealand.
   [Asrani, Varsha M.] Auckland City Hosp, Nutr & Dietet, Auckland, New Zealand.
RP Petrov, MS (reprint author), Univ Auckland, Dept Surg, Auckland City Hosp, Room 12-085A,Private Bag 92019,,Victoria St West, Auckland 1142, New Zealand.
EM max.petrov@gmail.com
FU Mylan New Zealand Limited
FX This study was part of the Clinical and epidemiOlogical inveStigations
   in Metabolism, nutritiOn, and pancreatic diseaseS (COSMOS) program.
   COSMOS is supported in part by Mylan New Zealand Limited, which played
   no role in the study design; collection, analysis, or interpretation of
   data; or writing of the manuscript.
CR ARIENTI V, 1994, ALIMENT PHARM THERAP, V8, P631
   Ariyasu H, 2014, ENDOCR J, V61, P735, DOI 10.1507/endocrj.EJ14-0088
   Arts J, 2005, GUT, V54, P455, DOI 10.1136/gut.2003.035279
   Asrani V, 2013, PANCREATOLOGY, V13, P468, DOI 10.1016/j.pan.2013.07.282
   BADIALI D, 1995, DIGEST DIS SCI, V40, P349, DOI 10.1007/BF02065421
   Banani SJ, 2008, AM J HEALTH-SYST PH, V65, P1057, DOI 10.2146/ajhp070381
   Berne JD, 2002, J TRAUMA, V53, P422, DOI 10.1097/01.TA.0000019795.11972.FD
   Bharucha AE, 2013, GUT, V62, P708, DOI 10.1136/gutjnl-2012-302483
   BONACINI M, 1993, AM J GASTROENTEROL, V88, P208
   Bortolotti M, 1999, DIGEST DIS SCI, V44, P2439, DOI 10.1023/A:1026674719476
   Bouras EP, 2001, GASTROENTEROLOGY, V120, P354, DOI 10.1053/gast.2001.21166
   Braden B, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2008.01249.x
   Camilleri M, 2011, AM J GASTROENTEROL, V106, P835, DOI 10.1038/ajg.2011.30
   CANN PA, 1984, DIGEST DIS SCI, V29, P239, DOI 10.1007/BF01296258
   Cappello C, 2013, INT J COLORECTAL DIS, V28, P349, DOI 10.1007/s00384-012-1552-1
   Chapman M, 2003, INTENS CARE MED, V29, P1169, DOI 10.1007/s00134-003-1803-2
   Chapman MJ, 2013, CURR OPIN CLIN NUTR, V16, P209, DOI 10.1097/MCO.0b013e32835c1fa5
   Chapman MJ, 2000, CRIT CARE MED, V28, P2334, DOI 10.1097/00003246-200007000-00026
   Choung RS, 2014, NEUROGASTROENT MOTIL, V26, P13, DOI 10.1111/nmo.12214
   Deane AM, 2009, CRIT CARE RESUSC, V11, P132
   Deitch EA, 2006, FRONT BIOSCI, V11, P520, DOI 10.2741/1816
   Deng G, 2013, ANN SURG ONCOL, V20, P1164, DOI 10.1245/s10434-012-2759-7
   DIVE A, 1995, CRIT CARE MED, V23, P1356, DOI 10.1097/00003246-199508000-00008
   Dvir D, 2006, CLIN NUTR, V25, P37, DOI 10.1016/j.clnu.2005.10.010
   Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864
   Ejskjaer N, 2013, NEUROGASTROENT MOTIL, V25, pE140, DOI 10.1111/nmo.12064
   Foschi D, 2008, DIGEST LIVER DIS, V40, P667, DOI 10.1016/j.dld.2008.02.040
   Fraser RJL, 2010, NUTR CLIN PRACT, V25, P26, DOI 10.1177/0884533609357570
   FRISELL J, 1985, ACTA CHIR SCAND, V151, P557
   Galligan JJ, 2005, NEUROGASTROENT MOTIL, V17, P643, DOI 10.1111/j.1365-2982.2005.00675.x
   Gui D, 2006, ALIMENT PHARM THER, V23, P675, DOI 10.1111/j.1365-2036.2006.02773.x
   Harvey KP, 2009, AM J SURG, V198, P231, DOI 10.1016/j.amjsurg.2008.10.015
   Herbert MK, 2008, CLIN NUTR, V27, P25, DOI 10.1016/j.clnu.2007.08.001
   Herzog T, 2011, INT J COLORECTAL DIS, V26, P645, DOI 10.1007/s00384-010-1092-5
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Hill LT, 2013, SOUTH AFR J CRIT CAR, V29, P11, DOI 10.7196/SAJCC.148
   Kar P, 2014, CLIN NUTR, P557
   Kastrup M, 2004, ACTA ANAESTH SCAND, V51, P347
   Kollmar O, 2008, EJSO-EUR J SURG ONC, V34, P868, DOI 10.1016/j.ejso.2008.01.014
   Koskenpato J, 2008, DIGEST DIS SCI, V53, P352, DOI 10.1007/s10620-007-9898-x
   Landzinski J, 2007, JPEN, V32, P45
   Lee CT, 2014, EUR UROL, V66, P265, DOI 10.1016/j.eururo.2014.02.036
   Lu WZ, 2009, DIGEST DIS SCI, V54, P1087, DOI 10.1007/s10620-008-0463-z
   Ma JM, 2016, NUTR CLIN PRACT, V31, P99, DOI 10.1177/0884533615603967
   MANSI C, 1995, AM J GASTROENTEROL, V90, P1989
   MARSHALL JC, 1993, ANN SURG, V218, P111, DOI 10.1097/00000658-199308000-00001
   McCallum RW, 2013, NEUROGASTROENT MOTIL, V25, pE705, DOI 10.1111/nmo.12184
   McKenzie SJL, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.20
   Melga P, 1997, DIABETES CARE, V20, P55, DOI 10.2337/diacare.20.1.55
   Mentec H, 2001, CRIT CARE MED, V29, P1955, DOI 10.1097/00003246-200110000-00018
   Nathens AB, 2004, CRIT CARE MED, V32, P2524, DOI 10.1097/01.CCM.0000148222.09869.92
   PASSARETTI S, 1989, ALIMENT PHARM THERAP, V3, P267
   Petrov MS, 2008, ALIMENT PHARM THER, V28, P704, DOI 10.1111/j.1365-2036.2008.03786.x
   Petrov MS, 2013, CURR OPIN CLIN NUTR, V16, P557, DOI 10.1097/MCO.0b013e3283638ed1
   Rogha Mehran, 2014, Gastroenterol Hepatol Bed Bench, V7, P156
   Schiller Lawrence R, 2004, Rev Gastroenterol Disord, V4 Suppl 2, pS43
   Setchell KDR, 2013, DIABETES CARE, V36, P3495, DOI 10.2337/dc12-1615
   Shimizu K, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01653.x
   Smith AJ, 2000, DIS COLON RECTUM, V43, P333, DOI 10.1007/BF02258298
   Stevens JE, 2008, NEUROGASTROENT MOTIL, V20, P456, DOI 10.1111/j.1365-2982.2007.01058.x
   Tack J, 2005, ALIMENT PHARM THER, V22, P847, DOI 10.1111/j.1365-2036.2005.02658.x
   Taghavi SA, 2010, INT J COLORECTAL DIS, V25, P389, DOI 10.1007/s00384-009-0794-z
   Nguyen T, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.12.003
   Ukleja A, 2010, NUTR CLIN PRACT, V25, P16, DOI 10.1177/0884533609357568
   Varadhan KK, 2010, CRIT CARE CLIN, V26, P527, DOI 10.1016/j.ccc.2010.04.003
   Vella A, 2002, NEUROGASTROENT MOTIL, V14, P123, DOI 10.1046/j.1365-2982.2002.00311.x
   Waseem S, 2009, WORLD J GASTROENTERO, V15, P25, DOI 10.3748/wjg.15.25
   Wu LM, 2014, BRIT J SURG, V101, P1644, DOI 10.1002/bjs.9665
   Wu TZ, 2013, DIABETES CARE, V36, P1913, DOI 10.2337/dc12-2294
   Yeh DD, 2016, JPEN-PARENTER ENTER, V40, P37, DOI 10.1177/0148607115585142
   Yoon JS, 2014, J GASTROEN HEPATOL, V29, P52, DOI 10.1111/jgh.12322
   Zingg U, 2008, INT J COLORECTAL DIS, V23, P1175, DOI 10.1007/s00384-008-0536-7
NR 72
TC 2
Z9 2
U1 3
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD FEB
PY 2016
VL 95
IS 5
AR UNSP e2463
DI 10.1097/MD.0000000000002463
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA DE2YS
UT WOS:000370494500001
PM 26844455
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Liu, J
   Sheng, ZX
   Zhang, YX
   Li, GX
AF Liu, Jin
   Sheng, Zhixin
   Zhang, Yanxia
   Li, Guixin
TI RETRACTED: The Efficacy of Epidermal Growth Factor Receptor Tyrosine
   Kinase Inhibitors for Molecularly Selected Patients with Non-Small Cell
   Lung Cancer: A Meta-Analysis of 30 Randomized Controlled
   Trials(Retracted article. See vol.11,pg.837,2016)
SO TARGETED ONCOLOGY
LA English
DT Article; Retracted Publication
ID PHASE-III TRIAL; WILD-TYPE EGFR; 2ND-LINE TREATMENT; OPEN-LABEL;
   1ST-LINE TREATMENT; CARBOPLATIN-PACLITAXEL; MAINTENANCE THERAPY;
   CLINICAL-TRIALS; DOUBLE-BLIND; ERLOTINIB
AB To determine the efficacy of first-generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in molecularly selected patients with advanced non-small cell lung cancer (NSCLC), we performed this pooled analysis.
   Randomized trials of EGFR-TKIs as treatment for advanced NSCLC were included for this meta-analysis. We used published hazard ratios (HRs), if available, or derived treatment estimates from other survival data. Pooled estimates of treatment efficacy of EGFR-TKIs in the selected patients by EGFR-mutation status were calculated.
   Out of 2134 retrieved articles, 30 randomized controlled trials (RCTs) enrolling more than 4053 patients with wild-type EGFR tumors and 1592 patients with mutant EGFR tumors were identified. For EGFR mutant patients, EGFR-TKIs treatment improved progression-free survival (PFS) compared with chemotherapy: the summary HRs were 0.41 (p < 0.00001) for the first-line setting and 0.46 (p = 0.02) for second/third-line setting, respectively. Also, the same superior trend was found with TKIs maintenance over placebo (HR = 0.14, p < 0.00001) and with TKIs combined with chemotherapy over chemotherapy (HR = 0.49, p = .002) in both the first-line and maintenance therapy settings. For EGFR wild-type patients, EGFR-TKIs have fared worse than chemotherapy in the first-line setting (HR = 1.65, p = .03) and in the second/third-line setting (HR = 1.27, p = .005). However, EGFR-TKIs maintenance still produced a reduction of 19 % in the risk of progression over placebo (HR = 0.81, p = .02). Furthermore, EGFR-TKIs added to chemotherapy as first-line treatment resulted in an improvement of PFS over chemotherapy alone in such wild-type EGFR patients (HR = 0.82, p = .03). In overall survival (OS) analysis, only EGFR-TKIs single agent was inferior to chemotherapy in EGFR wild-type patients (HR = 1.13, p = .02). No statistically significant difference in terms of OS was observed in any other subgroup analysis.
   For EGFR mutant patients, EGFR-TKIs therapy produced a prominent PFS benefit in all settings. Among EGFR wild-type patients, EGFR-TKIs were inferior to chemotherapy both for first-line treatment and for second/third-line treatment. However, EGFR-TKIs maintenance and addition of EGFR-TKIs to chemotherapy could provide additive benefit over chemotherapy alone in such EGFR wild-type patients.
C1 [Liu, Jin] Shandong Univ, Jinan 250100, Shandong, Peoples R China.
   [Sheng, Zhixin] Weifang Peoples Hosp, Dept Hematol, Weifang, Peoples R China.
   [Zhang, Yanxia] Lin Yi Peoples Hosp, Dept Oncol, Linyi 276003, Peoples R China.
   [Li, Guixin] Weifang Med Univ, Dept Oncol, Weifang, Shandong, Peoples R China.
RP Li, GX (reprint author), Weifang Med Univ, Dept Oncol, Weifang, Shandong, Peoples R China.
EM shengzhixin5569@163.com
CR Alimujiang S, 2013, ASIAN PAC J CANCER P, V14, P2413, DOI 10.7314/APJCP.2013.14.4.2413
   Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622
   Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078
   Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8
   Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1
   Chen YM, 2012, J THORAC ONCOL, V7, P412, DOI 10.1097/JTO.0b013e31823a39e8
   Ciardiello F, 2000, CLIN CANCER RES, V6, P2053
   Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0
   Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5
   Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030
   Ettinger DS, 2012, J NATL COMPR CANC NE, V10, P1236, DOI 10.6004/jnccn.2012.0130
   Fidias PM, 2009, J CLIN ONCOL, V27, P591, DOI 10.1200/JCO.2008.17.1405
   Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235
   Garassino MC, 2013, LANCET ONCOL, V14, P981, DOI 10.1016/S1470-2045(13)70310-3
   Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474
   Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001
   Gregorc V, 2014, LANCET ONCOL, V15, P713, DOI 10.1016/S1470-2045(14)70162-7
   Gridelli C, 2012, J CLIN ONCOL, V30, P3002, DOI 10.1200/JCO.2011.41.2056
   Han JY, 2012, J CLIN ONCOL, V30, P1122, DOI 10.1200/JCO.2011.36.8456
   Heigener DF, 2014, LUNG CANCER, V84, P62, DOI 10.1016/j.lungcan.2014.01.024
   Herbst RS, 2004, J CLIN ONCOL, V22, P785, DOI 10.1200/JCO.2004.07.215
   Herbst RS, 2005, J CLIN ONCOL, V23, P5892, DOI 10.1200/JCO.2005.02.840
   Hirsch FR, 2009, LANCET ONCOL, V10, P432, DOI 10.1016/S1470-2045(09)70110-X
   Inoue A, 2013, ANN ONCOL, V24, P54, DOI 10.1093/annonc/mds214
   Janne PA, 2012, J CLIN ONCOL, V30, P2063, DOI 10.1200/JCO.2011.40.1315
   Johnson BE, 2013, J CLIN ONCOL, V31, P3926, DOI 10.1200/JCO.2012.47.3983
   Karampeazis A, 2013, CANCER-AM CANCER SOC, V119, P2754, DOI 10.1002/cncr.28132
   Kawaguchi T, 2014, J CLIN ONCOL, V32, P1902, DOI 10.1200/JCO.2013.52.4694
   Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4
   Laurie SA, 2013, J CLIN ONCOL, V31, P1061, DOI 10.1200/JCO.2012.43.4522
   Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072
   Lee JK, 2014, JAMA-J AM MED ASSOC, V311, P1430, DOI 10.1001/jama.2014.3314
   Lee SM, 2012, LANCET ONCOL, V13, P1161, DOI 10.1016/S1470-2045(12)70412-6
   Li N, 2014, CANCER-AM CANCER SOC, V120, P1379, DOI 10.1002/cncr.28591
   Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938
   Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530
   Maruyama R, 2008, J CLIN ONCOL, V26, P4244, DOI 10.1200/JCO.2007.15.0185
   Mitsudomi T, 2012, J CLIN ONCOL, V30
   Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X
   Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699
   Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314
   Park K, 2006, CURR MED RES OPIN, V22, P561, DOI 10.1185/030079906X89847
   Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8
   Perol M, 2012, J CLIN ONCOL, V30, P3516, DOI 10.1200/JCO.2011.39.9782
   Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X
   Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753
   Sirotnak FM, 2000, CLIN CANCER RES, V6, P4885
   Sun JM, 2012, CANCER-AM CANCER SOC, V118, P6234, DOI 10.1002/cncr.27630
   Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8
   Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16
   Zhang L, 2012, LANCET ONCOL, V13, P466, DOI 10.1016/S1470-2045(12)70117-1
   Zhao N, 2014, LUNG CANCER, V85, P66, DOI 10.1016/j.lungcan.2014.03.026
   Zhou C, 2012, J CLIN ONCOL S, V30
   Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X
   Zhou Q, 2014, ANN ONCOL, V25, P2385, DOI 10.1093/annonc/mdu463
   Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924
NR 56
TC 7
Z9 7
U1 2
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1776-2596
EI 1776-260X
J9 TARGET ONCOL
JI Target. Oncol.
PD FEB
PY 2016
VL 11
IS 1
BP 49
EP 58
DI 10.1007/s11523-015-0376-7
PG 10
WC Oncology
SC Oncology
GA DE7EZ
UT WOS:000370799400005
PM 26206590
DA 2018-12-27
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI RETRACTED: Discovery of a novel inhibitory mechanism of kaempferol on
   TGF-beta ligand-receptor interaction by single-molecule techniques
   (Retracted Article)
SO BIOTECHNOLOGY LETTERS
LA English
DT Correction; Retracted Publication
CR YANG Y, 2011, BIOTECHNOL LETT, DOI DOI 10.1039/C1CC10778J
NR 1
TC 0
Z9 0
U1 2
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
EI 1573-6776
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD FEB
PY 2016
VL 38
IS 2
BP 367
EP 367
DI 10.1007/s10529-015-1959-1
PG 1
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA DE1GG
UT WOS:000370374300022
OA Bronze
DA 2018-12-27
ER

PT J
AU Cui, LB
   Li, BW
   Liang, C
   Dong, Z
   Chen, P
   Zhao, CR
   Liu, YC
   Zheng, LL
   Chen, SB
   Xu, J
   Jin, XH
   Shi, J
AF Cui, Long-Biao
   Li, Bo-Wei
   Liang, Chen
   Dong, Zheng
   Chen, Peng
   Zhao, Chun-Rong
   Liu, Yun-Chao
   Zheng, Long-Long
   Chen, Si-Bo
   Xu, Jie
   Jin, Xiao-Hang
   Shi, Juan
TI RETRACTED: Morphological Identification of TRPC7 in Cardiomyocytes From
   Normal and Renovascular Hypertensive Rats (Retracted article. See vol.
   68, pg. 96, 2016)
SO JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
LA English
DT Article; Retracted Publication
DE cardiomyocyte; cardiac hypertrophy; hypertension; transient receptor
   potential canonical 7; angiotensin II
ID PROTEIN-KINASE-C; PATHOLOGICAL CARDIAC-HYPERTROPHY; RECEPTOR POTENTIAL
   CHANNELS; AXIAL TUBULAR SYSTEM; TRANSIENT RECEPTOR; HEART-FAILURE;
   VENTRICULAR MYOCYTES; SMALL-MOLECULE; ACTIVATION; CALCIUM
AB Objective:
   We aimed to investigate the expression characteristics of transient receptor potential canonical 7 (TRPC7) in normal and hypertrophic cardiac myocytes.
   Methods:
   The 2-kidney 1-clip (2K1C) method was used to induce renovascular hypertension. Losartan, the potent inhibitor of angiotensin II (Ang II) receptor, was applied to the drinking water of 2K1C rats to inhibit Ang II-mediated responses. TRPC7 expression was examined by immunohisto/cytochemistry and Western blot analyses in normal and hypertrophic hearts. The expression level of protein kinase C (PKC), a negative regulator of TRPC7 channel in in vitro study, was also evaluated.
   Results:
   In normal rat ventricles, strong TRPC7 immunoreactivity was distributed in the surface sarcolemma of cardiomyocytes, and a moderate but striated TRPC7 immunoreactivity was also detected in the subcellular regions. The 2K1C operation caused significant hypertension and cardiac hypertrophy as demonstrated by respective biophysical or biochemical assays. At this stage, expression of TRPC7 was significantly downregulated at both tissue and cell levels, whereas that of PKC was upregulated. Further analysis revealed a negative correlation between TRPC7 and PKC expression patterns. Oral application of losartan ameliorated the extent of experimentally induced hypertension and cardiac hypertrophy. Simultaneously, it effectively reversed the downregulation of TRPC7 and mildly antagonized the upregulation of PKC.
   Conclusions:
   Taken together, these results for the first time show that TRPC7 localizes in the surface and tubular sarcolemma of cardiomyocytes in normal adult rats and its expression significantly decreases in hypertrophied cardiomyocytes from renovascular hypertensive rats. TRPC7 may thus play a significant role in normal physiological settings in the heart.
C1 [Cui, Long-Biao; Li, Bo-Wei; Liang, Chen; Dong, Zheng; Chen, Peng; Jin, Xiao-Hang; Shi, Juan] Fourth Mil Med Univ, Xijing Hosp, Dept Human Anat Histol & Embryol, Xian 710032, Peoples R China.
   [Cui, Long-Biao] Fourth Mil Med Univ, Xijing Hosp, Dept Radiol, Xian 710032, Peoples R China.
   [Li, Bo-Wei; Liu, Yun-Chao; Zheng, Long-Long; Chen, Si-Bo; Xu, Jie] Fourth Mil Med Univ, Div Grad, Xian 710032, Peoples R China.
   [Zhao, Chun-Rong] Changsha Cent Hosp, Dept Ultrasound, Changsha, Hunan, Peoples R China.
RP Jin, XH; Shi, J (reprint author), Fourth Mil Med Univ, Dept Human Anat Histol & Embryol, 169 West Changle Rd, Xian 710032, Peoples R China.
EM jinxh@fmmu.edu.cn; shixjuan@fmmu.edu.cn
FU Natural Science Basic Research Plan in Shaanxi Province of China
   [2014JZ2-004]; National Natural Science Foundation of China [31071012,
   30871004]
FX Supported by Natural Science Basic Research Plan in Shaanxi Province of
   China (No. 2014JZ2-004) and National Natural Science Foundation of China
   (No. 31071012 and 30871004).
CR Bae S, 2011, CARDIOVASC RES, V91, P632, DOI 10.1093/cvr/cvr133
   Belin RJ, 2007, CIRC RES, V101, P195, DOI 10.1161/CIRCRESAHA.107.148288
   Bon RS, 2013, BRIT J PHARMACOL, V170, P459, DOI 10.1111/bph.12274
   Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000
   Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200
   Chang H, 2011, J CELL BIOCHEM, V112, P571, DOI 10.1002/jcb.22947
   Cui LB, 2010, NEUROSCI BULL, V26, P381, DOI 10.1007/s12264-010-0410-9
   Dietrich A, 2014, HANDB EXP PHARMACOL, V222, P157, DOI 10.1007/978-3-642-54215-2_7
   Dyachenko V, 2009, CELL CALCIUM, V45, P38, DOI 10.1016/j.ceca.2008.06.003
   Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888
   Friedrich O, 2012, PROG BIOPHYS MOL BIO, V110, P226, DOI 10.1016/j.pbiomolbio.2012.08.009
   Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200
   Goel M, 2007, AM J PHYSIOL-HEART C, V292, pH874, DOI 10.1152/ajpheart.00785.2006
   Huang H, 2009, EUR J HISTOCHEM, V53, P217, DOI 10.4081/ejh.2009.e26
   Inoue R, 2009, PHARMACOL THERAPEUT, V123, P371, DOI 10.1016/j.pharmthera.2009.05.009
   Jiang Y, 2014, CELL TISSUE RES, V355, P201, DOI 10.1007/s00441-013-1733-4
   Katayama IA, 2014, J NUTR, V144, P1571, DOI 10.3945/jn.114.192054
   Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702
   Kwan HY, 2006, J CELL PHYSIOL, V207, P315, DOI 10.1002/jcp.20567
   Mohl MC, 2011, CARDIOVASC RES, V91, P310, DOI 10.1093/cvr/cvr081
   Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com
   Niizeki T, 2008, AM J PHYSIOL-HEART C, V295, pH245, DOI 10.1152/ajpheart.00066.2008
   Nishida M, 2008, N-S ARCH PHARMACOL, V378, P395, DOI 10.1007/s00210-008-0321-8
   Ohba T, 2007, J MOL CELL CARDIOL, V42, P498, DOI 10.1016/j.yjmcc.2006.10.020
   Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359
   Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417
   Oparil S, 2013, HYPERTENSION, V61, P977, DOI 10.1161/HYPERTENSIONAHA.111.00213
   Pinto YM, 1998, CARDIOVASC RES, V39, P77, DOI 10.1016/S0008-6363(98)00077-7
   Sacconi L, 2012, P NATL ACAD SCI USA, V109, P5815, DOI 10.1073/pnas.1120188109
   Satoh S, 2007, MOL CELL BIOCHEM, V294, P205, DOI 10.1007/s11010-006-9261-0
   Seo K, 2014, P NATL ACAD SCI USA, V111, P1551, DOI 10.1073/pnas.1308963111
   Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581
   Shi J, 2004, J PHYSIOL-LONDON, V561, P415, DOI 10.1113/jphysiol.2004.075051
   Stiber JA, 2012, CURR HYPERTENS REP, V14, P492, DOI 10.1007/s11906-012-0313-4
   Trebak M, 2005, MOL PHARMACOL, V67, P558, DOI 10.1124/mol.104.007252
   Ward ML, 2008, PROG BIOPHYS MOL BIO, V97, P232, DOI 10.1016/j.pbiomolbio.2008.02.009
   Watanabe H, 2009, CIRC J, V73, P419, DOI 10.1253/circj.CJ-08-1153
   Wehrens XHT, 2005, ANNU REV PHYSIOL, V67, P69, DOI 10.1146/annurev.physiol.67.040403.114521
   Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107
   Zhang J, 2014, INT J CANCER, V134, P606, DOI 10.1002/ijc.28394
NR 40
TC 3
Z9 4
U1 1
U2 12
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0160-2446
EI 1533-4023
J9 J CARDIOVASC PHARM
JI J. Cardiovasc. Pharmacol.
PD FEB
PY 2016
VL 67
IS 2
BP 121
EP 128
DI 10.1097/FJC.0000000000000321
PG 8
WC Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy
SC Cardiovascular System & Cardiology; Pharmacology & Pharmacy
GA DE3RP
UT WOS:000370548000003
PM 26371949
DA 2018-12-27
ER

PT J
AU Wei, CJ
   Zhang, F
   Chen, L
   Ma, XF
   Zhang, N
   Hao, JW
AF Wei, Changjuan
   Zhang, Fang
   Chen, Li
   Ma, Xiaofeng
   Zhang, Nan
   Hao, Junwei
TI RETRACTED: Factors associated with post-stroke depression and fatigue:
   lesion location and coping styles (Retracted article. See vol. 265, pg.
   451, 2018)
SO JOURNAL OF NEUROLOGY
LA English
DT Article; Retracted Publication
DE Post-stroke depression; Post-stroke fatigue; Coping styles; Lesion
   location
ID STROKE PATIENTS; EMOTIONAL INCONTINENCE; RISK-FACTORS; FOLLOW-UP;
   HEALTH; STRATEGIES; DOPAMINE; SYMPTOMS
AB Post-stroke depression (PSD) and post-stroke fatigue (PSF) are frequent and persistent problems among stroke survivors. Therefore, awareness of signs and symptoms of PSD and PSF is important for their treatment and recovery from stroke. Additionally, since sudden serious illness can result in disequilibrium, early institution of a coping process is essential to restoring stability. The brain damage of stroke leaves patients with unique physical and mental dysfunctions for which coping maybe a key resource while rebuilding lives. We evaluated 368 consecutive patients with acute ischemic stroke for post-stroke emotional disorders at admission and 3 months later. PSD was evaluated by using the Beck Depression Inventory, and PSF was scored with the Fatigue Severity Scale. The Social Support Rating Scale and Medical Coping Modes Questionnaire were also used as measurement tools. Locations of lesions were based on MRI. Those scans revealed infarcts located in the basal ganglia, corona radiate and internal capsule and constituted the independent factors associated with PSF 3 months after stroke occurrence. Conversely, PSD was not related to lesion location. Acceptance-resignation related to PSD and PSF both at admission and 3 months after stroke. Avoidance was the independent factor most closely related to PSD, whereas confrontation was the independent factor best related to PSF at 3 months after stroke onset.
C1 [Wei, Changjuan; Zhang, Fang; Chen, Li; Ma, Xiaofeng; Zhang, Nan; Hao, Junwei] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China.
   [Wei, Changjuan; Zhang, Fang; Chen, Li; Ma, Xiaofeng; Zhang, Nan; Hao, Junwei] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China.
RP Hao, JW (reprint author), Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China.; Hao, JW (reprint author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China.
EM hjw@tijmu.edu.cn
OI Ma, Xiaofeng/0000-0001-7032-4033
FU National Natural Science Foundation of China [81100887, 81273287];
   National Key Clinical Specialty Construction Project of China
FX We thank our patients for participating this study; Drs. C. Chen, M.
   Xing for facilitating recruitment of the patients; Dr. C. Zhang for
   advice; Drs. R. Xue for technical support. This work was financially
   supported by the National Natural Science Foundation of China (81100887
   and 81273287 to Junwei Hao) and the National Key Clinical Specialty
   Construction Project of China.
CR Abudi S, 1997, J ADV NURS, V25, P54, DOI 10.1046/j.1365-2648.1997.1997025054.x
   [Anonymous], 2004, Indian J Med Sci, V58, P405
   ASTROM M, 1993, STROKE, V24, P976, DOI 10.1161/01.STR.24.7.976
   BISHOP GA, 1985, BRAIN RES, V331, P195, DOI 10.1016/0006-8993(85)91545-8
   Brodtmann A, 2013, NEUROLOGY, V81, P1566, DOI 10.1212/WNL.0b013e3182a9f59b
   Carlsson GE, 2003, CEREBROVASC DIS, V16, P383, DOI 10.1159/000072561
   Chen SX, 2008, J PRACT TRADIT CHIN, V22, P17
   Chen YK, 2015, INT J STROKE, V10, P506, DOI 10.1111/ijs.12409
   Choi-Kwon S, 2005, CEREBROVASC DIS, V19, P84, DOI 10.1159/000082784
   Choi-Kwon S, 2012, NEUROLOGY, V78, P1130, DOI 10.1212/WNL.0b013e31824f8090
   De Ryck A, 2014, J GERIATR PSYCH NEUR, V27, P147, DOI 10.1177/0891988714527514
   Donnellan C, 2006, J NEUROL NEUROSUR PS, V77, P1208, DOI 10.1136/jnnp.2005.085670
   FEIFEL H, 1987, PSYCHOSOM MED, V49, P616, DOI 10.1097/00006842-198711000-00007
   FOLKMAN S, 1986, J PERS SOC PSYCHOL, V50, P571, DOI 10.1037/0022-3514.50.3.571
   FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
   Glader EL, 2002, STROKE, V33, P1327, DOI 10.1161/01.STR.0000014248.28711.D6
   Hori H, 2014, J AFFECT DISORDERS, V152, P441, DOI 10.1016/j.jad.2013.10.013
   Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004
   Ikemoto S, 2015, BEHAV BRAIN RES, V290, P17, DOI 10.1016/j.bbr.2015.04.018
   Lakey B, 2011, PSYCHOL REV, V118, P482, DOI 10.1037/a0023477
   Li M, 2015, INT J CARDIOL, V180, P103, DOI 10.1016/j.ijcard.2014.11.198
   MOHSENIN V, 1995, ARCH PHYS MED REHAB, V76, P71, DOI 10.1016/S0003-9993(95)80046-8
   Moos R, 1977, COPING PHYSICAL ILLN, P3, DOI [10.1007/978-1-4615-9089-7_1, DOI 10.1007/978-1-4615-9089-7_1]
   Pompili M, 2012, CNS NEUROSCI THER, V18, P711, DOI 10.1111/j.1755-5949.2012.00364.x
   Richard PO, 2015, BJU INT, V116, P744, DOI 10.1111/bju.12755
   SCHWARTZ JE, 1993, J PSYCHOSOM RES, V37, P753, DOI 10.1016/0022-3999(93)90104-N
   SHEK DTL, 1990, J CLIN PSYCHOL, V46, P35, DOI 10.1002/1097-4679(199001)46:1<35::AID-JCLP2270460106>3.0.CO;2-W
   Smi CK, 2006, STROKE, V37, P156, DOI 10.1161/01.STR.0000190892.93663.e2
   Tang WK, 2010, J NEUROL, V257, P178, DOI 10.1007/s00415-009-5284-2
   Wang XD, 1999, CHINESE MENTAL HLTH, P250, DOI DOI 10.1111/J.1365-2230.2010.03831.X
   Xiao S. Y., 1994, J CLIN PSYCHIAT, V2, P98, DOI DOI 10.1002/DDRR.101
NR 31
TC 17
Z9 21
U1 6
U2 29
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
PD FEB
PY 2016
VL 263
IS 2
BP 269
EP 276
DI 10.1007/s00415-015-7958-2
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA DD9UB
UT WOS:000370270100010
PM 26568559
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Ahmad, T
AF Ahmad, Tanveer
TI RETRACTED: A hybrid grid connected PV battery energy storage system with
   power quality improvement (Retracted Article. See vol 139, pg A1, 2016)
SO SOLAR ENERGY
LA English
DT Article; Retracted Publication
DE Battery; Dynamic energy management; Photovoltaic (PV) system;
   Small-signal models; Supercapacitor
ID DC-DC CONVERTERS; GENERATION; MANAGEMENT
AB In this paper, fast acting dc-link voltage-based energy management schemes are proposed for a hybrid energy storage system fed by solar photovoltaic (PV) energy. Fast dc-link voltage, effective energy management, and reduced current stress on battery are the main features achieved from the proposed control schemes. The main features obtained from the proposed control schemes are tight dc-link voltage regulation, effective power management at the dc-link, allows current limits for both the battery and the supercapacitor. The effectiveness of the proposed control schemes are compared with the unified cascaded control. Using the proposed control schemes, quick fluctuations of load are supplied by the super capacitors and the average load demand is controlled by the batteries. Small-signal control gains are formulated to design the voltage and current loops of the proposed energy management schemes. Detailed stability analysis is also presented to find the boundary values of compensator gains. In addition, a high-gain PV converter is proposed for extraction of maximum power from the solar panels. High voltage gain, reduced reverse recovery of diodes, and less duty cycle operation are the key features obtained from the proposed high-gain converter. The validity of the proposed energy management schemes with high gain converter is verified by the detailed simulation and experimental studies. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Ahmad, Tanveer] Comsats Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan.
RP Ahmad, T (reprint author), Comsats Inst Informat Technol, Dept Elect Engn, Islamabad, Pakistan.
EM tanveer1_ahmed@yahoo.com
CR Al-Saffar MA, 2015, RENEW ENERG, V82, P35, DOI 10.1016/j.renene.2014.08.020
   Alamir M, 2014, APPL ENERG, V118, P192, DOI 10.1016/j.apenergy.2013.12.044
   Changchien SK, 2010, IEEE T IND ELECTRON, V57, P2007, DOI 10.1109/TIE.2009.2026364
   Datta A, 2014, SUSTAIN ENERGY TECHN, V7, P111, DOI 10.1016/j.seta.2014.04.003
   Duong M. B., 2015, ELECTR POW SYST RES, V120, P214
   Fazia B., 2015, ENERG CONVERS MANAGE, V105, P471
   Guo ZQ, 2014, IEEE T POWER ELECTR, V29, P5081, DOI 10.1109/TPEL.2014.2309342
   Hajizadeh A, 2010, IEEE T ENERGY CONVER, V25, P1195, DOI 10.1109/TEC.2010.2062516
   Hredzak B, 2015, J POWER SOURCES, V277, P84, DOI 10.1016/j.jpowsour.2014.11.148
   Jia HJ, 2014, INT J ELEC POWER, V54, P516, DOI 10.1016/j.ijepes.2013.07.025
   Jianwei L., 2015, ENERGY, V86, P175
   Kou P, 2015, RENEW ENERG, V80, P286, DOI 10.1016/j.renene.2015.02.001
   Melero-Perez A., 2009, P IEEE VEH POW PROP, P199
   Michael K., 2015, ELECTR POW SYST RES, V120, P128
   Mohamed A, 2012, IEEE T SMART GRID, V3, P1911, DOI 10.1109/TSG.2012.2200702
   Rizoug N, 2012, IEEE T ENERGY CONVER, V27, P220, DOI 10.1109/TEC.2012.2186814
   Sabzali AJ, 2015, RENEW ENERG, V82, P44, DOI 10.1016/j.renene.2014.08.034
   Senjyu T, 2009, IEEE T ENERGY CONVER, V24, P520, DOI 10.1109/TEC.2008.2001436
   Sharaf OZ, 2014, RENEW SUST ENERG REV, V32, P810, DOI 10.1016/j.rser.2014.01.012
   Solomon AA, 2014, APPL ENERG, V134, P75, DOI 10.1016/j.apenergy.2014.07.095
   Tofoli FL, 2012, IEEE T POWER ELECTR, V27, P3897, DOI 10.1109/TPEL.2012.2190943
   Xu L, 2011, IEEE T POWER DELIVER, V26, P2513, DOI 10.1109/TPWRD.2011.2158456
   Zlatina D., 2015, ENERGY, V91, P630
NR 23
TC 4
Z9 5
U1 1
U2 33
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0038-092X
J9 SOL ENERGY
JI Sol. Energy
PD FEB
PY 2016
VL 125
BP 180
EP 191
DI 10.1016/j.solener.2015.12.036
PG 12
WC Energy & Fuels
SC Energy & Fuels
GA DD7IS
UT WOS:000370097600016
DA 2018-12-27
ER

PT J
AU Ni, ZL
   Zhao, HJ
   Mi, PB
   Ye, FX
AF Ni, Zenglei
   Zhao, Hongjian
   Mi, Pengbo
   Ye, Fuxing
TI RETRACTED: Effect of sintering time on the bending strength and CTE of
   SiC/Al-35Si composite(Retracted article. See vol.141,pg.329,2017)
SO VACUUM
LA English
DT Article; Retracted Publication
DE Composite materials; Silicon phase; Sintering; Bending strength; CTE
ID MATRIX COMPOSITES; MECHANICAL-PROPERTIES; VOLUME FRACTION; SIC
   PARTICLES; ALLOY; MICROSTRUCTURE; BEHAVIOR
AB SiC/Al-35Si composite were prepared using a novel addition method of silicon particles. The effects of sintering time on the bending strength and CTE of the composite were investigated. The results showed that the optimal properties could be obtained when sintering time is 4 h. The prolongation of the sintering time increased the size of silicon phase and alpha-Al phase without solution strengthening of silicon, resulting in the increase of CTE. However, the increase of silicon phase size within a certain scope is beneficial to load transfer due to the formation of less pores and good bond interfaces. The bending strength first increases up to the maximum value and then trends to decrease. Overall, SiC/Al-35Si composite has a good combination of bending strength and CTE. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Ni, Zenglei; Zhao, Hongjian; Mi, Pengbo; Ye, Fuxing] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
RP Ni, ZL (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
EM zlni@tju.edu.cn
FU National Natural Science Foundation of China [51375332]; Natural Science
   Foundation of Tianjin [12JCYBJ12300]; Specialized Research Fund for the
   Doctoral Program of Higher Education [20120032110031]
FX This research was financially supported by the National Natural Science
   Foundation of China (No. 51375332), the Natural Science Foundation of
   Tianjin (No. 12JCYBJ12300) and the Specialized Research Fund for the
   Doctoral Program of Higher Education (No. 20120032110031).
CR Chawla N, 2006, MAT SCI ENG A-STRUCT, V426, P314, DOI 10.1016/j.msea.2006.04.054
   Chu K, 2009, MATER DESIGN, V30, P3497, DOI 10.1016/j.matdes.2009.03.009
   Diler EA, 2012, MAT SCI ENG A-STRUCT, V548, P43, DOI 10.1016/j.msea.2012.03.066
   Ghosh SK, 2011, MATER DESIGN, V32, P139, DOI 10.1016/j.matdes.2010.06.020
   Huber T, 2006, COMPOS SCI TECHNOL, V66, P2206, DOI 10.1016/j.compscitech.2005.12.012
   Kim YM, 2006, MAT SCI ENG A-STRUCT, V420, P8, DOI 10.1016/j.msea.2005.12.032
   Lee HS, 2001, J MATER PROCESS TECH, V113, P202, DOI 10.1016/S0924-0136(01)00680-X
   Nam TH, 2008, COMPOS PART A-APPL S, V39, P856, DOI 10.1016/j.compositesa.2008.01.011
   Ren SB, 2007, MAT SCI ENG B-SOLID, V138, P263, DOI 10.1016/j.mseb.2007.01.023
   Shi Z, 2002, APPL PHYS A-MATER, V74, P97, DOI 10.1007/s003390100844
   Wang ZW, 2010, MAT SCI ENG A-STRUCT, V527, P6537, DOI 10.1016/j.msea.2010.07.017
   Xue C, 2014, MATER DESIGN, V53, P74, DOI 10.1016/j.matdes.2013.06.056
   Yu K, 2012, T NONFERR METAL SOC, V22, P1412, DOI 10.1016/S1003-6326(11)61334-4
   Zhang QQ, 2006, MAT SCI ENG A-STRUCT, V419, P86, DOI 10.1016/j.msea.2005.11.050
   Zhang ZH, 2010, MAT SCI ENG A-STRUCT, V527, P7235, DOI 10.1016/j.msea.2010.07.043
NR 15
TC 3
Z9 3
U1 3
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0042-207X
J9 VACUUM
JI Vacuum
PD FEB
PY 2016
VL 124
BP 28
EP 31
DI 10.1016/j.vacuum.2015.11.013
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA DC4OO
UT WOS:000369200400005
DA 2018-12-27
ER

PT J
AU Stang, J
   Couto, M
   Stensrud, T
   Mowinckel, P
   Moreira, A
   Carlsen, KH
AF Stang, Julie
   Couto, Mariana
   Stensrud, Trine
   Mowinckel, Petter
   Moreira, Andre
   Carlsen, Kai-Hakon
TI RETRACTED: Assessment of Parasympathetic Activity in Athletes: Comparing
   Two Different Methods (Retracted article. See vol. 50, pg. 389, 2018)
SO MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
LA English
DT Article; Retracted Publication
DE BRONCHIAL VAGAL TONE; EXERCISE; ENDURANCE ATHLETES; HEART RATE
   VARIABILITY; IPRATROPIUM BROMIDE; PUPILLOMETRY
ID EXERCISE-INDUCED ASTHMA; CARDIAC VAGAL TONE; HEART-RATE; IPRATROPIUM
   BROMIDE; AIRWAY RESPONSE; ELITE SWIMMERS; HYPERRESPONSIVENESS;
   PUPILLOMETRY; ATROPINE
AB Introduction: A variety of methods are used to assess parasympathetic activity in athletes targeting different organs; however, the reliability of or interchangeability between measurement procedures is not clear. Objective: The purpose of this study is to identify the repeatability of two parasympathetic activity measurement procedures, the HR variability during a 4-s exercise test (4sET), and the contractile properties of the pupil (pupillometry), and to assess their agreement. The secondary objective of this study is to assess their relationship with the bronchodilating effect of inhaled ipratropium bromide (iIB), blocking parasympathetic signals to the lungs. Methods: Forty athletic subjects were enrolled in a cross-sectional study. After 15-min resting in semidarkness, subjects underwent pupillometry (PLR-200 (TM), NeurOptics Inc., CA), followed by 4sET on a cycle ergometer. HR variability was assessed by Polar Electro (R) HR monitor (RS-800CX/G3; Oy, Kempele, Finland). Both protocols were repeated after 5 min. Statistical analysis was performed according to Bland and Altman and by using Pearson's correlation coefficient and intraclass correlation. Lung function measurements by flow volume curves were performed before and 45 min after iIB. Results: The means of differences were 1.21% (limits of agreement, -3.59 to 6.02) for pupil constriction and 0.05 mm (-0.28 to 0.39) for pupil amplitude. The mean of differences for 4sET was 0.005 (-0.31 to 0.32). A very weak intraclass correlation (r = -0.01, P = 0.58) showed no agreement between the methods. No correlation was observed between pupillometry variables or 4sET with the change in lung function after iIB. Conclusion: Pupillometry showed better repeatability compared with the 4sET. There is poor agreement between parasympathetic activity levels measured in three different target organs of athletic subjects; the heart, the pupil, and the lung. Thus, methods assessing parasympathetic activity in different target organs cannot be used interchangeably.
C1 [Stang, Julie; Stensrud, Trine; Carlsen, Kai-Hakon] Norwegian Sch Sport Sci, Dept Sports Med, NO-0806 Oslo, Norway.
   [Couto, Mariana; Moreira, Andre] Univ Porto, Fac Med, Immunol Lab, Rua Campo Alegre 823, P-4100 Porto, Portugal.
   [Couto, Mariana; Moreira, Andre] Hosp & Inst CUF Porto, Allergy Unit, Porto, Portugal.
   [Mowinckel, Petter; Carlsen, Kai-Hakon] Oslo Univ Hosp, Dept Paediat, Oslo, Norway.
   [Mowinckel, Petter; Carlsen, Kai-Hakon] Univ Oslo, Fac Med, N-0316 Oslo, Norway.
RP Stang, J (reprint author), Norwegian Sch Sport Sci, Sognsveien 220,POB 4014 Ulleval Stadion, NO-0806 Oslo, Norway.
EM julie.stang@nih.no
RI Moreira, Andre/A-9504-2010
OI Moreira, Andre/0000-0002-7294-9296; Couto, Mariana/0000-0003-4987-9346
FU European Academy of Allergy and Clinical Immunology
FX The authors acknowledge the European Academy of Allergy and Clinical
   Immunology for the fellowship attributed to Mariana Couto, Professor
   Luis Delgado and Dr. Miguel Capao Filipe for their contribution in the
   critical discussion of the pupillometry protocol, Stian Roterud, M.Sc.,
   for his contribution as the second rater of the cardiac vagal index, and
   all the subjects who kindly agreed to be involved in this project.
CR Araujo C G, 1992, Clin Auton Res, V2, P35, DOI 10.1007/BF01824209
   Araujo CG, 2003, BRAZ J SPORTS MED, V9, P299
   ARAUJO CGS, 1989, BRAZ J MED BIOL RES, V22, P909
   Araujo CGS, 1994, MED SCI SPORTS EXERC, V26, P53
   Boev AN, 2005, J NEUROSURG, V103, P496, DOI 10.3171/ped.2005.103.6.0496
   Bougault V, 2010, CHEST, V138, p31S, DOI 10.1378/chest.09-1689
   Camm AJ, 1996, EUR HEART J, V17, P354
   Canning BJ, 2001, RESP PHYSIOL, V125, P113, DOI 10.1016/S0034-5687(00)00208-5
   Carlsen KH, 2008, ALLERGY, V63, P387, DOI 10.1111/j.1398-9995.2008.01662.x
   Carlsen KH, 2012, BRIT J SPORT MED, V46, P796, DOI 10.1136/bjsports-2012-091292
   Carter JB, 2003, SPORTS MED, V33, P33, DOI 10.2165/00007256-200333010-00003
   Couto M, 2015, REV PORT PNEUMOL, V21, P22, DOI 10.1016/j.rppnen.2014.05.004
   Barbosa MPDD, 2016, CLIN PHYSIOL FUNCT I, V36, P112, DOI 10.1111/cpf.12203
   DEAL EC, 1978, J APPL PHYSIOL, V45, P238
   DEJONGSTE JC, 1991, AM REV RESPIR DIS, V143, P1421, DOI 10.1164/ajrccm/143.6.1421
   Filipe JAC, 2003, AUTON NEUROSCI-BASIC, V104, P66, DOI 10.1016/S1566-0702(02)00268-0
   Goldsmith RL, 1997, MED SCI SPORT EXER, V29, P812, DOI 10.1097/00005768-199706000-00012
   Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014
   HORVATH I, 1995, CHEST, V108, P701, DOI 10.1378/chest.108.3.701
   Kaltsatou A, 2011, EUR J APPL PHYSIOL, V111, P2079, DOI 10.1007/s00421-011-1836-0
   Knopfli BH, 2005, MED SCI SPORT EXER, V37, P354, DOI 10.1249/01.MSS.0000155436.31581.90
   Knopfli BH, 1999, CLIN J SPORT MED, V9, P170
   Meeker Michele, 2005, J Neurosci Nurs, V37, P34
   Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805
   Moreira A, 2011, EXPERT REV RESP MED, V5, P1, DOI 10.1586/ERS.10.88
   Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205
   Pichon AL, 2005, CHEST, V127, P23, DOI 10.1378/chest.127.1.23
   QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693
   Stang J, 2015, BRIT J SPORT MED, V49, P56, DOI 10.1136/bjsports-2014-094053
NR 29
TC 4
Z9 5
U1 1
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0195-9131
EI 1530-0315
J9 MED SCI SPORT EXER
JI Med. Sci. Sports Exerc.
PD FEB
PY 2016
VL 48
IS 2
BP 316
EP 322
DI 10.1249/MSS.0000000000000769
PG 7
WC Sport Sciences
SC Sport Sciences
GA DB8JX
UT WOS:000368764100017
PM 26355246
DA 2018-12-27
ER

PT J
AU Whitfield, ST
   Burston, HE
   Bean, BDM
   Raghuram, N
   Maldonado-Baez, L
   Davey, M
   Wendland, B
   Conibear, E
AF Whitfield, Shawn T.
   Burston, Helen E.
   Bean, Bjoern D. M.
   Raghuram, Nandini
   Maldonado-Baez, Lymarie
   Davey, Michael
   Wendland, Beverly
   Conibear, Elizabeth
TI RETRACTED: The alternate AP-1 adaptor subunit Apm2 interacts with the
   Mil1 regulatory protein and confers differential cargo sorting
   (Retracted article. See vol. 27, pg. 2515, 2016)
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article; Retracted Publication
ID TRANS-GOLGI NETWORK; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; ER
   EXIT; QUANTITATIVE-ANALYSIS; FLUORESCENT PROTEIN; YEAST; CLATHRIN;
   COMPLEX; TRAFFICKING
AB Heterotetrameric adaptor protein complexes are important mediators of cargo protein sorting in clathrin-coated vesicles. The cell type-specific expression of alternate mu chains creates distinct forms of AP-1 with altered cargo sorting, but how these subunits confer differential function is unclear. Whereas some studies suggest the mu subunits specify localization to different cellular compartments, others find that the two forms of AP-1 are present in the same vesicle but recognize different cargo. Yeast have two forms of AP-1, which differ only in the mu chain. Here we show that the variant mu chain Apm2 confers distinct cargo-sorting functions. Loss of Apm2, but not of Apm1, increases cell surface levels of the v-SNARE Snc1. However, Apm2 is unable to replace Apm1 in sorting Chs3, which requires a dileucine motif recognized by the gamma/sigma subunits common to both complexes. Apm2 and Apm1 colocalize at Golgi/early endosomes, suggesting that they do not associate with distinct compartments. We identified a novel, conserved regulatory protein that is required for Apm2-dependent sorting events. Mil1 is a predicted lipase that binds Apm2 but not Apm1 and contributes to its membrane recruitment. Interactions with specific regulatory factors may provide a general mechanism to diversify the functional repertoire of clathrin adaptor complexes.
C1 [Whitfield, Shawn T.; Burston, Helen E.; Bean, Bjoern D. M.; Raghuram, Nandini; Davey, Michael; Conibear, Elizabeth] Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada.
   [Whitfield, Shawn T.; Burston, Helen E.; Bean, Bjoern D. M.; Conibear, Elizabeth] Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.
   [Whitfield, Shawn T.; Burston, Helen E.; Bean, Bjoern D. M.; Conibear, Elizabeth] Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada.
   [Maldonado-Baez, Lymarie; Wendland, Beverly] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.
RP Conibear, E (reprint author), Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada.; Conibear, E (reprint author), Univ British Columbia, Fac Med, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.; Conibear, E (reprint author), Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada.
EM conibear@cmmt.ubc.ca
OI Conibear, Elizabeth/0000-0001-5129-0499
FU Canadian Institutes of Health Research [64394]; Natural Sciences and
   Engineering Council of Canada [371618-09]; Canada Foundation for
   Innovation [7664, 30636]; National Institutes of Health [R01 GM-60979,
   NIGMS T32 007231]; Natural Sciences and Engineering Research Council of
   Canada Postgraduate Scholarship; Canada Graduate Scholarship; Ford
   Foundation Diversity Fellowship
FX We thank P. Morsomme and C. Slubowski for reagents and E. Perlstein for
   helpful discussions. This work was supported by funding from the
   Canadian Institutes of Health Research (64394 to E. C.), the Natural
   Sciences and Engineering Council of Canada (371618-09 to E. C.), the
   Canada Foundation for Innovation (7664 and 30636 to E. C.), and the
   National Institutes of Health (R01 GM-60979 and NIGMS T32 007231 to
   B.W.). Additional support was provided by Natural Sciences and
   Engineering Research Council of Canada Postgraduate Scholarship and
   Canada Graduate Scholarship awards (to H.E.B.) and a Ford Foundation
   Diversity Fellowship (to L.M.B.).
CR Babu M, 2012, NATURE, V489, P585, DOI 10.1038/nature11354
   Baxter SM, 2004, MOL CELL PROTEOMICS, V3, P209, DOI 10.1074/mcp.M300082-MCP200
   Bechler ME, 2012, TRENDS CELL BIOL, V22, P116, DOI 10.1016/j.tcb.2011.10.003
   Boll W, 2002, TRAFFIC, V3, P590, DOI 10.1034/j.1600-0854.2002.30808.x
   Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021
   Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015
   Burston HE, 2009, J CELL BIOL, V185, P1097, DOI 10.1083/jcb.200811116
   Burston Helen E., 2008, V457, P29, DOI 10.1007/978-1-59745-261-8_3
   Canagarajah BJ, 2013, PROTEIN SCI, V22, P517, DOI 10.1002/pro.2235
   Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649
   Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305
   Daboussi L, 2012, NAT CELL BIOL, V14, P239, DOI 10.1038/ncb2427
   Dalton Lauren, 2015, Methods Mol Biol, V1270, P395, DOI 10.1007/978-1-4939-2309-0_27
   Daniel JA, 2015, TRAFFIC, V16, P635, DOI 10.1111/tra.12272
   Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012
   Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Fields IC, 2010, MOL BIOL CELL, V21, P95, DOI 10.1091/mbc.E09-01-0036
   Folsch H, 2003, J CELL BIOL, V163, P351, DOI 10.1083/jcb.200309020
   Foote C, 2006, J CELL BIOL, V173, P615, DOI 10.1083/jcb.200510161
   Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532
   Guo XL, 2013, DEV CELL, V27, P353, DOI 10.1016/j.devcel.2013.10.006
   Ha KD, 2012, BBA-MOL CELL BIOL L, V1821, P1078, DOI 10.1016/j.bbalip.2012.04.004
   Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101
   Hirst J, 2013, TRAFFIC, V14, P153, DOI 10.1111/tra.12028
   Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004
   James P, 1996, GENETICS, V144, P1425
   Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142
   Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328
   Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3
   Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016
   Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2
   Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422
   Klinkenberg D, 2014, J CELL SCI, V127, P1765, DOI 10.1242/jcs.138784
   Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103
   Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Kunduri G, 2014, J CELL BIOL, V206, P79, DOI 10.1083/jcb.201405020
   Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049
   Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217
   Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154
   Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023
   Liu K, 2008, MOL BIOL CELL, V19, P3526, DOI 10.1091/mbc.E08-01-0025
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Mardones GA, 2013, J BIOL CHEM, V288, P9563, DOI 10.1074/jbc.M113.450775
   Mattera R, 2011, J BIOL CHEM, V286, P2022, DOI 10.1074/jbc.M110.197178
   Montpetit A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000296
   Nakatsu F, 2014, MEMBRANES, V4, P747, DOI 10.3390/membranes4040747
   Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014
   Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327
   Rainey MM, 2010, GENETICS, V185, P1221, DOI 10.1534/genetics.110.117846
   Ren XF, 2013, CELL, V152, P755, DOI 10.1016/j.cell.2012.12.042
   Renard HF, 2010, TRAFFIC, V11, P931, DOI 10.1111/j.1600-0854.2010.01070.x
   Rodriguez-Boulan E, 2013, DEV CELL, V27, P247, DOI 10.1016/j.devcel.2013.10.022
   Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x
   Setta-Kaffetzi N, 2014, AM J HUM GENET, V94, P790, DOI 10.1016/j.ajhg.2014.04.005
   Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130
   Slubowski CJ, 2015, YEAST, V32, P379, DOI 10.1002/yea.3065
   Starr TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046386
   STEPP JD, 1995, MOL BIOL CELL, V6, P41
   Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137
   Traub LM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016790
   Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2
   Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643
NR 64
TC 5
Z9 5
U1 2
U2 7
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD FEB 1
PY 2016
VL 27
IS 3
BP 588
EP 598
DI 10.1091/mbc.E15-09-0621
PG 11
WC Cell Biology
SC Cell Biology
GA DC3NY
UT WOS:000369127200014
PM 26658609
OA Green Published
DA 2018-12-27
ER

PT J
AU Assemi, B
   Schlagwein, D
AF Assemi, Behrang
   Schlagwein, Daniel
TI RETRACTED: Provider feedback information and customer choice decisions
   on crowdsourcing marketplaces: Evidence from two discrete choice
   experiments(Retracted article. See vol. 95, pg. 117, 2017) (Retracted
   article. See vol. 95, pg. 117, 2017)
SO DECISION SUPPORT SYSTEMS
LA English
DT Article; Retracted Publication
DE Crowdsourcing; Provider profile; Feedback information; Customer
   decision; Discrete choice experiment; Nested logit model
ID SIGNALING THEORY; PRODUCT REVIEWS; MECHANICAL TURK; ONLINE MARKETS;
   PRICE PREMIUMS; REPUTATION; TRUST; QUALITY; UNCERTAINTY; CHALLENGES
AB Crowdsourcing marketplaces are increasingly becoming popular for the online transactions of services. On these marketplaces, profile information of providers, especially feedback left by previous customers, is the main information source for choice decisions of prospective customers. In the study reported in this paper, we examined the impacts of various feedback information components on provider profiles on the decisions of customers. We conducted two fractional factorial discrete choice experiments, one in a controlled laboratory setting and one online on a crowdsourcing marketplace. We found that the feedback information components "number of reviews" and "average weighted rating" have the largest impacts on the decisions of customers. We also found that "positive ratings" and "positive comments" have significant impacts on customers' decision-making, especially when they appear on the first feedback page. We also found in the lack of highly visible feedback components on the subsequent feedback pages, "negative comments" become a significant determinant of customers' decisions. We also showed the significant impact of information consistency on customers' decision-making, through the synergistic interaction effects between different feedback components. Finally, we found evidence that the cost of evaluating a feedback information component has a negative impact on the likelihood of customers evaluating that information component. The article concludes with implications of the findings of the study for theory and practice. (C) 2015 Elsevier B.V. All rights reserved.
C1 [Assemi, Behrang; Schlagwein, Daniel] UNSW Australia Business Sch, Sydney, NSW, Australia.
   [Assemi, Behrang] Univ Queensland, Fac Engn Architecture & Informat Technol, Brisbane, Qld, Australia.
RP Assemi, B (reprint author), Univ Queensland, Fac Engn Architecture & Informat Technol, Brisbane, Qld, Australia.
EM b.assemi@unsw.edu.au; schlagwein@unsw.edu.au
RI Assemi, Behrang/A-5864-2016; Schlagwein, Daniel/N-4638-2018
OI Assemi, Behrang/0000-0003-2043-8782; Schlagwein,
   Daniel/0000-0002-1591-4660
FU UNSW Australia Business School [PS29546]
FX This research was supported by UNSW Australia Business School grant
   PS29546. The authors wish to express their appreciation and to
   acknowledge the valuable comments, feedback and support by Aybtike
   Aurum, Claes Wohlin, Fred Mannering and Simon Washington.
CR Ba SL, 2002, MIS QUART, V26, P243, DOI 10.2307/4132332
   Banker R., 2011, HAW INT C SYST SCI
   Banker RD, 2008, CONTEMP ACCOUNT RES, V25, P307, DOI 10.1506/car.25.2.1
   Chamodrakas I, 2010, EXPERT SYST APPL, V37, P490, DOI 10.1016/j.eswa.2009.05.043
   Chen CC, 2011, DECIS SUPPORT SYST, V50, P755, DOI 10.1016/j.dss.2010.08.023
   Chen J, 2012, J STAT PLAN INFER, V142, P390, DOI 10.1016/j.jspi.2011.06.028
   Chen L, 2013, DECIS SUPPORT SYST, V56, P270, DOI 10.1016/j.dss.2013.06.010
   Chorus CG, 2012, RANDOM REGRET BASED
   Cohen BD, 2005, STRATEGIC MANAGE J, V26, P683, DOI 10.1002/smj.463
   Connelly BL, 2011, J MANAGE, V37, P39, DOI 10.1177/0149206310388419
   Dellarocas C, 2005, INFORM SYST RES, V16, P209, DOI 10.1287/isre.1050.0054
   Dellarocas C, 2003, MANAGE SCI, V49, P1407, DOI 10.1287/mnsc.49.10.1407.17308
   Devos J., 2012, INFORM SYSTEMS THEOR, P213
   Duan WJ, 2008, DECIS SUPPORT SYST, V45, P1007, DOI 10.1016/j.dss.2008.04.001
   Eriksson K, 2010, JUDGM DECIS MAK, V5, P159
   Eriksson L, 2008, DESIGN EXPT PRINCIPL
   Fischer E, 2007, ENTREP THEORY PRACT, V31, P53, DOI 10.1111/j.1540-6520.2007.00163.x
   Gao J, 2012, DECIS SUPPORT SYST, V53, P772, DOI 10.1016/j.dss.2012.05.011
   Gefen D, 2003, MIS QUART, V27, P51
   Gefen D., 2010, MCIS 2010
   Gefen D, 2008, MIS QUART, V32, P367
   Gefen D, 2013, EUR J INFORM SYST, V22, P604, DOI 10.1057/ejis.2012.49
   GESSNER G, 1988, J BUS RES, V16, P49, DOI 10.1016/0148-2963(88)90080-X
   Grabner-Krauter S, 2003, INT J HUM-COMPUT ST, V58, P783, DOI 10.1016/S1071-5819(03)00043-0
   GREEN PE, 1990, J MARKETING, V54, P3, DOI 10.2307/1251756
   Greene W. H., 2012, NLOGIT VERSION 5 0 R
   Greiner B, 2004, GWDG BERICHT, V63, P79
   Gumbel E. J., 1958, STAT EXTREMES
   Haaijer R, 2001, INT J MARKET RES, V43, P93
   Hair JF, 2010, MULTIVARIATE DATA AN
   Hong Y., 2012, 33 INT C INF SYST IC
   Hu XR, 2010, DECIS SUPPORT SYST, V48, P407, DOI 10.1016/j.dss.2009.10.004
   IBISWorld, 2014, CROWDS SERV PROV MAR
   Kim J.Y., 2009, AMCIS 2009
   Kim J.Y., 2009, E SERVICE J, V6, P40
   Kim J.Y., 2010, E SERVICE J, V7, P2
   Lee J, 2008, ELECTRON COMMER R A, V7, P341, DOI 10.1016/j.elerap.2007.05.004
   Lee KT, 2012, COMPUT HUM BEHAV, V28, P1974, DOI 10.1016/j.chb.2012.05.018
   Lelis S, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P2285
   Li XX, 2008, INFORM SYST RES, V19, P456, DOI 10.1287/isre.1070.0154
   Manski CF, 2001, SCAND J ECON, V103, P217, DOI 10.1111/1467-9442.00241
   Mason W., 2009, P ACM SIGKDD WORKSH, P77, DOI DOI 10.1145/1600150.1600175
   Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6
   Mavlanova T, 2012, INFORM MANAGE-AMSTER, V49, P240, DOI 10.1016/j.im.2012.05.004
   McFadden D., 1974, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592
   Mee RW, 2009, COMPREHENSIVE GUIDE TO FACTORIAL TWO-LEVEL EXPERIMENTATION, P3, DOI 10.1007/b105081_1
   Paolacci G, 2010, JUDGM DECIS MAK, V5, P411
   Pavlou PA, 2007, MIS QUART, V31, P105
   Pavlou PA, 2006, INFORM SYST RES, V17, P392, DOI 10.1287/isre.1060.0106
   Qu Z, 2008, DECIS SUPPORT SYST, V46, P440, DOI 10.1016/j.dss.2008.08.004
   R Core Team, 2014, R LANG ENV STAT COMP
   Radkevitch U, 2009, DECIS SUPPORT SYST, V47, P297, DOI 10.1016/j.dss.2009.05.007
   Raghavarao D, 2006, J STAT PLAN INFER, V136, P3287, DOI 10.1016/j.jspi.2004.12.006
   Raghavarao D, 1998, AUST NZ J STAT, V40, P425, DOI 10.1111/1467-842X.00047
   Raghavarao D., 2011, CHOICE BASED CONJOIN
   Rahhal TA, 2002, PSYCHOL SCI, V13, P101, DOI 10.1111/1467-9280.00419
   Resnick P, 2002, ADV APP M-E, V11, P127
   Rice SC, 2012, INFORM SYST RES, V23, P436, DOI 10.1287/isre.1110.0362
   Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015
   Snir EM, 2003, MANAGE SCI, V49, P1504, DOI 10.1287/mnsc.49.11.1504.20587
   SPENCE M, 1973, Q J ECON, V87, P355, DOI 10.2307/1882010
   Standifird SS, 2001, J MANAGE, V27, P279, DOI 10.1016/S0149-2063(01)00092-7
   Suri R, 2003, J CONSUM RES, V30, P92, DOI 10.1086/374696
   Washington S. P, 2010, STAT ECONOMETRIC MET
   Wiley J.B., 1995, MARK SCI M SYDN
   Zikmund W.G., 2007, MEASURING CONSUMER U, P467
NR 66
TC 4
Z9 4
U1 3
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9236
EI 1873-5797
J9 DECIS SUPPORT SYST
JI Decis. Support Syst.
PD FEB
PY 2016
VL 82
BP 1
EP 11
DI 10.1016/j.dss.2015.11.001
PG 11
WC Computer Science, Artificial Intelligence; Computer Science, Information
   Systems; Operations Research & Management Science
SC Computer Science; Operations Research & Management Science
GA DD7MI
UT WOS:000370108200001
DA 2018-12-27
ER

PT J
AU Kim, KO
   Park, CJ
   Jo, D
AF Kim, Kyung-O
   Park, Chang Je
   Jo, Daeseong
TI RETRACTED: A new strategy to select axial power distribution for thermal
   hydraulic analysis (Retracted article. See vol. 116, pg. 450, 2018)
SO ANNALS OF NUCLEAR ENERGY
LA English
DT Article; Retracted Publication
DE Axial power distribution; Sum-to-peak; Thermal margin; Power peaking;
   Hottest channel
ID PLATE-TYPE FUEL; RESEARCH REACTORS
AB An appropriate method for selecting the axial power distribution that results in the most conservative thermal margins was developed in this study. Nuclear physics calculations provided axial power distributions with various shapes based on the core states and cycles. A total of 17 cycles were required to reach the equilibrium core from the initial core. The axial power distributions were sorted based on the power peaking and sum-to-peak (STP) values. In the present study, three different power peaking criteria were used to sort the axial power distributions: the upper 50%, upper 25%, and upper 10%. After the first sorting based on the power peaking, the axial power distributions were grouped based on the power peak location in the axial direction. In each group, the axial power distribution with the highest STP was chosen for thermal margin analyses. In addition, the axial power distributions in the hottest channel and fuel assembly from the initial to the equilibrium core were obtained. Since the axial power distributions in the hottest channel and fuel assembly were bounded by the axial power distribution with the upper 10% F-Q, the thermal hydraulic analysis results gave the more conservative thermal margins using the selection method presented in this study. The Onset of Nucleate Boiling (ONB) temperature margin with the upper 10% F-Q was 22.5 degrees C, but it was 25.0 degrees C for the hottest channel. Therefore, the axial power distribution used for thermal hydraulic and safety analyses should be selected using the appropriate method presented in this study. (C) 2015 Elsevier Ltd. All rights reserved.
C1 [Kim, Kyung-O] Korea Atom Energy Res Inst, Taejon 305353, South Korea.
   [Park, Chang Je] Sejong Univ, Dept Nucl Engn, Seoul 143747, South Korea.
   [Jo, Daeseong] Kyungpook Natl Univ, Sch Mech Engn, Taegu 702701, South Korea.
RP Jo, D (reprint author), Kyungpook Natl Univ, Sch Mech Engn, 80 Daehak Ro, Taegu 702701, South Korea.
EM djo@knu.ac.kr
OI KIM, Kyung-O/0000-0002-3370-8879
FU National Research Foundation of Korea (NRF) - Korean government (MSIP)
   [2015M2B2A9030425]
FX This research was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korean government (MSIP) (2015M2B2A9030425).
CR Alawneh LM, 2014, ANN NUCL ENERGY, V71, P37, DOI 10.1016/j.anucene.2014.03.029
   Albati MA, 2014, PROG NUCL ENERG, V71, P1, DOI 10.1016/j.pnucene.2013.10.015
   BERGLES A. E., 1964, J HEAT MASS TRANSF C, V86, P365, DOI 10.1115/1.3688697
   Dittus F. W., 1930, U CALIF BERKELEY PUB, V2, P443, DOI DOI 10.1016/0735-1933(85)90003-X
   Jo D, 2014, NUCL ENG TECHNOL, V46, P195, DOI 10.5516/NET.02.2013.057
   Jo D, 2014, PROG NUCL ENERG, V71, P39, DOI 10.1016/j.pnucene.2013.11.006
   Kaminaga M, 1998, J NUCL SCI TECHNOL, V35, P943, DOI 10.1080/18811248.1998.9733966
   Wilson E.H., 2012, ANLRERTRTM123
NR 8
TC 2
Z9 2
U1 1
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4549
J9 ANN NUCL ENERGY
JI Ann. Nucl. Energy
PD FEB
PY 2016
VL 88
BP 265
EP 271
DI 10.1016/j.anucene.2015.11.010
PG 7
WC Nuclear Science & Technology
SC Nuclear Science & Technology
GA DA5RA
UT WOS:000367859000026
DA 2018-12-27
ER

PT J
AU Sinha, DK
   Chandran, P
   Timm, AE
   Aguirre-Rojas, L
   Smith, M
AF Sinha, Deepak K.
   Chandran, Predeesh
   Timm, Alicia E.
   Aguirre-Rojas, Lina
   Smith, Michael
TI RETRACTED: Virulent Diuraphis noxia Aphids Over-Express Calcium
   Signaling Proteins to Overcome Defenses of Aphid-Resistant Wheat Plants
   (Retracted article. See vol.13, artn.e0191678, 2018)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID HEMIPTERA APHIDIDAE; RUSSIAN WHEAT; ACYRTHOSIPHON-PISUM; BIOTYPE 2;
   FEEDING-BEHAVIOR; ARTIFICIAL DIET; SOUTH-AFRICA; HOMOPTERA; SELECTION;
   PATHWAY
AB The Russian wheat aphid, Diuraphis noxia, an invasive phytotoxic pest of wheat, Triticum aestivum, and barley, Hordeum vulgare, causes huge economic losses in Africa, South America, and North America. Most acceptable and ecologically beneficial aphid management strategies include selection and breeding of D. noxia-resistant varieties, and numerous D. noxia resistance genes have been identified in T. aestivum and H. vulgare. North American D. noxia biotype 1 is avirulent to T. aestivum varieties possessing Dn4 or Dn7 genes, while biotype 2 is virulent to Dn4 and avirulent to Dn7. The current investigation utilized next-generation RNAseq technology to reveal that biotype 2 over expresses proteins involved in calcium signaling, which activates phosphoinositide (PI) metabolism. Calcium signaling proteins comprised 36% of all transcripts identified in the two D. noxia biotypes. Depending on plant resistance gene-aphid biotype interaction, additional transcript groups included those involved in tissue growth; defense and stress response; zinc ion and related cofactor binding; and apoptosis. Activation of enzymes involved in PI metabolism by D. noxia biotype 2 aphids allows depletion of plant calcium that normally blocks aphid feeding sites in phloem sieve elements and enables successful, continuous feeding on plants resistant to avirulent biotype 1. Inhibition of the key enzyme phospholipase C significantly reduced biotype 2 salivation into phloem and phloem sap ingestion.
C1 [Sinha, Deepak K.] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India.
   [Sinha, Deepak K.; Chandran, Predeesh; Timm, Alicia E.; Aguirre-Rojas, Lina; Smith, Michael] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.
RP Smith, M (reprint author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.
EM cmsmith@ksu.edu
FU Kansas Wheat Alliance [15-215-J]; Kansas State University Open Access
   Publishing Fund
FX This work was supported by the Kansas Wheat Alliance (contribution
   #15-215-J; http://kswheatalliance.org/). Publication of this article was
   funded in part by the Kansas State University Open Access Publishing
   Fund. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.; The
   authors thank Drs. Subbaratnam Muthukrishnan, Yoonseong Park and Gregory
   Ragland for critical review of the manuscript, and Dr. John Reese for
   use of EPG equipment. Publication of this article was funded in part by
   the Kansas State University Open Access Publishing Fund. This is
   contribution number 15-215-J from the Kansas Agricultural Experiment
   Station.
CR Anathakrishnan R, 2014, ARTHROPOD-PLANT INTE, V8, P79, DOI 10.1007/s11829-014-9293-4
   Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106
   Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864
   Baines AJ, 2009, MOL BIOL EVOL, V26, P2005, DOI 10.1093/molbev/msp115
   Bass C, 2014, INSECT BIOCHEM MOLEC, V51, P41, DOI 10.1016/j.ibmb.2014.05.003
   Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005
   Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216
   Brubaker-Purkey BJ, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6801
   Burd JD, 2006, J ECON ENTOMOL, V99, P1862, DOI 10.1603/0022-0493-99.5.1862
   Chandran P, 2013, J ECON ENTOMOL, V106, P2234, DOI 10.1603/EC13126
   Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028
   Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015
   Cristofoletti PT, 2006, FEBS J, V273, P5574, DOI 10.1111/j.1742-4658.2006.05547.x
   Cui F, 2012, INSECT SCI, V19, P429, DOI 10.1111/j.1744-7917.2011.01487.x
   FAIN JN, 1979, BIOCHEM J, V178, P45, DOI 10.1042/bj1780045
   FEBVAY G, 1988, CAN J ZOOL, V66, P2449, DOI 10.1139/z88-362
   Ferreira C, 2015, INSECT MOL BIOL, V24, P222, DOI 10.1111/imb.12151
   Gallun RL, 1980, BREEDING PLANTS RESI, P64
   Getahun MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058889
   Giordanengo P, 2014, ARTHROPOD-PLANT INTE, V8, P163, DOI 10.1007/s11829-014-9298-z
   Giordanengo P, 2010, CR BIOL, V333, P516, DOI 10.1016/j.crvi.2010.03.007
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Greene WK, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0972-5
   Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236
   Haley SD, 2004, CROP SCI, V44, P1589, DOI 10.2135/cropsci2004.1589
   Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003
   Jankielsohn A, 2011, J ECON ENTOMOL, V104, P1736, DOI 10.1603/EC11061
   Khan SA, 2009, J ECON ENTOMOL, V102, P1654, DOI 10.1603/029.102.0433
   Lazzari S, 2009, J ECON ENTOMOL, V102, P1291, DOI 10.1603/029.102.0356
   Lehiy CJ, 2014, PEERJ, V2, DOI 10.7717/peerj.426
   Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323
   Littell R. C, 1996, SAS SYSTEM MIXED MOD
   Liu W, 2014, J BIOL CHEM, V289, P13026, DOI 10.1074/jbc.M113.547018
   Liu X, 2010, J ECON ENTOMOL, V103, P958, DOI 10.1603/EC09376
   MARAIS GF, 1994, PLANT BREEDING, V113, P265, DOI 10.1111/j.1439-0523.1994.tb00735.x
   MELDRUM E, 1991, BIOCHIM BIOPHYS ACTA, V1092, P49, DOI 10.1016/0167-4889(91)90177-Y
   Merrill SC, 2014, J ECON ENTOMOL, V107, P1471, DOI 10.1603/EC13557
   Nicholson SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1525-1
   Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031
   Nishida K., 2014, ZINC SIGNALS CELLULA, P89
   Onstad D.W, 2008, INSECT RESISTANCE MA
   Pannabecker TL, 2014, AM J PHYSIOL-REG I, V307, pR819, DOI 10.1152/ajpregu.00336.2014
   Pinheiro P, 2014, J PROTEOME RES, V13, P2094, DOI 10.1021/pr4012415
   Powell G, 2005, J GEN VIROL, V86, P469, DOI 10.1099/vir.0.80632-0
   Quick JS, 2001, CROP SCI, V41, P1363, DOI 10.2135/cropsci2001.4141363x
   Quisenberry SS, 1998, RESPONSE MODEL INTRO
   Sadeghi A, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.6501
   SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063
   SHAPIRO SS, 1972, J AM STAT ASSOC, V67, P215, DOI 10.2307/2284728
   Sinha DK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05059
   Smith CM, 2014, PEST MANAG SCI, V70, P528, DOI 10.1002/ps.3689
   Smith CM, 2005, PLANT RESISTANCE ART, P423, DOI [10.1007/1-4020-3702-3, DOI 10.1007/1-4020-3702-3]
   Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800
   Swanevelder ZH, 2010, J ECON ENTOMOL, V103, P887, DOI 10.1603/EC09257
   Teets NM, 2013, P NATL ACAD SCI USA, V110, P9154, DOI 10.1073/pnas.1306705110
   Tjallingii W, 2008, PHYSIOL ENTOMOL, V18, P317
   Tjallingii W.F., 1988, P95
   Tjallingii WF, 2006, J EXP BOT, V57, P739, DOI 10.1093/jxb/erj088
   Tolmay VL, 2013, J APPL ENTOMOL, V137, P476, DOI 10.1111/jen.12008
   van Bel AJE, 2014, J EXP BOT, V65, P1761, DOI 10.1093/jxb/ert425
   Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104
NR 61
TC 5
Z9 5
U1 4
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 27
PY 2016
VL 11
IS 1
AR e0146809
DI 10.1371/journal.pone.0146809
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DC9GD
UT WOS:000369528200021
PM 26815857
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Xiang, JF
   Wang, WQ
   Liu, L
   Xu, HX
   Wu, CT
   Yang, JX
   Qi, ZH
   Wang, YQ
   Xu, J
   Liu, C
   Long, J
   Ni, QX
   Li, M
   Yu, XJ
AF Xiang, Jin-Feng
   Wang, Wen-Quan
   Liu, Liang
   Xu, Hua-Xiang
   Wu, Chun-Tao
   Yang, Jing-Xuan
   Qi, Zi-Hao
   Wang, Ya-Qi
   Xu, Jin
   Liu, Chen
   Long, Jiang
   Ni, Quan-Xing
   Li, Min
   Yu, Xian-Jun
TI RETRACTED: Mutant p53 determines pancreatic cancer poor prognosis to
   pancreatectomy through upregulation of cavin-1 in patients with
   preoperative serum CA19-9 >= 1,000 U/mL (Retracted article. See vol. 6,
   25115, 2016)
SO SCIENTIFIC REPORTS
LA English
DT Article; Retracted Publication
ID COLONY-STIMULATING FACTOR; PERITUMORAL LIVER-TISSUE; METABOLIC TUMOR
   BURDEN; HEPATOCELLULAR-CARCINOMA; DUCTAL ADENOCARCINOMA; CURATIVE
   RESECTION; HIGH EXPRESSION; SURVIVAL; METASTASIS; CAVEOLIN-1
AB Patients with pancreatic ductal adenocarcinoma (PDAC) and preoperative CA19-9 >= 1,000 U/mL that does not decrease postresection have the worst prognosis, but the mechanism is unclear. Here, we elucidated the relationship between this signature and driver-gene mutations, and the cavins/caveolin-1 axis. Four major driver-genes (KRAS, TP53, CDKN2A/p16, and SMAD4/DPC4) that are associated with PDAC and five critical molecules (cavin-1/-2/-3/-4 and caveolin-1) in the cavins/caveolin-1 axis were screened by immunohistochemistry in tumor tissue microarrays. Additionally, six pancreatic cancer cell lines and a spleen subcapsular inoculation nude mouse model were also used. Overexpression of mutant p53 was the major mutational event in patients with the CA19-9 signature. Cavin-1 was also overexpressed, and mutant p53 correlated directly with high cavin-1 expression in pancreatic cancer cell lines and tumor specimens (P < 0.01). Furthermore, mutant p53(R172H) upregulated cavin-1 and promoted invasiveness and metastasis of pancreatic cancer cells in vitro and in vivo. Finally, combination of mutant p53 and high cavin-1 density indicated the shortest survival for patients with PDAC after resection (P < 0.001). Mutant p53-driven upregulation of cavin-1 represents the major mechanism of poor outcome for PDAC patients with the CA19-9 signature after resection, indicating that inhibition of cavin-1 may improve the long-term efficacy of pancreatectomy.
C1 [Xiang, Jin-Feng; Wang, Wen-Quan; Liu, Liang; Xu, Hua-Xiang; Wu, Chun-Tao; Qi, Zi-Hao; Wang, Ya-Qi; Xu, Jin; Liu, Chen; Long, Jiang; Ni, Quan-Xing; Li, Min; Yu, Xian-Jun] Fudan Univ, Dept Pancreat & Hepatobiliary Surg, Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China.
   [Xiang, Jin-Feng; Wang, Wen-Quan; Liu, Liang; Xu, Hua-Xiang; Wu, Chun-Tao; Qi, Zi-Hao; Wang, Ya-Qi; Xu, Jin; Liu, Chen; Long, Jiang; Ni, Quan-Xing; Li, Min; Yu, Xian-Jun] Fudan Univ, Pancreat Canc Inst, Shanghai 200433, Peoples R China.
   [Yang, Jing-Xuan] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Dept Surg, Oklahoma City, OK USA.
   [Li, Min] Univ Texas Med Sch Houston, Vivian L Smith Dept Neurosurg, Houston, TX USA.
   [Wang, Wen-Quan; Yu, Xian-Jun] Fudan Univ, Shanghai Canc Ctr, Collaborat Innovat Ctr Canc Med, Shanghai 200433, Peoples R China.
RP Yu, XJ (reprint author), Fudan Univ, Dept Pancreat & Hepatobiliary Surg, Shanghai Canc Ctr, Dept Oncol,Shanghai Med Coll, Shanghai 200433, Peoples R China.
EM yuxianjun@fudanpci.org
OI yu, xianjun/0000-0002-6697-7143
FU National Natural Science Foundation of China [81402397, 81472670,
   81402398, 81172005]; National Natural Science Foundation of Shanghai
   [14ZR1407600]; "Yang-Fan" Plan for Young Scientists of Shanghai
   [14YF1401100]; Ph.D. Programs Foundation of Ministry of Education of
   China [20110071120096]
FX This study was supported by the National Natural Science Foundation of
   China (81402397, 81472670, 81402398, and 81172005), the National Natural
   Science Foundation of Shanghai (14ZR1407600), the "Yang-Fan" Plan for
   Young Scientists of Shanghai (14YF1401100), and the Ph.D. Programs
   Foundation of Ministry of Education of China (20110071120096).
CR Bai L, 2011, CELL RES, V21, P1088, DOI 10.1038/cr.2011.56
   Balzano G, 2008, LANCET ONCOL, V9, P89, DOI 10.1016/S1470-2045(08)70011-1
   Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053
   Biankin AV, 2002, J CLIN ONCOL, V20, P4531, DOI 10.1200/JCO.2002.12.063
   Blackford A, 2009, CLIN CANCER RES, V15, P4674, DOI 10.1158/1078-0432.CCR-09-0227
   Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713
   DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235
   Edge SB BD, 2010, AJCC CANC STAGING MA
   Ferrone CR, 2006, J CLIN ONCOL, V24, P2897, DOI 10.1200/JCO.2005.05.3934
   Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112
   Goetz JG, 2008, CANCER METAST REV, V27, P715, DOI 10.1007/s10555-008-9160-9
   Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887
   Hartwig W, 2013, LANCET ONCOL, V14, pE476, DOI 10.1016/S1470-2045(13)70172-4
   Hata S, 2012, ANN SURG ONCOL, V19, P636, DOI 10.1245/s10434-011-2020-9
   Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042
   Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023
   Humphris JL, 2012, ANN ONCOL, V23, P1713, DOI 10.1093/annonc/mdr561
   Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188
   Jia JB, 2010, ONCOLOGIST, V15, P732, DOI 10.1634/theoncologist.2009-0170
   Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368
   Lee SH, 2013, ONCOTARGET, V4, P2523, DOI 10.18632/oncotarget.1550
   Liu C, 2012, J SURG RES, V172, pE11, DOI 10.1016/j.jss.2011.09.002
   Liu L, 2014, ONCOGENE, V33, P2728, DOI 10.1038/onc.2013.223
   Liu L, 2015, INT J CANCER, V136, P2216, DOI 10.1002/ijc.29242
   Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644
   McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46
   Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107
   Nenutil R, 2005, J PATHOL, V207, P251, DOI 10.1002/path.1838
   Oshima M, 2013, ANN SURG, V258, P336, DOI 10.1097/SLA.0b013e3182827a65
   Poruk KE, 2013, CURR MOL MED, V13, P340
   Ryan DP, 2014, NEW ENGL J MED, V371, P1039, DOI 10.1056/NEJMra1404198
   Shi S, 2015, CANCER LETT, V360, P227, DOI 10.1016/j.canlet.2015.02.014
   Takahashi H, 2010, ANN SURG, V251, P461, DOI 10.1097/SLA.0b013e3181cc90a3
   Tanase CP, 2009, J MOL HISTOL, V40, P23, DOI 10.1007/s10735-008-9209-7
   Volonte D, 2011, J BIOL CHEM, V286, P28657, DOI 10.1074/jbc.C111.235119
   Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169
   Wang WQ, 2014, ONCOTARGET, V5, P3895, DOI 10.18632/oncotarget.2019
   Wang WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071189
   Wang WQ, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-69
   Weissmueller S, 2014, CELL, V157, P382, DOI 10.1016/j.cell.2014.01.066
   Xu HX, 2014, EUR J NUCL MED MOL I, V41, P1093, DOI 10.1007/s00259-014-2688-8
   Yachida S, 2012, CLIN CANCER RES, V18, P6339, DOI 10.1158/1078-0432.CCR-12-1215
   Yachida S, 2012, CURR PHARM DESIGN, V18, P2452, DOI 10.2174/13816128112092452
   Zhu XD, 2008, J CLIN ONCOL, V26, P2707, DOI 10.1200/JCO.2007.15.6521
   Zhu XD, 2013, ANGIOGENESIS, V16, P809, DOI 10.1007/s10456-013-9357-6
NR 45
TC 12
Z9 13
U1 4
U2 15
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 12
PY 2016
VL 6
AR 19222
DI 10.1038/srep19222
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA9DC
UT WOS:000368106800002
PM 26753987
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Malhotra, S
   Vinod, PK
   Mansfeld, J
   Stemmann, O
   Mayer, TU
AF Malhotra, Saurav
   Vinod, Palakkad Krishnanunni
   Mansfeld, Joerg
   Stemmann, Olaf
   Mayer, Thomas U.
TI RETRACTED: The Anaphase-Promoting Complex/Cyclosome Is Essential for
   Entry into Meiotic M-Phase (Retracted article. See vol. 37, pg. 289,
   2016)
SO DEVELOPMENTAL CELL
LA English
DT Article; Retracted Publication
ID MEIOSIS-SPECIFIC APC/C-AMA1; MESSENGER-RNA TRANSLATION; XENOPUS OOCYTES;
   PROTEIN-KINASE; MOUSE OOCYTES; CELL-CYCLE; MITOTIC REGULATION; APC(CDH1)
   ACTIVITY; SIGNALING PATHWAY; CYTOSTATIC FACTOR
AB Vertebrate immature oocytes are arrested at prophase of meiosis I (MI). Hormonal stimulation breaks this prophase-I arrest and induces re-entry into MI. The mechanism underlying meiotic resumption remains largely elusive. Here, we demonstrate that the anaphase-promoting complex/cyclosome (APC/C) in complex with Cdh1 has an unexpected function in meiosis in that it is essential for meiotic resumption. We identify the catalytic subunit of protein phosphatase 6 (PP6c) as the critical substrate whose APC/C-Cdh1-mediated destruction is a prerequisite for the re-entry of immature Xenopus laevis oocytes into MI. Preventing PP6c destruction impairs activating autophosphorylation of Aurora A, a cell-cycle kinase critical for meiotic translation. Restoring meiotic translation rescues the meiotic resumption defect of Cdh1-depleted oocytes. Thus, our studies discover that the essential function of the APC/C in triggering cell-cycle transitions is not limited to M-phase exit but also applies to entry into meiotic M-phase, and identify a crucial APC/C-PP6c-Aurora A axis in the resumption of female meiosis.
C1 [Malhotra, Saurav; Mayer, Thomas U.] Univ Konstanz, Dept Mol Genet, Konstanz Res Sch Chem Biol KoRS CB, D-78457 Constance, Germany.
   [Vinod, Palakkad Krishnanunni] Univ Oxford, OCISB, Dept Biochem, Oxford OX1 3QU, England.
   [Mansfeld, Joerg] Tech Univ Dresden, Ctr Biotechnol, Cell Cycle, D-01307 Dresden, Germany.
   [Stemmann, Olaf] Univ Bayreuth, Dept Genet, D-95440 Bayreuth, Germany.
RP Mayer, TU (reprint author), Univ Konstanz, Dept Mol Genet, Konstanz Res Sch Chem Biol KoRS CB, Univ Str 10, D-78457 Constance, Germany.
EM thomas.u.mayer@uni-konstanz.de
RI Mansfeld, Joerg/B-4154-2014
FU DFG [SPP-1384, CRC-969]
FX We are grateful to S. Mochida, J. Maller, V. Joukov, E. Hormanseder, T.
   Tischer, and M. Scheffner for reagents and scientific advice. We thank
   G. Bakos for establishing ubiquitylation assays and M. Baack, A. Heim,
   and A. Brendel for experimental support. The work was funded by the DFG
   SPP-1384 and CRC-969.
CR Andresson T, 1998, EMBO J, V17, P5627, DOI 10.1093/emboj/17.19.5627
   Bastians H, 1996, J CELL SCI, V109, P2865
   Charlesworth A, 2006, EMBO J, V25, P2792, DOI 10.1038/sj.emboj.7601159
   Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299
   DUNPHY WG, 1989, CELL, V58, P181, DOI 10.1016/0092-8674(89)90414-5
   Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0
   GAUTIER J, 1991, EMBO J, V10, P177, DOI 10.1002/j.1460-2075.1991.tb07934.x
   Gui LM, 2013, DEV CELL, V25, P43, DOI 10.1016/j.devcel.2013.02.008
   Hellmuth S, 2014, EMBO J, V33, P1134, DOI 10.1002/embj.201488098
   Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192
   Holt JE, 2010, DEVELOPMENT, V137, P1297, DOI 10.1242/dev.047555
   HUCHON D, 1981, MOL CELL ENDOCRINOL, V22, P211, DOI 10.1016/0303-7207(81)90092-7
   Karaiskou A, 2001, BIOL CELL, V93, P35, DOI 10.1016/S0248-4900(01)01126-1
   Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627
   Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023
   Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555
   Liu JJ, 2005, CURR BIOL, V15, P1458, DOI 10.1016/j.cub.2005.07.030
   Lorca T, 1998, EMBO J, V17, P3565, DOI 10.1093/emboj/17.13.3565
   Lorca T, 2013, ONCOGENE, V32, P537, DOI 10.1038/onc.2012.79
   MALLER JL, 1977, J BIOL CHEM, V252, P1712
   Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347
   Marangos P, 2007, J CELL BIOL, V176, P65, DOI 10.1083/jcb.200607070
   Mendez R, 2000, NATURE, V404, P302
   Mi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004395
   Mochida S, 2012, EMBO REP, V13, P197, DOI 10.1038/embor.2011.263
   Nakahata S, 2001, J BIOL CHEM, V276, P20945, DOI 10.1074/jbc.M010528200
   Nakajo N, 2000, GENE DEV, V14, P328
   Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696
   Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032
   Okaz E, 2012, CELL, V151, P603, DOI 10.1016/j.cell.2012.08.044
   Padmanabhan K, 2006, GENE DEV, V20, P199, DOI 10.1101/gad.1382106
   Papin C, 2004, DEV BIOL, V272, P66, DOI 10.1016/j.ydbio.2004.04.018
   Reis A, 2006, NAT CELL BIOL, V8, P539, DOI 10.1038/ncb1406
   Reis A, 2007, NAT CELL BIOL, V9, P1192, DOI 10.1038/ncb1640
   Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377
   SADLER SE, 1981, J BIOL CHEM, V256, P6368
   Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004
   Schindler K, 2009, BIOL REPROD, V80, P795, DOI 10.1095/biolreprod.108.074906
   Schmidt A, 2005, GENE DEV, V19, P502, DOI 10.1101/gad.320705
   Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953
   Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877
   Tang WL, 2008, MOL BIOL CELL, V19, P3536, DOI 10.1091/mbc.E08-04-0417
   You DJ, 2010, MOL CELLS, V30, P527, DOI 10.1007/s10059-010-0155-3
   Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721
   Zeng K, 2010, J CELL BIOL, V191, P1315, DOI 10.1083/jcb.201008106
   Zhou Y, 2002, BIOCHEM BIOPH RES CO, V294, P120, DOI 10.1016/S0006-291X(02)00447-3
NR 46
TC 3
Z9 3
U1 2
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD JAN 11
PY 2016
VL 36
IS 1
BP 94
EP 102
DI 10.1016/j.devcel.2015.12.009
PG 9
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA DA9ET
UT WOS:000368112000011
PM 26766445
OA Bronze
DA 2018-12-27
ER

PT J
AU Graf, H
   Metzger, CD
   Walter, M
   Abler, B
AF Graf, Heiko
   Metzger, Coraline D.
   Walter, Martin
   Abler, Birgit
TI RETRACTED: Serotonergic antidepressants decrease hedonic signals but
   leave learning signals in the nucleus accumbens unaffected (Retracted
   article. See vol. 129, pg. 1340, 2018)
SO NEUROREPORT
LA English
DT Article; Retracted Publication
DE functional MRI; nucleus accumbens; prediction error; primary and
   secondary rewards
ID PREDICTION ERROR; SEXUAL DYSFUNCTION; HEALTHY-MALES; REWARD; DEPRESSION;
   PHARMACOTHERAPY; PSYCHOTHERAPY; MODULATION; PAROXETINE; FMRI
AB Investigating the effects of serotonergic antidepressants on neural correlates of visual erotic stimulation revealed decreased reactivity within the dopaminergic reward network along with decreased subjective sexual functioning compared with placebo. However, a global dampening of the reward system under serotonergic drugs is not intuitive considering clinical observations of their beneficial effects in the treatment of depression. Particularly, learning signals as coded in prediction error processing within the dopaminergic reward system can be assumed to be rather enhanced as antidepressant drugs have been demonstrated to facilitate the efficacy of psychotherapeutic interventions relying on learning processes. Within the same study sample, we now explored the effects of serotonergic and dopaminergic/noradrenergic antidepressants on prediction error signals compared with placebo by functional MRI. A total of 17 healthy male participants (mean age: 25.4 years) were investigated under the administration of paroxetine, bupropion and placebo for 7 days each within a randomized, double-blind, within-subject cross-over design. During functional MRI, we used an established monetary incentive task to explore neural prediction error signals within the bilateral nucleus accumbens as region of interest within the dopaminergic reward system. In contrast to diminished neural activations and subjective sexual functioning under the serotonergic agent paroxetine under visual erotic stimulation, we revealed unaffected or even enhanced neural prediction error processing within the nucleus accumbens under this antidepressant along with unaffected behavioural processing. Our study provides evidence that serotonergic antidepressants facilitate prediction error signalling and may support suggestions of beneficial effects of these agents on reinforced learning as an essential element in behavioural psychotherapy. Copyright (C) 2015 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Graf, Heiko; Abler, Birgit] Univ Ulm, Dept Psychiat & Psychotherapy 3, Leimgrubenweg 12-14, D-89075 Ulm, Germany.
   [Metzger, Coraline D.; Walter, Martin] Univ Magdeburg, Dept Psychiat, Magdeburg, Germany.
   [Metzger, Coraline D.] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany.
   [Walter, Martin] Leibniz Inst Neurobiol, Magdeburg, Germany.
RP Graf, H (reprint author), Univ Ulm, Dept Psychiat & Psychotherapy 3, Leimgrubenweg 12-14, D-89075 Ulm, Germany.
EM heiko.graf@uni-ulm.de
OI Walter, Martin/0000-0001-7857-4483
FU  [SFB-779]
FX The authors thank Professor Dr C. Hiemke and his staff at the University
   of Mainz (Germany), Department of Psychiatry and Psychotherapy, for
   measurements of bupropion and paroxetine blood serum levels. M.W. was
   supported by the SFB-779.
CR Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001
   Abler B, 2012, J NEUROSCI, V32, P1329, DOI 10.1523/JNEUROSCI.5826-11.2012
   Abler B, 2011, NEUROPSYCHOPHARMACOL, V36, P1837, DOI 10.1038/npp.2011.66
   Gradin VB, 2011, BRAIN, V134, P1751, DOI 10.1093/brain/awr059
   Macoveanu J, 2014, NEUROIMAGE, V99, P434, DOI 10.1016/j.neuroimage.2014.05.040
   Macoveanu J, 2014, BRAIN RES, V1556, P19, DOI 10.1016/j.brainres.2014.02.003
   Marutani T, 2011, PSYCHIAT CLIN NEUROS, V65, P191, DOI 10.1111/j.1440-1819.2011.02189.x
   McCabe C, 2010, BIOL PSYCHIAT, V67, P439, DOI 10.1016/j.biopsych.2009.11.001
   Opbroek A, 2002, INT J NEUROPSYCHOPH, V5, P147, DOI 10.1017/S1461145702002870
   Pampallona S, 2004, ARCH GEN PSYCHIAT, V61, P714, DOI 10.1001/archpsyc.61.7.714
   Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051
   Price J, 2009, BRIT J PSYCHIAT, V195, P211, DOI 10.1192/bjp.bp.108.051110
   Schramm E, 2007, AM J PSYCHIAT, V164, P768, DOI 10.1176/appi.ajp.164.5.768
   Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007
   Thase ME, 1997, ARCH GEN PSYCHIAT, V54, P1009
   Ubl B, 2015, SOC COGN AFFECT NEUR, V10, P1102, DOI 10.1093/scan/nsu158
NR 16
TC 3
Z9 3
U1 0
U2 14
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0959-4965
EI 1473-558X
J9 NEUROREPORT
JI Neuroreport
PD JAN 6
PY 2016
VL 27
IS 1
BP 18
EP 22
DI 10.1097/WNR.0000000000000487
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA CX4TV
UT WOS:000365694100004
PM 26555033
DA 2018-12-27
ER

PT J
AU Liu, MJ
   Xiong, CH
   Xiong, L
   Huang, XL
AF Liu, Ming-Jin
   Xiong, Cai-Hua
   Xiong, Le
   Huang, Xiao-Lin
TI RETRACTED: Biomechanical Characteristics of Hand Coordination in
   Grasping Activities of Daily Living (Retracted article. See vol. 11,
   e0151685, 2016)
SO PLOS ONE
LA English
DT Article; Retracted Publication
ID FINGER MOVEMENTS; TOOL USE; MODEL; CONSTRAINTS; SYNERGIES; EVOLUTION;
   MOTION
AB Hand coordination can allow humans to have dexterous control with many degrees of freedom to perform various tasks in daily living. An important contributing factor to this important ability is the complex biomechanical architecture of the human hand. However, drawing a clear functional link between biomechanical architecture and hand coordination is challenging. It is not understood which biomechanical characteristics are responsible for hand coordination and what specific effect each biomechanical characteristic has. To explore this link, we first inspected the characteristics of hand coordination during daily tasks through a statistical analysis of the kinematic data, which were collected from thirty right-handed subjects during a multitude of grasping tasks. Then, the functional link between biomechanical architecture and hand coordination was drawn by establishing the clear corresponding causality between the tendinous connective characteristics of the human hand and the coordinated characteristics during daily grasping activities. The explicit functional link indicates that the biomechanical characteristic of tendinous connective architecture between muscles and articulations is the proper design by the Creator to perform a multitude of daily tasks in a comfortable way. The clear link between the structure and the function of the human hand also suggests that the design of a multifunctional robotic hand should be able to better imitate such basic architecture.
C1 [Liu, Ming-Jin; Xiong, Cai-Hua] Huazhong Univ Sci & Technol, Inst Rehabil & Med Robot, State Key Lab Digital Mfg Equipment & Technol, Wuhan 430074, Hubei, Peoples R China.
   [Xiong, Le] Worcester Polytech Inst, Foisie Sch Business, Worcester, MA 01609 USA.
   [Huang, Xiao-Lin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China.
RP Xiong, CH (reprint author), Huazhong Univ Sci & Technol, Inst Rehabil & Med Robot, State Key Lab Digital Mfg Equipment & Technol, Wuhan 430074, Hubei, Peoples R China.
EM chxiong@hust.edu.cn
FU National Basic Research Program of China (973 Program) [2011CB013301];
   National Natural Science Foundation of China [51335004]
FX This work was partly supported by the National Basic Research Program of
   China (973 Program, Grant No. 2011CB013301), and National Natural
   Science Foundation of China (Grant No. 51335004).
CR Braido P, 2004, HUM MOVEMENT SCI, V22, P661, DOI 10.1016/j.humov.2003.10.001
   BROOK N, 1995, MED ENG PHYS, V17, P54, DOI 10.1016/1350-4533(95)90378-O
   BUCHNER HJ, 1988, J BIOMECH, V21, P459, DOI 10.1016/0021-9290(88)90238-2
   Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744
   Chang LY, 2006, INT C ROB AUT
   Chen WB, 2015, IEEE-ASME T MECH, V20, P1249, DOI 10.1109/TMECH.2014.2329006
   Chen WB, 2010, GAIT POSTURE, V32, P475, DOI 10.1016/j.gaitpost.2010.07.005
   CUTKOSKY MR, 1989, IEEE T ROBOTIC AUTOM, V5, P269, DOI 10.1109/70.34763
   d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006
   Diogo R, 2012, COMP ANATOMY PHYLOGE
   Diogo R, 2012, J HUM EVOL, V63, P64, DOI 10.1016/j.jhevol.2012.04.001
   Doyle J. R., 2003, SURG ANATOMY HAND UP
   Edwards S. J., 2002, DEV FUNCTIONAL HAND
   Feix T., 2009, ROB SCI SYST WORKSH
   Fok KS, 2010, J BIOMECH, V43, P701, DOI 10.1016/j.jbiomech.2009.10.020
   GARCIAELIAS M, 1991, J HAND SURG-AM, V16A, P1130, DOI 10.1016/S0363-5023(10)80079-6
   Gray H., 1918, ANATOMY HUMAN BODY
   Hager-Ross C, 2000, J NEUROSCI, V20, P8542, DOI 10.1523/JNEUROSCI.20-22-08542.2000
   HOLM S, 1979, SCAND J STAT, V6, P65
   Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3
   Inman Mason, 2006, PLoS Biol, V4, pe196, DOI 10.1371/journal.pbio.0040196
   Johnson RA, 2007, APPL MULTIVARIATE ST
   Jolliffe L., 2005, PRINCIPAL COMPONENT
   Kahle W., 2003, COLOR ATLAS HUMAN AN
   KLATZKY RL, 1987, J MOTOR BEHAV, V19, P187
   LANDSMEER JMF, 1963, J BONE JOINT SURG AM, V45, P1654, DOI 10.2106/00004623-196345080-00007
   Leijnse JNAL, 2012, J BIOMECH, V45, P569, DOI 10.1016/j.jbiomech.2011.11.002
   Li KR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0084171, 10.1371/journal.pone.0058057]
   Marzke MW, 2000, J ANAT, V197, P121, DOI 10.1046/j.1469-7580.2000.19710121.x
   Mason CR, 2001, J NEUROPHYSIOL, V86, P2896
   NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902
   OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4
   Palastanga N, 2006, ANATOMY HUMAN MOVEME
   Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002
   Santello M, 1998, J NEUROSCI, V18, P10105
   Santello M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00023
   Schieber MH, 2004, J APPL PHYSIOL, V96, P2293, DOI 10.1152/japplphysiol.01063.2003
   Soechting JF, 1997, J COMPUT NEUROSCI, V4, P29, DOI 10.1023/A:1008812426305
   STANDRING S, 2005, GRAYS ANATOMY ANATOM
   van Duinen H, 2011, J PHYSIOL-LONDON, V589, P5583, DOI 10.1113/jphysiol.2011.217810
   Xiong CH, 1999, INT J ROBOT RES, V18, P951, DOI 10.1177/02783649922066682
   Xiong CH, 2007, FUNDAMENTALS ROBOTIC
NR 42
TC 3
Z9 3
U1 2
U2 37
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 5
PY 2016
VL 11
IS 1
AR e0146193
DI 10.1371/journal.pone.0146193
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA DA4VZ
UT WOS:000367801400113
PM 26730579
OA DOAJ Gold, Green Published
DA 2018-12-27
ER

PT J
AU Barzic, AI
   Popovici, D
   Hulubei, C
   Stoica, I
   Aflori, M
   Dunca, S
AF Barzic, Andreea Irina
   Popovici, Dumitru
   Hulubei, Camelia
   Stoica, Iuliana
   Aflori, Magdalena
   Dunca, Simona
TI RETRACTED: Polyimide surface modification by RF plasma for biocide
   attachment (Retracted article. See vol. 21, pg. 459, 2016)
SO INTERNATIONAL JOURNAL OF POLYMER ANALYSIS AND CHARACTERIZATION
LA English
DT Article; Retracted Publication
DE Antibacterial activity; plasma; polyimide; silver nitride
ID ANTIBACTERIAL SURFACES; FILMS; COATINGS
AB A polyimide containing alicyclic sequences was synthesized by a two-step solution polycondensation reaction, and the film's properties were characterized in order to assess its suitability as antibacterial material. The sample was subjected to RF plasma treatment to facilitate silver-based biocide attachment on the film surface. Surface properties of the prepared polyimide film were investigated by FT-IR, contact angle, and atomic force microscopy measurements, before and after the treatments with plasma and plasma/silver-based biocide. Antibacterial tests showed that the polyimide films inhibit the growth of Staphylococcus aureus ATCC 25923 and Escherichia coli ATCC 25922. The differences in biocidal activity are discussed in terms of sample and bacteria hydrophobic/hydrophilic interactions.
C1 [Barzic, Andreea Irina; Popovici, Dumitru; Hulubei, Camelia; Stoica, Iuliana; Aflori, Magdalena] Petru Poni Inst Macromol Chem, Dept Phys Chem Polymers, Iasi 700487, Romania.
   [Popovici, Dumitru] Univ Politehn Bucuresti, Bucharest, Romania.
   [Dunca, Simona] Alexandru Ioan Cuza Univ, Fac Biol, Iasi, Romania.
RP Barzic, AI (reprint author), Petru Poni Inst Macromol Chem, Dept Phys Chem Polymers, Iasi 700487, Romania.
EM irina_cosutchi@yahoo.com
OI Aflori, Magdalena/0000-0001-5919-221X
FU Sectoral Operational Programme Human Resources Development of the
   Ministry of European Funds [POSDRU/159/1.5/S/132395]
FX The work has been funded by the Sectoral Operational Programme Human
   Resources Development 2007-2013 of the Ministry of European Funds
   through the Financial Agreement POSDRU/159/1.5/S/132395.
CR Aflori M, 2015, HIGH PERFORM POLYM, V27, P655, DOI 10.1177/0954008315584171
   Barzic AI, 2013, J MOL STRUCT, V1044, P206, DOI 10.1016/j.molstruc.2012.12.044
   Bordianu IE, 2015, J MATER CHEM B, V3, P723, DOI 10.1039/c4tb01932f
   Goy RC, 2009, POLIMEROS, V19, P241, DOI 10.1590/S0104-14282009000300013
   Han EL, 2013, ACS APPL MATER INTER, V5, P4293, DOI 10.1021/am4005094
   Hasenkamp W, 2012, BIOMED MICRODEVICES, V14, P819, DOI 10.1007/s10544-012-9661-8
   He JH, 2005, APPL SURF SCI, V241, P279, DOI 10.1016/j.apsusc.2004.06.161
   Kim JT, 2002, POLYM INT, V51, P1063, DOI 10.1002/pi.948
   Kochkodan V, 2008, DESALINATION, V220, P380, DOI 10.1016/j.desal.2007.01.042
   Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099
   Li L, 2008, POLYM INT, V57, P1275, DOI 10.1002/pi.2474
   Liao YA, 2010, MATER CHEM PHYS, V121, P534, DOI 10.1016/j.matchemphys.2010.02.019
   Merchan M, 2010, INT J POLYM ANAL CH, V15, P360, DOI 10.1080/1023666X.2010.500534
   Necula AM, 2010, INT J POLYM ANAL CH, V15, P341, DOI 10.1080/1023666X.2010.500524
   Ploux L, 2012, J NANOMATER, DOI 10.1155/2012/674145
   Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32
   Rankl M, 2003, COLLOID SURFACE B, V30, P177, DOI 10.1016/S0927-7765(03)00085-7
   Siegel J, 2015, MATER LETT, V145, P87, DOI 10.1016/j.matlet.2015.01.050
   Singha AS, 2015, INT J POLYM ANAL CH, V20, P357, DOI 10.1080/1023666X.2015.1018491
   Sowe M, 2009, INT J POLYM ANAL CH, V14, P678, DOI 10.1080/10236660903298327
   Stejskal J, 2009, REACT FUNCT POLYM, V69, P86, DOI 10.1016/j.reactfunctpolym.2008.11.004
   VANOSS CJ, 1988, LANGMUIR, V4, P884, DOI 10.1021/la00082a018
   Xue Y, 2015, INT J MOL SCI, V16, P3626, DOI 10.3390/ijms16023626
NR 23
TC 1
Z9 1
U1 2
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1023-666X
EI 1563-5341
J9 INT J POLYM ANAL CH
JI Int. J. Polym. Anal. Charact.
PD JAN 2
PY 2016
VL 21
IS 1
BP 77
EP 84
DI 10.1080/1023666X.2016.1101833
PG 8
WC Polymer Science
SC Polymer Science
GA DA5AZ
UT WOS:000367815800008
DA 2018-12-27
ER

PT J
AU Shah, AF
   Batra, M
   Ishrat, A
AF Shah, Aasim Farooq
   Batra, Manu
   Ishrat, A.
TI RETRACTED: Transition in Dental Treatment Utilization in Jammu And
   Kashmir, India - A 10 Year Retrospective Study (Retracted article. See
   vol. 07, pg. 699, 2017)
SO NEPAL JOURNAL OF EPIDEMIOLOGY
LA English
DT Article; Retracted Publication
DE Utilization Trend; Dentistry; Behaviour; Restorative Dentistry; Oral
   health
ID CARE SERVICES; REASONS
AB Background: Utilization of health services is the actual attendance by the members of the public at health care facilities to receive care. Utilization, serves as an important tool for oral health policy decision-making. The aim of the present study was to retrospectively gauge and assess the utilization pattern of the dental treatments which was given in hospital for last 10 years.
   Materials and Methods: This retrospective infirmary based study was carried out at Sheri Kashmir Institute of Medical Sciences (SKIMS), Srinagar, Jammu and Kashmir, India. The yearly outpatient department (OPD) records for the utilization of specific dental treatment of a total of 103963 patients were assessed retrospectively from 2014 to 2003. Trend analysis was used to assess the trend of utilization of each speciality with best fitted linear trend lines.
   Results: The pattern of new patients has also shown a constant rise during the study period except for 2008 and 2009. The utilization of oral surgery speciality has shown a tremendous fall from 2003 to 2014 whereas the number of patients coming to periodontics and conservative dentistry has shown an increasing pattern.
   Conclusion: Utilization of oral health care has long been used as an indicator of oral health related behaviour of a population. In the present study it can be conclude that the outlook of the population under study has changed from blood and vulcanite dentistry outlook and is moving towards restorative dentistry.
C1 [Shah, Aasim Farooq] Govt Dent Coll & Hosp, Dept Publ Hlth Dent, Srinagar 190010, Jammu & Kashmir, India.
   [Batra, Manu] UCMS Coll Dent Surg, Dept Community & Prevent Dent, Bhairahawa, Nepal.
   [Ishrat, A.] J&K Govt Hlth Services, Sch Hlth Program, Srinagar 190001, Jammu & Kashmir, India.
RP Shah, AF (reprint author), Govt Dent Coll & Hosp, Dept Publ Hlth Dent, Srinagar 190010, Jammu & Kashmir, India.
EM dr_aasimshah@yahoo.com
FU medical records department (MRD); data keeper of the dental section at
   SK Institute of Medical Sciences
FX The authors are very thankful to members of the medical records
   department (MRD) and the data keeper of the dental section at SK
   Institute of Medical Sciences for their support in acquiring the records
   of the patients.
CR ALLUKIAN M, 1982, AM J PUBLIC HEALTH, V72, P653, DOI 10.2105/AJPH.72.7.653
   Brown LJ, 1999, J AM DENT ASSOC, V130, P573, DOI 10.14219/jada.archive.1999.0255
   HELDERMAN WHV, 1990, COMMUNITY DENT ORAL, V18, P85
   HELOE LA, 1978, COMMUNITY DENT ORAL, V6, P53, DOI 10.1111/j.1600-0528.1978.tb01120.x
   Kkgelks SS, 1974, HLTH ED MOTTOGR, V2, P197
   Lo ECM, 2001, J DENT RES, V80, P1471, DOI 10.1177/00220345010800051701
   Manski RJ, 2001, J AM DENT ASSOC, V132, P655, DOI 10.14219/jada.archive.2001.0243
   Petersen P E, 1984, Scand J Prim Health Care, V2, P167, DOI 10.3109/02813438409017716
   Petersen PE, 2003, COMMUNITY DENT ORAL, V31, P3, DOI 10.1046/j..2003.com122.x
   Pizarro V, 2009, COMMUNITY DENT ORAL, V37, P78, DOI 10.1111/j.1600-0528.2008.00439.x
   Poudyal Sijan, 2010, Indian J Community Med, V35, P424, DOI 10.4103/0970-0218.69278
   SCHWARZ E, 1976, COMMUNITY DENT ORAL, V4, P221, DOI 10.1111/j.1600-0528.1976.tb00988.x
   SYRJALA AMH, 1992, COMMUNITY DENT ORAL, V20, P10, DOI 10.1111/j.1600-0528.1992.tb00665.x
   Varenne B, 2005, B WORLD HEALTH ORGAN, V83, P650
   WARNAKULASURIYA S, 1985, COMMUNITY DENT ORAL, V13, P68, DOI 10.1111/j.1600-0528.1985.tb01678.x
NR 15
TC 1
Z9 1
U1 2
U2 2
PU INT NEPAL EPIDEMIOLOGICAL ASSOC
PI POKHARA
PA DEPARTMENT OF COMMUNITY MEDICINE, MUNICIPAL COLLEGE OF MEDICAL SCIENCES,
   PO BOX 155 DEEP HEIGHTS, POKHARA, 00000, NEPAL
SN 2091-0800
J9 NEPAL J EPIDEMIOL
JI Nepal J. Epidemiol.
PY 2016
VL 6
IS 4
BP 631
EP 639
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ET8PV
UT WOS:000400563100005
PM 28804675
OA Green Published, Other Gold
DA 2018-12-27
ER

PT J
AU Dabija, DC
   Pop, CM
   Babut, R
AF Dabija, Dan-Cristian
   Pop, Ciprian-Marcel
   Babut, Raluca
TI RETRACTED: The Image of Local Public Administrations in Transylvania
   among Citizens: A Comparative Empirical Study by Locality Size
   (Retracted Article)
SO TRANSYLVANIAN REVIEW
LA English
DT Article; Retracted Publication
DE public administration; image; citizens; Transylvania; empirical
   research; small; medium; large localities
ID SATISFACTION; LOYALTY; IMPACT; MODEL
AB Due to the European integration and to the need of making the entire decisional process more transparent at local and central level, several aspects are becoming imperative in what concerns the public administration bodies, such as the necessity of making a good impression on citizens, raising their interest, increasing notoriety, developing a mutually advantageous relationship and practically gaining people's trust. Developing a positive image is all the more important as, regularly, by voting, people can sanction the behavior of the public administration representatives. This is why, by facilitating the free and unimpeded access of citizens to various public services and by supporting them any time they need it, the public administrators lay the foundations for a long-term relationship with the former. Starting from an empirical research conducted using the social survey technique and with a questionnaire administered by operators as a working tool, the authors point out some major flaws that the public administration authorities in Transylvanian localities of various sizes face in their effort to build a trustworthy relationship with their citizens. The conclusions are meant to allow the management of these public administrations to find and adopt the most appropriate strategies that can help develop and consolidate citzens' trust in the local administration and which can help improve the administration-citizen relationship.
C1 [Dabija, Dan-Cristian; Pop, Ciprian-Marcel; Babut, Raluca] Babes Bolyai Univ, Dept Mkt, Fac Econ & Business Adm, 58-60 Teodor Mihali St, Cluj Napoca 400591, Romania.
RP Dabija, DC (reprint author), Babes Bolyai Univ, Dept Mkt, Fac Econ & Business Adm, 58-60 Teodor Mihali St, Cluj Napoca 400591, Romania.
EM cristian.dabija@econ.ubbcluj.ro; marcel.pop@econ.ubbcluj.ro;
   raluca.babut@econ.ubbcluj.ro
CR Androniceanu A., 2009, 926 TUCS, V926, P1
   ARNOLD SJ, 1983, J MARKETING RES, V20, P149, DOI 10.2307/3151681
   Baciu (Suciu) L., 2014, RESURSELE UMANE DIN
   Barzelay M., 1992, BREAKING BUREAUCRACY
   Binninger AS, 2008, INT J RETAIL DISTRIB, V36, P94, DOI 10.1108/09590550810853057
   Cheben J., 2010, WORKING PAPERS FAKUL, V9, P5
   Chowdhury J., 1998, J MARKETING THEORY P, V6, P72, DOI DOI 10.1080/10696679.1998.11501797
   Churchill G.A., 1991, MARKETING RES METHOD
   Coman-Kund E, 2000, POLITICA COMUNICARE
   da Silva R, 2007, INT J PUBLIC SECT MA, V20, P588, DOI 10.1108/09513550710823506
   Dabija D.C., 2012, ROMANIANS PERCEPTION
   Dabija D. C, 2010, MARKETINGUL INTREPRI
   Dabija DC, 2013, TRANSYLV REV ADM SCI, P26
   Denhardt J. V, 2007, NEW PUBLIC SERVICE S
   Ferlie E, 1996, NEW PUBLIC MANAGEMEN
   Fernandez S., 2006, REV PUBLIC PERS ADM, V26, P356, DOI [10.1177/0734371X05281629, DOI 10.1177/0734371X05281629]
   Forza C, 1998, INT J PROD ECON, V55, P1, DOI 10.1016/S0925-5273(98)00007-3
   Gay R., 2009, MARKETING ON LINE AB
   HANSEN RA, 1978, J RETAILING, V53, P59
   HOOD C, 1991, PUBLIC ADMIN, V69, P3, DOI 10.1111/j.1467-9299.1991.tb00779.x
   Jezequel B., 2012, BOITE OUTILS RESPONS
   Jiang JJ, 1999, J MANAGE INFORM SYST, V16, P219, DOI 10.1080/07421222.1999.11518262
   Ju TL, 2006, TOTAL QUAL MANAG BUS, V17, P373, DOI 10.1080/14783360500451614
   KELLER KL, 1993, J MARKETING, V57, P1, DOI 10.2307/1252054
   KOTLER P, 2008, MARKETING SECTORUL P
   LEO PY, 2002, THE SERVICE INDUSTRI, V22, P122
   Libaert Th, 2009, COMMUNICATOR TOUTE C
   Martin-Consuegra D, 2007, J PROD BRAND MANAG, V16, P459, DOI 10.1108/10610420710834913
   MAZURSKY D, 1986, J RETAILING, V62, P145
   Meffert H., 2013, DIENSTLEISTUNGSMARKE
   Miege B, 2000, SOC CUCERITA COMUNIC
   Munteanu V.A., 2003, MANAGEMENT PUBLIC LO
   Nedelea A., 2006, MARKETING ADM PUBLIC
   PAYNE A., 1993, ESSENCE SERVICES MAR
   PETERS G, 1996, FUTURE GOVERNING 4 E
   Pina V, 2009, ONLINE INFORM REV, V33, P1137, DOI 10.1108/14684520911011052
   Potcaliu C., 2011, AMFITEATRU ECON, V13, P497
   Radulescu C., 2013, REV EC, V65, P50
   Rodrik D, 1996, J ECON LIT, V34, P9
   Sirdeshmukh D, 2002, J MARKETING, V66, P15, DOI 10.1509/jmkg.66.1.15.18449
   Suditu B, 2014, AMFITEATRU ECON, V16, P154
   Vida I., 1994, PUTEREA EXECUTIVA SI
   Wallis J., INT J SOCIAL EC, V32, P291
   Williamson J., 1994, POLITICAL EC EPOLIG
   Yoo B., 2002, J PRODUCT BRAND MANA, V11, P380
   Zhang Q., 2013, EKON ISTRAZ, V26, P46
NR 46
TC 0
Z9 0
U1 2
U2 4
PU CENTER TRANSYLVANIAN STUDIES
PI CLUJ-NAPOCA
PA 2 NASAUD ST, CLUJ-NAPOCA, 400610, ROMANIA
SN 1221-1249
J9 TRANSYLV REV
JI Transylv. Rev.
PY 2016
VL 25
SU 2
BP 268
EP 278
PG 11
WC Area Studies; History
SC Area Studies; History
GA ET8HF
UT WOS:000400539000023
DA 2018-12-27
ER

EF